Citrus Sinensis ID: 005871
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 672 | 2.2.26 [Sep-21-2011] | |||||||
| Q8GYA4 | 669 | Cysteine-rich receptor-li | yes | no | 0.866 | 0.869 | 0.425 | 1e-137 | |
| O65468 | 676 | Cysteine-rich receptor-li | no | no | 0.866 | 0.860 | 0.423 | 1e-132 | |
| Q9M0X5 | 675 | Cysteine-rich receptor-li | no | no | 0.788 | 0.785 | 0.440 | 1e-131 | |
| Q8GWJ7 | 645 | Cysteine-rich receptor-li | no | no | 0.891 | 0.928 | 0.421 | 1e-131 | |
| Q8W4G6 | 627 | Cysteine-rich receptor-li | no | no | 0.809 | 0.867 | 0.436 | 1e-129 | |
| Q9C5S9 | 674 | Cysteine-rich receptor-li | no | no | 0.818 | 0.816 | 0.414 | 1e-128 | |
| O65479 | 666 | Putative cysteine-rich re | no | no | 0.872 | 0.879 | 0.413 | 1e-127 | |
| Q9C5S8 | 659 | Cysteine-rich receptor-li | no | no | 0.855 | 0.872 | 0.415 | 1e-126 | |
| Q8L7G3 | 659 | Cysteine-rich receptor-li | no | no | 0.854 | 0.871 | 0.422 | 1e-126 | |
| Q9LZU4 | 676 | Cysteine-rich receptor-li | no | no | 0.863 | 0.857 | 0.411 | 1e-123 |
| >sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 490 bits (1262), Expect = e-137, Method: Compositional matrix adjust.
Identities = 270/634 (42%), Positives = 382/634 (60%), Gaps = 52/634 (8%)
Query: 80 VSNNTASNTFTSNLNILFNQKLHSEAGKSL-YYNASEGEFPDSVYGLYLCKFNVSFQSCQ 138
+N T+++T+ +NL L A S + NA+ G+ PD V GL+ C+ +VS + C+
Sbjct: 47 TANYTSNSTYNNNLKTLLASLSSRNASYSTGFQNATVGQAPDRVTGLFNCRGDVSTEVCR 106
Query: 139 NCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHSSSIMDTSAPLCMKIFQNTYNVTK 198
C+ AVN L +C KEA ++Y EC++R+S+ + I+ T I NT NVT
Sbjct: 107 RCVSFAVNDTLTRCPNQKEATLYYD--ECVLRYSNQN--ILSTLITTGGVILVNTRNVTS 162
Query: 199 SLAQSFNDVIAMPSL---------SSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDC 249
+ +D++ +P+L SS + T++ N + + QC P L+ DC C
Sbjct: 163 NQLDLLSDLV-LPTLNQAATVALNSSKKFGTRKNNFTALQSFYGLVQCTPDLTRQDCSRC 221
Query: 250 LNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKVPAVGAL------------APS 297
L I I P RI+ PSC +E+Y + AV AP
Sbjct: 222 LQLVINQI-----PTDRIGARIINPSCTSRYEIYAFYTESAVPPPPPPPSISTPPVSAPP 276
Query: 298 SAPEEKRNSQEVQ----------------FLHWEGRIRNHYAYNILRGGKQQAESQEFPL 341
+ ++ + V + R R Y G + L
Sbjct: 277 RSGKDGNSKVLVIAIVVPIIVAVLLFIAGYCFLTRRARKSYYTPSAFAGDDITTADSLQL 336
Query: 342 FPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNL 401
R AT+ F + NK+GQGGFG VYKGTL+DG +AVKRLS++SGQG EFKNEV L
Sbjct: 337 -DYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSGQGEVEFKNEVVL 395
Query: 402 IAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIA 461
+AKLQH+NLVRLLG CL+G+E +L+YEY+PNKSLD LFD + QLDW RR II G+A
Sbjct: 396 VAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLDWTRRYKIIGGVA 455
Query: 462 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 521
RGILYLH+DSRL IIHRDLKASNILLD DMNPKI+DFG+ARIFG +Q + NT+ I GTYG
Sbjct: 456 RGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTEENTSRIVGTYG 515
Query: 522 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAV 581
YM+PEYAM G +S+KSDV+SFGVL+LEIISG+KN+ FY ++ L++Y W LW G +
Sbjct: 516 YMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHDLVSYAWGLWSNGRPL 575
Query: 582 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPA-F 640
EL+DP + ++C +E+++ +HIGLLCVQ+DPA+RPT+S++V+ML S+++T+P P +P F
Sbjct: 576 ELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLMLTSNTVTLPVPRQPGLF 635
Query: 641 SVGRVVANSGHFLSPAKAC--TVNNVTVSDVSPR 672
R+ + + +K+ +V++ +++D+ PR
Sbjct: 636 FQSRIGKDPLDTDTTSKSLLGSVDDASITDIHPR 669
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|O65468|CRK8_ARATH Cysteine-rich receptor-like protein kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 474 bits (1219), Expect = e-132, Method: Compositional matrix adjust.
Identities = 268/633 (42%), Positives = 379/633 (59%), Gaps = 51/633 (8%)
Query: 84 TASNTFTSNLNILFNQKLHSEAGKSL-YYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIV 142
++++T+++NL L + A S + N G+ PD V GL+LC+ ++S + C NC+
Sbjct: 51 SSNSTYSTNLKTLLSSFASRNASYSTGFQNIRAGQTPDRVTGLFLCRGDLSPEVCSNCVA 110
Query: 143 AAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHS-SSIMDTSAPLCMK------IFQNTYN 195
+VN L +C +EA +Y+ EC++R+S + S + L M+ QN +
Sbjct: 111 FSVNESLTRCPNQREAVFYYE--ECILRYSHKNFLSTVTYEGELIMRNPNNISSIQNQRD 168
Query: 196 VTKSLAQS-FNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTI 254
L QS N + SS + +T +T ++++ L QC P L+ DC CL ++I
Sbjct: 169 QFIDLVQSNMNQAANEAANSSRKFSTIKTELTSLQTLYGLVQCTPDLARQDCFSCLTSSI 228
Query: 255 RWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKVPAVGALAPS-------------SAPE 301
+ F +G R +PSC +ELY + A+G +P S P
Sbjct: 229 NRMMPLFR---IG-ARQFWPSCNSRYELYAFYNETAIGTPSPPPLFPGSTPPLTSPSIPG 284
Query: 302 EKRNSQE----------------VQFLHWEGRIRNHY-AYNILRGGKQQAESQEFPLFPL 344
+ NS V + R + + + G A + L
Sbjct: 285 KSGNSTVLVVAIVVLAVLLFIALVGYCFLAQRTKKTFDTASASEVGDDMATADSLQL-DY 343
Query: 345 RLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK 404
R ATN F++ NK+G+GGFG VYKGT ++GK +AVKRLS+ S QG EFK EV ++AK
Sbjct: 344 RTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQGEAEFKTEVVVVAK 403
Query: 405 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 464
LQH+NLVRLLG L+G+E +L+YEYMPNKSLD LFD T+ QLDW +R +II GIARGI
Sbjct: 404 LQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQLDWMQRYNIIGGIARGI 463
Query: 465 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 524
LYLH+DSRL IIHRDLKASNILLD D+NPKI+DFG+ARIFG +Q Q NT+ I GTYGYMA
Sbjct: 464 LYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQTQDNTSRIVGTYGYMA 523
Query: 525 PEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584
PEYAM G FS+KSDV+SFGVL+LEIISGRKN+ F S+ Q LLT+TW+LW A++L+
Sbjct: 524 PEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESDGAQDLLTHTWRLWTNRTALDLV 583
Query: 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAF---- 640
DP++ +C E+++ IHIGLLCVQ+DPA RPT+S+V +ML S+++T+P P +P F
Sbjct: 584 DPLIANNCQNSEVVRCIHIGLLCVQEDPAKRPTISTVFMMLTSNTVTLPVPRQPGFFIQS 643
Query: 641 -SVGRVVANSGHFLSPAKACTVNNVTVSDVSPR 672
V + + + ++++ ++D+ PR
Sbjct: 644 SPVKDPTDSDQSTTTKSTPASIDDELITDLYPR 676
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 470 bits (1210), Expect = e-131, Method: Compositional matrix adjust.
Identities = 254/577 (44%), Positives = 349/577 (60%), Gaps = 47/577 (8%)
Query: 105 AGKSLYYNASEGEFPDS--VYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWY 162
A SL+ NA+ GE DS VYG++LC+ +VS + C++C+ A N LQ+C K A IWY
Sbjct: 63 AYASLFDNAAAGEENDSNRVYGVFLCRGDVSAEICRDCVAFAANETLQRCPREKVAVIWY 122
Query: 163 QVQECMVRFSDHSSSIMDTSAPLCMKIFQNTYNVTKSLAQSFN--------DVIAMPSLS 214
ECMVR+S+ S I+ N N+T++ FN DV +LS
Sbjct: 123 D--ECMVRYSNQS--IVGQMRIRPGVFLTNKQNITENQVSRFNESLPALLIDVAVKAALS 178
Query: 215 SFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRILFP 274
S + AT++ N + + + QC P L+ DC CL I ++ RC D +G GR++ P
Sbjct: 179 SRKFATEKANFTVFQTIYSLVQCTPDLTNQDCESCLRQVINYLPRCCDR-SVG-GRVIAP 236
Query: 275 SCIMGFELYRY-----------SKVPAVGALAPSSAPEEKRNSQEVQFLHWEGRIRNHYA 323
SC +ELY + + P + P EK + + + +
Sbjct: 237 SCSFRYELYPFYNETIAAAPMAPPPSSTVTAPPLNIPSEKGKGKNLTVIVTAIAVPVSVC 296
Query: 324 YNIL----------RGGKQQAESQEFP----------LFPLRLALEATNHFSDENKLGQG 363
+L R K AE+++ F ATN FS+ NKLG G
Sbjct: 297 VLLLGAMCWLLARRRNNKLSAETEDLDEDGITSTETLQFQFSAIEAATNKFSESNKLGHG 356
Query: 364 GFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 423
GFG VYKG L G+ +A+KRLS+ S QG +EFKNEV+++AKLQH+NL +LLG CL+G+E
Sbjct: 357 GFGEVYKGQLITGETVAIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEK 416
Query: 424 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKAS 483
+L+YE++PNKSLD LFD + LDW+RR II GIARGILYLH DSRL IIHRDLKAS
Sbjct: 417 ILVYEFVPNKSLDYFLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKAS 476
Query: 484 NILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFG 543
NILLD DM+PKISDFG+ARIFG +Q QANT I GTYGYM+PEYA+ G +S+KSDV+SFG
Sbjct: 477 NILLDADMHPKISDFGMARIFGVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFG 536
Query: 544 VLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHI 603
VL+LE+I+G+KN+ FY + L+TY WKLW E +EL+D ++ + +E+++ IHI
Sbjct: 537 VLVLELITGKKNSSFYEEDGLGDLVTYVWKLWVENSPLELVDEAMRGNFQTNEVIRCIHI 596
Query: 604 GLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAF 640
LLCVQ+D ++RP+M ++VM+ S ++T+P P F
Sbjct: 597 ALLCVQEDSSERPSMDDILVMMNSFTVTLPIPKRSGF 633
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8GWJ7|CRK19_ARATH Cysteine-rich receptor-like protein kinase 19 OS=Arabidopsis thaliana GN=CRK19 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 469 bits (1208), Expect = e-131, Method: Compositional matrix adjust.
Identities = 272/646 (42%), Positives = 382/646 (59%), Gaps = 47/646 (7%)
Query: 59 SIVSSVMSQYFAEEDMVLSCAVSNNTASN-TFTSNLNILFNQKLHSEAGKSL--YYNASE 115
SI +S + ++ + +C+V+ +SN T+++NL L + A + A+
Sbjct: 15 SITASAQNTFY----LYHNCSVTTTFSSNSTYSTNLKTLLSSLSSLNASSYSTGFQTATA 70
Query: 116 GEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHS 175
G+ PD V GL+LC+ +VS + C++C+ AVN L +C KE +Y+ +C++R+S+ +
Sbjct: 71 GQAPDRVTGLFLCRVDVSSEVCRSCVTFAVNETLTRCPKDKEGVFYYE--QCLLRYSNRN 128
Query: 176 -SSIMDTSAPLCMKIFQNTYNVTKSLAQSFNDVIAMP-------SLSSFRN-ATKRTNIS 226
+ ++T + M+ +N +V + F D++ P + SF+ A ++ +++
Sbjct: 129 IVATLNTDGGMFMQSARNPLSVKQ---DQFRDLVLTPMNLAAVEAARSFKKWAVRKIDLN 185
Query: 227 NIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYS 286
L +C P L DC DCL I Q +D G GRIL PSC ++ Y +
Sbjct: 186 ASQSLYGMVRCTPDLREQDCLDCLKIGIN--QVTYDKIG---GRILLPSCASRYDNYAFY 240
Query: 287 KVPAVGALAPSSA-PEEKRNSQEVQ----------FLH----WEGRIRNHYAYN----IL 327
VG SS P + NS + FL + R +N N +
Sbjct: 241 NESNVGTPQDSSPRPGKGGNSSVIIIAVVVPITVLFLLLVAVFSVRAKNKRTLNEKEPVA 300
Query: 328 RGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT 387
G + F + ATN F NKLGQGGFG VYKGTL+ G +AVKRLS+T
Sbjct: 301 EDGNDITTAGSLQ-FDFKAIEAATNCFLPINKLGQGGFGEVYKGTLSSGLQVAVKRLSKT 359
Query: 388 SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ 447
SGQG +EF+NEV ++AKLQH+NLV+LLG CLEG+E +L+YE++PNKSLD LFD+T ++
Sbjct: 360 SGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLDHFLFDSTMKMK 419
Query: 448 LDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507
LDW RR II GIARGILYLH+DSRL IIHRDLKA NILLDDDMNPKI+DFG+ARIFG +
Sbjct: 420 LDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDDDMNPKIADFGMARIFGMD 479
Query: 508 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY-FSEHGQT 566
Q +A T + GTYGYM+PEYAM G FS+KSDV+SFGVL+LEIISG KN+ Y E
Sbjct: 480 QTEAMTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGMKNSSLYQMDESVGN 539
Query: 567 LLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626
L+TYTW+LW G EL+DP + E+ + IHI LLCVQ+D DRPTMSS+V ML
Sbjct: 540 LVTYTWRLWSNGSPSELVDPSFGDNYQTSEITRCIHIALLCVQEDAEDRPTMSSIVQMLT 599
Query: 627 SDSMTIPQPTEPAFSVGRVVANSGHFLSPAKACTVNNVTVSDVSPR 672
+ + + +P P F +G + + C+V+ +++ V+PR
Sbjct: 600 TSLIALAEPRPPGFFFRSKQEQAGPSIDSSTHCSVDEASITRVTPR 645
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8W4G6|CRK15_ARATH Cysteine-rich receptor-like protein kinase 15 OS=Arabidopsis thaliana GN=CRK15 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 462 bits (1190), Expect = e-129, Method: Compositional matrix adjust.
Identities = 259/593 (43%), Positives = 356/593 (60%), Gaps = 49/593 (8%)
Query: 89 FTSNLNILFNQKLHSEAGKSL-YYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNS 147
+ +NL L + A S + +A G+ PD V GL+LC+ +VS C+NC+ ++N
Sbjct: 43 YLTNLRTLLSSLSAPNASYSTGFQSARAGQAPDRVTGLFLCRGDVSPAVCRNCVAFSIND 102
Query: 148 VLQKCSGTKEAFIWYQVQECMVRFSDHS--SSIMDTSAPLCMK----IFQNTYNVTKSLA 201
L +C +++ +Y ECM+R+SD + S++ A + M I QN N K
Sbjct: 103 TLVQCPSERKSVFYYD--ECMLRYSDQNILSTLAYDGAWIRMNGNISIDQNQMNRFKDFV 160
Query: 202 QSFNDVIAMPSLSSFRN-ATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRC 260
S + A+ + SS R T + + + L QC P L+ DC CL ++I+ +
Sbjct: 161 SSTMNQAAVKAASSPRKFYTVKATWTALQTLYGLVQCTPDLTRQDCFSCLESSIKLM--- 217
Query: 261 FDPPGMGFGRILFPSCIMGFELYRYSKVPAV--------------GALAPSSAPEEKRNS 306
P GR L+ SC +EL+ + V + S P + NS
Sbjct: 218 --PLYKTGGRTLYSSCNSRYELFAFYNETTVRTQQAPPPLPPSSTPLVTSPSLPGKSWNS 275
Query: 307 QEV-----------QFLHWEG-----RIRNHYA-YNILRGGKQQAESQEFPLFPLRLALE 349
+ L G R++N G ES + R+
Sbjct: 276 NVLVVAIVLTILVAALLLIAGYCFAKRVKNSSDNAPAFDGDDITTESLQLDY---RMIRA 332
Query: 350 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 409
ATN FS+ NK+GQGGFG VYKGT ++G +AVKRLS++SGQG EFKNEV ++AKLQH+N
Sbjct: 333 ATNKFSENNKIGQGGFGEVYKGTFSNGTEVAVKRLSKSSGQGDTEFKNEVVVVAKLQHRN 392
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 469
LVRLLG + G E +L+YEYMPNKSLD LFD + QLDW RR +I GIARGILYLH+
Sbjct: 393 LVRLLGFSIGGGERILVYEYMPNKSLDYFLFDPAKQNQLDWTRRYKVIGGIARGILYLHQ 452
Query: 470 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 529
DSRL IIHRDLKASNILLD DMNPK++DFGLARIFG +Q Q NT+ I GT+GYMAPEYA+
Sbjct: 453 DSRLTIIHRDLKASNILLDADMNPKLADFGLARIFGMDQTQENTSRIVGTFGYMAPEYAI 512
Query: 530 GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589
G FS+KSDV+SFGVL+LEIISG+KNN FY ++ L+T+ W+LW G A++L+DP++
Sbjct: 513 HGQFSVKSDVYSFGVLVLEIISGKKNNSFYETDGAHDLVTHAWRLWSNGTALDLVDPIII 572
Query: 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAFSV 642
+C E+++ IHI LLCVQ+DPA+RP +S++ +ML S+++T+P P +P F V
Sbjct: 573 DNCQKSEVVRCIHICLLCVQEDPAERPILSTIFMMLTSNTVTLPVPLQPGFPV 625
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C5S9|CRK6_ARATH Cysteine-rich receptor-like protein kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 461 bits (1185), Expect = e-128, Method: Compositional matrix adjust.
Identities = 257/620 (41%), Positives = 366/620 (59%), Gaps = 70/620 (11%)
Query: 110 YYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQECMV 169
+ NA+ G+ PD V GL+LC+ +VS + C+NC+ +VN L C +EA +Y+ +C++
Sbjct: 68 FQNATAGKAPDRVTGLFLCRGDVSPEVCRNCVAFSVNQTLNLCPKVREAVFYYE--QCIL 125
Query: 170 RFSDHSSSIMDTSAPLCMKIFQNTYNV----------TKSLAQSFNDVIAMPSLSSFRNA 219
R+S H + + I NT + T ++ + ++ + SS +
Sbjct: 126 RYS-HKNILSTAITNEGEFILSNTNTISPNQKQIDGFTSFVSSTMSEAAGKAANSSRKLY 184
Query: 220 TKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRI----LFPS 275
T T ++ L QC P L+ DC CL ++I GM RI +PS
Sbjct: 185 TVNTELTAYQNLYGLLQCTPDLTRADCLSCLQSSIN---------GMALSRIGARLYWPS 235
Query: 276 CIMGFELYRYSKVPAVGA---------------------LAPSSAPEEKRNSQEVQ---- 310
C +ELY + A+ ++ SS P + NS +
Sbjct: 236 CTARYELYPFYNESAIETPPLPPPPPPPPPRESLVSTPPISSSSLPGKSGNSTVLVVAVV 295
Query: 311 ------FLHWEG-------RIRNHYAYNILRGGKQQAESQEFPLFPLRLALEATNHFSDE 357
F+ G + + + G A + L R ATN F++
Sbjct: 296 VLAVLLFIALVGYCFLAKKKKKTFDTASASEVGDDMATADSLQL-DYRTIQTATNDFAES 354
Query: 358 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 417
NK+G+GGFG VYKGT ++GK +AVKRLS+ S QG EFK EV ++AKLQH+NLVRLLG
Sbjct: 355 NKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQGEAEFKTEVVVVAKLQHRNLVRLLGFS 414
Query: 418 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 477
L+G+E +L+YEYMPNKSLD LFD T+ +QLDW +R +II GIARGILYLH+DSRL IIH
Sbjct: 415 LQGEERILVYEYMPNKSLDCLLFDPTKQIQLDWMQRYNIIGGIARGILYLHQDSRLTIIH 474
Query: 478 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 537
RDLKASNILLD D+NPKI+DFG+ARIFG +Q Q NT+ I GTYGYMAPEYAM G FS+KS
Sbjct: 475 RDLKASNILLDADINPKIADFGMARIFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKS 534
Query: 538 DVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDEL 597
DV+SFGVL+LEIISGRKN+ F S+ Q LLT+ W+LW A++L+DP++ ++C E+
Sbjct: 535 DVYSFGVLVLEIISGRKNSSFGESDGAQDLLTHAWRLWTNKKALDLVDPLIAENCQNSEV 594
Query: 598 LKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAF-----SVGRVVANSGHF 652
++ IHIGLLCVQ+DPA RP +S+V +ML S+++T+P P +P F +V + +
Sbjct: 595 VRCIHIGLLCVQEDPAKRPAISTVFMMLTSNTVTLPVPRQPGFFIQCRAVKDPLDSDQST 654
Query: 653 LSPAKACTVNNVTVSDVSPR 672
+ + ++++ +++D+ PR
Sbjct: 655 TTKSFPASIDDESITDLYPR 674
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65479|CRK20_ARATH Putative cysteine-rich receptor-like protein kinase 20 OS=Arabidopsis thaliana GN=CRK20 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 455 bits (1171), Expect = e-127, Method: Compositional matrix adjust.
Identities = 267/645 (41%), Positives = 370/645 (57%), Gaps = 59/645 (9%)
Query: 77 SCAVSNNTASN-TFTSNLNILFNQKLHSEAGKSL-YYNASEGEFPDSVYGLYLCKFNVSF 134
+C+++ +SN T+++NL L + A S + NA+ G+ PD V GL+LC+ NVS
Sbjct: 32 NCSITTTYSSNSTYSTNLKTLLSSLSSRNASYSTGFQNATAGQAPDMVTGLFLCRGNVSP 91
Query: 135 QSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHSS-SIMDTSAPLCMKIFQNT 193
+ C++CI +VN L +C +EA +Y+ +CM+R+S+ + S ++T + M QN
Sbjct: 92 EVCRSCIALSVNESLSRCPNEREAVFYYE--QCMLRYSNRNILSTLNTDGGVFM---QNA 146
Query: 194 YNVTKSLAQSFNDVIAMP--------SLSSFRNATKRTNISNIIRLETFGQCIPVLSVDD 245
N F D++ P + S R A + +++ + L QC P L+ D
Sbjct: 147 RNPISVKQDRFRDLVLNPMNLAAIEAARSIKRFAVTKFDLNALQSLYGMVQCTPDLTEQD 206
Query: 246 CRDCLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKVPAVGALAPSSA-PEEKR 304
C DCL +I Q +D G GR PSC ++ Y + VG SS P +
Sbjct: 207 CLDCLQQSIN--QVTYDKIG---GRTFLPSCTSRYDNYEFYNEFNVGTPQDSSPRPGKGG 261
Query: 305 NSQE----------------VQF--LHWEGRIRNHYAYNILRGGKQQAESQEFPL----- 341
NS V F + R + A + + +++ E E P
Sbjct: 262 NSSVIVIAVVVPITVLFLLFVAFFSVRRAKRKKTIGAIPLFKVKRKETEVTEPPAETTDG 321
Query: 342 ----------FPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQG 391
F + + AT+ F NKLGQGGFG VYKGT G +AVKRLS+ SGQG
Sbjct: 322 DDITTAGSLQFDFKAIVAATDIFLPINKLGQGGFGEVYKGTFPSGVQVAVKRLSKNSGQG 381
Query: 392 LQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWK 451
+EF+NEV ++AKLQH+NLV+LLG CLEG+E +L+YE++PNKSLD LFD T QLDW
Sbjct: 382 EKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLDYFLFDPTMQGQLDWS 441
Query: 452 RRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 511
RR II GIARGILYLH+DSRL IIHRDLKA NILLD DMNPK++DFG+ARIFG +Q +A
Sbjct: 442 RRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMARIFGMDQTEA 501
Query: 512 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHG-QTLLTY 570
NT + GTYGYMAPEYAM G FS+KSDV+SFGVL+LEI+SG KN+ + L+TY
Sbjct: 502 NTRRVVGTYGYMAPEYAMYGKFSMKSDVYSFGVLVLEIVSGMKNSSLDQMDGSISNLVTY 561
Query: 571 TWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSM 630
TW+LW G EL+DP + E+ + IHI LLCVQ+D DRPTMS++V ML + S+
Sbjct: 562 TWRLWSNGSPSELVDPSFGDNYQTSEITRCIHIALLCVQEDANDRPTMSAIVQMLTTSSI 621
Query: 631 TIPQPTEPAF---SVGRVVANSGHFLSPAKACTVNNVTVSDVSPR 672
+ P P F S + + + +++ +++ V+PR
Sbjct: 622 ALAVPRPPGFFLRSKQEQAERACPSMDTSDLFSIDEASITSVAPR 666
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C5S8|CRK5_ARATH Cysteine-rich receptor-like protein kinase 5 OS=Arabidopsis thaliana GN=CRK5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 453 bits (1166), Expect = e-126, Method: Compositional matrix adjust.
Identities = 266/640 (41%), Positives = 372/640 (58%), Gaps = 65/640 (10%)
Query: 81 SNNTASNT-FTSNLNILFNQKLHSEAGKSL-YYNASEGEFPDSVYGLYLCKFNVSFQSCQ 138
+N + N+ + SNL L + A SL ++ ++G+ D V+GLYLCK ++S +SC+
Sbjct: 37 TNRISRNSIYFSNLQTLLTSLSSNNAYFSLGSHSLTKGQNSDMVFGLYLCKGDLSPESCR 96
Query: 139 NCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHSSSIMDTSAPLCMKIFQNTYNVTK 198
C++ A +C G KE I Y ECM+ +SD + MDT + + NT VT
Sbjct: 97 ECVIFAAKDTRSRCPGGKEFLIQYD--ECMLGYSDRNI-FMDTVTTTTIITW-NTQKVTA 152
Query: 199 SLAQSFNDVI---------AMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDC 249
+ FND + + +S + A K+++ S+ L QCIP L+ +DC C
Sbjct: 153 DQSDRFNDAVLSLMKKSAEEAANSTSKKFAVKKSDFSSSQSLYASVQCIPDLTSEDCVMC 212
Query: 250 LNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKVPAVGAL--------------A 295
L +I+ + F+ G GR L PSC +E+Y + K G +
Sbjct: 213 LQQSIKELY--FNKVG---GRFLVPSCNSRYEVYPFYKETIEGTVLPPPVSAPPLPLVST 267
Query: 296 PSSAPEEKRNSQ------------------EVQFLHWEGRIRNHYAY----NILRGGKQQ 333
PS P + +NS V H R + Y +I G Q
Sbjct: 268 PSFPPGKGKNSTVIIIAIVVPVAISVLICVAVFSFHASKRAKKTYDTPEEDDITTAGSLQ 327
Query: 334 AESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQ 393
F ++ AT+ FS NKLGQGGFG VYKGTL +G +AVKRLS+TSGQG +
Sbjct: 328 --------FDFKVIEAATDKFSMCNKLGQGGFGQVYKGTLPNGVQVAVKRLSKTSGQGEK 379
Query: 394 EFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR 453
EFKNEV ++AKLQH+NLV+LLG CLE +E +L+YE++ NKSLD LFD+ QLDW R
Sbjct: 380 EFKNEVVVVAKLQHRNLVKLLGFCLEREEKILVYEFVSNKSLDYFLFDSRMQSQLDWTTR 439
Query: 454 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 513
II GIARGILYLH+DSRL IIHRDLKA NILLD DMNPK++DFG+ARIF +Q +A+T
Sbjct: 440 YKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMARIFEIDQTEAHT 499
Query: 514 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHG-QTLLTYTW 572
+ GTYGYM+PEYAM G FS+KSDV+SFGVL+LEIISGRKN+ Y + L+TYTW
Sbjct: 500 RRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGRKNSSLYQMDASFGNLVTYTW 559
Query: 573 KLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTI 632
+LW +G ++L+D + S +E+++ IHI LLCVQ+D +RPTMS++V ML + S+ +
Sbjct: 560 RLWSDGSPLDLVDSSFRDSYQRNEIIRCIHIALLCVQEDTENRPTMSAIVQMLTTSSIAL 619
Query: 633 PQPTEPAFSVGRVVANSGHFLSPAKACTVNNVTVSDVSPR 672
P P F +G + + C+++ +++ ++PR
Sbjct: 620 AVPQPPGFFFRSNHEQAGPSMDKSSLCSIDAASITILAPR 659
|
Involved in multiple distinct defense responses. May function as a disease resistance (R) protein. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8L7G3|CRK7_ARATH Cysteine-rich receptor-like protein kinase 7 OS=Arabidopsis thaliana GN=CRK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 452 bits (1164), Expect = e-126, Method: Compositional matrix adjust.
Identities = 268/635 (42%), Positives = 371/635 (58%), Gaps = 61/635 (9%)
Query: 84 TASNTFTSNLNILFNQKLHSEAGKSL-YYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIV 142
++++T+ +NL L + A S + NA+ G+ D V GL+LC+ +VS + C+NC+
Sbjct: 40 SSNSTYLTNLKTLLSSLSSRNASYSTGFQNATVGQALDRVTGLFLCRGDVSPEVCRNCVT 99
Query: 143 AAVNSVLQKCSGTKEAFIWYQVQECMVRFSDH---SSSIMDTSA-----PLCMKIFQNTY 194
AVN+ +C +EA +Y+ EC++R+S S++I + P + QN
Sbjct: 100 FAVNNTFSRCPNQREAVFYYE--ECILRYSHKNILSTAITNEGEFILRNPNHISPIQNQI 157
Query: 195 NVTKSLAQSFNDVIAMPSLSSFRN-ATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNT 253
N +L S + IA+ + + R +T +T ++ + QC P LS +C +CL ++
Sbjct: 158 NQFTNLVLSNMNQIAIEAADNPRKFSTIKTELTALQTFYGLVQCTPDLSRQNCMNCLTSS 217
Query: 254 IRWIQRCFDPPGMGFGRI----LFPSCIMGFELYRYSKVPAVGALAPSSAP-------EE 302
I M F RI +PSC +ELY + A+G P P ++
Sbjct: 218 INR---------MPFSRIGARQFWPSCNSRYELYDFYNETAIGTPPPPLPPLASPSLSDK 268
Query: 303 KRNSQEVQ-----------------FLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPLR 345
NS V + + R + Y + + L R
Sbjct: 269 SGNSNVVVVAVVVPIIVAVLIFIAGYCFFAKRAKKTYGTTPALDEDDKTTIESLQL-DYR 327
Query: 346 LALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL 405
ATN FS+ NK+G+GGFG VYKGT ++G +AVKRLS+TS QG EFKNEV ++A L
Sbjct: 328 AIQAATNDFSENNKIGRGGFGDVYKGTFSNGTEVAVKRLSKTSEQGDTEFKNEVVVVANL 387
Query: 406 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 465
+HKNLVR+LG +E +E +L+YEY+ NKSLD LFD + QL W +R II GIARGIL
Sbjct: 388 RHKNLVRILGFSIEREERILVYEYVENKSLDNFLFDPAKKGQLYWTQRYHIIGGIARGIL 447
Query: 466 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 525
YLH+DSRL IIHRDLKASNILLD DMNPKI+DFG+ARIFG +Q Q NT+ I GTYGYM+P
Sbjct: 448 YLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGMDQTQQNTSRIVGTYGYMSP 507
Query: 526 EYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585
EYAM G FS+KSDV+SFGVL+LEIISGRKNN F ++ Q L+T+ W+LW G A++L+D
Sbjct: 508 EYAMRGQFSMKSDVYSFGVLVLEIISGRKNNSFIETDDAQDLVTHAWRLWRNGTALDLVD 567
Query: 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAFSV-GR 644
P + SC E+++ HIGLLCVQ+DP RP MS++ VML S++M +P P +P F V R
Sbjct: 568 PFIADSCRKSEVVRCTHIGLLCVQEDPVKRPAMSTISVMLTSNTMALPAPQQPGFFVRSR 627
Query: 645 VVANSGHFLSPAKACTVNNVTV-------SDVSPR 672
N L ++ T +VTV SD+ PR
Sbjct: 628 PGTNR---LDSDQSTTNKSVTVSIDDKSMSDLDPR 659
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LZU4|CRK4_ARATH Cysteine-rich receptor-like protein kinase 4 OS=Arabidopsis thaliana GN=CRK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 441 bits (1135), Expect = e-123, Method: Compositional matrix adjust.
Identities = 271/658 (41%), Positives = 372/658 (56%), Gaps = 78/658 (11%)
Query: 77 SCAVSNNTAS--NTFTSNLNILFNQKLHSEAGKSL-YYNASEGEFPDSVYGLYLCKFNVS 133
SC S T S +T+ +NL L + A S + A+ G+ PD V GL+LC+ +VS
Sbjct: 35 SCPSSILTYSRNSTYFTNLKTLLSSLSSRNASYSTGFQTATAGQAPDRVTGLFLCRGDVS 94
Query: 134 FQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHSSSIMDTSAPLCMKIFQNT 193
+ C+NC+ +V L C KE ++Y ECM+R+S + I+ T I N
Sbjct: 95 QEVCRNCVAFSVKETLYWCPYNKEVVLYYD--ECMLRYSHRN--ILSTVTYDGSAILLNG 150
Query: 194 YNVTKS---LAQSFNDVIAMP-SLSSFR--NATKRTNISNIIR---LETFGQCIPVLSVD 244
N++ S F D+++ +L++ N++K+ +I L QC P L+
Sbjct: 151 ANISSSNQNQVDEFRDLVSSTLNLAAVEAANSSKKFYTRKVITPQPLYLLVQCTPDLTRQ 210
Query: 245 DCRDCLNNTIRWIQRCFDPPGMGF----GRILFPSCIMGFELYRYSKVPAVGALAPSSAP 300
DC CL +I+ GM GR +PSC +E Y + A + +P S P
Sbjct: 211 DCLRCLQKSIK---------GMSLYRIGGRFFYPSCNSRYENYSFYNETATRSSSPPSLP 261
Query: 301 EEKRNSQEVQF-----LHWEGRIRNH-----------------YAYNILRGGKQQAESQE 338
Q+++ + G+ RN A+ LR K + +
Sbjct: 262 PRSTPQQQLKLAPPPLISERGKGRNSSVIIVVVVPIIALLLLFVAFFSLRAKKTRTNYER 321
Query: 339 FPL--------------FPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRL 384
PL F + ATN F + NKLGQGGFG VYKG G +AVKRL
Sbjct: 322 EPLTEESDDITTAGSLQFDFKAIEAATNKFCETNKLGQGGFGEVYKGIFPSGVQVAVKRL 381
Query: 385 SRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATR 444
S+TSGQG +EF NEV ++AKLQH+NLVRLLG CLE E +L+YE++PNKSLD +FD+T
Sbjct: 382 SKTSGQGEREFANEVIVVAKLQHRNLVRLLGFCLERDERILVYEFVPNKSLDYFIFDSTM 441
Query: 445 SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 504
LDW RR II GIARGILYLH+DSRL IIHRDLKA NILL DDMN KI+DFG+ARIF
Sbjct: 442 QSLLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLGDDMNAKIADFGMARIF 501
Query: 505 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSE-- 562
G +Q +ANT I GTYGYM+PEYAM G FS+KSDV+SFGVL+LEIISG+KN+ Y +
Sbjct: 502 GMDQTEANTRRIVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGKKNSNVYQMDGT 561
Query: 563 HGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 622
L+TYTW+LW G +EL+DP + + +E+ + IHI LLCVQ++ DRPTMS++V
Sbjct: 562 SAGNLVTYTWRLWSNGSPLELVDPSFRDNYRINEVSRCIHIALLCVQEEAEDRPTMSAIV 621
Query: 623 VMLASDSMTIPQPTEPAF--------SVGRVVANSGHFLSPAKACTVNNVTVSDVSPR 672
ML + S+ + P P F VG V S ++ + C+V++ ++++V+PR
Sbjct: 622 QMLTTSSIALAVPQRPGFFFRSSKHEQVGLVDRLS---INTSALCSVDDASITNVTPR 676
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 672 | ||||||
| 359477817 | 670 | PREDICTED: cysteine-rich receptor-like p | 0.875 | 0.877 | 0.508 | 1e-167 | |
| 147776074 | 815 | hypothetical protein VITISV_005300 [Viti | 0.909 | 0.749 | 0.489 | 1e-166 | |
| 224076400 | 666 | predicted protein [Populus trichocarpa] | 0.855 | 0.863 | 0.514 | 1e-165 | |
| 356554943 | 670 | PREDICTED: cysteine-rich receptor-like p | 0.855 | 0.858 | 0.446 | 1e-145 | |
| 358346817 | 626 | Cysteine-rich receptor-like protein kina | 0.897 | 0.963 | 0.452 | 1e-145 | |
| 356510387 | 647 | PREDICTED: cysteine-rich receptor-like p | 0.813 | 0.845 | 0.461 | 1e-144 | |
| 356546303 | 662 | PREDICTED: cysteine-rich receptor-like p | 0.854 | 0.867 | 0.454 | 1e-144 | |
| 356575783 | 619 | PREDICTED: cysteine-rich receptor-like p | 0.845 | 0.917 | 0.465 | 1e-143 | |
| 358346648 | 573 | Cysteine-rich receptor-like protein kina | 0.813 | 0.954 | 0.476 | 1e-143 | |
| 356575781 | 659 | PREDICTED: cysteine-rich receptor-like p | 0.875 | 0.892 | 0.453 | 1e-142 |
| >gi|359477817|ref|XP_003632027.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 596 bits (1536), Expect = e-167, Method: Compositional matrix adjust.
Identities = 327/643 (50%), Positives = 409/643 (63%), Gaps = 55/643 (8%)
Query: 78 CAVSNNTASNTFTSNLNILFNQKLHSEAGKSLYYNASEGEFPDSVYGLYLCKFNVSFQSC 137
C +++ S F SNL L ++ L++E G S + EGE PD VYGL+LC+ +VS C
Sbjct: 35 CNNNSHAGSTKFQSNLGALLSRSLNNEGGISSFSMVYEGEDPDKVYGLFLCRPDVSKHIC 94
Query: 138 QNCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHSS-SIMDTSAPLCMKIFQNTYNV 196
Q+CI AA ++Q C KEA IWY EC +R+S+ S S ++ L M QN
Sbjct: 95 QSCIDAATLKIVQVCQHKKEAIIWYN--ECFLRYSNRSFFSNLEMKPTLYMWNTQNASAP 152
Query: 197 TK---SLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNT 253
K L + F ++ A + S A + +SN + L QC L + CR CL+
Sbjct: 153 DKFDQKLGEMFQNLTAQATSSDDMYAIGQVEVSNFLNLYGIVQCTRDLRMSYCRRCLDEV 212
Query: 254 IRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKV--PAVGALAPSSA------------ 299
+ +I + G GR+L PSC + +E+Y ++ V P V A PSS
Sbjct: 213 VGYIPNFME--GKQGGRVLAPSCYIRYEVYPFAAVEDPVVEAQVPSSISPRGRKGRKTKW 270
Query: 300 ----------------------------PEEKRNSQEVQFLHWEG-RIR-NHYAYNILRG 329
PEEK + ++ L G R+ Y+ L+G
Sbjct: 271 IATGTSLSGIVVVAFCVYYVIRRRKGADPEEKESKGDLCLLDLGGGRLDAEDYSSETLQG 330
Query: 330 GKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG 389
A+S+EFP+ + EAT HFS++NKLG+GGFGPVYKGTL+DGK IAVKRLS TSG
Sbjct: 331 -DMLAKSKEFPVIGFDIVYEATQHFSNDNKLGEGGFGPVYKGTLSDGKEIAVKRLSSTSG 389
Query: 390 QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLD 449
QGLQEFKNEV LIAKLQH+NLVRLLGCCLEG ELLLIYEYMPNKSLD LFD+TR ++LD
Sbjct: 390 QGLQEFKNEVILIAKLQHRNLVRLLGCCLEGNELLLIYEYMPNKSLDFFLFDSTRGLELD 449
Query: 450 WKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509
WK R SIINGIARGI YLHEDSRL+IIHRDLK SNILLD DMNPKISDFGLARIF G++N
Sbjct: 450 WKTRFSIINGIARGISYLHEDSRLRIIHRDLKPSNILLDGDMNPKISDFGLARIFAGSEN 509
Query: 510 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLT 569
NT I G+YGYMAPEYAM G++S KSDVFSFGV+LLEII+GRKN GF+ S G +LL+
Sbjct: 510 GTNTAKIVGSYGYMAPEYAMEGLYSNKSDVFSFGVVLLEIITGRKNAGFHLSGMGLSLLS 569
Query: 570 YTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDS 629
Y W+LW EG +EL+DP+L SC PDE L+ HIGLLCVQ+D DRPTMSSV++ML S+S
Sbjct: 570 YAWQLWNEGKGLELMDPLLGDSCCPDEFLRCYHIGLLCVQEDAFDRPTMSSVIIMLRSES 629
Query: 630 MTIPQPTEPAFSVGRVVANSGHFLSPAKACTVNNVTVSDVSPR 672
+T+ QP PAFSVGR N ++ + +VN +T S PR
Sbjct: 630 LTLRQPERPAFSVGRFANN--QEIASGSSSSVNGLTASTTVPR 670
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147776074|emb|CAN65425.1| hypothetical protein VITISV_005300 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 592 bits (1527), Expect = e-166, Method: Compositional matrix adjust.
Identities = 330/674 (48%), Positives = 419/674 (62%), Gaps = 63/674 (9%)
Query: 55 LHLLSIVSSVMSQYFAEEDMVLSCAVSNNTA--------SNTFTSNLNILFNQKLHSEAG 106
+ L+ I ++ +F + + + N+T N SNL L ++ L++E G
Sbjct: 149 IGLVDIAFGWLAYWFEGTEEAVGTKLLNSTTFPRLHAWIQNFKQSNLGALLSRSLNNEGG 208
Query: 107 KSLYYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQE 166
S + EGE PD VYGL+LC+ +VS CQ+CI AA ++Q C KEA IWY E
Sbjct: 209 ISSFSMVYEGEDPDKVYGLFLCRPDVSKHICQSCIDAATLKIVQVCQHKKEAIIWYN--E 266
Query: 167 CMVRFSDHSS-SIMDTSAPLCMKIFQNTYNVTK---SLAQSFNDVIAMPSLSSFRNATKR 222
C +R+S+ S S ++ L M QN K L + F ++ A + S A +
Sbjct: 267 CFLRYSNRSFFSNLEMKPTLYMWNRQNASAPDKFDQKLGEMFQNLTAKATSSDGMYAIGQ 326
Query: 223 TNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFEL 282
+SN + L QC L + CR CL+ + +I + G GR+L PSC + +E+
Sbjct: 327 VEVSNFLNLYGIVQCTRDLRMSYCRQCLDEVVGYIPNFME--GKEGGRVLAPSCYIRYEI 384
Query: 283 YRYSKV--PAVGALAPSSA----------------------------------------P 300
Y ++ V P V A PSS P
Sbjct: 385 YPFAAVEDPIVEAQVPSSISPRGRKGRKTKWIATGTSLSGIVVVAFCVYYVIRRRKGADP 444
Query: 301 EEKRNSQEVQFLHWEG-RI-RNHYAYNILRGGKQQAESQEFPLFPLRLALEATNHFSDEN 358
EEK + ++ L G R+ Y+ L+G A+S+EFP+ + EAT HFS++N
Sbjct: 445 EEKESKGDLCLLDLGGGRLDAEDYSSETLQG-DMLAKSKEFPVIGFDIVYEATQHFSNDN 503
Query: 359 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL 418
KLG+GGFGPVYKGTL+DGK IAVKRLSRTSGQGLQEFKNEV LIAKLQH+NLVRLLGCCL
Sbjct: 504 KLGEGGFGPVYKGTLSDGKEIAVKRLSRTSGQGLQEFKNEVILIAKLQHRNLVRLLGCCL 563
Query: 419 EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHR 478
EG ELLLIYEYMPNKSLD LFD+TR ++LDWK R SIINGIARGI YLHEDSRL+IIHR
Sbjct: 564 EGNELLLIYEYMPNKSLDFFLFDSTRGLELDWKTRFSIINGIARGISYLHEDSRLRIIHR 623
Query: 479 DLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSD 538
DLK SNILLD DMNPKISDFGLARIF G++N NT I G+YGYMAPEYAM G++S KSD
Sbjct: 624 DLKPSNILLDGDMNPKISDFGLARIFAGSENGTNTAKIVGSYGYMAPEYAMEGLYSNKSD 683
Query: 539 VFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELL 598
VFSFGV+LLEII+GRKN GF+ S G +LL+Y W+LW EG +EL+DP+L SC PDE L
Sbjct: 684 VFSFGVVLLEIITGRKNAGFHLSGMGLSLLSYAWQLWNEGKGLELMDPLLGDSCCPDEFL 743
Query: 599 KFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAFSVGRVVANSGHFLSPAKA 658
+ HIGLLCVQ+D DRPTMSSV++ML S+S+++ QP PAFSVGR N ++ +
Sbjct: 744 RCYHIGLLCVQEDAFDRPTMSSVIIMLRSESLSLRQPERPAFSVGRFANN--QEIASGSS 801
Query: 659 CTVNNVTVSDVSPR 672
+VN +T S PR
Sbjct: 802 SSVNGLTASTAVPR 815
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224076400|ref|XP_002304937.1| predicted protein [Populus trichocarpa] gi|222847901|gb|EEE85448.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 587 bits (1514), Expect = e-165, Method: Compositional matrix adjust.
Identities = 321/624 (51%), Positives = 407/624 (65%), Gaps = 49/624 (7%)
Query: 89 FTSNLNILFNQKLHSEAGKSL-YYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNS 147
+ NLN L + + S+ ++NAS G PD VYGL+ C+ ++S CQNC+ A
Sbjct: 52 YKDNLNTLLSSLASNATSNSIGFFNASAGLEPDDVYGLFFCRGDLSTDVCQNCVANATKD 111
Query: 148 VLQ-KCSGTKEAFIWYQVQECMVRFSDHSS-SIMDTSAPLCMKIFQNT-------YNVTK 198
++Q +C K AFIWY EC +R+S+ S M+ + +N +
Sbjct: 112 IVQRRCPTQKVAFIWY--DECFLRYSNKIMFSTMERDPNYTLWNPENVAVHADFNRELLN 169
Query: 199 SLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQ 258
++ + N MP+ + ATK N + L QC P LS DC CL ++
Sbjct: 170 TIFTAVNRAANMPAGAKKFRATK-ANYTTEHYLYVLVQCTPDLSSGDCEQCLLAAYSGLE 228
Query: 259 RCFDPPGMGFGRILFPSCIMGFELY-RYSKVPA-VGALAPSSAPEEKR--------NSQE 308
C + GRILFPSCI+ FE Y Y++ ALAPS P+EK +S++
Sbjct: 229 ICCNEKRG--GRILFPSCIVNFETYINYNETYVESAALAPSPVPQEKHFCYAGDKGSSKK 286
Query: 309 V--------------------QFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRLAL 348
+ W + R+ + I+ G + +SQ+ L L + L
Sbjct: 287 TWIIIGATLSTIVGVLLLSSFAYTMWRRKKRDDCSNEIMYG---EVKSQDSFLIQLDIVL 343
Query: 349 EATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHK 408
+ATN +S+ENKLGQGGFGPVYKG + DGK IAVKRLSRTSGQGL+EF NEVNLIA+LQH+
Sbjct: 344 KATNQYSNENKLGQGGFGPVYKGVMEDGKEIAVKRLSRTSGQGLREFMNEVNLIARLQHR 403
Query: 409 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 468
NLV+LLGCCLE E LL+YEYMPNKSLDV LFD+ VQLDW+RR SIINGIARG+LYLH
Sbjct: 404 NLVKLLGCCLEKNEKLLVYEYMPNKSLDVFLFDSAMRVQLDWQRRLSIINGIARGLLYLH 463
Query: 469 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 528
EDSRL+IIHRDLKASNILLD +MNPKISDFG+ARIFGGN ++ANTN I GTYGYMAPEYA
Sbjct: 464 EDSRLRIIHRDLKASNILLDYEMNPKISDFGMARIFGGNHSEANTNRIVGTYGYMAPEYA 523
Query: 529 MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588
M G+ S+KSDVFSFGVL+LEIISG++N GF+ SE G++LL +TWKLW EG +EL+D +L
Sbjct: 524 MEGLSSVKSDVFSFGVLMLEIISGKRNGGFHLSEEGKSLLNFTWKLWSEGKGLELMDSLL 583
Query: 589 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAFSVGRVVAN 648
++S E+LK IHIGLLCVQ+DP DRPTMSSVVVMLA D+ IP PT+PAFSVGR+VA
Sbjct: 584 EKSSVATEVLKCIHIGLLCVQEDPVDRPTMSSVVVMLAGDNFKIPIPTKPAFSVGRIVAE 643
Query: 649 SGHFLSPAKACTVNNVTVSDVSPR 672
S + +VN VT+S+V PR
Sbjct: 644 ETTS-SNQRVSSVNKVTLSNVLPR 666
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356554943|ref|XP_003545800.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 522 bits (1344), Expect = e-145, Method: Compositional matrix adjust.
Identities = 283/634 (44%), Positives = 391/634 (61%), Gaps = 59/634 (9%)
Query: 86 SNTFTSNLNILFNQKLHSEAGKSLYYN-------ASEGEFPDSVYGLYLCKFNVSFQSCQ 138
S+ + +NLN + + L ++A S YN S G+ D+VYGLY C+ ++ CQ
Sbjct: 49 SSAYKTNLNSVLSW-LSTDAATSKGYNHNSFGNNTSGGDASDAVYGLYDCRGDIVGYFCQ 107
Query: 139 NCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHSSSIMDTSAPLCMKIFQNTYNVTK 198
C+ A VLQ+C A +WY C++R+S+ + T P + + +
Sbjct: 108 FCVSTASREVLQRCPNRVSAIVWYDF--CILRYSNENFFGNVTVYPSWHAVRPKIVSSKE 165
Query: 199 SLAQSFNDVIAMPSLSSFRNATKRTNI---------SNIIRLETFGQCIPVLSVDDCRDC 249
+ + + + + R AT TN+ S+ R QC L+ D CR+C
Sbjct: 166 EIQKGLDFMRGL-----IRKATVETNLLYFMDGFNLSSTQRRYGLVQCSRDLTNDGCREC 220
Query: 250 LNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKVPAVGALAPSSAPEEKRNSQEV 309
L + + +C + +G+ ++L SC++ ++ Y + + ++ S+ +
Sbjct: 221 LEAMLAHVPKCCEQ-NLGW-QVLAASCLIKYDDYIFYLFRTQASDTQTAKQRGASKSRII 278
Query: 310 -----------------QFLHW-----------EGRIRN---HYAYNILRGGKQQAESQE 338
+ W +GRI + +Y+ ++ ++ + +
Sbjct: 279 LIIGLSVLGAVALLCFSVYCFWFRKRTRRGRGKDGRIPDTIHQSSYHNVQ--TEETLNTD 336
Query: 339 FPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNE 398
P PL L++T++FS+ +KLG+GG+GPVYKG L DG+ IAVKRLS+ SGQG +EFKNE
Sbjct: 337 LPTIPLITILKSTDNFSEASKLGEGGYGPVYKGILPDGRQIAVKRLSQASGQGSEEFKNE 396
Query: 399 VNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN 458
V IAKLQH+NLVRLL CCLEG E +L+YEY+ N SLD HLFD + QLDW R SIIN
Sbjct: 397 VMFIAKLQHRNLVRLLACCLEGHEKILVYEYLSNASLDFHLFDERKKRQLDWNLRLSIIN 456
Query: 459 GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAG 518
GIA+G+LYLHEDSRLK+IHRDLKASNILLDD+MNPKISDFGLAR F QNQANT + G
Sbjct: 457 GIAKGLLYLHEDSRLKVIHRDLKASNILLDDEMNPKISDFGLARAFEKGQNQANTKRVMG 516
Query: 519 TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 578
TYGYM+PEYAM G+FS+KSDVFS+GVL+LEII G+KN+GFY SE GQ+L Y WKLWC G
Sbjct: 517 TYGYMSPEYAMEGLFSVKSDVFSYGVLVLEIICGKKNSGFYLSECGQSLTLYAWKLWCAG 576
Query: 579 PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEP 638
+EL+DPVL++SC E++K IHIGLLCVQ+D ADRPTMS+VVVMLASD M +P+P +P
Sbjct: 577 KCLELLDPVLEESCIESEVVKCIHIGLLCVQEDAADRPTMSTVVVMLASDKMPLPKPNQP 636
Query: 639 AFSVGRVVANSGHFLSPAKACTVNNVTVSDVSPR 672
AFSVGR+ +K ++N+VTVS++ PR
Sbjct: 637 AFSVGRMTLEDASTSKSSKNLSINDVTVSNILPR 670
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|358346817|ref|XP_003637461.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355503396|gb|AES84599.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 520 bits (1340), Expect = e-145, Method: Compositional matrix adjust.
Identities = 288/637 (45%), Positives = 395/637 (62%), Gaps = 34/637 (5%)
Query: 52 IRWLHLLSIVSSVMSQYFAEEDMVLSCAVSNNTA---SNTFTSNLNILFNQKLHSEAGKS 108
I L LSI++ + ++ A+ + N+T + T+ SNLN + + L S+A S
Sbjct: 8 ISILRFLSIIT-LFTKSLAQSPNYVGDDCHNSTEKSLTTTYKSNLNKVLSL-LSSDAIVS 65
Query: 109 LYYNASE--GEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQE 166
YN + D+VYGLY C+ +V+ CQ C+ A + +LQ C A IWY
Sbjct: 66 KGYNHTSIGDNTVDAVYGLYDCRGDVTGSFCQFCVSTAASDILQHCPNRASAVIWYNF-- 123
Query: 167 CMVRFSDHSSSIMDTSAPLCMKIFQNTYNVTKSLAQSFNDVIAMPSLSSFRN----ATKR 222
C++R+S+H+ T+ P + + L + +++ ++ S ++ +
Sbjct: 124 CILRYSNHNFFGNLTTNPSWQMLGSKNITNPQELDKGEDNMQSLISEATLETNKLYGMRE 183
Query: 223 TNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFG-RILFPSCIMGFE 281
+S + QC LS C CL + + +C G G +++ PSC++ ++
Sbjct: 184 FTLSPTEKRYGLVQCSRDLSDKQCNQCLEAMLDKVPKCC---GTKIGWQVVAPSCLIKYD 240
Query: 282 LYRYSK-VPAVGALAPSSA--PEEKRNS---QEVQFLHWEGRIRNHYAYNILRGGKQQAE 335
+ + K + P+SA E+ R++ + + G I+ YN
Sbjct: 241 DFMFYKLIFQTSPPLPNSALAGEQGRSNGLPSKTTPISQHGHIQGEDTYN---------- 290
Query: 336 SQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEF 395
+ P+ PL ++TN+FS+ KLG+GGFGPVYKG L DG +A+KRLS TSGQG +EF
Sbjct: 291 -ADLPIIPLIWIRQSTNNFSEFCKLGEGGFGPVYKGNLVDGTEVAIKRLSITSGQGSEEF 349
Query: 396 KNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQS 455
KNEV IAKLQH+NLVRLLGCC+E E LL+YEYMPN SLD HLFD + LDWK R +
Sbjct: 350 KNEVIFIAKLQHRNLVRLLGCCIEDNEKLLVYEYMPNSSLDFHLFDEEKRKLLDWKLRLN 409
Query: 456 IINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 515
IINGIA+G+LYLHEDSRL++IHRDLKASN+LLD +MNPKISDFGLAR F +Q Q NT
Sbjct: 410 IINGIAKGLLYLHEDSRLRVIHRDLKASNVLLDQEMNPKISDFGLARAFEKDQCQENTRR 469
Query: 516 IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLW 575
+ GTYGYMAPEYAM G++S+KSDVFSFGVLLLEII GR+N GFY +EHGQ+LL Y+W LW
Sbjct: 470 VVGTYGYMAPEYAMEGLYSVKSDVFSFGVLLLEIICGRRNGGFYLAEHGQSLLVYSWNLW 529
Query: 576 CEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQP 635
CE ++EL+DP+LK + +E++K IHIGLLCVQ+D DRPTMS+VVVMLASD+MT+P P
Sbjct: 530 CEDKSLELLDPILKNTYTTNEVIKCIHIGLLCVQEDAVDRPTMSNVVVMLASDTMTLPNP 589
Query: 636 TEPAFSVGRVVANSGHFLSPAKACTVNNVTVSDVSPR 672
PAFSVGR V + +VN VTV+++ PR
Sbjct: 590 NHPAFSVGRKVVEGESTSKASNDPSVNEVTVTNILPR 626
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356510387|ref|XP_003523920.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 519 bits (1336), Expect = e-144, Method: Compositional matrix adjust.
Identities = 280/607 (46%), Positives = 379/607 (62%), Gaps = 60/607 (9%)
Query: 110 YYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQECMV 169
+ N + G + VYGLYLC+ +V+ C +C+ + + Q C T A +WY C++
Sbjct: 57 FGNGTSGIDENMVYGLYLCRGDVNTSLCHSCVQNSSILLKQHCPNTASAILWYPF--CLL 114
Query: 170 RFSDHSSSIMDTSAPLCMKIFQNTYNVTKSLAQSF--------NDVIAMPSLSSFRNATK 221
R+S+ + T P + +F T N T A F N +I M S T
Sbjct: 115 RYSNQNFFGNLTLTPR-IPMFDATQNFTS--AGEFDSDARVLMNGLIQMGSEEPLMFGTH 171
Query: 222 RTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFE 281
NI+ R + QC ++ ++CR CL+N + ++ C + + R+ PSCI+
Sbjct: 172 MFNINGTQRRYGWVQCSRDITTEECRTCLSNMLEDVENCCEEKKVW--RVFSPSCIV--- 226
Query: 282 LYRYSKVPAVGALAPSSAPEE------------------------------------KRN 305
+Y G P+ +E K++
Sbjct: 227 MYETQPFFLNGTSEPTPQQDEDGDNRRWLIIVIISVSGVVVVALLSISTYYFWCLKWKKD 286
Query: 306 SQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGF 365
Q +Q E + + ++ + + K+++ + + P+ PL L++TN+FSDE+KLG+GGF
Sbjct: 287 KQAIQ----EDGLNSMFSQD--QTDKEESMNADLPMMPLSTILKSTNNFSDEHKLGKGGF 340
Query: 366 GPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 425
GPVYKG L DG+ IAVKRLS+TS QG++EFKNEV LIAKLQH+NLVRLL CC+E E LL
Sbjct: 341 GPVYKGVLPDGRQIAVKRLSKTSVQGVEEFKNEVILIAKLQHRNLVRLLACCIEQNEKLL 400
Query: 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNI 485
+YE+MPN SLD HLFD + L+WK R +IINGIA+G+LYLHEDSRL++IHRDLKASNI
Sbjct: 401 VYEFMPNSSLDFHLFDMEKGEHLEWKNRLNIINGIAKGLLYLHEDSRLRVIHRDLKASNI 460
Query: 486 LLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVL 545
LLD +MNPKISDFGLAR FGG+Q QANT + GTYGYMAPEYAM G+FS+KSDVFSFGVL
Sbjct: 461 LLDHEMNPKISDFGLARTFGGDQKQANTIRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVL 520
Query: 546 LLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGL 605
LLEIISG++++ FY S+ GQ+LL Y W LWCE +EL+DP++++SC E+LK +HIGL
Sbjct: 521 LLEIISGKRSSKFYLSDQGQSLLIYAWNLWCERKGLELMDPIIEKSCVRSEVLKCMHIGL 580
Query: 606 LCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAFSVGRVVANSGHFLSPAKACTVNNVT 665
LCVQ+D ADRP MSSVV MLASD++++ PT PAFSVGR V + + +VN T
Sbjct: 581 LCVQEDAADRPKMSSVVHMLASDTVSLSVPTRPAFSVGRAVTERECSSNTSMHYSVNEAT 640
Query: 666 VSDVSPR 672
VS+V PR
Sbjct: 641 VSEVIPR 647
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356546303|ref|XP_003541568.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 519 bits (1336), Expect = e-144, Method: Compositional matrix adjust.
Identities = 285/627 (45%), Positives = 387/627 (61%), Gaps = 53/627 (8%)
Query: 86 SNTFTSNLNILFNQKLHSEAGKSLYYNA------SEGEFPDSVYGLYLCKFNVSFQSCQN 139
S+ + +NLN L + L ++A S YN + G +VYGLY C+ +V CQ
Sbjct: 49 SSAYQTNLNSLLSW-LSTDAATSKGYNHNSFGNNTPGGDDSAVYGLYNCRGDVVGYFCQF 107
Query: 140 CIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHSSSIMDTSAPLCMKIFQNTYNVTKS 199
C+ A VLQ+C A + Y C++R+S+ + T P + + +
Sbjct: 108 CVSTASREVLQRCPNRVSAIVLYDF--CILRYSNENFFGNVTVYPSWHAVQSKNVSSKEE 165
Query: 200 LAQSFNDVIAMPSLSSFRNATKRTNI---------SNIIRLETFGQCIPVLSVDDCRDCL 250
+ + + + + R AT TN+ S+ + QC L+ D CR+CL
Sbjct: 166 IQKGLDFMRGL-----IRKATVETNLLYYMDGFNLSSTQKRYGLVQCSRDLTSDGCRECL 220
Query: 251 NNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKVPAVGALAPSSAPEEKRNSQEVQ 310
+ + +C + +G+ ++L SC++ ++ Y + A + +KR + + +
Sbjct: 221 EAMLAQVPKCCEQ-NLGW-QVLAASCLIKYDDYIFY---LFRTQASDTQTAKKRGASKSR 275
Query: 311 FLHWEG----------------------RIRNHYAYNILRGGKQQAESQ---EFPLFPLR 345
+ G R N L+ Q E + P PL
Sbjct: 276 IILIIGLSVLGALALLCFSVYCFWFRKRSRRGRGKGNFLKQYNVQTEETLNVDLPTIPLI 335
Query: 346 LALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL 405
L++T++FS+ +KLG+GGFGPVYKGTL DG+ IAVKRLS+ SGQG +EFKNEV IAKL
Sbjct: 336 TILKSTDNFSEASKLGEGGFGPVYKGTLPDGRQIAVKRLSQASGQGSEEFKNEVMFIAKL 395
Query: 406 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 465
QH NLVRLL CCLEG+E +L+YEY+ N SLD HLFD + QLDW R SIINGIA+G+L
Sbjct: 396 QHCNLVRLLACCLEGKEKILVYEYLSNASLDFHLFDERKKRQLDWNLRLSIINGIAKGLL 455
Query: 466 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 525
YLHEDSRLK+IHRDLKASNILLDD+MNPKISDFGLAR F QNQANTN + GTYGYM+P
Sbjct: 456 YLHEDSRLKVIHRDLKASNILLDDEMNPKISDFGLARAFEKGQNQANTNRVMGTYGYMSP 515
Query: 526 EYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585
EYAM G+FS+KSDVFS+GVL+LEII G+KN+GFY SE GQ+L Y WK+WC G ++EL+D
Sbjct: 516 EYAMEGLFSVKSDVFSYGVLVLEIICGKKNSGFYLSECGQSLTLYAWKIWCAGKSLELMD 575
Query: 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAFSVGRV 645
PVL++SC E++K IHIGLLCVQ+D ADRPTMS+VVVMLASD M++P+P +PAFSVGR+
Sbjct: 576 PVLEKSCIESEVMKCIHIGLLCVQEDAADRPTMSTVVVMLASDKMSLPEPNQPAFSVGRM 635
Query: 646 VANSGHFLSPAKACTVNNVTVSDVSPR 672
+K ++N+VTV+++ PR
Sbjct: 636 TLEGASTSKSSKNLSINDVTVTNILPR 662
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575783|ref|XP_003556016.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 4 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 516 bits (1329), Expect = e-143, Method: Compositional matrix adjust.
Identities = 284/610 (46%), Positives = 383/610 (62%), Gaps = 42/610 (6%)
Query: 78 CAVSNNTASNTFTSNLNILFNQKLHSEAGKSLYYNAS-EGEFP-DSVYGLYLCKFNVSFQ 135
C + TA++TF N+ LF+ + +++YN++ G P D+VYGL++C+ +V FQ
Sbjct: 37 CPSNGTTANSTFQINIRTLFSSLSSNATANNVFYNSTVAGANPSDTVYGLFMCRGDVPFQ 96
Query: 136 SCQNCIVAAVNSVLQ--KCSGTKEAFIWYQVQECMVRFSDHSS-SIMDTSAPLCM---KI 189
C C++ A + +CS +K+A IWY ECMVR+S+ S S +DT + +
Sbjct: 97 LCGQCVINATQKLSSDLQCSLSKQAVIWYD--ECMVRYSNRSFFSTVDTRPAIGLLNSAN 154
Query: 190 FQNTYNVTKSLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDC 249
N N + + + N+ ++ + + ATK+ NIS L QC P LS CR C
Sbjct: 155 ISNQANFMRLMFDTMNETADEAAIGAKKYATKQANISGFQTLYCLVQCTPDLSTQGCRSC 214
Query: 250 LNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKVPAVGALAPSSAPEEKRNSQEV 309
L++ I + C + G GRIL PSC + ++LY + + V A S P + NS
Sbjct: 215 LSDAIGLLPWCCE--GKQGGRILNPSCNVRYDLYPFYRT-NVSAPPASVPPTDSSNS--- 268
Query: 310 QFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVY 369
G + + + E F AT+ FSD NKLG+GGFG VY
Sbjct: 269 -------------------GAETEISAVESLRFDFSTIEAATDKFSDANKLGEGGFGEVY 309
Query: 370 KGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429
KG L G+ +AVKRLS+ SGQG EFKNEV ++AKLQHKNLVRLLG CLEG+E +L+YE+
Sbjct: 310 KGLLPSGQEVAVKRLSKNSGQGGTEFKNEVEVVAKLQHKNLVRLLGFCLEGEEKILVYEF 369
Query: 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD 489
+ NKSLD LFD + LDW RR I+ GIARGI YLHEDSRLKIIHRDLKASN+LLD
Sbjct: 370 VANKSLDYILFDPEKQKSLDWTRRYKIVEGIARGIQYLHEDSRLKIIHRDLKASNVLLDG 429
Query: 490 DMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEI 549
DMNPKISDFG+ARIFG +Q QANTN I GTYGYM+PEYAM G +S KSDV+SFGVL+LEI
Sbjct: 430 DMNPKISDFGMARIFGVDQTQANTNRIVGTYGYMSPEYAMHGEYSAKSDVYSFGVLILEI 489
Query: 550 ISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQ 609
ISG++N+ FY ++ + LL+Y WKLW + +EL+D L++S +E+++ IHIGLLCVQ
Sbjct: 490 ISGKRNSSFYETDVAEDLLSYAWKLWKDEAPLELMDQSLRESYTRNEVIRCIHIGLLCVQ 549
Query: 610 QDPADRPTMSSVVVMLASDSMTIPQPTEPAFSV-GRVVANSGHFLSPAKACT------VN 662
+DP DRPTM+SVV+ML S S+T+ P +PAF + R N L ++ T VN
Sbjct: 550 EDPIDRPTMASVVLMLDSYSVTLQVPNQPAFYINSRTEPNMPKGLKIDQSTTNSTSKSVN 609
Query: 663 NVTVSDVSPR 672
+++VS+V PR
Sbjct: 610 DMSVSEVDPR 619
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|358346648|ref|XP_003637378.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355503313|gb|AES84516.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 516 bits (1328), Expect = e-143, Method: Compositional matrix adjust.
Identities = 274/575 (47%), Positives = 367/575 (63%), Gaps = 28/575 (4%)
Query: 110 YYNASEGEFP-DSVYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQECM 168
Y + S GE D+VYGLY C+ +V+ CQ C+ A + +LQ C A IWY C+
Sbjct: 15 YNHTSIGENTIDAVYGLYDCRGDVTGSFCQFCVSTAASDILQHCPNRASAVIWYNF--CI 72
Query: 169 VRFSDHSSSIMDTSAPLCMKIFQNTYNVTKSLAQSFNDVIAMPSLSSFRN----ATKRTN 224
+R+S+H+ T+ P + + L + +++ ++ S ++ +
Sbjct: 73 LRYSNHNFFGNLTTNPSWQMLGSKNITNPQELDKGEDNMQSLISEATLETNKLYGMREFT 132
Query: 225 ISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFG-RILFPSCIMGFELY 283
+S + QC LS C CL + + +C G G +++ PSC+M ++ +
Sbjct: 133 LSPTEKRYGLVQCSRDLSDKQCNQCLEAMLDKVPKCC---GTKIGWQVVAPSCLMKYDDF 189
Query: 284 RYSK-VPAVGALAPSSA--PEEKRNS---QEVQFLHWEGRIRNHYAYNILRGGKQQAESQ 337
+ K + P+SA E+ R++ + + G I+ YN
Sbjct: 190 MFYKLIFQTSPPLPNSALAGEQGRSNGLPSKTTPISQHGHIQGEDTYN-----------A 238
Query: 338 EFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKN 397
+ P+ PL ++TN+FS+ KLG+GGFGPVYKG L DG +A+KRLS TSGQG +EFKN
Sbjct: 239 DLPIIPLIWIRQSTNNFSEFCKLGEGGFGPVYKGNLVDGTEVAIKRLSITSGQGSEEFKN 298
Query: 398 EVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 457
EV IAKLQH+NLVRLLGCC+E E LL+YEYMPN SLD HLFD + LDWK R +II
Sbjct: 299 EVIFIAKLQHRNLVRLLGCCIEDNEKLLVYEYMPNSSLDFHLFDEEKRKLLDWKLRLNII 358
Query: 458 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 517
NGIA+G+LYLHEDSRL++IHRDLKASN+LLD +MNPKISDFGLAR F +Q Q NT +
Sbjct: 359 NGIAKGLLYLHEDSRLRVIHRDLKASNVLLDQEMNPKISDFGLARAFEKDQCQENTRRVV 418
Query: 518 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCE 577
GTYGYMAPEYAM G++S+KSDVFSFGVLLLEII GR+N GFY +EHGQ+LL Y+W LWCE
Sbjct: 419 GTYGYMAPEYAMEGLYSVKSDVFSFGVLLLEIICGRRNGGFYLAEHGQSLLVYSWNLWCE 478
Query: 578 GPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTE 637
++EL+DP+LK + +E++K IHIGLLCVQ+D DRPTMS+VVVMLASD+MT+P P
Sbjct: 479 DKSLELLDPILKNTYTTNEVIKCIHIGLLCVQEDAVDRPTMSNVVVMLASDTMTLPNPNH 538
Query: 638 PAFSVGRVVANSGHFLSPAKACTVNNVTVSDVSPR 672
PAFSVGR V + +VN VTV+++ PR
Sbjct: 539 PAFSVGRKVVEGESTSKASNDPSVNEVTVTNILPR 573
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575781|ref|XP_003556015.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 3 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 512 bits (1318), Expect = e-142, Method: Compositional matrix adjust.
Identities = 286/630 (45%), Positives = 391/630 (62%), Gaps = 42/630 (6%)
Query: 78 CAVSNNTASNTFTSNLNILFNQKLHSEAGKSLYYNAS-EGEFP-DSVYGLYLCKFNVSFQ 135
C + TA++TF N+ LF+ + +++YN++ G P D+VYGL++C+ +V FQ
Sbjct: 37 CPSNGTTANSTFQINIRTLFSSLSSNATANNVFYNSTVAGANPSDTVYGLFMCRGDVPFQ 96
Query: 136 SCQNCIVAAVNSVLQ--KCSGTKEAFIWYQVQECMVRFSDHSS-SIMDTSAPLCM---KI 189
C C++ A + +CS +K+A IWY ECMVR+S+ S S +DT + +
Sbjct: 97 LCGQCVINATQKLSSDLQCSLSKQAVIWYD--ECMVRYSNRSFFSTVDTRPAIGLLNSAN 154
Query: 190 FQNTYNVTKSLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDC 249
N N + + + N+ ++ + + ATK+ NIS L QC P LS CR C
Sbjct: 155 ISNQANFMRLMFDTMNETADEAAIGAKKYATKQANISGFQTLYCLVQCTPDLSTQGCRSC 214
Query: 250 LNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKVPAVGALAPSSAPEEKRNSQEV 309
L++ I + C + G GRIL PSC + ++LY + + V A S P + NS
Sbjct: 215 LSDAIGLLPWCCE--GKQGGRILNPSCNVRYDLYPFYRT-NVSAPPASVPPTDSSNSGGN 271
Query: 310 Q--------------------FLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRLALE 349
+L + + H +++ L + + + E F
Sbjct: 272 IIIVAIVVPITVAVLLFIVGIWLLSKRAAKKHMSFHFL--AETEISAVESLRFDFSTIEA 329
Query: 350 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 409
AT+ FSD NKLG+GGFG VYKG L G+ +AVKRLS+ SGQG EFKNEV ++AKLQHKN
Sbjct: 330 ATDKFSDANKLGEGGFGEVYKGLLPSGQEVAVKRLSKNSGQGGTEFKNEVEVVAKLQHKN 389
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 469
LVRLLG CLEG+E +L+YE++ NKSLD LFD + LDW RR I+ GIARGI YLHE
Sbjct: 390 LVRLLGFCLEGEEKILVYEFVANKSLDYILFDPEKQKSLDWTRRYKIVEGIARGIQYLHE 449
Query: 470 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 529
DSRLKIIHRDLKASN+LLD DMNPKISDFG+ARIFG +Q QANTN I GTYGYM+PEYAM
Sbjct: 450 DSRLKIIHRDLKASNVLLDGDMNPKISDFGMARIFGVDQTQANTNRIVGTYGYMSPEYAM 509
Query: 530 GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589
G +S KSDV+SFGVL+LEIISG++N+ FY ++ + LL+Y WKLW + +EL+D L+
Sbjct: 510 HGEYSAKSDVYSFGVLILEIISGKRNSSFYETDVAEDLLSYAWKLWKDEAPLELMDQSLR 569
Query: 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAFSV-GRVVAN 648
+S +E+++ IHIGLLCVQ+DP DRPTM+SVV+ML S S+T+ P +PAF + R N
Sbjct: 570 ESYTRNEVIRCIHIGLLCVQEDPIDRPTMASVVLMLDSYSVTLQVPNQPAFYINSRTEPN 629
Query: 649 SGHFLSPAKACT------VNNVTVSDVSPR 672
L ++ T VN+++VS+V PR
Sbjct: 630 MPKGLKIDQSTTNSTSKSVNDMSVSEVDPR 659
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 672 | ||||||
| TAIR|locus:2121676 | 669 | CRK10 "cysteine-rich RLK (RECE | 0.480 | 0.482 | 0.564 | 2.8e-120 | |
| TAIR|locus:2121651 | 676 | CRK8 "cysteine-rich RLK (RECEP | 0.464 | 0.461 | 0.594 | 1.2e-117 | |
| TAIR|locus:2115728 | 675 | CRK25 "cysteine-rich RLK (RECE | 0.437 | 0.435 | 0.569 | 3.3e-117 | |
| TAIR|locus:2121686 | 645 | CRK19 "cysteine-rich RLK (RECE | 0.485 | 0.505 | 0.560 | 2.6e-115 | |
| TAIR|locus:2121636 | 659 | CRK7 "cysteine-rich RLK (RECEP | 0.480 | 0.490 | 0.570 | 2.3e-114 | |
| TAIR|locus:2121626 | 830 | CRK23 "cysteine-rich RLK (RECE | 0.492 | 0.398 | 0.537 | 3e-110 | |
| TAIR|locus:2077147 | 676 | CRK4 "cysteine-rich RLK (RECEP | 0.480 | 0.477 | 0.543 | 3.9e-110 | |
| TAIR|locus:2123111 | 669 | CRK34 "cysteine-rich RLK (RECE | 0.492 | 0.494 | 0.543 | 5e-108 | |
| TAIR|locus:2121691 | 667 | CRK11 "cysteine-rich RLK (RECE | 0.433 | 0.436 | 0.588 | 1.9e-104 | |
| TAIR|locus:2141201 | 679 | CRK29 "cysteine-rich RLK (RECE | 0.479 | 0.474 | 0.542 | 2.7e-103 |
| TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 971 (346.9 bits), Expect = 2.8e-120, Sum P(2) = 2.8e-120
Identities = 184/326 (56%), Positives = 247/326 (75%)
Query: 350 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 409
AT+ F + NK+GQGGFG VYKGTL+DG +AVKRLS++SGQG EFKNEV L+AKLQH+N
Sbjct: 344 ATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSGQGEVEFKNEVVLVAKLQHRN 403
Query: 410 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 469
LVR +YEY+PNKSLD LFD + QLDW RR II G+ARGILYLH+
Sbjct: 404 LVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLDWTRRYKIIGGVARGILYLHQ 463
Query: 470 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 529
DSRL IIHRDLKASNILLD DMNPKI+DFG+ARIFG +Q + NT+ I GTYGYM+PEYAM
Sbjct: 464 DSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTEENTSRIVGTYGYMSPEYAM 523
Query: 530 GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589
G +S+KSDV+SFGVL+LEIISG+KN+ FY ++ L++Y W LW G +EL+DP +
Sbjct: 524 HGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHDLVSYAWGLWSNGRPLELVDPAIV 583
Query: 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPA-FSVGRVVAN 648
++C +E+++ +HIGLLCVQ+DPA+RPT+S++V+ML S+++T+P P +P F R+ +
Sbjct: 584 ENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLMLTSNTVTLPVPRQPGLFFQSRIGKD 643
Query: 649 SGHFLSPAKAC--TVNNVTVSDVSPR 672
+ +K+ +V++ +++D+ PR
Sbjct: 644 PLDTDTTSKSLLGSVDDASITDIHPR 669
|
|
| TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 963 (344.1 bits), Expect = 1.2e-117, Sum P(2) = 1.2e-117
Identities = 186/313 (59%), Positives = 234/313 (74%)
Query: 330 GKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG 389
G A + L R ATN F++ NK+G+GGFG VYKGT ++GK +AVKRLS+ S
Sbjct: 330 GDDMATADSLQL-DYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSR 388
Query: 390 QGLQEFKNEVNLIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLD 449
QG EFK EV ++AKLQH+NLVR +YEYMPNKSLD LFD T+ QLD
Sbjct: 389 QGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQLD 448
Query: 450 WKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509
W +R +II GIARGILYLH+DSRL IIHRDLKASNILLD D+NPKI+DFG+ARIFG +Q
Sbjct: 449 WMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQT 508
Query: 510 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLT 569
Q NT+ I GTYGYMAPEYAM G FS+KSDV+SFGVL+LEIISGRKN+ F S+ Q LLT
Sbjct: 509 QDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESDGAQDLLT 568
Query: 570 YTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDS 629
+TW+LW A++L+DP++ +C E+++ IHIGLLCVQ+DPA RPT+S+V +ML S++
Sbjct: 569 HTWRLWTNRTALDLVDPLIANNCQNSEVVRCIHIGLLCVQEDPAKRPTISTVFMMLTSNT 628
Query: 630 MTIPQPTEPAFSV 642
+T+P P +P F +
Sbjct: 629 VTLPVPRQPGFFI 641
|
|
| TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 881 (315.2 bits), Expect = 3.3e-117, Sum P(2) = 3.3e-117
Identities = 168/295 (56%), Positives = 219/295 (74%)
Query: 347 ALEA-TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL 405
A+EA TN FS+ NKLG GGFG VYKG L G+ +A+KRLS+ S QG +EFKNEV+++AKL
Sbjct: 339 AIEAATNKFSESNKLGHGGFGEVYKGQLITGETVAIKRLSQGSTQGAEEFKNEVDVVAKL 398
Query: 406 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 465
QH+NL + +YE++PNKSLD LFD + LDW+RR II GIARGIL
Sbjct: 399 QHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYFLFDNEKRRVLDWQRRYKIIEGIARGIL 458
Query: 466 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 525
YLH DSRL IIHRDLKASNILLD DM+PKISDFG+ARIFG +Q QANT I GTYGYM+P
Sbjct: 459 YLHRDSRLTIIHRDLKASNILLDADMHPKISDFGMARIFGVDQTQANTKRIVGTYGYMSP 518
Query: 526 EYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585
EYA+ G +S+KSDV+SFGVL+LE+I+G+KN+ FY + L+TY WKLW E +EL+D
Sbjct: 519 EYAIHGKYSVKSDVYSFGVLVLELITGKKNSSFYEEDGLGDLVTYVWKLWVENSPLELVD 578
Query: 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAF 640
++ + +E+++ IHI LLCVQ+D ++RP+M ++VM+ S ++T+P P F
Sbjct: 579 EAMRGNFQTNEVIRCIHIALLCVQEDSSERPSMDDILVMMNSFTVTLPIPKRSGF 633
|
|
| TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 929 (332.1 bits), Expect = 2.6e-115, Sum P(2) = 2.6e-115
Identities = 184/328 (56%), Positives = 232/328 (70%)
Query: 347 ALEA-TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL 405
A+EA TN F NKLGQGGFG VYKGTL+ G +AVKRLS+TSGQG +EF+NEV ++AKL
Sbjct: 318 AIEAATNCFLPINKLGQGGFGEVYKGTLSSGLQVAVKRLSKTSGQGEKEFENEVVVVAKL 377
Query: 406 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 465
QH+NLV+ +YE++PNKSLD LFD+T ++LDW RR II GIARGIL
Sbjct: 378 QHRNLVKLLGYCLEGEEKILVYEFVPNKSLDHFLFDSTMKMKLDWTRRYKIIGGIARGIL 437
Query: 466 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 525
YLH+DSRL IIHRDLKA NILLDDDMNPKI+DFG+ARIFG +Q +A T + GTYGYM+P
Sbjct: 438 YLHQDSRLTIIHRDLKAGNILLDDDMNPKIADFGMARIFGMDQTEAMTRRVVGTYGYMSP 497
Query: 526 EYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY-FSEHGQTLLTYTWKLWCEGPAVELI 584
EYAM G FS+KSDV+SFGVL+LEIISG KN+ Y E L+TYTW+LW G EL+
Sbjct: 498 EYAMYGQFSMKSDVYSFGVLVLEIISGMKNSSLYQMDESVGNLVTYTWRLWSNGSPSELV 557
Query: 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAFSVGR 644
DP + E+ + IHI LLCVQ+D DRPTMSS+V ML + + + +P P F
Sbjct: 558 DPSFGDNYQTSEITRCIHIALLCVQEDAEDRPTMSSIVQMLTTSLIALAEPRPPGFFFRS 617
Query: 645 VVANSGHFLSPAKACTVNNVTVSDVSPR 672
+G + + C+V+ +++ V+PR
Sbjct: 618 KQEQAGPSIDSSTHCSVDEASITRVTPR 645
|
|
| TAIR|locus:2121636 CRK7 "cysteine-rich RLK (RECEPTOR-like protein kinase) 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 938 (335.3 bits), Expect = 2.3e-114, Sum P(2) = 2.3e-114
Identities = 187/328 (57%), Positives = 236/328 (71%)
Query: 350 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 409
ATN FS+ NK+G+GGFG VYKGT ++G +AVKRLS+TS QG EFKNEV ++A L+HKN
Sbjct: 332 ATNDFSENNKIGRGGFGDVYKGTFSNGTEVAVKRLSKTSEQGDTEFKNEVVVVANLRHKN 391
Query: 410 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 469
LVR +YEY+ NKSLD LFD + QL W +R II GIARGILYLH+
Sbjct: 392 LVRILGFSIEREERILVYEYVENKSLDNFLFDPAKKGQLYWTQRYHIIGGIARGILYLHQ 451
Query: 470 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 529
DSRL IIHRDLKASNILLD DMNPKI+DFG+ARIFG +Q Q NT+ I GTYGYM+PEYAM
Sbjct: 452 DSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGMDQTQQNTSRIVGTYGYMSPEYAM 511
Query: 530 GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589
G FS+KSDV+SFGVL+LEIISGRKNN F ++ Q L+T+ W+LW G A++L+DP +
Sbjct: 512 RGQFSMKSDVYSFGVLVLEIISGRKNNSFIETDDAQDLVTHAWRLWRNGTALDLVDPFIA 571
Query: 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAFSV-GRVVAN 648
SC E+++ HIGLLCVQ+DP RP MS++ VML S++M +P P +P F V R N
Sbjct: 572 DSCRKSEVVRCTHIGLLCVQEDPVKRPAMSTISVMLTSNTMALPAPQQPGFFVRSRPGTN 631
Query: 649 --SGHFLSPAKACTVN--NVTVSDVSPR 672
+ K+ TV+ + ++SD+ PR
Sbjct: 632 RLDSDQSTTNKSVTVSIDDKSMSDLDPR 659
|
|
| TAIR|locus:2121626 CRK23 "cysteine-rich RLK (RECEPTOR-like protein kinase) 23" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 911 (325.7 bits), Expect = 3.0e-110, Sum P(2) = 3.0e-110
Identities = 180/335 (53%), Positives = 230/335 (68%)
Query: 342 FPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNL 401
F + + ATN+F NKLGQGGFG VYKGT G +AVKRLS+TSGQG +EF+NEV +
Sbjct: 496 FDFKAIVAATNNFLPINKLGQGGFGEVYKGTFPSGVQVAVKRLSKTSGQGEREFENEVVV 555
Query: 402 IAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIA 461
+AKLQH+NLVR +YE++ NKSLD LFD T QLDW RR II GIA
Sbjct: 556 VAKLQHRNLVRLLGYCLEGEEKILVYEFVHNKSLDYFLFDTTMKRQLDWTRRYKIIGGIA 615
Query: 462 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 521
RGILYLH+DSRL IIHRDLKA NILLD DMNPK++DFG+ARIFG +Q +ANT + GTYG
Sbjct: 616 RGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMARIFGMDQTEANTRRVVGTYG 675
Query: 522 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY-FSEHGQTLLTYTWKLWCEGPA 580
YMAPEYAM G FS+KSDV+SFGVL+ EIISG KN+ Y + L+TYTW+LW G
Sbjct: 676 YMAPEYAMYGQFSMKSDVYSFGVLVFEIISGMKNSSLYQMDDSVSNLVTYTWRLWSNGSQ 735
Query: 581 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAF 640
++L+DP + ++ + IHI LLCVQ+D DRP MS++V ML + S+ + P +P F
Sbjct: 736 LDLVDPSFGDNYQTHDITRCIHIALLCVQEDVDDRPNMSAIVQMLTTSSIVLAVPKQPGF 795
Query: 641 SV-GR--VVANSGHFLSPAKACTVNNVTVSDVSPR 672
GR V G + C++++ +++ V+PR
Sbjct: 796 FFRGRHEQVGEVGSSVDRLALCSIDDASITSVAPR 830
|
|
| TAIR|locus:2077147 CRK4 "cysteine-rich RLK (RECEPTOR-like protein kinase) 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 897 (320.8 bits), Expect = 3.9e-110, Sum P(2) = 3.9e-110
Identities = 183/337 (54%), Positives = 235/337 (69%)
Query: 347 ALEA-TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL 405
A+EA TN F + NKLGQGGFG VYKG G +AVKRLS+TSGQG +EF NEV ++AKL
Sbjct: 343 AIEAATNKFCETNKLGQGGFGEVYKGIFPSGVQVAVKRLSKTSGQGEREFANEVIVVAKL 402
Query: 406 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 465
QH+NLVR +YE++PNKSLD +FD+T LDW RR II GIARGIL
Sbjct: 403 QHRNLVRLLGFCLERDERILVYEFVPNKSLDYFIFDSTMQSLLDWTRRYKIIGGIARGIL 462
Query: 466 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 525
YLH+DSRL IIHRDLKA NILL DDMN KI+DFG+ARIFG +Q +ANT I GTYGYM+P
Sbjct: 463 YLHQDSRLTIIHRDLKAGNILLGDDMNAKIADFGMARIFGMDQTEANTRRIVGTYGYMSP 522
Query: 526 EYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSE--HGQTLLTYTWKLWCEGPAVEL 583
EYAM G FS+KSDV+SFGVL+LEIISG+KN+ Y + L+TYTW+LW G +EL
Sbjct: 523 EYAMYGQFSMKSDVYSFGVLVLEIISGKKNSNVYQMDGTSAGNLVTYTWRLWSNGSPLEL 582
Query: 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAF--- 640
+DP + + +E+ + IHI LLCVQ++ DRPTMS++V ML + S+ + P P F
Sbjct: 583 VDPSFRDNYRINEVSRCIHIALLCVQEEAEDRPTMSAIVQMLTTSSIALAVPQRPGFFFR 642
Query: 641 -----SVGRVVANSGHFLSPAKACTVNNVTVSDVSPR 672
VG V S ++ + C+V++ ++++V+PR
Sbjct: 643 SSKHEQVGLVDRLS---INTSALCSVDDASITNVTPR 676
|
|
| TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 939 (335.6 bits), Expect = 5.0e-108, Sum P(2) = 5.0e-108
Identities = 183/337 (54%), Positives = 242/337 (71%)
Query: 342 FPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNL 401
F + AT+ FSD N +G+GGFG VY+G L+ G +AVKRLS+TSGQG +EFKNE L
Sbjct: 333 FSFKTIEAATDKFSDSNMIGRGGFGEVYRGKLSSGPEVAVKRLSKTSGQGAEEFKNEAVL 392
Query: 402 IAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIA 461
++KLQHKNLVR +YE++PNKSLD LFD + +LDW RR +II GIA
Sbjct: 393 VSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLFDPAKQGELDWTRRYNIIGGIA 452
Query: 462 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 521
RGILYLH+DSRL IIHRDLKASNILLD DMNPKI+DFG+ARIFG +Q+QANT IAGT+G
Sbjct: 453 RGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGVDQSQANTRRIAGTFG 512
Query: 522 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY-FSEHGQTLLTYTWKLWCEGPA 580
YM+PEYAM G FS+KSDV+SFGVL+LEIISG+KN+ FY + G L+T+ W+LW G
Sbjct: 513 YMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKKNSSFYNIDDSGSNLVTHAWRLWRNGSP 572
Query: 581 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAF 640
+EL+DP + +S E + IHI LLCVQ+DPADRP + ++++ML S + T+ P P F
Sbjct: 573 LELVDPTIGESYQSSEATRCIHIALLCVQEDPADRPLLPAIIMMLTSSTTTLHVPRAPGF 632
Query: 641 SV-GRVVANSG--HFLSPAKAC--TVNNVTVSDVSPR 672
+ GR + G + S +++ ++N+ ++++ PR
Sbjct: 633 CLSGRDLEQDGVEYTESTSRSIPGSINDASITEFYPR 669
|
|
| TAIR|locus:2121691 CRK11 "cysteine-rich RLK (RECEPTOR-like protein kinase) 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 885 (316.6 bits), Expect = 1.9e-104, Sum P(2) = 1.9e-104
Identities = 173/294 (58%), Positives = 216/294 (73%)
Query: 350 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 409
ATN FS NKLG+GGFG VYKG L++G +AVKRLS+ SGQG +EF+NE L+ KLQH+N
Sbjct: 346 ATNKFSTSNKLGEGGFGAVYKGKLSNGTDVAVKRLSKKSGQGTREFRNEAVLVTKLQHRN 405
Query: 410 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 469
LVR IYE++ NKSLD LFD + QLDW RR II GIARGILYLH+
Sbjct: 406 LVRLLGFCLEREEQILIYEFVHNKSLDYFLFDPEKQSQLDWTRRYKIIGGIARGILYLHQ 465
Query: 470 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 529
DSRLKIIHRDLKASNILLD DMNPKI+DFGLA IFG Q Q NTN IAGTY YM+PEYAM
Sbjct: 466 DSRLKIIHRDLKASNILLDADMNPKIADFGLATIFGVEQTQGNTNRIAGTYAYMSPEYAM 525
Query: 530 GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQT---LLTYTWKLWCEGPAVELIDP 586
G +S+KSD++SFGVL+LEIISG+KN+G Y + T L+TY +LW +EL+DP
Sbjct: 526 HGQYSMKSDIYSFGVLVLEIISGKKNSGVYQMDETSTAGNLVTYASRLWRNKSPLELVDP 585
Query: 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAF 640
++ +E+ + IHI LLCVQ++P DRP +S++++ML S+++T+P P P F
Sbjct: 586 TFGRNYQSNEVTRCIHIALLCVQENPEDRPMLSTIILMLTSNTITLPVPRLPGF 639
|
|
| TAIR|locus:2141201 CRK29 "cysteine-rich RLK (RECEPTOR-like protein kinase) 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 853 (305.3 bits), Expect = 2.7e-103, Sum P(3) = 2.7e-103
Identities = 178/328 (54%), Positives = 226/328 (68%)
Query: 350 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 409
AT++FS EN+LG+GGFG VYKG G+ IAVKRLS SGQG EFKNE+ L+AKLQH+N
Sbjct: 353 ATDNFSSENELGRGGFGSVYKGVFPQGQEIAVKRLSGNSGQGDNEFKNEILLLAKLQHRN 412
Query: 410 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 469
LVR +YE++ N SLD +FD + LDW R +I GIARG+LYLHE
Sbjct: 413 LVRLIGFCIQGEERLLVYEFIKNASLDQFIFDTEKRQLLDWVVRYKMIGGIARGLLYLHE 472
Query: 470 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN--TNIIAGTYGYMAPEY 527
DSR +IIHRDLKASNILLD +MNPKI+DFGLA++F Q + T+ IAGTYGYMAPEY
Sbjct: 473 DSRFRIIHRDLKASNILLDQEMNPKIADFGLAKLFDSGQTMTHRFTSRIAGTYGYMAPEY 532
Query: 528 AMGGIFSIKSDVFSFGVLLLEIISGRKNN--GFYFSEHGQTLLTYTWKLWCEGPAVELID 585
AM G FS+K+DVFSFGVL++EII+G++NN G E + LL++ W+ W E + +ID
Sbjct: 533 AMHGQFSVKTDVFSFGVLVIEIITGKRNNNGGSNGDEDAEDLLSWVWRSWREDTILSVID 592
Query: 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAFSVGRV 645
P L + +E+L+ IHIGLLCVQ+ A RPTM++V +ML S S T+P P PAF + V
Sbjct: 593 PSLTAG-SRNEILRCIHIGLLCVQESAATRPTMATVSLMLNSYSFTLPTPLRPAFVLESV 651
Query: 646 VANSGHFLSP-AKACTVNNVTVSDVSPR 672
V S S + N+VTVS+ SPR
Sbjct: 652 VIPSNVSSSTEGLQMSSNDVTVSEFSPR 679
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8GYA4 | CRK10_ARATH | 2, ., 7, ., 1, 1, ., - | 0.4258 | 0.8660 | 0.8699 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00020409001 | SubName- Full=Chromosome chr5 scaffold_2, whole genome shotgun sequence; (654 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 672 | |||
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-57 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-56 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-56 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-54 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-54 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-53 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-52 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-45 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-41 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-38 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-36 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-35 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-35 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-35 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-34 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-34 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-33 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-32 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-32 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-32 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-31 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-31 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-31 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-31 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-30 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-29 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-29 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-29 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-28 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-28 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-28 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-27 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-27 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-27 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-27 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-27 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-27 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-26 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-26 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-25 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-25 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-25 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-25 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-25 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-25 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-25 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-25 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-25 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-25 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-24 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-24 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-24 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-24 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-24 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-24 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-24 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-23 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-23 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-23 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-23 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-23 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-23 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-23 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-23 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-22 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-22 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-21 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-21 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-21 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-21 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-21 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-21 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-21 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-21 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-21 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-21 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-20 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-20 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-20 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-20 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-20 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-20 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-20 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-20 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-20 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-20 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-20 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-20 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-20 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-19 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-19 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-19 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-19 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-18 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-18 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-18 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-18 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-18 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 4e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-18 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-18 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-18 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-17 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-17 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-17 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-17 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-17 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-16 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-15 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-15 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-14 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-14 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-14 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-14 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-14 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-14 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-14 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-13 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-13 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-13 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-12 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-12 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-12 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 9e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-09 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-06 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 4e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 6e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-05 | |
| pfam11883 | 48 | pfam11883, DUF3403, Domain of unknown function (DU | 2e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 8e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.002 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 193 bits (492), Expect = 9e-57
Identities = 104/291 (35%), Positives = 140/291 (48%), Gaps = 51/291 (17%)
Query: 358 NKLGQGGFGPVYKGTLADGK----AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLVR 412
KLG+G FG VYKG L +AVK L S + ++F E ++ KL H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVHL------FDATRSVQLDWKRRQSIINGIARGILY 466
LLG C E + L L+ EYM L +L F + L K S IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 467 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTN---IIAGTYGY 522
L K +HRDL A N L+ +D+ KISDFGL+R ++ + + T I +
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173
Query: 523 MAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVE 582
MAPE GIF+ KSDV+SFGVLL EI + G T + E
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFT-----------LGAT-------PYPGLSNEE 215
Query: 583 LIDPVLK-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626
+++ + K + C PDEL + + L C Q DP DRPT S +V L
Sbjct: 216 VLEYLRKGYRLPKPEYC-PDELYELM---LSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 190 bits (485), Expect = 6e-56
Identities = 100/284 (35%), Positives = 136/284 (47%), Gaps = 44/284 (15%)
Query: 357 ENKLGQGGFGPVYKGTLADGKA-----IAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNL 410
KLG+G FG VYKGTL +AVK L S Q ++EF E ++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 411 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 470
V+LLG C E + L+++ EYMP L +L R +L S IARG+ YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE-- 120
Query: 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ--NQANTNIIAGTYGYMAPEYA 528
IHRDL A N L+ +++ KISDFGL+R + + +MAPE
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL---PIRWMAPESL 176
Query: 529 MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588
G F+ KSDV+SFGVLL EI T + + E+++ +
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEI------------------FTLGEEPYPGMSNAEVLEYLK 218
Query: 589 K-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
K +C P EL K + L C +DP DRPT S +V +L
Sbjct: 219 KGYRLPKPPNC-PPELYKLM---LQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 190 bits (485), Expect = 7e-56
Identities = 95/284 (33%), Positives = 133/284 (46%), Gaps = 45/284 (15%)
Query: 357 ENKLGQGGFGPVYKGTLADGK-----AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNL 410
KLG+G FG VYKG L +AVK L S Q ++EF E ++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 411 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 470
V+LLG C E + L ++ EYM L +L +L S IARG+ YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE-- 119
Query: 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ--NQANTNIIAGTYGYMAPEYA 528
IHRDL A N L+ +++ KISDFGL+R + + + +MAPE
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL---PIRWMAPESL 175
Query: 529 MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588
G F+ KSDV+SFGVLL EI + G+ + + E+++ +
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTL-----------GE-------QPYPGMSNEEVLEYLK 217
Query: 589 K-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
+C P EL + L C +DP DRPT S +V +L
Sbjct: 218 NGYRLPQPPNC-PPELYDLM---LQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 187 bits (476), Expect = 1e-54
Identities = 90/270 (33%), Positives = 125/270 (46%), Gaps = 26/270 (9%)
Query: 359 KLGQGGFGPVYKGT-LADGKAIAVKRL--SRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 415
KLG G FG VYK GK +AVK L + Q + E+ ++ +L H N+VRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 416 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 475
+ L L+ EY L +L +R L + I I RG+ YLH I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHS---NGI 119
Query: 476 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI-FS 534
IHRDLK NILLD++ KI+DFGLA+ + ++ GT YMAPE +GG +
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLK--SSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 535 IKSDVFSFGVLLLEIISGRKNNGFYFSEHGQT--LLTYTWKLWCEGPAVELIDPVLKQSC 592
K DV+S GV+L E+++G+ FS L L L K S
Sbjct: 178 PKVDVWSLGVILYELLTGK----PPFSGENILDQLQLIRRILGP-----PLEFDEPKWSS 228
Query: 593 APDELLKFIHIGLLCVQQDPADRPTMSSVV 622
+E I L +DP+ RPT ++
Sbjct: 229 GSEEAKDLIK-KCLN--KDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 185 bits (473), Expect = 4e-54
Identities = 101/285 (35%), Positives = 135/285 (47%), Gaps = 50/285 (17%)
Query: 359 KLGQGGFGPVYKGTLADGKA-----IAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLVR 412
KLG+G FG VYKGTL +AVK L S + +EF E +++ KL H N+VR
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 472
LLG C +G+ L ++ EYMP L L + L + IA+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLL--QMALQIAKGMEYLES--- 120
Query: 473 LKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNIIAGTYG---YMAPEYA 528
+HRDL A N L+ +++ KISDFGL+R I+ + + G +MAPE
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG----GGKLPIKWMAPESL 176
Query: 529 MGGIFSIKSDVFSFGVLLLEIIS-------GRKNNGFYFS-EHGQTLLTYTWKLWCEGPA 580
G F+ KSDV+SFGVLL EI + G N E G L P
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPR---------P- 226
Query: 581 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
++C PDEL + + L C DP DRPT S +V L
Sbjct: 227 ---------ENC-PDELYELM---LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 180 bits (460), Expect = 8e-53
Identities = 75/194 (38%), Positives = 107/194 (55%), Gaps = 11/194 (5%)
Query: 360 LGQGGFGPVYKGT-LADGKAIAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 417
LG+GGFG VY GK +A+K + + S L+E E+ ++ KL H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 418 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 477
+ L L+ EY SL L + +L I+ I G+ YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 478 RDLKASNILLD-DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSI 535
RDLK NILLD D+ K++DFGL+++ +++ T I GT YMAPE +G G +S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173
Query: 536 KSDVFSFGVLLLEI 549
KSD++S GV+L E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 180 bits (459), Expect = 4e-52
Identities = 78/266 (29%), Positives = 117/266 (43%), Gaps = 24/266 (9%)
Query: 354 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLV 411
+ KLG+G FG VY GK +A+K + + + +E E+ ++ KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 412 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 471
RL + +L L+ EY L L + +L + + I + YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARFYLRQILSALEYLHS-- 115
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 531
I+HRDLK NILLD+D + K++DFGLAR + GT YMAPE +G
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE---KLTTFVGTPEYMAPEVLLGK 171
Query: 532 IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQS 591
+ D++S GV+L E+++G+ F Q L + K + +
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK----PPFPGDDQLLELF--KKIGKPK----PPFPPPEW 221
Query: 592 CAPDELLKFIHIGLLCVQQDPADRPT 617
E I LL DP R T
Sbjct: 222 DISPEAKDLIR-KLLVK--DPEKRLT 244
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 1e-45
Identities = 83/278 (29%), Positives = 127/278 (45%), Gaps = 51/278 (18%)
Query: 358 NKLGQGGFGPVYKGTLAD-GKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 414
LG+G FG VY D G+ +AVK LS S + L+ + E+ +++ LQH N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 415 GCCL--EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR-------------RQSIING 459
G E L + EY+ SL L K+ RQ
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL-----------KKFGKLPEPVIRKYTRQ----- 109
Query: 460 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 519
I G+ YLH I+HRD+K +NIL+D D K++DFG A+ G + T + GT
Sbjct: 110 ILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166
Query: 520 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGP 579
+MAPE G + +D++S G ++E+ +G+ +SE G + L+ G
Sbjct: 167 PYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP----WSELGNPM----AALYKIGS 218
Query: 580 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 617
+ E P + +E F+ C+++DP RPT
Sbjct: 219 SGEP--PEIP-EHLSEEAKDFL---RKCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 9e-41
Identities = 80/272 (29%), Positives = 126/272 (46%), Gaps = 35/272 (12%)
Query: 353 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 411
F K+G+GGFG VYK GK +A+K + S + ++ NE+ ++ K +H N+V
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 412 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR--QSIINGIARGIL---- 465
+ G L+ EL ++ E+ SL D +S + +S I + + +L
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLK----DLLKS----TNQTLTESQIAYVCKELLKGLE 112
Query: 466 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 525
YLH IIHRD+KA+NILL D K+ DFGL+ + +A ++ GT +MAP
Sbjct: 113 YLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL--SDTKARNTMV-GTPYWMAP 166
Query: 526 EYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585
E G + K+D++S G+ +E+ G+ Y L L +
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEGKPP---YSELPPMKALFKIAT----NGPPGLRN 219
Query: 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 617
P DE F+ C+Q++P RPT
Sbjct: 220 PEK----WSDEFKDFL---KKCLQKNPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 4e-38
Identities = 93/277 (33%), Positives = 133/277 (48%), Gaps = 44/277 (15%)
Query: 360 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE 419
+G+G FG V G G+ +AVK L S Q F E +++ L+H NLV+LLG L+
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 420 GQELLLIYEYMPNKSLDVHLFDATRSV-----QLDWKRRQSIINGIARGILYLHEDSRLK 474
G L ++ EYM SL +L R+V QL + + G+ YL E
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALD------VCEGMEYLEEK---N 122
Query: 475 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTY--GYMAPEYAMGGI 532
+HRDL A N+L+ +D+ K+SDFGLA+ +A+ +G + APE
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKK 175
Query: 533 FSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLW-CEGPAVELIDPVLKQ 590
FS KSDV+SFG+LL EI S GR Y + ++ + K + E P +
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVP---YPRIPLKDVVPHVEKGYRMEAP----------E 222
Query: 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627
C P E+ K + C + DPA RPT + LA
Sbjct: 223 GC-PPEVYKVM---KDCWELDPAKRPTFKQLREQLAL 255
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 88/269 (32%), Positives = 131/269 (48%), Gaps = 31/269 (11%)
Query: 354 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 413
F+ E KLG G FG V++G + +A+K L Q+F+ EV + +L+HK+L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 414 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGILYLHED 470
C G+ + +I E M SL L V S+I+ +A G+ YL E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVL----PVASLIDMACQVAEGMAYLEEQ 123
Query: 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN-QNQANTNIIAGTYGYMAPEYAM 529
IHRDL A NIL+ +D+ K++DFGLAR+ + ++ I Y + APE A
Sbjct: 124 ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI---PYKWTAPEAAS 177
Query: 530 GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589
G FS KSDV+SFG+LL E+ + +GQ + Y + I +
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFT-----------YGQ--VPYPGMN--NHEVYDQITAGYR 222
Query: 590 QSCAPDELLKFIH-IGLLCVQQDPADRPT 617
C P + + I+ I L C +P DRP+
Sbjct: 223 MPC-PAKCPQEIYKIMLECWAAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 83/284 (29%), Positives = 130/284 (45%), Gaps = 59/284 (20%)
Query: 353 HFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKN 409
++ + +G+G FG VYKG L G +A+K++S + L+ E++L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING---------- 459
+V+ +G L +I EY N SL + II
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSL------------------RQIIKKFGPFPESLVA 102
Query: 460 -----IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 514
+ +G+ YLHE +IHRD+KA+NIL D K++DFG+A +
Sbjct: 103 VYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS- 158
Query: 515 IIAGTYGYMAPE-YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWK 573
+ GT +MAPE M G S SD++S G ++E+++G N Y+ L
Sbjct: 159 -VVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTG---NPPYYD------LNPMAA 207
Query: 574 LWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 617
L+ V+ P L + +P EL F+ + C Q+DP RPT
Sbjct: 208 LFR---IVQDDHPPLPEGISP-ELKDFL---MQCFQKDPNLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 3e-35
Identities = 90/268 (33%), Positives = 127/268 (47%), Gaps = 35/268 (13%)
Query: 357 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 416
E KLG G FG V+ GT +AVK L + + F E ++ KL+H LV+L
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 417 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGILYLHEDSRL 473
C E + + ++ EYM SL L R +++ IA G+ YL
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKL----RLPQLVDMAAQIAEGMAYLE---SR 122
Query: 474 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI---IAGTYGYMAPEYAMG 530
IHRDL A NIL+ +++ KI+DFGLAR+ ++ A I T APE A
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAANY 178
Query: 531 GIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589
G F+IKSDV+SFG+LL EI++ GR Y + +L VE + +
Sbjct: 179 GRFTIKSDVWSFGILLTEIVTYGRVP---YPGMTNREVLE----------QVERGYRMPR 225
Query: 590 QSCAPDELLKFIHIGLLCVQQDPADRPT 617
P+EL + L C +DP +RPT
Sbjct: 226 PPNCPEELYD---LMLQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 5e-35
Identities = 89/283 (31%), Positives = 139/283 (49%), Gaps = 33/283 (11%)
Query: 358 NKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLV 411
+LG+G FG V G+ +AVK L+ + Q +F+ E+ ++ L H+N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 412 RLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 469
+ G C + G+ L LI EY+P+ SL +L Q++ KR + I +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 470 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN--QANTNIIAGTYGYMAPEY 527
+ IHRDL A NIL++ + KISDFGLA++ +++ + + Y APE
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183
Query: 528 AMGGIFSIKSDVFSFGVLLLEIIS-GRKNNG-------FYFSEHGQTLLTYTWKLWCEGP 579
FS SDV+SFGV L E+ + G + GQ ++T +L EG
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE 243
Query: 580 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 622
L P SC PDE+ + LC + +P DRP+ + ++
Sbjct: 244 --RLPRP---PSC-PDEVY---DLMKLCWEAEPQDRPSFADLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 83/271 (30%), Positives = 127/271 (46%), Gaps = 41/271 (15%)
Query: 359 KLGQGGFGPVYKGTL-ADGKAIAVKRL---SRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 414
LGQG G VYK GK A+K++ + ++ E+ + + +V+
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFR--KQLLRELKTLRSCESPYVVKCY 65
Query: 415 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL----YLHED 470
G + E+ ++ EYM SL D + V K + ++ IAR IL YLH
Sbjct: 66 GAFYKEGEISIVLEYMDGGSLA----DLLKKVG---KIPEPVLAYIARQILKGLDYLH-- 116
Query: 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 530
++ IIHRD+K SN+L++ KI+DFG++++ +Q NT + GT YM+PE G
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV--GTVTYMSPERIQG 174
Query: 531 GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQ----TLLTYTWKLWCEGPAVELIDP 586
+S +D++S G+ LLE G+ F F GQ L+ C+GP P
Sbjct: 175 ESYSYAADIWSLGLTLLECALGK----FPFLPPGQPSFFELMQAI----CDGPP-----P 221
Query: 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPT 617
L E FI C+Q+DP RP+
Sbjct: 222 SLPAEEFSPEFRDFIS---ACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 5e-34
Identities = 74/280 (26%), Positives = 126/280 (45%), Gaps = 49/280 (17%)
Query: 358 NKLGQGGFGPVYKGT-LADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 414
++G+G FG VY +DGK +K LS S + ++ NEV ++ KL H N+++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 415 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-------LDWKRRQSIINGIARGILYL 467
E +L ++ EY L + + + LDW + + + YL
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW-----FVQ-LCLALKYL 119
Query: 468 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 527
H KI+HRD+K NI L + K+ DFG++++ + A T + GT Y++PE
Sbjct: 120 HSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV--GTPYYLSPEL 174
Query: 528 AMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587
++ KSD++S G +L E+ + + F G+ LL EL +
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKH--PFE----GENLL-------------ELALKI 215
Query: 588 LKQSCAP------DELLKFIHIGLLCVQQDPADRPTMSSV 621
LK P EL + +Q+DP +RP+++ +
Sbjct: 216 LKGQYPPIPSQYSSELRNLVSS---LLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 5e-33
Identities = 80/239 (33%), Positives = 119/239 (49%), Gaps = 43/239 (17%)
Query: 338 EFPLFPLRLALEATNHFSDENKLGQGGFGPVYKG---TLADGK---AIAVKRLSRT-SGQ 390
E PL +R F +E LG+G FG VYKG + ++A+K L +
Sbjct: 1 EIPLSAVR--------FLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPK 50
Query: 391 GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL-----------DVHL 439
QEF+ E L++ LQH N+V LLG C + Q +++EY+ + L DV
Sbjct: 51 VQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGA 110
Query: 440 FDATRSVQ--LDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISD 497
+V+ LD I IA G+ YL S +HRDL A N L+ + + KISD
Sbjct: 111 ESGDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISD 167
Query: 498 FGLAR-IFGGN----QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 551
FGL+R I+ + Q+++ + +M PE + G F+ +SD++SFGV+L EI S
Sbjct: 168 FGLSRDIYSADYYRVQSKSLLPV-----RWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 84/264 (31%), Positives = 130/264 (49%), Gaps = 31/264 (11%)
Query: 359 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL 418
KLG G FG V++G + +AVK L + ++F E ++ KL+H L++L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 419 EGQELLLIYEYMPNKSLDVHL-FDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 477
+ + ++ E M SL +L A R+++L + + +A G+ YL + IH
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKL--PQLIDMAAQVASGMAYLEAQN---YIH 126
Query: 478 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI---IAGTYGYMAPEYAMGGIFS 534
RDL A N+L+ ++ K++DFGLAR+ + +A I T APE A+ FS
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT----APEAALYNRFS 182
Query: 535 IKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCA 593
IKSDV+SFG+LL EI++ GR G T ++ +D + C
Sbjct: 183 IKSDVWSFGILLTEIVTYGR------MPYPGMT----------NAEVLQQVDQGYRMPCP 226
Query: 594 PDELLKFIHIGLLCVQQDPADRPT 617
P + I L C ++DP DRPT
Sbjct: 227 PGCPKELYDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 82/282 (29%), Positives = 126/282 (44%), Gaps = 46/282 (16%)
Query: 360 LGQGGFGPVYKGTLADGKA------IAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVR 412
LG+G FG V+ G + +AVK L T+ ++ F+ E L+ QH+N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 413 LLGCCLEGQELLLIYEYMP----NKSLDVHLFDATRSVQLDWKRRQ-------SIINGIA 461
G C EG ++++EYM NK L H DA D + I IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 462 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNIIAGT- 519
G++YL + +HRDL N L+ D+ KI DFG++R ++ + + + G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR-----VGGHT 184
Query: 520 ---YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWC 576
+M PE M F+ +SDV+SFGV+L EI + K + S + C
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV--------IEC 236
Query: 577 EGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTM 618
L P ++C P E+ I L C ++DP R +
Sbjct: 237 ITQGRLLQRP---RTC-PSEVY---DIMLGCWKRDPQQRINI 271
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 9e-32
Identities = 92/282 (32%), Positives = 132/282 (46%), Gaps = 38/282 (13%)
Query: 358 NKLGQGGFGPVYKGT--LADGK--AIAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLVR 412
+LG G FG V KG + GK +AVK L + G +EF E +++A+L H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 472
L+G C G+ L+L+ E P L +L D K + + +A G+ YL
Sbjct: 61 LIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLK---ELAHQVAMGMAYLESK-- 114
Query: 473 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN--QANTNIIAGTY--GYMAPEYA 528
+HRDL A N+LL + KISDFG++R G + +A T AG + + APE
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT---AGRWPLKWYAPECI 170
Query: 529 MGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587
G FS KSDV+S+GV L E S G K Y G + +++
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAKP---YGEMKGAE-------------VIAMLESG 214
Query: 588 LKQSCAPDELLKFIH-IGLLCVQQDPADRPTMSSVVVMLASD 628
+ P+E + I+ I L C + P DRPT S + D
Sbjct: 215 ERLPR-PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 78/287 (27%), Positives = 125/287 (43%), Gaps = 32/287 (11%)
Query: 338 EFPLFPLRLALEA---TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQ 393
E L+ + + + K+G+G G VYK T A GK +A+K++ R Q +
Sbjct: 2 EELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKE 60
Query: 394 EFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR 453
NE+ ++ +H N+V L G EL ++ EYM SL D +
Sbjct: 61 LIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLT----DIITQNFVRMNEP 116
Query: 454 Q--SIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 511
Q + + +G+ YLH +IHRD+K+ NILL D + K++DFG A +++
Sbjct: 117 QIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR 173
Query: 512 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYT 571
N+ + GT +MAPE + K D++S G++ +E+ G Y E L
Sbjct: 174 NS--VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP---YLREPPLRALFLI 228
Query: 572 WKLWCEGPAVELIDPVLKQSCA-PDELLKFIHIGLLCVQQDPADRPT 617
P LK E F++ C+ +DP RP+
Sbjct: 229 TTKGI---------PPLKNPEKWSPEFKDFLN---KCLVKDPEKRPS 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 6e-31
Identities = 88/297 (29%), Positives = 134/297 (45%), Gaps = 62/297 (20%)
Query: 360 LGQGGFGPVYKGTLAD------GKAIAVKRLSR--TSGQGLQEFKNEVNLIAKLQHKNLV 411
LGQG FG VY+G +A+K ++ + + + EF NE +++ + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI-EFLNEASVMKEFNCHHVV 72
Query: 412 RLLGCCLEGQELLLIYEYMPNKSLDVHLF----DATRSVQLDWKRRQSIIN---GIARGI 464
RLLG GQ L++ E M L +L +A + L Q I IA G+
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 465 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNII-AGTYG- 521
YL K +HRDL A N ++ +D+ KI DFG+ R I+ T+ G G
Sbjct: 133 AYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY-------ETDYYRKGGKGL 182
Query: 522 ----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNGFYFSEHGQTLLTY 570
+MAPE G+F+ KSDV+SFGV+L E+ + G N + L
Sbjct: 183 LPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--------EVL--- 231
Query: 571 TWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627
K +G ++L + PD+LL+ + +C Q +P RPT +V L
Sbjct: 232 --KFVIDGGHLDLPE------NCPDKLLELM---RMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 7e-31
Identities = 69/206 (33%), Positives = 114/206 (55%), Gaps = 21/206 (10%)
Query: 360 LGQGGFGPVYKGT-LADGK----AIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRL 413
LG G FG VYKG + +G+ +A+K L + + +E +E ++A + H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 414 LGCCLEGQELLLIYEYMPNKSLDVHLF---DATRSVQ-LDWKRRQSIINGIARGILYLHE 469
LG CL ++ LI + MP L ++ D S L+W + IA+G+ YL E
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYL-E 126
Query: 470 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 529
+ RL +HRDL A N+L+ + KI+DFGLA++ ++ + + +MA E +
Sbjct: 127 EKRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 530 GGIFSIKSDVFSFGVLLLEIIS-GRK 554
I++ KSDV+S+GV + E+++ G K
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 124 bits (311), Expect = 7e-31
Identities = 84/276 (30%), Positives = 125/276 (45%), Gaps = 21/276 (7%)
Query: 359 KLGQGGFGPVYKGTLADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQH-KNLVRLL 414
KLG+G FG VY D K +A+K L++ + ++ F E+ ++A L H N+V+L
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 415 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 474
+ L L+ EY+ SL+ L R L I+ I + YLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KG 121
Query: 475 IIHRDLKASNILLD-DDMNPKISDFGLARIFGGNQ----NQANTNIIAGTYGYMAPEYAM 529
IIHRD+K NILLD D K+ DFGLA++ A + GT GYMAPE +
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 530 GGIF---SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586
G S SD++S G+ L E+++G F E + + T K+ E P +
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLP--PFEG-EKNSSATSQTLKIILELPT-PSLAS 237
Query: 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 622
L S + + +DP +R + SS +
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 9e-31
Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 12/202 (5%)
Query: 354 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 412
F KLG+G +G VYK G+ +A+K + LQE E++++ + +V+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVK 62
Query: 413 LLGCCLEGQELLLIYEYMPNKS-LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 471
G + +L ++ EY S D + T L + +I+ +G+ YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSD--IMKITNK-TLTEEEIAAILYQTLKGLEYLH--- 116
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 531
K IHRD+KA NILL+++ K++DFG++ + NT I GT +MAPE
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI--GTPFWMAPEVIQEI 174
Query: 532 IFSIKSDVFSFGVLLLEIISGR 553
++ K+D++S G+ +E+ G+
Sbjct: 175 GYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 76/201 (37%), Positives = 107/201 (53%), Gaps = 14/201 (6%)
Query: 357 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 416
KLG G FG V+ G +A+K L + S + F E NL+ +LQH LVRL
Sbjct: 11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAV 69
Query: 417 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 476
+ + + +I EYM N SL V ++L + + IA G+ ++ R I
Sbjct: 70 VTQ-EPIYIITEYMENGSL-VDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYI 124
Query: 477 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI---IAGTYGYMAPEYAMGGIF 533
HRDL+A+NIL+ + + KI+DFGLAR+ N+ A I T APE G F
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAINYGTF 180
Query: 534 SIKSDVFSFGVLLLEIIS-GR 553
+IKSDV+SFG+LL EI++ GR
Sbjct: 181 TIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 1e-29
Identities = 84/273 (30%), Positives = 138/273 (50%), Gaps = 36/273 (13%)
Query: 357 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 415
++KLG G +G VY+G +AVK L + ++EF E ++ +++H NLV+LLG
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 416 CCLEGQELLLIYEYMPNKSLDVHLFDATRS----VQLDWKRRQSIINGIARGILYLHEDS 471
C +I E+M +L +L + R V L + Q I+ + YL + +
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ-----ISSAMEYLEKKN 124
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT---YGYMAPEYA 528
IHRDL A N L+ ++ K++DFGL+R+ G+ A+ AG + APE
Sbjct: 125 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH----AGAKFPIKWTAPESL 177
Query: 529 MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588
FSIKSDV++FGVLL EI + + S + L+ ++L +G +E P
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEIAT------YGMSPYPGIDLSQVYELLEKGYRME--RP-- 227
Query: 589 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 621
+ C P ++ + + C Q +P+DRP+ + +
Sbjct: 228 -EGC-PPKVYELMR---ACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 78/267 (29%), Positives = 126/267 (47%), Gaps = 27/267 (10%)
Query: 359 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGL-QEFKNEVNLIAKLQHKNLVRLLGCC 417
K+G+G FG VYKG L +AVK T L ++F E ++ + H N+V+L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 418 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 477
++ Q + ++ E +P SL L + +L K+ + A G+ YL +S+ IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYL--ESK-NCIH 116
Query: 478 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 537
RDL A N L+ ++ KISDFG++R G + + + APE G ++ +S
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176
Query: 538 DVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSC---AP 594
DV+S+G+LL E S G T + E I+ + P
Sbjct: 177 DVWSYGILLWETFSL-----------GDT----PYPGMSNQQTRERIESGYRMPAPQLCP 221
Query: 595 DELLKFIHIGLLCVQQDPADRPTMSSV 621
+E+ + + L C DP +RP+ S +
Sbjct: 222 EEIYR---LMLQCWAYDPENRPSFSEI 245
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 8e-29
Identities = 80/267 (29%), Positives = 131/267 (49%), Gaps = 35/267 (13%)
Query: 360 LGQGGFGPVYKG-TLADGKAIAVKRLS-----RTSGQGLQEFKNEVNLIAKLQHKNLVRL 413
LG G FG VY+G L DG AVK +S +T + +++ + E+ L++KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 414 LGCCLEGQELLLIYEYMPNKSLDVHL--FDATRSVQLDWKRRQSIINGIARGILYLHEDS 471
LG E L + E +P SL L + + + RQ I G+ YLH+
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ-----ILLGLEYLHDR- 121
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG- 530
+HRD+K +NIL+D + K++DFG+A+ + G+ +MAPE
Sbjct: 122 --NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIAQQ 176
Query: 531 GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590
G + + +D++S G +LE+ +G+ +S+ + +K+ + D +
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKPP----WSQ--LEGVAAVFKIGRSKELPPIPDHL--- 227
Query: 591 SCAPDELLKFIHIGLLCVQQDPADRPT 617
DE FI L C+Q+DP+ RPT
Sbjct: 228 ---SDEAKDFI---LKCLQRDPSLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 78/268 (29%), Positives = 121/268 (45%), Gaps = 32/268 (11%)
Query: 358 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRLLG 415
+LG G G V K GK +AVK + + +Q + E++++ K +V G
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 416 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 475
++ + EYM SLD L + + + I + +G+ YLHE KI
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVAVLKGLTYLHEK--HKI 122
Query: 476 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 535
IHRD+K SNIL++ K+ DFG++ + A T GT YMAPE G +S+
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTF--VGTSSYMAPERIQGNDYSV 178
Query: 536 KSDVFSFGVLLLEIISGRKNNGFYFSEHGQT------LLTYTWKLWCEGPAVELIDPVLK 589
KSD++S G+ L+E+ +GR F + LL Y P P L
Sbjct: 179 KSDIWSLGLSLIELATGR----FPYPPENDPPDGIFELLQYI----VNEPP-----PRLP 225
Query: 590 QSCAPDELLKFIHIGLLCVQQDPADRPT 617
+ F++ LC+ +DP +RP+
Sbjct: 226 SGKFSPDFQDFVN---LCLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 9e-29
Identities = 88/267 (32%), Positives = 127/267 (47%), Gaps = 37/267 (13%)
Query: 359 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL 418
KLG G FG V+ G + +AVK L + +Q F E NL+ LQH LVRL
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 419 EGQELLLIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 477
+ + + +I EYM SL D D V L + IA G+ Y+ R IH
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNYIH 126
Query: 478 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 537
RDL+A+N+L+ + + KI+DFGLAR+ N+ A + APE G F+IKS
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREG-AKFPIKWTAPEAINFGSFTIKS 185
Query: 538 DVFSFGVLLLEIIS-------GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590
DV+SFG+LL EI++ G N+ + L +++ P +E
Sbjct: 186 DVWSFGILLYEIVTYGKIPYPGMSNSDV------MSALQRGYRM----PRME-------- 227
Query: 591 SCAPDELLKFIHIGLLCVQQDPADRPT 617
+C PDEL + C ++ +RPT
Sbjct: 228 NC-PDELYDIMK---TCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 68/202 (33%), Positives = 105/202 (51%), Gaps = 20/202 (9%)
Query: 360 LGQGGFGPVY----KGTLADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVR 412
LG+G FG V K T GK A+K L + + ++ E N+++++ H +V+
Sbjct: 1 LGKGSFGKVLLVRKKDT---GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 413 LLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 471
L + +E L L+ EY P L HL ++ + +R + I + YLH
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFSEERARFYAAEIVLALEYLH--- 110
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 531
L II+RDLK NILLD D + K++DFGLA+ ++ NT GT Y+APE +G
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGK 168
Query: 532 IFSIKSDVFSFGVLLLEIISGR 553
+ D +S GVLL E+++G+
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 68/206 (33%), Positives = 109/206 (52%), Gaps = 15/206 (7%)
Query: 354 FSDENKLGQGGFGPVYKGTL-ADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNL 410
F NK+G+G FG V+K AD + A+K+ LS+ + + +E +E ++AKL +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 411 VRLLGCCLEGQELLLIYEYMPNKSLD--VHLFDATR-SVQLDWKRRQSIINGIARGILYL 467
+R L+ +L ++ EY N L + + W+ I+ G+A +L
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----HL 117
Query: 468 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 527
H KI+HRD+K+ N+ LD N KI D G+A++ N N ANT I GT Y++PE
Sbjct: 118 HSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPEL 172
Query: 528 AMGGIFSIKSDVFSFGVLLLEIISGR 553
++ KSDV++ GV+L E +G+
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 84/279 (30%), Positives = 134/279 (48%), Gaps = 35/279 (12%)
Query: 357 ENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLV 411
E +G G FG V +G L +A+K L S + +F E +++ + H N++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 412 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 471
RL G + + +++I EYM N SLD L + + ++ GIA G+ YL S
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYL---S 123
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 531
+ +HRDL A NIL++ ++ K+SDFGL+R ++ T + APE
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR 183
Query: 532 IFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVE----LIDP 586
F+ SDV+SFG+++ E++S G + Y+ Q ++ AVE L P
Sbjct: 184 KFTSASDVWSFGIVMWEVMSYGERP---YWDMSNQDVIK----------AVEDGYRLPPP 230
Query: 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
+ C P L + + L C Q+D +RPT S +V L
Sbjct: 231 M---DC-PSALYQLM---LDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 7e-28
Identities = 84/262 (32%), Positives = 131/262 (50%), Gaps = 24/262 (9%)
Query: 357 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 416
KLG G FG V+ GT +AVK L + + F E ++ KL+H LV+L
Sbjct: 11 IKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAV 69
Query: 417 CLEGQELLLIYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKI 475
E + + ++ EYM SL L D R+++L + +A G+ Y+ R+
Sbjct: 70 VSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKL--PNLVDMAAQVAAGMAYIE---RMNY 123
Query: 476 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 535
IHRDL+++NIL+ D + KI+DFGLAR+ N+ A + APE A+ G F+I
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYGRFTI 182
Query: 536 KSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPD 595
KSDV+SFG+LL E+++ K Y + + +L E ++ + C D
Sbjct: 183 KSDVWSFGILLTELVT--KGRVPYPGMNNREVL-------------EQVERGYRMPCPQD 227
Query: 596 ELLKFIHIGLLCVQQDPADRPT 617
+ + L C ++DP +RPT
Sbjct: 228 CPISLHELMLQCWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 7e-28
Identities = 68/266 (25%), Positives = 123/266 (46%), Gaps = 26/266 (9%)
Query: 354 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS-RTSGQGLQEFKNEVNLIAKLQHKNLV 411
F+ +G+G FG VYK + +A+K + + +++ + E+ +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 412 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 471
+ G L+G +L +I EY S D + +LD I+ + G+ YLHE+
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 531
IHRD+KA+NILL ++ + K++DFG++ ++ NT GT +MAPE
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQS 173
Query: 532 IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQS 591
+ K+D++S G+ +E+ G H +L K P L+ +
Sbjct: 174 GYDEKADIWSLGITAIELAKGEPPLSDL---HPMRVLFLIPKNNP---------PSLEGN 221
Query: 592 CAPDELLKFIHIGLLCVQQDPADRPT 617
F+ LC+ +DP +RP+
Sbjct: 222 KFSKPFKDFVS---LCLNKDPKERPS 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 91/276 (32%), Positives = 134/276 (48%), Gaps = 37/276 (13%)
Query: 360 LGQGGFGPVYKGT----LADGKA---IAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLV 411
LG G FG VY+GT L G +AVK L + + Q +EF E +L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 412 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDA----TRSVQLDWKRRQSIINGIARGILYL 467
+LLG CL + +I E M L +L DA L K I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 468 HEDSRLKIIHRDLKASNILL-----DDDMNPKISDFGLAR-IFGGNQNQANTNIIAGTYG 521
++ IHRDL A N L+ D D KI DFGLAR I+ + + +
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178
Query: 522 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAV 581
+MAPE + G F+ +SDV+SFGVL+ EI++ Y + + Q +L + G +
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT--LGQQPYPALNNQEVLQHV----TAGGRL 232
Query: 582 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 617
+ K PD++ + + C QDP++RPT
Sbjct: 233 Q------KPENCPDKIYQLM---TNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 86/287 (29%), Positives = 122/287 (42%), Gaps = 49/287 (17%)
Query: 359 KLGQGGFGPVYKGTL--ADGKAI--AVKRLSRTSGQG-LQEFKNEVNLIAKLQHKNLVRL 413
KLG G FG V +G + GK I AVK L + +F E ++ L H+NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 414 LGCCLEGQELLLIYEYMPNKSL-----DVHLFDATRSVQLDWKRRQSIINGIARGILYLH 468
G L L+++ E P SL L S D+ + IA G+ YL
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQ------IANGMRYLE 114
Query: 469 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN----QANTNIIAGTYGYMA 524
+ IHRDL A NILL D KI DFGL R N++ + + + + + A
Sbjct: 115 SK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV---PFAWCA 168
Query: 525 PEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLW--CEGPAV- 581
PE FS SDV+ FGV L E + TY + W G +
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWE------------------MFTYGEEPWAGLSGSQIL 210
Query: 582 ELIDPVLKQSCAPDEL-LKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627
+ ID ++ P+ ++ L C +PADRPT +++ L
Sbjct: 211 KKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 67/211 (31%), Positives = 111/211 (52%), Gaps = 26/211 (12%)
Query: 354 FSDENKLGQGGFGPVYKGT-LADGKAIAVKR---------LSRTSGQGLQEFKNEVNLIA 403
+ KLG+G +G VYK G+ +A+K+ + T+ L+E ++L+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA---LRE----ISLLK 53
Query: 404 KLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARG 463
+L+H N+V+LL ++L L++EY +D+ + R L +SI+ + RG
Sbjct: 54 ELKHPNIVKLLDVIHTERKLYLVFEYC---DMDLKKYLDKRPGPLSPNLIKSIMYQLLRG 110
Query: 464 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYM 523
+ Y H S +I+HRDLK NIL++ D K++DFGLAR FG ++ T Y
Sbjct: 111 LAYCH--SH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYR 165
Query: 524 APEYAMGG-IFSIKSDVFSFGVLLLEIISGR 553
APE +G +S D++S G + E+I+G+
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 85/283 (30%), Positives = 123/283 (43%), Gaps = 53/283 (18%)
Query: 358 NKLGQGGFGPVYKGTLADGKAI-AVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRLLG 415
++LG+G G V K L + I A+K ++ LQ + E+ + + +V+ G
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 416 CCLEGQE--LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---------GIARGI 464
L+ + + EY SLD S+ K+R I + +G+
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLD--------SIYKKVKKRGGRIGEKVLGKIAESVLKGL 118
Query: 465 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 524
YLH KIIHRD+K SNILL K+ DFG++ + A T GT YMA
Sbjct: 119 SYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV--NSLAGT--FTGTSFYMA 171
Query: 525 PEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQT------LLTYTWKLWCEG 578
PE G +SI SDV+S G+ LLE+ R F F G+ LL+Y
Sbjct: 172 PERIQGKPYSITSDVWSLGLTLLEVAQNR----FPFPPEGEPPLGPIELLSYI------- 220
Query: 579 PAVELIDPVLKQSCAPDELLK----FIHIGLLCVQQDPADRPT 617
V + +P LK P +K F C+++DP RPT
Sbjct: 221 --VNMPNPELKDE--PGNGIKWSEEFKDFIKQCLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 60/205 (29%), Positives = 106/205 (51%), Gaps = 19/205 (9%)
Query: 358 NKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEF----KNEVNLIAKLQHKNLVR 412
++G+G +G VYK G+ +A+K++ R + F E+ L+ KL+H N+VR
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKI-RME-NEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 413 LLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 470
L + +++EYM + D+ + V+ + + + + G+ YLH +
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDH---DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN 119
Query: 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN-IIAGTYGYMAPEYAM 529
I+HRD+K SNIL+++D K++DFGLAR + + TN +I T Y PE +
Sbjct: 120 ---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI--TLWYRPPELLL 174
Query: 530 GGI-FSIKSDVFSFGVLLLEIISGR 553
G + + D++S G +L E+ G+
Sbjct: 175 GATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 9e-27
Identities = 75/217 (34%), Positives = 113/217 (52%), Gaps = 18/217 (8%)
Query: 338 EFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKN 397
E P LRL E KLGQG FG V+ GT +A+K L + + F
Sbjct: 2 EIPRESLRL----------EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQ 50
Query: 398 EVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 457
E ++ KL+H+ LV+L E + + ++ EYM SL + L + +
Sbjct: 51 EAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL-LDFLKGEMGKYLRLPQLVDMA 108
Query: 458 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 517
IA G+ Y+ R+ +HRDL+A+NIL+ +++ K++DFGLAR+ N+ A
Sbjct: 109 AQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AK 164
Query: 518 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GR 553
+ APE A+ G F+IKSDV+SFG+LL E+ + GR
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 9e-27
Identities = 82/282 (29%), Positives = 132/282 (46%), Gaps = 38/282 (13%)
Query: 359 KLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 412
+LG+G FG V+ D +AVK L S Q+F+ E L+ LQH+++VR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 413 LLGCCLEGQELLLIYEYMPNKSL---------DVHLFDATRSV---QLDWKRRQSIINGI 460
G C EG+ LL+++EYM + L D + V QL + +I + I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 461 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNIIAGT 519
A G++YL + L +HRDL N L+ + KI DFG++R I+ + + +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 520 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGP 579
+M PE + F+ +SD++SFGV+L EI F + + L+ T + C
Sbjct: 189 R-WMPPESILYRKFTTESDIWSFGVVLWEI--------FTYGKQPWYQLSNTEAIECITQ 239
Query: 580 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 621
EL P ++C P E+ + C Q++P R + +
Sbjct: 240 GRELERP---RTC-PPEVYAIMQ---GCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 82/296 (27%), Positives = 125/296 (42%), Gaps = 69/296 (23%)
Query: 360 LGQGGFGPVYK---GTLAD--GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 414
LG+G FG V L D G+ +AVK+L ++ + L++F+ E+ ++ LQH N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 415 GCCLEG--QELLLIYEYMPNKSL------DVHLFDATRSVQLDWKRRQSIINGIARGILY 466
G C + L L+ EY+P SL D + + + I +G+ Y
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ--------ICKGMEY 123
Query: 467 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN------QNQANTNIIAGTY 520
L + +HRDL NIL++ + KI DFGL ++ + + + I
Sbjct: 124 L---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF---- 176
Query: 521 GYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS----------------GRKNNGFYFSEHG 564
+ APE FS+ SDV+SFGV+L E+ + G G H
Sbjct: 177 -WYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235
Query: 565 QTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIH-IGLLCVQQDPADRPTMS 619
LL +L PA C P E I+ I C DP+ RP+ S
Sbjct: 236 IELLKNNGRL----PAPP--------GC-PAE----IYAIMKECWNNDPSQRPSFS 274
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 5e-26
Identities = 84/283 (29%), Positives = 130/283 (45%), Gaps = 44/283 (15%)
Query: 359 KLGQGGFGPVYK-GTLADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 415
KLG+G +G VYK L+D + A+K L S + ++ NE+ ++A + H N++
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66
Query: 416 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQ-------SIINGIARGILYLH 468
L+G +L ++ EY P L + + KR+ I + RG+ LH
Sbjct: 67 AFLDGNKLCIVMEYAPFGDL------SKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 469 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 528
E KI+HRDLK++NILL + KI D G++++ +N A T I GT YMAPE
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKVL--KKNMAKTQI--GTPHYMAPEVW 173
Query: 529 MGGIFSIKSDVFSFGVLLLEIISGRKN-NGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587
G +S KSD++S G LL E+ + + + + P I P+
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY------PP---IPPI 224
Query: 588 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSM 630
Q +L FI +Q P RP + LAS ++
Sbjct: 225 YSQ-----DLQNFIR---SMLQVKPKLRPNCDKI---LASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 8e-26
Identities = 88/285 (30%), Positives = 136/285 (47%), Gaps = 34/285 (11%)
Query: 338 EFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKN 397
E P LRL + KLGQG FG V+ GT +A+K L + + F
Sbjct: 2 EIPRESLRL----------DVKLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQ 50
Query: 398 EVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 457
E ++ KL+H LV L E + + ++ E+M SL + L + +
Sbjct: 51 EAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSL-LDFLKEGDGKYLKLPQLVDMA 108
Query: 458 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 517
IA G+ Y+ R+ IHRDL+A+NIL+ D++ KI+DFGLAR+ N+ A
Sbjct: 109 AQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQG-AK 164
Query: 518 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWC 576
+ APE A+ G F+IKSDV+SFG+LL E+++ GR + + +++ C
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPC 224
Query: 577 EGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 621
Q C P+ L + + LC ++DP +RPT +
Sbjct: 225 ------------PQGC-PESLHELMK---LCWKKDPDERPTFEYI 253
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 65/202 (32%), Positives = 105/202 (51%), Gaps = 19/202 (9%)
Query: 360 LGQGGFGPVYKGTLAD-GKAIAVKR-----LSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 413
LGQG FG VY D G+ +AVK+ S + + + + E+ L+ LQH+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 414 LGCCLEGQELLLIYEYMPNKSLDVHL--FDA-TRSVQLDWKRRQSIINGIARGILYLHED 470
GC + + L + EYMP S+ L + A T +V + R+ I G+ YLH +
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQ------ILEGVEYLHSN 123
Query: 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLA-RIFGGNQNQANTNIIAGTYGYMAPEYAM 529
I+HRD+K +NIL D N K+ DFG + R+ + + GT +M+PE
Sbjct: 124 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180
Query: 530 GGIFSIKSDVFSFGVLLLEIIS 551
G + K+DV+S G ++E+++
Sbjct: 181 GEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 82/297 (27%), Positives = 137/297 (46%), Gaps = 48/297 (16%)
Query: 357 ENKLGQGGFGPVYKGTLA------DGKAIAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKN 409
+GQG FG V++ +AVK L S +F+ E L+A+ H N
Sbjct: 10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPN 69
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDAT-------------------RSVQLDW 450
+V+LLG C G+ + L++EYM L+ L + + L
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 451 KRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQN 509
+ I +A G+ YL E K +HRDL N L+ ++M KI+DFGL+R I+ +
Sbjct: 130 TEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 510 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLL 568
+A+ N A +M PE ++ +SDV+++GV+L EI S G + Y+ + ++
Sbjct: 187 KASEN-DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP---YYGMAHEEVI 242
Query: 569 TYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
Y +G + SC + L+ ++ LC + P+DRP+ +S+ +L
Sbjct: 243 YYVR----DGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRIL 286
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 75/280 (26%), Positives = 118/280 (42%), Gaps = 47/280 (16%)
Query: 358 NKLGQGGFGPVYKG-TLADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 414
NK+G G FG VY L G+ +AVK R+ + ++E +E+ ++ L+H NLV+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 415 GCCLEGQELLLIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRL 473
G + +++ + EY +L + LD + + G+ YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTL----EELLEHGRILDEHVIRVYTLQLLEGLAYLHSH--- 118
Query: 474 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT--NIIAGTYGYMAPEYAMGG 531
I+HRD+K +NI LD + K+ DFG A N +AGT YMAPE GG
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 532 IFSIK---SDVFSFGVLLLEIISGRKNNGFYFSEH--------GQTLLTYTWKLWCEGPA 580
+D++S G ++LE+ +G++ +E G
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHK-------------- 224
Query: 581 VELIDPVLKQS-CAPDELLKFIHIGLLCVQQDPADRPTMS 619
P + S E F+ C++ DP RPT S
Sbjct: 225 -----PPIPDSLQLSPEGKDFLD---RCLESDPKKRPTAS 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 60/227 (26%), Positives = 98/227 (43%), Gaps = 33/227 (14%)
Query: 352 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFK-----NEVNLIAKL 405
+ F +G+G F V K A+K L + Q ++E K E ++ +L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRL 58
Query: 406 -QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 464
H +++L + + L + EY PN L ++ + LD K + I +
Sbjct: 59 NGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLAL 115
Query: 465 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ---------------- 508
YLH IIHRDLK NILLD DM+ KI+DFG A++ N
Sbjct: 116 EYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 509 --NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 553
N+ GT Y++PE SD+++ G ++ ++++G+
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 72/215 (33%), Positives = 116/215 (53%), Gaps = 29/215 (13%)
Query: 352 NHFSDENKLGQGGFGPVYKGTL-ADGK---AIAVKRLS--RTSGQGLQEFKNEVNLIAKL 405
+H + + +G G FG V++G L G+ A+A+K L T Q Q+F +E +++ +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQ-RQDFLSEASIMGQF 63
Query: 406 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDAT---RSVQLDWKRRQSIINGIAR 462
H N++RL G + + ++I EYM N +LD +L D S QL ++ GIA
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-----VGMLRGIAA 118
Query: 463 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG- 521
G+ YL S + +HRDL A NIL++ ++ K+SDFGL+R+ + T T G
Sbjct: 119 GMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYT-----TSGG 170
Query: 522 -----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 551
+ APE F+ SDV+SFG+++ E++S
Sbjct: 171 KIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 88/287 (30%), Positives = 123/287 (42%), Gaps = 48/287 (16%)
Query: 358 NKLGQGGFGPVYKGTLA--DGKA----IAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNL 410
LG G FG VY+G DG A +AVK L S Q +F E +++K H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 411 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFD----ATRSVQLDWKRRQSIINGIARGILY 466
VRL+G E ++ E M L L + R L K +A+G Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 467 LHEDSRLKIIHRDLKASNILLDD---DMNPKISDFGLAR-IFGGNQNQANTNIIAGTYGY 522
L E+ IHRD+ A N LL KI+DFG+AR I+ + + + +
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML-PIKW 187
Query: 523 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNGFYFSEHGQTLLTYTWKLW 575
M PE + GIF+ K+DV+SFGVLL EI S GR N + +T +L
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN------QEVMEFVTGGGRL- 240
Query: 576 CEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 622
P PV + I C Q P DRP ++++
Sbjct: 241 --DPPKGCPGPVYR-------------IMTDCWQHTPEDRPNFATIL 272
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 82/265 (30%), Positives = 130/265 (49%), Gaps = 30/265 (11%)
Query: 357 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 416
E KLG G FG V+ T +AVK + + ++ F E N++ LQH LV+L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKL-HA 68
Query: 417 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGILYLHEDSRL 473
+ + + +I E+M SL D +S + + +I+ IA G+ ++ + +
Sbjct: 69 VVTKEPIYIITEFMAKGSL----LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN-- 122
Query: 474 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 533
IHRDL+A+NIL+ + KI+DFGLAR+ N+ A + APE G F
Sbjct: 123 -YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG-AKFPIKWTAPEAINFGSF 180
Query: 534 SIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSC 592
+IKSDV+SFG+LL+EI++ GR + L +++ P E +C
Sbjct: 181 TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM----PRPE--------NC 228
Query: 593 APDELLKFIHIGLLCVQQDPADRPT 617
P+EL + + C + P +RPT
Sbjct: 229 -PEELYNIM---MRCWKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 5e-25
Identities = 77/274 (28%), Positives = 131/274 (47%), Gaps = 34/274 (12%)
Query: 359 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL 418
++G G FG V+ G + + +A+K + R ++F E ++ KL H LV+L G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 419 EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHR 478
E + L++E+M + L +L + + + + + G+ YL + +IHR
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 479 DLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT---YGYMAPEYAMGGIFSI 535
DL A N L+ ++ K+SDFG+ R +Q ++T GT + +PE +S
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSS 180
Query: 536 KSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP---VLKQSC 592
KSDV+SFGVL+ E+ FSE G+T ++ VE I+ + K
Sbjct: 181 KSDVWSFGVLMWEV----------FSE-GKT----PYENRSNSEVVETINAGFRLYKPRL 225
Query: 593 APDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626
A + + + C ++ P DRP+ S ++ LA
Sbjct: 226 ASQSVYELMQ---HCWKERPEDRPSFSLLLHQLA 256
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 81/290 (27%), Positives = 130/290 (44%), Gaps = 51/290 (17%)
Query: 360 LGQGGFGPVYKGTLA--DGKA--IAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 413
LG+G FG V +G L+ DG +AVK +L + ++EF +E + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 414 LGCCLEGQEL------LLIYEYMPNKSLDVHLFD---ATRSVQLDWKRRQSIINGIARGI 464
+G C E L ++I +M + L L +L + + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 465 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNIIAGTYGYM 523
YL S IHRDL A N +L +DM ++DFGL++ I+ G+ + I ++
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYR-QGRIAKMPVKWI 182
Query: 524 APEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNGFY-FSEHGQTLLTYTWKLW 575
A E +++ KSDV++FGV + EI + G +N+ Y + HG
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR--------- 233
Query: 576 CEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
LKQ D L + + C + DP DRPT + + +L
Sbjct: 234 ------------LKQ--PEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 65/198 (32%), Positives = 93/198 (46%), Gaps = 11/198 (5%)
Query: 360 LGQGGFGPVYKGTLAD-GKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLG 415
LG+GGFG V + GK A K+L + +G Q NE ++ K+ + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 416 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 475
+L L+ M L H+++ R I G+ +LH + +I
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPG-FPEARAIFYAAQIICGLEHLH---QRRI 116
Query: 476 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 535
++RDLK N+LLDD N +ISD GLA G AGT GYMAPE G ++
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGTPGYMAPEVLQGEVYDF 173
Query: 536 KSDVFSFGVLLLEIISGR 553
D F+ G L E+I+GR
Sbjct: 174 SVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 87/281 (30%), Positives = 132/281 (46%), Gaps = 25/281 (8%)
Query: 360 LGQGGFGPV----YKGTLAD-GKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRL 413
LG+G FG V Y G+ +AVK L R GQ +K E+N++ L H+N+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 414 LGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 471
GCC E G+ L LI EY+P SL +L ++ Q I G+A YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMA----YLHSQ- 126
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLARIF--GGNQNQANTNIIAGTYGYMAPEYAM 529
IHRDL A N+LLD+D KI DFGLA+ G + + + + Y A E
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVECLK 183
Query: 530 GGIFSIKSDVFSFGVLLLEIIS---GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586
FS SDV+SFGV L E+++ +++ F E ++ +EL++
Sbjct: 184 ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE----MIGPKQGQMTVVRLIELLER 239
Query: 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627
++ C + + + C + + RPT S++ +L
Sbjct: 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE 280
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 70/220 (31%), Positives = 108/220 (49%), Gaps = 31/220 (14%)
Query: 360 LGQGGFGPVYKGT------LADGKAIAVKRLSRTSGQG-LQEFKNEVNLIAKLQHKNLVR 412
LG+G FG V K T A +AVK L + L++ +E NL+ ++ H ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATR----SVQLDWKRRQSIING--------- 459
L G C + LLLI EY SL L ++ + + D R S ++
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 460 --------IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 511
I+RG+ YL E +K++HRDL A N+L+ + KISDFGL+R +
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 512 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 551
+ +MA E I++ +SDV+SFGVLL EI++
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 66/198 (33%), Positives = 98/198 (49%), Gaps = 13/198 (6%)
Query: 360 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE 419
LG G FG V+ G +A+K + R +F E ++ KL H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 420 GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRD 479
+ + ++ EYM N L +L + + +W + + + + YL + IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 480 LKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT---YGYMAPEYAMGGIFSIK 536
L A N L+ +D K+SDFGLAR +Q ++ GT + PE FS K
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRFSSK 181
Query: 537 SDVFSFGVLLLEIISGRK 554
SDV+SFGVL+ E+ S K
Sbjct: 182 SDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-24
Identities = 73/197 (37%), Positives = 103/197 (52%), Gaps = 16/197 (8%)
Query: 359 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL 418
+G+G FG V +G G+ +AVK + Q F E ++ KL HKNLVRLLG L
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 419 EGQELLLIYEYMPNKSLDVHLFDATRS-VQLDWKRRQSIINGIARGILYLHEDSRLKIIH 477
L ++ E M +L L R+ V + + S+ +A G+ YL K++H
Sbjct: 70 H-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL--DVAEGMEYLESK---KLVH 123
Query: 478 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 537
RDL A NIL+ +D K+SDFGLAR+ + + + + APE FS KS
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKLP--VKWTAPEALKHKKFSSKS 178
Query: 538 DVFSFGVLLLEIIS-GR 553
DV+S+GVLL E+ S GR
Sbjct: 179 DVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 88/287 (30%), Positives = 131/287 (45%), Gaps = 45/287 (15%)
Query: 360 LGQGGFGPVYKGTLAD------GKAIAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHKNLV 411
LG+G FG V K +AVK L + + L + +E+ ++ + +HKN++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 412 RLLGCCLEGQELLLIYEYMPNKSLDVHL-----------FDATRSV--QLDWKRRQSIIN 458
LLG C + L ++ EY + +L L D R L K S
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 459 GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNIIA 517
+ARG+ +L S+ K IHRDL A N+L+ +D KI+DFGLAR I + + TN
Sbjct: 140 QVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN--- 193
Query: 518 G--TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLW 575
G +MAPE +++ +SDV+SFGVLL EI + S + + +KL
Sbjct: 194 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT------LGGSPYPGIPVEELFKLL 247
Query: 576 CEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 622
EG +E K EL H+ C + P+ RPT +V
Sbjct: 248 KEGYRME------KPQNCTQELY---HLMRDCWHEVPSQRPTFKQLV 285
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 71/221 (32%), Positives = 107/221 (48%), Gaps = 30/221 (13%)
Query: 353 HFSDEN-----KLGQGGFGPVY----KGTLADGK--AIAVKRLSRTSGQGLQ-EFKNEVN 400
F N LG+G FG V+ KG +G + VK L +T + LQ EF+ E++
Sbjct: 1 AFPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELD 60
Query: 401 LIAKLQHKNLVRLLGCCLEGQELLLIYEY----------MPNKSLDVHLFDATRSVQLDW 450
+ KL HKN+VRLLG C E + +I EY KS D + + L
Sbjct: 61 MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKD----EKLKPPPLST 116
Query: 451 KRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510
K++ ++ IA G+ +L S + +HRDL A N L+ K+S L++ ++
Sbjct: 117 KQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY 173
Query: 511 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 551
N + ++APE FS KSDV+SFGVL+ E+ +
Sbjct: 174 KLRNALI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 68/208 (32%), Positives = 110/208 (52%), Gaps = 20/208 (9%)
Query: 360 LGQGGFGPVYKGTLA-DGKAIAVKR--LSRTSGQG-------LQEFKNEVNLIAKLQHKN 409
+G G FG VY G A G+ +AVK+ L S L E+ L+ +LQH+N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 469
+V+ LG L+ L + EY+P S+ L + ++ + I +G+ YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVRNFVRQILKGLNYLH- 123
Query: 470 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI----IAGTYGYMAP 525
+R IIHRD+K +NIL+D+ KISDFG+++ N TN + G+ +MAP
Sbjct: 124 -NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 526 EYAMGGIFSIKSDVFSFGVLLLEIISGR 553
E ++ K+D++S G L++E+++G+
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 88/308 (28%), Positives = 144/308 (46%), Gaps = 55/308 (17%)
Query: 360 LGQGGFGPVYKGT-LADGKAI----AVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRL 413
LG G FG VYKG + +G+ + A+K L+ T+G + EF +E ++A + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 414 LGCCLEGQELLLIYEYMPNKSL----DVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 469
LG CL + L+ + MP+ L H + + L+W + IA+G++YL E
Sbjct: 75 LGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127
Query: 470 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 529
+++HRDL A N+L+ + KI+DFGLAR+ G++ + N + +MA E
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 530 GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589
F+ +SDV+S+GV + E L+T+ K + P E+ D + K
Sbjct: 185 YRKFTHQSDVWSYGVTIWE------------------LMTFGGKPYDGIPTREIPDLLEK 226
Query: 590 QSCAPDELLKFIHIGLL---CVQQDPADRPTMSSV--------------VVMLASDSMTI 632
P + I + ++ C D RP + +V+ D M +
Sbjct: 227 GERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYLVIQGDDRMKL 286
Query: 633 PQPTEPAF 640
P P + F
Sbjct: 287 PSPNDSKF 294
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 61/203 (30%), Positives = 109/203 (53%), Gaps = 23/203 (11%)
Query: 360 LGQGGFGPVYKGT-LADGKAIAVKRLS-RTSGQGLQEFKNEVNLIAKLQH---KNLVRLL 414
+G+G +G VY+G + G+ +A+K ++ T + + + EV L+++L+ N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 415 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL----YLHED 470
G L+G L +I EY S+ R++ + I+ I R +L Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSV--------RTLMKAGPIAEKYISVIIREVLVALKYIHKV 120
Query: 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 530
+IHRD+KA+NIL+ + N K+ DFG+A + NQN + + GT +MAPE
Sbjct: 121 G---VIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGTPYWMAPEVITE 175
Query: 531 GI-FSIKSDVFSFGVLLLEIISG 552
G + K+D++S G+ + E+ +G
Sbjct: 176 GKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 359 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKN--EVNLIAKLQHKNLVRLLG 415
K+G+G +G VYK G+ +A+K++ E+ L+ +L H N+++LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 416 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 475
+L L++E+M D++ R L +S + + +G+ + H I
Sbjct: 66 VFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGI 119
Query: 476 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFS 534
+HRDLK N+L++ + K++DFGLAR FG + T+ + T Y APE +G +S
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGS-PVRPYTHYVV-TRWYRAPELLLGDKGYS 177
Query: 535 IKSDVFSFGVLLLEIISGR 553
D++S G + E++S R
Sbjct: 178 TPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 80/225 (35%), Positives = 120/225 (53%), Gaps = 31/225 (13%)
Query: 350 ATNHFSDENKLGQGGFGPVYKGTL---ADG---KAIAVKRLS-RTSGQGLQEFKNEVNLI 402
+T F +E LG+ FG VYKG L A G +A+A+K L + G +EFK+E +
Sbjct: 5 STVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMR 62
Query: 403 AKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDW------KRRQS- 455
++LQH N+V LLG + Q L +I+ Y + D+H F RS D K +S
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHS--DLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 456 --------IINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGG 506
I+ IA G+ +L S ++H+DL N+L+ D +N KISD GL R ++
Sbjct: 121 LEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 507 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 551
+ + N + +M+PE M G FSI SD++S+GV+L E+ S
Sbjct: 178 DYYKLMGNSLLPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 64/200 (32%), Positives = 109/200 (54%), Gaps = 13/200 (6%)
Query: 359 KLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQHKNLVRLLG 415
K+G+G +G VYK G+ +A+K++ T +G+ E++L+ +L H N+VRLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 416 CCLEGQELLLIYEYMPNKSLDV-HLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 474
+L L++E++ LD+ D++ LD +S + + +GI Y H S +
Sbjct: 66 VVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH--SH-R 119
Query: 475 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IF 533
++HRDLK N+L+D + K++DFGLAR FG ++ T Y APE +G +
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGSRQY 177
Query: 534 SIKSDVFSFGVLLLEIISGR 553
S D++S G + E+++ R
Sbjct: 178 STPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 9e-24
Identities = 65/210 (30%), Positives = 100/210 (47%), Gaps = 21/210 (10%)
Query: 356 DENK----LGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 410
DEN LG+G +G VY L+ IA+K + + +Q E+ L + L+H+N+
Sbjct: 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNI 67
Query: 411 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL----Y 466
V+ LG E + E +P SL L RS K + I + IL Y
Sbjct: 68 VQYLGSDSENGFFKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIIFYTKQILEGLKY 123
Query: 467 LHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGYMAP 525
LH+ +I+HRD+K N+L++ KISDFG ++ G T GT YMAP
Sbjct: 124 LHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET--FTGTLQYMAP 178
Query: 526 EYAMGGI--FSIKSDVFSFGVLLLEIISGR 553
E G + +D++S G ++E+ +G+
Sbjct: 179 EVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 75/284 (26%), Positives = 127/284 (44%), Gaps = 56/284 (19%)
Query: 360 LGQGGFGPVYKGTLAD-GKAIAVKR--LSRTSGQGLQE--------FKNEVNLIAKLQHK 408
+G+G +G VY G+ +AVK+ L T ++E+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 409 NLVRLLGCCLEGQELLLIY-EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 467
N+V+ LG +E L I+ EY+P S+ L + + + + + G+ YL
Sbjct: 69 NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCL---RTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 468 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR----IFGGNQNQANTNIIAGTYGYM 523
H I+HRDLKA N+L+D D KISDFG+++ I+ N N + + G+ +M
Sbjct: 125 HSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYD---NDQNMS-MQGSVFWM 177
Query: 524 APE--YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAV 581
APE ++ +S K D++S G ++LE+ +GR+ W + A+
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-------------------WSDEEAI 218
Query: 582 ELIDPVLKQSCAP----DELLKFIHIGL----LCVQQDPADRPT 617
+ + + AP D + + L C +P +RPT
Sbjct: 219 AAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPT 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 64/206 (31%), Positives = 114/206 (55%), Gaps = 14/206 (6%)
Query: 354 FSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTS-GQGLQEFK-NEVNLIAKLQHKNL 410
++ K+G+G +G VYKG G+ +A+K++ S +G+ E++L+ +LQH N+
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 411 VRLLGCCLEGQELLLIYEYMPNKSLDVHLF-DATRSVQ-LDWKRRQSIINGIARGILYLH 468
V L ++ L LI+E++ S+D+ + D+ Q +D + +S + I +GIL+ H
Sbjct: 62 VCLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 469 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 528
+++HRDLK N+L+D+ K++DFGLAR FG ++ T Y APE
Sbjct: 119 ---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPEVL 173
Query: 529 MGGI-FSIKSDVFSFGVLLLEIISGR 553
+G +S D++S G + E+ + +
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 2e-23
Identities = 69/196 (35%), Positives = 100/196 (51%), Gaps = 14/196 (7%)
Query: 360 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE 419
+G+G FG V G G +AVK + + Q F E +++ +L+H NLV+LLG +E
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 420 GQ-ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHR 478
+ L ++ EYM SL +L RSV L + + YL ++ +HR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 479 DLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSD 538
DL A N+L+ +D K+SDFGL + Q+ + + APE FS KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREKKFSTKSD 181
Query: 539 VFSFGVLLLEIIS-GR 553
V+SFG+LL EI S GR
Sbjct: 182 VWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 65/201 (32%), Positives = 110/201 (54%), Gaps = 15/201 (7%)
Query: 359 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFK-NEVNLIAKLQHKNLVRLLGC 416
KLG+G + VYKG G+ +A+K + + +G E++L+ +L+H+N+VRL
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66
Query: 417 CLEGQELLLIYEYMPN---KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 473
+L+L++EYM K +D H LD +S + +GI + HE+
Sbjct: 67 IHTENKLMLVFEYMDKDLKKYMDTH----GVRGALDPNTVKSFTYQLLKGIAFCHEN--- 119
Query: 474 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-I 532
+++HRDLK N+L++ K++DFGLAR FG N + ++ T Y AP+ +G
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLLGSRT 177
Query: 533 FSIKSDVFSFGVLLLEIISGR 553
+S D++S G ++ E+I+GR
Sbjct: 178 YSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 358 NKLGQGGFGPVYKGT-LADGKAIAVKRLS--RTSGQGLQEFKNEVNLIAKLQHKNLVRLL 414
+G+G FG V K +DGK + K + + + Q+ +EVN++ +L+H N+VR
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 415 GCCL--EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY-----L 467
+ Q L ++ EY D + +Q K R+ I IL L
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGG-------DLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118
Query: 468 HE-----DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 522
+E D ++HRDLK +NI LD + N K+ DFGLA+I G + + A T GT Y
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYY 176
Query: 523 MAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 553
M+PE + KSD++S G L+ E+ +
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 3e-23
Identities = 81/280 (28%), Positives = 129/280 (46%), Gaps = 44/280 (15%)
Query: 360 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRLLGCCL 418
LG+G FG V+KGTL D +AVK Q L+ +F +E ++ + H N+V+L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 419 EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI--ARGILYLHEDSRLKII 476
+ Q + ++ E +P L R + + K +Q + + A G+ YL + I
Sbjct: 63 QRQPIYIVMELVPGGDFLSFL----RKKKDELKTKQLVKFALDAAAGMAYLESKN---CI 115
Query: 477 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT------YGYMAPEYAMG 530
HRDL A N L+ ++ KISDFG++R Q + I + + + APE
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR-------QEDDGIYSSSGLKQIPIKWTAPEALNY 168
Query: 531 GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590
G +S +SDV+S+G+LL E S L + A E ++ +
Sbjct: 169 GRYSSESDVWSYGILLWETFS---------------LGVCPYPGMTNQQAREQVEKGYRM 213
Query: 591 SC---APDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627
SC PD++ K + C P +RP S + LA+
Sbjct: 214 SCPQKCPDDVYK---VMQRCWDYKPENRPKFSELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 70/227 (30%), Positives = 115/227 (50%), Gaps = 28/227 (12%)
Query: 357 ENKLGQGGFGPVYKGT------LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 410
+ +LG+G FG V+ D +AVK L + ++F+ E L+ LQH+++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 411 VRLLGCCLEGQELLLIYEYMP----NKSLDVHLFDATRSVQLDWKRRQS----------- 455
V+ G C +G L++++EYM NK L H DA + +D + RQ+
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAM--ILVDGQPRQAKGELGLSQMLH 127
Query: 456 IINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTN 514
I + IA G++YL + +HRDL N L+ ++ KI DFG++R ++ + + +
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 184
Query: 515 IIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFS 561
+ +M PE M F+ +SDV+SFGV+L EI + K F S
Sbjct: 185 TMLPIR-WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 230
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 93/316 (29%), Positives = 138/316 (43%), Gaps = 60/316 (18%)
Query: 338 EFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSR-TSGQG 391
E PL +R E LG+ FG +YKG L + +A+K L + Q
Sbjct: 1 ELPLSAVRFMEE----------LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQ 50
Query: 392 LQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLF----------- 440
EF+ E +L+A+L H N+V LLG + Q + +++EY+ D+H F
Sbjct: 51 WGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQG--DLHEFLIMRSPHSDVG 108
Query: 441 -----DATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 495
D T LD I IA G+ YL S +H+DL A NIL+ + ++ KI
Sbjct: 109 CSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKI 165
Query: 496 SDFGLAR-IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRK 554
SD GL+R I+ + + + +M PE M G FS SD++SFGV+L EI S
Sbjct: 166 SDLGLSREIYSADYYRVQPKSLLPIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGL 224
Query: 555 NNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQS---CAPDELLKFIHIGLLCVQQD 611
+ FS E+I+ V K+ C+ D + + C Q+
Sbjct: 225 QPYYGFSNQ------------------EVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEG 266
Query: 612 PADRPTMSSVVVMLAS 627
P+ RP + L S
Sbjct: 267 PSRRPRFKDIHTRLRS 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 63/218 (28%), Positives = 100/218 (45%), Gaps = 43/218 (19%)
Query: 357 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN-----------EVNLIAK 404
KLG+G + VYK G+ +A+K++ L E K E+ L+ +
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIK------LGERKEAKDGINFTALREIKLLQE 58
Query: 405 LQHKNLVRLLGCCLEGQELLLIYEYMP--------NKSLDVHLFDATRSVQLDWKRRQSI 456
L+H N++ LL + L++E+M +KS+ L A D K S
Sbjct: 59 LKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIV--LTPA------DIK---SY 107
Query: 457 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 516
+ RG+ YLH I+HRDLK +N+L+ D K++DFGLAR FG + ++
Sbjct: 108 MLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV 164
Query: 517 AGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGR 553
T Y APE G + + D++S G + E++
Sbjct: 165 --TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 4e-23
Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 41/277 (14%)
Query: 360 LGQGGFGP--VYKGTLADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 415
LG+G FG +Y+ T D + K L+R S + ++ NE+ +++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 416 CCLEGQELLLIYEYMPNKSL-------DVHLFDATRSVQLDWKRRQSIINGIARGILYLH 468
++ LL+ EY +L LF+ + W Q I + Y+H
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEE---MVLWYLFQ-----IVSAVSYIH 118
Query: 469 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 528
+ I+HRD+K NI L K+ DFG+++I G + A T + GT YM+PE
Sbjct: 119 KAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELC 173
Query: 529 MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588
G ++ KSD+++ G +L E+++ ++ F L K+ +
Sbjct: 174 QGVKYNFKSDIWALGCVLYELLTLKRT----FD--ATNPLNLVVKIVQGNYTPVV----- 222
Query: 589 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
S EL+ +H +QQDP RPT V+
Sbjct: 223 --SVYSSELISLVH---SLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 9e-23
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 13/206 (6%)
Query: 353 HFSDENKLGQGGFGPVYKGTLADGKAI-AVKRLSRT---SGQGLQEFKNEVNLIAKLQHK 408
HF +G+G FG V D K + A+K +++ ++ NE ++ +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 409 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 468
LV L + + + L+ + + L HL ++ V+ ++ + I I + YLH
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHL---SQKVKFSEEQVKFWICEIVLALEYLH 117
Query: 469 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 528
IIHRD+K NILLD+ + I+DF +A + T +GT GYMAPE
Sbjct: 118 SK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVL 171
Query: 529 MGGIFSIKSDVFSFGVLLLEIISGRK 554
+S+ D +S GV E + G++
Sbjct: 172 CRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 1e-22
Identities = 82/301 (27%), Positives = 139/301 (46%), Gaps = 50/301 (16%)
Query: 357 ENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 410
+ +LG+G FG V+ D +AVK L S ++F E L+ LQH+++
Sbjct: 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 411 VRLLGCCLEGQELLLIYEYMP----NKSLDVHLFDA------TRSVQLDWKRRQSIINGI 460
V+ G C+EG L++++EYM NK L H DA R +L + I I
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 461 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNIIAGT 519
A G++YL + +HRDL N L+ +++ KI DFG++R ++ + + + +
Sbjct: 130 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 520 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGP 579
+M PE M F+ +SDV+S GV+L EI TY + W +
Sbjct: 187 R-WMPPESIMYRKFTTESDVWSLGVVLWEI------------------FTYGKQPWYQLS 227
Query: 580 AVELIDPVLK-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTI 632
E+I+ + + ++C P E+ + L C Q++P R + + +L + +
Sbjct: 228 NNEVIECITQGRVLQRPRTC-PKEVYDLM---LGCWQREPHMRLNIKEIHSLLQNLAKAS 283
Query: 633 P 633
P
Sbjct: 284 P 284
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 25/206 (12%)
Query: 359 KLGQGGFGPVYKGT-LADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 415
++G+G G V+K G+ +A+K+ L R G + E+ + QH +V+LL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 416 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQ--SIINGIARGILYLHEDSRL 473
G +L+ EYMP+ L + R + Q S + + +G+ Y+H
Sbjct: 67 VFPHGSGFVLVMEYMPSD-----LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---N 118
Query: 474 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG--- 530
I+HRDLK +N+L+ D KI+DFGLAR+F + + ++ +A T Y APE G
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-TRWYRAPELLYGARK 177
Query: 531 ---GIFSIKSDVFSFGVLLLEIISGR 553
G+ D+++ G + E+++G
Sbjct: 178 YDPGV-----DLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 58/199 (29%), Positives = 105/199 (52%), Gaps = 19/199 (9%)
Query: 358 NKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 416
++G G +G VYK +A G+ +A+K + G + + E++++ + +H N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 417 CLEGQELLLIYEYMPNKSLDVHLFDATR----SVQLDWKRRQSIINGIARGILYLHEDSR 472
L +L ++ EY SL ++ TR +Q+ + R+++ +G+ YLHE
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQ-DIYQVTRGPLSELQIAYVCRETL-----KGLAYLHE--- 119
Query: 473 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA---M 529
IHRD+K +NILL +D + K++DFG++ + + I GT +MAPE A
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI--GTPYWMAPEVAAVER 177
Query: 530 GGIFSIKSDVFSFGVLLLE 548
G + K D+++ G+ +E
Sbjct: 178 KGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 4e-22
Identities = 74/268 (27%), Positives = 125/268 (46%), Gaps = 21/268 (7%)
Query: 358 NKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 415
+G G VY L + + +A+KR+ + E + EV +++ H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 416 CCLEGQELLLIYEYMPNKS-LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 474
+ G EL L+ Y+ S LD+ R LD +++ + +G+ YLH + +
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG-LDEAIIATVLKEVLKGLEYLHSNGQ-- 123
Query: 475 IIHRDLKASNILLDDDMNPKISDFGL-ARIFGGNQNQANT-NIIAGTYGYMAPEYAMGGI 532
IHRD+KA NILL +D + KI+DFG+ A + G GT +MAPE
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182
Query: 533 -FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQS 591
+ K+D++SFG+ +E+ +G Y + L + P++E K S
Sbjct: 183 GYDFKADIWSFGITAIELATGAAPYSKYPP-----MKVLMLTLQNDPPSLETGADYKKYS 237
Query: 592 CAPDELLKFIHIGLLCVQQDPADRPTMS 619
+ +++ LC+Q+DP+ RPT
Sbjct: 238 KSFRKMIS------LCLQKDPSKRPTAE 259
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 7e-22
Identities = 70/210 (33%), Positives = 111/210 (52%), Gaps = 29/210 (13%)
Query: 357 ENKLGQGGFGPVYKGTLA-DGK---AIAVKRLS--RTSGQGLQEFKNEVNLIAKLQHKNL 410
E +G G FG V G L GK +A+K L T Q ++F +E +++ + H N+
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ-RRDFLSEASIMGQFDHPNI 67
Query: 411 VRLLGCCLEGQELLLIYEYMPNKSLDVHL--FDATRSV-QLDWKRRQSIINGIARGILYL 467
+ L G + + ++++ EYM N SLD L D +V QL ++ GIA G+ YL
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL-----VGMLRGIASGMKYL 122
Query: 468 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG------ 521
S + +HRDL A NIL++ ++ K+SDFGL+R+ + A T T G
Sbjct: 123 ---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT-----TRGGKIPIR 174
Query: 522 YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 551
+ APE F+ SDV+S+G+++ E++S
Sbjct: 175 WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 7e-22
Identities = 60/205 (29%), Positives = 107/205 (52%), Gaps = 11/205 (5%)
Query: 354 FSDENKLGQGGFGPVYKGTLADGK-AIAVKRLSRTSGQG-LQEFKNEVNLIAKLQHKNLV 411
F+ ++G+G FG VYKG K +A+K + + +++ + E+ ++++ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 412 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 471
R G L+G +L +I EY+ S D + L+ +I+ I +G+ YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSA----LDLLKPGPLEETYIATILREILKGLDYLHSER 121
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 531
+ IHRD+KA+N+LL + + K++DFG+A Q + NT GT +MAPE
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 176
Query: 532 IFSIKSDVFSFGVLLLEIISGRKNN 556
+ K+D++S G+ +E+ G N
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPPN 201
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 9e-22
Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 20/208 (9%)
Query: 358 NKLGQGGFGPVYKGTLADGKAIAVKRLS------RTSGQGLQEFKNEVNLIAKLQHKNLV 411
LG+G +G VY G G+ IAVK++ + + ++ + EV+L+ L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 412 RLLGCCLEGQELLLIYEYMPNKSLDVHL--FDATRSVQLDWKRRQSIINGIARGILYLHE 469
+ LG CL+ + + E++P S+ L F +Q I G+ YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQ-----ILDGVAYLHN 120
Query: 470 DSRLKIIHRDLKASNILLDDDMNPKISDFGLA-RIFGGNQNQANTNIIAGTYG---YMAP 525
+ ++HRD+K +N++L + K+ DFG A R+ + ++N++ +G +MAP
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 526 EYAMGGIFSIKSDVFSFGVLLLEIISGR 553
E + KSD++S G + E+ +G+
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 9e-22
Identities = 79/274 (28%), Positives = 134/274 (48%), Gaps = 40/274 (14%)
Query: 354 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAKLQHKN 409
F+D ++G G FG VY + + +A+K++S + Q +++++ EV + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKS---LDVHLFDATRSVQLDWKRRQSIINGIARGILY 466
+ GC L L+ EY + L+VH + V++ +I +G +G+ Y
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDILEVHK-KPLQEVEI-----AAICHGALQGLAY 130
Query: 467 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 526
LH + IHRD+KA NILL + K++DFG A + + AN+ + GT +MAPE
Sbjct: 131 LHS---HERIHRDIKAGNILLTEPGTVKLADFGSASL----VSPANSFV--GTPYWMAPE 181
Query: 527 --YAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583
AM G + K DV+S G+ +E ++ RK F+ + + L + +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIE-LAERKPP--LFNMNAMSALYHI---------AQN 229
Query: 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 617
P L + D F+ C+Q+ P DRP+
Sbjct: 230 DSPTLSSNDWSDYFRNFVD---SCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 2e-21
Identities = 88/313 (28%), Positives = 144/313 (46%), Gaps = 53/313 (16%)
Query: 354 FSDENKLGQGGFGPVYKGT-LADGKAI----AVKRLSR-TSGQGLQEFKNEVNLIAKLQH 407
F LG G FG VYKG + +G+ + A+K L TS + +E +E ++A + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 408 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGI 464
++ RLLG CL + LI + MP L D R + D Q ++N IA+G+
Sbjct: 69 PHVCRLLGICLT-STVQLITQLMPFGCL----LDYVREHK-DNIGSQYLLNWCVQIAKGM 122
Query: 465 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 524
YL E+ RL +HRDL A N+L+ + KI+DFGLA++ G ++ + + +MA
Sbjct: 123 NYL-EERRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179
Query: 525 PEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584
E + I++ +SDV+S+GV + E L+T+ K + PA E+
Sbjct: 180 LESILHRIYTHQSDVWSYGVTVWE------------------LMTFGSKPYDGIPASEIS 221
Query: 585 DPVLKQSCAPDELLKFIHIGLL---CVQQDPADRPTMSSVV--------------VMLAS 627
+ K P + I + ++ C D RP ++ V+
Sbjct: 222 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGD 281
Query: 628 DSMTIPQPTEPAF 640
+ M +P PT+ F
Sbjct: 282 ERMHLPSPTDSNF 294
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 81/284 (28%), Positives = 136/284 (47%), Gaps = 44/284 (15%)
Query: 359 KLGQGGFGPVYKGTLADG-------KAIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNL 410
+LGQG FG VY+G +A G +A+K ++ + + EF NE +++ + ++
Sbjct: 13 ELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 411 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLD-----------WKRRQSIING 459
VRLLG +GQ L+I E M L +L RS++ + K+ +
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 460 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNIIAG 518
IA G+ YL+ + K +HRDL A N ++ +D KI DFG+ R I+ + + +
Sbjct: 128 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 519 TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 578
+M+PE G+F+ SDV+SFGV+L EI + + Y + +L + EG
Sbjct: 185 VR-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGMSNEQVLRFV----MEG 237
Query: 579 PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 622
++ K PD L + + +C Q +P RP+ ++
Sbjct: 238 GLLD------KPDNCPDMLFELMR---MCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 66/200 (33%), Positives = 100/200 (50%), Gaps = 12/200 (6%)
Query: 360 LGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLG 415
LG+GGFG V + A GK A K+L++ +G + E ++AK+ H + L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59
Query: 416 CCLEGQ-ELLLIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRL 473
+ + +L L+ M L H+++ + R I G+ +LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116
Query: 474 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 533
+II+RDLK N+LLD+D N +ISD GLA Q++ T AGT G+MAPE G +
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEEY 174
Query: 534 SIKSDVFSFGVLLLEIISGR 553
D F+ GV L E+I+ R
Sbjct: 175 DFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 66/198 (33%), Positives = 105/198 (53%), Gaps = 12/198 (6%)
Query: 360 LGQGGFGPVYKGT-LADGKAI----AVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLVRL 413
LG G FG V+KG + +G +I A+K + R+ Q QE + + + L H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 414 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 473
LG C G L L+ + P SL H+ LD +R + IA+G+ YL E
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQIAKGMYYLEEH--- 128
Query: 474 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 533
+++HR+L A NILL D +I+DFG+A + + + + +MA E + G +
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188
Query: 534 SIKSDVFSFGVLLLEIIS 551
+ +SDV+S+GV + E++S
Sbjct: 189 THQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 3e-21
Identities = 71/273 (26%), Positives = 127/273 (46%), Gaps = 31/273 (11%)
Query: 354 FSDENKLGQGGFGPVYKGTLADGKA---IAVKRLSRTSGQG-LQEFKNEVNLIAKLQHKN 409
F+ ++G+G FG V+KG D + +A+K + + +++ + E+ ++++
Sbjct: 6 FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 469
+ + G L+G +L +I EY+ S D R+ D + +++ I +G+ YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDYLHS 119
Query: 470 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 529
+ K IHRD+KA+N+LL + + K++DFG+A Q + NT GT +MAPE
Sbjct: 120 E---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQ 174
Query: 530 GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589
+ K+D++S G+ +E+ G N H +L K L K
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPPNS---DMHPMRVLFLIPKN----NPPTLTGEFSK 227
Query: 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 622
F C+ +DP+ RPT ++
Sbjct: 228 P---------FKEFIDACLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 89/331 (26%), Positives = 144/331 (43%), Gaps = 89/331 (26%)
Query: 338 EFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKA----------------IAV 381
EFP LRL + KLG+G FG V+ A+G A +AV
Sbjct: 1 EFPRQQLRL----------KEKLGEGQFGEVHLCE-AEGLAEFLGEGAPEFDGQPVLVAV 49
Query: 382 KRL-SRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLF 440
K L + + +F E+ ++++L++ N++RLLG C+ L +I EYM N D++ F
Sbjct: 50 KMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENG--DLNQF 107
Query: 441 DATRSVQLDWKRRQSIIN-----------GIARGILYLHEDSRLKIIHRDLKASNILLDD 489
+ R ++ + +I + IA G+ YL + L +HRDL N L+ +
Sbjct: 108 LSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGN 164
Query: 490 DMNPKISDFGLAR-IFGGN----QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGV 544
KI+DFG++R ++ G+ Q +A I +MA E + G F+ SDV++FGV
Sbjct: 165 HYTIKIADFGMSRNLYSGDYYRIQGRAVLPI-----RWMAWESILLGKFTTASDVWAFGV 219
Query: 545 LLLEIISGRK--------------NNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590
L E+ + K N G +F G+ + L C P +L+
Sbjct: 220 TLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPL-CPSPVFKLM------ 272
Query: 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSV 621
+ C +D DRPT + +
Sbjct: 273 --------------MRCWSRDIKDRPTFNKI 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 5e-21
Identities = 60/199 (30%), Positives = 103/199 (51%), Gaps = 18/199 (9%)
Query: 359 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 417
K+GQG G VY +A G+ +A+K+++ + NE+ ++ + +H N+V L
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 418 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL----YLHEDSRL 473
L G EL ++ EY+ SL D +D + I + R L +LH +
Sbjct: 86 LVGDELWVVMEYLAGGSLT----DVVTETCMD----EGQIAAVCRECLQALEFLHSN--- 134
Query: 474 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 533
++IHRD+K+ NILL D + K++DFG Q++ +T + GT +MAPE +
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAY 192
Query: 534 SIKSDVFSFGVLLLEIISG 552
K D++S G++ +E++ G
Sbjct: 193 GPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 5e-21
Identities = 82/272 (30%), Positives = 127/272 (46%), Gaps = 42/272 (15%)
Query: 358 NKLGQGGFGPVYK----GTLADGKAIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVR 412
N++G G G VYK T G+ A+K + ++ + E+ ++ + H N+V+
Sbjct: 80 NRIGSGAGGTVYKVIHRPT---GRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 413 LLGCCLEGQELLLIYEYMPNKSLD-VHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 471
E+ ++ E+M SL+ H+ D L RQ I++GIA YLH
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIAD---EQFLADVARQ-ILSGIA----YLH--- 185
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE----- 526
R I+HRD+K SN+L++ N KI+DFG++RI + N+++ GT YM+PE
Sbjct: 186 RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV--GTIAYMSPERINTD 243
Query: 527 YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTW-KLWCEGPAVELID 585
G D++S GV +LE GR F F Q W L C A+ +
Sbjct: 244 LNHGAYDGYAGDIWSLGVSILEFYLGR----FPFGVGRQG----DWASLMC---AICMSQ 292
Query: 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 617
P + A E FI C+Q++PA R +
Sbjct: 293 PPEAPATASREFRHFIS---CCLQREPAKRWS 321
|
Length = 353 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 7e-21
Identities = 65/206 (31%), Positives = 113/206 (54%), Gaps = 19/206 (9%)
Query: 357 ENKLGQGGFGPVYKGTL-ADGKA---IAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLV 411
E +G G FG V +G L GK +A+K L S + + ++F +E +++ + H N++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 412 RLLGCCLEGQELLLIYEYMPNKSLD--VHLFDATRSV-QLDWKRRQSIINGIARGILYLH 468
L G + + +++I E+M N +LD + D +V QL ++ GIA G+ YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL-----VGMLRGIAAGMKYLS 123
Query: 469 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN-QNQANTNIIAGTYG--YMAP 525
E + +HRDL A NIL++ ++ K+SDFGL+R + + T+ + G + AP
Sbjct: 124 E---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 526 EYAMGGIFSIKSDVFSFGVLLLEIIS 551
E F+ SDV+S+G+++ E++S
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 8e-21
Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 23/223 (10%)
Query: 350 ATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRL---SRTSGQGLQEFKNEVNLIAKL 405
+ KLG+G FG VYK + G+ +A+K++ + G + + E+ ++ KL
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKL 64
Query: 406 QHKNLVRLLGCCLE-----GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI 460
+H N+V L+ +E ++ +Y P D+ SV+L + + + +
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQL 124
Query: 461 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAG-- 518
GI YLHE+ I+HRD+KA+NIL+D+ KI+DFGLAR + G G
Sbjct: 125 LEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTR 181
Query: 519 -------TYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 553
T Y PE +G ++ D++ G + E+ + R
Sbjct: 182 KYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 23/205 (11%)
Query: 360 LGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 413
LG G FG VYK G A K I ++ S + L++F E++++++ +H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIE-----SEEELEDFMVEIDILSECKHPNIVGL 67
Query: 414 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 473
+L ++ E+ +LD + L + + + + + +LH
Sbjct: 68 YEAYFYENKLWILIEFCDGGALD-SIMLELERG-LTEPQIRYVCRQMLEALNFLHSH--- 122
Query: 474 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 533
K+IHRDLKA NILL D + K++DFG++ + +T I GT +MAPE F
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI--GTPYWMAPEVVACETF 180
Query: 534 S-----IKSDVFSFGVLLLEIISGR 553
K+D++S G+ L+E+
Sbjct: 181 KDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 56/199 (28%), Positives = 88/199 (44%), Gaps = 15/199 (7%)
Query: 360 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQE-FKNEVNLIAKLQHKNLVRLLG 415
LG GGFG V + + A+K + + G QE +E ++ + H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 416 CCLEGQELLLIYEYMPNKSLDVHLFDATRSV-QLDWKRRQSIINGIARGILYLHEDSRLK 474
+ + + ++ EY L + R D + I + YLH
Sbjct: 61 TFKDKKYIYMLMEYCLGGEL----WTILRDRGLFDEYTARFYIACVVLAFEYLH---NRG 113
Query: 475 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 534
II+RDLK N+LLD + K+ DFG A+ Q T GT Y+APE + +
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYD 170
Query: 535 IKSDVFSFGVLLLEIISGR 553
D +S G+LL E+++GR
Sbjct: 171 FSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 69/203 (33%), Positives = 103/203 (50%), Gaps = 18/203 (8%)
Query: 360 LGQGGFGPVYKGT---LADGKA---IAVKRLSRTSGQGLQE-FKNEVNLIAKL-QHKNLV 411
LG G FG V + T L+ A +AVK L T+ +E +E+ +++ L H+N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 412 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 471
LLG C G +L+I EY L ++ R L + S +A+G+ +L +
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDL-LNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN 161
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN---QANTNIIAGTYGYMAPEYA 528
IHRDL A N+LL KI DFGLAR + N + N + +MAPE
Sbjct: 162 ---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL---PVKWMAPESI 215
Query: 529 MGGIFSIKSDVFSFGVLLLEIIS 551
+++ +SDV+S+G+LL EI S
Sbjct: 216 FNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-20
Identities = 79/271 (29%), Positives = 127/271 (46%), Gaps = 34/271 (12%)
Query: 354 FSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS---RTSGQGLQEFKNEVNLIAKLQHKN 409
FSD ++G G FG VY + + + +A+K++S + S + Q+ EV + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 469
++ GC L L+ EY + D L + + L ++ +G +G+ YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKK-PLQEVEIAAVTHGALQGLAYLHS 133
Query: 470 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 529
+ +IHRD+KA NILL + K+ DFG A I A N GT +MAPE +
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 184
Query: 530 G---GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586
G + K DV+S G+ +E+ + RK F+ + + L + + P
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL-AERKPP--LFNMNAMSALYHI---------AQNESP 232
Query: 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPT 617
L+ + F+ C+Q+ P DRPT
Sbjct: 233 ALQSGHWSEYFRNFVDS---CLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 76/206 (36%), Positives = 111/206 (53%), Gaps = 25/206 (12%)
Query: 360 LGQGGFGPVYKGTL--ADGKAI--AVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLVRLL 414
+G+G FG VY GTL +DG+ I AVK L+R T + +++F E ++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 415 GCCL--EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING--IARGILYLHED 470
G CL EG L+++ YM K D+ F RS + + I G +A+G+ YL
Sbjct: 63 GICLPSEGSPLVVL-PYM--KHGDLRNF--IRSETHNPTVKDLIGFGLQVAKGMEYLASK 117
Query: 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGN----QNQANTNIIAGTYGYMAP 525
K +HRDL A N +LD+ K++DFGLAR I+ N + +MA
Sbjct: 118 ---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL---PVKWMAL 171
Query: 526 EYAMGGIFSIKSDVFSFGVLLLEIIS 551
E F+ KSDV+SFGVLL E+++
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 82/272 (30%), Positives = 124/272 (45%), Gaps = 36/272 (13%)
Query: 359 KLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRLLGC 416
++G+G FG V+ G L AD +AVK T L+ +F E ++ + H N+VRL+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 417 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 476
C + Q + ++ E + + D F T +L K ++ A G+ YL I
Sbjct: 62 CTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 477 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG-------YMAPEYAM 529
HRDL A N L+ + KISDFG++R + + A T G + APE
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR-------EEEDGVYASTGGMKQIPVKWTAPEALN 169
Query: 530 GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589
G +S +SDV+SFG+LL E S Y + Q + V L P
Sbjct: 170 YGRYSSESDVWSFGILLWEAFS--LGAVPYANLSNQQTREAIEQ------GVRLPCP--- 218
Query: 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 621
+ C PD + + + C + DP RP+ S+V
Sbjct: 219 ELC-PDAVYRLM---ERCWEYDPGQRPSFSTV 246
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 64/202 (31%), Positives = 104/202 (51%), Gaps = 23/202 (11%)
Query: 359 KLGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 412
+LG G FG VYK G LA K I K S + L+++ E+ ++A H +V+
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYMVEIEILATCNHPYIVK 73
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 472
LLG +L ++ E+ P ++D + + R + + Q I + + YLH
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLT--EPQIQVICRQMLEALQYLHS--- 128
Query: 473 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM--- 529
+KIIHRDLKA N+LL D + K++DFG++ + ++ I GT +MAPE M
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI--GTPYWMAPEVVMCET 186
Query: 530 --GGIFSIKSDVFSFGVLLLEI 549
+ K+D++S G+ L+E+
Sbjct: 187 MKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 75/285 (26%), Positives = 129/285 (45%), Gaps = 41/285 (14%)
Query: 351 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS---RTSGQGLQEFKNEVNLIAKLQ 406
+F E K+G+G F VYK L DG+ +A+K++ + Q+ E++L+ +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 407 HKNLVRLLGCCLEGQELLLIYEYMPNKSL---------DVHLFDATRSVQLDWKRRQSII 457
H N+++ L +E EL ++ E L L R++ WK
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPE-RTI---WK----YF 112
Query: 458 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 517
+ + ++H +I+HRD+K +N+ + K+ D GL R F A++ +
Sbjct: 113 VQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-- 167
Query: 518 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL-WC 576
GT YM+PE ++ KSD++S G LL E+ + + + FY + L + K+ C
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYGDK--MNLYSLCKKIEKC 223
Query: 577 EGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 621
+ P + P S +EL + C+ DP RP +S V
Sbjct: 224 DYPPL----PADHYS---EELRDLVSR---CINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 4e-20
Identities = 85/289 (29%), Positives = 129/289 (44%), Gaps = 56/289 (19%)
Query: 359 KLGQGGFGPVYKG---TLADGKAIAVKRLSRTSGQGL--QEFKNEVNLIAKLQHKNLVRL 413
+LG G FG V KG K +AVK L + E E N++ +L + +VR+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 414 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 473
+G C E + +L+ E L+ L ++ + K +++ ++ G+ YL E +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN-- 115
Query: 474 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG-----YMAPEYA 528
+HRDL A N+LL KISDFGL++ G ++N A T+G + APE
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK----AKTHGKWPVKWYAPECM 170
Query: 529 MGGIFSIKSDVFSFGVLLLEIIS-GRK-------NNGFYFSEHGQTLLTYTWKLWCEGPA 580
FS KSDV+SFGVL+ E S G+K N E G+ + E P
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERM---------ECP- 220
Query: 581 VELIDPVLKQSCAPD--ELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627
Q C P+ +L+K LC +RP + V + L +
Sbjct: 221 ---------QRCPPEMYDLMK------LCWTYGVDERPGFAVVELRLRN 254
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 4e-20
Identities = 75/281 (26%), Positives = 136/281 (48%), Gaps = 25/281 (8%)
Query: 356 DENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 414
+EN + +G G YKG ++ +G VK ++ + E + + KLQH N+V+L+
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLI 749
Query: 415 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 474
G C + LI+EY+ K+L L + L W+RR+ I GIA+ + +LH
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPA 803
Query: 475 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 534
++ +L I++D P + L + + I+ Y+APE +
Sbjct: 804 VVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----TKCFISS--AYVAPETRETKDIT 856
Query: 535 IKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPA-VEL-IDPVLKQ-- 590
KSD++ FG++L+E+++G+ F HG + W +C +++ IDP ++
Sbjct: 857 EKSDIYGFGLILIELLTGKSPADAEFGVHGSIV---EWARYCYSDCHLDMWIDPSIRGDV 913
Query: 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMT 631
S +E+++ +++ L C DP RP + V+ L S S +
Sbjct: 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954
|
Length = 968 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 359 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKN----EVNLIAKLQHKNLVRL 413
+G+G +G V K A G+ +A+K+ + ++ K EV ++ +L+H+N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLRHENIVNL 65
Query: 414 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 473
L L++EY+ L+ L +A+ L +S I + + I Y H
Sbjct: 66 KEAFRRKGRLYLVFEYVERTLLE--LLEASPG-GLPPDAVRSYIWQLLQAIAYCH---SH 119
Query: 474 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 533
IIHRD+K NIL+ + K+ DFG AR T+ +A T Y APE +G
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPELLVGDTN 178
Query: 534 SIKS-DVFSFGVLLLEIISGR 553
K DV++ G ++ E++ G
Sbjct: 179 YGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 4e-20
Identities = 62/200 (31%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 360 LGQGGFGPV------YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 413
LG+GGFG V G + K + KRL + SG+ + + E+ + K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 414 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 473
L L+ M L H+++ L+ +R I GIL+LH +
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVG-ERGLEMERVIHYSAQITCGILHLHS---M 114
Query: 474 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 533
I++RD+K N+LLDD N ++SD GLA + AGT GYMAPE +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILKEEPY 171
Query: 534 SIKSDVFSFGVLLLEIISGR 553
S D F+ G + E+++GR
Sbjct: 172 SYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 5e-20
Identities = 63/202 (31%), Positives = 106/202 (52%), Gaps = 23/202 (11%)
Query: 360 LGQGGFGPVYKGTLADGKA---------IAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 410
+G+G FG V+ L KA I V+++++ Q NE ++ L H N+
Sbjct: 8 VGRGAFGIVH---LCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNI 61
Query: 411 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 470
+ LE + L+++ EY P +L ++ S+ LD +I++ + +L LH
Sbjct: 62 IEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LD---EDTILHFFVQILLALHHV 117
Query: 471 SRLKIIHRDLKASNILLDD-DMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 529
I+HRDLK NILLD M KI DFG+++I ++++A T + GT Y++PE
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL-SSKSKAYT--VVGTPCYISPELCE 174
Query: 530 GGIFSIKSDVFSFGVLLLEIIS 551
G ++ KSD+++ G +L E+ S
Sbjct: 175 GKPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 5e-20
Identities = 70/215 (32%), Positives = 104/215 (48%), Gaps = 26/215 (12%)
Query: 360 LGQGGFGPVY--------KGTLADGKAIAVKRLSR-TSGQGLQEFKNEVNLIAKL-QHKN 409
LG+G FG V K +AVK L + + L + +E+ ++ + +HKN
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHL-----------FDATR--SVQLDWKRRQSI 456
++ LLG C + L ++ EY +L +L FD + QL +K S
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 457 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 516
+ARG+ YL + K IHRDL A N+L+ +D KI+DFGLAR T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 517 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 551
+MAPE +++ +SDV+SFGVLL EI +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 5e-20
Identities = 89/294 (30%), Positives = 131/294 (44%), Gaps = 51/294 (17%)
Query: 360 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNE------VNLIAKLQ------- 406
LG+G FG V + A+ I R +T ++ K+ +LI++++
Sbjct: 20 LGEGCFGQVVR---AEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK 76
Query: 407 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL-----------FDATRSV--QLDWKRR 453
HKN++ LLG C + L +I EY +L L FD T+ QL +K
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 454 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 513
S +ARG+ YL +SR + IHRDL A N+L+ +D KI+DFGLAR T
Sbjct: 137 VSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 514 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEI--ISGRKNNGFYFSEHGQTLLTYT 571
+ +MAPE +++ +SDV+SFG+L+ EI + G G E
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE--------L 245
Query: 572 WKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
+KL EG ++ K S EL + C P RPT +V L
Sbjct: 246 FKLLREGHRMD------KPSNCTHELYMLMR---ECWHAVPTQRPTFKQLVEAL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 6e-20
Identities = 84/290 (28%), Positives = 135/290 (46%), Gaps = 44/290 (15%)
Query: 359 KLGQGGFGPVYKGTLAD---GKA---IAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLV 411
+LGQG FG VY+G D G+A +AVK ++ + S + EF NE +++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 412 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQ-----------SIINGI 460
RLLG +GQ L++ E M + L +L RS++ + + + I
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 461 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNIIAGT 519
A G+ YL+ K +HRDL A N ++ D KI DFG+ R I+ + + +
Sbjct: 129 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 520 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGP 579
MAPE G+F+ SD++SFGV+L E I+ + + Q L K +G
Sbjct: 186 RW-MAPESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQVL-----KFVMDGG 238
Query: 580 AVELIDPVLKQSCAPDELLKFIH-IGLLCVQQDPADRPTMSSVVVMLASD 628
++ PD + + + +C Q +P RPT +V +L D
Sbjct: 239 YLD----------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 6e-20
Identities = 63/195 (32%), Positives = 98/195 (50%), Gaps = 11/195 (5%)
Query: 359 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL 418
+LG G FG V G +A+K + S EF E ++ KL H+ LV+L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 419 EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHR 478
+ + + ++ EYM N L +L + + Q + + + G+ YL + IHR
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQP--SQLLEMCKDVCEGMAYLESK---QFIHR 124
Query: 479 DLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTY--GYMAPEYAMGGIFSIK 536
DL A N L+DD K+SDFGL+R ++ T+ + + + PE + FS K
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLLYSKFSSK 181
Query: 537 SDVFSFGVLLLEIIS 551
SDV++FGVL+ E+ S
Sbjct: 182 SDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 7e-20
Identities = 72/272 (26%), Positives = 116/272 (42%), Gaps = 48/272 (17%)
Query: 360 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRLLGCC 417
LG G G VYK L + +AVK + LQ + +E+ ++ K ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 418 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIA----RGILYLHEDSRL 473
+ + E+M SLDV+ K + ++ IA +G+ YL L
Sbjct: 69 FVENRISICTEFMDGGSLDVY-----------RKIPEHVLGRIAVAVVKGLTYLWS---L 114
Query: 474 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTY----GYMAPEYAM 529
KI+HRD+K SN+L++ K+ DFG++ N IA TY YMAPE
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL--------VNSIAKTYVGTNAYMAPERIS 166
Query: 530 GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589
G + I SDV+S G+ +E+ GR G + ++L+ ++
Sbjct: 167 GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM------------PLQLLQCIVD 214
Query: 590 QSCA--PDELL--KFIHIGLLCVQQDPADRPT 617
+ P KF+H C+++ P +RP
Sbjct: 215 EDPPVLPVGQFSEKFVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 8e-20
Identities = 68/215 (31%), Positives = 105/215 (48%), Gaps = 26/215 (12%)
Query: 360 LGQGGFGPVY--------KGTLADGKAIAVKRLS-RTSGQGLQEFKNEVNLIAKL-QHKN 409
LG+G FG V K + +AVK L + + L + +E+ ++ + +HKN
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHL-----------FDATR--SVQLDWKRRQSI 456
++ LLG C + L +I EY +L +L +D R Q+ +K S
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 457 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 516
+ARG+ YL + K IHRDL A N+L+ ++ KI+DFGLAR T
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 517 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 551
+MAPE +++ +SDV+SFGVL+ EI +
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 90.2 bits (223), Expect = 8e-20
Identities = 55/200 (27%), Positives = 106/200 (53%), Gaps = 10/200 (5%)
Query: 354 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 412
++ K+GQG G V+ +A G+ +A+K+++ + NE+ ++ +L++ N+V
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 472
L L G EL ++ EY+ SL D +D + ++ + + +LH +
Sbjct: 81 FLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQALEFLHAN-- 134
Query: 473 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 532
++IHRD+K+ N+LL D + K++DFG Q++ +T + GT +MAPE
Sbjct: 135 -QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 191
Query: 533 FSIKSDVFSFGVLLLEIISG 552
+ K D++S G++ +E++ G
Sbjct: 192 YGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 1e-19
Identities = 57/201 (28%), Positives = 102/201 (50%), Gaps = 11/201 (5%)
Query: 354 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG-LQEFKNEVNLIAKLQHKNLV 411
F+ K+G+G FG V+KG K +A+K + + +++ + E+ ++++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 412 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 471
+ G L+ +L +I EY+ S D LD + +I+ I +G+ YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 531
+ IHRD+KA+N+LL + K++DFG+A Q N GT +MAPE
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 532 IFSIKSDVFSFGVLLLEIISG 552
+ K+D++S G+ +E+ G
Sbjct: 177 AYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 76/274 (27%), Positives = 127/274 (46%), Gaps = 40/274 (14%)
Query: 354 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLS---RTSGQGLQEFKNEVNLIAKLQHKN 409
F+D ++G G FG VY + +A+K++S + S + Q+ EV + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKS---LDVHLFDATRSVQLDWKRRQSIINGIARGILY 466
+ GC L L+ EY + L+VH + V++ +I +G +G+ Y
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEI-----AAITHGALQGLAY 140
Query: 467 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 526
LH + +IHRD+KA NILL + K++DFG A I + N GT +MAPE
Sbjct: 141 LHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYWMAPE 191
Query: 527 YAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583
+ G + K DV+S G+ +E+ + F+ + + L + +
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHI---------AQN 239
Query: 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 617
P L+ + D F+ C+Q+ P DRPT
Sbjct: 240 ESPTLQSNEWSDYFRNFVDS---CLQKIPQDRPT 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 1e-19
Identities = 74/277 (26%), Positives = 130/277 (46%), Gaps = 48/277 (17%)
Query: 360 LGQGGFGPVYKGT-LADGKAIAVKRLS---RTSGQG---LQEFKNEVNLIAKLQHKNLVR 412
LG G F Y+ + G +AVK+++ TS + ++ + E+ L+A+L H +++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVHLFDA---TRSVQLDWKRRQSIINGIARGILYLHE 469
+LG E L E+M S+ L +V +++ + + RG+ YLHE
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQ------LLRGLSYLHE 121
Query: 470 DSRLKIIHRDLKASNILLDDD-MNPKISDFGLA-----RIFGGNQNQANTNIIAGTYGYM 523
+ +IIHRD+K +N+L+D +I+DFG A + G + Q + GT +M
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ---LLGTIAFM 175
Query: 524 APEYAMGGIFSIKSDVFSFGVLLLEIISGRKN-NGFYFSEHGQTLLTYTWKLWC--EGPA 580
APE G + DV+S G +++E+ + + N S H + +K+ P+
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI----FKIASATTAPS 231
Query: 581 V-ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRP 616
+ E + P L+ + L C++ P DRP
Sbjct: 232 IPEHLSPGLRD------------VTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 58/204 (28%), Positives = 109/204 (53%), Gaps = 11/204 (5%)
Query: 354 FSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQHKNL 410
F K+G+G +G VYK G+ +A+K++ T +G+ E++L+ +L H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 411 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 470
V+LL +L L++E++ ++ L + DA+ + +S + + +G+ + H
Sbjct: 62 VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 530
+++HRDLK N+L++ + K++DFGLAR FG ++ T Y APE +G
Sbjct: 120 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLG 174
Query: 531 G-IFSIKSDVFSFGVLLLEIISGR 553
+S D++S G + E+++ R
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 68/230 (29%), Positives = 102/230 (44%), Gaps = 51/230 (22%)
Query: 359 KLGQGGFGPVY------------KGTLADGKA-----IAVKRLSRT-SGQGLQEFKNEVN 400
KLG+G FG V+ K + A +AVK L S ++F EV
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 401 LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL-----FDATRSVQLDWKRRQS 455
++++L N+ RLLG C L +I EYM N L+ L + + +
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 456 IIN---GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 512
++ IA G+ YL L +HRDL N L+ + KI+DFG++R
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR---------- 178
Query: 513 TNIIAGTY----G-------YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 551
N+ + Y G +MA E + G F+ KSDV++FGV L EI++
Sbjct: 179 -NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 78/282 (27%), Positives = 137/282 (48%), Gaps = 35/282 (12%)
Query: 360 LGQGGFGPVY------KGTLADGKAIAVKRLS-RTSGQGLQEFKNEVNLIAKLQHKNLVR 412
LG+G FG V +G G+ +AVK L + G + + K E+ ++ L H+N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 413 LLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 470
G C E G + LI E++P+ SL +L + L + + ++ I +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAV--QICKGMDYL--G 126
Query: 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN--QANTNIIAGTYGYMAPEYA 528
SR + +HRDL A N+L++ + KI DFGL + ++ ++ + + Y APE
Sbjct: 127 SR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECL 184
Query: 529 MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSE--------HGQTLLTYTWKLWCEGPA 580
+ F I SDV+SFGV L E+++ + + HGQ +T ++ EG
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKR 244
Query: 581 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 622
+ +C P+E+ + + C + P+ R T +++
Sbjct: 245 LPRPP-----NC-PEEVYQLMR---KCWEFQPSKRTTFQNLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 62/203 (30%), Positives = 109/203 (53%), Gaps = 19/203 (9%)
Query: 358 NKLGQGGFGPVYKGT-LADGKAIAVKRLS-RTSGQGL-QEFKNEVNLIAKLQ---HKNLV 411
++G+G +G VYK L G+ +A+K++ S +G+ E+ L+ +L+ H N+V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 412 RLLGCCL-----EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 466
RLL C +L L++E++ ++ L +L + L + + ++ + RG+ +
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPG-LPPETIKDLMRQLLRGVDF 122
Query: 467 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 526
LH +I+HRDLK NIL+ D KI+DFGLARI+ A T+++ T Y APE
Sbjct: 123 LHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS--FEMALTSVVV-TLWYRAPE 176
Query: 527 YAMGGIFSIKSDVFSFGVLLLEI 549
+ ++ D++S G + E+
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 25/203 (12%)
Query: 359 KLGQGGFGPVYKGTLADGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 417
+LG G FG VYK + +A ++ T S + L+++ E++++A H N+V+LL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 418 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 477
L ++ E+ ++D + + R L + + + + YLHE+ KIIH
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERP--LTEPQIRVVCKQTLEALNYLHEN---KIIH 126
Query: 478 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA------GTYGYMAPEYAMGG 531
RDLKA NIL D + K++DFG++ NT I GT +MAPE M
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS--------AKNTRTIQRRDSFIGTPYWMAPEVVMCE 178
Query: 532 I-----FSIKSDVFSFGVLLLEI 549
+ K+DV+S G+ L+E+
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-19
Identities = 77/274 (28%), Positives = 128/274 (46%), Gaps = 40/274 (14%)
Query: 354 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ---GLQEFKNEVNLIAKLQHKN 409
F +++G G FG VY T + + +AVK++S + Q Q+ EV + +L+H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKS---LDVHLFDATRSVQLDWKRRQSIINGIARGILY 466
+ GC L+ L+ EY + L+VH + V++ +I +G +G+ Y
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHK-KPLQEVEI-----AAITHGALQGLAY 136
Query: 467 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 526
LH + +IHRD+KA NILL + K++DFG A + N GT +MAPE
Sbjct: 137 LHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASK------SSPANSFVGTPYWMAPE 187
Query: 527 YAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583
+ G + K DV+S G+ +E ++ RK F+ + + L + +
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIE-LAERKPP--LFNMNAMSALYHI---------AQN 235
Query: 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 617
P L+ + D F+ C+Q+ P +RP
Sbjct: 236 DSPTLQSNEWTDSFRGFVD---YCLQKIPQERPA 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 87.9 bits (217), Expect = 5e-19
Identities = 56/195 (28%), Positives = 103/195 (52%), Gaps = 10/195 (5%)
Query: 359 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 417
K+GQG G VY +A G+ +A+K+++ + NE+ ++ + ++ N+V L
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 418 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 477
L G EL ++ EY+ SL D +D + ++ + + +LH + ++IH
Sbjct: 86 LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALDFLHSN---QVIH 138
Query: 478 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 537
RD+K+ NILL D + K++DFG Q++ +T + GT +MAPE + K
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKV 196
Query: 538 DVFSFGVLLLEIISG 552
D++S G++ +E++ G
Sbjct: 197 DIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 6e-19
Identities = 67/214 (31%), Positives = 110/214 (51%), Gaps = 26/214 (12%)
Query: 357 ENKLGQGGFGPVYKGTL-ADGKAI--AVKRLSRTSGQG-LQEFKNEVNLIAKL-QHKNLV 411
++ +G+G FG V K + DG + A+KR+ + + ++F E+ ++ KL H N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 412 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLD-----WKRRQSIING------- 459
LLG C L L EY P+ +L + +R ++ D S ++
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNL-LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 460 --IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 517
+ARG+ YL S+ + IHRDL A NIL+ ++ KI+DFGL+R G + +
Sbjct: 131 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGR 184
Query: 518 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 551
+MA E +++ SDV+S+GVLL EI+S
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 8e-19
Identities = 56/201 (27%), Positives = 103/201 (51%), Gaps = 18/201 (8%)
Query: 359 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTS-GQGLQEFK-NEVNLIAKLQHKNLVRLLG 415
K+G+G +G V+K + +A+KR+ +G+ E+ L+ +L+HKN+VRL
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 416 CCLEGQELLLIYEYMPNKSLDVHL---FDATRSVQLDWKRRQSIINGIARGILYLHEDSR 472
++L L++EY D L FD+ +D + +S + + +G+ + H
Sbjct: 67 VLHSDKKLTLVFEY-----CDQDLKKYFDSCNG-DIDPEIVKSFMFQLLKGLAFCHSH-- 118
Query: 473 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG- 531
++HRDLK N+L++ + K++DFGLAR FG + ++ T Y P+ G
Sbjct: 119 -NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAK 175
Query: 532 IFSIKSDVFSFGVLLLEIISG 552
++S D++S G + E+ +
Sbjct: 176 LYSTSIDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 8e-19
Identities = 64/210 (30%), Positives = 108/210 (51%), Gaps = 29/210 (13%)
Query: 360 LGQGGFGPVYKGTLAD-GKAIAVKRL-----SRTSGQGLQEFKNEVNLIAKLQHKNLVRL 413
LGQG FG VY AD G+ +AVK++ S + + + + E+ L+ L H+ +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 414 LGCCLEGQE--LLLIYEYMPNKSLDVHL--FDA-TRSVQLDWKRRQSIINGIARGILYLH 468
GC + E L + E+MP S+ L + A T +V + R+ I G+ YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQ------ILEGVSYLH 123
Query: 469 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-----IFGGNQNQANTNIIAGTYGYM 523
+ I+HRD+K +NIL D N K+ DFG ++ G ++ + GT +M
Sbjct: 124 SN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS----VTGTPYWM 176
Query: 524 APEYAMGGIFSIKSDVFSFGVLLLEIISGR 553
+PE G + K+D++S G ++E+++ +
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 9e-19
Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 26/208 (12%)
Query: 360 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQG---LQEFKNEVNLIAKLQHKNLVR 412
+ +G +G V+ K T G A+K + + + + E +++++ Q +V+
Sbjct: 1 ISKGAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 413 LLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 471
L +G++ L L+ EY+P L L + S+ D R I I + YLH
Sbjct: 58 LY-YSFQGKKNLYLVMEYLPGGDL-ASLLENVGSLDEDVAR--IYIAEIVLALEYLH--- 110
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI-------IAGTYGYMA 524
IIHRDLK NIL+D + + K++DFGL++ G + Q N N I GT Y+A
Sbjct: 111 SNGIIHRDLKPDNILIDSNGHLKLTDFGLSK-VGLVRRQINLNDDEKEDKRIVGTPDYIA 169
Query: 525 PEYAMGGIFSIKSDVFSFGVLLLEIISG 552
PE +G S D +S G +L E + G
Sbjct: 170 PEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 18/213 (8%)
Query: 354 FSDENKLGQGGFGPVYKG---TLADGKAIAVKRL--SRTSGQGL-QEFKNEVNLIAKLQH 407
+ E +G+G +G VYK DGK A+K+ + G+ Q E+ L+ +L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 408 KNLVRLLGCCLEGQE--LLLIYEYMPNKSLDV-HLFDATRSVQLDWKRRQSIINGIARGI 464
+N+V L+ LE + + L+++Y + + + V + +S++ I G+
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 465 LYLHEDSRLKIIHRDLKASNILLDDDMNP----KISDFGLARIFGGNQNQ-ANTNIIAGT 519
YLH + ++HRDLK +NIL+ + KI D GLAR+F A+ + + T
Sbjct: 122 HYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVT 178
Query: 520 YGYMAPEYAMGGIFSIKS-DVFSFGVLLLEIIS 551
Y APE +G K+ D+++ G + E+++
Sbjct: 179 IWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 1e-18
Identities = 66/206 (32%), Positives = 108/206 (52%), Gaps = 21/206 (10%)
Query: 360 LGQGGFGPVYKGTLAD-GKAIAVKRL-----SRTSGQGLQEFKNEVNLIAKLQHKNLVRL 413
LGQG FG VY D G+ +A K++ S + + + + E+ L+ LQH+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 414 LGCCLE-GQELLLIY-EYMPNKSLDVHL--FDA-TRSVQLDWKRRQSIINGIARGILYLH 468
GC + ++ L I+ EYMP S+ L + A T SV + R+ I G+ YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQ------ILEGMSYLH 123
Query: 469 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLA-RIFGGNQNQANTNIIAGTYGYMAPEY 527
+ I+HRD+K +NIL D N K+ DFG + R+ + + GT +M+PE
Sbjct: 124 SN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180
Query: 528 AMGGIFSIKSDVFSFGVLLLEIISGR 553
G + K+DV+S G ++E+++ +
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 72/269 (26%), Positives = 123/269 (45%), Gaps = 33/269 (12%)
Query: 360 LGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 413
LG G G V K GT+ K + + S Q L+E + ++ + + +V
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRE----LQIMHECRSPYIVSF 68
Query: 414 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 473
G L + + E+M SLD ++ + ++ + I + G+ YL+ R
Sbjct: 69 YGAFLNENNICMCMEFMDCGSLD-RIYKKGGPIPVEILGK--IAVAVVEGLTYLYNVHR- 124
Query: 474 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 533
I+HRD+K SNIL++ K+ DFG++ G + + GT YM+PE GG +
Sbjct: 125 -IMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQGGKY 179
Query: 534 SIKSDVFSFGVLLLEIISGR-----KNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588
++KSDV+S G+ ++E+ G+ N + +L ++ E P P L
Sbjct: 180 TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP------PRL 233
Query: 589 KQSCAPDELLKFIHIGLLCVQQDPADRPT 617
S P++L F+ C+ +DP +RPT
Sbjct: 234 PSSDFPEDLRDFVDA---CLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 65/204 (31%), Positives = 108/204 (52%), Gaps = 21/204 (10%)
Query: 360 LGQGGFGPVYKGTLAD-GKAIAVKRL-----SRTSGQGLQEFKNEVNLIAKLQHKNLVRL 413
LG+G FG VY AD G+ +AVK++ S+ + + + + E+ L+ L+H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 414 LGCCLEGQE--LLLIYEYMPNKSLDVHL--FDA-TRSVQLDWKRRQSIINGIARGILYLH 468
GC + +E L + EYMP S+ L + A T +V + R+ I +G+ YLH
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQ------ILQGVSYLH 123
Query: 469 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLA-RIFGGNQNQANTNIIAGTYGYMAPEY 527
+ I+HRD+K +NIL D N K+ DFG + RI + + GT +M+PE
Sbjct: 124 SN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV 180
Query: 528 AMGGIFSIKSDVFSFGVLLLEIIS 551
G + K+DV+S ++E+++
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 53/201 (26%), Positives = 103/201 (51%), Gaps = 12/201 (5%)
Query: 354 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 412
+ K+G+G G V T + G+ +AVK++ Q + NEV ++ QH N+V
Sbjct: 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVE 80
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 472
+ L G EL ++ E++ +L D +++ ++ ++ + + + +LH
Sbjct: 81 MYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ-- 134
Query: 473 LKIIHRDLKASNILLDDDMNPKISDFGL-ARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 531
+IHRD+K+ +ILL D K+SDFG A++ ++ + GT +MAPE
Sbjct: 135 -GVIHRDIKSDSILLTSDGRVKLSDFGFCAQV---SKEVPRRKSLVGTPYWMAPEVISRL 190
Query: 532 IFSIKSDVFSFGVLLLEIISG 552
+ + D++S G++++E++ G
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 67/214 (31%), Positives = 107/214 (50%), Gaps = 26/214 (12%)
Query: 357 ENKLGQGGFGPVYKGTLA-DGKAI--AVKRLSR-TSGQGLQEFKNEVNLIAKL-QHKNLV 411
E+ +G+G FG V + + DG + A+K L S ++F E+ ++ KL H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 412 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLD------------WKRRQ--SII 457
LLG C L + EY P +L + +R ++ D +Q
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNL-LDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 458 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 517
+ +A G+ YL E + IHRDL A N+L+ +++ KI+DFGL+R G + +
Sbjct: 126 SDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGR 179
Query: 518 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 551
+MA E +++ KSDV+SFGVLL EI+S
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 1e-18
Identities = 62/205 (30%), Positives = 106/205 (51%), Gaps = 19/205 (9%)
Query: 360 LGQGGFGPVYKGTLADGKAI---AVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 414
LG+G FG V +G L +I AVK +++ + +++F +E + + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 415 GCCLEGQEL------LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGIL 465
G CL+ E ++I +M + L L + + Q ++ IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 466 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA-RIFGGNQNQANTNIIAGTYGYMA 524
YL S IHRDL A N +L+++MN ++DFGL+ +I+ G+ + I ++A
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQG-RIAKMPVKWIA 182
Query: 525 PEYAMGGIFSIKSDVFSFGVLLLEI 549
E +++ KSDV+SFGV + EI
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 73/282 (25%), Positives = 132/282 (46%), Gaps = 33/282 (11%)
Query: 353 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS---RTSGQGLQEFKNEVNLIAKLQHK 408
+F E K+G+G F VY+ T L DG +A+K++ + + E++L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 409 NLVRLLGCCLEGQELLLIYEYMPNKSLD--VHLFDATRSV---QLDWKRRQSIINGIARG 463
N+++ +E EL ++ E L + F + + + WK + + +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE-- 120
Query: 464 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYM 523
H SR +++HRD+K +N+ + K+ D GL R F A++ + GT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 524 APEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583
+PE ++ KSD++S G LL E+ + + FY G + Y+ C+ +E
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAA--LQSPFY----GDKMNLYS---LCK--KIEQ 222
Query: 584 ID-PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624
D P L +EL + ++ +C+ DP RP ++ V +
Sbjct: 223 CDYPPLPSDHYSEELRQLVN---MCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 66/215 (30%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 352 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQH-K 408
D ++G+G FG V K G +AVKR+ T + Q +++++ +
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCP 63
Query: 409 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR--QSIINGIA----R 462
+V+ G + + E M D+ L + V K + I+ IA +
Sbjct: 64 YIVKFYGALFREGDCWICMELM-----DISLDKFYKYVYEVLKSVIPEEILGKIAVATVK 118
Query: 463 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 522
+ YL E+ LKIIHRD+K SNILLD + N K+ DFG I G + AG Y
Sbjct: 119 ALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFG---ISGQLVDSIAKTRDAGCRPY 173
Query: 523 MAPE----YAMGGIFSIKSDVFSFGVLLLEIISGR 553
MAPE A G + ++SDV+S G+ L E+ +G+
Sbjct: 174 MAPERIDPSARDG-YDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 59/193 (30%), Positives = 94/193 (48%), Gaps = 7/193 (3%)
Query: 359 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL 418
+LG G FG V+ G +A+K + ++F E ++ KL H LV+L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 419 EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHR 478
+ + L ++ E+M N L +L R +L S+ + G+ YL +S IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 479 DLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSD 538
DL A N L+ K+SDFG+ R ++ +++ + PE +S KSD
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG-AKFPVKWSPPEVFNFSKYSSKSD 183
Query: 539 VFSFGVLLLEIIS 551
V+SFGVL+ E+ +
Sbjct: 184 VWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 81/275 (29%), Positives = 130/275 (47%), Gaps = 39/275 (14%)
Query: 360 LGQGGFGPVYKGTLA-DGKAI----AVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLVRL 413
LG G FG VYKG DG+ + A+K L TS + +E +E ++A + + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 414 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGILYLHED 470
LG CL + L+ + MP L D R + D Q ++N IA+G+ YL E
Sbjct: 75 LGICLT-STVQLVTQLMPYGCL----LDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEE- 127
Query: 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 530
++++HRDL A N+L+ + KI+DFGLAR+ ++ + + + +MA E +
Sbjct: 128 --VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH 185
Query: 531 GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590
F+ +SDV+S+GV + E L+T+ K + PA E+ D + K
Sbjct: 186 RRFTHQSDVWSYGVTVWE------------------LMTFGAKPYDGIPAREIPDLLEKG 227
Query: 591 SCAPDELLKFIHIGLL---CVQQDPADRPTMSSVV 622
P + I + ++ C D RP +V
Sbjct: 228 ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 57/196 (29%), Positives = 104/196 (53%), Gaps = 12/196 (6%)
Query: 359 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 417
K+GQG G VY +A G+ +A+++++ + NE+ ++ + ++ N+V L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 418 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 477
L G EL ++ EY+ SL D +D + ++ + + +LH + ++IH
Sbjct: 87 LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 478 RDLKASNILLDDDMNPKISDFGL-ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 536
RD+K+ NILL D + K++DFG A+I Q+ + + GT +MAPE + K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 537 SDVFSFGVLLLEIISG 552
D++S G++ +E+I G
Sbjct: 197 VDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 64/210 (30%), Positives = 107/210 (50%), Gaps = 18/210 (8%)
Query: 352 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHK 408
+ + K+G+G +G VYK + IA+K RL + E++L+ ++QH
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 409 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHL---FDATRSVQLDWKRRQSIINGIARGIL 465
N+VRL + L L++EY LD+ L D++ + + ++ + I RGI
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 466 YLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGYMA 524
Y H S +++HRDLK N+L+D N K++DFGLAR FG ++ T Y A
Sbjct: 117 YCH--SH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRA 171
Query: 525 PEYAMGG-IFSIKSDVFSFGVLLLEIISGR 553
PE +G +S D++S G + E+++ +
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 59/209 (28%), Positives = 108/209 (51%), Gaps = 21/209 (10%)
Query: 359 KLGQGGFGPVYKGTLA----DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 414
K+G+G G V +A G+ +AVK + Q + NEV ++ QH+N+V +
Sbjct: 28 KIGEGSTGIV---CIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 415 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 474
L G+EL ++ E++ +L D +L+ ++ ++ + + + YLH
Sbjct: 85 KSYLVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG--- 137
Query: 475 IIHRDLKASNILLDDDMNPKISDFGL-ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 533
+IHRD+K+ +ILL D K+SDFG A+I +++ + GT +MAPE +
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSLVGTPYWMAPEVISRTPY 194
Query: 534 SIKSDVFSFGVLLLEIISGRKNNGFYFSE 562
+ D++S G++++E++ G YFS+
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPP---YFSD 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 4e-18
Identities = 81/308 (26%), Positives = 134/308 (43%), Gaps = 74/308 (24%)
Query: 359 KLGQGGFGPVY------------KGTLADGKA-----IAVKRLSRTSGQGLQ-EFKNEVN 400
KLG+G FG V+ K D +AVK L + + + +F E+
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 401 LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL--------FDATRSVQLDWKR 452
++++L+ N++RLL C+ L +I EYM N L+ L + V + +
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 453 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGN---- 507
+ IA G+ YL S L +HRDL N L+ + KI+DFG++R ++ G+
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 508 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRK------------- 554
Q +A I +M+ E + G F+ SDV++FGV L EI++ K
Sbjct: 189 QGRAVLPI-----RWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI 243
Query: 555 -NNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPA 613
N G +F + G+ Y + K + PD L K + L C +++
Sbjct: 244 ENTGEFFRDQGRQ--VY----------------LPKPALCPDSLYKLM---LSCWRRNAK 282
Query: 614 DRPTMSSV 621
+RP+ +
Sbjct: 283 ERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 4e-18
Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 83 NTASNTFTSNLNILFNQKLHSEAGKS---LYYNASEGEFPDSVYGLYLCKFNVSFQSCQN 139
TA++TF SNLN L + L S A S + + G PD+VYGL C+ ++S C++
Sbjct: 13 TTANSTFESNLNALLSS-LSSNAASSSGKGFAAGTSGAAPDTVYGLAQCRGDLSASDCRS 71
Query: 140 CIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSD 173
C+ AV+ + + C K IWY C +R+
Sbjct: 72 CLATAVSELRRCCPNKKGGRIWY--DSCFLRYES 103
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 4e-18
Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 39/222 (17%)
Query: 353 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------EVNLI 402
+ +G G +G V G+ +A+K++S F + E+ L+
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-------FDDLIDAKRILREIKLL 53
Query: 403 AKLQHKNLVRLL-----GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSI 456
L+H+N++ LL + ++ ++ E M + L +S Q L Q
Sbjct: 54 RHLRHENIIGLLDILRPPSPEDFNDVYIVTELM-----ETDLHKVIKSPQPLTDDHIQYF 108
Query: 457 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN--TN 514
+ I RG+ YLH +IHRDLK SNIL++ + + KI DFGLAR ++++ T
Sbjct: 109 LYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165
Query: 515 IIAGTYGYMAPEYAMGGI---FSIKSDVFSFGVLLLEIISGR 553
+ T Y APE + +I D++S G + E+++ +
Sbjct: 166 YVV-TRWYRAPELLLSSSRYTKAI--DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 34/214 (15%)
Query: 360 LGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCC 417
+G+G +G VYK G+ +A+K + +E K E N++ K H N+ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 418 L------EGQELLLIYEYMPNKSLDVHLFDATRSVQ--LDWKRRQS------IINGIARG 463
+ +L L+ E S T V+ +R I+ RG
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGS-------VTDLVKGLRKKGKRLKEEWIAYILRETLRG 125
Query: 464 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYM 523
+ YLHE+ K+IHRD+K NILL + K+ DFG++ + NT I GT +M
Sbjct: 126 LAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI--GTPYWM 180
Query: 524 APE-----YAMGGIFSIKSDVFSFGVLLLEIISG 552
APE + +SDV+S G+ +E+ G
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 71/218 (32%), Positives = 104/218 (47%), Gaps = 32/218 (14%)
Query: 360 LGQGGFGPVYKGTLADG-----------KAIAVKRL-SRTSGQGLQEFKNEVNLIAKL-Q 406
LG+G FG V +A+ +AVK L S + + L + +E+ ++ + +
Sbjct: 26 LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 407 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLF-------------DATRSVQLDWKRR 453
HKN++ LLG C + L +I EY +L +L QL +K
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 454 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 513
S +ARG+ YL + K IHRDL A N+L+ +D KI+DFGLAR T
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199
Query: 514 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 551
+MAPE I++ +SDV+SFGVLL EI +
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 5e-18
Identities = 60/211 (28%), Positives = 109/211 (51%), Gaps = 20/211 (9%)
Query: 349 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAK 404
E TN + D +G G FG V G+ +A+K++ + T + ++ E+ L+
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKH 65
Query: 405 LQHKNLVRLLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARG 463
L+H+N++ L + E + + E + D+H +R ++ + Q + I RG
Sbjct: 66 LRHENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRPLEKQFI--QYFLYQILRG 120
Query: 464 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYM 523
+ Y+H ++HRDLK SNIL++++ + KI DFGLARI Q+ T ++ Y Y
Sbjct: 121 LKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRY-YR 172
Query: 524 APEYAMG-GIFSIKSDVFSFGVLLLEIISGR 553
APE + + ++ D++S G + E++ G+
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-18
Identities = 72/278 (25%), Positives = 128/278 (46%), Gaps = 33/278 (11%)
Query: 354 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS---RTSGQGLQEFKNEVNLIAKLQHKN 409
F E K+G+G F VY+ T L D K +A+K++ + Q+ E++L+ +L H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLD--VHLFDATRSV---QLDWKRRQSIINGIARGI 464
+++ L +E EL ++ E L + F + + + WK + + +
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE--- 120
Query: 465 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 524
H SR +++HRD+K +N+ + K+ D GL R F A++ + GT YM+
Sbjct: 121 ---HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMS 174
Query: 525 PEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL-WCEGPAVEL 583
PE ++ KSD++S G LL E+ + + FY + L + K+ C+ P
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAA--LQSPFYGDK--MNLFSLCQKIEQCDYP---- 226
Query: 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 621
P+ + + K + +C+ DP RP + V
Sbjct: 227 --PLPTEHYSE----KLRELVSMCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-18
Identities = 57/206 (27%), Positives = 107/206 (51%), Gaps = 15/206 (7%)
Query: 359 KLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 417
K+G+G G V T+ + GK +AVK++ Q + NEV ++ QH+N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 418 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 477
L G EL ++ E++ +L D +++ ++ ++ + + + LH +IH
Sbjct: 87 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139
Query: 478 RDLKASNILLDDDMNPKISDFGL-ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 536
RD+K+ +ILL D K+SDFG A++ ++ + GT +MAPE + +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKSLVGTPYWMAPELISRLPYGPE 196
Query: 537 SDVFSFGVLLLEIISGRKNNGFYFSE 562
D++S G++++E++ G YF+E
Sbjct: 197 VDIWSLGIMVIEMVDGEPP---YFNE 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 360 LGQGGFGPVYK--GTLADGKAIAVKRLS----------RTSGQGLQEFKNEVNLIAK-LQ 406
LG G FG VYK +A+K ++ R + + + +EV +I + L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 407 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGIL 465
H N+VR LE L ++ + + L H Q +R +I + +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 466 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI--IAGTYGYM 523
YLH++ R I+HRDL +NI+L +D I+DFGLA+ Q Q + + + GT Y
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK-----QKQPESKLTSVVGTILYS 180
Query: 524 APEYAMGGIFSIKSDVFSFGVLLLEI 549
PE + K+DV++FG +L ++
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 84/297 (28%), Positives = 133/297 (44%), Gaps = 72/297 (24%)
Query: 362 QGGFGPVYKGTLADGK-----AIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLG 415
+G FG ++ G L D K + VK + + + + E L+ L H+N++ +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 416 CCLEGQEL-LLIYEYMPNKSLDVHL-----FDATRSVQLDWKRRQSIINGIARGILYLHE 469
C+E E ++Y YM +L + L +A L ++ + IA G+ YLH
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH- 134
Query: 470 DSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IF-------GGNQNQANTNIIAGTYG 521
+ +IH+D+ A N ++D+++ KI+D L+R +F G N+N+
Sbjct: 135 --KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP--------VK 184
Query: 522 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAV 581
+MA E + +S SDV+SFGVLL E+++ GQT P V
Sbjct: 185 WMALESLVNKEYSSASDVWSFGVLLWELMT-----------LGQT------------PYV 221
Query: 582 ELIDPV-----------LKQ--SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
E IDP L Q +C PDEL + C DP +RP+ S +V L
Sbjct: 222 E-IDPFEMAAYLKDGYRLAQPINC-PDELFA---VMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 78/276 (28%), Positives = 125/276 (45%), Gaps = 45/276 (16%)
Query: 357 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFK--------NEVNLIAKLQHK 408
+ +LG+G FG VY + D KA+A +RL + E E L++KL H
Sbjct: 5 QQRLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62
Query: 409 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-------LDWKRRQSIINGIA 461
+V+ LE +I EY + LD L + + + +W +
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW------FIQLL 116
Query: 462 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 521
G+ Y+H+ +I+HRDLKA NI L +++ KI DFG++R+ G+ + A T GT
Sbjct: 117 LGVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPY 170
Query: 522 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAV 581
YM+PE + KSD++S G +L E+ + F GQ L+ ++ EGP
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYEMCC--LAHAF----EGQNFLSVVLRI-VEGPTP 223
Query: 582 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 617
L + +L + L +DP+ RP+
Sbjct: 224 SLPE------TYSRQLNSIMQSML---NKDPSLRPS 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 16/198 (8%)
Query: 359 KLGQGGFGPVYKGTLADGKA------IAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 412
K+G+G FG +Y LA K+ I L++ + + K EV L+AK++H N+V
Sbjct: 7 KIGEGSFGKIY---LAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVT 63
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 472
E L ++ EY L + + R V + S I+ G+ ++H+
Sbjct: 64 FFASFQENGRLFIVMEYCDGGDL-MKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR-- 120
Query: 473 LKIIHRDLKASNILLDDD-MNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 531
KI+HRD+K+ NI L + M K+ DFG+AR + A T GT Y++PE
Sbjct: 121 -KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPYYLSPEICQNR 177
Query: 532 IFSIKSDVFSFGVLLLEI 549
++ K+D++S G +L E+
Sbjct: 178 PYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 352 NHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRLSRTSGQGLQEFK---NEVNLIAKLQH 407
F ++GQGG+G V+ D I A+KR+ ++ L E + E +++ +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 408 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 467
+ LV+LL + + L L EY+P L + + D R +A +
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRT-LLNNLGVLSEDHARFY-----MAEMFEAV 114
Query: 468 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 527
L IHRDLK N L+D + K++DFGL++ G AN+ + G+ YMAPE
Sbjct: 115 DALHELGYIHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANS--VVGSPDYMAPEV 169
Query: 528 AMGGIFSIKSDVFSFGVLLLEIISG 552
G + D +S G +L E + G
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 66/211 (31%), Positives = 107/211 (50%), Gaps = 26/211 (12%)
Query: 360 LGQGGFGPVYKGTLA-DGKAI--AVKRLSRTSGQG-LQEFKNEVNLIAKL-QHKNLVRLL 414
+G+G FG V K + DG + A+KR+ + + ++F E+ ++ KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 415 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLD--WKRRQSIINGI------------ 460
G C L L EY P+ +L + +R ++ D + S + +
Sbjct: 63 GACEHRGYLYLAIEYAPHGNL-LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 461 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTY 520
ARG+ YL + + IHRDL A NIL+ ++ KI+DFGL+R G + +
Sbjct: 122 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPV 175
Query: 521 GYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 551
+MA E +++ SDV+S+GVLL EI+S
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 3e-17
Identities = 62/201 (30%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 358 NKLGQGGFGPVYKG--TLADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 413
+KLG+G + VYKG L D +A+K RL G + EV+L+ L+H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTL 69
Query: 414 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 473
+ L L++EY+ +K L +L D S+ + + + + RG+ Y H R
Sbjct: 70 HDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINM--HNVKLFLFQLLRGLNYCH---RR 123
Query: 474 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI- 532
K++HRDLK N+L+++ K++DFGLAR + ++ T Y P+ +G
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTD 181
Query: 533 FSIKSDVFSFGVLLLEIISGR 553
+S + D++ G + E+ +GR
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 3e-17
Identities = 71/238 (29%), Positives = 109/238 (45%), Gaps = 59/238 (24%)
Query: 359 KLGQGGFGPV---------------YKGTLADGKA--IAVKRL-SRTSGQGLQEFKNEVN 400
KLG+G FG V + + G+ +AVK L + +F EV
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 401 LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDV-----HLFDAT--------RSVQ 447
++++L+ N++RLLG C++ L +I EYM N L+ HL D +
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 448 LDWKRRQSIIN---GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 504
L S+++ IA G+ YL S L +HRDL N L+ +++ KI+DFG++R
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSR-- 186
Query: 505 GGNQNQANTNIIAGTY-----------GYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 551
N+ AG Y +MA E + G F+ SDV++FGV L EI+
Sbjct: 187 ---------NLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 59/206 (28%), Positives = 105/206 (50%), Gaps = 15/206 (7%)
Query: 359 KLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 417
K+G+G G V T GK +AVK++ Q + NEV ++ H+N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 418 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 477
L G EL ++ E++ +L D +++ ++ ++ + R + YLH +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 478 RDLKASNILLDDDMNPKISDFGL-ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 536
RD+K+ +ILL D K+SDFG A++ ++ + GT +MAPE + +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQV---SKEVPKRKSLVGTPYWMAPEVISRLPYGTE 198
Query: 537 SDVFSFGVLLLEIISGRKNNGFYFSE 562
D++S G++++E+I G YF+E
Sbjct: 199 VDIWSLGIMVIEMIDGEPP---YFNE 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 3e-17
Identities = 67/214 (31%), Positives = 98/214 (45%), Gaps = 49/214 (22%)
Query: 360 LGQGGFGPV----YKGTLADGKAIAVKRLSRT----SGQGLQEFKNEVNLIAKLQHKNLV 411
LG G FG V +KG+ GK A+K LS+ Q ++ NE ++ ++H LV
Sbjct: 9 LGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLV 64
Query: 412 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR--------G 463
L G + L L+ EY+P L HL ++ +AR
Sbjct: 65 NLYGSFQDDSNLYLVMEYVPGGELFSHL-----------RKSGRFPEPVARFYAAQVVLA 113
Query: 464 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYM 523
+ YLH L I++RDLK N+LLD D KI+DFG A+ G T + GT Y+
Sbjct: 114 LEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYTLCGTPEYL 165
Query: 524 APEYAMGGIFSIK-----SDVFSFGVLLLEIISG 552
APE I K D ++ G+L+ E+++G
Sbjct: 166 APE-----IILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 6e-17
Identities = 61/205 (29%), Positives = 107/205 (52%), Gaps = 18/205 (8%)
Query: 359 KLGQGGFGPVYKGTLADGKA---IAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRLL 414
+LG G FG V KG K +A+K L + + ++ E E ++ +L + +VR++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 415 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 474
G C E + L+L+ E L + F + + ++ +++ ++ G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPL--NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 475 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN--QANTNIIAGTY--GYMAPEYAMG 530
+HRDL A N+LL + KISDFGL++ G + + +A + AG + + APE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS---AGKWPLKWYAPECINF 172
Query: 531 GIFSIKSDVFSFGVLLLEIIS-GRK 554
FS +SDV+S+G+ + E S G+K
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 6e-17
Identities = 67/218 (30%), Positives = 108/218 (49%), Gaps = 42/218 (19%)
Query: 358 NKLGQGGFGPVYKGTLAD---GKAIAVKRL-----SRTSGQG-------LQEFKNEVNLI 402
KLG+G +G V+K D + +A+K++ + T Q LQE +
Sbjct: 13 QKLGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD----- 65
Query: 403 AKLQHKNLVRLLGC--CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI 460
H N+V+LL +++ L++EYM D+H R+ L+ ++ I+ +
Sbjct: 66 ----HPNIVKLLNVIKAENDKDIYLVFEYMET---DLH--AVIRANILEDVHKRYIMYQL 116
Query: 461 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF----GGNQNQANTNII 516
+ + Y+H S +IHRDLK SNILL+ D K++DFGLAR +N T+ +
Sbjct: 117 LKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173
Query: 517 AGTYGYMAPEYAMGGIFSIKS-DVFSFGVLLLEIISGR 553
A T Y APE +G K D++S G +L E++ G+
Sbjct: 174 A-TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 75/286 (26%), Positives = 136/286 (47%), Gaps = 40/286 (13%)
Query: 359 KLGQGGFGPVYKGTLAD-GKAIAVKR-LSRTSGQGLQEFK-NEVNLIAKLQHKNLVRLLG 415
+G+G +G V K + G+ +A+K+ L + +++ E+ ++ +L+H+NLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 416 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGILYLHEDSRLK 474
+ L L++E++ + LD D + LD R + + I RGI + H +
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLD----DLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--- 120
Query: 475 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI-F 533
IIHRD+K NIL+ K+ DFG AR + T+ +A T Y APE +G +
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYTDYVA-TRWYRAPELLVGDTKY 178
Query: 534 SIKSDVFSFGVLLLEIISGRKNNGFYF---SEHGQ---------TLLTYTWKLWCEG--- 578
D+++ G L+ E+++G F S+ Q L+ +++ +
Sbjct: 179 GRAVDIWAVGCLVTEMLTGEP----LFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234
Query: 579 -----PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMS 619
P V+ I+P+ K+ L+ + + C++ DP DRP+ S
Sbjct: 235 AGMRLPEVKEIEPLEKRFPKLSGLV--LDLAKQCLRIDPDDRPSSS 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 18/205 (8%)
Query: 360 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCL 418
+G G +G VYKG +A ++ +G +E K E+N++ K H+N+ G +
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 419 EGQ------ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 472
+ +L L+ E+ S+ L T+ L + I I RG+ +LH+
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130
Query: 473 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM--- 529
K+IHRD+K N+LL ++ K+ DFG++ + NT I GT +MAPE
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI--GTPYWMAPEVIACDE 187
Query: 530 --GGIFSIKSDVFSFGVLLLEIISG 552
+ KSD++S G+ +E+ G
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 79/282 (28%), Positives = 126/282 (44%), Gaps = 50/282 (17%)
Query: 357 ENKLGQGGFGPVYKGTLA-DGK---AIAVKRLSRTSGQGLQE--FKNEVNLIAKLQHKNL 410
E LG G FG + +G L K +A+ L R Q F E + + H N+
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTL-RAGCSDKQRRGFLAEALTLGQFDHSNI 68
Query: 411 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 470
VRL G G ++++ EYM N +LD L QL + ++ G+A G+ YL E
Sbjct: 69 VRLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYLSE- 125
Query: 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG------YMA 524
+ +H+ L A +L++ D+ KIS F ++++ I T + A
Sbjct: 126 --MGYVHKGLAAHKVLVNSDLVCKISGFR-----RLQEDKSEA--IYTTMSGKSPVLWAA 176
Query: 525 PEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVE- 582
PE FS SDV+SFG+++ E++S G + Y+ GQ ++ AVE
Sbjct: 177 PEAIQYHHFSSASDVWSFGIVMWEVMSYGERP---YWDMSGQDVIK----------AVED 223
Query: 583 ---LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 621
L P +C P+ L + + L C Q++ +RP S +
Sbjct: 224 GFRLPAPR---NC-PNLLHQLM---LDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 2e-16
Identities = 80/291 (27%), Positives = 120/291 (41%), Gaps = 55/291 (18%)
Query: 359 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN--EVNLIAKLQ-HKNLVRLL 414
+LG G FG VY G+ +A+K++ + +E N EV + KL H N+V+L
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKF-YSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 415 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 474
E EL ++EYM +L L + +SII I +G+ ++H +
Sbjct: 65 EVFRENDELYFVFEYM-EGNL-YQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHG 119
Query: 475 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN-TNIIAGTYGYMAPE------- 526
HRDLK N+L+ KI+DFGLAR +++ T+ + T Y APE
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAR---EIRSRPPYTDYV-STRWYRAPEILLRSTS 175
Query: 527 YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF---SEHGQ------TLLTYTWKLWCE 577
Y S D+++ G ++ E+ + R F SE Q L T T + W E
Sbjct: 176 Y------SSPVDIWALGCIMAELYTLRP----LFPGSSEIDQLYKICSVLGTPTKQDWPE 225
Query: 578 G-----------PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 617
G P A E + I ++ DP RPT
Sbjct: 226 GYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKD---MLRWDPKKRPT 273
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 67/207 (32%), Positives = 100/207 (48%), Gaps = 29/207 (14%)
Query: 360 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL------QHKN 409
LG+G FG V KGT + AVK L + LQ+ E + K +H
Sbjct: 3 LGKGSFGKVLLAELKGT---DELYAVKVLKK--DVILQDDDVECTMTEKRVLALAGKHPF 57
Query: 410 LVRLLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 468
L +L C + ++ L + EY+ L H+ RS + D R + I G+ +LH
Sbjct: 58 LTQLH-SCFQTKDRLFFVMEYVNGGDLMFHI---QRSGRFDEPRARFYAAEIVLGLQFLH 113
Query: 469 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR--IFGGNQNQANTNIIAGTYGYMAPE 526
E II+RDLK N+LLD + + KI+DFG+ + I GG T+ GT Y+APE
Sbjct: 114 ER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT----TSTFCGTPDYIAPE 166
Query: 527 YAMGGIFSIKSDVFSFGVLLLEIISGR 553
+ D ++ GVLL E+++G+
Sbjct: 167 ILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 60/200 (30%), Positives = 92/200 (46%), Gaps = 15/200 (7%)
Query: 360 LGQGGFGPV------YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 413
LG+GGFG V G + K + KR+ + G+ + NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65
Query: 414 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 473
L L+ M L H++ + + R I G+ LH++
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEA-GFEEGRAVFYAAEICCGLEDLHQE--- 121
Query: 474 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 533
+I++RDLK NILLDD + +ISD GLA Q GT GYMAPE +
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGYMAPEVVKNERY 178
Query: 534 SIKSDVFSFGVLLLEIISGR 553
+ D ++ G LL E+I+G+
Sbjct: 179 TFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 8e-16
Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 27/205 (13%)
Query: 359 KLGQGGFGPVYKGTLA----DGKAIAVKRL--SRTSGQGLQEFKNEVNLIAKLQHKNLVR 412
K+G+G FG K L DGK +K + S+ S + +E + EV +++ ++H N+V+
Sbjct: 7 KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ------LDWKRRQSIINGIARGILY 466
E L ++ +Y L +A R V LDW + I + +
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDL-YKKINAQRGVLFPEDQILDWFVQ------ICLALKH 116
Query: 467 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 526
+H+ KI+HRD+K+ NI L D K+ DFG+AR+ A T I GT Y++PE
Sbjct: 117 VHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI--GTPYYLSPE 171
Query: 527 YAMGGIFSIKSDVFSFGVLLLEIIS 551
++ KSD+++ G +L E+ +
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 8e-16
Identities = 63/203 (31%), Positives = 94/203 (46%), Gaps = 54/203 (26%)
Query: 376 GKAIAVKRLSRTSGQGLQEFKN---------EVNLIAKLQHKNLVRLLGCCLEGQELLLI 426
G+ +A+K+LSR F+N E+ L+ + HKN++ LL
Sbjct: 41 GQNVAIKKLSRP-------FQNVTHAKRAYRELVLMKLVNHKNIIGLLNV---------- 83
Query: 427 YEYMPNKSLD--------VHLFDAT--RSVQ--LDWKRRQSIINGIARGILYLHEDSRLK 474
+ P KSL+ + L DA + +Q LD +R ++ + GI +LH
Sbjct: 84 --FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG--- 138
Query: 475 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTY----GYMAPEYAMG 530
IIHRDLK SNI++ D KI DFGLAR A T+ + Y Y APE +G
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLART-------AGTSFMMTPYVVTRYYRAPEVILG 191
Query: 531 GIFSIKSDVFSFGVLLLEIISGR 553
+ D++S G ++ E+I G
Sbjct: 192 MGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 9e-16
Identities = 57/197 (28%), Positives = 102/197 (51%), Gaps = 16/197 (8%)
Query: 359 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 417
++G G +G VYK L G+ AVK + G + E+ ++ + +H N+V G
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 418 LEGQELLLIYEYMPNKSL-DV-HLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 475
L ++L + EY SL D+ H+ +Q+ + R+++ +G+ YLH ++
Sbjct: 76 LSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGKM-- 128
Query: 476 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM---GGI 532
HRD+K +NILL D+ + K++DFG+A + + I GT +MAPE A G
Sbjct: 129 -HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI--GTPYWMAPEVAAVEKNGG 185
Query: 533 FSIKSDVFSFGVLLLEI 549
++ D+++ G+ +E+
Sbjct: 186 YNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 15/215 (6%)
Query: 345 RLALEATNHFSDENKLGQGGFGPVYKGTLADGKA-IAVKRLSRTSGQGLQEFKN---EVN 400
+ E + + + + +G G +G V +A+K+LSR Q K E+
Sbjct: 8 KTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELR 66
Query: 401 LIAKLQHKNLVRLLGCCLEGQELLLIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIING 459
L+ + H+N++ LL L + Y+ + L + + +L Q ++
Sbjct: 67 LLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQ 126
Query: 460 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 519
I RG+ Y+H IIHRDLK SNI +++D KI DFGLAR T
Sbjct: 127 ILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDEMTGYVAT 178
Query: 520 YGYMAPEYAMGGIFSIKS-DVFSFGVLLLEIISGR 553
Y APE + + ++ D++S G ++ E+++G+
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 24/211 (11%)
Query: 354 FSDENKLGQGGFGPVYKG-TLADGKAIAVK--RLSRTSG----QGLQEFKNEVNLIAKLQ 406
F N++G+G +G VY+ G+ +A+K R+ L+E + L+ L+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLRE----ITLLLNLR 64
Query: 407 HKNLVRLLGCCLEGQEL---LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARG 463
H N+V L + G+ L L+ EY + L L + + + ++ + RG
Sbjct: 65 HPNIVELKEV-VVGKHLDSIFLVMEYC-EQDLASLLDNMPTP--FSESQVKCLMLQLLRG 120
Query: 464 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYM 523
+ YLHE+ IIHRDLK SN+LL D KI+DFGLAR +G ++ T Y
Sbjct: 121 LQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLWYR 175
Query: 524 APEYAMGGIFSIKS-DVFSFGVLLLEIISGR 553
APE +G + D+++ G +L E+++ +
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 47/132 (35%), Positives = 74/132 (56%), Gaps = 9/132 (6%)
Query: 422 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLK 481
E+ + E+M SLD L A R + + + SI + RG+ YL E + KI+HRD+K
Sbjct: 73 EISICMEHMDGGSLDQVLKKAGR-IPENILGKISI--AVLRGLTYLRE--KHKIMHRDVK 127
Query: 482 ASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFS 541
SNIL++ K+ DFG++ G + N GT YM+PE G ++++SD++S
Sbjct: 128 PSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWS 183
Query: 542 FGVLLLEIISGR 553
G+ L+E+ GR
Sbjct: 184 LGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 64/201 (31%), Positives = 93/201 (46%), Gaps = 17/201 (8%)
Query: 360 LGQGGFGPVYKGTL-ADGKAIAVKRLS-----RTSGQGLQEFKNEVNLIAKLQHKNLVRL 413
LG+GGFG V + A GK A K+L + G+ + NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65
Query: 414 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 473
L L+ M L H+++ D +R I G+ LH R
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNP-GFDEERAVFYAAEITCGLEDLH---RE 121
Query: 474 KIIHRDLKASNILLDDDMNPKISDFGLA-RIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 532
+I++RDLK NILLDD + +ISD GLA I G + GT GYMAPE
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV----GTVGYMAPEVVKNER 177
Query: 533 FSIKSDVFSFGVLLLEIISGR 553
++ D + G L+ E+I G+
Sbjct: 178 YTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 60/201 (29%), Positives = 102/201 (50%), Gaps = 15/201 (7%)
Query: 358 NKLGQGGFGPVYKG--TLADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 413
KLG+G + V+KG L + +A+K RL G + EV+L+ L+H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTL 69
Query: 414 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 473
+ L L++EY+ +K L ++ D + + + + I RG+ Y H R
Sbjct: 70 HDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSM--HNVKIFLYQILRGLAYCH---RR 123
Query: 474 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI- 532
K++HRDLK N+L+++ K++DFGLAR + ++ T Y P+ +G
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSE 181
Query: 533 FSIKSDVFSFGVLLLEIISGR 553
+S + D++ G + E+ SGR
Sbjct: 182 YSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 64/204 (31%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 360 LGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK------LQHKNLVR 412
LG+G FG V+ L + A+K L + L + E ++ K +H L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 413 LLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 471
L C + +E L + EY+ L H+ + D R I G+ +LH
Sbjct: 61 LY-CTFQTKENLFFVMEYLNGGDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLHSKG 116
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLAR--IFGGNQNQANTNIIAGTYGYMAPEYAM 529
I++RDLK NILLD D + KI+DFG+ + + G A T GT Y+APE +
Sbjct: 117 ---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFCGTPDYIAPEILL 169
Query: 530 GGIFSIKSDVFSFGVLLLEIISGR 553
G ++ D +SFGVLL E++ G+
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-15
Identities = 59/169 (34%), Positives = 80/169 (47%), Gaps = 23/169 (13%)
Query: 460 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 519
+ARG+ +L SR K IHRDL A NILL ++ KI DFGLAR + +
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 520 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS--GRKNNGFYFSEHGQTLLTYTWKLWCE 577
+MAPE +++ +SDV+SFGVLL EI S G E +C
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-----------FCR 287
Query: 578 GPAVELIDPVLKQSCAPDELLKFIH-IGLLCVQQDPADRPTMSSVVVML 625
L + + AP+ I+ I L C +P DRPT S +V +L
Sbjct: 288 ----RLKEGT--RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 62/199 (31%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 360 LGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLG 415
LG+GGFG V + A GK A KRL + +G NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 416 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 475
L L+ M L H+++ + +R I G+ LH ++
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNP-GFEEERALFYAAEILCGLEDLHREN---T 123
Query: 476 IHRDLKASNILLDDDMNPKISDFGLA-RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 534
++RDLK NILLDD + +ISD GLA +I G + GT GYMAPE ++
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV----GTVGYMAPEVLNNQRYT 179
Query: 535 IKSDVFSFGVLLLEIISGR 553
+ D + G L+ E+I G+
Sbjct: 180 LSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 62/199 (31%), Positives = 106/199 (53%), Gaps = 14/199 (7%)
Query: 360 LGQGGFGPVY---KGTLAD-GKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRL 413
LGQG FG V+ K T D G+ A+K L + + + K E +++A++ H +V+L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 414 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 473
+L LI +++ L L ++ V + + + +A + +LH L
Sbjct: 64 HYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHLH---SL 117
Query: 474 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 533
II+RDLK NILLD++ + K++DFGL++ ++ +A + GT YMAPE
Sbjct: 118 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRRGH 175
Query: 534 SIKSDVFSFGVLLLEIISG 552
+ +D +SFGVL+ E+++G
Sbjct: 176 TQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 72/271 (26%), Positives = 120/271 (44%), Gaps = 33/271 (12%)
Query: 358 NKLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 414
++LG+G +G VYK G +A+K RL + + E++++ K +V
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDFY 65
Query: 415 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 474
G + + EYM SLD + + + I + +G+ +L E+
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HN 123
Query: 475 IIHRDLKASNILLDDDMNPKISDFGLARIFGGN--QNQANTNIIAGTYGYMAPEYAMGG- 531
IIHRD+K +N+L++ + K+ DFG++ GN + A TNI G YMAPE G
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTNI--GCQSYMAPERIKSGG 177
Query: 532 -----IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586
++++SDV+S G+ +LE+ GR Y E + + +G P
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYP---YPPETYANIFAQLSAI-VDGDP-----P 228
Query: 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPT 617
L + D F+ C+ + P RPT
Sbjct: 229 TLPSGYSDDA-QDFVA---KCLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 359 KLGQGGFGPVYKGTLADGK----AIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRL 413
+G+G FG VY+G + A+AVK + ++E F E ++ + H ++V+L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 414 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 473
+G E + ++ E P L +L LD ++ + YL
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES---K 126
Query: 474 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 533
+ +HRD+ A N+L+ K+ DFGL+R +++ + +MAPE F
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPESINFRRF 185
Query: 534 SIKSDVFSFGVLLLEIIS 551
+ SDV+ FGV + EI+
Sbjct: 186 TSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 4e-15
Identities = 68/203 (33%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 360 LGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK----LQHKN-LVRL 413
LG+G FG V L G+ AVK L + L + E ++ K L +N +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVV--LIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 414 LGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 472
L C + +E L + E++ L H+ D R D R I G+ +LH
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR---FDLYRATFYAAEIVCGLQFLHSKG- 116
Query: 473 LKIIHRDLKASNILLDDDMNPKISDFGLAR--IFGGNQNQANTNIIAGTYGYMAPEYAMG 530
II+RDLK N++LD D + KI+DFG+ + +FG N+A+T GT Y+APE G
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRAST--FCGTPDYIAPEILQG 170
Query: 531 GIFSIKSDVFSFGVLLLEIISGR 553
++ D +SFGVLL E++ G+
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 360 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFK---NEVNLIAKLQH-KNLVRLL 414
LG+G +G V K + G +AVKR+ T QE K ++++ + V
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS--QEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 415 GCCLEGQELLLIYEYMPNKSLD---VHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 471
G ++ + E M + SLD ++D ++ D + I I + + YLH
Sbjct: 67 GALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGK--IAVSIVKALEYLHS-- 121
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 531
+L +IHRD+K SN+L++ + K+ DFG I G + I AG YMAPE
Sbjct: 122 KLSVIHRDVKPSNVLINRNGQVKLCDFG---ISGYLVDSVAKTIDAGCKPYMAPERINPE 178
Query: 532 I----FSIKSDVFSFGVLLLEIISGR 553
+ + +KSDV+S G+ ++E+ +GR
Sbjct: 179 LNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 5e-15
Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 17/200 (8%)
Query: 360 LGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK------LQHKNLVR 412
LG+G FG V L G+ AVK L + LQ+ E + K H L +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 472
L C L + E++ L +F +S + D R + I +++LH+
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDKG- 116
Query: 473 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 532
II+RDLK N+LLD + + K++DFG+ + G N T+ GT Y+APE +
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEML 172
Query: 533 FSIKSDVFSFGVLLLEIISG 552
+ D ++ GVLL E++ G
Sbjct: 173 YGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 5e-15
Identities = 48/150 (32%), Positives = 72/150 (48%), Gaps = 9/150 (6%)
Query: 358 NKLGQGGFGPVYKGTLADGKAIA---VKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRL 413
+++G G FG V G G + A VK L ++ Q F EV +L H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 414 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR--QSIINGIARGILYLHEDS 471
LG C+E LL+ E+ P L +L V ++ Q + +A G+L+LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLA 501
+ IH DL N L D++ KI D+GLA
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 6e-15
Identities = 57/212 (26%), Positives = 104/212 (49%), Gaps = 31/212 (14%)
Query: 335 ESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRL---SRTSGQ 390
+ EFP + + + K+GQG FG V+K + +A+K++ + G
Sbjct: 1 DQYEFPF------CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGF 54
Query: 391 GLQEFKNEVNLIAKLQHKNLVRLLGCC---------LEGQELLLIYEYMPNKSLDVHLFD 441
+ + E+ ++ L+H+N+V L+ C +G L++E+ + D+
Sbjct: 55 PITALR-EIKILQLLKHENVVNLIEICRTKATPYNRYKGS-FYLVFEFCEH---DLAGLL 109
Query: 442 ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 501
+ ++V+ + ++ + G+ Y+H R KI+HRD+KA+NIL+ D K++DFGLA
Sbjct: 110 SNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLA 166
Query: 502 RIFGGNQNQAN---TNIIAGTYGYMAPEYAMG 530
R F ++N TN + T Y PE +G
Sbjct: 167 RAFSLSKNSKPNRYTNRVV-TLWYRPPELLLG 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 7e-15
Identities = 52/197 (26%), Positives = 98/197 (49%), Gaps = 16/197 (8%)
Query: 359 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 417
++G G +G VYK + G+ A+K + G+ + E+ ++ +H N+V G
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY 75
Query: 418 LEGQELLLIYEYMPNKSLD--VHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 475
L +L + E+ SL H+ Q+ + R+++ +G+ YLH +
Sbjct: 76 LRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKGK--- 127
Query: 476 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM---GGI 532
+HRD+K +NILL D+ + K++DFG++ + + I GT +MAPE A G
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI--GTPYWMAPEVAAVERKGG 185
Query: 533 FSIKSDVFSFGVLLLEI 549
++ D+++ G+ +E+
Sbjct: 186 YNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-15
Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 38/212 (17%)
Query: 360 LGQGGFGPVY---KGTLAD-GKAIAVKRLSR----TSGQGLQEFKNEVNLIAKLQHKNLV 411
LG+GG+G V+ K T AD GK A+K L + + + K E N++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 412 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSI---------INGIAR 462
L+ G +L LI EY+ L +HL R+ I ++ I+
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHL------------EREGIFMEDTACFYLSEISL 111
Query: 463 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR--IFGGNQNQANTNIIAGTY 520
+ +LH + II+RDLK NILLD + K++DFGL + I G T+ GT
Sbjct: 112 ALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG----TVTHTFCGTI 164
Query: 521 GYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 552
YMAPE M D +S G L+ ++++G
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 9e-15
Identities = 60/219 (27%), Positives = 106/219 (48%), Gaps = 35/219 (15%)
Query: 353 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS---------RTSGQGLQEFKNEVNLI 402
+ + + +G+G +G V T G +A+K++S RT L+E K ++
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT----LREIK----IL 57
Query: 403 AKLQHKNLVRLL-----GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 457
+ +H+N++ +L ++ ++ E M D++ ++ L Q +
Sbjct: 58 RRFKHENIIGILDIIRPPSFESFNDVYIVQELMET---DLY--KLIKTQHLSNDHIQYFL 112
Query: 458 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN--TNI 515
I RG+ Y+H + ++HRDLK SN+LL+ + + KI DFGLARI + T
Sbjct: 113 YQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEY 169
Query: 516 IAGTYGYMAPEYAMGGIFSIKS-DVFSFGVLLLEIISGR 553
+A T Y APE + K+ D++S G +L E++S R
Sbjct: 170 VA-TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 61/219 (27%), Positives = 109/219 (49%), Gaps = 27/219 (12%)
Query: 352 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRL---SRTSGQGLQEFKNEVNLIAKLQH 407
+ F ++G+G +G VYK D G+ +A+K++ + G + + E+ ++ +L H
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNH 65
Query: 408 KNLVRLLGCCLEGQELL----------LIYEYMPNKSLDVHLFDATRSVQLDWKRRQ--S 455
+N+V L + Q+ L L++EYM D L S + + S
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDHIKS 120
Query: 456 IINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 515
+ + G+ Y H+ + L HRD+K SNILL++ K++DFGLAR++ +++ TN
Sbjct: 121 FMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNK 177
Query: 516 IAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGR 553
+ T Y PE +G + DV+S G +L E+ + +
Sbjct: 178 VI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 63/202 (31%), Positives = 98/202 (48%), Gaps = 19/202 (9%)
Query: 360 LGQGGFGPVYKGTLADGKAI-AVKRLSRTSGQGLQEFKNEVNLIAK------LQHKNLVR 412
LG+G FG V L A+K L + L++ E ++ + +H L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVV--LEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 413 LLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 471
L C + +E L + EY+ L H+ + R D R + I G+ +LH+
Sbjct: 61 LF-CTFQTKEHLFFVMEYLNGGDLMFHIQSSGR---FDEARARFYAAEIICGLQFLHKKG 116
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 531
II+RDLK N+LLD D + KI+DFG+ + + +A+T GT Y+APE G
Sbjct: 117 ---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYIAPEILKGQ 171
Query: 532 IFSIKSDVFSFGVLLLEIISGR 553
++ D +SFGVLL E++ G+
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 27/211 (12%)
Query: 359 KLGQGGFGPVYKG-TLADGKAIAVKR-LSRTSGQGLQEFK-NEVNLIAKLQHKN-LVRLL 414
K+G+G +G VYK GK +A+K+ +G+ E++L+ L +VRLL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 415 GCCLEGQE-------LLLIYEYMPNKSLDVHLF-DATR---SVQLDWKRRQSIINGIARG 463
+E E L L++EY+ D+ F D+ L K +S + + +G
Sbjct: 68 --DVEHVEEKNGKPSLYLVFEYL---DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 464 ILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGY 522
+ + H + ++HRDLK N+L+D KI+D GL R F I+ T Y
Sbjct: 123 VAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV--TLWY 177
Query: 523 MAPEYAMGGI-FSIKSDVFSFGVLLLEIISG 552
APE +G +S D++S G + E+
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 57/207 (27%), Positives = 107/207 (51%), Gaps = 20/207 (9%)
Query: 359 KLGQGGFGPVYKG-TLADG-KAIAVKRLS-RTSGQGLQ-EFKNEVNLIAKLQ---HKNLV 411
++G+G +G V+K L +G + +A+KR+ +T +G+ EV ++ L+ H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 412 RLLGCCLEGQ-----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 466
RL C + +L L++E++ ++ L +L D + + + ++ + RG+ +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 467 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 526
LH +++HRDLK NIL+ K++DFGLARI+ Q + T Y APE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPE 179
Query: 527 YAMGGIFSIKSDVFSFGVLLLEIISGR 553
+ ++ D++S G + E+ +
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 52/196 (26%), Positives = 87/196 (44%), Gaps = 17/196 (8%)
Query: 362 QGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKN----EVNLIAKLQHKNLVRLLGC 416
+G FG VY + G A+K L ++ + N ++ + + + +L
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 417 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 476
L L+ EY+ L + DW ++ I + G+ LH+ II
Sbjct: 66 FQSKDYLYLVMEYLNGGDCAS-LIKTLGGLPEDWAKQ--YIAEVVLGVEDLHQRG---II 119
Query: 477 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 536
HRD+K N+L+D + K++DFGL+R G +N+ GT Y+APE +G
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRN--GLENKK----FVGTPDYLAPETILGVGDDKM 173
Query: 537 SDVFSFGVLLLEIISG 552
SD +S G ++ E + G
Sbjct: 174 SDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 13/198 (6%)
Query: 359 KLGQGGFGPVYKG-TLADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 415
KLG+G + VYKG + +GK +A+K RL G + E +L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHD 70
Query: 416 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 475
+ L L++EY+ D+ + L + + + + RG+ Y+H+ I
Sbjct: 71 IIHTKETLTLVFEYV---HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---I 124
Query: 476 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI-FS 534
+HRDLK N+L+ D K++DFGLAR + + ++ T Y P+ +G +S
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDVLLGSTEYS 182
Query: 535 IKSDVFSFGVLLLEIISG 552
D++ G + +E+I G
Sbjct: 183 TCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 24/208 (11%)
Query: 360 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCC 417
+G G +G VYKG + G+ A+K + T + +E K E+N++ K H+N+ G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 418 LE----GQ--ELLLIYEYMPNKSLDVHLFDATR--SVQLDWKRRQSIINGIARGILYLHE 469
++ G +L L+ E+ S+ L T+ +++ DW I I RG+ +LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSV-TDLVKNTKGNALKEDWI--AYICREILRGLAHLHA 139
Query: 470 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 529
K+IHRD+K N+LL ++ K+ DFG++ + NT I GT +MAPE
Sbjct: 140 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI--GTPYWMAPEVIA 194
Query: 530 -----GGIFSIKSDVFSFGVLLLEIISG 552
+ +SD++S G+ +E+ G
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-14
Identities = 64/193 (33%), Positives = 94/193 (48%), Gaps = 36/193 (18%)
Query: 376 GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 435
G +AVK+LSR F+N+ + AK ++ LV LL C + L+ + P KSL
Sbjct: 46 GINVAVKKLSRP-------FQNQTH--AKRAYRELV-LLKCVNHKNIISLLNVFTPQKSL 95
Query: 436 D--------VHLFDATRS----VQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKAS 483
+ + L DA ++LD +R ++ + GI +LH IIHRDLK S
Sbjct: 96 EEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPS 152
Query: 484 NILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTY----GYMAPEYAMGGIFSIKSDV 539
NI++ D KI DFGLAR A TN + Y Y APE +G + D+
Sbjct: 153 NIVVKSDCTLKILDFGLAR-------TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDI 205
Query: 540 FSFGVLLLEIISG 552
+S G ++ E++ G
Sbjct: 206 WSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 58/207 (28%), Positives = 108/207 (52%), Gaps = 24/207 (11%)
Query: 358 NKLGQGGFGPVYKGT-LADGKAIAVKRL---SRTSGQGLQEFKNEVNLIAKLQHKNLVRL 413
N++ +G +G VY+ G+ +A+K+L G + + E+N++ KLQH N+V +
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQHPNIVTV 69
Query: 414 ----LGCCLEGQELLLIYEYMPN--KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 467
+G L+ ++ ++ EY+ + KSL + + + ++ + G+ +L
Sbjct: 70 KEVVVGSNLD--KIYMVMEYVEHDLKSL---METMKQPFLQ--SEVKCLMLQLLSGVAHL 122
Query: 468 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 527
H++ I+HRDLK SN+LL++ KI DFGLAR +G ++ T Y APE
Sbjct: 123 HDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV--TLWYRAPEL 177
Query: 528 AMG-GIFSIKSDVFSFGVLLLEIISGR 553
+G +S D++S G + E+++ +
Sbjct: 178 LLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 42/154 (27%), Positives = 74/154 (48%), Gaps = 9/154 (5%)
Query: 398 EVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 457
E L+ + H +++R+ + G ++ +P+ S D++ + RS L + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 458 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 517
I G+ YLH +IIHRD+K NI ++D I D G A+ +A
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLA 217
Query: 518 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 551
GT APE ++ K+D++S G++L E+++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 81/283 (28%), Positives = 122/283 (43%), Gaps = 66/283 (23%)
Query: 360 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAKLQH--KNLVRL 413
+G G G VYK G +AVK++ RT + +E K +++++ K H +V+
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLK-SHDCPYIVKC 79
Query: 414 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL-------- 465
G + ++ + E M S LD K + I I IL
Sbjct: 80 YGYFITDSDVFICMELM--------------STCLD-KLLKRIQGPIPEDILGKMTVAIV 124
Query: 466 ----YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA-RIFGGNQNQANTNIIAGTY 520
YL E +IHRD+K SNILLD N K+ DFG++ R+ ++A T AG
Sbjct: 125 KALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTR-SAGCA 178
Query: 521 GYMAPEY----AMGGIFSIKSDVFSFGVLLLEIISGR---KNNGFYFSEHGQTLLTYTWK 573
YMAPE + I++DV+S G+ L+E+ +G+ KN F +LT K
Sbjct: 179 AYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-----EVLT---K 230
Query: 574 LWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRP 616
+ E P + +PD F LC+ +D RP
Sbjct: 231 ILQEEPPS----LPPNEGFSPD----FCSFVDLCLTKDHRKRP 265
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 60/203 (29%), Positives = 90/203 (44%), Gaps = 22/203 (10%)
Query: 360 LGQGGFGPV----YKGTLADGKAIAVKRL------SRTSGQGLQEFKNEVNLIAKLQHKN 409
LG+G FG V YK T G+ A+K L +R + L K +H
Sbjct: 7 LGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 469
LV L C + + EY L +H+ R + G+ YLHE
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHE 119
Query: 470 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 529
+ KI++RDLK N+LLD + KI+DFGL + G ++ +T GT ++APE
Sbjct: 120 N---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST--FCGTPEFLAPEVLT 174
Query: 530 GGIFSIKSDVFSFGVLLLEIISG 552
++ D + GVL+ E++ G
Sbjct: 175 ETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 360 LGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLG 415
LG+GGFG V + A GK A K+L + +G NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 416 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 475
L L+ M L H+++ D +R + G+ L R +I
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNP-GFDEQRAIFYAAELCCGLEDLQ---RERI 123
Query: 476 IHRDLKASNILLDDDMNPKISDFGLA-RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 534
++RDLK NILLDD + +ISD GLA +I G + GT GYMAPE ++
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV----GTVGYMAPEVINNEKYT 179
Query: 535 IKSDVFSFGVLLLEIISGR 553
D + G L+ E+I G+
Sbjct: 180 FSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-14
Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 15/211 (7%)
Query: 349 EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAK 404
E + + + +G G +G V G +AVK+LSR Q + K E+ L+
Sbjct: 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKH 72
Query: 405 LQHKNLVRLLGCCLEGQELLLIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARG 463
++H+N++ LL + L + Y+ + L + + +L Q +I I RG
Sbjct: 73 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 132
Query: 464 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYM 523
+ Y+H IIHRDLK SN+ +++D KI DFGLAR + + T +A T Y
Sbjct: 133 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVA-TRWYR 184
Query: 524 APEYAMGGI-FSIKSDVFSFGVLLLEIISGR 553
APE + + ++ D++S G ++ E+++GR
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 4e-14
Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 17/207 (8%)
Query: 359 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFK-NEVNLIAKLQHKNLVRLLGCC 417
K+G+G +G VYK DGK L + G G+ E+ L+ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 418 LE--GQELLLIYEYMPNKSLDVHLFDAT-----RSVQLDWKRRQSIINGIARGILYLHED 470
L +++ L+++Y + + F + VQL +S++ I GI YLH +
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 471 SRLKIIHRDLKASNILL----DDDMNPKISDFGLARIFGGN-QNQANTNIIAGTYGYMAP 525
++HRDLK +NIL+ + KI+D G AR+F + A+ + + T+ Y AP
Sbjct: 128 W---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 526 EYAMGGIFSIKS-DVFSFGVLLLEIIS 551
E +G K+ D+++ G + E+++
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 50/156 (32%), Positives = 83/156 (53%), Gaps = 9/156 (5%)
Query: 398 EVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 457
E+ ++ + +V G E+ + E+M SLD L +A R + + + SI
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR-IPEEILGKVSI- 110
Query: 458 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 517
+ RG+ YL E + +I+HRD+K SNIL++ K+ DFG++ G + N
Sbjct: 111 -AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFV 163
Query: 518 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 553
GT YM+PE G +S++SD++S G+ L+E+ GR
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 59/202 (29%), Positives = 104/202 (51%), Gaps = 19/202 (9%)
Query: 359 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQ-GLQ-EFKNEVNLIAKLQ---HKNLVR 412
++G G +G VYK G +A+K + + + GL EV L+ +L+ H N+VR
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 413 LLGCCLEGQ-----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 467
L+ C + ++ L++E++ ++ L +L D L + + ++ RG+ +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 468 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 527
H + I+HRDLK NIL+ K++DFGLARI+ + A T ++ T Y APE
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY--SCQMALTPVVV-TLWYRAPEV 178
Query: 528 AMGGIFSIKSDVFSFGVLLLEI 549
+ ++ D++S G + E+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 360 LGQGGFGPVY----KGTLADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKN-L 410
LG G +G V+ G GK A+K L + + + + + E ++ ++ L
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 411 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 470
V L +L LI +Y+ L HL+ + I I + +LH+
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH---FTESEVRVYIAEIVLALDHLHQ- 123
Query: 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIF-GGNQNQANTNIIAGTYGYMAPEYAM 529
L II+RD+K NILLD + + ++DFGL++ F + +A + GT YMAPE
Sbjct: 124 --LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS--FCGTIEYMAPEVIR 179
Query: 530 GGI--FSIKSDVFSFGVLLLEIISG 552
GG D +S GVL E+++G
Sbjct: 180 GGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 6e-14
Identities = 60/203 (29%), Positives = 104/203 (51%), Gaps = 22/203 (10%)
Query: 358 NKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKN--EVNLIAKLQ-HKNLVRL 413
K+G+G F V K + GK A+K + + + L++ N E+ + +L H N++RL
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF-KSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 414 LGCCLEGQE--LLLIYEYMPNKSLDVHLFDATRSVQ--LDWKRRQSIINGIARGILYLHE 469
+ + + L L++E M D++L++ + + L KR +S + + + + ++H
Sbjct: 64 IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH- 117
Query: 470 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 529
R I HRD+K NIL+ DD K++DFG R G T I+ T Y APE +
Sbjct: 118 --RNGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYIS-TRWYRAPECLL 171
Query: 530 -GGIFSIKSDVFSFGVLLLEIIS 551
G + K D+++ G + EI+S
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 9e-14
Identities = 56/200 (28%), Positives = 99/200 (49%), Gaps = 13/200 (6%)
Query: 358 NKLGQGGFGPVYKG-TLADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 414
+KLG+G + V+KG + +A+K RL G + EV+L+ L+H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69
Query: 415 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 474
+ L L++EY+ + D+ + + + + + RG+ Y H + K
Sbjct: 70 DIIHTERCLTLVFEYLDS---DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRK 123
Query: 475 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI-F 533
I+HRDLK N+L+++ K++DFGLAR + ++ T Y P+ +G +
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTEY 181
Query: 534 SIKSDVFSFGVLLLEIISGR 553
S D++ G +L E+ +GR
Sbjct: 182 STPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 9e-14
Identities = 58/207 (28%), Positives = 104/207 (50%), Gaps = 17/207 (8%)
Query: 359 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFK-NEVNLIAKLQHKNLVRLLGCC 417
K+G+G +G VYK DGK L + G G+ E+ L+ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 418 L--EGQELLLIYEYMPNKSLDVHLFDAT-----RSVQLDWKRRQSIINGIARGILYLHED 470
L +++ L+++Y + + F + +QL +S++ I GI YLH +
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 471 SRLKIIHRDLKASNILL----DDDMNPKISDFGLARIFGGN-QNQANTNIIAGTYGYMAP 525
++HRDLK +NIL+ + KI+D G AR+F + A+ + + T+ Y AP
Sbjct: 128 W---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 526 EYAMGGIFSIKS-DVFSFGVLLLEIIS 551
E +G K+ D+++ G + E+++
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 30/213 (14%)
Query: 360 LGQGGFGPVYKGTL----ADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRL 413
LG+G FG V + L + +AVK L S ++EF E + + H N+++L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 414 LGCCLEGQEL------LLIYEYMPNKSLDVHLF-----DATRSVQLDWKRRQSIINGIAR 462
+G L + ++I +M K D+H F L + + IA
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFM--KHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 463 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGN---QNQANTNIIAG 518
G+ YL S IHRDL A N +L+++M ++DFGL++ I+ G+ Q A+ +
Sbjct: 125 GMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK- 180
Query: 519 TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 551
++A E +++ SDV++FGV + EI++
Sbjct: 181 ---WLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 63/198 (31%), Positives = 92/198 (46%), Gaps = 13/198 (6%)
Query: 360 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---EVN-LIAKLQHKNLVRLL 414
+G+G FG V ADGK AVK L + + +E K+ E N L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 415 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 474
+L + +Y+ L HL R R + IA + YLH L
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHL---QRERSFPEPRARFYAAEIASALGYLHS---LN 116
Query: 475 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 534
II+RDLK NILLD + ++DFGL + G ++ T+ GT Y+APE +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQPYD 174
Query: 535 IKSDVFSFGVLLLEIISG 552
D + G +L E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 62/234 (26%), Positives = 97/234 (41%), Gaps = 57/234 (24%)
Query: 360 LGQGGFGPVYKGTLA----DGKAIAVKRLSRT----SGQGLQEFKNEVNLIAKLQHKNLV 411
+G+G FG V+ L G+ A+K L ++ Q + + E +++A +V
Sbjct: 9 IGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWIV 64
Query: 412 RLLGCCLEGQE-LLLIYEYMPNKSL-----DVHLFDATRSVQLDWKRRQSIINGIARGIL 465
+L + +E L L+ EYMP L +F + R IA +L
Sbjct: 65 KLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE------ETARFY-----IAELVL 112
Query: 466 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA------------------------ 501
L +L IHRD+K NIL+D D + K++DFGL
Sbjct: 113 ALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172
Query: 502 ---RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 552
R Q + N GT Y+APE G + ++ D +S GV+L E++ G
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 61/169 (36%), Positives = 84/169 (49%), Gaps = 23/169 (13%)
Query: 460 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 519
+ARG+ +L SR K IHRDL A NILL ++ KI DFGLAR + +
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 520 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS--GRKNNGFYFSEHGQTLLTYTWKLWCE 577
+MAPE +++ +SDV+SFGVLL EI S G +E +C+
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-----------FCQ 288
Query: 578 GPAVELIDPVLKQSCAPDELLKFIH-IGLLCVQQDPADRPTMSSVVVML 625
L D + AP+ I+ I L C Q DP +RPT S++V +L
Sbjct: 289 ----RLKDGTRMR--APENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-13
Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 13/203 (6%)
Query: 354 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGL--QEFKNEVNLIAKLQHKNLV 411
F ++LG G G V+K + I ++L + + E+ ++ + +V
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 412 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHED 470
G E+ + E+M SLD L A R Q+ K ++I +G+ YL E
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI----KGLTYLRE- 121
Query: 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 530
+ KI+HRD+K SNIL++ K+ DFG++ G + N GT YM+PE G
Sbjct: 122 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQG 176
Query: 531 GIFSIKSDVFSFGVLLLEIISGR 553
+S++SD++S G+ L+E+ GR
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-13
Identities = 60/189 (31%), Positives = 93/189 (49%), Gaps = 28/189 (14%)
Query: 377 KAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLD 436
+ +A+K+LSR F+N+ + AK ++ LV L+ C + L+ + P KSL+
Sbjct: 50 RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLE 99
Query: 437 --------VHLFDATR----SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASN 484
+ L DA ++LD +R ++ + GI +LH IIHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156
Query: 485 ILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGV 544
I++ D KI DFGLAR G ++ T Y APE +G + D++S G
Sbjct: 157 IVVKSDCTLKILDFGLART-AGTSFMMTPYVV--TRYYRAPEVILGMGYKENVDIWSVGC 213
Query: 545 LLLEIISGR 553
++ E+I G
Sbjct: 214 IMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 8e-13
Identities = 58/171 (33%), Positives = 80/171 (46%), Gaps = 23/171 (13%)
Query: 460 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 519
+A+G+ +L SR K IHRDL A NILL ++ KI DFGLAR + +
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 520 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS--GRKNNGFYFSEHGQTLLTYTWKLWCE 577
+MAPE +++I+SDV+SFGVLL EI S G E L E
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK-------E 297
Query: 578 GPAVELIDPVLKQSCAPDELLKFIHIGLL-CVQQDPADRPTMSSVVVMLAS 627
G + APD ++ +L C +P+ RPT S +V L +
Sbjct: 298 GTRMR----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-13
Identities = 70/231 (30%), Positives = 107/231 (46%), Gaps = 23/231 (9%)
Query: 339 FPLFPLRLALEATNHFSDE----NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQ 393
FP L LE+ +D +G+G +G VYK T DG AVK L S +
Sbjct: 5 FPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-E 63
Query: 394 EFKNEVNLIAKL-QHKNLVRLLGCC-----LEGQELLLIYEYMPNKSLDVHLFDATRSVQ 447
E + E N++ L H N+V+ G L G +L L+ E S+ + Q
Sbjct: 64 EIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ 123
Query: 448 -LDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506
LD I+ G G+ +LH + +IIHRD+K +NILL + K+ DFG++
Sbjct: 124 RLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180
Query: 507 NQNQANTNIIAGTYGYMAPEY-----AMGGIFSIKSDVFSFGVLLLEIISG 552
+ + NT++ GT +MAPE + + DV+S G+ +E+ G
Sbjct: 181 TRLRRNTSV--GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 63/201 (31%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 360 LGQGGFGPVYKGTLAD-GKAIAVKRLSRTS---GQGLQEFKNE---VNLIAKLQHKNLVR 412
+G+GGFG VY AD GK A+K L + QG NE ++L++ +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 472
+ +L I + M L HL Q + A IL L
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHL------SQHGVFSEAEMRFYAAEIILGLEHMHN 115
Query: 473 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 532
+++RDLK +NILLD+ + +ISD GLA F + A+ GT+GYMAPE G+
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKGV 171
Query: 533 -FSIKSDVFSFGVLLLEIISG 552
+ +D FS G +L +++ G
Sbjct: 172 AYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 17/216 (7%)
Query: 345 RLALEATNHFSDENKLGQGGFGPV-YKGTLADGKAIAVKRLSRTSGQGL--QEFKNEVNL 401
+ E + + D ++G G +G V G +A+K+L R L + E+ L
Sbjct: 8 KTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRL 67
Query: 402 IAKLQHKNLVRLLGCCLEGQELLLIYEY---MPNKSLDVHLFDATRSVQLDWKRRQSIIN 458
+ ++H+N++ LL L +++ MP D L + +L R Q ++
Sbjct: 68 LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTD--LGKLMKHEKLSEDRIQFLVY 125
Query: 459 GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAG 518
+ +G+ Y+H IIHRDLK N+ +++D KI DFGLAR Q +
Sbjct: 126 QMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVV 177
Query: 519 TYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 553
T Y APE + + ++ D++S G ++ E+++G+
Sbjct: 178 TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 13/199 (6%)
Query: 359 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFK--NEVNLIAKLQHKNLVRLLG 415
KLG+G + VYKG + +G+ +A+K +S + +G+ F E +L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLHD 70
Query: 416 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 475
+ L ++EYM D+ + L + + + RG+ Y+H I
Sbjct: 71 IIHTKETLTFVFEYM---HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHI 124
Query: 476 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI-FS 534
+HRDLK N+L+ K++DFGLAR ++ ++ T Y P+ +G +S
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATDYS 182
Query: 535 IKSDVFSFGVLLLEIISGR 553
D++ G + +E++ G+
Sbjct: 183 SALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 63/201 (31%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 360 LGQGGFGPVYKGTLAD-GKAIAVKRLSRTS---GQGLQEFKNE---VNLIAKLQHKNLVR 412
+G+GGFG VY AD GK A+K L + QG NE ++L++ +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 472
+ +L I + M L HL ++ K + I G+ ++H +R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHL---SQHGVFSEKEMRFYATEIILGLEHMH--NR 116
Query: 473 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 532
+++RDLK +NILLD+ + +ISD GLA F + A+ GT+GYMAPE G
Sbjct: 117 F-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKGT 171
Query: 533 -FSIKSDVFSFGVLLLEIISG 552
+ +D FS G +L +++ G
Sbjct: 172 AYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 62/222 (27%), Positives = 98/222 (44%), Gaps = 48/222 (21%)
Query: 359 KLGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQG------------LQEFKNEVNLI 402
+LGQG +G V T ++ + +A+K+++ + L+ F+
Sbjct: 7 ELGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG----- 60
Query: 403 AKLQHKNLVRLLGCCLEGQELLL------IYEYMPNKSLDVHLFDATRS-VQLDWKRRQS 455
HKN+ CL +++ +Y Y D+H RS L QS
Sbjct: 61 ----HKNIT-----CLYDMDIVFPGNFNELYLYEELMEADLH--QIIRSGQPLTDAHFQS 109
Query: 456 IINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN--- 512
I I G+ Y+H + ++HRDLK N+L++ D KI DFGLAR F N +
Sbjct: 110 FIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM 166
Query: 513 TNIIAGTYGYMAPEYAMGGIFSIKS-DVFSFGVLLLEIISGR 553
T +A T Y APE + K+ DV+S G +L E++ +
Sbjct: 167 TEYVA-TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 54/200 (27%), Positives = 97/200 (48%), Gaps = 16/200 (8%)
Query: 359 KLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN----EVNLIAKLQHKNLVRL 413
K+G+G +G V+K + G+ +A+K+ + + K E+ ++ +L+H NLV L
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPV--IKKIALREIRMLKQLKHPNLVNL 65
Query: 414 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 473
+ ++L L++EY + L + + + + II + + + H +
Sbjct: 66 IEVFRRKRKLHLVFEYCDHTVL--NELEK-NPRGVPEHLIKKIIWQTLQAVNFCH---KH 119
Query: 474 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI- 532
IHRD+K NIL+ K+ DFG ARI G T+ +A T Y APE +G
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTG-PGDDYTDYVA-TRWYRAPELLVGDTQ 177
Query: 533 FSIKSDVFSFGVLLLEIISG 552
+ DV++ G + E+++G
Sbjct: 178 YGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 59/212 (27%), Positives = 92/212 (43%), Gaps = 31/212 (14%)
Query: 360 LGQGGFGPVYKGTL-------ADGKAIAVKRLSRTSGQGLQ---EFKNEVNLIAKLQHKN 409
LGQG F +YKG L G V + + G + F +L+++L HK+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 469
LV+L G C+ E +++ EY+ LDV L +V L WK + +A + YL +
Sbjct: 63 LVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLED 119
Query: 470 DSRLKIIHRDLKASNILL---DDDMNP----KISDFGLARIFGGNQNQANTNIIAGTYGY 522
K++H ++ NIL+ + K+SD G+ + +
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL------SREERVERIPW 170
Query: 523 MAPEYAMGGIFSIKS--DVFSFGVLLLEIISG 552
+APE G S+ D +SFG LLEI S
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 23/204 (11%)
Query: 360 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK------LQHKN 409
LG+G FG V KGT + A+K L + LQ+ + + K +H
Sbjct: 3 LGKGSFGKVMLAELKGT---DEVYAIKVLKKDVI--LQDDDVDCTMTEKRILALAAKHPF 57
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 469
L L C L + EY+ L +F RS + D R + + +++LH
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLH- 113
Query: 470 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 529
R +I+RDLK NILLD + + K++DFG+ + G N T GT Y+APE
Sbjct: 114 --RHGVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQ 169
Query: 530 GGIFSIKSDVFSFGVLLLEIISGR 553
+ D ++ GVL+ E+++G+
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 38/96 (39%), Positives = 56/96 (58%), Gaps = 9/96 (9%)
Query: 460 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR--IFGGNQNQANTNIIA 517
IA G+ +LH II+RDLK N++LD + + KI+DFG+ + IFGG T
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG----KTTRTFC 162
Query: 518 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 553
GT Y+APE + D ++FGVLL E+++G+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 50/205 (24%), Positives = 89/205 (43%), Gaps = 31/205 (15%)
Query: 360 LGQGGFGPVYKGT-LADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLG 415
+G G FG V+ A+K ++ + Q NE ++ ++ H ++RL
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 416 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR--------GILYL 467
+ + L ++ EY+P L +L + N + YL
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYL-----------RNSGRFSNSTGLFYASEIVCALEYL 117
Query: 468 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 527
H +I++RDLK NILLD + + K++DFG A+ + + T + GT Y+APE
Sbjct: 118 HS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPEV 169
Query: 528 AMGGIFSIKSDVFSFGVLLLEIISG 552
+ D ++ G+L+ E++ G
Sbjct: 170 IQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-12
Identities = 53/166 (31%), Positives = 79/166 (47%), Gaps = 17/166 (10%)
Query: 460 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 519
+A+G+ +L + IHRDL A NILL KI DFGLAR + N
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 520 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGP 579
+MAPE +++ +SDV+S+G+LL EI S + Y G + + +K+ EG
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFS--LGSSPY---PGMPVDSKFYKMIKEG- 333
Query: 580 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
++ P CAP E+ + C DP RPT +V ++
Sbjct: 334 -YRMLSP----ECAPSEMYDIMKS---CWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 55/227 (24%), Positives = 100/227 (44%), Gaps = 41/227 (18%)
Query: 358 NKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKN--------------EVNLI 402
LG+G +G V K GK +A+K++ E+ ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 403 AKLQHKNLVRLLGCCLEGQELLLIYEYMPN---KSLDVHLFDATRSVQLDWKRRQSIING 459
+++H+N++ L+ +EG + L+ + M + K +D R ++L + + I+
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVD-------RKIRLTESQVKCILLQ 127
Query: 460 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN----------QN 509
I G+ LH+ +HRDL +NI ++ KI+DFGLAR +G
Sbjct: 128 ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 510 QANTNIIAG--TYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGR 553
Q + + T Y APE MG + D++S G + E+++G+
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 27/206 (13%)
Query: 359 KLGQGGFGPVYKG-TLADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 415
KLG+G + VYKG + G+ +A+K RL G + E +L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHD 70
Query: 416 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 475
+ L L++EY+ + L ++ D + + R + + RG+ Y H + ++
Sbjct: 71 IIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVR--LFLFQLLRGLAYCH---QRRV 124
Query: 476 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG-------YMAPEYA 528
+HRDLK N+L+ + K++DFGLAR ++ + TY Y P+
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLARA---------KSVPSKTYSNEVVTLWYRPPDVL 175
Query: 529 MGGI-FSIKSDVFSFGVLLLEIISGR 553
+G +S D++ G + E+ +GR
Sbjct: 176 LGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 4e-12
Identities = 46/147 (31%), Positives = 73/147 (49%), Gaps = 8/147 (5%)
Query: 407 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 466
H LV L C L + EY+ L +F R +L + + I+ + Y
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 111
Query: 467 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 526
LHE II+RDLK N+LLD + + K++D+G+ + G + T+ GT Y+APE
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPE 166
Query: 527 YAMGGIFSIKSDVFSFGVLLLEIISGR 553
G + D ++ GVL+ E+++GR
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 5e-12
Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 360 LGQGGFGPVYKGT-LADGKAIAVKRLSR--TSGQGLQEFKNEVNLIAKLQHKNLVRLLG- 415
+G G +G V G+ +A+K+LSR S + E+ L+ +QH+N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 416 --CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 473
+ G E Y MP D+ L + Q ++ + G+ Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTDLQ---KIMGHPLSEDKVQYLVYQMLCGLKYIHSAG-- 137
Query: 474 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 533
IIHRDLK N+ +++D KI DFGLAR A T Y APE + +
Sbjct: 138 -IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILNWMH 191
Query: 534 SIKS-DVFSFGVLLLEIISGR 553
++ D++S G ++ E+++G+
Sbjct: 192 YNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 360 LGQGGFGPVY---KGTLAD-GKAIAVKRLSRTS----GQGLQEFKNEVNLIAKL-QHKNL 410
LG G +G V+ K + D GK A+K L + + + + + E ++ + Q L
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 411 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 470
V L +L LI +Y+ L HL ++ + + Q I + +LH
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELFTHL---SQRERFKEQEVQIYSGEIVLALEHLH-- 122
Query: 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 530
+L II+RD+K NILLD + + ++DFGL++ F ++ + + GT YMAP+ G
Sbjct: 123 -KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEYMAPDIVRG 180
Query: 531 GI--FSIKSDVFSFGVLLLEIISG 552
G D +S GVL+ E+++G
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 46/166 (27%), Positives = 81/166 (48%), Gaps = 24/166 (14%)
Query: 354 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 412
+ D LG G G V+ +D K +AVK++ T Q ++ E+ +I +L H N+V+
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 413 L--------------LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN 458
+ +G E + ++ EYM + L + L + + +
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLSEEHARLFMY 121
Query: 459 GIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARI 503
+ RG+ Y+H + ++HRDLK +N+ ++ +D+ KI DFGLARI
Sbjct: 122 QLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARI 164
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 6e-12
Identities = 59/186 (31%), Positives = 93/186 (50%), Gaps = 28/186 (15%)
Query: 377 KAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLD 436
+ +A+K+LSR F+N+ + AK ++ LV L+ C + L+ + P KSL+
Sbjct: 43 RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKSLE 92
Query: 437 --------VHLFDATR----SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASN 484
+ L DA ++LD +R ++ + GI +LH IIHRDLK SN
Sbjct: 93 EFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 149
Query: 485 ILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGV 544
I++ D KI DFGLAR G + T + Y Y APE +G + D++S G
Sbjct: 150 IVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGC 206
Query: 545 LLLEII 550
++ E++
Sbjct: 207 IMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 46/144 (31%), Positives = 71/144 (49%), Gaps = 8/144 (5%)
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 469
LV L C L L+ EY+ L +F R +L + + I + +LHE
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHE 114
Query: 470 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 529
II+RDLK N+LLD D + K++D+G+ + G T+ GT Y+APE
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILR 169
Query: 530 GGIFSIKSDVFSFGVLLLEIISGR 553
G + D ++ GVL+ E+++GR
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 9e-12
Identities = 59/210 (28%), Positives = 92/210 (43%), Gaps = 37/210 (17%)
Query: 358 NKLGQGGFGPV----YKGTLADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNL 410
LG G FG V +KGT G+ A+K L + + +Q E +++ +L H +
Sbjct: 24 ETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFI 80
Query: 411 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR-------- 462
V ++ + + + E++ L HL A R N +A+
Sbjct: 81 VNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGR-----------FPNDVAKFYHAELVL 129
Query: 463 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 522
YLH II+RDLK N+LLD+ + K++DFG A+ + T + GT Y
Sbjct: 130 AFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEY 181
Query: 523 MAPEYAMGGIFSIKSDVFSFGVLLLEIISG 552
+APE D ++ GVLL E I+G
Sbjct: 182 LAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 19/213 (8%)
Query: 349 EATNHFSDENKLGQGGFGPV---YKGTLADGKAIAVKRLSRTSGQGLQEFKN---EVNLI 402
E + + +G G +G V Y L + +AVK+LSR Q L + E+ L+
Sbjct: 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLR--QKVAVKKLSRPF-QSLIHARRTYRELRLL 68
Query: 403 AKLQHKNLVRLLGCCLEGQELLLIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIA 461
++H+N++ LL + E Y+ + L + + +L + Q +I +
Sbjct: 69 KHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLL 128
Query: 462 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 521
RG+ Y+H IIHRDLK SN+ +++D +I DFGLAR + T +A T
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR----QADDEMTGYVA-TRW 180
Query: 522 YMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 553
Y APE + + ++ D++S G ++ E++ G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 51/150 (34%), Positives = 74/150 (49%), Gaps = 11/150 (7%)
Query: 359 KLGQGGFGPVYKGTLADG---KAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLL 414
++G G FG V G + G + VK L ++ Q +F E LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 415 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQL---DWKRRQSIINGIARGILYLHEDS 471
G C E LL+ E+ P L +L + R +L D Q + IA G+L+LH+++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYL-RSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLA 501
IH DL N LL D+ KI D+GL+
Sbjct: 121 ---FIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 42/210 (20%)
Query: 360 LGQGGFGPVYKGTL----ADGKAIAVKRLS--RTSGQGLQEFKNEVNLIAKLQHKNLVR- 412
+G+G +G V +L DGK +K+L+ S + + + E L+++L+H N+V
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 413 -------------LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING 459
++G C EG +L Y K L + V +W +
Sbjct: 65 RESWEGEDGLLYIVMGFC-EGGDL-----YHKLKEQKGKLLPENQVV--EWFVQ------ 110
Query: 460 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 519
IA + YLHE I+HRDLK N+ L K+ D G+AR+ + A+T I GT
Sbjct: 111 IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI--GT 165
Query: 520 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEI 549
YM+PE ++ KSDV++ G + E+
Sbjct: 166 PYYMSPELFSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 62/208 (29%), Positives = 90/208 (43%), Gaps = 14/208 (6%)
Query: 360 LGQGGFGPV-YKGTLADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAKLQHKNLVRLLG 415
LG+G FG V A GK A+K L + E + E ++ +H L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 416 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 475
L + EY+ L HL +R R + I + YLH KI
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHL---SRERVFSEDRTRFYGAEIVSALDYLHSG---KI 116
Query: 476 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 535
++RDLK N++LD D + KI+DFGL + G + A GT Y+APE +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 536 KSDVFSFGVLLLEIISGRKNNGFYFSEH 563
D + GV++ E++ GR FY +H
Sbjct: 175 AVDWWGLGVVMYEMMCGRLP--FYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-11
Identities = 51/192 (26%), Positives = 90/192 (46%), Gaps = 22/192 (11%)
Query: 376 GKAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVRLL--GCCLEGQELLLIYEYM 430
G +A+K L + + + F+ E L A+L H N+V LL G G L ++EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFEYV 61
Query: 431 PNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL-- 487
P ++L +V D + +++ +A H I+HRDLK NI++
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACA----H---NQGIVHRDLKPQNIMVSQ 114
Query: 488 -DDDMNPKISDFGLARIFGGNQNQANTNIIA-----GTYGYMAPEYAMGGIFSIKSDVFS 541
+ K+ DFG+ + G ++ + GT Y APE G + SD+++
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174
Query: 542 FGVLLLEIISGR 553
+G++ LE ++G+
Sbjct: 175 WGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 61/198 (30%), Positives = 92/198 (46%), Gaps = 13/198 (6%)
Query: 360 LGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAK-LQHKNLVRLL 414
+G+G FG V +DG AVK L + + +E + E N++ K L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 415 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 474
++L + +Y+ L HL R R + +A I YLH L
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHL---QRERCFLEPRARFYAAEVASAIGYLHS---LN 116
Query: 475 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 534
II+RDLK NILLD + ++DFGL + G + + T+ GT Y+APE +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174
Query: 535 IKSDVFSFGVLLLEIISG 552
D + G +L E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 352 NHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRLSRTSGQGLQEFKN----EVNLIAKLQ 406
N F +G+G +G V K + K I A+K+ + +E K E+ ++ L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN--EEVKETTLRELKMLRTLK 58
Query: 407 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 466
+N+V L +L L++EY+ L++ L + V + + +S I + + I +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLEL-LEEMPNGVPPE--KVRSYIYQLIKAIHW 115
Query: 467 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 526
H++ I+HRD+K N+L+ + K+ DFG AR N T +A T Y +PE
Sbjct: 116 CHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVA-TRWYRSPE 171
Query: 527 YAMGGIFSIKSDVFSFGVLLLEIISGR 553
+G + D++S G +L E+ G+
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 44/147 (29%), Positives = 73/147 (49%), Gaps = 8/147 (5%)
Query: 407 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 466
H LV L C L + E++ L H+ R +L + + I+ + +
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM---QRQRKLPEEHARFYSAEISLALNF 111
Query: 467 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 526
LHE II+RDLK N+LLD + + K++D+G+ + G + T+ GT Y+APE
Sbjct: 112 LHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPE 166
Query: 527 YAMGGIFSIKSDVFSFGVLLLEIISGR 553
G + D ++ GVL+ E+++GR
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 33/211 (15%)
Query: 360 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAKLQHKNLVRLLG 415
+G G FG V+ T DGK +A+K++ Q L K E+ ++ +H N++ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSAL- 65
Query: 416 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWK----RRQSI--------INGIARG 463
++L P+ ++ T +Q D Q + + I RG
Sbjct: 66 ------DIL----QPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRG 115
Query: 464 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYM 523
+ YLH I+HRD+K N+L++ + KI DFGLAR+ ++++ T + Y Y
Sbjct: 116 LKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YR 171
Query: 524 APEYAMGGI-FSIKSDVFSFGVLLLEIISGR 553
APE MG ++ D++S G + E++ R
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 360 LGQGGFGPVY---KGTLAD-GKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKNLV 411
LG G +G V+ K T D GK A+K L + + + ++ + E N++ ++ +
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 412 RLLGCCLEGQ-ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 470
L + + +L LI +Y+ + HL+ Q D + IL L
Sbjct: 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLY------QRDNFSEDEVRFYSGEIILALEHL 121
Query: 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 530
+L I++RD+K NILLD + + ++DFGL++ F ++ + T GT YMAPE G
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCGTIEYMAPEIIRG 180
Query: 531 GIFSIKS-DVFSFGVLLLEIISG 552
K+ D +S G+L+ E+++G
Sbjct: 181 KGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 58/201 (28%), Positives = 93/201 (46%), Gaps = 16/201 (7%)
Query: 360 LGQGGFGPVYKGTLADGKAI-AVKRLSRTSGQGLQEFKN---EVNLIAKLQHKNLVRLLG 415
+G+G FG VY+ D + I A+K LS+ +E + E N++ + ++G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 416 CCLEGQ---ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 472
Q +L L+ +YM L HL R R + I + + +LH+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR---FSEDRAKFYIAELVLALEHLHKYD- 116
Query: 473 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 532
I++RDLK NILLD + + DFGL++ + TN GT Y+APE +
Sbjct: 117 --IVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEK 172
Query: 533 -FSIKSDVFSFGVLLLEIISG 552
++ D +S GVL+ E+ G
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 6e-11
Identities = 45/161 (27%), Positives = 72/161 (44%), Gaps = 36/161 (22%)
Query: 476 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQN---QANTNIIAGTYGYMAPEYAMGGI 532
IHRD+ A N+LL D KI DFGLAR + N + N + +MAPE +
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL---PVKWMAPESIFDCV 290
Query: 533 FSIKSDVFSFGVLLLEIIS-GRK-------NNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584
++++SDV+S+G+LL EI S G+ N+ FY +++
Sbjct: 291 YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFY----------------------KMV 328
Query: 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
+ S + I +C +P +RPT S + ++
Sbjct: 329 KRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLI 369
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 8e-11
Identities = 61/300 (20%), Positives = 109/300 (36%), Gaps = 57/300 (19%)
Query: 360 LGQGGFGPVYKGTLADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 417
+ K +AVK+ L S + L+ + E+ +LQH N++ +
Sbjct: 10 FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 418 LEGQELLLIYEYMPNKS----LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 473
+ EL ++ M S L H + + + + I+ + + Y+H
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-----ILKDVLNALDYIH---SK 120
Query: 474 KIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQAN----TNIIAGTYGYMAPEY- 527
IHR +KAS+ILL D +S + + + Q +++PE
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180
Query: 528 --AMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY-FSEHGQTLLTYTWKLWCEGPAVELI 584
+ G ++ KSD++S G+ E+ NG F + T + K+ G L+
Sbjct: 181 QQNLQG-YNEKSDIYSVGITACEL-----ANGHVPFKDMPATQM-LLEKV--RGTVPCLL 231
Query: 585 D----PVLKQSCAPDELL--------------------KFIHIGLLCVQQDPADRPTMSS 620
D P+ + S + F LC+Q+DP RP+ S
Sbjct: 232 DKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQ 291
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 31/208 (14%)
Query: 360 LGQGGFGPVYKGTLADGKAI----AVKRLSRTSGQGLQEFKNEVNLIAK----LQHKN-- 409
LG+G FG V LA+ K A+K L + +Q+ E ++ K LQ K
Sbjct: 8 LGKGSFGKV---MLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLALQDKPPF 62
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING--IARGILYL 467
L +L C L + EY+ L H+ + +K Q++ I+ G+ +L
Sbjct: 63 LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK-----FKEPQAVFYAAEISVGLFFL 117
Query: 468 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR--IFGGNQNQANTNIIAGTYGYMAP 525
H II+RDLK N++LD + + KI+DFG+ + + G T GT Y+AP
Sbjct: 118 HRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----VTTRTFCGTPDYIAP 170
Query: 526 EYAMGGIFSIKSDVFSFGVLLLEIISGR 553
E + D +++GVLL E+++G+
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-10
Identities = 57/222 (25%), Positives = 95/222 (42%), Gaps = 33/222 (14%)
Query: 359 KLGQGGFGPVYKG-TLADGKAIAVKRLSRT-SGQGL--QEFKNEVNLIAKLQHKNLVRLL 414
+G+GG G VY + +A+K++ S L + F E + A L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 415 GCCLEGQELLLIYEYMPNKSLDVHLFDATR---SVQLDWKRRQS------IINGIARGIL 465
C +G + Y+ +L L + S+ + + S I + I I
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLK-SLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 466 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ-------------AN 512
Y+H S+ ++HRDLK NILL I D+G A + ++
Sbjct: 128 YVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 513 TNI---IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 551
I I GT YMAPE +G S +D+++ GV+L ++++
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 31/208 (14%)
Query: 360 LGQGGFGPVYKGTLADGKAI----AVKRLSRTSGQGLQEFKNEVNLIAK----LQHKN-- 409
LG+G FG V LA+ K A+K L + +Q+ E ++ K L K
Sbjct: 8 LGKGSFGKV---MLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLALSGKPPF 62
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING--IARGILYL 467
L +L C L + EY+ L + R +K ++ IA G+ +L
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR-----FKEPHAVFYAAEIAIGLFFL 117
Query: 468 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR--IFGGNQNQANTNIIAGTYGYMAP 525
H II+RDLK N++LD + + KI+DFG+ + ++ G T GT Y+AP
Sbjct: 118 HSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG----VTTKTFCGTPDYIAP 170
Query: 526 EYAMGGIFSIKSDVFSFGVLLLEIISGR 553
E + D ++FGVLL E+++G+
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 360 LGQGGFGPVYK-GTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCC 417
+G+G +G V+K +G AVK L +E + E N++ L H N+V+ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 418 LE-----GQELLLIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 471
+ G +L L+ E S+ D+ R +++ I++ G+ +LH +
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN- 143
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY---- 527
K IHRD+K +NILL + K+ DFG++ + + NT++ GT +MAPE
Sbjct: 144 --KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV--GTPFWMAPEVIACE 199
Query: 528 -AMGGIFSIKSDVFSFGVLLLEIISG 552
+ + + DV+S G+ +E+ G
Sbjct: 200 QQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 49/164 (29%), Positives = 80/164 (48%), Gaps = 18/164 (10%)
Query: 398 EVNLIAKLQHKNLVRLLGCCLEGQ-----ELLLIYEYMPNKSLDVHLFDATRSVQ-LDWK 451
E+ L+ L H+N++ + ++ ++YE M D L RS Q L
Sbjct: 54 EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDD 108
Query: 452 RRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 511
Q + + RG+ Y+H + ++HRDLK SN+LL+ + + KI DFGLAR +
Sbjct: 109 HCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM 165
Query: 512 NTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRK 554
++ T Y APE + ++ DV+S G + E++ GRK
Sbjct: 166 TEYVV--TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 2e-10
Identities = 49/183 (26%), Positives = 89/183 (48%), Gaps = 20/183 (10%)
Query: 377 KAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI--YEYMPNKS 434
+ + KR+ S +Q +NE+ + +L H+N++++ +E+L YM +
Sbjct: 193 ERLIAKRVKAGSRAAIQ-LENEILALGRLNHENILKI-------EEILRSEANTYMITQK 244
Query: 435 LDVHLFDATRSVQLDWKRR------QSIINGIARGILYLHEDSRLKIIHRDLKASNILLD 488
D L+ DWK R ++I+ + + Y+H+ K+IHRD+K NI L+
Sbjct: 245 YDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301
Query: 489 DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLE 548
D + DFG A F + +A GT +PE G + +D++S G++LL+
Sbjct: 302 CDGKIVLGDFGTAMPF-EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLD 360
Query: 549 IIS 551
++S
Sbjct: 361 MLS 363
|
Length = 501 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 59/198 (29%), Positives = 89/198 (44%), Gaps = 13/198 (6%)
Query: 360 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKN---EVNLIAK-LQHKNLVRLL 414
+G+G FG V DGK AVK L + +E K+ E N++ K ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 415 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 474
++L + +++ L HL R R + IA + YLH +
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHL---QRERSFPEPRARFYAAEIASALGYLHS---IN 116
Query: 475 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 534
I++RDLK NILLD + ++DFGL + G T GT Y+APE +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 535 IKSDVFSFGVLLLEIISG 552
D + G +L E++ G
Sbjct: 175 NTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 44/153 (28%), Positives = 68/153 (44%), Gaps = 20/153 (13%)
Query: 359 KLGQGGFGPVYKGTLADGKAIA---VKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRLL 414
++G G FG V + +A VK L + Q EF + + LQH N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 415 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR-------QSIINGIARGILYL 467
G C+E LL++EY L +L Q W RR Q + IA G+ ++
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYL------SQEQWHRRNSQLLLLQRMACEIAAGVTHM 115
Query: 468 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 500
H + +H DL N L D+ K+ D+G+
Sbjct: 116 H---KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 13/208 (6%)
Query: 360 LGQGGFGPV-YKGTLADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAKLQHKNLVRLLG 415
LG+G FG V A G+ A+K L + E + E ++ +H L L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 416 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 475
L + EY L HL +R R + I + YLH S +
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYLH--SEKNV 117
Query: 476 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 535
++RDLK N++LD D + KI+DFGL + G ++ A GT Y+APE +
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 175
Query: 536 KSDVFSFGVLLLEIISGRKNNGFYFSEH 563
D + GV++ E++ GR FY +H
Sbjct: 176 AVDWWGLGVVMYEMMCGRLP--FYNQDH 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 52/197 (26%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 360 LGQGGFGPVYKGTLADGKAI----AVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 415
+G+G FG V + D + I +++ S + E ++A++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 416 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 475
++L L+ ++ L HL R + D R + + + LH+ +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHL---QREGRFDLSRARFYTAELLCALENLHK---FNV 114
Query: 476 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 535
I+RDLK NILLD + + DFGL ++ + ++ NT GT Y+APE +G ++
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGTPEYLAPELLLGHGYTK 172
Query: 536 KSDVFSFGVLLLEIISG 552
D ++ GVLL E+++G
Sbjct: 173 AVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 20/198 (10%)
Query: 360 LGQGGFGP--VYKGTLADGK-AIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 416
+G+G FG + + +D K A+ RL ++S +++ + E L+AK++H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 417 CLEGQELLLIYEYMPNKSLDVHLFDA-----TRSVQLDWKRRQSIINGIARGILYLHEDS 471
L ++ EY L + L W + G+ ++HE
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW------FVQMCLGVQHIHEK- 119
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 531
+++HRD+K+ NI L + K+ DFG AR+ A T + GT Y+ PE
Sbjct: 120 --RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV--GTPYYVPPEIWENM 175
Query: 532 IFSIKSDVFSFGVLLLEI 549
++ KSD++S G +L E+
Sbjct: 176 PYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 9e-10
Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 28/210 (13%)
Query: 360 LGQGGFGPVYKGT---LADGKA-----IAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 411
LGQG F ++KG + D + +K L ++ + F +++++L HK+LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 412 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 471
G C+ G E +++ EY+ SLD +L + + WK + +A + +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLE--VAKQLAWALHFLEDK- 119
Query: 472 RLKIIHRDLKASNILL-----DDDMNP---KISDFGLARIFGGNQNQANTNIIAGTYGYM 523
+ H ++ A N+LL NP K+SD G++ I+ ++
Sbjct: 120 --GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV------LPKEILLERIPWV 171
Query: 524 APE-YAMGGIFSIKSDVFSFGVLLLEIISG 552
PE S+ +D +SFG L EI SG
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 58/208 (27%), Positives = 89/208 (42%), Gaps = 14/208 (6%)
Query: 360 LGQGGFGPV-YKGTLADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAKLQHKNLVRLLG 415
LG+G FG V A G+ A+K L + E + E ++ +H L L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 416 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 475
L + EY L HL +R +R + I + YLH +
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLHSRD---V 116
Query: 476 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 535
++RD+K N++LD D + KI+DFGL + G + A GT Y+APE +
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 536 KSDVFSFGVLLLEIISGRKNNGFYFSEH 563
D + GV++ E++ GR FY +H
Sbjct: 175 AVDWWGLGVVMYEMMCGRLP--FYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 460 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 519
+ARG+ +L + +HRDL A N+LL KI DFGLAR + N +
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 520 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 551
+MAPE +++ SDV+S+G+LL EI S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 51/203 (25%), Positives = 87/203 (42%), Gaps = 26/203 (12%)
Query: 360 LGQGGFGPVYKGTLADGK--AIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLL 414
LG G FG V T + +A+KR ++ + + +E ++ + H V L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 415 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI-----ARGILYLHE 469
G + L L+ E++ L +R + N + A+ +L
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFL-----------RRNKRFPNDVGCFYAAQIVLIFEY 146
Query: 470 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 529
L I++RDLK N+LLD D K++DFG A++ T + GT Y+APE +
Sbjct: 147 LQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIAPEILL 201
Query: 530 GGIFSIKSDVFSFGVLLLEIISG 552
+D ++ G+ + EI+ G
Sbjct: 202 NVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 61/257 (23%), Positives = 96/257 (37%), Gaps = 69/257 (26%)
Query: 352 NHFSDENKLGQGGFGPV-YKGTLADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQH 407
F +G+G FG V GK A+K L ++ L K E +++A+
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 408 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLF-------DATRSVQLDWKRRQSIINGI 460
+V L + Q L LI E++P L L D TR +
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFY-------------M 107
Query: 461 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA-------------RIFGGN 507
A +L + +L IHRD+K NIL+D + K+SDFGL+ ++ G
Sbjct: 108 AECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGK 167
Query: 508 QNQ----------------------------ANTNIIA----GTYGYMAPEYAMGGIFSI 535
N+ N ++A GT Y+APE + +
Sbjct: 168 SNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ 227
Query: 536 KSDVFSFGVLLLEIISG 552
+ D +S G ++ E + G
Sbjct: 228 ECDWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 56/186 (30%), Positives = 87/186 (46%), Gaps = 24/186 (12%)
Query: 464 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYM 523
+L +H +IHRD+K++NILL + K+ DFG ++++ + GT Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 524 APEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVE 582
APE +S K+D+FS GVLL E+++ R +G E L +
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY---------- 262
Query: 583 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM-----LASDSMTIPQPTE 637
DP L S +P+ ++ I LL DP RP+ S ++ M S + I Q T+
Sbjct: 263 --DP-LPPSISPE--MQEIVTALLS--SDPKRRPSSSKLLNMPICKLFISGLLEIVQ-TQ 314
Query: 638 PAFSVG 643
P FS
Sbjct: 315 PGFSGP 320
|
Length = 496 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 33/100 (33%), Positives = 56/100 (56%), Gaps = 11/100 (11%)
Query: 460 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN---TNII 516
+ RG+ Y+H +IHRDLK SN+L+++D +I DFG+AR + + T +
Sbjct: 116 LLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 517 AGTYGYMAPE--YAMGGIFSIKSDVFSFGVLLLEIISGRK 554
A T Y APE ++ ++ D++S G + E++ GR+
Sbjct: 173 A-TRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEML-GRR 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 7/104 (6%)
Query: 460 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 519
I + YLH +++RDLK N++LD D + KI+DFGL + G + A GT
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 158
Query: 520 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH 563
Y+APE + D + GV++ E++ GR FY +H
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 50/173 (28%), Positives = 81/173 (46%), Gaps = 33/173 (19%)
Query: 398 EVNLIAKLQHKNLVRLLGCCL-----EGQELLLIYEYMPNKSLDVHLF-----DATRSVQ 447
E+ L+ L+H ++V + L E +++ +++E M + D+H D T
Sbjct: 49 EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES---DLHQVIKANDDLTP--- 102
Query: 448 LDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507
+ Q + + R + Y+H + + HRDLK NIL + D KI DFGLAR+
Sbjct: 103 ---EHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV---A 153
Query: 508 QNQANTNII----AGTYGYMAPEYAMGGIFSIKS---DVFSFGVLLLEIISGR 553
N T I T Y APE G FS + D++S G + E+++G+
Sbjct: 154 FNDTPTAIFWTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 59/198 (29%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 360 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFK---NEVNLIAK-LQHKNLVRLL 414
+G+G FG V A+ K AVK L + + +E K +E N++ K ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 415 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 474
+L + +Y+ L HL R R + IA + YLH L
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHL---QRERCFLEPRARFYAAEIASALGYLHS---LN 116
Query: 475 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 534
I++RDLK NILLD + ++DFGL + ++ T+ GT Y+APE +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174
Query: 535 IKSDVFSFGVLLLEIISG 552
D + G +L E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 22/215 (10%)
Query: 352 NHFSDENKLGQGGFGPVY----KGTLADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAK 404
F ++ +G+G FG V K T G A+K + ++ + + + F+ E ++++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57
Query: 405 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 464
+ +L + L L+ EY P L + L + Q D Q + + I
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDL-LSLLNRYED-QFDEDMAQFYLAELVLAI 115
Query: 465 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 524
+H+ + +HRD+K N+L+D + K++DFG A N+ N+ + GT Y+A
Sbjct: 116 HSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVGTPDYIA 171
Query: 525 PEY------AMGGIFSIKSDVFSFGVLLLEIISGR 553
PE G + ++ D +S GV+ E+I GR
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 460 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 519
+A G+ +L + +HRDL A N+L+ + KI DFGLAR + N +
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 520 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 551
+MAPE +++ SDV+SFG+LL EI +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 42/156 (26%), Positives = 73/156 (46%), Gaps = 8/156 (5%)
Query: 398 EVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 457
E +++ + H ++++L G + LI +P D++ + A + + +I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKR-NIAICDILAIE 188
Query: 458 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 517
+ R I YLHE+ IIHRD+KA NI ++ + + DFG A F + N A
Sbjct: 189 RSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWA 244
Query: 518 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 553
GT APE + D++S G++L E+ +
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 60/244 (24%), Positives = 97/244 (39%), Gaps = 68/244 (27%)
Query: 360 LGQGGFGPV----YKGTLADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKNLV 411
+G+G FG V K T G A+K+L ++ Q + + E +++A+ + +V
Sbjct: 9 IGRGAFGEVRLVQKKDT---GHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEADNPWVV 64
Query: 412 RLLGCCLEGQELLLIYEYMPNKSL-------DVHLFDATRSVQLDWKRRQSIINGIARGI 464
+L + L LI EY+P + D + TR IA I
Sbjct: 65 KLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFY-------------IAETI 111
Query: 465 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL------------ARIFGGNQNQAN 512
L + +L IHRD+K N+LLD + K+SDFGL RI
Sbjct: 112 LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171
Query: 513 TNIIA------------------------GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLE 548
+ I+ GT Y+APE + ++ + D +S GV++ E
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231
Query: 549 IISG 552
++ G
Sbjct: 232 MLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 22/204 (10%)
Query: 360 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVR 412
+G+G FG V +K T K A+K LS+ + F E +++A +V+
Sbjct: 51 IGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 472
L + + L ++ EYMP L V+L + V W R + A +L L
Sbjct: 108 LFYAFQDDRYLYMVMEYMPGGDL-VNLM-SNYDVPEKWARFYT-----AEVVLALDAIHS 160
Query: 473 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG-- 530
+ IHRD+K N+LLD + K++DFG + + GT Y++PE
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM-NKEGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 531 --GIFSIKSDVFSFGVLLLEIISG 552
G + + D +S GV L E++ G
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 22/204 (10%)
Query: 360 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVR 412
+G+G FG V +K + K A+K LS+ + F E +++A +V+
Sbjct: 51 IGRGAFGEVQLVRHK---SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 472
L + + L ++ EYMP L V+L + V W + + A +L L
Sbjct: 108 LFCAFQDDKYLYMVMEYMPGGDL-VNLM-SNYDVPEKWAKFYT-----AEVVLALDAIHS 160
Query: 473 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG-- 530
+ +IHRD+K N+LLD + K++DFG + GT Y++PE
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM-DETGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 531 --GIFSIKSDVFSFGVLLLEIISG 552
G + + D +S GV L E++ G
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 4e-07
Identities = 70/255 (27%), Positives = 115/255 (45%), Gaps = 66/255 (25%)
Query: 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSR------TSGQGLQEFKN-----EVN 400
N + K+G G FG V+ + KR S +GL+E + EVN
Sbjct: 13 NEYEVIKKIGNGRFGEVF--------LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVN 64
Query: 401 LIAKLQHKNLVRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSI-- 456
++ +L+HKN+VR + L Q+L ++ E+ D +R++Q +K I
Sbjct: 65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAG-------DLSRNIQKCYKMFGKIEE 117
Query: 457 --INGIARGIL----YLHE----DSRLKIIHRDLKASNILLD-------------DDMN- 492
I I R +L Y H + +++HRDLK NI L +++N
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177
Query: 493 ---PKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI--KSDVFSFGVLLL 547
KI DFGL++ G ++ A++ + GT Y +PE + S KSD+++ G ++
Sbjct: 178 RPIAKIGDFGLSKNI-GIESMAHSCV--GTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234
Query: 548 EIISGR----KNNGF 558
E+ SG+ K N F
Sbjct: 235 ELCSGKTPFHKANNF 249
|
Length = 1021 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 49/163 (30%), Positives = 81/163 (49%), Gaps = 19/163 (11%)
Query: 395 FKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQ 454
F +L++++ H +L + G C+ G E +++ E++ + LDV L V + WK
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWK--I 120
Query: 455 SIINGIARGILYLHEDSRLKIIHRDLKASNIL-----LDDDMNP--KISDFGLARIFGGN 507
++ +A + YL ED L +H ++ A NIL L + +P K+SD G++ F
Sbjct: 121 TVAQQLASALSYL-EDKNL--VHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTAL 175
Query: 508 QNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEI 549
+ I ++APE GG S +D +SFG LLEI
Sbjct: 176 SREERVERIP----WIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 43/158 (27%), Positives = 80/158 (50%), Gaps = 6/158 (3%)
Query: 396 KNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQS 455
++E++ +A H +V+ +LLLI EY L+ + + L ++ +
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKE-HLPFQEYEV 171
Query: 456 IINGIA--RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 513
G+ + +L L E K++HRDLK++NI L K+ DFG ++ + + +
Sbjct: 172 ---GLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA 228
Query: 514 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 551
+ GT Y+APE +S K+D++S GV+L E+++
Sbjct: 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 7e-07
Identities = 38/152 (25%), Positives = 71/152 (46%), Gaps = 7/152 (4%)
Query: 398 EVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 457
E++++ + H+ ++ L+ + ++ MP D+ + RS L ++ +I
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTY-VDRSGPLPLEQAITIQ 191
Query: 458 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 517
+ + YLH IIHRD+K NI LD+ N + DFG A + + +
Sbjct: 192 RRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWS 248
Query: 518 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEI 549
GT +PE + K+D++S G++L E+
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 8e-07
Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 25/208 (12%)
Query: 358 NKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHKNLVRLLG 415
N +G G FG VY+ D + +A+K++ + ++KN E+ ++ L H N++ L
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKD 126
Query: 416 C----CLEGQE----LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 467
C + E L ++ E++P A + L + + R + Y+
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186
Query: 468 HEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLAR-IFGGNQNQANTNIIAGTYGYMAP 525
H I HRDLK N+L+D + + K+ DFG A+ + G Q + + I + Y AP
Sbjct: 187 HSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG---QRSVSYICSRF-YRAP 239
Query: 526 EYAMGGI-FSIKSDVFSFGVLLLEIISG 552
E +G ++ D++S G ++ E+I G
Sbjct: 240 ELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 8e-07
Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 22/204 (10%)
Query: 360 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVR 412
+G+G FG V +K + + A+K LS+ + F E +++A + +V+
Sbjct: 51 IGRGAFGEVQLVRHKSS---KQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQ 107
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 472
L + + L ++ EYMP L V+L + + W R A +L L
Sbjct: 108 LHYAFQDDKYLYMVMEYMPGGDL-VNLM-SNYDIPEKWARFY-----TAEVVLALDAIHS 160
Query: 473 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG-- 530
+ IHRD+K N+LLD + K++DFG N + GT Y++PE
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN-GMVRCDTAVGTPDYISPEVLKSQG 219
Query: 531 --GIFSIKSDVFSFGVLLLEIISG 552
G + + D +S GV L E++ G
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 6/152 (3%)
Query: 397 NEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSI 456
+E L+ +L H ++ LL + G L+ +P D++ + R L + ++
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQVTAV 265
Query: 457 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 516
+ I Y+H + IIHRD+K N+L++ + + DFG A G+ + I
Sbjct: 266 ARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGI 322
Query: 517 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLE 548
AGT APE G ++ D++S G+++ E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 4e-06
Identities = 20/51 (39%), Positives = 27/51 (52%), Gaps = 2/51 (3%)
Query: 235 GQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRY 285
QC LS DCR CL + ++RC P G GRI + SC + +E Y +
Sbjct: 58 AQCRGDLSASDCRSCLATAVSELRRCC-PNKKG-GRIWYDSCFLRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 6e-06
Identities = 42/196 (21%), Positives = 87/196 (44%), Gaps = 22/196 (11%)
Query: 368 VYKGTLADGKAIAVKRL---SRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 424
+YKG + K + ++ + + +NE+ + ++ N++++ G ++ + L
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 425 ----LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDL 480
LI EY L L + L +K + + +G+ L+ +++L
Sbjct: 95 PRLSLILEYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNLY--KYTNKPYKNL 149
Query: 481 KASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS---IKS 537
+ + L+ ++ KI GL +I + N N + Y + + + IFS IK
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKILS-SPPFKNVNFMV----YFSYKM-LNDIFSEYTIKD 203
Query: 538 DVFSFGVLLLEIISGR 553
D++S GV+L EI +G+
Sbjct: 204 DIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 55/237 (23%), Positives = 95/237 (40%), Gaps = 45/237 (18%)
Query: 354 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKN 409
F +G+G FG V D G A+K L + + + + E +++ +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 469
+V++ + L LI E++P + T ++ D + IA +L +
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDM------MTLLMKKDTLTEEETQFYIAETVLAIDS 116
Query: 470 DSRLKIIHRDLKASNILLDDDMNPKISDFGL----------------------------- 500
+L IHRD+K N+LLD + K+SDFGL
Sbjct: 117 IHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176
Query: 501 -----ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 552
A + N+ Q + + GT Y+APE M ++ D +S GV++ E++ G
Sbjct: 177 NSKRKAETWKRNRRQLAFSTV-GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 53/237 (22%), Positives = 96/237 (40%), Gaps = 45/237 (18%)
Query: 354 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG----QGLQEFKNEVNLIAKLQHKN 409
F +G+G FG V D I ++ R + + + + E +++ +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 469
+V++ + + L LI E++P + T ++ D ++ IA +L +
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDM------MTLLMKKDTLSEEATQFYIAETVLAIDA 116
Query: 470 DSRLKIIHRDLKASNILLDDDMNPKISDFGL----------------------------- 500
+L IHRD+K N+LLD + K+SDFGL
Sbjct: 117 IHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176
Query: 501 -----ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 552
A + N+ Q + + GT Y+APE M ++ D +S GV++ E++ G
Sbjct: 177 NSKRKAETWKKNRRQLAYSTV-GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 61/239 (25%), Positives = 86/239 (35%), Gaps = 49/239 (20%)
Query: 353 HFSDENKLGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAKL 405
HF LG+G G V+ KGT GK A+K L + + K E ++A L
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATL 58
Query: 406 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 465
H L L L L+ +Y P Q + + A +L
Sbjct: 59 DHPFLPTLYASFQTETYLCLVMDYCPGGE-----LFRLLQRQPGKCLSEEVARFYAAEVL 113
Query: 466 ----YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL---------ARIF-------G 505
YLH L I++RDLK NILL + + +SDF L
Sbjct: 114 LALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170
Query: 506 GNQNQ-----------ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 553
+ N +N GT Y+APE G D ++ G+LL E++ G
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 46/175 (26%), Positives = 73/175 (41%), Gaps = 32/175 (18%)
Query: 354 FSDENKLGQGGFGPVYKGTLADGKAIAVKR--LSRTSGQGLQE-FKNE------VNLIAK 404
F KLG+G FG VYK +L + ++ + L + + G E + NE N A
Sbjct: 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCAD 193
Query: 405 LQHKNLVRLLGCCLEGQELLLIYEY---------MPNK----SLDVHLFDATRSVQLDWK 451
+ L + + E L++ Y M +K +++ +L + + +
Sbjct: 194 FVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLE 251
Query: 452 RRQSIINGIARGILY----LHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLA 501
R II I R IL+ LH I+HRD+K NI+ + KI D G A
Sbjct: 252 RENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403) | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 2e-05
Identities = 19/48 (39%), Positives = 26/48 (54%), Gaps = 2/48 (4%)
Query: 627 SDSMTIPQPTEPAFSVGR--VVANSGHFLSPAKACTVNNVTVSDVSPR 672
S++ IPQP +P F VGR +S ++ TVN VTVS + R
Sbjct: 1 SETTEIPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48
|
This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 31/99 (31%), Positives = 54/99 (54%), Gaps = 8/99 (8%)
Query: 460 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG-LARIFGGNQNQANTNIIAG 518
+A +L + +L +HRD+K N+LLD + + +++DFG R+ Q +N+ G
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ--SNVAVG 165
Query: 519 TYGYMAPEY--AMG---GIFSIKSDVFSFGVLLLEIISG 552
T Y++PE AM G + + D +S GV + E++ G
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 64/291 (21%), Positives = 121/291 (41%), Gaps = 48/291 (16%)
Query: 371 GTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430
GTL + + L + + L+ +NEV L +H N++ G L +I +M
Sbjct: 25 GTLV---TVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM 81
Query: 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD 490
S + L + +I+ G RG+ YLH++ IHR++KAS+IL+ D
Sbjct: 82 AYGSAN-SLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGD 137
Query: 491 MNPKISDFGLARIFGGNQNQANTNII-------AGTYGYMAPEYAMGGI--FSIKSDVFS 541
+S GL+ ++ +N ++ +++PE + +++KSD++S
Sbjct: 138 GLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYS 195
Query: 542 FGVLLLEIISGR--------------KNNGFYFS-------EHGQTLLTYTWKLWCEGPA 580
G+ E+ +GR K G +S ++ + + G
Sbjct: 196 VGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIG 255
Query: 581 VELIDPVLKQSCAPDELLK---------FIHIGLLCVQQDPADRPTMSSVV 622
++ + Q+ + L F ++ LC+QQDP RP+ SS++
Sbjct: 256 ESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLL 306
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 33/151 (21%), Positives = 54/151 (35%), Gaps = 15/151 (9%)
Query: 355 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV--R 412
S L G VY D + +K + + EV ++ L K L +
Sbjct: 1 SSIKLLKGGLTNRVYLLGTKDEDYV-LKINPSREKG--ADREREVAILQLLARKGLPVPK 57
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 472
+L L+ E++ ++LD + + Q +A + LH+
Sbjct: 58 VLASGESDGWSYLLMEWIEGETLDE-----VSEEEKEDIAEQ-----LAELLAKLHQLPL 107
Query: 473 LKIIHRDLKASNILLDDDMNPKISDFGLARI 503
L + H DL NIL+DD I D+ A
Sbjct: 108 LVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 28/98 (28%), Positives = 52/98 (53%), Gaps = 6/98 (6%)
Query: 460 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 519
IA +L +H +L +HRD+K N+LLD + + +++DFG + + +++ GT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGT 166
Query: 520 YGYMAPEYAMG-----GIFSIKSDVFSFGVLLLEIISG 552
Y++PE G + + D +S GV + E++ G
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 54/246 (21%), Positives = 98/246 (39%), Gaps = 51/246 (20%)
Query: 353 HFSDENKLGQGGFGPVYKGTLADGKAI-AVKRLSRTS---GQGLQEFKNEVNLIAKLQHK 408
F +G G FG V D A+ A+K L + K E +++A+ ++
Sbjct: 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNE 61
Query: 409 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 468
+V+L + L + +Y+P + + L + D R I + I +H
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDYIPGGDM-MSLLIRLGIFEEDLAR--FYIAELTCAIESVH 118
Query: 469 EDSRLKIIHRDLKASNILLDDDMNPKISDFGL---------ARIFGGNQN---------- 509
++ IHRD+K NIL+D D + K++DFGL ++ + +
Sbjct: 119 ---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175
Query: 510 ------------------QANTNIIA----GTYGYMAPEYAMGGIFSIKSDVFSFGVLLL 547
+ + +A GT Y+APE + ++ D +S GV+L
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235
Query: 548 EIISGR 553
E++ G+
Sbjct: 236 EMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 6e-05
Identities = 44/152 (28%), Positives = 76/152 (50%), Gaps = 22/152 (14%)
Query: 362 QGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 417
+G FG VY G + K AVK + + + + + + E + +A + +V L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 418 LEGQELLLIYEYMPN---KSLDVHL---FDATRSVQLDWKRRQSIINGIARGILYLHEDS 471
+ L+ EY+ KSL +H+ FD +V+ I+ +A + YLH
Sbjct: 74 QSANNVYLVMEYLIGGDVKSL-LHIYGYFDEEMAVKY--------ISEVALALDYLH--- 121
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLARI 503
R IIHRDLK N+L+ ++ + K++DFGL+++
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-05
Identities = 57/243 (23%), Positives = 95/243 (39%), Gaps = 55/243 (22%)
Query: 360 LGQGGFGPVYKGTLADGKAI-AVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLG 415
LG G FG V D KA+ A+K L + + K E +++A+ ++ +VRL
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 416 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 475
+ L + +Y+P + + L D R IA + ++
Sbjct: 69 SFQDKDNLYFVMDYIPGGDM-MSLLIRMGIFPEDLARFY-----IAELTCAVESVHKMGF 122
Query: 476 IHRDLKASNILLDDDMNPKISDFGLARIF-----------GGNQNQANTNI--------- 515
IHRD+K NIL+D D + K++DFGL F G + Q + +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 516 -------------------------IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEII 550
+ GT Y+APE + ++ D +S GV+L E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 551 SGR 553
G+
Sbjct: 243 VGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 50/211 (23%), Positives = 88/211 (41%), Gaps = 32/211 (15%)
Query: 360 LGQGGFGPVYKGTLAD---------GKAIAVKRLSRTSGQGLQE----FKNEVNLIAKLQ 406
LG+G +Y G L +K + + ++ F +++ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 407 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 466
HK++V L G C+ E +++ E++ LD+ + + + WK + + +A + Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFK--VAKQLASALSY 120
Query: 467 LHEDSRLKIIHRDLKASNILL-----DDDMNP--KISDFGLARIFGGNQNQANTNIIAGT 519
L ED L +H ++ NILL D + P K+SD G+ Q
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE------R 171
Query: 520 YGYMAPEYAM-GGIFSIKSDVFSFGVLLLEI 549
++APE SI +D +SFG L EI
Sbjct: 172 IPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 31/103 (30%), Positives = 50/103 (48%), Gaps = 22/103 (21%)
Query: 466 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI---------- 515
YLH I+HRDLK N+L+ + K++DFGL++I G + TN+
Sbjct: 116 YLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKI--GLMSLT-TNLYEGHIEKDTR 169
Query: 516 ------IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 552
+ GT Y+APE + + D ++ G++L E + G
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 48/204 (23%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 360 LGQGGFGPVYKGTLADG-KAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVRLLG 415
+G+G FG V L + K A+K L++ E F+ E +++ ++ + L
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 416 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 475
+ L L+ +Y L L + D R +A ++ + +L
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----LAEMVIAIDSVHQLHY 123
Query: 476 IHRDLKASNILLDDDMNPKISDFG--LARIFGGNQNQANTNIIAGTYGYMAPEYAMG--- 530
+HRD+K NIL+D + + +++DFG L + G +++ GT Y++PE
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT---VQSSVAVGTPDYISPEILQAMED 180
Query: 531 --GIFSIKSDVFSFGVLLLEIISG 552
G + + D +S GV + E++ G
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 55/243 (22%), Positives = 97/243 (39%), Gaps = 55/243 (22%)
Query: 360 LGQGGFGPVYKGTLADGKAI-AVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLG 415
LG G FG V D A+ A+K L + + + K E +++A+ ++ +V+L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 416 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 475
+ L + +Y+P + L ++++ IA L + ++
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLL------IRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 476 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQN----QANTNI---------------- 515
IHRD+K NIL+D D + K++DFGL F N Q ++I
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 516 -------------------------IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEII 550
+ GT Y+APE + ++ D +S GV+L E++
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 551 SGR 553
G+
Sbjct: 243 VGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 35/103 (33%), Positives = 49/103 (47%), Gaps = 18/103 (17%)
Query: 335 ESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGT-LADGK-----AIAVKRLSRTS 388
E EFP L+ LG G FG V + T GK +AVK L ++
Sbjct: 31 EKWEFPRDNLQFG----------KTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA 80
Query: 389 GQGLQE-FKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEY 429
+E +E+ +++ L QHKN+V LLG C G +L+I EY
Sbjct: 81 HTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEY 123
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 8e-04
Identities = 37/167 (22%), Positives = 55/167 (32%), Gaps = 51/167 (30%)
Query: 359 KLGQGGFGPVYKGTLADGKAIAVK----------------RLSRTSGQGLQEFKNEVNLI 402
+ QG +Y A+ VK R RT + E ++
Sbjct: 3 LIKQGAEAIIYLTDFLGLPAV-VKERIPKRYRHPELDEKLRRERT--------RREARIL 53
Query: 403 AKLQHKNLVRLLGCC------LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSI 456
AK R G ++ L++ EY+ + L DA + D R
Sbjct: 54 AKA------REAGVPVPIVYDVDPDNGLIVMEYIEGELLK----DALEEARPDLLRE--- 100
Query: 457 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503
+ R + LH+ I+H DL SNI+L DFGL
Sbjct: 101 ---VGRLVGKLHKA---GIVHGDLTTSNIILSGG-RIYFIDFGLGEF 140
|
Length = 204 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 22/52 (42%), Positives = 32/52 (61%), Gaps = 1/52 (1%)
Query: 451 KRRQSIINGIARGILY-LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 501
KR ++I G+ R +L L + R+ I+HRD+K N+L+ D KI DFG A
Sbjct: 305 KRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 672 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.81 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.43 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.41 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.38 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.32 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.29 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.26 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.25 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.15 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.11 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.06 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.06 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.99 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.97 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.87 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.84 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.83 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.77 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.61 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.49 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.48 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.47 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.47 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.34 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.3 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.24 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.18 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.17 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.13 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.07 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.04 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.01 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.97 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.93 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.92 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.9 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.89 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.8 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.65 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.56 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.56 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 97.55 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.54 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.5 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.48 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.28 | |
| PLN02236 | 344 | choline kinase | 97.16 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.99 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.95 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.93 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.77 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.6 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.55 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.51 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.41 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.3 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.21 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.15 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.96 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.88 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.76 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.64 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.48 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.1 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.0 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-50 Score=430.71 Aligned_cols=288 Identities=49% Similarity=0.790 Sum_probs=253.9
Q ss_pred CccccchHHHHHHhcCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEE
Q 005871 338 EFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 417 (672)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~ 417 (672)
....|++.++..+|++|...+.||+|+||.||+|.+.++..||||++.....+...+|.+|+.++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 55678999999999999999999999999999999999999999988776543135599999999999999999999999
Q ss_pred EeCc-eEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEE
Q 005871 418 LEGQ-ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKIS 496 (672)
Q Consensus 418 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~ 496 (672)
.+.+ +.+||||||++|+|.++|+..... .++|..|.+|+.++|+||+|||+....+||||||||+|||+|+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9998 599999999999999999875444 89999999999999999999999887789999999999999999999999
Q ss_pred eecCceeeCCCCCCcccccc-cccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhc
Q 005871 497 DFGLARIFGGNQNQANTNII-AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLW 575 (672)
Q Consensus 497 DFgla~~~~~~~~~~~~~~~-~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 575 (672)
|||+++..... ....... .||.+|+|||++..+..++|+|||||||+++||+||+++.+.........+..|.+..+
T Consensus 220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999654321 1111112 79999999999999999999999999999999999999876555445556888999999
Q ss_pred cCCCcccccChhhc-CCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 576 CEGPAVELIDPVLK-QSCAP-DELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 576 ~~~~~~~l~d~~l~-~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
.++...+++|+.+. ..... .++.++..++..|++.+|.+||+|.+|+++|...
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 99999999999987 55554 6899999999999999999999999999999544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=390.29 Aligned_cols=251 Identities=25% Similarity=0.387 Sum_probs=211.0
Q ss_pred cCCccccccccCCceeEEeeee-cCCceeEEEEeccc---CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
.+|...+.||+|||+.||.+++ ..|+.||+|++.+. .....+...+|++|.+.|+|||||+++++|++.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999998 67999999999774 3455678999999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
|+|++++|.+++. ++..+++.+++.+++||+.||.|||+.+ |||||||..|+|++++.++||+|||+|..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999884 5678999999999999999999999997 999999999999999999999999999988654
Q ss_pred CCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChh
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 587 (672)
.. +...++|||-|+|||++.....+..+||||+|||+|-||.|++||+-..... .+......+..+
T Consensus 172 ~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-----ty~~Ik~~~Y~~------- 237 (592)
T KOG0575|consen 172 GE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-----TYNKIKLNEYSM------- 237 (592)
T ss_pred cc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-----HHHHHHhcCccc-------
Confidence 33 3445899999999999999999999999999999999999999985321111 111111111111
Q ss_pred hcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 588 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 588 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
+........+||.++|+.||.+|||+++|+..=-.
T Consensus 238 -----P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 238 -----PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred -----ccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 11222345677789999999999999999976543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=367.60 Aligned_cols=255 Identities=29% Similarity=0.417 Sum_probs=207.4
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCc-eEEEEEe
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-ELLLIYE 428 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~-~~~lV~E 428 (672)
.+.+.++.||+|..|+||++.++ +++-+|+|.+.... ....+++.+|++++++.+||+||+++|.|..+. .+.|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 46777899999999999999987 68899999996543 445678999999999999999999999999998 5999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
||++|+|+.++... +.+++....+|+.++++||.|||+.. +||||||||+||||+..|.+||+|||.++.+.+.
T Consensus 159 YMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred hcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 99999999998543 56999999999999999999999632 4999999999999999999999999999977544
Q ss_pred CCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhh
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 588 (672)
.....+||..|||||.+.+..|+.++||||||++++|+.+|+.|+..... ......+....+. .++...+
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-~~~~~~~Ll~~Iv-~~ppP~l----- 302 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-PYLDIFELLCAIV-DEPPPRL----- 302 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC-CCCCHHHHHHHHh-cCCCCCC-----
Confidence 34457899999999999999999999999999999999999999754411 1111222221111 1122222
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 589 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 589 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
... ....++.+++..||++||.+|||+.+++++-
T Consensus 303 P~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 303 PEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred Ccc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 222 1234567777799999999999999998753
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=378.99 Aligned_cols=258 Identities=34% Similarity=0.515 Sum_probs=209.2
Q ss_pred CCccccccccCCceeEEeeeecCCceeEEEEecccCcc--cHHHHHHHHHHHHhccCCCeeeEEEEEEeCc-eEEEEEee
Q 005871 353 HFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ--GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-ELLLIYEY 429 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~-~~~lV~Ey 429 (672)
.+.+.+.||+|+||+||+|.++....||+|++...... ..+.|.+|+.+|++++|||||+++|++.+.. ..++||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 34455669999999999999975555999999765422 2568999999999999999999999999988 79999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-CeEEEeecCceeeCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIFGGNQ 508 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~-~~kL~DFgla~~~~~~~ 508 (672)
+++|+|..+++.. ....+++..+..|+.||++||.|||++++ ||||||||+||||+.++ ++||+|||+++......
T Consensus 122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999999999764 45679999999999999999999999863 99999999999999998 99999999998765332
Q ss_pred CCcccccccccCCcCChhhhc--CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 509 NQANTNIIAGTYGYMAPEYAM--GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~--~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||..... ..........+....+
T Consensus 199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~Rp~~--- 267 (362)
T KOG0192|consen 199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGLRPPI--- 267 (362)
T ss_pred --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCCCCC---
Confidence 1222357999999999999 56899999999999999999999999864332 1222222222222221
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCC
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSM 630 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 630 (672)
+......+..|+..||+.||+.||++.+++.+|+....
T Consensus 268 ------p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 268 ------PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred ------CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 11233457777779999999999999999999986533
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=367.21 Aligned_cols=198 Identities=30% Similarity=0.538 Sum_probs=180.3
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
..+|...++||+|+|++||+|+++ ++..||||.+.+. ..+..+.+..|+++|+.++|||||.+++++..++.++|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 367899999999999999999986 5899999999876 5666788899999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC------CCeEEEeecCc
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD------MNPKISDFGLA 501 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~------~~~kL~DFgla 501 (672)
|||.||+|.+++.. .+.+++..++.++.||+.||++||+++ ||||||||+||||+.. -.+||+|||++
T Consensus 89 EyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999954 346999999999999999999999998 9999999999999865 45899999999
Q ss_pred eeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCC
Q 005871 502 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNG 557 (672)
Q Consensus 502 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~ 557 (672)
+.+.... .....+|++.|||||+++..+|+.|+|+||+|+|+|++++|+.||.
T Consensus 163 R~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~ 215 (429)
T KOG0595|consen 163 RFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD 215 (429)
T ss_pred hhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence 9886333 3345799999999999999999999999999999999999999985
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=374.85 Aligned_cols=255 Identities=25% Similarity=0.359 Sum_probs=204.2
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcc-------cHHHHHHHHHHHHhccCCCeeeEEEEEEeCc
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ-------GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ 421 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~ 421 (672)
..+.|.+.+.||+|+||.|-+|..+ +|+.||||++++.... ......+|++||++|+|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4567899999999999999999875 7999999999765321 1233579999999999999999999999999
Q ss_pred eEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC---CCeEEEee
Q 005871 422 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD---MNPKISDF 498 (672)
Q Consensus 422 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~---~~~kL~DF 498 (672)
..||||||++||.|.+.+.. +..+.+..-..++.|++.||.|||++| |+||||||+|||++.+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 99999999999999999854 345788888999999999999999998 9999999999999866 67999999
Q ss_pred cCceeeCCCCCCcccccccccCCcCChhhhcCCC---CChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhc
Q 005871 499 GLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI---FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLW 575 (672)
Q Consensus 499 gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 575 (672)
|+|+..+. .......+|||.|.|||++.++. +..++|+||+||+||-+++|.+||........ +.+ ..
T Consensus 324 GlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--l~e----QI 394 (475)
T KOG0615|consen 324 GLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--LKE----QI 394 (475)
T ss_pred chhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--HHH----HH
Confidence 99998753 23345689999999999998765 34588999999999999999999864322210 111 11
Q ss_pred cCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 576 CEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 576 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
..+.... ....+.+..++.+++|.+||..||++|||++|+|+.-
T Consensus 395 ~~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp 438 (475)
T KOG0615|consen 395 LKGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHP 438 (475)
T ss_pred hcCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence 1111100 0011234456778889999999999999999998643
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=364.84 Aligned_cols=242 Identities=28% Similarity=0.392 Sum_probs=200.2
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
.++|++++.||+|+||.||.++.+ .++.+|+|++++.. ....+..++|..||.+++||.||+++..|++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 478999999999999999999976 58999999998753 34567889999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
+||+.||.|...|. +...+++..+..++..|+.||.|||++| ||||||||+|||+|++|+++|+|||+++..-.
T Consensus 104 ld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999984 4456999999999999999999999998 99999999999999999999999999986432
Q ss_pred CCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
. ...+..++||+.|||||++.+..|+..+|+||||+++|||++|.+||..... ......+. .++..
T Consensus 178 ~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~------~~~~~~I~-~~k~~----- 243 (357)
T KOG0598|consen 178 D--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV------KKMYDKIL-KGKLP----- 243 (357)
T ss_pred C--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH------HHHHHHHh-cCcCC-----
Confidence 2 2234458999999999999999999999999999999999999999853321 11111111 11100
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRP 616 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 616 (672)
..... ......+++.++|+.||++|.
T Consensus 244 -~~p~~---ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 244 -LPPGY---LSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -CCCcc---CCHHHHHHHHHHhccCHHHhc
Confidence 00111 223456777799999999996
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=352.93 Aligned_cols=259 Identities=27% Similarity=0.393 Sum_probs=208.9
Q ss_pred cCCccccccccCCceeEEeeee-cCCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEE-EEEeCce-EEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLG-CCLEGQE-LLLI 426 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~-~~~~~~~-~~lV 426 (672)
.+|+++++||+|.||+||++.. .+|..+|.|.+.-. .....+....|+.+|++|+|||||++++ .+.++.+ ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 5799999999999999999986 58999999998743 3445677899999999999999999998 5555555 9999
Q ss_pred EeecCCCChhHHhhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCeeecCCCCCcEEEcCCCCeEEEeecCceee
Q 005871 427 YEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDS-RLKIIHRDLKASNILLDDDMNPKISDFGLARIF 504 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~g-~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~ 504 (672)
||||.+|+|...+... .....++++.+|+++.|++.||.++|++- +..|+||||||.||+|+.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999998764 34556899999999999999999999943 235999999999999999999999999999988
Q ss_pred CCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 505 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 505 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
..... -....+|||.||+||.+.+..|+.|+||||+||++|||..-++||... .+.....++ ..++..-+-
T Consensus 179 ~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI-~qgd~~~~p 249 (375)
T KOG0591|consen 179 SSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKI-EQGDYPPLP 249 (375)
T ss_pred cchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHH-HcCCCCCCc
Confidence 65433 234578999999999999999999999999999999999999998533 333322222 222211111
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
+ ..-..++..||..|+..||+.||+.-.+++.+.+
T Consensus 250 ~--------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 250 D--------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred H--------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 0 2234567788889999999999996666665544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=340.61 Aligned_cols=264 Identities=22% Similarity=0.339 Sum_probs=205.0
Q ss_pred cCCccccccccCCceeEEeeeecC-CceeEEEEecccCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
+.|+.+.++|+|+||.||++++++ |+.||||++..... .-.+-.++|+++|++|+|+|+|.++++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 568899999999999999999874 99999999976543 234567899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
||+..-|+++-. ....++.+.+.+++.|++.|+.|+|+++ +|||||||+||||+.+|.+||+|||+|+.+..+.
T Consensus 82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 999877766542 2335899999999999999999999997 9999999999999999999999999999886422
Q ss_pred CCcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhh--------hhhhhccCC-
Q 005871 509 NQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLT--------YTWKLWCEG- 578 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~--------~~~~~~~~~- 578 (672)
...+..+.|.+|.|||.+.+ ..|++.+|||++||++.||++|.+.|......+...... ...+++...
T Consensus 156 --d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 156 --DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred --chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 22334577999999999988 689999999999999999999999876544333221111 111111111
Q ss_pred -----CcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 579 -----PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 579 -----~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
.+.+.-++.--+...+....-+++++.+||+.||.+|++-++++.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111111111001111223335789999999999999999999875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=326.93 Aligned_cols=274 Identities=26% Similarity=0.402 Sum_probs=214.9
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCcc--cHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ--GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
.+|...++||+|.||.||+|++. .|+.||||++...... ......+|++.|++++|+||+.++++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 47888999999999999999974 6999999999865432 23467899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|++ .+|+..+.+ +...++..++..++.++++||+|||+++ |+||||||.|+||+++|.+||+|||+++.+....
T Consensus 82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 996 578888854 3457899999999999999999999998 9999999999999999999999999999987665
Q ss_pred CCcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhc---cCCCccccc
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLW---CEGPAVELI 584 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~ 584 (672)
.....+ +-|.+|.|||.+.+. .|+..+|+||.|||+.||+.|.+-|......+. +..+...+ ++..+.++.
T Consensus 156 ~~~~~~--V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ---L~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 156 RIQTHQ--VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ---LSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred cccccc--eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH---HHHHHHHcCCCCcccCcccc
Confidence 444333 569999999999875 589999999999999999999887654333222 22222221 222222211
Q ss_pred ---C--------hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCCCCCCCCC
Q 005871 585 ---D--------PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEP 638 (672)
Q Consensus 585 ---d--------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~~p~~p 638 (672)
| ........+......++|+.+++..||.+|+|++|++++=-..+ +|.|..|
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~--~P~pt~~ 293 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS--LPLPTPP 293 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc--CCCCCCh
Confidence 1 00111123344556789999999999999999999998876655 4444443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=355.98 Aligned_cols=257 Identities=25% Similarity=0.335 Sum_probs=210.1
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEeccc---CcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEE
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELL 424 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~ 424 (672)
..++|...+.||+|+|++|++++.. .+++||||++.+. .....+-...|-++|.+| .||.|++++..|++...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 3478999999999999999999975 5999999998764 233345567799999999 8999999999999999999
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceee
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 504 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~ 504 (672)
+|+||+++|.|.++|.. .+.+++.-.+.++.+|+.||+|||+.| ||||||||+|||+|++|++||+|||.++.+
T Consensus 151 FvLe~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 99999999999999954 456999999999999999999999998 999999999999999999999999999988
Q ss_pred CCCCCC---------cc--cccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhh
Q 005871 505 GGNQNQ---------AN--TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWK 573 (672)
Q Consensus 505 ~~~~~~---------~~--~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~ 573 (672)
...... .. ...++||..|.+||++..+..++.+|+|+||||||+|+.|++||..... ..+.+.+..
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne---yliFqkI~~ 301 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE---YLIFQKIQA 301 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH---HHHHHHHHH
Confidence 643222 11 1458999999999999999999999999999999999999999853211 011111100
Q ss_pred hccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 005871 574 LWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDS 629 (672)
Q Consensus 574 ~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 629 (672)
++-. +++.......+|+.+.|..||.+|+|.++|-+..-...
T Consensus 302 ----------l~y~----fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 302 ----------LDYE----FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred ----------hccc----CCCCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 1111 11222245678888999999999999999998875543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=352.63 Aligned_cols=269 Identities=25% Similarity=0.370 Sum_probs=206.0
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeC--ceEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLL 425 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~l 425 (672)
.+.|+.+++||+|.||.||++++. +|+.||+|++.... ........+|+.||++|+||||+++.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 356889999999999999999964 69999999997654 45566778999999999999999999999887 68999
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
|+|||+.. |.-++. .....+++.++..++.||+.||+|+|++| |+|||||.+|||||.+|.+||+|||+|+++.
T Consensus 196 VFeYMdhD-L~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDHD-LSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccch-hhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 99999873 444442 33457999999999999999999999998 9999999999999999999999999999887
Q ss_pred CCCCCcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhh-----hhhccCCC
Q 005871 506 GNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYT-----WKLWCEGP 579 (672)
Q Consensus 506 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~-----~~~~~~~~ 579 (672)
.......++ .+-|.+|.|||++.+. .|+.++|+||.||||.||++|++.+............... ...|....
T Consensus 270 ~~~~~~~T~-rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 270 PSGSAPYTS-RVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CCCCccccc-ceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 665544443 4569999999999886 5999999999999999999999987644332221111110 01121111
Q ss_pred --cccccChh------hcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 580 --AVELIDPV------LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 580 --~~~l~d~~------l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
....+.+. +... ........++|+..+|..||.+|.|+.++|+.=-.
T Consensus 349 LP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF 403 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF 403 (560)
T ss_pred CCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence 11111111 1110 01112346677889999999999999999865433
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=359.47 Aligned_cols=254 Identities=34% Similarity=0.494 Sum_probs=205.7
Q ss_pred CCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCC
Q 005871 353 HFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 432 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~ 432 (672)
.+..++.||+|-||+||.|.++....||+|.+.... ...+.|.+|+++|++|+|+|||+++++|..++.++||||||+.
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 355678899999999999999888899999987653 3347888999999999999999999999998899999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcc
Q 005871 433 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 512 (672)
Q Consensus 433 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~ 512 (672)
|+|.++|.. .....++..+.+.++.||++|++||++++ +|||||...||||+++..+||+|||+++...++.....
T Consensus 286 GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~ 361 (468)
T KOG0197|consen 286 GSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS 361 (468)
T ss_pred CcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeec
Confidence 999999975 34566899999999999999999999997 99999999999999999999999999995544333222
Q ss_pred cccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCC
Q 005871 513 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQS 591 (672)
Q Consensus 513 ~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~ 591 (672)
.. ..-...|.|||.+..+.++.|||||||||+||||+| |+.|++..... +.+ +.++.-.+-.
T Consensus 362 ~~-~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~------ev~----------~~le~GyRlp 424 (468)
T KOG0197|consen 362 EG-GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE------EVL----------ELLERGYRLP 424 (468)
T ss_pred CC-CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH------HHH----------HHHhccCcCC
Confidence 21 122457999999999999999999999999999999 56564322211 111 1111111112
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 592 CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 592 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
.+......+.+||..||+.+|++|||++.+...|...
T Consensus 425 ~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 425 RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 2334455677888899999999999999999888754
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=329.20 Aligned_cols=237 Identities=27% Similarity=0.344 Sum_probs=199.4
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCc---ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
.++|+.++.||.|+||.|.+++.+ +|..+|+|++.+... ...++..+|..+|+.+.||+++++.+.+.+.+.++||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 368999999999999999999986 588999999987643 3456788999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||.+||.|..++. +.+.+++..++.++.||+.||+|||+.+ |++|||||+|||+|.+|++||+|||+++...
T Consensus 123 meyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~- 195 (355)
T KOG0616|consen 123 MEYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS- 195 (355)
T ss_pred EeccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec-
Confidence 99999999999994 4456999999999999999999999998 9999999999999999999999999999764
Q ss_pred CCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
..+-.++|||.|+|||+++...++.++|+|+|||++|||+.|.+||....+ +..+. ...++.+
T Consensus 196 ----~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-----~~iY~--KI~~~~v------ 258 (355)
T KOG0616|consen 196 ----GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-----IQIYE--KILEGKV------ 258 (355)
T ss_pred ----CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-----HHHHH--HHHhCcc------
Confidence 335568999999999999999999999999999999999999999864433 11111 1111111
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCC
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADR 615 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~R 615 (672)
.++.-....+.+|+.++|+.|-.+|
T Consensus 259 ----~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 ----KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ----cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1222223346677779999999998
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=351.60 Aligned_cols=257 Identities=22% Similarity=0.297 Sum_probs=205.2
Q ss_pred HHHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceE
Q 005871 348 LEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 423 (672)
Q Consensus 348 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 423 (672)
+...++|++++.||+|+||+||+++.+ .|+.+|+|++++.. ...++..+.|..+|....+|+||+++..|++.+.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 345689999999999999999999976 59999999998764 45677889999999999999999999999999999
Q ss_pred EEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 424 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
||||||++||++..+|. +...|++..++.++.+++.|++.||+.| +|||||||+|+|||..|++||+||||+.-
T Consensus 217 YLiMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence 99999999999999994 5567999999999999999999999998 99999999999999999999999999853
Q ss_pred eCCC----------------------CCCc----c-------------------cccccccCCcCChhhhcCCCCChhhH
Q 005871 504 FGGN----------------------QNQA----N-------------------TNIIAGTYGYMAPEYAMGGIFSIKSD 538 (672)
Q Consensus 504 ~~~~----------------------~~~~----~-------------------~~~~~gt~~Y~aPE~~~~~~~s~ksD 538 (672)
+... .... . ....+|||.|||||++.+..|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 3210 0000 0 01247999999999999999999999
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCcccc-cchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 005871 539 VFSFGVLLLEIISGRKNNGFYFSEHG-QTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 617 (672)
Q Consensus 539 vwSlGvil~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt 617 (672)
+||||||+||||.|-+||....+... ..+..|. ..|.. -+ ......+..+||.+||. ||++|.-
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr-~~l~f------P~-------~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWR-ETLKF------PE-------EVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-hhccC------CC-------cCcccHHHHHHHHHHhc-CHHHhcC
Confidence 99999999999999999864433221 1111111 00100 00 01111446677788998 9999985
Q ss_pred ---HHHHHHHh
Q 005871 618 ---MSSVVVML 625 (672)
Q Consensus 618 ---~~evl~~L 625 (672)
++||-++-
T Consensus 436 ~~G~~EIK~HP 446 (550)
T KOG0605|consen 436 SKGAEEIKKHP 446 (550)
T ss_pred cccHHHHhcCC
Confidence 66666554
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=344.82 Aligned_cols=258 Identities=27% Similarity=0.408 Sum_probs=204.7
Q ss_pred cCCccccccccCCceeEEeeeecC-CceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCc--eEEEEEe
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ--ELLLIYE 428 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~--~~~lV~E 428 (672)
.+|...+.||+|+||.||++...+ |...|||.+........+.+.+|+.+|++++|||||+++|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 468888999999999999999764 8999999987764444677899999999999999999999854444 6999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-CCCeEEEeecCceeeCC-
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFGLARIFGG- 506 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~-~~~~kL~DFgla~~~~~- 506 (672)
|+++|+|.+++.+... .+++..+..+++||++||.|||++| |+||||||+||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999965432 6999999999999999999999998 999999999999999 79999999999987764
Q ss_pred CCCCcccccccccCCcCChhhhcCCC-CChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccC
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 585 (672)
...........||+.|||||++..+. ...++|||||||++.||+||++||... ..................+
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P~i-- 244 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLPEI-- 244 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCCCC--
Confidence 11222233468999999999998643 346999999999999999999997543 1112222222222222222
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
... ......+++.+|++.||++|||++++|+..-..
T Consensus 245 ---p~~----ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 245 ---PDS----LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred ---Ccc----cCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 112 223355666699999999999999999887554
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=350.59 Aligned_cols=269 Identities=25% Similarity=0.330 Sum_probs=208.1
Q ss_pred HHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHH--HHHHHHHHHhcc-CCCeeeEEEEEEeCc-eE
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQE--FKNEVNLIAKLQ-HKNLVRLLGCCLEGQ-EL 423 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~--~~~E~~il~~l~-h~niv~l~~~~~~~~-~~ 423 (672)
...++|.++++||.|+||.||+|+.. .+..||||++++.-.. +++ -++|++.|++|+ ||||+++++++.+.+ .+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 34578999999999999999999965 6899999999776433 332 368999999998 999999999999988 99
Q ss_pred EEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 424 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
++|||||+. +|.+++.+. +..+++..++.|+.||++||+|+|.+| +.|||+||+||||.....+||+|||+|+.
T Consensus 86 ~fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 86 YFVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eeeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccc
Confidence 999999965 677777543 678999999999999999999999998 99999999999999999999999999998
Q ss_pred eCCCCCCcccccccccCCcCChhhhc-CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhh-----hhhccC
Q 005871 504 FGGNQNQANTNIIAGTYGYMAPEYAM-GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYT-----WKLWCE 577 (672)
Q Consensus 504 ~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~-----~~~~~~ 577 (672)
...... .+..+.|.+|+|||++. .+.|+.+.|+|++|||++|+.+-++.|......+.......+ +..|.+
T Consensus 160 v~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 160 VRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred cccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence 654332 23357899999999875 567899999999999999999999988654332221111111 111111
Q ss_pred C---------CcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 578 G---------PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 578 ~---------~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
+ ...+.....+. ...+....++++++..|+.+||.+|||+++.+++--.+
T Consensus 237 g~~La~~mnf~~P~~~~~~l~-~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq 295 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLK-DLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQ 295 (538)
T ss_pred HHHHHHHhccCCCcCCCCChH-HhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccc
Confidence 1 00000000011 11123456788899999999999999999999987543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=353.92 Aligned_cols=252 Identities=26% Similarity=0.407 Sum_probs=212.2
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
..|....+||+|+-|.||.+... .++.||||++........+.+.+|+.+|+..+|+|||.+++.|..++++|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 56888899999999999999864 68999999998877666788999999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
+||+|.+.+-. ..+++.++..|+++++.||+|||.+| |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 353 ~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 353 EGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred CCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 99999988833 34999999999999999999999998 99999999999999999999999999998765543
Q ss_pred cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcC
Q 005871 511 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 590 (672)
.....+|||.|||||+.....|++|+||||||++++||+-|.+||=. +..+...+.+...+... +-.
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln------E~PlrAlyLIa~ng~P~-lk~----- 491 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN------ENPLRALYLIATNGTPK-LKN----- 491 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC------CChHHHHHHHhhcCCCC-cCC-----
Confidence 34457899999999999999999999999999999999999999621 33444444444444331 111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 591 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
.......+.+++.+||+.|+++||++.|+|+.=.
T Consensus 492 --~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpF 525 (550)
T KOG0578|consen 492 --PEKLSPELKDFLDRCLVVDVEQRASAKELLEHPF 525 (550)
T ss_pred --ccccCHHHHHHHHHHhhcchhcCCCHHHHhcChh
Confidence 1112233556666999999999999999997543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=350.60 Aligned_cols=248 Identities=27% Similarity=0.417 Sum_probs=209.7
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
++|-+.+.||+|+||.||||+.+ +.+.||+|.+.+.. ....+.+.+|++|+++++||||+.++++|+...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888999999999999999976 58899999987653 4456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|+.| +|..+|. ....++++.++.|+.+++.||.|||+.+ |+|||+||.|||++..|.+|++|||+++.+..+
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~- 153 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN- 153 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-
Confidence 9988 9999984 4456999999999999999999999997 999999999999999999999999999987643
Q ss_pred CCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhh
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 588 (672)
......+.|||.|||||+..+..|+..+|+||+|||+||+++|++||- ...+.+.+..+..+...
T Consensus 154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~------a~si~~Lv~~I~~d~v~-------- 218 (808)
T KOG0597|consen 154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY------ARSITQLVKSILKDPVK-------- 218 (808)
T ss_pred -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch------HHHHHHHHHHHhcCCCC--------
Confidence 233456789999999999999999999999999999999999999972 22233333333322111
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 589 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 589 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
.+......+..++...|++||..|.|..+++..-
T Consensus 219 ---~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 219 ---PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred ---CcccccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence 1223345678888899999999999999998754
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=335.37 Aligned_cols=264 Identities=25% Similarity=0.373 Sum_probs=209.6
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
.+.|++...||.|.-++||+|+.. .+..||||++..... ...+.+.+|+..|+.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 368999999999999999999964 679999999976543 336889999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
||.+|++.+++...-.. .+++..+..|++++++||.|||.+| .||||||+.||||+++|.|||+|||.+..+....
T Consensus 105 fMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999999765444 3999999999999999999999998 9999999999999999999999999987664433
Q ss_pred CCc--ccccccccCCcCChhhhcC--CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 509 NQA--NTNIIAGTYGYMAPEYAMG--GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 509 ~~~--~~~~~~gt~~Y~aPE~~~~--~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
... +.+.++||+.|||||+++. ..|+.|+||||||++..||.+|..||..+.+- ......+.+.. ..+.
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm------kvLl~tLqn~p-p~~~ 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM------KVLLLTLQNDP-PTLL 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH------HHHHHHhcCCC-CCcc
Confidence 221 1256789999999999654 46899999999999999999999998644321 11111111111 1111
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
...+..+........+.+++..||++||.+|||++++++.=
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~ 294 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHA 294 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccH
Confidence 11111111122233677888899999999999999998643
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=350.35 Aligned_cols=259 Identities=29% Similarity=0.439 Sum_probs=201.6
Q ss_pred hcCCccccccccCCceeEEeeee------cCCceeEEEEecccC-cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeC-c
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG-Q 421 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~-~ 421 (672)
.++|++.++||+|+||.||+|.+ ..++.||+|++.... ......+.+|+.++..+ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46899999999999999999974 235689999987543 23346789999999999 899999999988764 4
Q ss_pred eEEEEEeecCCCChhHHhhhccc---------------------------------------------------------
Q 005871 422 ELLLIYEYMPNKSLDVHLFDATR--------------------------------------------------------- 444 (672)
Q Consensus 422 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 444 (672)
.+++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 68999999999999998864211
Q ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcccccccccCCc
Q 005871 445 --SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 522 (672)
Q Consensus 445 --~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y 522 (672)
...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...............++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 134788899999999999999999997 999999999999999999999999999865433222222233466789
Q ss_pred CChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHH
Q 005871 523 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFI 601 (672)
Q Consensus 523 ~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~ 601 (672)
+|||++.+..++.++||||||+++|||++ |..||...... .. .......+..... +......+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--~~----~~~~~~~~~~~~~---------~~~~~~~l~ 307 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--EE----FCQRLKDGTRMRA---------PENATPEIY 307 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--HH----HHHHHhcCCCCCC---------CCCCCHHHH
Confidence 99999999999999999999999999997 99997542211 11 1111111111110 111234577
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 602 HIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 602 ~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
+|+.+||+.||++|||+.||++.|..
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~ 333 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGD 333 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHH
Confidence 88889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=348.68 Aligned_cols=249 Identities=25% Similarity=0.373 Sum_probs=204.6
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEeccc----Cc-ccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCce
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT----SG-QGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQE 422 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~ 422 (672)
...+|.+.+.||+|+||.|+.|... ++..||+|++.+. .. ...+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4568999999999999999999865 6899999977664 22 23456778999999999 9999999999999999
Q ss_pred EEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC-CCeEEEeecCc
Q 005871 423 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-MNPKISDFGLA 501 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~-~~~kL~DFgla 501 (672)
+++||||+.||.|.+++.+ .+.+.+..+..+++||+.|++|+|+.| |+||||||+|||++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999954 456899999999999999999999998 9999999999999999 99999999999
Q ss_pred eeeCCCCCCcccccccccCCcCChhhhcCCC-C-ChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCC-
Q 005871 502 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGI-F-SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG- 578 (672)
Q Consensus 502 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~-s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~- 578 (672)
.... .........+|++.|+|||++.+.. | +.++||||+||+||.|++|+.||.... ....... ...+
T Consensus 169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~------~~~l~~k-i~~~~ 239 (370)
T KOG0583|consen 169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN------VPNLYRK-IRKGE 239 (370)
T ss_pred cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc------HHHHHHH-HhcCC
Confidence 9864 2223345579999999999999877 7 589999999999999999999986411 1111111 1111
Q ss_pred -CcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 579 -PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 579 -~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.....+. ..++.+|+.+||+.||.+|+|+.+|++.
T Consensus 240 ~~~p~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 240 FKIPSYLL-----------SPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred ccCCCCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 1111110 3457788889999999999999999943
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=340.58 Aligned_cols=264 Identities=27% Similarity=0.415 Sum_probs=202.0
Q ss_pred cCCccccccccCCceeEEeeeecC-----------------CceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLAD-----------------GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRL 413 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l 413 (672)
++|.+.++||+|+||.||++.+++ +..||+|.+.... ......+.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578999999999999999997532 3369999987643 3345678999999999999999999
Q ss_pred EEEEEeCceEEEEEeecCCCChhHHhhhcc----------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 005871 414 LGCCLEGQELLLIYEYMPNKSLDVHLFDAT----------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 477 (672)
Q Consensus 414 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiH 477 (672)
++++.+.+..++||||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999885421 1134788899999999999999999997 999
Q ss_pred cCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcC--CCC
Q 005871 478 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG--RKN 555 (672)
Q Consensus 478 rDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG--~~p 555 (672)
|||||+|||++.++.+||+|||+++.+.............++..|+|||++.++.++.++||||||+++|||+++ ..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999866443322223334567889999999988999999999999999999975 445
Q ss_pred CCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 556 NGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
+..... ..........+..... ... ...++.....+.+|+.+||+.||++|||+.+|.+.|+.
T Consensus 242 ~~~~~~---~~~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTD---EQVIENAGEFFRDQGR-QVY-----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCH---HHHHHHHHHHhhhccc-ccc-----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 432211 1111111111111100 000 00112223467888899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=340.17 Aligned_cols=249 Identities=25% Similarity=0.416 Sum_probs=207.6
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
..|...++||+|.||.||+|.+. .++.||+|++.... ....+.+.+|+.+|.+++++||.++++.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 45777899999999999999975 58999999998654 45578899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
|.||++.+.+. ....+++..+..|+++++.||.|||.++ .+|||||+.|||+..+|.+||+|||.+..+.....
T Consensus 93 ~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999883 3344588888999999999999999997 99999999999999999999999999998765544
Q ss_pred CcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhc
Q 005871 510 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 589 (672)
.. ..++|||.|||||++++..|+.|+||||||++.+||.+|.+|+....+.....+ +.+-..|.+.
T Consensus 167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl------------Ipk~~PP~L~ 232 (467)
T KOG0201|consen 167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL------------IPKSAPPRLD 232 (467)
T ss_pred cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe------------ccCCCCCccc
Confidence 33 568999999999999988999999999999999999999999754433111110 1122223333
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 590 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
+.+. ..+.+++..||++||+.||++.++++.
T Consensus 233 ~~~S----~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 233 GDFS----PPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cccC----HHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 3332 336677779999999999999998863
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=350.00 Aligned_cols=268 Identities=25% Similarity=0.335 Sum_probs=217.3
Q ss_pred HHHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCce
Q 005871 348 LEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQE 422 (672)
Q Consensus 348 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~ 422 (672)
....++|..++.||+|.||.|+++..+ +++.+|||.+++.. .++++..+.|..|+.... ||.++.++..|+.+++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 345689999999999999999999987 58899999998863 567788899999998885 9999999999999999
Q ss_pred EEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCce
Q 005871 423 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 502 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~ 502 (672)
+++||||+.||++..+ .....+++..+..++..|+.||.|||++| |||||||.+|||+|.+|++||+|||+++
T Consensus 444 l~fvmey~~Ggdm~~~----~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHH----IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEE----EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 9999999999994433 34457999999999999999999999998 9999999999999999999999999999
Q ss_pred eeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccc
Q 005871 503 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVE 582 (672)
Q Consensus 503 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (672)
.--. ....+..++|||.|||||++.+..|+..+|+|||||+||||+.|+.||..... .+
T Consensus 517 e~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE-------------------ee 575 (694)
T KOG0694|consen 517 EGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE-------------------EE 575 (694)
T ss_pred ccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH-------------------HH
Confidence 6432 23356678999999999999999999999999999999999999999853221 12
Q ss_pred ccChhhcCC--CCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHHh--ccC------CCCCCCCCCCccccc
Q 005871 583 LIDPVLKQS--CAPDELLKFIHIGLLCVQQDPADRPTM-----SSVVVML--ASD------SMTIPQPTEPAFSVG 643 (672)
Q Consensus 583 l~d~~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~L--~~~------~~~l~~p~~p~~~~~ 643 (672)
++|..+..+ ++.....+.+.|+.++|..+|++|.-+ .+|.+.- +.+ +..++||=.|.....
T Consensus 576 ~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~ 651 (694)
T KOG0694|consen 576 VFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGP 651 (694)
T ss_pred HHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCCh
Confidence 222222221 223334567788889999999999966 4444332 222 345677777877653
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=331.08 Aligned_cols=252 Identities=25% Similarity=0.328 Sum_probs=200.0
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
.|+..+.||+|+||.||++.+. +++.||+|++.... ......+.+|+.++++++|+||+++++.+.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3778899999999999999874 68999999986543 2233467899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|+++|+|...+... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999998877543 2335899999999999999999999997 9999999999999999999999999998753322
Q ss_pred CCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhh
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 588 (672)
. .....|+..|+|||++.+..++.++|||||||++|||++|+.||........ ............
T Consensus 157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~--------- 221 (285)
T cd05631 157 T---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK---REEVDRRVKEDQ--------- 221 (285)
T ss_pred e---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh---HHHHHHHhhccc---------
Confidence 1 2234689999999999999999999999999999999999999864322111 111111110000
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 005871 589 KQSCAPDELLKFIHIGLLCVQQDPADRPT-----MSSVVVM 624 (672)
Q Consensus 589 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 624 (672)
..........+.+|+.+||+.||++||+ ++++++.
T Consensus 222 -~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 222 -EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred -ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0011112345678888999999999997 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=336.05 Aligned_cols=199 Identities=28% Similarity=0.395 Sum_probs=175.5
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
.++|++.+.||+|+||.||++++. ++..+|+|.+.... ....+.+.+|+++|++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999986 58889999887543 3345679999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 9999999999854 335899999999999999999999863 49999999999999999999999999997653221
Q ss_pred CCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCC
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF 558 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~ 558 (672)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 ----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 2335689999999999999999999999999999999999999853
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=330.46 Aligned_cols=245 Identities=19% Similarity=0.320 Sum_probs=195.6
Q ss_pred cccccCCceeEEeeeecCCceeEEEEecccCccc---HHHHHHHHHHHHhccCCCeeeEEEEEEe----CceEEEEEeec
Q 005871 358 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQG---LQEFKNEVNLIAKLQHKNLVRLLGCCLE----GQELLLIYEYM 430 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~----~~~~~lV~Ey~ 430 (672)
..||+|++|.||+|.+ +|+.||||.+....... .+.+.+|+.+|++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999998 68899999987654332 5678899999999999999999999877 35789999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
++|+|.+++.. ...+++.....++.|++.||.|||+.. +++||||||+|||+++++.+||+|||+++.+....
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 99999999854 346889999999999999999999852 28899999999999999999999999998654322
Q ss_pred cccccccccCCcCChhhhcC--CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhh
Q 005871 511 ANTNIIAGTYGYMAPEYAMG--GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 588 (672)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... ..+... ....+.... +
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~---~~~~~~---i~~~~~~~~-----~ 243 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT---KEIYDL---IINKNNSLK-----L 243 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH---HHHHHH---HHhcCCCCC-----C
Confidence 12357899999999976 6789999999999999999999999853211 111111 111111000 1
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 589 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 589 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
+......+.+++.+||+.||++|||++||++.|+..
T Consensus 244 ----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 244 ----PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred ----CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 111234577888899999999999999999999764
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=338.20 Aligned_cols=260 Identities=29% Similarity=0.471 Sum_probs=206.0
Q ss_pred cCCccccccccCCceeEEeeeecCCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
+.+.+..+||+|.||+||+|.|. ..||||++... ..+..+.|++|+..+++-+|.||+-++|++..+.. .||+-+
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqw 468 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQW 468 (678)
T ss_pred HHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehh
Confidence 55778899999999999999985 46999998754 45678899999999999999999999999998877 999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
|+|.+|..+++..+ ..++..+...|++||++|+.|||.++ |||||||..||++.+++.|||+|||++..-.....
T Consensus 469 CeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 469 CEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred ccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 99999999997543 45889999999999999999999997 99999999999999999999999999975433322
Q ss_pred CcccccccccCCcCChhhhcC---CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 510 QANTNIIAGTYGYMAPEYAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
........|...|||||+++. .+|++++||||||+++|||++|..|+.. ...+ +. +|..+.-.-..|.
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi--~~~d----qI---ifmVGrG~l~pd~ 614 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI--QNRD----QI---IFMVGRGYLMPDL 614 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC--CChh----he---EEEecccccCccc
Confidence 222334467788999999964 4689999999999999999999999751 1111 11 1222222222222
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCC
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMT 631 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 631 (672)
....... .+.+.+|+..||..++++||.+.+|+.+|...-.+
T Consensus 615 s~~~s~~---pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 615 SKIRSNC---PKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred hhhhccC---HHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 2222222 33455666799999999999999999988776443
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=341.01 Aligned_cols=252 Identities=24% Similarity=0.346 Sum_probs=210.8
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCce-EEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE-LLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~lV~ 427 (672)
++|..++.+|+|+||.++.++++ +++.+++|++.... ....+...+|+.++++++|||||.+.+.|.+++. ++|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57999999999999999999976 68899999987543 3344578999999999999999999999999988 99999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
+||+||++.+.+...+ ...++++.+..|+.||+.|+.|||++. |+|||||+.|||++.++.+||+|||+++.++..
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999997654 567999999999999999999999876 999999999999999999999999999998765
Q ss_pred CCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChh
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 587 (672)
.. .....+||+.||+||++.+.+|+.|+|||||||++|||++-+++|... +....+.++... .+.
T Consensus 160 ~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~------~m~~Li~ki~~~-----~~~-- 224 (426)
T KOG0589|consen 160 DS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS------NMSELILKINRG-----LYS-- 224 (426)
T ss_pred hh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc------chHHHHHHHhhc-----cCC--
Confidence 42 234578999999999999999999999999999999999999997532 112222111111 111
Q ss_pred hcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 588 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 588 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
..+......+..++..||+.+|+.||++.++|.+.
T Consensus 225 ---Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 225 ---PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred ---CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 12333445677788899999999999999999874
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=327.56 Aligned_cols=265 Identities=21% Similarity=0.293 Sum_probs=201.1
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
++|++.+.||+|+||.||+++++ +++.+|+|++.... ....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999986 58899999987542 3345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|++++.+..+.. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999987765542 2345899999999999999999999997 9999999999999999999999999998764322
Q ss_pred CCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhh--------hhhhc-cCCC
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTY--------TWKLW-CEGP 579 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~--------~~~~~-~~~~ 579 (672)
.. ......|++.|+|||++.+..++.++|||||||++|||++|+.||.............. .+..+ ....
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 NA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred cc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 21 22235689999999999998999999999999999999999999864321111000000 00000 0000
Q ss_pred cccccChhhc------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 580 AVELIDPVLK------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 580 ~~~l~d~~l~------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
......+... ..........+.+++.+||+.||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000 0001112345788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=345.72 Aligned_cols=259 Identities=31% Similarity=0.433 Sum_probs=202.0
Q ss_pred hcCCccccccccCCceeEEeeee------cCCceeEEEEecccC-cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCce
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE 422 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~ 422 (672)
.++|++.++||+|+||.||++++ ..+..||||++.... ....+.+.+|+.+++.+ +||||+++++++.+...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 35799999999999999999963 236689999986543 33456788999999999 89999999999999999
Q ss_pred EEEEEeecCCCChhHHhhhccc----------------------------------------------------------
Q 005871 423 LLLIYEYMPNKSLDVHLFDATR---------------------------------------------------------- 444 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 444 (672)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999988854211
Q ss_pred --------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 445 --------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 445 --------------~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 124788999999999999999999997 999999999999999999999999999876443322
Q ss_pred cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhc
Q 005871 511 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 589 (672)
.......++..|+|||++.+..++.++||||||+++|||++ |..||...... ... .+....+....
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~----~~~~~~~~~~~------- 337 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKF----YKMIKEGYRML------- 337 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHH----HHHHHhCccCC-------
Confidence 22222345667999999999999999999999999999998 78886432111 111 11111111000
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 590 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
.+.....++.+|+.+||+.||++|||+.+|+++|..
T Consensus 338 --~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 338 --SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred --CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 001112357788889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=328.89 Aligned_cols=261 Identities=23% Similarity=0.342 Sum_probs=197.4
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
++|++.++||+|+||.||+|..+ +++.||+|++.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57999999999999999999876 68899999987543 23345678999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+++ +|..++... ...+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 985 788777432 235789999999999999999999997 99999999999999999999999999986543221
Q ss_pred CcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhh--------ccCC--
Q 005871 510 QANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL--------WCEG-- 578 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~--------~~~~-- 578 (672)
......|++.|+|||++.+ ..++.++||||+||++|+|++|+.||........ ....... |..-
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE---LHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHHhhcccc
Confidence 1223467999999999876 5689999999999999999999999854322111 1111110 1000
Q ss_pred --CcccccChhhcCC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 579 --PAVELIDPVLKQS----CAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 579 --~~~~l~d~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
......-+..... ..+.....+.+++.+||+.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000000000 00111235678889999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=339.09 Aligned_cols=253 Identities=23% Similarity=0.322 Sum_probs=202.8
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
++|++.+.||+|+||.||+|++. +++.||||++.+.. ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36899999999999999999986 58899999987542 234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 99999999999843 346899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCC-CcccccCh
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG-PAVELIDP 586 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~d~ 586 (672)
......|++.|+|||++.+..++.++|||||||++|||++|+.||....... ..... ..+... ......++
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~~i-~~~~~~~~~~~~~~~ 225 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE---TWENL-KYWKETLQRPVYDDP 225 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH---HHHHH-HhccccccCCCCCcc
Confidence 2234578999999999999999999999999999999999999985332111 00000 001000 00000000
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
.......+.+++.+||+.+|++||++.++++.-
T Consensus 226 ------~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 226 ------RFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred ------ccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 011234567788899999999999999999874
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=313.50 Aligned_cols=280 Identities=24% Similarity=0.331 Sum_probs=207.5
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcc--cHHHHHHHHHHHHhccCCCeeeEEEEEEeC--ceEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ--GLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLL 425 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~l 425 (672)
.++|+.+++|++|+||.||+|+++ +++.||+|+++..... .--.-.+|+.+|.+.+|||||.+-.+.... +.+||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 467999999999999999999986 6889999999765422 123457899999999999999999988743 57999
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
|||||+. +|..++..-. ..+...++..+..|+++||+|||+++ |+||||||+|+|++..|.+||+|||+|+.++
T Consensus 155 VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999976 5666664322 56889999999999999999999998 9999999999999999999999999999987
Q ss_pred CCCCCcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchh--------hhhhhhcc
Q 005871 506 GNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLL--------TYTWKLWC 576 (672)
Q Consensus 506 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~--------~~~~~~~~ 576 (672)
.+... .+..+-|.+|.|||++.+. .|++.+|+||+|||+.||+++++.|......+..... ...|.-+.
T Consensus 229 sp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 229 SPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred CCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 66332 2335669999999999875 5899999999999999999999988654333322111 11222111
Q ss_pred CCCccc------ccChhhcCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCCCCCCCCCcc
Q 005871 577 EGPAVE------LIDPVLKQSCAPD-ELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAF 640 (672)
Q Consensus 577 ~~~~~~------l~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~~p~~p~~ 640 (672)
.-...+ .....+...+... ..+.-.+|+..+|..||.+|.|++|.|+.=-... .|.|..|.+
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e--~P~p~~P~~ 375 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE--TPLPIDPSM 375 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc--CCCCCChhh
Confidence 111111 0111111111111 1234457777999999999999999987654433 344444444
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=344.17 Aligned_cols=259 Identities=30% Similarity=0.447 Sum_probs=201.8
Q ss_pred hcCCccccccccCCceeEEeeeec------CCceeEEEEecccC-cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCce
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE 422 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~ 422 (672)
.++|++.+.||+|+||.||++.+. ++..||+|++.... ....+.+.+|+.+++.+ +|+||+++++++.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 357999999999999999998742 34579999997543 33456788999999999 89999999999999999
Q ss_pred EEEEEeecCCCChhHHhhhccc----------------------------------------------------------
Q 005871 423 LLLIYEYMPNKSLDVHLFDATR---------------------------------------------------------- 444 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 444 (672)
.++||||+++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999998854211
Q ss_pred ---------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCccccc
Q 005871 445 ---------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 515 (672)
Q Consensus 445 ---------~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~ 515 (672)
...+++.++..++.||+.||.|||++| |+||||||+|||+++++.+||+|||+++.+...........
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 124788899999999999999999997 99999999999999999999999999986543322221222
Q ss_pred ccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCH
Q 005871 516 IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAP 594 (672)
Q Consensus 516 ~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~ 594 (672)
..++..|+|||++.+..++.++||||||+++|||++ |+.||....... .. ......+. .... +.
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~----~~~~~~~~-----~~~~----~~ 338 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KF----YKMVKRGY-----QMSR----PD 338 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HH----HHHHHccc-----CccC----CC
Confidence 335668999999999999999999999999999997 999975432111 11 11111110 0000 01
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 595 DELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 595 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
.....+.+++.+||+.||++|||+.+|+++|..
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 112457788889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=327.32 Aligned_cols=257 Identities=31% Similarity=0.493 Sum_probs=204.9
Q ss_pred cCCccccccccCCceeEEeeeecC------CceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 424 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 424 (672)
++|++.+.||+|+||.||+|.+.. ...+++|.+.... ......+.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 478899999999999999998643 2579999886543 334567899999999999999999999999999999
Q ss_pred EEEeecCCCChhHHhhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC
Q 005871 425 LIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM 491 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~ 491 (672)
++|||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999865321 145889999999999999999999997 99999999999999999
Q ss_pred CeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhh
Q 005871 492 NPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTY 570 (672)
Q Consensus 492 ~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~ 570 (672)
.+||+|||+++...............+++.|+|||.+.++.++.++|||||||++|||++ |..||...... .+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~-- 236 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVI-- 236 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHH--
Confidence 999999999986543332222333456888999999999999999999999999999998 99887432211 111
Q ss_pred hhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 571 TWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 571 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
..+..+.... .+......+.+|+.+||+.||++||+++||+++|.+
T Consensus 237 --~~i~~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 237 --EMIRSRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred --HHHHcCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1111111111 112223567788889999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=332.89 Aligned_cols=246 Identities=24% Similarity=0.257 Sum_probs=199.9
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
++|++.+.||+|+||.||++.+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47889999999999999999976 68999999986532 234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+++++|.+++.. ...+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999998853 345899999999999999999999998 999999999999999999999999999865322
Q ss_pred CCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChh
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 587 (672)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||..... ........ .+.. +
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~------~~~~~~i~-~~~~-~----- 216 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP------FGIYEKIL-AGKL-E----- 216 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHH-hCCc-C-----
Confidence 2235689999999999998899999999999999999999999753211 11111111 1100 0
Q ss_pred hcCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHh
Q 005871 588 LKQSCAPDELLKFIHIGLLCVQQDPADRPT-----MSSVVVML 625 (672)
Q Consensus 588 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L 625 (672)
.+......+.+++.+||+.||.+||+ ++++++.-
T Consensus 217 ----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 217 ----FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred ----CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 01111234678888999999999995 88888664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=327.09 Aligned_cols=255 Identities=25% Similarity=0.391 Sum_probs=202.5
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCc--------------ccHHHHHHHHHHHHhccCCCeeeEE
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--------------QGLQEFKNEVNLIAKLQHKNLVRLL 414 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~E~~il~~l~h~niv~l~ 414 (672)
..+.|++.+.||+|.||.|-+++.. +++.||||++.+... ...+...+|+.||++++|||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 4578999999999999999999975 699999999976421 1235788999999999999999999
Q ss_pred EEEEeC--ceEEEEEeecCCCChhHHhhhccccCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC
Q 005871 415 GCCLEG--QELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM 491 (672)
Q Consensus 415 ~~~~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~ 491 (672)
++..+. +.+|||+|||..|.+... ..... +++.++++++++++.||+|||.+| ||||||||+|+||+++|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence 999864 679999999999887532 22333 999999999999999999999998 99999999999999999
Q ss_pred CeEEEeecCceeeCCCC---CCcccccccccCCcCChhhhcCCC----CChhhHHHHHHHHHHHHHcCCCCCCCCCcccc
Q 005871 492 NPKISDFGLARIFGGNQ---NQANTNIIAGTYGYMAPEYAMGGI----FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHG 564 (672)
Q Consensus 492 ~~kL~DFgla~~~~~~~---~~~~~~~~~gt~~Y~aPE~~~~~~----~s~ksDvwSlGvil~elltG~~p~~~~~~~~~ 564 (672)
++||+|||.+..+.... ........+|||.|+|||...++. .+.+.||||+||+||-|+.|+.||- +
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~------~ 321 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF------D 321 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc------c
Confidence 99999999998763321 112223468999999999987743 3789999999999999999999973 1
Q ss_pred cchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 565 QTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
...+....+ +++..+.-...+++-+.+.+||+++|++||++|.++.+|..+.-
T Consensus 322 ~~~~~l~~K---------Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 322 DFELELFDK---------IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred chHHHHHHH---------HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 122222211 12222222222345567888999999999999999999987774
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=355.68 Aligned_cols=261 Identities=31% Similarity=0.480 Sum_probs=212.9
Q ss_pred HhcCCccccccccCCceeEEeeeec------CCceeEEEEecccCcc-cHHHHHHHHHHHHhccCCCeeeEEEEEEeCce
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 422 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~ 422 (672)
...+....+.||+|.||+||+|+.. +...||||.++..... ...+|++|+++|..++|||||+++|+|.+++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 3456777889999999999999842 3578999999877655 77899999999999999999999999999999
Q ss_pred EEEEEeecCCCChhHHhhhccc-----------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC
Q 005871 423 LLLIYEYMPNKSLDVHLFDATR-----------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM 491 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~ 491 (672)
++||+|||..|+|.++|..... ..+++..+.+.|+.|||.|++||-++. +|||||-..|+||.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccce
Confidence 9999999999999999964221 223889999999999999999999987 99999999999999999
Q ss_pred CeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhh
Q 005871 492 NPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTY 570 (672)
Q Consensus 492 ~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~ 570 (672)
.|||+|||+++.....+.........-..+|||||-++.++||+++|||||||+|||+++ |+.|+.....+ .
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~-------E 713 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ-------E 713 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH-------H
Confidence 999999999997655444333322334678999999999999999999999999999999 66664322211 1
Q ss_pred hhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 005871 571 TWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDS 629 (672)
Q Consensus 571 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 629 (672)
+.+....+.+. ..+...+.++.+||..||+.+|++||+++||-..|..-.
T Consensus 714 VIe~i~~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 714 VIECIRAGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred HHHHHHcCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 22222233221 233445567889999999999999999999999997653
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=326.37 Aligned_cols=257 Identities=28% Similarity=0.445 Sum_probs=204.9
Q ss_pred hcCCccccccccCCceeEEeeeecC------CceeEEEEecccCcc-cHHHHHHHHHHHHhccCCCeeeEEEEEEeCceE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 423 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 423 (672)
.++|.+.+.||+|+||.||+|.+.+ +..||+|.+...... ..+.+.+|+++++.++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3568889999999999999998632 478999998765443 457899999999999999999999999999999
Q ss_pred EEEEeecCCCChhHHhhhcc-----------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC
Q 005871 424 LLIYEYMPNKSLDVHLFDAT-----------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN 492 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~ 492 (672)
++||||+++++|.+++.... ....+++..+..++.||+.+|.|||+++ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999986432 2345789999999999999999999997 999999999999999999
Q ss_pred eEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhh
Q 005871 493 PKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYT 571 (672)
Q Consensus 493 ~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~ 571 (672)
+||+|||++................+++.|+|||++.++.++.++||||||+++|||++ |..||..... .......
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---~~~~~~~ 237 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---EEVIECI 237 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH
Confidence 99999999986543322222223346788999999999999999999999999999998 9998743221 1111111
Q ss_pred hhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 572 WKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 572 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
. .+..... +......+.+++.+||+.||++||++.||++.|+
T Consensus 238 ~----~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 T----QGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred H----cCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1 1111100 1112345778888999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=349.56 Aligned_cols=252 Identities=20% Similarity=0.243 Sum_probs=203.7
Q ss_pred CCccccccccCCceeEEeeeec-C-CceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-D-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
.|.+.+.||+|+||.||++... + +..||+|.+..........+.+|+.+|+.++||||+++++++...+..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4889999999999999999864 3 6788888876655555567889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 431 PNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 431 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
++|+|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999888643 33456899999999999999999999997 99999999999999999999999999997654333
Q ss_pred CcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhc
Q 005871 510 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 589 (672)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......... +... +
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~~-~~~~----~--- 290 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVLY-GKYD----P--- 290 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHh-CCCC----C---
Confidence 2333456799999999999999999999999999999999999999743211 111111111 1100 0
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 590 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
.+......+.+++.+||+.||++||++.++++
T Consensus 291 --~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 --FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 01112235778888999999999999999874
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=339.25 Aligned_cols=250 Identities=27% Similarity=0.343 Sum_probs=206.1
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
.-|+..+.||+|+-|.|-+|++. .|+..|||++.+.. ......+.+|+.||+.+.|||+++++++|.+++++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 34788899999999999999975 69999999997652 223456789999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+++|-|.+++. +.+.+.+.++.++++||+.|+.|+|..+ |+||||||+|+|+|..+++||+|||+|..-...
T Consensus 92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 9999999999994 4567999999999999999999999987 999999999999999999999999999863322
Q ss_pred CCCcccccccccCCcCChhhhcCCCC-ChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
. -...-||.|.|.|||++++..| +.++||||.|||||.|+||+.||+.. .-..++..+. .|..
T Consensus 166 k---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd---Nir~LLlKV~----~G~f------ 229 (786)
T KOG0588|consen 166 K---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD---NIRVLLLKVQ----RGVF------ 229 (786)
T ss_pred c---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc---cHHHHHHHHH----cCcc------
Confidence 2 2334699999999999999998 78999999999999999999998621 1112222111 1111
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
+++.....+..+|+.+||..||++|.|++||++..--
T Consensus 230 ----~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l 266 (786)
T KOG0588|consen 230 ----EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFL 266 (786)
T ss_pred ----cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchh
Confidence 1122233456788889999999999999999987643
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=331.27 Aligned_cols=199 Identities=28% Similarity=0.402 Sum_probs=174.3
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
.++|++.++||+|+||.||++.+. ++..+|+|.+.... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999986 58889999876542 3345678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++..+...
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 9999999999853 345889999999999999999999853 4999999999999999999999999998755322
Q ss_pred CCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCC
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF 558 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~ 558 (672)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 12234689999999999988899999999999999999999999854
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=336.91 Aligned_cols=245 Identities=24% Similarity=0.293 Sum_probs=199.8
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
++|.+.+.||+|+||.||+++++ +++.||+|++.+.. ....+.+.+|+.++++++||||+++++.+.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 67999999999999999999986 58899999987542 234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+.+++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999988854 345889999999999999999999997 999999999999999999999999999875432
Q ss_pred CCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChh
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 587 (672)
. ....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ....... ..+.. .
T Consensus 172 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~i-~~~~~-~----- 233 (329)
T PTZ00263 172 T-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP------FRIYEKI-LAGRL-K----- 233 (329)
T ss_pred c-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH------HHHHHHH-hcCCc-C-----
Confidence 2 235789999999999999999999999999999999999999743211 1111111 11110 0
Q ss_pred hcCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 005871 588 LKQSCAPDELLKFIHIGLLCVQQDPADRPT-----MSSVVVM 624 (672)
Q Consensus 588 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 624 (672)
+... ....+.+++.+||+.||.+||+ ++++++.
T Consensus 234 ~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 234 FPNW----FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCCC----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0011 1234668888999999999997 6888755
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=331.79 Aligned_cols=242 Identities=24% Similarity=0.288 Sum_probs=193.6
Q ss_pred cccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCCC
Q 005871 358 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 433 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~g 433 (672)
+.||+|+||.||++... +|+.||+|++.... ......+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999975 68999999987542 234556788999999999999999999999999999999999999
Q ss_pred ChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCccc
Q 005871 434 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 513 (672)
Q Consensus 434 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~ 513 (672)
+|..++.. ...+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~ 152 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence 99888743 346899999999999999999999997 9999999999999999999999999987532211 112
Q ss_pred ccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCC
Q 005871 514 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCA 593 (672)
Q Consensus 514 ~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~ 593 (672)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...... ... ...... .. .+....
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~---~~~~~~-~~------~~p~~~- 218 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLF---ELILME-EI------RFPRTL- 218 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---HHH---HHHhcC-CC------CCCCCC-
Confidence 3357999999999999999999999999999999999999997432111 111 111100 00 011112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005871 594 PDELLKFIHIGLLCVQQDPADRP-----TMSSVVVM 624 (672)
Q Consensus 594 ~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 624 (672)
...+.+++.+||+.||++|| ++.++++.
T Consensus 219 ---~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 219 ---SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred ---CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 23466788899999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=335.64 Aligned_cols=242 Identities=24% Similarity=0.273 Sum_probs=194.6
Q ss_pred cccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCCC
Q 005871 358 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 433 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~g 433 (672)
+.||+|+||.||+++.+ +|+.||+|++.+.. ......+.+|+.++++++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 68999999987542 234467788999999999999999999999999999999999999
Q ss_pred ChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCccc
Q 005871 434 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 513 (672)
Q Consensus 434 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~ 513 (672)
+|..++.. ...+++..+..++.||+.||+|||+.| |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~ 152 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccc
Confidence 99888853 346899999999999999999999998 9999999999999999999999999987532211 122
Q ss_pred ccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCC
Q 005871 514 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCA 593 (672)
Q Consensus 514 ~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~ 593 (672)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.. ... .+.. .+ +
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~---~~~-~~~~------~~----p 215 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFE---LIL-MEEI------RF----P 215 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH---HHHHH---HHH-cCCC------CC----C
Confidence 345799999999999999999999999999999999999999743211 11111 111 1100 01 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005871 594 PDELLKFIHIGLLCVQQDPADRP-----TMSSVVVM 624 (672)
Q Consensus 594 ~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 624 (672)
......+.+++.+||+.||++|| ++.++++.
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 11223467788899999999999 79999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=336.39 Aligned_cols=264 Identities=23% Similarity=0.271 Sum_probs=209.9
Q ss_pred hcCCccccccccCCceeEEeeeecC--CceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLAD--GKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l 425 (672)
.++|.+.+.||+|+||.||+|.++. +..||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 4679999999999999999998643 3689999986532 3345678899999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
||||+.+|+|.+++.. ...+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++....
T Consensus 109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999998853 345899999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccC
Q 005871 506 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585 (672)
Q Consensus 506 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 585 (672)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ .+.. . +
T Consensus 183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~------~~~~~~i~-~~~~-~-~- 247 (340)
T PTZ00426 183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP------LLIYQKIL-EGII-Y-F- 247 (340)
T ss_pred CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH------HHHHHHHh-cCCC-C-C-
Confidence 22 2235799999999999998899999999999999999999999853211 11111111 1110 0 0
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhccC--------CCCCCCCCCCcccc
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVVMLASD--------SMTIPQPTEPAFSV 642 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L~~~--------~~~l~~p~~p~~~~ 642 (672)
.... ...+.+++.+||+.||++|+ +++++++.--.. ...+++|..|.+..
T Consensus 248 ---p~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~~ 310 (340)
T PTZ00426 248 ---PKFL----DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKN 310 (340)
T ss_pred ---CCCC----CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCC
Confidence 1111 23456788899999999995 899998873221 23467778887755
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=326.15 Aligned_cols=264 Identities=23% Similarity=0.315 Sum_probs=196.7
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
.++|++.++||+|+||.||+|+.. +++.||+|++..... .....+.+|+.+++.++||||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999986 688999999875432 223467889999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|+. ++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 566666643 2345889999999999999999999998 9999999999999999999999999997643322
Q ss_pred CCcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhcc---CCCcc---
Q 005871 509 NQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWC---EGPAV--- 581 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~--- 581 (672)
. ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .........+. ...+.
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 158 H--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred c--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccchh
Confidence 1 1223468899999999875 458999999999999999999999986432111 00000000000 00000
Q ss_pred ---ccc--------ChhhcCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 582 ---ELI--------DPVLKQSCA-PDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 582 ---~l~--------d~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
... ...+..... ......+.+++.+||+.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 000 000000000 0012346688889999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=323.61 Aligned_cols=255 Identities=26% Similarity=0.376 Sum_probs=200.9
Q ss_pred hcCCccccccccCCceeEEeeeec----CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l 425 (672)
.++|++.+.||+|+||.||+|.++ .+..+|+|.+.... ......+.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 357899999999999999999763 36689999987653 2334678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999988543 246899999999999999999999997 9999999999999999999999999876532
Q ss_pred CCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 506 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 506 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
..... ......++..|+|||.+.++.++.++||||||+++|||++ |+.||..... ....... ..+...
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~---~~~~~~~----~~~~~~--- 227 (266)
T cd05064 159 SEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG---QDVIKAV----EDGFRL--- 227 (266)
T ss_pred ccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHH----HCCCCC---
Confidence 22111 1112235678999999999999999999999999999775 9998743211 1111111 111000
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
..+......+.+++..||+.+|++||++++|++.|+.
T Consensus 228 ------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 228 ------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 0111223457788889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=322.45 Aligned_cols=255 Identities=32% Similarity=0.486 Sum_probs=208.3
Q ss_pred hcCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
..+|.+.++||.|+||.||+|.+.++..+++|.+..........+..|+.+++.++|+||+++++++.+....++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45789999999999999999999889999999998776656778999999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
++++|.+++... ....+++..+..++.||+.||.|||+.| |+|+||||+||++++++.+||+|||.+.........
T Consensus 85 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 85 EKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred ccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 999999999653 2346899999999999999999999997 999999999999999999999999999865432211
Q ss_pred cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhc
Q 005871 511 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 589 (672)
.. ...++..|+|||.+.+..++.++||||||+++|+|++ |+.||.... ......... .+..
T Consensus 161 ~~--~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~---~~~~~~~~~----~~~~--------- 222 (261)
T cd05148 161 SS--DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN---NHEVYDQIT----AGYR--------- 222 (261)
T ss_pred cc--CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC---HHHHHHHHH----hCCc---------
Confidence 11 2335678999999998899999999999999999998 888874322 111111111 1100
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 590 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
...+......+.+++.+||+.||++|||+.++++.|..
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 01112223457788899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=319.76 Aligned_cols=252 Identities=26% Similarity=0.402 Sum_probs=200.9
Q ss_pred cCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecC
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 431 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 431 (672)
++|++.+.||+|+||.||++.++++..+|+|.+.... .....+.+|+.++++++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4688899999999999999998888899999876443 334678899999999999999999999999999999999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCc
Q 005871 432 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 511 (672)
Q Consensus 432 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 511 (672)
+++|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||.++.........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999988542 235899999999999999999999997 9999999999999999999999999988654322211
Q ss_pred ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcC
Q 005871 512 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590 (672)
Q Consensus 512 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 590 (672)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||..... ......... +... ..+
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~i~~----~~~~--~~~---- 223 (256)
T cd05114 158 -SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEMISR----GFRL--YRP---- 223 (256)
T ss_pred -cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHC----CCCC--CCC----
Confidence 112235568999999988889999999999999999999 8888743211 111111111 1100 000
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 591 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
......+.+++.+||+.+|++||+++++++.|.
T Consensus 224 ---~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 224 ---KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ---CCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111235778888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=344.79 Aligned_cols=258 Identities=25% Similarity=0.312 Sum_probs=209.0
Q ss_pred HhcCCccccccccCCceeEEeeeecCC-ceeEEEEecccCcccHHHHHHHHHHHHhcc-CCCeeeEEEE-EEe------C
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLADG-KAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGC-CLE------G 420 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~-~~~------~ 420 (672)
...++++.+.|.+|||+.||.+.+..+ .+||+|++........+...+|+.+|++|+ |+|||.+++. ... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 346788999999999999999998765 999999998888888999999999999997 9999999993 221 2
Q ss_pred ceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecC
Q 005871 421 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 500 (672)
Q Consensus 421 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgl 500 (672)
-+++|.||||.||.|-+++....... |++.++++|+.++++|+.+||... .+|||||||-+||||+.+++.||||||.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence 47899999999999999997644443 999999999999999999999985 6899999999999999999999999999
Q ss_pred ceeeCCCCC-Ccccc------cccccCCcCChhhh---cCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhh
Q 005871 501 ARIFGGNQN-QANTN------IIAGTYGYMAPEYA---MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTY 570 (672)
Q Consensus 501 a~~~~~~~~-~~~~~------~~~gt~~Y~aPE~~---~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~ 570 (672)
+.-...... ..... ...-|+.|+|||++ .+...++|+|||+|||+||-|+....||+..-
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg---------- 262 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG---------- 262 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc----------
Confidence 874322211 11000 12358999999987 56778999999999999999999999985221
Q ss_pred hhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 571 TWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 571 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
-..+++....-.-.+.....+.+||..||+.||++||++-+|+..+-..
T Consensus 263 ---------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 263 ---------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred ---------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 1122222221122245677899999999999999999999999988553
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=324.20 Aligned_cols=258 Identities=28% Similarity=0.432 Sum_probs=201.6
Q ss_pred HhcCCccccccccCCceeEEeeeec------CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCce
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 422 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~ 422 (672)
..++|++.+.||+|+||.||+|.+. .+..+|+|++.... ......+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999998753 25679999886433 2334568899999999999999999999999999
Q ss_pred EEEEEeecCCCChhHHhhhccc-------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 005871 423 LLLIYEYMPNKSLDVHLFDATR-------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 495 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL 495 (672)
.++||||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999864321 234678899999999999999999987 999999999999999999999
Q ss_pred EeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhh
Q 005871 496 SDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKL 574 (672)
Q Consensus 496 ~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 574 (672)
+|||++................++..|+|||++.++.++.++||||||+++|||++ |..||...... .... .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~----~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLR----F 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----H
Confidence 99999876543332222222345778999999999899999999999999999999 67776432111 1111 1
Q ss_pred ccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 575 WCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 575 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
......... +......+.+++.+||+.+|++|||+.|+++.|.
T Consensus 234 ~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 234 VMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHcCCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 111111110 1112245778888999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=336.33 Aligned_cols=264 Identities=20% Similarity=0.209 Sum_probs=196.8
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
..+|++.++||+|+||.||++.+. .++.||+|.... ..+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 367999999999999999999975 588999996532 3467899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+. ++|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 95 577777643 345899999999999999999999997 99999999999999999999999999975432211
Q ss_pred CcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCccccc----chhhhhhhhccCCC------
Q 005871 510 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQ----TLLTYTWKLWCEGP------ 579 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~----~~~~~~~~~~~~~~------ 579 (672)
.......||+.|+|||++.+..++.++|||||||++|||++|+.|+-......+. ..+..........+
T Consensus 238 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 238 -NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred -cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 1223357999999999999999999999999999999999999875322111110 00000000000000
Q ss_pred cccccChhh----------cCCC--C---HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 580 AVELIDPVL----------KQSC--A---PDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 580 ~~~l~d~~l----------~~~~--~---~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
....++... .... . ......+.+|+.+||+.||++|||++|+++.--..
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~ 380 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQ 380 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhc
Confidence 000000000 0000 0 11234677889999999999999999999754443
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=319.94 Aligned_cols=254 Identities=31% Similarity=0.457 Sum_probs=204.5
Q ss_pred cCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecC
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 431 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 431 (672)
++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.+++.++|+||+++++.+.+....++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 5799999999999999999998888899999876543 335788999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCc
Q 005871 432 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 511 (672)
Q Consensus 432 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 511 (672)
+++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..........
T Consensus 85 ~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 85 KGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred CCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 99999988543 2345888999999999999999999987 9999999999999999999999999998765432221
Q ss_pred ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcC
Q 005871 512 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590 (672)
Q Consensus 512 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 590 (672)
.....++..|+|||++.++.++.++||||||+++|+|++ |+.||...... ....... ..... +
T Consensus 161 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~----~~~~~----~---- 224 (261)
T cd05072 161 -REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSALQ----RGYRM----P---- 224 (261)
T ss_pred -cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHHHH----cCCCC----C----
Confidence 122345678999999998899999999999999999998 88887432111 1111111 11000 0
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 591 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
........+.+++.+|++.+|++||+++++++.|+.
T Consensus 225 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 225 -RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred -CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 001122457788889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=302.41 Aligned_cols=250 Identities=26% Similarity=0.374 Sum_probs=207.7
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEE
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l 425 (672)
..++|++.+.||+|.||.||.|+.+ ++..||+|++.+.. .+..+++.+|++|-+.|+||||++++++|.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 4578999999999999999999975 67889999987653 2334678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
++||..+|.+...|.+. +...+++.....++.|++.||.|+|.+. +|||||||+|+|++.++.+||+|||.+..-.
T Consensus 100 ilEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999988643 3456899999999999999999999987 9999999999999999999999999998632
Q ss_pred CCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccC
Q 005871 506 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585 (672)
Q Consensus 506 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 585 (672)
.......+||..|.+||...+..++..+|+|++|++.||++.|.+||+... .........+. ++..
T Consensus 176 ----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~~etYkrI~k~-------~~~~ 241 (281)
T KOG0580|consen 176 ----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---HSETYKRIRKV-------DLKF 241 (281)
T ss_pred ----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---hHHHHHHHHHc-------cccC
Confidence 334456899999999999999999999999999999999999999986443 11111111111 1111
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
+........++|..|+..+|.+|.+..|+++.
T Consensus 242 -------p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 242 -------PSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -------CcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 12223446788889999999999999999864
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=326.60 Aligned_cols=260 Identities=27% Similarity=0.426 Sum_probs=208.9
Q ss_pred cCCccccccccCCceeEEeeeec------CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l 425 (672)
.+|.+.+.||+|+||.||+|... ++..+++|.+........+.+.+|+.++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46888899999999999999742 355689999877666666789999999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhhcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC
Q 005871 426 IYEYMPNKSLDVHLFDAT-------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN 492 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~ 492 (672)
||||+++++|.+++.... ....+++..++.++.||+.+|.|||+++ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999986432 1235899999999999999999999998 999999999999999999
Q ss_pred eEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhh
Q 005871 493 PKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYT 571 (672)
Q Consensus 493 ~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~ 571 (672)
++|+|||++................++..|+|||++.+..++.++||||||+++|||++ |+.||...... . .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~----~ 234 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---E----V 234 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---H----H
Confidence 99999999986544332222233456788999999999999999999999999999999 99886432211 1 1
Q ss_pred hhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCC
Q 005871 572 WKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSM 630 (672)
Q Consensus 572 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 630 (672)
......+...+. .......+.+++.+||+.+|++|||+.+|+++|.....
T Consensus 235 ~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 235 IECITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 111122222111 11123457788889999999999999999999988744
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=330.51 Aligned_cols=265 Identities=23% Similarity=0.335 Sum_probs=194.7
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeC-----ceEE
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QELL 424 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~~~ 424 (672)
+|++.++||+|+||.||+|.+. ++..||||++... .......+.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999975 6899999998643 223345688999999999999999999988643 3589
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceee
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 504 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~ 504 (672)
+||||+. ++|..++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 578777743 345899999999999999999999998 999999999999999999999999999864
Q ss_pred CCCCC-CcccccccccCCcCChhhhcC--CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhh--------hhhh
Q 005871 505 GGNQN-QANTNIIAGTYGYMAPEYAMG--GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLT--------YTWK 573 (672)
Q Consensus 505 ~~~~~-~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~--------~~~~ 573 (672)
..... ........|++.|+|||++.+ ..++.++|||||||++|||++|+.||............. ..+.
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32221 111233578999999999876 678999999999999999999999985432111000000 0000
Q ss_pred hccCCCcccccChhhcCC------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 574 LWCEGPAVELIDPVLKQS------CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 574 ~~~~~~~~~l~d~~l~~~------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.+......+.++...... ..+.....+.+++.+||+.||++|||++|+++.
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000000000000000 000112346788889999999999999999965
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=323.30 Aligned_cols=257 Identities=31% Similarity=0.461 Sum_probs=202.4
Q ss_pred cCCccccccccCCceeEEeeee-----cCCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l 425 (672)
.+|++.++||+|+||.||+|.+ .++..+++|.+.... .+....+.+|+.++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4688899999999999999984 246789999987533 3445678899999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhhccc--------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC
Q 005871 426 IYEYMPNKSLDVHLFDATR--------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM 491 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~ 491 (672)
||||+++++|.+++..... ...+++.++..++.|++.||.|||+++ |+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999998853211 235788999999999999999999997 99999999999999999
Q ss_pred CeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhh
Q 005871 492 NPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTY 570 (672)
Q Consensus 492 ~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~ 570 (672)
.+||+|||+++...............++..|+|||++.++.++.++||||||+++|||++ |..||..... ......
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~~~ 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVIEM 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH
Confidence 999999999987644332222333446778999999998889999999999999999998 8888643211 111111
Q ss_pred hhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 571 TWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 571 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
. ....... .+......+.+++.+||+.||++||++.+|+++|..
T Consensus 239 ~----~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 V----RKRQLLP---------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred H----HcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1 1111110 011112356778889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=321.88 Aligned_cols=248 Identities=22% Similarity=0.398 Sum_probs=207.7
Q ss_pred hcCCccccccccCCceeEEeeee-cCCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
..+|++.+.||+|.||.|-++.. ..|+.||||.+++.. .++.-.+.+|++||+.|+||||+.++++|++.+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35799999999999999999986 579999999998753 44566789999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||..+|.|.+++. ....+++.+++.+++||+.|+.|+|.++ ++|||||.+|||+|.++++||+|||++-.+..
T Consensus 132 MEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999994 4567999999999999999999999987 99999999999999999999999999987643
Q ss_pred CCCCcccccccccCCcCChhhhcCCCC-ChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccC
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 585 (672)
.. -.+.++|+|.|.+||++.+..| ++.+|-|||||+||-|+.|.-||+.... ...+.++ ..+...+
T Consensus 206 ~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh------k~lvrQI-s~GaYrE--- 272 (668)
T KOG0611|consen 206 KK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH------KRLVRQI-SRGAYRE--- 272 (668)
T ss_pred cc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH------HHHHHHh-hcccccC---
Confidence 32 3456799999999999999888 7999999999999999999999854321 1112111 1111111
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
++......-||+|||..||++|.|+.+|...-
T Consensus 273 --------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 273 --------PETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred --------CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 11223345677899999999999999998764
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=333.52 Aligned_cols=248 Identities=26% Similarity=0.394 Sum_probs=194.0
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
++|+..++||+|+||.||++++. +++.||||++..... .....+.+|+++++.++|+||+++++++.+.+.+++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 56788899999999999999975 689999999865433 3356789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+++++|.... ..++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999986432 3567788899999999999999997 99999999999999999999999999987643221
Q ss_pred CcccccccccCCcCChhhhcC-----CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 510 QANTNIIAGTYGYMAPEYAMG-----GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
......|+..|+|||++.. ...+.++|||||||++|||++|+.||....... ........... ..
T Consensus 224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~-~~---- 293 (353)
T PLN00034 224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WASLMCAICMS-QP---- 293 (353)
T ss_pred --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHHHHHhcc-CC----
Confidence 1223578999999998743 234579999999999999999999986221111 11111100000 00
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
..........+.+|+.+||+.||++|||+.||++.
T Consensus 294 -----~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 -----PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -----CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111223457788889999999999999999975
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=331.12 Aligned_cols=240 Identities=23% Similarity=0.289 Sum_probs=191.7
Q ss_pred cccCCceeEEeeeec-CCceeEEEEeccc---CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCCCCh
Q 005871 360 LGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 435 (672)
Q Consensus 360 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL 435 (672)
||+|+||.||++++. +++.||+|++.+. .......+..|+.++++++||||+++++.+.+.+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999976 5889999998653 234456788999999999999999999999999999999999999999
Q ss_pred hHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCccccc
Q 005871 436 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 515 (672)
Q Consensus 436 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~ 515 (672)
..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 152 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT 152 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence 988853 345899999999999999999999997 9999999999999999999999999997543222 22334
Q ss_pred ccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHH
Q 005871 516 IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPD 595 (672)
Q Consensus 516 ~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 595 (672)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......... +.. ..+..
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~~-~~~----------~~~~~ 215 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKILQ-EPL----------RFPDG 215 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHHc-CCC----------CCCCc
Confidence 5799999999999999999999999999999999999999853211 111111111 100 01111
Q ss_pred HHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 005871 596 ELLKFIHIGLLCVQQDPADRPT---MSSVVVM 624 (672)
Q Consensus 596 ~~~~l~~li~~cl~~dP~~RPt---~~evl~~ 624 (672)
....+.+++.+||+.||++||+ +.|+++.
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 2234677888999999999986 5565543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=324.38 Aligned_cols=260 Identities=27% Similarity=0.459 Sum_probs=206.4
Q ss_pred hcCCccccccccCCceeEEeeeec------CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 424 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 424 (672)
.++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|+.++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 357889999999999999999742 34568999988766666778999999999999999999999999999999
Q ss_pred EEEeecCCCChhHHhhhcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeE
Q 005871 425 LIYEYMPNKSLDVHLFDAT----------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPK 494 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~k 494 (672)
+||||+++++|.+++.... +...+++..+..++.|++.+|+|||+.| ++||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999886432 2235899999999999999999999997 99999999999999999999
Q ss_pred EEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhh
Q 005871 495 ISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWK 573 (672)
Q Consensus 495 L~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~ 573 (672)
|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||...... ....
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~---~~~~---- 233 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIE---- 233 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----
Confidence 999999986543322222223345778999999998899999999999999999998 88886432211 1111
Q ss_pred hccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 005871 574 LWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDS 629 (672)
Q Consensus 574 ~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 629 (672)
....+..... ... ....+.+|+.+||+.||.+|||+.+|++.|....
T Consensus 234 ~i~~~~~~~~-----~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 234 CITQGRVLQR-----PRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HHHcCCcCCC-----CCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1111111111 111 1235788889999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=338.27 Aligned_cols=260 Identities=29% Similarity=0.394 Sum_probs=204.0
Q ss_pred hcCCccccccccCCceeEEeeeec------CCceeEEEEecccC-cccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCce
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQE 422 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~ 422 (672)
.++|.+.++||+|+||.||+|++. .+..||||++.... ....+.+.+|+++|+++. ||||+++++++.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 468999999999999999999853 13479999997543 333567899999999996 9999999999999999
Q ss_pred EEEEEeecCCCChhHHhhhccc----------------------------------------------------------
Q 005871 423 LLLIYEYMPNKSLDVHLFDATR---------------------------------------------------------- 444 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 444 (672)
.+|||||+++|+|.+++.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999988864211
Q ss_pred -----------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC
Q 005871 445 -----------------------------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD 489 (672)
Q Consensus 445 -----------------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~ 489 (672)
...+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 124788889999999999999999987 999999999999999
Q ss_pred CCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchh
Q 005871 490 DMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLL 568 (672)
Q Consensus 490 ~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~ 568 (672)
++.+||+|||+++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |..||...... ...
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--~~~- 349 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--STF- 349 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--HHH-
Confidence 99999999999987644332222333456788999999999999999999999999999997 88887532211 111
Q ss_pred hhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 569 TYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 569 ~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
......+.... ........+.+++.+||+.+|++|||+.+|.++|...
T Consensus 350 ---~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 350 ---YNKIKSGYRMA---------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred ---HHHHhcCCCCC---------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 11111110000 0112234577888999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=316.60 Aligned_cols=248 Identities=29% Similarity=0.424 Sum_probs=194.9
Q ss_pred cccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCCCCh
Q 005871 358 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 435 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL 435 (672)
+.||+|+||.||+|.+. +++.+|+|.+.... .+....+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999975 68999999876543 34456799999999999999999999999999999999999999999
Q ss_pred hHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCccccc
Q 005871 436 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 515 (672)
Q Consensus 436 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~ 515 (672)
.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..............
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9988532 335899999999999999999999997 99999999999999999999999999876443221111111
Q ss_pred ccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCH
Q 005871 516 IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAP 594 (672)
Q Consensus 516 ~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~ 594 (672)
..++..|+|||.+.++.++.++||||||+++|||++ |..|+....... ...... ... ....+.
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~---~~~~~~----~~~---------~~~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ---TREAIE----QGV---------RLPCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH---HHHHHH----cCC---------CCCCcc
Confidence 223457999999999999999999999999999998 887764322111 111110 000 000111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 595 DELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 595 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
.....+.+++.+||+.+|++|||+.+|+++|.
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 12345778888999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=318.33 Aligned_cols=255 Identities=31% Similarity=0.464 Sum_probs=204.1
Q ss_pred hcCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
.++|++.+.||+|++|.||+|.+.+++.||+|.+.... ...+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45789999999999999999998778889999986543 33567899999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++..+......
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999985432 345899999999999999999999997 999999999999999999999999999877532211
Q ss_pred cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhc
Q 005871 511 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 589 (672)
. .....++..|+|||++.+..++.++||||||+++|||++ |+.||.... ...........+ ..
T Consensus 160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~~~~~~---~~--------- 223 (261)
T cd05068 160 A-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT---NAEVLQQVDQGY---RM--------- 223 (261)
T ss_pred c-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHHcCC---CC---------
Confidence 1 111223457999999998899999999999999999999 888874321 111111111100 00
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 590 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
.........+.+++.+|++.+|++||++.+|++.|+.
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 -PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0111223567888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=323.10 Aligned_cols=261 Identities=24% Similarity=0.342 Sum_probs=193.2
Q ss_pred cCCccccccccCCceeEEeeeec--CCceeEEEEecccC--cccHHHHHHHHHHHHhc---cCCCeeeEEEEEEe-----
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA--DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKL---QHKNLVRLLGCCLE----- 419 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l---~h~niv~l~~~~~~----- 419 (672)
++|++.+.||+|+||.||+|++. +++.+|+|++.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47899999999999999999863 46889999886543 22234566788877776 69999999999852
Q ss_pred CceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeec
Q 005871 420 GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 499 (672)
Q Consensus 420 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFg 499 (672)
....++||||+. ++|..++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 456899999997 5788877543 2345899999999999999999999997 9999999999999999999999999
Q ss_pred CceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhc---c
Q 005871 500 LARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLW---C 576 (672)
Q Consensus 500 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~---~ 576 (672)
+++..... .......|++.|+|||.+.+..++.++|||||||++|||++|++||....... ......... .
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~ 229 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPG 229 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCC
Confidence 99876433 22234568999999999998899999999999999999999999986432211 111000000 0
Q ss_pred CCCccc---ccChhhc----C---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 577 EGPAVE---LIDPVLK----Q---SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 577 ~~~~~~---l~d~~l~----~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
...+.+ +....+. . ...+.....+.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000000 0000000 0 000112235678889999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=335.24 Aligned_cols=254 Identities=22% Similarity=0.311 Sum_probs=195.4
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
.|.+++.||+|+||+||+|++. +++.||||++.+.. ......+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5889999999999999999875 58899999997542 3345678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++++||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999998853 345889999999999999999999997 9999999999999999999999999976432100
Q ss_pred CC---------------------------------------------cccccccccCCcCChhhhcCCCCChhhHHHHHH
Q 005871 509 NQ---------------------------------------------ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFG 543 (672)
Q Consensus 509 ~~---------------------------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlG 543 (672)
.. ......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 00 001235799999999999988999999999999
Q ss_pred HHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHH--hcccCCCCCCCHHHH
Q 005871 544 VLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLL--CVQQDPADRPTMSSV 621 (672)
Q Consensus 544 vil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~--cl~~dP~~RPt~~ev 621 (672)
|++|||++|+.||....... .............. .. ....+ ..+.+++.+ |+..+|..||++.+|
T Consensus 236 ~il~elltG~~Pf~~~~~~~------~~~~i~~~~~~~~~-~~--~~~~s----~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTE------TQLKVINWENTLHI-PP--QVKLS----PEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHH------HHHHHHccccccCC-CC--CCCCC----HHHHHHHHHHccCcccccCCCCHHHH
Confidence 99999999999985432111 00111100000000 00 00111 234555555 556677779999999
Q ss_pred HHHh
Q 005871 622 VVML 625 (672)
Q Consensus 622 l~~L 625 (672)
++.-
T Consensus 303 l~hp 306 (381)
T cd05626 303 KAHP 306 (381)
T ss_pred hcCc
Confidence 9864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=314.48 Aligned_cols=266 Identities=25% Similarity=0.348 Sum_probs=203.3
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcc--cHHHHHHHHHHHHhccCCC-eeeEEEEEEeCc-----
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ--GLQEFKNEVNLIAKLQHKN-LVRLLGCCLEGQ----- 421 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~n-iv~l~~~~~~~~----- 421 (672)
...|..+++||+|+||+||+|+.+ +|+.||+|++.....+ .-....+|+.+|++|+|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 356888899999999999999975 6899999999876542 2345689999999999999 999999999877
Q ss_pred -eEEEEEeecCCCChhHHhhhcccc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeec
Q 005871 422 -ELLLIYEYMPNKSLDVHLFDATRS-VQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 499 (672)
Q Consensus 422 -~~~lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFg 499 (672)
.+++|+||++ .+|..++...... ..++...+..+++||+.||+|||+++ |+||||||+||||+++|.+||+|||
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 8999999995 4777777654422 35777899999999999999999998 9999999999999999999999999
Q ss_pred CceeeCCCCCCcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhc---
Q 005871 500 LARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLW--- 575 (672)
Q Consensus 500 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~--- 575 (672)
+++.+.-+... ...-++|..|.|||++.+. .|+...||||+|||+.||+++++.|....... .+..+.+..
T Consensus 166 lAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~---ql~~If~~lGtP 240 (323)
T KOG0594|consen 166 LARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID---QLFRIFRLLGTP 240 (323)
T ss_pred hHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH---HHHHHHHHcCCC
Confidence 99976543332 2334679999999999887 68999999999999999999998886544321 111222111
Q ss_pred cCCCccccc-----Chhhc-----CCCCH---HHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 576 CEGPAVELI-----DPVLK-----QSCAP---DELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 576 ~~~~~~~l~-----d~~l~-----~~~~~---~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
.+..+..+. +.... ..... .......+++.+||+.+|.+|.|++.++++-
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~ 303 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHP 303 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcCh
Confidence 111111111 00000 00001 1113577888899999999999999999873
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.13 Aligned_cols=242 Identities=24% Similarity=0.266 Sum_probs=194.7
Q ss_pred cccccCCceeEEeeeec-CCceeEEEEeccc---CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCCC
Q 005871 358 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 433 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~g 433 (672)
+.||+|+||.||++... +++.||+|++.+. .......+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999975 6899999998754 2334567889999999999999999999999999999999999999
Q ss_pred ChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCccc
Q 005871 434 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 513 (672)
Q Consensus 434 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~ 513 (672)
+|..++.. ...+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~ 152 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM 152 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence 99888743 346899999999999999999999997 9999999999999999999999999987532211 122
Q ss_pred ccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCC
Q 005871 514 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCA 593 (672)
Q Consensus 514 ~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~ 593 (672)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .......... . ..+...
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~------~~~~~~~~~~-~------~~~p~~-- 217 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILME-D------IKFPRT-- 217 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH------HHHHHHhccC-C------ccCCCC--
Confidence 345799999999999999999999999999999999999999843211 1111111110 0 011111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005871 594 PDELLKFIHIGLLCVQQDPADRP-----TMSSVVVM 624 (672)
Q Consensus 594 ~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 624 (672)
....+.+++.+||+.||++|| ++.++++.
T Consensus 218 --~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 218 --LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred --CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 223467788899999999997 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=318.63 Aligned_cols=270 Identities=25% Similarity=0.336 Sum_probs=203.7
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEecc--cCcccHHHHHHHHHHHHhccCCCeeeEEEEEEe-----Cc
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSR--TSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE-----GQ 421 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~-----~~ 421 (672)
...+|...+.||+|+||.|.++.++ +|+.||||++.. ...-..++..+|+++|+.++|+||+.+++++.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3456777899999999999999975 689999999973 344556788999999999999999999999875 35
Q ss_pred eEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCc
Q 005871 422 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 501 (672)
Q Consensus 422 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla 501 (672)
.+|+|+|+| +.+|...+ +.+..++...+..++.||++||.|+|+.+ |+||||||+|++++.+..+||+|||+|
T Consensus 100 DvYiV~elM-etDL~~ii---k~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQII---KSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHH---HcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence 799999999 56777776 33444999999999999999999999997 999999999999999999999999999
Q ss_pred eeeCCCCCCcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCc
Q 005871 502 RIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPA 580 (672)
Q Consensus 502 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (672)
+..........-+..+-|.+|.|||++.. ..|+...||||+|||+.||++|++.|.+....+...+....-....+...
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 98765422233244567999999998754 57999999999999999999999998765443332222111100000000
Q ss_pred ccc--------cChhh---cCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 581 VEL--------IDPVL---KQS---CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 581 ~~l--------~d~~l---~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
..+ +...- +.. ..+......++|+.+||..||.+|+|++|.|+.--
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPY 312 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPY 312 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChh
Confidence 000 00000 000 00111234667888999999999999999998753
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=318.57 Aligned_cols=255 Identities=30% Similarity=0.459 Sum_probs=202.6
Q ss_pred cCCccccccccCCceeEEeeeecC----CceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
++|++.+.||+|+||.||+|.+.. ...+|+|.+.... ......+.+|+.++++++||||+++++.+...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 578999999999999999998742 4578999887543 33456788999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++..+..
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 9999999999998543 236899999999999999999999987 99999999999999999999999999987752
Q ss_pred CCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccC
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 585 (672)
...........++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ...... ..+...
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~----~~~~~~---- 227 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIKAV----EDGYRL---- 227 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHHHH----HcCCCC----
Confidence 222222222345678999999998899999999999999999998 88886432211 111111 111000
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
+ ........+.+++.+|++.+|++||++.+|+++|..
T Consensus 228 ~-----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 228 P-----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred C-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0 011123457788899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=346.64 Aligned_cols=257 Identities=23% Similarity=0.316 Sum_probs=205.1
Q ss_pred HHhcCCccccccccCCceeEEeeeec-CCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCc----
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ---- 421 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~---- 421 (672)
...++|.+.+.||+|+||.||++++. +++.||||++... .......+.+|+.++..++|+|++++++.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34579999999999999999999865 6899999998654 3344567889999999999999999988775432
Q ss_pred ----eEEEEEeecCCCChhHHhhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEE
Q 005871 422 ----ELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKIS 496 (672)
Q Consensus 422 ----~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~ 496 (672)
.+++||||+++|+|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEE
Confidence 378999999999999988653 23356899999999999999999999997 9999999999999999999999
Q ss_pred eecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhcc
Q 005871 497 DFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWC 576 (672)
Q Consensus 497 DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 576 (672)
|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.... .........
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~------~~~~~~~~~- 258 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN------MEEVMHKTL- 258 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHh-
Confidence 9999987654433333445679999999999999999999999999999999999999985321 111111111
Q ss_pred CCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 577 EGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 577 ~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.+.. ++ .+......+.+++.+||+.||.+||++.+++++
T Consensus 259 ~~~~----~~-----~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AGRY----DP-----LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cCCC----CC-----CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1111 00 111223457788889999999999999999864
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=317.98 Aligned_cols=247 Identities=28% Similarity=0.365 Sum_probs=194.8
Q ss_pred cccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCCCCh
Q 005871 360 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 435 (672)
Q Consensus 360 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL 435 (672)
||+|+||+||++.+. +++.+|+|++.... ....+.+..|+.+++.++|+||+++.+++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999875 68899999987543 22345678899999999999999999999999999999999999999
Q ss_pred hHHhhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcccc
Q 005871 436 DVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 514 (672)
Q Consensus 436 ~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~ 514 (672)
...+.... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..+...... ..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence 88875432 3456899999999999999999999997 999999999999999999999999999876443221 22
Q ss_pred cccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCH
Q 005871 515 IIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAP 594 (672)
Q Consensus 515 ~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~ 594 (672)
...|++.|+|||++.+..++.++||||||+++|||++|+.||........ ......... .... ..+.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~-~~~~----------~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRIL-NDSV----------TYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhhc-ccCC----------CCcc
Confidence 35689999999999999999999999999999999999999853221110 000000110 0000 0111
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005871 595 DELLKFIHIGLLCVQQDPADRP-----TMSSVVVM 624 (672)
Q Consensus 595 ~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 624 (672)
.....+.+++.+||+.||++|| |++++++.
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 2234567788899999999999 77888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=335.12 Aligned_cols=254 Identities=21% Similarity=0.273 Sum_probs=198.7
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
++|++.+.||+|+||.||++++. +++.||||++.... ......+.+|+.+++.++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999976 58999999997532 334566889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999998853 345899999999999999999999998 999999999999999999999999998765322
Q ss_pred CCCc------------------------------------ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc
Q 005871 508 QNQA------------------------------------NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 551 (672)
Q Consensus 508 ~~~~------------------------------------~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt 551 (672)
.... .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1100 0012469999999999999999999999999999999999
Q ss_pred CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHHh
Q 005871 552 GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT---MSSVVVML 625 (672)
Q Consensus 552 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~L 625 (672)
|..||...... ................+ . ......+.+++.+|+. +|.+|++ +.++++.-
T Consensus 235 G~~Pf~~~~~~------~~~~~i~~~~~~~~~~~-----~--~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~ 297 (364)
T cd05599 235 GYPPFCSDNPQ------ETYRKIINWKETLQFPD-----E--VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHP 297 (364)
T ss_pred CCCCCCCCCHH------HHHHHHHcCCCccCCCC-----C--CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence 99998533211 11111111000000000 0 0112345667778886 9999998 99888753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=316.63 Aligned_cols=252 Identities=28% Similarity=0.412 Sum_probs=200.9
Q ss_pred cCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecC
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 431 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 431 (672)
++|.+.+.||+|+||.||++.+.++..+|+|.+.... ...+.+.+|+.++++++||||+++++++.+....++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4688899999999999999998777789999887543 234678999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCc
Q 005871 432 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 511 (672)
Q Consensus 432 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 511 (672)
+++|.+++.... ..+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||.++.........
T Consensus 83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 999999885432 25899999999999999999999997 9999999999999999999999999988654332111
Q ss_pred ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcC
Q 005871 512 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590 (672)
Q Consensus 512 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 590 (672)
.....++..|++||.+.+..++.++||||||+++|+|++ |+.||...... .... ... .+.....
T Consensus 158 -~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~---~~~-~~~~~~~------- 222 (256)
T cd05113 158 -SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETVE---KVS-QGLRLYR------- 222 (256)
T ss_pred -cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHH---HHh-cCCCCCC-------
Confidence 112235667999999998889999999999999999998 88887432211 1111 111 1110000
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 591 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
.......+.+++.+||+.+|++||++.+|++.|+
T Consensus 223 --~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 --PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0112356788888999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=332.66 Aligned_cols=244 Identities=29% Similarity=0.433 Sum_probs=200.2
Q ss_pred ccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCCCChh
Q 005871 357 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLD 436 (672)
Q Consensus 357 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 436 (672)
++-||.|+.|.||+|+++ ++.||||+++... ..+++-|++|+||||+.+.|+|....-++||||||..|-|.
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 456999999999999985 7889999876433 34788899999999999999999999999999999999999
Q ss_pred HHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcccccc
Q 005871 437 VHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 516 (672)
Q Consensus 437 ~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~ 516 (672)
..|. ....+.......|..+||.|+.|||.+. |||||||.-||||+.+..|||+|||-++..... ...-.+
T Consensus 201 ~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSF 271 (904)
T KOG4721|consen 201 EVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSF 271 (904)
T ss_pred HHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhh
Confidence 9994 4556889999999999999999999997 999999999999999999999999999876433 112246
Q ss_pred cccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHHH
Q 005871 517 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDE 596 (672)
Q Consensus 517 ~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~ 596 (672)
+||..|||||++.+...++|+|||||||+||||+||..|+..- +-...+|..-. ....+ ..+...
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdV------dssAIIwGVGs--NsL~L-------pvPstc 336 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDV------DSSAIIWGVGS--NSLHL-------PVPSTC 336 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcccc------chheeEEeccC--Ccccc-------cCcccC
Confidence 8999999999999999999999999999999999999996321 11112222211 11111 122334
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCCC
Q 005871 597 LLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTI 632 (672)
Q Consensus 597 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l 632 (672)
.+.|.-|+++||+..|..||++.+|+..|.-.+..+
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel 372 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL 372 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence 455777788999999999999999999998765554
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=322.28 Aligned_cols=250 Identities=35% Similarity=0.547 Sum_probs=192.0
Q ss_pred cccccccCCceeEEeeeec-----CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 356 DENKLGQGGFGPVYKGTLA-----DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 356 ~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
+.+.||.|.||.||+|.+. .+..|+||.+.... .+..+.+.+|++++++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4678999999999999876 26789999996543 34478899999999999999999999999988889999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+++|+|.++|... ....+++..+..|+.||+.||.|||+.+ |+|+||+++||++++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999654 2356899999999999999999999987 99999999999999999999999999987633322
Q ss_pred CcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhh
Q 005871 510 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 588 (672)
........+...|+|||.+.+..++.++||||||+++|||++ |+.|+.... ... ..... .++....
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~---~~~---~~~~~-~~~~~~~------ 225 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD---NEE---IIEKL-KQGQRLP------ 225 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC---HHH---HHHHH-HTTEETT------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc---ccc---ccccc-cccccce------
Confidence 222233456778999999999999999999999999999999 677753321 111 11111 1111111
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 589 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 589 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
........+.+++..||+.+|++|||+.+|++.|
T Consensus 226 ---~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 ---IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 0111234467888899999999999999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=320.06 Aligned_cols=272 Identities=27% Similarity=0.430 Sum_probs=200.8
Q ss_pred cCCccccccccCCceeEEeeee-----cCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEe--CceEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELL 424 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~~ 424 (672)
++|++.+.||+|+||.||++.. .++..||+|++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 5788999999999999999974 2578999999987766667789999999999999999999998754 34689
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceee
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 504 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~ 504 (672)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+.| |+||||||+||++++++.+||+|||++..+
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998542 235899999999999999999999997 999999999999999999999999999876
Q ss_pred CCCCCCcc-cccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccc
Q 005871 505 GGNQNQAN-TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583 (672)
Q Consensus 505 ~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 583 (672)
........ .....++..|+|||++.+..++.++||||||+++|||++|..++.........................+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 43222111 11122345699999999889999999999999999999988764322110000000000000000000000
Q ss_pred cChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 584 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
+...............+.+++.+||+.+|++|||+.||+++|+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000000001112234578888899999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=328.32 Aligned_cols=253 Identities=25% Similarity=0.326 Sum_probs=197.6
Q ss_pred CCccccccccCCceeEEeeeec----CCceeEEEEecccC----cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceE
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQEL 423 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~ 423 (672)
+|++.++||+|+||.||+++.. +++.||+|++.+.. ....+.+..|+.+++.+ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4889999999999999998752 57899999986532 23345688899999999 599999999999999999
Q ss_pred EEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 424 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
++||||+++++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999988853 345899999999999999999999997 99999999999999999999999999986
Q ss_pred eCCCCCCcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccc
Q 005871 504 FGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVE 582 (672)
Q Consensus 504 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (672)
+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ..........
T Consensus 155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~~----- 226 (332)
T cd05614 155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEVSRRILKC----- 226 (332)
T ss_pred ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHHHHHHhcC-----
Confidence 5432222 22235799999999999865 4789999999999999999999998533221111 1111111100
Q ss_pred ccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 005871 583 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVVML 625 (672)
Q Consensus 583 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 625 (672)
++.+. ......+.+++.+||+.||++|| +++++++.-
T Consensus 227 --~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 227 --DPPFP----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268 (332)
T ss_pred --CCCCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence 11111 11223466788899999999999 777887653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=301.50 Aligned_cols=265 Identities=23% Similarity=0.273 Sum_probs=210.0
Q ss_pred HHhcCCccccccccCCceeEEeeee-cCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeC-----ce
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QE 422 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~ 422 (672)
...++|.+.++||+|||+-||+++. .+++.||+|++.-.+.++.+..++|++..++++|||+++++++...+ .+
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 3567999999999999999999984 57899999999888888889999999999999999999998877543 35
Q ss_pred EEEEEeecCCCChhHHhhhccc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCc
Q 005871 423 LLLIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 501 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla 501 (672)
.||+++|...|+|.+.+..... ...+++.+++.|+.+|++||++||+.. .++.||||||.|||+++.+.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 9999999999999999876443 347999999999999999999999986 37999999999999999999999999998
Q ss_pred eeeCCCCCCcc-------cccccccCCcCChhhhc---CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhh
Q 005871 502 RIFGGNQNQAN-------TNIIAGTYGYMAPEYAM---GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYT 571 (672)
Q Consensus 502 ~~~~~~~~~~~-------~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~ 571 (672)
....-...... ...-..|..|.|||.+. +...++++|||||||++|+|+.|..||+.-.. .+..+.-.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~GgSlaLA- 254 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGGSLALA- 254 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCCeEEEe-
Confidence 75421111100 00123588999999984 34578999999999999999999999865433 22211111
Q ss_pred hhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 572 WKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 572 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
+....+.-.......+.+.+++.+||+.||.+||++.+++..+..
T Consensus 255 -----------v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 255 -----------VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred -----------eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 111111111112245678899999999999999999999998864
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=319.36 Aligned_cols=264 Identities=28% Similarity=0.414 Sum_probs=204.6
Q ss_pred hcCCccccccccCCceeEEeeeecC-----------------CceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeee
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLAD-----------------GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVR 412 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~ 412 (672)
.++|++.+.||+|+||.||++.+.+ +..+|+|++.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3579999999999999999987642 2458999987653 344678899999999999999999
Q ss_pred EEEEEEeCceEEEEEeecCCCChhHHhhhcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCc
Q 005871 413 LLGCCLEGQELLLIYEYMPNKSLDVHLFDAT--------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASN 484 (672)
Q Consensus 413 l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~N 484 (672)
+++++..++..++||||+++++|..++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999986532 1225899999999999999999999987 9999999999
Q ss_pred EEEcCCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc--CCCCCCCCCcc
Q 005871 485 ILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS--GRKNNGFYFSE 562 (672)
Q Consensus 485 Ill~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt--G~~p~~~~~~~ 562 (672)
|+++.++.++|+|||+++...............+++.|+|||++.++.++.++||||||+++|||++ |..|+....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-- 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence 9999999999999999986544333222334456788999999998889999999999999999998 555653221
Q ss_pred cccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 563 HGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
...........+.........+ .......++.+++.+||+.||++|||+.||++.|.
T Consensus 239 -~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 239 -DQQVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred -hHHHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1111111211111111111110 11112346888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=314.96 Aligned_cols=252 Identities=28% Similarity=0.405 Sum_probs=199.9
Q ss_pred cCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecC
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 431 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 431 (672)
.+|.+.+.||+|+||.||++.++++..+|+|++..... ....+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 35888999999999999999988778899998865432 34578889999999999999999999999999999999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCc
Q 005871 432 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 511 (672)
Q Consensus 432 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 511 (672)
+++|.+++.... ..+++..+..++.||+.+|.|||+.+ |+||||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 999999885432 36899999999999999999999997 9999999999999999999999999998654322111
Q ss_pred ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcC
Q 005871 512 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590 (672)
Q Consensus 512 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 590 (672)
.....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... ... .... .+. ..
T Consensus 158 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~---~~~~-~~~-----~~---- 220 (256)
T cd05059 158 -SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVV---ESVS-AGY-----RL---- 220 (256)
T ss_pred -cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHH---HHHH-cCC-----cC----
Confidence 111223457999999999999999999999999999999 78887532211 111 1111 110 00
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 591 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
..+......+.+++.+||+.+|++|||+.||++.|.
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 001112345778888999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=335.15 Aligned_cols=254 Identities=24% Similarity=0.338 Sum_probs=203.0
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
++|.+.+.||+|+||.||++.+. +++.||||++.+.. ......+.+|+.++..++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999976 68999999987542 244567889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+++++|.+++... ..+++..+..++.||+.||.|||+.| |+||||||+||||+.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998543 56899999999999999999999987 999999999999999999999999999866433
Q ss_pred C---------------------------CCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCC
Q 005871 508 Q---------------------------NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF 560 (672)
Q Consensus 508 ~---------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~ 560 (672)
. .........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0011233569999999999999999999999999999999999999985432
Q ss_pred cccccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHh
Q 005871 561 SEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT-MSSVVVML 625 (672)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~L 625 (672)
.. ............... . . .......+.+++..||+ ||.+||+ ++++++..
T Consensus 235 ~~------~~~~~i~~~~~~~~~-p----~--~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 235 LQ------ETYNKIINWKESLRF-P----P--DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred HH------HHHHHHhccCCcccC-C----C--CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 11 111111110000000 0 0 00023456677789997 9999999 99999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=331.77 Aligned_cols=201 Identities=25% Similarity=0.366 Sum_probs=174.8
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
++|++.+.||+|+||+||++... +++.||+|++.+.. ......+.+|+.++.+++|+||+++++.+.+...+++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999875 58899999987542 233467888999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+++|+|.+++.. ...+++..+..++.||+.||.|||++| |+||||||+|||++.++++||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999999853 346899999999999999999999997 999999999999999999999999998754321
Q ss_pred CCC---------------------------------cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCC
Q 005871 508 QNQ---------------------------------ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRK 554 (672)
Q Consensus 508 ~~~---------------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~ 554 (672)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 00123579999999999999999999999999999999999999
Q ss_pred CCCC
Q 005871 555 NNGF 558 (672)
Q Consensus 555 p~~~ 558 (672)
||..
T Consensus 235 Pf~~ 238 (363)
T cd05628 235 PFCS 238 (363)
T ss_pred CCCC
Confidence 9853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=327.49 Aligned_cols=255 Identities=27% Similarity=0.449 Sum_probs=200.2
Q ss_pred cCCccccccccCCceeEEeeeec-CCc----eeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGK----AIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l 425 (672)
.+|++.+.||+|+||.||+|++. ++. .||+|++.... ....+.+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 57999999999999999999864 333 48999987543 34456789999999999999999999999865 5789
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
|+||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999988543 235889999999999999999999997 9999999999999999999999999998765
Q ss_pred CCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 506 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 506 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
............++..|+|||++.+..++.++||||||+++|||++ |+.||...... .+ ......+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~----~~~~~~~~~~~-- 231 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EI----SSILEKGERLP-- 231 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HH----HHHHhCCCCCC--
Confidence 4333222222334678999999999999999999999999999998 99887532111 11 11111111000
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
........+.+++.+||+.+|++||++.+|++.|...
T Consensus 232 -------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 232 -------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred -------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0111223567888899999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=321.49 Aligned_cols=241 Identities=26% Similarity=0.344 Sum_probs=189.4
Q ss_pred cccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEEEEEeecCC
Q 005871 358 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 432 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lV~Ey~~~ 432 (672)
+.||+|+||.||+|++. +++.||+|++.... ....+.+..|..++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 57889999987542 23345566777777755 899999999999999999999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcc
Q 005871 433 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 512 (672)
Q Consensus 433 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~ 512 (672)
++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 999988843 345899999999999999999999997 9999999999999999999999999998643322 22
Q ss_pred cccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCC
Q 005871 513 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSC 592 (672)
Q Consensus 513 ~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 592 (672)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........... +.+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~-------~~~~--- 216 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE------DELFDSILNDR-------PHFP--- 216 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCC-------CCCC---
Confidence 3345799999999999998999999999999999999999999853221 11111111110 0011
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 005871 593 APDELLKFIHIGLLCVQQDPADRPTMS-SVVV 623 (672)
Q Consensus 593 ~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~ 623 (672)
......+.+++.+||+.||++||++. ++++
T Consensus 217 -~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 217 -RWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred -CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 11123456778899999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=315.18 Aligned_cols=270 Identities=23% Similarity=0.273 Sum_probs=214.6
Q ss_pred cCCccccccccCCceeEEeeeecC-CceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
+.|+++++||+|.-|+||++++++ +..+|+|++.+.. .+...+.+.|-+||+.++||.++.++..|+.++..++||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 568889999999999999999875 6889999998764 344567788999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC-
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG- 506 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~- 506 (672)
|||+||+|..+++.. ....+++..++.++..++-||+|||-.| ||+|||||+||||.++|++-|+||.++.....
T Consensus 157 eyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 999999999888654 4457999999999999999999999998 99999999999999999999999999753211
Q ss_pred --------------------------------CCC---------------------CcccccccccCCcCChhhhcCCCC
Q 005871 507 --------------------------------NQN---------------------QANTNIIAGTYGYMAPEYAMGGIF 533 (672)
Q Consensus 507 --------------------------------~~~---------------------~~~~~~~~gt~~Y~aPE~~~~~~~ 533 (672)
... ......++||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 001223679999999999999999
Q ss_pred ChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCC
Q 005871 534 SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPA 613 (672)
Q Consensus 534 s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~ 613 (672)
+.++|+|+|||++|||+.|..||....... ++...+ -..+.-...+.....+.+||+++|.+||+
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~--Tl~NIv-------------~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKE--TLRNIV-------------GQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchh--hHHHHh-------------cCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 999999999999999999999986543322 122211 11111111223445678999999999999
Q ss_pred CCCC----HHHHHHHh--ccCCCCCCCCCCCcc
Q 005871 614 DRPT----MSSVVVML--ASDSMTIPQPTEPAF 640 (672)
Q Consensus 614 ~RPt----~~evl~~L--~~~~~~l~~p~~p~~ 640 (672)
+|.. +.||-+.- .+.++.|-.-.+|.+
T Consensus 378 kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~ 410 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKRHPFFEGVNWALIRCARPPE 410 (459)
T ss_pred hhhccccchHHhhcCccccCCChhheeccCCCc
Confidence 9998 88887754 455666633333333
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=330.20 Aligned_cols=258 Identities=30% Similarity=0.439 Sum_probs=201.3
Q ss_pred cCCccccccccCCceeEEeeeec------CCceeEEEEecccC-cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeC-ce
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG-QE 422 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~-~~ 422 (672)
++|++.+.||+|+||.||+|.+. .++.||+|++.... ....+.+..|+.++.++ +|+||+++++++... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 57999999999999999999742 24789999987543 23345678899999999 899999999988654 57
Q ss_pred EEEEEeecCCCChhHHhhhccc----------------------------------------------------------
Q 005871 423 LLLIYEYMPNKSLDVHLFDATR---------------------------------------------------------- 444 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 444 (672)
++++|||+++++|..++.....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 8899999999999988853211
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcccccccccCCcCC
Q 005871 445 SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 524 (672)
Q Consensus 445 ~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~a 524 (672)
...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 126899999999999999999999987 99999999999999999999999999987643332222333456778999
Q ss_pred hhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHH
Q 005871 525 PEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHI 603 (672)
Q Consensus 525 PE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l 603 (672)
||++.+..++.++|||||||++|||++ |..||...... .. .......+.... .+......+.++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~--~~----~~~~~~~~~~~~---------~~~~~~~~~~~l 308 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--EE----FCRRLKEGTRMR---------APEYATPEIYSI 308 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc--HH----HHHHHhccCCCC---------CCccCCHHHHHH
Confidence 999999999999999999999999998 99887432111 11 111111111100 011223457888
Q ss_pred HHHhcccCCCCCCCHHHHHHHhcc
Q 005871 604 GLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 604 i~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
+.+||+.+|++||++.||+++|..
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHH
Confidence 899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=321.93 Aligned_cols=257 Identities=30% Similarity=0.416 Sum_probs=201.2
Q ss_pred cCCccccccccCCceeEEeeeec------CCceeEEEEecccCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 424 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 424 (672)
.+|.+.++||+|+||.||+|.+. .++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 45788899999999999999863 257899999875543 23466889999999999999999999999999999
Q ss_pred EEEeecCCCChhHHhhhcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC
Q 005871 425 LIYEYMPNKSLDVHLFDAT-------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM 491 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~ 491 (672)
+++||+.+++|..++.... ....+++..+..++.|++.||.|||+.| |+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999999885311 1235788899999999999999999997 99999999999999999
Q ss_pred CeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhh
Q 005871 492 NPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTY 570 (672)
Q Consensus 492 ~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~ 570 (672)
.+||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |..|+..... ...
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~ 235 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------QDV 235 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH------HHH
Confidence 999999999886543332222233456788999999998899999999999999999998 7777643211 111
Q ss_pred hhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 571 TWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 571 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
... ........ ........+.+++..||+.+|++||++++|++.|+.
T Consensus 236 ~~~-i~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IEM-IRNRQVLP---------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHH-HHcCCcCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111 11111110 111223446788889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=320.03 Aligned_cols=263 Identities=26% Similarity=0.378 Sum_probs=199.4
Q ss_pred cCCccccccccCCceeEEeeeecC---------------CceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLAD---------------GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLG 415 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~ 415 (672)
++|++.++||+|+||.||+++..+ ...||+|.+.... ......+.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 579999999999999999987642 2358999887542 334567899999999999999999999
Q ss_pred EEEeCceEEEEEeecCCCChhHHhhhccc---------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 005871 416 CCLEGQELLLIYEYMPNKSLDVHLFDATR---------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNIL 486 (672)
Q Consensus 416 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIl 486 (672)
++...+..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999998854221 123688999999999999999999997 999999999999
Q ss_pred EcCCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcC--CCCCCCCCcccc
Q 005871 487 LDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG--RKNNGFYFSEHG 564 (672)
Q Consensus 487 l~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG--~~p~~~~~~~~~ 564 (672)
++.++.+||+|||++................++..|+|||++.++.++.++||||||+++|+|+++ ..||.....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~--- 238 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD--- 238 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh---
Confidence 999999999999999765432222222233456789999999988999999999999999999984 445432211
Q ss_pred cchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 565 QTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
........+.+......... ...+.....+.+|+.+|++.+|++||++++|++.|.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 239 EQVIENTGEFFRNQGRQIYL------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHHhhhhccccccC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 11111111111110000000 001112346888999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=318.04 Aligned_cols=267 Identities=30% Similarity=0.422 Sum_probs=199.6
Q ss_pred CccccccccCCceeEEeeee-----cCCceeEEEEecccCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeC--ceEEE
Q 005871 354 FSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLL 425 (672)
Q Consensus 354 ~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~l 425 (672)
|.+.+.||+|+||+||++.. .++..+|+|.+..... .....+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 48899999999999988652 3578899999876432 3456788999999999999999999988753 46899
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
||||+++++|.+++.. ..+++.++..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||++..+.
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999998843 34899999999999999999999997 9999999999999999999999999998764
Q ss_pred CCCCCcc-cccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 506 GNQNQAN-TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 506 ~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
....... .....++..|+|||.+.+..++.++||||||+++|||++|..|+........ ................+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhhh
Confidence 3222111 1122356679999999988899999999999999999999998643221110 0111000001111111111
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
+.......+......+.+++..||+.+|++|||+++|+++|...
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11111111122235677888899999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=316.13 Aligned_cols=254 Identities=29% Similarity=0.433 Sum_probs=202.6
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
.+|.+.++||+|+||.||+|.++ .++.+|+|++.... .....+.+|++++++++|+||+++++++..+...++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45888999999999999999975 58899999886543 34567899999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
++++|.+++.... ...+++..++.++.|++++|.|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999885432 345899999999999999999999987 999999999999999999999999999876433221
Q ss_pred cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhc
Q 005871 511 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 589 (672)
. .....++..|+|||.+.+..++.++||||||+++|||++ |..|+...... . .+........ .
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~----~~~~~~~~~~-----~--- 224 (263)
T cd05052 161 A-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---Q----VYELLEKGYR-----M--- 224 (263)
T ss_pred c-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---H----HHHHHHCCCC-----C---
Confidence 1 112234567999999999999999999999999999998 88886432111 1 1111111100 0
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 590 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
..+......+.+++.+||+.+|++|||+.+++++|+.
T Consensus 225 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 225 -ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred -CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 0111122457778889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=335.44 Aligned_cols=254 Identities=22% Similarity=0.264 Sum_probs=196.2
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
++|.+.++||+|+||.||++... +++.||||++.+.. ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47899999999999999999875 68999999986532 334567889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+++|+|..++.. ...+++..+..++.|++.||.|||+.| |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999998853 345889999999999999999999998 999999999999999999999999998643211
Q ss_pred CCC------------c---------------------------------ccccccccCCcCChhhhcCCCCChhhHHHHH
Q 005871 508 QNQ------------A---------------------------------NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSF 542 (672)
Q Consensus 508 ~~~------------~---------------------------------~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSl 542 (672)
... . .....+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 0 0012469999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCC---CCHH
Q 005871 543 GVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADR---PTMS 619 (672)
Q Consensus 543 Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~ 619 (672)
||++|||++|+.||...... .. ............+- .. ......+.+++.+||+ +|.+| +++.
T Consensus 235 Gvil~elltG~~Pf~~~~~~---~~---~~~i~~~~~~~~~p-----~~--~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSH---ET---YRKIINWRETLYFP-----DD--IHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred chhhhhhhcCCCCCCCCCHH---HH---HHHHHccCCccCCC-----CC--CCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 99999999999998532211 11 11111100000000 00 0112345677778997 66665 5999
Q ss_pred HHHHHh
Q 005871 620 SVVVML 625 (672)
Q Consensus 620 evl~~L 625 (672)
++++.-
T Consensus 301 ~~l~hp 306 (377)
T cd05629 301 EIKSHP 306 (377)
T ss_pred HHhcCC
Confidence 998874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=318.98 Aligned_cols=256 Identities=29% Similarity=0.459 Sum_probs=202.8
Q ss_pred cCCccccccccCCceeEEeeeec------CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l 425 (672)
.+|...++||+|+||.||++... ++..+++|.+........+.+.+|+++++.++|+||+++++++.+....++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 56888999999999999999632 356889998887766667789999999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhhccc------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCe
Q 005871 426 IYEYMPNKSLDVHLFDATR------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP 493 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~ 493 (672)
||||+++++|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999864321 135889999999999999999999987 9999999999999999999
Q ss_pred EEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhh
Q 005871 494 KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTW 572 (672)
Q Consensus 494 kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 572 (672)
||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |++||..... ........
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~ 238 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN---TEAIECIT 238 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH---HHHHHHHH
Confidence 9999999986543322222223345678999999999999999999999999999998 8888642211 11111110
Q ss_pred hhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 573 KLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 573 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
.+..... .... ...+.+++.+||+.||++||++.||++.|.
T Consensus 239 ----~~~~~~~-----~~~~----~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 239 ----QGRELER-----PRTC----PPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ----cCccCCC-----CCCC----CHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1100000 0111 234668888999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=334.42 Aligned_cols=253 Identities=21% Similarity=0.289 Sum_probs=195.3
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
.+|++.++||+|+||.||+++.. +++.||||++.+.. ......+.+|+.+|++++|+||+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999975 58899999986532 233567889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 99999999999853 345889999999999999999999997 999999999999999999999999997533110
Q ss_pred CC-----------------------------------------CcccccccccCCcCChhhhcCCCCChhhHHHHHHHHH
Q 005871 508 QN-----------------------------------------QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 546 (672)
Q Consensus 508 ~~-----------------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil 546 (672)
.. .......+||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 00 0001234799999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCC---CHHHHHH
Q 005871 547 LEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRP---TMSSVVV 623 (672)
Q Consensus 547 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~evl~ 623 (672)
|||++|+.||........ ... ...+... ..... .... ...+.+++.+|+ .+|++|+ ++.++++
T Consensus 235 yell~G~~Pf~~~~~~~~---~~~-i~~~~~~--~~~~~---~~~~----s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 235 YEMLVGQPPFLADTPAET---QLK-VINWETT--LHIPS---QAKL----SREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred eehhhCCCCCCCCCHHHH---HHH-HhccCcc--ccCCC---CCCC----CHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 999999999854322110 000 0011100 00000 0111 223455566665 5999999 8899987
Q ss_pred H
Q 005871 624 M 624 (672)
Q Consensus 624 ~ 624 (672)
.
T Consensus 301 h 301 (376)
T cd05598 301 H 301 (376)
T ss_pred C
Confidence 7
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=311.09 Aligned_cols=259 Identities=23% Similarity=0.356 Sum_probs=206.3
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEeccc---CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
++|++.+.||+|+||.||+|+.. +++.||||.+... .......+.+|+++++.++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999975 6899999987542 2333457889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 428 EYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
||+++++|..++.... ....+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998885432 2345889999999999999999999987 99999999999999999999999999987643
Q ss_pred CCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
... ......|++.|+|||.+.+..++.++|+||||+++|||++|+.|+..... .......... ......
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~~-~~~~~~---- 227 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQKIE-QCDYPP---- 227 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHHHh-cCCCCC----
Confidence 321 12234688899999999988899999999999999999999999742211 1111111111 100000
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
.........+.+++.+||+.+|++||++.+|++.|.+.
T Consensus 228 ----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 ----LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ----CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 00112235577888899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=320.00 Aligned_cols=257 Identities=31% Similarity=0.437 Sum_probs=201.2
Q ss_pred CCccccccccCCceeEEeeeec------CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEE
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l 425 (672)
+|++.+.||+|+||.||+|+.. ....+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4788899999999999999853 23568888876543 2345678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhhcc---------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCc
Q 005871 426 IYEYMPNKSLDVHLFDAT---------------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASN 484 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~N 484 (672)
||||+.+++|.+++.... ....+++..++.++.|++.+|.|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999875421 1235889999999999999999999987 9999999999
Q ss_pred EEEcCCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCccc
Q 005871 485 ILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEH 563 (672)
Q Consensus 485 Ill~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~ 563 (672)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 9999999999999999986543322222223345678999999988889999999999999999998 88887432111
Q ss_pred ccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 564 GQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
..+......... ..+......+.+++.+||+.+|++||++.+|++.|...
T Consensus 237 ------~~~~~~~~~~~~---------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 237 ------RLFNLLKTGYRM---------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred ------HHHHHHhCCCCC---------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 111111111000 00111224577888899999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=327.29 Aligned_cols=243 Identities=27% Similarity=0.343 Sum_probs=193.7
Q ss_pred ccccccCCceeEEeeee----cCCceeEEEEecccC----cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 357 ENKLGQGGFGPVYKGTL----ADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 357 ~~~LG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
+++||+|+||.||+++. ..++.||+|++.+.. ......+.+|+.+|+.++||||+++++.+..++..++|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 36799999999999985 257899999987532 2334567889999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|+++++|..++.. ...+.+..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 81 YLSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 9999999988843 345788999999999999999999997 9999999999999999999999999987543222
Q ss_pred CCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhh
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 588 (672)
.......|++.|+|||++.+..++.++||||||+++|||++|+.||..... ........ .+..
T Consensus 155 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~------~~~~~~~~-~~~~-------- 217 (323)
T cd05584 155 --TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR------KKTIDKIL-KGKL-------- 217 (323)
T ss_pred --CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH------HHHHHHHH-cCCC--------
Confidence 122335799999999999988899999999999999999999999853221 11111111 1110
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005871 589 KQSCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVVM 624 (672)
Q Consensus 589 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 624 (672)
..++.....+.+++.+||+.+|++|| ++.++++.
T Consensus 218 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 218 --NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred --CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 01111223567888899999999999 88888774
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=318.11 Aligned_cols=258 Identities=29% Similarity=0.420 Sum_probs=200.7
Q ss_pred HhcCCccccccccCCceeEEeeeecC------CceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCce
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 422 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~ 422 (672)
.+++|.+.+.||+|+||.||+|.+.+ +..|++|.+.... ......+.+|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34679999999999999999998753 5678999876543 3334578999999999999999999999999999
Q ss_pred EEEEEeecCCCChhHHhhhccc----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC---CeEE
Q 005871 423 LLLIYEYMPNKSLDVHLFDATR----SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM---NPKI 495 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~---~~kL 495 (672)
.++||||+++++|.+++..... ...+++..+..++.||+.+|.|||+.+ ++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999865321 235899999999999999999999997 99999999999998755 5999
Q ss_pred EeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhh
Q 005871 496 SDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKL 574 (672)
Q Consensus 496 ~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 574 (672)
+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||...... .+.....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~~~~-- 235 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVMEFVT-- 235 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHH--
Confidence 99999987633222211222234567999999999999999999999999999997 88887532211 1111111
Q ss_pred ccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 575 WCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 575 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
..... ..+......+.+++.+|++.+|++||++.+|++.|.
T Consensus 236 -~~~~~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 -GGGRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -cCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 01000 011112345778888999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=327.79 Aligned_cols=253 Identities=23% Similarity=0.303 Sum_probs=200.6
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
++|.+.+.||+|+||.||++... +++.||+|++.... .+..+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47899999999999999999975 68899999987642 234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998543 246899999999999999999999997 999999999999999999999999999876543
Q ss_pred CCCcccccccccCCcCChhhhc------CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcc
Q 005871 508 QNQANTNIIAGTYGYMAPEYAM------GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAV 581 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~------~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (672)
... ......||+.|+|||++. ...++.++|||||||++|||++|+.||...... .............
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~ 228 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQRFL 228 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCCCcc
Confidence 222 223347899999999986 456789999999999999999999998532211 1111111111111
Q ss_pred cccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 582 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 582 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
...+ .......+.+|+.+||+ +|++|||++++++.
T Consensus 229 ~~~~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 229 KFPE-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CCCC-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 1100 01122346677789998 99999999999865
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=312.63 Aligned_cols=255 Identities=24% Similarity=0.368 Sum_probs=201.5
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
..+|++.+.||+|+||.||+|++. +++.+|+|++..........+.+|+.++++++||||+++++.+...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 457999999999999999999974 6889999998766555566788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+++++|.+++.. ...+++..+..++.|++.+|.|||+.+ |+||||||+||+++.++.+||+|||++..+.....
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 999999988843 346899999999999999999999987 99999999999999999999999999987643221
Q ss_pred CcccccccccCCcCChhhhc---CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 510 QANTNIIAGTYGYMAPEYAM---GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
......|++.|+|||.+. ...++.++||||||+++|||++|+.|+......... .. +..... ..+
T Consensus 162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--~~-----~~~~~~---~~~ 229 (267)
T cd06646 162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--FL-----MSKSNF---QPP 229 (267)
T ss_pred --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh--ee-----eecCCC---CCC
Confidence 122346889999999884 345788999999999999999999987422111100 00 000000 000
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
.... .......+.+++.+||+.+|++|||+++|++.|
T Consensus 230 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0000 011224577888899999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=326.32 Aligned_cols=249 Identities=22% Similarity=0.346 Sum_probs=195.1
Q ss_pred cccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEEEEEeecCC
Q 005871 358 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 432 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lV~Ey~~~ 432 (672)
+.||+|+||.||++++. +++.||+|++.+.. ......+..|..++..+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999975 58899999997542 33456688999999999 799999999999999999999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcc
Q 005871 433 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 512 (672)
Q Consensus 433 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~ 512 (672)
++|..++.. ...+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Cc
Confidence 999888743 346999999999999999999999998 9999999999999999999999999987432111 12
Q ss_pred cccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCccc--ccchhhhhhhhccCCCcccccChhhcC
Q 005871 513 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH--GQTLLTYTWKLWCEGPAVELIDPVLKQ 590 (672)
Q Consensus 513 ~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~d~~l~~ 590 (672)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ......+.......... .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~p~ 226 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RIPR 226 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CCCC
Confidence 234579999999999999999999999999999999999999986422111 11111112221111111 0111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 005871 591 SCAPDELLKFIHIGLLCVQQDPADRPT------MSSVVVM 624 (672)
Q Consensus 591 ~~~~~~~~~l~~li~~cl~~dP~~RPt------~~evl~~ 624 (672)
.....+.+++.+||+.||++||+ ++++++.
T Consensus 227 ----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 227 ----SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred ----CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 12234678888999999999997 6777754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=314.67 Aligned_cols=252 Identities=24% Similarity=0.368 Sum_probs=198.8
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
++|++.++||+|+||.||+|.+. +++.+|+|.+.... ......+.+|++++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 46888999999999999999874 68899999986542 33456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++..+...
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999987542 4788899999999999999999998 999999999999999999999999999865432
Q ss_pred CcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhc
Q 005871 510 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 589 (672)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||.......................... +.
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~ 221 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV-----LP 221 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCC-----CC
Confidence 22335789999999999998999999999999999999999999854322211110000011111111000 00
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 590 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
. ......+.+++.+||+.+|++||+++|+++..
T Consensus 222 ~---~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 222 V---GQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred C---CcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 0 11223567888899999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=313.63 Aligned_cols=249 Identities=27% Similarity=0.329 Sum_probs=193.8
Q ss_pred cccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCCCCh
Q 005871 360 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 435 (672)
Q Consensus 360 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL 435 (672)
||+|+||.||+++.+ +|+.||+|++.... ......+..|++++++++||||+++++.+.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999875 58999999986432 12234556799999999999999999999999999999999999999
Q ss_pred hHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCccccc
Q 005871 436 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 515 (672)
Q Consensus 436 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~ 515 (672)
..++... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~ 153 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQ 153 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eec
Confidence 8887543 2345889999999999999999999997 99999999999999999999999999987643221 223
Q ss_pred ccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHH
Q 005871 516 IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPD 595 (672)
Q Consensus 516 ~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 595 (672)
..|+..|+|||++.+..++.++|||||||++|||++|+.||........ ........... . +.. ....
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~-~----~~~-~~~~---- 221 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLED-E----VKF-EHQN---- 221 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhcc-c----ccc-cccc----
Confidence 4689999999999998999999999999999999999999854322111 11111111110 0 000 0011
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 596 ELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 596 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
....+.+++.+||+.||++||++.|+++.+..
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~ 253 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDDPRK 253 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhhhhc
Confidence 12346788889999999999999877655544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=325.64 Aligned_cols=249 Identities=24% Similarity=0.361 Sum_probs=194.2
Q ss_pred cccccCCceeEEeeeec-CCceeEEEEeccc---CcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEEEEEeecCC
Q 005871 358 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 432 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lV~Ey~~~ 432 (672)
+.||+|+||.||++.+. +++.+|+|++.+. .......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 5789999998764 233445678899998877 899999999999999999999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcc
Q 005871 433 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 512 (672)
Q Consensus 433 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~ 512 (672)
++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~ 152 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence 999887743 346899999999999999999999997 9999999999999999999999999987532211 12
Q ss_pred cccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccc--cchhhhhhhhccCCCcccccChhhcC
Q 005871 513 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHG--QTLLTYTWKLWCEGPAVELIDPVLKQ 590 (672)
Q Consensus 513 ~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~d~~l~~ 590 (672)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .....+..........
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------- 222 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------
Confidence 2345799999999999999999999999999999999999999853221111 1111122222111111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 005871 591 SCAPDELLKFIHIGLLCVQQDPADRPT------MSSVVVM 624 (672)
Q Consensus 591 ~~~~~~~~~l~~li~~cl~~dP~~RPt------~~evl~~ 624 (672)
..+......+.+++.+||+.||++||+ +.++++.
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 011122345678888999999999998 4676654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=335.17 Aligned_cols=200 Identities=26% Similarity=0.385 Sum_probs=172.5
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
+|+++++||+|+||.||+|+.. +++.+|+|++.+.. ......+.+|+.++++++||||+++++.+.+++.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 6889999999999999999975 58899999987542 2345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999998854 245889999999999999999999997 9999999999999999999999999975332100
Q ss_pred C---------------------------------------------CcccccccccCCcCChhhhcCCCCChhhHHHHHH
Q 005871 509 N---------------------------------------------QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFG 543 (672)
Q Consensus 509 ~---------------------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlG 543 (672)
. .......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0 0001234799999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCC
Q 005871 544 VLLLEIISGRKNNGF 558 (672)
Q Consensus 544 vil~elltG~~p~~~ 558 (672)
|++|||++|+.||..
T Consensus 236 vil~elltG~~Pf~~ 250 (382)
T cd05625 236 VILYEMLVGQPPFLA 250 (382)
T ss_pred HHHHHHHhCCCCCCC
Confidence 999999999999854
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=326.22 Aligned_cols=246 Identities=25% Similarity=0.323 Sum_probs=193.1
Q ss_pred CccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHH---HhccCCCeeeEEEEEEeCceEEEE
Q 005871 354 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLI---AKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 354 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il---~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
|++.+.||+|+||.||++.+. +++.||||++.+.. ....+.+..|..++ +.++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678899999999999999875 68999999987542 23345666676655 566799999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||+++++|...+. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999987773 245899999999999999999999997 99999999999999999999999999875322
Q ss_pred CCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
.. .......|++.|+|||++.+..++.++|||||||++|||++|+.||...... ....... .+..
T Consensus 154 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~------~~~~~i~-~~~~------ 218 (324)
T cd05589 154 FG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------EVFDSIV-NDEV------ 218 (324)
T ss_pred CC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH------HHHHHHH-hCCC------
Confidence 11 1223457999999999999999999999999999999999999997532211 1111111 1100
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVVML 625 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 625 (672)
..... ....+.+++.+||+.||++|| ++.++++.-
T Consensus 219 ~~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~ 258 (324)
T cd05589 219 RYPRF----LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP 258 (324)
T ss_pred CCCCC----CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence 01111 123467788899999999999 577777653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=325.89 Aligned_cols=237 Identities=27% Similarity=0.335 Sum_probs=186.4
Q ss_pred cccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHH-HHHhccCCCeeeEEEEEEeCceEEEEEeecCC
Q 005871 358 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVN-LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 432 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~ 432 (672)
+.||+|+||.||++++. +++.||+|++.+.. ......+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999985 68999999987542 222344555554 56789999999999999999999999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcc
Q 005871 433 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 512 (672)
Q Consensus 433 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~ 512 (672)
++|..++.. ...+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT 152 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence 999988853 346899999999999999999999998 9999999999999999999999999987532211 22
Q ss_pred cccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCC
Q 005871 513 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSC 592 (672)
Q Consensus 513 ~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 592 (672)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ .+.. . +.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~i~-~~~~-~-----~~--- 216 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYDNIL-NKPL-R-----LK--- 216 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHHHHH-cCCC-C-----CC---
Confidence 2345799999999999999999999999999999999999999753211 11111111 1110 0 11
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHH
Q 005871 593 APDELLKFIHIGLLCVQQDPADRPTMS 619 (672)
Q Consensus 593 ~~~~~~~l~~li~~cl~~dP~~RPt~~ 619 (672)
+.....+.+++.+||+.||.+||++.
T Consensus 217 -~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 -PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 11234567888899999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=321.63 Aligned_cols=260 Identities=30% Similarity=0.434 Sum_probs=204.3
Q ss_pred HhcCCccccccccCCceeEEeeeecC------CceeEEEEecccC-cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCc
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ 421 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~ 421 (672)
..++|++.+.||+|+||.||++...+ ...+|+|.+.... ......+.+|+.+++++ +|+||+++++++..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 34679999999999999999998642 3678999887542 33456788999999999 8999999999999999
Q ss_pred eEEEEEeecCCCChhHHhhhc-------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc
Q 005871 422 ELLLIYEYMPNKSLDVHLFDA-------------TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD 488 (672)
Q Consensus 422 ~~~lV~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~ 488 (672)
..++||||+++++|..++... .....+++..+..++.||+.||.|||+.+ |+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999998542 22346899999999999999999999987 99999999999999
Q ss_pred CCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccch
Q 005871 489 DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTL 567 (672)
Q Consensus 489 ~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~ 567 (672)
.++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..|+...... .
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~- 242 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE---E- 242 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH---H-
Confidence 999999999999987654332222222335678999999998899999999999999999998 88886422111 1
Q ss_pred hhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 568 LTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 568 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
.......+... ..+......+.+|+.+|++.+|++|||+.|+++.|...
T Consensus 243 ---~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 243 ---LFKLLKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ---HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 11111111100 01112234577889999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=314.45 Aligned_cols=255 Identities=27% Similarity=0.449 Sum_probs=199.6
Q ss_pred CccccccccCCceeEEeeeecC----CceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCce-----
Q 005871 354 FSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE----- 422 (672)
Q Consensus 354 ~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~----- 422 (672)
|.+.+.||+|+||.||+|.+.. +..+|+|++.... ......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998642 3679999987543 3345678999999999999999999998876554
Q ss_pred -EEEEEeecCCCChhHHhhhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEee
Q 005871 423 -LLLIYEYMPNKSLDVHLFDAT---RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDF 498 (672)
Q Consensus 423 -~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DF 498 (672)
.++||||+++++|..++.... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 799999999999998885432 2346899999999999999999999987 999999999999999999999999
Q ss_pred cCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccC
Q 005871 499 GLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCE 577 (672)
Q Consensus 499 gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 577 (672)
|+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..||.... ......... .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~---~~~~~~~~~----~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE---NHEIYDYLR----H 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHH----c
Confidence 99987654333222222345678999999988889999999999999999999 888864321 111111111 1
Q ss_pred CCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 578 GPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 578 ~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
+.... .+......+.+++.+||+.||++|||+.||++.|..
T Consensus 231 ~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 231 GNRLK---------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred CCCCC---------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 11111 111223467888889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=309.25 Aligned_cols=259 Identities=24% Similarity=0.378 Sum_probs=207.2
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEeccc---CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
++|.+.+.||+|+||.||+|... +++.+|+|.+... .....+.+.+|++++++++|+|++++++.+.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999986 7899999988642 2333567899999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 428 EYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
||+++++|..++... .....+++.++..++.+++.+|.|||+.| |+||||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988653 23455899999999999999999999997 99999999999999999999999999886543
Q ss_pred CCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
.... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ......... ...+.. .+
T Consensus 159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~-~~~~~~----~~ 227 (267)
T cd08224 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKK-IEKCDY----PP 227 (267)
T ss_pred CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhh-hhcCCC----CC
Confidence 3221 223468889999999998889999999999999999999999974221 111111111 111111 00
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
.. .......+.+++.+||+.+|++|||+.+|+++|...
T Consensus 228 ~~----~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 228 LP----ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CC----hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 00 112234577888899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=336.84 Aligned_cols=263 Identities=21% Similarity=0.284 Sum_probs=193.2
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeC--------
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-------- 420 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-------- 420 (672)
...+|.+.+.||+|+||.||+|.+. .++.||||++.... ....+|+.+|+.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3468999999999999999999975 58899999886533 2345799999999999999999887432
Q ss_pred ceEEEEEeecCCCChhHHhhh-ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-CeEEEee
Q 005871 421 QELLLIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDF 498 (672)
Q Consensus 421 ~~~~lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~-~~kL~DF 498 (672)
..+++||||+++ +|..++.. ......+++..+..++.||+.||.|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 247799999986 56555543 233456899999999999999999999998 99999999999999665 6999999
Q ss_pred cCceeeCCCCCCcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccC
Q 005871 499 GLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCE 577 (672)
Q Consensus 499 gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 577 (672)
|+++.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|.+||....... .+.. .......
T Consensus 216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~-i~~~~~~ 289 (440)
T PTZ00036 216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVR-IIQVLGT 289 (440)
T ss_pred ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHH-HHHHhCC
Confidence 99986543221 2234689999999998764 68999999999999999999999985432211 1111 1111000
Q ss_pred C---------------CcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 578 G---------------PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 578 ~---------------~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
. .........+....+.....++.+|+.+||+.||.+|||+.|+++.--
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 0 000000011111111112346778889999999999999999986643
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.33 Aligned_cols=255 Identities=27% Similarity=0.448 Sum_probs=196.7
Q ss_pred CccccccccCCceeEEeeeecC-Cc--eeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeC------ce
Q 005871 354 FSDENKLGQGGFGPVYKGTLAD-GK--AIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------QE 422 (672)
Q Consensus 354 ~~~~~~LG~G~fg~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~------~~ 422 (672)
|.+.+.||+|+||.||+|++.+ +. .+|+|.+... .....+.+.+|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999764 32 6899987654 344467789999999999999999999987532 25
Q ss_pred EEEEEeecCCCChhHHhhhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeec
Q 005871 423 LLLIYEYMPNKSLDVHLFDAT---RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 499 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFg 499 (672)
.+++|||+.+++|..++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 789999999999998874321 2345899999999999999999999987 9999999999999999999999999
Q ss_pred CceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCC
Q 005871 500 LARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEG 578 (672)
Q Consensus 500 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 578 (672)
+++.+.............+++.|++||.+.+..++.++||||||+++|||++ |+.||.... ...+.. ....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~~~----~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE---NSEIYD----YLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHH----HHHcC
Confidence 9987644332222223346778999999999999999999999999999999 788874321 111111 11111
Q ss_pred CcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 579 PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 579 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
..... .......+.+++.+||+.+|++|||+.+|++.|+.
T Consensus 231 ~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 231 NRLKQ---------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 11110 11122347788889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=317.23 Aligned_cols=257 Identities=28% Similarity=0.431 Sum_probs=203.9
Q ss_pred hcCCccccccccCCceeEEeeeecC------CceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 423 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 423 (672)
.++|.+.+.||+|+||.||+|.+.. +..+|+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3578999999999999999998642 4689999986543 23456788999999999999999999999999999
Q ss_pred EEEEeecCCCChhHHhhhccc-------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEE
Q 005871 424 LLIYEYMPNKSLDVHLFDATR-------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKIS 496 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~ 496 (672)
++||||+++++|..++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999864321 234788999999999999999999987 9999999999999999999999
Q ss_pred eecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhc
Q 005871 497 DFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLW 575 (672)
Q Consensus 497 DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 575 (672)
|||+++...............++..|+|||.+.++.++.++||||||+++|||++ |+.||..... ..... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~----~~ 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVLK----FV 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHHH----HH
Confidence 9999986544332222233456788999999998889999999999999999998 8888643211 11111 11
Q ss_pred cCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 576 CEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 576 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
..+..... +......+.+++.+||+.+|++|||+.+|++.|.
T Consensus 235 ~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 IDGGHLDL---------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred hcCCCCCC---------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11111111 1111345778888999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=324.74 Aligned_cols=242 Identities=25% Similarity=0.359 Sum_probs=192.4
Q ss_pred cccccCCceeEEeeeec-CCceeEEEEeccc---CcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEEEEEeecCC
Q 005871 358 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 432 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lV~Ey~~~ 432 (672)
+.||+|+||.||+++++ +++.||+|++.+. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999976 5889999998753 234456778899999877 699999999999999999999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcc
Q 005871 433 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 512 (672)
Q Consensus 433 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~ 512 (672)
++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~ 152 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT 152 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence 999988843 345899999999999999999999997 9999999999999999999999999987543221 12
Q ss_pred cccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCC
Q 005871 513 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSC 592 (672)
Q Consensus 513 ~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 592 (672)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ....... .+.. . .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~-~~~~------~----~ 215 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAIL-NDEV------V----Y 215 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHHHHh-cCCC------C----C
Confidence 23457999999999999999999999999999999999999998532211 1111111 1110 0 0
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 005871 593 APDELLKFIHIGLLCVQQDPADRPTM------SSVVVM 624 (672)
Q Consensus 593 ~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~~ 624 (672)
+......+.+++.+||+.||++||++ +++++.
T Consensus 216 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 216 PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 11122356788889999999999998 666554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=324.73 Aligned_cols=243 Identities=23% Similarity=0.311 Sum_probs=193.7
Q ss_pred cccccCCceeEEeeeec-CCceeEEEEeccc---CcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEEEEEeecCC
Q 005871 358 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 432 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lV~Ey~~~ 432 (672)
+.||+|+||.||+|++. +++.||+|++.+. .....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999976 5789999998754 234456678899999876 799999999999999999999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcc
Q 005871 433 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 512 (672)
Q Consensus 433 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~ 512 (672)
++|...+.. ...+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--T 152 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc--c
Confidence 999888843 345899999999999999999999998 99999999999999999999999999876432221 1
Q ss_pred cccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCC
Q 005871 513 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSC 592 (672)
Q Consensus 513 ~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 592 (672)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...... ........ +.. . .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~------~~~~~i~~-~~~------~----~ 215 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED------DLFESILH-DDV------L----Y 215 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH------HHHHHHHc-CCC------C----C
Confidence 23357899999999999999999999999999999999999998533211 11111111 110 0 0
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCC-------CHHHHHHHh
Q 005871 593 APDELLKFIHIGLLCVQQDPADRP-------TMSSVVVML 625 (672)
Q Consensus 593 ~~~~~~~l~~li~~cl~~dP~~RP-------t~~evl~~L 625 (672)
+......+.+++.+||+.||++|| +++++++.-
T Consensus 216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence 111123567888899999999999 888887653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=324.15 Aligned_cols=247 Identities=24% Similarity=0.303 Sum_probs=195.5
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEeccc---CcccHHHHHHHHHHHHhccCC-CeeeEEEEEEeCceEEEEE
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHK-NLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~-niv~l~~~~~~~~~~~lV~ 427 (672)
+|.+.+.||+|+||.||+|++. +++.||+|++.+. .....+.+..|..++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5888999999999999999976 4788999998754 234456788899999999765 5888999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+++++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999988843 345889999999999999999999997 999999999999999999999999998753221
Q ss_pred CCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChh
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 587 (672)
. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ..+.. ... .... .
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~---~i~-~~~~------~ 219 (324)
T cd05587 155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DELFQ---SIM-EHNV------S 219 (324)
T ss_pred C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHH---HHH-cCCC------C
Confidence 1 122345799999999999999999999999999999999999999853221 11111 111 1100 0
Q ss_pred hcCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 005871 588 LKQSCAPDELLKFIHIGLLCVQQDPADRPTM-----SSVVVM 624 (672)
Q Consensus 588 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~ 624 (672)
.+......+.+++.+||+.||++|++. .++++.
T Consensus 220 ----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 220 ----YPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred ----CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 011122346788889999999999986 566554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=330.02 Aligned_cols=254 Identities=20% Similarity=0.240 Sum_probs=199.9
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEeccc---CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
.++|++.++||+|+||.||+++.. +++.||+|++.+. .......+.+|+.+++.++||||+++++++.+....++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 468999999999999999999976 5889999998653 223345678899999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||+++|+|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 122 ~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 122 MEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999988843 24788899999999999999999997 99999999999999999999999999987643
Q ss_pred CCCCcccccccccCCcCChhhhcCC----CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccc
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGG----IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVE 582 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (672)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...............
T Consensus 195 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~~~~ 267 (370)
T cd05596 195 NGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMDHKNSLT 267 (370)
T ss_pred CCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCCCcCC
Confidence 2221 12345799999999998653 478999999999999999999999853221 111111111111001
Q ss_pred ccChhhcCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHh
Q 005871 583 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPAD--RPTMSSVVVML 625 (672)
Q Consensus 583 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L 625 (672)
.. . .......+.+++.+||+.+|.+ |||++++++.-
T Consensus 268 ~~-----~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 268 FP-----D--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred CC-----C--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 10 0 0112345677888999999988 99999998764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=315.72 Aligned_cols=252 Identities=27% Similarity=0.326 Sum_probs=200.1
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
+|++.++||+|+||.||++.+. +++.||+|++.... ......+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788999999999999999975 68999999986542 2223457889999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|+++++|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999887543 2345899999999999999999999997 9999999999999999999999999998754322
Q ss_pred CCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhh
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 588 (672)
. .....|++.|+|||++.+..++.++||||+|+++|||++|+.||....... .............
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~--------- 221 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERRVKEDQ--------- 221 (285)
T ss_pred c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHHhhhcc---------
Confidence 1 123468999999999998899999999999999999999999985322111 0011111000000
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005871 589 KQSCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVVM 624 (672)
Q Consensus 589 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 624 (672)
..........+.+|+.+||+.||++|| ++.++++.
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 -EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 011122334567888899999999999 88898765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=300.72 Aligned_cols=252 Identities=23% Similarity=0.302 Sum_probs=202.3
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
.++.|++.+.||+|.|+.||+..+. .|+.+|+|++... +..+.+.+.+|+.|-+.|+||||+++++.+.+....+||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 3578999999999999999999875 6999999987543 344678899999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC---CCeEEEeecCcee
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD---MNPKISDFGLARI 503 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~---~~~kL~DFgla~~ 503 (672)
+|++.|+.|-.-+.. +..+++..+...++||+++|.|+|.++ |||||+||+|+++-+. --+||+|||++..
T Consensus 89 Fe~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999999766643 345788899999999999999999998 9999999999999643 3589999999998
Q ss_pred eCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccc
Q 005871 504 FGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583 (672)
Q Consensus 504 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 583 (672)
++... .....+|||+|||||++...+|+..+|||+-|||||-|+.|.+||-. ++...+.+.+...--+-
T Consensus 163 l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~---~~~~rlye~I~~g~yd~----- 231 (355)
T KOG0033|consen 163 VNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD---EDQHRLYEQIKAGAYDY----- 231 (355)
T ss_pred eCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC---ccHHHHHHHHhccccCC-----
Confidence 87322 23346899999999999999999999999999999999999999732 12223332222111000
Q ss_pred cChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 584 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
.....+...++..+|+++||..||.+|.|+.|.|+
T Consensus 232 -----~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 232 -----PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred -----CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 11112222334567788999999999999998764
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=311.27 Aligned_cols=253 Identities=32% Similarity=0.487 Sum_probs=200.9
Q ss_pred cCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecC
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 431 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 431 (672)
++|++.++||+|+||.||++.+.++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 57899999999999999999988888899999876433 3467899999999999999999999875 456899999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCc
Q 005871 432 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 511 (672)
Q Consensus 432 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 511 (672)
+++|.+++... ....+++..+..++.|++.+|.|||+.+ |+||||||+||++++++.++|+|||++..+.......
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 99999988543 2345899999999999999999999997 9999999999999999999999999998764332211
Q ss_pred ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcC
Q 005871 512 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590 (672)
Q Consensus 512 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 590 (672)
.....++..|+|||++.+..++.++||||||+++|+|++ |..||.... ....... .......
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~---~~~~~~~---~~~~~~~---------- 222 (260)
T cd05070 160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN---NREVLEQ---VERGYRM---------- 222 (260)
T ss_pred -ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC---HHHHHHH---HHcCCCC----------
Confidence 112235567999999988889999999999999999999 888874321 1111111 1110000
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 591 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
..+......+.+++.+|++.+|++|||++++++.|..
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111223457888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=327.52 Aligned_cols=242 Identities=24% Similarity=0.287 Sum_probs=193.2
Q ss_pred cccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCCC
Q 005871 358 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 433 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~g 433 (672)
+.||+|+||.||++... +++.||+|++.+.. ......+.+|+++++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 68999999987542 234566788999999999999999999999999999999999999
Q ss_pred ChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcc
Q 005871 434 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE-DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 512 (672)
Q Consensus 434 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~ 512 (672)
+|..++.. ...+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT 152 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence 99888743 3468999999999999999999997 56 9999999999999999999999999987543221 11
Q ss_pred cccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCC
Q 005871 513 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSC 592 (672)
Q Consensus 513 ~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 592 (672)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ...... .... . ..+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~---~~~~~~---i~~~-~------~~~p~~~ 219 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFEL---ILME-E------IRFPRTL 219 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH---HHHHHH---HhcC-C------CCCCCCC
Confidence 2335799999999999999999999999999999999999999843211 111111 1100 0 0011112
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005871 593 APDELLKFIHIGLLCVQQDPADRP-----TMSSVVVM 624 (672)
Q Consensus 593 ~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 624 (672)
...+.+++.+||+.||++|+ ++.++++.
T Consensus 220 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 220 ----SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred ----CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 23466788899999999996 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=310.56 Aligned_cols=258 Identities=23% Similarity=0.372 Sum_probs=204.7
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
++|.+.+.||+|+||.||++... +++.++||.+.... ......+.+|+.+++.++||||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46888999999999999999964 78999999876532 233467889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 428 EYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
||+++++|.+++... .....+++..+..++.||+.+|.|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988642 23456899999999999999999999997 99999999999999999999999999886543
Q ss_pred CCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
.... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...... ....... ..... .+
T Consensus 159 ~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~-~~~~~-----~~ 226 (267)
T cd08229 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKK-IEQCD-----YP 226 (267)
T ss_pred CCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhh-hhcCC-----CC
Confidence 3221 12346889999999999888999999999999999999999997422111 0111000 00000 00
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
.+. .......+.+++.+||+.+|++|||+.+|++++..
T Consensus 227 ~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 227 PLP---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred CCC---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 000 11223457788889999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=315.91 Aligned_cols=255 Identities=30% Similarity=0.430 Sum_probs=198.4
Q ss_pred cCCccccccccCCceeEEeeeec-CCc----eeEEEEecccCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGK----AIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l 425 (672)
++|++.+.||+|+||.||+|.+. +++ .+++|.+..... .....+..|+.++++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 57888999999999999999874 344 477787754432 23467788899999999999999999875 456789
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
++||+++|+|.+++... ...+++..+..|+.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999998543 345899999999999999999999987 9999999999999999999999999998764
Q ss_pred CCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 506 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 506 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
............++..|+|||.+.++.++.++||||||+++|||++ |+.||....... . ...+..+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~----~~~~~~~~~~~-- 231 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---V----PDLLEKGERLA-- 231 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHHCCCcCC--
Confidence 4332222333457788999999999999999999999999999998 998874322111 1 11111111111
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
.+ .. ....+.+++..|++.+|++|||+.|+++.|...
T Consensus 232 ~~---~~----~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~ 268 (279)
T cd05111 232 QP---QI----CTIDVYMVMVKCWMIDENVRPTFKELANEFTRM 268 (279)
T ss_pred CC---CC----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 00 01 123456778899999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=311.66 Aligned_cols=246 Identities=30% Similarity=0.426 Sum_probs=193.1
Q ss_pred ccccCCceeEEeeeec---CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCCC
Q 005871 359 KLGQGGFGPVYKGTLA---DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 433 (672)
Q Consensus 359 ~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~g 433 (672)
+||+|+||.||+|.++ ++..+|+|++.... ....+.+.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6899999999999753 57889999886543 234567899999999999999999999875 45678999999999
Q ss_pred ChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcc-
Q 005871 434 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN- 512 (672)
Q Consensus 434 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~- 512 (672)
+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..+........
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99998843 345899999999999999999999997 99999999999999999999999999987654332211
Q ss_pred cccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCC
Q 005871 513 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQS 591 (672)
Q Consensus 513 ~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~ 591 (672)
.....++..|+|||.+....++.++||||||+++|||++ |+.||..... ....... ..+.... .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~i----~~~~~~~-----~--- 219 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NEVTQMI----ESGERME-----C--- 219 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----HCCCCCC-----C---
Confidence 112234578999999988889999999999999999998 9999753321 1111111 1111111 1
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 592 CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 592 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
+......+.+++.+||+.||++||++++|.+.|..
T Consensus 220 -~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 220 -PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 11123456788889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=312.95 Aligned_cols=252 Identities=29% Similarity=0.478 Sum_probs=199.5
Q ss_pred CccccccccCCceeEEeeeec-CCceeEEEEecccCcccHH--HHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 354 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQ--EFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 354 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
|++.+.||+|+||.||++... +++.+|+|++......... ....|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 678899999999999999986 4678999999877644332 3456999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
.+++|.+++. ....+++..+..++.||++||.+||+.+ |+|+||||+||++++++.++|+|||.+..+. ...
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENN 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--STT
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--ccc
Confidence 9999999985 3456899999999999999999999997 9999999999999999999999999998752 222
Q ss_pred cccccccccCCcCChhhhc-CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhc
Q 005871 511 ANTNIIAGTYGYMAPEYAM-GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 589 (672)
.......++..|+|||++. +..++.++||||||+++|+|++|..|+............ ...... .....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~---~~~~~~----~~~~~--- 222 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEII---EKILKR----PLPSS--- 222 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHH---HHHHHT----HHHHH---
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhh---hhcccc----ccccc---
Confidence 2334457899999999998 788999999999999999999999997643111111111 000000 00000
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 590 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
..........+.+++.+||+.||++|||+.++++
T Consensus 223 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 223 SQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000011256888888999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=315.65 Aligned_cols=263 Identities=25% Similarity=0.396 Sum_probs=200.2
Q ss_pred cCCccccccccCCceeEEeeeec-----------------CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-----------------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRL 413 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l 413 (672)
++|++.++||+|+||.||++.+. ++..+|+|++.... ......+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 57999999999999999998532 24468999987543 3345688999999999999999999
Q ss_pred EEEEEeCceEEEEEeecCCCChhHHhhhccc--------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 005871 414 LGCCLEGQELLLIYEYMPNKSLDVHLFDATR--------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNI 485 (672)
Q Consensus 414 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NI 485 (672)
++++...+..++||||+++++|.+++..... ...+++.++..++.||+.||.|||+.+ |+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999865321 134778899999999999999999997 99999999999
Q ss_pred EEcCCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc--CCCCCCCCCccc
Q 005871 486 LLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS--GRKNNGFYFSEH 563 (672)
Q Consensus 486 ll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt--G~~p~~~~~~~~ 563 (672)
|++.++.++|+|||++..+.............++..|++||...++.++.++|||||||++|||++ |..||......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~- 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE- 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH-
Confidence 999999999999999986543322222222344678999999988899999999999999999998 56665422111
Q ss_pred ccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 564 GQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
.........+......... + ........+.+++.+||+.||++||++.+|++.|.
T Consensus 241 --~~~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 --QVIENTGEFFRDQGRQVYL-P-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred --HHHHHHHHHHhhccccccC-C-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1111111111110000000 0 01112356778889999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=311.44 Aligned_cols=254 Identities=31% Similarity=0.476 Sum_probs=201.0
Q ss_pred hcCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
.++|.+.++||+|+||.||+|++.+...+|+|++..... ..+.+.+|+.+++.++||||+++++.+.+ ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 357999999999999999999987777899999875332 34678999999999999999999998754 5679999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
++++|.+++... ....+++..+..++.|++.+|.|||+.+ |+||||||+||++++++.+||+|||.+..+......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999998543 2335789999999999999999999987 999999999999999999999999999876433221
Q ss_pred cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhc
Q 005871 511 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 589 (672)
. .....++..|+|||+..++.++.++||||||+++|+|++ |+.||...... .... ........
T Consensus 159 ~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~~~---~~~~~~~~--------- 222 (262)
T cd05071 159 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLD---QVERGYRM--------- 222 (262)
T ss_pred c-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HHHH---HHhcCCCC---------
Confidence 1 122345678999999988899999999999999999999 77776432211 1111 11110000
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 590 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
.........+.+++.+|++.+|++||++.++++.|..
T Consensus 223 -~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 223 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred -CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 0112234567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=306.32 Aligned_cols=250 Identities=37% Similarity=0.520 Sum_probs=202.0
Q ss_pred cccccCCceeEEeeeecC----CceeEEEEecccCcc-cHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCC
Q 005871 358 NKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 432 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~ 432 (672)
+.||+|+||.||++.... +..+++|.+...... ..+.+.+|+++++.++|+||+++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999753 788999998765443 367889999999999999999999999999999999999999
Q ss_pred CChhHHhhhccc------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 433 KSLDVHLFDATR------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 433 gsL~~~l~~~~~------~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
++|.+++..... ...+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999865421 367999999999999999999999987 99999999999999999999999999987654
Q ss_pred CCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccC
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 585 (672)
...........++..|+|||.+.+..++.++||||||+++|+|++ |..||..... .... .....+....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~----~~~~~~~~~~--- 227 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVL----EYLRKGYRLP--- 227 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHH----HHHHcCCCCC---
Confidence 432222334567889999999988899999999999999999999 5888754311 1111 1111111100
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
.+......+.+++.+||+.+|++|||+.++++.|.
T Consensus 228 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 228 ------KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ------CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11112345778888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=326.40 Aligned_cols=240 Identities=26% Similarity=0.313 Sum_probs=187.6
Q ss_pred cccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHH-HHHhccCCCeeeEEEEEEeCceEEEEEeecCC
Q 005871 358 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVN-LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 432 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~ 432 (672)
+.||+|+||+||+++.. +|+.+|+|++.+.. ......+..|.. +++.++||||+++++.+...+..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999875 68999999987542 223345555655 56779999999999999999999999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcc
Q 005871 433 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 512 (672)
Q Consensus 433 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~ 512 (672)
++|..++.. ...+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 152 (325)
T cd05604 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DT 152 (325)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CC
Confidence 999888743 346899999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred cccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCC
Q 005871 513 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSC 592 (672)
Q Consensus 513 ~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 592 (672)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......... ... .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~------~~~~~~~~~-~~~------~~---- 215 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV------AEMYDNILH-KPL------VL---- 215 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH------HHHHHHHHc-CCc------cC----
Confidence 2345799999999999999999999999999999999999999753211 111111111 110 00
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005871 593 APDELLKFIHIGLLCVQQDPADRPTMSSVV 622 (672)
Q Consensus 593 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl 622 (672)
.+.....+.+++.+||+.+|.+||++.+.+
T Consensus 216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 216 RPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 111233466788899999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=322.31 Aligned_cols=249 Identities=24% Similarity=0.372 Sum_probs=195.6
Q ss_pred cccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEEEEEeecCC
Q 005871 358 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 432 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lV~Ey~~~ 432 (672)
+.||+|+||.||++... +++.+|+|++.+.. ....+.+.+|..++.++ +||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 57899999997642 23456688999999998 699999999999999999999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcc
Q 005871 433 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 512 (672)
Q Consensus 433 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~ 512 (672)
++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT 152 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence 999888743 345999999999999999999999997 9999999999999999999999999987532211 12
Q ss_pred cccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCC
Q 005871 513 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSC 592 (672)
Q Consensus 513 ~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 592 (672)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......................... +
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------~---- 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR------I---- 222 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC------C----
Confidence 234579999999999999999999999999999999999999986433222222222222222221110 1
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 005871 593 APDELLKFIHIGLLCVQQDPADRPTM------SSVVVM 624 (672)
Q Consensus 593 ~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~~ 624 (672)
+......+.+++.+||+.||++||++ +++++.
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 11112346678889999999999984 577654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=319.67 Aligned_cols=264 Identities=24% Similarity=0.343 Sum_probs=197.6
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
++|.+.++||+|+||.||+|+++ +++.+|+|.+..... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57999999999999999999976 578899999875432 2334678899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+++ +|..++... ...+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 985 777766432 235789999999999999999999997 99999999999999999999999999986543222
Q ss_pred CcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhh--------hhhhhccCCCc
Q 005871 510 QANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLT--------YTWKLWCEGPA 580 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~ 580 (672)
. .....+++.|+|||++.+ ..++.++||||||+++|+|++|++||............. ..|..+...
T Consensus 160 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 235 (309)
T cd07872 160 T--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN-- 235 (309)
T ss_pred c--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch--
Confidence 1 223467899999999865 468999999999999999999999985432211110000 001100000
Q ss_pred ccccChhhcC-------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 581 VELIDPVLKQ-------SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 581 ~~l~d~~l~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
.+..+..... ...+.....+.+++.+||+.||.+|||+.|+++.-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 287 (309)
T cd07872 236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287 (309)
T ss_pred hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence 0000000000 00011223567888899999999999999998744
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=323.56 Aligned_cols=237 Identities=25% Similarity=0.299 Sum_probs=185.9
Q ss_pred cccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHH-HHHhccCCCeeeEEEEEEeCceEEEEEeecCC
Q 005871 358 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVN-LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 432 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~ 432 (672)
+.||+|+||.||++++. +++.||+|++.+.. ......+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999985 58899999987542 222344555554 67889999999999999999999999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcc
Q 005871 433 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 512 (672)
Q Consensus 433 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~ 512 (672)
++|...+.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET 152 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence 999887743 345889999999999999999999987 9999999999999999999999999987532221 12
Q ss_pred cccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCC
Q 005871 513 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSC 592 (672)
Q Consensus 513 ~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 592 (672)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||.... .......... ... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~i~~-~~~----------~~ 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------VSQMYDNILH-KPL----------QL 215 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC------HHHHHHHHhc-CCC----------CC
Confidence 234578999999999999899999999999999999999999974321 1111111111 110 01
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHH
Q 005871 593 APDELLKFIHIGLLCVQQDPADRPTMS 619 (672)
Q Consensus 593 ~~~~~~~l~~li~~cl~~dP~~RPt~~ 619 (672)
+......+.+++.+||+.||.+||+..
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 122234577888899999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=323.21 Aligned_cols=252 Identities=25% Similarity=0.331 Sum_probs=209.4
Q ss_pred HhcCCccccccccCCceeEEeeeecC-CceeEEEEecccCcc---cHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCceEE
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQ---GLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELL 424 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~ 424 (672)
....|++.+.||+|.||.||+++.+. |+.+|+|.+.+.... ..+...+|+.+|++++ ||||+.+++.|.+...++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 44679999999999999999999874 999999999876442 4468999999999998 999999999999999999
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC----CCeEEEeecC
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD----MNPKISDFGL 500 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~----~~~kL~DFgl 500 (672)
+|||++.||.|.+.+... .+++..+..+++||+.++.|||+.| |+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999998654 3999999999999999999999988 9999999999999643 5799999999
Q ss_pred ceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCc
Q 005871 501 ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPA 580 (672)
Q Consensus 501 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (672)
+..... ......++||+.|+|||++....|+..+||||+|+++|.|++|.+||........ ... ...+..
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~--~~~-----i~~~~~ 255 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI--FLA-----ILRGDF 255 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH--HHH-----HHcCCC
Confidence 998765 3445668999999999999999999999999999999999999999853322111 111 111111
Q ss_pred ccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 581 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 581 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.......+.......+++..++..||.+|+|+.++|+.
T Consensus 256 ------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 ------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11222233345567788889999999999999999984
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=307.73 Aligned_cols=248 Identities=29% Similarity=0.440 Sum_probs=197.2
Q ss_pred cccccCCceeEEeeeecCCceeEEEEecccCcc-cHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCCCChh
Q 005871 358 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLD 436 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 436 (672)
++||+|+||.||++.+.+++.+++|++...... ....+.+|++++++++|+||+++++++.+....++||||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999988765433 5678999999999999999999999999999999999999999999
Q ss_pred HHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcccccc
Q 005871 437 VHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 516 (672)
Q Consensus 437 ~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~ 516 (672)
+++... ...+++..+..++.+++.+|.|||+++ ++||||||+||+++.++.+||+|||++...............
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 988543 235789999999999999999999997 999999999999999999999999999865422222211222
Q ss_pred cccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHH
Q 005871 517 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPD 595 (672)
Q Consensus 517 ~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 595 (672)
.++..|+|||.+.++.++.++|+||||+++|||++ |..||....... ..... .... .. ..+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~~~~~----~~~~--~~-------~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TRERI----ESGY--RM-------PAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---HHHHH----hcCC--CC-------CCCcc
Confidence 34567999999998899999999999999999999 777764332111 11111 0000 00 01112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 596 ELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 596 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
....+.+++.+||+.+|++|||+.||++.|.
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 2345778888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=319.83 Aligned_cols=242 Identities=26% Similarity=0.321 Sum_probs=193.5
Q ss_pred cccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEEEEEeecCC
Q 005871 358 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 432 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lV~Ey~~~ 432 (672)
+.||+|+||.||++++. +++.||+|++.+.. ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999976 57899999987542 33456678899999888 799999999999999999999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcc
Q 005871 433 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 512 (672)
Q Consensus 433 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~ 512 (672)
++|...+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT 152 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence 999888743 346899999999999999999999997 9999999999999999999999999987532211 12
Q ss_pred cccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCC
Q 005871 513 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSC 592 (672)
Q Consensus 513 ~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 592 (672)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||..... . ....... .... ..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~---~---~~~~~i~-~~~~------~~---- 215 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE---D---ELFQSIL-EDEV------RY---- 215 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH---H---HHHHHHH-cCCC------CC----
Confidence 2335689999999999999999999999999999999999999853221 1 1111111 1100 00
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 005871 593 APDELLKFIHIGLLCVQQDPADRPTM-----SSVVVM 624 (672)
Q Consensus 593 ~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~ 624 (672)
+......+.+++.+||+.||++||++ .++++.
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 11122456788889999999999999 888764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=309.43 Aligned_cols=252 Identities=25% Similarity=0.401 Sum_probs=200.4
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCc-----ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-----QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l 425 (672)
++|.+.+.||+|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57999999999999999999875 589999998865421 224568899999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
||||+++++|.+.+.. ...+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999988853 345889999999999999999999997 9999999999999999999999999998654
Q ss_pred CCCCCcc-cccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 506 GNQNQAN-TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 506 ~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
....... .....|+..|+|||++.+..++.++||||||+++|||++|+.||..... ..............
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~--- 226 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA------MAAIFKIATQPTNP--- 226 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch------HHHHHHHhccCCCC---
Confidence 3221111 1234678899999999998899999999999999999999999742211 11111111111110
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.+ +......+.+++.+||+.+|++|||+.++++.
T Consensus 227 --~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 227 --QL----PSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred --CC----CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11 11122346778889999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=319.26 Aligned_cols=258 Identities=31% Similarity=0.431 Sum_probs=202.4
Q ss_pred hcCCccccccccCCceeEEeeeec------CCceeEEEEecccC-cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCce
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE 422 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~ 422 (672)
.++|.+.+.||+|+||.||++.+. .+..+|+|.+.... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 357999999999999999999741 35679999887543 33456789999999999 79999999999999999
Q ss_pred EEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCce
Q 005871 423 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 502 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~ 502 (672)
.++||||+.+++|..++.... ...+++.++..++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999985422 234899999999999999999999997 9999999999999999999999999998
Q ss_pred eeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcc
Q 005871 503 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAV 581 (672)
Q Consensus 503 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (672)
.+.............++..|+|||.+.++.++.++||||||+++|||++ |..||..... ...... ....+...
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~--~~~~~~----~~~~~~~~ 263 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV--DSKFYK----LIKEGYRM 263 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc--hHHHHH----HHHcCCcC
Confidence 6543322212222345778999999999999999999999999999998 8888643211 011111 11111000
Q ss_pred cccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 582 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 582 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
.........+.+++.+||+.+|++|||+.+|++.|..
T Consensus 264 ---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 264 ---------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 0011112457788889999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.35 Aligned_cols=260 Identities=28% Similarity=0.429 Sum_probs=202.0
Q ss_pred HhcCCccccccccCCceeEEeeeec------CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCce
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 422 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~ 422 (672)
..++|++.++||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3578999999999999999999753 24579999876443 2334567899999999999999999999999999
Q ss_pred EEEEEeecCCCChhHHhhhccc-------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 005871 423 LLLIYEYMPNKSLDVHLFDATR-------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 495 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL 495 (672)
.++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+++ |+||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999964321 234567888999999999999999997 999999999999999999999
Q ss_pred EeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhh
Q 005871 496 SDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKL 574 (672)
Q Consensus 496 ~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 574 (672)
+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||..... ...... .
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~---~~~~~~---~ 234 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---EQVLKF---V 234 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH---H
Confidence 99999986543322222222345678999999999999999999999999999998 6777643211 111111 1
Q ss_pred ccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 575 WCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 575 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
. .+..... .......+.+++.+||+.+|++|||+.++++.|...
T Consensus 235 ~-~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 235 M-DGGYLDQ---------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred H-cCCCCCC---------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1 1111000 011124677888899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=327.74 Aligned_cols=261 Identities=24% Similarity=0.361 Sum_probs=196.1
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCc-----eEE
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-----ELL 424 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~-----~~~ 424 (672)
+|++.++||+|+||.||++.+. +++.||||++... .....+.+.+|+++++.++|+||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999974 6899999998653 2234567889999999999999999999998776 799
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceee
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 504 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~ 504 (672)
+||||+. ++|...+. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 46666663 3346899999999999999999999997 999999999999999999999999999865
Q ss_pred CCCCCCcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccc
Q 005871 505 GGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583 (672)
Q Consensus 505 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 583 (672)
...... ......+++.|+|||++.+. .++.++|||||||++|||++|+.||....... ...............++
T Consensus 154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~g~~~~~~~ 229 (372)
T cd07853 154 EPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ---QLDLITDLLGTPSLEAM 229 (372)
T ss_pred ccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcCCCCHHHH
Confidence 432221 12234578999999998874 47999999999999999999999985432211 01111000000000000
Q ss_pred ----------c------Chhhc--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 584 ----------I------DPVLK--QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 584 ----------~------d~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
+ .+... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0 00000 00111123457788899999999999999999975
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=322.75 Aligned_cols=247 Identities=23% Similarity=0.304 Sum_probs=195.4
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEEEEE
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lV~ 427 (672)
+|.+.+.||+|+||.||+|++. +++.+|+|++.+.. ....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5788999999999999999876 57899999987542 23345667788888887 5899999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+++|+|...+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999888843 345899999999999999999999997 999999999999999999999999999754322
Q ss_pred CCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChh
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 587 (672)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.. ... ....
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~---~i~-~~~~------- 218 (323)
T cd05616 155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQ---SIM-EHNV------- 218 (323)
T ss_pred C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHHHH---HHH-hCCC-------
Confidence 1 122345799999999999999999999999999999999999999853221 11111 111 1110
Q ss_pred hcCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 005871 588 LKQSCAPDELLKFIHIGLLCVQQDPADRPTM-----SSVVVM 624 (672)
Q Consensus 588 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~ 624 (672)
..+......+.+++.+||+.+|++|++. .++++.
T Consensus 219 ---~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 219 ---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred ---CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 0111123456788889999999999984 666543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=319.38 Aligned_cols=259 Identities=29% Similarity=0.407 Sum_probs=203.4
Q ss_pred hcCCccccccccCCceeEEeeeec--------CCceeEEEEecccC-cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeC
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG 420 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~ 420 (672)
.++|.+.+.||+|+||.||+++.. ++..+|+|.+.... ......+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 467889999999999999999741 24578999886543 34456789999999999 899999999999999
Q ss_pred ceEEEEEeecCCCChhHHhhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE
Q 005871 421 QELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 487 (672)
Q Consensus 421 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll 487 (672)
...++||||+++++|.+++..... ...+++.++..++.||+.||.|||++| |+||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999865321 235788999999999999999999997 9999999999999
Q ss_pred cCCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccc
Q 005871 488 DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQT 566 (672)
Q Consensus 488 ~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~ 566 (672)
+.++.+||+|||+++.+.............+++.|+|||++.+..++.++||||||+++|+|++ |..|+....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------ 244 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------ 244 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC------
Confidence 9999999999999987654333222223345678999999999889999999999999999998 677753221
Q ss_pred hhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 567 LLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 567 ~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
........ ..+.... ........+.+++.+||+.+|++|||+.||++.|...
T Consensus 245 ~~~~~~~~-~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 245 VEELFKLL-KEGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred HHHHHHHH-HcCCcCC---------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 11111111 1111100 0112234577788899999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=306.86 Aligned_cols=247 Identities=29% Similarity=0.415 Sum_probs=196.5
Q ss_pred cccccCCceeEEeeeecCCceeEEEEecccCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCCCChh
Q 005871 358 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLD 436 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 436 (672)
+.||+|+||.||+|...++..+|+|.+..... .....+.+|+++++.++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36999999999999988889999999876543 33457889999999999999999999999999999999999999999
Q ss_pred HHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcccccc
Q 005871 437 VHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 516 (672)
Q Consensus 437 ~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~ 516 (672)
+++... ...+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||++......... .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~ 154 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK 154 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence 988532 345889999999999999999999987 999999999999999999999999998754322211 11122
Q ss_pred cccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHH
Q 005871 517 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPD 595 (672)
Q Consensus 517 ~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 595 (672)
.++..|+|||++.++.++.++||||||+++|+|++ |..||...... ..... ...+.... ....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~~~----~~~~~~~~---------~~~~ 218 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QAREQ----VEKGYRMS---------CPQK 218 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHH----HHcCCCCC---------CCCC
Confidence 34567999999998899999999999999999998 88887432111 11111 11111000 1112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 596 ELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 596 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
....+.+++.+|++.+|++||++.|+++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 2356788888999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=317.87 Aligned_cols=241 Identities=27% Similarity=0.347 Sum_probs=190.2
Q ss_pred cccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEEEEEeecCC
Q 005871 358 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 432 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lV~Ey~~~ 432 (672)
+.||+|+||.||+++++ +++.||+|++.+.. ......+..|..++..+ +||||+++++++.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999986 58899999987542 23455677788888765 899999999999999999999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcc
Q 005871 433 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 512 (672)
Q Consensus 433 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~ 512 (672)
++|..++.. ...+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence 999988843 345899999999999999999999997 9999999999999999999999999987532111 12
Q ss_pred cccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCC
Q 005871 513 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSC 592 (672)
Q Consensus 513 ~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 592 (672)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.. ...... +.+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~~~----~~~~~~------~~~~~-- 217 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DELFE----SIRVDT------PHYPR-- 217 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHH----HHHhCC------CCCCC--
Confidence 2345799999999999999999999999999999999999999853221 11111 111100 01111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 005871 593 APDELLKFIHIGLLCVQQDPADRPTMS-SVVV 623 (672)
Q Consensus 593 ~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~ 623 (672)
....++.+++.+||+.||++||++. ++++
T Consensus 218 --~~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 218 --WITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred --CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1123466788899999999999984 6653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=308.15 Aligned_cols=250 Identities=28% Similarity=0.391 Sum_probs=203.0
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
+|.+.+.||+|++|.||++.++ +++.|++|.+... .......+.+|+++++.++||||+++++.+.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4788899999999999999975 6899999988643 334567789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+++++|.+++... ....+++..+..++.|++.+|.|||+.+ |+|+||||+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999988653 2356899999999999999999999987 99999999999999999999999999987654322
Q ss_pred CcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhc
Q 005871 510 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 589 (672)
. .....|++.|+|||++.+..++.++|+||||+++++|++|+.||..... . ...... ..+....
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~---~~~~~~-~~~~~~~------- 220 (256)
T cd08529 157 F--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---G---ALILKI-IRGVFPP------- 220 (256)
T ss_pred h--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---H---HHHHHH-HcCCCCC-------
Confidence 2 2234688999999999999999999999999999999999999753321 1 111111 1111111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 590 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
........+.+++.+||+.+|++||++.++++.
T Consensus 221 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 --VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111223457788889999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=332.42 Aligned_cols=261 Identities=32% Similarity=0.431 Sum_probs=202.5
Q ss_pred cCCccccccccCCceeEEeeeecC--C--ce-eEEEEecc---cCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLAD--G--KA-IAVKRLSR---TSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 423 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~--~--~~-vavK~~~~---~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 423 (672)
++....++||+|.||+||+|+++. + .. ||+|.... ...+....|.+|+++|++++|||||+++|++...+.+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 445556899999999999998753 2 23 89998875 3356778999999999999999999999999999999
Q ss_pred EEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 424 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
++|||+|.||+|.++|..... .++..++..++.+.+.||+|||+++ +|||||-..|+|++.++.+||+|||+++.
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccC
Confidence 999999999999999965432 5999999999999999999999997 99999999999999999999999999875
Q ss_pred eCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCccc
Q 005871 504 FGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVE 582 (672)
Q Consensus 504 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (672)
-......... ..-...|+|||.+..+.|++++|||||||++||+++ |..|+...... +........+....
T Consensus 312 ~~~~~~~~~~--~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------~v~~kI~~~~~r~~ 383 (474)
T KOG0194|consen 312 GSQYVMKKFL--KKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------EVKAKIVKNGYRMP 383 (474)
T ss_pred Ccceeecccc--ccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH------HHHHHHHhcCccCC
Confidence 4311111111 123568999999999999999999999999999999 77775432211 11111111111111
Q ss_pred ccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCCCCC
Q 005871 583 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQ 634 (672)
Q Consensus 583 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~~ 634 (672)
.+......+..++.+|+..+|++||||.++.+.|.........
T Consensus 384 ---------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 384 ---------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ---------CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 1112233445555699999999999999999999876544443
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=319.76 Aligned_cols=258 Identities=31% Similarity=0.405 Sum_probs=201.1
Q ss_pred cCCccccccccCCceeEEeeeec--------CCceeEEEEecccC-cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCc
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ 421 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~ 421 (672)
++|.+.+.||+|+||.||++.+. ....+|+|.+.... ......+.+|+++++.+ +||||+++++++....
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 57999999999999999999752 23469999987542 33456788999999999 7999999999999999
Q ss_pred eEEEEEeecCCCChhHHhhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc
Q 005871 422 ELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD 488 (672)
Q Consensus 422 ~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~ 488 (672)
..++||||+++++|.+++..... ...+++.++..++.||+.||+|||+.| ++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence 99999999999999999965321 235889999999999999999999987 99999999999999
Q ss_pred CCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccch
Q 005871 489 DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTL 567 (672)
Q Consensus 489 ~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~ 567 (672)
.++.+||+|||++................++..|+|||++.+..++.++||||||+++|||++ |+.||.... .
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~------~ 248 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------V 248 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC------H
Confidence 999999999999876543222111222234568999999999899999999999999999998 777764221 1
Q ss_pred hhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 568 LTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 568 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
..... ........+ .+......+.+++.+||+.+|++|||+.+|++.|...
T Consensus 249 ~~~~~-~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 249 EELFK-LLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred HHHHH-HHHcCCCCC---------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 11111 111111101 1112234567788899999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=315.22 Aligned_cols=268 Identities=24% Similarity=0.311 Sum_probs=201.9
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEeccc-CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
++|++.++||+|+||.||++.+. ++..+|+|.+... .......+.+|++++++++||||+++++.+.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46899999999999999999875 5788899988654 233456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+++++|.+++... ..+++..+..++.||++||.|||+.. +++|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence 9999999998532 45899999999999999999999842 39999999999999999999999999987543221
Q ss_pred CcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCC----------
Q 005871 510 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGP---------- 579 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---------- 579 (672)
.....|+..|+|||.+.+..++.++||||||+++|+|++|+.||.......................
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 2235688999999999888899999999999999999999999753221111100000000000000
Q ss_pred -------cccccChhhcC---CCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 580 -------AVELIDPVLKQ---SCA-PDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 580 -------~~~l~d~~l~~---~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
..+..+..... ..+ ......+.+++.+||+.+|++|||+.+|++..-..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~ 291 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence 00000000000 000 01223577888999999999999999999775433
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=328.13 Aligned_cols=255 Identities=20% Similarity=0.240 Sum_probs=198.1
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEeccc---CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEE
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l 425 (672)
..++|++.+.||+|+||.||++++. +++.+|+|++.+. .......+.+|+.+++.++||||+++++.+.+++..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3478999999999999999999986 5889999998653 22334567899999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.
T Consensus 121 v~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 121 VMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 9999999999998843 24789999999999999999999997 9999999999999999999999999998764
Q ss_pred CCCCCcccccccccCCcCChhhhcCC----CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcc
Q 005871 506 GNQNQANTNIIAGTYGYMAPEYAMGG----IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAV 581 (672)
Q Consensus 506 ~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (672)
.... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..............
T Consensus 194 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~ 266 (370)
T cd05621 194 ETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VGTYSKIMDHKNSL 266 (370)
T ss_pred cCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCccc
Confidence 3221 122345799999999998653 378999999999999999999999853221 11111111111111
Q ss_pred cccChhhcCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHh
Q 005871 582 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPAD--RPTMSSVVVML 625 (672)
Q Consensus 582 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L 625 (672)
.+. . .......+.+++..||+.++.+ |||+.|+++.-
T Consensus 267 ~~p-----~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 267 NFP-----E--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred CCC-----C--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 110 0 0111234566777888755543 89999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=348.83 Aligned_cols=259 Identities=34% Similarity=0.498 Sum_probs=207.0
Q ss_pred hcCCccccccccCCceeEEeeeecC--C----ceeEEEEeccc-CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLAD--G----KAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 423 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~--~----~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 423 (672)
..+....+.||+|.||+||.|...+ + ..||+|.+.+. +.+....|.+|..+|++++|||||+++|++.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4566778899999999999998653 3 34899998876 456678999999999999999999999999999999
Q ss_pred EEEEeecCCCChhHHhhhcc----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeec
Q 005871 424 LLIYEYMPNKSLDVHLFDAT----RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 499 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFg 499 (672)
+|++|||++|+|..+|.+.+ ....++..+.+.++.|||+|+.||++++ +|||||...|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999997641 2456899999999999999999999997 9999999999999999999999999
Q ss_pred CceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCC
Q 005871 500 LARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEG 578 (672)
Q Consensus 500 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 578 (672)
+|+.+...+.........-...|||||.++.+.++.|+|||||||++||++| |..|++..... .... .....+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~---~v~~---~~~~gg 921 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF---EVLL---DVLEGG 921 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH---HHHH---HHHhCC
Confidence 9995443332222222222457999999999999999999999999999999 66665422111 1111 111122
Q ss_pred CcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 579 PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 579 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
++ ..+.....++.+||..||+.+|++||++..|++.+...
T Consensus 922 RL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 922 RL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred cc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 11 11234456677999999999999999999999988765
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=312.80 Aligned_cols=279 Identities=24% Similarity=0.347 Sum_probs=201.9
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCc-----eEEEE
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-----ELLLI 426 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~-----~~~lV 426 (672)
.|...+++|.|+||.||+|... +++.||||+....... -..|+.+|++++|||||++..+|.... .+.+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4777899999999999999976 4799999998765432 246999999999999999999987432 35789
Q ss_pred EeecCCCChhHHhhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC-CCeEEEeecCceee
Q 005871 427 YEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-MNPKISDFGLARIF 504 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~-~~~kL~DFgla~~~ 504 (672)
|||++. +|.+.+... ..+..++...+.-+..||.+||.|||+.| |+||||||+|+|||.+ |.+||+|||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999976 566666432 23456888888999999999999999987 9999999999999965 99999999999987
Q ss_pred CCCCCCcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCC---c
Q 005871 505 GGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGP---A 580 (672)
Q Consensus 505 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~ 580 (672)
...... .+ ..-+..|+|||.+.+. .|+.+.||||.||++.||+-|++.|......+. +..+.+.+...+ +
T Consensus 177 ~~~epn--iS-YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ---L~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 177 VKGEPN--IS-YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ---LVEIIKVLGTPTREDI 250 (364)
T ss_pred ccCCCc--ee-EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH---HHHHHHHhCCCCHHHH
Confidence 644332 22 2348899999999875 689999999999999999999999865433322 211111111110 0
Q ss_pred -------ccccChhhcCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh-----ccCCCCC--CCCCCCccc
Q 005871 581 -------VELIDPVLKQS-----CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML-----ASDSMTI--PQPTEPAFS 641 (672)
Q Consensus 581 -------~~l~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L-----~~~~~~l--~~p~~p~~~ 641 (672)
.+.-.+.++.. .......+.++++.++|+.+|.+|.++.|++.+= +..+..+ ..|..|-|.
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~~lp~lf~ 330 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGRPLPPLFN 330 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCCcCCCccC
Confidence 01111111111 1222334677888899999999999999998654 3333333 234455555
Q ss_pred cccc
Q 005871 642 VGRV 645 (672)
Q Consensus 642 ~~~~ 645 (672)
+.+.
T Consensus 331 f~~~ 334 (364)
T KOG0658|consen 331 FKRA 334 (364)
T ss_pred chHH
Confidence 5444
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=310.09 Aligned_cols=254 Identities=32% Similarity=0.474 Sum_probs=202.4
Q ss_pred hcCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
.++|++.++||+|+||.||+|..++++.+|+|.+..... ....+.+|+.++++++|+||+++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 467999999999999999999988899999999875543 3467899999999999999999999874 45789999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
.+++|.+++... ....+++.++..++.|++.+|+|||+.+ ++||||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 83 ENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 999999988543 2346899999999999999999999987 999999999999999999999999999876532211
Q ss_pred cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhc
Q 005871 511 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 589 (672)
. .....++..|+|||++.+..++.++||||||+++|||++ |+.||..... ...... ...+....
T Consensus 159 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~----~~~~~~~~------- 223 (260)
T cd05067 159 A-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PEVIQN----LERGYRMP------- 223 (260)
T ss_pred c-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HHHHHH----HHcCCCCC-------
Confidence 1 122345678999999998889999999999999999999 9998753221 111111 11110000
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 590 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
........+.+++.+||+.+|++|||++++++.|..
T Consensus 224 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 --RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 011122457788889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=324.22 Aligned_cols=238 Identities=25% Similarity=0.291 Sum_probs=189.7
Q ss_pred cccccCCceeEEeeee----cCCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecC
Q 005871 358 NKLGQGGFGPVYKGTL----ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 431 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 431 (672)
+.||+|+||.||+++. .+|+.+|+|++.+.. ......+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999875 357899999987543 2234567889999999999999999999999999999999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCc
Q 005871 432 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 511 (672)
Q Consensus 432 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 511 (672)
+++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~ 153 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 153 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence 9999988843 345899999999999999999999997 9999999999999999999999999988653321 1
Q ss_pred ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCC
Q 005871 512 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQS 591 (672)
Q Consensus 512 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~ 591 (672)
......|++.|+|||++.+..++.++||||||+++|||++|+.||..... .......... .. .
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~------~~~~~~i~~~-~~-~--------- 216 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR------KETMTMILKA-KL-G--------- 216 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH------HHHHHHHHcC-CC-C---------
Confidence 22235789999999999988899999999999999999999999753211 1111111110 00 0
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 005871 592 CAPDELLKFIHIGLLCVQQDPADRPTMSS 620 (672)
Q Consensus 592 ~~~~~~~~l~~li~~cl~~dP~~RPt~~e 620 (672)
.+......+.+++.+||+.||++||++.+
T Consensus 217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11111234667888999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=319.51 Aligned_cols=241 Identities=27% Similarity=0.373 Sum_probs=190.3
Q ss_pred cccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEEEEEeecCC
Q 005871 358 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 432 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lV~Ey~~~ 432 (672)
+.||+|+||.||+|++. +++.||+|++.... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 57899999987642 23345667788888765 999999999999999999999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcc
Q 005871 433 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 512 (672)
Q Consensus 433 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~ 512 (672)
|+|..++.. ...+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence 999988843 345889999999999999999999997 9999999999999999999999999987532211 12
Q ss_pred cccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCC
Q 005871 513 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSC 592 (672)
Q Consensus 513 ~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 592 (672)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+... . .... +...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~~---i-~~~~------~~~~--- 216 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EELFQS---I-RMDN------PCYP--- 216 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHHHHH---H-HhCC------CCCC---
Confidence 2345789999999999998999999999999999999999999853221 111111 1 0000 0011
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 005871 593 APDELLKFIHIGLLCVQQDPADRPTMS-SVVV 623 (672)
Q Consensus 593 ~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~ 623 (672)
......+.+++.+||+.||++||++. ++++
T Consensus 217 -~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 217 -RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred -ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 11123467788899999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=315.08 Aligned_cols=257 Identities=29% Similarity=0.490 Sum_probs=201.8
Q ss_pred hcCCccccccccCCceeEEeeeec------CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 423 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 423 (672)
.++|++.+.||+|+||.||++.+. ++..+|+|++.... ......+.+|+.++++++||||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467999999999999999999863 46789999887543 33456789999999999999999999999999999
Q ss_pred EEEEeecCCCChhHHhhhcc-------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCc
Q 005871 424 LLIYEYMPNKSLDVHLFDAT-------------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASN 484 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~N 484 (672)
++||||+++++|.+++.... ....+++.+++.++.||+.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999986421 1134788899999999999999999997 9999999999
Q ss_pred EEEcCCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCccc
Q 005871 485 ILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEH 563 (672)
Q Consensus 485 Ill~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~ 563 (672)
|+++.++.++|+|||++..+.............++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-- 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999886543322222222334667999999998899999999999999999998 7777632111
Q ss_pred ccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 564 GQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
..... ....+.... .+......+.+++.+||+.+|++|||+.||++.|.
T Consensus 239 ----~~~~~-~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 239 ----EEVIY-YVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred ----HHHHH-HHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 11111 111111110 01112345778889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=327.28 Aligned_cols=261 Identities=20% Similarity=0.252 Sum_probs=199.3
Q ss_pred HhcCCccccccccCCceeEEeeeec---CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA---DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
...+|.+.++||+|+||.||++... .+..||+|.+... ....+|+++|++++||||+++++++......++|
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 3468999999999999999999753 3678999987643 2346899999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
||++. ++|..++. ....+++..+..|+.||+.||.|||+.| |+||||||+|||++.++.+||+|||++..+..
T Consensus 165 ~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 165 MPKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred ehhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 99996 56777762 3356899999999999999999999997 99999999999999999999999999987654
Q ss_pred CCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCc------
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPA------ 580 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~------ 580 (672)
...........||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..+.........
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 44333334467999999999999999999999999999999999999998543322111111111110000000
Q ss_pred -----------------ccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 581 -----------------VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 581 -----------------~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
...+.+.+... .....+.+++.+||+.||++|||+.|++..-
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKY---GMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhcc---CcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 00000001000 1123566788899999999999999999763
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=312.13 Aligned_cols=264 Identities=25% Similarity=0.339 Sum_probs=196.9
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
+|++.+.||+|++|.||+|+.. ++..||+|++.... ......+.+|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788999999999999999975 68999999986542 22346788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+. ++|..++........+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 578777755444467899999999999999999999997 99999999999999999999999999986543221
Q ss_pred CcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccc--------hhhhhhhhccCC--
Q 005871 510 QANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQT--------LLTYTWKLWCEG-- 578 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~--------~~~~~~~~~~~~-- 578 (672)
......+++.|+|||++.+. .++.++||||||+++|+|++|+.||.......... .....|..+...
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 11223568899999988764 47899999999999999999999985332111000 000000000000
Q ss_pred ---CcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 579 ---PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 579 ---~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
.........+.. .......++.+++.+||+.||++|||+.+|++
T Consensus 235 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSLRS-AVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchhHH-hcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000000 00112235668888999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=314.17 Aligned_cols=260 Identities=25% Similarity=0.388 Sum_probs=204.4
Q ss_pred HhcCCccccccccCCceeEEeeeecC-----CceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEe-Cce
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLAD-----GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE-GQE 422 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~-~~~ 422 (672)
..++|.+.+.||+|+||.||+|.+.+ +..|++|++.... ....+.+.+|+.++++++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 34689999999999999999999765 6889999887542 3445678899999999999999999998776 567
Q ss_pred EEEEEeecCCCChhHHhhhcccc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEe
Q 005871 423 LLLIYEYMPNKSLDVHLFDATRS-----VQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISD 497 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~D 497 (672)
.++++||+.+++|..++...... ..+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998654322 46899999999999999999999987 99999999999999999999999
Q ss_pred ecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhcc
Q 005871 498 FGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWC 576 (672)
Q Consensus 498 Fgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 576 (672)
||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||..... ..+... ..
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~----~~ 233 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAY----LK 233 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHH----HH
Confidence 999986543322211222345678999999998889999999999999999999 9998743211 111111 11
Q ss_pred CCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 577 EGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 577 ~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
.+.... ........+.+++.+||+.+|++|||+.+|++.|...
T Consensus 234 ~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 234 DGYRLA---------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred cCCCCC---------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 111000 0011123577888899999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=308.49 Aligned_cols=254 Identities=24% Similarity=0.370 Sum_probs=200.6
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
.++|.+.+.||+|+||.||++++. +++.||+|.+..........+.+|+.+++.++||||+++++.+...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 357899999999999999999875 5889999998766555566788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+++++|.+++.. ...+++.++..++.|++.+|.|||+.| |+|+||||+||+++.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 88 CGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 999999998843 346899999999999999999999997 9999999999999999999999999987664322
Q ss_pred CcccccccccCCcCChhhhc---CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 510 QANTNIIAGTYGYMAPEYAM---GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
.......|+..|+|||++. ...++.++|||||||++|+|++|+.|+....... . .......... .+
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~--~----~~~~~~~~~~----~~ 229 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--A----LFLMTKSNFQ----PP 229 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh--h----HHhhhccCCC----CC
Confidence 1223457899999999974 4568899999999999999999999864221110 0 0000000000 00
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
..... ......+.+++.+||+.+|++|||+++|+++
T Consensus 230 ~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 230 KLKDK--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ccccc--CCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00000 0112346788889999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=307.23 Aligned_cols=254 Identities=29% Similarity=0.412 Sum_probs=191.6
Q ss_pred cccccCCceeEEeeeecC---CceeEEEEecccCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCCC
Q 005871 358 NKLGQGGFGPVYKGTLAD---GKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 433 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~g 433 (672)
+.||+|+||.||+|.+.+ +..+|+|.+..... .....+.+|+.++++++||||+++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999998643 46789998876542 33457889999999999999999999999999999999999999
Q ss_pred ChhHHhhhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCc
Q 005871 434 SLDVHLFDAT--RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 511 (672)
Q Consensus 434 sL~~~l~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 511 (672)
+|.+++.... .....++..+..++.|++.||.|||+.+ ++|+||||+||+++.++++||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999986532 2235677888899999999999999997 9999999999999999999999999987543332222
Q ss_pred ccccccccCCcCChhhhcCC-------CCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccc
Q 005871 512 NTNIIAGTYGYMAPEYAMGG-------IFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583 (672)
Q Consensus 512 ~~~~~~gt~~Y~aPE~~~~~-------~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 583 (672)
......|+..|+|||++.+. .++.++||||||+++|||++ |+.||....... ...... .+.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~~----~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTYTV----REQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHHh----hcccCCC
Confidence 22334678889999998642 35789999999999999996 999975432211 111111 0111111
Q ss_pred cChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 584 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
.++.+... ....+.+++..|+ .+|++|||++||++.|+
T Consensus 231 ~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 22222111 1223566777898 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=315.19 Aligned_cols=196 Identities=29% Similarity=0.481 Sum_probs=160.5
Q ss_pred ccccccCCceeEEeeeec---CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEe--CceEEEEEeecC
Q 005871 357 ENKLGQGGFGPVYKGTLA---DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELLLIYEYMP 431 (672)
Q Consensus 357 ~~~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~~lV~Ey~~ 431 (672)
.++||+|+||+||+|+.. +++.+|+|.+..... ...+.+|+.++++++||||+++++.+.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 467899999865432 3457889999999999999999999864 457899999986
Q ss_pred CCChhHHhhhc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE----cCCCCeEEEeecCc
Q 005871 432 NKSLDVHLFDA------TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL----DDDMNPKISDFGLA 501 (672)
Q Consensus 432 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll----~~~~~~kL~DFgla 501 (672)
+ +|..++... .....+++..+..++.||+.||.|||+++ |+||||||+|||+ +..+.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 666665421 12235899999999999999999999998 9999999999999 45678999999999
Q ss_pred eeeCCCCCC-cccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCC
Q 005871 502 RIFGGNQNQ-ANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGF 558 (672)
Q Consensus 502 ~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~ 558 (672)
+.+...... .......||+.|+|||++.+. .++.++||||+||++|+|++|++||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 876543221 222345789999999999774 589999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=321.49 Aligned_cols=242 Identities=25% Similarity=0.289 Sum_probs=187.0
Q ss_pred cccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHH-HHHHhccCCCeeeEEEEEEeCceEEEEEeecCC
Q 005871 358 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEV-NLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 432 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~ 432 (672)
+.||+|+||.||++++. +++.+|+|++.+.. ......+..|. .+++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999976 57889999987542 12223444444 457889999999999999999999999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcc
Q 005871 433 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 512 (672)
Q Consensus 433 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~ 512 (672)
++|..++.. ...+.+..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~ 152 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT 152 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence 999988853 345788899999999999999999998 9999999999999999999999999997543221 12
Q ss_pred cccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCC
Q 005871 513 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSC 592 (672)
Q Consensus 513 ~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 592 (672)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .......... .. . +
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~-~~-~-----~---- 215 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILNK-PL-Q-----L---- 215 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH------HHHHHHHHhC-Cc-C-----C----
Confidence 3345799999999999999999999999999999999999999753211 1111111111 10 0 0
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 593 APDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 593 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.+.....+.+++.+||+.||.+||++.+.+..
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 11122346778889999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=318.69 Aligned_cols=241 Identities=24% Similarity=0.306 Sum_probs=191.4
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCceEEEEE
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lV~ 427 (672)
+|+..+.||+|+||.||++... +++.||+|++.+.. ....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999875 68899999987542 334466788999998885 577888999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+++++|..++.. ...+++.++..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999988843 345899999999999999999999997 999999999999999999999999998754322
Q ss_pred CCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChh
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 587 (672)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... ...... ...
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~---~~~i~~-~~~------- 218 (323)
T cd05615 155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DEL---FQSIME-HNV------- 218 (323)
T ss_pred C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHH---HHHHHh-CCC-------
Confidence 1 122345689999999999999999999999999999999999999753321 111 111111 100
Q ss_pred hcCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 005871 588 LKQSCAPDELLKFIHIGLLCVQQDPADRPTM 618 (672)
Q Consensus 588 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 618 (672)
..+......+.+++.+||+.+|.+|++.
T Consensus 219 ---~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 ---SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ---CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0011122356778889999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=329.24 Aligned_cols=195 Identities=25% Similarity=0.306 Sum_probs=167.8
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
...+|.+.++||+|+||.||++.+. .++.||||.... ..+.+|+++|++++|+||+++++++...+..++|||
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 3568999999999999999999986 478899996432 345789999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
++. ++|..++.. ....+++.+++.|+.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.+....
T Consensus 241 ~~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 241 KYR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred ccC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 995 577777643 2236999999999999999999999997 9999999999999999999999999998764433
Q ss_pred CCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCC
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNN 556 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~ 556 (672)
.........||+.|+|||++.+..++.++|||||||++|||++|..++
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 222223457999999999999999999999999999999999988654
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=313.57 Aligned_cols=260 Identities=25% Similarity=0.358 Sum_probs=192.2
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEecccCc--ccHHHHHHHHHHHHhc---cCCCeeeEEEEEEe-----Cc
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKL---QHKNLVRLLGCCLE-----GQ 421 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l---~h~niv~l~~~~~~-----~~ 421 (672)
+|++.+.||+|+||.||++.+. +++.||+|.+..... .....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888999999999999999976 588999998875422 2234556777777766 69999999998864 34
Q ss_pred eEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCc
Q 005871 422 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 501 (672)
Q Consensus 422 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla 501 (672)
..++||||+.+ +|..++... ....+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 58999999985 777777542 2345899999999999999999999998 999999999999999999999999999
Q ss_pred eeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhcc---CC
Q 005871 502 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWC---EG 578 (672)
Q Consensus 502 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~ 578 (672)
........ .....|+..|+|||++.+..++.++|||||||++|+|++|++||....... .......... ..
T Consensus 156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~ 229 (288)
T cd07863 156 RIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLIGLPPED 229 (288)
T ss_pred ccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH---HHHHHHHHhCCCChh
Confidence 87643221 223468899999999999999999999999999999999999975322111 1111100000 00
Q ss_pred Cccc-------ccChhhc---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 579 PAVE-------LIDPVLK---QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 579 ~~~~-------l~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
.+.. ...+... ....+.....+.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 0000000 0011122345678899999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=328.46 Aligned_cols=258 Identities=28% Similarity=0.393 Sum_probs=201.0
Q ss_pred cCCccccccccCCceeEEeeeec------CCceeEEEEecccC-cccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCceE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQEL 423 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~ 423 (672)
++|.+.++||+|+||.||+|++. .++.||+|++.... ....+.+.+|+++|.++. ||||+++++++......
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 46888999999999999999853 34689999997653 233457889999999997 99999999999999999
Q ss_pred EEEEeecCCCChhHHhhhccc-----------------------------------------------------------
Q 005871 424 LLIYEYMPNKSLDVHLFDATR----------------------------------------------------------- 444 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~----------------------------------------------------------- 444 (672)
++||||+++|+|.+++.....
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 999999999999999864321
Q ss_pred ------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc
Q 005871 445 ------------------------------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD 488 (672)
Q Consensus 445 ------------------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~ 488 (672)
...+++..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEe
Confidence 123677888999999999999999987 99999999999999
Q ss_pred CCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccch
Q 005871 489 DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTL 567 (672)
Q Consensus 489 ~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~ 567 (672)
+++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ...
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~--~~~- 350 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM--NEQ- 350 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc--hHH-
Confidence 999999999999986543322222223457788999999998889999999999999999998 8888643211 000
Q ss_pred hhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 568 LTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 568 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
.......+.... .+......+.+|+.+||+.+|++||++++|++.|..
T Consensus 351 ---~~~~~~~~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 351 ---FYNAIKRGYRMA---------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred ---HHHHHHcCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111111110000 011123457788889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=317.73 Aligned_cols=255 Identities=29% Similarity=0.429 Sum_probs=197.5
Q ss_pred cCCccccccccCCceeEEeeeecC-Cc--eeEEEEeccc-CcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLAD-GK--AIAVKRLSRT-SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lV 426 (672)
++|++.+.||+|+||.||+|.+++ +. .+++|.+... .....+.+.+|+.++.++ +||||+++++++.+....++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578999999999999999998753 33 4688887643 334456789999999999 799999999999999999999
Q ss_pred EeecCCCChhHHhhhcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCe
Q 005871 427 YEYMPNKSLDVHLFDAT-------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP 493 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~ 493 (672)
|||+++++|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999985422 1135889999999999999999999987 9999999999999999999
Q ss_pred EEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhh
Q 005871 494 KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTW 572 (672)
Q Consensus 494 kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 572 (672)
||+|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||...... ....
T Consensus 159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---~~~~--- 229 (297)
T cd05089 159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---ELYE--- 229 (297)
T ss_pred EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH---
Confidence 999999986432111 1111123457999999998889999999999999999997 99987432211 1111
Q ss_pred hhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 573 KLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 573 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
....+.... .+......+.+|+.+||+.+|.+|||+++|++.|...
T Consensus 230 -~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 230 -KLPQGYRME---------KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred -HHhcCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111110000 0111224567888899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=311.62 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=199.9
Q ss_pred cCCccccccccCCceeEEeeeecC-C---ceeEEEEeccc-CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLAD-G---KAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
.+|++.+.||+|+||.||+|.+.. + ..||+|.+... .......|..|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 458889999999999999998753 3 36999998754 344467899999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||+++++|.+++... ...+++.++..++.|++.||.|||+.| ++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999988542 346899999999999999999999997 99999999999999999999999999886543
Q ss_pred CCCCccccc-cc--ccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCccc
Q 005871 507 NQNQANTNI-IA--GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVE 582 (672)
Q Consensus 507 ~~~~~~~~~-~~--gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (672)
......... .. .+..|+|||++.+..++.++||||||+++|||++ |..||...... ......... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~~~---~~~~- 231 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIEQD---YRLP- 231 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHHcC---CcCC-
Confidence 322211111 11 2357999999999999999999999999999886 99887432111 111111100 0000
Q ss_pred ccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 583 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 583 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
...+....+.+++..||+.+|++||++.+|++.|+.
T Consensus 232 ---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 232 ---------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred ---------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 011122346788889999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=313.00 Aligned_cols=250 Identities=24% Similarity=0.389 Sum_probs=202.8
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
.+|.+.+.||+|+||.||+|... +++.+++|.+........+.+.+|+.+++.++|+||+++++.+......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 58999999999999999999864 68899999998766666678899999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
++++|.+++.. ..+++.++..++.|++.||.|||+.| |+||||||+|||++.++.+||+|||++........
T Consensus 100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~- 171 (296)
T cd06654 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (296)
T ss_pred CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence 99999998842 34789999999999999999999998 99999999999999999999999999876533221
Q ss_pred cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcC
Q 005871 511 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 590 (672)
......|++.|+|||.+.+..++.++|||||||++|+|++|+.||....... .. ......+. ..+.
T Consensus 172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~----~~~~~~~~-~~~~------ 237 (296)
T cd06654 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--AL----YLIATNGT-PELQ------ 237 (296)
T ss_pred -ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hH----HHHhcCCC-CCCC------
Confidence 1223468899999999998889999999999999999999999984322110 00 01111110 0000
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 591 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
........+.+++.+||+.+|++|||+.+|++.
T Consensus 238 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 238 -NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 011222457788889999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=307.14 Aligned_cols=253 Identities=32% Similarity=0.491 Sum_probs=199.9
Q ss_pred cCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecC
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 431 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 431 (672)
++|.+.++||+|++|.||++.+.++..+|+|++.... ...+.+.+|+.++++++|+|++++++++. .+..++||||+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5688999999999999999998777789999876543 23467889999999999999999999875 456889999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCc
Q 005871 432 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 511 (672)
Q Consensus 432 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 511 (672)
+++|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++..........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 99999988643 2345889999999999999999999987 9999999999999999999999999998764332211
Q ss_pred ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcC
Q 005871 512 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590 (672)
Q Consensus 512 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 590 (672)
.....++..|+|||...+..++.++||||||+++|+|++ |+.||..... ...... . ..+...
T Consensus 160 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~---~-~~~~~~--------- 222 (260)
T cd05069 160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---REVLEQ---V-ERGYRM--------- 222 (260)
T ss_pred -cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH---H-HcCCCC---------
Confidence 112345678999999998899999999999999999999 8888743211 111111 1 111000
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 591 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
..+......+.+++.+||+.||++||++++|++.|..
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111223457788889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=307.72 Aligned_cols=250 Identities=33% Similarity=0.460 Sum_probs=202.7
Q ss_pred hcCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
.++|++.+.||+|+||.||++... ++.+|+|.+..... ..+.+.+|+.++++++|+||+++++++.+....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 357899999999999999999875 78899999976654 5678999999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
++++|.+++.... ...+++..+..++.|++.+|.|||+.+ |+|+||||+||+++.++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 9999999885432 236899999999999999999999997 99999999999999999999999999986632221
Q ss_pred cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhc
Q 005871 511 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 589 (672)
...++..|+|||++.++.++.++||||||+++|+|++ |..||..... ..+..... .+...+.
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~----~~~~~~~------ 220 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPHVE----KGYRMEA------ 220 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHh----cCCCCCC------
Confidence 2234567999999998899999999999999999997 8888743211 11111111 1100000
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 590 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
+......+.+++.+||+.+|++|||+.||+++|..
T Consensus 221 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 221 ---PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ---ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 11123457788889999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=309.46 Aligned_cols=256 Identities=30% Similarity=0.459 Sum_probs=201.3
Q ss_pred hcCCccccccccCCceeEEeeeec-CC---ceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DG---KAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l 425 (672)
.++|...+.||+|+||.||+|.+. ++ ..+++|++.... ....+.+.+|++++++++|+|++++++++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 357888999999999999999975 23 368999887553 3445678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
||||+++++|..++... ...+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999999988542 346899999999999999999999997 9999999999999999999999999998764
Q ss_pred CCCCCccc-ccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccc
Q 005871 506 GNQNQANT-NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583 (672)
Q Consensus 506 ~~~~~~~~-~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 583 (672)
........ .....+..|+|||++.+..++.++||||||+++|||++ |+.||..... .... ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~---~~i~~~~~~~-- 230 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVM---KAINDGFRLP-- 230 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHH---HHHhcCCCCC--
Confidence 33221111 11223457999999998889999999999999999997 9999743211 1111 1111000000
Q ss_pred cChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 584 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
........+.+++.+|++.+|++||++.+|++.|..
T Consensus 231 --------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 231 --------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred --------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 011123457788899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=307.21 Aligned_cols=255 Identities=33% Similarity=0.497 Sum_probs=203.9
Q ss_pred hcCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
.++|.+.++||+|+||.||++.+++++.+|+|.+.... ...+.+.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 46899999999999999999998888899999987544 33567899999999999999999999999989999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
++++|.+++... ....+++..+..++.|++.||.|||+++ |+|+||||+||++++++.+||+|||++..+......
T Consensus 84 ~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 84 SKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred CCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 999999998543 2245899999999999999999999997 999999999999999999999999999876532211
Q ss_pred cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhc
Q 005871 511 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 589 (672)
. .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.... ............ . .
T Consensus 160 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~---~~~~~~~~~~~~---~------~--- 223 (261)
T cd05034 160 A-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT---NREVLEQVERGY---R------M--- 223 (261)
T ss_pred h-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCC---C------C---
Confidence 1 112234568999999998889999999999999999998 898874221 111111111100 0 0
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 590 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
..+......+.+++.+|++.+|++||+++++++.|..
T Consensus 224 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 -PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0011113457788889999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=310.94 Aligned_cols=252 Identities=27% Similarity=0.349 Sum_probs=198.5
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEecccCc---ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
.|+..+.||+|+||.||++.+. +++.||+|.+..... .....+.+|+.++++++|+|++++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3678889999999999999875 688999999865432 223457789999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|+.+++|.+++... ....+++.++..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 99999999888543 2345899999999999999999999987 9999999999999999999999999987653222
Q ss_pred CCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhh
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 588 (672)
. .....|+..|+|||++.+..++.++||||||+++|+|++|+.||.......... ........ .....
T Consensus 157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~---~~~~~~~~------~~~~~ 224 (285)
T cd05630 157 T---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE---EVERLVKE------VQEEY 224 (285)
T ss_pred c---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH---HHHhhhhh------hhhhc
Confidence 1 123468999999999999999999999999999999999999985432111000 00000000 00001
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 005871 589 KQSCAPDELLKFIHIGLLCVQQDPADRPT-----MSSVVVM 624 (672)
Q Consensus 589 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 624 (672)
... ....+.+|+.+||+.||++||| +.|++++
T Consensus 225 ~~~----~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 225 SEK----FSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred Ccc----CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 111 2234678888999999999999 8888873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=311.39 Aligned_cols=256 Identities=27% Similarity=0.408 Sum_probs=199.7
Q ss_pred hcCCccccccccCCceeEEeeeec-CCc----eeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGK----AIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 424 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 424 (672)
.++|++.++||+|+||.||+|.+. +++ .||+|.+.... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 367899999999999999999864 444 47999886543 33456788999999999999999999998754 578
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceee
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 504 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~ 504 (672)
+++||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999888542 345899999999999999999999997 999999999999999999999999999876
Q ss_pred CCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccc
Q 005871 505 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583 (672)
Q Consensus 505 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 583 (672)
.............+++.|+|||.+.+..++.++||||||+++|||++ |..||..... ..+.. ....+....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~----~~~~~~~~~- 231 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPD----LLEKGERLP- 231 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH----HHHCCCcCC-
Confidence 54332222222234678999999998899999999999999999998 8888643211 11111 111111000
Q ss_pred cChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 584 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
........+.+++.+||+.||++||++.++++.|...
T Consensus 232 --------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 232 --------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred --------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 0111234577888899999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=312.94 Aligned_cols=263 Identities=30% Similarity=0.462 Sum_probs=203.4
Q ss_pred cCCccccccccCCceeEEeeeec-----CCceeEEEEecccCcc-cHHHHHHHHHHHHhccCCCeeeEEEEEEe--CceE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-----DGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLE--GQEL 423 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~ 423 (672)
.+|.+.+.||+|+||.||++.+. .++.+|+|++...... ..+.+.+|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46788899999999999999853 3688999998766543 46789999999999999999999999887 5679
Q ss_pred EEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 424 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.| |+|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 99999999999999985432 25899999999999999999999997 99999999999999999999999999987
Q ss_pred eCCCCCC-cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCccccc--------chhhhhhhh
Q 005871 504 FGGNQNQ-ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQ--------TLLTYTWKL 574 (672)
Q Consensus 504 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~--------~~~~~~~~~ 574 (672)
....... .......++..|++||.+.+..++.++||||||+++|||++|+.|+......... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 6532221 1111223456799999998889999999999999999999999886432211100 000000011
Q ss_pred ccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 575 WCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 575 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
..... ...........+.+++.+||+.+|++|||+.||+++|...
T Consensus 239 ~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGE---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCC---------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11100 0011112235678889999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=313.75 Aligned_cols=262 Identities=27% Similarity=0.457 Sum_probs=200.8
Q ss_pred cCCccccccccCCceeEEeeee-----cCCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeC--ceE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QEL 423 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~ 423 (672)
..|.+.+.||+|+||.||++.. .++..||+|.+.... ......+.+|+.+++.++|||++++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578899999999999999974 247889999987543 34456789999999999999999999998875 568
Q ss_pred EEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 424 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
++||||+++++|.+++... ...+++..+..++.||+.+|.|||+.| |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 9999999999999988542 235899999999999999999999998 99999999999999999999999999987
Q ss_pred eCCCCCC-cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcc--------cccchhhhhhhh
Q 005871 504 FGGNQNQ-ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSE--------HGQTLLTYTWKL 574 (672)
Q Consensus 504 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~--------~~~~~~~~~~~~ 574 (672)
+...... .......|+..|+|||++.+..++.++||||||+++|||++++.|....... ............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6433221 1122345677899999999888999999999999999999988764221110 000000000011
Q ss_pred ccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 575 WCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 575 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
...+... .........+.+|+.+||+.+|++|||+.++++.|..
T Consensus 239 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 239 LEEGKRL---------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred HHcCccC---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 1111100 0111223468888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=306.83 Aligned_cols=250 Identities=21% Similarity=0.314 Sum_probs=201.6
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEeccc-CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
+|++.++||+|+||.||++.+. +++.+|+|.+... .....+.+.+|+.+++.++|+||+++++.+..++.+++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5788999999999999999976 6889999988643 3344577889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
++++|.+++... ....+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.++|+|||.+..+......
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 999998887532 3345889999999999999999999997 999999999999999999999999999876432221
Q ss_pred cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcC
Q 005871 511 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 590 (672)
.....|++.|+|||++.+..++.++|+||||+++|+|++|+.||..... ........ .+....+
T Consensus 157 --~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~~~~-~~~~~~~------- 220 (255)
T cd08219 157 --ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW------KNLILKVC-QGSYKPL------- 220 (255)
T ss_pred --cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH------HHHHHHHh-cCCCCCC-------
Confidence 2234688999999999988899999999999999999999999753211 11111111 1111110
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 591 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
+......+.+++.+||+.||++|||+.+|+..
T Consensus 221 --~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 --PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11122346788889999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=325.80 Aligned_cols=258 Identities=21% Similarity=0.236 Sum_probs=199.5
Q ss_pred HHHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceE
Q 005871 348 LEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 423 (672)
Q Consensus 348 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 423 (672)
....++|++.+.||+|+||.||++.++ +++.+|+|++.+.. ......+.+|+.+++.++||||+++++.+.+....
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 344589999999999999999999986 58899999986432 23345678899999999999999999999999999
Q ss_pred EEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 424 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
++||||+++++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++++||+|||++..
T Consensus 119 ~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred EEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 999999999999988843 24788999999999999999999998 99999999999999999999999999987
Q ss_pred eCCCCCCcccccccccCCcCChhhhcCC----CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCC
Q 005871 504 FGGNQNQANTNIIAGTYGYMAPEYAMGG----IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGP 579 (672)
Q Consensus 504 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 579 (672)
+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ............
T Consensus 192 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~ 264 (371)
T cd05622 192 MNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMNHKN 264 (371)
T ss_pred cCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCC
Confidence 6433221 12345799999999998653 378999999999999999999999853211 111111111111
Q ss_pred cccccChhhcCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHhc
Q 005871 580 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPAD--RPTMSSVVVMLA 626 (672)
Q Consensus 580 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L~ 626 (672)
.....+ .......+.+++.+||+.++.+ ||++.+|++..-
T Consensus 265 ~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 265 SLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred cccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 111111 0112334567777999844433 789999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=315.23 Aligned_cols=256 Identities=19% Similarity=0.241 Sum_probs=195.6
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEeccc---CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
++|++.+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999975 5899999998753 2233456889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+++++|..++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999998542 345899999999999999999999998 999999999999999999999999999765432
Q ss_pred CCCcccccccccCCcCChhhhcC-----CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccc
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMG-----GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVE 582 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (672)
... ......||+.|+|||++.. +.++.++|||||||++|+|++|+.||.... ................
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~------~~~~~~~i~~~~~~~~ 228 (331)
T cd05597 156 GTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHKEHFQ 228 (331)
T ss_pred CCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC------HHHHHHHHHcCCCccc
Confidence 221 1223469999999999863 457889999999999999999999974321 1111111111111111
Q ss_pred ccChhhcCCCCHHHHHHHHHHHHHhccc--CCCCCCCHHHHHHHh
Q 005871 583 LIDPVLKQSCAPDELLKFIHIGLLCVQQ--DPADRPTMSSVVVML 625 (672)
Q Consensus 583 l~d~~l~~~~~~~~~~~l~~li~~cl~~--dP~~RPt~~evl~~L 625 (672)
+... .......+.+++.+||.. ++..||++.++++.-
T Consensus 229 ~~~~------~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp 267 (331)
T cd05597 229 FPPD------VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP 267 (331)
T ss_pred CCCc------cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence 1100 011123455666676654 444488999999873
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=317.67 Aligned_cols=258 Identities=30% Similarity=0.432 Sum_probs=201.3
Q ss_pred cCCccccccccCCceeEEeeeec--------CCceeEEEEecccC-cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCc
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ 421 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~ 421 (672)
++|.+.++||+|+||.||+++.. ....+|+|.+.... ......+.+|+.+++++ +||||+++++++.+..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 57889999999999999999742 24578999887543 34456788999999999 6999999999999999
Q ss_pred eEEEEEeecCCCChhHHhhhcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc
Q 005871 422 ELLLIYEYMPNKSLDVHLFDAT-------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD 488 (672)
Q Consensus 422 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~ 488 (672)
..++||||+++++|..++.... ....+++.++..++.||+.||.|||+.| |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 9999999999999999986532 1245899999999999999999999987 99999999999999
Q ss_pred CCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccch
Q 005871 489 DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTL 567 (672)
Q Consensus 489 ~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~ 567 (672)
.++.+||+|||+++...............++..|+|||.+.++.++.++||||||+++|+|++ |..||..... ...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---~~~ 245 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---EEL 245 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---HHH
Confidence 999999999999986543222211112234567999999999899999999999999999999 7887642211 111
Q ss_pred hhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 568 LTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 568 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
.... ..+...+. .......+.+++.+||+.+|++|||+.++++.|...
T Consensus 246 ~~~~----~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 246 FKLL----REGHRMDK---------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred HHHH----HcCCCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1111 11111110 111233567888899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=322.69 Aligned_cols=264 Identities=25% Similarity=0.263 Sum_probs=195.7
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCc-----
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ----- 421 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~----- 421 (672)
..++|++.+.||+|+||.||++.+. .++.||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999875 5899999998654 2334567889999999999999999999986543
Q ss_pred -eEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecC
Q 005871 422 -ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 500 (672)
Q Consensus 422 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgl 500 (672)
..++||||++++ |...+. ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 579999999765 444442 24788999999999999999999998 99999999999999999999999999
Q ss_pred ceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccc---------hhh--
Q 005871 501 ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQT---------LLT-- 569 (672)
Q Consensus 501 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~---------~~~-- 569 (672)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... ...
T Consensus 170 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 170 ARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred ccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 97543221 1223468999999999999999999999999999999999999986432111000 000
Q ss_pred -----hhhhhccCC------CcccccChhhcC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 570 -----YTWKLWCEG------PAVELIDPVLKQ---SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 570 -----~~~~~~~~~------~~~~l~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
......... ...+........ .........+.+++.+||+.||++|||+.|+++.-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 000000000 000000000000 00011124567888999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=325.52 Aligned_cols=201 Identities=25% Similarity=0.374 Sum_probs=174.3
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEeccc---CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
++|++.+.||+|+||.||++... +++.||+|++... .......+.+|+.++..++||||+++++.+.+.+.+++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999976 5899999998753 2334567889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999998843 346899999999999999999999998 999999999999999999999999998754321
Q ss_pred CCC---------------------------------cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCC
Q 005871 508 QNQ---------------------------------ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRK 554 (672)
Q Consensus 508 ~~~---------------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~ 554 (672)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 100 00113479999999999999999999999999999999999999
Q ss_pred CCCC
Q 005871 555 NNGF 558 (672)
Q Consensus 555 p~~~ 558 (672)
||..
T Consensus 235 Pf~~ 238 (360)
T cd05627 235 PFCS 238 (360)
T ss_pred CCCC
Confidence 9853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=318.52 Aligned_cols=259 Identities=30% Similarity=0.408 Sum_probs=202.0
Q ss_pred cCCccccccccCCceeEEeeeecC--------CceeEEEEecccC-cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCc
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLAD--------GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ 421 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~ 421 (672)
.+|.+.+.||+|+||.||++.+.. ...+|+|.+.... ....+.+.+|+++++++ +||||+++++++....
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468999999999999999997421 2368999877543 34457889999999999 8999999999999999
Q ss_pred eEEEEEeecCCCChhHHhhhcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc
Q 005871 422 ELLLIYEYMPNKSLDVHLFDAT-------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD 488 (672)
Q Consensus 422 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~ 488 (672)
..+++|||+++++|.+++.... ....+++.++..++.||+.||.|||++| |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999986422 2335888999999999999999999997 99999999999999
Q ss_pred CCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccch
Q 005871 489 DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTL 567 (672)
Q Consensus 489 ~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~ 567 (672)
.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.... .
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------~ 242 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP------V 242 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC------H
Confidence 999999999999987644322222222334567999999999999999999999999999998 777764221 1
Q ss_pred hhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 005871 568 LTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDS 629 (672)
Q Consensus 568 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 629 (672)
....... ..+.... ........+.+++.+||+.+|++|||+.||++.|....
T Consensus 243 ~~~~~~~-~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 243 EELFKLL-KEGHRMD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HHHHHHH-HcCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 1111111 1111100 11122345778888999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=304.98 Aligned_cols=254 Identities=26% Similarity=0.362 Sum_probs=187.5
Q ss_pred cccccCCceeEEeeeecC---CceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCCC
Q 005871 358 NKLGQGGFGPVYKGTLAD---GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 433 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~g 433 (672)
+.||+|+||.||+|...+ ...+++|.+.... ......+.+|+.+++.++|+||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 4567888776443 233456889999999999999999999999999999999999999
Q ss_pred ChhHHhhhccc--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCc
Q 005871 434 SLDVHLFDATR--SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 511 (672)
Q Consensus 434 sL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 511 (672)
+|.+++..... ....++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999865432 233567888999999999999999997 9999999999999999999999999987543222111
Q ss_pred ccccccccCCcCChhhhcC-------CCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccc
Q 005871 512 NTNIIAGTYGYMAPEYAMG-------GIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583 (672)
Q Consensus 512 ~~~~~~gt~~Y~aPE~~~~-------~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 583 (672)
......++..|+|||++.. ..++.++||||||+++|||++ |..||...... . ......... ...+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~---~~~~~~~~~-~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---Q---VLKQVVREQ-DIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH---H---HHHHHhhcc-CccC
Confidence 1223345778999998743 356889999999999999999 67776432111 1 111111111 1112
Q ss_pred cChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 584 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
.++.+.... ...+.+++..|+ .||++|||+++|+++|+
T Consensus 231 ~~~~~~~~~----~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLDLKY----SDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcccccC----CHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 222222122 233455666787 59999999999999984
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=305.17 Aligned_cols=249 Identities=33% Similarity=0.464 Sum_probs=198.1
Q ss_pred cccccCCceeEEeeeecC--C--ceeEEEEecccCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCC
Q 005871 358 NKLGQGGFGPVYKGTLAD--G--KAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 432 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~ 432 (672)
++||+|++|.||+|.+.+ + ..+|+|.+..... ...+.+.+|+.++++++||||+++++.+.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998743 2 3689999987765 567789999999999999999999999988 889999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC-c
Q 005871 433 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ-A 511 (672)
Q Consensus 433 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~-~ 511 (672)
++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+...... .
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999865432 46899999999999999999999997 999999999999999999999999999876542221 1
Q ss_pred ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcC
Q 005871 512 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590 (672)
Q Consensus 512 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 590 (672)
......++..|+|||++.+..++.++||||||+++|||++ |+.||..... ......... ......
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~---~~~~~~-------- 221 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG---SQILKKIDK---EGERLE-------- 221 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHh---cCCcCC--------
Confidence 1123456788999999998899999999999999999999 9998742211 111111110 110000
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 591 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
.+......+.+++.+|++.+|++||++.+|++.|.
T Consensus 222 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 -RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 01112345778888999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=308.89 Aligned_cols=255 Identities=27% Similarity=0.439 Sum_probs=200.8
Q ss_pred cCCccccccccCCceeEEeeeec-C---CceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-D---GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
++|++.+.||+|+||.||+|++. + +..+|+|.+.... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57889999999999999999864 2 3478999886543 33456789999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||+++++|.+++... ...+++.++..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++..+..
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999998543 245899999999999999999999997 99999999999999999999999999987654
Q ss_pred CCCCcc-cccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 507 NQNQAN-TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 507 ~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
...... .....++..|+|||++.+..++.++|+||||+++||+++ |..||...... .........+ ..
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~~~~---~~---- 228 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKAIEEGY---RL---- 228 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHHHhCCC---cC----
Confidence 322111 111223567999999998899999999999999999887 99987432211 1111111100 00
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
.........+.+++.+|++.+|++||++.++++.|..
T Consensus 229 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 229 ------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred ------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 0011123456788889999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=295.32 Aligned_cols=256 Identities=27% Similarity=0.379 Sum_probs=203.3
Q ss_pred HHHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCc--------ccHHHHHHHHHHHHhc-cCCCeeeEEEEE
Q 005871 348 LEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--------QGLQEFKNEVNLIAKL-QHKNLVRLLGCC 417 (672)
Q Consensus 348 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l-~h~niv~l~~~~ 417 (672)
....+.|...+.||.|..++|-++..+ .|+++|+|++..... +-.+.-.+|+.||+++ .||+|+++.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 345577888999999999999998765 689999999864321 1234557899999999 699999999999
Q ss_pred EeCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEe
Q 005871 418 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISD 497 (672)
Q Consensus 418 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~D 497 (672)
+.+..+++|+|.|+.|.|.++| .....++++..+.|++|+.+|+.|||... |+||||||+|||+|++.++||+|
T Consensus 93 es~sF~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred cCcchhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence 9999999999999999999999 45567999999999999999999999986 99999999999999999999999
Q ss_pred ecCceeeCCCCCCcccccccccCCcCChhhhcC------CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhh
Q 005871 498 FGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG------GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYT 571 (672)
Q Consensus 498 Fgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~ 571 (672)
||++..+.... .....+|||+|+|||.+.- ..|+..+|+|+.|||+|-|+.|.+||- .. ..++ .
T Consensus 167 FGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw--HR---kQml--M 236 (411)
T KOG0599|consen 167 FGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW--HR---KQML--M 236 (411)
T ss_pred cceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh--HH---HHHH--H
Confidence 99999875433 2345799999999999842 458999999999999999999999962 00 0000 1
Q ss_pred hhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 572 WKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 572 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
-....+|... .......+......+||.+||+.||.+|.|++|+|+.-
T Consensus 237 LR~ImeGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 237 LRMIMEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred HHHHHhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 1111122110 01111233344567888899999999999999998654
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=306.10 Aligned_cols=247 Identities=26% Similarity=0.422 Sum_probs=192.1
Q ss_pred ccccCCceeEEeeeec---CCceeEEEEecccCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCCCC
Q 005871 359 KLGQGGFGPVYKGTLA---DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKS 434 (672)
Q Consensus 359 ~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gs 434 (672)
.||+|+||.||+|.+. .+..||+|++..... ...+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999764 355799998876543 33467899999999999999999999885 457899999999999
Q ss_pred hhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcc-c
Q 005871 435 LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN-T 513 (672)
Q Consensus 435 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~-~ 513 (672)
|.+++.. ....+++..++.++.||+.||.|||++| ++||||||+||+++.++.+||+|||++..+........ .
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9998853 2346899999999999999999999997 99999999999999999999999999986543322111 1
Q ss_pred ccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCC
Q 005871 514 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSC 592 (672)
Q Consensus 514 ~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 592 (672)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ... .....+... ..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~----~~~~~~~~~---------~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---EVM----SFIEQGKRL---------DC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---HHH----HHHHCCCCC---------CC
Confidence 11233578999999988889999999999999999996 99987432111 111 111111110 11
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 593 APDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 593 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
+......+.+++..||+.+|++||++.+|.+.|..
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 12223456778889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=313.17 Aligned_cols=265 Identities=23% Similarity=0.319 Sum_probs=197.0
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
++|.+.++||+|+||.||+|.++ +++.||+|.+.... ......+.+|+.++++++||||+++++++......++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57999999999999999999876 58899999986543 23345678899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
++ ++|..++... ...+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 4787777543 335889999999999999999999997 99999999999999999999999999976433221
Q ss_pred CcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccch--------hhhhhhhccCC-C
Q 005871 510 QANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTL--------LTYTWKLWCEG-P 579 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~--------~~~~~~~~~~~-~ 579 (672)
. .....+++.|+|||++.+. .++.++||||||+++|+|++|++||........... ....|..+... .
T Consensus 160 ~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 160 T--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred c--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 1 1223568899999998764 578999999999999999999999854322110000 00011111000 0
Q ss_pred cccccChhhcCC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 580 AVELIDPVLKQS----CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 580 ~~~l~d~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
....--+..... ........+.+|+.+||+.||.+|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000000000 001112346788889999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=316.51 Aligned_cols=255 Identities=30% Similarity=0.444 Sum_probs=197.5
Q ss_pred hcCCccccccccCCceeEEeeeec-CCc--eeEEEEeccc-CcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGK--AIAVKRLSRT-SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~l 425 (672)
.++|++.+.||+|+||.||+|.++ ++. .+++|.+... .......+.+|++++.++ +|+||+++++++.+.+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357899999999999999999975 344 4577776643 234456788999999999 89999999999999999999
Q ss_pred EEeecCCCChhHHhhhcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC
Q 005871 426 IYEYMPNKSLDVHLFDAT-------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN 492 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~ 492 (672)
||||+++++|.+++.... ....+++.+++.++.||+.||+|||+.| |+||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999986432 1235889999999999999999999987 999999999999999999
Q ss_pred eEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhh
Q 005871 493 PKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYT 571 (672)
Q Consensus 493 ~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~ 571 (672)
+||+|||++...... .......++..|+|||++.+..++.++||||||+++|||+| |..||...... ......
T Consensus 163 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~ 236 (303)
T cd05088 163 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEKL 236 (303)
T ss_pred EEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHHHHH
Confidence 999999998642211 11111234567999999988889999999999999999998 99887422111 111111
Q ss_pred hhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 572 WKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 572 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
..+...+ ........+.+|+.+||+.+|++||+++++++.|..
T Consensus 237 ----~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 237 ----PQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred ----hcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0000000 001112346788889999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=342.46 Aligned_cols=259 Identities=23% Similarity=0.317 Sum_probs=200.3
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
++|++.++||+|+||.||+|++. .++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999975 58999999987542 223457899999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccc--------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeec
Q 005871 428 EYMPNKSLDVHLFDATR--------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 499 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFg 499 (672)
||++|++|.+++..... ...+++..+..++.||++||+|||+.| |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998864211 234567788999999999999999997 9999999999999999999999999
Q ss_pred CceeeCCCCC----------------CcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCccc
Q 005871 500 LARIFGGNQN----------------QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH 563 (672)
Q Consensus 500 la~~~~~~~~----------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~ 563 (672)
+++....... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~-- 236 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG-- 236 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch--
Confidence 9987622110 0011235799999999999999999999999999999999999999753211
Q ss_pred ccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhcc
Q 005871 564 GQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRP-TMSSVVVMLAS 627 (672)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~ 627 (672)
.... ...... ...+.. + .......+.+++.+||+.||++|| +++++++.|..
T Consensus 237 -~ki~---~~~~i~-~P~~~~-p------~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 237 -RKIS---YRDVIL-SPIEVA-P------YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred -hhhh---hhhhcc-Chhhcc-c------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1000 000000 000000 0 011223467788899999999996 66777777654
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=323.78 Aligned_cols=196 Identities=28% Similarity=0.387 Sum_probs=169.4
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhcc-C-----CCeeeEEEEEEeCceEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-H-----KNLVRLLGCCLEGQELL 424 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h-----~niv~l~~~~~~~~~~~ 424 (672)
-+|++++.||+|+||+|-++++. .++.||||+++... ....+...|+.+|..|+ | -|+|+++++|...+++|
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 48999999999999999999975 59999999987654 44566788999999997 4 48999999999999999
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC--CCeEEEeecCce
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD--MNPKISDFGLAR 502 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~--~~~kL~DFgla~ 502 (672)
||+|.+ ..+|.++|... +...++...++.|+.||+.+|.+||+.+ |||+||||+||||.+. ..+||+|||.+.
T Consensus 265 iVfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 265 IVFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eeehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence 999988 56888888654 3455999999999999999999999987 9999999999999754 369999999998
Q ss_pred eeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCC
Q 005871 503 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF 558 (672)
Q Consensus 503 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~ 558 (672)
....... ....+..|.|||++.+.+|+.+.||||||||+.||++|.+.|..
T Consensus 340 ~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 340 FESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred ccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 7543222 33567889999999999999999999999999999999887754
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=308.52 Aligned_cols=252 Identities=26% Similarity=0.398 Sum_probs=201.2
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
+.|++.++||+|+||.||+|++. +++.+++|.+........+.+.+|+.+++.++||||+++++.+..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 67999999999999999999976 58899999998777677788999999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
++++|..++... ...+++..+..++.|++.+|.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-- 164 (292)
T cd06644 92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-- 164 (292)
T ss_pred CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--
Confidence 999998877432 245899999999999999999999987 9999999999999999999999999987543221
Q ss_pred cccccccccCCcCChhhhc-----CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccC
Q 005871 511 ANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 585 (672)
.......+++.|+|||++. ...++.++|||||||++|||++|+.||..... ........ ........
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~-~~~~~~~~- 236 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIA-KSEPPTLS- 236 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHHh-cCCCccCC-
Confidence 1122346788999999984 34578899999999999999999999753221 11111111 11100000
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
........+.+++.+||+.+|++||++.++++.
T Consensus 237 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 237 ------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 011122357788889999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=304.85 Aligned_cols=252 Identities=27% Similarity=0.446 Sum_probs=200.4
Q ss_pred cCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecC
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 431 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 431 (672)
.+|.+.+.||+|+||.||++.+.++..+|+|++..... ....+.+|++++++++|||++++++++......++||||+.
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46888999999999999999987788999998865432 34678999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCc
Q 005871 432 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 511 (672)
Q Consensus 432 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 511 (672)
+++|.+++... ...+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99999888532 235889999999999999999999987 9999999999999999999999999998654322211
Q ss_pred ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcC
Q 005871 512 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590 (672)
Q Consensus 512 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 590 (672)
.....++..|+|||.+.++.++.++||||||+++|||++ |..||..... .... ... ..+ .....+
T Consensus 158 -~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~---~~~-~~~--~~~~~~---- 223 (256)
T cd05112 158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---SEVV---ETI-NAG--FRLYKP---- 223 (256)
T ss_pred -cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHHH---HHH-hCC--CCCCCC----
Confidence 112234678999999998899999999999999999998 8888743211 1111 111 111 000111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 591 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
.. ....+.+|+.+||+.+|++|||+.+++++|.
T Consensus 224 ~~---~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 224 RL---ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CC---CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 11 1245778889999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=305.49 Aligned_cols=240 Identities=22% Similarity=0.331 Sum_probs=187.7
Q ss_pred cccccCCceeEEeeeecC-------------CceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEE
Q 005871 358 NKLGQGGFGPVYKGTLAD-------------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 424 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 424 (672)
+.||+|+||.||+|.+.. ...+++|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358888877665555668889999999999999999999999999999
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC-------eEEEe
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN-------PKISD 497 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~-------~kL~D 497 (672)
+||||+++++|+.++.. ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999888743 2345899999999999999999999997 999999999999987664 89999
Q ss_pred ecCceeeCCCCCCcccccccccCCcCChhhhc-CCCCChhhHHHHHHHHHHHHH-cCCCCCCCCCcccccchhhhhhhhc
Q 005871 498 FGLARIFGGNQNQANTNIIAGTYGYMAPEYAM-GGIFSIKSDVFSFGVLLLEII-SGRKNNGFYFSEHGQTLLTYTWKLW 575 (672)
Q Consensus 498 Fgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDvwSlGvil~ell-tG~~p~~~~~~~~~~~~~~~~~~~~ 575 (672)
||++...... ....|+..|+|||.+. +..++.++||||||+++|||+ +|..|+...... .. ....
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~-~~~~ 222 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA------EK-ERFY 222 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh------HH-HHHH
Confidence 9998754321 1235788899999887 466899999999999999998 577775422110 00 0111
Q ss_pred cCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 576 CEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 576 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
.. .. .. .......+.+|+.+||+.||++||++.+|++.|+
T Consensus 223 ~~-~~-~~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 EG-QC-ML---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hc-Cc-cC---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 10 00 00 1112345778888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=308.11 Aligned_cols=253 Identities=26% Similarity=0.422 Sum_probs=198.2
Q ss_pred HHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeC------
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG------ 420 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~------ 420 (672)
.+++.|++.+.||+|+||.||+|.+. +++.+|+|++.... .....+.+|+.+++++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35678999999999999999999875 58899999986543 3446788999999999 799999999998753
Q ss_pred ceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecC
Q 005871 421 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 500 (672)
Q Consensus 421 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgl 500 (672)
...++||||+.+++|..++... ....+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 4689999999999999988542 3346899999999999999999999997 99999999999999999999999999
Q ss_pred ceeeCCCCCCcccccccccCCcCChhhhc-----CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhc
Q 005871 501 ARIFGGNQNQANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLW 575 (672)
Q Consensus 501 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 575 (672)
+....... .......|+..|+|||++. +..++.++|||||||++|||++|+.||...... .......
T Consensus 158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~------~~~~~~~ 229 (272)
T cd06637 158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------RALFLIP 229 (272)
T ss_pred ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH------HHHHHHh
Confidence 98654322 1223456899999999986 345788999999999999999999997432211 1111111
Q ss_pred cCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 576 CEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 576 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
.. ......+ ......+.+++.+||+.+|.+|||+.+|++
T Consensus 230 ~~-~~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 230 RN-PAPRLKS--------KKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred cC-CCCCCCC--------CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 11 0011110 111235778888999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=302.26 Aligned_cols=249 Identities=26% Similarity=0.446 Sum_probs=202.0
Q ss_pred cCCccccccccCCceeEEeeeecC-CceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
++|++.++||+|+||.||++.+.+ ++.+++|.+..... .+.+.+|++++++++|+||+++++.+.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 679999999999999999999864 78999999875533 678999999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
.+++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 999999988532 346899999999999999999999997 99999999999999999999999999987643321
Q ss_pred cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcC
Q 005871 511 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 590 (672)
......|+..|+|||++.+..++.++||||||+++|+|++|+.|+......... . .. ..... +.+
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~--~----~~-~~~~~-----~~~-- 219 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI--F----MI-PNKPP-----PTL-- 219 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh--h----hh-ccCCC-----CCC--
Confidence 223345788999999999889999999999999999999999997532211100 0 00 00000 000
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 591 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
..+......+.+++.+||+.+|++|||+.+|++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 001112245778888999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.16 Aligned_cols=249 Identities=25% Similarity=0.429 Sum_probs=202.3
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
++|++.+.||.|++|.||+|.+. +++.+|+|.+.... ......+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46889999999999999999976 58899999987543 34456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+++++|.+++... .+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 9999999888432 6899999999999999999999987 99999999999999999999999999987754321
Q ss_pred CcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhc
Q 005871 510 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 589 (672)
......|++.|+|||++.+..++.++||||||+++|+|++|+.||..... ........ ......+ .
T Consensus 154 --~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~------~~~~~~~~-~~~~~~~-----~ 219 (274)
T cd06609 154 --KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP------MRVLFLIP-KNNPPSL-----E 219 (274)
T ss_pred --ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch------HHHHHHhh-hcCCCCC-----c
Confidence 22334688899999999988899999999999999999999999753221 11111111 1111111 1
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 590 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.. .....+.+++.+||+.+|++|||++++++.
T Consensus 220 ~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 220 GN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred cc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11 022346778889999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=320.45 Aligned_cols=259 Identities=29% Similarity=0.416 Sum_probs=198.4
Q ss_pred cCCccccccccCCceeEEeeee------cCCceeEEEEecccC-cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeC-ce
Q 005871 352 NHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG-QE 422 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~-~~ 422 (672)
++|++.++||+|+||.||+|.+ .+++.||||++.... ......+.+|+.++.++ +||||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5799999999999999999973 247889999987543 33456788999999999 689999999988654 56
Q ss_pred EEEEEeecCCCChhHHhhhccc----------------------------------------------------------
Q 005871 423 LLLIYEYMPNKSLDVHLFDATR---------------------------------------------------------- 444 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 444 (672)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 8999999999999998854210
Q ss_pred ------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcccccccc
Q 005871 445 ------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAG 518 (672)
Q Consensus 445 ------~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~g 518 (672)
...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++..+.............+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 123678889999999999999999997 99999999999999999999999999986533222222222345
Q ss_pred cCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHHHH
Q 005871 519 TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDEL 597 (672)
Q Consensus 519 t~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~ 597 (672)
+..|+|||.+.+..++.++||||||+++|+|++ |..|+...... ... ......+..... ... ..
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~----~~~~~~~~~~~~-----~~~----~~ 308 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEF----CRRLKEGTRMRA-----PDY----TT 308 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHH----HHHHhccCCCCC-----CCC----CC
Confidence 678999999999999999999999999999997 88886432111 011 111111111110 001 12
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 598 LKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 598 ~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
..+.+++..||+.+|++|||+.||++.|...
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 3477888899999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=320.27 Aligned_cols=193 Identities=25% Similarity=0.312 Sum_probs=164.5
Q ss_pred HHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
....+|.+.+.||+|+||.||+|++. .++.||+|+.... ....|+.++++++||||+++++++......++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34568999999999999999999976 4778999975432 2356999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
|++. ++|..++.. ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 9996 567766643 3346899999999999999999999997 999999999999999999999999999753221
Q ss_pred CCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCC
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNN 556 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~ 556 (672)
.......||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus 211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1222356899999999999999999999999999999999866553
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=309.63 Aligned_cols=251 Identities=24% Similarity=0.379 Sum_probs=202.9
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
..+|.+.++||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++|+||+++++.+...+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 368999999999999999999974 6899999999776655667789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+++++|..++.. ..+++.++..++.|++.+|.|||+.+ |+||||||+|||++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999998843 34789999999999999999999997 99999999999999999999999999986543322
Q ss_pred CcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhc
Q 005871 510 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 589 (672)
. .....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||........ +. .....+. ....
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--~~----~~~~~~~-~~~~----- 236 (297)
T cd06656 171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LY----LIATNGT-PELQ----- 236 (297)
T ss_pred C--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--ee----eeccCCC-CCCC-----
Confidence 1 2234688899999999998899999999999999999999999843221110 00 0000000 0000
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 590 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
........+.+++.+||+.+|++||++.+|++.
T Consensus 237 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 237 --NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred --CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011122346678889999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=323.14 Aligned_cols=262 Identities=25% Similarity=0.261 Sum_probs=196.1
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeC------
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------ 420 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~------ 420 (672)
..++|.+.+.||+|+||.||++.+. .++.+|+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999875 58899999987542 23346778899999999999999999998643
Q ss_pred ceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecC
Q 005871 421 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 500 (672)
Q Consensus 421 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgl 500 (672)
...++||||+++ ++...+. ..+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 357999999976 4554442 24788999999999999999999998 99999999999999999999999999
Q ss_pred ceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhh--------
Q 005871 501 ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTW-------- 572 (672)
Q Consensus 501 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~-------- 572 (672)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ......
T Consensus 166 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~ 240 (355)
T cd07874 166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ--WNKVIEQLGTPCPE 240 (355)
T ss_pred cccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHH
Confidence 98653322 12234689999999999999999999999999999999999999854321100 000000
Q ss_pred ----------hhccC-CCc-----ccccChhhc---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 573 ----------KLWCE-GPA-----VELIDPVLK---QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 573 ----------~~~~~-~~~-----~~l~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
..... ... .+.....+. ..........+.+++.+||+.||++|||+.|+++.-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp 312 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence 00000 000 000000000 001111234577899999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=303.56 Aligned_cols=238 Identities=25% Similarity=0.405 Sum_probs=187.6
Q ss_pred cccccCCceeEEeeeecCCc-----------eeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 358 NKLGQGGFGPVYKGTLADGK-----------AIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999986432 5777876654433 6788999999999999999999999988 778999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-------CeEEEeec
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-------NPKISDFG 499 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~-------~~kL~DFg 499 (672)
|||+++++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999986432 26899999999999999999999987 99999999999999887 79999999
Q ss_pred CceeeCCCCCCcccccccccCCcCChhhhcCC--CCChhhHHHHHHHHHHHHHcC-CCCCCCCCcccccchhhhhhhhcc
Q 005871 500 LARIFGGNQNQANTNIIAGTYGYMAPEYAMGG--IFSIKSDVFSFGVLLLEIISG-RKNNGFYFSEHGQTLLTYTWKLWC 576 (672)
Q Consensus 500 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDvwSlGvil~elltG-~~p~~~~~~~~~~~~~~~~~~~~~ 576 (672)
++..... .....++..|+|||++.+. .++.++||||||+++|+|++| ..|+....... ... .+.
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~----~~~ 220 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KER----FYQ 220 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHH----HHh
Confidence 9986543 1223567789999999876 789999999999999999995 55553321110 000 000
Q ss_pred CCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 577 EGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 577 ~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
.... ........+.+++.+||+.+|.+|||+.+|++.|+
T Consensus 221 ~~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 DQHR-----------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred cCCC-----------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 00011156778889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=333.90 Aligned_cols=263 Identities=19% Similarity=0.229 Sum_probs=191.1
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCC------CeeeEEEEEEeC-c
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHK------NLVRLLGCCLEG-Q 421 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~------niv~l~~~~~~~-~ 421 (672)
..++|++.++||+|+||.||++.+. .++.||||++.... .....+..|+.++++++|. +++++++++... .
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 4678999999999999999999975 57889999986532 2234567788888887654 588899988764 5
Q ss_pred eEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEEcCCC---------
Q 005871 422 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED-SRLKIIHRDLKASNILLDDDM--------- 491 (672)
Q Consensus 422 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-g~~~iiHrDlkp~NIll~~~~--------- 491 (672)
..++|||++ +++|.+++.. ...+++..+..|+.||+.||.|||++ | ||||||||+|||++.++
T Consensus 206 ~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 206 HMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred eEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccccc
Confidence 789999988 6677777743 34689999999999999999999984 6 99999999999998765
Q ss_pred -------CeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccc
Q 005871 492 -------NPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHG 564 (672)
Q Consensus 492 -------~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~ 564 (672)
.+||+|||.+.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 353 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353 (467)
T ss_pred ccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 49999999876422 122346799999999999999999999999999999999999999864322111
Q ss_pred cchhhh-------hhhhc-cCCCcccc----------cChh-h---cCCC---CHHHHHHHHHHHHHhcccCCCCCCCHH
Q 005871 565 QTLLTY-------TWKLW-CEGPAVEL----------IDPV-L---KQSC---APDELLKFIHIGLLCVQQDPADRPTMS 619 (672)
Q Consensus 565 ~~~~~~-------~~~~~-~~~~~~~l----------~d~~-l---~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~ 619 (672)
...... .|... ......++ .++. + .... .......+.+|+.+||+.||++|||++
T Consensus 354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~ 433 (467)
T PTZ00284 354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR 433 (467)
T ss_pred HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence 000000 00000 00000000 0000 0 0000 001124577999999999999999999
Q ss_pred HHHHHh
Q 005871 620 SVVVML 625 (672)
Q Consensus 620 evl~~L 625 (672)
|+++.-
T Consensus 434 e~L~Hp 439 (467)
T PTZ00284 434 QMTTHP 439 (467)
T ss_pred HHhcCc
Confidence 999743
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=312.26 Aligned_cols=195 Identities=29% Similarity=0.483 Sum_probs=159.5
Q ss_pred cccccCCceeEEeeeec---CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEe--CceEEEEEeecCC
Q 005871 358 NKLGQGGFGPVYKGTLA---DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELLLIYEYMPN 432 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~~lV~Ey~~~ 432 (672)
.+||+|+||.||+|+.. ++..||+|.+..... ...+.+|+.++++++||||+++++++.. +...++||||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 57999999999999865 357899998865432 3467889999999999999999999854 5678999999876
Q ss_pred CChhHHhhhc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE----cCCCCeEEEeecCce
Q 005871 433 KSLDVHLFDA------TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL----DDDMNPKISDFGLAR 502 (672)
Q Consensus 433 gsL~~~l~~~------~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll----~~~~~~kL~DFgla~ 502 (672)
+|..++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 555555321 12335889999999999999999999997 9999999999999 566789999999998
Q ss_pred eeCCCCCC-cccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCC
Q 005871 503 IFGGNQNQ-ANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGF 558 (672)
Q Consensus 503 ~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~ 558 (672)
........ .......||+.|+|||++.+. .++.++|||||||++|||+||++||..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 76543221 122345789999999998764 579999999999999999999999854
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=302.12 Aligned_cols=253 Identities=25% Similarity=0.390 Sum_probs=203.4
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
++|++.+.||+|+||.||++... +++.+++|.+........+.+.+|+.++++++||||+++++.+.+...++++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 67999999999999999999975 57889999998766666788999999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
.+++|.+++... ...+++.++..++.|++.+|.|||+.+ |+|+||||+||++++++.+||+|||++........
T Consensus 83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence 999999988542 246899999999999999999999987 99999999999999999999999999876543221
Q ss_pred cccccccccCCcCChhhhcCC---CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChh
Q 005871 511 ANTNIIAGTYGYMAPEYAMGG---IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~---~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 587 (672)
......++..|+|||.+.+. .++.++||||||+++|+|++|+.|+....... .... .. ... .....
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--~~~~----~~-~~~---~~~~~ 225 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--ALFL----IS-KSN---FPPPK 225 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHH----HH-hcc---CCCcc
Confidence 12234678899999999776 78999999999999999999999974322111 0000 00 000 00000
Q ss_pred hcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 588 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 588 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
+ .........+.+++.+||+.+|.+|||+++|+.
T Consensus 226 ~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 226 L--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred c--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 011223456788899999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=303.78 Aligned_cols=257 Identities=25% Similarity=0.364 Sum_probs=199.8
Q ss_pred HHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
.+++++.....||+|+||.||+|.+. ++..|++|.+........+.+.+|+.+++.++|+||+++++++...+..++|+
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 34556666778999999999999965 57889999988776666788999999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-CCCeEEEeecCceeeCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFGLARIFGG 506 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~-~~~~kL~DFgla~~~~~ 506 (672)
||+++++|..++.........++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.++|+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 99999999999864322222378889999999999999999987 999999999999986 67999999999976543
Q ss_pred CCCCcccccccccCCcCChhhhcCCC--CChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGI--FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
... ......|++.|+|||++.+.. ++.++||||||+++|+|++|+.|+........ ..+.......
T Consensus 162 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~----- 229 (268)
T cd06624 162 INP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-----AMFKVGMFKI----- 229 (268)
T ss_pred CCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh-----hHhhhhhhcc-----
Confidence 221 122245789999999987654 78999999999999999999999743211100 0010000000
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.+ ..+......+.+++.+||+.+|++|||+.+|++.
T Consensus 230 ~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 230 HP----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CC----CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00 1111223457788889999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=308.10 Aligned_cols=265 Identities=23% Similarity=0.340 Sum_probs=199.3
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
++|++.+.||+|+||.||++.++ +++.||+|++.... ....+.+.+|+.+++.++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47899999999999999999986 58999999886542 2234567899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|+++++|..++. ....+++..+..++.||+.+|.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999998887763 2345899999999999999999999987 9999999999999999999999999998765432
Q ss_pred CCcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhh-h-------hhhhccCCC
Q 005871 509 NQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLT-Y-------TWKLWCEGP 579 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~-~-------~~~~~~~~~ 579 (672)
. ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||............. . ....+....
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 2 1223457889999999876 457899999999999999999999985332211100000 0 000000000
Q ss_pred cc-cccChhhcCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 580 AV-ELIDPVLKQSC-----APDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 580 ~~-~l~d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.. ....+...... .+.....+.+++.+||+.+|++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00 00000000000 01113457789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=307.79 Aligned_cols=251 Identities=27% Similarity=0.336 Sum_probs=197.2
Q ss_pred CccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 354 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 354 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
|+..+.||+|+||+||++.+. +++.+|+|.+.... ......+.+|+++++.++|+|++++++.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 677889999999999999875 68899999986543 22334578899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+++++|..++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 99999998885432 346999999999999999999999997 99999999999999999999999999976532211
Q ss_pred CcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhc
Q 005871 510 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 589 (672)
.....|+..|+|||++.+..++.++|+||||+++|+|++|..||........ ............ .. .
T Consensus 158 ---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~~~~--~~----~- 224 (285)
T cd05632 158 ---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVLETE--EV----Y- 224 (285)
T ss_pred ---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhhccc--cc----c-
Confidence 1234689999999999988999999999999999999999999853221110 011111110000 00 1
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 005871 590 QSCAPDELLKFIHIGLLCVQQDPADRPT-----MSSVVVM 624 (672)
Q Consensus 590 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 624 (672)
.......+.+|+..||+.||++||+ +.++++.
T Consensus 225 ---~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 225 ---SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ---CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 1111234567888999999999999 6677764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=305.06 Aligned_cols=249 Identities=25% Similarity=0.427 Sum_probs=202.5
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
..|+..++||+|+||.||+|.+. ++..+|+|.+.... ......+.+|+.+++.++||||+++++.+.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 46788899999999999999975 58899999887543 34567889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+++++|.+++.. ..+++.++..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999988742 35889999999999999999999987 99999999999999999999999999987643322
Q ss_pred CcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhc
Q 005871 510 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 589 (672)
......++..|+|||++.+..++.++|+||||+++|||++|+.|+....... ..... ... ..
T Consensus 157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~------~~~~~-~~~---------~~ 218 (277)
T cd06640 157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR------VLFLI-PKN---------NP 218 (277)
T ss_pred --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh------Hhhhh-hcC---------CC
Confidence 1223467889999999998889999999999999999999999975322110 00000 000 01
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 590 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
..........+.+++.+||+.+|++||++.++++.-
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK 254 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence 112223445678888999999999999999998763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=305.85 Aligned_cols=249 Identities=29% Similarity=0.472 Sum_probs=198.5
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEecccCcc---------cHHHHHHHHHHHHhccCCCeeeEEEEEEeCce
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ---------GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 422 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~ 422 (672)
+|.+.+.||+|++|.||+|.+. +++.+|+|.+...... ..+.+.+|+.++++++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778899999999999999875 5889999988654322 23568899999999999999999999999999
Q ss_pred EEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCce
Q 005871 423 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 502 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~ 502 (672)
.++||||+++++|..++.. ...+++..+..++.|++.+|.|||+.+ ++||||+|+||++++++.+||+|||.++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999843 345889999999999999999999987 9999999999999999999999999998
Q ss_pred eeCCCCCC----cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCC
Q 005871 503 IFGGNQNQ----ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 578 (672)
Q Consensus 503 ~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 578 (672)
........ .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||..... ......... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~ 227 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ------LQAIFKIGE-N 227 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH------HHHHHHHhc-c
Confidence 76532211 111234588899999999998899999999999999999999999753211 011111100 0
Q ss_pred CcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 579 PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 579 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
..+.+ +......+.+++.+||+.||.+||++.+|++
T Consensus 228 -----~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 -----ASPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -----CCCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 01111 1122345677888999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=306.10 Aligned_cols=252 Identities=25% Similarity=0.381 Sum_probs=199.4
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecC
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 431 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 431 (672)
.|++.++||+|+||.||++.+. ++..+++|.+........+.+.+|+++++.++||||+++++.+......++||||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 3678899999999999999976 478889999877666667789999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCc
Q 005871 432 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 511 (672)
Q Consensus 432 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 511 (672)
+++|..++.. ....+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++....... .
T Consensus 86 ~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~ 158 (282)
T cd06643 86 GGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q 158 (282)
T ss_pred CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence 9999888753 2346899999999999999999999997 9999999999999999999999999987653222 1
Q ss_pred ccccccccCCcCChhhhc-----CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 512 NTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 512 ~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
......|+..|+|||++. +..++.++|||||||++|+|++|++||..... ........ .........
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~~~-~~~~~~~~~- 230 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP------MRVLLKIA-KSEPPTLAQ- 230 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH------HHHHHHHh-hcCCCCCCC-
Confidence 223346899999999984 34578899999999999999999999743211 11111110 000001100
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
+......+.+++.+||+.+|.+||++.++++.-
T Consensus 231 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 231 ------PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred ------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 111124567888899999999999999997544
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=304.05 Aligned_cols=248 Identities=33% Similarity=0.491 Sum_probs=194.3
Q ss_pred cccccCCceeEEeeeecC----CceeEEEEecccCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCC
Q 005871 358 NKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 432 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~ 432 (672)
++||+|+||.||+|.+.. +..+|+|.+..... ...+.+.+|+.++++++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997532 36899999876543 34567899999999999999999999876 4568999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcc
Q 005871 433 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 512 (672)
Q Consensus 433 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~ 512 (672)
++|.+++... ..+++..+..++.|++.+|.|||+.+ ++|+||||+|||++.++.+||+|||+++.+........
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 9999998543 36899999999999999999999987 99999999999999999999999999987643332211
Q ss_pred -cccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcC
Q 005871 513 -TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590 (672)
Q Consensus 513 -~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 590 (672)
.....++..|+|||.+.+..++.++||||||+++|+|++ |+.||..... ......... .....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~~----~~~~~-------- 218 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLES----GERLP-------- 218 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHc----CCcCC--------
Confidence 111223567999999998899999999999999999998 9998753221 111111111 11000
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 591 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
........+.+++.+||+.+|++||++.+|++.|...
T Consensus 219 -~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 -RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 0111224577888899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=314.56 Aligned_cols=255 Identities=18% Similarity=0.226 Sum_probs=196.2
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEeccc---CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
++|.+.+.||+|+||.||++++. +++.||+|++.+. .......+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999976 5788999998653 2233456788999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+++|+|..++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999998542 245899999999999999999999997 999999999999999999999999999876433
Q ss_pred CCCcccccccccCCcCChhhhcC-----CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccc
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMG-----GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVE 582 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (672)
... ......|++.|+|||++.+ +.++.++||||||+++|+|++|+.||..... ...............
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~~ 228 (331)
T cd05624 156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHEERFQ 228 (331)
T ss_pred Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH------HHHHHHHHcCCCccc
Confidence 221 1233579999999999875 5678999999999999999999999743211 111111111111000
Q ss_pred ccChhhcCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 005871 583 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPAD--RPTMSSVVVM 624 (672)
Q Consensus 583 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 624 (672)
+ .... ......+.+++.+||+.++.+ |++++++++.
T Consensus 229 ~-p~~~-----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 F-PSHI-----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred C-CCcc-----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0 1100 112245667777888865544 5688888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=305.24 Aligned_cols=254 Identities=30% Similarity=0.449 Sum_probs=202.3
Q ss_pred hcCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
.++|++.++||+|+||.||++.+.++..+++|.+.... ...+.+.+|+++++.++|+||+++++.+.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 46899999999999999999998778889999886543 345678899999999999999999999887 7789999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
++++|.+++... ....+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.+||+|||.+..+......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 999999998643 2345888999999999999999999987 999999999999999999999999999866432221
Q ss_pred cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhc
Q 005871 511 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 589 (672)
......++..|+|||++..+.++.++|+||||+++|+|++ |+.||..... ..+... ...+....
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~----~~~~~~~~------- 223 (260)
T cd05073 159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRA----LERGYRMP------- 223 (260)
T ss_pred -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH---HHHHHH----HhCCCCCC-------
Confidence 1122345677999999998889999999999999999999 8888743211 111111 11111100
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 590 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
........+.+++.+|++.+|++||++.+|++.|+.
T Consensus 224 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 --RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011223457788889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=304.92 Aligned_cols=251 Identities=26% Similarity=0.412 Sum_probs=198.6
Q ss_pred CCccccccccCCceeEEeeeecCCceeEEEEecccC------cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 353 HFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS------GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
+|.+.+.||+|+||.||+|...+++.+|+|.+.... ......+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 478889999999999999998889999999886432 12345688999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||+++++|.+++.. ...+++..+..++.|++.+|.|||+.+ |+|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999999853 245889999999999999999999987 99999999999999999999999999876532
Q ss_pred CC----CCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccc
Q 005871 507 NQ----NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVE 582 (672)
Q Consensus 507 ~~----~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (672)
.. .........|+..|+|||++.+..++.++||||||+++|+|++|+.||...... .............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~-- 227 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL-----AAMFYIGAHRGLM-- 227 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH-----HHHHHhhhccCCC--
Confidence 11 111122346889999999999888999999999999999999999997532111 0000000000000
Q ss_pred ccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 583 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 583 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
+.+. ......+.+++.+||+.+|++||++.++++
T Consensus 228 ---~~~~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 ---PRLP----DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---CCCC----CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111 112344677888999999999999999985
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=301.90 Aligned_cols=251 Identities=25% Similarity=0.389 Sum_probs=203.2
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
+|+..+.||+|+||.||.++.. +++.+++|.+... .......+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5889999999999999999865 5889999987654 344556788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+++++|.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999885432 346899999999999999999999987 99999999999999999999999999987644332
Q ss_pred CcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhc
Q 005871 510 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 589 (672)
......|++.|+|||++.+..++.++||||||+++|+|++|..||..... ........ .+.....
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~-~~~~~~~------ 221 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP------LNLVVKIV-QGNYTPV------ 221 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHH-cCCCCCC------
Confidence 22335689999999999888899999999999999999999999743211 11111111 1111110
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 590 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
.......+.+++.+||+.+|++||++.++++.+
T Consensus 222 ---~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 ---VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ---ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 011234577788899999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.84 Aligned_cols=239 Identities=23% Similarity=0.342 Sum_probs=186.0
Q ss_pred ccccCCceeEEeeeecC-------------------------CceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeE
Q 005871 359 KLGQGGFGPVYKGTLAD-------------------------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 413 (672)
Q Consensus 359 ~LG~G~fg~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l 413 (672)
.||+|+||.||+|.+.. ...|++|++..........+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 23588898876555555678899999999999999999
Q ss_pred EEEEEeCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC--
Q 005871 414 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-- 491 (672)
Q Consensus 414 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~-- 491 (672)
++++.+....++||||+++++|..++... ...+++..+..++.||++||+|||+++ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999888532 346889999999999999999999987 99999999999998644
Q ss_pred -----CeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHH-cCCCCCCCCCcccc
Q 005871 492 -----NPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEII-SGRKNNGFYFSEHG 564 (672)
Q Consensus 492 -----~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~ell-tG~~p~~~~~~~~~ 564 (672)
.+||+|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+.......
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~- 229 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE- 229 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH-
Confidence 3799999988643211 12356788999998876 56899999999999999995 6888864322111
Q ss_pred cchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 565 QTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
....... ... . +......+.+++.+||+.+|++|||+.+|++.|+
T Consensus 230 --~~~~~~~---~~~--------~----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 --KERFYEK---KHR--------L----PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred --HHHHHHh---ccC--------C----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1111000 000 0 0111235778888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=301.40 Aligned_cols=258 Identities=26% Similarity=0.417 Sum_probs=204.8
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
++|++.+.||.|+||+||+|... ++..+++|++.... ......+.+|+++++.++|+||+++++.+...+..++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999965 68899999986543 33567889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+++++|.+++........+++..+..++.|++.+|.|||+.| |+|+||||+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999865433356899999999999999999999987 99999999999999999999999999987654332
Q ss_pred Cc--ccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 510 QA--NTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 510 ~~--~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
.. ......|+..|+|||++... .++.++|+||||+++|+|++|+.||...... ........... .. +..
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~~~~~~~-~~-~~~ 229 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM------KVLMLTLQNDP-PS-LET 229 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh------hhHHHHhcCCC-CC-cCC
Confidence 21 22345689999999999877 7899999999999999999999997532211 11111111110 00 000
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
. .........+.+++.+||+.||++|||+.+|++
T Consensus 230 ~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 230 G---ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred c---cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 001122345778888999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=308.78 Aligned_cols=249 Identities=27% Similarity=0.462 Sum_probs=200.0
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
+.|+..+.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|++++++++||||+++++.+..+...++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 35777889999999999999875 57889999887543 34456789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+++++|..++.. ..+++..+..++.||+.||.|||+++ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 84 ~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 84 LGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred cCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 999999988732 45899999999999999999999987 99999999999999999999999999986543221
Q ss_pred CcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhc
Q 005871 510 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 589 (672)
......|+..|+|||++.+..++.++||||||+++|||++|+.|+....... .. .. ..... .+.+
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~---~~-~~~~~-----~~~~- 221 (277)
T cd06642 157 --KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VL---FL-IPKNS-----PPTL- 221 (277)
T ss_pred --hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HH---hh-hhcCC-----CCCC-
Confidence 1223467889999999999899999999999999999999999974322111 00 00 00110 0111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 590 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
.......+.+++.+||+.+|++||++.+|++.-
T Consensus 222 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 222 ---EGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred ---CcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 112234577888899999999999999999853
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=308.97 Aligned_cols=259 Identities=25% Similarity=0.377 Sum_probs=204.0
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
.++|++.+.||+|+||+||++.+. +++.+|+|++.... ....+.+.+|+++++.++||||+++++.+......++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 357889999999999999999975 58899999876543 3345788999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|+++++|..++.. ...+++..+..++.+++.+|.|||+.. +++||||||+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 84 FMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred cCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 9999999988743 346899999999999999999999742 3999999999999999999999999998754322
Q ss_pred CCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccc-----cchhhhhhhhccCCCcccc
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHG-----QTLLTYTWKLWCEGPAVEL 583 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l 583 (672)
......|+..|+|||++.++.++.++|||||||++|+|++|+.||........ ............. ....
T Consensus 158 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~- 232 (284)
T cd06620 158 ---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-PPPR- 232 (284)
T ss_pred ---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-cCCC-
Confidence 12245789999999999888999999999999999999999999864332111 0111111111111 0000
Q ss_pred cChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 584 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
+. .......+.+++.+|++.||++|||+.||+++.-.
T Consensus 233 ----~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 233 ----LP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred ----CC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 00 01123457788889999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=318.94 Aligned_cols=241 Identities=24% Similarity=0.292 Sum_probs=185.6
Q ss_pred cccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhc---cCCCeeeEEEEEEeCceEEEEEeecCC
Q 005871 360 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL---QHKNLVRLLGCCLEGQELLLIYEYMPN 432 (672)
Q Consensus 360 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l---~h~niv~l~~~~~~~~~~~lV~Ey~~~ 432 (672)
||+|+||+||+|++. +++.||+|++.+.. ......+..|..++..+ +||||+++++.+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999976 58999999986532 22234456677777766 699999999999999999999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcc
Q 005871 433 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 512 (672)
Q Consensus 433 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~ 512 (672)
++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~ 152 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT 152 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence 999888743 346899999999999999999999997 9999999999999999999999999987533222 12
Q ss_pred cccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCC
Q 005871 513 TNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQS 591 (672)
Q Consensus 513 ~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~ 591 (672)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||..... .... .....+.. .+ ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~------~~~~-~~i~~~~~-~~-----~~~ 219 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT------QQMY-RNIAFGKV-RF-----PKN 219 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH------HHHH-HHHHcCCC-CC-----CCc
Confidence 2345799999999998765 479999999999999999999999743211 1111 11111110 00 011
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCC----CHHHHHHH
Q 005871 592 CAPDELLKFIHIGLLCVQQDPADRP----TMSSVVVM 624 (672)
Q Consensus 592 ~~~~~~~~l~~li~~cl~~dP~~RP----t~~evl~~ 624 (672)
. ....+.+++.+||+.||.+|| ++.++++.
T Consensus 220 ~---~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 220 V---LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred c---CCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 1 123456778899999999998 56666653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=307.06 Aligned_cols=256 Identities=28% Similarity=0.388 Sum_probs=201.2
Q ss_pred cCCccccccccCCceeEEeeeec------CCceeEEEEecccCcc-cHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 424 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 424 (672)
++|++.+.||+|+||.||+++.+ +.+.+++|.+...... ....+.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57889999999999999999864 2467899988765443 4578999999999999999999999999999999
Q ss_pred EEEeecCCCChhHHhhhcccc------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEee
Q 005871 425 LIYEYMPNKSLDVHLFDATRS------VQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDF 498 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DF 498 (672)
+||||+++++|.+++...... ..+++..+..++.||+.+|.|||+.+ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998654322 25899999999999999999999997 999999999999999999999999
Q ss_pred cCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccC
Q 005871 499 GLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCE 577 (672)
Q Consensus 499 gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 577 (672)
|++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||..... .. .... ...
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~---~~~~-~~~ 233 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EE---VLNR-LQA 233 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HH---HHHH-HHc
Confidence 99875432221 12223356778999999988889999999999999999999 7777642211 11 1111 111
Q ss_pred CCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 578 GPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 578 ~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
+...... .......+.+++.+||+.+|++|||+.++++.|.
T Consensus 234 ~~~~~~~--------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLELPV--------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcCCCC--------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1111000 1112235778888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=302.89 Aligned_cols=248 Identities=30% Similarity=0.398 Sum_probs=196.5
Q ss_pred cCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEE-eCceEEEEEeec
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL-EGQELLLIYEYM 430 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~-~~~~~~lV~Ey~ 430 (672)
++|.+.+.||+|+||.||++... +..+++|.+.... ..+.+.+|+.++++++|+|++++++++. ++...++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 57889999999999999999865 7789999886543 3467899999999999999999999764 456789999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
++++|.+++... ....+++..+..++.|++.+|.|||++| |+||||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 999999988543 2335889999999999999999999997 9999999999999999999999999988643222
Q ss_pred cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhc
Q 005871 511 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 589 (672)
....++..|+|||++.+..++.++||||||+++|+|++ |+.|+.... ........ ..+....
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------~~~~~~~~-~~~~~~~------- 219 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPRV-EKGYKMD------- 219 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHH-hcCCCCC-------
Confidence 12234568999999998889999999999999999997 888864221 11111111 1110000
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 590 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
........+.+++.+|++.+|++|||+.++++.|..
T Consensus 220 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 220 --APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred --CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 111123456788889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=312.33 Aligned_cols=255 Identities=19% Similarity=0.229 Sum_probs=194.5
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEeccc---CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
++|.+.++||+|+||.||+++++ .++.+|+|++.+. .......+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47899999999999999999976 4788999998643 2223445788999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999998542 235899999999999999999999997 999999999999999999999999999765332
Q ss_pred CCCcccccccccCCcCChhhhc-----CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccc
Q 005871 508 QNQANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVE 582 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (672)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||.... ................
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~------~~~~~~~i~~~~~~~~ 228 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHKERFQ 228 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC------HHHHHHHHhCCCcccc
Confidence 21 1223457999999999986 3468899999999999999999999975321 1111111111111000
Q ss_pred ccChhhcCCCCHHHHHHHHHHHHHhcccCC--CCCCCHHHHHHH
Q 005871 583 LIDPVLKQSCAPDELLKFIHIGLLCVQQDP--ADRPTMSSVVVM 624 (672)
Q Consensus 583 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP--~~RPt~~evl~~ 624 (672)
. ... .......+.+++.+|+..++ ..|++++|+++.
T Consensus 229 ~-p~~-----~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 F-PAQ-----VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred C-CCc-----cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 000 01112345666677775544 447899999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=306.70 Aligned_cols=250 Identities=35% Similarity=0.492 Sum_probs=195.7
Q ss_pred cccccCCceeEEeeeecC-------CceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 358 NKLGQGGFGPVYKGTLAD-------GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
+.||+|+||.||+|++.+ +..+++|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998643 2578999876543 23456789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhcc----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-----CeEEEeecC
Q 005871 430 MPNKSLDVHLFDAT----RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-----NPKISDFGL 500 (672)
Q Consensus 430 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~-----~~kL~DFgl 500 (672)
+++++|.+++.... ....+++.++..++.|++.+|.|||+.+ ++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986532 2234789999999999999999999987 99999999999999877 899999999
Q ss_pred ceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCC
Q 005871 501 ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGP 579 (672)
Q Consensus 501 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 579 (672)
+................++..|+|||++.++.++.++||||||+++|||++ |+.||..... ...... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~---~~~~~~ 231 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQH---VTAGGR 231 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHH---HhcCCc
Confidence 986543332222223345778999999999999999999999999999998 9988742211 111111 111100
Q ss_pred cccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 580 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 580 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
. .........+.+++.+||+.+|++||++.+|++.|.
T Consensus 232 ~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 232 L----------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred c----------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0 011122345678888999999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=305.57 Aligned_cols=248 Identities=30% Similarity=0.453 Sum_probs=191.5
Q ss_pred cccccCCceeEEeeeecC-Cc--eeEEEEeccc-CcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEEEEEeecCC
Q 005871 358 NKLGQGGFGPVYKGTLAD-GK--AIAVKRLSRT-SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 432 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lV~Ey~~~ 432 (672)
+.||+|+||.||+|++.+ +. .+++|.+... .....+.+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999754 43 4688887653 334456788999999999 899999999999999999999999999
Q ss_pred CChhHHhhhcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeec
Q 005871 433 KSLDVHLFDAT-------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 499 (672)
Q Consensus 433 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFg 499 (672)
++|.+++.... ....+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 1234789999999999999999999987 9999999999999999999999999
Q ss_pred CceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCC
Q 005871 500 LARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEG 578 (672)
Q Consensus 500 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 578 (672)
++...... ........+..|+|||++....++.++||||||+++|||++ |..||..... ..... ....+
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~~----~~~~~ 227 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYE----KLPQG 227 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH---HHHHH----HHhCC
Confidence 98632211 11111223567999999988889999999999999999997 9988743211 11111 11111
Q ss_pred CcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 579 PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 579 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
...+ ........+.+++.+|++.+|.+|||+.++++.|..
T Consensus 228 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~ 267 (270)
T cd05047 228 YRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 267 (270)
T ss_pred CCCC---------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 0000 011122356788889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=320.08 Aligned_cols=264 Identities=25% Similarity=0.267 Sum_probs=196.0
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeC------
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------ 420 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~------ 420 (672)
..++|.+.+.||+|+||.||++.+. .++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999975 58899999987542 33456788999999999999999999987643
Q ss_pred ceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecC
Q 005871 421 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 500 (672)
Q Consensus 421 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgl 500 (672)
...++||||+++ +|...+. ..+++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999976 5555552 23788999999999999999999997 99999999999999999999999999
Q ss_pred ceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccch-hh-------hhh
Q 005871 501 ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTL-LT-------YTW 572 (672)
Q Consensus 501 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~-~~-------~~~ 572 (672)
++...... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||........... .. ..+
T Consensus 173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 98653322 12234689999999999999999999999999999999999999854321110000 00 000
Q ss_pred hhc---------cCC-----CcccccChhhc---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 573 KLW---------CEG-----PAVELIDPVLK---QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 573 ~~~---------~~~-----~~~~l~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
..+ ... ...++....+. ..........+.+++.+||+.||.+|||+.++++.-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp 319 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 000 000 00000000000 000111234577889999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=297.90 Aligned_cols=250 Identities=23% Similarity=0.343 Sum_probs=199.9
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEe-CceEEEEEe
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE-GQELLLIYE 428 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~-~~~~~lV~E 428 (672)
+|++.+.||+|++|.||++.+. +++.+|+|++.... ....+.+.+|++++++++|+|++++++.+.. +..+++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4889999999999999999975 57889999986543 3345678999999999999999999998864 446899999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|+++++|.+++... ....+++.++..++.|++.+|.+||+.+ |+||||||+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999888643 2345899999999999999999999997 9999999999999999999999999998764332
Q ss_pred CCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhh
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 588 (672)
. ......|++.|+|||++.+..++.++||||||+++++|++|+.||.... ......... .+....
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~------~~~~~~~~~-~~~~~~------ 221 (257)
T cd08223 157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD------MNSLVYRII-EGKLPP------ 221 (257)
T ss_pred C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHH-hcCCCC------
Confidence 2 2233568899999999999999999999999999999999999975321 111111111 111100
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 589 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 589 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
........+.+++.+|++.+|++|||+.++++.
T Consensus 222 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 ---MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ---CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 111223457788889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=311.50 Aligned_cols=199 Identities=18% Similarity=0.254 Sum_probs=165.9
Q ss_pred cccccccC--CceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 356 DENKLGQG--GFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 356 ~~~~LG~G--~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
++++||+| +|++||++..+ +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 78999999875 68999999987543 334456788999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
++++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+++.||+...........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999885432 235899999999999999999999997 999999999999999999999999875443211110
Q ss_pred -----cccccccccCCcCChhhhcC--CCCChhhHHHHHHHHHHHHHcCCCCCCC
Q 005871 511 -----ANTNIIAGTYGYMAPEYAMG--GIFSIKSDVFSFGVLLLEIISGRKNNGF 558 (672)
Q Consensus 511 -----~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDvwSlGvil~elltG~~p~~~ 558 (672)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 01122356778999999976 3589999999999999999999999853
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=307.50 Aligned_cols=240 Identities=24% Similarity=0.383 Sum_probs=188.6
Q ss_pred cccccCCceeEEeeeecC--------CceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 358 NKLGQGGFGPVYKGTLAD--------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
+.||+|+||.||+|..+. ...+++|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998642 235888887665555567889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC--------eEEEeecCc
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN--------PKISDFGLA 501 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~--------~kL~DFgla 501 (672)
+++|+|..++.... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999985432 35899999999999999999999997 999999999999987765 699999988
Q ss_pred eeeCCCCCCcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCC-CCCCCCCcccccchhhhhhhhccCCC
Q 005871 502 RIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGR-KNNGFYFSEHGQTLLTYTWKLWCEGP 579 (672)
Q Consensus 502 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 579 (672)
..... .....++..|+|||++.+. .++.++||||||+++|+|++|. .|+....... .... .....
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~---~~~~---~~~~~- 222 (258)
T cd05078 156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---KLQF---YEDRH- 222 (258)
T ss_pred cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH---HHHH---HHccc-
Confidence 65432 2234678899999999874 5799999999999999999995 4432211110 0000 00000
Q ss_pred cccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 580 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 580 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
..+.....++.+++.+||+.+|++|||+++|++.|+
T Consensus 223 -----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 223 -----------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 111122345778888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=309.55 Aligned_cols=251 Identities=24% Similarity=0.396 Sum_probs=202.5
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
.+|++.+.||.|++|.||++.+. +++.|++|.+........+.+.+|+.+++.++|||++++++.+......++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 46999999999999999999864 68999999997666556678899999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
++++|..++.. ..+++.++..++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 99999988743 35899999999999999999999997 999999999999999999999999998865433221
Q ss_pred cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcC
Q 005871 511 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 590 (672)
.....|+..|+|||.+.+..++.++|||||||++|+|++|+.||........ ........ ...+..
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~------~~~~~~~~-~~~~~~----- 237 (296)
T cd06655 172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATNG-TPELQN----- 237 (296)
T ss_pred --CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhcC-CcccCC-----
Confidence 2234688999999999988899999999999999999999999753321110 00111010 000000
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 591 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
.......+.+++.+||+.||++|||+.+|++.=
T Consensus 238 --~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~ 270 (296)
T cd06655 238 --PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (296)
T ss_pred --cccCCHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 111123466788899999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=307.55 Aligned_cols=254 Identities=23% Similarity=0.375 Sum_probs=199.7
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEeccc-CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
++|++.+.||+|+||.||++.+. +++.+|+|.+... .......+.+|+.++++++|+||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46889999999999999999986 6899999988654 333456789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+++++|..++........+++..+..++.||+.+|.|||+.. +|+|+||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 999999988855333346899999999999999999999742 39999999999999999999999999987653222
Q ss_pred CcccccccccCCcCChhhhcCCC------CChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccc
Q 005871 510 QANTNIIAGTYGYMAPEYAMGGI------FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~~~------~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 583 (672)
.....|++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||..... .......... ..+...
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~-~~~~~~-- 228 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY---ANIFAQLSAI-VDGDPP-- 228 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch---hhHHHHHHHH-hhcCCC--
Confidence 22345788999999985543 58899999999999999999999753211 1111111111 011111
Q ss_pred cChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 584 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.........+.+++.+||+.+|++||++.++++.
T Consensus 229 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 229 -------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1112234456788889999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=308.88 Aligned_cols=261 Identities=25% Similarity=0.380 Sum_probs=198.2
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
++|++.++||+|+||.||++.++ +++.+|+|++..... ...+.+.+|+++++.++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46889999999999999999986 589999998765432 234578899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|+++++|..+... ...+++.++..++.||+.+|.|||+.+ |+|+||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999999877632 234899999999999999999999997 9999999999999999999999999998764332
Q ss_pred CCcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhh-----------hcc
Q 005871 509 NQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWK-----------LWC 576 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~-----------~~~ 576 (672)
. ......++..|+|||++.+ ..++.++||||||+++|||++|++||....... ....... .+.
T Consensus 155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07846 155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID---QLYHIIKCLGNLIPRHQEIFQ 229 (286)
T ss_pred c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH---HHHHHHHHhCCCchhhHHHhc
Confidence 2 1223457889999999876 447899999999999999999998875322110 0000000 000
Q ss_pred CCC------cccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 577 EGP------AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 577 ~~~------~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
... ..+...........+.....+.+++.+||+.+|++||++.+|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000 00000000000001122456888999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=299.21 Aligned_cols=247 Identities=28% Similarity=0.420 Sum_probs=199.8
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEecccC-----cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-----GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
+|+..+.||+|+||.||+|... +++.|++|.+.... .+..+.+.+|+.+++.++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778899999999999999986 78999999886543 23456789999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||+++++|.+++.. ...+++..+..++.||+.+|.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999998853 245889999999999999999999997 99999999999999999999999999887543
Q ss_pred CCCCcccccccccCCcCChhhhcCCC-CChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccC
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 585 (672)
.. ......|+..|++||.+.... ++.++|+||||+++|+|++|+.||..... ....+..........
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~--- 222 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKELPP--- 222 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhcccCCC---
Confidence 33 123356889999999987776 89999999999999999999999754321 111111111011111
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
.+......+.+++.+||+.+|++||++.++++
T Consensus 223 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 ------IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ------cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11112345677888999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=300.62 Aligned_cols=251 Identities=37% Similarity=0.547 Sum_probs=198.9
Q ss_pred CccccccccCCceeEEeeeecC-----CceeEEEEecccCcc-cHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 354 FSDENKLGQGGFGPVYKGTLAD-----GKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 354 ~~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
+.+.+.||.|+||.||++++.+ +..+|+|.+...... ..+.+.+|+.+++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999999753 378999998765433 5678999999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+++++|.+++..... ..+++..+..++.|++.+|.+||+.+ ++|+||||+||++++++.++|+|||++......
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999854322 12899999999999999999999997 999999999999999999999999999876544
Q ss_pred CCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
...... ...+++.|+|||.+.+..++.++||||||+++++|++ |+.|+... ......... ........
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~---~~~~~~~~~----~~~~~~~~--- 225 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM---SNEEVLEYL----KKGYRLPK--- 225 (258)
T ss_pred cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHH----hcCCCCCC---
Confidence 222211 2236789999999988889999999999999999998 77776431 111111111 11111100
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
.......+.+++.+|++.+|++|||+.++++.|
T Consensus 226 ------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 ------PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111234577788899999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=311.04 Aligned_cols=256 Identities=29% Similarity=0.476 Sum_probs=198.5
Q ss_pred hcCCccccccccCCceeEEeeeec-CCc----eeEEEEecccCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGK----AIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 424 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 424 (672)
.++|+..+.||+|+||.||+|.+. ++. .+|+|.+..... .....+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 357888999999999999999864 343 468888765432 2334688999999999999999999998754 467
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceee
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 504 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~ 504 (672)
+++||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+
T Consensus 85 ~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 999999999999988542 235889999999999999999999997 999999999999999999999999999876
Q ss_pred CCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccc
Q 005871 505 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583 (672)
Q Consensus 505 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 583 (672)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ... .....+....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~---~~~----~~~~~~~~~~- 231 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---EIP----DLLEKGERLP- 231 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHCCCCCC-
Confidence 53332222223345778999999998899999999999999999997 88887432111 111 1111111000
Q ss_pred cChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 584 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
........+.+++..|+..+|++||++.+|++.|...
T Consensus 232 --------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 232 --------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred --------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0111224577888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=305.11 Aligned_cols=253 Identities=25% Similarity=0.395 Sum_probs=201.8
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
.++|++.++||.|+||.||++.+. ++..+|+|.+........+.+..|++++++++||||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 367999999999999999999975 6889999999877666677899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+++++|..++... ...+++..+..++.|++.+|.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 9999999988543 235899999999999999999999998 99999999999999999999999999876432221
Q ss_pred CcccccccccCCcCChhhhc-----CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 510 QANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
......|++.|+|||.+. ...++.++||||||+++|+|++|+.||...... ...... .......+.
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~~~~-~~~~~~~~~ 229 (280)
T cd06611 159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVLLKI-LKSEPPTLD 229 (280)
T ss_pred --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHHHHH-hcCCCCCcC
Confidence 122356899999999975 344788999999999999999999997533211 111111 111110000
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
. +......+.+++..||+.+|.+||++.+|++.
T Consensus 230 ~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 230 Q-------PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred C-------cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0 11112346678889999999999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=305.60 Aligned_cols=262 Identities=24% Similarity=0.330 Sum_probs=198.5
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEecccCcc-----cHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ-----GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
+|.+.+.||+|+||.||+|.+. +++.||+|++...... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999975 6899999998765322 335677899999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||+ +++|..++.... ..+++..+..++.||++||.|||+++ |+|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999885432 36899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccC--------
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCE-------- 577 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-------- 577 (672)
.... .....+++.|+|||.+.+ ..++.++|||||||++|||++|.++|...... ............
T Consensus 155 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 155 PNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI---DQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred CCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH---HHHHHHHHHcCCCchhhhhh
Confidence 3221 122346788999999865 45789999999999999999998776432211 111100000000
Q ss_pred -CCcccccChhhcC-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 578 -GPAVELIDPVLKQ-----SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 578 -~~~~~l~d~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
............. .........+.+++.+||+.+|++|||+.||++.=
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~ 283 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHP 283 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCc
Confidence 0000000000000 01112245678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=319.94 Aligned_cols=259 Identities=24% Similarity=0.335 Sum_probs=194.3
Q ss_pred HHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeC-----
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG----- 420 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~----- 420 (672)
...++|.+.+.||+|+||.||++.+. +++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34578999999999999999999875 68899999987542 22345678899999999999999999987643
Q ss_pred -ceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeec
Q 005871 421 -QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 499 (672)
Q Consensus 421 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFg 499 (672)
...++++|++ +++|..++. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 4578999987 778877763 245899999999999999999999998 9999999999999999999999999
Q ss_pred CceeeCCCCCCcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCC
Q 005871 500 LARIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 578 (672)
Q Consensus 500 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 578 (672)
+++..... .....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ......... ..
T Consensus 164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~-~~ 234 (343)
T cd07878 164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID---QLKRIMEVV-GT 234 (343)
T ss_pred cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHh-CC
Confidence 99865432 223468999999999877 568999999999999999999999985322110 000000000 00
Q ss_pred CcccccChh--------hc--CCCCH--------HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 579 PAVELIDPV--------LK--QSCAP--------DELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 579 ~~~~l~d~~--------l~--~~~~~--------~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
...+..... +. ..... .....+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 235 PSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000 00 00000 011246788899999999999999999965
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=306.35 Aligned_cols=255 Identities=27% Similarity=0.431 Sum_probs=200.5
Q ss_pred cCCccccccccCCceeEEeeeecC-Cc----eeEEEEecccCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLAD-GK----AIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l 425 (672)
.+|++.+.||+|+||.||+|.+++ +. .+|+|.+..... .....+.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 578899999999999999998643 33 589998876543 345678899999999999999999999987 78999
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
||||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999998543 335899999999999999999999987 9999999999999999999999999998765
Q ss_pred CCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 506 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 506 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
............++..|+|||.+....++.++|+||||+++|||++ |+.||...... .+... ...+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~----~~~~~~~--- 230 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIPDL----LEKGERL--- 230 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHH----HhCCCCC---
Confidence 3322221112223567999999988899999999999999999998 99997533211 11111 1111100
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
..+......+.+++.+||..+|++||++.++++.|...
T Consensus 231 ------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 231 ------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 00111123467788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=320.63 Aligned_cols=246 Identities=30% Similarity=0.457 Sum_probs=204.0
Q ss_pred ccccCCceeEEeeeecC-CceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCCCChhH
Q 005871 359 KLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDV 437 (672)
Q Consensus 359 ~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 437 (672)
+||+|.||+||.|++.+ ...+|||.+........+.+..|+.+.+.|+|.|||+++|.+.+++.+-|.||-.+||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999865 56789999988777788899999999999999999999999999999999999999999999
Q ss_pred HhhhccccCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc-CCCCeEEEeecCceeeCCCCCCcccc
Q 005871 438 HLFDATRSVQL--DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGGNQNQANTN 514 (672)
Q Consensus 438 ~l~~~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~-~~~~~kL~DFgla~~~~~~~~~~~~~ 514 (672)
+|. .+-+++ ++.++..+.+||++||.|||++. |||||||-+||||+ -.|.+||.|||-++.+.. ....+.
T Consensus 662 LLr--skWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TE 734 (1226)
T KOG4279|consen 662 LLR--SKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTE 734 (1226)
T ss_pred HHH--hccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCcccc
Confidence 984 344566 88899999999999999999997 99999999999997 578999999999987643 334455
Q ss_pred cccccCCcCChhhhcCC--CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCC
Q 005871 515 IIAGTYGYMAPEYAMGG--IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSC 592 (672)
Q Consensus 515 ~~~gt~~Y~aPE~~~~~--~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 592 (672)
.+.||..|||||++-.| .|+.++|||||||++.||.||++||-........ .+.-|. .+. -...
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--------MFkVGm-yKv-----HP~i 800 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--------MFKVGM-YKV-----HPPI 800 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--------hhhhcc-eec-----CCCC
Confidence 67899999999999776 4899999999999999999999997432222111 011110 000 1223
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 593 APDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 593 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
+.+...+...+|++|+.+||.+||++.++|+.-
T Consensus 801 Peelsaeak~FilrcFepd~~~R~sA~~LL~Dp 833 (1226)
T KOG4279|consen 801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQDP 833 (1226)
T ss_pred cHHHHHHHHHHHHHHcCCCcccCccHHHhccCc
Confidence 455667788899999999999999999999754
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=303.34 Aligned_cols=249 Identities=29% Similarity=0.406 Sum_probs=189.4
Q ss_pred cccccCCceeEEeeeec----CCceeEEEEeccc-CcccHHHHHHHHHHHHhccCCCeeeEEEEEE-eCceEEEEEeecC
Q 005871 358 NKLGQGGFGPVYKGTLA----DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL-EGQELLLIYEYMP 431 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~-~~~~~~lV~Ey~~ 431 (672)
+.||+|+||.||+|.+. ++..+|+|++... .....+.+.+|+.+++.++||||+++++++. .+...++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999863 2457999988643 3344678889999999999999999999776 4556899999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC-
Q 005871 432 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ- 510 (672)
Q Consensus 432 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~- 510 (672)
+++|..++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999998543 234677888999999999999999987 999999999999999999999999999765432211
Q ss_pred -cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCC-CCCCCCCcccccchhhhhhhhccCCCcccccChhh
Q 005871 511 -ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR-KNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588 (672)
Q Consensus 511 -~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 588 (672)
.......++..|+|||.+.+..++.++||||||+++|||++|. +|+... ....+... ........ .
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~---~~~~~~~~---~~~~~~~~------~ 223 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV---DSFDITVY---LLQGRRLL------Q 223 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHH---HhcCCCCC------C
Confidence 1111234577899999998889999999999999999999965 444321 11111111 11111100 0
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 589 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 589 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
... ....+.+++.+||+.+|++||++.+|++.|..
T Consensus 224 ~~~----~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~ 258 (262)
T cd05058 224 PEY----CPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ 258 (262)
T ss_pred CCc----CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 011 12357788889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=300.96 Aligned_cols=254 Identities=25% Similarity=0.412 Sum_probs=199.4
Q ss_pred CCccccccccCCceeEEeeeecC--CceeEEEEeccc----------CcccHHHHHHHHHHHHh-ccCCCeeeEEEEEEe
Q 005871 353 HFSDENKLGQGGFGPVYKGTLAD--GKAIAVKRLSRT----------SGQGLQEFKNEVNLIAK-LQHKNLVRLLGCCLE 419 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~il~~-l~h~niv~l~~~~~~ 419 (672)
+|++.+.||+|+||.||+|.+.. ++.+|+|.+... .......+.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47889999999999999999764 688999987532 22234567788888875 799999999999999
Q ss_pred CceEEEEEeecCCCChhHHhhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEee
Q 005871 420 GQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDF 498 (672)
Q Consensus 420 ~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DF 498 (672)
++..++||||+++++|.+++... .....+++..++.++.|++.+|.|||+.. +++|+||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999887542 23456899999999999999999999632 3999999999999999999999999
Q ss_pred cCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCC
Q 005871 499 GLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 578 (672)
Q Consensus 499 gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 578 (672)
|.+....... ......|+..|++||.+.++.++.++||||||+++|+|++|+.||..... ....... ...
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~------~~~~~~~-~~~ 228 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM------LSLATKI-VEA 228 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH------HHHHHHH-hhc
Confidence 9998765432 23345688999999999998899999999999999999999999742211 1111111 011
Q ss_pred CcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 579 PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 579 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
... +.... .....+.+++.+||+.||++||++.||.++|.
T Consensus 229 ~~~----~~~~~----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 VYE----PLPEG----MYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCC----cCCcc----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 100 00000 11235677888999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=309.37 Aligned_cols=268 Identities=24% Similarity=0.339 Sum_probs=197.7
Q ss_pred CCccccccccCCceeEEeeeec---CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeC--ceEE
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA---DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELL 424 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~ 424 (672)
+|.+.++||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999975 47899999998743 34456778899999999999999999999988 8899
Q ss_pred EEEeecCCCChhHHhhhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC----CCCeEEEee
Q 005871 425 LIYEYMPNKSLDVHLFDAT--RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD----DMNPKISDF 498 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~----~~~~kL~DF 498 (672)
+||||+++ ++...+.... ....+++..++.++.||+.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999976 5555554322 2236899999999999999999999997 999999999999999 899999999
Q ss_pred cCceeeCCCCC-CcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCccccc-ch-----hhh
Q 005871 499 GLARIFGGNQN-QANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQ-TL-----LTY 570 (672)
Q Consensus 499 gla~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~-~~-----~~~ 570 (672)
|++........ ........+++.|+|||.+.+. .++.++||||||+++|+|++|++||......... .. ...
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987644322 1222345678999999988764 5799999999999999999999998654332200 00 000
Q ss_pred hhhhccCC------------CcccccChhhcCCCC----H-------HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 571 TWKLWCEG------------PAVELIDPVLKQSCA----P-------DELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 571 ~~~~~~~~------------~~~~l~d~~l~~~~~----~-------~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
....+... ......+........ . .....+.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000000 000000000000000 0 223457889999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=300.94 Aligned_cols=253 Identities=25% Similarity=0.434 Sum_probs=199.9
Q ss_pred CCccccccccCCceeEEeeee-cCCceeEEEEecccC------cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEE
Q 005871 353 HFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS------GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l 425 (672)
+|+..+.||+|++|.||++.. .+++.+|+|++.... ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999986 468999999987543 1235678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-CeEEEeecCceee
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIF 504 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~-~~kL~DFgla~~~ 504 (672)
||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ ++|+||||+||+++.++ .+||+|||.+..+
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999998853 346889999999999999999999997 99999999999998776 5999999999876
Q ss_pred CCCCCC--cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccc
Q 005871 505 GGNQNQ--ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVE 582 (672)
Q Consensus 505 ~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (672)
...... .......|+..|+|||.+.+..++.++||||+|+++++|++|+.||....... .............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~--- 228 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN---HLALIFKIASATT--- 228 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc---hHHHHHHHhccCC---
Confidence 543211 11223468899999999988889999999999999999999999975322111 1111111100000
Q ss_pred ccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 583 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 583 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
....+......+.+++.+||+.+|++|||+.++++
T Consensus 229 ------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 ------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 01112223356778888999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=304.88 Aligned_cols=262 Identities=24% Similarity=0.355 Sum_probs=200.2
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
+|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5888999999999999999975 68999999987654 33456789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+ +++|.+++.... ..+++.+++.++.||+.+|.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999998885433 46899999999999999999999997 99999999999999999999999999987654322
Q ss_pred CcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCC----------
Q 005871 510 QANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG---------- 578 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 578 (672)
.......|+..|+|||++.+. .++.++||||+|+++|||++|+++|...... .............
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhccC
Confidence 112234688999999998654 4689999999999999999998776432211 1111111100000
Q ss_pred --CcccccChhh----cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 579 --PAVELIDPVL----KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 579 --~~~~l~d~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
....+..+.. .....+.....+.+++.+||+.+|++|||++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000 000011223677888999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=300.55 Aligned_cols=254 Identities=22% Similarity=0.339 Sum_probs=188.0
Q ss_pred cccccCCceeEEeeeecCC---ceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCCC
Q 005871 358 NKLGQGGFGPVYKGTLADG---KAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 433 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~g 433 (672)
+.||+|+||.||++...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975433 345677665443 334578999999999999999999999999999999999999999
Q ss_pred ChhHHhhhccc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcc
Q 005871 434 SLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 512 (672)
Q Consensus 434 sL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~ 512 (672)
+|.+++..... ....++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999865322 234677788899999999999999987 99999999999999999999999999864322222222
Q ss_pred cccccccCCcCChhhhcC-------CCCChhhHHHHHHHHHHHHHcC-CCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 513 TNIIAGTYGYMAPEYAMG-------GIFSIKSDVFSFGVLLLEIISG-RKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 513 ~~~~~gt~~Y~aPE~~~~-------~~~s~ksDvwSlGvil~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
.....|+..|+|||++.. ..++.++||||||+++|||+++ ..|+.... . .......+ .+....+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~---~---~~~~~~~~-~~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS---D---REVLNHVI-KDQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC---H---HHHHHHHH-hhcccccC
Confidence 234567889999998753 2357899999999999999975 55653211 1 11111111 11122233
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
++.+..... ..+.+++..|+ .+|++||++++|++.|.
T Consensus 231 ~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 333322222 34566777898 67999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=300.92 Aligned_cols=255 Identities=26% Similarity=0.412 Sum_probs=198.3
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEecccCc----------ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCc
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG----------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ 421 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~ 421 (672)
+|.+.+.||+|+||.||+|... +++.+|+|.+..... ...+.+..|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5778899999999999999865 688999998754211 12346788999999999999999999999999
Q ss_pred eEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCc
Q 005871 422 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 501 (672)
Q Consensus 422 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla 501 (672)
..++||||+++++|.+++... ..+++..+..++.||+.+|.|||+++ ++||||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999988543 46899999999999999999999987 999999999999999999999999999
Q ss_pred eeeCCCCCCcccccccccCCcCChhhhcCCC--CChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCC
Q 005871 502 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGI--FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGP 579 (672)
Q Consensus 502 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 579 (672)
................|+..|+|||.+.... ++.++|+||||+++|+|++|..|+.... .............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~~~ 229 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE------AIAAMFKLGNKRS 229 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc------hHHHHHHhhcccc
Confidence 8654322222223346888999999987654 7999999999999999999999974211 1111111111111
Q ss_pred cccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 580 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 580 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
...+ .. .........+.+++.+||+.+|++|||+.+|++.
T Consensus 230 ~~~~-~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 APPI-PP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCcC-Cc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1111 11 1111223567788889999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=302.78 Aligned_cols=257 Identities=25% Similarity=0.372 Sum_probs=198.5
Q ss_pred HHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhc-cCCCeeeEEEEEE-----eCc
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCL-----EGQ 421 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~-----~~~ 421 (672)
...++|++.+.||+|+||.||++.+. +++.+|+|++.... .....+.+|+.+++++ +||||+++++++. .+.
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 93 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGD 93 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCC
Confidence 45689999999999999999999875 58899999876533 2235678899999999 6999999999884 345
Q ss_pred eEEEEEeecCCCChhHHhhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecC
Q 005871 422 ELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 500 (672)
Q Consensus 422 ~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgl 500 (672)
..++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~ 170 (286)
T cd06638 94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGV 170 (286)
T ss_pred eEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCc
Confidence 789999999999999887542 23356889999999999999999999987 99999999999999999999999999
Q ss_pred ceeeCCCCCCcccccccccCCcCChhhhcC-----CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhc
Q 005871 501 ARIFGGNQNQANTNIIAGTYGYMAPEYAMG-----GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLW 575 (672)
Q Consensus 501 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 575 (672)
+..+..... ......|++.|+|||++.. ..++.++|||||||++|||++|+.|+....... .....
T Consensus 171 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~------~~~~~- 241 (286)
T cd06638 171 SAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR------ALFKI- 241 (286)
T ss_pred eeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH------HHhhc-
Confidence 987643222 1223468999999999853 457899999999999999999999975322110 00000
Q ss_pred cCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 576 CEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 576 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
.........++ ......+.+++.+||+.||++|||+.||++.+
T Consensus 242 ~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 242 PRNPPPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred cccCCCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00000011111 01123577888899999999999999999753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=306.26 Aligned_cols=265 Identities=24% Similarity=0.345 Sum_probs=200.7
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
++|++.++||+|+||.||+|.++ +++.|++|++.... ....+.+.+|+++++.++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36899999999999999999976 58899999886542 3345778999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|++++.+..+.. +...+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999877765552 2345899999999999999999999997 9999999999999999999999999998765433
Q ss_pred CCcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhh--------hhhhccCC-
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTY--------TWKLWCEG- 578 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~--------~~~~~~~~- 578 (672)
.. ......++..|+|||++.+. .++.++||||||+++|+|++|++||.............. .+..+...
T Consensus 155 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 155 AS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred cc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 21 22234678899999999888 789999999999999999999998753221100000000 00000000
Q ss_pred -----CcccccChh-hcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 579 -----PAVELIDPV-LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 579 -----~~~~l~d~~-l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
...+..+.. ............+.+++.+||+.+|++|||+++|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000000000 000111122456888999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=339.83 Aligned_cols=256 Identities=23% Similarity=0.326 Sum_probs=197.5
Q ss_pred HHhcCCccccccccCCceeEEeeeec-CCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEe--CceE
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE--GQEL 423 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~ 423 (672)
...++|.+.++||+|+||.||++.+. .+..+|+|.+... .......+..|+.+|++|+||||++++++|.+ ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34578999999999999999999976 5778899988654 23345678999999999999999999999865 3579
Q ss_pred EEEEeecCCCChhHHhhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeeecCCCCCcEEEcC---------
Q 005871 424 LLIYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSR----LKIIHRDLKASNILLDD--------- 489 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~g~----~~iiHrDlkp~NIll~~--------- 489 (672)
+|||||+++++|..+|.... ....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999986532 23569999999999999999999998531 24999999999999964
Q ss_pred --------CCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcC--CCCChhhHHHHHHHHHHHHHcCCCCCCCC
Q 005871 490 --------DMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG--GIFSIKSDVFSFGVLLLEIISGRKNNGFY 559 (672)
Q Consensus 490 --------~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDvwSlGvil~elltG~~p~~~~ 559 (672)
.+.+||+|||++..+..... .....||+.|+|||++.+ ..++.++||||||||+|||++|+.||...
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 23489999999986543221 233579999999999864 45899999999999999999999998532
Q ss_pred CcccccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 560 FSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
.. ..... ........ +.. ......+.+||..||+.+|.+||++.++++
T Consensus 247 ~~-----~~qli-~~lk~~p~-------lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NN-----FSQLI-SELKRGPD-------LPI---KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred Cc-----HHHHH-HHHhcCCC-------CCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 11 11111 11111110 000 111245778888999999999999999984
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=309.05 Aligned_cols=251 Identities=25% Similarity=0.374 Sum_probs=199.3
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
+.|.....||+|+||.||++... ++..+|||++........+.+.+|+.+++.++|+||+++++.+...+..++||||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 44555678999999999999875 58899999987665556677899999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
++++|.+++.. ..+++..+..++.||+.+|.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 102 ~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~- 173 (292)
T cd06658 102 EGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP- 173 (292)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-
Confidence 99999988732 34889999999999999999999997 99999999999999999999999999876533221
Q ss_pred cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcC
Q 005871 511 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 590 (672)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ........ . .+.+.+..
T Consensus 174 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~~~-~-----~~~~~~~~ 240 (292)
T cd06658 174 -KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP------LQAMRRIR-D-----NLPPRVKD 240 (292)
T ss_pred -cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHH-h-----cCCCcccc
Confidence 12234688999999999888899999999999999999999999753211 11111100 0 00111111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 591 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
. ......+.+++.+|++.||++|||++++++.-
T Consensus 241 ~--~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~ 273 (292)
T cd06658 241 S--HKVSSVLRGFLDLMLVREPSQRATAQELLQHP 273 (292)
T ss_pred c--cccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence 0 11123466777899999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=299.02 Aligned_cols=250 Identities=23% Similarity=0.375 Sum_probs=200.7
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
+|++.++||+|+||.||++... +++.+|+|.+... .......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999875 6889999998653 233456789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+.+++|.+.+... ....+++.++..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999999888542 2235789999999999999999999987 99999999999999999999999999987644322
Q ss_pred CcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhc
Q 005871 510 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 589 (672)
. .....|++.|+|||++.+..++.++|+||||+++++|++|+.|+.... .......... +....
T Consensus 157 ~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~------~~~~~~~~~~-~~~~~------- 220 (256)
T cd08218 157 L--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN------MKNLVLKIIR-GSYPP------- 220 (256)
T ss_pred h--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC------HHHHHHHHhc-CCCCC-------
Confidence 1 123457889999999998889999999999999999999999974221 1111111111 11100
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 590 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.+......+.+++.+||+.+|++||++.+|++.
T Consensus 221 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 --VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred --CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 111223457788889999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=304.95 Aligned_cols=262 Identities=23% Similarity=0.341 Sum_probs=195.8
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
++|++.++||+|++|.||+|..+ +++.||+|.+..... .....+.+|++++++++|+||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67999999999999999999976 689999999875432 2234567899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+.+ +|..++.... ..+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 985 8888775432 36899999999999999999999997 99999999999999999999999999875432221
Q ss_pred CcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCC---Cccc---
Q 005871 510 QANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG---PAVE--- 582 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~--- 582 (672)
. .....++..|+|||++.+ ..++.++||||+|+++|+|++|+.||...... .......+...... .+..
T Consensus 159 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 159 T--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred c--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhhhhhhh
Confidence 1 112346788999999876 45799999999999999999999998533210 01111111111000 0000
Q ss_pred -----------ccChhhcCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 583 -----------LIDPVLKQSCA-PDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 583 -----------l~d~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
.....+..... ......+.+++.+||+.+|++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000000000 011245678889999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=299.76 Aligned_cols=251 Identities=25% Similarity=0.411 Sum_probs=206.8
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
+-|.++.+||+|+||.||++.++ .|+.+|||++...+ +.+++.+|+.||++.+.|++|+++|.+.....+++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 34788999999999999999986 59999999886543 4688999999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
..|++.+.+.. ++.++++.++..+++..++||+|||... =||||||..|||++.+|+.||+|||.+..+.....
T Consensus 111 GAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA- 184 (502)
T KOG0574|consen 111 GAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA- 184 (502)
T ss_pred CCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHH-
Confidence 99999999853 5568999999999999999999999986 89999999999999999999999999987754332
Q ss_pred cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcC
Q 005871 511 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 590 (672)
..+.+.|||.|||||+++.-.|..++||||||++..||..|++|+..-.+-.. +.-+.++ +...+-.
T Consensus 185 -KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA------IFMIPT~-PPPTF~K----- 251 (502)
T KOG0574|consen 185 -KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA------IFMIPTK-PPPTFKK----- 251 (502)
T ss_pred -hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce------eEeccCC-CCCCCCC-----
Confidence 23457899999999999999999999999999999999999999642211111 1111111 1111111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 591 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
+..-...+-+++++||-++|++|-|+.++++.-
T Consensus 252 --PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 252 --PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred --hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 223345677888899999999999999988754
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=304.90 Aligned_cols=261 Identities=22% Similarity=0.319 Sum_probs=193.7
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
+|++.++||+|+||.||+|.+. +|+.+|+|++.... ......+.+|+.++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 5888999999999999999985 68899999986542 22235678899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+++ +|..++... ...+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+.....
T Consensus 81 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 975 666666432 345899999999999999999999997 99999999999999999999999999986543221
Q ss_pred CcccccccccCCcCChhhhcCCC-CChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhh-----------hhhccC
Q 005871 510 QANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYT-----------WKLWCE 577 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~-----------~~~~~~ 577 (672)
. .....+++.|+|||.+.+.. ++.++|||||||++|+|++|+.|+...... ....... |.....
T Consensus 155 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 155 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred C--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH--HHHHHHHHHHhCCCChHHhHHhhh
Confidence 1 12235788999999987754 799999999999999999999885321110 0011100 000000
Q ss_pred CCcccccChhhc----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 578 GPAVELIDPVLK----QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 578 ~~~~~l~d~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
............ ....+.....+.+++.+||+.||.+|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000000000000 0001112345678888999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=299.51 Aligned_cols=250 Identities=26% Similarity=0.416 Sum_probs=193.1
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC-----cccHHHHHHHHHHHHhccCCCeeeEEEEEEe--CceE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-----GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE--GQEL 423 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~ 423 (672)
.+|...+.||+|+||.||++.+. .+..|++|++.... ......+.+|+.+++.++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47899999999999999999875 58899999886432 2234568899999999999999999999875 3578
Q ss_pred EEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 424 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
+++|||+++++|.+++.. ...+++...+.++.|++.+|.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 999999999999998853 235889999999999999999999987 99999999999999999999999999986
Q ss_pred eCCCCC-CcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccc
Q 005871 504 FGGNQN-QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVE 582 (672)
Q Consensus 504 ~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (672)
+..... ........++..|+|||.+.+..++.++||||||+++|||++|+.||..... ............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~~~~~~~~~~--- 226 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAAIFKIATQPT--- 226 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHHHHHHhcCCC---
Confidence 543211 1112234588899999999988899999999999999999999999753211 111111111100
Q ss_pred ccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 583 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 583 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
.+. .+......+.+++ .|+..+|++||+++||++
T Consensus 227 --~~~----~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 --NPQ----LPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred --CCC----CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 111 1111122344444 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=296.25 Aligned_cols=252 Identities=27% Similarity=0.413 Sum_probs=205.4
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
++|++.+.||+|++|.||++++. +++.+++|++..... .....+.+|+.++++++|+|++++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46889999999999999999986 599999999876654 4467899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE-DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
+++++|.+++... ..+++..+..++.|++++|.|||+ .+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999998543 568999999999999999999999 87 9999999999999999999999999998764333
Q ss_pred CCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhh
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 588 (672)
... ....++..|+|||.+.+..++.++|+||||+++|+|++|+.|+........ ........ ...... +
T Consensus 155 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~---~~~~~~~~-~~~~~~-----~ 223 (264)
T cd06623 155 DQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF---FELMQAIC-DGPPPS-----L 223 (264)
T ss_pred Ccc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCH---HHHHHHHh-cCCCCC-----C
Confidence 221 234678899999999999999999999999999999999999754432111 11111111 111110 1
Q ss_pred cCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 589 KQSCAPD-ELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 589 ~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
... ....+.+++.+||+.+|++||++.++++.
T Consensus 224 ----~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 ----PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ----CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111 23467788889999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=302.57 Aligned_cols=254 Identities=24% Similarity=0.365 Sum_probs=199.1
Q ss_pred cCCccccccccCCceeEEeeeecC----CceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
++|.+.++||+|+||.||+|.+.+ ...+++|...... .+..+.+.+|+.++++++||||+++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 568889999999999999998643 3468999887654 4456789999999999999999999998875 457899
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 9999999999998542 235899999999999999999999987 99999999999999999999999999987654
Q ss_pred CCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccC
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 585 (672)
...... ....++..|+|||.+....++.++||||||+++|||++ |+.||...... .... ... .+.....
T Consensus 160 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~---~~~-~~~~~~~-- 229 (270)
T cd05056 160 ESYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIG---RIE-NGERLPM-- 229 (270)
T ss_pred ccceec-CCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHH---HHH-cCCcCCC--
Confidence 322111 12234567999999988889999999999999999996 99997433211 1111 111 1111000
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
.......+.+++.+|+..+|++|||+.++++.|...
T Consensus 230 -------~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 230 -------PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred -------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111223577788899999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=299.39 Aligned_cols=247 Identities=31% Similarity=0.424 Sum_probs=195.9
Q ss_pred cCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecC
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 431 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 431 (672)
++|.+.+.||+|+||.||++.. .++.+|+|++.... ..+.+.+|+.+++.++|||++++++++... ..++||||+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4688999999999999999975 57889999886543 346788999999999999999999998764 4799999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCc
Q 005871 432 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 511 (672)
Q Consensus 432 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 511 (672)
+++|..++.... ...+++..+..++.|++.||.|||+.| ++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 999999986432 335889999999999999999999987 9999999999999999999999999987643211
Q ss_pred ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcC
Q 005871 512 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590 (672)
Q Consensus 512 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 590 (672)
.....+..|+|||++.++.++.++|+||||+++|+|++ |+.||...... .... ....+.....
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~----~~~~~~~~~~------- 218 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK---EVKE----CVEKGYRMEP------- 218 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH---HHHH----HHhCCCCCCC-------
Confidence 11233567999999998899999999999999999998 88887432211 1111 1111110000
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 591 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
.......+.+++.+||+.+|++||++++|++.|..
T Consensus 219 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 --PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred --CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11123456788889999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=299.14 Aligned_cols=254 Identities=27% Similarity=0.402 Sum_probs=202.1
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
++|+..+.||+|++|.||++.++ +++.+++|.+.... ......+.+|++++++++||||+++++.+..+...++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36888899999999999999986 68899999987654 34456789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE-DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
+++++|.+++.... ..+++..+..++.|++.+|.|||+ .+ ++|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999885432 568999999999999999999999 76 9999999999999999999999999987653221
Q ss_pred CCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhh
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 588 (672)
. ....|+..|+|||.+.+..++.++||||||+++|+|++|+.|+....... ............ .....+
T Consensus 156 ~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~-~~~~~~----- 224 (265)
T cd06605 156 A----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVN-EPPPRL----- 224 (265)
T ss_pred h----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhc-CCCCCC-----
Confidence 1 11568889999999999999999999999999999999999975432211 111111111111 111011
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 589 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 589 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
... .....+.+++.+||..+|++|||+.+++..
T Consensus 225 ~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 225 PSG---KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred Chh---hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 000 023447788889999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=300.03 Aligned_cols=264 Identities=28% Similarity=0.397 Sum_probs=198.6
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEecccCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
+|++.++||+|++|.||+|++. +++.||+|++..... .....+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5889999999999999999986 588999999876532 23466788999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
++ +|.+++........+++..+..++.||+.||.|||+.+ |+||||||+||++++++.++|+|||++.........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 85 77777755444456899999999999999999999987 999999999999999999999999999765432211
Q ss_pred cccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccc-hh-------hhhhhhccCCC--
Q 005871 511 ANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQT-LL-------TYTWKLWCEGP-- 579 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~-~~-------~~~~~~~~~~~-- 579 (672)
.....++..|++||.+.+. .++.++||||||+++|+|++|+.||.......... .. ...|+.+....
T Consensus 157 --~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 157 --FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred --cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 1223568899999998664 57899999999999999999999975432211000 00 00011110000
Q ss_pred ---cccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 580 ---AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 580 ---~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
.....+... ....+.....+.+++.+|++.||.+||++.+|++
T Consensus 235 ~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 235 KPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000000 0011122345778889999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.57 Aligned_cols=251 Identities=25% Similarity=0.380 Sum_probs=195.8
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC-----cccHHHHHHHHHHHHhccCCCeeeEEEEEEeC--ceE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-----GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QEL 423 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~ 423 (672)
++|.+.+.||+|+||.||++.+. ++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47899999999999999999975 58999999875322 22346788999999999999999999998764 468
Q ss_pred EEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 424 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
++||||+++++|.+++... ..+++..+..++.|++.+|.|||+.+ |+|+||||+||+++.++.++|+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 8999999999999888532 35788999999999999999999997 99999999999999999999999999986
Q ss_pred eCCCCCC-cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccc
Q 005871 504 FGGNQNQ-ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVE 582 (672)
Q Consensus 504 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (672)
....... .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||..... ..... ..... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~~~-~~~~~-~~-- 226 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-----MAAIF-KIATQ-PT-- 226 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-----HHHHH-HHhcC-CC--
Confidence 5432111 122334688999999999888899999999999999999999999753211 11111 11000 00
Q ss_pred ccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 583 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 583 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
. ...+......+.+++.+|+. +|++||+++||++.
T Consensus 227 --~----~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 --N----PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred --C----CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0 11122333456777788885 99999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=298.72 Aligned_cols=251 Identities=25% Similarity=0.374 Sum_probs=200.1
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEe--CceEEEEE
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELLLIY 427 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~~lV~ 427 (672)
+|++.+.||.|+||.||++.+. +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788999999999999999875 6889999988653 23345678899999999999999999998764 45689999
Q ss_pred eecCCCChhHHhhhc-cccCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeeecCCCCCcEEEcCCCCeEEEeecCc
Q 005871 428 EYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLH-----EDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 501 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH-----~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla 501 (672)
||+++++|..++... .....+++..++.++.||+.+|.||| +.+ |+|+||||+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999998653 22456899999999999999999999 655 999999999999999999999999999
Q ss_pred eeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcc
Q 005871 502 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAV 581 (672)
Q Consensus 502 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (672)
......... .....|++.|+|||.+.+..++.++|+||||+++++|++|+.|+..... ..... ....+...
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~----~~~~~~~~ 228 (265)
T cd08217 158 KILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLAS----KIKEGKFR 228 (265)
T ss_pred ccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHHH----HHhcCCCC
Confidence 876543321 1234689999999999998899999999999999999999999754321 11111 11111111
Q ss_pred cccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 582 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 582 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.........+.+++.+||+.+|++|||+.+|+++
T Consensus 229 ---------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 ---------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1112233567788889999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=313.14 Aligned_cols=266 Identities=26% Similarity=0.417 Sum_probs=212.8
Q ss_pred HhcCCccccccccCCceeEEeeeecCCceeEEEEecccCcc-cHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
......+.++||+|-||+|.++....+..||+|.++..... ....|..|+++|.+|+||||+.++|+|..++.+++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 34567788999999999999999988899999999876544 44889999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
||++|+|..++..+.... +..+....|+.||+.|++||.+.. +|||||.+.|+|++.++++||+|||+++-+...+
T Consensus 616 YmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence 999999999997653322 455666779999999999999875 9999999999999999999999999999766555
Q ss_pred CCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc--CCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS--GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
........+-..+|||||.+..++++.++|||+||+++||+++ ...|++....+ ...+-....+..+.....+
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~~~~~~l-- 766 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQGRQVVL-- 766 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCCCcceec--
Confidence 5544445566789999999999999999999999999999876 55665432221 1222222222222211111
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
..++-...++.++++.||..+-++||++++|...|..+
T Consensus 767 ----~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 767 ----SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ----cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11233445677999999999999999999999888654
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=303.03 Aligned_cols=264 Identities=23% Similarity=0.327 Sum_probs=198.3
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeC--ceEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLLI 426 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~lV 426 (672)
++|++.+.||+|+||.||+|.++ +++.+++|.+..... .....+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57999999999999999999986 588999999865432 2234567899999999999999999999877 899999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||+.+ +|..++.... ..+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++..+..
T Consensus 85 ~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999975 8887775432 36899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCcccccccccCCcCChhhhcCCC-CChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchh--------hhhhhhccC
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLL--------TYTWKLWCE 577 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~--------~~~~~~~~~ 577 (672)
... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||............ ...|..+..
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 321 122345788999999987654 689999999999999999999998643221110000 001111100
Q ss_pred ------CCcccccChhhcCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 578 ------GPAVELIDPVLKQSCAPD-ELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 578 ------~~~~~l~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
..........+....... ....+.+++.+||+.+|++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 001111111111111111 2445778888999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=291.64 Aligned_cols=251 Identities=28% Similarity=0.451 Sum_probs=204.9
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEecccCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeC--ceEEEEE
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLLIY 427 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~lV~ 427 (672)
+|.+.+.||+|++|.||+|... +++.+++|++..... ...+.+.+|+.++++++|+||+++++.+.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999986 689999999876543 4567889999999999999999999999988 8999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+++++|.+++.... .+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999985432 6899999999999999999999987 999999999999999999999999999877554
Q ss_pred CCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChh
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 587 (672)
..........++..|++||.+.+...+.++||||||+++++|++|+.||.... ......+..........
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~----- 224 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEPPE----- 224 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCCcC-----
Confidence 33212234568899999999988889999999999999999999999975433 11111222111111111
Q ss_pred hcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 588 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 588 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
.+......+.+++.+|++.+|++||++.++++
T Consensus 225 ----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 225 ----IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ----CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11122456778888999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.08 Aligned_cols=256 Identities=18% Similarity=0.219 Sum_probs=199.2
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
++|.+.+.||+|+||.||++.+. .++.|++|.+.... ......+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47889999999999999999976 57899999887653 233457889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+++++|..++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999999843 245899999999999999999999987 999999999999999999999999998642111
Q ss_pred CC-------------CcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhh
Q 005871 508 QN-------------QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL 574 (672)
Q Consensus 508 ~~-------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 574 (672)
.. ........|+..|+|||.+.+..++.++|+||||+++|||++|..||.... ........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~------~~~~~~~~ 228 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT------PEELFGQV 228 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHH
Confidence 00 001112457889999999988889999999999999999999999974221 11111111
Q ss_pred ccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 575 WCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 575 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
. .+.. ..+... ......+.+++.+||+.+|++||+..++.+.|..
T Consensus 229 ~-~~~~---~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 229 I-SDDI---EWPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred H-hccc---CCCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1 1100 000000 1122346788889999999999997777776655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=298.26 Aligned_cols=262 Identities=27% Similarity=0.347 Sum_probs=201.6
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeC--ceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~lV~ 427 (672)
++|...++||.|++|.||++.+. +++.+|+|.+..... .....+.+|++++++++||||+++++++.+. ..+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888999999999999999985 588999998875433 3456789999999999999999999998654 4789999
Q ss_pred eecCCCChhHHhhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 428 EYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
||+++++|.+++... .....+++..+..++.||+.+|.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999887542 23455889999999999999999999997 99999999999999999999999999875432
Q ss_pred CCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||.......... ........ ......+.+.
T Consensus 158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~ 231 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGP-IELLSYIV-NMPNPELKDE 231 (287)
T ss_pred ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCCh-HHHHHHHh-cCCchhhccC
Confidence 221 23457889999999999999999999999999999999999986442211111 11111110 1111111111
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
... .......+.+++.+||+.+|++|||+.||++.-
T Consensus 232 ~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 232 PGN---GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred CCC---CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 000 011234577888999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=300.11 Aligned_cols=248 Identities=26% Similarity=0.440 Sum_probs=199.2
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
+-|++.++||+|+||.||+|.+. ++..+|+|.+.... ......+.+|+.++++++||||+++++.+.++...++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 34778899999999999999875 68899999876443 33456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+++++|..++.. ..+++..+..++.|++.+|.+||+.+ ++|+||||+||+++.++.++|+|||++..+.....
T Consensus 84 ~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 84 LGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 999999988742 35899999999999999999999987 99999999999999999999999999886643321
Q ss_pred CcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhc
Q 005871 510 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 589 (672)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..|+...... ...... ..... +.+
T Consensus 157 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~-~~~~~-----~~~- 221 (277)
T cd06641 157 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------KVLFLI-PKNNP-----PTL- 221 (277)
T ss_pred --hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------HHHHHH-hcCCC-----CCC-
Confidence 122346788999999998888999999999999999999999997432111 111111 00100 011
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 590 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.......+.+++.+||+.+|++||++.++++.
T Consensus 222 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 ---EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ---CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11123456778889999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=306.37 Aligned_cols=251 Identities=24% Similarity=0.364 Sum_probs=199.2
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecC
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 431 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 431 (672)
.|....+||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++.+..++..++||||++
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~ 101 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence 3445568999999999999875 689999999876555556778999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCc
Q 005871 432 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 511 (672)
Q Consensus 432 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 511 (672)
+++|..++.. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+.....
T Consensus 102 ~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-- 172 (297)
T cd06659 102 GGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-- 172 (297)
T ss_pred CCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--
Confidence 9999887632 35899999999999999999999997 99999999999999999999999999875533221
Q ss_pred ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCC
Q 005871 512 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQS 591 (672)
Q Consensus 512 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~ 591 (672)
......|+..|+|||++.+..++.++||||||+++|||++|+.||..... ....... ..........
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~-~~~~~~~~~~------ 239 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP------VQAMKRL-RDSPPPKLKN------ 239 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHH-hccCCCCccc------
Confidence 12235689999999999988999999999999999999999999753221 1111111 1110000000
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 592 CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 592 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
.......+.+++.+||+.+|++||++++|++.--
T Consensus 240 -~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~ 273 (297)
T cd06659 240 -AHKISPVLRDFLERMLTREPQERATAQELLDHPF 273 (297)
T ss_pred -cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChh
Confidence 0111234667888999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=301.07 Aligned_cols=255 Identities=25% Similarity=0.411 Sum_probs=197.1
Q ss_pred CccccccccCCceeEEeeeec----CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCc------
Q 005871 354 FSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------ 421 (672)
Q Consensus 354 ~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~------ 421 (672)
|.+.+.||+|+||.||+|.+. .+..+|||++.... ....+.+.+|+.++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999853 36889999886542 334567889999999999999999999886542
Q ss_pred eEEEEEeecCCCChhHHhhhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEee
Q 005871 422 ELLLIYEYMPNKSLDVHLFDAT---RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDF 498 (672)
Q Consensus 422 ~~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DF 498 (672)
..++++||+.+++|..++.... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999988875321 2235789999999999999999999987 999999999999999999999999
Q ss_pred cCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccC
Q 005871 499 GLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCE 577 (672)
Q Consensus 499 gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 577 (672)
|+++...............+++.|++||.+.+..++.++||||||+++|+|++ |++||..... ..+...... .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~---~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLIK---G 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHHc---C
Confidence 99987643332222223345678999999998889999999999999999999 7888642211 111111111 1
Q ss_pred CCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 578 GPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 578 ~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
... . ........+.+++.+||+.+|++||++.+|++.|..
T Consensus 232 ~~~-~---------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 232 NRL-K---------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred CcC-C---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 000 0 011223468888899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=350.63 Aligned_cols=262 Identities=26% Similarity=0.490 Sum_probs=209.7
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
....+...+.||+|+||.||+|++. ++..||+|++...... ...|++++++++||||+++++++.+.+..++|||
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 3456888899999999999999974 7899999998654322 2356889999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|+++|+|.+++. .++|..+..|+.||++||+|||.....+|+||||||+||+++.++..++. ||.......
T Consensus 764 y~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-- 834 (968)
T PLN00113 764 YIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-- 834 (968)
T ss_pred CCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--
Confidence 999999999983 38999999999999999999996544469999999999999999888875 665543211
Q ss_pred CCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhh
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 588 (672)
.....|++.|+|||++.+..++.++|||||||++|||+||+.|+...... ...+..+............++++.+
T Consensus 835 ----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (968)
T PLN00113 835 ----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMWIDPSI 909 (968)
T ss_pred ----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhheeCccc
Confidence 11236789999999999999999999999999999999999998533222 2234444444443444445556555
Q ss_pred cCC--CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 005871 589 KQS--CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDS 629 (672)
Q Consensus 589 ~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 629 (672)
... ...++..++.+++.+|++.||++||||+||+++|....
T Consensus 910 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 432 34566778899999999999999999999999998753
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=300.37 Aligned_cols=245 Identities=27% Similarity=0.340 Sum_probs=198.9
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
++|.+.+.||+|+||.||++.+. +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47889999999999999999976 58999999986542 234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+++++|.+++... ..+++..+..++.||+.+|.|||+.+ |+|+||+|+||+|+.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999888443 46899999999999999999999987 999999999999999999999999999875433
Q ss_pred CCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChh
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 587 (672)
.....|++.|+|||.+.+...+.++||||||+++|+|++|+.||..... . . .......+.. .
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~---~-~~~~~~~~~~------~ 216 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP---I---Q-IYEKILEGKV------R 216 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---H---H-HHHHHhcCCc------c
Confidence 2234688999999999888889999999999999999999999753221 0 0 0111111110 0
Q ss_pred hcCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005871 588 LKQSCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVVM 624 (672)
Q Consensus 588 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 624 (672)
+ +......+.+++.+||+.||.+|| +++|+++.
T Consensus 217 ~----~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 217 F----PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred C----CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 1 111134567788899999999999 77777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=305.86 Aligned_cols=254 Identities=24% Similarity=0.285 Sum_probs=200.5
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCcc---cHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ---GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
++|++.+.||+|+||.||++... +++.+|+|.+...... ..+.+..|+++++.++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 46889999999999999999986 4899999998765422 4567889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+.+++|.+++... ....+++..+..++.||+.+|.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999988532 3356899999999999999999999987 999999999999999999999999998754322
Q ss_pred CCC---------------------------cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCC
Q 005871 508 QNQ---------------------------ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF 560 (672)
Q Consensus 508 ~~~---------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~ 560 (672)
... .......|+..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 01123468899999999999889999999999999999999999975332
Q ss_pred cccccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCC----HHHHHHH
Q 005871 561 SEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT----MSSVVVM 624 (672)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~evl~~ 624 (672)
.. .. ........ . .. .........+.+++.+||+.+|++||| +.++++.
T Consensus 237 ~~--~~----~~~~~~~~-~-~~-------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 237 RD--ET----FSNILKKE-V-TF-------PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred hH--HH----HHHHhcCC-c-cC-------CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 11 00 01111000 0 00 001112356778888999999999999 6666653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=302.97 Aligned_cols=248 Identities=23% Similarity=0.340 Sum_probs=206.7
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCcc--cHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ--GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
.-|.+.+.||+|.|..|-++++- .|..||||++.+..-+ ...++++|+.-|+.++|||||++|++......+|||.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 45888899999999999999864 7999999999876543 34578999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE-cCCCCeEEEeecCceeeCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL-DDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll-~~~~~~kL~DFgla~~~~~~ 507 (672)
.-++|+|.++|..+.. .+++..+.+++.||+.|+.|+|+.. +|||||||+||.+ ..-|-+||+|||++-.+...
T Consensus 98 LGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999976544 5999999999999999999999986 9999999999876 56789999999999876543
Q ss_pred CCCcccccccccCCcCChhhhcCCCC-ChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
. .....+|...|.|||++.+..| -+++||||||||||.|++|++||........ +-.++|-
T Consensus 173 ~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmImDC 234 (864)
T KOG4717|consen 173 K---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMIMDC 234 (864)
T ss_pred c---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhhhcc
Confidence 3 2345699999999999999998 4789999999999999999999864322111 1112221
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
+-..+.....++.+||..||+.||.+|.+.+||+..
T Consensus 235 --KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 235 --KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred --cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 112344456678899999999999999999999754
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=300.57 Aligned_cols=258 Identities=27% Similarity=0.373 Sum_probs=199.8
Q ss_pred HHHHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeC----
Q 005871 347 ALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG---- 420 (672)
Q Consensus 347 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~---- 420 (672)
+..+.++|.+.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.+++++ +|||++++++++...
T Consensus 17 ~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 3345788999999999999999999975 68899999886543 2245678899999999 899999999998754
Q ss_pred -ceEEEEEeecCCCChhHHhhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEee
Q 005871 421 -QELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDF 498 (672)
Q Consensus 421 -~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DF 498 (672)
...++||||+++++|.+++... .....+++..++.++.|++.+|.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~df 172 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDF 172 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeec
Confidence 3589999999999999888542 23356899999999999999999999987 999999999999999999999999
Q ss_pred cCceeeCCCCCCcccccccccCCcCChhhhcCC-----CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhh
Q 005871 499 GLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-----IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWK 573 (672)
Q Consensus 499 gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~ 573 (672)
|++......... .....|+..|+|||.+... .++.++|||||||++|||++|+.||...... .....
T Consensus 173 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~------~~~~~ 244 (291)
T cd06639 173 GVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV------KTLFK 244 (291)
T ss_pred ccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH------HHHHH
Confidence 998865432221 1234688999999998643 3689999999999999999999997432111 11111
Q ss_pred hccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 574 LWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 574 ~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.. ......+.+ .......+.+++.+||+.+|++||++.|+++.
T Consensus 245 ~~-~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 245 IP-RNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred Hh-cCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11 111111111 11122357888899999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=301.60 Aligned_cols=257 Identities=26% Similarity=0.421 Sum_probs=198.6
Q ss_pred HHHHHHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEe---
Q 005871 345 RLALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLE--- 419 (672)
Q Consensus 345 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~--- 419 (672)
.........|++.+.||+|+||.||+|.+. +++.+|+|++.... .....+..|+.+++++ +|+||+++++++..
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 334445678999999999999999999975 58899999886543 2345688899999999 69999999999853
Q ss_pred ---CceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEE
Q 005871 420 ---GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKIS 496 (672)
Q Consensus 420 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~ 496 (672)
....+++|||+.+++|.+++... ....+++..+..++.||+.+|.|||+.+ |+|+||||+||++++++.++|+
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~ 163 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLV 163 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEe
Confidence 45789999999999999888543 2345888999999999999999999997 9999999999999999999999
Q ss_pred eecCceeeCCCCCCcccccccccCCcCChhhhc-----CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhh
Q 005871 497 DFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYT 571 (672)
Q Consensus 497 DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~ 571 (672)
|||++........ ......|++.|+|||.+. +..++.++||||||+++|||++|+.||....... ...
T Consensus 164 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~--~~~--- 236 (282)
T cd06636 164 DFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR--ALF--- 236 (282)
T ss_pred eCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh--hhh---
Confidence 9999876532221 123356899999999875 3467889999999999999999999974322110 000
Q ss_pred hhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 572 WKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 572 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
..... . ...... ......+.+++.+||+.||.+|||+.||++
T Consensus 237 -~~~~~-~-----~~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 -LIPRN-P-----PPKLKS---KKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -hHhhC-C-----CCCCcc---cccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00000 0 000000 112245778888999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=298.15 Aligned_cols=248 Identities=25% Similarity=0.450 Sum_probs=198.4
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEeccc-CcccHHHHHHHHHHHHhcc---CCCeeeEEEEEEeCceEEEEE
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQ---HKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~---h~niv~l~~~~~~~~~~~lV~ 427 (672)
.|++.+.||+|+||.||+|.+. +++.+|+|.+... .......+.+|+.++++++ |||++++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 5788899999999999999974 6899999998754 3344567889999999997 999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+++++|.+++.. ..+++..+..++.|++.+|.|||+.| |+|+||+|+||+++.++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999988743 26899999999999999999999997 999999999999999999999999999876544
Q ss_pred CCCcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
... .....|+..|+|||.+.++ .++.++|+||||+++|+|++|+.||...... ...... ..... +
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~------~~~~~~-~~~~~-----~ 220 (277)
T cd06917 155 SSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF------RAMMLI-PKSKP-----P 220 (277)
T ss_pred ccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh------hhhhcc-ccCCC-----C
Confidence 321 2234688999999998765 4689999999999999999999998532111 111000 00000 1
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.+... .....+.+++.+||+.||++||++.++++.
T Consensus 221 ~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 221 RLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 11111 123457788889999999999999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=301.49 Aligned_cols=262 Identities=25% Similarity=0.319 Sum_probs=194.2
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCc--ccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCce-----
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQE----- 422 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~----- 422 (672)
++|++.+.||+|+||.||+|.+. +++.||+|++..... .....+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46899999999999999999975 689999998765432 23457888999999995 6999999999987665
Q ss_pred EEEEEeecCCCChhHHhhhccc--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-CCCeEEEeec
Q 005871 423 LLLIYEYMPNKSLDVHLFDATR--SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFG 499 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~-~~~~kL~DFg 499 (672)
.++||||+++ +|..++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 78777754322 346899999999999999999999997 999999999999998 8899999999
Q ss_pred CceeeCCCCCCcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCC
Q 005871 500 LARIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 578 (672)
Q Consensus 500 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 578 (672)
++..+...... .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||....... ...... ......
T Consensus 157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~-~~~~~~ 231 (295)
T cd07837 157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLHIF-KLLGTP 231 (295)
T ss_pred cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHH-HHhCCC
Confidence 99865432221 122356888999998865 457999999999999999999999975422111 000000 000000
Q ss_pred ---Ccc------------cccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 579 ---PAV------------ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 579 ---~~~------------~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
... +.....+. ...+.....+.+++.+||+.||++||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLS-RAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHH-HhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 00000000 001122345778889999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=310.48 Aligned_cols=255 Identities=24% Similarity=0.378 Sum_probs=199.8
Q ss_pred HhcCCccccccccCCceeEEeeeecCCceeEEEEeccc--CcccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCceEEEE
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lV 426 (672)
....|+++++||+||.+.||++...+.+.||+|++... ..+....|.+|++.|.+|+ |.+|+++++|-..++.+|||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 45679999999999999999999988889999987543 4556788999999999994 89999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||= ..+|..+|.... .....| .+..+..||+.++.++|++| |||.||||.|+|+-. |.+||+|||+|..+..
T Consensus 439 mE~G-d~DL~kiL~k~~-~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKK-SIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred eecc-cccHHHHHHhcc-CCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 9964 567888875432 222334 77889999999999999998 999999999999864 6899999999998876
Q ss_pred CCCCcccccccccCCcCChhhhcCC-----------CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhc
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGG-----------IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLW 575 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~-----------~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 575 (672)
....-....-+||+-||+||.+... +.++++||||||||||+|+.|+.||+.+... |..
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~---------~aK- 581 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ---------IAK- 581 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH---------HHH-
Confidence 6655555567899999999998532 2578999999999999999999998633211 111
Q ss_pred cCCCcccccChhhcCCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 576 CEGPAVELIDPVLKQSCAP-DELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 576 ~~~~~~~l~d~~l~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
+..+.++.-.-+++. ..-..+++++..||+.||.+|||..|||+.-
T Consensus 582 ----l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhp 628 (677)
T KOG0596|consen 582 ----LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHP 628 (677)
T ss_pred ----HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCc
Confidence 112223211111111 0111288999999999999999999999653
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=295.41 Aligned_cols=249 Identities=25% Similarity=0.396 Sum_probs=199.2
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
+|+..+.||+|+||.||++... +++.+|+|.+... .....+.+.+|++++++++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999999875 6889999998654 234467889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-CeEEEeecCceeeCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIFGGNQ 508 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~-~~kL~DFgla~~~~~~~ 508 (672)
+++++|.+++... ....+++..+..++.|++.+|.|||+++ |+|+||||+||+++.++ .+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999998543 2345899999999999999999999997 99999999999998654 57999999998765432
Q ss_pred CCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhh
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 588 (672)
. .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ........ .....+
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~~~-~~~~~~----- 221 (256)
T cd08220 157 K---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVLKIMS-GTFAPI----- 221 (256)
T ss_pred c---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHHHHHh-cCCCCC-----
Confidence 2 22346889999999999888999999999999999999999997532211 11111110 111111
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 589 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 589 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.......+.+++.+||+.+|++|||+.|+++.
T Consensus 222 ----~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 222 ----SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ----CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11123356788889999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=315.27 Aligned_cols=246 Identities=30% Similarity=0.434 Sum_probs=197.5
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecc---cCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
..|..++.||.|+||.||-+++. +.+.||||++.. .+.+.|+++..|+..|++++|||++.+-|+|..+...||||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 35778889999999999999975 678899999974 45667889999999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
|||-| +-.+++.- ...++.+.++..|+++.+.||.|||+.+ .||||||..|||+++.|.|||+|||.+....
T Consensus 106 EYClG-SAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~-- 177 (948)
T KOG0577|consen 106 EYCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA-- 177 (948)
T ss_pred HHHhc-cHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC--
Confidence 99965 44555532 2346899999999999999999999997 9999999999999999999999999997643
Q ss_pred CCCcccccccccCCcCChhhhc---CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 508 QNQANTNIIAGTYGYMAPEYAM---GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
..+.++|||.|||||++. .|.|+-|+||||||++..||...++|.-... .-..+.. +. +.-
T Consensus 178 ----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN--AMSALYH-IA---------QNe 241 (948)
T KOG0577|consen 178 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--AMSALYH-IA---------QNE 241 (948)
T ss_pred ----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch--HHHHHHH-HH---------hcC
Confidence 234579999999999984 5789999999999999999999999842110 0011111 11 111
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.|.+. .++....|.+++..||++-|.+|||.++++..
T Consensus 242 sPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 242 SPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 12222 23445567777789999999999999988753
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=294.59 Aligned_cols=252 Identities=28% Similarity=0.457 Sum_probs=200.2
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEecccCcc--cHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ--GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
+|.+.+.||+|+||.||+|... +++.+++|.+...... ..+.+.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5888999999999999999875 6889999998766543 677899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999998853 234789999999999999999999998 99999999999999999999999999987654332
Q ss_pred Ccc--cccccccCCcCChhhhcCCC---CChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 510 QAN--TNIIAGTYGYMAPEYAMGGI---FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 510 ~~~--~~~~~gt~~Y~aPE~~~~~~---~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
... .....++..|+|||++.+.. ++.++||||||+++|+|++|+.||...... ......... +....+
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-----~~~~~~~~~-~~~~~~- 227 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-----FQIMFHVGA-GHKPPI- 227 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-----HHHHHHHhc-CCCCCC-
Confidence 211 12346788999999998766 899999999999999999999998532211 011111100 111011
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
... ......+.+++.+||+.+|++|||+.+++.
T Consensus 228 ----~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 228 ----PDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ----Ccc--cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 011234567888999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=303.32 Aligned_cols=273 Identities=26% Similarity=0.367 Sum_probs=198.8
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeC--ceEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLL 425 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~l 425 (672)
.++|++.+.||+|+||.||+|.+. +|+.||+|++..... .....+.+|+.++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 468999999999999999999975 589999999865432 2233567899999999999999999998765 56899
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
||||+.+ +|..++... ...+++.++..++.||+.||.|||+.| ++||||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 777777432 246899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCCcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchh--------hhhhhhcc
Q 005871 506 GNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLL--------TYTWKLWC 576 (672)
Q Consensus 506 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~--------~~~~~~~~ 576 (672)
..... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||............ ...|..+.
T Consensus 160 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 160 LPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred CccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 43211 122345788999999876 45799999999999999999999998532211100000 00010000
Q ss_pred CCCcccccC---h---hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCCC
Q 005871 577 EGPAVELID---P---VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTI 632 (672)
Q Consensus 577 ~~~~~~l~d---~---~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l 632 (672)
.......+. . .+.. ........+.+++.+||+.||++|||+.++++.--.....+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~ 298 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKH-KFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL 298 (309)
T ss_pred cccccccccccCCCCCchHH-hccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCC
Confidence 000000000 0 0000 00111345678888999999999999999998665543333
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=315.37 Aligned_cols=254 Identities=25% Similarity=0.409 Sum_probs=206.8
Q ss_pred hcCCccccccccCCceeEEeeeecCC-ceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLADG-KAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
.+.|.++..||.|+||.||++..++. -.-|.|++.-.+.+..+.+.-|++||....||+||++++.|...+.++|..||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 35688999999999999999998764 44577888888888899999999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
|.||-++..+.... ..+.+.++.-++.|++.||.|||++. |||||||..|||++-+|.++|+|||.+..... .
T Consensus 111 C~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t 183 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--T 183 (1187)
T ss_pred cCCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--H
Confidence 99999999886543 46999999999999999999999996 99999999999999999999999999865322 2
Q ss_pred CcccccccccCCcCChhhhc-----CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 510 QANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
......+.|||.|||||+.+ ..+|+.++||||||++|.||..+.+|-. ...+.....+ ..+.....++
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh------elnpMRVllK-iaKSePPTLl 256 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH------ELNPMRVLLK-IAKSEPPTLL 256 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc------ccchHHHHHH-HhhcCCCccc
Confidence 22344578999999999874 4679999999999999999999998832 1111111111 1222223333
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
.+ ......+.+++..||.+||..||+++++++.-
T Consensus 257 qP-------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 257 QP-------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred Cc-------chhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence 22 23345577888899999999999999998754
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=301.27 Aligned_cols=251 Identities=24% Similarity=0.390 Sum_probs=202.6
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
.+|.+.+.||+|+||.||++... +++.+++|.+........+.+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 68999999999999999999864 68899999987655555678899999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
++++|.+++.. ..+++.++..++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++..+.....
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 99999998843 34789999999999999999999998 99999999999999999999999999876543322
Q ss_pred cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcC
Q 005871 511 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 590 (672)
......|++.|++||.+.++.++.++||||||+++|+|++|+.||........ .......+.. ..
T Consensus 171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~------~~~~~~~~~~-~~------- 235 (293)
T cd06647 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATNGTP-EL------- 235 (293)
T ss_pred -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh------eeehhcCCCC-CC-------
Confidence 12234688899999999888899999999999999999999999853221110 0000001000 00
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 591 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
.........+.+++.+||+.+|++||++.+++++-
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 00111223567788899999999999999999773
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=299.98 Aligned_cols=252 Identities=24% Similarity=0.385 Sum_probs=192.6
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHH-HHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNL-IAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~i-l~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
++|++.+.||+|+||.||++.+. +|+.||+|++.... .+....+..|+.+ ++.++||||+++++++..+...++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47889999999999999999986 69999999987643 2233455566665 666799999999999999999999999
Q ss_pred ecCCCChhHHhhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 429 YMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHED-SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 429 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~-g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|++ ++|..++... .....+++..++.++.||+.||.|||++ + ++||||||+||+++.++.+||+|||++..+..
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 6777776542 2335689999999999999999999987 5 99999999999999999999999999986543
Q ss_pred CCCCcccccccccCCcCChhhhcC----CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccc
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMG----GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVE 582 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~----~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (672)
.. ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...... ......... +....
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~-~~~~~ 227 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQLKQVVE-EPSPQ 227 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----HHHHHHHHh-cCCCC
Confidence 21 1122467889999998865 44689999999999999999999997532111 111111111 11111
Q ss_pred ccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 583 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 583 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
... . .....+.+++.+||+.+|++||++.+|++.
T Consensus 228 ~~~----~----~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 228 LPA----E----KFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCc----c----ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 100 0 112457788889999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=297.11 Aligned_cols=254 Identities=27% Similarity=0.427 Sum_probs=199.3
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCc------
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ------ 421 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~------ 421 (672)
.+++|++.+.||+|++|.||+|.++ +++.+++|++..... ..+.+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4688999999999999999999985 578899998876543 346789999999999 7999999999997644
Q ss_pred eEEEEEeecCCCChhHHhhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecC
Q 005871 422 ELLLIYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 500 (672)
Q Consensus 422 ~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgl 500 (672)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999998886532 2456899999999999999999999997 99999999999999999999999999
Q ss_pred ceeeCCCCCCcccccccccCCcCChhhhcC-----CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhc
Q 005871 501 ARIFGGNQNQANTNIIAGTYGYMAPEYAMG-----GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLW 575 (672)
Q Consensus 501 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 575 (672)
+........ ......|+..|+|||++.. ..++.++||||||+++|+|++|+.||..... ...+. +.
T Consensus 160 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~----~~- 230 (275)
T cd06608 160 SAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP--MRALF----KI- 230 (275)
T ss_pred ceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch--HHHHH----Hh-
Confidence 986543221 2223468899999998753 3468899999999999999999999752211 11111 11
Q ss_pred cCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 576 CEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 576 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
.......+.. .......+.+++.+||..||++|||+.+|++
T Consensus 231 ~~~~~~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 231 PRNPPPTLKS-------PENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hccCCCCCCc-------hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1111111111 1112345778888999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=300.23 Aligned_cols=270 Identities=29% Similarity=0.384 Sum_probs=204.6
Q ss_pred hcCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhc--cCCCeeeEEEEEEeCc----eEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL--QHKNLVRLLGCCLEGQ----ELL 424 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l--~h~niv~l~~~~~~~~----~~~ 424 (672)
.......+.||+|.||.||||++. ++.||||++... ..+.|.+|-+|.+.. +|+||+++++.-.... +++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 345677889999999999999995 599999998654 446778888877765 8999999999876554 899
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCeeecCCCCCcEEEcCCCCeEEEee
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED------SRLKIIHRDLKASNILLDDDMNPKISDF 498 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~------g~~~iiHrDlkp~NIll~~~~~~kL~DF 498 (672)
||+||.+.|+|.++|.. ..++|....+|+.-+++||+|||+. .+..|+|||||..||||.+|++..|+||
T Consensus 285 LVt~fh~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EEeeeccCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 99999999999999943 4599999999999999999999974 2457999999999999999999999999
Q ss_pred cCceeeCCCCCCcccccccccCCcCChhhhcCCC-CC-----hhhHHHHHHHHHHHHHcCCCCCCC-CCcccccchhhhh
Q 005871 499 GLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI-FS-----IKSDVFSFGVLLLEIISGRKNNGF-YFSEHGQTLLTYT 571 (672)
Q Consensus 499 gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s-----~ksDvwSlGvil~elltG~~p~~~-~~~~~~~~~~~~~ 571 (672)
|++..+.........-.-+||.+|||||++.+.. +. .+.||||+|.++|||++.-.-... ..++........+
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 9999988666555555578999999999997643 22 579999999999999997654321 1111111111111
Q ss_pred hhh----------ccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCCC
Q 005871 572 WKL----------WCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTI 632 (672)
Q Consensus 572 ~~~----------~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l 632 (672)
... ..+.....+-+...+. ..+.-+.+.+..||..||+-|.|+.=|-+++......-
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 111 1111111222221111 23456778888999999999999999999998875543
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=297.44 Aligned_cols=247 Identities=26% Similarity=0.313 Sum_probs=200.0
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
+|++.+.||.|+||.||++.+. +++.+|+|.+.+.. ....+.+.+|++++++++||||+++++.+.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5889999999999999999986 58999999987543 2346788999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|+.+++|..++... ..+++..+..++.||+++|.|||+++ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999988432 46899999999999999999999997 9999999999999999999999999988654332
Q ss_pred CCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhh
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 588 (672)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.|+......... . ....... ..
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~-~~~~~~~--~~------- 218 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD---Q-IRAKQET--AD------- 218 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHH---H-HHHHhcc--cc-------
Confidence 122346788999999998888999999999999999999999997643322111 1 1111100 00
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 005871 589 KQSCAPDELLKFIHIGLLCVQQDPADRPTM--SSVV 622 (672)
Q Consensus 589 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~--~evl 622 (672)
...+......+.+++.+||+.||.+||+. +|++
T Consensus 219 -~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 -VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 01111123567788889999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=293.68 Aligned_cols=267 Identities=26% Similarity=0.308 Sum_probs=210.3
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
.++|..++.||+|.||.|.+++.+ .++.||+|++++.- .+.+.+-..|-++|+..+||.+..+...|+..+.+++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 478999999999999999999876 69999999998753 34456678899999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||..||.|..+|. +...+++...+.+-..|+.||.|||+++ ||.||||.+|.|+|.+|++||+|||+++.-
T Consensus 247 MeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~-- 318 (516)
T KOG0690|consen 247 MEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE-- 318 (516)
T ss_pred EEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc--
Confidence 99999999988884 3456899999999999999999999987 999999999999999999999999999852
Q ss_pred CCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
.......+.++|||.|+|||++....|+..+|+|.+||++|||++|+.||.....+. +...+ .- -|-
T Consensus 319 I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k---LFeLI----l~------ed~ 385 (516)
T KOG0690|consen 319 IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK---LFELI----LM------EDL 385 (516)
T ss_pred ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH---HHHHH----Hh------hhc
Confidence 223334567899999999999999999999999999999999999999974322111 11110 00 011
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh--ccC------CCCCCCCCCCcccc
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVVML--ASD------SMTIPQPTEPAFSV 642 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L--~~~------~~~l~~p~~p~~~~ 642 (672)
...+...+ +...|+...|.+||.+|. .+.||.+.= .+. ...++||-+|+..+
T Consensus 386 kFPr~ls~----eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtS 450 (516)
T KOG0690|consen 386 KFPRTLSP----EAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTS 450 (516)
T ss_pred cCCccCCH----HHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCccc
Confidence 11222222 244555689999999996 344444332 222 23578888888754
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=303.84 Aligned_cols=248 Identities=29% Similarity=0.362 Sum_probs=198.9
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
.+.|..-+.||+||||+||-++.+ .|+.||.|++.+.. ..+....++|-.||.+++.+.||.+-..|+.++.++||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 367888999999999999999876 69999999886543 34456678999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
+..|.||+|..+|.+... ..+++..+..++.+|+.||++||..+ ||+|||||+|||+|+.|+++|+|+|+|..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999977554 46999999999999999999999987 99999999999999999999999999998754
Q ss_pred CCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
.... ...+||.+|||||++.++.|+...|+|||||++|||+.|+.||..+-...... .+.+.. +-++
T Consensus 340 g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e---Evdrr~-------~~~~ 406 (591)
T KOG0986|consen 340 GKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE---EVDRRT-------LEDP 406 (591)
T ss_pred CCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHH---HHHHHH-------hcch
Confidence 4332 23489999999999999999999999999999999999999985332211110 000000 0011
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTM 618 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 618 (672)
..++....++..+|....|++||++|..-
T Consensus 407 ---~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 407 ---EEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred ---hhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 11222222334455558999999998743
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=298.56 Aligned_cols=263 Identities=23% Similarity=0.315 Sum_probs=197.2
Q ss_pred CccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeC--ceEEEEEe
Q 005871 354 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLLIYE 428 (672)
Q Consensus 354 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~lV~E 428 (672)
|++.+.||+|+||.||+|... +++.+|+|++.... ......+.+|+.++++++|+|++++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 677899999999999999976 58899999998663 33456788999999999999999999999988 89999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|+++ +|..++... ...+++..++.++.||++||.|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 777777432 246899999999999999999999987 9999999999999999999999999998765443
Q ss_pred CCcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcc------
Q 005871 509 NQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAV------ 581 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 581 (672)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......................+.
T Consensus 155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 155 SA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred cc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence 21 1223356788999998765 457999999999999999999999975433211100000000000000000
Q ss_pred --------cccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 582 --------ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 582 --------~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
......+...........+.+++.+||+.+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000001111111112456788999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=298.24 Aligned_cols=264 Identities=23% Similarity=0.319 Sum_probs=194.7
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcc-cHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
++++|.+.+.||+|+||.||+|... +++.+|+|.+...... ....+.+|+.+++.++|+||+++++++..+...++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578999999999999999999875 6889999998754332 2346788999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+. +++...+... ...+.+..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 5666555332 235788889999999999999999997 999999999999999999999999998764332
Q ss_pred CCCcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCC--------
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG-------- 578 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 578 (672)
... .....+++.|+|||.+.+. .++.++||||||+++|+|++|+.||....... ......|..+...
T Consensus 157 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 157 SQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF--EQLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred CCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH--HHHHHHHHHcCCCChhhhhhh
Confidence 211 1223578899999998764 57899999999999999999999985432210 1111111110000
Q ss_pred -CcccccChhh----cCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 579 -PAVELIDPVL----KQSC-----APDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 579 -~~~~l~d~~l----~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
......+... .... .......+.+++.+|++.||++|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000 0000 0001245667888999999999999999974
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=290.60 Aligned_cols=250 Identities=30% Similarity=0.485 Sum_probs=202.9
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecC
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 431 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 431 (672)
+|...+.||+|++|.||++.+. +++.+++|++..........+.+|++++++++|+|++++++.+..+...++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999986 688999999987665566889999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCc
Q 005871 432 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 511 (672)
Q Consensus 432 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 511 (672)
+++|.+++.... ..+++..+..++.|++.+|.+||+.+ ++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999885432 46899999999999999999999987 99999999999999999999999999987644322
Q ss_pred ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCC
Q 005871 512 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQS 591 (672)
Q Consensus 512 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~ 591 (672)
.....|+..|++||++.+..++.++||||||+++|+|++|+.|+...... ....... ..........
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~~~~~~----- 220 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM------KALFKIA-TNGPPGLRNP----- 220 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH------HHHHHHH-hcCCCCcCcc-----
Confidence 23456889999999999888999999999999999999999997432110 1000000 0111111110
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 592 CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 592 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
......+.+++.+||+.||++|||+.++++.
T Consensus 221 --~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 --EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred --cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0013457788889999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=329.31 Aligned_cols=255 Identities=28% Similarity=0.419 Sum_probs=191.0
Q ss_pred HHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEe-------
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE------- 419 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~------- 419 (672)
.-..+|+.++.||+||||.||+++.+ ||..||||+|.... ......+.+|+..|++|+|||||+++..|.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34578999999999999999999987 89999999997663 3445678999999999999999998755421
Q ss_pred ------------------------------------------------C-------------------------------
Q 005871 420 ------------------------------------------------G------------------------------- 420 (672)
Q Consensus 420 ------------------------------------------------~------------------------------- 420 (672)
.
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred ---------------------------------ceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHH
Q 005871 421 ---------------------------------QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 467 (672)
Q Consensus 421 ---------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~L 467 (672)
..+||-||||+..++.+++.+..... .....+.++++|++||.|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence 12678899999988888775432211 4678899999999999999
Q ss_pred HhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC----C------------CCCCcccccccccCCcCChhhhcCC
Q 005871 468 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG----G------------NQNQANTNIIAGTYGYMAPEYAMGG 531 (672)
Q Consensus 468 H~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~----~------------~~~~~~~~~~~gt~~Y~aPE~~~~~ 531 (672)
|++| ||||||||.||+++++.+|||+|||++.... . .......+..+||..|+|||++.+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9998 9999999999999999999999999998621 0 0111123456899999999999764
Q ss_pred ---CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhc
Q 005871 532 ---IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCV 608 (672)
Q Consensus 532 ---~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl 608 (672)
.|+.|+|+||||+|++||+. ||+-.+. . .. +...+.++.+..- ..+..++...=..+|.+++
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME-R----a~-iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSME-R----AS-ILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchHH-H----HH-HHHhcccCCCCCC------cccccccchHHHHHHHHHh
Confidence 49999999999999999995 3321110 0 01 1112223333222 1122223333456778999
Q ss_pred ccCCCCCCCHHHHHH
Q 005871 609 QQDPADRPTMSSVVV 623 (672)
Q Consensus 609 ~~dP~~RPt~~evl~ 623 (672)
+.||.+|||+.|+|+
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999984
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=299.42 Aligned_cols=262 Identities=23% Similarity=0.354 Sum_probs=195.4
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
+|++.+.||+|++|.||+|++. +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4888999999999999999875 68899999886543 23345788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+. ++|..++... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++..+.....
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 5787777543 2356899999999999999999999997 99999999999999999999999999876543221
Q ss_pred CcccccccccCCcCChhhhcCCC-CChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhh----------hhhccC-
Q 005871 510 QANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYT----------WKLWCE- 577 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~----------~~~~~~- 577 (672)
. .....+++.|+|||++.+.. ++.++||||||+++|+|+||+.||....... ...... |..+..
T Consensus 156 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 156 T--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred c--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhhhHH
Confidence 1 12234688999999887654 5899999999999999999999975322111 111100 000000
Q ss_pred ----CCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 578 ----GPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 578 ----~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
....+.....+.. ..+.....+.+++.+||+.||++|||++++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 232 PDYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000000000 001112346688889999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=301.52 Aligned_cols=268 Identities=23% Similarity=0.343 Sum_probs=194.1
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCc------
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------ 421 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~------ 421 (672)
.++|++.++||+|+||.||++... +++.||+|.+.... ......+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357999999999999999999975 68999999886543 222345678999999999999999999987654
Q ss_pred --eEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeec
Q 005871 422 --ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 499 (672)
Q Consensus 422 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFg 499 (672)
..++||||+.+ +|...+.. ....+++.++..++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 45999999975 67666643 2235899999999999999999999997 9999999999999999999999999
Q ss_pred CceeeCCCCCC--cccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhcc
Q 005871 500 LARIFGGNQNQ--ANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWC 576 (672)
Q Consensus 500 la~~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 576 (672)
++..+...... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||....................
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99866433221 112234578889999988765 478999999999999999999998754322111111111110000
Q ss_pred CCCc-----ccccC---------hhhcCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 577 EGPA-----VELID---------PVLKQSC-APDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 577 ~~~~-----~~l~d---------~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.... ....+ ....... .......+.+++.+||+.||++|||++++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000 00000 0000000 00112356788999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=307.04 Aligned_cols=264 Identities=27% Similarity=0.301 Sum_probs=197.5
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeC------
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------ 420 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~------ 420 (672)
..++|++.+.||+|+||.||++.+. +++.||+|++.+. .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999975 6899999998653 233445678899999999999999999998643
Q ss_pred ceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecC
Q 005871 421 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 500 (672)
Q Consensus 421 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgl 500 (672)
...++||||+.+ +|...+.. .+++..+..++.|++.||.|||+.| |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 357999999965 67666632 2889999999999999999999997 99999999999999999999999999
Q ss_pred ceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCccccc---------chhhh-
Q 005871 501 ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQ---------TLLTY- 570 (672)
Q Consensus 501 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~---------~~~~~- 570 (672)
++....... .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||......... ....+
T Consensus 165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 987643222 22346788999999999999999999999999999999999998543211000 00000
Q ss_pred -----hhhhccC-------CCcccccChhhcC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 571 -----TWKLWCE-------GPAVELIDPVLKQ----SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 571 -----~~~~~~~-------~~~~~l~d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
....+.. ....++....+.. .........+.+++.+||+.||++|||+.|+++.=
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~ 312 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP 312 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence 0000000 0011111111100 00112344577889999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=324.36 Aligned_cols=255 Identities=29% Similarity=0.467 Sum_probs=210.4
Q ss_pred cCCccccccccCCceeEEeeeecC----CceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
....+.+.||.|.||+|++|+++- ...||||-++... +....+|+.|+.||-+++||||+++.|+......++||
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 456788999999999999999862 4578999998654 45567899999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
.|||++|+|+.+|.. +.+++++.+...++++|+.|+.||-+.+ +|||||...||||+.+..+|++|||+++.+.+
T Consensus 709 TEyMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 999999999999964 3467999999999999999999999997 99999999999999999999999999998865
Q ss_pred CCCCcccccccc--cCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccc
Q 005871 507 NQNQANTNIIAG--TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583 (672)
Q Consensus 507 ~~~~~~~~~~~g--t~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 583 (672)
..... .+..-| ..+|.|||.+...+++.++||||+|+++||.++ |.+|+-.+ .+.++.+.
T Consensus 784 d~~~~-ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm----------------SNQdVIka 846 (996)
T KOG0196|consen 784 DPEAA-YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM----------------SNQDVIKA 846 (996)
T ss_pred CCCcc-ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc----------------chHHHHHH
Confidence 54222 111112 457999999999999999999999999999877 88884211 11122222
Q ss_pred cChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 584 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
+++-.+-.-+.+....+.+||+.|||+|-.+||.+.+|+.+|+..
T Consensus 847 Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 847 IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 222222223445667899999999999999999999999999863
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=296.98 Aligned_cols=261 Identities=26% Similarity=0.371 Sum_probs=195.3
Q ss_pred CccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 354 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 354 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
|++.+.||.|++|.||+|.+. +|..||+|++.... ......+.+|++++++++|||++++++++.+.+..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 677899999999999999875 69999999987543 223457889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
. ++|..++.... ...+++..+..++.|++++|.|||+.+ ++||||+|+||+++.++.++|+|||++..+......
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 5 68888875432 246899999999999999999999987 999999999999999999999999999765432211
Q ss_pred cccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhh----------hhhhccCC-
Q 005871 511 ANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTY----------TWKLWCEG- 578 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~----------~~~~~~~~- 578 (672)
.....++..|+|||++.+. .++.++||||||+++|+|++|+.||....... ..... .|.....-
T Consensus 156 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 156 --YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred --cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhch
Confidence 1223568899999988664 57899999999999999999999975332111 00000 00000000
Q ss_pred C----cccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 579 P----AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 579 ~----~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
. ......... ....+.....+.+++.+||+.+|++|||++|+++.
T Consensus 232 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 232 DYKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 000000000 00011122457789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=295.63 Aligned_cols=249 Identities=23% Similarity=0.358 Sum_probs=199.3
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecC
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 431 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 431 (672)
+|...++||+|++|.||++... +++.+++|++........+.+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 4556689999999999999864 688999999876655556678999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCc
Q 005871 432 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 511 (672)
Q Consensus 432 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 511 (672)
+++|.+++.. ..+++..+..++.|++.+|.|||+.+ |+||||+|+||+++.++.++|+|||.+........
T Consensus 100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-- 170 (285)
T cd06648 100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-- 170 (285)
T ss_pred CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence 9999998854 35899999999999999999999997 99999999999999999999999998875433221
Q ss_pred ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCC
Q 005871 512 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQS 591 (672)
Q Consensus 512 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~ 591 (672)
......|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ........ ........+
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~~~-~~~~~~~~~------ 237 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKRIR-DNLPPKLKN------ 237 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHH-hcCCCCCcc------
Confidence 12234688999999999888899999999999999999999999743211 11111111 111001000
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 592 CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 592 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.......+.+++.+||+.+|++|||+.++++.
T Consensus 238 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 238 -LHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred -cccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 01122457788889999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=321.02 Aligned_cols=268 Identities=22% Similarity=0.311 Sum_probs=187.3
Q ss_pred HHhcCCccccccccCCceeEEeeeecC--CceeEEEE--------------ec---ccCcccHHHHHHHHHHHHhccCCC
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLAD--GKAIAVKR--------------LS---RTSGQGLQEFKNEVNLIAKLQHKN 409 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~--------------~~---~~~~~~~~~~~~E~~il~~l~h~n 409 (672)
...++|+++++||+|+||.||++.++. +...++|. +. .........+.+|+.+|++++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 345789999999999999999987542 22222221 11 111223456889999999999999
Q ss_pred eeeEEEEEEeCceEEEEEeecCCCChhHHhhhccc--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE
Q 005871 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATR--SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 487 (672)
Q Consensus 410 iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll 487 (672)
|+++++++...+..++|+|++.+ +|..++..... .......++..|+.||+.||.|||+++ |+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 99999999999999999999865 55555533211 122345677889999999999999997 9999999999999
Q ss_pred cCCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCC-CCCCCcccccc
Q 005871 488 DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKN-NGFYFSEHGQT 566 (672)
Q Consensus 488 ~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p-~~~~~~~~~~~ 566 (672)
+.++.+||+|||+++.+....... .....||..|+|||++.+..++.++|||||||++|||++|..+ +..........
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 999999999999998765432221 2235799999999999999999999999999999999998754 32211111111
Q ss_pred hhhhhhhhc-cCCCcc-------------------cccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 567 LLTYTWKLW-CEGPAV-------------------ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 567 ~~~~~~~~~-~~~~~~-------------------~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
+........ ...... ..+.+.+.... ....+.+++.+||+.||.+|||+.|++++
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLG---LPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcC---CChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 111110000 000000 00111111100 11245677889999999999999999875
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=307.74 Aligned_cols=263 Identities=24% Similarity=0.336 Sum_probs=195.0
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeC-----ceE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QEL 423 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~~ 423 (672)
+++|++.++||+|+||.||+|.+. +++.||+|++.... ......+.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 478999999999999999999875 68999999986432 23446688899999999999999999887654 358
Q ss_pred EEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 424 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
++|+||+.+ +|...+. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999975 6665552 345899999999999999999999998 99999999999999999999999999987
Q ss_pred eCCCCCCc-ccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCC--
Q 005871 504 FGGNQNQA-NTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGP-- 579 (672)
Q Consensus 504 ~~~~~~~~-~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 579 (672)
........ ......|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||....... .............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~ 232 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQE 232 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHH
Confidence 54322211 1223468999999998755 468999999999999999999999985321110 0000000000000
Q ss_pred -cccccChh-------hc--CC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 580 -AVELIDPV-------LK--QS-----CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 580 -~~~l~d~~-------l~--~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
...+.+.. .. .. ..+.....+.+++.+||+.+|++|||+.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 00 00 001123457789999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=297.08 Aligned_cols=256 Identities=26% Similarity=0.370 Sum_probs=194.4
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCceEEEEEe
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lV~E 428 (672)
++|...+.||+|+||.||++.+. +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 35677889999999999999975 58999999987543 234567889999999996 9999999999999999999999
Q ss_pred ecCCCChhHHhhh--ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 429 YMPNKSLDVHLFD--ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 429 y~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|+.. ++..+... ......+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||++..+..
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9864 44443221 122356899999999999999999999752 399999999999999999999999999976543
Q ss_pred CCCCcccccccccCCcCChhhhcCC---CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccc
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGG---IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~---~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 583 (672)
.... ....|+..|+|||++.+. .++.++||||||+++|+|++|+.||.... ........... +....
T Consensus 161 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~-~~~~~- 230 (288)
T cd06616 161 SIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVK-GDPPI- 230 (288)
T ss_pred CCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcC-CCCCc-
Confidence 2211 223578899999999776 68999999999999999999999975432 11111111111 11111
Q ss_pred cChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 584 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
+...........+.+++.+||+.+|++|||+.+|++.
T Consensus 231 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 231 ----LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ----CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111233457788889999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=285.37 Aligned_cols=280 Identities=23% Similarity=0.324 Sum_probs=207.7
Q ss_pred HhcCCccccccccCCceeEEeeeec---C--CceeEEEEecccCcc--cHHHHHHHHHHHHhccCCCeeeEEEEEEe-Cc
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA---D--GKAIAVKRLSRTSGQ--GLQEFKNEVNLIAKLQHKNLVRLLGCCLE-GQ 421 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~---~--~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~-~~ 421 (672)
....|+...+||+|.||.||++... + .+.+|||+++..... .-...-+|+.++++++|||++.+..++.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 4467999999999999999999643 2 348999999765321 23467889999999999999999999987 78
Q ss_pred eEEEEEeecCCCChhHHhhh--ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC----CCeEE
Q 005871 422 ELLLIYEYMPNKSLDVHLFD--ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD----MNPKI 495 (672)
Q Consensus 422 ~~~lV~Ey~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~----~~~kL 495 (672)
.+++++||.+.. |...+.. ..+...++...+..|+.||+.|+.|||++. |+||||||.||||..+ |.+||
T Consensus 102 ~v~l~fdYAEhD-L~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEHD-LWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhhh-HHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEe
Confidence 899999999874 4445543 233457899999999999999999999999 9999999999999877 89999
Q ss_pred EeecCceeeCCCCCCc-ccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccc------cch
Q 005871 496 SDFGLARIFGGNQNQA-NTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHG------QTL 567 (672)
Q Consensus 496 ~DFgla~~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~------~~~ 567 (672)
+|||+++.+.+.-..- ....++-|.+|.|||.+.+. .|+++.|||++|||+.||+|-++.|........ .+.
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 9999999987654433 34456779999999999886 589999999999999999999988754322111 111
Q ss_pred hhhhhhhcc---CCCcccc---------cChhhcCCCCHH-----------HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 568 LTYTWKLWC---EGPAVEL---------IDPVLKQSCAPD-----------ELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 568 ~~~~~~~~~---~~~~~~l---------~d~~l~~~~~~~-----------~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
+..+...+. ...+..+ +...-.....+- ....-.+|+.++|+.||-+|.|+++.++.
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 111111111 1111111 000000011110 01125678889999999999999999999
Q ss_pred hccCCCCCC
Q 005871 625 LASDSMTIP 633 (672)
Q Consensus 625 L~~~~~~l~ 633 (672)
.-....++|
T Consensus 338 ~yF~~d~lp 346 (438)
T KOG0666|consen 338 PYFTEDPLP 346 (438)
T ss_pred cccccCCCC
Confidence 887776665
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=296.20 Aligned_cols=254 Identities=26% Similarity=0.404 Sum_probs=204.0
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
..+.|+..+.||+|++|.||++.++ ++..+++|++..... ..+.+.+|+++++.++|+|++++++.+......++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567899999999999999999986 689999999876554 55778899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|+++++|.+++.... ..+++..+..++.|++.+|.|||+.| |+|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999986532 36999999999999999999999987 9999999999999999999999999987554322
Q ss_pred CCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhh
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 588 (672)
. ......++..|++||++.+..++.++|+||||+++|+|++|+.|+...... ....... ........+
T Consensus 171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~~~~~--- 238 (286)
T cd06614 171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL------RALFLIT-TKGIPPLKN--- 238 (286)
T ss_pred h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHH-hcCCCCCcc---
Confidence 1 122345788999999998888999999999999999999999997432111 0011111 111111100
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 589 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 589 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
.......+.+++.+||+.+|.+|||+.+|++..
T Consensus 239 ----~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 239 ----PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred ----hhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 011224567788899999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=294.17 Aligned_cols=258 Identities=23% Similarity=0.288 Sum_probs=191.3
Q ss_pred CccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeC--ceEEEEEe
Q 005871 354 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEG--QELLLIYE 428 (672)
Q Consensus 354 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~--~~~~lV~E 428 (672)
|.+.++||+|+||.||+|... +++.+|+|++.... ........+|+.++.++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 677889999999999999975 68899999987642 222234567899999995 99999999999987 88999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|+.+ +|.+.+... ...+++.++..++.||+.||.|||+.+ |+||||||+||+++. +.+||+|||++.......
T Consensus 81 ~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMDM-NLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCCc-cHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 9975 666666432 246899999999999999999999997 999999999999999 999999999998764322
Q ss_pred CCcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhh-----------hhhcc
Q 005871 509 NQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYT-----------WKLWC 576 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~-----------~~~~~ 576 (672)
.. ....++..|+|||++.. +.++.++|||||||++|||++|..||....... ..... .....
T Consensus 154 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 154 PY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred Cc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhc
Confidence 21 22457889999997654 557899999999999999999999985432211 00000 00000
Q ss_pred CCCcccccChhhcC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 577 EGPAVELIDPVLKQ----SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 577 ~~~~~~l~d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.........+.... .........+.+++.+||+.+|++|||++++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000000000 0011234678899999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=292.98 Aligned_cols=244 Identities=29% Similarity=0.373 Sum_probs=191.3
Q ss_pred cccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCCCCh
Q 005871 360 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 435 (672)
Q Consensus 360 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL 435 (672)
||+|+||+||++... +++.+|+|.+.... ......+.+|+++++.++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999865 68899999986532 22345677899999999999999999999999999999999999999
Q ss_pred hHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCccccc
Q 005871 436 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 515 (672)
Q Consensus 436 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~ 515 (672)
.+++..... ..+++.++..++.|++.+|.|||+.+ ++||||+|+||++++++.+||+|||.+....... ....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 153 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG 153 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence 998865332 36899999999999999999999997 9999999999999999999999999987654311 1223
Q ss_pred ccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHH
Q 005871 516 IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPD 595 (672)
Q Consensus 516 ~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 595 (672)
..++..|+|||.+.++.++.++||||||+++|+|++|+.||.......... ......... . ...+..
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~------~----~~~~~~ 220 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE---ELKRRTLEM------A----VEYPDK 220 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH---HHHhccccc------c----ccCCcc
Confidence 457889999999988889999999999999999999999975432211111 000000000 0 001111
Q ss_pred HHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005871 596 ELLKFIHIGLLCVQQDPADRP-----TMSSVVV 623 (672)
Q Consensus 596 ~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 623 (672)
....+.+++.+||+.+|++|| ++.++++
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 234567888899999999999 6776765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=295.16 Aligned_cols=259 Identities=24% Similarity=0.353 Sum_probs=197.6
Q ss_pred CccccccccCCceeEEeeeec-CCceeEEEEecccCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 354 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 354 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
|.+.+.||+|++|.||++... +++.+++|++..... .....+.+|+.++++++|+||+++++++..+...++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567889999999999999875 688999999875433 24567889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
++ +|..++... ...+++..+..++.||+.+|.|||+.+ |+|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~- 153 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR- 153 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence 76 777777442 246899999999999999999999997 99999999999999999999999999987754431
Q ss_pred cccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccC---CCcccccC-
Q 005871 511 ANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCE---GPAVELID- 585 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~d- 585 (672)
......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||....... ........... ..+....+
T Consensus 154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID---QLFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCchHhcccchhh
Confidence 12224578899999998876 78999999999999999999999875322111 00000000000 00000000
Q ss_pred -----hhhc-------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 586 -----PVLK-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 586 -----~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
.... ....+....++.+++.+||+.||.+||++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000 0011223456889999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=328.82 Aligned_cols=277 Identities=21% Similarity=0.252 Sum_probs=215.6
Q ss_pred HHHHHhcCCccccccccCCceeEEeeeec-CCceeEEEEeccc---CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCc
Q 005871 346 LALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ 421 (672)
Q Consensus 346 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~ 421 (672)
.++...++|.+++.||+|+||.|..++.+ .++.||+|++++- ......-|..|..+|..-+.+.|+.++..|+++.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 33445679999999999999999999986 5889999999873 3344567899999999999999999999999999
Q ss_pred eEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCc
Q 005871 422 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 501 (672)
Q Consensus 422 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla 501 (672)
++|+|||||+||+|-.++... ..++++-++.++..|+.||..||+.| +|||||||+|||||..|++||+|||.+
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred ceEEEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhH
Confidence 999999999999999999543 36999999999999999999999998 999999999999999999999999999
Q ss_pred eeeCCCCCCcccccccccCCcCChhhhc----C-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhcc
Q 005871 502 RIFGGNQNQANTNIIAGTYGYMAPEYAM----G-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWC 576 (672)
Q Consensus 502 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 576 (672)
-.+..+.. ......+|||.|++||+++ + +.|++.+|+||+||++|||+.|..||. ...+..-..++..
T Consensus 223 lkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY------adslveTY~KIm~ 295 (1317)
T KOG0612|consen 223 LKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY------ADSLVETYGKIMN 295 (1317)
T ss_pred HhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch------HHHHHHHHHHHhc
Confidence 88764332 2344578999999999995 2 569999999999999999999999983 2222222223332
Q ss_pred CCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHHhcc--CCC----CCCCCCCCccccc
Q 005871 577 EGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT---MSSVVVMLAS--DSM----TIPQPTEPAFSVG 643 (672)
Q Consensus 577 ~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~L~~--~~~----~l~~p~~p~~~~~ 643 (672)
......+-+... -+++ ..+||...+ -+|+.|.. ++++-...-. +.+ ..+||-.|.++.+
T Consensus 296 hk~~l~FP~~~~----VSee---akdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd 363 (1317)
T KOG0612|consen 296 HKESLSFPDETD----VSEE---AKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSD 363 (1317)
T ss_pred hhhhcCCCcccc----cCHH---HHHHHHHHh-cChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCC
Confidence 222222221110 1233 344444444 47778887 9999887644 333 3577778887663
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=296.39 Aligned_cols=263 Identities=25% Similarity=0.378 Sum_probs=193.9
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
++|++.+.||+|++|.||+|.+. +++.||+|++..... .....+.+|++++++++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999976 688999998865432 334678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-CCCeEEEeecCceeeCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFGLARIFGGN 507 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~-~~~~kL~DFgla~~~~~~ 507 (672)
|+++ +|..++... ....+++..+..++.||+.||+|||+++ |+|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLDL-DLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred cccc-cHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9964 676666332 2234688889999999999999999997 999999999999985 567999999999765432
Q ss_pred CCCcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCC---Ccc--
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG---PAV-- 581 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~-- 581 (672)
.. ......+++.|+|||++.+. .++.++||||||+++|+|++|+.||....... .... ........ .+.
T Consensus 157 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~--~~~~-~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 157 VR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID--ELFK-IFRILGTPNEETWPGV 231 (294)
T ss_pred cc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHhCCCChhhcccc
Confidence 21 11223578899999998764 57999999999999999999999985432111 0000 00000000 000
Q ss_pred ----cccC--hhhcC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 582 ----ELID--PVLKQ----SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 582 ----~l~d--~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.... +.... ...+.....+.+++.+||+.+|++||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 00000 0011123457788889999999999999999963
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=291.01 Aligned_cols=242 Identities=24% Similarity=0.319 Sum_probs=193.8
Q ss_pred cccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCCCCh
Q 005871 360 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 435 (672)
Q Consensus 360 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL 435 (672)
||+|++|.||++++. +++.+++|++.+.. ....+.+.+|+.+++.++||||+++++.+.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999986 48999999987543 23456789999999999999999999999999999999999999999
Q ss_pred hHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCccccc
Q 005871 436 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 515 (672)
Q Consensus 436 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~ 515 (672)
.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 999854 235899999999999999999999987 9999999999999999999999999998765432 1223
Q ss_pred ccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHH
Q 005871 516 IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPD 595 (672)
Q Consensus 516 ~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 595 (672)
..|++.|++||.+.+..++.++|+||||+++|+|++|..||...... ............. ....+..
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~---------~~~~~~~ 218 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYNDILKGNG---------KLEFPNY 218 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHHHhccCC---------CCCCCcc
Confidence 46889999999998888999999999999999999999997543221 1111111110000 0011111
Q ss_pred HHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005871 596 ELLKFIHIGLLCVQQDPADRPT-----MSSVVV 623 (672)
Q Consensus 596 ~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 623 (672)
....+.+++.+||+.+|++||+ +.|+++
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 2346788888999999999999 677765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=305.36 Aligned_cols=264 Identities=24% Similarity=0.359 Sum_probs=196.5
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEeccc--CcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeC--ceE
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG--QEL 423 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~--~~~ 423 (672)
..++|.+.+.||+|+||.||+|.+. +++.+|+|++... .......+..|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4578999999999999999999976 5889999988543 233445677899999999 999999999998653 468
Q ss_pred EEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 424 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
++||||+. ++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 488777632 26889999999999999999999987 99999999999999999999999999986
Q ss_pred eCCCCCC---cccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhh-----
Q 005871 504 FGGNQNQ---ANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL----- 574 (672)
Q Consensus 504 ~~~~~~~---~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~----- 574 (672)
+...... .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||........ .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~ 233 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ---LEKIIEVIGPPS 233 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCC
Confidence 6433221 22233568999999998765 4578999999999999999999999854322110 0000000
Q ss_pred ------ccCCCcccccChhhcC------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 575 ------WCEGPAVELIDPVLKQ------SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 575 ------~~~~~~~~l~d~~l~~------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
+......++++..... ...+.....+.+++.+||+.+|++|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000000000000 0001123467888899999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=298.36 Aligned_cols=248 Identities=28% Similarity=0.424 Sum_probs=194.5
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
.++|.+.+.||+|+||.||+|.+. +++.||+|++.... .+..+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356899999999999999999975 68999999886433 23345788999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||+.+ ++.+.+... ...+++..+..++.||+.+|.|||+.+ |+||||+|+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~g-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCLG-SASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhCC-CHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 999974 555555322 235899999999999999999999987 99999999999999999999999999876432
Q ss_pred CCCCcccccccccCCcCChhhhc---CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccc
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAM---GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 583 (672)
. ....|++.|+|||++. .+.++.++||||||+++|||++|+.|+..... .......... ....+
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~------~~~~~~~~~~-~~~~~ 234 (307)
T cd06607 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQN-DSPTL 234 (307)
T ss_pred C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH------HHHHHHHhcC-CCCCC
Confidence 2 2346788999999874 45688999999999999999999999742211 0101111000 00000
Q ss_pred cChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 584 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
. .......+.+++.+||+.+|++||++.+|+++.
T Consensus 235 -----~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 235 -----S---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred -----C---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0 111234578888899999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=293.49 Aligned_cols=243 Identities=26% Similarity=0.297 Sum_probs=186.2
Q ss_pred ccccCCceeEEeeeec-CCceeEEEEecccCc---ccHHHHHHHHHHHHh---ccCCCeeeEEEEEEeCceEEEEEeecC
Q 005871 359 KLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAK---LQHKNLVRLLGCCLEGQELLLIYEYMP 431 (672)
Q Consensus 359 ~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~---l~h~niv~l~~~~~~~~~~~lV~Ey~~ 431 (672)
.||+|+||.||++.+. +++.+|+|.+.+... .....+.+|..+++. .+|||++.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999975 588999998865421 112334455544444 479999999999999999999999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCc
Q 005871 432 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 511 (672)
Q Consensus 432 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 511 (672)
+++|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 9999988843 345999999999999999999999998 9999999999999999999999999987654322
Q ss_pred ccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcC
Q 005871 512 NTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590 (672)
Q Consensus 512 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 590 (672)
.....|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||......... ........ ....
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~~~------~~~~--- 217 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTLT------VNVE--- 217 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH----HHHHHhhc------CCcC---
Confidence 122468999999999864 55899999999999999999999998543221111 11111000 0111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 005871 591 SCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVVML 625 (672)
Q Consensus 591 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 625 (672)
.+......+.+++.+||+.||++|| +++|++++.
T Consensus 218 -~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 218 -LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred -CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 1122234567788899999999999 699999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=306.11 Aligned_cols=261 Identities=23% Similarity=0.330 Sum_probs=196.1
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeC-----ce
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QE 422 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~ 422 (672)
.++|.+.+.||+|+||.||++++. +++.||||.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 467999999999999999999975 6899999998753 233345678899999999999999999988654 35
Q ss_pred EEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCce
Q 005871 423 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 502 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~ 502 (672)
.++||||+. ++|..++. ....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 899999996 57777774 3346999999999999999999999997 9999999999999999999999999998
Q ss_pred eeCCCCCCcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhh-------
Q 005871 503 IFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL------- 574 (672)
Q Consensus 503 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~------- 574 (672)
...... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ........
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~ 231 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH---QLKLITELLGSPSEE 231 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCChH
Confidence 654322 11223457889999998865 468999999999999999999999985432110 00000000
Q ss_pred ----ccCCCccccc-------ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 575 ----WCEGPAVELI-------DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 575 ----~~~~~~~~l~-------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.......+.+ +.... ...+.....+.+++.+||+.+|++|||++++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0000000000 00000 0011223457889999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=291.05 Aligned_cols=249 Identities=28% Similarity=0.395 Sum_probs=202.2
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
+|++.++||+|+||.||++... +++.+++|.+.... ......+.+|+.+++.++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5888999999999999999865 68899999987542 33456778899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 430 MPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 430 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
+++++|..++.... ....+++..++.++.|++.||.|||+.| ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999886522 2356899999999999999999999997 9999999999999999999999999998765431
Q ss_pred CCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhh
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 588 (672)
.....|++.|++||.+.+..++.++|+||||+++|+|++|+.||...... ..... ........
T Consensus 158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~~~~~-~~~~~~~~------ 220 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ------DLRYK-VQRGKYPP------ 220 (256)
T ss_pred ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-HhcCCCCC------
Confidence 22245788999999999999999999999999999999999997533211 11111 11111111
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 589 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 589 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
........+.+++.+||+.+|++|||+.++++.
T Consensus 221 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 221 ---IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ---CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 112334568888999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=291.85 Aligned_cols=250 Identities=25% Similarity=0.395 Sum_probs=199.4
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
+|.+.+.||+|+||.||++..+ ++..+|+|.+.... ....+.+.+|+.+++.++|+||+++++.+.+....++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788999999999999999986 58899999986542 23456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC-eEEEeecCceeeCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN-PKISDFGLARIFGGNQ 508 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~-~kL~DFgla~~~~~~~ 508 (672)
+++++|.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||||+||++++++. +||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999886432 235799999999999999999999987 999999999999998864 6999999998764332
Q ss_pred CCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhh
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 588 (672)
.. .....|++.|+|||++.+..++.++|+||||+++++|++|+.|+.... ......... .+.....
T Consensus 157 ~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~-~~~~~~~----- 222 (257)
T cd08225 157 EL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKIC-QGYFAPI----- 222 (257)
T ss_pred cc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHh-cccCCCC-----
Confidence 21 122458899999999988889999999999999999999999974321 111111111 1111111
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 589 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 589 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.+.....+.+++.+|++.+|++|||+.+|++.
T Consensus 223 ----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 ----SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ----CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11122457788889999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=296.02 Aligned_cols=248 Identities=24% Similarity=0.356 Sum_probs=196.4
Q ss_pred CccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCC
Q 005871 354 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 432 (672)
Q Consensus 354 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~ 432 (672)
|....+||+|+||.||++..+ +++.+|+|++..........+.+|+.+++.++|+|++++++.+...+..++||||+++
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 334468999999999999875 6899999998765555567789999999999999999999999999999999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcc
Q 005871 433 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 512 (672)
Q Consensus 433 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~ 512 (672)
++|.+++.. ..+++..+..++.|++.+|.|||+.| ++|+||+|+||+++.++.++|+|||++........ .
T Consensus 102 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~ 172 (292)
T cd06657 102 GALTDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R 172 (292)
T ss_pred CcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--c
Confidence 999987632 34789999999999999999999997 99999999999999999999999999876543221 1
Q ss_pred cccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCC
Q 005871 513 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSC 592 (672)
Q Consensus 513 ~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 592 (672)
.....|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...... .......... .+.+..
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~~~~~~---------~~~~~~-- 238 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRDNL---------PPKLKN-- 238 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhhC---------CcccCC--
Confidence 23346889999999998888999999999999999999999997532111 0011000000 000000
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 593 APDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 593 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.......+.+++.+||+.+|.+||++.+|++.
T Consensus 239 ~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 239 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 01112345677889999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=297.13 Aligned_cols=264 Identities=23% Similarity=0.344 Sum_probs=195.5
Q ss_pred HHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCc----
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ---- 421 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~---- 421 (672)
...++|++.+.||+|+||.||+|.++ +++.||+|++.... ......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999986 58899999987543 233456788999999999999999999987655
Q ss_pred ------eEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 005871 422 ------ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 495 (672)
Q Consensus 422 ------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL 495 (672)
..++|+||+++ ++...+.. ....+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 79999999987 55555532 2346899999999999999999999997 999999999999999999999
Q ss_pred EeecCceeeCCCCCCcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhh
Q 005871 496 SDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL 574 (672)
Q Consensus 496 ~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 574 (672)
+|||++..+....... .....++..|+|||.+.+. .++.++|||||||++|+|++|++||...... ..+......
T Consensus 158 ~dfg~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~---~~~~~~~~~ 233 (302)
T cd07864 158 ADFGLARLYNSEESRP-YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL---AQLELISRL 233 (302)
T ss_pred CcccccccccCCcccc-cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHH
Confidence 9999998764433211 1223467789999988654 5789999999999999999999997532211 111111111
Q ss_pred ccCC---Ccccc--------cC------hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 575 WCEG---PAVEL--------ID------PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 575 ~~~~---~~~~l--------~d------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
.... ....+ .+ ...... .......+.+++..||+.+|++|||+.+|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 00000 00 000000 0011345778888999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=284.09 Aligned_cols=247 Identities=28% Similarity=0.425 Sum_probs=201.1
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEecccCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
+|++.++||+|++|.||++.+. +++.+++|.+..... .....+.+|++++++++|+|++++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788999999999999999875 578999999876653 4567899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+++++|.+++... ..+++..+..++.|++.+|.+||+.| |+||||||+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999988543 56899999999999999999999997 99999999999999999999999999987654332
Q ss_pred CcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhc
Q 005871 510 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 589 (672)
. .....++..|+|||.+.+..++.++||||+|+++|+|++|+.|+.... .....+..... .... +
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~-~~~~-----~- 219 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN------PMAALFRIVQD-DHPP-----L- 219 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhcc-CCCC-----C-
Confidence 1 223467889999999988888999999999999999999999974321 11111111111 1100 1
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 590 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
+......+.+++.+||+.+|++|||+.+++.
T Consensus 220 ---~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 ---PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ---CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1111345678888999999999999999984
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=306.30 Aligned_cols=246 Identities=26% Similarity=0.363 Sum_probs=204.8
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
...|.+.+.||+|.|+.|.++++. .+.+||||.+.+..- ...+.+.+|+++|..|+|||||+++.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 467999999999999999999975 699999999987643 33456899999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+.+|.+.+++... +.+.+..+..++.|++.+++|||+++ |+|||||++|||++.+.++||+|||++..+...
T Consensus 135 eya~~ge~~~yl~~~---gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 135 EYASGGELFDYLVKH---GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EeccCchhHHHHHhc---ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc
Confidence 999999999999544 44667889999999999999999997 999999999999999999999999999988633
Q ss_pred CCCcccccccccCCcCChhhhcCCCC-ChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
. .....+|++.|.|||++.+..| ++++|+||+|+++|-|+.|..||+... +.++-++
T Consensus 209 ~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~-------------------lk~Lr~r 266 (596)
T KOG0586|consen 209 L---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN-------------------LKELRPR 266 (596)
T ss_pred c---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc-------------------cccccch
Confidence 2 3345799999999999999877 799999999999999999999985321 1111111
Q ss_pred hhcCC--CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 587 VLKQS--CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 587 ~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.+.+. .+.....++-+|++++|-.+|.+|++++++.+.
T Consensus 267 vl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 267 VLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred heeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 11111 112223356788889999999999999998764
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.06 Aligned_cols=248 Identities=24% Similarity=0.374 Sum_probs=193.4
Q ss_pred CccccccccCCceeEEeeeec-CCceeEEEEec----ccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCce--EEEE
Q 005871 354 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLS----RTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE--LLLI 426 (672)
Q Consensus 354 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~----~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~--~~lV 426 (672)
.+....||+|+|-+||+|.+. +|.+||--.++ ..++...+.|..|+.+|+.|+||||++++++|.+... +.+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 345678999999999999985 57777654332 1245566899999999999999999999999997654 8899
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-CCCeEEEeecCceeeC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFGLARIFG 505 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~-~~~~kL~DFgla~~~~ 505 (672)
+|.+..|+|..++.+. ..++.+.+..|++||++||.|||++. .+|||||||-+||||+. .|.|||+|+|+|..+.
T Consensus 122 TEL~TSGtLr~Y~kk~---~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKH---RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred eecccCCcHHHHHHHh---ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 9999999999999544 45899999999999999999999985 68999999999999985 5899999999998764
Q ss_pred CCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccC
Q 005871 506 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585 (672)
Q Consensus 506 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 585 (672)
... ...+.|||.|||||++. ..|.+.+||||||++++||+|+..|+. ......+...+.. .|.-.+-+.
T Consensus 198 ~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs-----EC~n~AQIYKKV~-SGiKP~sl~ 266 (632)
T KOG0584|consen 198 KSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS-----ECTNPAQIYKKVT-SGIKPAALS 266 (632)
T ss_pred ccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh-----hhCCHHHHHHHHH-cCCCHHHhh
Confidence 332 33478999999999887 789999999999999999999999853 1122222222221 111111111
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
. .... .+.++|.+||.. .++|||+.|+|+.=
T Consensus 267 ----k-V~dP---evr~fIekCl~~-~~~R~sa~eLL~d~ 297 (632)
T KOG0584|consen 267 ----K-VKDP---EVREFIEKCLAT-KSERLSAKELLKDP 297 (632)
T ss_pred ----c-cCCH---HHHHHHHHHhcC-chhccCHHHHhhCh
Confidence 1 1122 355666799999 99999999999754
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=311.42 Aligned_cols=257 Identities=25% Similarity=0.378 Sum_probs=200.9
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeC------ceE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------QEL 423 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~------~~~ 423 (672)
..|...+.||+|+||.||+|+++ .|+.||||.++... ....+....|+++|++|+|+|||+++++=.+. ...
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 34667788999999999999965 69999999988753 34457788999999999999999999886543 357
Q ss_pred EEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc--CCCC--eEEEeec
Q 005871 424 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD--DDMN--PKISDFG 499 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~--~~~~--~kL~DFg 499 (672)
.+|||||.+|+|...|....+...+++.+.+.++.++..||.|||++| |+||||||.||++- ++|+ .||+|||
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 899999999999999998888888999999999999999999999997 99999999999994 3344 6999999
Q ss_pred CceeeCCCCCCcccccccccCCcCChhhhc-CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCC
Q 005871 500 LARIFGGNQNQANTNIIAGTYGYMAPEYAM-GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 578 (672)
Q Consensus 500 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 578 (672)
.|+.+..+. ....++||..|++||++. .+.|+..+|.|||||++|+.+||..||........ ..+..|....+.
T Consensus 170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~--~~~~~~~~~tkk 244 (732)
T KOG4250|consen 170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKN--NKEIMWHIITKK 244 (732)
T ss_pred ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccc--cchhhhhhhccC
Confidence 999876544 455679999999999998 58899999999999999999999999864433321 122333332222
Q ss_pred Ccccc--cChh----------h--cCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 005871 579 PAVEL--IDPV----------L--KQSCAPDELLKFIHIGLLCVQQDPADRP 616 (672)
Q Consensus 579 ~~~~l--~d~~----------l--~~~~~~~~~~~l~~li~~cl~~dP~~RP 616 (672)
+.... ..+. + .....+.....+-..+..+|..+|++|.
T Consensus 245 p~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 245 PSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred CCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 11110 0100 0 1122344455666666788899999998
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=298.83 Aligned_cols=250 Identities=28% Similarity=0.408 Sum_probs=195.0
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
+.|...+.||+|+||.||++++. ++..+|+|++.... .+....+.+|+.++++++|||++++++++.++...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34778899999999999999975 68899999986542 233457889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+.+ ++.+.+... ...+++.++..++.||+.+|.|||+.+ |+||||+|+||+++.++.+||+|||++.....
T Consensus 105 e~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~- 177 (317)
T cd06635 105 EYCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP- 177 (317)
T ss_pred eCCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence 99975 666665432 345899999999999999999999997 99999999999999999999999999875432
Q ss_pred CCCcccccccccCCcCChhhhc---CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 508 QNQANTNIIAGTYGYMAPEYAM---GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
.....|++.|+|||++. ++.++.++||||||+++|||++|+.||..... . .......... ...
T Consensus 178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~---~~~~~~~~~~-~~~-- 243 (317)
T cd06635 178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---M---SALYHIAQNE-SPT-- 243 (317)
T ss_pred -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH---H---HHHHHHHhcc-CCC--
Confidence 12346788999999974 45689999999999999999999999642210 0 0000010000 000
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
.........+.+++.+||+.+|.+||++.+|++.+-..
T Consensus 244 ------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 244 ------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred ------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 00111223567888899999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=287.96 Aligned_cols=251 Identities=23% Similarity=0.399 Sum_probs=204.0
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEecccCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
+|.+.+.||.|+||.||++.+. +++.+++|++..... .....+.+|+++++.++|+|++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5888999999999999999975 589999999876543 4566789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 430 MPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 430 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
+++++|.+.+.... ....+++..+..++.+++.||.|||+.| ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999886532 2357899999999999999999999997 9999999999999999999999999998765433
Q ss_pred CCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhh
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 588 (672)
.......|++.|+|||.+.+..++.++|+||+|+++++|++|+.|+.... ......... ......+
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~------~~~~~~~~~-~~~~~~~----- 223 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN------LLELALKIL-KGQYPPI----- 223 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc------HHHHHHHHh-cCCCCCC-----
Confidence 12233468899999999988889999999999999999999999974322 111111111 1111111
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 589 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 589 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
+......+.+++.+||+.+|++|||+.++++.
T Consensus 224 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 ----PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ----CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11223457788889999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=298.44 Aligned_cols=262 Identities=24% Similarity=0.324 Sum_probs=192.8
Q ss_pred cccccC--CceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCC
Q 005871 358 NKLGQG--GFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 432 (672)
Q Consensus 358 ~~LG~G--~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~ 432 (672)
..||+| +||+||++++. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 457777 99999999975 69999999987532 33457789999999999999999999999999999999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCc-
Q 005871 433 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA- 511 (672)
Q Consensus 433 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~- 511 (672)
+++.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+++.||+.+..........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99998886532 235899999999999999999999987 9999999999999999999999998654322111100
Q ss_pred ----ccccccccCCcCChhhhcCC--CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhh------------
Q 005871 512 ----NTNIIAGTYGYMAPEYAMGG--IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWK------------ 573 (672)
Q Consensus 512 ----~~~~~~gt~~Y~aPE~~~~~--~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~------------ 573 (672)
......++..|+|||++.+. .++.++|||||||++|+|++|+.||........ .......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccccc
Confidence 01112356679999999764 478999999999999999999999854321110 0000000
Q ss_pred ----h-------c---------cCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 574 ----L-------W---------CEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 574 ----~-------~---------~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
. + .......+.+..+...........+.+++.+||+.||++|||+.|+++.-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 0 0 00000011111111111223456788999999999999999999998653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=288.84 Aligned_cols=250 Identities=25% Similarity=0.387 Sum_probs=195.4
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEeccc-----CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeC--ceE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-----SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QEL 423 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~ 423 (672)
.+|.+.+.||+|+||.||++.+. +++.+|+|.+... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47899999999999999999975 5899999987532 223456788999999999999999999998764 468
Q ss_pred EEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 424 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
++|+||+++++|.+.+.. ...+++..+..++.||+.+|.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999988843 235889999999999999999999998 99999999999999999999999999986
Q ss_pred eCCCCCC-cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccc
Q 005871 504 FGGNQNQ-ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVE 582 (672)
Q Consensus 504 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (672)
....... .......|+..|+|||++.+..++.++|+||||+++|+|++|+.||..... ... ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~-~~~~~~~~~~-- 227 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA-----MAA-IFKIATQPTK-- 227 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH-----HHH-HHHHHcCCCC--
Confidence 5432111 112234688999999999988899999999999999999999999753211 111 1111111100
Q ss_pred ccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 583 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 583 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
+ ..+......+.+++.+|++ +|..||+..++++
T Consensus 228 ---~----~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 228 ---P----MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ---C----CCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1 1122223456777789999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=304.50 Aligned_cols=270 Identities=20% Similarity=0.316 Sum_probs=199.1
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEe----CceE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE----GQEL 423 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~----~~~~ 423 (672)
.++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+|++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 378999999999999999999975 58999999987643 2345677889999999999999999988763 3568
Q ss_pred EEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 424 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
++||||+. ++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 578877742 345899999999999999999999987 99999999999999999999999999987
Q ss_pred eCCCCCCc--ccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhh--------hhh
Q 005871 504 FGGNQNQA--NTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLT--------YTW 572 (672)
Q Consensus 504 ~~~~~~~~--~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~--------~~~ 572 (672)
........ ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||............. ..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 64332211 1123468899999999866 458999999999999999999999985322111000000 000
Q ss_pred hhccCCCcccccChhhc-CCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 573 KLWCEGPAVELIDPVLK-QSC-----APDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 573 ~~~~~~~~~~l~d~~l~-~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
.........+..+.... ... .+.....+.+++.+||+.+|++|||++++++..-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~ 297 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhh
Confidence 00000000000000000 000 11224567888999999999999999999986543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=287.64 Aligned_cols=244 Identities=22% Similarity=0.254 Sum_probs=187.0
Q ss_pred cccccCCceeEEeeeec-CCceeEEEEecccCc---ccHHHHHHHHHHH-HhccCCCeeeEEEEEEeCceEEEEEeecCC
Q 005871 358 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLI-AKLQHKNLVRLLGCCLEGQELLLIYEYMPN 432 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il-~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~ 432 (672)
+.||+|+||.||+|... +++.||+|.+.+... .....+..|..++ ...+|+|++++++.+...+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999875 588999999875432 2223345555544 445899999999999999999999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcc
Q 005871 433 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 512 (672)
Q Consensus 433 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~ 512 (672)
++|..++.. ...+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 999998843 245899999999999999999999987 99999999999999999999999999876432
Q ss_pred cccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCC
Q 005871 513 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSC 592 (672)
Q Consensus 513 ~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 592 (672)
.....|+..|+|||.+.+..++.++||||||+++|+|++|..||..... .. .+......... .....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~----~~~~~~~~~~~--~~~~~---- 216 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP---DA----VFDNILSRRIN--WPEEV---- 216 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---HH----HHHHHHhcccC--CCCcc----
Confidence 2234678899999999888899999999999999999999999753211 11 11111111000 00000
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 593 APDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 593 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
.......+.+++.+||+.+|++||++.++.+.|+
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 1112345778888999999999998766655543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=292.47 Aligned_cols=261 Identities=16% Similarity=0.200 Sum_probs=182.9
Q ss_pred HhcCCccccccccCCceeEEeeeecC----CceeEEEEecccCcccH-----------HHHHHHHHHHHhccCCCeeeEE
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTSGQGL-----------QEFKNEVNLIAKLQHKNLVRLL 414 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~E~~il~~l~h~niv~l~ 414 (672)
..++|.+.++||+|+||.||+|.+.+ +..+|+|+......... .....+...+..++|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 34689999999999999999999754 34566665433221110 1122344456667899999999
Q ss_pred EEEEeCc----eEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC
Q 005871 415 GCCLEGQ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD 490 (672)
Q Consensus 415 ~~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~ 490 (672)
+.+.... ..++++|++.. ++...+.. ....++..+..|+.|++.||.|||+.+ |+||||||+|||++.+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 8776543 34677887643 45444422 223578889999999999999999997 9999999999999999
Q ss_pred CCeEEEeecCceeeCCCCCC-----cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCccccc
Q 005871 491 MNPKISDFGLARIFGGNQNQ-----ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQ 565 (672)
Q Consensus 491 ~~~kL~DFgla~~~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~ 565 (672)
+.++|+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~-- 240 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG-- 240 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--
Confidence 99999999999876432211 11233569999999999999999999999999999999999999986432111
Q ss_pred chhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 566 TLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 566 ~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
.........+. ..+....+.- +.....+.+++..|++.+|++||++++|++.|.
T Consensus 241 ~~~~~~~~~~~----~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 241 NLIHAAKCDFI----KRLHEGKIKI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHhHHHHH----HHhhhhhhcc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11110000000 0000000000 111245677888999999999999999998873
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=302.56 Aligned_cols=266 Identities=24% Similarity=0.327 Sum_probs=200.3
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCc-----eEE
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-----ELL 424 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~-----~~~ 424 (672)
+|.+.+.||+|++|.||+|+.. .++.+|+|++.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999976 48999999987654 344568899999999999999999999998775 789
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceee
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 504 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~ 504 (672)
+||||+.+ +|..++.. ...+++..+..++.||+.||.|||+.| |+||||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~~-~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELMET-DLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchhh-hHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 99999984 77777743 337999999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCC-cccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhh--------hhhhh
Q 005871 505 GGNQNQ-ANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLT--------YTWKL 574 (672)
Q Consensus 505 ~~~~~~-~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~--------~~~~~ 574 (672)
...... .......++..|+|||++.+. .++.++|+||||+++|+|++|+.||............. ..+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 543311 112334678899999999887 78999999999999999999999985432211000000 00000
Q ss_pred ccCCCcccccChhhc------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 575 WCEGPAVELIDPVLK------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 575 ~~~~~~~~l~d~~l~------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
.......+.+..... ....+.....+.+++..||+.+|++|||+.++++.-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 290 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHP 290 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCc
Confidence 000000000000000 000111234577888999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=289.86 Aligned_cols=246 Identities=26% Similarity=0.360 Sum_probs=194.3
Q ss_pred cccCCceeEEeeeec-CCceeEEEEecccCc---ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCCCCh
Q 005871 360 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 435 (672)
Q Consensus 360 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL 435 (672)
||+|+||.||++++. +++.+++|.+..... ...+.+.+|++++++++||||+++++.+......++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999986 489999999876543 4556789999999999999999999999999999999999999999
Q ss_pred hHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC------
Q 005871 436 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN------ 509 (672)
Q Consensus 436 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~------ 509 (672)
.+++... ..+++..+..++.||+++|.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9988543 36899999999999999999999997 99999999999999999999999999876433221
Q ss_pred CcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhc
Q 005871 510 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 589 (672)
........++..|++||...+...+.++||||||+++|+|++|+.||...... ....... .+.. ...
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~-~~~~-~~~----- 221 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EIFQNIL-NGKI-EWP----- 221 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHh-cCCc-CCC-----
Confidence 11223356788999999998888999999999999999999999997532211 1111111 0100 000
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 590 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
.. ......+.+++.+||+.+|++|||+.++.+.|+
T Consensus 222 ~~--~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 222 ED--VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred cc--ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00 001345678888999999999999966665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=284.71 Aligned_cols=245 Identities=20% Similarity=0.242 Sum_probs=188.2
Q ss_pred HHhcCCcccccc--ccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEE
Q 005871 349 EATNHFSDENKL--GQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELL 424 (672)
Q Consensus 349 ~~~~~~~~~~~L--G~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~ 424 (672)
...++|.+.+.+ |+|+||.||+++.+ ++..+|+|.+....... .|+.....+ +||||+++++.+...+..+
T Consensus 11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 345677777776 99999999999975 57889999886543221 123333323 7999999999999999999
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-CeEEEeecCcee
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARI 503 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~-~~kL~DFgla~~ 503 (672)
+||||+++++|.+++... ..+++.++..++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||++..
T Consensus 86 iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred EEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 999999999999988532 37899999999999999999999998 99999999999999988 999999999886
Q ss_pred eCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccc
Q 005871 504 FGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583 (672)
Q Consensus 504 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 583 (672)
..... ...|+..|+|||++.+..++.++||||||+++|+|++|+.||....... .....+.... . .....
T Consensus 160 ~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~--~-~~~~~ 229 (267)
T PHA03390 160 IGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ--Q-KKLPF 229 (267)
T ss_pred cCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh--c-ccCCc
Confidence 54221 2357899999999999899999999999999999999999986322111 1111111110 0 00000
Q ss_pred cChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 005871 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT-MSSVVV 623 (672)
Q Consensus 584 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~ 623 (672)
.......+.+++.+||+.+|.+||+ ++++++
T Consensus 230 ---------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 230 ---------IKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ---------ccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 1122345778888999999999996 699874
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=297.62 Aligned_cols=268 Identities=22% Similarity=0.312 Sum_probs=196.9
Q ss_pred hcCCcc-ccccccCCceeEEeeeec-CCceeEEEEecccCccc--------------HHHHHHHHHHHHhccCCCeeeEE
Q 005871 351 TNHFSD-ENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQG--------------LQEFKNEVNLIAKLQHKNLVRLL 414 (672)
Q Consensus 351 ~~~~~~-~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~il~~l~h~niv~l~ 414 (672)
.++|.. .+.||+|+||.||++.+. +++.||||++....... ...+.+|+++++.++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 356654 567999999999999975 68999999986543211 12477899999999999999999
Q ss_pred EEEEeCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeE
Q 005871 415 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPK 494 (672)
Q Consensus 415 ~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~k 494 (672)
+++...+..++||||+. ++|.+++.. ...+++.....++.|++.||.|||+.| |+|+||+|+||+++.++.+|
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 99999999999999997 578877743 345899999999999999999999997 99999999999999999999
Q ss_pred EEeecCceeeCCCCC------------CcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005871 495 ISDFGLARIFGGNQN------------QANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFS 561 (672)
Q Consensus 495 L~DFgla~~~~~~~~------------~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~ 561 (672)
|+|||++..+..... ........+++.|+|||.+.+. .++.++||||||+++|+|++|+.||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999987652110 1111223468889999998764 469999999999999999999999864332
Q ss_pred ccccchhhhhhhhccCCC---cccc--------cChhhcC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 562 EHGQTLLTYTWKLWCEGP---AVEL--------IDPVLKQ---SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~---~~~l--------~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
.. ............. +.+. ....... .........+.+++.+||+.+|++|||++|++..--.
T Consensus 240 ~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~ 316 (335)
T PTZ00024 240 ID---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF 316 (335)
T ss_pred HH---HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence 11 1111111110000 0000 0000000 0011123457788899999999999999999976544
Q ss_pred C
Q 005871 628 D 628 (672)
Q Consensus 628 ~ 628 (672)
.
T Consensus 317 ~ 317 (335)
T PTZ00024 317 K 317 (335)
T ss_pred C
Confidence 3
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=292.32 Aligned_cols=263 Identities=21% Similarity=0.220 Sum_probs=192.2
Q ss_pred cccccccCCceeEEeeeecCCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCCC
Q 005871 356 DENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 433 (672)
Q Consensus 356 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~g 433 (672)
+.+.+|.|+++.||++.. +++.||||++... .....+.+.+|+.+++.++|+||+++++++.+.+..+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 444455556655555554 6899999998764 3455678999999999999999999999999999999999999999
Q ss_pred ChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC----
Q 005871 434 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN---- 509 (672)
Q Consensus 434 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~---- 509 (672)
+|.+++.... ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||.+..+.....
T Consensus 85 ~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999886532 235889999999999999999999997 99999999999999999999999999876532211
Q ss_pred -CcccccccccCCcCChhhhcCC--CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhh----hccC-----
Q 005871 510 -QANTNIIAGTYGYMAPEYAMGG--IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWK----LWCE----- 577 (672)
Q Consensus 510 -~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~----~~~~----- 577 (672)
........++..|+|||++.+. .++.++||||||+++|||++|+.||...... ......... .+..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchhh
Confidence 1112234577889999998763 5889999999999999999999998532211 001110000 0000
Q ss_pred --CCccc----ccChhh----cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 578 --GPAVE----LIDPVL----KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 578 --~~~~~----l~d~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
....+ ..++.. ...........+.+++.+||+.||++|||++++++.-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 00000 000000 0011122334678899999999999999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=290.44 Aligned_cols=249 Identities=26% Similarity=0.353 Sum_probs=200.7
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEeccc---CcccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCceEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lV 426 (672)
++|.+.+.||+|+||.||++.+. +++.+|+|++.+. .......+.+|++++++++ ||||+++++.+..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47899999999999999999976 6899999998753 2233467889999999998 99999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||+++++|.+++.. ...+++..++.++.|++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999998854 336999999999999999999999997 99999999999999999999999999987654
Q ss_pred CCCC------------------cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchh
Q 005871 507 NQNQ------------------ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLL 568 (672)
Q Consensus 507 ~~~~------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~ 568 (672)
.... .......|+..|+|||.+.+..++.++||||||++++++++|+.|+..... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~ 228 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE------Y 228 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH------H
Confidence 3321 222334678999999999888899999999999999999999999753321 0
Q ss_pred hhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 005871 569 TYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTM----SSVVV 623 (672)
Q Consensus 569 ~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~----~evl~ 623 (672)
....... .. ....+......+.+++.+||+.+|++||++ +++++
T Consensus 229 ~~~~~~~-~~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 229 LTFQKIL-KL----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHHH-hc----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0011111 00 001111123457788889999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=297.71 Aligned_cols=266 Identities=27% Similarity=0.384 Sum_probs=193.4
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeC-------
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------- 420 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~------- 420 (672)
.++|.+.++||+|+||.||+|.+. +++.+|+|++..... .....+.+|+++++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999975 588999998865432 2234678899999999999999999987543
Q ss_pred -ceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeec
Q 005871 421 -QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 499 (672)
Q Consensus 421 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFg 499 (672)
...++||||+.+ ++...+.. ....+++..+..++.||+++|.|||+.| |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 346999999976 55555533 2346999999999999999999999998 9999999999999999999999999
Q ss_pred CceeeCCCCCCc---------ccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhh
Q 005871 500 LARIFGGNQNQA---------NTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLT 569 (672)
Q Consensus 500 la~~~~~~~~~~---------~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~ 569 (672)
++.......... ......|++.|+|||.+.+. .++.++||||||+++|||++|++||.............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 998654322111 11234678889999988654 57999999999999999999999975432211100000
Q ss_pred --------hhhhhccCCCc------ccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 570 --------YTWKLWCEGPA------VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 570 --------~~~~~~~~~~~------~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
..+..+..... .....+.+... .......+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEER-FGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHH-cccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00000000000 00000000000 0112246778999999999999999999975
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=307.85 Aligned_cols=252 Identities=31% Similarity=0.416 Sum_probs=204.0
Q ss_pred CCccccccccCCceeEEeeeecC--C--ceeEEEEecccCcc-cHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 353 HFSDENKLGQGGFGPVYKGTLAD--G--KAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
.....++||+|.||.|++|.|.. | -.||||.+...... ....|.+|+.+|.+|+|+|++++||+..+ +...|||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 44566889999999999999863 4 36799999876544 67899999999999999999999999987 7889999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
|.++.|+|.+.|.+ .....+-......++.||+.|+.||.+++ +|||||-..|+||-....+||+|||+.+.++.+
T Consensus 190 ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 99999999999977 45567888999999999999999999997 999999999999999999999999999988654
Q ss_pred CCCc-ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcC-CCCCCCCCcccccchhhhhhhhccCCCcccccC
Q 005871 508 QNQA-NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG-RKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585 (672)
Q Consensus 508 ~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 585 (672)
.... ......-.+.|+|||.+....++.++|||+|||++|||+|+ ..||. ...+..+ .+.+|
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~---G~~g~qI-------------L~~iD 329 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWV---GCRGIQI-------------LKNID 329 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCC---CCCHHHH-------------HHhcc
Confidence 4322 12222335679999999999999999999999999999994 44532 2222222 22333
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
..-.-..+....+++.++++.||..+|++|||+..|.+.+
T Consensus 330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 2212223455677899999999999999999999997544
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=287.06 Aligned_cols=260 Identities=25% Similarity=0.357 Sum_probs=193.2
Q ss_pred CccccccccCCceeEEeeeec-CCceeEEEEecccCc--ccHHHHHHHHHHHHhc---cCCCeeeEEEEEEeCce-----
Q 005871 354 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKL---QHKNLVRLLGCCLEGQE----- 422 (672)
Q Consensus 354 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l---~h~niv~l~~~~~~~~~----- 422 (672)
|++.+.||+|+||.||+|+++ +++.+|+|++..... .....+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 677899999999999999986 489999999875432 2234566788877776 59999999999998776
Q ss_pred EEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCce
Q 005871 423 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 502 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~ 502 (672)
.+++|||+.+ +|.+++.... ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 9999999975 7877775422 235899999999999999999999997 9999999999999999999999999998
Q ss_pred eeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhh-------hc
Q 005871 503 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWK-------LW 575 (672)
Q Consensus 503 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~-------~~ 575 (672)
.+...... ....++..|+|||++.+..++.++||||||+++|+|++|++||........ ....... .+
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 230 (287)
T cd07838 156 IYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDKIFDVIGLPSEEEW 230 (287)
T ss_pred eccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHHHHHHcCCCChHhc
Confidence 76443221 223578899999999999999999999999999999999988753221110 0000000 00
Q ss_pred cCCCc--ccccChhhc---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 576 CEGPA--VELIDPVLK---QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 576 ~~~~~--~~l~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
..... ......... ....+.....+.+++.+||+.||++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000 000000000 0111223356778899999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=302.51 Aligned_cols=265 Identities=22% Similarity=0.326 Sum_probs=194.1
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeC---------
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--------- 420 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--------- 420 (672)
..+|.+.+.||.|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 368999999999999999999975 5899999998776666677889999999999999999999776543
Q ss_pred -----ceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc-CCCCeE
Q 005871 421 -----QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPK 494 (672)
Q Consensus 421 -----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~-~~~~~k 494 (672)
...++||||++ ++|..++. ...+++..+..++.||++||.|||+.| |+||||||+||+++ +++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35799999997 47777663 235889999999999999999999997 99999999999998 456789
Q ss_pred EEeecCceeeCCCCCC-cccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhh
Q 005871 495 ISDFGLARIFGGNQNQ-ANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTW 572 (672)
Q Consensus 495 L~DFgla~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~ 572 (672)
|+|||++..+...... .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ ......
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--~~~~~~ 233 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ--MQLILE 233 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHH
Confidence 9999999876432221 11223357889999998755 4578999999999999999999999853221100 000000
Q ss_pred hhcc--C---CCcccccChhh-----cCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 573 KLWC--E---GPAVELIDPVL-----KQSC-----APDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 573 ~~~~--~---~~~~~l~d~~l-----~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
.... . ......+.... .... .+.....+.+++.+||+.||++|||+.+|++.=
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~ 301 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHP 301 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCC
Confidence 0000 0 00000000000 0000 011224577888999999999999999998643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=299.44 Aligned_cols=253 Identities=26% Similarity=0.426 Sum_probs=201.9
Q ss_pred hcCCccccccccCCceeEEeeeecC-----CceeEEEEeccc-CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLAD-----GKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 424 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 424 (672)
.+.....+.||+|-||.||+|...+ .-.||||..+.+ ..+..+.|+.|..+|++++||||++++|+|.+ ...+
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~W 466 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMW 466 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-ccee
Confidence 3445566789999999999998532 346888988763 45668899999999999999999999999986 4689
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceee
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 504 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~ 504 (672)
||||.++.|.|..+|... ...++......++.||..+|.|||+.. +|||||...||||.+..-+||+|||+++.+
T Consensus 467 ivmEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred EEEecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhc
Confidence 999999999999999653 345888999999999999999999986 999999999999999999999999999988
Q ss_pred CCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccc
Q 005871 505 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583 (672)
Q Consensus 505 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 583 (672)
......... ...-...|||||-+.-..++.++|||-|||++||++. |..||..-... ++.-.
T Consensus 542 ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs----------------DVI~~ 604 (974)
T KOG4257|consen 542 EDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS----------------DVIGH 604 (974)
T ss_pred cccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc----------------ceEEE
Confidence 765543333 2233567999999999999999999999999999886 88887432111 11111
Q ss_pred cChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 584 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
++.--+-.+++.+...+..|+.+||..+|.+||++.+|...|+
T Consensus 605 iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~ls 647 (974)
T KOG4257|consen 605 IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILS 647 (974)
T ss_pred ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence 1111112234445556778899999999999999999887765
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=287.31 Aligned_cols=242 Identities=26% Similarity=0.297 Sum_probs=185.8
Q ss_pred ccccCCceeEEeeeec-CCceeEEEEecccCcc---cHHHHHHHHH---HHHhccCCCeeeEEEEEEeCceEEEEEeecC
Q 005871 359 KLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ---GLQEFKNEVN---LIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 431 (672)
Q Consensus 359 ~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~---il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 431 (672)
.||+|+||.||++.+. +++.||+|.+.+.... ....+..|.. +++...||||+++++.+.+.+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 5889999998764321 1223344444 4444579999999999999999999999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCc
Q 005871 432 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 511 (672)
Q Consensus 432 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 511 (672)
+++|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 9999988843 346999999999999999999999987 9999999999999999999999999987653321
Q ss_pred ccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcC
Q 005871 512 NTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590 (672)
Q Consensus 512 ~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 590 (672)
.....|+..|+|||.+.++ .++.++||||+|+++|+|++|+.||.......... ........ ...+
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~------~~~~-- 218 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLTM------AVEL-- 218 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHHhhcc------CCCC--
Confidence 2234689999999999755 58999999999999999999999985432211111 01100000 0111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005871 591 SCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVVM 624 (672)
Q Consensus 591 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 624 (672)
+......+.+++.+||+.+|++|| ++.++++.
T Consensus 219 --~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 219 --PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred --CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 111234577888899999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=289.44 Aligned_cols=255 Identities=24% Similarity=0.329 Sum_probs=197.4
Q ss_pred CCccccccccCCceeEEeeeec----CCceeEEEEecccC----cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceE
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQEL 423 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~ 423 (672)
+|.+.+.||+|++|.||+++.. +++.+|+|.+.+.. ....+.+.+|+.++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788899999999999999752 57889999886532 23345688999999999 599999999999999999
Q ss_pred EEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 424 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
++||||+.+++|..++.. ...+++..+..++.|++++|.|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999988843 345889999999999999999999987 99999999999999999999999999886
Q ss_pred eCCCCCCcccccccccCCcCChhhhcCCC--CChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcc
Q 005871 504 FGGNQNQANTNIIAGTYGYMAPEYAMGGI--FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAV 581 (672)
Q Consensus 504 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (672)
+...... ......|+..|+|||.+.+.. .+.++||||||+++|+|++|..||....... .............
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~--- 228 (288)
T cd05583 155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKSK--- 228 (288)
T ss_pred ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHccC---
Confidence 5433221 122346889999999987765 7899999999999999999999975322111 1111111111110
Q ss_pred cccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 582 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 582 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
... +......+.+++.+||+.+|++|||+.++.+.|.-
T Consensus 229 ----~~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 229 ----PPF----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ----CCC----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 001 11112346678889999999999998888776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=294.91 Aligned_cols=260 Identities=23% Similarity=0.337 Sum_probs=194.7
Q ss_pred HHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCc----
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ---- 421 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~---- 421 (672)
...++|++.+.||+|+||.||++... ++..||||++.... ......+.+|+.++++++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 45678999999999999999999865 68999999986532 223456889999999999999999999987653
Q ss_pred --eEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeec
Q 005871 422 --ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 499 (672)
Q Consensus 422 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFg 499 (672)
..++||||+ +++|..++. ...+++..++.++.||++||.|||+.| |+||||||+||+++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 468999998 778887763 245899999999999999999999987 9999999999999999999999999
Q ss_pred CceeeCCCCCCcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhh--------
Q 005871 500 LARIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTY-------- 570 (672)
Q Consensus 500 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~-------- 570 (672)
++...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||....... .....
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~ 236 (343)
T cd07880 164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD--QLMEIMKVTGTPS 236 (343)
T ss_pred cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCC
Confidence 99865322 123457889999999876 458999999999999999999999985332110 00000
Q ss_pred --hhhhccCCCccccc-------ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 571 --TWKLWCEGPAVELI-------DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 571 --~~~~~~~~~~~~l~-------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.+..+......... ...+. .........+.+++.+||+.||++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFR-SLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHHHhhcchhHHHHHHhccccCcchHH-HhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000000 00000 0001122347788999999999999999999954
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=288.09 Aligned_cols=252 Identities=25% Similarity=0.329 Sum_probs=195.3
Q ss_pred CCccccccccCCceeEEeeee----cCCceeEEEEecccC----cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceE
Q 005871 353 HFSDENKLGQGGFGPVYKGTL----ADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQEL 423 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~ 423 (672)
+|++.+.||+|+||.||++.. .+|+.||+|++.... ....+.+.+|+.+++++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478899999999999999986 368899999987532 22346778899999999 599999999999999999
Q ss_pred EEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 424 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
++||||+++++|.+++.. ...+++..+..++.||++||.|||+.+ ++||||||+|||++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999998853 345889999999999999999999987 99999999999999999999999999987
Q ss_pred eCCCCCCcccccccccCCcCChhhhcCC--CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcc
Q 005871 504 FGGNQNQANTNIIAGTYGYMAPEYAMGG--IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAV 581 (672)
Q Consensus 504 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (672)
....... ......|+..|+|||.+.+. .++.++||||||+++|+|++|+.|+...... ...............
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~-- 229 (290)
T cd05613 155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSEP-- 229 (290)
T ss_pred ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhccCC--
Confidence 5432221 12234688999999998753 4688999999999999999999997532111 111111111111110
Q ss_pred cccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005871 582 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVVM 624 (672)
Q Consensus 582 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 624 (672)
. .+......+.+++.+||+.+|++|| ++.+++..
T Consensus 230 -----~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 230 -----P----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -----C----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0 1111223466788899999999997 77777664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=291.07 Aligned_cols=245 Identities=28% Similarity=0.428 Sum_probs=190.7
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
.|...++||+|+||.||+|++. +++.+++|++.... ......+.+|+.+++.++|||++++++++.+....++|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 3677788999999999999975 58899999986532 2334578899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|+.+ ++...+.. ....+++.++..++.||+.+|.|||+.| |+|+||+|+||+++.++.+||+|||++....
T Consensus 102 ~~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~--- 172 (313)
T cd06633 102 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS--- 172 (313)
T ss_pred cCCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC---
Confidence 9965 66665533 2345899999999999999999999997 9999999999999999999999999986422
Q ss_pred CCcccccccccCCcCChhhhc---CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccC
Q 005871 509 NQANTNIIAGTYGYMAPEYAM---GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 585 (672)
......|+..|+|||++. .+.++.++||||||+++|+|++|..|+..... .......... ......
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~-~~~~~~- 241 (313)
T cd06633 173 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQN-DSPTLQ- 241 (313)
T ss_pred ---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhc-CCCCCC-
Confidence 122356888999999984 45688999999999999999999999643211 1111111101 111111
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.......+.+++.+||+.+|.+||++.++++.
T Consensus 242 -------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 -------SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01112346778889999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=288.95 Aligned_cols=263 Identities=26% Similarity=0.321 Sum_probs=194.3
Q ss_pred CccccccccCCceeEEeeeec-CCceeEEEEecccCc-ccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCceEEEEEeec
Q 005871 354 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 354 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
|.+.+.||+|++|.||+|+.. +++.++||++..... .......+|+..+++++ |+|++++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 667889999999999999986 478899999865432 22234567999999999 999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
+++|.+.+.... ...+++..+..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 788888775432 246899999999999999999999987 99999999999999999999999999986543222
Q ss_pred cccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccch-hh----hhhhhccCC-----C
Q 005871 511 ANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTL-LT----YTWKLWCEG-----P 579 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~-~~----~~~~~~~~~-----~ 579 (672)
.....|+..|+|||++.+ ..++.++|+||||+++++|++|++||........... .. .....|.+. .
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 122457889999998854 4579999999999999999999998754322110000 00 000000000 0
Q ss_pred cccccChhhc---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 580 AVELIDPVLK---QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 580 ~~~l~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
....+..... ....+.....+.+++.+||+.+|++|||+.|++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000000 00001113568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=290.09 Aligned_cols=253 Identities=26% Similarity=0.390 Sum_probs=192.7
Q ss_pred hcCCccccccccCCceeEEeeeecC-CceeEEEEecccC-cccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCceEEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lV~ 427 (672)
.++|.+.+.||+|+||.||+|.+++ ++.||||.+.... ......+..|+.++.++. ||||+++++++.+....++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3678999999999999999999874 8999999987543 233455677887777775 999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED-SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
||+.+ ++..++... ...+++..+..++.||+.+|.|||+. + |+||||+|+||++++++.+||+|||++..+..
T Consensus 94 e~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 99854 666665432 23689999999999999999999974 5 99999999999999999999999999876543
Q ss_pred CCCCcccccccccCCcCChhhhcCCC----CChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccc
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGI----FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVE 582 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~----~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (672)
.... ....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... ........... ...
T Consensus 168 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~-~~~ 238 (296)
T cd06618 168 SKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEE-PPS 238 (296)
T ss_pred CCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCC-CCC
Confidence 2221 2235788999999987553 789999999999999999999997532111 11111111111 000
Q ss_pred ccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 583 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 583 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
+.. . ......+.+++.+||+.||++||++.+++++.
T Consensus 239 ~~~-----~--~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 239 LPP-----N--EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred CCC-----C--CCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 000 0 01224577888899999999999999998664
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=293.74 Aligned_cols=264 Identities=24% Similarity=0.372 Sum_probs=195.8
Q ss_pred HHhcCCccccccccCCceeEEeeeec-CCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEe-CceEE
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE-GQELL 424 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~-~~~~~ 424 (672)
..+++|++.+.||+|+||.||++... +++.+|+|++.+. .....+.+.+|+++++.++||||+++++++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 46789999999999999999999865 6899999988643 22345678899999999999999999999876 56789
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceee
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 504 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~ 504 (672)
+||||+ +++|..++. ...+++..+..++.||++||.|||+.+ |+||||+|+||++++++.+||+|||++...
T Consensus 87 lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 87 FVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 999998 567877763 235788889999999999999999997 999999999999999999999999998754
Q ss_pred CCCCCCcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchh--------hhhhhhc
Q 005871 505 GGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLL--------TYTWKLW 575 (672)
Q Consensus 505 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~--------~~~~~~~ 575 (672)
... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||............ ......+
T Consensus 159 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 159 DPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred CCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 321 122357889999998766 56899999999999999999999998543221100000 0000000
Q ss_pred cCCCcccccChhhc-CCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 576 CEGPAVELIDPVLK-QSCA-----PDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 576 ~~~~~~~l~d~~l~-~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
..+...+.+..... ...+ +.....+.+++.+||+.+|++|||+++++..=
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~ 289 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP 289 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence 00000011000000 0000 11234677888899999999999999997663
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=329.80 Aligned_cols=259 Identities=27% Similarity=0.360 Sum_probs=203.7
Q ss_pred HHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEE
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l 425 (672)
..+-+|....+||.|.||.||.+... +|.-.|+|.+.... ......+.+|..++..++|||+|+++|+=.+.+..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 34568889999999999999999864 68889999876543 3345678899999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
.||||++|+|.+.+... ...++.....+..|++.|+.|||++| ||||||||+||+++.+|.+|++|||.|..+.
T Consensus 1312 FMEyC~~GsLa~ll~~g---ri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHG---RIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHhccCcHHHHHHhc---chhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEec
Confidence 99999999999998443 34667777789999999999999998 9999999999999999999999999999876
Q ss_pred CCC--CCcccccccccCCcCChhhhcCC---CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCc
Q 005871 506 GNQ--NQANTNIIAGTYGYMAPEYAMGG---IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPA 580 (672)
Q Consensus 506 ~~~--~~~~~~~~~gt~~Y~aPE~~~~~---~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (672)
.+. .....+...||+-|||||++.+. ....+.|||||||++.||+||++||.....+-. +.. ...-+..
T Consensus 1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a--IMy----~V~~gh~ 1459 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA--IMY----HVAAGHK 1459 (1509)
T ss_pred CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH--HHh----HHhccCC
Confidence 542 33444567899999999999764 356799999999999999999999754332211 111 1111111
Q ss_pred ccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 581 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 581 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
.++ . ......=.+++..||+.||++|+++.++++.=...
T Consensus 1460 Pq~-----P----~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1460 PQI-----P----ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred CCC-----c----hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccc
Confidence 111 1 11122234555699999999999999998875443
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=297.16 Aligned_cols=268 Identities=24% Similarity=0.287 Sum_probs=197.0
Q ss_pred HHHHHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeC--
Q 005871 346 LALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-- 420 (672)
Q Consensus 346 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-- 420 (672)
.+....++|.+.+.||+|+||.||++.+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred HHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 34556789999999999999999999864 68999999987542 22346788899999999999999999988643
Q ss_pred ----ceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEE
Q 005871 421 ----QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKIS 496 (672)
Q Consensus 421 ----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~ 496 (672)
...+++++++ +++|..++.. ..+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~ 162 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKIL 162 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEe
Confidence 3467888876 7788777632 35899999999999999999999997 9999999999999999999999
Q ss_pred eecCceeeCCCCCCcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhh--
Q 005871 497 DFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWK-- 573 (672)
Q Consensus 497 DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~-- 573 (672)
|||++...... .....|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ........
T Consensus 163 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~ 235 (345)
T cd07877 163 DFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILRLVG 235 (345)
T ss_pred ccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhC
Confidence 99998754321 223467889999999876 568899999999999999999999974322111 00000000
Q ss_pred --------hccCCCcccc---cChhhcCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 574 --------LWCEGPAVEL---IDPVLKQSC---APDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 574 --------~~~~~~~~~l---~d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
.+........ ++....... .......+.+++.+||+.||.+||++.++++.--..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~ 304 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 304 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhh
Confidence 0000000000 000000000 001123567888899999999999999998775433
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=286.04 Aligned_cols=261 Identities=28% Similarity=0.363 Sum_probs=197.5
Q ss_pred CccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 354 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 354 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
|+..+.||+|++|.||+|+.. +++.+|+|++.... ....+.+..|+.++++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 567788999999999999986 58999999987653 334567889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
+ ++|.+++.... ..+++..+..++.|++.+|.|||+.+ |+||||+|+||++++++.++|+|||++.........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 8 58988885432 46899999999999999999999997 999999999999999999999999999876433221
Q ss_pred cccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccc--------hhhhhhhhccCC---
Q 005871 511 ANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQT--------LLTYTWKLWCEG--- 578 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~--------~~~~~~~~~~~~--- 578 (672)
.....++..|+|||.+.+. .++.++||||||+++|||++|++||.......... .....|..+..-
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 155 --YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred --cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 1223457789999998776 78999999999999999999999875432111000 000111111000
Q ss_pred --CcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 579 --PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 579 --~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
............ ..+.....+.+++..||+.+|++||++++|+.
T Consensus 233 ~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 233 KPTFPKFPPKDLEK-VLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccCccchHH-hcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000000000 01112346888999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=278.45 Aligned_cols=251 Identities=23% Similarity=0.360 Sum_probs=197.1
Q ss_pred cccccCCceeEEeee-ecCCceeEEEEecccCcccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCceEEEEEeecCCCCh
Q 005871 358 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEYMPNKSL 435 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lV~Ey~~~gsL 435 (672)
+.||+|+|+.|--+. ..+|.+||||++.+.......+..+|++++...+ |+||++++++|+++..+|||||.|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 579999999999887 4689999999999998888899999999999995 99999999999999999999999999999
Q ss_pred hHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC---eEEEeecCceeeC--CCC--
Q 005871 436 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN---PKISDFGLARIFG--GNQ-- 508 (672)
Q Consensus 436 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~---~kL~DFgla~~~~--~~~-- 508 (672)
...|.. +..+++.++..++.+|+.||.|||.+| |.||||||+|||.....+ +||+||.+..-.. ..-
T Consensus 164 LshI~~---~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQK---RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 988854 456999999999999999999999998 999999999999986654 7999998875432 111
Q ss_pred -CCcccccccccCCcCChhhhc-----CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCc--
Q 005871 509 -NQANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPA-- 580 (672)
Q Consensus 509 -~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 580 (672)
.....-..+|+..|||||+.. ...|+.+.|.||||||+|-|++|.+||...=..+. . |..++.
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC------G---WdrGe~Cr 308 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC------G---WDRGEVCR 308 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC------C---ccCCCccH
Confidence 122233468999999999862 34589999999999999999999999854322111 1 112211
Q ss_pred ---ccccChhhcC--CCCHHH----HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 581 ---VELIDPVLKQ--SCAPDE----LLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 581 ---~~l~d~~l~~--~~~~~~----~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
..+++....+ +++..+ .....+++..+|..++.+|.++..+++
T Consensus 309 ~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 309 VCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1122222222 122322 234457777899999999999999987
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=283.27 Aligned_cols=275 Identities=25% Similarity=0.344 Sum_probs=209.1
Q ss_pred ccchHHHHHHhcCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhc--cCCCeeeEEEEEE
Q 005871 341 LFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL--QHKNLVRLLGCCL 418 (672)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l--~h~niv~l~~~~~ 418 (672)
-+|+...+.......+.+.||+|.||+||+|.++ |+.||||++....+ ..+++|.+|.+.+ +|+||+.+++.-.
T Consensus 200 GlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~ 275 (513)
T KOG2052|consen 200 GLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADN 275 (513)
T ss_pred CchhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccc
Confidence 3455566667778999999999999999999996 88999999976554 5667788887765 9999999998865
Q ss_pred eC----ceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeeecCCCCCcEEEcC
Q 005871 419 EG----QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE-----DSRLKIIHRDLKASNILLDD 489 (672)
Q Consensus 419 ~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-----~g~~~iiHrDlkp~NIll~~ 489 (672)
.+ .+++||.+|.+.|||.++|.. ..++.+..++++..++.||+|||- +|+..|.|||||..||||..
T Consensus 276 ~~~gs~TQLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk 351 (513)
T KOG2052|consen 276 KDNGSWTQLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 351 (513)
T ss_pred cCCCceEEEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc
Confidence 43 369999999999999999954 468999999999999999999994 56778999999999999999
Q ss_pred CCCeEEEeecCceeeCCCC--CCcccccccccCCcCChhhhcCCC----C--ChhhHHHHHHHHHHHHHcCC--------
Q 005871 490 DMNPKISDFGLARIFGGNQ--NQANTNIIAGTYGYMAPEYAMGGI----F--SIKSDVFSFGVLLLEIISGR-------- 553 (672)
Q Consensus 490 ~~~~kL~DFgla~~~~~~~--~~~~~~~~~gt~~Y~aPE~~~~~~----~--s~ksDvwSlGvil~elltG~-------- 553 (672)
++...|+|+|+|....... .....+..+||.+|||||++.... + -..+||||||.++||+.-.-
T Consensus 352 n~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ee 431 (513)
T KOG2052|consen 352 NGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEE 431 (513)
T ss_pred CCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehh
Confidence 9999999999998776442 233345678999999999985432 2 24699999999999997532
Q ss_pred --CCCCCCCcccccchhhhhhhhccCCCcccccChhhcC-CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 005871 554 --KNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ-SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDS 629 (672)
Q Consensus 554 --~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 629 (672)
.||....+. +.. .+...+... .+-+.|.+.. -.+.+.+..+.+||+.||..||.-|.|+-.|-+.|....
T Consensus 432 y~~Pyyd~Vp~-DPs-~eeMrkVVC----v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 432 YQLPYYDVVPS-DPS-FEEMRKVVC----VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred hcCCcccCCCC-CCC-HHHHhccee----ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 332211111 110 111111111 1112222221 123467788999999999999999999999999887754
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=291.38 Aligned_cols=250 Identities=30% Similarity=0.422 Sum_probs=194.5
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEeccc---CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
+.|...+.||+|+||.||+|++. ++..+++|.+... .......+.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 45788899999999999999975 5788999988643 2334567889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+. +++...+... ...+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9997 5676666432 345899999999999999999999987 999999999999999999999999998765322
Q ss_pred CCCcccccccccCCcCChhhhc---CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 508 QNQANTNIIAGTYGYMAPEYAM---GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
....|++.|+|||.+. .+.++.++|||||||++|+|++|+.|+...... ..... +........
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~-----~~~~~~~~~- 234 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYH-----IAQNESPAL- 234 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--HHHHH-----HhhcCCCCc-
Confidence 2346788999999975 356789999999999999999999986432110 00000 001110000
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
. .......+.+++.+||+.+|++||++.+|++..-..
T Consensus 235 ----~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 235 ----Q---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred ----C---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence 0 112234467888899999999999999999765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=272.37 Aligned_cols=253 Identities=26% Similarity=0.392 Sum_probs=196.1
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCceEEEEEe
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lV~E 428 (672)
++.+.+..||.|.-|+||+.+.+ .|..+|||.+.+.. .+..++++..+.++..-+ +|+||+.+|+|..+..+++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 45667788999999999999976 58999999998764 455667888888887775 8999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
.|. ..++.++.. -..++++..+-++...+++||.||.++. +|+|||+||+|||+|+.|++||+|||++..+....
T Consensus 172 lMs-~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 172 LMS-TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHH-HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 873 344555533 2346899999999999999999999876 79999999999999999999999999998775443
Q ss_pred CCcccccccccCCcCChhhhcC---CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccC
Q 005871 509 NQANTNIIAGTYGYMAPEYAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 585 (672)
.. +...|-+.|||||.+.- ..|..++||||||++++||.||+.|+..-.. +... .-+..++++
T Consensus 247 Ah---trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t--dFe~---ltkvln~eP------ 312 (391)
T KOG0983|consen 247 AH---TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT--DFEV---LTKVLNEEP------ 312 (391)
T ss_pred cc---ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc--cHHH---HHHHHhcCC------
Confidence 32 23478999999999853 4689999999999999999999999753211 1111 122222211
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
+.+.... .....+++++..||++|+.+||...++++.-
T Consensus 313 P~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~ 350 (391)
T KOG0983|consen 313 PLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEHP 350 (391)
T ss_pred CCCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence 2222111 1234577788899999999999999998753
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=293.55 Aligned_cols=261 Identities=25% Similarity=0.301 Sum_probs=190.7
Q ss_pred CCccccccccCCceeEEeeeec-C--CceeEEEEecccC--cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeC----ce
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-D--GKAIAVKRLSRTS--GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG----QE 422 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~----~~ 422 (672)
+|.+.+.||+|+||.||+++.. . +..+|+|++.... ....+.+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999975 3 7889999886532 22346788899999999 599999999875432 45
Q ss_pred EEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCce
Q 005871 423 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 502 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~ 502 (672)
.++++||+. ++|...+. ....+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 788899886 57887774 3346899999999999999999999998 9999999999999999999999999998
Q ss_pred eeCCCCCC--cccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhh--------
Q 005871 503 IFGGNQNQ--ANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYT-------- 571 (672)
Q Consensus 503 ~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~-------- 571 (672)
.+...... .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||....... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~ 230 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQVLGTPD 230 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHHHHhCCCC
Confidence 76432221 11233578999999998766 468999999999999999999999975422110 00000
Q ss_pred ---hhhccCCCccccc-------ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 572 ---WKLWCEGPAVELI-------DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 572 ---~~~~~~~~~~~l~-------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
+..+......... ...+. ...+.....+.+++.+||+.||++|||+.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 231 EETLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000000 00000 0001113457788889999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=299.06 Aligned_cols=252 Identities=30% Similarity=0.468 Sum_probs=203.1
Q ss_pred CCccccccccCCceeEEeeeecC-CceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecC
Q 005871 353 HFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 431 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 431 (672)
+....++||-|-||.||.|.|+. .-.||||.++... ..+++|+.|..+|+.++|||+|+++|+|..+..+|||+|||.
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 45567899999999999999974 6789999886543 457899999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCc
Q 005871 432 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 511 (672)
Q Consensus 432 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 511 (672)
.|+|.++|....+ ..++.-..+.++.||..|++||..+. +|||||...|.||.++..+|++|||+++++..+....
T Consensus 347 yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA 422 (1157)
T KOG4278|consen 347 YGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA 422 (1157)
T ss_pred CccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence 9999999977544 45777888999999999999999986 9999999999999999999999999999876543322
Q ss_pred ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcC
Q 005871 512 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590 (672)
Q Consensus 512 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 590 (672)
.. ...-...|.|||-+.-..++.|+|||+|||+||||.| |-.|+ .+.++.+ +..+ ++.-.+-
T Consensus 423 HA-GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPY------PGidlSq-VY~L---------LEkgyRM 485 (1157)
T KOG4278|consen 423 HA-GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPY------PGIDLSQ-VYGL---------LEKGYRM 485 (1157)
T ss_pred cc-CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCC------CCccHHH-HHHH---------Hhccccc
Confidence 11 1112457999999999999999999999999999998 44443 2323222 2222 2222222
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 591 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
+.+..+..++.+||+.||+++|.+||++.|+-+.++
T Consensus 486 ~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE 521 (1157)
T KOG4278|consen 486 DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE 521 (1157)
T ss_pred cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence 233445567889999999999999999999877654
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=281.04 Aligned_cols=250 Identities=26% Similarity=0.386 Sum_probs=193.7
Q ss_pred CCccccccccCCceeEEeeeecC-CceeEEEEeccc-----CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 353 HFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRT-----SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
+|.+.++||+|+||.||++.+.. +..+++|.+... .......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58889999999999999998753 455666655432 122334677899999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 427 YEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
|||+++++|..++... .....+++..++.++.|++.||.|||+.+ ++|+||||+||++++ +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999888642 23456899999999999999999999987 999999999999975 569999999998764
Q ss_pred CCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccC
Q 005871 506 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585 (672)
Q Consensus 506 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 585 (672)
.... ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.... ......... .+....
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~-~~~~~~--- 224 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIV-EGPTPS--- 224 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHH-cCCCCC---
Confidence 3222 1223457889999999988888999999999999999999999974211 111111111 111111
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.+......+.+++.+||+.+|++||++.++++.
T Consensus 225 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 225 ------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 112233467788889999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=294.77 Aligned_cols=257 Identities=25% Similarity=0.353 Sum_probs=191.0
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeC------c
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------Q 421 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~------~ 421 (672)
.++|.+.+.||+|+||.||+|.+. +++.||+|++.+.. ......+.+|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999975 68999999987532 23345688999999999999999999998754 3
Q ss_pred eEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCc
Q 005871 422 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 501 (672)
Q Consensus 422 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla 501 (672)
..++|+||+.. +|...+ ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 56999999964 565443 235889999999999999999999997 999999999999999999999999998
Q ss_pred eeeCCCCCCcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhh------
Q 005871 502 RIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL------ 574 (672)
Q Consensus 502 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~------ 574 (672)
+..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .....+..
T Consensus 165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~ 236 (342)
T cd07879 165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGP 236 (342)
T ss_pred cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCH
Confidence 754221 123467889999999876 468999999999999999999999985422110 01000000
Q ss_pred -----ccCCCccccc---ChhhcCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 575 -----WCEGPAVELI---DPVLKQS---CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 575 -----~~~~~~~~l~---d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
+........+ ....... ..+.....+.+++.+||+.||++||++.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000000 0000000 001122357788999999999999999999865
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=296.97 Aligned_cols=259 Identities=25% Similarity=0.345 Sum_probs=195.4
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCce----
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE---- 422 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~---- 422 (672)
..++|.+.+.||+|++|.||+|.+. +++.||+|++... .......+.+|+.++++++|||++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4578999999999999999999986 5889999988653 22344667889999999999999999988876554
Q ss_pred --EEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecC
Q 005871 423 --LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 500 (672)
Q Consensus 423 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgl 500 (672)
.++|+||+ +++|.+++.. ..+++..+..++.||+++|.|||+.| |+||||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 5688887742 45899999999999999999999987 99999999999999999999999999
Q ss_pred ceeeCCCCCCcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhh--------
Q 005871 501 ARIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYT-------- 571 (672)
Q Consensus 501 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~-------- 571 (672)
+...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... .....
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~---~~~~i~~~~~~~~ 236 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID---QLKRIMNLVGTPD 236 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHhcCCCC
Confidence 9865432 223467889999999865 367899999999999999999999985322110 00000
Q ss_pred ---hhhccCCCcccccChhhc---CC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 572 ---WKLWCEGPAVELIDPVLK---QS---CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 572 ---~~~~~~~~~~~l~d~~l~---~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
+..+........+..... .. ........+.+++.+||+.+|++|||+.+|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000000000000000000 00 001124568889999999999999999999865
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=273.40 Aligned_cols=236 Identities=30% Similarity=0.374 Sum_probs=190.3
Q ss_pred cccCCceeEEeeeec-CCceeEEEEecccCc---ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCCCCh
Q 005871 360 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 435 (672)
Q Consensus 360 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL 435 (672)
||+|+||.||++.+. +++.+++|.+..... .....+..|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 799999999999976 589999999876532 2456789999999999999999999999999999999999999999
Q ss_pred hHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCccccc
Q 005871 436 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 515 (672)
Q Consensus 436 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~ 515 (672)
.+++... ..+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 9988532 35899999999999999999999987 9999999999999999999999999998764332 12234
Q ss_pred ccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHH
Q 005871 516 IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPD 595 (672)
Q Consensus 516 ~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 595 (672)
..++..|++||.+.+...+.++|+||||+++|+|++|+.||..... ......... .. ...+..
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~-~~----------~~~~~~ 215 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILK-DP----------LRFPEF 215 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhc-CC----------CCCCCC
Confidence 5678899999999888899999999999999999999999743221 111111110 00 001111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHH
Q 005871 596 ELLKFIHIGLLCVQQDPADRPTMSS 620 (672)
Q Consensus 596 ~~~~l~~li~~cl~~dP~~RPt~~e 620 (672)
....+.+++.+||+.||++||++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 1345678888999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=310.52 Aligned_cols=145 Identities=27% Similarity=0.419 Sum_probs=131.2
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
++|.+.++||+|+||.||+|.+. +++.||||++.... ......+..|+.++..++||||+++++.+......+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 68999999999999999999986 68999999987543 233467889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCce
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 502 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~ 502 (672)
||+.+++|..++.. ...+++..++.|+.||+.||.|||..+ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999998853 235889999999999999999999987 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-33 Score=270.97 Aligned_cols=274 Identities=23% Similarity=0.383 Sum_probs=199.2
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEe--------C
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE--------G 420 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~--------~ 420 (672)
..|+...+||+|.||+||+++.+ .|+.||+|++-... ...-....+|+++|..|+|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 56888899999999999999976 57888998764422 2223566889999999999999999988763 2
Q ss_pred ceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecC
Q 005871 421 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 500 (672)
Q Consensus 421 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgl 500 (672)
..+++||.+|+. +|.-+|.+ ....++..++.+++.+++.||.|+|... |+|||+||.|+||+.+|.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 458999999976 45555533 3356889999999999999999999986 99999999999999999999999999
Q ss_pred ceeeCCCCC--CcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhh-------
Q 005871 501 ARIFGGNQN--QANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTY------- 570 (672)
Q Consensus 501 a~~~~~~~~--~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~------- 570 (672)
++.+..... ....+..+-|.+|.+||.+.+. .|+++.|||+.|||+.||+||.+.+..........+...
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 987754332 2223344569999999998875 689999999999999999999987654333322222221
Q ss_pred -hhhhccCCCccccc--ChhhcCCCC--HHHH------HHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCC
Q 005871 571 -TWKLWCEGPAVELI--DPVLKQSCA--PDEL------LKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMT 631 (672)
Q Consensus 571 -~~~~~~~~~~~~l~--d~~l~~~~~--~~~~------~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 631 (672)
+|....+-+..+.+ ++..++... .+.. ...++|+.++|..||.+|+++++++..--.-+.+
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence 22222221111211 111111100 1111 1456778899999999999999998876554433
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-33 Score=287.84 Aligned_cols=244 Identities=24% Similarity=0.352 Sum_probs=196.9
Q ss_pred ccccccCCceeEEeeeec-CCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCCC
Q 005871 357 ENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 433 (672)
Q Consensus 357 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~g 433 (672)
.+.||.|-||+||-|.++ +|+.||||++.+. .......+.+|+.||++++||.||.+...|+..+.+++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 478999999999999975 7999999999765 3444578999999999999999999999999999999999999888
Q ss_pred ChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC---CCeEEEeecCceeeCCCCCC
Q 005871 434 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD---MNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 434 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~---~~~kL~DFgla~~~~~~~~~ 510 (672)
-|+..|.. ..+.+++..-..++.||+.||.|||.++ |+|+||||+|||+.+. -++||+|||++++.+....
T Consensus 649 MLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF- 722 (888)
T KOG4236|consen 649 MLEMILSS--EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF- 722 (888)
T ss_pred HHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence 88877754 3456999999999999999999999997 9999999999999754 4699999999999865443
Q ss_pred cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcC
Q 005871 511 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 590 (672)
...++|||.|+|||+++++.|...-|+||.|||+|--++|.-||.......+ ..+-..-.+...+
T Consensus 723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd--QIQNAaFMyPp~P----------- 787 (888)
T KOG4236|consen 723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND--QIQNAAFMYPPNP----------- 787 (888)
T ss_pred --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH--HhhccccccCCCc-----------
Confidence 3357899999999999999999999999999999999999999743221111 1111111111111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 591 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
..+.....++||...||..-++|-+.+.-+.
T Consensus 788 --W~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 788 --WSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred --hhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 2233345678888999999999998876543
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-34 Score=273.82 Aligned_cols=257 Identities=26% Similarity=0.359 Sum_probs=197.5
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCc-ccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEEEEEe
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lV~E 428 (672)
++.+-+..||.|.||+|+|-.++ .|+.+|||+++.... ...++++.|.+...+- +.||||+++|.+..++..|+.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 34556778999999999999876 699999999987654 4566788888876665 78999999999999999999999
Q ss_pred ecCCCChhHHhhh--ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 429 YMPNKSLDVHLFD--ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 429 y~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
.|+ .+|+.+... ..+...++++.+..|....+.||.||...- .|||||+||+|||++..|.+||+|||++..+..
T Consensus 144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 994 566554432 234556999999999999999999999864 799999999999999999999999999976643
Q ss_pred CCCCcccccccccCCcCChhhhcC--CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMG--GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
.. ..+.-.|-..|||||.+.. ..|..++||||||++|||+.||+.|+..|.+. .+...+. ..+....+.
T Consensus 221 Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv-----feql~~V-v~gdpp~l~ 291 (361)
T KOG1006|consen 221 SI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV-----FEQLCQV-VIGDPPILL 291 (361)
T ss_pred HH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-----HHHHHHH-HcCCCCeec
Confidence 22 1223468889999999853 35899999999999999999999997655442 1122222 122222222
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.+. ..-.....+..++..||.+|-++||...++.++
T Consensus 292 ~~~----~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 292 FDK----ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred Ccc----cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 211 112234467778889999999999999998754
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-33 Score=280.81 Aligned_cols=271 Identities=24% Similarity=0.314 Sum_probs=209.6
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~l 425 (672)
..+|..+..||+|+||.|.++..+ ..+.||||++++.- .++.+--+.|-++|... +-|.+++++.+|+.-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 457899999999999999999876 46789999988752 34445556777888777 56889999999999999999
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
||||+.||+|-..+... +.+.+..+..++..|+-||-+||++| ||+||||.+|||+|.+|++||+|||+++.--
T Consensus 428 VMEyvnGGDLMyhiQQ~---GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQV---GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHHHh---cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence 99999999998888543 44778888999999999999999998 9999999999999999999999999998522
Q ss_pred CCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccC
Q 005871 506 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585 (672)
Q Consensus 506 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 585 (672)
.....+..++|||.|+|||++.-.+|+..+|+||+||+||||+.|++||+... ...+...+. +.
T Consensus 502 --~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD---E~elF~aI~----eh------- 565 (683)
T KOG0696|consen 502 --FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED---EDELFQAIM----EH------- 565 (683)
T ss_pred --cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHH----Hc-------
Confidence 22234556899999999999999999999999999999999999999985332 122221111 11
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH--hc------cCCCCCCCCCCCcccccccc
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTM-----SSVVVM--LA------SDSMTIPQPTEPAFSVGRVV 646 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~--L~------~~~~~l~~p~~p~~~~~~~~ 646 (672)
+-.++.....+.+.|....|.+.|.+|... .+|-+. .+ .+...++||-+|....++..
T Consensus 566 ---nvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k~~r~~ 636 (683)
T KOG0696|consen 566 ---NVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIKCGRDA 636 (683)
T ss_pred ---cCcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCccccCCch
Confidence 012233334456677778999999998632 222211 11 13456889999988666553
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-33 Score=289.85 Aligned_cols=268 Identities=22% Similarity=0.270 Sum_probs=214.5
Q ss_pred hcCCccccccccCCceeEEeeeecC-CceeEEEEeccc---CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
..+++++..||-|+||.|=++..+. ...+|+|++++. .....++...|-.||...+.|.||+++-.|.++..+|+.
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 3567788899999999999998764 335899988764 334567889999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
||-|-||.|...|. .++.++......++..+++|++|||+++ ||+|||||+|.|++.+|.+||.|||+++.+..
T Consensus 499 mEaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 499 MEACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HHhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 99999999999994 4567999999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
.. .+..++|||.|.|||++.+...+.++|.||||+++|||++|.+||....+-....+.-... +.
T Consensus 573 g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi------d~------ 637 (732)
T KOG0614|consen 573 GR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI------DK------ 637 (732)
T ss_pred CC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh------hh------
Confidence 43 4556899999999999999999999999999999999999999986443322211111100 00
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhcc--------CCCCCCCCCCCcccc
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPT-----MSSVVVMLAS--------DSMTIPQPTEPAFSV 642 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L~~--------~~~~l~~p~~p~~~~ 642 (672)
-.++........+|++++...+|.+|.. +.+|-+.-=. .+..|++|-.|....
T Consensus 638 ---i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ 703 (732)
T KOG0614|consen 638 ---IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVAN 703 (732)
T ss_pred ---hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCC
Confidence 1122223345668888999999999986 6666554311 244678888777655
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=271.10 Aligned_cols=219 Identities=19% Similarity=0.147 Sum_probs=173.6
Q ss_pred CCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCCCChhHHhhh
Q 005871 363 GGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD 441 (672)
Q Consensus 363 G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~ 441 (672)
|.+|.||++++. +++.+|+|++.... .+..|...+....||||+++++++.+.+..++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999985 68999999987653 233455555666799999999999999999999999999999988854
Q ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcccccccccCC
Q 005871 442 ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 521 (672)
Q Consensus 442 ~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~ 521 (672)
. ..+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.++|+|||.+..+.... ....++..
T Consensus 79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~ 147 (237)
T cd05576 79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM 147 (237)
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence 2 35899999999999999999999987 9999999999999999999999999887654321 12345678
Q ss_pred cCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHH
Q 005871 522 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFI 601 (672)
Q Consensus 522 Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~ 601 (672)
|+|||.+.+..++.++||||+|+++|||++|+.|+....... ... ....+ +......+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~-----~~~~~----~~~~~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTH-----TTLNI----PEWVSEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------ccc-----cccCC----cccCCHHHH
Confidence 999999988889999999999999999999998753211000 000 00001 111223467
Q ss_pred HHHHHhcccCCCCCCCH
Q 005871 602 HIGLLCVQQDPADRPTM 618 (672)
Q Consensus 602 ~li~~cl~~dP~~RPt~ 618 (672)
+++.+||+.||++||++
T Consensus 207 ~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 207 SLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHccCCHHHhcCC
Confidence 78889999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=292.30 Aligned_cols=242 Identities=23% Similarity=0.264 Sum_probs=190.5
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEEEEE
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lV~ 427 (672)
.++.|.....+|.|+|+.|-.+... .++..++|++.+...+ -.+|+.++... +||||+++++.+.+..+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc----cccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 3567888888999999999999875 6889999999876322 34577666666 7999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE-cCCCCeEEEeecCceeeCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL-DDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll-~~~~~~kL~DFgla~~~~~ 506 (672)
|++.|+-+.+.+.... .....+..|+.+|+.++.|||++| ++||||||+|||+ ++.++++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999998877774322 223778889999999999999998 9999999999999 5999999999999987654
Q ss_pred CCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
. ....+-|..|.|||++....|++++||||||++||+|++|+.||...... ..+.. ...
T Consensus 469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~----~i~---------- 527 (612)
T KOG0603|consen 469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHT----RIQ---------- 527 (612)
T ss_pred h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHH----hhc----------
Confidence 4 22234588999999999999999999999999999999999997532211 11111 111
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
...+.........+|+.+||+.||.+||++.++...=
T Consensus 528 --~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~ 564 (612)
T KOG0603|consen 528 --MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHP 564 (612)
T ss_pred --CCccccccCHHHHHHHHHhccCChhhCcChhhhccCc
Confidence 1111122233455777799999999999999997643
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-32 Score=285.50 Aligned_cols=205 Identities=25% Similarity=0.373 Sum_probs=175.6
Q ss_pred HHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEE
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 424 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 424 (672)
-...-|..++.||-|+||+|.++... ....||+|.+++.. ...+...+.|..||.+-..+.||+++..|++++.+|
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 33456888999999999999999754 47789999988764 344567889999999999999999999999999999
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceee
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 504 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~ 504 (672)
+||+|++||++-.+|. +-+.+.+..++.++..+..|+++.|..| +|||||||+|||||.+|++||+||||+.-+
T Consensus 706 FVMdYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred EEEeccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccc
Confidence 9999999999999884 4456899999999999999999999998 999999999999999999999999998533
Q ss_pred ---------CCCCCCc-------------------------------ccccccccCCcCChhhhcCCCCChhhHHHHHHH
Q 005871 505 ---------GGNQNQA-------------------------------NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGV 544 (672)
Q Consensus 505 ---------~~~~~~~-------------------------------~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGv 544 (672)
.+.+... .....+||+.|+|||++....++..+|+||.||
T Consensus 780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv 859 (1034)
T KOG0608|consen 780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV 859 (1034)
T ss_pred eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence 1111000 011257999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCC
Q 005871 545 LLLEIISGRKNNGFY 559 (672)
Q Consensus 545 il~elltG~~p~~~~ 559 (672)
|||||+.|++||-..
T Consensus 860 il~em~~g~~pf~~~ 874 (1034)
T KOG0608|consen 860 ILYEMLVGQPPFLAD 874 (1034)
T ss_pred HHHHHhhCCCCccCC
Confidence 999999999998543
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-32 Score=246.53 Aligned_cols=263 Identities=22% Similarity=0.300 Sum_probs=194.3
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCcc--cHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ--GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
.+|...++||+|.||+||+++.+ .++.||+|+++....+ --....+|+-+|++++|.|||++++....++.+.+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 35777899999999999999976 4788999998765432 24578899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
||+. +|..+.. .-++.++.+....++.|+++||.++|++. +.||||||.|.||+.+|.+||+|||+++.++-+.
T Consensus 82 ~cdq-dlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 82 FCDQ-DLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred HhhH-HHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 9954 4444442 23456899999999999999999999996 9999999999999999999999999999876543
Q ss_pred CCcccccccccCCcCChhhhcCCC-CChhhHHHHHHHHHHHHHcCCCC-CCCCCcccccchhhhhhh--hccCCCcccc-
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKN-NGFYFSEHGQTLLTYTWK--LWCEGPAVEL- 583 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDvwSlGvil~elltG~~p-~~~~~~~~~~~~~~~~~~--~~~~~~~~~l- 583 (672)
.-. +.-+-|.+|.+|.++.+.+ |++..|+||.|||+.|+....+| |...... ..+....|. ...++.+..+
T Consensus 156 rcy--saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd--dqlkrif~~lg~p~ed~wps~t 231 (292)
T KOG0662|consen 156 RCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEDQWPSMT 231 (292)
T ss_pred Eee--eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH--HHHHHHHHHhCCCccccCCccc
Confidence 222 1224588999999998865 79999999999999999985555 4322221 122222222 2223333222
Q ss_pred --cChhhcCCCC-----HHHHH----HHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 584 --IDPVLKQSCA-----PDELL----KFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 584 --~d~~l~~~~~-----~~~~~----~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
-|-.....++ .+.+. .=.+++.+.|.-+|..|.++++.++.
T Consensus 232 ~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 232 KLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1111111111 11111 22366678899999999999998864
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-32 Score=264.73 Aligned_cols=271 Identities=22% Similarity=0.238 Sum_probs=203.8
Q ss_pred HhcCCccc-cccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEe----Cce
Q 005871 350 ATNHFSDE-NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLE----GQE 422 (672)
Q Consensus 350 ~~~~~~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~----~~~ 422 (672)
.+++|.+. ++||-|-.|.|-.+..+ .++.+|+|++... ....+|+++.-.. .|||||.+++++.+ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 35666654 57999999999999876 6899999988543 3457788876665 69999999999874 356
Q ss_pred EEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---CCCeEEEeec
Q 005871 423 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFG 499 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~---~~~~kL~DFg 499 (672)
+.+|||.|+||.|...+.+. ....++++++..|++||..|+.|||+.. |.||||||+|+|... +-.+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 89999999999999888654 3456999999999999999999999986 999999999999974 4569999999
Q ss_pred CceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCC
Q 005871 500 LARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGP 579 (672)
Q Consensus 500 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 579 (672)
+++.-.. .......+-||.|.|||++...+|+...|+||+||++|-|++|.+||-.. .+..+..-.......+.
T Consensus 210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~---hg~aispgMk~rI~~gq 283 (400)
T KOG0604|consen 210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN---HGLAISPGMKRRIRTGQ 283 (400)
T ss_pred cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccccc---CCccCChhHHhHhhccC
Confidence 9996432 23334467799999999999999999999999999999999999998432 22222221111111111
Q ss_pred cccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCCCCCCCCCcccc
Q 005871 580 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAFSV 642 (672)
Q Consensus 580 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~~p~~p~~~~ 642 (672)
. ++ .........+...++|+.+|..+|.+|.|+.++++.-=- +-.-..|.+|.+..
T Consensus 284 y-~F-----P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi-~~~~~vp~tpl~t~ 339 (400)
T KOG0604|consen 284 Y-EF-----PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWI-NQYEAVPQTPLSTS 339 (400)
T ss_pred c-cC-----CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchh-cccccCCCCCchhh
Confidence 1 11 111233445566789999999999999999999865311 12234556666544
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=290.29 Aligned_cols=255 Identities=25% Similarity=0.413 Sum_probs=207.5
Q ss_pred HHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEe-----Cc
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLE-----GQ 421 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~-----~~ 421 (672)
..++.|++.+.||+|.+|.||+++.. +++..|+|++..... ..+++..|.+||+.+ .|||++.++|++.. ++
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 44678999999999999999999965 688889998876553 346778899999998 69999999999874 56
Q ss_pred eEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCc
Q 005871 422 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 501 (672)
Q Consensus 422 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla 501 (672)
.+|||||||.+|+..+++.+.. ...+.|..+..|++.++.||.+||.+. ++|||||-.|||++.++.|||+|||.+
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvS 170 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVS 170 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeee
Confidence 8999999999999999997765 677999999999999999999999986 999999999999999999999999999
Q ss_pred eeeCCCCCCcccccccccCCcCChhhhcC-----CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhcc
Q 005871 502 RIFGGNQNQANTNIIAGTYGYMAPEYAMG-----GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWC 576 (672)
Q Consensus 502 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 576 (672)
..+.... .......|||.|||||++.. ..|+..+|+||||++..||--|.+|+-...+- .....+.
T Consensus 171 aQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm------raLF~Ip- 241 (953)
T KOG0587|consen 171 AQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM------RALFLIP- 241 (953)
T ss_pred eeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh------hhhccCC-
Confidence 9875433 33445789999999999853 34788999999999999999999996432221 1111111
Q ss_pred CCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 577 EGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 577 ~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
..+..++. .+..-.+++.++|..||.+|.+.||++.++++.
T Consensus 242 RNPPPkLk-------rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 242 RNPPPKLK-------RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred CCCCcccc-------chhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11222221 134556788899999999999999999998864
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=276.00 Aligned_cols=256 Identities=28% Similarity=0.374 Sum_probs=196.5
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC-------cccHHHHHHHHHHHHhccCCCeeeEEEEEE-eCc
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-------GQGLQEFKNEVNLIAKLQHKNLVRLLGCCL-EGQ 421 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~E~~il~~l~h~niv~l~~~~~-~~~ 421 (672)
.++|..+++||+|||++||++.+- +.+.||+|+-..+. ....+...+|..|.+.|.||.||+++++|. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 468999999999999999999864 57888999754332 122345678999999999999999999997 456
Q ss_pred eEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---CCCeEEEee
Q 005871 422 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDF 498 (672)
Q Consensus 422 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~---~~~~kL~DF 498 (672)
.++-|.|||+|.+|+.+|. ....+++++++.|+.||+.||.||.+.. .+|||.||||.|||+.+ .|.+||+||
T Consensus 542 sFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeec
Confidence 7899999999999999994 4456999999999999999999999985 68999999999999964 478999999
Q ss_pred cCceeeCCCCCCc-----ccccccccCCcCChhhhcCC----CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhh
Q 005871 499 GLARIFGGNQNQA-----NTNIIAGTYGYMAPEYAMGG----IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLT 569 (672)
Q Consensus 499 gla~~~~~~~~~~-----~~~~~~gt~~Y~aPE~~~~~----~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~ 569 (672)
|+++++....... -+....||.+|++||.+.-+ +.+.|+||||+|||+|+-+.|++||+-.....+ +++
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd--ILq 695 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD--ILQ 695 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH--HHh
Confidence 9999987554332 23456899999999988543 478999999999999999999999975433222 221
Q ss_pred hhhhhccCCCcccccChhhc-CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005871 570 YTWKLWCEGPAVELIDPVLK-QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 622 (672)
Q Consensus 570 ~~~~~~~~~~~~~l~d~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 622 (672)
+ .++.+..+-.+. ...... ....+|+.||++--++|....++.
T Consensus 696 e-------NTIlkAtEVqFP~KPvVss---eAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 696 E-------NTILKATEVQFPPKPVVSS---EAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred h-------hchhcceeccCCCCCccCH---HHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1 111111111111 111122 244566799999999998877764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=261.93 Aligned_cols=238 Identities=29% Similarity=0.359 Sum_probs=191.7
Q ss_pred CceeEEeeeec-CCceeEEEEecccCccc-HHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCCCChhHHhhh
Q 005871 364 GFGPVYKGTLA-DGKAIAVKRLSRTSGQG-LQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD 441 (672)
Q Consensus 364 ~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~ 441 (672)
+||.||+++.. +++.+++|++....... .+.+.+|++.+++++|+|++++++.+......+++|||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999986 48999999998765544 68899999999999999999999999999999999999999999998854
Q ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcccccccccCC
Q 005871 442 ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 521 (672)
Q Consensus 442 ~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~ 521 (672)
.. .+++..+..++.+++.++.+||+.+ |+|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 32 2899999999999999999999997 9999999999999999999999999998765432 2233467889
Q ss_pred cCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHH
Q 005871 522 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFI 601 (672)
Q Consensus 522 Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~ 601 (672)
|++||.+.+..++.++|||+||+++++|++|..|+.... ....... .......... . ........+.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~--~~~~~~~----~~~~~~~~~~-~------~~~~~~~~~~ 218 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD--QLLELFK----KIGKPKPPFP-P------PEWKISPEAK 218 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHH----HHhccCCCCc-c------ccccCCHHHH
Confidence 999999998889999999999999999999999874321 1111111 1111111000 0 0000234677
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 005871 602 HIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 602 ~li~~cl~~dP~~RPt~~evl~ 623 (672)
+++.+|+..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 8888999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=291.30 Aligned_cols=254 Identities=28% Similarity=0.397 Sum_probs=207.2
Q ss_pred CCccccccccCCceeEEeeee-cC----CceeEEEEeccc-CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 353 HFSDENKLGQGGFGPVYKGTL-AD----GKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~-~~----~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
.....++||+|+||+||+|.+ .+ +-+||||++... ..+.-.+++.|+.+|.+|+|||++++++++..+. +.||
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 456678999999999999986 23 457899988654 4555678999999999999999999999998766 8899
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
++|++.|+|.+++..+ +..+..+..+.|..||++|+.|||++. ++||||-..||||.+-.++||.|||+++.+..
T Consensus 776 tq~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHhcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 9999999999999754 346888999999999999999999986 99999999999999999999999999998876
Q ss_pred CCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccC
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 585 (672)
...........-.+.|||=|.+....|+.++|||||||++||++| |..|..... ...+...+.++.
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~-------~~eI~dlle~ge------ 917 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP-------AEEIPDLLEKGE------ 917 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC-------HHHhhHHHhccc------
Confidence 665555555555678999999999999999999999999999998 777743211 111111222221
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
+-..++....++..++.+||..|+..||+++++...++.-
T Consensus 918 ---RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 918 ---RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred ---cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 1123455567788888999999999999999999988764
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=294.48 Aligned_cols=261 Identities=20% Similarity=0.231 Sum_probs=169.0
Q ss_pred HhcCCccccccccCCceeEEeeeec-C----CceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEE------EE
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-D----GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC------CL 418 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~------~~ 418 (672)
..++|++.++||+|+||.||+|++. + +..||+|++...... +.+.+| .+....+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4578999999999999999999975 4 689999987654321 111111 1222222222222211 24
Q ss_pred eCceEEEEEeecCCCChhHHhhhcccc-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 005871 419 EGQELLLIYEYMPNKSLDVHLFDATRS-----------------VQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLK 481 (672)
Q Consensus 419 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlk 481 (672)
.....++||||+.+++|.+++...... .......+..++.||+.||.|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566899999999999999888542210 11123456689999999999999987 9999999
Q ss_pred CCcEEEcC-CCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCC----------------------CCChhhH
Q 005871 482 ASNILLDD-DMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG----------------------IFSIKSD 538 (672)
Q Consensus 482 p~NIll~~-~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----------------------~~s~ksD 538 (672)
|+|||++. ++.+||+|||+++.+...... ......|++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 689999999999865432221 22345789999999976432 2345679
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCC-C---cccccChh----hcCCC--CHHHHHHHHHHHHHhc
Q 005871 539 VFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG-P---AVELIDPV----LKQSC--APDELLKFIHIGLLCV 608 (672)
Q Consensus 539 vwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-~---~~~l~d~~----l~~~~--~~~~~~~l~~li~~cl 608 (672)
||||||++|||+++..+++.. +..........+ . +...+++. +...+ .........+|+.+||
T Consensus 362 VwSlGviL~el~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSN-------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchH-------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 999999999999977653211 111100000000 0 00000100 00000 0011123457888999
Q ss_pred ccCCCCCCCHHHHHHHh
Q 005871 609 QQDPADRPTMSSVVVML 625 (672)
Q Consensus 609 ~~dP~~RPt~~evl~~L 625 (672)
+.||++|||+.++++.-
T Consensus 435 ~~dP~kR~ta~e~L~Hp 451 (566)
T PLN03225 435 RFKGRQRISAKAALAHP 451 (566)
T ss_pred cCCcccCCCHHHHhCCc
Confidence 99999999999999763
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=260.16 Aligned_cols=279 Identities=22% Similarity=0.339 Sum_probs=212.4
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEeccc---CcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~l 425 (672)
.++|..++.||+|+|..|..++++ ..+.||+|++++. ..++..-.+.|-.+..+- +||.+|-++.+|+.+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 478999999999999999999975 5788999998764 344455566677777766 79999999999999999999
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
|.||.+||+|..++.. ...++++.++.+...|..||.|||+.| ||.||||.+|+|+|..|++||+|+|+++.--
T Consensus 329 vieyv~ggdlmfhmqr---qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehhh---hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 9999999999877743 345999999999999999999999998 9999999999999999999999999998532
Q ss_pred CCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCC-CcccccchhhhhhhhccCCCccccc
Q 005871 506 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY-FSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 506 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
. ....++.++|||.|+|||++.+..|+..+|+|+|||+++||+.|+.||+.- ....+.....+..+...+..+.
T Consensus 403 ~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir--- 477 (593)
T KOG0695|consen 403 G--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR--- 477 (593)
T ss_pred C--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc---
Confidence 2 223355689999999999999999999999999999999999999999752 2222333334444433222111
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH--hccC------CCCCCCCCCCccccccccc
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT------MSSVVVM--LASD------SMTIPQPTEPAFSVGRVVA 647 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt------~~evl~~--L~~~------~~~l~~p~~p~~~~~~~~~ 647 (672)
.+....-+...++..-|.+||.+|.. ++++-.. ++.. .....||-+|+......+.
T Consensus 478 -------iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~i~~d~~l~ 547 (593)
T KOG0695|consen 478 -------IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQITDDYGLD 547 (593)
T ss_pred -------ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCccccccCcc
Confidence 11112223445666889999999853 3343221 1221 2235678888887765544
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=267.30 Aligned_cols=268 Identities=21% Similarity=0.250 Sum_probs=201.3
Q ss_pred HHHHHhcCCccccccccCCceeEEeeeecC-CceeEEEEecccCcccHHHHHHHHHHHHhccC--CC----eeeEEEEEE
Q 005871 346 LALEATNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH--KN----LVRLLGCCL 418 (672)
Q Consensus 346 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h--~n----iv~l~~~~~ 418 (672)
.....+++|.+...+|+|.||.|-.+.+.. +..||||+++.-. ...+..+-|+++|+++.+ |+ ++++.++|.
T Consensus 83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 334457899999999999999999998764 7889999886433 334567889999999943 33 888999999
Q ss_pred eCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---------
Q 005871 419 EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD--------- 489 (672)
Q Consensus 419 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~--------- 489 (672)
-.++.+||+|.+ |.|+.++|.. +...+++...++.+..|+++++++||+.+ ++|.||||+|||+.+
T Consensus 162 yrghiCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~ 236 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNP 236 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEecc
Confidence 999999999988 6688888854 34567899999999999999999999997 999999999999932
Q ss_pred -----------CCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCC
Q 005871 490 -----------DMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF 558 (672)
Q Consensus 490 -----------~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~ 558 (672)
+..++|+|||.+..-... ...++.|..|.|||++.+-.++.++||||+||||+|+.||...|..
T Consensus 237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 237 KKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred CCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 235899999999864322 2457889999999999999999999999999999999999988754
Q ss_pred CCcccccchhhh--------------hhhhccCCC--cccc------------cChhh-cCCCCHHHHHHHHHHHHHhcc
Q 005871 559 YFSEHGQTLLTY--------------TWKLWCEGP--AVEL------------IDPVL-KQSCAPDELLKFIHIGLLCVQ 609 (672)
Q Consensus 559 ~~~~~~~~~~~~--------------~~~~~~~~~--~~~l------------~d~~l-~~~~~~~~~~~l~~li~~cl~ 609 (672)
........+.+. ..+.+..+. +.+. ..+.- .......+...+++|+..||.
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 331110011110 001111110 0000 00000 011234566789999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 005871 610 QDPADRPTMSSVVVM 624 (672)
Q Consensus 610 ~dP~~RPt~~evl~~ 624 (672)
.||.+|+|+.|++..
T Consensus 392 fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 392 FDPARRITLREALSH 406 (415)
T ss_pred cCccccccHHHHhcC
Confidence 999999999999864
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=282.31 Aligned_cols=262 Identities=19% Similarity=0.213 Sum_probs=179.4
Q ss_pred hcCCccccccccCCceeEEeeee-----------------cCCceeEEEEecccCcccHH--------------HHHHHH
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTL-----------------ADGKAIAVKRLSRTSGQGLQ--------------EFKNEV 399 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~--------------~~~~E~ 399 (672)
.++|++.++||+|+||.||+|.+ ..++.||||++........+ ....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 46899999999999999999964 23567999998654332222 234577
Q ss_pred HHHHhccCCCe-----eeEEEEEEe--------CceEEEEEeecCCCChhHHhhhccc---------------------c
Q 005871 400 NLIAKLQHKNL-----VRLLGCCLE--------GQELLLIYEYMPNKSLDVHLFDATR---------------------S 445 (672)
Q Consensus 400 ~il~~l~h~ni-----v~l~~~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~~---------------------~ 445 (672)
.++.+++|.++ ++++++|.. .+..+|||||+++++|.+++..... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 78888877654 667777653 3568999999999999998864211 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcccccccccCCcCCh
Q 005871 446 VQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 525 (672)
Q Consensus 446 ~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aP 525 (672)
..+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++..+...... ......+++.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeCh
Confidence 23567889999999999999999987 999999999999999999999999999765432211 11122357899999
Q ss_pred hhhcCCC--------------------C--ChhhHHHHHHHHHHHHHcCCC-CCCCCCccccc----chhhhhhhhccCC
Q 005871 526 EYAMGGI--------------------F--SIKSDVFSFGVLLLEIISGRK-NNGFYFSEHGQ----TLLTYTWKLWCEG 578 (672)
Q Consensus 526 E~~~~~~--------------------~--s~ksDvwSlGvil~elltG~~-p~~~~~~~~~~----~~~~~~~~~~~~~ 578 (672)
|.+.... + ..+.||||+||++|+|++|.. |+......... ......|..+...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 9885432 1 235799999999999999875 54311000000 0001112222111
Q ss_pred CcccccChhhcCCCCHHHHHHHHHHHHHhcccCC---CCCCCHHHHHHH
Q 005871 579 PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDP---ADRPTMSSVVVM 624 (672)
Q Consensus 579 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP---~~RPt~~evl~~ 624 (672)
... + + ..........+++.++|..+| .+|+|++|+|++
T Consensus 460 ~~~-~-~------~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 460 KYD-F-S------LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred CCC-c-c------cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 110 0 0 011123446677778998765 689999999854
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=286.55 Aligned_cols=259 Identities=31% Similarity=0.415 Sum_probs=201.2
Q ss_pred hcCCccccccccCCceeEEeeeec----C----CceeEEEEecccC-cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeC
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA----D----GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG 420 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~----~----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~ 420 (672)
.++..+.+.||+|.||.|++|... . ...||||.+.... ....+.+..|+++|+.+ +|+||+.++|++...
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 345566679999999999999743 1 4578999887553 34567899999999999 699999999999999
Q ss_pred ceEEEEEeecCCCChhHHhhhcc-----c------c--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE
Q 005871 421 QELLLIYEYMPNKSLDVHLFDAT-----R------S--VQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 487 (672)
Q Consensus 421 ~~~~lV~Ey~~~gsL~~~l~~~~-----~------~--~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll 487 (672)
+..++|+||+..|+|..++.... . . ..+...+.+.++.||+.|++||++.. +|||||-..||||
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEe
Confidence 99999999999999999997654 0 0 23889999999999999999999987 9999999999999
Q ss_pred cCCCCeEEEeecCceeeCCCCCCccc-ccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCccccc
Q 005871 488 DDDMNPKISDFGLARIFGGNQNQANT-NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQ 565 (672)
Q Consensus 488 ~~~~~~kL~DFgla~~~~~~~~~~~~-~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~ 565 (672)
..+..+||+|||+++........... +...-...|||||.+....|+.|+||||||++||||+| |..|+.. .
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~------~ 525 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG------I 525 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC------C
Confidence 99999999999999965443322211 11011335999999999999999999999999999999 5555432 1
Q ss_pred chhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 566 TLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 566 ~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
......++...+|...+. +.....++.++|+.||+.+|++||++.++.+.|..
T Consensus 526 ~~~~~l~~~l~~G~r~~~---------P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 526 PPTEELLEFLKEGNRMEQ---------PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred CcHHHHHHHHhcCCCCCC---------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 101111223333322211 22224557788899999999999999999999987
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=237.44 Aligned_cols=204 Identities=27% Similarity=0.399 Sum_probs=168.6
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEeccc-CcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEEEEEe
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lV~E 428 (672)
+.......||+|++|.|-+-++. +|...|+|.+... +.+..++.+.|+.+..+. .+|.+|.++|........++.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 44555678999999999988875 7999999998764 334456777888877665 79999999999999999999999
Q ss_pred ecCCCChhHHhhh-ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 429 YMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 429 y~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
.|+ .||+.+... ..+...+++..+-+|+..++.||.|||++ +.+||||+||+||||+.+|++|++|||++-.+.+.
T Consensus 126 ~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 984 566655543 24566799999999999999999999996 47999999999999999999999999999887543
Q ss_pred CCCcccccccccCCcCChhhhcC----CCCChhhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMG----GIFSIKSDVFSFGVLLLEIISGRKNNGFYFS 561 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~----~~~s~ksDvwSlGvil~elltG~~p~~~~~~ 561 (672)
.. .+...|-..|||||.+.. ..|+.|+||||||+++.||.+++.|++.+..
T Consensus 203 iA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 203 IA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred hH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 22 222457788999998843 4689999999999999999999999765543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-28 Score=236.35 Aligned_cols=211 Identities=36% Similarity=0.610 Sum_probs=183.9
Q ss_pred cccCCceeEEeeeecC-CceeEEEEecccCcc-cHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCCCChhH
Q 005871 360 LGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDV 437 (672)
Q Consensus 360 LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 437 (672)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|+..++.++|++++++++++......+++|||+.+++|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999864 899999998766543 35678999999999999999999999999999999999999999999
Q ss_pred HhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-CCCeEEEeecCceeeCCCCCCcccccc
Q 005871 438 HLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFGLARIFGGNQNQANTNII 516 (672)
Q Consensus 438 ~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~-~~~~kL~DFgla~~~~~~~~~~~~~~~ 516 (672)
++.... ..+++..+..++.+++++|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 885432 35899999999999999999999997 999999999999999 89999999999987654321 12234
Q ss_pred cccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHH
Q 005871 517 AGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPD 595 (672)
Q Consensus 517 ~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 595 (672)
.+...|++||.+... ..+.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 578899999999887 789999999999999999
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 596 ELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 596 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
..+.+++.+|++.+|++||++.++++.|
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4577888899999999999999998653
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=237.55 Aligned_cols=254 Identities=20% Similarity=0.326 Sum_probs=191.5
Q ss_pred HhcCCccccccccCCceeEEeeee-cCCceeEEEEecccCcccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeC--ceEEE
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEG--QELLL 425 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~--~~~~l 425 (672)
..++|++.+++|+|.+++||.|.. .++++++||+++.-. .+.+.+|++||..|. ||||++++++..+. ....|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 357899999999999999999985 468889999886533 467899999999997 99999999999865 56889
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-CCCeEEEeecCceee
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFGLARIF 504 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~-~~~~kL~DFgla~~~ 504 (672)
|+||+.+.+...+. ..++.-.+..++.+++.||.|+|+.| |+|||+||.|+|||. .-.++|+|||+|.++
T Consensus 113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999998876554 34777889999999999999999998 999999999999995 456999999999987
Q ss_pred CCCCCCcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhh---------
Q 005871 505 GGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL--------- 574 (672)
Q Consensus 505 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~--------- 574 (672)
..... .+..+.+..|--||.+..- .|...-|+|||||++..|+..+.||-...+.. ..+...+.-.
T Consensus 184 Hp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~-DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 184 HPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred CCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCH-HHHHHHHHHhChHHHHHHH
Confidence 54332 3344667788999998764 47899999999999999999999973222111 1122111100
Q ss_pred -----------------ccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 575 -----------------WCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 575 -----------------~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
.....+...+.+. ++.... .+.++++.+.|..|-.+|||+.|.+.
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~-n~hl~~---peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSE-NQHLVS---PEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCcc-ccccCC---hHHHHHHHHHHhhccccccchHHHhc
Confidence 0011111111111 011111 34567777999999999999999874
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=264.18 Aligned_cols=275 Identities=21% Similarity=0.260 Sum_probs=211.5
Q ss_pred ccchHHHHHHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccC------CCeeeE
Q 005871 341 LFPLRLALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH------KNLVRL 413 (672)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h------~niv~l 413 (672)
.+.+...+....+|.+....|+|-|++|-+|.+. -|+.||||+|..+... .+.=+.|++||++|+. -|++++
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 3566777788899999999999999999999975 4889999999876533 2334679999999963 479999
Q ss_pred EEEEEeCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC-CC
Q 005871 414 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-MN 492 (672)
Q Consensus 414 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~-~~ 492 (672)
+..|...+++|||+|-+ ..+|.++|....++..|....+..++.|+..||..|...| |+|.||||+||||++. ..
T Consensus 500 ~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcce
Confidence 99999999999999977 5688999988888888999999999999999999999987 9999999999999865 45
Q ss_pred eEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhh--
Q 005871 493 PKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTY-- 570 (672)
Q Consensus 493 ~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~-- 570 (672)
+||||||.|.....+...+. .-+..|.|||++.+-.|+...|+||+||+||||.||+..|......+-..+..-
T Consensus 576 LKLCDfGSA~~~~eneitPY----LVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K 651 (752)
T KOG0670|consen 576 LKLCDFGSASFASENEITPY----LVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK 651 (752)
T ss_pred eeeccCccccccccccccHH----HHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence 89999999987765544332 235679999999999999999999999999999999998865432221111100
Q ss_pred ---hhhhccCC---------------------------CcccccCh------hhcC--CC---CHHHHHHHHHHHHHhcc
Q 005871 571 ---TWKLWCEG---------------------------PAVELIDP------VLKQ--SC---APDELLKFIHIGLLCVQ 609 (672)
Q Consensus 571 ---~~~~~~~~---------------------------~~~~l~d~------~l~~--~~---~~~~~~~l~~li~~cl~ 609 (672)
..+++.++ .+...+.| .+.. .+ ....+..|.+|+.+||.
T Consensus 652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~ 731 (752)
T KOG0670|consen 652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI 731 (752)
T ss_pred CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence 00000000 00111111 1111 11 23446678899999999
Q ss_pred cCCCCCCCHHHHHHH
Q 005871 610 QDPADRPTMSSVVVM 624 (672)
Q Consensus 610 ~dP~~RPt~~evl~~ 624 (672)
.||++|.|..+.|+.
T Consensus 732 LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 732 LDPEKRITVNQALKH 746 (752)
T ss_pred cChhhcCCHHHHhcC
Confidence 999999999999854
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-30 Score=248.86 Aligned_cols=267 Identities=24% Similarity=0.367 Sum_probs=190.6
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeC-----ceEE
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QELL 424 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~~~ 424 (672)
+.+-.+.||-|+||.||.+++. +|+.||+|++... +-...+.+.+|+++|.-.+|.|++..+++.+.. +++|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 4556788999999999999984 8999999998643 223456789999999999999999998887654 3567
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceee
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 504 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~ 504 (672)
+++|.|.. +|...+ .....++...+.-++.||++||.|||+.+ |+||||||.|.||+++..+||+|||+++.-
T Consensus 134 V~TELmQS-DLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 134 VLTELMQS-DLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHHh-hhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence 78887743 444444 34456888889999999999999999997 999999999999999999999999999975
Q ss_pred CCCCCCcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhh--------hhhhc
Q 005871 505 GGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTY--------TWKLW 575 (672)
Q Consensus 505 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~--------~~~~~ 575 (672)
+..+....+. -+-|..|.|||++++. .|+.+.||||.|||+.||+..+..|.-..+.....+..- ..+.-
T Consensus 207 e~d~~~hMTq-EVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 207 DQRDRLNMTH-EVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred chhhhhhhHH-HHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 4333333222 2458889999999986 589999999999999999988877654333222211110 00011
Q ss_pred cCCCcccccChhhc---------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 576 CEGPAVELIDPVLK---------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 576 ~~~~~~~l~d~~l~---------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
.++--..++..-.+ -......-..-+.+..+++..||.+|.+..+.+..+..
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 11100000000000 00011122334566678999999999999999887754
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-29 Score=273.10 Aligned_cols=246 Identities=29% Similarity=0.407 Sum_probs=186.0
Q ss_pred CccccccccCCce-eEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEEEEEeecC
Q 005871 354 FSDENKLGQGGFG-PVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMP 431 (672)
Q Consensus 354 ~~~~~~LG~G~fg-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lV~Ey~~ 431 (672)
|.-.+.+|.|..| .||+|.. +|++||||++-... .....+|+..|+.- +|||||++++.-.+.+..||..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 4445678899987 5799988 58899999886533 34668899999999 69999999999999999999999994
Q ss_pred CCChhHHhhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---C--CCeEEEeecCceeeC
Q 005871 432 NKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---D--MNPKISDFGLARIFG 505 (672)
Q Consensus 432 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~---~--~~~kL~DFgla~~~~ 505 (672)
-+|.+++... ...........+.++.|+++||++||+.+ ||||||||.||||+. + ..++|+|||+++.+.
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5888888542 11111222455778999999999999987 999999999999986 3 468999999999886
Q ss_pred CCCCCc-ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcC-CCCCCCCCcccccchhhhhhhhccCCCcccc
Q 005871 506 GNQNQA-NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG-RKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583 (672)
Q Consensus 506 ~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 583 (672)
.....- ......||.+|+|||++....-+..+|||||||++|+.++| .+||+.....+.. ....+.....+
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N-------Il~~~~~L~~L 735 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN-------ILTGNYTLVHL 735 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh-------hhcCccceeee
Confidence 554332 23456799999999999998888899999999999999997 8898754322211 11111111111
Q ss_pred cChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 584 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
.+ ..+. ...+||.+|+..+|..||++.+|+.
T Consensus 736 -~~------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 736 -EP------LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -cc------CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 11 0111 4567888999999999999999984
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=260.14 Aligned_cols=195 Identities=24% Similarity=0.399 Sum_probs=166.6
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCc--------ccHHHHHHHHHHHHhcc---CCCeeeEEEEEEe
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--------QGLQEFKNEVNLIAKLQ---HKNLVRLLGCCLE 419 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~---h~niv~l~~~~~~ 419 (672)
.+|..+++||+|+||.|+.+.++ +..+|+||.+.+..- ...-..-.|+.||..|+ |+||+|++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46899999999999999999986 467889998866431 11123456999999997 9999999999999
Q ss_pred CceEEEEEeec-CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEee
Q 005871 420 GQELLLIYEYM-PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDF 498 (672)
Q Consensus 420 ~~~~~lV~Ey~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DF 498 (672)
++.+||+||-- ++.+|.+++. ....+++.++.-|++|++.|+++||++| |||||||-+|+.|+.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 99999999965 4556777773 3446999999999999999999999998 999999999999999999999999
Q ss_pred cCceeeCCCCCCcccccccccCCcCChhhhcCCCC-ChhhHHHHHHHHHHHHHcCCCCC
Q 005871 499 GLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNN 556 (672)
Q Consensus 499 gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltG~~p~ 556 (672)
|.+.... ......++||..|.|||++.+..| +..-|||++|++||-++....|+
T Consensus 715 gsaa~~k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 715 GSAAYTK----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred cchhhhc----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 9997642 334566899999999999999887 78899999999999999887774
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=244.98 Aligned_cols=141 Identities=25% Similarity=0.390 Sum_probs=114.5
Q ss_pred cchHHHHHHh-cCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhcc-----C---CCee
Q 005871 342 FPLRLALEAT-NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-----H---KNLV 411 (672)
Q Consensus 342 ~~~~~~~~~~-~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----h---~niv 411 (672)
.+++...... .+|-+.++||.|.|++||++.+. ..+.||+|+.+.. ....+....|+++|++++ | ..||
T Consensus 67 HpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV 145 (590)
T KOG1290|consen 67 HPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVV 145 (590)
T ss_pred ceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceee
Confidence 4555555554 89999999999999999999985 5778899987543 234566788999999994 3 3599
Q ss_pred eEEEEEEe----CceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE
Q 005871 412 RLLGCCLE----GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 487 (672)
Q Consensus 412 ~l~~~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll 487 (672)
++++.|.. +.+++||+|++ |.+|..+|.. .....++...+.+|++||+.||.|||... +|||-||||+|||+
T Consensus 146 ~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~-s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 146 QLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKY-SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred eeeccceecCCCCcEEEEEehhh-hhHHHHHHHH-hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 99999974 56899999999 5555556643 33456899999999999999999999986 79999999999999
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=245.60 Aligned_cols=261 Identities=22% Similarity=0.288 Sum_probs=202.3
Q ss_pred HHHhcCCccccccccCCceeEEeeeecC------CceeEEEEeccc-CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeC
Q 005871 348 LEATNHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG 420 (672)
Q Consensus 348 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~ 420 (672)
....++++....+-+|.||+||.|.|++ .+.+-+|.++.. +.-....+..|.-++..+.|||+..+.+++.++
T Consensus 280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~ 359 (563)
T KOG1024|consen 280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED 359 (563)
T ss_pred hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec
Confidence 3445678888999999999999996642 456677766544 344567889999999999999999999998765
Q ss_pred -ceEEEEEeecCCCChhHHhh-----hccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeE
Q 005871 421 -QELLLIYEYMPNKSLDVHLF-----DATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPK 494 (672)
Q Consensus 421 -~~~~lV~Ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~k 494 (672)
...+.++.++.-|+|..+|. +......++..+...++.|++.|++|||..+ |||.||...|.+||+..++|
T Consensus 360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVk 436 (563)
T KOG1024|consen 360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVK 436 (563)
T ss_pred cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEE
Confidence 56788999999999999997 4444556888889999999999999999998 99999999999999999999
Q ss_pred EEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhh
Q 005871 495 ISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWK 573 (672)
Q Consensus 495 L~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~ 573 (672)
|+|=.+++.+-..+...-...-.....||+||.+.+..|+..+|||||||++|||+| |+.|+.. .+......+..
T Consensus 437 ltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae---IDPfEm~~ylk- 512 (563)
T KOG1024|consen 437 LTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE---IDPFEMEHYLK- 512 (563)
T ss_pred eccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc---cCHHHHHHHHh-
Confidence 999999997654443332222223567999999999999999999999999999998 6666421 11111111111
Q ss_pred hccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 574 LWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 574 ~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
...++. .+.....++..++.-||...|++||+.++++.-|+.
T Consensus 513 --dGyRla----------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 513 --DGYRLA----------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred --ccceec----------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 111111 122344567888889999999999999999998864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-29 Score=265.08 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=204.0
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
.++|+.+.++|.|.||.|||+++. .++..|+|+++....+...-+.+|+-+++..+||||+.+++.+...+.+++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 468999999999999999999975 6899999999998888888899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
|.+|+|.+..+ -.+++++.++..+++..++||+|||++| =+|||||-.||++++.|.+||+|||.+..++...
T Consensus 94 cgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati- 166 (829)
T KOG0576|consen 94 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI- 166 (829)
T ss_pred cCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh-
Confidence 99999988764 3467999999999999999999999998 7999999999999999999999999987665322
Q ss_pred CcccccccccCCcCChhhh---cCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCC--Cccccc
Q 005871 510 QANTNIIAGTYGYMAPEYA---MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG--PAVELI 584 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~---~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~ 584 (672)
...+.+.||+.|||||+. +.+.|..++|||++|+...|+---++|--. ....... ....+. ....+-
T Consensus 167 -~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfd------lhpmr~l-~LmTkS~~qpp~lk 238 (829)
T KOG0576|consen 167 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFD------LHPMRAL-FLMTKSGFQPPTLK 238 (829)
T ss_pred -hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccc------cchHHHH-HHhhccCCCCCccc
Confidence 233457899999999987 567899999999999999999888877211 1111111 011110 111111
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
|+ ......+.++++.+|.++|.+|||++.+|+
T Consensus 239 Dk-------~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 239 DK-------TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CC-------ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11 122345677888999999999999988765
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-26 Score=230.67 Aligned_cols=198 Identities=34% Similarity=0.500 Sum_probs=172.5
Q ss_pred CccccccccCCceeEEeeeecC-CceeEEEEecccCcc-cHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecC
Q 005871 354 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 431 (672)
Q Consensus 354 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 431 (672)
|.+.+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5677899999999999999875 889999999876554 67889999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCc
Q 005871 432 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 511 (672)
Q Consensus 432 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 511 (672)
+++|..++..... .+++..+..++.+++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-A 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-c
Confidence 9999998854321 1889999999999999999999997 99999999999999999999999999987654321 1
Q ss_pred ccccccccCCcCChhhh-cCCCCChhhHHHHHHHHHHHHHcCCCCCC
Q 005871 512 NTNIIAGTYGYMAPEYA-MGGIFSIKSDVFSFGVLLLEIISGRKNNG 557 (672)
Q Consensus 512 ~~~~~~gt~~Y~aPE~~-~~~~~s~ksDvwSlGvil~elltG~~p~~ 557 (672)
......++..|++||.+ ....++.++|||+||+++++|++|+.||.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 22334678899999998 66678889999999999999999999973
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=237.58 Aligned_cols=264 Identities=24% Similarity=0.260 Sum_probs=192.9
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeC------c
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------Q 421 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~------~ 421 (672)
..+|..++.+|.|.- .|-.+.+. .++.||+|++... ....+++..+|...+..++|+||++++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 357888899999998 55555543 5899999988654 234467788999999999999999999999743 4
Q ss_pred eEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCc
Q 005871 422 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 501 (672)
Q Consensus 422 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla 501 (672)
+.|+|||+|.. +|...+. ..++-+.+..|+.|++.|+.|||+.| |+||||||+||+|..+..+||.|||++
T Consensus 95 e~y~v~e~m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhhhh-HHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 68999999954 5666654 34788899999999999999999998 999999999999999999999999999
Q ss_pred eeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchh-------------
Q 005871 502 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLL------------- 568 (672)
Q Consensus 502 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~------------- 568 (672)
+.-+.. -..+..+.|..|.|||++.+..+.+.+||||+||++.||++|+..|......+.....
T Consensus 166 r~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 166 RTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred cccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 864322 1223356788999999999988999999999999999999999887532211111000
Q ss_pred ---hhhhhhcc-CCCcc-cccChhhcCC-------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 569 ---TYTWKLWC-EGPAV-ELIDPVLKQS-------CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 569 ---~~~~~~~~-~~~~~-~l~d~~l~~~-------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
..+..... ..+.. -.+.+.+++. .+........+++.+||..||++|.+++++|+.---
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~ 313 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYI 313 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCee
Confidence 00000000 00000 0011111111 111233455678889999999999999999987643
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-26 Score=235.23 Aligned_cols=267 Identities=24% Similarity=0.371 Sum_probs=196.9
Q ss_pred HHhcCCccccccccCCceeEEeeeec----CCceeEEEEecccCcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceE
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQEL 423 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~ 423 (672)
...+.|..+++||+|.|++||++.+. ..+.||+|.+...+. ...+.+|+++|..+ -+.||+++.+++...+..
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 34578999999999999999999864 367899999876653 35689999999999 599999999999999999
Q ss_pred EEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-CCCeEEEeecCce
Q 005871 424 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFGLAR 502 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~-~~~~kL~DFgla~ 502 (672)
.+|+||++.....+++. .++..++..+++.++.||.++|.+| ||||||||+|+|.+. -+.-.|+|||++.
T Consensus 111 ~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred EEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHH
Confidence 99999999999888874 3778899999999999999999998 999999999999984 4678999999997
Q ss_pred eeCCCC-------------CC-----------------------------cccccccccCCcCChhhhcC-CCCChhhHH
Q 005871 503 IFGGNQ-------------NQ-----------------------------ANTNIIAGTYGYMAPEYAMG-GIFSIKSDV 539 (672)
Q Consensus 503 ~~~~~~-------------~~-----------------------------~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDv 539 (672)
...... .. ...-...||++|.|||++.. ..-++++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 321100 00 00001359999999999865 456899999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCcccccchhhhhh---------------h--hccCCCccccc-----------ChhhcCC
Q 005871 540 FSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTW---------------K--LWCEGPAVELI-----------DPVLKQS 591 (672)
Q Consensus 540 wSlGvil~elltG~~p~~~~~~~~~~~~~~~~~---------------~--~~~~~~~~~l~-----------d~~l~~~ 591 (672)
||.|||++-+++++.||-.... +...+.+.+. . .|.+.....+. ....+..
T Consensus 262 ws~GVI~Lslls~~~PFf~a~d-d~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKD-DADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeccceeehhhccccccccCcc-ccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 9999999999999999732221 1112221110 0 11111100000 0000000
Q ss_pred --------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 592 --------CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 592 --------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
........+++++.+|+..||.+|.|++|.|..--.
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF 384 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFF 384 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCC
Confidence 001112367788889999999999999999965433
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=265.29 Aligned_cols=198 Identities=20% Similarity=0.236 Sum_probs=137.5
Q ss_pred HhccC-CCeeeEEEEE-------EeCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 005871 403 AKLQH-KNLVRLLGCC-------LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 474 (672)
Q Consensus 403 ~~l~h-~niv~l~~~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~ 474 (672)
+.++| +||++++++| .+...+++++||+ +++|.++|... ...+++.++..++.||++||.|||++|
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 34555 5777788777 2334677888987 56999998532 345999999999999999999999998
Q ss_pred eeecCCCCCcEEEcCCC-------------------CeEEEeecCceeeCCCCC--------------CcccccccccCC
Q 005871 475 IIHRDLKASNILLDDDM-------------------NPKISDFGLARIFGGNQN--------------QANTNIIAGTYG 521 (672)
Q Consensus 475 iiHrDlkp~NIll~~~~-------------------~~kL~DFgla~~~~~~~~--------------~~~~~~~~gt~~ 521 (672)
|+||||||+||||+..+ .+||+|||+++....... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 99999999999996544 455556665543211000 000112358899
Q ss_pred cCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHH
Q 005871 522 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFI 601 (672)
Q Consensus 522 Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~ 601 (672)
|||||++.+..++.++|||||||++|||++|.+|+.... ......... ...+.. ........
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~~~~~~~~---------~~~~~~-----~~~~~~~~ 242 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----RTMSSLRHR---------VLPPQI-----LLNWPKEA 242 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HHHHHHHHh---------hcChhh-----hhcCHHHH
Confidence 999999999999999999999999999999888743110 000000000 011110 11123345
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 005871 602 HIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 602 ~li~~cl~~dP~~RPt~~evl~~ 624 (672)
+++.+||+.+|.+||++.||++.
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhhc
Confidence 77789999999999999999864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5e-25 Score=213.81 Aligned_cols=243 Identities=20% Similarity=0.332 Sum_probs=180.9
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhc-cCCCeeeEEEE-EEeCceEEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGC-CLEGQELLLIY 427 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~-~~~~~~~~lV~ 427 (672)
.+.|.+.+.||+|.||.+-+++++ ..+.+++|-+.+.. ....+|.+|...--.| .|.||+.-++. |+..+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 367999999999999999999987 57889999876544 3457788888876666 58999987654 66778899999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc--CCCCeEEEeecCceeeC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD--DDMNPKISDFGLARIFG 505 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~--~~~~~kL~DFgla~~~~ 505 (672)
||++.|+|...+-. ..+.+.....++.|++.||.|+|++. +||||||.+||||- +..++||+|||+.+..+
T Consensus 102 E~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 99999999887733 34788888999999999999999996 99999999999994 44579999999998644
Q ss_pred CCCCCcccccccccCCcCChhhhcC---CC--CChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCc
Q 005871 506 GNQNQANTNIIAGTYGYMAPEYAMG---GI--FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPA 580 (672)
Q Consensus 506 ~~~~~~~~~~~~gt~~Y~aPE~~~~---~~--~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (672)
..-. ...-+..|.+||.... +. ..+.+|+|.||+++|..+||+.||.-.. ..+ .-.+-|..|..+..
T Consensus 175 ~tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-~~d--~~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 175 TTVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-IMD--KPYWEWEQWLKRKN 246 (378)
T ss_pred ceeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-ccC--chHHHHHHHhcccC
Confidence 2221 2234667999998743 22 4788999999999999999999986322 222 22334444544433
Q ss_pred ccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCC
Q 005871 581 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADR 615 (672)
Q Consensus 581 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R 615 (672)
..+-+. . .....+.+++.++-|..+|++|
T Consensus 247 ~~~P~~-F-----~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 247 PALPKK-F-----NPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred ccCchh-h-----cccCHHHHHHHHHhcCCccccc
Confidence 322111 1 1122345556668899999999
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=203.10 Aligned_cols=166 Identities=20% Similarity=0.147 Sum_probs=122.7
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcc
Q 005871 433 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 512 (672)
Q Consensus 433 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~ 512 (672)
|+|.+++... ...+++.+++.|+.||+.||.|||+++ ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 6788888532 346999999999999999999999874 999999999999999 99998764322
Q ss_pred cccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCC
Q 005871 513 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSC 592 (672)
Q Consensus 513 ~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 592 (672)
..|++.|+|||++.+..++.++|||||||++|||++|+.||...... ................. + ...
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~---~----~~~ 131 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPADDPR---D----RSN 131 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhccCCcc---c----ccc
Confidence 25889999999999999999999999999999999999997432211 11111111111000000 0 000
Q ss_pred CHHHH--HHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 593 APDEL--LKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 593 ~~~~~--~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
..... ..+.+++..||+.+|++||++.++++.+..
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 11111 258899999999999999999999998854
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=221.23 Aligned_cols=167 Identities=20% Similarity=0.219 Sum_probs=130.5
Q ss_pred HHhcCCccccccccCCceeEEeeeec--CCceeEEEEeccc-----CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCc
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLA--DGKAIAVKRLSRT-----SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ 421 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~ 421 (672)
...++|.+.+.||+|+||+||+|+++ +++.+|||++... .....+.+.+|+++|++++|+|+++.+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 45678999999999999999999875 4777899987533 12235678999999999999999853332 24
Q ss_pred eEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCcEEEcCCCCeEEEeecC
Q 005871 422 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDL-KASNILLDDDMNPKISDFGL 500 (672)
Q Consensus 422 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDl-kp~NIll~~~~~~kL~DFgl 500 (672)
..++||||++|++|.... . .. ...++.|++++|.|||+.| |+|||| ||+|||++.++.+||+|||+
T Consensus 92 ~~~LVmE~~~G~~L~~~~----~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLAR----P---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CcEEEEEccCCCCHHHhC----c---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 579999999999996221 1 11 1467899999999999998 999999 99999999999999999999
Q ss_pred ceeeCCCCCCcc------cccccccCCcCChhhhcCC
Q 005871 501 ARIFGGNQNQAN------TNIIAGTYGYMAPEYAMGG 531 (672)
Q Consensus 501 a~~~~~~~~~~~------~~~~~gt~~Y~aPE~~~~~ 531 (672)
++.+........ .....+++.|+|||++...
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 997754331111 1345788999999998543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-22 Score=213.76 Aligned_cols=259 Identities=22% Similarity=0.260 Sum_probs=192.2
Q ss_pred CCccccccccCCceeEEeeeecCC--ceeEEEEecccCcccHHHHHHHHHHHHhccC----CCeeeEEEEE-EeCceEEE
Q 005871 353 HFSDENKLGQGGFGPVYKGTLADG--KAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH----KNLVRLLGCC-LEGQELLL 425 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~il~~l~h----~niv~l~~~~-~~~~~~~l 425 (672)
+|.+.++||+|+||.||++..... ..+|+|............+..|+.++..+.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999997653 4788888766543333378889999999973 6899999998 57788999
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC-----CCeEEEeecC
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-----MNPKISDFGL 500 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~-----~~~kL~DFgl 500 (672)
||+.+ |.+|.++..... ...++..+...|+.|++.+|.+||+.| ++||||||+|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99977 888888775444 567999999999999999999999998 9999999999999854 3599999999
Q ss_pred ce--eeCCCCC----Ccc--cccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhh
Q 005871 501 AR--IFGGNQN----QAN--TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTW 572 (672)
Q Consensus 501 a~--~~~~~~~----~~~--~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~ 572 (672)
++ .+..... ... .....||..|.+++...+...+.+.|+||++.++.|++.|..||........ .....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~---~~~~~ 250 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL---KSKFE 250 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch---HHHHH
Confidence 98 4322221 111 1235699999999999999999999999999999999999998743222111 11111
Q ss_pred hhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 573 KLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 573 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
..... ..... .....+.+...+.. .+-..+..++|....+...|...
T Consensus 251 ~~~~~----~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 251 KDPRK----LLTDR--FGDLKPEEFAKILE---YIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred HHhhh----hcccc--ccCCChHHHHHHHH---HhhccCCcCCCCHHHHHHHHHHH
Confidence 10000 01110 11123344444443 45558999999999999887654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-21 Score=201.17 Aligned_cols=261 Identities=30% Similarity=0.387 Sum_probs=197.5
Q ss_pred CccccccccCCceeEEeeeecCCceeEEEEecccCcc---cHHHHHHHHHHHHhccCC-CeeeEEEEEEeCceEEEEEee
Q 005871 354 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ---GLQEFKNEVNLIAKLQHK-NLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 354 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~h~-niv~l~~~~~~~~~~~lV~Ey 429 (672)
|.+.+.||.|+||.||++.+. ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999987 78899988765433 367899999999999988 799999999877778999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-CeEEEeecCceeeCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIFGGNQ 508 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~-~~kL~DFgla~~~~~~~ 508 (672)
+.++++..++........+.......++.|++.++.|+|+.+ ++||||||+||+++..+ .++++|||.++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966533211126889999999999999999999998 99999999999999988 79999999998665443
Q ss_pred CCc----ccccccccCCcCChhhhcC---CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcc-cccchhhhhhhhccCCCc
Q 005871 509 NQA----NTNIIAGTYGYMAPEYAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSE-HGQTLLTYTWKLWCEGPA 580 (672)
Q Consensus 509 ~~~----~~~~~~gt~~Y~aPE~~~~---~~~s~ksDvwSlGvil~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~ 580 (672)
... ......|+..|++||.+.+ ...+...|+|++|++++++++|..|+...... .........+..... ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 235 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SL 235 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-cc
Confidence 322 2355689999999999987 57899999999999999999999995433321 001111111111111 00
Q ss_pred ccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 581 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 581 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
..... ..........+.+++..++..+|..|.+..+....
T Consensus 236 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 ASPLS----PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccC----ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000 00001223456777889999999999999987764
|
|
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.5e-23 Score=180.43 Aligned_cols=99 Identities=31% Similarity=0.622 Sum_probs=76.5
Q ss_pred cccCC---CCcc-CCCchHHHHHHHHHHhhhhcccCC---CCceecccCCCCCcEEEEEeccCCCChhchHHHHHHHHHH
Q 005871 75 VLSCA---VSNN-TASNTFTSNLNILFNQKLHSEAGK---SLYYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNS 147 (672)
Q Consensus 75 ~~~C~---~~~~-~~~s~f~~nl~~ll~~l~~~~~~~---~~f~~~~~g~~~~~vygl~qCr~D~s~~~C~~Cl~~a~~~ 147 (672)
|+.|+ .++| +++++|++||+.||+.| .+.++. .+|++++.|.++++|||++||++|+++.+|..||+.|+..
T Consensus 1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l-~~~a~~~~~~~f~~~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~ 79 (106)
T PF01657_consen 1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSL-VSNAASSSSKGFATGSAGSGPDTVYGLAQCRGDLSPSDCRACLADAVAN 79 (106)
T ss_dssp ---E---SSB----TT-THHHHHHHHHHHH-HHHGGGTT-TEEEEEE--ST---EEEEEEE-TTS-HHHHHHHHHHHHCC
T ss_pred CCcCCCCCCCCcCCCCchHHHHHHHHHHHH-HHHHhhccccCcEEeecCCCCCeEEEEEEcCCCCChhhhHHHHHHHHHH
Confidence 67898 5567 57888999999999999 666554 4899999899999999999999999999999999999999
Q ss_pred HhhcCCCccceEEeccccceEEEEcCCCC
Q 005871 148 VLQKCSGTKEAFIWYQVQECMVRFSDHSS 176 (672)
Q Consensus 148 ~~~~C~~~~~a~~~~~~~~C~lrYs~~~f 176 (672)
+...|+.+++|+||++. |+||||+++|
T Consensus 80 ~~~~C~~~~g~~v~~~~--C~lRY~~~~F 106 (106)
T PF01657_consen 80 ISSCCPGSRGGRVWYDS--CFLRYENYPF 106 (106)
T ss_dssp HHHHTTSBSSEEEEESS--EEEEEESS--
T ss_pred HHHhCCCCceEEEECCC--EEEEEECCCC
Confidence 99999999999999999 9999999988
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-21 Score=193.10 Aligned_cols=203 Identities=22% Similarity=0.338 Sum_probs=172.7
Q ss_pred hcCCccccccccCCceeEEeeee-cCCceeEEEEecccCcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEEEEEe
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lV~E 428 (672)
.-+|.+.++||+|.||+++.|+. -+++.||||.-...+. .-++..|....+.| ..++|...+.+..++.+-.||+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 45799999999999999999985 4799999997654443 35677788888888 57999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-----CeEEEeecCcee
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-----NPKISDFGLARI 503 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~-----~~kL~DFgla~~ 503 (672)
.+ |-+|+++..-..+ .++.+++..|+.|++.-++|+|++. +|.|||||+|+||...+ .+.|+|||+++.
T Consensus 105 LL-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hh-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 87 8899888754443 4899999999999999999999997 99999999999997433 489999999998
Q ss_pred eCCCCCCc-----ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005871 504 FGGNQNQA-----NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFS 561 (672)
Q Consensus 504 ~~~~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~ 561 (672)
+..+.... +.+...||.+||+=....+..-+...|+=|||-+++..+-|..||...-.
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 87654332 34557899999999999999999999999999999999999999865433
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=186.83 Aligned_cols=204 Identities=22% Similarity=0.298 Sum_probs=171.6
Q ss_pred HhcCCccccccccCCceeEEeeee-cCCceeEEEEecccCcccHHHHHHHHHHHHhccC-CCeeeEEEEEEeCceEEEEE
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH-KNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h-~niv~l~~~~~~~~~~~lV~ 427 (672)
....|.++++||.|+||.+|.|.. .+|.+||||.-+..... .++..|..+.+.|++ ..|..+..+..+...-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 357899999999999999999985 57999999987654432 467789999999976 67888888888999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC---CCeEEEeecCceee
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD---MNPKISDFGLARIF 504 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~---~~~kL~DFgla~~~ 504 (672)
+.+ |.+|++++.-..+ .++.++.+.++-|++.-++|+|.++ +|||||||+|+|+.-+ ..+.|+|||+++.+
T Consensus 91 dLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 987 8899988866554 4889999999999999999999998 9999999999999744 45899999999987
Q ss_pred CCCCCC-----cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005871 505 GGNQNQ-----ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFS 561 (672)
Q Consensus 505 ~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~ 561 (672)
.+.... .......||..|.+-....+..-+...|+-|+|.+|..+--|..||.....
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 544322 223446799999998888788889999999999999999999999865443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-22 Score=227.23 Aligned_cols=253 Identities=23% Similarity=0.271 Sum_probs=186.6
Q ss_pred ccccccccCCceeEEeeeec-CCceeEEEEeccc--Ccc----cHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 355 SDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQ----GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 355 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
...+.+|.|.+|.|+..... ..+..+.|..... ..+ ....+..|+-+-..++|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45678999999988877653 3444444433211 111 1122566788888889999988877777766666669
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
|||++ +|...+.. ...+...++..++.|++.||.|||+.| |.||||||+|++++.+|.+||+|||.+..+...
T Consensus 401 E~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 88887743 245888999999999999999999998 999999999999999999999999999887654
Q ss_pred CCC--cccccccccCCcCChhhhcCCCCC-hhhHHHHHHHHHHHHHcCCCCCCCCCcccccc--hhhhhhhhccCCCccc
Q 005871 508 QNQ--ANTNIIAGTYGYMAPEYAMGGIFS-IKSDVFSFGVLLLEIISGRKNNGFYFSEHGQT--LLTYTWKLWCEGPAVE 582 (672)
Q Consensus 508 ~~~--~~~~~~~gt~~Y~aPE~~~~~~~s-~ksDvwSlGvil~elltG~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 582 (672)
... .....++|...|+|||++.+..|. ...||||.|+++..|++|+.||......+... .....+..
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~-------- 545 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRN-------- 545 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccc--------
Confidence 443 445567899999999999999985 57999999999999999999986554443321 00000000
Q ss_pred ccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 583 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 583 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
... -..............++..+|+.||.+|.|+++|++.
T Consensus 546 ~~~--~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 546 IFE--GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ccc--ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 000 0011112334556788889999999999999999864
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.2e-21 Score=189.49 Aligned_cols=172 Identities=14% Similarity=0.163 Sum_probs=134.8
Q ss_pred HHhcCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHH---H------HHHHHHHHHhccCCCeeeEEEEEEe
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQ---E------FKNEVNLIAKLQHKNLVRLLGCCLE 419 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~il~~l~h~niv~l~~~~~~ 419 (672)
...++|.+.+.||.|+||.||+... ++..+|||.+......... . +.+|+..+.++.|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 4578999999999999999999765 5778999999754332222 2 6789999999999999999888664
Q ss_pred C--------ceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC
Q 005871 420 G--------QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM 491 (672)
Q Consensus 420 ~--------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~ 491 (672)
. ...+|||||++|.+|.++. .++. ....+++.+|..+|+.| ++||||||+||+++.+|
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~-------~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMP-------EISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhh-------hccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence 3 3589999999999997763 1232 24568999999999998 99999999999999988
Q ss_pred CeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHH
Q 005871 492 NPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEII 550 (672)
Q Consensus 492 ~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ell 550 (672)
++|+|||........... ..+.....+..++|+|+||+++..+.
T Consensus 173 -i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988754211110 11344455667999999999987765
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=184.52 Aligned_cols=139 Identities=17% Similarity=0.191 Sum_probs=108.7
Q ss_pred ccccccCCceeEEeeeecCCceeEEEEecccCcc--c-------H-----------------HHHHHHHHHHHhccCCCe
Q 005871 357 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ--G-------L-----------------QEFKNEVNLIAKLQHKNL 410 (672)
Q Consensus 357 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~il~~l~h~ni 410 (672)
...||+|+||.||+|.+.+|+.||||+++..... . . .....|++++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999998754211 1 1 122459999999988776
Q ss_pred eeEEEEEEeCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeecCCCCCcEEEcC
Q 005871 411 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL-HEDSRLKIIHRDLKASNILLDD 489 (672)
Q Consensus 411 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~g~~~iiHrDlkp~NIll~~ 489 (672)
.....+.. ...+|||||++++++...+. ....+++.++..++.|++.+|.+| |+.| |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 43332222 22389999999987765432 224688999999999999999999 6877 99999999999998
Q ss_pred CCCeEEEeecCceee
Q 005871 490 DMNPKISDFGLARIF 504 (672)
Q Consensus 490 ~~~~kL~DFgla~~~ 504 (672)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3e-21 Score=187.41 Aligned_cols=248 Identities=24% Similarity=0.349 Sum_probs=186.5
Q ss_pred CccccccccCCceeEEeeeecCCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecC
Q 005871 354 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 431 (672)
Q Consensus 354 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 431 (672)
.....+|.+...|+.|+|+++ |..+++|++... .....+.|..|.-.|+...||||+++++.|....++.++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 445668999999999999996 556677877543 23344678999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeec-CCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 432 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHR-DLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 432 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHr-Dlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
.|+|...|+.. ....++..++.+++.+|++|++|||+.. +++-| -|+...++||++.+.+|.- +-.++.- +
T Consensus 271 ~gslynvlhe~-t~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarism-ad~kfsf--q-- 342 (448)
T KOG0195|consen 271 FGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISM-ADTKFSF--Q-- 342 (448)
T ss_pred chHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheec-ccceeee--e--
Confidence 99999999764 3456788899999999999999999986 45544 5889999999998877641 1111100 0
Q ss_pred cccccccccCCcCChhhhcCCC---CChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChh
Q 005871 511 ANTNIIAGTYGYMAPEYAMGGI---FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~~---~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 587 (672)
.....-.|.||+||.++..+ .-..+|+|||++++|||.|...||....+-.. ..+. .-+-
T Consensus 343 --e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec------gmki---------aleg 405 (448)
T KOG0195|consen 343 --EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC------GMKI---------ALEG 405 (448)
T ss_pred --ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh------hhhh---------hhcc
Confidence 01123468899999998765 35789999999999999999999864432211 1111 1111
Q ss_pred hcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 588 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 588 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
++-..++.....+.+|+.-|+..||.+||.++.|+-.|+.
T Consensus 406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 2223344455567778888999999999999999988864
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.4e-21 Score=218.19 Aligned_cols=254 Identities=20% Similarity=0.257 Sum_probs=182.8
Q ss_pred CCccccccccCCceeEEeeeecCCceeEEEEecccCc-ccHHHHHHHHHH--HHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 353 HFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG-QGLQEFKNEVNL--IAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~i--l~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
++...+.||.+.|=.|.++++++|. |+||++.+..+ -..+.|.++++- ...+++||++++..+-..+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6777889999999999999998887 99999877653 334445444433 4455899999998887777778888898
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC-CCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG-GNQ 508 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~-~~~ 508 (672)
..+ +|.+.+ ..+.-+..-+...|+.||+.||..+|..| |+|||||.+||||++-..+.|+||...+... ..+
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 865 344444 23345677788899999999999999998 9999999999999999999999998876432 233
Q ss_pred CCccccccccc----CCcCChhhhcCC-----------CCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhh
Q 005871 509 NQANTNIIAGT----YGYMAPEYAMGG-----------IFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTW 572 (672)
Q Consensus 509 ~~~~~~~~~gt----~~Y~aPE~~~~~-----------~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 572 (672)
+......+..| ..|+|||.+..+ ..+++.||||+||++.||++ |+++|... .+..|..
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aYr~ 249 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAYRS 249 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhHhc
Confidence 34444444333 359999988431 26889999999999999998 57776421 1111110
Q ss_pred hhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCC
Q 005871 573 KLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSM 630 (672)
Q Consensus 573 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 630 (672)
. ......++++. . +...+.++++.|++.||++|.++++.|+--++..+
T Consensus 250 ~--~~~~~e~~Le~-----I---ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~F 297 (1431)
T KOG1240|consen 250 G--NADDPEQLLEK-----I---EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVF 297 (1431)
T ss_pred c--CccCHHHHHHh-----C---cCccHHHHHHHHHccCchhccCHHHHHHhhhcccc
Confidence 0 00011111110 0 11246788899999999999999999999777643
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-19 Score=177.96 Aligned_cols=140 Identities=19% Similarity=0.256 Sum_probs=111.5
Q ss_pred ccccccCCceeEEeeeecCCceeEEEEecccCccc--------------------------HHHHHHHHHHHHhccCCCe
Q 005871 357 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQG--------------------------LQEFKNEVNLIAKLQHKNL 410 (672)
Q Consensus 357 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~il~~l~h~ni 410 (672)
...||+|+||.||+|.+.+|+.||||++....... ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 57899999999999998789999999987642110 1224678999999999987
Q ss_pred eeEEEEEEeCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEEcC
Q 005871 411 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE-DSRLKIIHRDLKASNILLDD 489 (672)
Q Consensus 411 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~g~~~iiHrDlkp~NIll~~ 489 (672)
.....+... ..+|||||++++++..... ....++......++.|++.+|.+||+ .| |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 544333332 2489999999886544322 22357888999999999999999999 87 99999999999999
Q ss_pred CCCeEEEeecCceeeC
Q 005871 490 DMNPKISDFGLARIFG 505 (672)
Q Consensus 490 ~~~~kL~DFgla~~~~ 505 (672)
++.++|+|||++..+.
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 8899999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.9e-20 Score=213.86 Aligned_cols=199 Identities=21% Similarity=0.247 Sum_probs=164.7
Q ss_pred HHHhcCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhcc---CCCeeeEEEEEEeCceEE
Q 005871 348 LEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ---HKNLVRLLGCCLEGQELL 424 (672)
Q Consensus 348 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---h~niv~l~~~~~~~~~~~ 424 (672)
+...+.|.+.+.||+|+||.||+|...+|+.+|||+-+..... +|.--.+++.+|+ -+.|.++...+.-.+..+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 3445789999999999999999999888999999987665542 2333345556665 244566666666778889
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc-------CCCCeEEEe
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-------DDMNPKISD 497 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~-------~~~~~kL~D 497 (672)
||+||.+-|+|.++++ ....++|.....+..|++..+++||..+ |||+||||+|.||. +..-++|+|
T Consensus 771 lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence 9999999999999995 4567999999999999999999999998 99999999999994 234589999
Q ss_pred ecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCC
Q 005871 498 FGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKN 555 (672)
Q Consensus 498 Fgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p 555 (672)
||.+-.+.--......+..++|-.+-.+|+..+..|+.++|.|.|+.+++-|+.|+..
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 9999766544444455667889999999999999999999999999999999999865
|
|
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.3e-20 Score=161.43 Aligned_cols=91 Identities=30% Similarity=0.366 Sum_probs=73.0
Q ss_pred ccchHHHHHHHHHHHHHHhccCCCCccceeeeeccccccceeeEEeeeccCCChhhhhHHHHHHHHHhhhhcCCCCccce
Q 005871 190 FQNTYNVTKSLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFG 269 (672)
Q Consensus 190 ~~~~~~~~~~l~~~l~~~a~~~~~~~~~~a~~~~~~~~~~~vy~laQCt~DLs~~dC~~CL~~a~~~i~~~c~~~~~~gg 269 (672)
...|...+..++..|...++ ..++.+|++++. ..+..+||||+||++||++.||..||+.++..++.+|+++ .||
T Consensus 16 ~~~f~~~l~~ll~~l~~~a~--~~~~~~f~~~~~-~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~~~~C~~~--~g~ 90 (106)
T PF01657_consen 16 NSTFEQNLNSLLSSLVSNAA--SSSSKGFATGSA-GSGPDTVYGLAQCRGDLSPSDCRACLADAVANISSCCPGS--RGG 90 (106)
T ss_dssp T-THHHHHHHHHHHHHHHGG--GTT-TEEEEEE---ST---EEEEEEE-TTS-HHHHHHHHHHHHCCHHHHTTSB--SSE
T ss_pred CchHHHHHHHHHHHHHHHHh--hccccCcEEeec-CCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHHHHhCCCC--ceE
Confidence 34599999999999999887 223579999986 4578899999999999999999999999999999999876 999
Q ss_pred EEEcccccceeeeccc
Q 005871 270 RILFPSCIMGFELYRY 285 (672)
Q Consensus 270 rv~~~~C~lRye~y~F 285 (672)
+|++++|+||||.|+|
T Consensus 91 ~v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 91 RVWYDSCFLRYENYPF 106 (106)
T ss_dssp EEEESSEEEEEESS--
T ss_pred EEECCCEEEEEECCCC
Confidence 9999999999999998
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.4e-19 Score=170.59 Aligned_cols=184 Identities=18% Similarity=0.118 Sum_probs=139.6
Q ss_pred ccccccccCCceeEEeeeecCCceeEEEEecccCcc----cHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCceEEEEEee
Q 005871 355 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ----GLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 355 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
.+...|++|+||+||.+.. .+.+++.+.+.....- ....+.+|+++|++|+ |+++++++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999997765 6777887777654331 1235789999999995 5889999886 346999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDL-KASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDl-kp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
+.|.+|...+. . ....++.|++.+|.++|+.| |+|||| ||+|||++.++.++|+|||++.......
T Consensus 80 I~G~~L~~~~~---------~-~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPP---------R-GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhh---------h-hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 99998864431 0 11357889999999999998 999999 7999999999999999999998654322
Q ss_pred CC----cc-------cccccccCCcCChhhhcCC-CC-ChhhHHHHHHHHHHHHHcCCCCC
Q 005871 509 NQ----AN-------TNIIAGTYGYMAPEYAMGG-IF-SIKSDVFSFGVLLLEIISGRKNN 556 (672)
Q Consensus 509 ~~----~~-------~~~~~gt~~Y~aPE~~~~~-~~-s~ksDvwSlGvil~elltG~~p~ 556 (672)
.. .. ......++.|+.|+...-- .. -...++++.|.-+|.++|++.+.
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 10 00 0112368888888865332 23 36789999999999999999874
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.4e-20 Score=200.23 Aligned_cols=251 Identities=24% Similarity=0.288 Sum_probs=190.9
Q ss_pred ccccCCceeEEeeee----cCCceeEEEEecccCcc--cHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCceEEEEEeecC
Q 005871 359 KLGQGGFGPVYKGTL----ADGKAIAVKRLSRTSGQ--GLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEYMP 431 (672)
Q Consensus 359 ~LG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lV~Ey~~ 431 (672)
.+|+|.||.|+++.. +.++-+|+|++.+.... .......|..++..++ ||.+++++..++.+..++++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998763 34888999988765321 1225677889999997 9999999999999999999999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCc
Q 005871 432 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 511 (672)
Q Consensus 432 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 511 (672)
+|.|...+ .+...+++.....+...++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l---~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 81 GGDLFTRL---SKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred cchhhhcc---ccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 99987776 34455778888888999999999999998 99999999999999999999999999986532222
Q ss_pred ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCC
Q 005871 512 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQS 591 (672)
Q Consensus 512 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~ 591 (672)
.+||..|||||++. .....+|+||||++++||+||..||.. +....+... +-.
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il~~-----------~~~ 205 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRILKA-----------ELE 205 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHhhh-----------ccC
Confidence 28999999999998 557789999999999999999999864 111111110 011
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCH--HHHHHHhccC-----------CCCCCCCCCCcccccc
Q 005871 592 CAPDELLKFIHIGLLCVQQDPADRPTM--SSVVVMLASD-----------SMTIPQPTEPAFSVGR 644 (672)
Q Consensus 592 ~~~~~~~~l~~li~~cl~~dP~~RPt~--~evl~~L~~~-----------~~~l~~p~~p~~~~~~ 644 (672)
.+.+......+++..++..+|.+|.-. ..+.+.++.. ....++|-+|.....+
T Consensus 206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~e~ 271 (612)
T KOG0603|consen 206 MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSITER 271 (612)
T ss_pred CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcccchh
Confidence 233344455667778999999999855 4555544331 2345666666665533
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.1e-19 Score=183.26 Aligned_cols=233 Identities=21% Similarity=0.282 Sum_probs=149.8
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccC----------CCeeeEEEEEE
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQH----------KNLVRLLGCCL 418 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h----------~niv~l~~~~~ 418 (672)
.+...+.||.|+++.||.+++. .++++|+|++.... ...++.+++|.-....+.+ -.++.-++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4566788999999999999986 48999999876433 3356677777655555322 12222222222
Q ss_pred ---------eC---c-----eEEEEEeecCCCChhHHhhh---ccc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 005871 419 ---------EG---Q-----ELLLIYEYMPNKSLDVHLFD---ATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 477 (672)
Q Consensus 419 ---------~~---~-----~~~lV~Ey~~~gsL~~~l~~---~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiH 477 (672)
.. . ..+++|+-+ .++|..++.- ... ...+....+..+..|+++.+++||+.| ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 11 1 236677776 4566665432 111 123445666788899999999999998 999
Q ss_pred cCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCC--------CCChhhHHHHHHHHHHHH
Q 005871 478 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG--------IFSIKSDVFSFGVLLLEI 549 (672)
Q Consensus 478 rDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--------~~s~ksDvwSlGvil~el 549 (672)
+||||+|++++.+|.++|+||+.....+..... ...+..|.+||..... .++.+.|.|+||+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 999999999999999999999988764432111 1235679999977432 478999999999999999
Q ss_pred HcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCC
Q 005871 550 ISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADR 615 (672)
Q Consensus 550 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R 615 (672)
++|..||+.......... .+ ..+. +..+.+..||..+|+.||++|
T Consensus 244 WC~~lPf~~~~~~~~~~~-------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW-------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG-------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc-------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999876544333221 11 1233 455667788889999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=6e-18 Score=167.02 Aligned_cols=137 Identities=19% Similarity=0.299 Sum_probs=107.1
Q ss_pred CccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhc-----cCCCeeeEEEEEEeCc---e-EE
Q 005871 354 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-----QHKNLVRLLGCCLEGQ---E-LL 424 (672)
Q Consensus 354 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-----~h~niv~l~~~~~~~~---~-~~ 424 (672)
+...+.||+|+||.||. +.+....+||++........+.+.+|+.+++.+ .||||+++++++.++. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34467899999999996 433333479988765545567899999999999 5799999999999873 3 33
Q ss_pred EEEee--cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeeecCCCCCcEEEcC----CCCeEEEe
Q 005871 425 LIYEY--MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI-LYLHEDSRLKIIHRDLKASNILLDD----DMNPKISD 497 (672)
Q Consensus 425 lV~Ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L-~~LH~~g~~~iiHrDlkp~NIll~~----~~~~kL~D 497 (672)
+|+|| +.+++|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+|||++. +++++|+|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 78999 5589999999432 25554 35678888777 8999998 999999999999973 34799999
Q ss_pred ecCc
Q 005871 498 FGLA 501 (672)
Q Consensus 498 Fgla 501 (672)
|+.+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5444
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.9e-18 Score=176.15 Aligned_cols=199 Identities=24% Similarity=0.313 Sum_probs=136.8
Q ss_pred cCCCeeeEEEEEEe---------------------------CceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHH
Q 005871 406 QHKNLVRLLGCCLE---------------------------GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN 458 (672)
Q Consensus 406 ~h~niv~l~~~~~~---------------------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 458 (672)
+|||||+++++|.+ ...+|+||.-.+. +|..++.- ...+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc----CCCchHHHHHHHH
Confidence 59999999988753 3358999987743 67777743 2356677788999
Q ss_pred HHHHHHHHHHhcCCCCeeecCCCCCcEEEc--CCC--CeEEEeecCceeeCCCCCCc----ccccccccCCcCChhhhcC
Q 005871 459 GIARGILYLHEDSRLKIIHRDLKASNILLD--DDM--NPKISDFGLARIFGGNQNQA----NTNIIAGTYGYMAPEYAMG 530 (672)
Q Consensus 459 qi~~~L~~LH~~g~~~iiHrDlkp~NIll~--~~~--~~kL~DFgla~~~~~~~~~~----~~~~~~gt~~Y~aPE~~~~ 530 (672)
|+++|+.|||.+| |.|||+|.+||||. +|+ .+.|+|||.+-.-.....+. ..-..-|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999998 99999999999995 333 47899999886432211111 1112346677899999854
Q ss_pred CC------CChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHH
Q 005871 531 GI------FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIG 604 (672)
Q Consensus 531 ~~------~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li 604 (672)
.. .-.|+|.|+.|.+.||+++...||-. .++..++. ..+.+..... + +......+.+++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~----rGem~L~~--r~Yqe~qLPa-----l----p~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK----RGEMLLDT--RTYQESQLPA-----L----PSRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccc----cchheech--hhhhhhhCCC-----C----cccCChHHHHHH
Confidence 32 24689999999999999999999742 11111110 0011111111 1 122223466788
Q ss_pred HHhcccCCCCCCCHHHHHHHhcc
Q 005871 605 LLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 605 ~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
...|+.||++|++..-....|+.
T Consensus 491 ~~lL~r~pskRvsp~iAANvl~L 513 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVLNL 513 (598)
T ss_pred HHHhcCCccccCCccHHHhHHHH
Confidence 89999999999998877777754
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.7e-18 Score=184.71 Aligned_cols=216 Identities=25% Similarity=0.411 Sum_probs=161.7
Q ss_pred HHhccCCCeeeEEEEEEeCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 005871 402 IAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLK 481 (672)
Q Consensus 402 l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlk 481 (672)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ....+++.-...++++|+.||.|||... . -.|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i-~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP-I-GYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc-c-eeeeeec
Confidence 4678999999999999999999999999999999999965 4567999999999999999999999875 2 2999999
Q ss_pred CCcEEEcCCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCC-------CChhhHHHHHHHHHHHHHcCCC
Q 005871 482 ASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI-------FSIKSDVFSFGVLLLEIISGRK 554 (672)
Q Consensus 482 p~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-------~s~ksDvwSlGvil~elltG~~ 554 (672)
..|.++|..+.+||+|||+.................-...|.|||.+.... .+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999999999999999999988764311111111122345699999987631 4778999999999999999999
Q ss_pred CCCCCCcccc-cchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 555 NNGFYFSEHG-QTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 555 p~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
||+....... ..+...+.... ...+.+.+.... +....++.++..||..+|++||+++.|-..+...
T Consensus 157 ~~~~~~~~~~~~eii~~~~~~~-----~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKKGG-----SNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred ccccccccCChHHHHHHHHhcC-----CCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 9875332222 22333222211 111222221110 2222577888899999999999999998887665
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.4e-17 Score=166.58 Aligned_cols=145 Identities=17% Similarity=0.187 Sum_probs=113.1
Q ss_pred hcCCccccccccCCceeEEeee--ecCCceeEEEEecccCcc------------------------cHHHHHHHHHHHHh
Q 005871 351 TNHFSDENKLGQGGFGPVYKGT--LADGKAIAVKRLSRTSGQ------------------------GLQEFKNEVNLIAK 404 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~il~~ 404 (672)
...|.+.+.||+|+||.||+|. ..+|+.||+|++...... ....+..|+.++.+
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3458899999999999999998 457999999998754210 01235689999999
Q ss_pred ccCCC--eeeEEEEEEeCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 005871 405 LQHKN--LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKA 482 (672)
Q Consensus 405 l~h~n--iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp 482 (672)
+.+.+ ++++++. ...++||||+++.+|...+. ....+...+...++.||+.+|.+||+.| .|+||||||
T Consensus 107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp 177 (237)
T smart00090 107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSE 177 (237)
T ss_pred HHhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCCh
Confidence 97633 4455543 23589999999988865542 2234566677899999999999999985 499999999
Q ss_pred CcEEEcCCCCeEEEeecCceeeC
Q 005871 483 SNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 483 ~NIll~~~~~~kL~DFgla~~~~ 505 (672)
+||+++ ++.++|+|||.+....
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccC
Confidence 999999 8899999999987543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.8e-17 Score=160.13 Aligned_cols=134 Identities=19% Similarity=0.305 Sum_probs=112.7
Q ss_pred cccccCCceeEEeeeecCCceeEEEEecccCcc--------cHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 358 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ--------GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
+.||+|++|.||+|.+ ++..+++|+....... ....+.+|+.++..++|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6778999986543211 123578899999999999988777777777888999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
++|++|.+.+... .. .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999888432 12 77889999999999999998 99999999999999 78999999998874
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.2e-17 Score=158.23 Aligned_cols=144 Identities=21% Similarity=0.209 Sum_probs=112.7
Q ss_pred HHHHhcCCccccccccCCceeEEeeeecCCceeEEEEecccCcc----------------------cHHHHHHHHHHHHh
Q 005871 347 ALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ----------------------GLQEFKNEVNLIAK 404 (672)
Q Consensus 347 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~il~~ 404 (672)
+......|.+.+.||+|+||.||++...+|+.+|||++...... ....+..|+.++..
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 33334458889999999999999999888999999987643210 11236778999999
Q ss_pred ccCCC--eeeEEEEEEeCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 005871 405 LQHKN--LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKA 482 (672)
Q Consensus 405 l~h~n--iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp 482 (672)
+.|++ +++.++ ....++||||+++++|..... ......++.+++.++.++|+.| |+||||||
T Consensus 90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p 153 (198)
T cd05144 90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLSE 153 (198)
T ss_pred HHHcCCCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence 98874 444443 235589999999999875431 0335678899999999999987 99999999
Q ss_pred CcEEEcCCCCeEEEeecCceeeCC
Q 005871 483 SNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 483 ~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
+||++++++.++|+|||++..+..
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.1e-17 Score=185.37 Aligned_cols=215 Identities=21% Similarity=0.266 Sum_probs=140.8
Q ss_pred hcCCccccccccCCceeEEeeeecC-CceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
..+|..++.|..|++|.||.++++. .+.+|+ ++.++.-- +++ |+.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~li----lRn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLI----LRN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhh-cccccchh----hhc---cccccCCccee------------------
Confidence 3689999999999999999999874 678888 44433210 001 23333334333
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
|+-...+. .-+.++. +++.+++|||+.| |+|||+||+|.+|+.-|++|++|||+++.-.....
T Consensus 136 ---gDc~tllk---~~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLLK---NIGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhcc---cCCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 22222231 1122322 2378999999998 99999999999999999999999999875321110
Q ss_pred -------------CcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhcc
Q 005871 510 -------------QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWC 576 (672)
Q Consensus 510 -------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 576 (672)
.-..+.++||+.|+|||++....|+..+|+|++|+|+||.+.|..||....++. ++..+...
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee---lfg~visd-- 273 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LFGQVISD-- 273 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH---HHhhhhhh--
Confidence 111234689999999999999999999999999999999999999985442221 11111000
Q ss_pred CCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005871 577 EGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 622 (672)
Q Consensus 577 ~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 622 (672)
...+.|- | ...+. +..+++..+|+.+|..|.-....+
T Consensus 274 ~i~wpE~-d-----ea~p~---Ea~dli~~LL~qnp~~Rlgt~ga~ 310 (1205)
T KOG0606|consen 274 DIEWPEE-D-----EALPP---EAQDLIEQLLRQNPLCRLGTGGAL 310 (1205)
T ss_pred hcccccc-C-----cCCCH---HHHHHHHHHHHhChHhhcccchhh
Confidence 0011111 1 11222 345566689999999997444433
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.5e-16 Score=155.01 Aligned_cols=130 Identities=22% Similarity=0.357 Sum_probs=105.4
Q ss_pred ccccCCceeEEeeeecCCceeEEEEecccCcc--------cHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 359 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ--------GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 359 ~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
.||+|+||.||+|.+ ++..+++|+....... ....+.+|++++..++|+++....-++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 5788999986543211 1256778999999999887655444455666779999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
+|++|.+.+.... ..++.+++.+|.+||+.| ++|+|++|+||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999988773311 078999999999999998 99999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.9e-17 Score=175.84 Aligned_cols=125 Identities=30% Similarity=0.449 Sum_probs=109.2
Q ss_pred ceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecC
Q 005871 421 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 500 (672)
Q Consensus 421 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgl 500 (672)
..++|.|++|...+|.++|.+.......++...+.++.|++.+++| +| .+|+|+||.||+...+..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 3589999999999999999766666678889999999999999999 66 99999999999999999999999999
Q ss_pred ceeeCCCC----CCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc
Q 005871 501 ARIFGGNQ----NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 551 (672)
Q Consensus 501 a~~~~~~~----~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt 551 (672)
........ ........+||..||+||.+.+..|+.|+|||+||++|+||+.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 88664433 1122344579999999999999999999999999999999997
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.1e-16 Score=178.98 Aligned_cols=139 Identities=19% Similarity=0.306 Sum_probs=112.8
Q ss_pred HHhcCCccccccccCCceeEEeeeecCCceeEEEEec-cc-Cc------ccHHHHHHHHHHHHhccCCCeeeEEEEEEeC
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLS-RT-SG------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG 420 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~-~~-~~------~~~~~~~~E~~il~~l~h~niv~l~~~~~~~ 420 (672)
.....|...+.||+|+||.||+|.+.+. .+++|+.. +. .. ...+.+.+|+++++.++|++++....++...
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 3345667789999999999999987544 34444322 21 11 1235688999999999999998887777777
Q ss_pred ceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecC
Q 005871 421 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 500 (672)
Q Consensus 421 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgl 500 (672)
...++||||+++++|.+++. ....++.+++++|.+||+.+ |+||||||+|||+ .++.++|+|||+
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGl 473 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGL 473 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcc
Confidence 78899999999999998873 34678999999999999997 9999999999999 678999999999
Q ss_pred cee
Q 005871 501 ARI 503 (672)
Q Consensus 501 a~~ 503 (672)
++.
T Consensus 474 a~~ 476 (535)
T PRK09605 474 GKY 476 (535)
T ss_pred ccc
Confidence 975
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.1e-15 Score=146.80 Aligned_cols=137 Identities=20% Similarity=0.268 Sum_probs=100.1
Q ss_pred ccccccCCceeEEeeeecCCceeEEEEecccCcc--cHHH----------------------HHHHHHHHHhccCCC--e
Q 005871 357 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ--GLQE----------------------FKNEVNLIAKLQHKN--L 410 (672)
Q Consensus 357 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~il~~l~h~n--i 410 (672)
.+.||+|+||.||++.+.+++.||||++...... .... ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 5689999999999999888999999988653211 1111 135666677765443 4
Q ss_pred eeEEEEEEeCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEEcC
Q 005871 411 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE-DSRLKIIHRDLKASNILLDD 489 (672)
Q Consensus 411 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~g~~~iiHrDlkp~NIll~~ 489 (672)
.+.++. ...++||||++++.+......... .. .+...++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 455543 245899999999554321111100 11 5678899999999999999 76 99999999999999
Q ss_pred CCCeEEEeecCceeeC
Q 005871 490 DMNPKISDFGLARIFG 505 (672)
Q Consensus 490 ~~~~kL~DFgla~~~~ 505 (672)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.3e-15 Score=137.46 Aligned_cols=135 Identities=22% Similarity=0.224 Sum_probs=114.5
Q ss_pred cccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccC--CCeeeEEEEEEeCceEEEEEeecCCC
Q 005871 356 DENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH--KNLVRLLGCCLEGQELLLIYEYMPNK 433 (672)
Q Consensus 356 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h--~niv~l~~~~~~~~~~~lV~Ey~~~g 433 (672)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .++++++.+....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 46789999999999999854 7899998865543 4678899999999987 58999999888888899999999988
Q ss_pred ChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 434 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 434 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
.+... +......++.+++++|.+||.....+++|+||+|+||+++..+.++++|||.+..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 76532 4566678899999999999986434599999999999999989999999998863
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.9e-16 Score=179.24 Aligned_cols=255 Identities=23% Similarity=0.331 Sum_probs=190.3
Q ss_pred cCCccccccccCCceeEEeeeecC--CceeEEEEecccC--cccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCceEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLAD--GKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lV 426 (672)
..|.+.+.||+|.|+.|-...... ...+|.|.+.... .........|..+-..+. |+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 457777889999999999887643 4456666665443 334455666888888887 99999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeeecCCCCCcEEEcCCC-CeEEEeecCceee
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH-EDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIF 504 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~g~~~iiHrDlkp~NIll~~~~-~~kL~DFgla~~~ 504 (672)
.||..++++...+.. ......+......++.|+..++.|+| ..+ +.|+||||+|.+++..+ .+++.|||++..+
T Consensus 100 ~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999998877731 11114566677789999999999999 776 99999999999999999 9999999999987
Q ss_pred CC-CCCCcccccccc-cCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcc
Q 005871 505 GG-NQNQANTNIIAG-TYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAV 581 (672)
Q Consensus 505 ~~-~~~~~~~~~~~g-t~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (672)
.. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+........... .|. +...
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~---~~~---~~~~- 248 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS---SWK---SNKG- 248 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce---eec---cccc-
Confidence 76 444444555678 9999999999884 457899999999999999999999865544432211 111 1100
Q ss_pred cccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005871 582 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 622 (672)
Q Consensus 582 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 622 (672)
.. ............+++..+++..+|..|.+.+++-
T Consensus 249 -~~----~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 249 -RF----TQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred -cc----ccCccccCChhhhhcccccccCCchhcccccccc
Confidence 00 0001111222345666688999999999988874
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.1e-14 Score=144.10 Aligned_cols=134 Identities=23% Similarity=0.289 Sum_probs=104.0
Q ss_pred cccc-cCCceeEEeeeecCCceeEEEEecccC-------------cccHHHHHHHHHHHHhccCCCe--eeEEEEEEeCc
Q 005871 358 NKLG-QGGFGPVYKGTLADGKAIAVKRLSRTS-------------GQGLQEFKNEVNLIAKLQHKNL--VRLLGCCLEGQ 421 (672)
Q Consensus 358 ~~LG-~G~fg~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~il~~l~h~ni--v~l~~~~~~~~ 421 (672)
..|| .||.|+||++... +..++||.+.... ......+.+|++++.+|+|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4577 8889999998874 7789999875321 1223567889999999998875 67777654322
Q ss_pred ----eEEEEEeecCC-CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEE
Q 005871 422 ----ELLLIYEYMPN-KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKIS 496 (672)
Q Consensus 422 ----~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~ 496 (672)
..++|||+++| .+|.+++.. ..++.. .+.+|+.+|.+||+.| |+||||||+|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 23599999997 688877743 234443 3578999999999998 9999999999999999999999
Q ss_pred eecCcee
Q 005871 497 DFGLARI 503 (672)
Q Consensus 497 DFgla~~ 503 (672)
|||.+..
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9999875
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.43 E-value=5.6e-13 Score=146.51 Aligned_cols=141 Identities=23% Similarity=0.294 Sum_probs=99.6
Q ss_pred ccccccCCceeEEeeeecCCceeEEEEecccCcccH----------------------------------------HHHH
Q 005871 357 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGL----------------------------------------QEFK 396 (672)
Q Consensus 357 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~ 396 (672)
.+.||.|++|+||+|++++|+.||||+.+....+.. -+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 368999999999999999999999999865421110 0244
Q ss_pred HHHHHHHhcc----CCCeeeEEEEEE-eCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHH-HHHHHHhc
Q 005871 397 NEVNLIAKLQ----HKNLVRLLGCCL-EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR-GILYLHED 470 (672)
Q Consensus 397 ~E~~il~~l~----h~niv~l~~~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~-~L~~LH~~ 470 (672)
+|...+.++. |.+-+.+-..+. .....+|||||++|++|.+....... ..+ ...++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CCC---HHHHHHHHHHHHHHHHHhC
Confidence 4555555553 333333333332 23457999999999999877642111 122 3445666655 46788988
Q ss_pred CCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 471 g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
| ++|+|+||.||+++.+++++|+|||++..+.
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 7 9999999999999999999999999998653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=7.7e-13 Score=143.68 Aligned_cols=251 Identities=22% Similarity=0.246 Sum_probs=181.1
Q ss_pred hcCCcccccccc--CCceeEEeeee--c-CCceeEEEEecc--cCcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCce
Q 005871 351 TNHFSDENKLGQ--GGFGPVYKGTL--A-DGKAIAVKRLSR--TSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE 422 (672)
Q Consensus 351 ~~~~~~~~~LG~--G~fg~Vy~~~~--~-~~~~vavK~~~~--~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~ 422 (672)
.+.|.+.+.+|. |.+|.||.+.. . ++..+|+|+-.. ..+.....=.+|+...+++ .|+|.++.+..+...+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 356788899999 99999999987 3 688999997432 2223223335677777777 59999999999999999
Q ss_pred EEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeeecCCCCCcEEEcCC-CCeEEEe
Q 005871 423 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR----GILYLHEDSRLKIIHRDLKASNILLDDD-MNPKISD 497 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~----~L~~LH~~g~~~iiHrDlkp~NIll~~~-~~~kL~D 497 (672)
.++-.|++. .+|..+... ....+....++.++.+... ||.++|+.. |+|-|+||.||++..+ ...+++|
T Consensus 193 lfiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred ceeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCC
Confidence 999999986 555555532 3334777888888888888 999999987 9999999999999999 8899999
Q ss_pred ecCceeeCCCCCCccc---ccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhh
Q 005871 498 FGLARIFGGNQNQANT---NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL 574 (672)
Q Consensus 498 Fgla~~~~~~~~~~~~---~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 574 (672)
||+...+......... ....|...|++||.. ++.++...|+|++|.++.+..++........ ...|..
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~--------~~~W~~ 337 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGK--------NSSWSQ 337 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCC--------CCCccc
Confidence 9999988765533222 223577889999965 5677999999999999999999876532110 011211
Q ss_pred ccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 575 WCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 575 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
..... +-++ +......++...+.++++.+|-.|++.+.+...
T Consensus 338 ~r~~~---ip~e-----~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 338 LRQGY---IPLE-----FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred ccccc---Cchh-----hhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 11111 1111 111112233336678999999999999887653
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.1e-13 Score=134.75 Aligned_cols=206 Identities=20% Similarity=0.238 Sum_probs=141.1
Q ss_pred HHHHHhccCCCeeeEEEEEEeCc-----eEEEEEeecCCCChhHHhhhccc-cCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 005871 399 VNLIAKLQHKNLVRLLGCCLEGQ-----ELLLIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSR 472 (672)
Q Consensus 399 ~~il~~l~h~niv~l~~~~~~~~-----~~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~g~ 472 (672)
..-|-++-|.|||+++.++.+.+ ...++.|||..|++..+|.+..+ ...+..+...+|+-||+.||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 44556677999999999987643 58999999999999999977433 456888889999999999999999985
Q ss_pred CCeeecCCCCCcEEEcCCCCeEEEeecCc--eeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHH
Q 005871 473 LKIIHRDLKASNILLDDDMNPKISDFGLA--RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEII 550 (672)
Q Consensus 473 ~~iiHrDlkp~NIll~~~~~~kL~DFgla--~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ell 550 (672)
..|+|+++..+-|++..+|-+|+.--... ...-..........-.|.++|.+||+=.....+..+|||+||...+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 57999999999999999988887421111 0000011111222345788999999877777788999999999999998
Q ss_pred cCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 551 SGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 551 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.|..-.....+.. . .+ ..........+.-+. ..++.+|++..|..||+|.+++..
T Consensus 277 ilEiq~tnseS~~--~-~e-----e~ia~~i~~len~lq-----------r~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 277 ILEIQSTNSESKV--E-VE-----ENIANVIIGLENGLQ-----------RGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HheeccCCCccee--e-hh-----hhhhhheeeccCccc-----------cCcCcccccCCCCCCcchhhhhcC
Confidence 8764311110000 0 00 000000000111011 134458999999999999998754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.32 E-value=6.3e-12 Score=120.11 Aligned_cols=131 Identities=22% Similarity=0.188 Sum_probs=98.2
Q ss_pred ccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCee-eEEEEEEeCceEEEEEeecCCCCh
Q 005871 357 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV-RLLGCCLEGQELLLIYEYMPNKSL 435 (672)
Q Consensus 357 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv-~l~~~~~~~~~~~lV~Ey~~~gsL 435 (672)
.+.|+.|.++.||+++.. +..+++|....... ....+..|+.+++.+.+.+++ +++... ....++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 357899999999999875 77899998755432 223567899999999766654 454443 2345899999999887
Q ss_pred hHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 436 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS--RLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 436 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
.... . ....++.+++++|..||..+ ...++|+|++|+||+++ ++.++++|||.+..
T Consensus 79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5320 1 11345678999999999986 23469999999999999 67899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.7e-11 Score=136.43 Aligned_cols=144 Identities=17% Similarity=0.209 Sum_probs=96.2
Q ss_pred cCCccccccccCCceeEEeeeecC-CceeEEEEecccCcc----------------------------------cHH---
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQ----------------------------------GLQ--- 393 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~--- 393 (672)
..|+. +.||+|++|+||+|++++ |+.||||+++....+ ..+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35666 799999999999999987 999999999754211 011
Q ss_pred ---HHHHHHHHHHhcc----CCCeeeEEEEEEe-CceEEEEEeecCCCChhHHhhhcccc---CCCCHHHHHHHHHHHHH
Q 005871 394 ---EFKNEVNLIAKLQ----HKNLVRLLGCCLE-GQELLLIYEYMPNKSLDVHLFDATRS---VQLDWKRRQSIINGIAR 462 (672)
Q Consensus 394 ---~~~~E~~il~~l~----h~niv~l~~~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~qi~~ 462 (672)
++.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.+.-.-.... ..+....+..++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 1334444444442 3444444444433 45678999999999997642111111 123333334444444
Q ss_pred HHHHHHhcCCCCeeecCCCCCcEEEcCCC----CeEEEeecCceeeCC
Q 005871 463 GILYLHEDSRLKIIHRDLKASNILLDDDM----NPKISDFGLARIFGG 506 (672)
Q Consensus 463 ~L~~LH~~g~~~iiHrDlkp~NIll~~~~----~~kL~DFgla~~~~~ 506 (672)
...| ++|+|+||.||+++.++ +++++|||++..+..
T Consensus 277 -----f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -----FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3455 99999999999999888 999999999987754
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.3e-10 Score=127.45 Aligned_cols=167 Identities=20% Similarity=0.275 Sum_probs=129.2
Q ss_pred cCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCCCChhHHhhhccccCCCCHHHH
Q 005871 374 ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR 453 (672)
Q Consensus 374 ~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~ 453 (672)
.++.++.|......+........+-++-|+.++||||+++++.+..++..|||+|.+. .|..++.. +.....
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~v 106 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEEV 106 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHHH
Confidence 3688888888877666555667888999999999999999999999999999999873 45555632 335667
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCC
Q 005871 454 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 533 (672)
Q Consensus 454 ~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~ 533 (672)
...+.||+.||.|||+.+ +++|++|.-+.|+|+..|..||++|.++........ ......-...|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc-
Confidence 778999999999999877 799999999999999999999999998875432221 111112233466676543322
Q ss_pred ChhhHHHHHHHHHHHHHcCCC
Q 005871 534 SIKSDVFSFGVLLLEIISGRK 554 (672)
Q Consensus 534 s~ksDvwSlGvil~elltG~~ 554 (672)
-..|.|.||++++|++.|..
T Consensus 182 -~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred -cchhhhhHHHHHHHHhCccc
Confidence 34699999999999999943
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.3e-10 Score=112.94 Aligned_cols=138 Identities=13% Similarity=0.149 Sum_probs=100.4
Q ss_pred ccccccCCceeEEeeeecC-------CceeEEEEecccC------------c----------ccHHHH----HHHHHHHH
Q 005871 357 ENKLGQGGFGPVYKGTLAD-------GKAIAVKRLSRTS------------G----------QGLQEF----KNEVNLIA 403 (672)
Q Consensus 357 ~~~LG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~------------~----------~~~~~~----~~E~~il~ 403 (672)
...||.|.-+.||.|...+ +..+|||+.+-.. . .....+ .+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4579999999999998543 4799999764211 0 011223 38999999
Q ss_pred hccC--CCeeeEEEEEEeCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeecCC
Q 005871 404 KLQH--KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL-HEDSRLKIIHRDL 480 (672)
Q Consensus 404 ~l~h--~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~g~~~iiHrDl 480 (672)
++.. -++++.+++ ...+|||||+.+..+..... +...++.++...+..+++.+|..| |..| |+|+||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 9964 456667764 45689999998754422111 112355566778889999999999 7877 999999
Q ss_pred CCCcEEEcCCCCeEEEeecCceeeC
Q 005871 481 KASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 481 kp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
++.|||++ ++.++|+|||.+....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4689999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.1e-10 Score=113.18 Aligned_cols=142 Identities=18% Similarity=0.295 Sum_probs=110.5
Q ss_pred ccccccCCceeEEeeeecCCceeEEEEecccCc-ccHHHHHHHHHHHHhccCC--CeeeEEEEEEeCc---eEEEEEeec
Q 005871 357 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHK--NLVRLLGCCLEGQ---ELLLIYEYM 430 (672)
Q Consensus 357 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~--niv~l~~~~~~~~---~~~lV~Ey~ 430 (672)
.+.|+.|..+.||++...+|+.+++|....... .....+.+|+++++.+.+. ++.+++.+..... ..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 357899999999999987778999998765432 2346788999999999764 4577777766542 568999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS--------------------------------------- 471 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--------------------------------------- 471 (672)
+|.++...+.. ..++..+...++.++++.|..||+..
T Consensus 83 ~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 83 DGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99888765421 24677777888888888888888521
Q ss_pred --------------CCCeeecCCCCCcEEEcC--CCCeEEEeecCce
Q 005871 472 --------------RLKIIHRDLKASNILLDD--DMNPKISDFGLAR 502 (672)
Q Consensus 472 --------------~~~iiHrDlkp~NIll~~--~~~~kL~DFgla~ 502 (672)
...++|+|++|.||+++. ++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 245899999999999998 5668999998876
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.11 E-value=2.4e-09 Score=114.25 Aligned_cols=169 Identities=24% Similarity=0.372 Sum_probs=130.9
Q ss_pred ceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEE----eCceEEEEEeecCC-CChhHH
Q 005871 365 FGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL----EGQELLLIYEYMPN-KSLDVH 438 (672)
Q Consensus 365 fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~----~~~~~~lV~Ey~~~-gsL~~~ 438 (672)
-.+.|++... ||..|++|++.............-+++++++.|+|+|++.++|. .+..+++||+|.++ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3578888864 89999999995544333334455688999999999999999887 34578999999986 566666
Q ss_pred hhhcc------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 439 LFDAT------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 439 l~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
.+... .....++..+|.++.|+..||.++|+.| +.-+-|.|.+|+++.+.+++|...|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 55322 2234678999999999999999999998 88899999999999999999998888876654
Q ss_pred CCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCC
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKN 555 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p 555 (672)
+.... +.+ -.+-|.=.||.+++.|.||...
T Consensus 446 d~~~~----------------le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPTEP----------------LES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCcc----------------hhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 33110 111 2367999999999999999754
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2e-09 Score=101.42 Aligned_cols=131 Identities=24% Similarity=0.343 Sum_probs=100.0
Q ss_pred cccccCCceeEEeeeecCCceeEEEEecccC---cc-----cHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 358 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTS---GQ-----GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
..+++|+-+.+|.+.+. |..+++|.=.++. ++ ..+.-.+|+.++.+++--.|.--.=+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46889999999999774 4446666432221 11 123567899999999876665555555667778999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
++|..|.+.+... ...++..+-..+.-||..| |+|+||.++||+++.++ +.++|||++..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888543 2557777888888999998 99999999999998775 99999999974
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.2e-10 Score=126.72 Aligned_cols=247 Identities=22% Similarity=0.212 Sum_probs=175.8
Q ss_pred hcCCccccccccCCceeEEeeeec--CCceeEEEEecccCcccHHH--HHHHHHHHHhc-cCCCeeeEEEEEEeCceEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA--DGKAIAVKRLSRTSGQGLQE--FKNEVNLIAKL-QHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~~~~~--~~~E~~il~~l-~h~niv~l~~~~~~~~~~~l 425 (672)
..+|..+..||.|.|+.|++...+ ++..|++|.+.+.......+ -..|+.+...+ .|.+++..+..|......++
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 457889999999999999998754 57788999876654333222 24566666666 58889998888888888889
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC-CCeEEEeecCceee
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-MNPKISDFGLARIF 504 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~-~~~kL~DFgla~~~ 504 (672)
--|||+++++...+ .-...+++..++.+..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||....+
T Consensus 344 p~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred chhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccccc
Confidence 99999999987665 22345788888999999999999999987 9999999999999986 78899999998642
Q ss_pred CCCCCCcccccccccCCcC--ChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccc
Q 005871 505 GGNQNQANTNIIAGTYGYM--APEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVE 582 (672)
Q Consensus 505 ~~~~~~~~~~~~~gt~~Y~--aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (672)
.... ....+.-+++ +|+......+..+.|++|||..+.+.+++..-.. .+. .|.....+..
T Consensus 418 ~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~-----~~~-----~~~~i~~~~~-- 480 (524)
T KOG0601|consen 418 AFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE-----SGV-----QSLTIRSGDT-- 480 (524)
T ss_pred ceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCc-----ccc-----cceeeecccc--
Confidence 2111 1112233344 5555566778999999999999999999876421 110 0111111111
Q ss_pred ccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 583 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 583 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
+.+ +.....+..+...++..++..||.+.++..+....
T Consensus 481 ---p~~-----~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 481 ---PNL-----PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ---cCC-----CchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 011 11124455556678899999999999887766544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.3e-10 Score=132.58 Aligned_cols=250 Identities=19% Similarity=0.214 Sum_probs=169.7
Q ss_pred HHhcCCccccccccCCceeEEeeeec-CCceeEEEEecc---cCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEE
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 424 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 424 (672)
...+.+.+.+.+-+|.++.++.+.-. .|...++|.... ......+....+-.++-..++|-++.....+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 45678888899999999999987643 243333333221 11222333344444444456677776666666677899
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceee
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 504 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~ 504 (672)
|+++|..+++|...|+.. ...+.+-.+..+..+...+++||... +.|+|++|.|+++..+++.++.|||.....
T Consensus 881 L~~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 999999999998888543 24666666777888999999999875 899999999999999999999999844322
Q ss_pred CCC-------------------------CCC----cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCC
Q 005871 505 GGN-------------------------QNQ----ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKN 555 (672)
Q Consensus 505 ~~~-------------------------~~~----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p 555 (672)
+.. ... .......||+.|.+||.+.+......+|+|++|++++|.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 110 000 012235799999999999999999999999999999999999999
Q ss_pred CCCCCcccccchhhhhhhhccCC-CcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 005871 556 NGFYFSEHGQTLLTYTWKLWCEG-PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMS 619 (672)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 619 (672)
|....+.... ..+.... .+. ...........+++...+..+|.+|..+.
T Consensus 1035 ~na~tpq~~f------~ni~~~~~~~p---------~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQIF------ENILNRDIPWP---------EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhhhh------hccccCCCCCC---------CCccccChhhhhhhhhhhccCchhccCcc
Confidence 8544332221 1110000 000 00111222344556678888998888776
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=7.9e-09 Score=96.87 Aligned_cols=143 Identities=24% Similarity=0.326 Sum_probs=106.2
Q ss_pred cccccccCCceeEEeeeecCCceeEEEE-eccc----C---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 356 DENKLGQGGFGPVYKGTLADGKAIAVKR-LSRT----S---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 356 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~-~~~~----~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
.+..|-+|+-+.|+++.+. |+...||. +.+. . .-...+.++|+++|.++.--.|.--.=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5678899999999999884 66766764 2221 1 112356788999999997666555445566666778999
Q ss_pred eecCC-CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC---eEEEeecCcee
Q 005871 428 EYMPN-KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN---PKISDFGLARI 503 (672)
Q Consensus 428 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~---~kL~DFgla~~ 503 (672)
||++| .++.+++......... ......++.+|-+.+.-||.++ |||+||..+||++..++. +.|+|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~-d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESE-DEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCccc-chhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99988 5677777654443322 2333678899999999999998 999999999999976553 58999999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.8e-08 Score=97.69 Aligned_cols=126 Identities=26% Similarity=0.323 Sum_probs=83.0
Q ss_pred eEEeeeecCCceeEEEEecccCc---------------------c-----cHHHHHHHHHHHHhccCC--CeeeEEEEEE
Q 005871 367 PVYKGTLADGKAIAVKRLSRTSG---------------------Q-----GLQEFKNEVNLIAKLQHK--NLVRLLGCCL 418 (672)
Q Consensus 367 ~Vy~~~~~~~~~vavK~~~~~~~---------------------~-----~~~~~~~E~~il~~l~h~--niv~l~~~~~ 418 (672)
.||.|...+|..+|||+...... . ......+|.+.|.++..- ++++.+++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999988899999998743210 0 112457899999999876 466666552
Q ss_pred eCceEEEEEeecC--CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 005871 419 EGQELLLIYEYMP--NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY-LHEDSRLKIIHRDLKASNILLDDDMNPKI 495 (672)
Q Consensus 419 ~~~~~~lV~Ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~-LH~~g~~~iiHrDlkp~NIll~~~~~~kL 495 (672)
...|||||++ |..+..+. +.. ++......++.+++..+.. +|..| |+|+||.+.|||++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~-~~~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLK-DVD----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHH-HCG----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHH-hcc----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 3479999999 65554433 211 1133456677788885555 57777 9999999999999988 9999
Q ss_pred EeecCceeeC
Q 005871 496 SDFGLARIFG 505 (672)
Q Consensus 496 ~DFgla~~~~ 505 (672)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=4.4e-08 Score=100.54 Aligned_cols=133 Identities=20% Similarity=0.171 Sum_probs=97.3
Q ss_pred eeEEeeeecCCceeEEEEecccCcc-cH----------HHHHHHHHHHHhccCCCe--eeEEEEEEe-----CceEEEEE
Q 005871 366 GPVYKGTLADGKAIAVKRLSRTSGQ-GL----------QEFKNEVNLIAKLQHKNL--VRLLGCCLE-----GQELLLIY 427 (672)
Q Consensus 366 g~Vy~~~~~~~~~vavK~~~~~~~~-~~----------~~~~~E~~il~~l~h~ni--v~l~~~~~~-----~~~~~lV~ 427 (672)
..|.++.+ +|+.|.||+....... .. ..+.+|+..+.++...+| ++.+++... ....+||+
T Consensus 36 rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 36 RRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred ceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 34666655 5778999977443211 11 147899999999865443 344555543 23578999
Q ss_pred eecCCC-ChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-------CCCeEEEeec
Q 005871 428 EYMPNK-SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-------DMNPKISDFG 499 (672)
Q Consensus 428 Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~-------~~~~kL~DFg 499 (672)
|++++. +|.+++.+.. ....+......++.+++..+.-||+.| |+|+|+++.|||++. ++.+.|+||+
T Consensus 115 e~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~ 190 (268)
T PRK15123 115 EDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLH 190 (268)
T ss_pred eeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence 999986 7888874322 234566778899999999999999998 999999999999975 4679999999
Q ss_pred Ccee
Q 005871 500 LARI 503 (672)
Q Consensus 500 la~~ 503 (672)
.++.
T Consensus 191 r~~~ 194 (268)
T PRK15123 191 RAQI 194 (268)
T ss_pred cccc
Confidence 8864
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.83 E-value=2e-08 Score=100.09 Aligned_cols=148 Identities=20% Similarity=0.212 Sum_probs=106.4
Q ss_pred ccchHHHHHHhcCCccccccccCCceeEEeeeecCCceeEEEEecccCc----------------------ccHHHHHHH
Q 005871 341 LFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG----------------------QGLQEFKNE 398 (672)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E 398 (672)
.+.+........-..+..+||.|.-+.||.|....|.++|||.-+.... -.....++|
T Consensus 80 ~LAL~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rE 159 (304)
T COG0478 80 ALALHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAERE 159 (304)
T ss_pred HHHHHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHH
Confidence 3444444444444667789999999999999999999999995432110 012346789
Q ss_pred HHHHHhccCC--CeeeEEEEEEeCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 005871 399 VNLIAKLQHK--NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 476 (672)
Q Consensus 399 ~~il~~l~h~--niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~ii 476 (672)
.++|.+|... .+++.+++ +...+||||++|..|...- ++.+....++..|++-+.-+-..| ||
T Consensus 160 f~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iV 224 (304)
T COG0478 160 FEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IV 224 (304)
T ss_pred HHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---cc
Confidence 9999999765 67777655 4568999999997664322 233444455556666665555666 99
Q ss_pred ecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 477 HRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 477 HrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
|+|+++-||+|+++|.++++||-.+..
T Consensus 225 HGDlSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 225 HGDLSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred ccCCchheEEEecCCCEEEEeCccccc
Confidence 999999999999999999999976653
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=2.3e-07 Score=97.00 Aligned_cols=193 Identities=19% Similarity=0.205 Sum_probs=128.3
Q ss_pred ccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhc-cCCCeeeEEEEE-------EeCceEEEE
Q 005871 355 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCC-------LEGQELLLI 426 (672)
Q Consensus 355 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~-------~~~~~~~lV 426 (672)
.....||+|+-+.+|-.-. -...+.|+.......... +.+..|... .||-+-.-+.+= .......+.
T Consensus 14 ~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecch--hhchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 3456799999999996532 122355777665543222 223334443 455332211111 112236788
Q ss_pred EeecCCCC-hhHHhhhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCce
Q 005871 427 YEYMPNKS-LDVHLFDAT---RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 502 (672)
Q Consensus 427 ~Ey~~~gs-L~~~l~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~ 502 (672)
|+.+.+.- +..++.-.. .....+|.-.+.+.+.++.+.+.||..| .+-+|++++|+||++++.+.|.|=....
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 88887642 223332111 2234789999999999999999999998 8999999999999999999999865544
Q ss_pred eeCCCCCCcccccccccCCcCChhhhc-----CCCCChhhHHHHHHHHHHHHHcC-CCCCCC
Q 005871 503 IFGGNQNQANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISG-RKNNGF 558 (672)
Q Consensus 503 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltG-~~p~~~ 558 (672)
... +....--.+|.+.|.+||... +-.-+...|.|.||+++++++.| ++||..
T Consensus 166 i~~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 166 INA---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred ecc---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 321 112222347899999999764 22346789999999999999987 888743
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.61 E-value=4.5e-07 Score=89.82 Aligned_cols=107 Identities=27% Similarity=0.291 Sum_probs=85.1
Q ss_pred HHHHHHHHHHHHhccCCC--eeeEEEEEEeC----ceEEEEEeecCCC-ChhHHhhhccccCCCCHHHHHHHHHHHHHHH
Q 005871 392 LQEFKNEVNLIAKLQHKN--LVRLLGCCLEG----QELLLIYEYMPNK-SLDVHLFDATRSVQLDWKRRQSIINGIARGI 464 (672)
Q Consensus 392 ~~~~~~E~~il~~l~h~n--iv~l~~~~~~~----~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L 464 (672)
.....+|...+..|...+ .++.+++.... ...+||+|++++. +|.+++.+... .+......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 346788999988886543 44566666543 2468999999984 78888854222 56677889999999999
Q ss_pred HHHHhcCCCCeeecCCCCCcEEEcCCC---CeEEEeecCceee
Q 005871 465 LYLHEDSRLKIIHRDLKASNILLDDDM---NPKISDFGLARIF 504 (672)
Q Consensus 465 ~~LH~~g~~~iiHrDlkp~NIll~~~~---~~kL~DFgla~~~ 504 (672)
.-||+.| |+|+|+++.|||++.++ .+.|+||+.++..
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999998 99999999999999887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=6.7e-07 Score=99.35 Aligned_cols=142 Identities=16% Similarity=0.218 Sum_probs=93.5
Q ss_pred cccccCCceeEEeeeecCCceeEEEEecccCcccH------------------------------H----------HHHH
Q 005871 358 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGL------------------------------Q----------EFKN 397 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------------~----------~~~~ 397 (672)
+.|+.++-|+||+|++++|+.||||+.+..-.+.. + ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 68999999999999999999999998865422110 0 1234
Q ss_pred HHHHHHhcc----CCCeeeEEEEE-EeCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 005871 398 EVNLIAKLQ----HKNLVRLLGCC-LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 472 (672)
Q Consensus 398 E~~il~~l~----h~niv~l~~~~-~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~ 472 (672)
|..-+.++. ...-+++=.++ .-...-.|+|||++|..+.+...-.. ..++.+.+.....++. +..+=..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~ia~~~~~~f--~~q~~~dg- 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKELAELLVRAF--LRQLLRDG- 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHHHHHHHHHHH--HHHHHhcC-
Confidence 555555552 12222222222 23456799999999999988753222 3355444433333222 22222244
Q ss_pred CCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 473 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 473 ~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
+.|.|.+|.||+++.+|++.+.|||+...+..
T Consensus 286 --ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 --FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999987643
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.48 E-value=3.3e-08 Score=109.35 Aligned_cols=157 Identities=22% Similarity=0.361 Sum_probs=102.3
Q ss_pred HHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcc-------cccccccCCcCChhhhc
Q 005871 457 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN-------TNIIAGTYGYMAPEYAM 529 (672)
Q Consensus 457 ~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~-------~~~~~gt~~Y~aPE~~~ 529 (672)
+.+++.|+.|+|..- .+||++|.|++|.++..+..||+.|+.+........... .........|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 334558999999875 799999999999999999999999998865433211110 01112356799999999
Q ss_pred CCCCChhhHHHHHHHHHHHHHcCCCC-CCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhc
Q 005871 530 GGIFSIKSDVFSFGVLLLEIISGRKN-NGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCV 608 (672)
Q Consensus 530 ~~~~s~ksDvwSlGvil~elltG~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl 608 (672)
+...+.++|+||+|+++|.+..|..+ +... + ....+.... ..+..-...+......++.+-+.+++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~----~-~~~~~~~~~--------~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAAN----G-GLLSYSFSR--------NLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhcc----C-Ccchhhhhh--------cccccccccccccCcHHHHHHHHHHh
Confidence 98889999999999999999955544 2111 0 011111000 00000011112222334445555899
Q ss_pred ccCCCCCCCHHHHHHHhccC
Q 005871 609 QQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 609 ~~dP~~RPt~~evl~~L~~~ 628 (672)
..++..||++.++.......
T Consensus 250 ~~~~~~rp~~~~l~~~~ff~ 269 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLSIPFFS 269 (700)
T ss_pred cCCcccCcchhhhhcccccC
Confidence 99999999888887655443
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.47 E-value=3.2e-06 Score=82.69 Aligned_cols=139 Identities=18% Similarity=0.164 Sum_probs=103.3
Q ss_pred cccCCceeEEeeeecCCceeEEEEecccC------cccHHHHHHHHHHHHhccCCC--eeeEEEEEEe----CceEEEEE
Q 005871 360 LGQGGFGPVYKGTLADGKAIAVKRLSRTS------GQGLQEFKNEVNLIAKLQHKN--LVRLLGCCLE----GQELLLIY 427 (672)
Q Consensus 360 LG~G~fg~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~il~~l~h~n--iv~l~~~~~~----~~~~~lV~ 427 (672)
-|+||.+.|++.... |+.+-+|+-...- +-....|.+|+..|.+|..-+ +++....-.. .-..+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 367999999998764 4468888765221 335678999999999996433 4455422211 12478999
Q ss_pred eecCC-CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC--eEEEeecCcee
Q 005871 428 EYMPN-KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN--PKISDFGLARI 503 (672)
Q Consensus 428 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~--~kL~DFgla~~ 503 (672)
|-+.+ .+|.+++.+.. ..+.+......++.+++..+.-||+.| +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97765 57777774322 234677888899999999999999998 999999999999987677 99999987764
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.47 E-value=3e-06 Score=85.10 Aligned_cols=139 Identities=17% Similarity=0.193 Sum_probs=86.2
Q ss_pred cccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCC--eeeEEEEEEeCceEEEEEeecCCCC-
Q 005871 358 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN--LVRLLGCCLEGQELLLIYEYMPNKS- 434 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~l~~~~~~~~~~~lV~Ey~~~gs- 434 (672)
.+||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++..+.+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 25567888876533 2355688999999997544 4677888877888899999999963
Q ss_pred hhHHhh--------------h----ccc--cCCCCHHHHH-HHHHH----------HHH-HHHHHHh-cCCCCeeecCCC
Q 005871 435 LDVHLF--------------D----ATR--SVQLDWKRRQ-SIING----------IAR-GILYLHE-DSRLKIIHRDLK 481 (672)
Q Consensus 435 L~~~l~--------------~----~~~--~~~l~~~~~~-~i~~q----------i~~-~L~~LH~-~g~~~iiHrDlk 481 (672)
+...+. . -.. .......... .+..+ +.. ...+|.. .....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 211110 0 000 0001100000 00000 001 1112221 123457899999
Q ss_pred CCcEEEcCCCCeEEEeecCce
Q 005871 482 ASNILLDDDMNPKISDFGLAR 502 (672)
Q Consensus 482 p~NIll~~~~~~kL~DFgla~ 502 (672)
|.||++++++ +.|+||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999888 9999998775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.34 E-value=3.2e-06 Score=84.68 Aligned_cols=144 Identities=23% Similarity=0.243 Sum_probs=86.4
Q ss_pred ccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCC--eeeEEEEEEe---CceEEEEEeecC
Q 005871 357 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN--LVRLLGCCLE---GQELLLIYEYMP 431 (672)
Q Consensus 357 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~l~~~~~~---~~~~~lV~Ey~~ 431 (672)
++.|+.|..+.||++...+ ..+++|..... .....+.+|..+++.+.... +.+++..... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4678999999999999877 69999987655 44567888999999986443 4566664433 335799999999
Q ss_pred CCChhH----------------Hhhh---c-cccCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 005871 432 NKSLDV----------------HLFD---A-TRSVQLDWKR---------RQSI------------INGIAR-GILYLHE 469 (672)
Q Consensus 432 ~gsL~~----------------~l~~---~-~~~~~l~~~~---------~~~i------------~~qi~~-~L~~LH~ 469 (672)
|..+.. .+.. . .......... .... ...+.+ .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 1110 0 0000111100 0000 111222 2333332
Q ss_pred ----cCCCCeeecCCCCCcEEEc-CCCCeEEEeecCcee
Q 005871 470 ----DSRLKIIHRDLKASNILLD-DDMNPKISDFGLARI 503 (672)
Q Consensus 470 ----~g~~~iiHrDlkp~NIll~-~~~~~kL~DFgla~~ 503 (672)
.....++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1334699999999999999 666667999988763
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.1e-05 Score=79.24 Aligned_cols=139 Identities=18% Similarity=0.187 Sum_probs=91.9
Q ss_pred HHhcCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHH---------HHHHHHHHhccC---CCeeeEEEE
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEF---------KNEVNLIAKLQH---KNLVRLLGC 416 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~il~~l~h---~niv~l~~~ 416 (672)
....+|.+.+.+-.....-|.+... +|+.+++|.........++.| .+++..+.+++. ..+..++.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 3457788888887777777766665 578899998765433222222 234444444432 223333322
Q ss_pred EE-----eCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC
Q 005871 417 CL-----EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM 491 (672)
Q Consensus 417 ~~-----~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~ 491 (672)
.. .....+|+|||++|..|.+.. .+++ .+...|.+++.-||+.| +.|+|.+|.|+++++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~-------~i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~ 172 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIE-------DIDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG 172 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccch-------hcCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc
Confidence 22 234567999999998876543 1222 24456778899999998 99999999999999655
Q ss_pred CeEEEeecCcee
Q 005871 492 NPKISDFGLARI 503 (672)
Q Consensus 492 ~~kL~DFgla~~ 503 (672)
++++||+..+.
T Consensus 173 -i~iID~~~k~~ 183 (229)
T PF06176_consen 173 -IRIIDTQGKRM 183 (229)
T ss_pred -EEEEECccccc
Confidence 99999977653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.24 E-value=1e-05 Score=80.22 Aligned_cols=154 Identities=18% Similarity=0.233 Sum_probs=102.2
Q ss_pred ccchHHHHHHhcCCcccc---ccccCCceeEEeeeecCCceeEEEEecccCccc-------------------HH-----
Q 005871 341 LFPLRLALEATNHFSDEN---KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQG-------------------LQ----- 393 (672)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~---~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-------------------~~----- 393 (672)
.....++....++..+.. .|+.|.-+.||+|...++..+|+|++....... ..
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 344455555555555444 466788889999998889999999885432111 00
Q ss_pred HHHHHHHHHHhccC--CCeeeEEEEEEeCceEEEEEeecCCCChh-HHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhc
Q 005871 394 EFKNEVNLIAKLQH--KNLVRLLGCCLEGQELLLIYEYMPNKSLD-VHLFDATRSVQLDWKRRQSIINGIARGILYLHED 470 (672)
Q Consensus 394 ~~~~E~~il~~l~h--~niv~l~~~~~~~~~~~lV~Ey~~~gsL~-~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~ 470 (672)
-..+|+.-|+++.. -.+++-+.+. ...|||||+....+- -.| +...+..++...+..++++.+.-|-..
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~ 185 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKE 185 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHh
Confidence 12457777777743 3344555543 347999999654211 111 122233346777788888888877773
Q ss_pred CCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 471 g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
. ++||+||+.-|||+. ++.+.++|||.+....
T Consensus 186 a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 186 A--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred c--CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 2 499999999999999 8899999999987654
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.4e-05 Score=75.20 Aligned_cols=131 Identities=22% Similarity=0.263 Sum_probs=92.9
Q ss_pred CccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCCC
Q 005871 354 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 433 (672)
Q Consensus 354 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~g 433 (672)
..+.+.|++|++|.||++.+. |.++|+|+-...+. ...+..|+++|..++-.++-+=+..+. ..++.|||+.|.
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg---~~~i~me~i~G~ 97 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYG---EDFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEec---hhhhhhhhhcCc
Confidence 445678999999999999996 55889998766554 478899999999998877655333332 234569999998
Q ss_pred ChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC-CCcEEEcCCCCeEEEeecCcee
Q 005871 434 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLK-ASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 434 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlk-p~NIll~~~~~~kL~DFgla~~ 503 (672)
.|...-... +.+. +..+++.---|...| |-|+.|+ |..++|.+++.+.|+||..|..
T Consensus 98 ~L~~~~~~~------~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGG------DRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhcc------cHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 887655211 2222 333555544455555 9999997 6666666666999999999874
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.3e-05 Score=79.71 Aligned_cols=140 Identities=15% Similarity=0.147 Sum_probs=86.1
Q ss_pred ccccCCc-eeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCceEEEEEeecCCCChh
Q 005871 359 KLGQGGF-GPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEYMPNKSLD 436 (672)
Q Consensus 359 ~LG~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 436 (672)
.|..|.. ..||+.... +..+.+|+..... .....+|+++++.+. +--+.+++++....+..++|||+++|.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555555 788999764 4678888775543 345678999998884 344667888777766789999999998876
Q ss_pred HHhh-------------------hccc-cCCCCH--HHHHHHHH--------------------HHHHHHHHHHh----c
Q 005871 437 VHLF-------------------DATR-SVQLDW--KRRQSIIN--------------------GIARGILYLHE----D 470 (672)
Q Consensus 437 ~~l~-------------------~~~~-~~~l~~--~~~~~i~~--------------------qi~~~L~~LH~----~ 470 (672)
.... .... ...+.. ........ .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4421 0000 001110 00000000 01111222211 1
Q ss_pred CCCCeeecCCCCCcEEEcCCCCeEEEeecCce
Q 005871 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLAR 502 (672)
Q Consensus 471 g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~ 502 (672)
....++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 12459999999999999998778899998775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.2e-05 Score=89.34 Aligned_cols=139 Identities=14% Similarity=0.171 Sum_probs=91.4
Q ss_pred cccccCCceeEEeeeecCCceeEEEEecccCccc-------------------------------HH------HHHHHHH
Q 005871 358 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQG-------------------------------LQ------EFKNEVN 400 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------~~------~~~~E~~ 400 (672)
+.||.-+.|+||++++++|+.||||+-+..-.+. .+ +|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6799999999999999999999999875432111 00 1233443
Q ss_pred HHHhc----cCCC------eeeEEEEEEeCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhc
Q 005871 401 LIAKL----QHKN------LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 470 (672)
Q Consensus 401 il~~l----~h~n------iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~ 470 (672)
-..+. .|-+ |++++-.+ .....|+||||+|..+.+.-.- ....++...+..-+.+...-.-+- .
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~~~l~~~~~~qIf~--~ 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAI--DKRGISPHDILNKLVEAYLEQIFK--T 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHH--HHcCCCHHHHHHHHHHHHHHHHHh--c
Confidence 33333 3444 33333222 3467999999999988776432 223466665544444433222222 3
Q ss_pred CCCCeeecCCCCCcEEEcC----CCCeEEEeecCceeeC
Q 005871 471 SRLKIIHRDLKASNILLDD----DMNPKISDFGLARIFG 505 (672)
Q Consensus 471 g~~~iiHrDlkp~NIll~~----~~~~kL~DFgla~~~~ 505 (672)
| ++|+|=.|.||+|+. ++.+.+.|||+...+.
T Consensus 321 G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 321 G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred C---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 4 999999999999983 6789999999988654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.07 E-value=6.2e-07 Score=98.31 Aligned_cols=189 Identities=19% Similarity=0.166 Sum_probs=139.1
Q ss_pred HhcCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCC-eeeEEEEEEeCceEEEEEe
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN-LVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n-iv~l~~~~~~~~~~~lV~E 428 (672)
.+..+...+-+++|+++.++|.+..-.+....+.+... ....-++++|.+++||| .+..++-+..+...+++++
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 34556667788999999999987543344445544333 44566899999999999 7777777777788999999
Q ss_pred ecCCC-ChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 429 YMPNK-SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 429 y~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
++.++ +...... .....+..-+...+.+.-.+++++||+.. =+|+| ||+..+ +..++.||+....+...
T Consensus 315 i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 315 ICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred hhcCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence 99887 2221111 11222444455667777888999999863 48888 777766 67899999998876544
Q ss_pred CCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCC
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNN 556 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~ 556 (672)
. ......+++.++|||+.+.+.+..+.|+|++|+-..+|--|-+|-
T Consensus 385 ~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 385 M---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred c---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 3 234567899999999999999999999999998888887777763
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.04 E-value=8.6e-05 Score=72.65 Aligned_cols=129 Identities=19% Similarity=0.293 Sum_probs=91.9
Q ss_pred cccccccCCceeEEeeeecCCceeEEEEecccC----------------cccHHHHHHHHHHHHhcc------CCCeeeE
Q 005871 356 DENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS----------------GQGLQEFKNEVNLIAKLQ------HKNLVRL 413 (672)
Q Consensus 356 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~il~~l~------h~niv~l 413 (672)
....||+|+.-.||. +.+....+||+..... ........+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 356799999999995 4456677889887655 123456677777777776 7889999
Q ss_pred EEEEEeCceEEEEEeecCC------CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE
Q 005871 414 LGCCLEGQELLLIYEYMPN------KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 487 (672)
Q Consensus 414 ~~~~~~~~~~~lV~Ey~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll 487 (672)
+|+.+.+....+|+|.+.+ .+|.+++ ....++. .....+. +-..||-+.. |+.+|++|+||++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l----~~~~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYL----KEGGLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIVV 151 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHH----HcCCccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEEE
Confidence 9999999999999998743 3455555 3334555 3333333 3445666665 9999999999999
Q ss_pred cCC--C--CeEEEe
Q 005871 488 DDD--M--NPKISD 497 (672)
Q Consensus 488 ~~~--~--~~kL~D 497 (672)
... + .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 632 2 578888
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.01 E-value=2.4e-05 Score=76.10 Aligned_cols=104 Identities=23% Similarity=0.249 Sum_probs=83.1
Q ss_pred HHHHHHHHhccC-CCeeeEEEEEEeCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 005871 396 KNEVNLIAKLQH-KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 474 (672)
Q Consensus 396 ~~E~~il~~l~h-~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~ 474 (672)
.+|.-+|+.+++ +++++++|+|-. ++|.||...+++......-..-...+|..+.+|+.++++.+.+|+......
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458889999976 699999999943 789999987765321000011224789999999999999999999865556
Q ss_pred eeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 475 IIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 475 iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
+...|++|+|+-+++++++|++|.+.+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 89999999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.97 E-value=9.6e-05 Score=88.36 Aligned_cols=79 Identities=16% Similarity=0.379 Sum_probs=58.8
Q ss_pred ccccccCCceeEEeeeecCC---ceeEEEEecccC-cccHHHHHHHHHHHHhcc-CCCe--eeEEEEEEeC---ceEEEE
Q 005871 357 ENKLGQGGFGPVYKGTLADG---KAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQ-HKNL--VRLLGCCLEG---QELLLI 426 (672)
Q Consensus 357 ~~~LG~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-h~ni--v~l~~~~~~~---~~~~lV 426 (672)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|+++|+.+. |.++ ++++.++.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56789999999999887553 467888764432 123457889999999995 6664 7888887664 467899
Q ss_pred EeecCCCCh
Q 005871 427 YEYMPNKSL 435 (672)
Q Consensus 427 ~Ey~~~gsL 435 (672)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998653
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.93 E-value=6.7e-05 Score=75.86 Aligned_cols=74 Identities=15% Similarity=0.245 Sum_probs=47.7
Q ss_pred ccccccCCce-eEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCC---CeeeEEEEEEeC---ceEEEEEee
Q 005871 357 ENKLGQGGFG-PVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHK---NLVRLLGCCLEG---QELLLIYEY 429 (672)
Q Consensus 357 ~~~LG~G~fg-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~---niv~l~~~~~~~---~~~~lV~Ey 429 (672)
++.|+.|+.. .||+. +..+++|..... .....+.+|.++|..+... .+.++++..... ...+++|++
T Consensus 2 ~~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 2 IEPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred ceeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 3567877776 49976 235777865442 2245788999999988632 344455443332 234889999
Q ss_pred cCCCChh
Q 005871 430 MPNKSLD 436 (672)
Q Consensus 430 ~~~gsL~ 436 (672)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.92 E-value=5.6e-05 Score=77.48 Aligned_cols=139 Identities=17% Similarity=0.129 Sum_probs=80.6
Q ss_pred ccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCe-eeEEEEEEeCceEEEEEeecCCCChhH
Q 005871 359 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIYEYMPNKSLDV 437 (672)
Q Consensus 359 ~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~ni-v~l~~~~~~~~~~~lV~Ey~~~gsL~~ 437 (672)
.+..|-.+.+|+... +++.+++|..........-...+|..+++.+....+ .+++.... -++||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 456788889998873 567888887654332211235789999999965444 34444432 368999999876542
Q ss_pred H-----------------hhhcc-ccCCCCHH-HHHHHHHHH---------HHHHHHHHhc-----CCCCeeecCCCCCc
Q 005871 438 H-----------------LFDAT-RSVQLDWK-RRQSIINGI---------ARGILYLHED-----SRLKIIHRDLKASN 484 (672)
Q Consensus 438 ~-----------------l~~~~-~~~~l~~~-~~~~i~~qi---------~~~L~~LH~~-----g~~~iiHrDlkp~N 484 (672)
. ++... ....++.. .+..+..++ ...+..+-.. .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11100 01112211 111111111 1112222111 12358999999999
Q ss_pred EEEcCCCCeEEEeecCcee
Q 005871 485 ILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 485 Ill~~~~~~kL~DFgla~~ 503 (672)
|++++++ +.|+||+.+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999988753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.0001 Score=74.29 Aligned_cols=141 Identities=20% Similarity=0.285 Sum_probs=83.5
Q ss_pred ccccccCCceeEEeeeecC--CceeEEEEecccCcccHHHHHHHHHHHHhccCCCe-eeEEEEEEeCceEEEEEeecCCC
Q 005871 357 ENKLGQGGFGPVYKGTLAD--GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIYEYMPNK 433 (672)
Q Consensus 357 ~~~LG~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~ni-v~l~~~~~~~~~~~lV~Ey~~~g 433 (672)
++.|..|-...+|++...+ ++.|++|+....... .....+|+.+++.+...++ +++++... -.++|||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 4567888889999998764 678899976543222 2233579999999964444 44544332 24899999997
Q ss_pred ChhHH-------h----------hhccccC--------CCC-HHHHHHHHHH----------------------HHHHHH
Q 005871 434 SLDVH-------L----------FDATRSV--------QLD-WKRRQSIING----------------------IARGIL 465 (672)
Q Consensus 434 sL~~~-------l----------~~~~~~~--------~l~-~~~~~~i~~q----------------------i~~~L~ 465 (672)
++... + +...... ... ++.+..+... +...+.
T Consensus 78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 157 (235)
T cd05157 78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS 157 (235)
T ss_pred cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence 76321 0 0000000 111 2222222111 111111
Q ss_pred H----HHhc-CCCCeeecCCCCCcEEEcC-CCCeEEEeecCce
Q 005871 466 Y----LHED-SRLKIIHRDLKASNILLDD-DMNPKISDFGLAR 502 (672)
Q Consensus 466 ~----LH~~-g~~~iiHrDlkp~NIll~~-~~~~kL~DFgla~ 502 (672)
. +... .+..++|+|+.+.|||+++ ++.+.|+||..+.
T Consensus 158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 1 1111 2346999999999999998 5789999998775
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00018 Score=75.41 Aligned_cols=80 Identities=11% Similarity=0.062 Sum_probs=59.0
Q ss_pred CCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccC---CCeeeEEEEEEe---CceEEEE
Q 005871 353 HFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH---KNLVRLLGCCLE---GQELLLI 426 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h---~niv~l~~~~~~---~~~~~lV 426 (672)
.....+.||.|..+.||+....++ .+++|..+... ....+..|.+.|+.|.- -.++++++.+.. .+..+||
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 344567899999999999876555 46667643311 23578899999999953 367888888754 3568999
Q ss_pred EeecCCCCh
Q 005871 427 YEYMPNKSL 435 (672)
Q Consensus 427 ~Ey~~~gsL 435 (672)
||++++.++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998765
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00021 Score=69.49 Aligned_cols=125 Identities=25% Similarity=0.383 Sum_probs=90.9
Q ss_pred cCCccccccccCCc-eeEEeeeecCCceeEEEEecc---cCc------------------ccHHHHHHHHHHHHhcc---
Q 005871 352 NHFSDENKLGQGGF-GPVYKGTLADGKAIAVKRLSR---TSG------------------QGLQEFKNEVNLIAKLQ--- 406 (672)
Q Consensus 352 ~~~~~~~~LG~G~f-g~Vy~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~il~~l~--- 406 (672)
.+++.++.||.|.- |.||+++.. |+.||||.+.. ... .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888999999999 999999984 77999999321 110 11236788999888885
Q ss_pred CCCe--eeEEEEEEeC------------------ceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHH
Q 005871 407 HKNL--VRLLGCCLEG------------------QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 466 (672)
Q Consensus 407 h~ni--v~l~~~~~~~------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~ 466 (672)
+.++ ++++|+..-. ....||.||.+... .+.... +.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~~----~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIRD----IPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchhH----HHHHHHHHHH
Confidence 4456 9999998422 12467888876543 122233 4556677788
Q ss_pred HHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCc
Q 005871 467 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 501 (672)
Q Consensus 467 LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla 501 (672)
+|..| |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99988 999999999986 4589999864
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00058 Score=73.98 Aligned_cols=76 Identities=14% Similarity=0.240 Sum_probs=55.2
Q ss_pred ccccccCCceeEEeeeecCC-ceeEEEEeccc------C-cccHHHHHHHHHHHHhcc---CCCeeeEEEEEEeCceEEE
Q 005871 357 ENKLGQGGFGPVYKGTLADG-KAIAVKRLSRT------S-GQGLQEFKNEVNLIAKLQ---HKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 357 ~~~LG~G~fg~Vy~~~~~~~-~~vavK~~~~~------~-~~~~~~~~~E~~il~~l~---h~niv~l~~~~~~~~~~~l 425 (672)
.+.||.|.+..||++...+| +.++||.-... . +...+.+..|.+.|+.+. ..++++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 35799999999999998776 58999974321 1 224567788888888873 2456777766 3456789
Q ss_pred EEeecCCCC
Q 005871 426 IYEYMPNKS 434 (672)
Q Consensus 426 V~Ey~~~gs 434 (672)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00054 Score=71.71 Aligned_cols=143 Identities=20% Similarity=0.209 Sum_probs=86.5
Q ss_pred cccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCC--eeeEEEE------EEeCceEEEEE
Q 005871 356 DENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN--LVRLLGC------CLEGQELLLIY 427 (672)
Q Consensus 356 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~l~~~------~~~~~~~~lV~ 427 (672)
..+.|..|....+|+.... +..+++|+... .....+..|+.++..+.+.+ +.+++.. ....+..++|+
T Consensus 18 ~i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 18 SFEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred heecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 3567888888899998764 44789998764 22356777888888885433 4444331 22345678999
Q ss_pred eecCCCChhH----H----------hhhcccc--------CCCCHHHHH----------HHHHHHHHHHHHHHh----cC
Q 005871 428 EYMPNKSLDV----H----------LFDATRS--------VQLDWKRRQ----------SIINGIARGILYLHE----DS 471 (672)
Q Consensus 428 Ey~~~gsL~~----~----------l~~~~~~--------~~l~~~~~~----------~i~~qi~~~L~~LH~----~g 471 (672)
+|++|..+.. . ++..... ....|.... .....+..++.++.. ..
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9999877532 0 0110000 001111110 011112334444443 11
Q ss_pred CCCeeecCCCCCcEEEcCCCCeEEEeecCce
Q 005871 472 RLKIIHRDLKASNILLDDDMNPKISDFGLAR 502 (672)
Q Consensus 472 ~~~iiHrDlkp~NIll~~~~~~kL~DFgla~ 502 (672)
+..++|+|+.|.||++++++.+.|+||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 2359999999999999998777899998775
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.0012 Score=69.97 Aligned_cols=142 Identities=18% Similarity=0.215 Sum_probs=78.6
Q ss_pred ccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCC--eeeEEE------EEEeCceEEEEEe
Q 005871 357 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN--LVRLLG------CCLEGQELLLIYE 428 (672)
Q Consensus 357 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~l~~------~~~~~~~~~lV~E 428 (672)
.+.|+.|....+|+....+| .+++|+..... .+....|..++..|...+ +.+.+. +....+..++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 45677788889999886555 68999876222 234445666666664222 333332 1223456789999
Q ss_pred ecCCCChhH-----------Hh---hhcccc--------CCC-CHHHHHH------------HHHH-HHHHHHHHHhc--
Q 005871 429 YMPNKSLDV-----------HL---FDATRS--------VQL-DWKRRQS------------IING-IARGILYLHED-- 470 (672)
Q Consensus 429 y~~~gsL~~-----------~l---~~~~~~--------~~l-~~~~~~~------------i~~q-i~~~L~~LH~~-- 470 (672)
|++|..+.. .+ +..... ..+ .|..... .+.+ +...+..+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 999875421 11 110000 011 1111111 1111 11122233211
Q ss_pred --CCCCeeecCCCCCcEEEcCCCCeEEEeecCce
Q 005871 471 --SRLKIIHRDLKASNILLDDDMNPKISDFGLAR 502 (672)
Q Consensus 471 --g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~ 502 (672)
-+.++||+|+.|.||+++.+...-|+||+.+.
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 13359999999999999976556899999875
|
|
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=97.55 E-value=6.1e-05 Score=55.13 Aligned_cols=45 Identities=33% Similarity=0.646 Sum_probs=37.7
Q ss_pred CCCCCCCCCCCcccccccccCCCCCCCCC--CCCccCccccccccCC
Q 005871 628 DSMTIPQPTEPAFSVGRVVANSGHFLSPA--KACTVNNVTVSDVSPR 672 (672)
Q Consensus 628 ~~~~l~~p~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~r 672 (672)
+...||.|.+|+|+..+...+...+.+.. ...|+|++|+|.|+||
T Consensus 2 e~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 2 ETATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred CcccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 45789999999999999877665555444 6889999999999998
|
; GO: 0004674 protein serine/threonine kinase activity |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00034 Score=82.31 Aligned_cols=200 Identities=19% Similarity=0.165 Sum_probs=135.1
Q ss_pred HHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE----EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHH
Q 005871 393 QEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI----YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 468 (672)
Q Consensus 393 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV----~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH 468 (672)
.....|.+.+.++.|+|++.++.+-.+.....++ -|++..-++...+.. -..++....+.+..++.+||.++|
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~---v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS---VGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh---ccccCHHHHHHHHHHHhhhHHHHH
Confidence 3445678888899999999999998765443333 367777777766643 345788899999999999999999
Q ss_pred hcCCCCeeecCCCCC---cEEEcCCCCeEEE--eecCceeeCCCCCCcccccccccCCcCChhhhcCCCCC--hhhHHHH
Q 005871 469 EDSRLKIIHRDLKAS---NILLDDDMNPKIS--DFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS--IKSDVFS 541 (672)
Q Consensus 469 ~~g~~~iiHrDlkp~---NIll~~~~~~kL~--DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s--~ksDvwS 541 (672)
+.. ..|.-+..+ +--++.++.+.+. ||+.++.+....... ...-...+.+||........ ...|+|.
T Consensus 304 ~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~ 377 (1351)
T KOG1035|consen 304 SLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWC 377 (1351)
T ss_pred Hhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHH
Confidence 974 555544444 4445566667766 888887654332211 12235567888887766654 4479999
Q ss_pred HHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 005871 542 FGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 621 (672)
Q Consensus 542 lGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev 621 (672)
+|.....+..|..+..... .....+...... ...+...+|+..++++|++..++
T Consensus 378 lgll~~~~~~~~~i~~~~~----------------------~~~~~l~~~~~~----~~~d~~~~~~~~~~~~Rl~~~~l 431 (1351)
T KOG1035|consen 378 LGLLLLQLSQGEDISEKSA----------------------VPVSLLDVLSTS----ELLDALPKCLDEDSEERLSALEL 431 (1351)
T ss_pred HHHHHhhhhhcCccccccc----------------------chhhhhccccch----hhhhhhhhhcchhhhhccchhhh
Confidence 9999999999886632110 011111111111 24455568999999999999999
Q ss_pred HHHhcc
Q 005871 622 VVMLAS 627 (672)
Q Consensus 622 l~~L~~ 627 (672)
+.+...
T Consensus 432 l~~~f~ 437 (1351)
T KOG1035|consen 432 LTHPFL 437 (1351)
T ss_pred hhchhc
Confidence 987643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0006 Score=71.60 Aligned_cols=140 Identities=25% Similarity=0.369 Sum_probs=85.0
Q ss_pred cccccCCceeEEeeeecC-------CceeEEEEecccCcccHHHHHHHHHHHHhccCCCe-eeEEEEEEeCceEEEEEee
Q 005871 358 NKLGQGGFGPVYKGTLAD-------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~ni-v~l~~~~~~~~~~~lV~Ey 429 (672)
+.|..|--..||+....+ ++.+++|+..... .......+|.+++..+...++ .++++.+.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456667777999988654 5789999866543 223456789999999864443 355555532 368999
Q ss_pred cCCCChhHHh-----------------hhccccC------CC--CHHHHHH--------------------------HHH
Q 005871 430 MPNKSLDVHL-----------------FDATRSV------QL--DWKRRQS--------------------------IIN 458 (672)
Q Consensus 430 ~~~gsL~~~l-----------------~~~~~~~------~l--~~~~~~~--------------------------i~~ 458 (672)
++|..+.... +...... .. -+..+.. +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 9987764310 1100000 00 0111111 112
Q ss_pred HHHHHHHHHHh------cCCCCeeecCCCCCcEEEcCC----CCeEEEeecCce
Q 005871 459 GIARGILYLHE------DSRLKIIHRDLKASNILLDDD----MNPKISDFGLAR 502 (672)
Q Consensus 459 qi~~~L~~LH~------~g~~~iiHrDlkp~NIll~~~----~~~kL~DFgla~ 502 (672)
.+...+.+|-. ..+..++|+|+.|.|||++++ +.++|+||+.+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22233334432 134579999999999999985 889999998875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.48 E-value=9.1e-05 Score=75.93 Aligned_cols=147 Identities=16% Similarity=0.172 Sum_probs=102.0
Q ss_pred ccchHHHHHHhcCCccccccccCCceeEEeeeecCCceeEEEEecccC-----------------cccH-----HHHHHH
Q 005871 341 LFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS-----------------GQGL-----QEFKNE 398 (672)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~-----------------~~~~-----~~~~~E 398 (672)
.+.++++..-..=+.+.+.||-|.-+.||.+.+.+|++.++|.-+... ...| -...+|
T Consensus 81 yLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kE 160 (465)
T KOG2268|consen 81 YLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKE 160 (465)
T ss_pred HHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHH
Confidence 344444444444578899999999999999999999999999532210 0011 124578
Q ss_pred HHHHHhccC--CCeeeEEEEEEeCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 005871 399 VNLIAKLQH--KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 476 (672)
Q Consensus 399 ~~il~~l~h--~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~ii 476 (672)
...|+.|.. --+++.+++ ...++|||++.+..|...-. ..+.. .+...++.-+.-|-.+| +|
T Consensus 161 fafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~---~ly~~lm~~Iv~la~~G---lI 224 (465)
T KOG2268|consen 161 FAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPP---TLYDDLMGLIVRLANHG---LI 224 (465)
T ss_pred HHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeee------cCChH---HHHHHHHHHHHHHHHcC---ce
Confidence 888888853 234455544 45689999999988764321 12233 34445555566677777 99
Q ss_pred ecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 477 HRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 477 HrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
|+|.+--||+|++++.++++||-....
T Consensus 225 HgDFNEFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 225 HGDFNEFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred ecccchheeEEecCCCEEEeechHhhc
Confidence 999999999999999999999976543
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0041 Score=65.55 Aligned_cols=143 Identities=17% Similarity=0.194 Sum_probs=83.1
Q ss_pred ccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCC--eeeEEEE------EEeCceEEEEEe
Q 005871 357 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN--LVRLLGC------CLEGQELLLIYE 428 (672)
Q Consensus 357 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~l~~~------~~~~~~~~lV~E 428 (672)
.+.++.|....+|+....++ .+++|+...... ......|.+++..|.... +++++.. ....+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 56677887789999876544 688897654321 234556778887775322 3444332 122456789999
Q ss_pred ecCCCChhH-----------H---hhhccccC---------CCCHHHHH------------HHHHHHHHHHHHHHh----
Q 005871 429 YMPNKSLDV-----------H---LFDATRSV---------QLDWKRRQ------------SIINGIARGILYLHE---- 469 (672)
Q Consensus 429 y~~~gsL~~-----------~---l~~~~~~~---------~l~~~~~~------------~i~~qi~~~L~~LH~---- 469 (672)
|++|..+.. . ++...... .-.|.... .....+...++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 999865421 0 11100000 01111100 011123334555532
Q ss_pred cCCCCeeecCCCCCcEEEcCCCCeEEEeecCce
Q 005871 470 DSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 502 (672)
Q Consensus 470 ~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~ 502 (672)
.-+..++|+|+++.||+++.++...|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 123469999999999999988777899998775
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0033 Score=67.37 Aligned_cols=141 Identities=19% Similarity=0.279 Sum_probs=84.5
Q ss_pred cccccCCceeEEeeeecC-----CceeEEEEecccCcccHHHHHHHHHHHHhccCCCee-eEEEEEEeCceEEEEEeecC
Q 005871 358 NKLGQGGFGPVYKGTLAD-----GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV-RLLGCCLEGQELLLIYEYMP 431 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv-~l~~~~~~~~~~~lV~Ey~~ 431 (672)
..|-.|-...+|++...+ ++.|++|+.......... -.+|..+++.+...++. ++++.+... .|.||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 456567788899987532 367888987665433333 37899999999755544 556665332 5899998
Q ss_pred CCChhHH-----------------hhhcc-c--cCCCCHHHHHHHHHHH-----------------HHHHHHH----Hh-
Q 005871 432 NKSLDVH-----------------LFDAT-R--SVQLDWKRRQSIINGI-----------------ARGILYL----HE- 469 (672)
Q Consensus 432 ~gsL~~~-----------------l~~~~-~--~~~l~~~~~~~i~~qi-----------------~~~L~~L----H~- 469 (672)
+.++... ++... . .....++++..+..++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8776421 01100 0 0011233333333222 1112222 22
Q ss_pred cCCCCeeecCCCCCcEEEcC-CCCeEEEeecCcee
Q 005871 470 DSRLKIIHRDLKASNILLDD-DMNPKISDFGLARI 503 (672)
Q Consensus 470 ~g~~~iiHrDlkp~NIll~~-~~~~kL~DFgla~~ 503 (672)
..+..++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22346999999999999986 46899999988753
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0056 Score=63.46 Aligned_cols=70 Identities=14% Similarity=0.043 Sum_probs=41.2
Q ss_pred cccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccC--CC-eeeEEEEEEeCceEEEEEeecCCCCh
Q 005871 360 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH--KN-LVRLLGCCLEGQELLLIYEYMPNKSL 435 (672)
Q Consensus 360 LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h--~n-iv~l~~~~~~~~~~~lV~Ey~~~gsL 435 (672)
.++|-...|+.....+|..+++|.-... .....+.+|.++|+.+.. +- +.+++.. . .-+++|+++.|..+
T Consensus 19 ~~~g~~~~v~~i~~~~g~~~VlR~p~~~--~~~~~l~rE~~vL~~L~~~l~vpvP~~~~~--~--~~~~~y~~i~G~p~ 91 (276)
T cd05152 19 NESGLDFQVVFAKDTDGVPWVLRIPRRP--DVSERAAAEKRVLALVRKHLPVQVPDWRVH--T--PELIAYPKLPGVPA 91 (276)
T ss_pred cCCcceeEEEEEEcCCCCeEEEEecCCH--HHHHHHHHHHHHHHHHHhcCCCCCCceeee--c--CceEEEeccCCCcc
Confidence 4455555667665556889999876432 234567899999999953 21 1222211 1 22456777666543
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0042 Score=64.58 Aligned_cols=76 Identities=17% Similarity=0.274 Sum_probs=49.2
Q ss_pred CccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhcc---CCCeeeEEEEEEeCceEEEEEeec
Q 005871 354 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ---HKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 354 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
....+.|+.|....+|+.. .+++.+.||.-.. .....|..|.+-|+.|. --.+++.+++....+..+|||||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 4455679999999999988 5688899997762 23356788888888884 345778888887777779999999
Q ss_pred CCC
Q 005871 431 PNK 433 (672)
Q Consensus 431 ~~g 433 (672)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0072 Score=63.37 Aligned_cols=142 Identities=18% Similarity=0.274 Sum_probs=86.1
Q ss_pred CCccccccccCCceeEEeeeecCCceeEEEEec-ccCcccHHHHHHHHHHHHhccC--CCeeeEEEEEEeCc--eEEEEE
Q 005871 353 HFSDENKLGQGGFGPVYKGTLADGKAIAVKRLS-RTSGQGLQEFKNEVNLIAKLQH--KNLVRLLGCCLEGQ--ELLLIY 427 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~-~~~~~~~~~~~~E~~il~~l~h--~niv~l~~~~~~~~--~~~lV~ 427 (672)
...+.+.+..|..-.+|..... ++++++.+-. ...........+|+.+++.+.- --+...++.|.++. ..+.||
T Consensus 26 ~~~~v~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 26 GLLIVEEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred CCceeeeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 3444555544544555555543 7788888221 1223445667788888888853 33445667776665 679999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHH-HHHHHHHHHHH--------------------------------------
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSII-NGIARGILYLH-------------------------------------- 468 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~-~qi~~~L~~LH-------------------------------------- 468 (672)
+|++|..+...+... ... ..++ ..+++.|.-||
T Consensus 105 ~~veGe~~~~~~~~~----~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~ 176 (321)
T COG3173 105 EWVEGEVVWSALPPE----SLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGR 176 (321)
T ss_pred EEecceeccCcCCcc----cch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCC
Confidence 999985332221100 000 0111 13333333333
Q ss_pred ------------hc-----CCCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 469 ------------ED-----SRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 469 ------------~~-----g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
.+ ++..++|+|+.+.||+++.++-+-+.||+++..
T Consensus 177 ~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 177 IPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred CchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 22 235799999999999999988899999999864
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.01 Score=62.25 Aligned_cols=143 Identities=17% Similarity=0.197 Sum_probs=98.1
Q ss_pred ccccccccCCceeEEeeeecCCceeEEEEecccC------------------------c-cc-HHHHHHHHHHHHhccCC
Q 005871 355 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS------------------------G-QG-LQEFKNEVNLIAKLQHK 408 (672)
Q Consensus 355 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~------------------------~-~~-~~~~~~E~~il~~l~h~ 408 (672)
.+...|.-|.-+.||.+...+|..+|||+++-.. + .- ..-...|+.-|.+|+..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 4456788899999999999999999999763210 0 00 01235678888888755
Q ss_pred CeeeEEEEEEeCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc
Q 005871 409 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD 488 (672)
Q Consensus 409 niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~ 488 (672)
.|.----+.. ....|||+|+.....- .-.-+...++...+..+-++++..+.-|-... ++||.||+--|+|+-
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~---aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWA---APKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH 299 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCc---CcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE
Confidence 4331111111 2347999999643221 11123455777788888889999888888876 699999999999885
Q ss_pred CCCCeEEEeecCceeeC
Q 005871 489 DDMNPKISDFGLARIFG 505 (672)
Q Consensus 489 ~~~~~kL~DFgla~~~~ 505 (672)
+|.+.|+|-+.+....
T Consensus 300 -dG~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 300 -DGKLYIIDVSQSVEHD 315 (520)
T ss_pred -CCEEEEEEccccccCC
Confidence 5689999988776543
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.0044 Score=61.42 Aligned_cols=123 Identities=20% Similarity=0.277 Sum_probs=62.3
Q ss_pred CceeEEEEecccCcccHHHHHHHHHHHHhccCCCe-eeEEEEEEeCceEEEEEeecCCCChhHH-------h--------
Q 005871 376 GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIYEYMPNKSLDVH-------L-------- 439 (672)
Q Consensus 376 ~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~ni-v~l~~~~~~~~~~~lV~Ey~~~gsL~~~-------l-------- 439 (672)
++.|++++..... +..-.-..|..+++.+...++ .++++.+.+ ..|+||+++..|... +
T Consensus 2 ~~~~~~Ri~g~~t-~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEGT-ENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESCG-CSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCc-ccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence 4677888776653 344566889999999976555 456665433 257799977665321 0
Q ss_pred --hhcc----ccCCCCHHHHHHH----------------------HHHHHHHHHHHH----hc-CCCCeeecCCCCCcEE
Q 005871 440 --FDAT----RSVQLDWKRRQSI----------------------INGIARGILYLH----ED-SRLKIIHRDLKASNIL 486 (672)
Q Consensus 440 --~~~~----~~~~l~~~~~~~i----------------------~~qi~~~L~~LH----~~-g~~~iiHrDlkp~NIl 486 (672)
+... .....-+..+..+ +..+..-+..+. .. .+..++|+|+.|.|||
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 0000 0000112222222 111122222222 11 1245899999999999
Q ss_pred E-cCCCCeEEEeecCcee
Q 005871 487 L-DDDMNPKISDFGLARI 503 (672)
Q Consensus 487 l-~~~~~~kL~DFgla~~ 503 (672)
+ +.++.++|+||..+..
T Consensus 157 ~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp ETSSSSCEEE--GTT-EE
T ss_pred eccCCCeEEEecHHHHhh
Confidence 9 8899999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.0096 Score=58.27 Aligned_cols=139 Identities=15% Similarity=0.163 Sum_probs=87.2
Q ss_pred eeEEEEecccCcc-cHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHH
Q 005871 378 AIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSI 456 (672)
Q Consensus 378 ~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i 456 (672)
+..+|++....-. ....|.++..++.+++ .|+++..- +.-.+.++.|+|-..... . .-.|
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i~------------~---~N~i 147 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKIN------------F---SNFI 147 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcccc------------h---hHHH
Confidence 4566766554433 3456788999998886 46776632 344678899998442211 1 1112
Q ss_pred HHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChh
Q 005871 457 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 536 (672)
Q Consensus 457 ~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k 536 (672)
..+ ++.|.-.|+.. ...+|+|-.|+|||-|..|.+||.|-+..-.- +..|.--| -...+.+
T Consensus 148 ~ag-i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~~--------------~V~~vN~~---Y~~lT~~ 208 (308)
T PF07387_consen 148 TAG-IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLEN--------------QVNMVNIE---YESLTQE 208 (308)
T ss_pred HHh-HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhhh--------------eeeEEeee---ccccChH
Confidence 222 45677788442 36999999999999999999999997654210 11122111 1234677
Q ss_pred hHHHHHHHHHHHHHcCCC
Q 005871 537 SDVFSFGVLLLEIISGRK 554 (672)
Q Consensus 537 sDvwSlGvil~elltG~~ 554 (672)
+.+-+|=.-++++....+
T Consensus 209 aE~~~fv~s~l~~v~~~~ 226 (308)
T PF07387_consen 209 AEVKVFVKSCLKLVEKQR 226 (308)
T ss_pred HHHHHHHHHHHHHHHHHh
Confidence 888787777777776543
|
The function of this family is unknown. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.013 Score=62.52 Aligned_cols=141 Identities=15% Similarity=0.246 Sum_probs=81.8
Q ss_pred cccccCCceeEEeeeecC----CceeEEEEecccCcccHHHHHHHHHHHHhccCCCee-eEEEEEEeCceEEEEEeecCC
Q 005871 358 NKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV-RLLGCCLEGQELLLIYEYMPN 432 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv-~l~~~~~~~~~~~lV~Ey~~~ 432 (672)
+.|..|--..+|+....+ +..|++|+....... .-.-.+|..+++.+..-++- ++++++. .+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 445557777889886543 247888877654432 23346899999999765553 5666553 22 58999987
Q ss_pred CChhHH-------h----------hhcc-c--cCCCCHHHHHHHHHHH----------------------HHHHHHHH--
Q 005871 433 KSLDVH-------L----------FDAT-R--SVQLDWKRRQSIINGI----------------------ARGILYLH-- 468 (672)
Q Consensus 433 gsL~~~-------l----------~~~~-~--~~~l~~~~~~~i~~qi----------------------~~~L~~LH-- 468 (672)
..+... + +... . ...--+..+.++..++ ..-+..+.
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 765321 1 1100 0 0011233333332221 11122111
Q ss_pred --h-cCCCCeeecCCCCCcEEEcC-CCCeEEEeecCcee
Q 005871 469 --E-DSRLKIIHRDLKASNILLDD-DMNPKISDFGLARI 503 (672)
Q Consensus 469 --~-~g~~~iiHrDlkp~NIll~~-~~~~kL~DFgla~~ 503 (672)
. ..+..++|+|+.+.|||+++ ++.++++||+.+..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 12345899999999999974 57899999998753
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.036 Score=60.06 Aligned_cols=74 Identities=11% Similarity=0.092 Sum_probs=51.8
Q ss_pred cccccccCCceeEEeeeecCCceeEEEEeccc----Cc---ccHHHHHHHHHHHHhcc---CCCeeeEEEEEEeCceEEE
Q 005871 356 DENKLGQGGFGPVYKGTLADGKAIAVKRLSRT----SG---QGLQEFKNEVNLIAKLQ---HKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 356 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~----~~---~~~~~~~~E~~il~~l~---h~niv~l~~~~~~~~~~~l 425 (672)
..+.||.|....||+.... ++.++||.-... .. ....+...|...|+.+. ..++++++.++. +..++
T Consensus 36 ~~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred eEEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 3567899999999998874 557899975411 11 23445566677777664 247888888876 44678
Q ss_pred EEeecCC
Q 005871 426 IYEYMPN 432 (672)
Q Consensus 426 V~Ey~~~ 432 (672)
+|||+++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 8999977
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.00085 Score=80.68 Aligned_cols=161 Identities=12% Similarity=-0.037 Sum_probs=114.1
Q ss_pred HHHHHHHHHHhccCCCeeeEEEEEEe--CceEEEEEeecCCCChhHHhhhcccc-CCCCHHHHHHHHHHHHHHHHHHHhc
Q 005871 394 EFKNEVNLIAKLQHKNLVRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRS-VQLDWKRRQSIINGIARGILYLHED 470 (672)
Q Consensus 394 ~~~~E~~il~~l~h~niv~l~~~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~ 470 (672)
....|...+++..|+++.....-... ..+.+.+++|+.+|.+...+....++ ..++..-....-.+.+....-+|+.
T Consensus 1275 mll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence 34456666667789988776555443 34678899999999998888654333 3333333322222224455554443
Q ss_pred --CCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHH
Q 005871 471 --SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLE 548 (672)
Q Consensus 471 --g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~e 548 (672)
+...-+|+++|+-|.+|..+.++|+.++|+.+.... .....+..++++.|+.|++...-.++.++|+|..|+-+|+
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence 234578999999999999999999999999984321 1222334567888999999888899999999999999999
Q ss_pred HHcCCCCC
Q 005871 549 IISGRKNN 556 (672)
Q Consensus 549 lltG~~p~ 556 (672)
.--|..+|
T Consensus 1433 rs~~n~~f 1440 (2724)
T KOG1826|consen 1433 RSDGNAYF 1440 (2724)
T ss_pred HhcccHHH
Confidence 99888764
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.042 Score=58.54 Aligned_cols=72 Identities=15% Similarity=0.213 Sum_probs=48.2
Q ss_pred ccccCCceeEEeeeecCC-ceeEEEEecc-------cCcccHHHHHHHHHHHHhcc--CC-CeeeEEEEEEeCceEEEEE
Q 005871 359 KLGQGGFGPVYKGTLADG-KAIAVKRLSR-------TSGQGLQEFKNEVNLIAKLQ--HK-NLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 359 ~LG~G~fg~Vy~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~E~~il~~l~--h~-niv~l~~~~~~~~~~~lV~ 427 (672)
.||-|-..-||++...+| +.++||.-.. .-+-..++..-|.+.|+... -| .+++++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999998654 6899996321 11334456667888887763 34 34445443 445567999
Q ss_pred eecCC
Q 005871 428 EYMPN 432 (672)
Q Consensus 428 Ey~~~ 432 (672)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.057 Score=56.77 Aligned_cols=64 Identities=14% Similarity=0.255 Sum_probs=40.1
Q ss_pred eEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCC--eeeEEEE------EEeCceEEEEEeecCCCCh
Q 005871 367 PVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN--LVRLLGC------CLEGQELLLIYEYMPNKSL 435 (672)
Q Consensus 367 ~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~l~~~------~~~~~~~~lV~Ey~~~gsL 435 (672)
.||++...+| .+++|++... ...+..|...+..|.... +++++.. ...++..++++||++|..+
T Consensus 11 ~v~~v~t~~g-~~~LK~~~~~----~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~ 82 (313)
T TIGR02906 11 NVYKVETDSG-NKCLKKINYP----PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGREC 82 (313)
T ss_pred cEEEEEeCCC-CeEEEEcCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCC
Confidence 4888876545 6899987532 234555777777774333 3333322 2235678999999998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.072 Score=56.14 Aligned_cols=31 Identities=26% Similarity=0.372 Sum_probs=28.0
Q ss_pred CCCeeecCCCCCcEEEcCCCCeEEEeecCce
Q 005871 472 RLKIIHRDLKASNILLDDDMNPKISDFGLAR 502 (672)
Q Consensus 472 ~~~iiHrDlkp~NIll~~~~~~kL~DFgla~ 502 (672)
+.+++|+|+.++|||+++++.+.++||..+.
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 3469999999999999999999999998775
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.036 Score=59.80 Aligned_cols=74 Identities=9% Similarity=0.113 Sum_probs=50.8
Q ss_pred ccccccCCceeEEeeeecC-CceeEEEEecc------cCcccHHHHHHHHHHHHhcc--CC-CeeeEEEEEEeCceEEEE
Q 005871 357 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSR------TSGQGLQEFKNEVNLIAKLQ--HK-NLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 357 ~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~------~~~~~~~~~~~E~~il~~l~--h~-niv~l~~~~~~~~~~~lV 426 (672)
.+.||-|--.-||++.+.+ ++.++||.-.. .-+-..++..-|.+.|+... .| .+++++.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 5679999999999999853 56799985321 11334567778888888774 34 45555544 44566789
Q ss_pred EeecCC
Q 005871 427 YEYMPN 432 (672)
Q Consensus 427 ~Ey~~~ 432 (672)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998854
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.76 E-value=0.12 Score=54.83 Aligned_cols=140 Identities=25% Similarity=0.363 Sum_probs=81.9
Q ss_pred ccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCC------eeeEEE----EEEeCceEEEEEe
Q 005871 359 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN------LVRLLG----CCLEGQELLLIYE 428 (672)
Q Consensus 359 ~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n------iv~l~~----~~~~~~~~~lV~E 428 (672)
.|.+ .-..||+....+|+. ++|+.... .....+..|...|..|.-.+ +..+-| ........+-+++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 566789988877766 88887665 34466777888888884222 222211 1222237788999
Q ss_pred ecCCCChhH-H--------------hhhcccc---------CCCCHHH-------------HHHHHHHHHHHHHHHHhc-
Q 005871 429 YMPNKSLDV-H--------------LFDATRS---------VQLDWKR-------------RQSIINGIARGILYLHED- 470 (672)
Q Consensus 429 y~~~gsL~~-~--------------l~~~~~~---------~~l~~~~-------------~~~i~~qi~~~L~~LH~~- 470 (672)
|++|..+.. . |+...+. ....|.. -.....++...+..+.+.
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999988762 0 1100000 1122320 001222333333333322
Q ss_pred ---CC---CCeeecCCCCCcEEEcCCCC-eEEEeecCce
Q 005871 471 ---SR---LKIIHRDLKASNILLDDDMN-PKISDFGLAR 502 (672)
Q Consensus 471 ---g~---~~iiHrDlkp~NIll~~~~~-~kL~DFgla~ 502 (672)
-+ ..+||+|+.|.||+++.+.. ..++||+-+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 11 22999999999999998885 8899999875
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.64 E-value=0.083 Score=57.35 Aligned_cols=75 Identities=21% Similarity=0.351 Sum_probs=46.8
Q ss_pred ccccccCCceeEEeeeecCC--ce-----eEEEEecccCcccHHHHHHHHHHHHhccCCCee-eEEEEEEeCceEEEEEe
Q 005871 357 ENKLGQGGFGPVYKGTLADG--KA-----IAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV-RLLGCCLEGQELLLIYE 428 (672)
Q Consensus 357 ~~~LG~G~fg~Vy~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv-~l~~~~~~~~~~~lV~E 428 (672)
.+.|..|--..+|++...++ .. |.++.. ....+..-.-.+|+.+++.+...++- ++++.+.. ++|.|
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~-g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e 129 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKS-STYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE 129 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEec-cCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence 34566688899999976432 23 333322 22222222346799999999766554 55665542 69999
Q ss_pred ecCCCChh
Q 005871 429 YMPNKSLD 436 (672)
Q Consensus 429 y~~~gsL~ 436 (672)
|++|..|.
T Consensus 130 fIeGr~l~ 137 (383)
T PTZ00384 130 WVEGNTMG 137 (383)
T ss_pred EeccccCC
Confidence 99998764
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.48 E-value=0.36 Score=51.29 Aligned_cols=72 Identities=13% Similarity=0.066 Sum_probs=45.9
Q ss_pred CCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCC--eee---EEE--EEEeCceEEEEEeecCCCCh
Q 005871 363 GGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN--LVR---LLG--CCLEGQELLLIYEYMPNKSL 435 (672)
Q Consensus 363 G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~---l~~--~~~~~~~~~lV~Ey~~~gsL 435 (672)
+.-..||+....++..+++|+..... .....+..|.+.+..|.... ++. .-| ....++..+.++++++|...
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 45578999988788889999875322 23456677888888774322 122 111 12234567889999987653
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.10 E-value=0.21 Score=61.16 Aligned_cols=142 Identities=22% Similarity=0.280 Sum_probs=78.7
Q ss_pred cccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhcc-------CCCeeeE-----EEEEEe-Cc--e
Q 005871 358 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-------HKNLVRL-----LGCCLE-GQ--E 422 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-------h~niv~l-----~~~~~~-~~--~ 422 (672)
+.|+ |..-.+|+....+|..+++|+.+.... ......|...|..|. -|.+++- +..... ++ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4454 456788998887888999999876432 233444555665552 2233321 111111 22 4
Q ss_pred EEEEEeecCCCChhHH-----------------hhh----cc---ccCCCCHH-----------------HHHHHHHHHH
Q 005871 423 LLLIYEYMPNKSLDVH-----------------LFD----AT---RSVQLDWK-----------------RRQSIINGIA 461 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~-----------------l~~----~~---~~~~l~~~-----------------~~~~i~~qi~ 461 (672)
.+-+++|++|..+... ++. .. ....+.|. ..+.++.+++
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 6778999999877541 000 00 00112221 1122233333
Q ss_pred HHHH-----HHHhcCCCCeeecCCCCCcEEEcCCC--CeE-EEeecCcee
Q 005871 462 RGIL-----YLHEDSRLKIIHRDLKASNILLDDDM--NPK-ISDFGLARI 503 (672)
Q Consensus 462 ~~L~-----~LH~~g~~~iiHrDlkp~NIll~~~~--~~k-L~DFgla~~ 503 (672)
+.+. .+... +..+||+|+++.|||++.++ ++. |+|||.+..
T Consensus 188 ~~~~~~v~p~l~~L-p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRLAAL-PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHhcC-CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 3222 12111 23599999999999999875 555 999998753
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.00 E-value=0.18 Score=49.91 Aligned_cols=76 Identities=17% Similarity=0.281 Sum_probs=55.4
Q ss_pred ccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccC---CCeeeEEEEEEeCceEEEEEeecCCC
Q 005871 357 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH---KNLVRLLGCCLEGQELLLIYEYMPNK 433 (672)
Q Consensus 357 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h---~niv~l~~~~~~~~~~~lV~Ey~~~g 433 (672)
.+++.-|.--+.|...+ +..++.+|.- ..+....|..|+.-|..|.- -.+.+.+.+-.+..+.|+|+||++-+
T Consensus 21 r~~v~gG~inea~~v~d-g~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~ 96 (286)
T COG3001 21 REEVSGGDINEAWRLRD-GTDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG 96 (286)
T ss_pred ccccCCccccceeEeec-CCcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence 34566666666666654 4677888853 33445678888888877743 45788888888999999999999987
Q ss_pred Chh
Q 005871 434 SLD 436 (672)
Q Consensus 434 sL~ 436 (672)
.++
T Consensus 97 ~~d 99 (286)
T COG3001 97 PLD 99 (286)
T ss_pred CCC
Confidence 765
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 672 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-50 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-49 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-40 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-40 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-34 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-34 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-34 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-32 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-25 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-25 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-25 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-25 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-25 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-24 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-24 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-24 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-24 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-24 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-24 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-24 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-23 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-23 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-23 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-22 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-22 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-22 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-21 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-21 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-21 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-21 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-21 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-21 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-21 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-20 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 9e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-19 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-18 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-18 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-16 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-15 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-13 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-13 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-13 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-13 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-13 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-13 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-13 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-12 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-12 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-11 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-11 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-11 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 9e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 9e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-09 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 8e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 7e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 7e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 7e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 8e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 8e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 9e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 9e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 9e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 439 bits (1132), Expect = e-151
Identities = 124/293 (42%), Positives = 174/293 (59%), Gaps = 5/293 (1%)
Query: 342 FPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQ-EFKNEVN 400
F LR A+++FS++N LG+GGFG VYKG LADG +AVKRL QG + +F+ EV
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 401 LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRS-VQLDWKRRQSIING 459
+I+ H+NL+RL G C+ E LL+Y YM N S+ L + S LDW +RQ I G
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 460 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 519
ARG+ YLH+ KIIHRD+KA+NILLD++ + DFGLA++ T + GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-VRGT 198
Query: 520 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKN--NGFYFSEHGQTLLTYTWKLWCE 577
G++APEY G S K+DVF +GV+LLE+I+G++ ++ LL + L E
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258
Query: 578 GPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSM 630
L+D L+ + +E+ + I + LLC Q P +RP MS VV ML D +
Sbjct: 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 438 bits (1129), Expect = e-151
Identities = 110/310 (35%), Positives = 157/310 (50%), Gaps = 19/310 (6%)
Query: 333 QAESQEFPLFPLRLALEATNHFSDE------NKLGQGGFGPVYKGTLADGKAIAVKRLS- 385
+ F F TN+F + NK+G+GGFG VYKG + + +AVK+L+
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 386 ---RTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA 442
T+ + Q+F E+ ++AK QH+NLV LLG +G +L L+Y YMPN SL L
Sbjct: 65 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 443 TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 502
+ L W R I G A GI +LHE+ IHRD+K++NILLD+ KISDFGLAR
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 503 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSE 562
T+ I GT YMAPE + G + KSD++SFGV+LLEII+G
Sbjct: 182 ASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPA--VDEHR 238
Query: 563 HGQTLLTYTWKLWCEGPAVE-LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 621
Q LL ++ E +E ID + + + + C+ + RP + V
Sbjct: 239 EPQLLLDIKEEIEDEEKTIEDYIDKKMNDAD-STSVEAMYSVASQCLHEKKNKRPDIKKV 297
Query: 622 VVMLASDSMT 631
+L + +
Sbjct: 298 QQLLQEMTAS 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 393 bits (1012), Expect = e-133
Identities = 108/286 (37%), Positives = 162/286 (56%), Gaps = 6/286 (2%)
Query: 342 FPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNL 401
PL EATN+F + +G G FG VYKG L DG +A+KR + S QG++EF+ E+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 402 IAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGI 460
++ +H +LV L+G C E E++LIY+YM N +L HL+ + + W++R I G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 461 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF-GGNQNQANTNIIAGT 519
ARG+ YLH + IIHRD+K+ NILLD++ PKI+DFG+++ +Q +T + GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV-VKGT 204
Query: 520 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGP 579
GY+ PEY + G + KSDV+SFGV+L E++ R L + + G
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 580 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
+++DP L P+ L KF + C+ DRP+M V+ L
Sbjct: 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 314 bits (807), Expect = e-102
Identities = 71/311 (22%), Positives = 123/311 (39%), Gaps = 34/311 (10%)
Query: 342 FPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNL 401
+ +G FG V+K L + +AVK Q + + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 402 IAKLQHKNLVRLLGCCLEG----QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 457
+ ++H+N+++ +G G +L LI + SL L ++ + W I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127
Query: 458 NGIARGILYLHED-------SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510
+ARG+ YLHED + I HRD+K+ N+LL +++ I+DFGLA F ++
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 511 ANTNIIAGTYGYMAPEYAMGGI-----FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQ 565
+T+ GT YMAPE G I ++ D+++ G++L E+ S E+
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY-- 245
Query: 566 TLLTYTWKLWCEGP--------AVELIDPVLKQSCAPDELLK-FIHIGLLCVQQDPADRP 616
+L + ++ + PVL+ + C D R
Sbjct: 246 -MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304
Query: 617 TMSSVVVMLAS 627
+ V +
Sbjct: 305 SAGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 3e-85
Identities = 75/324 (23%), Positives = 126/324 (38%), Gaps = 41/324 (12%)
Query: 350 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 409
++ +G+G +G VYKG+L D + +AVK S + Q K + + ++H N
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NIYRVPLMEHDN 68
Query: 410 LVRLLGCCLEG-----QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 464
+ R + E LL+ EY PN SL +L T DW + + + RG+
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGL 124
Query: 465 LYLHED------SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN------QNQAN 512
YLH + + I HRDL + N+L+ +D ISDFGL+ GN +
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 513 TNIIAGTYGYMAPEYAMGGI-------FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQ 565
GT YMAPE G + + D+++ G++ EI R + F +
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM-RCTDLFPGESVPE 243
Query: 566 TLLTYTWKLWCEGPAVELID--------PVLKQSCAPDELLKFIHIGLL--CVQQDPADR 615
+ + ++ ++ P ++ + L + C QD R
Sbjct: 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEAR 303
Query: 616 PTMSSVVVMLASDSMTIPQPTEPA 639
T +A M + +
Sbjct: 304 LTAQXAEERMAELMMIWERNKSVS 327
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 1e-70
Identities = 76/287 (26%), Positives = 133/287 (46%), Gaps = 22/287 (7%)
Query: 357 ENKLGQGGFGPVYKGTLADGKAIAVKRL--SRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 414
+ K+G G FG V++ G +AVK L + + EF EV ++ +L+H N+V +
Sbjct: 42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 415 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 474
G + L ++ EY+ SL L + QLD +RR S+ +A+G+ YLH
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPP 159
Query: 475 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 534
I+HR+LK+ N+L+D K+ DFGL+R+ + + AGT +MAPE +
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA--AGTPEWMAPEVLRDEPSN 217
Query: 535 IKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAP 594
KSDV+SFGV+L E+ + ++ + + + + ++
Sbjct: 218 EKSDVYSFGVILWELATLQQ----PWGNLNPAQVVA-------AVGFKCKRLEIPRNL-N 265
Query: 595 DELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS-DSMTIPQPTEPAF 640
++ I C +P RP+ ++++ +L +P P
Sbjct: 266 PQVAAIIE---GCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 309
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 6e-70
Identities = 77/282 (27%), Positives = 117/282 (41%), Gaps = 32/282 (11%)
Query: 357 ENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 415
LG+G FG K T G+ + +K L R + + F EV ++ L+H N+++ +G
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 416 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 475
+ + L I EY+ +L + Q W +R S IA G+ YLH + I
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLH---SMNI 129
Query: 476 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI------------IAGTYGYM 523
IHRDL + N L+ ++ N ++DFGLAR+ + Q + G +M
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 524 APEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583
APE G + K DVFSFG++L EII + Y L
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV----------RGF 239
Query: 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
+D +C P + C DP RP+ + L
Sbjct: 240 LDRYCPPNC-PPSFFPIT---VRCCDLDPEKRPSFVKLEHWL 277
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 7e-69
Identities = 84/288 (29%), Positives = 123/288 (42%), Gaps = 25/288 (8%)
Query: 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 411
E +G+G FG V K K +A+K++ S + F E+ ++++ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIV 64
Query: 412 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 471
+L G CL + L+ EY SL L A S ++G+ YLH
Sbjct: 65 KLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 472 RLKIIHRDLKASNILLDDDMN-PKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 530
+IHRDLK N+LL KI DFG A Q N G+ +MAPE G
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACD---IQTHMTNNK--GSAAWMAPEVFEG 177
Query: 531 GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590
+S K DVFS+G++L E+I+ RK F E G W P L +
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK----PFDEIGGPAFRIMWA------VHNGTRPPLIK 227
Query: 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEP 638
+ P + + C +DP+ RP+M +V ++ P EP
Sbjct: 228 NL-PKPIESLMT---RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 3e-65
Identities = 82/288 (28%), Positives = 125/288 (43%), Gaps = 50/288 (17%)
Query: 357 ENKLGQGGFGPVYKGTLADGKAIAVKRL----SRTSGQGLQEFKNEVNLIAKLQHKNLVR 412
E +G GGFG VY+ G +AVK Q ++ + E L A L+H N++
Sbjct: 12 EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 472
L G CL+ L L+ E+ L ++ + IARG+ YLH+++
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPL----NRVLSGKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 473 LKIIHRDLKASNILLDDDMNP--------KISDFGLARIFGGNQNQANTNIIAGTYGYMA 524
+ IIHRDLK+SNIL+ + KI+DFGLAR + + AG Y +MA
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA----AGAYAWMA 182
Query: 525 PEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584
PE +FS SDV+S+GVLL E+++G + + +
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGE-------------------VPFRGIDGLAVA 223
Query: 585 DPVLKQ-------SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
V S P+ K + C DP RP+ ++++ L
Sbjct: 224 YGVAMNKLALPIPSTCPEPFAKLME---DCWNPDPHSRPSFTNILDQL 268
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 4e-65
Identities = 75/280 (26%), Positives = 127/280 (45%), Gaps = 36/280 (12%)
Query: 357 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 416
++G G FG VYKG A+ + ++ + Q LQ FKNEV ++ K +H N++ +G
Sbjct: 29 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 417 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 476
Q L ++ ++ SL HL + + K+ I ARG+ YLH II
Sbjct: 89 STAPQ-LAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLH---AKSII 142
Query: 477 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE---YAMGGIF 533
HRDLK++NI L +D KI DFGLA ++G+ +MAPE +
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 534 SIKSDVFSFGVLLLEIISGRK-----NNG---FYFSEHGQTLLTYTWKLWCEGPAVELID 585
S +SDV++FG++L E+++G+ NN G
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL--------------- 247
Query: 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
++ +C P + + + C+++ +RP+ ++ +
Sbjct: 248 SKVRSNC-PKRMKRLM---AECLKKKRDERPSFPRILAEI 283
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 1e-64
Identities = 81/289 (28%), Positives = 136/289 (47%), Gaps = 38/289 (13%)
Query: 352 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG-------LQEFKNEVNLIA 403
N E ++G+GGFG V+KG + D +A+K L +G QEF+ EV +++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 404 KLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARG 463
L H N+V+L G ++ E++P L L D ++ + W + ++ IA G
Sbjct: 79 NLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134
Query: 464 ILYLHEDSRLKIIHRDLKASNILLD-----DDMNPKISDFGLARIFGGNQNQANTNIIAG 518
I Y+ + I+HRDL++ NI L + K++DFGL++ + + + G
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSG-LLG 188
Query: 519 TYGYMAPE--YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWC 576
+ +MAPE A ++ K+D +SF ++L I++G F E+ + + +
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG----PFDEYSYGKIKFINMIRE 244
Query: 577 EGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
EG + P + + C P L I LC DP RP S +V L
Sbjct: 245 EG-----LRPTIPEDC-PPRLRNVIE---LCWSGDPKKRPHFSYIVKEL 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 210 bits (538), Expect = 2e-63
Identities = 65/281 (23%), Positives = 111/281 (39%), Gaps = 32/281 (11%)
Query: 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRL--SRTSGQGLQEFKNEVNLIAKLQHKN 409
+ KL + G ++KG G I VK L S + ++F E + H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 410 LVRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 467
++ +LG C LI +MP SL L + T V +D + +ARG+ +L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDMARGMAFL 127
Query: 468 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 527
H I L + ++++D+DM +IS + F ++APE
Sbjct: 128 H-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR-------MYAPAWVAPEA 179
Query: 528 AMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584
+D++SF VLL E+++ + + + K+ EG +
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREV---PF---ADLSNMEIGMKVALEG-----L 228
Query: 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
P + + K + I C+ +DPA RP +V +L
Sbjct: 229 RPTIPPGI-SPHVSKLMKI---CMNEDPAKRPKFDMIVPIL 265
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 3e-61
Identities = 74/290 (25%), Positives = 120/290 (41%), Gaps = 51/290 (17%)
Query: 357 ENKLGQGGFGPVYKGTLADGKAIAVKRL--SRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 414
+G+G FG VY G G+ +A++ + R + L+ FK EV + +H+N+V +
Sbjct: 38 GELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 415 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 474
G C+ L +I ++L + D + LD + + I I +G+ YLH
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLH---AKG 150
Query: 475 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN---IIAGTYGYMAPE----- 526
I+H+DLK+ N+ D+ I+DFGL I G Q + I G ++APE
Sbjct: 151 ILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 527 ----YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVE 582
FS SDVF+ G + E+ + + PA
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHARE-------------------WPFKTQPAEA 250
Query: 583 LID-------PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
+I P L Q E+ + L C + +RPT + ++ ML
Sbjct: 251 IIWQMGTGMKPNLSQIGMGKEISDIL---LFCWAFEQEERPTFTKLMDML 297
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 3e-57
Identities = 72/308 (23%), Positives = 122/308 (39%), Gaps = 58/308 (18%)
Query: 357 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNE--VNLIAKLQHKNLVRLL 414
+G+G +G V++G+ G+ +AVK S + + + E + L+H+N++ +
Sbjct: 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFI 68
Query: 415 GCCLEGQ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 470
+ + +L LI Y SL +L + LD I+ IA G+ +LH +
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 471 -----SRLKIIHRDLKASNILLDDDMNPKISDFGLARIF--GGNQNQANTNIIAGTYGYM 523
+ I HRDLK+ NIL+ + I+D GLA + NQ N GT YM
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 524 APE------YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF-------YFSEHGQTLLTY 570
APE + D+++FG++L E+ +NG ++
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND---- 240
Query: 571 TWKLWCEGPAVELID---------PVLKQSCAPDELLKFIHIGLL--CVQQDPADRPTMS 619
P+ E + P + D L + L+ C Q+P+ R T
Sbjct: 241 --------PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSL-AKLMKECWYQNPSARLTAL 291
Query: 620 SVVVMLAS 627
+ L
Sbjct: 292 RIKKTLTK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 4e-57
Identities = 74/296 (25%), Positives = 126/296 (42%), Gaps = 34/296 (11%)
Query: 357 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNE--VNLIAKLQHKNLVRLL 414
++G+G +G V+ G G+ +AVK + E + ++H+N++ +
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFI 97
Query: 415 GCCLEGQ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 470
++G +L LI +Y N SL +L +S LD K + G+ +LH +
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 471 -----SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN--TNIIAGTYGYM 523
+ I HRDLK+ NIL+ + I+D GLA F + N+ + N GT YM
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 524 APEYAMGGI------FSIKSDVFSFGVLLLEIISGRKNNGFYFSE----HGQTLLTYTWK 573
PE + I +D++SFG++L E+ + G H +++
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE 273
Query: 574 LWCEGPAVELIDPVLKQSCAPDELLKFIHIGLL--CVQQDPADRPTMSSVVVMLAS 627
E ++ + P + DE L+ + L+ C +PA R T V LA
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQM-GKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-53
Identities = 69/301 (22%), Positives = 121/301 (40%), Gaps = 44/301 (14%)
Query: 357 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNE--VNLIAKLQHKNLVRLL 414
+ +G+G FG V++G G+ +AVK S + + + E + L+H+N++ +
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFI 102
Query: 415 GCCLEGQ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 470
+ +L L+ +Y + SL FD + + + A G+ +LH +
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 471 -----SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT--NIIAGTYGYM 523
+ I HRDLK+ NIL+ + I+D GLA + + N GT YM
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 524 APEYAMGGI------FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCE 577
APE I ++D+++ G++ EI G H L Y + L
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG----IHEDYQLPY-YDLVPS 273
Query: 578 GPAVELID---------PVLKQSCAPDELLKFIHIGLL--CVQQDPADRPTMSSVVVMLA 626
P+VE + P + E L+ + ++ C + A R T + L+
Sbjct: 274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVM-AKIMRECWYANGAARLTALRIKKTLS 332
Query: 627 S 627
Sbjct: 333 Q 333
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 1e-51
Identities = 75/292 (25%), Positives = 119/292 (40%), Gaps = 41/292 (14%)
Query: 357 ENKLGQGGFGPVYKGTL---ADGKAI--AVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNL 410
LG+G FG V DG AVK L +G Q +K E++++ L H+++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 411 VRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 468
++ GCC + L L+ EY+P SL +L + + I G+ YLH
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 469 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG-----YM 523
IHRDL A N+LLD+D KI DFGLA+ G +
Sbjct: 152 A---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFWY 204
Query: 524 APEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVE 582
APE F SDV+SFGV L E+++ + + + +
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQG-----QMTVLR 259
Query: 583 LIDPVLK-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627
L + + + C P E+ + C + + + RPT +++ +L +
Sbjct: 260 LTELLERGERLPRPDKC-PAEVYH---LMKNCWETEASFRPTFENLIPILKT 307
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 7e-51
Identities = 71/290 (24%), Positives = 127/290 (43%), Gaps = 39/290 (13%)
Query: 357 ENKLGQGGFGPVYKGTLA-----DGKAIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNL 410
LG+G FG V G+ +AVK L + G + + K E+ ++ L H+N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 411 VRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 468
V+ G C E G + LI E++P+ SL +L +++ K++ I +G+ YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 469 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG-----YM 523
+ +HRDL A N+L++ + KI DFGL + ++ +
Sbjct: 144 S---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT----VKDDRDSPVFWY 196
Query: 524 APEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVE 582
APE M F I SDV+SFGV L E+++ ++ T+
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM-----TVTR 251
Query: 583 LIDPVLK-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
L++ + + +C PDE+ + + C + P++R + +++
Sbjct: 252 LVNTLKEGKRLPCPPNC-PDEVYQ---LMRKCWEFQPSNRTSFQNLIEGF 297
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 1e-50
Identities = 74/285 (25%), Positives = 115/285 (40%), Gaps = 50/285 (17%)
Query: 357 ENKLGQGGFGPVYKGTL-ADGKAIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 414
++G+G FG V+ G L AD +AVK +F E ++ + H N+VRL+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 415 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 474
G C + Q + ++ E + L T +L K ++ A G+ YL
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES---KC 233
Query: 475 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 534
IHRDL A N L+ + KISDFG++R A+ + + APE G +S
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 535 IKSDVFSFGVLLLEIIS-------GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587
+SDV+SFG+LL E S N + + V
Sbjct: 294 SESDVWSFGILLWETFSLGASPYPNLSNQ-------------------------QTREFV 328
Query: 588 LK-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
K + C PD + + + C +P RP+ S++ L
Sbjct: 329 EKGGRLPCPELC-PDAVFR---LMEQCWAYEPGQRPSFSTIYQEL 369
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-50
Identities = 80/312 (25%), Positives = 135/312 (43%), Gaps = 43/312 (13%)
Query: 357 ENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 411
++LG+G FG V G +AVK+L + ++F+ E+ ++ L +V
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 412 RLLGCCLEGQE--LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 469
+ G L L+ EY+P+ L L +LD R + I +G+ YL
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS 145
Query: 470 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG-----YMA 524
+ +HRDL A NIL++ + + KI+DFGLA++ +++ + G + A
Sbjct: 146 ---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYA 198
Query: 525 PEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAV-E 582
PE IFS +SDV+SFGV+L E+ + K+ + PA+
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKS---CS---PSAEFLRMMGCERDVPALSR 252
Query: 583 LIDPVLK-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML---ASDSMTI 632
L++ + + +C P E+ + + LC P DRP+ S++ L S S
Sbjct: 253 LLELLEEGQRLPAPPAC-PAEVHE---LMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 308
Query: 633 PQPTEPAFSVGR 644
A G+
Sbjct: 309 ETHAFTAHPEGK 320
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 2e-50
Identities = 76/288 (26%), Positives = 126/288 (43%), Gaps = 35/288 (12%)
Query: 357 ENKLGQGGFGPVYKGT---LADGKAI--AVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 411
+LG+G FG V L D AVK+L ++ + L++F+ E+ ++ LQH N+V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 412 RLLGCCLEGQE--LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 469
+ G C L LI EY+P SL +L ++D + + I +G+ YL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 470 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG-----YMA 524
+ IHRDL NIL++++ KI DFGL ++ ++ G + A
Sbjct: 133 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF----KVKEPGESPIFWYA 185
Query: 525 PEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584
PE FS+ SDV+SFGV+L E+ + + + +E + + LI
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM---IVFHLI 242
Query: 585 DPVLK-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
+ + C PDE+ I C + RP+ + + +
Sbjct: 243 ELLKNNGRLPRPDGC-PDEIY---MIMTECWNNNVNQRPSFRDLALRV 286
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 3e-50
Identities = 76/308 (24%), Positives = 127/308 (41%), Gaps = 77/308 (25%)
Query: 357 ENKLGQGGFGPVYKGTLADGK------AIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 410
+ +LG+G FG V+ + +AVK L + ++F+ E L+ LQH+++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 411 VRLLGCCLEGQELLLIYEYMPNKSLDVHL-------------FDATRSVQLDWKRRQSII 457
V+ G C +G L++++EYM + L+ L +L + I
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 458 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 517
+ IA G++YL + +HRDL N L+ ++ KI DFG++R ++ +
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-----------DVYS 185
Query: 518 GTYGY------------MAPEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNG- 557
Y Y M PE M F+ +SDV+SFGV+L EI + N
Sbjct: 186 TDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 244
Query: 558 FYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 617
G+ L E P + C P E+ + L C Q++P R
Sbjct: 245 IECITQGRVL---------ERP----------RVC-PKEVYD---VMLGCWQREPQQRLN 281
Query: 618 MSSVVVML 625
+ + +L
Sbjct: 282 IKEIYKIL 289
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 6e-50
Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 35/288 (12%)
Query: 357 ENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 411
+LG+G FG V G+ +AVK+L ++ + L++F+ E+ ++ LQH N+V
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 412 RLLGCCLEGQE--LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 469
+ G C L LI EY+P SL +L ++D + + I +G+ YL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 470 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG-----YMA 524
+ IHRDL NIL++++ KI DFGL ++ ++ G + A
Sbjct: 164 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPIFWYA 216
Query: 525 PEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584
PE FS+ SDV+SFGV+L E+ + + + +E + + LI
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM---IVFHLI 273
Query: 585 DPVLK-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
+ + C PDE+ I C + RP+ + + +
Sbjct: 274 ELLKNNGRLPRPDGC-PDEIY---MIMTECWNNNVNQRPSFRDLALRV 317
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-49
Identities = 81/307 (26%), Positives = 129/307 (42%), Gaps = 76/307 (24%)
Query: 357 ENKLGQGGFGPVYKGTLADGK------AIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 410
+ +LG+G FG V+ + +AVK L S Q+F+ E L+ LQH+++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 411 VRLLGCCLEGQELLLIYEYMPNKSLDVHL------------FDATRSVQLDWKRRQSIIN 458
VR G C EG+ LL+++EYM + L+ L + L + ++ +
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 459 GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAG 518
+A G++YL + L +HRDL N L+ + KI DFG++R +I +
Sbjct: 166 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-----------DIYST 211
Query: 519 TYGY------------MAPEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNG-F 558
Y Y M PE + F+ +SDV+SFGV+L EI + N
Sbjct: 212 DY-YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 270
Query: 559 YFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTM 618
G+ L E P ++C P E+ I C Q++P R ++
Sbjct: 271 DCITQGREL---------ERP----------RAC-PPEVYA---IMRGCWQREPQQRHSI 307
Query: 619 SSVVVML 625
V L
Sbjct: 308 KDVHARL 314
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-49
Identities = 88/309 (28%), Positives = 125/309 (40%), Gaps = 78/309 (25%)
Query: 357 ENKLGQGGFGPVYKGTLADGK------AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKN 409
+LG+ FG VYKG L A+A+K L + G +EF++E L A+LQH N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHL-------------FDATRSVQLDWKRRQSI 456
+V LLG + Q L +I+ Y + L L D T L+ +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 457 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 516
+ IA G+ YL S ++H+DL N+L+ D +N KISD GL R +
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR-----------EVY 179
Query: 517 AGTYGY------------MAPEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNG 557
A Y Y MAPE M G FSI SD++S+GV+L E+ S G N
Sbjct: 180 AADY-YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 238
Query: 558 -FYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRP 616
+ Q L P C P + + + C + P+ RP
Sbjct: 239 VVEMIRNRQVL---------PCP----------DDC-PAWVYA---LMIECWNEFPSRRP 275
Query: 617 TMSSVVVML 625
+ L
Sbjct: 276 RFKDIHSRL 284
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 8e-49
Identities = 81/302 (26%), Positives = 123/302 (40%), Gaps = 72/302 (23%)
Query: 358 NKLGQGGFGPVYKGTLADGK------AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNL 410
+LGQG FG VY+G +A+K + S + EF NE +++ + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 411 VRLLGCCLEGQELLLIYEYMPNKSLDVHL-------FDATRSVQLDWKRRQSIINGIARG 463
VRLLG +GQ L+I E M L +L + + + IA G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 464 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY- 522
+ YL+ K +HRDL A N ++ +D KI DFG+ R +I Y Y
Sbjct: 151 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----------DIYETDY-YR 195
Query: 523 -----------MAPEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNGFY-FSEH 563
M+PE G+F+ SDV+SFGV+L EI + G N F
Sbjct: 196 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255
Query: 564 GQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623
G L + P +C PD L + + +C Q +P RP+ ++
Sbjct: 256 GGLL---------DKP----------DNC-PDMLFE---LMRMCWQYNPKMRPSFLEIIS 292
Query: 624 ML 625
+
Sbjct: 293 SI 294
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 4e-48
Identities = 76/282 (26%), Positives = 131/282 (46%), Gaps = 46/282 (16%)
Query: 357 ENKLGQGGFGPVYKGTLADGK-AIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 415
++KLG G +G VY+G +AVK L + ++EF E ++ +++H NLV+LLG
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 416 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 475
C +I E+M +L +L + R ++ + I+ + YL +
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYL---EKKNF 132
Query: 476 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG-----YMAPEYAMG 530
IHRDL A N L+ ++ K++DFGL+R+ G+ A+ + APE
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG------AKFPIKWTAPESLAY 186
Query: 531 GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK- 589
FSIKSDV++FGVLL EI + +G + Y ++ + + K
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT-----------YGMS--PYPGI-----DLSQVYELLEKD 228
Query: 590 ------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
+ C P+++ + + C Q +P+DRP+ + +
Sbjct: 229 YRMERPEGC-PEKVYE---LMRACWQWNPSDRPSFAEIHQAF 266
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 8e-48
Identities = 82/317 (25%), Positives = 126/317 (39%), Gaps = 86/317 (27%)
Query: 357 ENKLGQGGFGPVYKGTLADGK------AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKN 409
LG+G FG V K T K +AVK L S L++ +E N++ ++ H +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSL---------------------DVHLFDATRSVQL 448
+++L G C + LLLI EY SL + D L
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 449 DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508
S I++G+ YL + +K++HRDL A NIL+ + KISDFGL+R
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR------ 198
Query: 509 NQANTNIIAGTYGY------------MAPEYAMGGIFSIKSDVFSFGVLLLEIIS----- 551
++ Y MA E I++ +SDV+SFGVLL EI++
Sbjct: 199 -----DVYEEDS-YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
Query: 552 --GRKNNGFY-FSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCV 608
G + + G + E P +C +E+ + L C
Sbjct: 253 YPGIPPERLFNLLKTGHRM---------ERP----------DNC-SEEMY---RLMLQCW 289
Query: 609 QQDPADRPTMSSVVVML 625
+Q+P RP + + L
Sbjct: 290 KQEPDKRPVFADISKDL 306
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 9e-48
Identities = 81/288 (28%), Positives = 125/288 (43%), Gaps = 50/288 (17%)
Query: 357 ENKLGQGGFGPVYKGTLADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLV 411
+ +G+G FG VY G D A+K LSR T Q ++ F E L+ L H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 412 RLLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 470
L+G L + ++ YM + L + R+ + K S +ARG+ YL
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV--KDLISFGLQVARGMEYL--- 140
Query: 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG-----YMAP 525
+ K +HRDL A N +LD+ K++DFGLAR ++ ++ + + A
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDI---LDREYYSVQQHRHARLPVKWTAL 197
Query: 526 EYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNG-FYFSEHGQTLLTYTWKLWCE 577
E F+ KSDV+SFGVLL E+++ +F G+ L
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL---------P 248
Query: 578 GPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
P + C PD L + + C + DPA RPT +V +
Sbjct: 249 QP----------EYC-PDSLYQ---VMQQCWEADPAVRPTFRVLVGEV 282
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-47
Identities = 86/320 (26%), Positives = 120/320 (37%), Gaps = 77/320 (24%)
Query: 357 ENKLGQGGFGPVYKGTLADGK------AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKN 409
LG G FG VY+G ++ +AVK L S Q +F E +I+K H+N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHL----FDATRSVQLDWKRRQSIINGIARGIL 465
+VR +G L+ ++ E M L L ++ L + IA G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 466 YLHEDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 522
YL IHRD+ A N LL KI DFG+AR +I +Y Y
Sbjct: 155 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----------DIYRASY-Y 199
Query: 523 ------------MAPEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNG-FYFSE 562
M PE M GIF+ K+D +SFGVLL EI S + N F
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 259
Query: 563 HGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 622
G + + P ++C P + I C Q P DRP + ++
Sbjct: 260 SGGRM---------DPP----------KNC-PGPVY---RIMTQCWQHQPEDRPNFAIIL 296
Query: 623 VML-----ASDSMTIPQPTE 637
+ D + P E
Sbjct: 297 ERIEYCTQDPDVINTALPIE 316
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-47
Identities = 84/303 (27%), Positives = 129/303 (42%), Gaps = 72/303 (23%)
Query: 357 ENKLGQGGFGPVYKGTLADGK----AIAVKRLSR--TSGQGLQEFKNEVNLIAKLQHKNL 410
LG+G FG V +G L +AVK + +S + ++EF +E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 411 VRLLGCCLEGQ-----ELLLIYEYMPNKSLDVHL---FDATRSVQLDWKRRQSIINGIAR 462
+RLLG C+E + ++I +M L +L T + + + IA
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 463 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 522
G+ YL S +HRDL A N +L DDM ++DFGL++ I +G Y Y
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK-----------KIYSGDY-Y 203
Query: 523 ------------MAPEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNGFY-FSE 562
+A E +++ KSDV++FGV + EI + G +N+ Y +
Sbjct: 204 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL 263
Query: 563 HGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 622
HG L + P + C DEL I C + DP DRPT S +
Sbjct: 264 HGHRL---------KQP----------EDC-LDELY---EIMYSCWRTDPLDRPTFSVLR 300
Query: 623 VML 625
+ L
Sbjct: 301 LQL 303
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 3e-47
Identities = 81/306 (26%), Positives = 128/306 (41%), Gaps = 69/306 (22%)
Query: 357 ENKLGQGGFGPVYKGTLADGK--------AIAVKRL-SRTSGQGLQEFKNEVNLIAKL-Q 406
LG+G FG V +AVK L + + L + +E+ ++ + +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 407 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL-------------FDATRSVQLDWKRR 453
HKN++ LLG C + L +I EY +L +L + Q+ +K
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 454 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQAN 512
S +ARG+ YL + K IHRDL A N+L+ ++ KI+DFGLAR I + +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 513 TNIIAGTYG-----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNGFY- 559
TN G +MAPE +++ +SDV+SFGVL+ EI + G +
Sbjct: 217 TN------GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270
Query: 560 FSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMS 619
+ G + + P +C +EL + C P+ RPT
Sbjct: 271 LLKEGHRM---------DKP----------ANC-TNELY---MMMRDCWHAVPSQRPTFK 307
Query: 620 SVVVML 625
+V L
Sbjct: 308 QLVEDL 313
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 3e-47
Identities = 74/289 (25%), Positives = 126/289 (43%), Gaps = 55/289 (19%)
Query: 357 ENKLGQGGFGPVYKGTLADGK-----AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNL 410
LG G FG VYKG +A+K L TS + +E +E ++A + + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 411 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGILYL 467
RLLG CL + LI + MP L ++ + ++ Q ++N IA+G+ YL
Sbjct: 80 CRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGS-----QYLLNWCVQIAKGMNYL 133
Query: 468 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI----IAGTYGYM 523
+++HRDL A N+L+ + KI+DFGLA++ G + + + I +M
Sbjct: 134 ---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WM 186
Query: 524 APEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583
A E + I++ +SDV+S+GV + E+++ G Y PA E+
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMT-----------FGSK--PYDGI-----PASEI 228
Query: 584 IDPVLK-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
+ K C ++ I C D RP +++
Sbjct: 229 SSILEKGERLPQPPIC-TIDVY---MIMRKCWMIDADSRPKFRELIIEF 273
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 4e-47
Identities = 84/305 (27%), Positives = 140/305 (45%), Gaps = 53/305 (17%)
Query: 357 ENKLGQGGFGPVYKGTLADGK----AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLV 411
E +G G G V G L +A+K L + + + ++F +E +++ + H N++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 412 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 471
RL G G+ +++ EYM N SLD L T Q + ++ G+ G+ YL S
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---S 168
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG------YMAP 525
L +HRDL A N+L+D ++ K+SDFGL+R+ + + A T T G + AP
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT-----TTGGKIPIRWTAP 223
Query: 526 EYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584
E FS SDV+SFGV++ E+++ G + Y++ + ++I
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGERP---YWNMTNR----------------DVI 264
Query: 585 DPVLK-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTE 637
V + C P L + + L C +D A RP S +V +L + P+
Sbjct: 265 SSVEEGYRLPAPMGC-PHALHQ---LMLDCWHKDRAQRPRFSQIVSVL-DALIRSPESLR 319
Query: 638 PAFSV 642
+V
Sbjct: 320 ATATV 324
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 4e-47
Identities = 66/286 (23%), Positives = 114/286 (39%), Gaps = 56/286 (19%)
Query: 357 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 416
+LG G FG V G +A+K + + EF E ++ L H+ LV+L G
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 417 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 476
C + + + +I EYM N L +L + ++ + + + YL + +
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFL 142
Query: 477 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT---YGYMAPEYAMGGIF 533
HRDL A N L++D K+SDFGL+R ++ ++ G+ + PE M F
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV----GSKFPVRWSPPEVLMYSKF 198
Query: 534 SIKSDVFSFGVLLLEIIS-------GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586
S KSD+++FGVL+ EI S N+ E +
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKMPYERFTNS-------------------------ETAEH 233
Query: 587 VLK-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
+ + +++ I C + +RPT ++ +
Sbjct: 234 IAQGLRLYRPHLA-SEKVYT---IMYSCWHEKADERPTFKILLSNI 275
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 5e-47
Identities = 76/303 (25%), Positives = 116/303 (38%), Gaps = 66/303 (21%)
Query: 357 ENKLGQGGFGPVYKGTLAD------GKAIAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHK 408
LG G FG V + T +AVK L S + +E+ +++ L QH+
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 409 NLVRLLGCCLEGQELLLIYEYMPNKSL-----------DVHLFDATRSVQLDWKRRQSII 457
N+V LLG C G +L+I EY L + A + +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 458 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNII 516
+ +A+G+ +L + IHRD+ A N+LL + KI DFGLAR I + N
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN-- 225
Query: 517 AGTYG-----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNG--FYFSE 562
+MAPE +++++SDV+S+G+LL EI S G N + +
Sbjct: 226 ----ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 281
Query: 563 HGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 622
G + P P + I C +P RPT +
Sbjct: 282 DGYQM---------AQP----------AFA-PKNIYS---IMQACWALEPTHRPTFQQIC 318
Query: 623 VML 625
L
Sbjct: 319 SFL 321
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 5e-47
Identities = 83/280 (29%), Positives = 130/280 (46%), Gaps = 44/280 (15%)
Query: 357 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 416
E KLG G FG V+ T +AVK + + ++ F E N++ LQH LV+L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 417 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 476
+ + + +I E+M SL L S + + IA G+ ++ + I
Sbjct: 252 VTK-EPIYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFI---EQRNYI 306
Query: 477 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT---YGYMAPEYAMGGIF 533
HRDL+A+NIL+ + KI+DFGLAR+ N+ A G + APE G F
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE----GAKFPIKWTAPEAINFGSF 362
Query: 534 SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG-PAVELIDPVLK--- 589
+IKSDV+SFG+LL+EI++ +G+ G E+I + +
Sbjct: 363 TIKSDVWSFGILLMEIVT-----------YGRI--------PYPGMSNPEVIRALERGYR 403
Query: 590 ----QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
++C P+EL I + C + P +RPT + +L
Sbjct: 404 MPRPENC-PEELYN---IMMRCWKNRPEERPTFEYIQSVL 439
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 5e-47
Identities = 79/283 (27%), Positives = 116/283 (40%), Gaps = 54/283 (19%)
Query: 357 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 416
+G+G FG V G G +AVK + + Q F E +++ +L+H NLV+LLG
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 254
Query: 417 CLEGQELL-LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 475
+E + L ++ EYM SL +L RS L + + YL
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYL---EGNNF 310
Query: 476 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG------YMAPEYAM 529
+HRDL A N+L+ +D K+SDFGL + + + APE
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWTAPEALR 359
Query: 530 GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589
FS KSDV+SFG+LL EI S G+ Y ++ P +++ V K
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYS-----------FGRV--PY-PRI----PLKDVVPRVEK 401
Query: 590 -------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
C P + + C D A RPT + L
Sbjct: 402 GYKMDAPDGC-PPAVYD---VMKNCWHLDAATRPTFLQLREQL 440
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 6e-47
Identities = 75/278 (26%), Positives = 132/278 (47%), Gaps = 38/278 (13%)
Query: 357 ENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 415
++KLG G +G VY+G +AVK L + + ++EF E ++ +++H NLV+LLG
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 416 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 475
C +I E+M +L +L + R ++ + I+ + YL +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYL---EKKNF 339
Query: 476 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 535
IHR+L A N L+ ++ K++DFGL+R+ G+ A+ + APE FSI
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSI 398
Query: 536 KSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG-PAVELIDPVLK----- 589
KSDV++FGVLL EI + +G + G ++ + + K
Sbjct: 399 KSDVWAFGVLLWEIAT-----------YGMS--------PYPGIDLSQVYELLEKDYRME 439
Query: 590 --QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
+ C P+++ + + C Q +P+DRP+ + +
Sbjct: 440 RPEGC-PEKVYE---LMRACWQWNPSDRPSFAEIHQAF 473
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 6e-47
Identities = 81/306 (26%), Positives = 128/306 (41%), Gaps = 69/306 (22%)
Query: 357 ENKLGQGGFGPVYKGTLADGK--------AIAVKRL-SRTSGQGLQEFKNEVNLIAKL-Q 406
LG+G FG V +AVK L + + L + +E+ ++ + +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 407 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL-------------FDATRSVQLDWKRR 453
HKN++ LLG C + L +I EY +L +L + Q+ +K
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 454 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQAN 512
S +ARG+ YL + K IHRDL A N+L+ ++ KI+DFGLAR I + +
Sbjct: 206 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 513 TNIIAGTYG-----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNGFY- 559
TN G +MAPE +++ +SDV+SFGVL+ EI + G +
Sbjct: 263 TN------GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316
Query: 560 FSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMS 619
+ G + + P +C +EL + C P+ RPT
Sbjct: 317 LLKEGHRM---------DKP----------ANC-TNELYMMM---RDCWHAVPSQRPTFK 353
Query: 620 SVVVML 625
+V L
Sbjct: 354 QLVEDL 359
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 6e-47
Identities = 82/317 (25%), Positives = 126/317 (39%), Gaps = 86/317 (27%)
Query: 357 ENKLGQGGFGPVYKGTLADGK------AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKN 409
+G+G FG V++ +AVK L S +F+ E L+A+ + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHL---------------------FDATRSVQL 448
+V+LLG C G+ + L++EYM L+ L + L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 449 DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508
+ I +A G+ YL S K +HRDL N L+ ++M KI+DFGL+R
Sbjct: 172 SCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR------ 222
Query: 509 NQANTNIIAGTYGY------------MAPEYAMGGIFSIKSDVFSFGVLLLEIIS----- 551
NI + Y Y M PE ++ +SDV+++GV+L EI S
Sbjct: 223 -----NIYSADY-YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
Query: 552 --GRKNNGFY-FSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCV 608
G + + G L P ++C P EL + LC
Sbjct: 277 YYGMAHEEVIYYVRDGNIL---------ACP----------ENC-PLELYN---LMRLCW 313
Query: 609 QQDPADRPTMSSVVVML 625
+ PADRP+ S+ +L
Sbjct: 314 SKLPADRPSFCSIHRIL 330
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 7e-47
Identities = 70/286 (24%), Positives = 114/286 (39%), Gaps = 56/286 (19%)
Query: 357 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 416
+LG G FG V G +AVK + + EF E + KL H LV+ G
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 417 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 476
C + + ++ EY+ N L +L + L+ + + + G+ +L + I
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFI 126
Query: 477 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT---YGYMAPEYAMGGIF 533
HRDL A N L+D D+ K+SDFG+ R +Q ++ GT + APE +
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV----GTKFPVKWSAPEVFHYFKY 182
Query: 534 SIKSDVFSFGVLLLEIIS-------GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586
S KSDV++FG+L+ E+ S N+ E++
Sbjct: 183 SSKSDVWAFGILMWEVFSLGKMPYDLYTNS-------------------------EVVLK 217
Query: 587 VLK-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
V + D + + I C + P RPT ++ +
Sbjct: 218 VSQGHRLYRPHLA-SDTIYQ---IMYSCWHELPEKRPTFQQLLSSI 259
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 7e-47
Identities = 86/320 (26%), Positives = 119/320 (37%), Gaps = 77/320 (24%)
Query: 357 ENKLGQGGFGPVYKGTLADGK------AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKN 409
LG G FG VY+G ++ +AVK L S Q +F E +I+K H+N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHL----FDATRSVQLDWKRRQSIINGIARGIL 465
+VR +G L+ ++ E M L L ++ L + IA G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 466 YLHEDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 522
YL IHRD+ A N LL KI DFG+AR +I Y Y
Sbjct: 196 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----------DIYRAGY-Y 240
Query: 523 ------------MAPEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNG-FYFSE 562
M PE M GIF+ K+D +SFGVLL EI S + N F
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300
Query: 563 HGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 622
G + + P ++C P + I C Q P DRP + ++
Sbjct: 301 SGGRM---------DPP----------KNC-PGPVY---RIMTQCWQHQPEDRPNFAIIL 337
Query: 623 VML-----ASDSMTIPQPTE 637
+ D + P E
Sbjct: 338 ERIEYCTQDPDVINTALPIE 357
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 8e-47
Identities = 71/304 (23%), Positives = 118/304 (38%), Gaps = 73/304 (24%)
Query: 357 ENKLGQGGFGPVYKGTLADGK----AIAVKRL--SRTSGQGLQEFKNEVNLIAKLQHKNL 410
LG+G FG V + L +AVK L + ++EF E + + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 411 VRLLGCCLEGQ------ELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRRQSIINGIA 461
+L+G L + ++I +M + L L L + + IA
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 462 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 521
G+ YL S IHRDL A N +L +DM ++DFGL+R I +G Y
Sbjct: 148 CGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR-----------KIYSGDY- 192
Query: 522 Y------------MAPEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNG-FYFS 561
Y +A E ++++ SDV++FGV + EI++ G +N + +
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL 252
Query: 562 EHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 621
G L + P C +E+ + C DP RP+ + +
Sbjct: 253 IGGNRL---------KQP----------PEC-MEEVY---DLMYQCWSADPKQRPSFTCL 289
Query: 622 VVML 625
+ L
Sbjct: 290 RMEL 293
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 8e-47
Identities = 87/322 (27%), Positives = 133/322 (41%), Gaps = 72/322 (22%)
Query: 357 ENKLGQGGFGPVYKGTLADGK--------AIAVKRL-SRTSGQGLQEFKNEVNLIAKL-Q 406
LG+G FG V +AVK L S + + L + +E+ ++ + +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 407 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING------- 459
HKN++ LLG C + L +I EY +L +L A R L++ S
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 460 -------IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQA 511
+ARG+ YL + K IHRDL A N+L+ +D KI+DFGLAR I + +
Sbjct: 193 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 512 NTNIIAGTYG-----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNGFY 559
TN G +MAPE I++ +SDV+SFGVLL EI + G +
Sbjct: 250 TTN------GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303
Query: 560 -FSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTM 618
+ G + + P +C +EL + C P+ RPT
Sbjct: 304 KLLKEGHRM---------DKP----------SNC-TNELYM---MMRDCWHAVPSQRPTF 340
Query: 619 SSVVVMLASDSMTIPQPTEPAF 640
+V L + + E +
Sbjct: 341 KQLVEDLD-RIVALTSNQEMGY 361
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 9e-47
Identities = 93/294 (31%), Positives = 139/294 (47%), Gaps = 47/294 (15%)
Query: 357 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 416
+LG G FG V+ G +AVK L + F E NL+ +LQH+ LVRL
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 417 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 476
+ + + +I EYM N SL L ++L + + IA G+ ++ I
Sbjct: 77 VTQ-EPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYI 131
Query: 477 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT---YGYMAPEYAMGGIF 533
HRDL+A+NIL+ D ++ KI+DFGLAR+ N+ A G + APE G F
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE----GAKFPIKWTAPEAINYGTF 187
Query: 534 SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK---- 589
+IKSDV+SFG+LL EI++ HG+ Y E+I + +
Sbjct: 188 TIKSDVWSFGILLTEIVT-----------HGRI--PYPGM-----TNPEVIQNLERGYRM 229
Query: 590 ---QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML-----ASDSMTIPQP 635
+C P+EL + + LC ++ P DRPT + +L A++ PQP
Sbjct: 230 VRPDNC-PEELYQ---LMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP 279
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 9e-47
Identities = 73/286 (25%), Positives = 122/286 (42%), Gaps = 56/286 (19%)
Query: 357 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 416
++G G FG V+ G + +A+K + R ++F E ++ KL H LV+L G
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 417 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 476
CLE + L+ E+M + L +L T+ + + + G+ YL +I
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---EEACVI 126
Query: 477 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT---YGYMAPEYAMGGIF 533
HRDL A N L+ ++ K+SDFG+ R +Q ++T GT + +PE +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRY 182
Query: 534 SIKSDVFSFGVLLLEIIS-------GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586
S KSDV+SFGVL+ E+ S R N+ E+++
Sbjct: 183 SSKSDVWSFGVLMWEVFSEGKIPYENRSNS-------------------------EVVED 217
Query: 587 VLK-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
+ + + + I C ++ P DRP S ++ L
Sbjct: 218 ISTGFRLYKPRLA-STHVYQ---IMNHCWRERPEDRPAFSRLLRQL 259
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-46
Identities = 79/284 (27%), Positives = 117/284 (41%), Gaps = 56/284 (19%)
Query: 357 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 416
+G+G FG V G G +AVK + + Q F E +++ +L+H NLV+LLG
Sbjct: 26 LQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 82
Query: 417 CLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 475
+E + L ++ EYM SL +L RS L + + YL
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYL---EGNNF 138
Query: 476 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG------YMAPEYAM 529
+HRDL A N+L+ +D K+SDFGL + + + APE
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWTAPEALR 187
Query: 530 GGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588
FS KSDV+SFG+LL EI S GR Y ++ P +++ V
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRV--------------PY-PRI----PLKDVVPRVE 228
Query: 589 K-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
K C P + + + C D A RP+ + L
Sbjct: 229 KGYKMDAPDGC-PPAVYE---VMKNCWHLDAAMRPSFLQLREQL 268
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-46
Identities = 84/340 (24%), Positives = 143/340 (42%), Gaps = 77/340 (22%)
Query: 318 IRNHYAYNILRGGKQQAESQEFPLFPL-RLALEATNHFSDENKLGQGGFGPVYKGTLADG 376
++ H+ GK + +P+ + + + +G+G FG V K +
Sbjct: 1 MKKHH---HHHHGKNNPDPTIYPVLDWNDIKFQ--------DVIGEGNFGQVLKARIKKD 49
Query: 377 KA---IAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMP 431
A+KR+ S ++F E+ ++ KL H N++ LLG C L L EY P
Sbjct: 50 GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 109
Query: 432 NKSLDVHL-------------FDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHR 478
+ +L L + + L ++ +ARG+ YL S+ + IHR
Sbjct: 110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHR 166
Query: 479 DLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI-IAGTYG-----YMAPEYAMGGI 532
DL A NIL+ ++ KI+DFGL+R + + T G +MA E +
Sbjct: 167 DLAARNILVGENYVAKIADFGLSR---------GQEVYVKKTMGRLPVRWMAIESLNYSV 217
Query: 533 FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK--- 589
++ SDV+S+GVLL EI+S G T +C EL + + +
Sbjct: 218 YTTNSDVWSYGVLLWEIVS-----------LGGT-------PYCGMTCAELYEKLPQGYR 259
Query: 590 ----QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
+C DE+ + C ++ P +RP+ + ++V L
Sbjct: 260 LEKPLNC-DDEVY---DLMRQCWREKPYERPSFAQILVSL 295
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 2e-46
Identities = 80/297 (26%), Positives = 117/297 (39%), Gaps = 68/297 (22%)
Query: 357 ENKLGQGGFGPVYKGTLADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLV 411
+G+G FG VY GTL D AVK L+R T + +F E ++ H N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 412 RLLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 470
LLG CL + L++ YM + L + + K +A+G+ YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYLAS- 146
Query: 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY-------- 522
K +HRDL A N +LD+ K++DFGLAR ++ Y Y
Sbjct: 147 --KKFVHRDLAARNCMLDEKFTVKVADFGLAR-----------DMYDKEY-YSVHNKTGA 192
Query: 523 ------MAPEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNG-FYFSEHGQTLL 568
MA E F+ KSDV+SFGVLL E+++ + G+ L
Sbjct: 193 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL- 251
Query: 569 TYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
P + C PD L + L C RP+ S +V +
Sbjct: 252 --------LQP----------EYC-PDPLY---EVMLKCWHPKAEMRPSFSELVSRI 286
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 3e-46
Identities = 80/311 (25%), Positives = 141/311 (45%), Gaps = 58/311 (18%)
Query: 357 ENKLGQGGFGPVYKGTLADGKA-----IAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNL 410
+ +G G FG VYKG L +A+K L + + + +F E ++ + H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 411 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 470
+RL G + + +++I EYM N +LD L + + + ++ GIA G+ YL
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYL--- 163
Query: 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG------YMA 524
+ + +HRDL A NIL++ ++ K+SDFGL+R+ + T T G + A
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT-----TSGGKIPIRWTA 218
Query: 525 PEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583
PE F+ SDV+SFG+++ E+++ G + Y+ E+
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGERP---YWELSNH----------------EV 259
Query: 584 IDPVLK-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML-----ASDSMT 631
+ + C P + + + + C QQ+ A RP + +V +L A DS+
Sbjct: 260 MKAINDGFRLPTPMDC-PSAIYQ---LMMQCWQQERARRPKFADIVSILDKLIRAPDSLK 315
Query: 632 IPQPTEPAFSV 642
+P S+
Sbjct: 316 TLADFDPRVSI 326
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-46
Identities = 77/307 (25%), Positives = 113/307 (36%), Gaps = 70/307 (22%)
Query: 357 ENKLGQGGFGPVYKGTLADGKA------IAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHK 408
LG G FG V + T +AVK L + +E+ +++ L H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 409 NLVRLLGCCLEGQELLLIYEYMPNKSL---------------DVHLFDATRSVQLDWKRR 453
N+V LLG C G L+I EY L + LD +
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 454 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQAN 512
S +A+G+ +L + IHRDL A NILL KI DFGLAR I +
Sbjct: 148 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 513 TNIIAGTYG-----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNG--F 558
N +MAPE +++ +SDV+S+G+ L E+ S G + +
Sbjct: 205 GN------ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 559 YFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTM 618
+ G + P + P E+ I C DP RPT
Sbjct: 259 KMIKEGFRM---------LSP----------EHA-PAEMYD---IMKTCWDADPLKRPTF 295
Query: 619 SSVVVML 625
+V ++
Sbjct: 296 KQIVQLI 302
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 7e-46
Identities = 78/288 (27%), Positives = 122/288 (42%), Gaps = 50/288 (17%)
Query: 357 ENKLGQGGFGPVYKGTLADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLV 411
+G+G FG VY GTL D AVK L+R T + +F E ++ H N++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 412 RLLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 470
LLG CL + L++ YM + L + + + K +A+G+ +L
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFL--- 208
Query: 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG-----YMAP 525
+ K +HRDL A N +LD+ K++DFGLAR ++ ++ T +MA
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM---YDKEFDSVHNKTGAKLPVKWMAL 265
Query: 526 EYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNG-FYFSEHGQTLLTYTWKLWCE 577
E F+ KSDV+SFGVLL E+++ + G+ L
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL---------L 316
Query: 578 GPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
P + C PD L + + L C RP+ S +V +
Sbjct: 317 QP----------EYC-PDPLYE---VMLKCWHPKAEMRPSFSELVSRI 350
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 8e-46
Identities = 79/311 (25%), Positives = 117/311 (37%), Gaps = 81/311 (26%)
Query: 358 NKLGQGGFGPVYKGTLAD------GKAIAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHKN 409
LG+G FG V + + +AVK L + + +E+ ++ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 410 LVRLLGCCL-EGQELLLIYEYMPNKSL-------------DVHLFDATRSVQLDWKRRQS 455
+V LLG C G L++I E+ +L + L +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 456 IINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 515
+A+G+ +L + K IHRDL A NILL + KI DFGLAR +I
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----------DI 198
Query: 516 IAGTYGY------------MAPEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNN 556
Y MAPE +++I+SDV+SFGVLL EI S G K +
Sbjct: 199 YKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257
Query: 557 G--FYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPAD 614
+ G + P E+ + L C +P+
Sbjct: 258 EEFCRRLKEGTRM---------RAP----------DYT-TPEMYQ---TMLDCWHGEPSQ 294
Query: 615 RPTMSSVVVML 625
RPT S +V L
Sbjct: 295 RPTFSELVEHL 305
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 9e-46
Identities = 81/306 (26%), Positives = 136/306 (44%), Gaps = 57/306 (18%)
Query: 357 ENKLGQGGFGPVYKGTLADGK----AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLV 411
+ +G G FG V G L ++A+K L + + ++F E +++ + H N++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 412 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 471
RL G + + ++++ EYM N SLD L Q + ++ GIA G+ YL S
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL---S 164
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG------YMAP 525
+ +HRDL A NIL++ ++ K+SDFGL R+ + A T T G + +P
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT-----TRGGKIPIRWTSP 219
Query: 526 EYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584
E F+ SDV+S+G++L E++S G + Y+ Q ++I
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERP---YWEMSNQ----------------DVI 260
Query: 585 DPVLK-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML-----ASDSMTI 632
V + C P L + + L C Q+D +RP +V +L S+ I
Sbjct: 261 KAVDEGYRLPPPMDC-PAALYQ---LMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKI 316
Query: 633 PQPTEP 638
Sbjct: 317 ITSAAA 322
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-45
Identities = 71/297 (23%), Positives = 117/297 (39%), Gaps = 54/297 (18%)
Query: 357 ENKLGQGGFGPVYKGTLADGK----AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLV 411
+G+G FG V++G + A+A+K + TS ++F E + + H ++V
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 412 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 471
+L+G E + +I E L L R LD ++ + YL
Sbjct: 80 KLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYL---E 133
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG-----YMAPE 526
+ +HRD+ A N+L+ + K+ DFGL+R ++ + G +MAPE
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM------EDSTYYKASKGKLPIKWMAPE 187
Query: 527 YAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNG-FYFSEHGQTLLTYTWKLWCEG 578
F+ SDV+ FGV + EI+ G KNN E+G+ L
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---------PM 238
Query: 579 PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQP 635
P +C P L + C DP+ RP + + L S + +
Sbjct: 239 P----------PNC-PPTLYS---LMTKCWAYDPSRRPRFTELKAQL-STILEEEKA 280
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-45
Identities = 70/283 (24%), Positives = 115/283 (40%), Gaps = 43/283 (15%)
Query: 357 ENKLGQGGFGPVYKGTLADGK-----AIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNL 410
LG G FG V+KG + +K + SG Q Q + + I L H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 411 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 470
VRLLG C L L+ +Y+P SL H+ L + + IA+G+ YL
Sbjct: 78 VRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYL--- 131
Query: 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 530
++HR+L A N+LL +++DFG+A + + Q + +MA E
Sbjct: 132 EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 531 GIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589
G ++ +SDV+S+GV + E+++ G + Y E+ D + K
Sbjct: 192 GKYTHQSDVWSYGVTVWELMTFGAE--------------PYAGL-----RLAEVPDLLEK 232
Query: 590 -------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
Q C ++ + + C D RPT +
Sbjct: 233 GERLAQPQIC-TIDVY---MVMVKCWMIDENIRPTFKELANEF 271
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 3e-45
Identities = 73/312 (23%), Positives = 116/312 (37%), Gaps = 75/312 (24%)
Query: 357 ENKLGQGGFGPVYKGTLADGKA------IAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHK 408
LG G FG V T +AVK L + + +E+ ++ +L H+
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 409 NLVRLLGCCLEGQELLLIYEYMPNKSL------------DVHLFDATRSVQLDWKRRQSI 456
N+V LLG C + LI+EY L + + + + + +
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 457 ING--------IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGN 507
+A+G+ +L +HRDL A N+L+ KI DFGLAR I +
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 508 QNQANTNIIAGTYG-----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKN 555
N +MAPE GI++IKSDV+S+G+LL EI S G
Sbjct: 227 NYVVRGN------ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280
Query: 556 NG--FYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPA 613
+ + ++G + + P +E+ I C D
Sbjct: 281 DANFYKLIQNGFKM---------DQP----------FYA-TEEIY---IIMQSCWAFDSR 317
Query: 614 DRPTMSSVVVML 625
RP+ ++ L
Sbjct: 318 KRPSFPNLTSFL 329
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-45
Identities = 78/294 (26%), Positives = 115/294 (39%), Gaps = 58/294 (19%)
Query: 357 ENKLGQGGFGPVYKGTL--ADGKAI--AVKRL---SRTSGQGLQEFKNEVNLIAKLQHKN 409
KLG G FG V +G GK + AVK L + + + +F EVN + L H+N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ----LDWKRRQSIINGIARGIL 465
L+RL G L + ++ E P SL L + +A G+
Sbjct: 83 LIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV------QVAEGMG 135
Query: 466 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT---YGY 522
YL E R IHRDL A N+LL KI DFGL R N + + +
Sbjct: 136 YL-ESKRF--IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ--EHRKVPFAW 190
Query: 523 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAV 581
APE FS SD + FGV L E+ + G++ + +G
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP---WIGLNGS---------------- 231
Query: 582 ELIDPVLKQ--------SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627
+++ + K+ C P ++ + + C P DRPT ++ L
Sbjct: 232 QILHKIDKEGERLPRPEDC-PQDIYN---VMVQCWAHKPEDRPTFVALRDFLLE 281
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 5e-45
Identities = 77/315 (24%), Positives = 133/315 (42%), Gaps = 63/315 (20%)
Query: 357 ENKLGQGGFGPVYKGTLADGK-----AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNL 410
LG G FG VYKG +A+K L TS + +E +E ++A + + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 411 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 470
RLLG CL + LI + MP L ++ + + + + IA+G+ YL
Sbjct: 80 CRLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL--- 133
Query: 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI----IAGTYGYMAPE 526
+++HRDL A N+L+ + KI+DFGLA++ G + + + I +MA E
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALE 189
Query: 527 YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586
+ I++ +SDV+S+GV + E+ +T+ K + PA E+
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWEL------------------MTFGSKPYDGIPASEISSI 231
Query: 587 VLK-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML-------------- 625
+ K C ++ I + C D RP +++
Sbjct: 232 LEKGERLPQPPIC-TIDVY---MIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQ 287
Query: 626 ASDSMTIPQPTEPAF 640
+ M +P PT+ F
Sbjct: 288 GDERMHLPSPTDSNF 302
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 8e-45
Identities = 75/298 (25%), Positives = 123/298 (41%), Gaps = 50/298 (16%)
Query: 357 ENKLGQGGFGPVYKGTL-ADGKAI--AVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLVR 412
+ +LG G FG V +G K I A+K L T +E E ++ +L + +VR
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 472
L+G C + L+L+ E L L + ++ +++ ++ G+ YL
Sbjct: 75 LIGVCQA-EALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EE 128
Query: 473 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG-----YMAPEY 527
+HRDL A N+LL + KISDFGL++ G + + A + G + APE
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY----YTARSAGKWPLKWYAPEC 184
Query: 528 AMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586
FS +SDV+S+GV + E +S G+K Y G E++
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQKP---YKKMKGP----------------EVMAF 225
Query: 587 VLK-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTE 637
+ + C P EL + C DRP +V + + ++ E
Sbjct: 226 IEQGKRMECPPEC-PPELYA---LMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-44
Identities = 70/287 (24%), Positives = 114/287 (39%), Gaps = 53/287 (18%)
Query: 357 ENKLGQGGFGPVYKGTLADGKA----IAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLV 411
LG+G FG VY+G + K +AVK + + ++F +E ++ L H ++V
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 412 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 471
+L+G E + +I E P L +L S+++ I + + YL
Sbjct: 77 KLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAYL---E 130
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG-----YMAPE 526
+ +HRD+ NIL+ K+ DFGL+R + + + +M+PE
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYI------EDEDYYKASVTRLPIKWMSPE 184
Query: 527 YAMGGIFSIKSDVFSFGVLLLEIIS-GRK-----NNG--FYFSEHGQTLLTYTWKLWCEG 578
F+ SDV+ F V + EI+S G++ N E G L
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL---------PK 235
Query: 579 PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
P C P L + C DP+DRP + +V L
Sbjct: 236 P----------DLC-PPVLYT---LMTRCWDYDPSDRPRFTELVCSL 268
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-44
Identities = 80/300 (26%), Positives = 124/300 (41%), Gaps = 54/300 (18%)
Query: 357 ENKLGQGGFGPVYKGTLADGKA---IAVKRL--SRTSGQGLQEFKNEVNLIAKLQHKNLV 411
+ +LG G FG V KG K +AVK L E E N++ +L + +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 412 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 471
R++G C + +L+ E L+ +L ++ + K +++ ++ G+ YL
Sbjct: 82 RMIGICE-AESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---E 134
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG-----YMAPE 526
+HRDL A N+LL KISDFGL++ ++N A T+G + APE
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK----AQTHGKWPVKWYAPE 190
Query: 527 YAMGGIFSIKSDVFSFGVLLLEIIS-GRK-----NNG--FYFSEHGQTLLTYTWKLWCEG 578
FS KSDV+SFGVL+ E S G+K E G+ +
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---------GC 241
Query: 579 PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEP 638
P C P E+ + LC D +RP ++V + L + E
Sbjct: 242 P----------AGC-PREMYD---LMNLCWTYDVENRPGFAAVELRL--RNYYYDVVNEG 285
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 3e-44
Identities = 64/301 (21%), Positives = 109/301 (36%), Gaps = 71/301 (23%)
Query: 357 ENKLGQGGFGPVYKGTL--------ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHK 408
LGQG F ++KG + +K L + + F ++++KL HK
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 409 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 468
+LV G C+ G E +L+ E++ SLD +L + + WK + +A + +L
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAAAMHFL- 129
Query: 469 EDSRLKIIHRDLKASNILLDDDMNP--------KISDFGLARIFGGNQNQANTNIIAGTY 520
+IH ++ A NILL + + K+SD G++ ++
Sbjct: 130 --EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-----------VLPKDI 176
Query: 521 GY-----MAPE-YAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNG-FYFSEHGQT 566
+ PE ++ +D +SFG L EI S + F E
Sbjct: 177 LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQ 236
Query: 567 LLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626
L P EL I C+ +P RP+ +++ L
Sbjct: 237 L---------PAP-------------KAAELANLI---NNCMDYEPDHRPSFRAIIRDLN 271
Query: 627 S 627
S
Sbjct: 272 S 272
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 4e-44
Identities = 83/276 (30%), Positives = 130/276 (47%), Gaps = 36/276 (13%)
Query: 357 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 416
E KLGQG FG V+ GT +A+K L + + F E ++ KL+H+ LV+L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 417 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 476
E + + ++ EYM SL L T L + + IA G+ Y+ R+ +
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYV---ERMNYV 302
Query: 477 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 536
HRDL+A+NIL+ +++ K++DFGLAR+ N+ A + APE A+ G F+IK
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 361
Query: 537 SDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK------- 589
SDV+SFG+LL E+ T + E++D V +
Sbjct: 362 SDVWSFGILLTELT------------------TKGRVPYPGMVNREVLDQVERGYRMPCP 403
Query: 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
C P+ L + C +++P +RPT + L
Sbjct: 404 PEC-PESLHD---LMCQCWRKEPEERPTFEYLQAFL 435
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-43
Identities = 83/276 (30%), Positives = 130/276 (47%), Gaps = 36/276 (13%)
Query: 357 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 416
E KLGQG FG V+ GT +A+K L + + F E ++ KL+H+ LV+L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 417 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 476
E + + ++ EYM SL L T L + + IA G+ Y+ R+ +
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYV---ERMNYV 385
Query: 477 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 536
HRDL+A+NIL+ +++ K++DFGLAR+ N+ A + APE A+ G F+IK
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 444
Query: 537 SDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK------- 589
SDV+SFG+LL E+ T + E++D V +
Sbjct: 445 SDVWSFGILLTELT------------------TKGRVPYPGMVNREVLDQVERGYRMPCP 486
Query: 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
C P+ L + C +++P +RPT + L
Sbjct: 487 PEC-PESLHD---LMCQCWRKEPEERPTFEYLQAFL 518
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-43
Identities = 67/294 (22%), Positives = 106/294 (36%), Gaps = 45/294 (15%)
Query: 352 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKN 409
F LG+GGFG V++ D A+KR+ ++ EV +AKL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 410 LVRLLGCCLEGQE------------LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 457
+VR LE L + + ++L + + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 458 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 517
IA + +LH ++HRDLK SNI D K+ DFGL ++ +
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 518 ----------GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTL 567
GT YM+PE G +S K D+FS G++L E++ + FS Q
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL-------YPFS--TQME 232
Query: 568 LTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 621
T P+ Q + + P +RP ++
Sbjct: 233 RVRTLTDVRNLK----FPPLFTQKY--PCEYVMVQ---DMLSPSPMERPEAINI 277
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 9e-43
Identities = 69/287 (24%), Positives = 114/287 (39%), Gaps = 49/287 (17%)
Query: 352 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 410
F + +G GGFG V+K DGK +KR+ + ++ + EV +AKL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 411 VRLLGC----------------CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQ 454
V GC + + L + E+ +L+ + R +LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLE-QWIEKRRGEKLDKVLAL 125
Query: 455 SIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 514
+ I +G+ Y+H K+I+RDLK SNI L D KI DFGL N + +
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-KNDGKRTRS 181
Query: 515 IIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL 574
GT YM+PE + + D+++ G++L E++ E +
Sbjct: 182 K--GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV----CDTAFETSKFFTD----- 230
Query: 575 WCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 621
L D ++ + + + + P DRP S +
Sbjct: 231 --------LRDGIISDIF-DKKEKTLLQ---KLLSKKPEDRPNTSEI 265
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-42
Identities = 64/266 (24%), Positives = 118/266 (44%), Gaps = 25/266 (9%)
Query: 359 KLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 415
K+G+G FG DG+ +K +SR S + +E + EV ++A ++H N+V+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 416 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 475
E L ++ +Y L +A + V + I + ++H+ KI
Sbjct: 91 SFEENGSLYIVMDYCEGGDLF-KRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KI 146
Query: 476 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 535
+HRD+K+ NI L D ++ DFG+AR+ A GT Y++PE ++
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEICENKPYNN 204
Query: 536 KSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPD 595
KSD+++ G +L E+ + + F ++ K+ G PV
Sbjct: 205 KSDIWALGCVLYELCTLKH----AF--EAGSMKNLVLKI-ISGS----FPPV--SLHYSY 251
Query: 596 ELLKFIHIGLLCVQQDPADRPTMSSV 621
+L + +++P DRP+++S+
Sbjct: 252 DLRSLVS---QLFKRNPRDRPSVNSI 274
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-42
Identities = 62/275 (22%), Positives = 121/275 (44%), Gaps = 23/275 (8%)
Query: 352 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRL---SRTSGQGLQEFKNEVNLIAKLQH 407
+F E K+G+G F VY+ L DG +A+K++ + + E++L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 408 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRS-VQLDWKRRQSIINGIARGILY 466
N+++ +E EL ++ E L + + + + + + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 467 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 526
+H +++HRD+K +N+ + K+ D GL R F A++ + GT YM+PE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV--GTPYYMSPE 206
Query: 527 YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586
++ KSD++S G LL E+ + + F L + K+ + P
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYSLCKKI-EQCD----YPP 257
Query: 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 621
+ +EL + ++ +C+ DP RP ++ V
Sbjct: 258 LPSDHY-SEELRQLVN---MCINPDPEKRPDVTYV 288
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 4e-42
Identities = 83/418 (19%), Positives = 148/418 (35%), Gaps = 64/418 (15%)
Query: 225 ISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYR 284
I + +T Q + L + G P+ +
Sbjct: 223 IPEGTKFDTLWQLVEYLKLKADGLIYCLK-EACPNSSASNASGAAAPTLPAHPSTLTHPQ 281
Query: 285 YSKVPAVGALAPSSAPEEKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPL 344
++ + + + P + + + ++ + ++ L
Sbjct: 282 -RRIDTLNSDGYTPEPARITSPD-----KPRPMPMDTSVFESPFSDPEELKDKKLFLKRD 335
Query: 345 RLALEATNHFSDENKLGQGGFGPVYKGTLADGKA---IAVKRL-SRTSGQGLQEFKNEVN 400
L + + +LG G FG V +G K +A+K L T +E E
Sbjct: 336 NLLIA-------DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 388
Query: 401 LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI 460
++ +L + +VRL+G C + L+L+ E L L + ++ +++ +
Sbjct: 389 IMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQV 445
Query: 461 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTY 520
+ G+ YL +HR+L A N+LL + KISDFGL++ G + + A +
Sbjct: 446 SMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY----YTARSA 498
Query: 521 G-----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRK-----NNG--FYFSEHGQTL 567
G + APE FS +SDV+S+GV + E +S G+K F E G+ +
Sbjct: 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM 558
Query: 568 LTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
E P C P EL + C DRP +V +
Sbjct: 559 ---------ECP----------PEC-PPELYA---LMSDCWIYKWEDRPDFLTVEQRM 593
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 5e-42
Identities = 70/287 (24%), Positives = 114/287 (39%), Gaps = 53/287 (18%)
Query: 357 ENKLGQGGFGPVYKGTLADGK----AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLV 411
+G+G FG V++G + A+A+K + TS ++F E + + H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 412 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 471
+L+G E + +I E L L R LD ++ + YL
Sbjct: 455 KLIGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---E 508
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG-----YMAPE 526
+ +HRD+ A N+L+ + K+ DFGL+R ++ + G +MAPE
Sbjct: 509 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM------EDSTYYKASKGKLPIKWMAPE 562
Query: 527 YAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNG-FYFSEHGQTLLTYTWKLWCEG 578
F+ SDV+ FGV + EI+ G KNN E+G+ L
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---------PM 613
Query: 579 PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
P +C P L + C DP+ RP + + L
Sbjct: 614 P----------PNC-PPTLYS---LMTKCWAYDPSRRPRFTELKAQL 646
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 4e-40
Identities = 69/271 (25%), Positives = 116/271 (42%), Gaps = 39/271 (14%)
Query: 359 KLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 415
++G+G F VYKG +A + + + Q FK E ++ LQH N+VR
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 416 CCLEGQE----LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 471
+ ++L+ E M + +L +L R + K +S I +G+ +LH +
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRT 149
Query: 472 RLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 530
IIHRDLK NI + + KI D GLA + + A I GT +MAPE
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAVI--GTPEFMAPEMYEE 204
Query: 531 GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG--PAV--ELIDP 586
+ DV++FG+ +LE+ + Y + ++ G PA ++ P
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSEYP---YSECQNAAQI---YRRVTSGVKPASFDKVAIP 257
Query: 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPT 617
+K+ I C++Q+ +R +
Sbjct: 258 EVKE---------IIE---GCIRQNKDERYS 276
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 7e-40
Identities = 70/277 (25%), Positives = 114/277 (41%), Gaps = 38/277 (13%)
Query: 359 KLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 415
+G G +G K +DGK + K + Q +EVNL+ +L+H N+VR
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 416 CCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGILYLHE--D 470
++ L ++ EY L + T+ Q LD + ++ + + H D
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 530
++HRDLK +N+ LD N K+ DFGLARI + + A T + GT YM+PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV--GTPYYMSPEQMNR 190
Query: 531 GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590
++ KSD++S G LL E+ + F + EL + +
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMP--PFT----AFSQK-------------ELAGKIREG 231
Query: 591 SCAP------DELLKFIHIGLLCVQQDPADRPTMSSV 621
DEL + I + RP++ +
Sbjct: 232 KFRRIPYRYSDELNEIIT---RMLNLKDYHRPSVEEI 265
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-39
Identities = 76/302 (25%), Positives = 114/302 (37%), Gaps = 56/302 (18%)
Query: 351 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 409
+ F + LGQG FG V K D + A+K++ T + L +EV L+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 410 LVRLLGCCLE-------------GQELLLIYEYMPNKSLDVHLFD--ATRSVQLDWKRRQ 454
+VR LE L + EY N +L +D + ++
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDEYW 119
Query: 455 SIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF---------- 504
+ I + Y+H IIHRDLK NI +D+ N KI DFGLA+
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 505 ----GGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFY 559
G+ + + I GT Y+A E G G ++ K D++S G++ E+I
Sbjct: 177 SQNLPGSSDNLTSAI--GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPF----ST 230
Query: 560 FSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMS 619
E K + P K I L + DP RP
Sbjct: 231 GMERVN-----ILKKLRSVS---IEFPPDFDDNKMKVEKKIIR---LLIDHDPNKRPGAR 279
Query: 620 SV 621
++
Sbjct: 280 TL 281
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-39
Identities = 74/262 (28%), Positives = 121/262 (46%), Gaps = 23/262 (8%)
Query: 360 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL 418
LG+G +G VY G L++ IA+K + + Q E+ L L+HKN+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 419 EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHR 478
E + + E +P SL L ++ + + I G+ YLH++ +I+HR
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHR 146
Query: 479 DLKASNILLDDDM-NPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI--FSI 535
D+K N+L++ KISDFG ++ G T GT YMAPE G +
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRGYGK 204
Query: 536 KSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPD 595
+D++S G ++E+ +G+ FY Q + +K+ + + P + +S +
Sbjct: 205 AADIWSLGCTIIEMATGKPP--FYELGEPQAAM---FKV-----GMFKVHPEIPESMSA- 253
Query: 596 ELLKFIHIGLLCVQQDPADRPT 617
E FI L C + DP R
Sbjct: 254 EAKAFI---LKCFEPDPDKRAC 272
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 66/273 (24%), Positives = 95/273 (34%), Gaps = 40/273 (14%)
Query: 353 HFSDENKLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKL-QHK 408
F ++LG G +G V+K DG+ AVK + EV K+ QH
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 409 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 468
VRL EG L L E SL H L + + + +LH
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAHLH 174
Query: 469 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 528
++H D+K +NI L K+ DFGL G G YMAPE
Sbjct: 175 S---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGEVQE--GDPRYMAPELL 228
Query: 529 MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPA----VELI 584
G + +DVFS G+ +LE+ +L G +
Sbjct: 229 QGS-YGTAADVFSLGLTILEVACN-------------------MELPHGGEGWQQLRQGY 268
Query: 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 617
P + EL + ++ ++ DP R T
Sbjct: 269 LPPEFTAGLSSELRSVL---VMMLEPDPKLRAT 298
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 6e-38
Identities = 68/272 (25%), Positives = 126/272 (46%), Gaps = 38/272 (13%)
Query: 354 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 412
++ K+GQG G VY +A G+ +A+++++ + NE+ ++ + ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 472
L L G EL ++ EY+ SL D +D + ++ + + +LH +
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 135
Query: 473 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 532
++IHRD+K+ NILL D + K++DFG Q++ +T + GT +MAPE
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 192
Query: 533 FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGP--AVELID----P 586
+ K D++S G++ +E+I G Y +E+ P A+ LI P
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPP---YLNEN---------------PLRALYLIATNGTP 234
Query: 587 VLKQSCA-PDELLKFIHIGLLCVQQDPADRPT 617
L+ F++ C++ D R +
Sbjct: 235 ELQNPEKLSAIFRDFLN---RCLEMDVEKRGS 263
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-38
Identities = 67/302 (22%), Positives = 117/302 (38%), Gaps = 35/302 (11%)
Query: 353 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 411
H+ KLG+GGF V L DG A+KR+ Q +E + E ++ H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 412 RLLGCCLE----GQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILY 466
RL+ CL E L+ + +L + + L + ++ GI RG+
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 467 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA-------GT 519
+H HRDLK +NILL D+ P + D G + + + T
Sbjct: 150 IHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 520 YGYMAPE---YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWC 576
Y APE + ++DV+S G +L ++ G + Q + +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP----YDMVFQKGDSVALAV-- 260
Query: 577 EGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPT 636
+L P + L + ++ + DP RP + ++ L +++ P P
Sbjct: 261 ---QNQLSIP--QSPRHSSALWQLLNS---MMTVDPHQRPHIPLLLSQL--EALQPPAPG 310
Query: 637 EP 638
+
Sbjct: 311 QH 312
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 69/272 (25%), Positives = 124/272 (45%), Gaps = 38/272 (13%)
Query: 354 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 412
K+G+G G V G+ +AVK + Q + NEV ++ QH N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 472
+ L G+EL ++ E++ +L D V+L+ ++ ++ + + + YLH
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQ-- 160
Query: 473 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 532
+IHRD+K+ +ILL D K+SDFG + + + + GT +MAPE +
Sbjct: 161 -GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSL 217
Query: 533 FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGP--AVELID----P 586
++ + D++S G++++E++ G YFS+ P A++ + P
Sbjct: 218 YATEVDIWSLGIMVIEMVDGEPP---YFSDS---------------PVQAMKRLRDSPPP 259
Query: 587 VLKQSCA-PDELLKFIHIGLLCVQQDPADRPT 617
LK S L F+ + +DP +R T
Sbjct: 260 KLKNSHKVSPVLRDFLE---RMLVRDPQERAT 288
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-37
Identities = 53/211 (25%), Positives = 87/211 (41%), Gaps = 23/211 (10%)
Query: 358 NKLGQGGFGPVYKGTLADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNL--VRL 413
++G GG V++ + A+K L Q L ++NE+ + KLQ + +RL
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 414 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 473
+ Q + ++ E N L+ L +D R+S + + +H+
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQ---H 146
Query: 474 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE------- 526
I+H DLK +N L+ D K+ DFG+A + + GT YM PE
Sbjct: 147 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 527 ----YAMGGIFSIKSDVFSFGVLLLEIISGR 553
S KSDV+S G +L + G+
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 72/267 (26%), Positives = 129/267 (48%), Gaps = 27/267 (10%)
Query: 353 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG-LQEFKNEVNLIAKLQHKNL 410
F+ K+G+G FG V+KG K +A+K + + +++ + E+ ++++ +
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 411 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 470
+ G L+ +L +I EY+ S D LD + +I+ I +G+ YLH +
Sbjct: 83 TKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLHSE 138
Query: 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 530
K IHRD+KA+N+LL + K++DFG+A Q + NT + GT +MAPE
Sbjct: 139 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV--GTPFWMAPEVIKQ 193
Query: 531 GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590
+ K+D++S G+ +E+ G + H +L K P P L+
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPP---HSELHPMKVLFLIPK---NNP------PTLEG 241
Query: 591 SCAPDELLKFIHIGLLCVQQDPADRPT 617
+ + L +F+ C+ ++P+ RPT
Sbjct: 242 NYSK-PLKEFVE---ACLNKEPSFRPT 264
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 67/275 (24%), Positives = 114/275 (41%), Gaps = 32/275 (11%)
Query: 349 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFK-NEVNLIAKLQ 406
E + + + ++G+G FG V++ G AVK++ L+ F+ E+ A L
Sbjct: 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLS 108
Query: 407 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 466
+V L G EG + + E + SL + + L R + G+ Y
Sbjct: 109 SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEY 165
Query: 467 LHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANT---NIIAGTYGY 522
LH +I+H D+KA N+LL D + + DFG A + + + I GT +
Sbjct: 166 LHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 222
Query: 523 MAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVE 582
MAPE MG K D++S ++L +++G + L K+ E P
Sbjct: 223 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP---WTQYFRGPLC---LKIASEPP--- 273
Query: 583 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 617
+ SCAP + I ++++P R +
Sbjct: 274 -PIREIPPSCAP-LTAQAI---QEGLRKEPVHRAS 303
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 67/319 (21%), Positives = 124/319 (38%), Gaps = 44/319 (13%)
Query: 331 KQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG 389
+Q+ + F ++ + F ++LG G G V+K + G +A K +
Sbjct: 12 QQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK 71
Query: 390 QGLQEF-KNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQL 448
++ E+ ++ + +V G E+ + E+M SLD + +
Sbjct: 72 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGRIPE 130
Query: 449 DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508
+ + + +G+ YL E KI+HRD+K SNIL++ K+ DFG++
Sbjct: 131 QILGK--VSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--ID 184
Query: 509 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR-----KNNGFYFSEH 563
+ AN+ + GT YM+PE G +S++SD++S G+ L+E+ GR +
Sbjct: 185 SMANSFV--GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 242
Query: 564 GQTLLTYTWKLWCEGPA-------------------------VELIDPVLKQSCAPDELL 598
G + + V P L E
Sbjct: 243 GCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 302
Query: 599 KFIHIGLLCVQQDPADRPT 617
F++ C+ ++PA+R
Sbjct: 303 DFVN---KCLIKNPAERAD 318
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 68/280 (24%), Positives = 120/280 (42%), Gaps = 40/280 (14%)
Query: 352 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSG-QGLQEFKNEVN-LIAKLQHK 408
+ +LG+G +G V K + G+ +AVKR+ T Q + +++ + +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 409 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR-RQSIINGIARGIL-- 465
V G ++ + E M + SLD + V + + I+ IA I+
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLD----KFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 466 --YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYM 523
+LH S+L +IHRD+K SN+L++ K+ DFG++ + + + G YM
Sbjct: 122 LEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDIDA--GCKPYM 176
Query: 524 APE----YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQ--TLLTYTWKLWCE 577
APE +S+KSD++S G+ ++E+ R F + G L E
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILR----FPYDSWGTPFQQLKQV----VE 228
Query: 578 GPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 617
P+ P L E + F C++++ +RPT
Sbjct: 229 EPS-----PQLPADKFSAEFVDFTS---QCLKKNSKERPT 260
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-36
Identities = 61/281 (21%), Positives = 109/281 (38%), Gaps = 45/281 (16%)
Query: 358 NKLGQGGFGPVYKGTLADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNL--VRL 413
++G GG V++ + A+K L Q L ++NE+ + KLQ + +RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 414 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 473
+ Q + ++ E N L+ L +D R+S + + +H+
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQ---H 127
Query: 474 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE------- 526
I+H DLK +N L+ D K+ DFG+A + + GT YM PE
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 527 ----YAMGGIFSIKSDVFSFGVLLLEIISGR----KNNGFYFSEHGQTLLTYTWKLWCEG 578
S KSDV+S G +L + G+ + H + +
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP--- 243
Query: 579 PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMS 619
++ + L+ ++LK C+++DP R ++
Sbjct: 244 ---DIPEKDLQ------DVLK------CCLKRDPKQRISIP 269
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 4e-36
Identities = 60/281 (21%), Positives = 108/281 (38%), Gaps = 45/281 (16%)
Query: 358 NKLGQGGFGPVYKGTLADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNL--VRL 413
++G GG V++ + A+K L Q L ++NE+ + KLQ + +RL
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 414 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 473
+ Q + ++ E N L+ L +D R+S + + +H+
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQ---H 174
Query: 474 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE------- 526
I+H DLK +N L+ D K+ DFG+A + + G YM PE
Sbjct: 175 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 527 ----YAMGGIFSIKSDVFSFGVLLLEIISGR----KNNGFYFSEHGQTLLTYTWKLWCEG 578
S KSDV+S G +L + G+ + H + +
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP--- 290
Query: 579 PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMS 619
++ + L+ ++LK C+++DP R ++
Sbjct: 291 ---DIPEKDLQ------DVLK------CCLKRDPKQRISIP 316
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-36
Identities = 71/281 (25%), Positives = 123/281 (43%), Gaps = 38/281 (13%)
Query: 352 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKL-QHK 408
D ++G+G +G V K G+ +AVKR+ T + ++ +++++ +
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 409 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR--QSIINGIARGIL- 465
+V+ G + + E M + S D + V + I+ I +
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFD----KFYKYVYSVLDDVIPEEILGKITLATVK 136
Query: 466 ---YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 522
+L E+ LKIIHRD+K SNILLD N K+ DFG++ + + AG Y
Sbjct: 137 ALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD---AGCRPY 191
Query: 523 MAPE----YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF-YFSEHGQT-LLTYTWKLWC 576
MAPE A + ++SDV+S G+ L E+ +GR F Y + LT
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGR----FPYPKWNSVFDQLTQV----V 243
Query: 577 EGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 617
+G +L + ++ + F++ LC+ +D + RP
Sbjct: 244 KGDPPQLSNSEERE--FSPSFINFVN---LCLTKDESKRPK 279
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-36
Identities = 62/283 (21%), Positives = 109/283 (38%), Gaps = 42/283 (14%)
Query: 354 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVR 412
F ++ LG G G + + D + +AVKR+ + EV L+ + +H N++R
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVIR 82
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVHLFD--ATRSVQLDWKRRQSIINGIARGILYLHED 470
+ Q + E L + + +++ G+ +LH
Sbjct: 83 YFCTEKDRQFQYIAIELCAAT-----LQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS- 136
Query: 471 SRLKIIHRDLKASNILL-----DDDMNPKISDFGLARIFGGNQN-QANTNIIAGTYGYMA 524
L I+HRDLK NIL+ + ISDFGL + ++ + + + GT G++A
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 525 PEYAMGGIF---SIKSDVFSFGVLLLEIISGRKNNG---FYFSEHGQTLLTYTWKLWCEG 578
PE + D+FS G + +IS G F S Q +
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISE----GSHPFGKSLQRQANILL------GA 244
Query: 579 PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 621
+++ + P + EL++ + DP RP+ V
Sbjct: 245 CSLDCLHPEKHEDVIARELIE------KMIAMDPQKRPSAKHV 281
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 71/273 (26%), Positives = 123/273 (45%), Gaps = 40/273 (14%)
Query: 354 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 412
F KLG+G +G VYK G+ +A+K++ LQE E++++ + ++V+
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVK 88
Query: 413 LLGCCLEGQELLLIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 471
G + +L ++ EY S+ D+ R+ L +I+ +G+ YLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLHFM- 144
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 531
+ IHRD+KA NILL+ + + K++DFG+A + NT I GT +MAPE
Sbjct: 145 --RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI--GTPFWMAPEVIQEI 200
Query: 532 IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGP--AVELID---- 585
++ +D++S G+ +E+ G+ Y H P A+ +I
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPP---YADIH---------------PMRAIFMIPTNPP 242
Query: 586 PVLKQSCA-PDELLKFIHIGLLCVQQDPADRPT 617
P ++ D F+ C+ + P R T
Sbjct: 243 PTFRKPELWSDNFTDFVK---QCLVKSPEQRAT 272
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-35
Identities = 63/282 (22%), Positives = 115/282 (40%), Gaps = 45/282 (15%)
Query: 351 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 409
+ +LG G FG VYK G A K + S + L+++ E+ ++A H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQ--SIINGIARGILYL 467
+V+LLG +L ++ E+ P ++D + Q + + + +L
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVD----AIMLELDRGLTEPQIQVVCRQMLEALNFL 133
Query: 468 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 527
H +IIHRDLKA N+L+ + + +++DFG++ + ++ I GT +MAPE
Sbjct: 134 HSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI--GTPYWMAPEV 188
Query: 528 AMGGIFS-----IKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGP--A 580
M K+D++S G+ L+E+ + + P
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPP---HHELN---------------PMRV 230
Query: 581 VELID----PVLKQSCA-PDELLKFIHIGLLCVQQDPADRPT 617
+ I P L E F+ + + ++P RP+
Sbjct: 231 LLKIAKSDPPTLLTPSKWSVEFRDFLK---IALDKNPETRPS 269
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 7e-35
Identities = 52/211 (24%), Positives = 88/211 (41%), Gaps = 22/211 (10%)
Query: 359 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRLLGC 416
LGQG V++G G A+K + S + E ++ KL HKN+V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 417 --CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 474
+ +LI E+ P SL L + + + L ++ + G+ +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NG 132
Query: 475 IIHRDLKASNILL----DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE---- 526
I+HR++K NI+ D K++DFG AR ++ Q + + GT Y+ P+
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS--LYGTEEYLHPDMYER 189
Query: 527 ----YAMGGIFSIKSDVFSFGVLLLEIISGR 553
+ D++S GV +G
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 76/280 (27%), Positives = 122/280 (43%), Gaps = 46/280 (16%)
Query: 351 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS---RTSGQGLQEFKNEVNLIAKLQ 406
FSD ++G G FG VY + + + +A+K++S + S + Q+ EV + KL+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 407 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 466
H N ++ GC L L+ EY + D+ L ++ +G +G+ Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAY 169
Query: 467 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 526
LH +IHRD+KA NILL + K+ DFG A AN+ + GT +MAPE
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANSFV--GTPYWMAPE 220
Query: 527 YAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGP--AV 581
+ G + K DV+S G+ +E+ + F+ + A+
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFNMN---------------AMSAL 262
Query: 582 ELID----PVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 617
I P L+ + F+ C+Q+ P DRPT
Sbjct: 263 YHIAQNESPALQSGHWSEYFRNFVD---SCLQKIPQDRPT 299
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-34
Identities = 58/292 (19%), Positives = 97/292 (33%), Gaps = 53/292 (18%)
Query: 351 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKL-Q 406
T F + K+G G FG V+K DG A+KR Q EV A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 407 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGIL 465
H ++VR E +L+ EY SL + + R + + ++ + RG+
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 466 YLHEDSRLKIIHRDLKASNILLDDDMNP-------------------KISDFGLARIFGG 506
Y+H ++H D+K SNI + P KI D G
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS- 185
Query: 507 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQ 565
+ + G ++A E K+D+F+ + ++ +
Sbjct: 186 -----SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP---LPRNGDQ- 236
Query: 566 TLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 617
W +G + E + + + + DP RP+
Sbjct: 237 ------WHEIRQGRLPRI------PQVLSQEFTELLK---VMIHPDPERRPS 273
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 8e-34
Identities = 52/211 (24%), Positives = 88/211 (41%), Gaps = 22/211 (10%)
Query: 359 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRLLGC 416
LGQG V++G G A+K + S + E ++ KL HKN+V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 417 --CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 474
+ +LI E+ P SL L + + + L ++ + G+ +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NG 132
Query: 475 IIHRDLKASNILL----DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE---- 526
I+HR++K NI+ D K++DFG AR ++ Q + + GT Y+ P+
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS--LYGTEEYLHPDMYER 189
Query: 527 ----YAMGGIFSIKSDVFSFGVLLLEIISGR 553
+ D++S GV +G
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-34
Identities = 63/277 (22%), Positives = 114/277 (41%), Gaps = 35/277 (12%)
Query: 352 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKL-QHK 408
N + ++G G G V+K G IAVK++ R+ + + +++++ K
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 409 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 468
+V+ G + ++ + E M + + + + I + + YL
Sbjct: 85 YIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGK--MTVAIVKALYYLK 141
Query: 469 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE-- 526
E +IHRD+K SNILLD+ K+ DFG++ G + + AG YMAPE
Sbjct: 142 EK--HGVIHRDVKPSNILLDERGQIKLCDFGIS---GRLVDDKAKDRSAGCAAYMAPERI 196
Query: 527 ---YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF-YFSEHGQ-TLLTYTWKLWCEGPAV 581
+ I++DV+S G+ L+E+ +G+ F Y + +LT +
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQ----FPYKNCKTDFEVLTKV----LQEEP- 247
Query: 582 ELIDPVLKQSCA-PDELLKFIHIGLLCVQQDPADRPT 617
P+L + F+ C+ +D RP
Sbjct: 248 ----PLLPGHMGFSGDFQSFVK---DCLTKDHRKRPK 277
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-33
Identities = 62/245 (25%), Positives = 90/245 (36%), Gaps = 36/245 (14%)
Query: 334 AESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQ 393
+ P F L N E LG G G V G+ +AVKR+
Sbjct: 1 SRIANIPNFEQSL----KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCD 53
Query: 394 EFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDV---HLFDATRSVQLD 449
E+ L+ + H N++R + L + E D+
Sbjct: 54 IALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQK 113
Query: 450 WKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-------------DDMNPKIS 496
S++ IA G+ +LH LKIIHRDLK NIL+ +++ IS
Sbjct: 114 EYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170
Query: 497 DFGLARIFGGNQN--QANTNIIAGTYGYMAPEYAMGGIFSI-------KSDVFSFGVLLL 547
DFGL + Q+ + N N +GT G+ APE D+FS G +
Sbjct: 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY 230
Query: 548 EIISG 552
I+S
Sbjct: 231 YILSK 235
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 37/285 (12%)
Query: 352 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKN 409
+ + + +G G V + +A+KR++ Q + E E+ +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGIL--- 465
+V + EL L+ + + S+ D+ + +S I I R +L
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 466 -YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL-ARIFGGNQNQANT--NIIAGTYG 521
YLH++ IHRD+KA NILL +D + +I+DFG+ A + G N GT
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 522 YMAPEYAM-GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPA 580
+MAPE + K+D++SFG+ +E+ +G Y +L T + P
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP---YHKYPPMKVLMLTLQ---NDP- 244
Query: 581 VELIDPVLKQSCAPDELLK--------FIHIGLLCVQQDPADRPT 617
P L+ E+LK I LC+Q+DP RPT
Sbjct: 245 -----PSLETGVQDKEMLKKYGKSFRKMIS---LCLQKDPEKRPT 281
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-33
Identities = 51/199 (25%), Positives = 93/199 (46%), Gaps = 14/199 (7%)
Query: 360 LGQGGFGPVYKGT-LADGKAIAVKRLSRTS--GQGLQE-FKNEVNLIAKLQHKNLVRLLG 415
LG+GGF ++ + + A K + ++ +E E+++ L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 416 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGILYLHEDSRLK 474
+ + ++ E +SL + + + L + + I G YLH R +
Sbjct: 83 FFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNR 135
Query: 475 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 534
+IHRDLK N+ L++D+ KI DFGLA + + + GT Y+APE S
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHS 193
Query: 535 IKSDVFSFGVLLLEIISGR 553
+ DV+S G ++ ++ G+
Sbjct: 194 FEVDVWSIGCIMYTLLVGK 212
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-33
Identities = 51/199 (25%), Positives = 93/199 (46%), Gaps = 14/199 (7%)
Query: 360 LGQGGFGPVYKGT-LADGKAIAVKRLSRTS--GQGLQE-FKNEVNLIAKLQHKNLVRLLG 415
LG+GGF ++ + + A K + ++ +E E+++ L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 416 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGILYLHEDSRLK 474
+ + ++ E +SL + + + L + + I G YLH R +
Sbjct: 109 FFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNR 161
Query: 475 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 534
+IHRDLK N+ L++D+ KI DFGLA + + + GT Y+APE S
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHS 219
Query: 535 IKSDVFSFGVLLLEIISGR 553
+ DV+S G ++ ++ G+
Sbjct: 220 FEVDVWSIGCIMYTLLVGK 238
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 75/288 (26%), Positives = 120/288 (41%), Gaps = 47/288 (16%)
Query: 351 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHK 408
F +G G +G VYKG + G+ A+K + +G +E K E+N++ K H+
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHR 81
Query: 409 NLVRLLGCCLEG------QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR 462
N+ G ++ +L L+ E+ S+ L T+ L + I I R
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILR 140
Query: 463 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 522
G+ +LH+ K+IHRD+K N+LL ++ K+ DFG++ + NT I GT +
Sbjct: 141 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI--GTPYW 195
Query: 523 MAPEYAMGGIFS-----IKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCE 577
MAPE KSD++S G+ +E+ G H
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP---LCDMH-------------- 238
Query: 578 GP--AVELID----PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMS 619
P A+ LI P LK + FI C+ ++ + RP
Sbjct: 239 -PMRALFLIPRNPAPRLKSKKWSKKFQSFIE---SCLVKNHSQRPATE 282
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 59/198 (29%), Positives = 102/198 (51%), Gaps = 11/198 (5%)
Query: 360 LGQGGFGPVYKGT-LADGKAIAVKRLSRTS--GQGLQE-FKNEVNLIAKLQHKNLVRLLG 415
LG+G F VY+ + G +A+K + + + G+ + +NEV + +L+H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 416 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 475
+ + L+ E N ++ +L + + + R ++ I G+LYLH I
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH--FMHQIITGMLYLH---SHGI 133
Query: 476 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 535
+HRDL SN+LL +MN KI+DFGLA + T + GT Y++PE A +
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATRSAHGL 191
Query: 536 KSDVFSFGVLLLEIISGR 553
+SDV+S G + ++ GR
Sbjct: 192 ESDVWSLGCMFYTLLIGR 209
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 132 bits (332), Expect = 2e-32
Identities = 65/281 (23%), Positives = 106/281 (37%), Gaps = 30/281 (10%)
Query: 359 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRLL-- 414
+LG GGFG V + G+ +A+K+ + +E + E+ ++ KL H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 415 ----GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 470
LL EY L +L L +++++ I+ + YLHE
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE- 139
Query: 471 SRLKIIHRDLKASNILLD---DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 527
+IIHRDLK NI+L + KI D G A+ + GT Y+APE
Sbjct: 140 --NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-LCTE--FVGTLQYLAPEL 194
Query: 528 AMGGIFSIKSDVFSFGVLLLEIISGR-------KNNGFYFSEHGQTLLTYTWKLWCEGPA 580
+++ D +SFG L E I+G + ++ ++ G
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAV 254
Query: 581 V---ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTM 618
L P +L +++ L R T
Sbjct: 255 KFSSVLPTPNHLSGILAGKLERWLQCML---MWHQRQRGTD 292
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 127 bits (319), Expect = 5e-32
Identities = 34/333 (10%), Positives = 68/333 (20%), Gaps = 51/333 (15%)
Query: 325 NILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKR 383
++ Q L + L G V+ + + A+K
Sbjct: 35 AMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKV 94
Query: 384 L---SRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC----------------------- 417
+ S L+ A+L ++
Sbjct: 95 FTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPG 154
Query: 418 ---LEGQELLLIYEYMPNKSLDV-HLFD--ATRSVQLDWKRRQSIINGIARGILYLHEDS 471
LL+ + D + + R L
Sbjct: 155 QDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ--- 211
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 531
++H N+ + D + D G + Y E+
Sbjct: 212 SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNAS 266
Query: 532 --IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589
F+ + + G+ + + F + +WK
Sbjct: 267 TATFTHALNAWQLGLSIYRVWCLF----LPF-GLVTPGIKGSWKRPSLRVPGTDSLAFGS 321
Query: 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 622
+ PD + I L D R +
Sbjct: 322 CTPLPDFVKTLIG-RFLNF--DRRRRLLPLEAM 351
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 63/314 (20%), Positives = 105/314 (33%), Gaps = 52/314 (16%)
Query: 357 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLL 414
L +GGF VY+ + G+ A+KRL + + EV + KL H N+V+
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 415 GCCL-------EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 467
GQ L+ + L L L I R + ++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 468 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA---------- 517
H + IIHRDLK N+LL + K+ DFG A + + +
Sbjct: 153 H-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 518 GTYGYMAPE---YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLL---TYT 571
T Y PE K D+++ G +L + + F + + + Y+
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP----FEDGAKLRIVNGKYS 267
Query: 572 WKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV----VMLAS 627
P P Q I +Q +P +R +++ VV + A+
Sbjct: 268 I------P------PHDTQY---TVFHSLIRA---MLQVNPEERLSIAEVVHQLQEIAAA 309
Query: 628 DSMTIPQPTEPAFS 641
++ P
Sbjct: 310 RNVNPKSPITELLE 323
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-31
Identities = 62/238 (26%), Positives = 96/238 (40%), Gaps = 26/238 (10%)
Query: 329 GGKQQAESQEFPLFPLRLALEATNHFSD----ENKLGQGGFGPVYKGT-LADGKAIAVKR 383
G + + P H S+ KLG G +G V A+K
Sbjct: 10 GRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKI 69
Query: 384 LSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD 441
+ +T S + EV ++ L H N+++L + + L+ E LFD
Sbjct: 70 IRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE----LFD 125
Query: 442 ATRSVQLDW---KRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKI 495
+ II + G+ YLH+ I+HRDLK N+LL + D KI
Sbjct: 126 --EIIHRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKI 180
Query: 496 SDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 553
DFGL+ +F + GT Y+APE + + K DV+S GV+L +++G
Sbjct: 181 VDFGLSAVFENQKKM---KERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-31
Identities = 49/308 (15%), Positives = 101/308 (32%), Gaps = 45/308 (14%)
Query: 351 TNHFSDENKLGQG--GFGPVYKGT-LADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKL 405
+ +G+G V G+ + V+R L S + + + E+++
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 406 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 465
H N+V + EL ++ +M S L ++ I+ G+ + +
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSA-KDLICTHFMDGMNELAIAYILQGVLKALD 142
Query: 466 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT-----NIIAGTY 520
Y+H +HR +KAS+IL+ D +S + +
Sbjct: 143 YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 521 GYMAPEYAMGGI--FSIKSDVFSFGVLLLEIISGR-----------------------KN 555
+++PE + + KSD++S G+ E+ +G +
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259
Query: 556 NGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLK------FIHIGLLCVQ 609
+E + + ++ P +P F H C+Q
Sbjct: 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQ 319
Query: 610 QDPADRPT 617
++P RP+
Sbjct: 320 RNPDARPS 327
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 6e-31
Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 11/199 (5%)
Query: 359 KLGQGGFGPVYKGT-LADGKAIAVKRLS---RTSGQGLQEFKNEVNLIAKLQHKNLVRLL 414
KLG GG VY +A+K + R + L+ F+ EV+ ++L H+N+V ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 415 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 474
E L+ EY+ +L ++ L + N I GI + H ++
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH---DMR 131
Query: 475 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 534
I+HRD+K NIL+D + KI DFG+A+ + TN + GT Y +PE A G
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 535 IKSDVFSFGVLLLEIISGR 553
+D++S G++L E++ G
Sbjct: 191 ECTDIYSIGIVLYEMLVGE 209
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 49/202 (24%), Positives = 81/202 (40%), Gaps = 23/202 (11%)
Query: 359 KLGQGGFGPVYKGT-LADGKAIAVK-----RLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 412
+G+G F V + G+ AVK + + + G ++ K E ++ L+H ++V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVHLFD-----ATRSVQLDWKRRQSIINGIARGILYL 467
LL L +++E+M L A + I + Y
Sbjct: 91 LLETYSSDGMLYMVFEFMDGAD----LCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 468 HEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 524
H+ IIHRD+K +LL ++ K+ FG+A G + A GT +MA
Sbjct: 147 HD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTPHFMA 201
Query: 525 PEYAMGGIFSIKSDVFSFGVLL 546
PE + DV+ GV+L
Sbjct: 202 PEVVKREPYGKPVDVWGCGVIL 223
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-30
Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 351 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQ 406
++ + + LG+G FG V G+ AVK +S+ + EV L+ +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 407 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDW---KRRQSIINGIARG 463
H N+++L + L+ E LFD + II + G
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFD--EIISRKRFSEVDAARIIRQVLSG 138
Query: 464 ILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGTY 520
I Y+H+ KI+HRDLK N+LL D N +I DFGL+ F ++ GT
Sbjct: 139 ITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTA 192
Query: 521 GYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 553
Y+APE + G + K DV+S GV+L ++SG
Sbjct: 193 YYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 52/218 (23%), Positives = 86/218 (39%), Gaps = 29/218 (13%)
Query: 359 KLGQGGFGPVY---------------KGTLADGKAIAVKRLSRTSGQGLQE-FKNEVNLI 402
L QG F + K L + + S + + FKNE+ +I
Sbjct: 38 TLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 403 AKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL-----FDATRSVQLDWKRRQSII 457
++++ + G E+ +IYEYM N S+ D + + + + II
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 458 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 517
+ Y+H + I HRD+K SNIL+D + K+SDFG + +
Sbjct: 158 KSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK----IKGSR 211
Query: 518 GTYGYMAPEYAMG--GIFSIKSDVFSFGVLLLEIISGR 553
GTY +M PE+ K D++S G+ L +
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-30
Identities = 63/212 (29%), Positives = 94/212 (44%), Gaps = 22/212 (10%)
Query: 351 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQH 407
++ LG+G FG V K + AVK +++ + EV L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 408 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDW---KRRQSIINGIARGI 464
N+++L + ++ E LFD ++ II + GI
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGE----LFD--EIIKRKRFSEHDAARIIKQVFSGI 134
Query: 465 LYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 521
Y+H+ I+HRDLK NILL + D + KI DFGL+ F N GT
Sbjct: 135 TYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAY 188
Query: 522 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 553
Y+APE + G + K DV+S GV+L ++SG
Sbjct: 189 YIAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 50/208 (24%), Positives = 92/208 (44%), Gaps = 25/208 (12%)
Query: 351 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG-LQEFKNEVNLIAKLQHK 408
+ F + KLG G FG V+ + G +K +++ Q +++ + E+ ++ L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 409 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQ-------SIINGIA 461
N++++ + + ++ E L + R V + + ++ +
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGEL----LE--RIVSAQARGKALSEGYVAELMKQMM 134
Query: 462 RGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAG 518
+ Y H ++H+DLK NIL KI DFGLA +F +++ N AG
Sbjct: 135 NALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN---AAG 188
Query: 519 TYGYMAPEYAMGGIFSIKSDVFSFGVLL 546
T YMAPE + K D++S GV++
Sbjct: 189 TALYMAPE-VFKRDVTFKCDIWSAGVVM 215
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-30
Identities = 41/203 (20%), Positives = 80/203 (39%), Gaps = 24/203 (11%)
Query: 359 KLGQGGFGPVYKG--TLADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRLL- 414
+ GG G +Y +G+ + +K L + Q E +A++ H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 415 -GCCLEGQELLLIY---EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 470
+ + Y EY+ +SL +L + + I + YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLH-- 199
Query: 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 530
+ +++ DLK NI+L ++ K+ D G + GT G+ APE
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEIVRT 251
Query: 531 GIFSIKSDVFSFGVLLLEIISGR 553
G ++ +D+++ G L +
Sbjct: 252 GP-TVATDIYTVGRTLAALTLDL 273
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 61/203 (30%), Positives = 90/203 (44%), Gaps = 18/203 (8%)
Query: 351 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQH 407
++ LG+G FG V K + AVK +++ + EV L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 408 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILY 466
N+++L + ++ E LFD + + II + GI Y
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 467 LHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYM 523
+H+ I+HRDLK NILL + D + KI DFGL+ F N GT Y+
Sbjct: 137 MHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYI 190
Query: 524 APEYAMGGIFSIKSDVFSFGVLL 546
APE + G + K DV+S GV+L
Sbjct: 191 APE-VLRGTYDEKCDVWSAGVIL 212
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 16/201 (7%)
Query: 358 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRT----SGQGLQEFKNEVNLIAKLQHKNLVR 412
LG+G FG VY +A+K L + +G Q + EV + + L+H N++R
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILR 73
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 472
L G + + LI EY P ++ L ++ D +R + I +A + Y H
Sbjct: 74 LYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCH---S 127
Query: 473 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 532
++IHRD+K N+LL KI+DFG + ++ + GT Y+ PE G +
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTD--LCGTLDYLPPEMIEGRM 183
Query: 533 FSIKSDVFSFGVLLLEIISGR 553
K D++S GVL E + G+
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGK 204
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 9e-30
Identities = 48/201 (23%), Positives = 86/201 (42%), Gaps = 16/201 (7%)
Query: 351 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 409
+++ EN +G+G +G V A K++ + + + FK E+ ++ L H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLH 468
++RL + ++ L+ E LF+ I+ + + Y H
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYCH 123
Query: 469 EDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 525
+ L + HRDLK N L D K+ DFGLA F + GT Y++P
Sbjct: 124 K---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT---KVGTPYYVSP 177
Query: 526 EYAMGGIFSIKSDVFSFGVLL 546
+ + G++ + D +S GV++
Sbjct: 178 Q-VLEGLYGPECDEWSAGVMM 197
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 1e-29
Identities = 32/222 (14%), Positives = 67/222 (30%), Gaps = 22/222 (9%)
Query: 351 TNHFSDENKLGQGGFGPVYKGT------LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK 404
+ + LG+G F VY+ T + + +K + + +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 405 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLD--VHLFDATRSVQLDWKRRQSIINGIAR 462
++ L +L+ E +L ++L+ T + S +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 463 GILYLHEDSRLKIIHRDLKASNILLDDDMNP-----------KISDFGLARIFGGNQNQA 511
I +H+ +IIH D+K N +L + + D G +
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 512 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 553
T G+ E ++ + D F + ++ G
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-29
Identities = 48/201 (23%), Positives = 87/201 (43%), Gaps = 15/201 (7%)
Query: 351 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 409
+++ +LG G FG V++ A G+ K ++ KNE++++ +L H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD--ATRSVQLDWKRRQSIINGIARGILYL 467
L+ L + E++LI E++ LFD A ++ + + G+ ++
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSG----GELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 165
Query: 468 HEDSRLKIIHRDLKASNILLDDDMNP--KISDFGLARIFGGNQNQANTNIIAGTYGYMAP 525
HE I+H D+K NI+ + KI DFGLA ++ + T + AP
Sbjct: 166 HE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAP 219
Query: 526 EYAMGGIFSIKSDVFSFGVLL 546
E +D+++ GVL
Sbjct: 220 EIVDREPVGFYTDMWAIGVLG 240
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-29
Identities = 60/249 (24%), Positives = 103/249 (41%), Gaps = 37/249 (14%)
Query: 329 GGKQQAESQEFPLFPLRLALEATNHFSD----ENKLGQGGFGPVYKGT-LADGKAIAVKR 383
G++ Q + P + + KLG G +G V A+K
Sbjct: 9 SGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKV 68
Query: 384 LSR-------------TSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430
+ + + +E NE++L+ L H N+++L + + L+ E+
Sbjct: 69 IKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFY 128
Query: 431 PNKSLDVHLFDATRSVQLDW---KRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 487
L F+ + + +I+ I GI YLH+ I+HRD+K NILL
Sbjct: 129 EGGEL----FE--QIINRHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILL 179
Query: 488 ---DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGV 544
+ +N KI DFGL+ F + + GT Y+APE + ++ K DV+S GV
Sbjct: 180 ENKNSLLNIKIVDFGLSSFFSKDYKLRD---RLGTAYYIAPE-VLKKKYNEKCDVWSCGV 235
Query: 545 LLLEIISGR 553
++ ++ G
Sbjct: 236 IMYILLCGY 244
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 61/220 (27%), Positives = 94/220 (42%), Gaps = 32/220 (14%)
Query: 349 EATNHFSDE----NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGL---------QE 394
+T+ F + LG+G V + K AVK + T G +
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 395 FKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKR 452
EV+++ K+ H N+++L L+++ M L FD T V L K
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKE 125
Query: 453 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 512
+ I+ + I LH+ L I+HRDLK NILLDDDMN K++DFG + +
Sbjct: 126 TRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---K 179
Query: 513 TNIIAGTYGYMAPEYAMGGIFSIKS------DVFSFGVLL 546
+ GT Y+APE + D++S GV++
Sbjct: 180 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 57/207 (27%), Positives = 88/207 (42%), Gaps = 21/207 (10%)
Query: 351 TNHFSDE----NKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIA 403
+ FSD +LG+G F V + G A K ++ S + Q+ + E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 404 KLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIAR 462
KLQH N+VRL E L+++ + LF+ I I
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILE 116
Query: 463 GILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGT 519
I Y H I+HR+LK N+LL K++DFGLA ++ + AGT
Sbjct: 117 SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGT 170
Query: 520 YGYMAPEYAMGGIFSIKSDVFSFGVLL 546
GY++PE +S D+++ GV+L
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 5e-29
Identities = 45/204 (22%), Positives = 89/204 (43%), Gaps = 22/204 (10%)
Query: 351 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 409
+ LG+G FG V++ + K K + + G K E++++ +H+N
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRN 62
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVH---LFD--ATRSVQLDWKRRQSIINGIARGI 464
++ L +EL++I+E+ + +F+ T + +L+ + S ++ + +
Sbjct: 63 ILHLHESFESMEELVMIFEF-------ISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115
Query: 465 LYLHEDSRLKIIHRDLKASNILLDDDMNP--KISDFGLARIFGGNQNQANTNIIAGTYGY 522
+LH I H D++ NI+ + KI +FG AR N ++ Y
Sbjct: 116 QFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEY 169
Query: 523 MAPEYAMGGIFSIKSDVFSFGVLL 546
APE + S +D++S G L+
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLV 193
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-29
Identities = 61/201 (30%), Positives = 92/201 (45%), Gaps = 21/201 (10%)
Query: 354 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 412
S LG G FG V+K A G +A K + + +E KNE++++ +L H NL++
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVH---LFD--ATRSVQLDWKRRQSIINGIARGILYL 467
L +++L+ EY V LFD S L + I GI ++
Sbjct: 151 LYDAFESKNDIVLVMEY-------VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHM 203
Query: 468 HEDSRLKIIHRDLKASNILL--DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 525
H+ + I+H DLK NIL D KI DFGLAR + + + GT ++AP
Sbjct: 204 HQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL---KVNFGTPEFLAP 257
Query: 526 EYAMGGIFSIKSDVFSFGVLL 546
E S +D++S GV+
Sbjct: 258 EVVNYDFVSFPTDMWSVGVIA 278
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 59/205 (28%), Positives = 90/205 (43%), Gaps = 17/205 (8%)
Query: 359 KLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRLL 414
LG GG V+ L D + +AVK R F+ E A L H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 415 --GCCLEGQELLLIY---EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 469
G E L Y EY+ +L + + KR +I + + + H
Sbjct: 79 DTGE-AETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH- 133
Query: 470 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ-ANTNIIAGTYGYMAPEYA 528
+ IIHRD+K +NI++ K+ DFG+AR + N T + GT Y++PE A
Sbjct: 134 --QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 529 MGGIFSIKSDVFSFGVLLLEIISGR 553
G +SDV+S G +L E+++G
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-29
Identities = 60/261 (22%), Positives = 104/261 (39%), Gaps = 21/261 (8%)
Query: 295 APSSAPEEKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRLALEATNHF 354
AP P ++R + + +G+I + + + +H
Sbjct: 98 APVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIW--KQYYPQPVEIKHDHV 155
Query: 355 SD----ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 409
D +LG G FG V++ T A G A K + + + E+ ++ L+H
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD--ATRSVQLDWKRRQSIINGIARGILYL 467
LV L + E+++IYE+M LF+ A ++ + + +G+ ++
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMS----GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271
Query: 468 HEDSRLKIIHRDLKASNILLDDDMNP--KISDFGLARIFGGNQNQANTNIIAGTYGYMAP 525
HE +H DLK NI+ + K+ DFGL Q + + GT + AP
Sbjct: 272 HE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAP 325
Query: 526 EYAMGGIFSIKSDVFSFGVLL 546
E A G +D++S GVL
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLS 346
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 58/215 (26%), Positives = 90/215 (41%), Gaps = 21/215 (9%)
Query: 343 PLRLALEATNHFSDE----NKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEF 395
+ A+ FSD +LG+G F V + G A K ++ S + Q+
Sbjct: 16 GSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL 75
Query: 396 KNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQ 454
+ E + KLQH N+VRL E L+++ + LF+
Sbjct: 76 EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADAS 131
Query: 455 SIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQA 511
I I I Y H I+HR+LK N+LL K++DFGLA ++
Sbjct: 132 HCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--- 185
Query: 512 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 546
+ AGT GY++PE +S D+++ GV+L
Sbjct: 186 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 1e-28
Identities = 46/247 (18%), Positives = 82/247 (33%), Gaps = 31/247 (12%)
Query: 385 SRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATR 444
+S + ++ + KN V L L + + ++L +
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157
Query: 445 SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 504
+ I IA + +LH ++HRDLK SNI D K+ DFGL
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214
Query: 505 GGNQNQANTNIIA----------GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRK 554
++ + GT YM+PE G +S K D+FS G++L E++
Sbjct: 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS 274
Query: 555 NNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPAD 614
E + + + + Q + + + P +
Sbjct: 275 T----QMERVRIIT----DV-RNLK----FPLLFTQKY--PQEHMMVQ---DMLSPSPTE 316
Query: 615 RPTMSSV 621
RP + +
Sbjct: 317 RPEATDI 323
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 45/201 (22%), Positives = 78/201 (38%), Gaps = 11/201 (5%)
Query: 357 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSR--TSGQGLQE-FKNEVNLIAKLQHKNLVR 412
+G+GG G VY+ + +A+K +S +S + + E +LQ ++V
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 472
+ +L + + L L L R +I+ I + H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA-- 153
Query: 473 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 532
HRD+K NIL+ D + DFG+A GT YMAPE
Sbjct: 154 -GATHRDVKPENILVSADDFAYLVDFGIASATTDE-KLTQLGNTVGTLYYMAPERFSESH 211
Query: 533 FSIKSDVFSFGVLLLEIISGR 553
+ ++D+++ +L E ++G
Sbjct: 212 ATYRADIYALTCVLYECLTGS 232
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 14/198 (7%)
Query: 360 LGQGGFGPVYKG-TLADGKAIAVKRLSRT--SGQGLQE-FKNEVNLIAKLQHKNLVRLLG 415
LG+G FG VY + +A+K L ++ +G++ + E+ + + L+H N++R+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 416 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 475
+ + + L+ E+ P L L R D +R + + +A + Y H K+
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALHYCH---ERKV 135
Query: 476 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 535
IHRD+K N+L+ KI+DFG + + + GT Y+ PE G
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDE 191
Query: 536 KSDVFSFGVLLLEIISGR 553
K D++ GVL E + G
Sbjct: 192 KVDLWCAGVLCYEFLVGM 209
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 52/207 (25%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 358 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN--------EVNLIAKLQHK 408
K+G+G +G V+K + +A+KR+ L + E+ L+ +L+HK
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLLKELKHK 61
Query: 409 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 468
N+VRL ++L L++E+ D+ + + + LD + +S + + +G+ + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFC---DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 469 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 528
++HRDLK N+L++ + K+++FGLAR F G + + + T Y P+
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLWYRPPDVL 173
Query: 529 MGG-IFSIKSDVFSFGVLLLEIISGRK 554
G ++S D++S G + E+ + +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 58/238 (24%), Positives = 100/238 (42%), Gaps = 31/238 (13%)
Query: 330 GKQQAESQEFPLFPLRLALEATNHFSDE----NKLGQGGFGPVYKGT-LADGKAIAVKRL 384
G + Q A F + + +G+G V + A G AVK +
Sbjct: 68 GTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIM 127
Query: 385 SRTSGQGLQE--------FKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPNKSL 435
T+ + E + E +++ ++ H +++ L+ + L+++ M L
Sbjct: 128 EVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL 187
Query: 436 DVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPK 494
FD T V L K +SI+ + + +LH I+HRDLK NILLDD+M +
Sbjct: 188 ----FDYLTEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIR 240
Query: 495 ISDFGLARIFGGNQNQANTNIIAGTYGYMAPE------YAMGGIFSIKSDVFSFGVLL 546
+SDFG + + + GT GY+APE + + D+++ GV+L
Sbjct: 241 LSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 60/205 (29%), Positives = 105/205 (51%), Gaps = 23/205 (11%)
Query: 358 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKN--------EVNLIAKLQHKN 409
K+G+G +G VYK + G+ +A+KR+ L E++L+ +L H N
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLKELHHPN 80
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 469
+V L+ + L L++E+M D+ L + + + + RG+ + H+
Sbjct: 81 IVSLIDVIHSERCLTLVFEFME---KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ 137
Query: 470 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 529
+I+HRDLK N+L++ D K++DFGLAR F G ++ T+ + T Y AP+ M
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYRAPDVLM 192
Query: 530 GG-IFSIKSDVFSFGVLLLEIISGR 553
G +S D++S G + E+I+G+
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 30/202 (14%)
Query: 357 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 415
LG G F V+ GK A+K + ++ +NE+ ++ K++H+N+V L
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 416 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQS--------IINGIARGILYL 467
L+ + + L FD R ++ R +I + + YL
Sbjct: 74 IYESTTHYYLVMQLVSGGEL----FD--RILE-----RGVYTEKDASLVIQQVLSAVKYL 122
Query: 468 HEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 524
HE I+HRDLK N+L +++ I+DFGL+++ + GT GY+A
Sbjct: 123 HE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MSTACGTPGYVA 175
Query: 525 PEYAMGGIFSIKSDVFSFGVLL 546
PE +S D +S GV+
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVIT 197
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 39/309 (12%), Positives = 85/309 (27%), Gaps = 78/309 (25%)
Query: 360 LGQGGFGPVYKGT-LADGKAIAVKRLS---RTSGQGLQEFKNEVNLIAKLQ--------- 406
LGQ + T G++ V R +++ K EV + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 407 -------------HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ------ 447
+++ L+ +++ ++ + + +L +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 448 --LDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505
L R + + R + LH ++H L+ +I+LD ++ F G
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 506 GNQNQANTNIIAGTYGYMAPEY----------AMGGIFSIKSDVFSFGVLLLEIISGRKN 555
+ + G+ PE + + D ++ G+ + I
Sbjct: 263 ------ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD-- 314
Query: 556 NGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCA--PDELLKFIHIGLLCVQQDPA 613
A + +SC P + + G L +
Sbjct: 315 --LPN----------------TDDAALGGSEWIFRSCKNIPQPVRALLE-GFL--RYPKE 353
Query: 614 DRPTMSSVV 622
DR +
Sbjct: 354 DRLLPLQAM 362
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 59/276 (21%), Positives = 94/276 (34%), Gaps = 52/276 (18%)
Query: 327 LRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVK--- 382
+ + +E F LE + + +GQG +G V A+K
Sbjct: 1 MHHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60
Query: 383 --RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP--------- 431
++ + + + ++ K EV L+ KL H N+ RL + Q + L+ E
Sbjct: 61 KNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN 120
Query: 432 --NKSLDVHLFDATRSVQLDWKRRQ--------------------------SIINGIARG 463
Q+ +I+ I
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180
Query: 464 ILYLHEDSRLKIIHRDLKASNILL--DDDMNPKISDFGLARIFGGNQNQANTNI--IAGT 519
+ YLH I HRD+K N L + K+ DFGL++ F N + AGT
Sbjct: 181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237
Query: 520 YGYMAPEYAMGGIFSI--KSDVFSFGVLLLEIISGR 553
++APE S K D +S GVLL ++ G
Sbjct: 238 PYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 23/205 (11%)
Query: 358 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKN--------EVNLIAKLQHKN 409
K+G+G +G VYK G+ A+K++ L++ E++++ +L+H N
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILKELKHSN 61
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 469
+V+L + L+L++E++ D+ L+ +S + + GI Y H+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHL---DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 470 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 529
+++HRDLK N+L++ + KI+DFGLAR F G + T+ I T Y AP+ M
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYRAPDVLM 173
Query: 530 GG-IFSIKSDVFSFGVLLLEIISGR 553
G +S D++S G + E+++G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 22/208 (10%)
Query: 351 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVK------RLSRTSGQGLQEFKNEVNLIA 403
+ + +LG G F V K + G A K + G +E + EV+++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 404 KLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIAR 462
++ H N++ L +++LI E + LFD + L + S I I
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSG----GELFDFLAQKESLSEEEATSFIKQILD 126
Query: 463 GILYLHEDSRLKIIHRDLKASNILL----DDDMNPKISDFGLARIFGGNQNQANTNIIAG 518
G+ YLH KI H DLK NI+L + K+ DFGLA I G
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFG 180
Query: 519 TYGYMAPEYAMGGIFSIKSDVFSFGVLL 546
T ++APE +++D++S GV+
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 43/311 (13%), Positives = 88/311 (28%), Gaps = 81/311 (26%)
Query: 360 LGQGGFGPVYKGT-LADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQ--------- 406
LGQ + T G++ V T +++ K EV + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 407 ----------------HKNLVRLLGCC--LEGQELLLIYEYMPNKSLDV--HLFD-ATRS 445
K ++R+ + +Y M + L ++
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 446 VQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505
L R + + R + LH ++H L+ +I+LD ++ F G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 506 GNQNQANTNIIAGTYGYMAPEY-----------AMGGIFSIKSDVFSFGVLLLEIISGRK 554
+ + + G+ PE + + D ++ G+++ I
Sbjct: 258 ------ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD- 310
Query: 555 NNGFYFSEHGQTLLTYTWKL-WCEGPAVELIDPVLKQSCA--PDELLKFIHIGLLCVQQD 611
L + A+ + + + SC P + + G L
Sbjct: 311 -------------------LPITKDAALGGSEWIFR-SCKNIPQPVRALLE-GFLRY--P 347
Query: 612 PADRPTMSSVV 622
DR +
Sbjct: 348 KEDRLLPLQAM 358
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-27
Identities = 56/222 (25%), Positives = 104/222 (46%), Gaps = 36/222 (16%)
Query: 349 EATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQH 407
+ +++ +G G FG V++ L + +A+K++ + + FKN E+ ++ ++H
Sbjct: 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKH 91
Query: 408 KNLVRLLGCCLEGQE------LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING-- 459
N+V L + L L+ EY+P V+ R+ + K +Q++
Sbjct: 92 PNVVDLKAFFYSNGDKKDEVFLNLVLEYVP---ETVY-----RASRHYAKLKQTMPMLLI 143
Query: 460 ------IARGILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQAN 512
+ R + Y+H + I HRD+K N+LLD K+ DFG A+I + N
Sbjct: 144 KLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPN 198
Query: 513 TNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 553
+ I Y Y APE G ++ D++S G ++ E++ G+
Sbjct: 199 VSYICSRY-YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-27
Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 20/212 (9%)
Query: 346 LALEATNHFSDE----NKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNE 398
+A F++E +LG+G F V + + G+ A ++ S + Q+ + E
Sbjct: 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 399 VNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSII 457
+ L+H N+VRL E LI++ + L F+ I
Sbjct: 61 ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADASHCI 116
Query: 458 NGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTN 514
I +L+ H+ + ++HR+LK N+LL K++DFGLA G Q
Sbjct: 117 QQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG- 172
Query: 515 IIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 546
AGT GY++PE + D+++ GV+L
Sbjct: 173 -FAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 22/208 (10%)
Query: 351 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVK------RLSRTSGQGLQEFKNEVNLIA 403
+ + +LG G F V K + G A K + G +E + EV+++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 404 KLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIAR 462
++ H N++ L +++LI E + LFD + L + S I I
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSG----GELFDFLAQKESLSEEEATSFIKQILD 126
Query: 463 GILYLHEDSRLKIIHRDLKASNILL----DDDMNPKISDFGLARIFGGNQNQANTNIIAG 518
G+ YLH KI H DLK NI+L + K+ DFGLA I G
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFG 180
Query: 519 TYGYMAPEYAMGGIFSIKSDVFSFGVLL 546
T ++APE +++D++S GV+
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 64/215 (29%), Positives = 109/215 (50%), Gaps = 18/215 (8%)
Query: 348 LEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG-----LQEFKNEVNL 401
+ +++ F KLG G + VYKG G +A+K + S +G ++E ++L
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISL 56
Query: 402 IAKLQHKNLVRLLGCCLEGQELLLIYEYMPN--KSLDVHLFDATRSVQLDWKRRQSIING 459
+ +L+H+N+VRL +L L++E+M N K L+ +
Sbjct: 57 MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 460 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 519
+ +G+ + HE+ KI+HRDLK N+L++ K+ DFGLAR F G ++ + T
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV-T 171
Query: 520 YGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGR 553
Y AP+ MG +S D++S G +L E+I+G+
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 67/306 (21%), Positives = 109/306 (35%), Gaps = 54/306 (17%)
Query: 351 TNHFSD-----ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK 404
+ F D E+ LG+G V L + AVK + + G EV ++ +
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66
Query: 405 LQ-HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIAR 462
Q H+N++ L+ E L++E M S+ + + ++ +A
Sbjct: 67 CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEASVVVQDVAS 122
Query: 463 GILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNI---- 515
+ +LH I HRDLK NIL + KI DF L N + + +
Sbjct: 123 ALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179
Query: 516 -IAGTYGYMAPEYAMGGIFSIKS-----DVFSFGVLLLEIISGRKNNGFY--FSEHGQTL 567
G+ YMAPE D++S GV+L ++SG Y F +
Sbjct: 180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG------YPPFVGRCGSD 233
Query: 568 LTYTWKLWCEGPAVELIDPVLKQ------------SCAPDELLKFIHIGLLCVQQDPADR 615
+ C L + + + SCA +L+ LL D R
Sbjct: 234 CGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLIS----KLLVR--DAKQR 287
Query: 616 PTMSSV 621
+ + V
Sbjct: 288 LSAAQV 293
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-27
Identities = 56/211 (26%), Positives = 88/211 (41%), Gaps = 28/211 (13%)
Query: 351 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRL------SRTSGQGLQEFKNEVNLIA 403
+++ +LG G F V K + G A K + S G ++ + EV+++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 404 KLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVH---LFDA-TRSVQLDWKRRQSIING 459
++QH N++ L +++LI E V LFD L + +
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILEL-------VAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 460 IARGILYLHEDSRLKIIHRDLKASNILL----DDDMNPKISDFGLARIFGGNQNQANTNI 515
I G+ YLH L+I H DLK NI+L KI DFGLA
Sbjct: 123 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKN 176
Query: 516 IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 546
I GT ++APE +++D++S GV+
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 53/207 (25%), Positives = 86/207 (41%), Gaps = 22/207 (10%)
Query: 360 LGQGGFGPVYKGT-LADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKNLVRLL 414
LG+G +G V + AVK L + G K E+ L+ +L+HKN+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 415 G--CCLEGQELLLIYEYMPNKSLDVHLFD--ATRSVQLDWKRR--QSIINGIARGILYLH 468
E Q++ ++ EY + + D + + +I+G+ YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH 126
Query: 469 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 528
I+H+D+K N+LL KIS G+A G+ + PE A
Sbjct: 127 ---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183
Query: 529 MG--GIFSIKSDVFSFGVLLLEIISGR 553
G K D++S GV L I +G
Sbjct: 184 NGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 26/210 (12%)
Query: 351 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVK------RLSRTSGQGLQEFKNEVNLIA 403
+H+ +LG G F V K GK A K S G +E + EVN++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 404 KLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDW---KRRQSIINGI 460
+++H N++ L +++LI E + L FD + + + I
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGEL----FD--FLAEKESLTEDEATQFLKQI 117
Query: 461 ARGILYLHEDSRLKIIHRDLKASNILL----DDDMNPKISDFGLARIFGGNQNQANTNII 516
G+ YLH +I H DLK NI+L + K+ DFG+A I
Sbjct: 118 LDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNI 171
Query: 517 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 546
GT ++APE +++D++S GV+
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-26
Identities = 51/204 (25%), Positives = 86/204 (42%), Gaps = 27/204 (13%)
Query: 359 KLGQGGFGPVYKGT-LADGKAIAVKRLSR--------TSGQGLQEFKNEVNLIAKLQHKN 409
LG G G V K +A++ +S+ + E+ ++ KL H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLH 468
++++ + ++ ++ E M L FD + +L + + + YLH
Sbjct: 202 IIKIKNFF-DAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLH 256
Query: 469 EDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 525
E IIHRDLK N+LL ++D KI+DFG ++I G + GT Y+AP
Sbjct: 257 E---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAP 310
Query: 526 E---YAMGGIFSIKSDVFSFGVLL 546
E ++ D +S GV+L
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 58/206 (28%), Positives = 108/206 (52%), Gaps = 21/206 (10%)
Query: 358 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN--------EVNLIAKLQHK 408
+ LG+G F VYK + +A+K++ + + E K+ E+ L+ +L H
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKI-KLGHR--SEAKDGINRTALREIKLLQELSHP 72
Query: 409 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 468
N++ LL + L++++M D+ + S+ L ++ + +G+ YLH
Sbjct: 73 NIIGLLDAFGHKSNISLVFDFME---TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 469 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 528
+ I+HRDLK +N+LLD++ K++DFGLA+ F G+ N+A T+ + T Y APE
Sbjct: 130 QH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV-TRWYRAPELL 184
Query: 529 MGG-IFSIKSDVFSFGVLLLEIISGR 553
G ++ + D+++ G +L E++
Sbjct: 185 FGARMYGVGVDMWAVGCILAELLLRV 210
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 359 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE--------FKNEVNLIAKLQHKN 409
LG G G V K +A+K +S+ + E+ ++ KL H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLH 468
++++ + ++ ++ E M L FD + +L + + + YLH
Sbjct: 77 IIKIKNFF-DAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLH 131
Query: 469 EDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 525
E IIHRDLK N+LL ++D KI+DFG ++I G + GT Y+AP
Sbjct: 132 E---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAP 185
Query: 526 EYAMGGI---FSIKSDVFSFGVLL 546
E + ++ D +S GV+L
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 24/206 (11%)
Query: 358 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN--------EVNLIAKLQHK 408
K+G+G +G V+K G+ +A+K+ E E+ ++ +L+H
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKF------LESEDDPVIKKIALREIRMLKQLKHP 62
Query: 409 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 468
NLV LL + L L++EY V + +SI + + + H
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYC---DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 469 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 528
+ IHRD+K NIL+ K+ DFG AR+ G + + +A T Y +PE
Sbjct: 120 ---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVA-TRWYRSPELL 174
Query: 529 MGG-IFSIKSDVFSFGVLLLEIISGR 553
+G + DV++ G + E++SG
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 47/196 (23%), Positives = 82/196 (41%), Gaps = 18/196 (9%)
Query: 357 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLL 414
+ LG+G F K +A AVK +S+ + E+ + + H N+V+L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLH 72
Query: 415 GCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRL 473
+ L+ E + L F+ + I+ + + ++H+ +
Sbjct: 73 EVFHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMHD---V 125
Query: 474 KIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 530
++HRDLK N+L +D++ KI DFG AR+ + T T Y APE
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPELLNQ 183
Query: 531 GIFSIKSDVFSFGVLL 546
+ D++S GV+L
Sbjct: 184 NGYDESCDLWSLGVIL 199
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 50/222 (22%), Positives = 87/222 (39%), Gaps = 25/222 (11%)
Query: 337 QEFPLFPLRLAL-EATNHFSDE----NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQ 390
Q + + L + F+D +G G + + A AVK + ++
Sbjct: 2 QTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD 61
Query: 391 GLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQL 448
E+ ++ + QH N++ L +G+ + ++ E M L D R
Sbjct: 62 P----TEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFF 113
Query: 449 DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNP-KISDFGLARIF 504
+ +++ I + + YLH ++HRDLK SNIL + +I DFG A+
Sbjct: 114 SEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170
Query: 505 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 546
T T ++APE + D++S GVLL
Sbjct: 171 RAENGLLMT--PCYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 59/235 (25%), Positives = 99/235 (42%), Gaps = 24/235 (10%)
Query: 329 GGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT 387
G S L L ++ + + +G+G +G V K G+ +A+K+
Sbjct: 2 GHHHHHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL-- 59
Query: 388 SGQGLQEFKN--------EVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL 439
+ E+ L+ +L+H+NLV LL C + + L++E++ +
Sbjct: 60 ----ESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV---DHTILD 112
Query: 440 FDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 499
LD++ Q + I GI + H IIHRD+K NIL+ K+ DFG
Sbjct: 113 DLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFG 169
Query: 500 LARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGR 553
AR + + +A T Y APE +G + DV++ G L+ E+ G
Sbjct: 170 FARTLAA-PGEVYDDEVA-TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 64/202 (31%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 360 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRLLGCC 417
LG+G +G V +A+AVK + E K E+ + L H+N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 418 LEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRR--QSIINGIARGILYLHEDSR 472
EG L EY L FD + +R ++ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123
Query: 473 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 532
+ I HRD+K N+LLD+ N KISDFGLA +F N + N + GT Y+APE
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 533 FS-IKSDVFSFGVLLLEIISGR 553
F DV+S G++L +++G
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGE 205
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 53/237 (22%), Positives = 91/237 (38%), Gaps = 39/237 (16%)
Query: 332 QQAESQEFPLFPLRLALEATNHFSD-----ENKLGQGGFGPVYKGT-LADGKAIAVK--R 383
S L L ++ +F++ +LG+G F V + + G+ A K +
Sbjct: 4 HHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK 63
Query: 384 LSRTSGQGLQEFKNEVNLIAKLQH-KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA 442
R E +E+ ++ + ++ L E++LI EY +F
Sbjct: 64 KRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGE----IFS- 118
Query: 443 TRSVQLDWKR----------RQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DD 489
+ + +Q I G+ YLH+ I+H DLK NILL
Sbjct: 119 -LCLPELAEMVSENDVIRLIKQ-----ILEGVYYLHQ---NNIVHLDLKPQNILLSSIYP 169
Query: 490 DMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 546
+ KI DFG++R G I GT Y+APE + +D+++ G++
Sbjct: 170 LGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 54/209 (25%), Positives = 99/209 (47%), Gaps = 19/209 (9%)
Query: 352 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG-----LQEFKNEVNLIAKL 405
+ +KLG+G + VYKG +A+K + +G ++E V+L+ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDL 57
Query: 406 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 465
+H N+V L + L L++EY+ D+ + ++ + + + RG+
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYL---DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114
Query: 466 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 525
Y H K++HRDLK N+L+++ K++DFGLAR + N + T Y P
Sbjct: 115 YCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLWYRPP 169
Query: 526 EYAMGG-IFSIKSDVFSFGVLLLEIISGR 553
+ +G +S + D++ G + E+ +GR
Sbjct: 170 DILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-26
Identities = 64/221 (28%), Positives = 104/221 (47%), Gaps = 37/221 (16%)
Query: 351 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHK 408
++D +G G FG VY+ L D G+ +A+K++ + + FKN E+ ++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 409 NLVRLLGCCLEGQE------LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING--- 459
N+VRL E L L+ +Y+P V+ R + + +Q++
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP---ETVY-----RVARHYSRAKQTLPVIYVK 159
Query: 460 -----IARGILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANT 513
+ R + Y+H I HRD+K N+LLD D K+ DFG A+ + + N
Sbjct: 160 LYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNV 214
Query: 514 NIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGR 553
+ I Y Y APE G + DV+S G +L E++ G+
Sbjct: 215 SYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-26
Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 35/225 (15%)
Query: 349 EATNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRL-------SRTSGQGLQEFKNEVN 400
+ + F E GQG FG V G G ++A+K++ +R LQ +
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE----LQIMQ---- 71
Query: 401 LIAKLQHKNLVRLLGCCLEGQE-------LLLIYEYMPNKSLDVHLF---DATRSVQLDW 450
+A L H N+V+L E L ++ EY+P +H R V
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP---DTLHRCCRNYYRRQVAPPP 128
Query: 451 KRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQN 509
+ + + R I LH S + + HRD+K N+L+++ K+ DFG A+ + +
Sbjct: 129 ILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL--SPS 185
Query: 510 QANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 553
+ N I Y Y APE G ++ D++S G + E++ G
Sbjct: 186 EPNVAYICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 64/202 (31%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 360 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRLLGCC 417
LG+G +G V +A+AVK + E K E+ + L H+N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 418 LEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRR--QSIINGIARGILYLHEDSR 472
EG L EY L FD + +R ++ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123
Query: 473 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 532
+ I HRD+K N+LLD+ N KISDFGLA +F N + N + GT Y+APE
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 533 FS-IKSDVFSFGVLLLEIISGR 553
F DV+S G++L +++G
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGE 205
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 417
+LG+G VY+ K A+K L +T + + + E+ ++ +L H N+++L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 418 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQS--------IINGIARGILYLHE 469
E+ L+ E + L FD R V+ + + I + YLHE
Sbjct: 118 ETPTEISLVLELVTGGEL----FD--RIVE-----KGYYSERDAADAVKQILEAVAYLHE 166
Query: 470 DSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 526
I+HRDLK N+L D KI+DFGL++I + GT GY APE
Sbjct: 167 ---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPE 220
Query: 527 YAMGGIFSIKSDVFSFGVLL 546
G + + D++S G++
Sbjct: 221 ILRGCAYGPEVDMWSVGIIT 240
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 57/211 (27%), Positives = 106/211 (50%), Gaps = 21/211 (9%)
Query: 359 KLGQGGFGPVYKG---TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 415
K+G+G +G VYK D K A+K++ +G + + E+ L+ +L+H N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQK 85
Query: 416 CCLEGQE--LLLIYEYMPN---KSLDVH--LFDATRSVQLDWKRRQSIINGIARGILYLH 468
L + + L+++Y + + H + VQL +S++ I GI YLH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 469 EDSRLKIIHRDLKASNILLDDDMNP----KISDFGLARIFGG-NQNQANTNIIAGTYGYM 523
+ ++HRDLK +NIL+ + KI+D G AR+F + A+ + + T+ Y
Sbjct: 146 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 202
Query: 524 APEYAMGG-IFSIKSDVFSFGVLLLEIISGR 553
APE +G ++ D+++ G + E+++
Sbjct: 203 APELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 32/212 (15%)
Query: 358 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN--------EVNLIAKLQHK 408
KLG+G +G VYK + +A+KR+ L+ + EV+L+ +LQH+
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLLKELQHR 93
Query: 409 NLVRLLGCCLEGQELLLIYEYMPNKSLDVH-LFDATRSVQLDWKRRQSIINGIARGILYL 467
N++ L L LI+EY D+ D ++ + + +S + + G+ +
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYA---ENDLKKYMD--KNPDVSMRVIKSFLYQLINGVNFC 148
Query: 468 HEDSRLKIIHRDLKASNILLDDDMNP-----KISDFGLARIFGGNQNQANTNIIAGTYGY 522
H + +HRDLK N+LL KI DFGLAR F G + T+ I T Y
Sbjct: 149 HSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEII-TLWY 203
Query: 523 MAPEYAMGG-IFSIKSDVFSFGVLLLEIISGR 553
PE +G +S D++S + E++
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 32/209 (15%)
Query: 360 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEF---KNEVNLIAKLQHKNLVR 412
LG+G F V T + A+K L + + E +++++L H V+
Sbjct: 38 LGEGSFSTVVLARELAT---SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR--------GI 464
L + ++L Y N L ++ ++ S R +
Sbjct: 95 LYFTFQDDEKLYFGLSYAKNGELLKYI-----------RKIGSFDETCTRFYTAEIVSAL 143
Query: 465 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 524
YLH IIHRDLK NILL++DM+ +I+DFG A++ QA N GT Y++
Sbjct: 144 EYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 200
Query: 525 PEYAMGGIFSIKSDVFSFGVLLLEIISGR 553
PE SD+++ G ++ ++++G
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 57/231 (24%), Positives = 94/231 (40%), Gaps = 51/231 (22%)
Query: 360 LGQGGFGPVYKGT-LADGKAIAVKRLSRT--------------------------SGQGL 392
+G+G +G V D A+K LS+ +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 393 QEFKNEVNLIAKLQHKNLVRLLGCCLEG---QELLLIYEYMPNKSLDVHLFDATRSVQLD 449
++ E+ ++ KL H N+V+L+ L+ L +++E + + + L
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLS 135
Query: 450 ----WKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505
Q +I GI YLH KIIHRD+K SN+L+ +D + KI+DFG++ F
Sbjct: 136 EDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 506 GNQNQANTNIIAGTYGYMAPEYAMGGIFSI---KSDVFSFGVLLLEIISGR 553
G+ + GT +MAPE DV++ GV L + G+
Sbjct: 189 GSDALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 78/276 (28%), Positives = 118/276 (42%), Gaps = 23/276 (8%)
Query: 290 AVGALAPSSAPEEKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRLALE 349
L + + + + F + H ++ +S F F LE
Sbjct: 122 FCSFLDAETVARARAGAGDGLFQPLLRAVLAHLGQAPF---QEFLDSLYFLRFLQWKWLE 178
Query: 350 AT----NHFSDENKLGQGGFGPVY----KGTLADGKAIAVKRLSR---TSGQGLQEFKNE 398
A + F D LG+GGFG V+ K T GK A K+L++ +G Q E
Sbjct: 179 AQPMGEDWFLDFRVLGRGGFGEVFACQMKAT---GKLYACKKLNKKRLKKRKGYQGAMVE 235
Query: 399 VNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSII 457
++AK+ + +V L +L L+ M + H+++ + R
Sbjct: 236 KKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 458 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 517
I G+ +LH+ II+RDLK N+LLDDD N +ISD GLA Q + A
Sbjct: 296 AQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YA 350
Query: 518 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 553
GT G+MAPE +G + D F+ GV L E+I+ R
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 54/215 (25%), Positives = 101/215 (46%), Gaps = 34/215 (15%)
Query: 358 NKLGQGGFGPVYKG--TLADGKAIAVKRLSRTSGQGLQEFKN--------EVNLIAKLQ- 406
++G+G +G V+K G+ +A+KR+ +Q + EV ++ L+
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAVLRHLET 70
Query: 407 --HKNLVRLLGCCLEGQE-----LLLIYEYMPNKSLDV-HLFDATRSVQLDWKRRQSIIN 458
H N+VRL C + L L++E++ D+ D + + + ++
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV---DQDLTTYLDKVPEPGVPTETIKDMMF 127
Query: 459 GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAG 518
+ RG+ +LH +++HRDLK NIL+ K++DFGLARI+ T+++
Sbjct: 128 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVV- 181
Query: 519 TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 553
T Y APE + ++ D++S G + E+ +
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 24/211 (11%)
Query: 358 NKLGQGGFGPVYKGT-LADGKAIAVKRLS-RTSGQGLQEFKN----EVNLIAKLQ---HK 408
++G G +G VYK G +A+K + G G EV L+ +L+ H
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 409 NLVRLLGCCLEGQE-----LLLIYEYMPNKSLDV-HLFDATRSVQLDWKRRQSIINGIAR 462
N+VRL+ C + + L++E++ D+ D L + + ++ R
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIKDLMRQFLR 131
Query: 463 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 522
G+ +LH + I+HRDLK NIL+ K++DFGLARI+ A T ++ T Y
Sbjct: 132 GLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYS--YQMALTPVVV-TLWY 185
Query: 523 MAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 553
APE + ++ D++S G + E+ +
Sbjct: 186 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 23/203 (11%)
Query: 360 LGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGC 416
+G+G F V + G+ +A+K + +T + LQ+ EV ++ L H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 417 CLEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRR--QSIINGIARGILYLHEDS 471
+ L LI EY + FD A ++ R + I++ + Y H
Sbjct: 83 IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSAVQ----YCH--- 131
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 531
+ +I+HRDLKA N+LLD DMN KI+DFG + F + + G Y APE G
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAF--CGAPPYAAPELFQGK 188
Query: 532 IFS-IKSDVFSFGVLLLEIISGR 553
+ + DV+S GV+L ++SG
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGS 211
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 54/217 (24%), Positives = 102/217 (47%), Gaps = 34/217 (15%)
Query: 358 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN--------EVNLIAKLQHK 408
K+GQG FG V+K G+ +A+K++ ++ K E+ ++ L+H+
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKILQLLKHE 76
Query: 409 NLVRLLGCCLEGQE--------LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI 460
N+V L+ C + L++++ D+ + V+ + ++ +
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFC---EHDLAGLLSNVLVKFTLSEIKRVMQML 133
Query: 461 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN---TNIIA 517
G+ Y+H + KI+HRD+KA+N+L+ D K++DFGLAR F +N TN +
Sbjct: 134 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 190
Query: 518 GTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGR 553
T Y PE +G + D++ G ++ E+ +
Sbjct: 191 -TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-24
Identities = 62/201 (30%), Positives = 90/201 (44%), Gaps = 17/201 (8%)
Query: 360 LGQGGFGPVY----KGTLADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQHKNLVR 412
LG+GGFG V + T GK A K+L + +G NE ++ K+ + +V
Sbjct: 192 LGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 472
L L L+ M L H++ ++ R I G+ LH
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG-FPEARAVFYAAEICCGLEDLHR--- 304
Query: 473 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 532
+I++RDLK NILLDD + +ISD GLA Q GT GYMAPE
Sbjct: 305 ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNER 361
Query: 533 FSIKSDVFSFGVLLLEIISGR 553
++ D ++ G LL E+I+G+
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQ 382
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-24
Identities = 48/211 (22%), Positives = 80/211 (37%), Gaps = 44/211 (20%)
Query: 356 DENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRL 413
+ LG G G V + G+ A+K L + + + EV+ + ++V +
Sbjct: 33 SKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCI 87
Query: 414 LGCCLEGQELLLIYEYMPNKSLDVH----------LFDATRSVQLDWKR---RQ--SIIN 458
L +YE M + + LF R + + R+ I+
Sbjct: 88 LD----------VYENMHHGKRCLLIIMECMEGGELFS--RIQERGDQAFTEREAAEIMR 135
Query: 459 GIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNI 515
I I +LH I HRD+K N+L + D K++DFG A+ N
Sbjct: 136 DIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQT 188
Query: 516 IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 546
T Y+APE + D++S GV++
Sbjct: 189 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 22/206 (10%)
Query: 360 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN------EVNLIAKLQHK--NL 410
LG GGFG VY G ++D +A+K + + E N EV L+ K+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 411 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIARGILYLHE 469
+RLL +LI E P D LFD T L + +S + + + H
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELARSFFWQVLEAVRHCH- 166
Query: 470 DSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 528
++HRD+K NIL+D + K+ DFG + GT Y PE+
Sbjct: 167 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTD--FDGTRVYSPPEWI 220
Query: 529 MGGIFS-IKSDVFSFGVLLLEIISGR 553
+ + V+S G+LL +++ G
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 49/215 (22%), Positives = 85/215 (39%), Gaps = 40/215 (18%)
Query: 360 LGQGGFGPVYKGT-LADGKAIAVKRLSRT--------SGQGLQEFKNEVNLIAKLQHKNL 410
LG G FG V+ K + VK + + L + E+ ++++++H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 411 VRLLGCCLEGQELLLIYEYMPNKS-----LDVH-----LFD-ATRSVQLDWKRRQSIING 459
+++ + N+ ++ H LF R +LD I
Sbjct: 92 IKV-------------LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 460 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 519
+ + YL IIHRD+K NI++ +D K+ DFG A + GT
Sbjct: 139 LVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFYTFCGT 192
Query: 520 YGYMAPEYAMGGIFS-IKSDVFSFGVLLLEIISGR 553
Y APE MG + + +++S GV L ++
Sbjct: 193 IEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-23
Identities = 56/238 (23%), Positives = 92/238 (38%), Gaps = 37/238 (15%)
Query: 329 GGKQQAESQEFPLFPLRLALEA-TNHFSDE-----NKLGQGGFGPVYKGT-LADGKAIAV 381
Q+FP F ++ L+ N D+ LG G G V + + A+
Sbjct: 33 AQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFAL 92
Query: 382 KRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLG----CCLEGQELLLIYEYMPNKSLD 436
K L + + EV L + ++VR++ + LL++ E + L
Sbjct: 93 KMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL- 146
Query: 437 VHLFDATRSVQLDWKR---RQ--SIINGIARGILYLHEDSRLKIIHRDLKASNILL---D 488
F R + R+ I+ I I YLH + I HRD+K N+L
Sbjct: 147 ---FS--RIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKR 198
Query: 489 DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 546
+ K++DFG A+ + N T T Y+APE + D++S GV++
Sbjct: 199 PNAILKLTDFGFAKETTSH-NSLTT--PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 7e-23
Identities = 55/208 (26%), Positives = 86/208 (41%), Gaps = 24/208 (11%)
Query: 360 LGQGGFGPVYKGT-LADGKAIAVKRLSRT------SGQGLQEFKNEVNLIAKL----QHK 408
LG+GGFG V+ G L D +A+K + R EV L+ K+ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 409 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIARGILYL 467
++RLL + +L+ E P + D LFD T L + + I +
Sbjct: 99 GVIRLLDWFETQEGFMLVLER-PLPAQD--LFDYITEKGPLGEGPSRCFFGQVVAAIQHC 155
Query: 468 HEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 526
H ++HRD+K NIL+D K+ DFG + GT Y PE
Sbjct: 156 H---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE----PYTDFDGTRVYSPPE 208
Query: 527 YAMGGIFS-IKSDVFSFGVLLLEIISGR 553
+ + + + V+S G+LL +++ G
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-22
Identities = 65/235 (27%), Positives = 103/235 (43%), Gaps = 29/235 (12%)
Query: 335 ESQEFPLFPLRLALEATNHFSDEN-----KLGQGGFGPVY----KGTLADGKAIAVKRLS 385
ES +F F +E H + + +G+GGFG VY T GK A+K L
Sbjct: 167 ESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADT---GKMYAMKCLD 223
Query: 386 RT---SGQGLQEFKNEVNLIAKLQHKN---LVRLLGCCLEGQELLLIYEYMPNKSLDVHL 439
+ QG NE +++ + + +V + +L I + M L HL
Sbjct: 224 KKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL 283
Query: 440 FDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 499
++ + I G+ ++H +++RDLK +NILLD+ + +ISD G
Sbjct: 284 ---SQHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLG 337
Query: 500 LARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS-DVFSFGVLLLEIISGR 553
LA F + + GT+GYMAPE G+ S D FS G +L +++ G
Sbjct: 338 LACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 53/222 (23%), Positives = 95/222 (42%), Gaps = 26/222 (11%)
Query: 349 EATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQE--FKN--------- 397
+ ++ + + G +G V G ++G +A+KR+ T G +
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 398 EVNLIAKLQHKNLVRLLGCCL-----EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 452
E+ L+ H N++ L + +L L+ E M D+ + + + +
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT---DLAQVIHDQRIVISPQH 135
Query: 453 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 512
Q + I G+ LHE ++HRDL NILL D+ + I DF LAR + N+
Sbjct: 136 IQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANK-- 190
Query: 513 TNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGR 553
T+ + Y APE M F+ D++S G ++ E+ + +
Sbjct: 191 THYVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 24/204 (11%)
Query: 360 LGQGGFGPVYKGT-LADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLG 415
LG G FG V G G +AVK L+R S + + K E+ + +H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 416 CCLEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRR--QSIINGIARGILYLHED 470
+ ++ EY+ L FD V+ RR Q I++ + Y H
Sbjct: 79 VISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVD----YCH-- 128
Query: 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 530
R ++HRDLK N+LLD MN KI+DFGL+ + T+ G+ Y APE G
Sbjct: 129 -RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTS--CGSPNYAAPEVISG 184
Query: 531 GIFS-IKSDVFSFGVLLLEIISGR 553
+++ + D++S GV+L ++ G
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGT 208
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-22
Identities = 64/221 (28%), Positives = 100/221 (45%), Gaps = 35/221 (15%)
Query: 349 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 398
+ + +G G G V + +A+K+LSR F+N E
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRE 74
Query: 399 VNLIAKLQHKNLVRLL------GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 452
+ L+ + HKN++ LL E Q++ ++ E M D +L + +LD +R
Sbjct: 75 LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQM-ELDHER 128
Query: 453 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 512
++ + GI +LH IIHRDLK SNI++ D KI DFGLAR G +
Sbjct: 129 MSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMM 183
Query: 513 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 553
T + T Y APE +G + D++S G ++ E+I G
Sbjct: 184 TPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 65/204 (31%), Positives = 105/204 (51%), Gaps = 25/204 (12%)
Query: 360 LGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQE-FKNEVNLIAKLQHKNLVRLLG 415
LG+G FG V T + +A+K +SR + + E++ + L+H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 416 CCLEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRR--QSIINGIARGILYLHED 470
+++++ EY + LFD + + D RR Q II I Y H
Sbjct: 77 VITTPTDIVMVIEYAGGE-----LFDYIVEKKRMTEDEGRRFFQQIICAIE----YCH-- 125
Query: 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 530
R KI+HRDLK N+LLDD++N KI+DFGL+ I N T+ G+ Y APE G
Sbjct: 126 -RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKTS--CGSPNYAAPEVING 181
Query: 531 GIFS-IKSDVFSFGVLLLEIISGR 553
+++ + DV+S G++L ++ GR
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 3e-21
Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 24/204 (11%)
Query: 360 LGQGGFGPVYKGT-LADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLG 415
LG G FG V G G +AVK L+R S + + + E+ + +H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 416 CCLEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRR--QSIINGIARGILYLHED 470
++ ++ EY+ LFD + RR Q I++G+ Y H
Sbjct: 84 VISTPSDIFMVMEYVSGG----ELFDYICKNGRLDEKESRRLFQQILSGVD----YCH-- 133
Query: 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 530
R ++HRDLK N+LLD MN KI+DFGL+ + T+ G+ Y APE G
Sbjct: 134 -RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTS--CGSPNYAAPEVISG 189
Query: 531 GIFS-IKSDVFSFGVLLLEIISGR 553
+++ + D++S GV+L ++ G
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGT 213
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-21
Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 37/222 (16%)
Query: 349 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 398
E + D +G G +G V G +A+K+L R F++ E
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAKRAYRE 74
Query: 399 VNLIAKLQHKNLVRLL------GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 452
+ L+ ++H+N++ LL + + L+ +M L + +L R
Sbjct: 75 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDR 129
Query: 453 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 512
Q ++ + +G+ Y+H IIHRDLK N+ +++D KI DFGLAR
Sbjct: 130 IQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM---- 182
Query: 513 TNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGR 553
T + T Y APE + ++ D++S G ++ E+I+G+
Sbjct: 183 TGYVV-TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 3e-21
Identities = 53/181 (29%), Positives = 79/181 (43%), Gaps = 47/181 (25%)
Query: 460 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 519
+A+G+ +L + K IHRDL A NILL + KI DFGLAR + + +
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKDPDYVRKG 253
Query: 520 YG-----YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL 574
+MAPE +++I+SDV+SFGVLL EI S G + Y
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----------LGAS--PY---- 296
Query: 575 WCEGPAVELIDPVLKQ----------SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624
P V++ + ++ E+ + L C +P+ RPT S +V
Sbjct: 297 ----PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ---TMLDCWHGEPSQRPTFSELVEH 349
Query: 625 L 625
L
Sbjct: 350 L 350
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 33/163 (20%), Positives = 60/163 (36%), Gaps = 19/163 (11%)
Query: 357 ENKLGQGGFGPVYKGTL------ADGKAIAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHK 408
LG+G FG V + A + +AVK L + + +E+ ++ + H
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 409 NLVRLLGCCL-EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 467
N+V LLG C G L++I E+ +L +L +R + +G +
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFR 136
Query: 468 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510
+ I DLK + + S F + + +
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 4e-21
Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 35/221 (15%)
Query: 349 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 398
+ + +G G G V + +A+K+LSR F+N E
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRE 111
Query: 399 VNLIAKLQHKNLVRLL------GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 452
+ L+ + HKN++ LL E Q++ L+ E M ++ ++LD +R
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA---NLC---QVIQMELDHER 165
Query: 453 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 512
++ + GI +LH IIHRDLK SNI++ D KI DFGLAR G +
Sbjct: 166 MSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMM 220
Query: 513 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 553
T + T Y APE +G + D++S G ++ E++ +
Sbjct: 221 TPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 6e-21
Identities = 54/253 (21%), Positives = 103/253 (40%), Gaps = 69/253 (27%)
Query: 351 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHK 408
+ +S LG G FG V + + GK A+K++ + +KN E++++ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVLDHV 60
Query: 409 NLVRLLGC--------------------------------------CLEGQELLLIYEYM 430
N+++L+ + + L +I EY+
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 431 PNKSLDVHLFDATRSVQLDWKRRQSIING--------IARGILYLHEDSRLKIIHRDLKA 482
P +H + ++ + +SI + R + ++H L I HRD+K
Sbjct: 121 P---DTLH-----KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKP 169
Query: 483 SNILLD-DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVF 540
N+L++ D K+ DFG A+ ++ + I + Y APE +G ++ D++
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEYTPSIDLW 226
Query: 541 SFGVLLLEIISGR 553
S G + E+I G+
Sbjct: 227 SIGCVFGELILGK 239
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 9e-21
Identities = 50/223 (22%), Positives = 106/223 (47%), Gaps = 35/223 (15%)
Query: 349 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 398
+ +++ + +G+G +G V + +A+K++S F++ E
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLRE 75
Query: 399 VNLIAKLQHKNLVRLLGCCL-----EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR 453
+ ++ + +H+N++ + + +++ ++ + M + L+ ++ L
Sbjct: 76 IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHI 130
Query: 454 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN- 512
+ I RG+ Y+H + ++HRDLK SN+LL+ + KI DFGLAR+ + +
Sbjct: 131 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 513 -TNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGR 553
T +A T Y APE + ++ D++S G +L E++S R
Sbjct: 188 LTEYVA-TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 50/233 (21%), Positives = 101/233 (43%), Gaps = 46/233 (19%)
Query: 349 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 398
+ + + D LG GG G V+ K +A+K++ + E
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALRE 58
Query: 399 VNLIAKLQHKNLVRLL--------------GCCLEGQELLLIYEYMPNKSLDVHLFDATR 444
+ +I +L H N+V++ G E + ++ EYM + L +
Sbjct: 59 IKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLE 113
Query: 445 SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARI 503
L + + + + RG+ Y+H + ++HRDLK +N+ ++ +D+ KI DFGLARI
Sbjct: 114 QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARI 170
Query: 504 FGGNQNQAN--TNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 553
+ + + + T Y +P + ++ D+++ G + E+++G+
Sbjct: 171 MDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 52/222 (23%), Positives = 97/222 (43%), Gaps = 38/222 (17%)
Query: 349 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 398
E + +G G +G V G+ +A+K+LSR F++ E
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAKRAYRE 73
Query: 399 VNLIAKLQHKNLVRLL------GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 452
+ L+ +QH+N++ LL + L+ +M L + ++
Sbjct: 74 LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGL-KFSEEK 127
Query: 453 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 512
Q ++ + +G+ Y+H ++HRDLK N+ +++D KI DFGLAR
Sbjct: 128 IQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM---- 180
Query: 513 TNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGR 553
T + T Y APE + ++ D++S G ++ E+++G+
Sbjct: 181 TGYVV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 20/201 (9%)
Query: 360 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRLLGCC 417
+G G FG + +AVK + R G + E + E+ L+H N+VR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 418 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR--QSIINGIARGILYLHEDSRLKI 475
L L +I EY L + +A R D R Q +++G++ Y H ++I
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGR-FSEDEARFFFQQLLSGVS----YCH---SMQI 137
Query: 476 IHRDLKASNILLDDD--MNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 533
HRDLK N LLD KI DFG ++ + +Q + + GT Y+APE + +
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTV--GTPAYIAPEVLLRQEY 194
Query: 534 S-IKSDVFSFGVLLLEIISGR 553
+DV+S GV L ++ G
Sbjct: 195 DGKIADVWSCGVTLYVMLVGA 215
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 4e-20
Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 32/217 (14%)
Query: 352 NHFSDENKLGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAK 404
+HF +G+G FG V T K A+K +++ E +N E+ ++
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDT---KKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 405 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 464
L+H LV L + +++ ++ + + L HL ++V + + I + +
Sbjct: 72 LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFKEETVKLFICELVMAL 128
Query: 465 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 524
YL +IIHRD+K NILLD+ + I+DF +A + Q T +AGT YMA
Sbjct: 129 DYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITT--MAGTKPYMA 182
Query: 525 PEYAMGGIFSIKS--------DVFSFGVLLLEIISGR 553
PE +FS + D +S GV E++ GR
Sbjct: 183 PE-----MFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 9e-20
Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 37/222 (16%)
Query: 349 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 398
E + + + +G G +G V G +AVK+LSR F++ E
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRE 78
Query: 399 VNLIAKLQHKNLVRLL------GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 452
+ L+ ++H+N++ LL E ++ L+ M L + + +L
Sbjct: 79 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDH 133
Query: 453 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 512
Q +I I RG+ Y+H IIHRDLK SN+ +++D KI DFGLAR
Sbjct: 134 VQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEM---- 186
Query: 513 TNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGR 553
T +A T Y APE + ++ D++S G ++ E+++GR
Sbjct: 187 TGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 1e-19
Identities = 43/196 (21%), Positives = 85/196 (43%), Gaps = 31/196 (15%)
Query: 349 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 398
+ + + + +G G +G V + + + +A+K++ R F++ E
Sbjct: 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILRE 102
Query: 399 VNLIAKLQHKNLVRLL-----GCCLEGQELLLIYEYMPNKSLDVH-LFDATRSVQLDWKR 452
+ ++ +L H ++V++L + EL ++ E D LF V L
Sbjct: 103 IAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD---SDFKKLFRT--PVYLTELH 157
Query: 453 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 512
++++ + G+ Y+H I+HRDLK +N L++ D + K+ DFGLAR +N +
Sbjct: 158 IKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNS 214
Query: 513 TNIIAGTYGYMAPEYA 528
I+ M
Sbjct: 215 QLPISPREDDMNLVTF 230
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 44/231 (19%)
Query: 349 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS---------RTSGQGLQEFKNE 398
++ F ++ LG+G +G V T G+ +A+K++ RT L+E K
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT----LREIK-- 61
Query: 399 VNLIAKLQHKNLVRLL-----GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR 453
++ +H+N++ + E+ +I E M L + L
Sbjct: 62 --ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSDDHI 114
Query: 454 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 513
Q I R + LH + +IHRDLK SN+L++ + + K+ DFGLARI +++ A+
Sbjct: 115 QYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAADN 169
Query: 514 NIIAGTYGYM----------APEYAMG-GIFSIKSDVFSFGVLLLEIISGR 553
+ G M APE + +S DV+S G +L E+ R
Sbjct: 170 SEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 42/199 (21%), Positives = 87/199 (43%), Gaps = 31/199 (15%)
Query: 349 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 398
+++ ++ +G+G +G VY K +A+K+++R F++ E
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-------FEDLIDCKRILRE 75
Query: 399 VNLIAKLQHKNLVRLLGCCL-----EGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKR 452
+ ++ +L+ ++RL + + EL ++ E + D+ ++ L +
Sbjct: 76 ITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS---DLK--KLFKTPIFLTEEH 130
Query: 453 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 512
++I+ + G ++HE IIHRDLK +N LL+ D + K+ DFGLAR ++
Sbjct: 131 IKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNI 187
Query: 513 TNIIAGTYGYMAPEYAMGG 531
N + +
Sbjct: 188 VNDLEENEEPGPHNKNLKK 206
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 54/209 (25%), Positives = 87/209 (41%), Gaps = 37/209 (17%)
Query: 360 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEF---KNEVNLIAKLQHKNLVR 412
LG G FG V K + G A+K L + L++ NE ++ + LV+
Sbjct: 49 LGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR--------GI 464
L + L ++ EY+ + HL +R AR
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL-----------RRIGRFSEPHARFYAAQIVLTF 154
Query: 465 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 524
YLH L +I+RDLK N+L+D +++DFG A+ G T + GT +A
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALA 206
Query: 525 PEYAMGGIFSIKSDVFSFGVLLLEIISGR 553
PE + ++ D ++ GVL+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 43/215 (20%), Positives = 72/215 (33%), Gaps = 64/215 (29%)
Query: 352 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKN 409
++ LG G G V + + A+K L + + EV L + Q +
Sbjct: 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPH 72
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVH----------LFDATRSVQLDWKR---RQ-- 454
+VR++ +YE + + LF R + R+
Sbjct: 73 IVRIVD----------VYENLYAGRKCLLIVMECLDGGELFS--RIQDRGDQAFTEREAS 120
Query: 455 SIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQA 511
I+ I I YLH + I HRD+K N+L + K++DFG A+
Sbjct: 121 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-------- 169
Query: 512 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 546
Y D++S GV++
Sbjct: 170 ---TTGEKYDK-------------SCDMWSLGVIM 188
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 6e-18
Identities = 61/238 (25%), Positives = 110/238 (46%), Gaps = 48/238 (20%)
Query: 349 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 398
+ KLG+G +G V+K G+ +AVK++ F+N E
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFRE 58
Query: 399 VNLIAKLQ-HKNLVRLLGCCL--EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQS 455
+ ++ +L H+N+V LL +++ L+++YM + L R+ L+ +Q
Sbjct: 59 IMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILEPVHKQY 113
Query: 456 IINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 515
++ + + I YLH S ++HRD+K SNILL+ + + K++DFGL+R F + N
Sbjct: 114 VVYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170
Query: 516 IAGTYG-------------------YMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 553
++ Y APE +G ++ D++S G +L EI+ G+
Sbjct: 171 LSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 57/201 (28%), Positives = 84/201 (41%), Gaps = 17/201 (8%)
Query: 360 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEF---KNEVNLIAKLQHKNLVR 412
LG+G FG V K T G+ A+K L + E E ++ +H L
Sbjct: 156 LGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 472
L L + EY L HL +R R + I + YLH S
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYLH--SE 267
Query: 473 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 532
+++RDLK N++LD D + KI+DFGL + + T GT Y+APE
Sbjct: 268 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLEDND 325
Query: 533 FSIKSDVFSFGVLLLEIISGR 553
+ D + GV++ E++ GR
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGR 346
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 37/209 (17%)
Query: 360 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEF---KNEVNLIAKLQHKNLVR 412
LG G FG V+ + G+ A+K L + L++ +E +++ + H ++R
Sbjct: 14 LGTGSFGRVHLIRSRHN---GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR--------GI 464
+ G + Q++ +I +Y+ L L ++ Q N +A+ +
Sbjct: 71 MWGTFQDAQQIFMIMDYIEGGELFSLL-----------RKSQRFPNPVAKFYAAEVCLAL 119
Query: 465 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 524
YLH II+RDLK NILLD + + KI+DFG A+ T + GT Y+A
Sbjct: 120 EYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIA 171
Query: 525 PEYAMGGIFSIKSDVFSFGVLLLEIISGR 553
PE ++ D +SFG+L+ E+++G
Sbjct: 172 PEVVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 4e-17
Identities = 32/295 (10%), Positives = 76/295 (25%), Gaps = 56/295 (18%)
Query: 359 KLGQGGFGPVYKGTLAD---GKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVR 412
G ++ D + +A+ + LQE + ++++ + R
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 472
+L L++ E++ SL + + +A H R
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAH---R 147
Query: 473 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 532
+ S + + D + ++ M
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVLAYP----------------------ATMPDA------ 179
Query: 533 FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSC 592
+ + D+ G L ++ R + L + ID +
Sbjct: 180 -NPQDDIRGIGASLYALLVNRWP--LPEAGVRSGLAPAERDTAGQPIEPADIDRDI---- 232
Query: 593 APDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAFSVGRVVA 647
P ++ VQ D R S+++ ++ + + V+
Sbjct: 233 -PFQISAVA---ARSVQGDGGIRSA-STLLNLMQQATAVADRTEVLGPIDEAPVS 282
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 45/213 (21%), Positives = 92/213 (43%), Gaps = 23/213 (10%)
Query: 349 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ- 406
+ + KLG+G + V++ + + + + VK L ++ K E+ ++ L+
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRG 89
Query: 407 HKNLVRLLGCCLEGQE--LLLIYEYMPNKSLDVH-LFDATRSVQLDWKRRQSIINGIARG 463
N++ L + L++E++ N D L+ L + + I +
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNN--TDFKQLYQT-----LTDYDIRFYMYEILKA 142
Query: 464 ILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 522
+ Y H S I+HRD+K N+++D + ++ D+GLA + Q +A Y +
Sbjct: 143 LDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY-F 196
Query: 523 MAPEYAMGGIFSIKS-DVFSFGVLLLEIISGRK 554
PE + S D++S G +L +I ++
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 5e-17
Identities = 59/200 (29%), Positives = 106/200 (53%), Gaps = 14/200 (7%)
Query: 360 LGQGGFGPVY---KGTLADGKAI-AVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRL 413
LGQG FG V+ K + +D + + A+K L + + + K E +++ ++ H +V+L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 414 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 473
+L LI +++ L L ++ V + + + +A + +LH L
Sbjct: 92 HYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHLHS---L 145
Query: 474 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 533
II+RDLK NILLD++ + K++DFGL++ ++ +A + GT YMAPE
Sbjct: 146 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRRGH 203
Query: 534 SIKSDVFSFGVLLLEIISGR 553
+ +D +SFGVL+ E+++G
Sbjct: 204 TQSADWWSFGVLMFEMLTGT 223
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 7e-17
Identities = 48/214 (22%), Positives = 83/214 (38%), Gaps = 37/214 (17%)
Query: 360 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVR 412
+G+G FG V K K A+K L++ E F+ E +++ K +
Sbjct: 82 IGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT 138
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR--------GI 464
L + L L+ +Y L L K + +AR I
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLS----------KFEDRLPEEMARFYLAEMVIAI 188
Query: 465 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 524
+H+ L +HRD+K NIL+D + + +++DFG + +++ GT Y++
Sbjct: 189 DSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQSSVAVGTPDYIS 244
Query: 525 PEYAMGGIFSIKS-----DVFSFGVLLLEIISGR 553
PE D +S GV + E++ G
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 8e-17
Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 22/205 (10%)
Query: 360 LGQGGFGPVY---KGTLADGKAI-AVKRLSRTSGQGLQEFKNEV-------NLIAKLQHK 408
LG+GG+G V+ K T A+ I A+K L + + + N++ +++H
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAM---IVRNAKDTAHTKAERNILEEVKHP 81
Query: 409 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 468
+V L+ G +L LI EY+ L + L R + I+ + +LH
Sbjct: 82 FIVDLIYAFQTGGKLYLILEYLSGGELFMQL---EREGIFMEDTACFYLAEISMALGHLH 138
Query: 469 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 528
+ II+RDLK NI+L+ + K++DFGL + + +T GT YMAPE
Sbjct: 139 Q---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYMAPEIL 193
Query: 529 MGGIFSIKSDVFSFGVLLLEIISGR 553
M + D +S G L+ ++++G
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 9e-17
Identities = 52/213 (24%), Positives = 84/213 (39%), Gaps = 38/213 (17%)
Query: 360 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVR 412
+G+G FG V K T K A+K LS+ + F E +++A +V+
Sbjct: 77 IGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR--------GI 464
L + + L ++ EYMP L + + AR +
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLVNLM------------SNYDVPEKWARFYTAEVVLAL 181
Query: 465 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 524
+H + IHRD+K N+LLD + K++DFG + GT Y++
Sbjct: 182 DAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYIS 237
Query: 525 PE--YAMGGIFSIKSDV--FSFGVLLLEIISGR 553
PE + GG + +S GV L E++ G
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 50/208 (24%), Positives = 86/208 (41%), Gaps = 23/208 (11%)
Query: 360 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVR 412
+G+G F V K T G+ A+K +++ E F+ E +++ + + +
Sbjct: 69 IGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 472
L + L L+ EY L L + + R + I I +H
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMAR--FYLAEIVMAIDSVHR--- 180
Query: 473 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE--YAMG 530
L +HRD+K NILLD + +++DFG + + + GT Y++PE A+G
Sbjct: 181 LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVG 239
Query: 531 GIFSIKS-----DVFSFGVLLLEIISGR 553
G S D ++ GV E+ G+
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 55/201 (27%), Positives = 84/201 (41%), Gaps = 18/201 (8%)
Query: 360 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQEF---KNEVNLIAKLQHKNLVR 412
LG+G FG V K T G+ A+K L + E E ++ +H L
Sbjct: 13 LGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 413 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 472
L L + EY L HL +R +R + I + YLH
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLHS--- 123
Query: 473 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 532
+++RD+K N++LD D + KI+DFGL + + T GT Y+APE
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLEDND 181
Query: 533 FSIKSDVFSFGVLLLEIISGR 553
+ D + GV++ E++ GR
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGR 202
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 27/206 (13%)
Query: 360 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEFKNEVN--------LIAKLQH 407
LG+G FG V K T G AVK L + + + ++V L H
Sbjct: 31 LGKGSFGKVMLARVKET---GDLYAVKVLKK---DVILQ-DDDVECTMTEKRILSLARNH 83
Query: 408 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 467
L +L C L + E++ L H+ +S + D R + I +++L
Sbjct: 84 PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI---QKSRRFDEARARFYAAEIISALMFL 140
Query: 468 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 527
H+ II+RDLK N+LLD + + K++DFG+ + N T GT Y+APE
Sbjct: 141 HD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTPDYIAPEI 195
Query: 528 AMGGIFSIKSDVFSFGVLLLEIISGR 553
++ D ++ GVLL E++ G
Sbjct: 196 LQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 27/206 (13%)
Query: 360 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVN--------LIAKLQH 407
LG+G FG V +K T + A+K L + + ++V L +H
Sbjct: 25 LGKGSFGKVFLAEFKKT---NQFFAIKALKK----DVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 408 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 467
L + + L + EY+ L H+ + D R I G+ +L
Sbjct: 78 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGLQFL 134
Query: 468 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 527
H I++RDLK NILLD D + KI+DFG+ + + NT GT Y+APE
Sbjct: 135 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEI 189
Query: 528 AMGGIFSIKSDVFSFGVLLLEIISGR 553
+G ++ D +SFGVLL E++ G+
Sbjct: 190 LLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 80.5 bits (198), Expect = 7e-16
Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 27/206 (13%)
Query: 360 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVN--------LIAKLQH 407
LG+G FG V KGT + AVK L + + ++V L +
Sbjct: 349 LGKGSFGKVMLSERKGT---DELYAVKILKK----DVVIQDDDVECTMVEKRVLALPGKP 401
Query: 408 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 467
L +L C L + EY+ L H+ + + IA G+ +L
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI---QQVGRFKEPHAVFYAAEIAIGLFFL 458
Query: 468 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 527
II+RDLK N++LD + + KI+DFG+ + + T GT Y+APE
Sbjct: 459 QS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYIAPEI 513
Query: 528 AMGGIFSIKSDVFSFGVLLLEIISGR 553
+ D ++FGVLL E+++G+
Sbjct: 514 IAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 31/208 (14%)
Query: 360 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVN--------LIAKLQH 407
LG+G FG V KGT + AVK L + + + ++V L +
Sbjct: 28 LGKGSFGKVMLSERKGT---DELYAVKILKKDV---VIQ-DDDVECTMVEKRVLALPGKP 80
Query: 408 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 467
L +L C L + EY+ L H+ + + IA G+ +L
Sbjct: 81 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI---QQVGRFKEPHAVFYAAEIAIGLFFL 137
Query: 468 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR--IFGGNQNQANTNIIAGTYGYMAP 525
II+RDLK N++LD + + KI+DFG+ + I+ G T GT Y+AP
Sbjct: 138 QS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT----TKTFCGTPDYIAP 190
Query: 526 EYAMGGIFSIKSDVFSFGVLLLEIISGR 553
E + D ++FGVLL E+++G+
Sbjct: 191 EIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 5e-15
Identities = 57/206 (27%), Positives = 85/206 (41%), Gaps = 27/206 (13%)
Query: 360 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEFKNEVN--------LIAKLQH 407
+G+G FG V K AVK L + L+ K E L+ ++H
Sbjct: 46 IGKGSFGKVLLARHKAE---EVFYAVKVLQK--KAILK--KKEEKHIMSERNVLLKNVKH 98
Query: 408 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 467
LV L +L + +Y+ L HL R R + IA + YL
Sbjct: 99 PFLVGLHFSFQTADKLYFVLDYINGGELFYHL---QRERCFLEPRARFYAAEIASALGYL 155
Query: 468 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 527
H L I++RDLK NILLD + ++DFGL + + + +T GT Y+APE
Sbjct: 156 HS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEYLAPEV 210
Query: 528 AMGGIFSIKSDVFSFGVLLLEIISGR 553
+ D + G +L E++ G
Sbjct: 211 LHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 5e-15
Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 27/206 (13%)
Query: 360 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEFKNEVN--------LIAKLQH 407
+G+G + V K T + A+K + + L +++ H
Sbjct: 17 IGRGSYAKVLLVRLKKT---DRIYAMKVVKK----ELVNDDEDIDWVQTEKHVFEQASNH 69
Query: 408 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 467
LV L C L + EY+ L H+ R +L + + I+ + YL
Sbjct: 70 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEISLALNYL 126
Query: 468 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 527
HE II+RDLK N+LLD + + K++D+G+ + + +T GT Y+APE
Sbjct: 127 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAPEI 181
Query: 528 AMGGIFSIKSDVFSFGVLLLEIISGR 553
G + D ++ GVL+ E+++GR
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 27/206 (13%)
Query: 360 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEFKNEVN--------LIAKLQH 407
+G+G + V K T + A++ + + L +++ H
Sbjct: 60 IGRGSYAKVLLVRLKKT---DRIYAMRVVKK----ELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 408 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 467
LV L C L + EY+ L H+ R +L + + I+ + YL
Sbjct: 113 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEISLALNYL 169
Query: 468 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 527
HE II+RDLK N+LLD + + K++D+G+ + + +T GT Y+APE
Sbjct: 170 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAPEI 224
Query: 528 AMGGIFSIKSDVFSFGVLLLEIISGR 553
G + D ++ GVL+ E+++GR
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 360 LGQGGFGPVY---KGTLADGKAI-AVKRLSRTS----GQGLQEFKNEVNLIAKLQHKN-L 410
LG G +G V+ K + D + A+K L + + + + + E ++ ++ L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 411 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 470
V L +L LI +Y+ L HL ++ + Q + I + +LH+
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHL---SQRERFTEHEVQIYVGEIVLALEHLHK- 177
Query: 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE---- 526
L II+RD+K NILLD + + ++DFGL++ F ++ + GT YMAP+
Sbjct: 178 --LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRG 234
Query: 527 YAMGGIFSIKSDVFSFGVLLLEIISGR 553
G ++ D +S GVL+ E+++G
Sbjct: 235 GDSGHDKAV--DWWSLGVLMYELLTGA 259
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 70.7 bits (172), Expect = 3e-13
Identities = 31/217 (14%), Positives = 61/217 (28%), Gaps = 52/217 (23%)
Query: 332 QQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--- 388
Q F T K+G+G FG V++ AD +A+K ++
Sbjct: 6 SQKGPVPFSHCL------PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDL 58
Query: 389 -----GQGLQEFKNEVNLIAKLQ---------HKNLVRLLGCCL----EGQELLLIYEYM 430
+ +E E+ + +L + + L LL +++
Sbjct: 59 VNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHY 118
Query: 431 PNK----------------------SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 468
+ + R+ +SI++ + +
Sbjct: 119 NSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE 178
Query: 469 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505
L+ HRDL N+LL K+ +
Sbjct: 179 A--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSST 213
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 63/322 (19%), Positives = 116/322 (36%), Gaps = 83/322 (25%)
Query: 359 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ----------- 406
KLG G F V+ + + +A+K + R + ++E+ L+ ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 407 HKNLVRLLGC----CLEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRRQSIING 459
++++LL G +++++E L +L + + I
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYEHRGIPLIYVKQISKQ 139
Query: 460 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNP------KISDFGLARIFGGNQNQANT 513
+ G+ Y+H R IIH D+K N+L++ +P KI+D G A ++ T
Sbjct: 140 LLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW----YDEHYT 193
Query: 514 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR-------------------- 553
N I T Y +PE +G + +D++S L+ E+I+G
Sbjct: 194 NSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252
Query: 554 ----------------KNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDEL 597
K +F+ G K W P +++ K + DE
Sbjct: 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFW---PLEDVL--TEKYKFSKDEA 307
Query: 598 LKFIHIGLL--CVQQDPADRPT 617
+ L +Q DP R
Sbjct: 308 KEISD--FLSPMLQLDPRKRAD 327
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 51/218 (23%), Positives = 88/218 (40%), Gaps = 30/218 (13%)
Query: 351 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVK---RLSRTSGQGLQEFKNEVNLIAKLQ 406
+ + ++ +G+G FG V K + + +A+K Q EV L+ +
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ----IEVRLLELMN 108
Query: 407 H------KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ---LDWKRRQSII 457
+V L + L L++E L +L+D R+ + +
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFA 163
Query: 458 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP--KISDFGLARIFGGNQNQANTNI 515
+ +L+L L IIH DLK NILL + KI DFG + Q
Sbjct: 164 QQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ----LGQRIYQY 218
Query: 516 IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 553
I + Y +PE +G + + D++S G +L+E+ +G
Sbjct: 219 IQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 47/209 (22%), Positives = 89/209 (42%), Gaps = 32/209 (15%)
Query: 360 LGQGGFGPVYKGT-LADGKAIAVKRL---SRTSGQGLQEFKNEVNLIAKLQHK------N 409
+G+G FG V K + +A+K + R Q E+ ++ L+ + N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA----EEIRILEHLRKQDKDNTMN 160
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRRQSIINGIARGILY 466
++ +L + + +E L ++L++ + + + I + +
Sbjct: 161 VIHMLENFTFRNHICMTFE-----LLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDA 215
Query: 467 LHEDSRLKIIHRDLKASNILLDDDMNP--KISDFGLARIFGGNQNQANTNIIAGTYGYMA 524
LH + +IIH DLK NILL K+ DFG + ++Q I + Y A
Sbjct: 216 LH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY----EHQRVYTYIQSRF-YRA 267
Query: 525 PEYAMGGIFSIKSDVFSFGVLLLEIISGR 553
PE +G + + D++S G +L E+++G
Sbjct: 268 PEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 41/158 (25%), Positives = 70/158 (44%), Gaps = 13/158 (8%)
Query: 352 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 410
N + K+G G FG +Y GT +A G+ +A+K + + E + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 66
Query: 411 V-RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 469
+ + C EG +++ E + SL+ LF+ S + K + + + I Y+H
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLE-DLFNFC-SRKFSLKTVLLLADQMISRIEYIHS 123
Query: 470 DSRLKIIHRDLKASNILLDDDMNPK---ISDFGLARIF 504
+ IHRD+K N L+ I DFGLA+ +
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 36/166 (21%), Positives = 73/166 (43%), Gaps = 27/166 (16%)
Query: 352 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 410
H+ ++G+G FG +++GT L + + +A+K R S + ++E L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 67
Query: 411 V-RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSI--INGIARGIL-- 465
+ + EG +L+ + + SL+ L D R+ S+ + A+ +L
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLLG-PSLE-DLLDLC-------GRKFSVKTVAMAAKQMLAR 118
Query: 466 --YLHEDSRLKIIHRDLKASNILLDDDMNPK-----ISDFGLARIF 504
+HE S +++RD+K N L+ + + DFG+ + +
Sbjct: 119 VQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 63/370 (17%), Positives = 117/370 (31%), Gaps = 139/370 (37%)
Query: 359 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ--------HKN 409
KLG G F V+ + K +A+K + +++ + +E+ L+ ++ +
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102
Query: 410 LVRLLGC-----------CL--E--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQ 454
+V+LL C+ E G LL + L + +
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCV-------------K 149
Query: 455 SIINGIARGILYLHEDSRLKIIHRDLKASNILL--------------------------- 487
II + +G+ YLH ++ +IIH D+K NILL
Sbjct: 150 KIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 488 ----------------------DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 525
+ + KI+D G A ++ T I T Y +
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWV----HKHFTEDI-QTRQYRSL 262
Query: 526 EYAMGGIFSIKSDVFSFGVLLLEIISGR-------------------------------- 553
E +G ++ +D++S + E+ +G
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL 322
Query: 554 ----KNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSC--APDELLKFIHIGLLC 607
K + +F++ G K + L + VL + + +E F L
Sbjct: 323 IVAGKYSKEFFTKKGD------LKHITKLKPWGLFE-VLVEKYEWSQEEAAGFTDFLLPM 375
Query: 608 VQQDPADRPT 617
++ P R T
Sbjct: 376 LELIPEKRAT 385
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 6e-08
Identities = 38/166 (22%), Positives = 66/166 (39%), Gaps = 27/166 (16%)
Query: 352 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH-KN 409
+F K+G G FG + G L + +A+K S + E +L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDG 66
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSI--INGIARGIL-- 465
+ ++ G+ ++ E + SL+ LFD R S+ + IA ++
Sbjct: 67 IPQVYYFGPCGKYNAMVLELL-GPSLE-DLFDLC-------DRTFSLKTVLMIAIQLISR 117
Query: 466 --YLHEDSRLKIIHRDLKASNILLDDDMNPK-----ISDFGLARIF 504
Y+H + +I+RD+K N L+ N I DF LA+ +
Sbjct: 118 MEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 40/165 (24%), Positives = 69/165 (41%), Gaps = 27/165 (16%)
Query: 352 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 410
N F K+G G FG +Y GT + + +A+K + + + E + LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTG 64
Query: 411 V-RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSI-------INGIAR 462
+ + +EG +L+ + + SL+ LF+ R+ S+ I R
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL-GPSLE-DLFNFC-------SRKLSLKTVLMLADQMINR 115
Query: 463 GILYLHEDSRLKIIHRDLKASNILLDDDMNPK---ISDFGLARIF 504
+ ++H S +HRD+K N L+ I DFGLA+ +
Sbjct: 116 -VEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 7e-08
Identities = 40/181 (22%), Positives = 67/181 (37%), Gaps = 39/181 (21%)
Query: 352 NHFSDENKLGQGGFGPVYKGTLADGKAI------AVKRLSRTSGQGLQEFK-----NEVN 400
+ +GQGGFG +Y + +++ VK +G E K +
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 401 LIAKLQHKNLVRLLGCCL---EGQELLLIYEY----MP--NKSLDVHLFDATRSVQLDWK 451
I K ++ LG G Y M L +++A
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQ-KIYEAN-------A 146
Query: 452 RRQSI--INGIARGIL----YLHEDSRLKIIHRDLKASNILLDDDMNPKI--SDFGLARI 503
+R S + ++ IL Y+HE +H D+KASN+LL+ ++ D+GLA
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
Query: 504 F 504
+
Sbjct: 204 Y 204
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 68/332 (20%), Positives = 114/332 (34%), Gaps = 97/332 (29%)
Query: 359 KLGQGGFGPVYKGT-LADGKAIAVK---RLSRTSGQGLQEFKNEVNLIAKLQH-----KN 409
K+G G FG V + + K AVK + + + K E +++ K+Q+ N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNN 97
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ---LDWKRRQSIINGIARGILY 466
+V+ G + + LI+E L L++ + + I + + Y
Sbjct: 98 IVKYHGKFMYYDHMCLIFE-----PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152
Query: 467 LHEDSRLKIIHRDLKASNILLDDDMNP-------------------------KISDFGLA 501
L + + + H DLK NILLDD K+ DFG A
Sbjct: 153 LRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209
Query: 502 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG--------- 552
F ++ + +II Y APE + + + SD++SFG +L E+ +G
Sbjct: 210 -TF---KSDYHGSIINTRQ-YRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEH 264
Query: 553 -----------------------RKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589
+ N Y ++ KL A +
Sbjct: 265 MEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDE-------LKLAWPENASSINSIKHV 317
Query: 590 QSCAPDELL----KFIHIGLLCVQQDPADRPT 617
+ C P + F +Q DP RP+
Sbjct: 318 KKCLPLYKIIKHELFCDFLYSILQIDPTLRPS 349
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 30/180 (16%), Positives = 66/180 (36%), Gaps = 37/180 (20%)
Query: 352 NHFSDENKLGQGGFGPVYKGT---------LADGKAIAVKRLSRTSGQGLQEFK------ 396
+ ++ + G +Y+ + ++K L G+ E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 397 --NEVNLIAKLQHKNLV---RLLGCCLEGQEL-LLIYEYMPNKSLDVHLFDATRSVQLDW 450
+VN KL L+ +G + + L+ + +SL D + L
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQ-SALDVSPKHVLSE 158
Query: 451 KRRQSIINGIARGIL----YLHEDSRLKIIHRDLKASNILLDDDMNPKI--SDFGLARIF 504
+ S++ +A +L +LHE+ +H ++ A NI +D + ++ + +G A +
Sbjct: 159 R---SVLQ-VACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 44/227 (19%), Positives = 82/227 (36%), Gaps = 50/227 (22%)
Query: 359 KLGQGGFGPVYKG--TLADGKAIAVK---RLSRTSGQGLQEFKNEVNLIAKLQHK----- 408
LG+G FG V + +A+K + + E +N++ K++ K
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE----INVLKKIKEKDKENK 81
Query: 409 -NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRRQSIINGIARGI 464
V + + + +E L + F+ + + + +
Sbjct: 82 FLCVLMSDWFNFHGHMCIAFE-----LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHAL 136
Query: 465 LYLHEDSRLKIIHRDLKASNILLDDDMNP-------------------KISDFGLARIFG 505
+LHE ++ H DLK NIL + +++DFG A F
Sbjct: 137 RFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA-TF- 191
Query: 506 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 552
++ +T I+A + Y PE + ++ DV+S G +L E G
Sbjct: 192 --DHEHHTTIVATRH-YRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.2 bits (124), Expect = 5e-07
Identities = 73/505 (14%), Positives = 144/505 (28%), Gaps = 146/505 (28%)
Query: 197 TKSLAQSFNDVIAMPSLSSFRNATKR----TNISNIIRLETFGQCIPVLSVDDCRDCLN- 251
T + D+ LS F +A ++ ++ + +LS ++ +
Sbjct: 11 TGEHQYQYKDI-----LSVFEDAFVDNFDCKDVQDMPK--------SILSKEEIDHIIMS 57
Query: 252 -NTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRY----SKVPAVGALAPSSAPEEKRNS 306
+ + R F L E+ + L E+++ S
Sbjct: 58 KDAVSGTLRLFW--------TL---LSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPS 106
Query: 307 -QEVQFLHWEGRIRNH---YA-YNILRGGKQQAESQEFPLFPLRLALEATNHFSDENKL- 360
++ R+ N +A YN+ R P LR AL +
Sbjct: 107 MMTRMYIEQRDRLYNDNQVFAKYNVSR---------LQPYLKLRQALL---ELRPAKNVL 154
Query: 361 --GQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL 418
G G G K +A + V + + ++ + L C
Sbjct: 155 IDGVLGSG---KTWVA----LDVCLSYKV----QCKMDFKIFWLN----------LKNCN 193
Query: 419 EGQELL-----LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 473
+ +L L+Y+ PN + + + RL
Sbjct: 194 SPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAE----------------LRRL 237
Query: 474 KIIHRDLKASNILLDDDMNPKISD-FGL-ARIFGGNQNQANTNIIAGTYGY--------- 522
+ + + ++L + N K + F L +I + + T+ ++
Sbjct: 238 -LKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSM 296
Query: 523 -MAPEYAMGGIFS---------IKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTW 572
+ P+ + + +V + L II+ +G TW
Sbjct: 297 TLTPDEVK-SLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDG-----------LATW 344
Query: 573 KLWCEGPAVELIDPVLKQSCA---PDELLK-------F-----IHIGLLCVQQDPADRPT 617
W + + + +++ S P E K F I LL + +
Sbjct: 345 DNW-KHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSD 403
Query: 618 MSSVVVMLASDSMTIPQPTEPAFSV 642
+ VV L S+ QP E S+
Sbjct: 404 VMVVVNKLHKYSLVEKQPKESTISI 428
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 33/180 (18%), Positives = 61/180 (33%), Gaps = 40/180 (22%)
Query: 352 NHFSDENKLGQGGFGPVYKG----TLADGKAIAVKRLSRTSGQGLQEFK-----NEVNLI 402
N + K+G GGFG +Y VK + +G E K + + I
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96
Query: 403 AKLQHKNLVRLLG----------CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 452
K + + LG ++ E + L +
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQ-KISG--------QNG 146
Query: 453 RQSI--INGIARGIL----YLHEDSRLKIIHRDLKASNILLDDDMNPKI--SDFGLARIF 504
+ + +L Y+HE+ +H D+KA+N+LL ++ +D+GL+ +
Sbjct: 147 TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 47/227 (20%), Positives = 87/227 (38%), Gaps = 50/227 (22%)
Query: 359 KLGQGGFGPVYKG--TLADGKAIAVK---RLSRTSGQGLQEFKNEVNLIAKLQHK----- 408
LG+G FG V + A G+ +AVK + R ++E+ ++ L
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPNST 76
Query: 409 -NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRRQSIINGIARGI 464
V++L + +++E L + +D + + + I + +
Sbjct: 77 FRCVQMLEWFEHHGHICIVFE-----LLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131
Query: 465 LYLHEDSRLKIIHRDLKASNILLDDDMNP-------------------KISDFGLARIFG 505
+LH K+ H DLK NIL K+ DFG A +
Sbjct: 132 NFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA-TY- 186
Query: 506 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 552
++ ++ +++ + Y APE + +S DV+S G +L+E G
Sbjct: 187 --DDEHHSTLVSTRH-YRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 672 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.92 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.83 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.82 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.65 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.33 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.16 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.01 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.94 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.6 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.47 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.46 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.39 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.28 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.26 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.01 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.01 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.92 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.81 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.61 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.56 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.4 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.36 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.27 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.26 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.2 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.07 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.02 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.85 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.41 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.35 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.44 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.33 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 83.77 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-53 Score=440.44 Aligned_cols=258 Identities=27% Similarity=0.457 Sum_probs=212.1
Q ss_pred cCCccccccccCCceeEEeeeec------CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l 425 (672)
++|.+.++||+|+||+||+|++. ++..||||++........+.|.+|+++|++++|||||++++++.+++.++|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 57889999999999999999863 477899999988777777889999999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhhcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 005871 426 IYEYMPNKSLDVHLFDAT----------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 495 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL 495 (672)
|||||++|+|.++|.... ....++|.++..|+.||+.||.|||+++ ||||||||+||||++++++||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999996532 2356999999999999999999999997 999999999999999999999
Q ss_pred EeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhh
Q 005871 496 SDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKL 574 (672)
Q Consensus 496 ~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 574 (672)
+|||+++...............||+.|||||++.++.|+.++|||||||++|||+| |+.||..... ..+...+
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~~i--- 243 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIECI--- 243 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHHH---
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH---
Confidence 99999987654443333444679999999999999999999999999999999999 8999853321 1111111
Q ss_pred ccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 575 WCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 575 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
..+.... .+......+.+|+.+||+.||++|||+++|++.|...
T Consensus 244 -~~~~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 244 -TQGRVLQ---------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp -HHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111111 1111234577888899999999999999999999765
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=439.78 Aligned_cols=258 Identities=29% Similarity=0.455 Sum_probs=204.7
Q ss_pred cCCccccccccCCceeEEeeeec------CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l 425 (672)
++|.+.++||+|+||+||+|+++ +++.||||++........+.|.+|+++|++++|||||++++++.+.+.++|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56788899999999999999864 478899999988777777899999999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhhcc------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCe
Q 005871 426 IYEYMPNKSLDVHLFDAT------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP 493 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~ 493 (672)
|||||++|+|.+++.... ....++|.++..|+.||+.||.|||+++ ||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 999999999999996532 1346999999999999999999999987 9999999999999999999
Q ss_pred EEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhh
Q 005871 494 KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTW 572 (672)
Q Consensus 494 kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 572 (672)
||+|||+++.+.............||+.|||||++.+..++.++|||||||++|||+| |+.||..... ......+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~~i- 273 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---TEAIDCI- 273 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---HHHHHHH-
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---HHHHHHH-
Confidence 9999999997755444444445689999999999999999999999999999999999 8999753221 1111111
Q ss_pred hhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 573 KLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 573 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
..+...+ ....+ ...+.+|+.+||+.||++|||++||+++|+..
T Consensus 274 ---~~g~~~~-----~p~~~----~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 274 ---TQGRELE-----RPRAC----PPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp ---HHTCCCC-----CCTTC----CHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred ---HcCCCCC-----Ccccc----cHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 1111111 11122 24577888899999999999999999999875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-52 Score=434.14 Aligned_cols=257 Identities=31% Similarity=0.452 Sum_probs=209.7
Q ss_pred cCCccccccccCCceeEEeeeec------CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 424 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 424 (672)
.++++.++||+|+||+||+|++. +++.||||++.... ....+.|.+|+.+|++++|||||+++|++.+++.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45677899999999999999863 46789999997543 344678999999999999999999999999999999
Q ss_pred EEEeecCCCChhHHhhhcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC
Q 005871 425 LIYEYMPNKSLDVHLFDAT-------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM 491 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~ 491 (672)
||||||++|+|.++|.... ....+++.++..|+.||+.||.|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 9999999999999996432 1346899999999999999999999997 99999999999999999
Q ss_pred CeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhh
Q 005871 492 NPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTY 570 (672)
Q Consensus 492 ~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~ 570 (672)
++||+|||+++.+.............||+.|||||++.++.|+.++|||||||++|||+| |+.||..... ..+...
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~~~~~ 259 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVVEM 259 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HHHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HHHHHH
Confidence 999999999987654443344445689999999999999999999999999999999999 8999754321 111111
Q ss_pred hhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 571 TWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 571 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
. ..+.... .+......+.+|+.+||+.||++|||++||+++|+.
T Consensus 260 ---i-~~~~~~~---------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 260 ---I-RNRQVLP---------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp ---H-HTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ---H-HcCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1 1221111 112223457788889999999999999999999975
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-51 Score=430.77 Aligned_cols=250 Identities=24% Similarity=0.328 Sum_probs=207.8
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
+.|++.++||+|+||.||+|+++ +|+.||||++........+.+.+|+.+|++++|||||++++++.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999986 69999999998766666677899999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
+||+|.+++.. ..+++.++..|+.||+.||.|||+++ ||||||||+||||+.+|++||+|||+++.+.....
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 225 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 225 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence 99999998853 35999999999999999999999998 99999999999999999999999999998754322
Q ss_pred cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcC
Q 005871 511 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 590 (672)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||..... ........... ...+-
T Consensus 226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~~~-~~~~~------ 291 (346)
T 4fih_A 226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------LKAMKMIRDNL-PPRLK------ 291 (346)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSS-CCCCS------
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHcCC-CCCCC------
Confidence 23456899999999999999999999999999999999999999853211 11111111110 00000
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 591 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
........+.+|+.+||+.||++|||++|+++.
T Consensus 292 -~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 292 -NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp -CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 011122456788889999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=427.01 Aligned_cols=263 Identities=26% Similarity=0.433 Sum_probs=203.0
Q ss_pred cCCccccccccCCceeEEeeeecCCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
+++.+.++||+|+||+||+|++++ .||||+++.. ..+..+.|.+|+.+|++++|||||++++++.+ +.++|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 578889999999999999998753 5999998643 34556789999999999999999999998865 568999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
|++|+|.++|... ...+++.++..|+.||+.||.|||+++ ||||||||+||||++++++||+|||+++.......
T Consensus 113 ~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 113 CEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred CCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 9999999999543 346999999999999999999999997 99999999999999999999999999987654444
Q ss_pred CcccccccccCCcCChhhhcC---CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 510 QANTNIIAGTYGYMAPEYAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
.......+||+.|||||++.+ +.|+.++|||||||++|||+||+.||...... ..+..............+
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--~~~~~~~~~~~~~p~~~~---- 261 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--DQIIFMVGRGYASPDLSK---- 261 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHTTCCCCCSTT----
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--HHHHHHHhcCCCCCCccc----
Confidence 344455789999999999964 46899999999999999999999998532211 111111111111111111
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCCCC
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIP 633 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~ 633 (672)
........+.+|+.+||+.||++|||+.||++.|....-++|
T Consensus 262 -----~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 262 -----LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp -----SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred -----ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 112223457788889999999999999999999987655554
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-51 Score=432.48 Aligned_cols=251 Identities=21% Similarity=0.357 Sum_probs=201.5
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
++|+++++||+|+||+||+|++. +|+.||||++.+.. ....+.+.+|+.+|++|+|||||++++++.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999975 69999999997643 3456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
||+||+|.++|... +...+++.+++.|+.||+.||.|||++| |+||||||+||||+.+|++||+|||+++.+....
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 99999999999543 3446899999999999999999999998 9999999999999999999999999998753211
Q ss_pred CCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhh
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 588 (672)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||.... ........... .... +
T Consensus 180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~i~~~-~~~~-----~ 245 (350)
T 4b9d_A 180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS------MKNLVLKIISG-SFPP-----V 245 (350)
T ss_dssp --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHT-CCCC-----C
T ss_pred --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHHcC-CCCC-----C
Confidence 12234689999999999999999999999999999999999999985321 11222222111 1111 1
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 589 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 589 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.... ...+.+|+.+||+.||++|||++|+++.
T Consensus 246 ~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 246 SLHY----SYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CccC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112 2346788889999999999999999863
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=428.83 Aligned_cols=248 Identities=23% Similarity=0.288 Sum_probs=208.3
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEeccc---CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
++|++.+.||+|+||+||+|++. +++.||||++.+. .....+.+.+|+++|++++|||||++++++.+++.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999975 6899999999754 2345678999999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
|||+||+|.+++.. ...+++.++..|+.||+.||.|||+++ |+||||||+||||+.++++||+|||+++.+...
T Consensus 112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 99999999999954 346999999999999999999999998 999999999999999999999999999988655
Q ss_pred CCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChh
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 587 (672)
.........+||+.|||||++.+..|+.++|||||||++|||++|+.||.... .......... +.. .
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~------~~~~~~~i~~-~~~-~----- 252 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN------EGLIFAKIIK-LEY-D----- 252 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHH-TCC-C-----
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHc-CCC-C-----
Confidence 55555566799999999999999999999999999999999999999985321 1111111111 111 0
Q ss_pred hcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005871 588 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 622 (672)
Q Consensus 588 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 622 (672)
+....+ ..+.+|+.+||+.||++|||++|++
T Consensus 253 ~p~~~s----~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 253 FPEKFF----PKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CCTTCC----HHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCcccC----HHHHHHHHHHccCCHhHCcChHHHc
Confidence 111222 3467888899999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=427.08 Aligned_cols=266 Identities=24% Similarity=0.305 Sum_probs=209.3
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
+.|.+.++||+|+||.||+|+++ +|+.||||++..... ..+|+.+|++++|||||++++++.+++.+|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 56888999999999999999975 689999999976432 246999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-CeEEEeecCceeeCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIFGGNQN 509 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~-~~kL~DFgla~~~~~~~~ 509 (672)
+||+|.+++.. ...+++.++..|+.||+.||.|||+++ ||||||||+||||+.+| ++||+|||+++.+.....
T Consensus 133 ~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 133 EGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 99999999954 346999999999999999999999997 99999999999999987 699999999998754332
Q ss_pred Cc---ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 510 QA---NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 510 ~~---~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
.. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||...... .+.. ..........
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~---~i~~~~~~~~---- 276 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG---PLCL---KIASEPPPIR---- 276 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS---CCHH---HHHHSCCGGG----
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HHHH---HHHcCCCCch----
Confidence 21 233468999999999999999999999999999999999999998543221 1111 1111111000
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC---CCCCCCCCCCcccc
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD---SMTIPQPTEPAFSV 642 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~---~~~l~~p~~p~~~~ 642 (672)
.+ ++.....+.+++.+||+.||++|||+.||++.|... ...+..|+-..+..
T Consensus 277 ~~----~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~ 331 (336)
T 4g3f_A 277 EI----PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE 331 (336)
T ss_dssp GS----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred hc----CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence 01 112234567788899999999999999999988653 23455666554443
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-50 Score=432.03 Aligned_cols=250 Identities=24% Similarity=0.341 Sum_probs=208.0
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
+.|++.++||+|+||.||+|+++ +|+.||||++........+.+.+|+.+|++++|||||++++++.+++.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 57999999999999999999986 69999999998776666778999999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
+||+|.+++.. ..+++.++..|+.||+.||.|||++| ||||||||+||||+.+|++||+|||+++.+.....
T Consensus 231 ~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~- 302 (423)
T 4fie_A 231 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 302 (423)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-
T ss_pred CCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc-
Confidence 99999998843 35999999999999999999999998 99999999999999999999999999998754322
Q ss_pred cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcC
Q 005871 511 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 590 (672)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||.... .......+..... ..+ .
T Consensus 303 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~------~~~~~~~i~~~~~-~~~-----~- 368 (423)
T 4fie_A 303 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP------PLKAMKMIRDNLP-PRL-----K- 368 (423)
T ss_dssp -CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSCC-CCC-----S-
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHHcCCC-CCC-----c-
Confidence 2345789999999999999999999999999999999999999985321 1111111111110 000 0
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 591 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
........+.+|+.+||+.||++|||++|+++.
T Consensus 369 -~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 369 -NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp -CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 001112346778889999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=409.82 Aligned_cols=248 Identities=25% Similarity=0.363 Sum_probs=197.1
Q ss_pred CccccccccCCceeEEeeeec-CCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEe----CceEEEE
Q 005871 354 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE----GQELLLI 426 (672)
Q Consensus 354 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~----~~~~~lV 426 (672)
|++.++||+|+||.||+|.+. ++..||+|++... .....+.|.+|+.+|++++|||||++++++.+ ++.++||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 367778999999999999976 5889999998654 33446789999999999999999999999875 3568999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-CCCeEEEeecCceeeC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFGLARIFG 505 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~-~~~~kL~DFgla~~~~ 505 (672)
||||++|+|.+++.. ...+++..+..|+.||+.||.|||+++ .+|+||||||+||||+. ++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 999999999999954 346999999999999999999999975 25999999999999984 7999999999998543
Q ss_pred CCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccC
Q 005871 506 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585 (672)
Q Consensus 506 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 585 (672)
. ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||..... .. ........+...
T Consensus 184 ~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-----~~-~~~~~i~~~~~~---- 248 (290)
T 3fpq_A 184 A----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AA-QIYRRVTSGVKP---- 248 (290)
T ss_dssp T----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HH-HHHHHHTTTCCC----
T ss_pred C----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-----HH-HHHHHHHcCCCC----
Confidence 2 22345689999999998865 699999999999999999999999853211 11 111111221111
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.......+ ..+.+|+.+||+.||++|||++|+++.
T Consensus 249 ~~~~~~~~----~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 249 ASFDKVAI----PEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGGGGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCccCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11111222 246778889999999999999999863
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=407.60 Aligned_cols=246 Identities=22% Similarity=0.361 Sum_probs=189.2
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
++|++.+.||+|+||+||+|++. +|+.||||++.+.. ....+.+.+|+.+|++++||||+++++++.+++.++|||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999975 69999999997543 334567999999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+ +|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.....
T Consensus 93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 6788888843 356999999999999999999999998 999999999999999999999999999875432
Q ss_pred CCCcccccccccCCcCChhhhcCCCC-ChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
. .....+||+.|||||++.+..+ +.++|||||||++|||++|+.||.... ......... .+.. .
T Consensus 166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~------~~~~~~~i~-~~~~-~---- 230 (275)
T 3hyh_A 166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES------IPVLFKNIS-NGVY-T---- 230 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHH-HTCC-C----
T ss_pred C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHH-cCCC-C----
Confidence 2 2234689999999999998876 689999999999999999999985321 111111111 1111 0
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
+.... ...+.+|+.+||+.||++|||++|+++.
T Consensus 231 -~p~~~----s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 231 -LPKFL----SPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp -CCTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred -CCCCC----CHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11112 2346778889999999999999999874
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-49 Score=410.09 Aligned_cols=267 Identities=24% Similarity=0.293 Sum_probs=199.6
Q ss_pred cCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCc----eEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ----ELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~----~~~lV~ 427 (672)
++|.+.++||+|+||+||+|++ +|+.||||++...... ...+..|+..+.+++|||||++++++.+++ .++|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4578889999999999999998 5889999999754322 223345666667899999999999998653 689999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeecCCCCCcEEEcCCCCeEEEeecCce
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS-----RLKIIHRDLKASNILLDDDMNPKISDFGLAR 502 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g-----~~~iiHrDlkp~NIll~~~~~~kL~DFgla~ 502 (672)
|||++|+|.+++.. ..++++.+..++.|++.||.|||+++ ..+|+||||||+||||+.++++||+|||+++
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999954 35899999999999999999999861 2249999999999999999999999999999
Q ss_pred eeCCCCCCc--ccccccccCCcCChhhhcCC------CCChhhHHHHHHHHHHHHHcCCCCCCCCCccccc--------c
Q 005871 503 IFGGNQNQA--NTNIIAGTYGYMAPEYAMGG------IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQ--------T 566 (672)
Q Consensus 503 ~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~------~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~--------~ 566 (672)
......... .....+||+.|||||++.+. .++.++|||||||++|||+||++|++........ .
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 875443322 22346899999999999764 3678999999999999999999886532211100 0
Q ss_pred hhhhhhhhccCCCcccccChhhcCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 567 LLTYTWKLWCEGPAVELIDPVLKQS-CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 567 ~~~~~~~~~~~~~~~~l~d~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
...........+ ..++.+... ...+....+.+|+.+||+.||++|||+.||+++|+..
T Consensus 237 ~~~~~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 237 SVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CHHHHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 001111111111 111111111 1234566788999999999999999999999999753
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=414.13 Aligned_cols=248 Identities=24% Similarity=0.288 Sum_probs=194.9
Q ss_pred cCCccccccccCCceeEEeeeec----CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l 425 (672)
++|++.+.||+|+||+||+|+.. .++.||||++.+.. ......+.+|+.+|++++|||||++++++.+++.++|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999852 46789999997643 2334568899999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
|||||+||+|.+++.. ...+++.++..++.||+.||.|||++| |+||||||+|||++.+|++||+|||+++...
T Consensus 104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999954 346999999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccC
Q 005871 506 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585 (672)
Q Consensus 506 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 585 (672)
.... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||..... .......... .. .
T Consensus 178 ~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~~-~~-~--- 244 (304)
T 3ubd_A 178 DHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR------KETMTMILKA-KL-G--- 244 (304)
T ss_dssp ---C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHC-CC-C---
T ss_pred CCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH------HHHHHHHHcC-CC-C---
Confidence 3222 23346899999999999999999999999999999999999999853221 1111111111 10 0
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPT-----MSSVVVM 624 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 624 (672)
..... ...+.+|+.+||+.||++||| ++|+++.
T Consensus 245 --~p~~~----s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 245 --MPQFL----SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp --CCTTS----CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred --CCCcC----CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 11112 234678888999999999998 4677753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=420.08 Aligned_cols=259 Identities=29% Similarity=0.408 Sum_probs=209.5
Q ss_pred hcCCccccccccCCceeEEeeeecC------CceeEEEEecccCc-ccHHHHHHHHHHHHhccC-CCeeeEEEEEEeC-c
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQH-KNLVRLLGCCLEG-Q 421 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h-~niv~l~~~~~~~-~ 421 (672)
.++|++.++||+|+||+||+|.+.. ++.||||++..... ...+.|.+|+++|.+++| ||||+++++|.+. +
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~ 142 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 142 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence 4789999999999999999998642 36799999976543 345679999999999965 8999999999764 5
Q ss_pred eEEEEEeecCCCChhHHhhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc
Q 005871 422 ELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD 488 (672)
Q Consensus 422 ~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~ 488 (672)
.++||||||++|+|.++|..... ...+++.++..|+.||++||.|||+++ ||||||||+||||+
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl~ 219 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 219 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceeeC
Confidence 78999999999999999965322 345899999999999999999999997 99999999999999
Q ss_pred CCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccch
Q 005871 489 DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTL 567 (672)
Q Consensus 489 ~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~ 567 (672)
+++.+||+|||+++.+.............||+.|||||++.+..|+.++|||||||++|||+| |+.||...... ..
T Consensus 220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~--~~- 296 (353)
T 4ase_A 220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EE- 296 (353)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--HH-
T ss_pred CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH--HH-
Confidence 999999999999997765544444556789999999999999999999999999999999998 89997532211 11
Q ss_pred hhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 568 LTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 568 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
.......+..... .... ...+.+++.+||+.||++|||++||+++|..
T Consensus 297 ---~~~~i~~g~~~~~-----p~~~----~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 297 ---FCRRLKEGTRMRA-----PDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp ---HHHHHHHTCCCCC-----CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---HHHHHHcCCCCCC-----CccC----CHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 1111112211111 1112 2357788889999999999999999999865
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=404.09 Aligned_cols=252 Identities=25% Similarity=0.345 Sum_probs=190.2
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCc--------
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-------- 421 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~-------- 421 (672)
++|++++.||+|+||+||+|+++ +|+.||||++..... ...+.+.+|+.+|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46999999999999999999975 689999999976543 34567899999999999999999999987543
Q ss_pred ----eEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEe
Q 005871 422 ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISD 497 (672)
Q Consensus 422 ----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~D 497 (672)
.+++|||||++|+|.+++.........++..++.|+.||++||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 47999999999999999976544445677889999999999999999998 99999999999999999999999
Q ss_pred ecCceeeCCCCCCc----------ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccch
Q 005871 498 FGLARIFGGNQNQA----------NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTL 567 (672)
Q Consensus 498 Fgla~~~~~~~~~~----------~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~ 567 (672)
||+++.+....... .....+||+.|||||++.+..|+.++|||||||++|||++ ||.... ..
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-----~~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-----ER 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----HH
Confidence 99999775432211 1233579999999999999999999999999999999996 542110 00
Q ss_pred hhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 568 LTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 568 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.... ......... +. .......+.+|+.+||+.||++|||+.|+++.
T Consensus 234 ~~~~-~~~~~~~~p----~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 234 VRTL-TDVRNLKFP----PL-----FTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHH-HHHHTTCCC----HH-----HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHH-HHHhcCCCC----CC-----CcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111 111111111 10 11222345678889999999999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=404.34 Aligned_cols=265 Identities=20% Similarity=0.305 Sum_probs=200.6
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEe------Cc
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE------GQ 421 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~------~~ 421 (672)
.++|+++++||+|+||+||+|++. +|+.||||++.+.. ....+.+.+|+.+|+.++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 368999999999999999999975 69999999997543 3345678899999999999999999999764 36
Q ss_pred eEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCc
Q 005871 422 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 501 (672)
Q Consensus 422 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla 501 (672)
.+|||||||+ |+|..++. +...+++..+..|+.||+.||.|||++| ||||||||+|||++.++.+||+|||++
T Consensus 133 ~~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 7999999996 56888874 3457999999999999999999999998 999999999999999999999999999
Q ss_pred eeeCCCC--CCcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCC
Q 005871 502 RIFGGNQ--NQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 578 (672)
Q Consensus 502 ~~~~~~~--~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 578 (672)
+.+.... ........+||+.|||||++.+. .++.++||||+||++|||++|++||....... .+..+.......
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~---~l~~I~~~~g~p 282 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH---QLQLIMMVLGTP 282 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH---HHHHHHHHHCCC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhcCCC
Confidence 8764332 22233456899999999998875 46999999999999999999999985432111 111111110000
Q ss_pred Ccc-----------cccChhhc-CCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 579 PAV-----------ELIDPVLK-QSCA-----PDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 579 ~~~-----------~l~d~~l~-~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
... ..+..... ...+ +.....+.+|+.+||+.||++|||++|+++.=
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 346 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHP 346 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSG
T ss_pred ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCH
Confidence 000 00000000 0000 01123567888999999999999999998753
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=387.60 Aligned_cols=277 Identities=38% Similarity=0.672 Sum_probs=240.0
Q ss_pred HHhcCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
..+++|++.+.||+|+||.||+|++++++.||||++........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 115 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK 115 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEE
T ss_pred HHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEE
Confidence 46689999999999999999999988899999999987777777889999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 429 YMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 429 y~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
|+++++|.+++.... ....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.....
T Consensus 116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTEL 192 (321)
T ss_dssp CCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred cCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999886432 2235899999999999999999999997 999999999999999999999999999876543
Q ss_pred CCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChh
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 587 (672)
..........||+.|+|||++.++.++.++||||||+++|||++|+.||....+........+.......+...+.+++.
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (321)
T 2qkw_B 193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPN 272 (321)
T ss_dssp SCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSS
T ss_pred cccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChh
Confidence 33333344579999999999999999999999999999999999999987655544444445544555566666777777
Q ss_pred hcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 588 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 588 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
+.....+.....+.+++.+||+.||++|||+.||++.|...
T Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 273 LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp CTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 66677788889999999999999999999999999999753
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=389.54 Aligned_cols=197 Identities=26% Similarity=0.377 Sum_probs=170.5
Q ss_pred HhcCCccccccccCCceeEEeeeec----CCceeEEEEecccCcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEE
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELL 424 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~ 424 (672)
..++|++.++||+|+||+||+|+++ .++.||||++.+... ...+.+|+++|+.+ +||||+++++++.+.+.++
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 4578999999999999999999863 367899999876543 45688999999999 6999999999999999999
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC-CCeEEEeecCcee
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-MNPKISDFGLARI 503 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~-~~~kL~DFgla~~ 503 (672)
|||||+++++|.+++. .+++.++..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+|+.
T Consensus 97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 9999999999998882 4899999999999999999999998 9999999999999876 7999999999987
Q ss_pred eCCCCCC--------------------------cccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCC
Q 005871 504 FGGNQNQ--------------------------ANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNN 556 (672)
Q Consensus 504 ~~~~~~~--------------------------~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~ 556 (672)
....... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 6432211 112235799999999999876 5899999999999999999999998
Q ss_pred C
Q 005871 557 G 557 (672)
Q Consensus 557 ~ 557 (672)
.
T Consensus 248 ~ 248 (361)
T 4f9c_A 248 Y 248 (361)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=382.00 Aligned_cols=293 Identities=42% Similarity=0.690 Sum_probs=245.5
Q ss_pred CCccccchHHHHHHhcCCccccccccCCceeEEeeeecCCceeEEEEecccCc-ccHHHHHHHHHHHHhccCCCeeeEEE
Q 005871 337 QEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLG 415 (672)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~ 415 (672)
.....++........++|++.+.||+|+||.||+|.+.+++.||||++..... .....+.+|+.+++.++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 34556788888889999999999999999999999988899999999876532 22346899999999999999999999
Q ss_pred EEEeCceEEEEEeecCCCChhHHhhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeE
Q 005871 416 CCLEGQELLLIYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPK 494 (672)
Q Consensus 416 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~k 494 (672)
++.+.+..++||||+++++|.+++.... ....+++..+..++.||+.||.|||+....+|+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 9999999999999999999999996543 334599999999999999999999999211299999999999999999999
Q ss_pred EEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCC--cccccchhhhhh
Q 005871 495 ISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF--SEHGQTLLTYTW 572 (672)
Q Consensus 495 L~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~--~~~~~~~~~~~~ 572 (672)
|+|||++......... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.... .........+..
T Consensus 175 l~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp ECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred eccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 9999999876543322 2334569999999999998899999999999999999999999985322 222334445555
Q ss_pred hhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCC
Q 005871 573 KLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSM 630 (672)
Q Consensus 573 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 630 (672)
..........+.+..+...........+.+++.+||+.||++|||++||+++|.....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 6666667777777777777888889999999999999999999999999999987643
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=408.37 Aligned_cols=265 Identities=26% Similarity=0.291 Sum_probs=206.0
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHH---HHHHHHhccCCCeeeEEEEEEeCceEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKN---EVNLIAKLQHKNLVRLLGCCLEGQELL 424 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---E~~il~~l~h~niv~l~~~~~~~~~~~ 424 (672)
++|++.+.||+|+||.||+|+++ +|+.||||++.+.. ........+ ++.+++.++|||||+++++|.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 68999999999999999999986 69999999997532 122233334 466677779999999999999999999
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceee
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 504 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~ 504 (672)
|||||++||+|..+|.. ...+++..+..++.||+.||.|||++| ||||||||+||||+.+|++||+|||+|+.+
T Consensus 269 lVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 99999999999999954 346999999999999999999999998 999999999999999999999999999986
Q ss_pred CCCCCCcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccc
Q 005871 505 GGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583 (672)
Q Consensus 505 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 583 (672)
.... ....+||+.|||||++.+ ..|+.++|||||||++|||++|++||....... ............ .
T Consensus 343 ~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~---~~~i~~~i~~~~-~--- 411 (689)
T 3v5w_A 343 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEIDRMTLTMA-V--- 411 (689)
T ss_dssp SSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC---HHHHHHHHHHCC-C---
T ss_pred CCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHhhcCCC-C---
Confidence 5432 334689999999999975 579999999999999999999999985322211 111111111110 0
Q ss_pred cChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhccC--------CCCCCCCCCCcc
Q 005871 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT-----MSSVVVMLASD--------SMTIPQPTEPAF 640 (672)
Q Consensus 584 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L~~~--------~~~l~~p~~p~~ 640 (672)
...... ...+.+|+.+||+.||++|++ ++||+++--.. ...+++|-.|..
T Consensus 412 ---~~p~~~----S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~~ 474 (689)
T 3v5w_A 412 ---ELPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPR 474 (689)
T ss_dssp ---CCCTTS----CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCCT
T ss_pred ---CCCccC----CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccCCC
Confidence 011112 234678888999999999998 68887653221 224566666643
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=409.37 Aligned_cols=253 Identities=23% Similarity=0.330 Sum_probs=208.4
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
.++|++.+.||+|+||.||++.++ +|+.||||++........+.+.+|+.+|+.++|||||++++++.+++.++|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 468999999999999999999986 6999999999877766678899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC--CCeEEEeecCceeeCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD--MNPKISDFGLARIFGGN 507 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~--~~~kL~DFgla~~~~~~ 507 (672)
|+||+|.+++.. +...+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999988843 3346999999999999999999999998 9999999999999854 89999999999987543
Q ss_pred CCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChh
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 587 (672)
. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||...... ........ ... . ++..
T Consensus 311 ~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~------~~~~~i~~-~~~-~-~~~~ 378 (573)
T 3uto_A 311 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRNVKS-CDW-N-MDDS 378 (573)
T ss_dssp S---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHT-TCC-C-CCSG
T ss_pred C---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHh-CCC-C-CCcc
Confidence 2 233468999999999999999999999999999999999999998533211 11111111 100 0 0111
Q ss_pred hcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 588 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 588 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
..... ...+.+|+.+||+.||++|||+.|++++
T Consensus 379 ~~~~~----s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 379 AFSGI----SEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp GGTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11112 2346788889999999999999999984
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=359.41 Aligned_cols=286 Identities=37% Similarity=0.573 Sum_probs=230.1
Q ss_pred cCCccccchHHHHHHhcCCccc------cccccCCceeEEeeeecCCceeEEEEecccC----cccHHHHHHHHHHHHhc
Q 005871 336 SQEFPLFPLRLALEATNHFSDE------NKLGQGGFGPVYKGTLADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKL 405 (672)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~------~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l 405 (672)
....+.+++..+..++++|... ++||+|+||.||+|.+ +++.||+|++.... ....+.+.+|+.+++++
T Consensus 9 ~~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l 87 (307)
T 2nru_A 9 DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC 87 (307)
T ss_dssp --CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC
T ss_pred CCCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc
Confidence 3455678888888999888877 8999999999999987 58899999986532 34467899999999999
Q ss_pred cCCCeeeEEEEEEeCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 005871 406 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNI 485 (672)
Q Consensus 406 ~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NI 485 (672)
+||||+++++++.+.+..++||||+++++|.+++........+++..++.++.||+.||.|||+.+ |+||||||+||
T Consensus 88 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Ni 164 (307)
T 2nru_A 88 QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANI 164 (307)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGE
T ss_pred CCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHE
Confidence 999999999999999999999999999999999976555567999999999999999999999998 99999999999
Q ss_pred EEcCCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCccccc
Q 005871 486 LLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQ 565 (672)
Q Consensus 486 ll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~ 565 (672)
+++.++.+||+|||++................|++.|+|||.+.+ .++.++||||||+++|+|++|+.||.......
T Consensus 165 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-- 241 (307)
T 2nru_A 165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-- 241 (307)
T ss_dssp EECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS--
T ss_pred EEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH--
Confidence 999999999999999987655443333445679999999998865 58999999999999999999999986433221
Q ss_pred chhhhhhhhcc-CCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 005871 566 TLLTYTWKLWC-EGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDS 629 (672)
Q Consensus 566 ~~~~~~~~~~~-~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 629 (672)
........... .....+.++..+ ..........+.+++.+||+.||++|||+.+|++.|....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 242 LLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp BTTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 11111111111 112222333322 2335566778899999999999999999999999998653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=363.35 Aligned_cols=260 Identities=30% Similarity=0.497 Sum_probs=212.1
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
.++|.+.++||+|+||.||++.+. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 367999999999999999999985 5899999999877777788999999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+++++|.+++... ...+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999999642 346999999999999999999999998 99999999999999999999999999987654332
Q ss_pred Ccc------------cccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccC
Q 005871 510 QAN------------TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCE 577 (672)
Q Consensus 510 ~~~------------~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 577 (672)
... .....||+.|+|||++.+..++.++||||||+++|||++|..|+...............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~------ 237 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR------ 237 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH------
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh------
Confidence 211 11457999999999999999999999999999999999999997654332221111000
Q ss_pred CCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 005871 578 GPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDS 629 (672)
Q Consensus 578 ~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 629 (672)
...+....... ...+.+++.+||+.||++|||+.+|++.|....
T Consensus 238 ----~~~~~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 238 ----GFLDRYCPPNC----PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp ----HHHHHTCCTTC----CTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----ccccccCCCCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00111111111 234678888999999999999999999998753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=359.15 Aligned_cols=252 Identities=24% Similarity=0.376 Sum_probs=207.8
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
.++|++.++||+|+||.||+|.+. +++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 468999999999999999999864 6899999999876666678899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+++++|.+++.. ..+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 999999999853 25899999999999999999999998 99999999999999999999999999987654332
Q ss_pred CcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhc
Q 005871 510 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 589 (672)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ............ ...
T Consensus 172 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~~-~~~----- 237 (297)
T 3fxz_A 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTP-ELQ----- 237 (297)
T ss_dssp --CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSC-CCS-----
T ss_pred --ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC-CCC-----
Confidence 233457999999999999999999999999999999999999998532211 111111111100 000
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 590 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
.+......+.+++.+||+.||++|||++|+++.-
T Consensus 238 --~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~ 271 (297)
T 3fxz_A 238 --NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQ 271 (297)
T ss_dssp --CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred --CccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence 0111234477888899999999999999998643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=361.38 Aligned_cols=261 Identities=29% Similarity=0.441 Sum_probs=202.0
Q ss_pred hcCCccccccccCCceeEEeeeecCCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
.++|++.++||+|+||.||+|++ .++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 46899999999999999999987 58889999987653 3445678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|+++++|.+++........+++..++.++.||+.||.|||+.| .+|+||||||+|||++.++.+||+|||+++......
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~ 193 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence 9999999999965443445999999999999999999999974 239999999999999999999999999998644322
Q ss_pred CCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhh
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 588 (672)
.......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... .............+ +
T Consensus 194 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~------~~~~~~~~~~~~~~-----~ 260 (309)
T 3p86_A 194 --LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA------QVVAAVGFKCKRLE-----I 260 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHHHSCCCCC-----C
T ss_pred --cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcCCCCC-----C
Confidence 1223457999999999999999999999999999999999999998543211 11111100111111 1
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCC
Q 005871 589 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSM 630 (672)
Q Consensus 589 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 630 (672)
.... ...+.+|+.+||+.||++|||+++|++.|+..-.
T Consensus 261 ~~~~----~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 261 PRNL----NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred CccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1112 2347788889999999999999999999987533
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=368.37 Aligned_cols=266 Identities=24% Similarity=0.338 Sum_probs=207.8
Q ss_pred hcCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCc----eEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ----ELLLI 426 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~----~~~lV 426 (672)
.++|++.++||+|+||.||+|++. ++.||||++..... ....+..|+.++++++||||+++++++.+.. .+++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 368999999999999999999875 78999999976543 3345667999999999999999999998743 47999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhc----------CCCCeeecCCCCCcEEEcCCCCeEEE
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED----------SRLKIIHRDLKASNILLDDDMNPKIS 496 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~----------g~~~iiHrDlkp~NIll~~~~~~kL~ 496 (672)
|||+++++|.+++.. ..+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+||+
T Consensus 101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence 999999999999854 3489999999999999999999998 7 9999999999999999999999
Q ss_pred eecCceeeCCCCCCcccccccccCCcCChhhhcCC-----CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhh-
Q 005871 497 DFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-----IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTY- 570 (672)
Q Consensus 497 DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~- 570 (672)
|||+++.+.............||+.|+|||++.+. .++.++|||||||++|||++|+.||..............
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 99999987665544444456799999999999873 456789999999999999999999865332221111100
Q ss_pred --------hhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 571 --------TWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 571 --------~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
.............+..... .......+.+|+.+||+.||++|||+.||++.|...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQ---KHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGG---SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCchhhhhhhhhcccCCCCcccccc---ccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0000011111111111111 123456688999999999999999999999999753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=370.41 Aligned_cols=259 Identities=29% Similarity=0.430 Sum_probs=210.0
Q ss_pred hcCCccccccccCCceeEEeeeec--------CCceeEEEEecccC-cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeC
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG 420 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~ 420 (672)
.++|.+.+.||+|+||.||+|++. ++..||||++.... ....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 468999999999999999999752 34579999997653 34457899999999999 899999999999999
Q ss_pred ceEEEEEeecCCCChhHHhhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE
Q 005871 421 QELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 487 (672)
Q Consensus 421 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll 487 (672)
+.+++||||+++|+|.+++..... ...+++.++..++.||+.||.|||+++ |+||||||+||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999965431 235899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccc
Q 005871 488 DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQT 566 (672)
Q Consensus 488 ~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~ 566 (672)
+.++.+||+|||+++.+.............|++.|+|||++.+..++.++|||||||++|||++ |+.||..... ..
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~---~~ 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EE 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GG
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH---HH
Confidence 9999999999999997765443333444567889999999999999999999999999999999 9998753221 11
Q ss_pred hhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 567 LLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 567 ~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
+.. ....+.... .+......+.+++.+||+.||++|||+.||++.|...
T Consensus 314 ~~~----~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 314 LFK----LLKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp HHH----HHHTTCCCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH----HHhcCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111 111111111 1112234577888899999999999999999999763
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=353.00 Aligned_cols=273 Identities=20% Similarity=0.248 Sum_probs=214.7
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCc--eEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ--ELLLI 426 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~--~~~lV 426 (672)
.++|.+.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 467999999999999999999986 58999999997543 344677889999999999999999999998765 78999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE----cCCCCeEEEeecCce
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL----DDDMNPKISDFGLAR 502 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll----~~~~~~kL~DFgla~ 502 (672)
|||+++++|.+++........+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999976555556999999999999999999999998 9999999999999 778889999999998
Q ss_pred eeCCCCCCcccccccccCCcCChhhhc--------CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccc-cchhhhhhh
Q 005871 503 IFGGNQNQANTNIIAGTYGYMAPEYAM--------GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHG-QTLLTYTWK 573 (672)
Q Consensus 503 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~--------~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~-~~~~~~~~~ 573 (672)
....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||........ .........
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 7654332 22357999999999986 57789999999999999999999999854332221 111111111
Q ss_pred hccCCCccc----------ccCh-hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 005871 574 LWCEGPAVE----------LIDP-VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDS 629 (672)
Q Consensus 574 ~~~~~~~~~----------l~d~-~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 629 (672)
......+.. +... .............+.+++.+||+.||++|||++|+++..+.+.
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 100000000 0000 0112334566677889999999999999999999999997653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=359.48 Aligned_cols=255 Identities=26% Similarity=0.364 Sum_probs=203.7
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
.++|++.+.||+|+||.||++.+. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999976 689999999865432 334668899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|+++++|.+++. ....+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++..+....
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999998884 3446999999999999999999999998 9999999999999999999999999998765443
Q ss_pred CCcccccccccCCcCChhhhcCCCC-ChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChh
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 587 (672)
.........||+.|+|||++.+..+ +.++||||||+++|+|++|+.||........ .... +..... ...+
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~~---~~~~~~--~~~~- 230 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---EYSD---WKEKKT--YLNP- 230 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH---HHHH---HHTTCT--TSTT-
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH---HHHH---Hhcccc--cCCc-
Confidence 3333445689999999999988775 7899999999999999999999854322111 1111 111100 0000
Q ss_pred hcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 588 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 588 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
.......+.+|+.+||+.||++|||+.|+++.-
T Consensus 231 -----~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 231 -----WKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp -----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred -----cccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 011223467888899999999999999998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=359.83 Aligned_cols=249 Identities=26% Similarity=0.353 Sum_probs=204.9
Q ss_pred hcCCccccccccCCceeEEeeee-cCCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
.++|.+.+.||+|+||.||+|.+ .+|+.||||++... .....+.+.+|+.+|+.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46899999999999999999997 47999999998764 3345677899999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+++++|.+++... ..+++..+..++.||+.||.|||++| |+||||||+|||++.++++||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 999999999998543 45999999999999999999999998 999999999999999999999999999865432
Q ss_pred CCCcccccccccCCcCChhhhcCCCC-ChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... .......... ..
T Consensus 168 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~-~~------ 231 (328)
T 3fe3_A 168 G---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL------KELRERVLRG-KY------ 231 (328)
T ss_dssp C---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHC-CC------
T ss_pred C---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhC-CC------
Confidence 2 2344679999999999998887 4899999999999999999999853321 1111111111 00
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
..+......+.+++.+||+.||++|||++|+++.-
T Consensus 232 ----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~ 266 (328)
T 3fe3_A 232 ----RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDR 266 (328)
T ss_dssp ----CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCT
T ss_pred ----CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCH
Confidence 00111123467888899999999999999998753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=353.48 Aligned_cols=263 Identities=23% Similarity=0.351 Sum_probs=211.7
Q ss_pred ccchHHHHHHhcC----------CccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCC
Q 005871 341 LFPLRLALEATNH----------FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 409 (672)
Q Consensus 341 ~~~~~~~~~~~~~----------~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n 409 (672)
.++......+++. |...++||+|+||.||+|++. +|+.||||++........+.+.+|+.++++++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 3455555555443 777889999999999999986 69999999998777677788999999999999999
Q ss_pred eeeEEEEEEeCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC
Q 005871 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD 489 (672)
Q Consensus 410 iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~ 489 (672)
|+++++++...+..++||||+++++|.+++.. ..+++..+..++.||+.||.|||+.| |+||||||+|||++.
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL 176 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence 99999999999999999999999999998842 35999999999999999999999997 999999999999999
Q ss_pred CCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhh
Q 005871 490 DMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLT 569 (672)
Q Consensus 490 ~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~ 569 (672)
++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ..
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~------~~ 248 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP------VQ 248 (321)
T ss_dssp TCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HH
T ss_pred CCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HH
Confidence 99999999999987654322 22345799999999999999999999999999999999999999753221 11
Q ss_pred hhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 570 YTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 570 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
...... ......+.. .......+.+++.+||+.||++|||+.++++..-
T Consensus 249 ~~~~~~-~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 297 (321)
T 2c30_A 249 AMKRLR-DSPPPKLKN-------SHKVSPVLRDFLERMLVRDPQERATAQELLDHPF 297 (321)
T ss_dssp HHHHHH-HSSCCCCTT-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred HHHHHh-cCCCCCcCc-------cccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 111111 111111100 0111234677888999999999999999997543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=359.02 Aligned_cols=265 Identities=23% Similarity=0.268 Sum_probs=212.0
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEeccc---CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
.++|++.+.||+|+||.||+++.+ +++.||+|++.+. .......+.+|+.+|+.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 368999999999999999999976 6899999999764 234567789999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||+++|+|..++.. ...+++..+..++.||+.||.|||++| |+||||||+|||++.++++||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999988854 346899999999999999999999998 99999999999999999999999999986432
Q ss_pred CCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
.. ......+||+.|+|||++.+..++.++||||||+++|||++|+.||..... ..+ ....... ..
T Consensus 158 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~---~~~i~~~-~~------ 222 (337)
T 1o6l_A 158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERL---FELILME-EI------ 222 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHH---HHHHHHC-CC------
T ss_pred CC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH---HHH---HHHHHcC-CC------
Confidence 22 223446899999999999999999999999999999999999999853211 111 1111111 00
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhccC--------CCCCCCCCCCcc
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVVMLASD--------SMTIPQPTEPAF 640 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L~~~--------~~~l~~p~~p~~ 640 (672)
.+.... ...+.+++.+||+.||++|| +++||++.--.. ...+++|-.|..
T Consensus 223 ~~p~~~----s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p~~ 285 (337)
T 1o6l_A 223 RFPRTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQV 285 (337)
T ss_dssp CCCTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred CCCCCC----CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCCCC
Confidence 011111 23467788899999999999 899998764322 234566666654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=350.96 Aligned_cols=263 Identities=25% Similarity=0.363 Sum_probs=200.9
Q ss_pred hcCCccccccccCCceeEEeeeecCCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
.++|++.++||+|+||.||++++.+++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 47899999999999999999999889999999987543 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|+++ +|...+.. ....+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 100 FMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp CCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred CCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9985 67666643 3345899999999999999999999998 9999999999999999999999999998765332
Q ss_pred CCcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCC---Ccccc-
Q 005871 509 NQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG---PAVEL- 583 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~l- 583 (672)
. ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||........ ........... .+...
T Consensus 174 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 174 R--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp C-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHHHHHHHCCCCTTTSGGGT
T ss_pred c--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHHCCCChHHhhhhh
Confidence 2 2233578999999999876 5689999999999999999999999864332221 11111111110 00000
Q ss_pred ------------cChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 584 ------------IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 584 ------------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.+........+.....+.+|+.+||+.||++|||++|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00000000001112357788899999999999999999964
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=360.80 Aligned_cols=264 Identities=27% Similarity=0.426 Sum_probs=204.4
Q ss_pred hcCCccccccccCCceeEEeeee-----cCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeC--ceE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QEL 423 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~ 423 (672)
.++|++.++||+|+||.||++++ .+++.||||++........+.+.+|+.++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46899999999999999999983 35889999999887777778899999999999999999999998654 458
Q ss_pred EEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 424 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
++||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999999653 235899999999999999999999997 99999999999999999999999999987
Q ss_pred eCCCCCC-cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCccc---------ccchhhhhhh
Q 005871 504 FGGNQNQ-ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH---------GQTLLTYTWK 573 (672)
Q Consensus 504 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~---------~~~~~~~~~~ 573 (672)
....... .......|+..|+|||.+.+..++.++||||||+++|||++|..|+....... ..........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 6543221 12223457788999999999999999999999999999999999875321110 0000000111
Q ss_pred hccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 574 LWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 574 ~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
....+.. ...+......+.+++.+||+.||++|||+.||++.|...
T Consensus 244 ~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 244 LLKNNGR---------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHTTCC---------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhccCc---------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1111110 011122234577888899999999999999999999764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=361.53 Aligned_cols=255 Identities=27% Similarity=0.449 Sum_probs=198.1
Q ss_pred hcCCccccccccCCceeEEeeeec-CCce----eEEEEeccc-CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKA----IAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 424 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 424 (672)
.++|++.++||+|+||.||+|++. +++. ||+|.+... .....+.+.+|+.++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 367999999999999999999964 4444 577877543 3345678999999999999999999999998754 78
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceee
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 504 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~ 504 (672)
+|+||+.+|+|.+++... ...+++..++.|+.||+.||.|||+++ |+||||||+|||++.++++||+|||+++.+
T Consensus 93 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 999999999999998653 346999999999999999999999997 999999999999999999999999999887
Q ss_pred CCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccc
Q 005871 505 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583 (672)
Q Consensus 505 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 583 (672)
.............||+.|+|||++.+..++.++||||||+++|||++ |+.||...... .+.... ..+...
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~----~~~~~~-- 238 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSIL----EKGERL-- 238 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHH----HTTCCC--
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH---HHHHHH----HcCCCC--
Confidence 65544443444567889999999999999999999999999999999 99998543221 111111 111100
Q ss_pred cChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 584 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
..+......+.+++.+||+.||++|||+.+|++.|..
T Consensus 239 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 275 (327)
T 3poz_A 239 -------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 275 (327)
T ss_dssp -------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHH
T ss_pred -------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 0112223457788889999999999999999999865
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=360.22 Aligned_cols=257 Identities=28% Similarity=0.446 Sum_probs=205.0
Q ss_pred hcCCccccccccCCceeEEeeeec----CCceeEEEEeccc-CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l 425 (672)
.++|.+.+.||+|+||.||+|.+. .+..||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 367999999999999999999974 3445999999765 34455789999999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
||||+++++|.+++... ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999998532 346999999999999999999999998 9999999999999999999999999999875
Q ss_pred CCCCCc-ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccc
Q 005871 506 GNQNQA-NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583 (672)
Q Consensus 506 ~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 583 (672)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... ....... .+...
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~~~----~~~~~-- 273 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DVISSVE----EGYRL-- 273 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHHHHH----TTCCC--
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHH----cCCCC--
Confidence 432221 2223356778999999998999999999999999999999 99997432211 1111111 11000
Q ss_pred cChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 584 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
..+......+.+|+.+||+.||++|||+.+|++.|...
T Consensus 274 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 274 -------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 01111234577888899999999999999999999875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=359.78 Aligned_cols=253 Identities=24% Similarity=0.276 Sum_probs=205.1
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCc------ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCce
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 422 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~ 422 (672)
..++|.+.+.||+|+||.||++.+. +|+.||+|++.+... ...+.+.+|+.+|++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3468999999999999999999976 689999999976532 235789999999999999999999999999999
Q ss_pred EEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC----CeEEEee
Q 005871 423 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM----NPKISDF 498 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~----~~kL~DF 498 (672)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.| |+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999999999843 456999999999999999999999998 99999999999998877 7999999
Q ss_pred cCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCC
Q 005871 499 GLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 578 (672)
Q Consensus 499 gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 578 (672)
|++..+.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ..... .. ...
T Consensus 164 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~---~~~~~---~i-~~~ 233 (361)
T 2yab_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLA---NI-TAV 233 (361)
T ss_dssp SSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHH---HH-HTT
T ss_pred CCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HHHHH---HH-Hhc
Confidence 9998765432 22345799999999999999999999999999999999999999853211 11111 11 111
Q ss_pred CcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 579 PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 579 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.. -+++...... ...+.+++.+||+.||++|||+.|+++.
T Consensus 234 ~~--~~~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 234 SY--DFDEEFFSQT----SELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp CC--CCCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CC--CCCchhccCC----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 10 0111111111 2346788889999999999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=362.90 Aligned_cols=274 Identities=23% Similarity=0.330 Sum_probs=210.7
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~l 425 (672)
.++|++.++||+|+||.||+++++ +++.||+|++.+.. ....+.+.+|..++.++ +||||+++++++.+.+.+++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 468999999999999999999976 58899999997643 23345688999999887 89999999999999999999
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
||||+++|+|..++.. ...+++..+..++.||+.||.|||++| |+||||||+||||+.++++||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999988854 345999999999999999999999998 9999999999999999999999999998533
Q ss_pred CCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccc--cchhhhhhhhccCCCcccc
Q 005871 506 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHG--QTLLTYTWKLWCEGPAVEL 583 (672)
Q Consensus 506 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~l 583 (672)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ................
T Consensus 205 ~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--- 279 (396)
T 4dc2_A 205 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--- 279 (396)
T ss_dssp CTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC---
T ss_pred cCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc---
Confidence 222 223456899999999999999999999999999999999999999854322111 1111111111111110
Q ss_pred cChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHHhccC--------CCCCCCCCCCcccc
Q 005871 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTM------SSVVVMLASD--------SMTIPQPTEPAFSV 642 (672)
Q Consensus 584 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~~L~~~--------~~~l~~p~~p~~~~ 642 (672)
..+......+.+|+.+||+.||++||++ +||++.--.. ...+++|-.|....
T Consensus 280 -------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p~~~~ 345 (396)
T 4dc2_A 280 -------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISG 345 (396)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCCCCCS
T ss_pred -------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCcCCCCC
Confidence 0111122356788889999999999995 6776654222 23456676776543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=344.16 Aligned_cols=256 Identities=27% Similarity=0.391 Sum_probs=208.4
Q ss_pred hcCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
.++|++.+.||+|+||.||++.++++..||+|++..... ..+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 468999999999999999999998888999999976543 3467899999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
++++|.+++... ...+++..++.++.||+.||.|||+.| |+||||||+||+++.++.+||+|||++.........
T Consensus 86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 999999998653 235899999999999999999999998 999999999999999999999999999876543322
Q ss_pred cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhc
Q 005871 511 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 589 (672)
. .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||....... ...... .+.. ... .
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~-~~~~--~~~---~ 227 (268)
T 3sxs_A 161 S-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE------VVLKVS-QGHR--LYR---P 227 (268)
T ss_dssp E-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHHHH-TTCC--CCC---C
T ss_pred c-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH------HHHHHH-cCCC--CCC---C
Confidence 2 223356778999999998889999999999999999999 999975332211 111111 1100 000 0
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 005871 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDS 629 (672)
Q Consensus 590 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 629 (672)
.. ....+.+++.+||+.||++|||+.+|++.|....
T Consensus 228 ~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 228 HL----ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp TT----SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred Cc----ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 11 1234778888999999999999999999998753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=363.88 Aligned_cols=261 Identities=29% Similarity=0.402 Sum_probs=207.7
Q ss_pred HHhcCCccccccccCCceeEEeeee------cCCceeEEEEecccC-cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeC
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG 420 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~ 420 (672)
...++|++.++||+|+||.||+|++ .+++.||||++.... ....+.+.+|++++.++ +||||+++++++.+.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 3467899999999999999999973 246899999997643 33456799999999999 789999999999876
Q ss_pred c-eEEEEEeecCCCChhHHhhhccc-------------------------------------------------------
Q 005871 421 Q-ELLLIYEYMPNKSLDVHLFDATR------------------------------------------------------- 444 (672)
Q Consensus 421 ~-~~~lV~Ey~~~gsL~~~l~~~~~------------------------------------------------------- 444 (672)
+ ..++||||+++|+|.+++.....
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 5 48999999999999999965432
Q ss_pred --------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcccccc
Q 005871 445 --------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 516 (672)
Q Consensus 445 --------~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~ 516 (672)
...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+............
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 255 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence 122899999999999999999999998 999999999999999999999999999876544443344456
Q ss_pred cccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHH
Q 005871 517 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPD 595 (672)
Q Consensus 517 ~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 595 (672)
.||+.|+|||++.+..++.++||||||+++|||++ |+.||....... ........+..... +..
T Consensus 256 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~~~~~~~---------~~~ 320 (359)
T 3vhe_A 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMRA---------PDY 320 (359)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHHTCCCCC---------CTT
T ss_pred CCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHHHHcCCCCCC---------CCC
Confidence 78999999999999999999999999999999998 999975332111 11111111111110 111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 596 ELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 596 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
....+.+++.+||+.||++|||+.||+++|..
T Consensus 321 ~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 321 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 12347788889999999999999999999975
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=349.88 Aligned_cols=259 Identities=25% Similarity=0.365 Sum_probs=204.2
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
.++|++.+.||+|+||.||++++. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 468999999999999999999975 68999999986543 33456789999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||+++++|.+++... ..+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++..+..
T Consensus 90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999998543 46999999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||..... ........... .... ..
T Consensus 164 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~-~~~~-~~ 234 (294)
T 4eqm_A 164 TSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQDS-VPNV-TT 234 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------HHHHHHHHSSC-CCCH-HH
T ss_pred ccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhhcc-CCCc-ch
Confidence 322 122345799999999999999999999999999999999999999853221 11111111111 1000 01
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhccC
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRP-TMSSVVVMLASD 628 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~ 628 (672)
..... ....+.+++.+||+.||++|| +++++.+.|...
T Consensus 235 ~~~~~----~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 235 DVRKD----IPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp HSCTT----SCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred hcccC----CCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 11111 234577888899999999999 999999999875
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=352.25 Aligned_cols=259 Identities=18% Similarity=0.206 Sum_probs=206.5
Q ss_pred hcCCccccccccCCceeEEeeee-cCCceeEEEEecccCcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEEEEEe
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lV~E 428 (672)
.++|++.+.||+|+||.||+|++ .+++.||||++..... .+.+.+|+.+++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46899999999999999999997 4689999999875533 24578999999999 99999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC-----eEEEeecCcee
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN-----PKISDFGLARI 503 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~-----~kL~DFgla~~ 503 (672)
|+ +++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999998643 346999999999999999999999998 999999999999998887 99999999997
Q ss_pred eCCCCCCc-----ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCC
Q 005871 504 FGGNQNQA-----NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 578 (672)
Q Consensus 504 ~~~~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 578 (672)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 65433221 1235679999999999999999999999999999999999999986542221111111110000000
Q ss_pred CcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 579 PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 579 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
.. ..+.. ..+ .+.+++..||+.||.+||++++|++.|..
T Consensus 240 ~~-----~~~~~-~~p----~~~~li~~~l~~~p~~RP~~~~l~~~l~~ 278 (330)
T 2izr_A 240 PI-----EVLCE-NFP----EMATYLRYVRRLDFFEKPDYDYLRKLFTD 278 (330)
T ss_dssp CH-----HHHTT-TCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred CH-----HHHhc-cCh----HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence 00 00011 111 67788889999999999999999999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=348.85 Aligned_cols=254 Identities=27% Similarity=0.391 Sum_probs=206.6
Q ss_pred cCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecC
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 431 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 431 (672)
++|++.+.||+|+||.||++.+.+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 67999999999999999999998889999999976543 34678999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCc
Q 005871 432 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 511 (672)
Q Consensus 432 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 511 (672)
+++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........ .
T Consensus 89 ~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 162 (269)
T 4hcu_A 89 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T 162 (269)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred CCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc-c
Confidence 9999999854 2346899999999999999999999998 99999999999999999999999999986543221 1
Q ss_pred ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcC
Q 005871 512 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590 (672)
Q Consensus 512 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 590 (672)
......|++.|+|||++.+..++.++||||||+++|+|++ |+.||...... ....... .+.. ...
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~------~~~~~~~-~~~~-----~~~-- 228 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDIS-TGFR-----LYK-- 228 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHH-TTCC-----CCC--
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH------HHHHHHh-cCcc-----CCC--
Confidence 1223456788999999999999999999999999999999 89997532211 1111111 1100 000
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 591 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
+......+.+++.+||+.||++|||+.++++.|...
T Consensus 229 --~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 229 --PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 111123477888899999999999999999999753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=347.06 Aligned_cols=263 Identities=21% Similarity=0.293 Sum_probs=199.6
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
++|++.++||+|+||.||+|.+. +++.||+|++.... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999986 58999999987543 3335778899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|++++.+. .+.. ....+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~l~~-~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQDLKK-YFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHH-HHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCCCHHH-HHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 99875444 4422 2356999999999999999999999998 9999999999999999999999999998765332
Q ss_pred CCcccccccccCCcCChhhhcCCC-CChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCC---Cccccc
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG---PAVELI 584 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~l~ 584 (672)
. ......||+.|+|||++.+.. ++.++||||||+++|+|++|..|+-.... ............... .+....
T Consensus 156 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred c--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHHhCCCChhhhhhhc
Confidence 2 223357899999999998766 79999999999999999999888522111 111111111111000 000000
Q ss_pred C------------hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 585 D------------PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 585 d------------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
+ ........+.....+.+|+.+||+.||++|||++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 000001111223456788889999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=351.25 Aligned_cols=253 Identities=25% Similarity=0.341 Sum_probs=201.1
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCc-------
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------- 421 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~------- 421 (672)
.++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.+|++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467999999999999999999986 79999999997543 335678999999999999999999999986543
Q ss_pred --------------------------------------------------eEEEEEeecCCCChhHHhhhccccCCCCHH
Q 005871 422 --------------------------------------------------ELLLIYEYMPNKSLDVHLFDATRSVQLDWK 451 (672)
Q Consensus 422 --------------------------------------------------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~ 451 (672)
..++||||+++++|.+++..........+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 389999999999999999776655667888
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC----------cccccccccCC
Q 005871 452 RRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ----------ANTNIIAGTYG 521 (672)
Q Consensus 452 ~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~----------~~~~~~~gt~~ 521 (672)
.++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999998 999999999999999999999999999987654221 12233579999
Q ss_pred cCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHH
Q 005871 522 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFI 601 (672)
Q Consensus 522 Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~ 601 (672)
|+|||++.+..++.++||||||+++|||++|..|+. ..... ............ .......+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~~~~-~~~~~~~~~~~~---------~~~~~~~~~ 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ERVRI-ITDVRNLKFPLL---------FTQKYPQEH 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HHHHH-HHHHHTTCCCHH---------HHHHCHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HHHHH-HHHhhccCCCcc---------cccCChhHH
Confidence 999999999999999999999999999999876621 00000 011111111000 122234567
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 005871 602 HIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 602 ~li~~cl~~dP~~RPt~~evl~~ 624 (672)
+++.+||+.||++|||++|+++.
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCCCCcCCCHHHHhhc
Confidence 88899999999999999999974
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=361.14 Aligned_cols=267 Identities=23% Similarity=0.312 Sum_probs=208.4
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEeccc---CcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEE
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELL 424 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~ 424 (672)
..++|++.+.||+|+||.||+++++ +++.||||++.+. .....+.+.+|..+++.+ +||||+++++++.+.+.++
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3478999999999999999999976 5899999999764 234456788999999998 7999999999999999999
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceee
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 504 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~ 504 (672)
+||||+++|+|..++... ..+++..+..++.||+.||.|||++| |+||||||+||||+.++++||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 999999999999998543 45999999999999999999999998 999999999999999999999999999854
Q ss_pred CCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 505 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 505 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......... ..
T Consensus 175 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~-~~---- 241 (353)
T 3txo_A 175 ICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAILND-EV---- 241 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHC-CC----
T ss_pred ccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH------HHHHHHHHcC-CC----
Confidence 3222 223346899999999999998999999999999999999999999853321 1111111111 00
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHHhccC--------CCCCCCCCCCccc
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTM------SSVVVMLASD--------SMTIPQPTEPAFS 641 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~~L~~~--------~~~l~~p~~p~~~ 641 (672)
..+......+.+++.+||+.||++||++ +||++.--.. ...+++|-.|...
T Consensus 242 ------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~~~ 306 (353)
T 3txo_A 242 ------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIK 306 (353)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred ------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCCCC
Confidence 0111122346778889999999999998 7887644222 2346677777653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=345.45 Aligned_cols=262 Identities=26% Similarity=0.334 Sum_probs=201.9
Q ss_pred HhcCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHh--ccCCCeeeEEEEEEe----CceE
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK--LQHKNLVRLLGCCLE----GQEL 423 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~h~niv~l~~~~~~----~~~~ 423 (672)
..++|++.+.||+|+||.||+|++ +++.||||++.... ...+..|.+++.. ++||||+++++++.. ....
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 347899999999999999999988 68899999986543 3556677777777 799999999999764 3568
Q ss_pred EEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeecCCCCCcEEEcCCCCeEE
Q 005871 424 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH--------EDSRLKIIHRDLKASNILLDDDMNPKI 495 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~g~~~iiHrDlkp~NIll~~~~~~kL 495 (672)
++||||+++++|.+++. ...+++..++.++.||+.||.||| +.+ |+||||||+|||++.++.+||
T Consensus 82 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred EEehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence 99999999999999983 246999999999999999999999 766 999999999999999999999
Q ss_pred EeecCceeeCCCCCCc--ccccccccCCcCChhhhcCC------CCChhhHHHHHHHHHHHHHcC----------CCCCC
Q 005871 496 SDFGLARIFGGNQNQA--NTNIIAGTYGYMAPEYAMGG------IFSIKSDVFSFGVLLLEIISG----------RKNNG 557 (672)
Q Consensus 496 ~DFgla~~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~------~~s~ksDvwSlGvil~elltG----------~~p~~ 557 (672)
+|||+++......... ......||+.|+|||++.+. .++.++||||||+++|||++| +.||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 9999998765443221 12334799999999999876 455899999999999999999 66654
Q ss_pred CCCcccccchhhhhhhhc-cCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 558 FYFSEHGQTLLTYTWKLW-CEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~-~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
........ ........ .......... ..........+.+|+.+||+.||++|||+.+|++.|...
T Consensus 235 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 235 DVVPNDPS--FEDMRKVVCVDQQRPNIPN----RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTSCSSCC--HHHHHHHHTTSCCCCCCCG----GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCCCcc--hhhhhHHHhccCCCCCCCh----hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 32222111 11111111 1111111111 111234567788999999999999999999999999753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=357.16 Aligned_cols=255 Identities=23% Similarity=0.307 Sum_probs=203.8
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC-----cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-----GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 424 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 424 (672)
.++|++.+.||+|+||.||++.+. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 357999999999999999999875 68999999986431 224678999999999999999999999999999999
Q ss_pred EEEeecCCCChhHHhhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC---eEEEeecC
Q 005871 425 LIYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN---PKISDFGL 500 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~---~kL~DFgl 500 (672)
+||||+++++|.+.+.... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988775432 3345899999999999999999999998 999999999999986654 99999999
Q ss_pred ceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCc
Q 005871 501 ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPA 580 (672)
Q Consensus 501 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (672)
+........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ..+... . ..+..
T Consensus 180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~---i-~~~~~ 249 (351)
T 3c0i_A 180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLFEG---I-IKGKY 249 (351)
T ss_dssp CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHHHH---H-HHTCC
T ss_pred eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHHHH---H-HcCCC
Confidence 988754322 1234579999999999999999999999999999999999999985321 111111 1 01110
Q ss_pred ccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 581 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 581 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
. ..+...... ...+.+|+.+||+.||++|||+.++++.
T Consensus 250 ~--~~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 250 K--MNPRQWSHI----SESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp C--CCHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred C--CCccccccC----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 011111111 2357788889999999999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=369.05 Aligned_cols=257 Identities=28% Similarity=0.406 Sum_probs=206.4
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
.++|.+.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.+|++++||||+++++++.+.+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 467999999999999999999986 68999999987543 3334578899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|+++++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 99999999998643 235899999999999999999999998 9999999999999999999999999998754332
Q ss_pred CCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChh
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 587 (672)
.........+++.|+|||.+.++.++.++||||||+++|||++ |..||...... .... ....+....
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---~~~~----~~~~~~~~~----- 335 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---QTRE----FVEKGGRLP----- 335 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---HHHH----HHHTTCCCC-----
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCCCC-----
Confidence 2222222345778999999999999999999999999999998 99887543211 1111 111111000
Q ss_pred hcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 588 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 588 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
.+......+.+|+.+||+.||++|||+++|++.|...
T Consensus 336 ----~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 336 ----CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 0111123567888899999999999999999999753
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=354.37 Aligned_cols=258 Identities=31% Similarity=0.444 Sum_probs=209.8
Q ss_pred hcCCccccccccCCceeEEeeee------cCCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 423 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 423 (672)
.++|.+.+.||+|+||.||++.+ .++..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 46899999999999999999985 235789999987643 44567889999999999999999999999999999
Q ss_pred EEEEeecCCCChhHHhhhccc---------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 005871 424 LLIYEYMPNKSLDVHLFDATR---------------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKA 482 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp 482 (672)
++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999975432 234899999999999999999999998 99999999
Q ss_pred CcEEEcCCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005871 483 SNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFS 561 (672)
Q Consensus 483 ~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~ 561 (672)
+|||++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999997765443333344567889999999999899999999999999999999 9999753322
Q ss_pred ccccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 562 EHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
. .... ....+.... .+......+.+++.+||+.||++|||+.+|++.|..
T Consensus 259 ~---~~~~----~~~~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~ 308 (314)
T 2ivs_A 259 E---RLFN----LLKTGHRME---------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308 (314)
T ss_dssp G---GHHH----HHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H---HHHH----HhhcCCcCC---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1 1111 111111111 111123457788889999999999999999999975
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=352.14 Aligned_cols=253 Identities=24% Similarity=0.288 Sum_probs=204.6
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCc------ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 423 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 423 (672)
.++|.+.+.||+|+||.||++.+. +++.||+|++..... ...+.+.+|+.+|++++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 457999999999999999999986 589999999876432 2467899999999999999999999999999999
Q ss_pred EEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC----CeEEEeec
Q 005871 424 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM----NPKISDFG 499 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~----~~kL~DFg 499 (672)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999843 356999999999999999999999998 99999999999999887 89999999
Q ss_pred CceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCC
Q 005871 500 LARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGP 579 (672)
Q Consensus 500 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 579 (672)
+++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ......... ..
T Consensus 164 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~~~~~--~~- 234 (326)
T 2y0a_A 164 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANVSAV--NY- 234 (326)
T ss_dssp TCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHHT--CC-
T ss_pred CCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HHHHHHHhc--CC-
Confidence 9987653322 23457999999999999999999999999999999999999997532211 111111000 00
Q ss_pred cccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 580 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 580 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
. ......... ...+.+++.+||+.||++|||+.|+++.-
T Consensus 235 --~-~~~~~~~~~----~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 273 (326)
T 2y0a_A 235 --E-FEDEYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQHP 273 (326)
T ss_dssp --C-CCHHHHTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred --C-cCccccccC----CHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 0 011111111 23467888899999999999999999753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=352.05 Aligned_cols=253 Identities=19% Similarity=0.276 Sum_probs=205.2
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
.++|.+.+.||+|+||.||++.+. +++.+|+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999976 58899999987543 3456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC--CCCeEEEeecCceeeCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD--DMNPKISDFGLARIFGGN 507 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~--~~~~kL~DFgla~~~~~~ 507 (672)
+++++|.+++.. ....+++..+..++.||+.||.|||+.| |+||||||+|||++. ++.+||+|||++..+...
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999998843 2346999999999999999999999998 999999999999997 789999999999876533
Q ss_pred CCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChh
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 587 (672)
. ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... ... ...... ... .+..
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~---~~i~~~-~~~--~~~~ 225 (321)
T 1tki_A 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QII---ENIMNA-EYT--FDEE 225 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHH---HHHHHT-CCC--CCHH
T ss_pred C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH---HHH---HHHHcC-CCC--CChh
Confidence 2 233457999999999999988999999999999999999999998532211 111 111111 000 0111
Q ss_pred hcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 588 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 588 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
..... ...+.+++.+||+.||++|||+.|+++.-
T Consensus 226 ~~~~~----s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 226 AFKEI----SIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp HHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred hhccC----CHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 11111 23577888899999999999999999854
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=363.93 Aligned_cols=260 Identities=32% Similarity=0.421 Sum_probs=211.1
Q ss_pred hcCCccccccccCCceeEEeeeec--------CCceeEEEEecccC-cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeC
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG 420 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~ 420 (672)
.++|.+.++||+|+||.||+|++. .+..||||++.... ......+.+|+++++++ +||||+++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 468999999999999999999852 23579999997653 34457889999999999 999999999999999
Q ss_pred ceEEEEEeecCCCChhHHhhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE
Q 005871 421 QELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 487 (672)
Q Consensus 421 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll 487 (672)
+..++||||+++++|.+++..... ...+++..++.|+.||+.||.|||+.+ |+||||||+||||
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 999999999999999999975432 245999999999999999999999997 9999999999999
Q ss_pred cCCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccc
Q 005871 488 DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQT 566 (672)
Q Consensus 488 ~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~ 566 (672)
+.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |+.||...... .
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~---~ 301 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---E 301 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---H
Confidence 9999999999999987765443344444567899999999999999999999999999999999 99987532211 1
Q ss_pred hhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 005871 567 LLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDS 629 (672)
Q Consensus 567 ~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 629 (672)
+ ......+..... +......+.+|+.+||+.||++|||+.||++.|....
T Consensus 302 ~----~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 302 L----FKLLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp H----HHHHHTTCCCCC---------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H----HHHHHcCCCCCC---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 111111111111 1112235778888999999999999999999998763
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=364.56 Aligned_cols=257 Identities=28% Similarity=0.452 Sum_probs=195.3
Q ss_pred hcCCccccccccCCceeEEeeeec----CCceeEEEEeccc-CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l 425 (672)
.++|.+.+.||+|+||.||+|++. ++..||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 358999999999999999999865 4778999999765 33445689999999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
||||+++++|.+++... ...+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999542 346999999999999999999999997 9999999999999999999999999998765
Q ss_pred CCCCCc-ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccc
Q 005871 506 GNQNQA-NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583 (672)
Q Consensus 506 ~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 583 (672)
...... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ...........
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~~~~~i~~~~-------- 267 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QDVIKAVDEGY-------- 267 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HHHHHHHHTTE--------
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCC--------
Confidence 432211 1122345778999999999999999999999999999998 9999743221 11111111100
Q ss_pred cChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 584 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
...........+.+++.+||+.||++||++.+|+++|...
T Consensus 268 -----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 268 -----RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp -----ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 0011112234577888899999999999999999999763
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=352.78 Aligned_cols=272 Identities=23% Similarity=0.336 Sum_probs=210.3
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lV 426 (672)
++|++.+.||+|+||.||+++++ +++.||+|++.+.. ....+.+.+|..+++++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 67999999999999999999986 58899999997642 33456788999999998 899999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||+++++|..++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++++||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 9999999999988543 45999999999999999999999998 99999999999999999999999999986432
Q ss_pred CCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCccccc--chhhhhhhhccCCCccccc
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQ--TLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~ 584 (672)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...............
T Consensus 163 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~---- 236 (345)
T 3a8x_A 163 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---- 236 (345)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC----
T ss_pred CC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC----
Confidence 22 2234468999999999999999999999999999999999999998542211110 111111111111110
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHHhccCC--------CCCCCCCCCccc
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTM------SSVVVMLASDS--------MTIPQPTEPAFS 641 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~~L~~~~--------~~l~~p~~p~~~ 641 (672)
..+......+.+++.+||+.||++||++ +|+++.--... ..+++|-.|...
T Consensus 237 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~~~p~~p~~~ 301 (345)
T 3a8x_A 237 ------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNIS 301 (345)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred ------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCC
Confidence 0111122356788889999999999995 67776532221 234556666543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=365.29 Aligned_cols=255 Identities=22% Similarity=0.278 Sum_probs=203.3
Q ss_pred HHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEE
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l 425 (672)
...++|++.+.||+|+||.||++.+. +|+.+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 34578999999999999999999875 68999999987654 3345678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc---CCCCeEEEeecCce
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD---DDMNPKISDFGLAR 502 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~---~~~~~kL~DFgla~ 502 (672)
||||+.+|+|.+.+.. ...+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.
T Consensus 88 v~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 9999999999988854 346999999999999999999999998 99999999999998 46789999999998
Q ss_pred eeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccc
Q 005871 503 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVE 582 (672)
Q Consensus 503 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (672)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||.... ......... .+.. .
T Consensus 162 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~---~~~~~~~i~----~~~~-~ 231 (444)
T 3soa_A 162 EVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED---QHRLYQQIK----AGAY-D 231 (444)
T ss_dssp CCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHH----HTCC-C
T ss_pred EecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHH----hCCC-C
Confidence 7654322 2234579999999999999999999999999999999999999984321 111111111 1110 0
Q ss_pred ccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 583 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 583 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
...+ ........+.+|+.+||+.||++|||+.|+++.
T Consensus 232 ~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 232 FPSP-----EWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CCTT-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCcc-----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0000 001112356788889999999999999999974
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=344.86 Aligned_cols=262 Identities=25% Similarity=0.353 Sum_probs=198.6
Q ss_pred cCCccccccccCCceeEEeeeecCCceeEEEEecccCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
++|.+.++||+|+||.||+|++.+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57999999999999999999998899999999865432 3346788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+++ +|.+++... ...+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 986 888777432 346899999999999999999999998 99999999999999999999999999986643221
Q ss_pred CcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCC---Cccc---
Q 005871 510 QANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG---PAVE--- 582 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~--- 582 (672)
......||+.|+|||++.+. .++.++||||||+++|||++|+.||....... ............ .+..
T Consensus 156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGG
T ss_pred --ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHHCCCChhhchhhhc
Confidence 12234689999999999764 58999999999999999999999985432111 111111110000 0000
Q ss_pred --ccChhhc-------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 583 --LIDPVLK-------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 583 --l~d~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
..++... ..........+.+++.+||+.||++|||++|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000 00011123456788889999999999999999863
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=364.98 Aligned_cols=259 Identities=31% Similarity=0.410 Sum_probs=206.9
Q ss_pred hcCCccccccccCCceeEEeeeec------CCceeEEEEeccc-CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 423 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 423 (672)
.++|.+.++||+|+||.||+|++. +++.||||++... .......+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 468999999999999999999843 4678999998654 344456789999999999999999999999999999
Q ss_pred EEEEeecCCCChhHHhhhcc----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC---CeEEE
Q 005871 424 LLIYEYMPNKSLDVHLFDAT----RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM---NPKIS 496 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~---~~kL~ 496 (672)
++||||+++++|.+++.... ....+++.+++.++.||+.||.|||++| |+||||||+||||+.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997543 2245899999999999999999999998 99999999999999555 59999
Q ss_pred eecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhc
Q 005871 497 DFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLW 575 (672)
Q Consensus 497 DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 575 (672)
|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++ |..||..... .... ....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~---~~~~---~~i~ 300 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVL---EFVT 300 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHH---HHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHH---HHHH
Confidence 9999986543333333334568999999999999999999999999999999998 9998753221 1111 1111
Q ss_pred cCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 576 CEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 576 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
.+..... .......+.+|+.+||+.||++|||+.+|++.|...
T Consensus 301 -~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 301 -SGGRMDP---------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp -TTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -cCCCCCC---------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1111000 111223477888899999999999999999999764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=354.61 Aligned_cols=259 Identities=25% Similarity=0.440 Sum_probs=192.2
Q ss_pred hcCCccccccccCCceeEEeeeecC-C---ceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceE-
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLAD-G---KAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL- 423 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~- 423 (672)
.++|++.+.||+|+||.||+|++.. + ..||||++... .....+.+.+|+.++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 4689999999999999999998754 3 27999998764 344567899999999999999999999999877655
Q ss_pred -----EEEEeecCCCChhHHhhhccc---cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 005871 424 -----LLIYEYMPNKSLDVHLFDATR---SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 495 (672)
Q Consensus 424 -----~lV~Ey~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL 495 (672)
++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEE
Confidence 999999999999999865332 225899999999999999999999998 999999999999999999999
Q ss_pred EeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhh
Q 005871 496 SDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKL 574 (672)
Q Consensus 496 ~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 574 (672)
+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ..... .
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~---~ 252 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---EIYNY---L 252 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHH---H
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH---HHHHH---H
Confidence 99999987654443333334457889999999999999999999999999999999 89887532211 11111 1
Q ss_pred ccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 575 WCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 575 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
. .+.... ........+.+++.+||+.||++|||+.++++.|...
T Consensus 253 ~-~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 253 I-GGNRLK---------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp H-TTCCCC---------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred h-cCCCCC---------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1 111100 1112224577888899999999999999999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=356.65 Aligned_cols=253 Identities=23% Similarity=0.310 Sum_probs=203.7
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
..++|.+.+.||+|+||.||++.++ +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4568999999999999999999975 68999999997543 34456789999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC---CeEEEeecCcee
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM---NPKISDFGLARI 503 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~---~~kL~DFgla~~ 503 (672)
|||+++++|.+.+.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++..
T Consensus 107 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999988843 346899999999999999999999998 99999999999998654 599999999987
Q ss_pred eCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccc
Q 005871 504 FGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583 (672)
Q Consensus 504 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 583 (672)
...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ..+.... ..+... .
T Consensus 181 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---~~~~~~i----~~~~~~-~ 249 (362)
T 2bdw_A 181 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYAQI----KAGAYD-Y 249 (362)
T ss_dssp CTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH----HHTCCC-C
T ss_pred ecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHH----HhCCCC-C
Confidence 653322 2345799999999999999999999999999999999999999753211 1111111 111100 0
Q ss_pred cChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 584 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
..+. .......+.+|+.+||+.||++|||+.++++.
T Consensus 250 ~~~~-----~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 PSPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CTTG-----GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred Cccc-----ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 01122456788889999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=358.04 Aligned_cols=263 Identities=29% Similarity=0.395 Sum_probs=207.7
Q ss_pred hcCCccccccccCCceeEEeeeec------CCceeEEEEecccC-cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCce
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE 422 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~ 422 (672)
.++|.+.+.||+|+||.||+|.+. ++..||||++.... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 478999999999999999999862 35689999997543 34457899999999999 89999999999999999
Q ss_pred EEEEEeecCCCChhHHhhhcccc--------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 005871 423 LLLIYEYMPNKSLDVHLFDATRS--------------------VQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKA 482 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp 482 (672)
.++||||+++++|.+++...... ..+++..++.++.||+.||.|||+.| |+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCh
Confidence 99999999999999999654321 34899999999999999999999998 99999999
Q ss_pred CcEEEcCCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCc
Q 005871 483 SNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFS 561 (672)
Q Consensus 483 ~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~ 561 (672)
+|||++.++.+||+|||++................||+.|+|||++.++.++.++||||||+++|+|++ |..||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999987654443333444567889999999999999999999999999999998 9999754321
Q ss_pred ccccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCC
Q 005871 562 EHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMT 631 (672)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 631 (672)
. .... .....+.... .+......+.+|+.+||+.||.+|||+.+|++.|......
T Consensus 281 ~--~~~~----~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 281 D--ANFY----KLIQNGFKMD---------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp S--HHHH----HHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred H--HHHH----HHHhcCCCCC---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 1 1111 1111111000 0111234577788899999999999999999999876443
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=349.73 Aligned_cols=263 Identities=25% Similarity=0.310 Sum_probs=210.7
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
.++|++.+.||+|+||.||+++.. +|+.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367999999999999999999976 68999999997542 23457788999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||+++++|.+++.. ...+++..+..++.||+.||.|||++| |+||||||+|||++.++++||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999854 345899999999999999999999997 99999999999999999999999999987543
Q ss_pred CCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......... .. .
T Consensus 159 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~-~~-~---- 221 (318)
T 1fot_A 159 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNA-EL-R---- 221 (318)
T ss_dssp C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHC-CC-C----
T ss_pred c-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhC-CC-C----
Confidence 2 2345799999999999999999999999999999999999999853211 1111111111 00 0
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhccC--------CCCCCCCCCCccc
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVVMLASD--------SMTIPQPTEPAFS 641 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L~~~--------~~~l~~p~~p~~~ 641 (672)
.+......+.+++.+||+.||++|| ++++|++.--.. ...+++|-.|...
T Consensus 222 -----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p~~p~~~ 284 (318)
T 1fot_A 222 -----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQ 284 (318)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC-
T ss_pred -----CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCCCCCCCCCcC
Confidence 0111123467788899999999999 899998653221 2335556666543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=343.36 Aligned_cols=253 Identities=32% Similarity=0.488 Sum_probs=194.8
Q ss_pred hcCCccccccccCCceeEEeeeecCCceeEEEEecccCc----ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG----QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
.++|++.+.||+|+||.||++.+. ++.+|||++..... ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 368999999999999999999975 88999999875432 3357789999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC--------CCCeEEEee
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD--------DMNPKISDF 498 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~--------~~~~kL~DF 498 (672)
|||+++++|.+++. ...+++..++.++.||+.||.|||+++..+|+||||||+|||++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999998883 346999999999999999999999987445899999999999986 778999999
Q ss_pred cCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCC
Q 005871 499 GLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 578 (672)
Q Consensus 499 gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 578 (672)
|++........ ....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ..........
T Consensus 161 g~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~ 230 (271)
T 3dtc_A 161 GLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL------AVAYGVAMNK 230 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHHTSC
T ss_pred Ccccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHhhhcCC
Confidence 99986543222 2346899999999999999999999999999999999999998532211 1111111111
Q ss_pred CcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 579 PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 579 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
.... .+......+.+++.+||+.||++|||+.|+++.|..
T Consensus 231 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 231 LALP---------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp CCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCC---------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1100 111122457788889999999999999999999975
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=344.14 Aligned_cols=261 Identities=17% Similarity=0.224 Sum_probs=208.3
Q ss_pred hcCCccccccccCCceeEEeeee-cCCceeEEEEecccCcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEEEEEe
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lV~E 428 (672)
.++|++.+.||+|+||.||+|.+ .+++.||||++..... .+.+.+|+.+++.+ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46899999999999999999996 4689999999865432 24578899999999 89999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC-----eEEEeecCcee
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN-----PKISDFGLARI 503 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~-----~kL~DFgla~~ 503 (672)
|+ +++|.+++... ...+++..+..++.||+.||.|||++| |+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 99999999643 335999999999999999999999997 999999999999987776 99999999998
Q ss_pred eCCCCCC-----cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCC
Q 005871 504 FGGNQNQ-----ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 578 (672)
Q Consensus 504 ~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 578 (672)
....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......................
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 7654322 12344679999999999999999999999999999999999999986533222211111111110000
Q ss_pred CcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 579 PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 579 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
... .+.... ...+.+++.+||+.||++|||+++|++.|...
T Consensus 241 ~~~-----~~~~~~----~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 241 PLR-----ELCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp CHH-----HHTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred cHH-----HHHhhC----cHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 110 111111 24577888899999999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=358.46 Aligned_cols=262 Identities=28% Similarity=0.437 Sum_probs=210.3
Q ss_pred HhcCCccccccccCCceeEEeeeec------CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCce
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 422 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~ 422 (672)
..++|.+.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 3578999999999999999999874 34789999997653 3445779999999999999999999999999999
Q ss_pred EEEEEeecCCCChhHHhhhccc---------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 005871 423 LLLIYEYMPNKSLDVHLFDATR---------------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLK 481 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlk 481 (672)
.++||||+++++|.+++..... ...+++.+++.++.||+.||.|||+++ |+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 9999999999999999965321 156899999999999999999999998 9999999
Q ss_pred CCcEEEcCCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCC
Q 005871 482 ASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYF 560 (672)
Q Consensus 482 p~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~ 560 (672)
|+|||++.++.+||+|||+++...............|++.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999987644332233334568899999999999999999999999999999999 998875321
Q ss_pred cccccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCC
Q 005871 561 SEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSM 630 (672)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 630 (672)
. ...... ...+..... +......+.+++.+||+.||++|||+.+|++.|.....
T Consensus 282 ~------~~~~~~-~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 282 H------EEVIYY-VRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp H------HHHHHH-HHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred h------HHHHHH-HhCCCcCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 1 111111 111111111 11122357788889999999999999999999988643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=351.11 Aligned_cols=260 Identities=29% Similarity=0.421 Sum_probs=209.6
Q ss_pred hcCCccccccccCCceeEEeeee------cCCceeEEEEecccCc-ccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCce
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE 422 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~ 422 (672)
.++|.+.+.||+|+||.||+|++ .+++.||+|++..... ...+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 36899999999999999999974 2468899999976543 3457889999999999 99999999999999999
Q ss_pred EEEEEeecCCCChhHHhhhccc---------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE
Q 005871 423 LLLIYEYMPNKSLDVHLFDATR---------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 487 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll 487 (672)
.++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999865432 225899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccc
Q 005871 488 DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQT 566 (672)
Q Consensus 488 ~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~ 566 (672)
+.++.+||+|||++................|++.|+|||++.+..++.++||||||+++|+|++ |+.||...... ..
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~ 256 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--SK 256 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--HH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch--hH
Confidence 9999999999999987665443333344567889999999999999999999999999999999 99987533211 11
Q ss_pred hhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 567 LLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 567 ~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
.......... .. ........+.+++.+||+.||.+|||+.||++.|...
T Consensus 257 ~~~~~~~~~~---------~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 257 FYKMIKEGFR---------ML----SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp HHHHHHHTCC---------CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhccCCC---------CC----CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 1111111100 00 0111224577888899999999999999999999764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=347.89 Aligned_cols=254 Identities=26% Similarity=0.386 Sum_probs=203.6
Q ss_pred hcCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
.++|++.+.||+|+||.||++.+.++..||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 468999999999999999999998888999999976543 3467899999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
++++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 102 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 175 (283)
T 3gen_A 102 ANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY- 175 (283)
T ss_dssp TTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-
T ss_pred CCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc-
Confidence 999999998542 345999999999999999999999998 99999999999999999999999999986543221
Q ss_pred cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhc
Q 005871 511 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 589 (672)
.......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...... .... ... .+.. ...
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~---~~~~---~~~-~~~~-----~~~- 242 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAE---HIA-QGLR-----LYR- 242 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHH---HHH-TTCC-----CCC-
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh---HHHH---HHh-cccC-----CCC-
Confidence 11222356788999999999999999999999999999998 99997543211 1111 111 1100 000
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 590 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
+......+.+++.+||+.||++|||+++|++.|..
T Consensus 243 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 243 ---PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp ---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 01112357788889999999999999999999965
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=348.90 Aligned_cols=265 Identities=26% Similarity=0.368 Sum_probs=189.3
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
.++|++.++||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 468999999999999999999875 68999999987553 2344678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 429 YMPNKSLDVHLFDAT---RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 429 y~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
|++ ++|.+++.... ....+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 58888875432 1235899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCCcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccC---CCcc
Q 005871 506 GNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCE---GPAV 581 (672)
Q Consensus 506 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~ 581 (672)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ........... ..+.
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE---QLKLIFDIMGTPNESLWP 234 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCTTTCG
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChhHhh
Confidence 3322 12235789999999999764 68999999999999999999999986432211 11111100000 0000
Q ss_pred -----------------cccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 582 -----------------ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 582 -----------------~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
..+...+...........+.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0000000000011122357788889999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=358.01 Aligned_cols=249 Identities=24% Similarity=0.363 Sum_probs=202.9
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
++|++.+.||+|+||.||++.+. +++.||+|++.+.. ....+.+.+|+.+|+.++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 68999999999999999999976 58899999986542 344678899999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+.+|+|..++.. ...+++..+..++.||+.||.|||+.| |+||||||+||||+.++++||+|||+++.+...
T Consensus 95 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999999853 346999999999999999999999998 999999999999999999999999999876433
Q ss_pred CCCcccccccccCCcCChhhhcC---CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
. .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.................. ..
T Consensus 169 ~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~--~~------ 237 (384)
T 4fr4_A 169 T---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT--VV------ 237 (384)
T ss_dssp C---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC--CC------
T ss_pred C---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc--cc------
Confidence 2 2334679999999999864 45899999999999999999999998643322211111111100 00
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT-MSSVVV 623 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~ 623 (672)
..+......+.+|+.+||+.||++||+ +++|++
T Consensus 238 ------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 ------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 011112245778888999999999998 777775
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=349.13 Aligned_cols=264 Identities=29% Similarity=0.433 Sum_probs=202.3
Q ss_pred cCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecC
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 431 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 431 (672)
++|++.+.||+|+||.||++++. ++.||+|++... ...+.+.+|+.++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 57999999999999999999875 788999998654 345788999999999999999999998874 4799999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC-eEEEeecCceeeCCCCCC
Q 005871 432 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN-PKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 432 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~-~kL~DFgla~~~~~~~~~ 510 (672)
+++|.+++........+++..++.++.||++||.|||+.+..+|+||||||+|||++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999975544445889999999999999999999932224999999999999998887 799999999765322
Q ss_pred cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcC
Q 005871 511 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 590 (672)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....+.... +..... ..
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~-~~~~~~-----~~ 227 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP----AFRIMWAVHN-GTRPPL-----IK 227 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS----HHHHHHHHHT-TCCCCC-----BT
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc----HHHHHHHHhc-CCCCCc-----cc
Confidence 12346899999999999999999999999999999999999998532211 1111111111 111111 11
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCCCCCCCCCc
Q 005871 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPA 639 (672)
Q Consensus 591 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~~p~~p~ 639 (672)
.. ...+.+++.+||+.||++|||+++|++.|......++.+..|.
T Consensus 228 ~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~ 272 (307)
T 2eva_A 228 NL----PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL 272 (307)
T ss_dssp TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCC
T ss_pred cc----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcc
Confidence 12 2346788889999999999999999999987655555444443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=357.56 Aligned_cols=254 Identities=21% Similarity=0.269 Sum_probs=206.4
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
.++|++.+.||+|+||.||+|.+. +++.+|+|++..........+.+|+.+|++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999976 6889999999877666667899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC--CCCeEEEeecCceeeCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD--DMNPKISDFGLARIFGGN 507 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~--~~~~kL~DFgla~~~~~~ 507 (672)
+++++|.+++.. ....+++..+..++.||+.||.|||+.| |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999998853 2346899999999999999999999998 999999999999974 578999999999976543
Q ss_pred CCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChh
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 587 (672)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......... ... . .+..
T Consensus 205 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~i~~----~~~-~-~~~~ 272 (387)
T 1kob_A 205 EI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQNVKR----CDW-E-FDED 272 (387)
T ss_dssp SC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHH----CCC-C-CCSS
T ss_pred cc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH---HHHHHHHHh----CCC-C-CCcc
Confidence 22 2335799999999999999999999999999999999999999854321 111111110 000 0 0000
Q ss_pred hcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 588 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 588 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
. .......+.+++.+||+.||++|||+.|+++.-
T Consensus 273 ~----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp 306 (387)
T 1kob_A 273 A----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 306 (387)
T ss_dssp T----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred c----cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCc
Confidence 0 111223577888899999999999999999863
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=346.89 Aligned_cols=249 Identities=24% Similarity=0.338 Sum_probs=194.7
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCc--------------------------ccHHHHHHHHHHHH
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--------------------------QGLQEFKNEVNLIA 403 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~il~ 403 (672)
.++|.+.+.||+|+||.||+|++. +++.||||++..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999975 688999999865431 12356889999999
Q ss_pred hccCCCeeeEEEEEEe--CceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 005871 404 KLQHKNLVRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLK 481 (672)
Q Consensus 404 ~l~h~niv~l~~~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlk 481 (672)
+++||||+++++++.+ ....++||||+++++|.+++ ....+++..+..++.||+.||.|||+++ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 56899999999999998754 3346999999999999999999999998 9999999
Q ss_pred CCcEEEcCCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCC---CChhhHHHHHHHHHHHHHcCCCCCCC
Q 005871 482 ASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI---FSIKSDVFSFGVLLLEIISGRKNNGF 558 (672)
Q Consensus 482 p~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~s~ksDvwSlGvil~elltG~~p~~~ 558 (672)
|+|||++.++.+||+|||+++.+..... ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999987654322 123357999999999997765 48899999999999999999999753
Q ss_pred CCcccccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 559 YFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
... ........ .... ...+ .... ...+.+++.+||+.||++|||+.||++
T Consensus 243 ~~~------~~~~~~~~-~~~~-~~~~---~~~~----~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ERI------MCLHSKIK-SQAL-EFPD---QPDI----AEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSH------HHHHHHHH-HCCC-CCCS---SSCC----CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccH------HHHHHHHh-cccC-CCCC---cccc----CHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 211 11111111 0000 0000 0111 234778888999999999999999975
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=355.57 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=196.3
Q ss_pred hcCCccccccccCCceeEEeeeecCCceeEEEEecccC--cccHHHHHHHHHHHHhccC--CCeeeEEEEEEeCceEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQH--KNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h--~niv~l~~~~~~~~~~~lV 426 (672)
.++|++.+.||+|+||.||++.+.+++.||||++.... ....+.+.+|+.+|++++| |||+++++++.+.+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 46799999999999999999998889999999987543 3445778999999999987 9999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|| +.+++|.+++.. ...+++.++..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 88 ~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 568899999854 346899999999999999999999998 99999999999997 57899999999987654
Q ss_pred CCCCcccccccccCCcCChhhhcC-----------CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhc
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMG-----------GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLW 575 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 575 (672)
...........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ........
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~~~ 234 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAII 234 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHH
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----HHHHHHHh
Confidence 443333345679999999999865 67899999999999999999999998532111 11111111
Q ss_pred cCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 576 CEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 576 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
... .....+......+.+|+.+||+.||++|||+.|+++..
T Consensus 235 ~~~---------~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 235 DPN---------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp CTT---------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred cCC---------cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 111 01111111123567888899999999999999999764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=353.12 Aligned_cols=262 Identities=22% Similarity=0.278 Sum_probs=212.1
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
++|++.+.||+|+||.||++++. +++.||+|++.+.. ....+.+.+|+.+|+.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 68999999999999999999976 68999999986542 244578899999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++++||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 999999999998543 45899999999999999999999998 999999999999999999999999999876432
Q ss_pred CCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChh
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 587 (672)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ .+.. .
T Consensus 195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~-~~~~-~----- 256 (350)
T 1rdq_E 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIV-SGKV-R----- 256 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-HCCC-C-----
T ss_pred -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH------HHHHHHHH-cCCC-C-----
Confidence 2345799999999999999999999999999999999999999853211 11111111 1110 0
Q ss_pred hcCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhccC--------CCCCCCCCCCccc
Q 005871 588 LKQSCAPDELLKFIHIGLLCVQQDPADRPT-----MSSVVVMLASD--------SMTIPQPTEPAFS 641 (672)
Q Consensus 588 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L~~~--------~~~l~~p~~p~~~ 641 (672)
+.... ...+.+++.+||+.||++||+ +++|++.--.. ...+++|-.|...
T Consensus 257 ~p~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p~~~ 319 (350)
T 1rdq_E 257 FPSHF----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFK 319 (350)
T ss_dssp CCTTC----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred CCCCC----CHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCCCCCCCC
Confidence 11112 234678888999999999998 89988754322 2345666666554
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=353.55 Aligned_cols=270 Identities=23% Similarity=0.335 Sum_probs=199.2
Q ss_pred hcCCccccccccCCceeEEeeee-cCCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCc----e
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ----E 422 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~----~ 422 (672)
.++|++.+.||+|+||.||++++ .+++.||||++.... ......+.+|+.++++++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 47899999999999999999997 468999999997653 334567899999999999999999999987654 3
Q ss_pred EEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCce
Q 005871 423 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 502 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~ 502 (672)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 59999999999999998543 46899999999999999999999998 9999999999999999999999999998
Q ss_pred eeCCCCCC-cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcc
Q 005871 503 IFGGNQNQ-ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAV 581 (672)
Q Consensus 503 ~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (672)
.+...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||..... ..............
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~ 238 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIP 238 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCCCCC
Confidence 76543222 223345799999999999999999999999999999999999999853221 11111111111110
Q ss_pred cccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH-HhccCCCCCCCCCCCcc
Q 005871 582 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV-MLASDSMTIPQPTEPAF 640 (672)
Q Consensus 582 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~-~L~~~~~~l~~p~~p~~ 640 (672)
........ ...+.+++.+||+.||++||+..++++ .|.... ...+|..|..
T Consensus 239 ---~~~~~~~~----~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~-~~~~~~~~~~ 290 (311)
T 3ork_A 239 ---PSARHEGL----SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH-NGEPPEAPKV 290 (311)
T ss_dssp ---HHHHSTTC----CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH-TTCCCSSCCC
T ss_pred ---cccccCCC----CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh-cCCCCCCCcc
Confidence 00001111 234678888999999999997666554 443332 2233444443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=356.14 Aligned_cols=267 Identities=25% Similarity=0.359 Sum_probs=206.9
Q ss_pred HHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceE
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQEL 423 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~ 423 (672)
...++|.+.+.||+|+||.||+|+++ +++.||||++.+.. ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34689999999999999999999986 58999999997642 34456788999999987 999999999999999999
Q ss_pred EEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 424 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
++||||+++|+|..++.. ...+++..+..++.||+.||.|||++| |+||||||+|||++.++++||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 999999999999999854 245899999999999999999999998 99999999999999999999999999986
Q ss_pred eCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccc
Q 005871 504 FGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583 (672)
Q Consensus 504 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 583 (672)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+. .......
T Consensus 168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~---~~i~~~~----- 234 (345)
T 1xjd_A 168 NMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EELF---HSIRMDN----- 234 (345)
T ss_dssp CCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH---HHHHHCC-----
T ss_pred cccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH---HHHH---HHHHhCC-----
Confidence 43222 223456899999999999999999999999999999999999999853221 1111 1111110
Q ss_pred cChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHHhccC--------CCCCCCCCCCcc
Q 005871 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMS-SVVVMLASD--------SMTIPQPTEPAF 640 (672)
Q Consensus 584 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~~L~~~--------~~~l~~p~~p~~ 640 (672)
...... ....+.+++.+||+.||++||++. +|++.--.. ...+++|-.|..
T Consensus 235 --~~~p~~----~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l~~~~~~~p~~p~~ 294 (345)
T 1xjd_A 235 --PFYPRW----LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKV 294 (345)
T ss_dssp --CCCCTT----SCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHHTTCSCC------
T ss_pred --CCCCcc----cCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHHHHhhCCCCCCcCCCC
Confidence 001111 123467888899999999999998 776433221 134566666654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=356.49 Aligned_cols=267 Identities=28% Similarity=0.408 Sum_probs=210.1
Q ss_pred hcCCccccccccCCceeEEeeee-----cCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEE--eCceE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL--EGQEL 423 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~--~~~~~ 423 (672)
.++|++.+.||+|+||.||++++ .+++.||||++........+.+.+|++++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36899999999999999999983 358899999998877777788999999999999999999999987 45679
Q ss_pred EEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 424 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
++||||+++++|.+++.... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 99999999999999986432 35899999999999999999999998 99999999999999999999999999997
Q ss_pred eCCCCCCc-ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCccc--------ccchhhhhhhh
Q 005871 504 FGGNQNQA-NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH--------GQTLLTYTWKL 574 (672)
Q Consensus 504 ~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~--------~~~~~~~~~~~ 574 (672)
........ ......|++.|+|||++.+..++.++||||||+++|+|++|+.||....... ...........
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 75433221 2233467888999999999999999999999999999999999864321110 00000000111
Q ss_pred ccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCC
Q 005871 575 WCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMT 631 (672)
Q Consensus 575 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 631 (672)
...+. ....+......+.+|+.+||+.||++|||+++|++.|...-..
T Consensus 257 ~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 257 LEEGQ---------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred hhccc---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 11110 1111222334577888899999999999999999999876433
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=362.23 Aligned_cols=273 Identities=20% Similarity=0.234 Sum_probs=212.2
Q ss_pred HHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEE
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 424 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 424 (672)
...++|++.+.||+|+||.||+++++ +++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+.+.++
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 34678999999999999999999986 58899999986532 223345789999999999999999999999999999
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceee
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 504 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~ 504 (672)
+||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.| |+||||||+|||++.++++||+|||+++..
T Consensus 146 lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~ 218 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218 (410)
T ss_dssp EEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEee
Confidence 99999999999998853 35899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCCcccccccccCCcCChhhhcCCC----CChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCc
Q 005871 505 GGNQNQANTNIIAGTYGYMAPEYAMGGI----FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPA 580 (672)
Q Consensus 505 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (672)
..... ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ......+......
T Consensus 219 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~ 291 (410)
T 3v8s_A 219 NKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMNHKNS 291 (410)
T ss_dssp CTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTHHHH
T ss_pred ccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh------hhHHHHHHhcccc
Confidence 54322 1233468999999999997655 78999999999999999999999853221 1111111100000
Q ss_pred ccccChhhcCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHhccCC--------CCCCCCCCCcccc
Q 005871 581 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPAD--RPTMSSVVVMLASDS--------MTIPQPTEPAFSV 642 (672)
Q Consensus 581 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L~~~~--------~~l~~p~~p~~~~ 642 (672)
... .. .......+.+|+.+||+.+|.+ ||+++||++.--... ..+++|-.|....
T Consensus 292 ~~~-----p~--~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~~~~ 356 (410)
T 3v8s_A 292 LTF-----PD--DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSS 356 (410)
T ss_dssp CCC-----CT--TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTTGGGSCCSCCCCCSS
T ss_pred ccC-----CC--cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHhhcccCCCCCCcCCC
Confidence 000 00 0011234677888999999988 999999998764332 1246677776543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=355.70 Aligned_cols=257 Identities=26% Similarity=0.385 Sum_probs=201.3
Q ss_pred hcCCccccccccCCceeEEeeeec-CCce----eEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKA----IAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 424 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 424 (672)
.++|++.+.||+|+||.||+|.+. +++. ||+|.+.... ......+.+|+.++++++||||+++++++. .+..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 367999999999999999999875 4554 6777765432 333456788999999999999999999986 45689
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceee
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 504 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~ 504 (672)
+||||+.+++|.+++... ...+++..+..|+.||+.||.|||+.| |+||||||+|||++.++++||+|||+++.+
T Consensus 91 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 999999999999998543 346899999999999999999999998 999999999999999999999999999987
Q ss_pred CCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccc
Q 005871 505 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583 (672)
Q Consensus 505 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 583 (672)
.............|+..|+|||++.++.++.++||||||+++|+|++ |+.||...... ...... ..+.....
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~----~~~~~~~~ 238 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA---EVPDLL----EKGERLAQ 238 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT---HHHHHH----HTTCBCCC
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH---HHHHHH----HcCCCCCC
Confidence 65544444455678889999999999999999999999999999999 99998543211 111111 11110000
Q ss_pred cChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 005871 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDS 629 (672)
Q Consensus 584 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 629 (672)
+......+.+++.+||+.||++|||+.+|++.|....
T Consensus 239 ---------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 239 ---------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp ---------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred ---------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0011123567888999999999999999999997653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=353.30 Aligned_cols=266 Identities=23% Similarity=0.262 Sum_probs=210.9
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEE
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELL 424 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~ 424 (672)
..++|++.+.||+|+||.||+++++ +++.||||++.+.. ....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3478999999999999999999986 48899999997642 34567788999999988 8999999999999999999
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceee
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 504 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~ 504 (672)
+||||+++|+|..++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++++||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 999999999999998543 45999999999999999999999998 999999999999999999999999999864
Q ss_pred CCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 505 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 505 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......... .. .
T Consensus 172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~-~~-~-- 239 (353)
T 2i0e_A 172 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIMEH-NV-A-- 239 (353)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHC-CC-C--
T ss_pred ccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH------HHHHHHHHhC-CC-C--
Confidence 3222 223456899999999999999999999999999999999999999853211 1111111111 10 0
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhccC--------CCCCCCCCCCcc
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT-----MSSVVVMLASD--------SMTIPQPTEPAF 640 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L~~~--------~~~l~~p~~p~~ 640 (672)
.+......+.+|+.+||+.||++||+ +++|++.--.. ...+++|-.|..
T Consensus 240 -------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~~ 301 (353)
T 2i0e_A 240 -------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKA 301 (353)
T ss_dssp -------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred -------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCCCC
Confidence 11112235778888999999999995 57877653221 234666666654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=351.97 Aligned_cols=248 Identities=25% Similarity=0.335 Sum_probs=200.7
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
.++|.+.+.||+|+||.||+|.+. +++.||+|++.... .+....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 368999999999999999999974 68999999986532 23346789999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||+ +|+|.+++.. ...+++.++..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 6788877754 345999999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCCcccccccccCCcCChhhhcCCCC-ChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccC
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 585 (672)
.. .....+||+.|+|||++.+..+ ++++||||||+++|+|++|+.||......... .......
T Consensus 161 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-------~~i~~~~------ 224 (336)
T 3h4j_B 161 GN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-------KKVNSCV------ 224 (336)
T ss_dssp SB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-------CCCCSSC------
T ss_pred Cc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-------HHHHcCC------
Confidence 32 2234579999999999988776 79999999999999999999998532211100 0000000
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
.. .+......+.+|+.+||+.||.+|||++|+++.-
T Consensus 225 ~~----~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 260 (336)
T 3h4j_B 225 YV----MPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP 260 (336)
T ss_dssp CC----CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred CC----CcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence 00 1111223467888899999999999999998754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=362.56 Aligned_cols=261 Identities=18% Similarity=0.173 Sum_probs=205.0
Q ss_pred HHHHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCce
Q 005871 347 ALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 422 (672)
Q Consensus 347 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~ 422 (672)
.....++|++.++||+|+||.||+|+++ +++.||+|++.+.. ......+.+|..++..++||||+++++++.+.+.
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 148 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence 3345689999999999999999999986 47899999987532 1223448899999999999999999999999999
Q ss_pred EEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCce
Q 005871 423 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 502 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~ 502 (672)
++|||||+++|+|..++... ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++++||+|||+++
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~ 223 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCL 223 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhh
Confidence 99999999999999999542 346999999999999999999999998 9999999999999999999999999998
Q ss_pred eeCCCCCCcccccccccCCcCChhhhc-----CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccC
Q 005871 503 IFGGNQNQANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCE 577 (672)
Q Consensus 503 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 577 (672)
........ .....+||+.|+|||++. ++.++.++|||||||++|||++|+.||...... ............
T Consensus 224 ~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~---~~~~~i~~~~~~ 299 (437)
T 4aw2_A 224 KLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKIMNHKER 299 (437)
T ss_dssp ECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTHHHH
T ss_pred hcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh---HHHHhhhhcccc
Confidence 76543322 223468999999999997 567899999999999999999999998532211 111111000000
Q ss_pred CCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHh
Q 005871 578 GPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPAD--RPTMSSVVVML 625 (672)
Q Consensus 578 ~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L 625 (672)
-...... .. ....+.+|+.+||+.+|++ ||+++||++.-
T Consensus 300 ~~~p~~~-----~~----~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp 340 (437)
T 4aw2_A 300 FQFPTQV-----TD----VSENAKDLIRRLICSREHRLGQNGIEDFKKHP 340 (437)
T ss_dssp CCCCSSC-----CC----SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred ccCCccc-----cc----CCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence 0000000 11 1234677888999888888 99999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=348.85 Aligned_cols=247 Identities=26% Similarity=0.352 Sum_probs=193.9
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEEE
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~l 425 (672)
..++|++.++||+|+||+||+|.+. +++.||||++.... ......+..|+..+.++ +||||+++++++.+.+..++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 4468999999999999999999986 69999999986543 23334555666666665 99999999999999999999
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
||||+ +++|..++... ...+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 135 v~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred EEecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 99999 66888887543 346999999999999999999999997 9999999999999999999999999998764
Q ss_pred CCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccC
Q 005871 506 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585 (672)
Q Consensus 506 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 585 (672)
... ......||+.|+|||++.+ .++.++||||||+++|||++|..|+... . .+.....+. ..
T Consensus 209 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~------~----~~~~~~~~~----~~ 270 (311)
T 3p1a_A 209 TAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG------E----GWQQLRQGY----LP 270 (311)
T ss_dssp ---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH------H----HHHHHTTTC----CC
T ss_pred cCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc------c----HHHHHhccC----CC
Confidence 332 2234569999999998876 7899999999999999999997764211 0 111111111 11
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
+...... ...+.+++.+||+.||++|||++|+++.
T Consensus 271 ~~~~~~~----~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 271 PEFTAGL----SSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccCC----CHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 1122222 2457788889999999999999999863
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=340.47 Aligned_cols=265 Identities=25% Similarity=0.358 Sum_probs=198.1
Q ss_pred HHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccC-----cccHHHHHHHHHHHHhcc---CCCeeeEEEEEEe
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-----GQGLQEFKNEVNLIAKLQ---HKNLVRLLGCCLE 419 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~---h~niv~l~~~~~~ 419 (672)
...++|++.++||+|+||.||+|++. +++.||||++.... ......+.+|+.++++++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 35679999999999999999999974 68999999986432 122346677888887775 9999999999987
Q ss_pred Cc-----eEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeE
Q 005871 420 GQ-----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPK 494 (672)
Q Consensus 420 ~~-----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~k 494 (672)
.. ..++||||+. ++|.+++.... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence 65 5899999997 58988885432 234999999999999999999999998 99999999999999999999
Q ss_pred EEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhh
Q 005871 495 ISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL 574 (672)
Q Consensus 495 L~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 574 (672)
|+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ........
T Consensus 161 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~ 234 (308)
T 3g33_A 161 LADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDL 234 (308)
T ss_dssp ECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH---HHHHHHHH
T ss_pred EeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHH
Confidence 99999998654322 2234578999999999999999999999999999999999999985432211 11111111
Q ss_pred cc---CCCccccc---ChhhcCC-------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 575 WC---EGPAVELI---DPVLKQS-------CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 575 ~~---~~~~~~l~---d~~l~~~-------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.. ...+.... ....... ..+.....+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 00 00010000 0000000 001123457788889999999999999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=368.64 Aligned_cols=264 Identities=30% Similarity=0.464 Sum_probs=205.9
Q ss_pred hcCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
.++|.+.++||+|+||.||+|.++++..||||++.... ...+.+.+|+.+|++++||||+++++++.+ +..++||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 46789999999999999999999888889999997654 335789999999999999999999999876 6789999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
++|+|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 261 ~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 261 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred cCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 999999999542 2245899999999999999999999997 999999999999999999999999999876432211
Q ss_pred cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhc
Q 005871 511 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 589 (672)
......++..|+|||.+.++.++.++||||||+++|||++ |+.||...... ...... ..+...
T Consensus 337 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i----~~~~~~-------- 400 (452)
T 1fmk_A 337 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQV----ERGYRM-------- 400 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHH----HTTCCC--------
T ss_pred -cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HcCCCC--------
Confidence 1223356788999999999999999999999999999999 89887532211 111111 111100
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCCCCCCCC
Q 005871 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTE 637 (672)
Q Consensus 590 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~~p~~ 637 (672)
..+......+.+|+.+||+.||++|||+++|++.|...-.+..+...
T Consensus 401 -~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~ 447 (452)
T 1fmk_A 401 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 447 (452)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCC
T ss_pred -CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcccc
Confidence 01112234577888899999999999999999999987555444333
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=350.55 Aligned_cols=261 Identities=23% Similarity=0.249 Sum_probs=201.7
Q ss_pred HHHhcCCccccccccCCceeEEeeeec-CCceeEEEEeccc-----CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCc
Q 005871 348 LEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-----SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ 421 (672)
Q Consensus 348 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~ 421 (672)
....++|++.+.||+|+||.||++.+. ++..||+|++... .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 356678999999999999999999975 6889999998654 3455678999999999999999999999999999
Q ss_pred eEEEEEeecCCCChhHHhhhcc-------------------------------------ccCCCCHHHHHHHHHHHHHHH
Q 005871 422 ELLLIYEYMPNKSLDVHLFDAT-------------------------------------RSVQLDWKRRQSIINGIARGI 464 (672)
Q Consensus 422 ~~~lV~Ey~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~qi~~~L 464 (672)
..++||||+++++|.+++.... ....+++..++.++.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 9999999999999999884211 022346788899999999999
Q ss_pred HHHHhcCCCCeeecCCCCCcEEEcCCC--CeEEEeecCceeeCCCCCCc--ccccccccCCcCChhhhcC--CCCChhhH
Q 005871 465 LYLHEDSRLKIIHRDLKASNILLDDDM--NPKISDFGLARIFGGNQNQA--NTNIIAGTYGYMAPEYAMG--GIFSIKSD 538 (672)
Q Consensus 465 ~~LH~~g~~~iiHrDlkp~NIll~~~~--~~kL~DFgla~~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~--~~~s~ksD 538 (672)
.|||+.+ |+||||||+|||++.++ .+||+|||++..+....... ......||+.|+|||++.+ ..++.++|
T Consensus 182 ~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 182 HYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 9999998 99999999999998776 89999999998764322211 2234579999999999975 67899999
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 005871 539 VFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTM 618 (672)
Q Consensus 539 vwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 618 (672)
|||||+++|||++|+.||...... ............. ..+.. ......+.+|+.+||+.||++|||+
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~~--~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~ 325 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDA------DTISQVLNKKLCF--ENPNY-----NVLSPLARDLLSNLLNRNVDERFDA 325 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCT--TSGGG-----GGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred HHHHHHHHHHHHHCCCCCCCCChH------HHHHHHHhccccc--CCccc-----ccCCHHHHHHHHHHcCCChhHCCCH
Confidence 999999999999999998533211 1111111111100 00100 1112457788889999999999999
Q ss_pred HHHHHH
Q 005871 619 SSVVVM 624 (672)
Q Consensus 619 ~evl~~ 624 (672)
.++++.
T Consensus 326 ~~~l~h 331 (345)
T 3hko_A 326 MRALQH 331 (345)
T ss_dssp HHHHHS
T ss_pred HHHhcC
Confidence 999975
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=354.11 Aligned_cols=260 Identities=28% Similarity=0.418 Sum_probs=207.9
Q ss_pred HhcCCccccccccCCceeEEeeeecC------CceeEEEEecccC-cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCc
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ 421 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~ 421 (672)
..++|.+.+.||+|+||.||+|.+.. ...||+|.+.... ....+.+.+|+.+++++ +||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 45789999999999999999998642 2479999987653 34457789999999999 8999999999999999
Q ss_pred eEEEEEeecCCCChhHHhhhccc-----------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC
Q 005871 422 ELLLIYEYMPNKSLDVHLFDATR-----------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD 490 (672)
Q Consensus 422 ~~~lV~Ey~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~ 490 (672)
..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence 99999999999999999865321 345899999999999999999999997 9999999999999999
Q ss_pred CCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhh
Q 005871 491 MNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLT 569 (672)
Q Consensus 491 ~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~ 569 (672)
+.+||+|||++................|++.|+|||++.+..++.++||||||+++|||++ |..||....... ....
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~ 278 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--KFYK 278 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--HHHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--HHHH
Confidence 9999999999987654433333334567889999999999999999999999999999999 888875322111 1111
Q ss_pred hhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 570 YTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 570 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
...... .. ..+......+.+++.+||+.||.+|||+.+|++.|..
T Consensus 279 ~~~~~~----~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 279 LVKDGY----QM---------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp HHHHTC----CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhcCC----CC---------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 111110 00 0011112457788889999999999999999999975
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=344.92 Aligned_cols=263 Identities=28% Similarity=0.461 Sum_probs=204.6
Q ss_pred hcCCccccccccCCceeEEeeee-----cCCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeC--ce
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QE 422 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~ 422 (672)
.++|++.++||+|+||.||++++ .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 35699999999999999999983 358899999997543 34567899999999999999999999999876 67
Q ss_pred EEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCce
Q 005871 423 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 502 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~ 502 (672)
.++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 89999999999999998543 245899999999999999999999998 9999999999999999999999999998
Q ss_pred eeCCCCCC-cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCc--------ccccchhhhhhh
Q 005871 503 IFGGNQNQ-ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFS--------EHGQTLLTYTWK 573 (672)
Q Consensus 503 ~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~--------~~~~~~~~~~~~ 573 (672)
........ .......||..|+|||++.+..++.++||||||+++|+|++|..|+..... ............
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 87544322 222335688889999999999999999999999999999999988532110 000000011111
Q ss_pred hccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 574 LWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 574 ~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
....+.. ...+......+.+|+.+||+.||++|||+.+|++.|..
T Consensus 255 ~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 255 TLKEGKR---------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHHTTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhccCC---------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 1111110 01112223457788889999999999999999999964
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=348.78 Aligned_cols=271 Identities=16% Similarity=0.183 Sum_probs=201.5
Q ss_pred hcCCccccccccCCceeEEeeeec----CCceeEEEEecccCcc-----------cHHHHHHHHHHHHhccCCCeeeEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTSGQ-----------GLQEFKNEVNLIAKLQHKNLVRLLG 415 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~il~~l~h~niv~l~~ 415 (672)
.++|.+.+.||+|+||.||+|.+. .+..+|+|++...... ....+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999975 5788999998765422 1234667889999999999999999
Q ss_pred EEEe----CceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC
Q 005871 416 CCLE----GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM 491 (672)
Q Consensus 416 ~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~ 491 (672)
++.. ....++||||+ +++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 78899999999 99999998543 36999999999999999999999997 99999999999999877
Q ss_pred --CeEEEeecCceeeCCCCCC-----cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccc
Q 005871 492 --NPKISDFGLARIFGGNQNQ-----ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHG 564 (672)
Q Consensus 492 --~~kL~DFgla~~~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~ 564 (672)
.+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~- 267 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP- 267 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH-
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc-
Confidence 9999999999876432211 11234579999999999999999999999999999999999999984221111
Q ss_pred cchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCCCCC
Q 005871 565 QTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQ 634 (672)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~~ 634 (672)
............ .....+....... .....+.+++..||+.||++|||+++|++.|.....++++
T Consensus 268 -~~~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 332 (345)
T 2v62_A 268 -VAVQTAKTNLLD-ELPQSVLKWAPSG---SSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGP 332 (345)
T ss_dssp -HHHHHHHHHHHH-TTTHHHHHHSCTT---SCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCCC
T ss_pred -HHHHHHHHhhcc-cccHHHHhhcccc---ccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcccC
Confidence 111111111100 0111110100000 1223577888899999999999999999999987654433
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=347.44 Aligned_cols=268 Identities=24% Similarity=0.318 Sum_probs=207.8
Q ss_pred hcCCccccccccCCceeEEeeee-cCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEe----CceEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE----GQELLL 425 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~----~~~~~l 425 (672)
.++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46899999999999999999997 4689999999987776777889999999999999999999999873 357899
Q ss_pred EEeecCCCChhHHhhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceee
Q 005871 426 IYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 504 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~ 504 (672)
||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 999999999999986532 3456999999999999999999999997 999999999999999999999999998764
Q ss_pred CCCCCCc-------ccccccccCCcCChhhhcCCC---CChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhh
Q 005871 505 GGNQNQA-------NTNIIAGTYGYMAPEYAMGGI---FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL 574 (672)
Q Consensus 505 ~~~~~~~-------~~~~~~gt~~Y~aPE~~~~~~---~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 574 (672)
....... ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||........ ........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~- 262 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALAVQN- 262 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHHHHC-
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHHhhc-
Confidence 3211110 012245799999999987654 68999999999999999999999742111111 11110000
Q ss_pred ccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCCCCCC
Q 005871 575 WCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQP 635 (672)
Q Consensus 575 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~~p 635 (672)
.... .........+.+++.+||+.||.+|||+.+|++.|.....+.|.+
T Consensus 263 --~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 311 (317)
T 2buj_A 263 --QLSI----------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311 (317)
T ss_dssp --C--C----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred --cCCC----------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence 0000 001112245778888999999999999999999999876544443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=353.64 Aligned_cols=204 Identities=18% Similarity=0.249 Sum_probs=177.8
Q ss_pred hcCCccccccccC--CceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEE
Q 005871 351 TNHFSDENKLGQG--GFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 351 ~~~~~~~~~LG~G--~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l 425 (672)
.++|++.++||+| +||.||++++. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4689999999999 99999999986 69999999997543 3445778899999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
||||+++++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||.+....
T Consensus 104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 99999999999998653 2345999999999999999999999998 9999999999999999999999999987543
Q ss_pred CCC-----CCcccccccccCCcCChhhhcC--CCCChhhHHHHHHHHHHHHHcCCCCCCC
Q 005871 506 GNQ-----NQANTNIIAGTYGYMAPEYAMG--GIFSIKSDVFSFGVLLLEIISGRKNNGF 558 (672)
Q Consensus 506 ~~~-----~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDvwSlGvil~elltG~~p~~~ 558 (672)
... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 221 1112233478999999999987 5789999999999999999999999854
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=358.33 Aligned_cols=253 Identities=22% Similarity=0.333 Sum_probs=197.1
Q ss_pred hcCCccccccccCCceeEEeeeecCCceeEEEEecccC--cccHHHHHHHHHHHHhcc--CCCeeeEEEEEEeCceEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQ--HKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~--h~niv~l~~~~~~~~~~~lV 426 (672)
..+|.+.+.||+|+||.||++.+.+++.||||++.... ....+.+.+|+.+|++++ ||||+++++++...+.+++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 35699999999999999999998889999999987543 345678999999999996 59999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|| +.+++|.+++... ..+++.++..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 135 ~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 6788999988543 46899999999999999999999997 99999999999995 58999999999987654
Q ss_pred CCCCcccccccccCCcCChhhhcC-----------CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhc
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMG-----------GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLW 575 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 575 (672)
..........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ........
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~~~~~ 281 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAII 281 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHHHHHH
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HHHHHHHh
Confidence 433333345679999999999865 46899999999999999999999998532211 11111111
Q ss_pred cCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 576 CEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 576 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
.... ....+......+.+|+.+||+.||++|||+.||++..
T Consensus 282 ~~~~---------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 282 DPNH---------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp CTTS---------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred Cccc---------cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 1110 0001111123567888899999999999999999764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=351.85 Aligned_cols=259 Identities=29% Similarity=0.427 Sum_probs=207.9
Q ss_pred hcCCccccccccCCceeEEeeeec--------CCceeEEEEecccC-cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeC
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG 420 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~ 420 (672)
.++|.+.+.||+|+||.||+|.+. ++..||+|++.... ....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 478999999999999999999863 46789999997653 34467789999999999 899999999999999
Q ss_pred ceEEEEEeecCCCChhHHhhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE
Q 005871 421 QELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 487 (672)
Q Consensus 421 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll 487 (672)
+..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 999999999999999999965332 234899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccc
Q 005871 488 DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQT 566 (672)
Q Consensus 488 ~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~ 566 (672)
+.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |+.||..... ..
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~ 267 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EE 267 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH---HH
Confidence 9999999999999998765443333344567889999999998889999999999999999999 9998753211 11
Q ss_pred hhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 567 LLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 567 ~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
+.... ..+.... .+......+.+++.+||+.||++|||+.+|++.|...
T Consensus 268 ~~~~~----~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 268 LFKLL----KEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp HHHHH----HHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHH----hcCCCCC---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11111 1111000 0111223577888899999999999999999999764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=352.93 Aligned_cols=267 Identities=18% Similarity=0.208 Sum_probs=202.2
Q ss_pred HhcCCccccccccCCceeEEeeeecC------CceeEEEEecccCcccH-----------HHHHHHHHHHHhccCCCeee
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRTSGQGL-----------QEFKNEVNLIAKLQHKNLVR 412 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~il~~l~h~niv~ 412 (672)
..++|.+.++||+|+||.||+|.+.. ++.||||++........ ..+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999998754 47899999876542211 12345666777788999999
Q ss_pred EEEEEEeC----ceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc
Q 005871 413 LLGCCLEG----QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD 488 (672)
Q Consensus 413 l~~~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~ 488 (672)
+++++... ...+|||||+ +++|.+++... ...+++..++.|+.||+.||.|||+++ |+||||||+||||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99999865 4589999999 99999998542 356999999999999999999999998 99999999999999
Q ss_pred --CCCCeEEEeecCceeeCCCCCCc-----ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005871 489 --DDMNPKISDFGLARIFGGNQNQA-----NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFS 561 (672)
Q Consensus 489 --~~~~~kL~DFgla~~~~~~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~ 561 (672)
.++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 88999999999998765332211 12335699999999999999999999999999999999999999853221
Q ss_pred ccccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 562 EHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
. ..........+ .....+++++.+..... ...+.+++..||+.||++||++++|++.|...
T Consensus 267 ~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~~---~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 267 D--PKYVRDSKIRY-RENIASLMDKCFPAANA---PGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp C--HHHHHHHHHHH-HHCHHHHHHHHSCTTCC---CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred C--HHHHHHHHHHh-hhhHHHHHHHhcccccC---HHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 1 11111111111 11222233322221112 23466777899999999999999999999764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=337.62 Aligned_cols=254 Identities=26% Similarity=0.369 Sum_probs=204.6
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
.++|++.+.||+|+||.||++.+. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467999999999999999999976 68999999987543 3445788999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|+++++|.+++. ....+++..+..++.||+.||.|||+.| |+||||||+||+++.++.+||+|||++..+....
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 999999998884 3346899999999999999999999998 9999999999999999999999999998764333
Q ss_pred CCcccccccccCCcCChhhhcCCCC-ChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChh
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 587 (672)
.........|++.|+|||++.+..+ +.++||||||+++|+|++|+.||........ . ...+..... ....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~---~~~~~~~~~--~~~~- 230 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---E---YSDWKEKKT--YLNP- 230 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH---H---HHHHHTTCT--TSTT-
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH---H---HHHhhhccc--ccCc-
Confidence 2223344678999999999987765 7899999999999999999999854322111 0 111111100 0000
Q ss_pred hcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 588 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 588 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.......+.+++.+||+.||++|||++||++.
T Consensus 231 -----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 231 -----WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp -----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 01122346788889999999999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=353.12 Aligned_cols=249 Identities=27% Similarity=0.309 Sum_probs=196.6
Q ss_pred ccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCCC
Q 005871 355 SDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 433 (672)
Q Consensus 355 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~g 433 (672)
...+.||+|+||.||+|.+. +|+.||+|++........+.+.+|+.+|++++||||+++++++.+.+..++||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 34678999999999999875 68999999998776666788999999999999999999999999999999999999999
Q ss_pred ChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE--cCCCCeEEEeecCceeeCCCCCCc
Q 005871 434 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL--DDDMNPKISDFGLARIFGGNQNQA 511 (672)
Q Consensus 434 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll--~~~~~~kL~DFgla~~~~~~~~~~ 511 (672)
+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.+.....
T Consensus 172 ~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 172 ELFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp EEHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred cHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 998888542 345899999999999999999999998 9999999999999 5678899999999997654322
Q ss_pred ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCC
Q 005871 512 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQS 591 (672)
Q Consensus 512 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~ 591 (672)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ...... .. ..... ....
T Consensus 245 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~---~~i~~~-~~-~~~~~-~~~~ 314 (373)
T 2x4f_A 245 -LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA---ETL---NNILAC-RW-DLEDE-EFQD 314 (373)
T ss_dssp -CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHH---HHHHHT-CC-CSCSG-GGTT
T ss_pred -cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHHHhc-cC-CCChh-hhcc
Confidence 22347999999999999999999999999999999999999998533211 111 111110 00 00000 0111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 592 CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 592 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
. ...+.+|+.+||+.||++|||+.|+++.
T Consensus 315 ~----~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 315 I----SEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp S----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C----CHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1 2357788889999999999999999973
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=343.24 Aligned_cols=266 Identities=23% Similarity=0.324 Sum_probs=198.6
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
++|++.++||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 68999999999999999999986 589999999865533 335678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|+++++|..++.. ...+++..+..++.|++.||.|||+.| |+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999888743 345899999999999999999999998 9999999999999999999999999998765332
Q ss_pred CCcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhh--------hhhhccCCC
Q 005871 509 NQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTY--------TWKLWCEGP 579 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~--------~~~~~~~~~ 579 (672)
.. .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.............. ....+....
T Consensus 157 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 157 DY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred cc--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 21 223478999999999976 5689999999999999999999999864332211110000 000000000
Q ss_pred cc---cccChhhcCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 580 AV---ELIDPVLKQS---CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 580 ~~---~l~d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
.. .+.++..... ..+.....+.+++.+||+.||++|||++|+++.-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 286 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHP 286 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSG
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcCh
Confidence 00 0000000000 0011233477888999999999999999999653
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=341.04 Aligned_cols=260 Identities=28% Similarity=0.473 Sum_probs=193.3
Q ss_pred hcCCccccccccCCceeEEeeeecCCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
.++|.+.++||+|+||.||+|++. ..+|+|++.... ....+.+.+|+.++++++||||++++++. .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 468999999999999999999864 359999987543 34557899999999999999999999965 5567899999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 100 WCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred ecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence 99999999988532 346899999999999999999999998 9999999999999999999999999998765433
Q ss_pred CCcccccccccCCcCChhhhc---CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccC
Q 005871 509 NQANTNIIAGTYGYMAPEYAM---GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 585 (672)
.........||+.|+|||++. +..++.++||||||+++|+|++|+.||...... ..................
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~--- 249 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIEMVGRGSLSPDLSK--- 249 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--HHHHHHHHHTSCCCCTTS---
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--HHHHHHhcccccCcchhh---
Confidence 333344567999999999986 667899999999999999999999998533211 111111111110111110
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDS 629 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 629 (672)
........+.+++.+||+.||++|||+.+|+++|....
T Consensus 250 ------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 250 ------VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp ------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ------ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 01122345778888999999999999999999998753
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=351.82 Aligned_cols=253 Identities=23% Similarity=0.271 Sum_probs=193.2
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
.++|.+.+.||+|+||.||++++. +++.||||++..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 468999999999999999999986 689999999976443 236788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC--eEEEeecCceeeCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN--PKISDFGLARIFGGN 507 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~--~kL~DFgla~~~~~~ 507 (672)
+++++|..++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 999999998854 345999999999999999999999998 999999999999987765 999999999753222
Q ss_pred CCCcccccccccCCcCChhhhcCCCCChh-hHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGGIFSIK-SDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k-sDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
. ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........ ............. .. .
T Consensus 172 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~~~~~~--~~-~- 242 (361)
T 3uc3_A 172 S---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRILSVKY--SI-P- 242 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHHHTTCC--CC-C-
T ss_pred C---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhcCCC--CC-C-
Confidence 1 2233579999999999988887655 9999999999999999999864322111 1111111111100 00 0
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
. .......+.+|+.+||+.||++|||+.|+++.
T Consensus 243 ---~--~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 243 ---D--DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ---T--TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ---C--cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0 00112356788889999999999999999986
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=349.14 Aligned_cols=252 Identities=22% Similarity=0.248 Sum_probs=179.8
Q ss_pred ccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCceEEEEEeecCCCC
Q 005871 357 ENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEYMPNKS 434 (672)
Q Consensus 357 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lV~Ey~~~gs 434 (672)
.++||+|+||.||++.+. +++.||||++.+. ....+.+|+.+++.+. ||||+++++++.+....++||||+++++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999986 6899999998654 3467789999999997 9999999999999999999999999999
Q ss_pred hhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC---CeEEEeecCceeeCCCCCCc
Q 005871 435 LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM---NPKISDFGLARIFGGNQNQA 511 (672)
Q Consensus 435 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~---~~kL~DFgla~~~~~~~~~~ 511 (672)
|.+++.. ...+++.++..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++.......
T Consensus 93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-- 164 (325)
T 3kn6_A 93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-- 164 (325)
T ss_dssp HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--
Confidence 9999854 346999999999999999999999998 99999999999998765 799999999987543322
Q ss_pred ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCC
Q 005871 512 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQS 591 (672)
Q Consensus 512 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~ 591 (672)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....................+... ...+. .
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~-~~~~~-~-- 240 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS-FEGEA-W-- 240 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC-CCSHH-H--
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC-CCccc-c--
Confidence 2234578999999999999999999999999999999999999986533221111111111111111110 00000 0
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 592 CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 592 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
......+.+|+.+||+.||++|||++|+++.-
T Consensus 241 --~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~ 272 (325)
T 3kn6_A 241 --KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNE 272 (325)
T ss_dssp --HTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCG
T ss_pred --cCCCHHHHHHHHHHCCCChhHCCCHHHHhcCh
Confidence 11234577888899999999999999998653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=349.17 Aligned_cols=252 Identities=24% Similarity=0.360 Sum_probs=188.3
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
..++|++.+.||+|+||.||+|++. +++.||||++.... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3578999999999999999999986 57899999987653 33668899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---CCCeEEEeecCceeeC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFGLARIFG 505 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~---~~~~kL~DFgla~~~~ 505 (672)
|+++++|.+++.. ...+++.++..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999998843 345899999999999999999999998 999999999999975 8899999999998754
Q ss_pred CCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccC
Q 005871 506 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585 (672)
Q Consensus 506 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 585 (672)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........... ....
T Consensus 203 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~i~~~~~-~~~~ 272 (349)
T 2w4o_A 203 HQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ------FMFRRILNCEY-YFIS 272 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH------HHHHHHHTTCC-CCCT
T ss_pred ccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH------HHHHHHHhCCC-ccCC
Confidence 322 1234578999999999999999999999999999999999999974322110 01111111111 0001
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
+ ........+.+|+.+||+.||++|||+.++++.
T Consensus 273 ~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 273 P-----WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp T-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c-----hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 011223457788889999999999999999974
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=355.64 Aligned_cols=270 Identities=21% Similarity=0.276 Sum_probs=212.4
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCc--eEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ--ELLLI 426 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~--~~~lV 426 (672)
.++|.+.++||+|+||.||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 467999999999999999999986 58999999997543 344677889999999999999999999998765 78999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE----cCCCCeEEEeecCce
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL----DDDMNPKISDFGLAR 502 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll----~~~~~~kL~DFgla~ 502 (672)
|||+++++|.+++........+++..++.++.||+.||.|||+.| |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999976555555999999999999999999999998 9999999999999 777889999999998
Q ss_pred eeCCCCCCcccccccccCCcCChhhhcC--------CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhh
Q 005871 503 IFGGNQNQANTNIIAGTYGYMAPEYAMG--------GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL 574 (672)
Q Consensus 503 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 574 (672)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .......
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~ 239 (396)
T 4eut_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKI 239 (396)
T ss_dssp ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHH
T ss_pred EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHH
Confidence 765432 2233579999999999865 56788999999999999999999998543322211 1111111
Q ss_pred ccCCC---cc----------cccCh-hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 575 WCEGP---AV----------ELIDP-VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 575 ~~~~~---~~----------~l~d~-~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
....+ +. .+.+. .............+.+++.+||+.||++|||+.++++.|...
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 11110 00 00000 011223456667788999999999999999999999988653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=348.06 Aligned_cols=251 Identities=25% Similarity=0.294 Sum_probs=194.1
Q ss_pred hcCCccccccccCCceeEEeeee----cCCceeEEEEecccC----cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCce
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTL----ADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 422 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~ 422 (672)
.++|++.+.||+|+||.||+++. .+++.||+|++.+.. ......+.+|+.+|++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 36899999999999999999986 468999999997642 2344567899999999999999999999999999
Q ss_pred EEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCce
Q 005871 423 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 502 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~ 502 (672)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999998854 345899999999999999999999998 9999999999999999999999999997
Q ss_pred eeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccc
Q 005871 503 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVE 582 (672)
Q Consensus 503 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (672)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ......... ..
T Consensus 170 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~-~~-- 238 (327)
T 3a62_A 170 ESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK------KTIDKILKC-KL-- 238 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHT-CC--
T ss_pred ccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhC-CC--
Confidence 6432221 223457999999999999999999999999999999999999998532211 111111111 00
Q ss_pred ccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhc
Q 005871 583 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVVMLA 626 (672)
Q Consensus 583 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L~ 626 (672)
..+......+.+++.+||+.||++|| ++.++++.--
T Consensus 239 --------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~ 279 (327)
T 3a62_A 239 --------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279 (327)
T ss_dssp --------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGG
T ss_pred --------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCc
Confidence 01111224567888899999999999 7888887543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=354.84 Aligned_cols=206 Identities=28% Similarity=0.355 Sum_probs=178.7
Q ss_pred cchHHHHHHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhcc-----CCCeeeEEE
Q 005871 342 FPLRLALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-----HKNLVRLLG 415 (672)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----h~niv~l~~ 415 (672)
+++.......++|.+.++||+|+||.||+|++. +++.||||++... ....+.+..|+.+++.++ ||||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 334444455689999999999999999999985 6889999998643 334567788999999997 999999999
Q ss_pred EEEeCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC------
Q 005871 416 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD------ 489 (672)
Q Consensus 416 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~------ 489 (672)
++...+..++||||+ +++|.+++.... ...+++..+..++.||+.||.|||+.| |+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccccc
Confidence 999999999999999 999999986532 335899999999999999999999998 999999999999975
Q ss_pred -------------------CCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHH
Q 005871 490 -------------------DMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEII 550 (672)
Q Consensus 490 -------------------~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ell 550 (672)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 789999999999864332 22357899999999999999999999999999999999
Q ss_pred cCCCCCCC
Q 005871 551 SGRKNNGF 558 (672)
Q Consensus 551 tG~~p~~~ 558 (672)
+|+.||..
T Consensus 254 ~g~~pf~~ 261 (360)
T 3llt_A 254 TGSLLFRT 261 (360)
T ss_dssp HSSCSCCC
T ss_pred HCCCCCCC
Confidence 99999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=370.34 Aligned_cols=256 Identities=27% Similarity=0.407 Sum_probs=208.5
Q ss_pred hcCCccccccccCCceeEEeeeecC-CceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
.++|.+.++||+|+||.||+|.++. +..||||++.... ...+.|.+|+.+|++++||||+++++++.+.+..++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 3578999999999999999999864 8899999987654 3467899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+++|+|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 298 ~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 298 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred cCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 9999999999653 2345899999999999999999999998 99999999999999999999999999987643321
Q ss_pred CcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhh
Q 005871 510 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 588 (672)
. ......+++.|+|||++.+..++.++||||||+++|||++ |+.||...... ..... ...+...
T Consensus 374 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~~~----~~~~~~~------- 438 (495)
T 1opk_A 374 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYEL----LEKDYRM------- 438 (495)
T ss_dssp E-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHH----HHTTCCC-------
T ss_pred e-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcCCCC-------
Confidence 1 1223356788999999999999999999999999999999 88887533211 11111 1111100
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 589 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 589 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
..+......+.+|+.+||+.||++|||+.+|++.|...
T Consensus 439 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 439 --ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred --CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 11112234577888899999999999999999999875
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=336.22 Aligned_cols=252 Identities=21% Similarity=0.300 Sum_probs=204.0
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
..++|.+.++||+|+||.||+|.+. ++..+|+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3467999999999999999999976 478899999987766677889999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE---cCCCCeEEEeecCceeeC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFG 505 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll---~~~~~~kL~DFgla~~~~ 505 (672)
|+++++|.+++.. ...+++..+..++.||+.||.|||+.| |+||||||+|||+ +.++.+||+|||++..+.
T Consensus 87 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999988854 345899999999999999999999998 9999999999999 788999999999998765
Q ss_pred CCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccC
Q 005871 506 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585 (672)
Q Consensus 506 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 585 (672)
.... .....||+.|+|||++.+. ++.++||||||+++|+|++|+.||...... ... .... .+... ..
T Consensus 161 ~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~---~~~~-~~~~~--~~ 227 (277)
T 3f3z_A 161 PGKM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS---EVM---LKIR-EGTFT--FP 227 (277)
T ss_dssp TTSC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHH-HCCCC--CC
T ss_pred Cccc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH---HHH---HHHH-hCCCC--CC
Confidence 4322 2335789999999988654 899999999999999999999998532211 111 1110 11000 00
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
...... ....+.+++.+||+.||++|||+.++++.
T Consensus 228 ~~~~~~----~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 228 EKDWLN----VSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred chhhhc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000011 12457788889999999999999999863
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=335.76 Aligned_cols=252 Identities=24% Similarity=0.323 Sum_probs=202.8
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
.++|++.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 578999999999999999999975 5899999998654 3344577889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC---eEEEeecCceee
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN---PKISDFGLARIF 504 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~---~kL~DFgla~~~ 504 (672)
||+++++|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 999999998888543 45899999999999999999999998 999999999999986655 999999999876
Q ss_pred CCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 505 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 505 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
..... .....|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ........ +.. ...
T Consensus 159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~~~~----~~~-~~~ 227 (284)
T 3kk8_A 159 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQIKA----GAY-DYP 227 (284)
T ss_dssp CSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH----TCC-CCC
T ss_pred ccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh---HHHHHHHh----ccc-cCC
Confidence 53322 23357899999999999999999999999999999999999997432211 11111110 000 000
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.+. .......+.+++.+||+.||++|||+.|+++.
T Consensus 228 ~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 228 SPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp TTT-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred chh-----hcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000 01112346788889999999999999999874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=361.08 Aligned_cols=250 Identities=30% Similarity=0.394 Sum_probs=202.4
Q ss_pred hcCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCc-eEEEEEee
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-ELLLIYEY 429 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~-~~~lV~Ey 429 (672)
.++|++.++||+|+||.||+|.++ ++.||||++.... ..+.|.+|+.+|++++||||+++++++.+.+ ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 467999999999999999999885 7799999997654 4578999999999999999999999987765 79999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+++|+|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 269 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 343 (450)
T 1k9a_A 269 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 343 (450)
T ss_dssp CTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-
Confidence 9999999999653 2334799999999999999999999997 9999999999999999999999999998643221
Q ss_pred CcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhh
Q 005871 510 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 588 (672)
....+++.|+|||++.+..++.++||||||+++|||++ |+.||...... ...... ..+....
T Consensus 344 ----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i----~~~~~~~------ 406 (450)
T 1k9a_A 344 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRV----EKGYKMD------ 406 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT---THHHHH----HTTCCCC------
T ss_pred ----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HcCCCCC------
Confidence 12356889999999999999999999999999999998 99997533211 111111 1111100
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 589 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 589 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
.+......+.+|+.+||+.||++|||+.+|++.|...
T Consensus 407 ---~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 407 ---APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111234577888899999999999999999999753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=340.44 Aligned_cols=250 Identities=24% Similarity=0.366 Sum_probs=202.2
Q ss_pred hcCCccccccccCCceeEEeeeecC-C-------ceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCce
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLAD-G-------KAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 422 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~ 422 (672)
.++|.+.+.||+|+||.||+|.+.. + ..||+|++........+.+.+|+.++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4689999999999999999998753 3 4699999987777777889999999999999999999999999999
Q ss_pred EEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC--------eE
Q 005871 423 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN--------PK 494 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~--------~k 494 (672)
.++||||+++++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999999643 234899999999999999999999998 999999999999998887 99
Q ss_pred EEeecCceeeCCCCCCcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhh
Q 005871 495 ISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWK 573 (672)
Q Consensus 495 L~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~ 573 (672)
|+|||++..... .....|++.|+|||++.+ ..++.++||||||+++|||++|..|+...... ..... .
T Consensus 162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~--~~~~~---~ 230 (289)
T 4fvq_A 162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS--QRKLQ---F 230 (289)
T ss_dssp ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHH---H
T ss_pred eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch--HHHHH---H
Confidence 999999864321 223468999999999987 67999999999999999999965553211110 00011 0
Q ss_pred hccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 574 LWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 574 ~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
......... .. ...+.+++.+||+.||++|||++++++.|...
T Consensus 231 ~~~~~~~~~--------~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l 273 (289)
T 4fvq_A 231 YEDRHQLPA--------PK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273 (289)
T ss_dssp HHTTCCCCC--------CS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTC
T ss_pred hhccCCCCC--------CC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 000111110 11 12366788899999999999999999999876
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=367.76 Aligned_cols=258 Identities=29% Similarity=0.417 Sum_probs=207.6
Q ss_pred HhcCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
..++|.+.++||+|+||.||+|.++++..||||++.... ...+.+.+|+.+|++++||||+++++++. .+..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 346899999999999999999999888999999997654 45688999999999999999999999986 5678999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+++|+|.+++.... ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 264 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 264 MAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 99999999996432 235889999999999999999999997 99999999999999999999999999987543211
Q ss_pred CcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhh
Q 005871 510 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 588 (672)
. ......++..|+|||++..+.++.++||||||+++|||++ |+.||...... ........ ....
T Consensus 340 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i~~---~~~~-------- 404 (454)
T 1qcf_A 340 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRALER---GYRM-------- 404 (454)
T ss_dssp H-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHHHH---TCCC--------
T ss_pred e-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHc---CCCC--------
Confidence 1 1122346778999999999999999999999999999999 99997532211 11111111 1000
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCC
Q 005871 589 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSM 630 (672)
Q Consensus 589 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 630 (672)
..+......+.+|+.+||+.||++|||+++|++.|.....
T Consensus 405 --~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 405 --PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred --CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 0011123457788889999999999999999999987643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=339.83 Aligned_cols=253 Identities=26% Similarity=0.397 Sum_probs=204.7
Q ss_pred HHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEe--------
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE-------- 419 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~-------- 419 (672)
....+|++.+.||+|+||.||++.+. +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 34567999999999999999999986 79999999997654 346789999999999999999999864
Q ss_pred --------CceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC
Q 005871 420 --------GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM 491 (672)
Q Consensus 420 --------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~ 491 (672)
....++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTK 159 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCC
Confidence 45689999999999999999653 2356999999999999999999999997 99999999999999999
Q ss_pred CeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhh
Q 005871 492 NPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYT 571 (672)
Q Consensus 492 ~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~ 571 (672)
.+||+|||++........ .....|++.|+|||++.+..++.++||||||+++|+|++|..|+... ...
T Consensus 160 ~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------~~~ 227 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------SKF 227 (284)
T ss_dssp EEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------HHH
T ss_pred CEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------HHH
Confidence 999999999987654332 22346899999999999999999999999999999999999874210 001
Q ss_pred hhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCCCC
Q 005871 572 WKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIP 633 (672)
Q Consensus 572 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~ 633 (672)
+.....+... ... ...+.+++.+||+.||++|||+.|+++.|.....+..
T Consensus 228 ~~~~~~~~~~--------~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 228 FTDLRDGIIS--------DIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp HHHHHTTCCC--------TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred HHHhhccccc--------ccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 1111111111 111 2346678889999999999999999999987655443
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=340.15 Aligned_cols=252 Identities=23% Similarity=0.266 Sum_probs=204.7
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcc------cHHHHHHHHHHHHhccCCCeeeEEEEEEeCceE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ------GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 423 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 423 (672)
.++|++.+.||+|+||.||++.+. +++.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467999999999999999999976 6899999998764321 367899999999999999999999999999999
Q ss_pred EEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC----CeEEEeec
Q 005871 424 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM----NPKISDFG 499 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~----~~kL~DFg 499 (672)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.| |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999853 346899999999999999999999998 99999999999999888 79999999
Q ss_pred CceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCC
Q 005871 500 LARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGP 579 (672)
Q Consensus 500 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 579 (672)
++........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ....... ...
T Consensus 165 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~i~-~~~ 234 (321)
T 2a2a_A 165 LAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANIT-SVS 234 (321)
T ss_dssp TCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHH-TTC
T ss_pred cceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHH-hcc
Confidence 9987654322 23457899999999999999999999999999999999999998532211 1111111 100
Q ss_pred cccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 580 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 580 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
. ..++...... ...+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~--~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 Y--DFDEEFFSHT----SELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp C--CCCHHHHTTC----CHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred c--ccChhhhccc----CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0111111122 2346788889999999999999999974
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=341.76 Aligned_cols=256 Identities=28% Similarity=0.408 Sum_probs=208.6
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
..++|++.+.||+|+||.||+|.+. ++..||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 3468999999999999999999986 48899999987543 346788999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999998653 3356999999999999999999999998 9999999999999999999999999998765332
Q ss_pred CCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChh
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 587 (672)
. .......+++.|+|||++.+..++.++||||||+++|+|++ |..||...... ....... .....
T Consensus 166 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---~~~~~~~----~~~~~------ 231 (288)
T 3kfa_A 166 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELLE----KDYRM------ 231 (288)
T ss_dssp S-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHHH----TTCCC------
T ss_pred c-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHh----ccCCC------
Confidence 2 22233457889999999999999999999999999999999 88887543211 1111111 11000
Q ss_pred hcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 588 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 588 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
..+......+.+++.+||+.||++|||+.+|++.|..
T Consensus 232 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~ 268 (288)
T 3kfa_A 232 ---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 268 (288)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence 0111122457788889999999999999999999875
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=357.10 Aligned_cols=273 Identities=18% Similarity=0.210 Sum_probs=209.0
Q ss_pred HHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEE
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 424 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 424 (672)
...++|++.+.||+|+||.||+++++ +++.||||++.+.. ....+.+.+|..++..++||||+++++++.+.+.++
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 137 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY 137 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 34688999999999999999999985 68999999997532 223456889999999999999999999999999999
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceee
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 504 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~ 504 (672)
+||||+++|+|..++... ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++++||+|||+++.+
T Consensus 138 lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~ 212 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKL 212 (412)
T ss_dssp EEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheec
Confidence 999999999999999643 236899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCCcccccccccCCcCChhhhc-------CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccC
Q 005871 505 GGNQNQANTNIIAGTYGYMAPEYAM-------GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCE 577 (672)
Q Consensus 505 ~~~~~~~~~~~~~gt~~Y~aPE~~~-------~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 577 (672)
..... ......+||+.|+|||++. +..++.++|||||||++|||++|+.||...... .....+......
T Consensus 213 ~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~i~~~~~~ 288 (412)
T 2vd5_A 213 RADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA---ETYGKIVHYKEH 288 (412)
T ss_dssp CTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTHHHH
T ss_pred cCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH---HHHHHHHhcccC
Confidence 54322 1223458999999999997 456899999999999999999999998532211 111111000000
Q ss_pred CCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHHhcc--CCC----CCCCCCCCcc
Q 005871 578 GPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADR---PTMSSVVVMLAS--DSM----TIPQPTEPAF 640 (672)
Q Consensus 578 ~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~evl~~L~~--~~~----~l~~p~~p~~ 640 (672)
... +...... ...+.+|+.+||+ +|++| |+++||++.--. ..+ ..++|-.|.+
T Consensus 289 ~~~-----p~~~~~~----s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~~~~~p~~p~~ 350 (412)
T 2vd5_A 289 LSL-----PLVDEGV----PEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTPDF 350 (412)
T ss_dssp CCC-----C----CC----CHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTSTTSCCSCCCC-
T ss_pred cCC-----CccccCC----CHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCCCcC
Confidence 000 0011112 2356778889999 99998 599999876432 222 2345555654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=352.45 Aligned_cols=268 Identities=27% Similarity=0.373 Sum_probs=203.3
Q ss_pred CCccccccccCCceeEEeeee-----cCCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeC--ceEE
Q 005871 353 HFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELL 424 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~ 424 (672)
.|++.++||+|+||.||++.+ .+++.||||++.... ....+.+.+|++++++++||||+++++++.+. ...+
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 349999999999999988753 258899999998654 34467789999999999999999999999874 6789
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceee
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 504 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~ 504 (672)
+||||+++++|.+++.. ..+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++...
T Consensus 112 lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccc
Confidence 99999999999999843 24899999999999999999999998 999999999999999999999999999987
Q ss_pred CCCCCC-cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccc
Q 005871 505 GGNQNQ-ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583 (672)
Q Consensus 505 ~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 583 (672)
...... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||......... ...............+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE-LIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HHCSCCHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh-hhcccccchhHHHHHHH
Confidence 543322 1223346788899999999989999999999999999999999987432110000 00000000000000000
Q ss_pred cChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 584 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
++.......+......+.+|+.+||+.||++|||+.+|++.|...
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 111001111222234678888899999999999999999999865
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=360.05 Aligned_cols=248 Identities=27% Similarity=0.429 Sum_probs=204.0
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
.++|.+.+.||+|+||.||+|++. +|+.||||++.... .+....+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 368999999999999999999986 69999999997542 23456789999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||+++++|.+++. +...+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 95 ~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999984 3456999999999999999999999997 99999999999999999999999999997654
Q ss_pred CCCCcccccccccCCcCChhhhcCCCC-ChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccC
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 585 (672)
.. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... ..+. .... .+...
T Consensus 169 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~~---~~i~-~~~~~---- 234 (476)
T 2y94_A 169 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---PTLF---KKIC-DGIFY---- 234 (476)
T ss_dssp TC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS---HHHH---HHHH-TTCCC----
T ss_pred cc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH---HHHH---HHHh-cCCcC----
Confidence 32 2234579999999999988775 7999999999999999999999853221 1111 1111 11100
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
..... ...+.+|+.+||+.||++|||+.||++.
T Consensus 235 --~p~~~----s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 235 --TPQYL----NPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp --CCTTC----CHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred --CCccC----CHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 00111 2346788889999999999999999984
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=335.12 Aligned_cols=254 Identities=30% Similarity=0.511 Sum_probs=200.4
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcc-------cHHHHHHHHHHHHhccCCCeeeEEEEEEeCce
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ-------GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 422 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~ 422 (672)
.++|++.+.||+|+||.||+|++. +++.||+|++...... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 478999999999999999999975 6899999998654322 1267899999999999999999999997665
Q ss_pred EEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC-----eEEEe
Q 005871 423 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN-----PKISD 497 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~-----~kL~D 497 (672)
++||||+++++|.+.+.. ....+++..++.++.|++.||.|||+.+ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 699999999999888854 3346999999999999999999999984 23999999999999988776 99999
Q ss_pred ecCceeeCCCCCCcccccccccCCcCChhhhc--CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhc
Q 005871 498 FGLARIFGGNQNQANTNIIAGTYGYMAPEYAM--GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLW 575 (672)
Q Consensus 498 Fgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 575 (672)
||+++.... ......||+.|+|||++. ...++.++||||||+++|+|++|+.||........ .......
T Consensus 173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~ 243 (287)
T 4f0f_A 173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----KFINMIR 243 (287)
T ss_dssp CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH----HHHHHHH
T ss_pred CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH----HHHHHHh
Confidence 999975332 233457899999999984 45679999999999999999999999854322211 1111111
Q ss_pred cCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 576 CEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 576 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
..... +.+ +......+.+++.+||+.||++|||+++|++.|..
T Consensus 244 ~~~~~-----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 244 EEGLR-----PTI----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HSCCC-----CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ccCCC-----CCC----CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 11111 111 11122457788889999999999999999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=364.29 Aligned_cols=250 Identities=24% Similarity=0.281 Sum_probs=193.8
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEeccc---CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
.++|++.++||+|+||.||++.+. +++.||||++... .......+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 367999999999999999999975 6899999999753 334456778999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE-DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
|||+++++|..++.. ...+++..+..++.||+.||.|||+ .| |+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999988854 3468999999999999999999998 76 9999999999999999999999999997533
Q ss_pred CCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccC
Q 005871 506 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585 (672)
Q Consensus 506 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 585 (672)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.. ...... .
T Consensus 301 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~---~i~~~~-~----- 366 (446)
T 4ejn_A 301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFE---LILMEE-I----- 366 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHHCC-C-----
T ss_pred CCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HHHHH---HHHhCC-C-----
Confidence 222 223346899999999999999999999999999999999999999853221 11111 111110 0
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVVML 625 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 625 (672)
.+.... ...+.+|+.+||+.||++|| +++|+++.-
T Consensus 367 -~~p~~~----~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp 406 (446)
T 4ejn_A 367 -RFPRTL----GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR 406 (446)
T ss_dssp -CCCTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred -CCCccC----CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence 001111 23467888899999999999 999999754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=342.31 Aligned_cols=263 Identities=22% Similarity=0.268 Sum_probs=199.2
Q ss_pred hcCCccc-cccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEEEEE
Q 005871 351 TNHFSDE-NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 351 ~~~~~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lV~ 427 (672)
.+.|.+. +.||+|+||.||++.+. +++.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3578885 78999999999999965 6899999999877666678899999999995 7999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC---eEEEeecCceee
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN---PKISDFGLARIF 504 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~---~kL~DFgla~~~ 504 (672)
||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++...
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999998543 45899999999999999999999997 999999999999998776 999999999865
Q ss_pred CCCCC-----CcccccccccCCcCChhhhcC-----CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccch-------
Q 005871 505 GGNQN-----QANTNIIAGTYGYMAPEYAMG-----GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTL------- 567 (672)
Q Consensus 505 ~~~~~-----~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~------- 567 (672)
..... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 42211 111223469999999999875 4578999999999999999999999865332211000
Q ss_pred -hhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 568 -LTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 568 -~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
..........+.. .. ....... ....+.+|+.+||+.||++|||+.|+++.-
T Consensus 245 ~~~~~~~~i~~~~~-~~-~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 297 (316)
T 2ac3_A 245 CQNMLFESIQEGKY-EF-PDKDWAH----ISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297 (316)
T ss_dssp HHHHHHHHHHHCCC-CC-CHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred HHHHHHHHHhccCc-cc-Cchhccc----CCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence 0000011111100 00 0000011 123577888899999999999999999854
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=341.28 Aligned_cols=254 Identities=23% Similarity=0.331 Sum_probs=192.5
Q ss_pred hcCCccccccccCCceeEEeeeecC----CceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l 425 (672)
.++|++.+.||+|+||.||+|.+.. +..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4689999999999999999998742 4569999987643 344567899999999999999999999985 467899
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
||||+++++|.+++... ...+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 99999999999998543 346899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 506 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 506 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
..... ......+++.|+|||++.+..++.++||||||+++|||++ |..||...... ...... . .+....
T Consensus 168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~~i---~-~~~~~~-- 237 (281)
T 1mp8_A 168 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRI---E-NGERLP-- 237 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHH---H-TTCCCC--
T ss_pred ccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHHHH---H-cCCCCC--
Confidence 43221 1223456788999999999999999999999999999997 88897543211 111111 1 111100
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
.+......+.+++.+||+.||++|||+.+|++.|..
T Consensus 238 -------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 273 (281)
T 1mp8_A 238 -------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 273 (281)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 111122457788889999999999999999999975
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=349.66 Aligned_cols=260 Identities=27% Similarity=0.427 Sum_probs=208.9
Q ss_pred HhcCCccccccccCCceeEEeeeec------CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCce
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 422 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~ 422 (672)
..++|.+.+.||+|+||.||+|.+. .++.||+|++.... ......+.+|+.++++++||||+++++++.+.+.
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 102 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 102 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCc
Confidence 4578999999999999999999864 36789999987543 3345678999999999999999999999999999
Q ss_pred EEEEEeecCCCChhHHhhhccc-------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 005871 423 LLLIYEYMPNKSLDVHLFDATR-------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 495 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL 495 (672)
.++||||+++++|.+++..... ...+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||
T Consensus 103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl 179 (322)
T 1p4o_A 103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 179 (322)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEE
Confidence 9999999999999999865321 145789999999999999999999998 999999999999999999999
Q ss_pred EeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhh
Q 005871 496 SDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKL 574 (672)
Q Consensus 496 ~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 574 (672)
+|||+++...............|++.|+|||++.+..++.++||||||+++|+|++ |+.||...... .... .
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~----~ 252 (322)
T 1p4o_A 180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QVLR----F 252 (322)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HHHH----H
T ss_pred CcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH---HHHH----H
Confidence 99999986544333233334467889999999999999999999999999999999 78887532111 1111 1
Q ss_pred ccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 575 WCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 575 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
...+..... .......+.+++.+||+.||++|||+.|+++.|...
T Consensus 253 ~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 253 VMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp HHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 111111111 111224477888899999999999999999999875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=348.81 Aligned_cols=257 Identities=27% Similarity=0.436 Sum_probs=197.4
Q ss_pred hcCCccccccccCCceeEEeeeec-CCcee----EEEEeccc-CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAI----AVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 424 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~v----avK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 424 (672)
.++|++.++||+|+||.||+|.+. +++.+ |+|.+... .....+.+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 468999999999999999999964 45554 66666543 3455678999999999999999999999998765 88
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceee
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 504 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~ 504 (672)
+|+||+.+++|.+++... ...+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999998643 345899999999999999999999998 999999999999999999999999999877
Q ss_pred CCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccc
Q 005871 505 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583 (672)
Q Consensus 505 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 583 (672)
.............||+.|+|||++.+..++.++||||||+++|||++ |+.||...... .+..... .+...
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~~~----~~~~~-- 238 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSILE----KGERL-- 238 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHH----TTCCC--
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHHH----cCCCC--
Confidence 55443333334567889999999999999999999999999999999 99998543221 1111111 11100
Q ss_pred cChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 005871 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDS 629 (672)
Q Consensus 584 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 629 (672)
..+......+.+++.+||+.||++|||+.||++.|....
T Consensus 239 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 239 -------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 011112335778888999999999999999999998753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=355.12 Aligned_cols=266 Identities=24% Similarity=0.289 Sum_probs=199.5
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHH-HHhccCCCeeeEEEEEEeCceEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNL-IAKLQHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~i-l~~l~h~niv~l~~~~~~~~~~~l 425 (672)
.++|++.+.||+|+||.||+++++ +++.||||++.+.. ......+..|..+ ++.++||||+++++++.+.+.+++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 367999999999999999999986 58899999997653 2234556777776 577899999999999999999999
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
||||+++|+|..++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++++||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999998854 345899999999999999999999998 9999999999999999999999999998643
Q ss_pred CCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccC
Q 005871 506 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585 (672)
Q Consensus 506 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 585 (672)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......... .. .
T Consensus 191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~-~~-~--- 257 (373)
T 2r5t_A 191 EHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILNK-PL-Q--- 257 (373)
T ss_dssp CCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------HHHHHHHHHS-CC-C---
T ss_pred cCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhc-cc-C---
Confidence 222 223456899999999999999999999999999999999999999853211 1111111111 10 0
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC------------CCCCCCCCCCccc
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD------------SMTIPQPTEPAFS 641 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~------------~~~l~~p~~p~~~ 641 (672)
+.... ...+.+|+.+||+.||.+||++.+.++.+..+ ...+++|-.|...
T Consensus 258 --~~~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p~~~ 319 (373)
T 2r5t_A 258 --LKPNI----TNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNVS 319 (373)
T ss_dssp --CCSSS----CHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCC
T ss_pred --CCCCC----CHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHHhCCCCCCCCCCCC
Confidence 01111 23467788899999999999985433333221 2345667677543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=340.60 Aligned_cols=271 Identities=25% Similarity=0.356 Sum_probs=202.6
Q ss_pred cchHHHHHHhcCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhc--cCCCeeeEEEEEEe
Q 005871 342 FPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL--QHKNLVRLLGCCLE 419 (672)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l--~h~niv~l~~~~~~ 419 (672)
.+........++|++.++||+|+||.||+|++. ++.||||++.... ...+..|.+++..+ +||||+++++++..
T Consensus 27 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp SCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred CCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 344455556689999999999999999999885 8999999986543 24455566666655 99999999999988
Q ss_pred C----ceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhc--------CCCCeeecCCCCCcEEE
Q 005871 420 G----QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED--------SRLKIIHRDLKASNILL 487 (672)
Q Consensus 420 ~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------g~~~iiHrDlkp~NIll 487 (672)
. ...++||||+++++|.+++.. ..+++..++.++.|++.||.|||+. + |+||||||+|||+
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill 175 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILV 175 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEE
T ss_pred CCCCCCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEE
Confidence 7 789999999999999999843 3589999999999999999999988 6 9999999999999
Q ss_pred cCCCCeEEEeecCceeeCCCCCCcc--cccccccCCcCChhhhcCCCCChh------hHHHHHHHHHHHHHcCCC-----
Q 005871 488 DDDMNPKISDFGLARIFGGNQNQAN--TNIIAGTYGYMAPEYAMGGIFSIK------SDVFSFGVLLLEIISGRK----- 554 (672)
Q Consensus 488 ~~~~~~kL~DFgla~~~~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~s~k------sDvwSlGvil~elltG~~----- 554 (672)
+.++.+||+|||+++.+........ .....||+.|+|||++.+...+.+ +|||||||++|||++|..
T Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~ 255 (337)
T 3mdy_A 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255 (337)
T ss_dssp CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence 9999999999999987654332211 224579999999999987766554 999999999999999944
Q ss_pred -----CCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 555 -----NNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 555 -----p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
||......... ..................... ........+.+|+.+||+.||++|||+.+|++.|...
T Consensus 256 ~~~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 256 EEYQLPYHDLVPSDPS--YEDMREIVCIKKLRPSFPNRW---SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp CCCCCTTTTTSCSSCC--HHHHHHHHTTSCCCCCCCGGG---GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccccHhhhcCCCCc--hhhhHHHHhhhccCccccccc---hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 43322111111 111111111111111111100 1124566788999999999999999999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=355.83 Aligned_cols=203 Identities=29% Similarity=0.473 Sum_probs=164.8
Q ss_pred HHhcCCccccccccCCceeEEeeeec-CCceeEEEEeccc--CcccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCc--e
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQ--E 422 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~--~ 422 (672)
...++|++.+.||+|+||.||+|.+. +++.||||++... .......+.+|+.+++.+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 45689999999999999999999975 6899999998653 3345567889999999997 999999999998544 7
Q ss_pred EEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCce
Q 005871 423 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 502 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~ 502 (672)
+++||||++ ++|..++.. ..+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 999999998 578877743 36899999999999999999999998 9999999999999999999999999998
Q ss_pred eeCCCCC-------------------CcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCC
Q 005871 503 IFGGNQN-------------------QANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFY 559 (672)
Q Consensus 503 ~~~~~~~-------------------~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~ 559 (672)
.+..... .......+||+.|+|||++.+ ..++.++|||||||++|||++|++||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 7643111 111233579999999999987 67899999999999999999999998643
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=349.34 Aligned_cols=259 Identities=22% Similarity=0.250 Sum_probs=191.2
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhcc-CCCeeeEEEEEE--------eC
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCL--------EG 420 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~--------~~ 420 (672)
..+|++.++||+|+||.||++++. +++.||||++........+.+.+|+.+++++. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 458999999999999999999975 68999999997777677788999999999996 999999999994 34
Q ss_pred ceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecC
Q 005871 421 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 500 (672)
Q Consensus 421 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgl 500 (672)
...++||||+. |+|.+++........+++..++.++.||+.||.|||+.+ .+|+||||||+||||+.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence 56899999996 688888866555567999999999999999999999874 2499999999999999999999999999
Q ss_pred ceeeCCCCCCc----------ccccccccCCcCChhhh---cCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccch
Q 005871 501 ARIFGGNQNQA----------NTNIIAGTYGYMAPEYA---MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTL 567 (672)
Q Consensus 501 a~~~~~~~~~~----------~~~~~~gt~~Y~aPE~~---~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~ 567 (672)
+.......... ......||+.|+|||++ .+..++.++||||||+++|+|++|+.||......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----- 259 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL----- 259 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-----
Confidence 98765432211 11134689999999998 5667899999999999999999999997532111
Q ss_pred hhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCC
Q 005871 568 LTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSM 630 (672)
Q Consensus 568 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 630 (672)
........ ....... ...+.+|+.+||+.||++|||+.|+++.|.....
T Consensus 260 -~~~~~~~~---------~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 260 -RIVNGKYS---------IPPHDTQ----YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp -------CC---------CCTTCCS----SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HhhcCccc---------CCccccc----chHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00000000 0000111 1236678889999999999999999999987643
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=348.90 Aligned_cols=251 Identities=14% Similarity=0.123 Sum_probs=202.1
Q ss_pred HhcCCccccccccCCceeEEeee------ecCCceeEEEEecccCcccHHHHHHHHHHHHhcc---CCCeeeEEEEEEeC
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGT------LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ---HKNLVRLLGCCLEG 420 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---h~niv~l~~~~~~~ 420 (672)
..++|.+.++||+|+||.||+|. ...++.||||++.... ...+..|+.++++++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 45789999999999999999994 3468999999997654 356778888888886 99999999999999
Q ss_pred ceEEEEEeecCCCChhHHhhhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---------
Q 005871 421 QELLLIYEYMPNKSLDVHLFDAT--RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD--------- 489 (672)
Q Consensus 421 ~~~~lV~Ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~--------- 489 (672)
+..++||||+++|+|.+++.... ....+++..+..|+.||+.||.|||+.+ |+||||||+||||+.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 99999999999999999996532 3456999999999999999999999997 999999999999998
Q ss_pred --CCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccch
Q 005871 490 --DMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTL 567 (672)
Q Consensus 490 --~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~ 567 (672)
++.+||+|||+++.+............+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~-- 292 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG--E-- 292 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT--E--
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC--c--
Confidence 8999999999998765433333445568999999999999999999999999999999999999997321110 0
Q ss_pred hhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHhcc
Q 005871 568 LTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADR-PTMSSVVVMLAS 627 (672)
Q Consensus 568 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R-Pt~~evl~~L~~ 627 (672)
+ .++..+...... ..+.+++..||+.+|.+| |+++++.+.|..
T Consensus 293 ----~----------~~~~~~~~~~~~---~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 293 ----C----------KPEGLFRRLPHL---DMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp ----E----------EECSCCTTCSSH---HHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred ----e----------eechhccccCcH---HHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 0 011111111122 335566679999999999 578887777754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=339.15 Aligned_cols=254 Identities=27% Similarity=0.382 Sum_probs=206.2
Q ss_pred cCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecC
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 431 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 431 (672)
++|++.+.||+|+||.||++.+.+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 57999999999999999999998888999999976543 34678999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCc
Q 005871 432 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 511 (672)
Q Consensus 432 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 511 (672)
+++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++........ .
T Consensus 87 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 160 (267)
T 3t9t_A 87 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T 160 (267)
T ss_dssp TCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred CCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-c
Confidence 99999998543 346899999999999999999999998 99999999999999999999999999986543211 1
Q ss_pred ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcC
Q 005871 512 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590 (672)
Q Consensus 512 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 590 (672)
......|++.|+|||++.+..++.++||||||+++|+|++ |+.||..... ........ .+... ..
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~i~-~~~~~-----~~-- 226 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVEDIS-TGFRL-----YK-- 226 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHH-TTCCC-----CC--
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH------HHHHHHHh-cCCcC-----CC--
Confidence 1223456788999999998999999999999999999999 8988753221 11111111 11000 00
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 591 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
+......+.+++.+||+.||++|||++++++.|...
T Consensus 227 --~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 227 --PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111123567788899999999999999999999753
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=336.38 Aligned_cols=263 Identities=22% Similarity=0.281 Sum_probs=201.1
Q ss_pred HHhcCCccccccccCCceeEEeeee-cCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEE-EeCceEEEE
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC-LEGQELLLI 426 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~-~~~~~~~lV 426 (672)
...++|++.+.||+|+||.||+|++ .+++.||||++...... ..+.+|+.+++.++|++++..+..+ .+.+..++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 3457899999999999999999997 46899999987654332 3578899999999988766665555 677889999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE---cCCCCeEEEeecCcee
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARI 503 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll---~~~~~~kL~DFgla~~ 503 (672)
|||+ +++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 84 ~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEcc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 9999 99999998532 345999999999999999999999998 9999999999999 7889999999999998
Q ss_pred eCCCCCCc-----ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCC
Q 005871 504 FGGNQNQA-----NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 578 (672)
Q Consensus 504 ~~~~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 578 (672)
........ ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 76543321 2234679999999999999999999999999999999999999986543322222221111110000
Q ss_pred CcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 579 PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 579 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
.. +.+.... ...+.+++.+||+.||++|||+++|++.|...
T Consensus 238 ~~-----~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 238 PI-----EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp CH-----HHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred hh-----hhhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 00 0011111 23577888899999999999999999999764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=345.58 Aligned_cols=261 Identities=29% Similarity=0.412 Sum_probs=207.8
Q ss_pred HhcCCccccccccCCceeEEeeee------cCCceeEEEEecccCc-ccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCc
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ 421 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~ 421 (672)
..++|.+.+.||+|+||.||+|.+ .+++.||||++..... ...+.+.+|+.+++++ +||||+++++++...+
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 104 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 104 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC
Confidence 457899999999999999999974 2468899999976543 3456789999999999 7999999999988754
Q ss_pred -eEEEEEeecCCCChhHHhhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE
Q 005871 422 -ELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 487 (672)
Q Consensus 422 -~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll 487 (672)
..++||||+++++|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~ 181 (316)
T 2xir_A 105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL 181 (316)
T ss_dssp SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEE
Confidence 58999999999999999965332 123889999999999999999999998 9999999999999
Q ss_pred cCCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccc
Q 005871 488 DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQT 566 (672)
Q Consensus 488 ~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~ 566 (672)
+.++.+||+|||+++.+.............||+.|+|||++.+..++.++||||||+++|+|++ |+.||...... ..
T Consensus 182 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~ 259 (316)
T 2xir_A 182 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EE 259 (316)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--HH
T ss_pred CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh--HH
Confidence 9999999999999987654443333444568899999999999999999999999999999998 99997532211 11
Q ss_pred hhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 567 LLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 567 ~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
. ......+..... +......+.+++.+||+.||++|||+.+|++.|...
T Consensus 260 ~----~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 260 F----CRRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp H----HHHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H----HHHhccCccCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 111111111000 111123577888899999999999999999999753
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=348.32 Aligned_cols=244 Identities=23% Similarity=0.333 Sum_probs=200.8
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCc--------ccHHHHHHHHHHHHhccCCCeeeEEEEEEeC
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG 420 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~h~niv~l~~~~~~~ 420 (672)
..++|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4578999999999999999999865 689999999876531 1234577899999999999999999999999
Q ss_pred ceEEEEEeecCCC-ChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeec
Q 005871 421 QELLLIYEYMPNK-SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 499 (672)
Q Consensus 421 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFg 499 (672)
+..++||||+.+| +|..++.. ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 89888843 345999999999999999999999998 9999999999999999999999999
Q ss_pred CceeeCCCCCCcccccccccCCcCChhhhcCCCC-ChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCC
Q 005871 500 LARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 578 (672)
Q Consensus 500 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 578 (672)
++........ .....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...... . .
T Consensus 176 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~-----~- 238 (335)
T 3dls_A 176 SAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------V-----E- 238 (335)
T ss_dssp TCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------T-----T-
T ss_pred cceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------H-----h-
Confidence 9987654322 233579999999999988876 89999999999999999999997431100 0 0
Q ss_pred CcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 579 PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 579 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
..... .... ...+.+|+.+||+.||++|||+++|++.-
T Consensus 239 ---~~~~~--~~~~----~~~l~~li~~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 239 ---AAIHP--PYLV----SKELMSLVSGLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp ---TCCCC--SSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred ---hccCC--Cccc----CHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 00000 0011 23467888899999999999999999863
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=340.81 Aligned_cols=261 Identities=22% Similarity=0.346 Sum_probs=197.7
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEeccc---CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
.++|++.+.||+|+||.||+|.+. +++.||||++... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 357999999999999999999974 6899999998753 234456789999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 427 YEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
|||+++++|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999998653 23456899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccC
Q 005871 506 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585 (672)
Q Consensus 506 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 585 (672)
.... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ....... ..........
T Consensus 188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~-~~~~~~~~~~- 259 (310)
T 2wqm_A 188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKK-IEQCDYPPLP- 259 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHHH-HHTTCSCCCC-
T ss_pred CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHHH-hhcccCCCCc-
Confidence 3322 122356899999999999999999999999999999999999997432111 1111111 1111111110
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDS 629 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 629 (672)
... ....+.+++.+||+.||++|||+++|++.|....
T Consensus 260 ---~~~----~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 260 ---SDH----YSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp ---TTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---ccc----cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 011 1234677888999999999999999999998763
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=335.15 Aligned_cols=262 Identities=22% Similarity=0.282 Sum_probs=204.9
Q ss_pred HhcCCccccccccCCceeEEeeee-cCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEE-EeCceEEEEE
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC-LEGQELLLIY 427 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~-~~~~~~~lV~ 427 (672)
..++|.+.+.||+|+||.||+|++ .+++.||||++...... +.+.+|+.+++.++|++++..+..+ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 357899999999999999999997 47899999998765432 4688999999999988766555554 6678899999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE---cCCCCeEEEeecCceee
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIF 504 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll---~~~~~~kL~DFgla~~~ 504 (672)
||+ +++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++...
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Eec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 999 99999998532 346999999999999999999999998 9999999999999 48899999999999987
Q ss_pred CCCCCCc-----ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCC
Q 005871 505 GGNQNQA-----NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGP 579 (672)
Q Consensus 505 ~~~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 579 (672)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 6543321 12345799999999999999999999999999999999999999865433222222211111100000
Q ss_pred cccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 580 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 580 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
. +.+.... ...+.+++.+||+.||++|||+++|++.|...
T Consensus 239 ~-----~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 239 I-----EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp H-----HHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred h-----HHHHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 0 0111112 23577888899999999999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=348.27 Aligned_cols=254 Identities=21% Similarity=0.296 Sum_probs=200.1
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEEEEE
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lV~ 427 (672)
..++|++.+.||+|+||.||++.++ +++.||||++.+.... ..+|++++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3567999999999999999999986 6899999999765432 35688888888 7999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC-C---CeEEEeecCcee
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-M---NPKISDFGLARI 503 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~-~---~~kL~DFgla~~ 503 (672)
||+++|+|.+.+.. ...+++..+..++.||+.||.|||++| |+||||||+|||+.++ + .+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 99999999998853 346999999999999999999999998 9999999999998543 3 499999999997
Q ss_pred eCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccc
Q 005871 504 FGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583 (672)
Q Consensus 504 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 583 (672)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..........+.... ..+... .
T Consensus 170 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i----~~~~~~-~ 242 (342)
T 2qr7_A 170 LRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI----GSGKFS-L 242 (342)
T ss_dssp CBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHH----HHCCCC-C
T ss_pred CcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHH----ccCCcc-c
Confidence 654322 223457899999999998888999999999999999999999998643221111111111 111110 0
Q ss_pred cChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 584 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
...........+.+|+.+||+.||++|||+.++++.-
T Consensus 243 -----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp 279 (342)
T 2qr7_A 243 -----SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP 279 (342)
T ss_dssp -----CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred -----CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence 0111112234577888899999999999999998753
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=336.92 Aligned_cols=253 Identities=23% Similarity=0.361 Sum_probs=198.0
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
.++|.+.++||+|+||.||++... ++..+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 467999999999999999999975 68899999987653 3456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE---cCCCCeEEEeecCceee
Q 005871 429 YMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIF 504 (672)
Q Consensus 429 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll---~~~~~~kL~DFgla~~~ 504 (672)
|+++++|.+.+... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++..+
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999888653 23456999999999999999999999998 9999999999999 45688999999999865
Q ss_pred CCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 505 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 505 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
..... .....|++.|+|||++. +.++.++||||||+++|+|++|+.||...... ...............
T Consensus 178 ~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~~~- 246 (285)
T 3is5_A 178 KSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE------EVQQKATYKEPNYAV- 246 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCCCC-
T ss_pred CCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH------HHHhhhccCCccccc-
Confidence 43322 23457899999999885 56899999999999999999999998543211 111111101000000
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
. .... ...+.+++.+||+.||++|||+.||++.
T Consensus 247 ~---~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 247 E---CRPL----TPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp -----CCC----CHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred c---cCcC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0111 2346688889999999999999999863
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=341.10 Aligned_cols=255 Identities=33% Similarity=0.482 Sum_probs=205.0
Q ss_pred hcCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
.++|++.+.||+|+||.||+|.+.++..||+|++.... ...+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 36799999999999999999998888899999987654 345788999999999999999999999864 5689999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
++++|.+++... ....+++..+..++.||+.||.|||++| |+||||||+||+++.++.+||+|||++.........
T Consensus 90 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 999999998542 1235899999999999999999999998 999999999999999999999999999876543221
Q ss_pred cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhc
Q 005871 511 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 589 (672)
......+++.|+|||++.++.++.++||||||+++|||++ |+.||...... ...... ..+.. ...
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~----~~~~~-----~~~- 231 (279)
T 1qpc_A 166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQNL----ERGYR-----MVR- 231 (279)
T ss_dssp -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHH----HTTCC-----CCC-
T ss_pred -cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHHHHH----hcccC-----CCC-
Confidence 1223456788999999998899999999999999999999 88887532211 111111 11100 000
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 590 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
+......+.+++.+||+.||++|||+++|++.|+..
T Consensus 232 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 232 ---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 111224577888899999999999999999999764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=359.57 Aligned_cols=260 Identities=25% Similarity=0.271 Sum_probs=195.4
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeC------c
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------Q 421 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~------~ 421 (672)
.++|++.++||+|+||.||++.+. +++.||||++... .....+.+.+|+.+|+.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 478999999999999999999875 6899999999764 334467788999999999999999999999754 4
Q ss_pred eEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCc
Q 005871 422 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 501 (672)
Q Consensus 422 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla 501 (672)
..++||||++++ |...+. ..+++..+..++.||+.||.|||+.| |+||||||+||||+.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 679999999876 444442 23899999999999999999999998 999999999999999999999999999
Q ss_pred eeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhh-------
Q 005871 502 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL------- 574 (672)
Q Consensus 502 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~------- 574 (672)
+...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .......
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~---~~~i~~~lg~p~~~ 285 (464)
T 3ttj_A 212 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ---WNKVIEQLGTPCPE 285 (464)
T ss_dssp -----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCSCCHH
T ss_pred eecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCHH
Confidence 8764322 22345799999999999999999999999999999999999999864321110 0000000
Q ss_pred ------------ccC------CCcccccChhhcCCCC---HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 575 ------------WCE------GPAVELIDPVLKQSCA---PDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 575 ------------~~~------~~~~~l~d~~l~~~~~---~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
... ....+.+...+..... ......+.+|+.+||+.||++|||++|+++.-
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 357 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence 000 0000111110000000 11245688999999999999999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=346.77 Aligned_cols=266 Identities=24% Similarity=0.355 Sum_probs=199.0
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
.++|++.+.||+|+||.||++++. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 368999999999999999999986 589999999865433 23456789999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+++++|..++.. ...+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++..+...
T Consensus 104 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 99999999887632 345999999999999999999999998 999999999999999999999999999865433
Q ss_pred CCCcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhh--------hhhh-----
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLT--------YTWK----- 573 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~--------~~~~----- 573 (672)
.. ......|++.|+|||++.+. .++.++||||||+++|+|++|+.||............. ..+.
T Consensus 178 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 178 GE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred cc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 22 12235689999999999875 78999999999999999999999986433211100000 0000
Q ss_pred -hccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 574 -LWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 574 -~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.+......++..........+.....+.+|+.+||+.||++|||++||++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 001111111111000000011223467888899999999999999999863
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=363.74 Aligned_cols=255 Identities=28% Similarity=0.355 Sum_probs=206.1
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
.++|.+.+.||+|+||.||++++. +|+.||+|++.+.. ......+.+|+.+|+.++||||+++++++.+.+.+++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999986 69999999996542 33456788999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||+++|+|..++.... ...+++..+..++.||+.||.|||++| |+||||||+||||+.++++||+|||+++.+..
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999885432 335999999999999999999999998 99999999999999999999999999987653
Q ss_pred CCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......... . .........
T Consensus 339 ~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~--~-i~~~i~~~~------- 405 (576)
T 2acx_A 339 GQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE--E-VERLVKEVP------- 405 (576)
T ss_dssp TCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH--H-HHHHHHHCC-------
T ss_pred Ccc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH--H-HHHHhhccc-------
Confidence 321 233589999999999999999999999999999999999999986432211111 1 111110000
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVVML 625 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 625 (672)
...+......+.+|+.+||+.||++|| +++||++.-
T Consensus 406 ---~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hp 446 (576)
T 2acx_A 406 ---EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHP 446 (576)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSG
T ss_pred ---ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhCh
Confidence 001111224577888899999999999 789998754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=345.08 Aligned_cols=272 Identities=22% Similarity=0.305 Sum_probs=201.3
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEe--------
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE-------- 419 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~-------- 419 (672)
.++|++.++||+|+||.||+|++. +++.||||++.... ......+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 368999999999999999999984 68999999986543 2334678899999999999999999999987
Q ss_pred CceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeec
Q 005871 420 GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 499 (672)
Q Consensus 420 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFg 499 (672)
.+..++||||+++ +|...+.. ....+++.++..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 3468999999986 56555543 2345999999999999999999999998 9999999999999999999999999
Q ss_pred CceeeCCCCCC--cccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhcc
Q 005871 500 LARIFGGNQNQ--ANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWC 576 (672)
Q Consensus 500 la~~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 576 (672)
+++.+...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....................
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 99876533222 22334578999999999876 4589999999999999999999999864322111111100000000
Q ss_pred CCCccc--------ccChhhcCCCC-HHH------HHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 577 EGPAVE--------LIDPVLKQSCA-PDE------LLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 577 ~~~~~~--------l~d~~l~~~~~-~~~------~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
...+.. .+......... ... ...+.+|+.+||+.||++|||++|+++.--..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 316 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 316 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcC
Confidence 000000 00000000000 111 23477899999999999999999999765443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=342.77 Aligned_cols=268 Identities=20% Similarity=0.230 Sum_probs=207.5
Q ss_pred chHHHHHHhcCCccc-cccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhc-cCCCeeeEEEEE
Q 005871 343 PLRLALEATNHFSDE-NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKL-QHKNLVRLLGCC 417 (672)
Q Consensus 343 ~~~~~~~~~~~~~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l-~h~niv~l~~~~ 417 (672)
.+.......++|.+. +.||+|+||.||++.+. +++.||+|++.... ......+.+|+.+++++ +||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 344455666788887 89999999999999976 68999999987543 34467889999999999 469999999999
Q ss_pred EeCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---CCCeE
Q 005871 418 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPK 494 (672)
Q Consensus 418 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~---~~~~k 494 (672)
.+.+..++||||+++++|.+++... ....+++..++.++.||+.||.|||+.| |+||||||+|||++. ++.+|
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEE
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEE
Confidence 9999999999999999999888432 2356999999999999999999999998 999999999999997 78999
Q ss_pred EEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhh
Q 005871 495 ISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL 574 (672)
Q Consensus 495 L~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 574 (672)
|+|||+++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ........
T Consensus 175 L~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~ 248 (327)
T 3lm5_A 175 IVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE---TYLNISQV 248 (327)
T ss_dssp ECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHT
T ss_pred EeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH---HHHHHHhc
Confidence 999999987653322 233579999999999999999999999999999999999999985332111 11111110
Q ss_pred ccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCC
Q 005871 575 WCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSM 630 (672)
Q Consensus 575 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 630 (672)
...... .........+.+++.+||+.||++|||++++++.--....
T Consensus 249 -~~~~~~---------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 249 -NVDYSE---------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp -CCCCCT---------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred -ccccCc---------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 000000 0011122446788889999999999999999987544433
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=339.90 Aligned_cols=272 Identities=24% Similarity=0.303 Sum_probs=211.1
Q ss_pred ccchHHHHHHhcCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHh--ccCCCeeeEEEEEE
Q 005871 341 LFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK--LQHKNLVRLLGCCL 418 (672)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~h~niv~l~~~~~ 418 (672)
..++.......++|.+.+.||+|+||.||++++ +++.||||++... ....+.+|.+++.. ++||||+++++++.
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 456666677788999999999999999999998 4899999998654 34667889999988 79999999999998
Q ss_pred eCc----eEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeecCCCCCcEE
Q 005871 419 EGQ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH--------EDSRLKIIHRDLKASNIL 486 (672)
Q Consensus 419 ~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~g~~~iiHrDlkp~NIl 486 (672)
... ..++||||+++++|.+++.. ..+++..++.++.||+.||.||| +.+ |+||||||+|||
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIl 179 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNIL 179 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEE
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEE
Confidence 876 89999999999999999953 35899999999999999999999 666 999999999999
Q ss_pred EcCCCCeEEEeecCceeeCCCCCCc--ccccccccCCcCChhhhcCCC------CChhhHHHHHHHHHHHHHcC------
Q 005871 487 LDDDMNPKISDFGLARIFGGNQNQA--NTNIIAGTYGYMAPEYAMGGI------FSIKSDVFSFGVLLLEIISG------ 552 (672)
Q Consensus 487 l~~~~~~kL~DFgla~~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~------~s~ksDvwSlGvil~elltG------ 552 (672)
|+.++.+||+|||++.......... ......||+.|+|||++.+.. ++.++||||||+++|||++|
T Consensus 180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 259 (342)
T 1b6c_B 180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259 (342)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence 9999999999999998775443221 223457999999999997763 34799999999999999999
Q ss_pred ----CCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 553 ----RKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 553 ----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
+.||........ . ................+.... ........+.+|+.+||+.||++|||+.+|++.|...
T Consensus 260 ~~~~~~p~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 260 HEDYQLPYYDLVPSDP-S-VEEMRKVVCEQKLRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp CCCCCCTTTTTSCSSC-C-HHHHHHHHTTSCCCCCCCGGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccccCccccCcCcc-c-HHHHHHHHHHHHhCCCCcccc---cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 555533221111 1 111111111111111111100 1234566788999999999999999999999999764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=351.30 Aligned_cols=264 Identities=27% Similarity=0.422 Sum_probs=206.7
Q ss_pred hcCCccccccccCCceeEEeeee-----cCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCc--eE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ--EL 423 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~--~~ 423 (672)
.++|++.+.||+|+||.||++++ .+++.||||++........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 36799999999999999999983 358899999998877677788999999999999999999999987654 78
Q ss_pred EEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 424 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999998643 245899999999999999999999997 99999999999999999999999999998
Q ss_pred eCCCCCCc-ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCccc---------ccchhhhhhh
Q 005871 504 FGGNQNQA-NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH---------GQTLLTYTWK 573 (672)
Q Consensus 504 ~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~---------~~~~~~~~~~ 573 (672)
........ ......++..|+|||.+.+..++.++||||||+++|||++|..|+....... ..........
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 75433211 1223456778999999998889999999999999999999998864221000 0000000001
Q ss_pred hccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 574 LWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 574 ~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
....+.. ...+......+.+++.+||+.||++|||+.+|++.|+..
T Consensus 275 ~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 275 LLKNNGR---------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHTTCC---------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HhhcCCC---------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111100 011112234577888899999999999999999999753
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=335.40 Aligned_cols=255 Identities=26% Similarity=0.408 Sum_probs=200.2
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
++|.....||+|+||.||+|.+. +++.||||++........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34555668999999999999975 68899999998776666788999999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-CCCeEEEeecCceeeCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~-~~~~kL~DFgla~~~~~~~~ 509 (672)
++++|.+++........+++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||++........
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 99999999976544556789999999999999999999997 999999999999987 89999999999987643221
Q ss_pred CcccccccccCCcCChhhhcCCC--CChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChh
Q 005871 510 QANTNIIAGTYGYMAPEYAMGGI--FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 587 (672)
......|++.|+|||++.++. ++.++||||||+++|+|++|+.||....... .......... ..+.
T Consensus 179 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~-------~~~~ 246 (295)
T 2clq_A 179 --CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ---AAMFKVGMFK-------VHPE 246 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH---HHHHHHHHHC-------CCCC
T ss_pred --cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh---HHHHhhcccc-------cccc
Confidence 123457899999999997654 8999999999999999999999974221110 0000000000 0011
Q ss_pred hcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 588 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 588 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
+ +......+.+++.+||+.||++|||+.++++.-
T Consensus 247 ~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~ 280 (295)
T 2clq_A 247 I----PESMSAEAKAFILKCFEPDPDKRACANDLLVDE 280 (295)
T ss_dssp C----CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSG
T ss_pred c----cccCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 1 111224567888899999999999999998643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=345.43 Aligned_cols=260 Identities=29% Similarity=0.449 Sum_probs=195.6
Q ss_pred HhcCCccccccccCCceeEEeeeec----CCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCc--
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-- 421 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~-- 421 (672)
..++|.+.+.||+|+||.||+|.+. .+..||+|++... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 3578999999999999999999864 2458999998754 3344577899999999999999999999998755
Q ss_pred ---eEEEEEeecCCCChhHHhhhc---cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 005871 422 ---ELLLIYEYMPNKSLDVHLFDA---TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 495 (672)
Q Consensus 422 ---~~~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL 495 (672)
..++||||+++++|..++... .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence 359999999999999998542 23356999999999999999999999997 999999999999999999999
Q ss_pred EeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhh
Q 005871 496 SDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKL 574 (672)
Q Consensus 496 ~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 574 (672)
+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... ..... .
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~---~ 262 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EMYDY---L 262 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHH---H
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHHH---H
Confidence 99999987654433333334567889999999999999999999999999999999 88887533211 11111 1
Q ss_pred ccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 575 WCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 575 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
. .+..... ... ....+.+++.+||+.||++|||+.+|++.|...
T Consensus 263 ~-~~~~~~~-----~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 263 L-HGHRLKQ-----PED----CLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp H-TTCCCCC-----BTT----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred H-cCCCCCC-----Ccc----ccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 1111110 111 224577888899999999999999999999865
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=346.91 Aligned_cols=266 Identities=24% Similarity=0.299 Sum_probs=192.9
Q ss_pred HHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEE
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l 425 (672)
...++|++.++||+|+||.||++.+. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 44578999999999999999999875 689999999975432 234567899999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc-----CCCCeEEEeecC
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-----DDMNPKISDFGL 500 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~-----~~~~~kL~DFgl 500 (672)
||||+++ +|.+++.. ...+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 111 v~e~~~~-~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCSE-EHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCCC-CHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999985 88888843 335899999999999999999999998 99999999999994 455599999999
Q ss_pred ceeeCCCCCCcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhh--ccC
Q 005871 501 ARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL--WCE 577 (672)
Q Consensus 501 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~--~~~ 577 (672)
++.+..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ +....... ...
T Consensus 184 a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 184 ARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ--LFKIFEVLGLPDD 259 (329)
T ss_dssp HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCT
T ss_pred ccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH--HHHHHHHhCCCch
Confidence 987643322 22334689999999999875 489999999999999999999999854322111 11100000 000
Q ss_pred CC-------------cccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 578 GP-------------AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 578 ~~-------------~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
.. ..+.....+...........+.+|+.+||+.||++|||++|+++.-
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 320 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHP 320 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCc
Confidence 00 0000000000000011224577888999999999999999999743
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=335.73 Aligned_cols=249 Identities=26% Similarity=0.376 Sum_probs=200.1
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEE
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l 425 (672)
..++|++.+.||+|+||.||++.+. ++..||+|++.... ......+.+|+.++++++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3478999999999999999999876 57899999986532 2335678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
||||+++++|.+++... ..+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999999999988543 45899999999999999999999997 9999999999999999999999999986543
Q ss_pred CCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccC
Q 005871 506 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585 (672)
Q Consensus 506 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 585 (672)
.. ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... ....... ....
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~--~~~~------ 225 (279)
T 3fdn_A 161 SS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TYKRISR--VEFT------ 225 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHH--TCCC------
T ss_pred cc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH---HHHHHHh--CCCC------
Confidence 22 1233578999999999999999999999999999999999999975322111 1110000 0000
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
.+......+.+++.+||+.||++|||++||++.-
T Consensus 226 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 226 ------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp ------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred ------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 1111223467788899999999999999999764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=338.35 Aligned_cols=255 Identities=26% Similarity=0.447 Sum_probs=204.5
Q ss_pred cCCcccc-ccccCCceeEEeeeec---CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 352 NHFSDEN-KLGQGGFGPVYKGTLA---DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 352 ~~~~~~~-~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
++|.+.+ .||+|+||.||+|.+. ++..||+|++.... ....+.+.+|+.++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4566666 9999999999999853 57789999997653 34567899999999999999999999999 55679999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999853 3346999999999999999999999998 99999999999999999999999999998754
Q ss_pred CCCC-cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 507 NQNQ-ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 507 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
.... .......||+.|+|||++.+..++.++||||||+++|||++ |+.||..... ....... ..+....
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~i----~~~~~~~-- 233 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFI----EQGKRME-- 233 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHHH----HTTCCCC--
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHH----hcCCcCC--
Confidence 3322 11223456889999999998889999999999999999998 9999754321 1111111 1111111
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
.+......+.+++.+||+.||++||++.+|++.|...
T Consensus 234 -------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 234 -------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp -------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1112234577888899999999999999999999875
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=359.68 Aligned_cols=256 Identities=28% Similarity=0.382 Sum_probs=205.9
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
.++|.+.+.||+|+||.||+++++ +|+.||+|++.+.. ....+.+.+|+.+|++++||||+++++++.+.+.+++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367999999999999999999986 69999999997542 23457789999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 427 YEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
|||++||+|..++..... ...+++..+..++.||+.||.|||++| |+||||||+||||+.+|++||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999865432 346999999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccC
Q 005871 506 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585 (672)
Q Consensus 506 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 585 (672)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ........... ..
T Consensus 341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i~~~-~~----- 410 (543)
T 3c4z_A 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRVLEQ-AV----- 410 (543)
T ss_dssp TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHHHHC-CC-----
T ss_pred CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHHhhc-cc-----
Confidence 4322 22345899999999999999999999999999999999999999864322111 11111111111 00
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTM-----SSVVVM 624 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~ 624 (672)
..+......+.+|+.+||+.||++||++ ++|++.
T Consensus 411 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 411 -----TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred -----CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 0111122456778889999999999975 677653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=345.36 Aligned_cols=270 Identities=23% Similarity=0.323 Sum_probs=199.0
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcc-----cHHHHHHHHHHHHhccCCCeeeEEEEEEeCceE
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ-----GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 423 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 423 (672)
..++|.+.+.||+|+||.||+|.+. +|+.||||++...... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3578999999999999999999986 5899999998753221 134678999999999999999999999999999
Q ss_pred EEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 424 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
++||||+++ +|..++.. ....+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+++.
T Consensus 88 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 999999986 77777743 2346889999999999999999999998 99999999999999999999999999987
Q ss_pred eCCCCCCcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccC---CC
Q 005871 504 FGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCE---GP 579 (672)
Q Consensus 504 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 579 (672)
+..... ......||+.|+|||++.+. .++.++||||||+++|||++|.+||...... ............ ..
T Consensus 162 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~---~~~~~i~~~~~~~~~~~ 236 (346)
T 1ua2_A 162 FGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL---DQLTRIFETLGTPTEEQ 236 (346)
T ss_dssp TTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCTTT
T ss_pred ccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHHcCCCChhh
Confidence 643322 22335789999999999764 5899999999999999999999987543211 111111111100 01
Q ss_pred ccccc---Chhhc---CCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCC
Q 005871 580 AVELI---DPVLK---QSCA-----PDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSM 630 (672)
Q Consensus 580 ~~~l~---d~~l~---~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 630 (672)
+.... +.... ...+ ......+.+|+.+||+.||++|||++|+++.--..+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 11000 00000 0000 1122467888889999999999999999988755443
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=356.98 Aligned_cols=196 Identities=24% Similarity=0.416 Sum_probs=155.5
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeC-----ce
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QE 422 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~ 422 (672)
.++|++.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+.+|++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999876 6899999998754 334457789999999999999999999999543 57
Q ss_pred EEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCce
Q 005871 423 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 502 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~ 502 (672)
+++||||+. ++|..++. ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeccc-cchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 999999985 67887773 3456999999999999999999999998 9999999999999999999999999998
Q ss_pred eeCCCCCC-------------------------cccccccccCCcCChhhh-cCCCCChhhHHHHHHHHHHHHHcCC
Q 005871 503 IFGGNQNQ-------------------------ANTNIIAGTYGYMAPEYA-MGGIFSIKSDVFSFGVLLLEIISGR 553 (672)
Q Consensus 503 ~~~~~~~~-------------------------~~~~~~~gt~~Y~aPE~~-~~~~~s~ksDvwSlGvil~elltG~ 553 (672)
........ ......+||+.|+|||++ .+..++.++|||||||++|||++|.
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~ 281 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence 76432211 112345789999999986 4567999999999999999999943
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=347.29 Aligned_cols=263 Identities=23% Similarity=0.350 Sum_probs=194.1
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCccc-HHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQG-LQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
++|.+.++||+|+||.||+|.+. +++.||+|++....... ...+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999986 68999999987543221 12455799999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+++ +|.+++... ...+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 82 LDK-DLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred ccc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 985 787777543 345899999999999999999999998 99999999999999999999999999986543221
Q ss_pred CcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhcc---CCCcccccC
Q 005871 510 QANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWC---EGPAVELID 585 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~d 585 (672)
......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....... .......... ...+.....
T Consensus 156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 156 --TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGG
T ss_pred --ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhchhhhc
Confidence 2223468999999999877 568999999999999999999999986433211 1111111111 111111100
Q ss_pred hh---------hcCC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 586 PV---------LKQS----CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 586 ~~---------l~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
.. .... ..+.....+.+|+.+||+.||++|||++|+++.-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 283 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP 283 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcCh
Confidence 00 0000 0011124567888899999999999999999854
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=335.23 Aligned_cols=247 Identities=25% Similarity=0.359 Sum_probs=199.0
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEEE
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~l 425 (672)
..++|++.+.||+|+||.||++.+. +++.||+|++.... ......+.+|+.++..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3568999999999999999999986 79999999987642 33456788999999999 99999999999999999999
Q ss_pred EEeecCCCChhHHhhhccc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC--------------
Q 005871 426 IYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-------------- 490 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~-------------- 490 (672)
||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999965422 256899999999999999999999998 9999999999999844
Q ss_pred -----CCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccc
Q 005871 491 -----MNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHG 564 (672)
Q Consensus 491 -----~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~ 564 (672)
..+||+|||++....... ...||+.|+|||++.+. .++.++||||||+++|+|++|.+++...
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----- 234 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----- 234 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-----
T ss_pred ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-----
Confidence 479999999998764322 23589999999999876 5678999999999999999998874311
Q ss_pred cchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 565 QTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.. +.....+....+ .... ...+.+++.+||+.||++|||+.++++.
T Consensus 235 ~~-----~~~~~~~~~~~~-----~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 235 DQ-----WHEIRQGRLPRI-----PQVL----SQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HH-----HHHHHTTCCCCC-----SSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred hH-----HHHHHcCCCCCC-----Cccc----CHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 11 111111111111 1112 2346788889999999999999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=346.79 Aligned_cols=258 Identities=24% Similarity=0.312 Sum_probs=204.0
Q ss_pred hcCCccccccccCCceeEEeeee----cCCceeEEEEecccC----cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCc
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTL----ADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ 421 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~ 421 (672)
.++|++.+.||+|+||.||+++. .+++.||||++.... ....+.+.+|+.+++++ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36899999999999999999987 368999999987542 23345677899999999 6999999999999999
Q ss_pred eEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCc
Q 005871 422 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 501 (672)
Q Consensus 422 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla 501 (672)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 999999999999999998543 45899999999999999999999997 999999999999999999999999999
Q ss_pred eeeCCCCCCcccccccccCCcCChhhhcCC--CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCC
Q 005871 502 RIFGGNQNQANTNIIAGTYGYMAPEYAMGG--IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGP 579 (672)
Q Consensus 502 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 579 (672)
+.+..... .......||+.|+|||++.++ .++.++|||||||++|||++|+.||........ ............
T Consensus 207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~- 282 (355)
T 1vzo_A 207 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSE- 282 (355)
T ss_dssp EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHHCC-
T ss_pred eecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhccC-
Confidence 87643222 122345799999999999863 478999999999999999999999854322111 111111111110
Q ss_pred cccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhccC
Q 005871 580 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVVMLASD 628 (672)
Q Consensus 580 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L~~~ 628 (672)
...+......+.+|+.+||+.||++|| |++|+++..-..
T Consensus 283 ----------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~ 326 (355)
T 1vzo_A 283 ----------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 326 (355)
T ss_dssp ----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred ----------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchh
Confidence 011112224567888899999999999 999999887554
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=343.07 Aligned_cols=250 Identities=22% Similarity=0.336 Sum_probs=204.3
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEeccc---CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
.++|.+.+.||+|+||.||++.+. +++.+|+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 367999999999999999999986 5788999998754 234457789999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||+++++|.+++.. ...+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 120 ~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 999999999998854 346899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ....... ....
T Consensus 194 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~-~~~~------ 258 (335)
T 2owb_A 194 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRIK-KNEY------ 258 (335)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHH-HTCC------
T ss_pred Ccc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH------HHHHHHh-cCCC------
Confidence 322 223457999999999999999999999999999999999999998532211 1111110 0000
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
.+.... ...+.+|+.+||+.||++|||++|+++.-
T Consensus 259 ~~~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~~~ 293 (335)
T 2owb_A 259 SIPKHI----NPVAASLIQKMLQTDPTARPTINELLNDE 293 (335)
T ss_dssp CCCTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred CCCccC----CHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 001111 23466788899999999999999999853
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=334.02 Aligned_cols=249 Identities=28% Similarity=0.431 Sum_probs=182.4
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
.++|.+.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 367999999999999999999974 68999999986542 23357789999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 9999999999998542 346899999999999999999999997 99999999999999999999999999987653
Q ss_pred CCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
.... .....|++.|+|||++.+..++.++||||||+++|+|++|+.||........ . .... .. +.
T Consensus 165 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~---~~~~-~~------~~ 229 (278)
T 3cok_A 165 PHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT---L---NKVV-LA------DY 229 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CC-SS------CC
T ss_pred CCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH---H---HHHh-hc------cc
Confidence 3221 2235689999999999998899999999999999999999999854321110 0 0000 00 00
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
.. +......+.+++.+||+.||++|||+++|++
T Consensus 230 ~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 EM----PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CC----ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 01 1111235678888999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=338.28 Aligned_cols=256 Identities=29% Similarity=0.357 Sum_probs=200.6
Q ss_pred CCccccccccCCceeEEeeeecC----CceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceE-EEE
Q 005871 353 HFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL-LLI 426 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~-~lV 426 (672)
.|.+.++||+|+||.||+|.+.+ +..+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 56677999999999999998642 2379999987643 34567889999999999999999999999876655 999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||+.+++|.+++.. ....+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999854 2356899999999999999999999998 99999999999999999999999999986543
Q ss_pred CC--CCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 507 NQ--NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 507 ~~--~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
.. .........|++.|+|||.+.+..++.++||||||+++|+|++|..|+..... ......... .+....
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~----~~~~~~-- 248 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID--PFDLTHFLA----QGRRLP-- 248 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--GGGHHHHHH----TTCCCC--
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC--HHHHHHHhh----cCCCCC--
Confidence 22 11222345678999999999999999999999999999999996665321111 111111111 111000
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
.+......+.+++.+||+.||++|||++++++.|...
T Consensus 249 -------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 249 -------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0111123577888899999999999999999999875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=339.06 Aligned_cols=257 Identities=29% Similarity=0.407 Sum_probs=199.2
Q ss_pred hcCCccccccccCCceeEEeeeecC----CceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEE-eCceEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCL-EGQELL 424 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~-~~~~~~ 424 (672)
..+|++.++||+|+||.||+|.+.+ ...+|+|.+.... ....+.+.+|+.++++++||||+++++++. .++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3578999999999999999998642 2358999887643 345578899999999999999999999865 456789
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceee
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 504 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~ 504 (672)
+||||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999954 3346899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCC--cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCC-CCCCCCCcccccchhhhhhhhccCCCcc
Q 005871 505 GGNQNQ--ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR-KNNGFYFSEHGQTLLTYTWKLWCEGPAV 581 (672)
Q Consensus 505 ~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (672)
...... .......||+.|+|||.+.+..++.++||||||+++|+|++|. +|+..... ........ .+...
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---~~~~~~~~----~~~~~ 251 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVYLL----QGRRL 251 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT---TTHHHHHH----TTCCC
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH---HHHHHHHh----cCCCC
Confidence 543221 1222346788999999999999999999999999999999954 44432211 11111111 11100
Q ss_pred cccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 582 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 582 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
. ..... ...+.+++.+||+.||++|||+++|++.|...
T Consensus 252 -~----~~~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 252 -L----QPEYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp -C----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -C----CCccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 00111 23477888899999999999999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=334.83 Aligned_cols=252 Identities=23% Similarity=0.324 Sum_probs=201.6
Q ss_pred cCCccccccccCCceeEEeeeecCCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeC--ceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~lV~ 427 (672)
++|.+.+.||+|+||.||+|+++ ++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 67999999999999999999985 8899999987653 34456799999999999999999999999887 7889999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+++++|.+++... ....+++..++.++.||+.||.|||+.+ ..|+||||||+|||++.++.++|.|||+......
T Consensus 89 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS- 165 (271)
T ss_dssp ECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred cccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence 999999999999642 2335899999999999999999999874 3499999999999999999999999988754221
Q ss_pred CCCcccccccccCCcCChhhhcCCCC---ChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGGIF---SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~~~---s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
....||+.|+|||++.+..+ +.++||||||+++|||++|+.||...... .........+....
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~-- 231 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------EIGMKVALEGLRPT-- 231 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH------HHHHHHHHSCCCCC--
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH------HHHHHHHhcCCCCC--
Confidence 22468999999999987654 44899999999999999999998532211 11111111111111
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
+... ....+.+++.+||+.||++|||++++++.|...
T Consensus 232 ---~~~~----~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 232 ---IPPG----ISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp ---CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 1111 223477888899999999999999999999764
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=334.68 Aligned_cols=250 Identities=22% Similarity=0.336 Sum_probs=204.6
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
.++|.+.+.||+|+||.||++.+. +++.+|+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 468999999999999999999986 57889999986542 34456789999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 999999999998743 346899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ...... ..... .
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~-~~~~~-~---- 233 (294)
T 2rku_A 168 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRI-KKNEY-S---- 233 (294)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHH-HTTCC-C----
T ss_pred Ccc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHH-hhccC-C----
Confidence 222 223457899999999999989999999999999999999999998533211 111111 11110 0
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
+.... ...+.+++.+||+.||++|||++++++.-
T Consensus 234 -~~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 234 -IPKHI----NPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp -CCTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred -Ccccc----CHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 01111 23467788899999999999999999864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=344.12 Aligned_cols=257 Identities=28% Similarity=0.453 Sum_probs=198.7
Q ss_pred hcCCccccccccCCceeEEeeeecC-----CceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLAD-----GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 424 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 424 (672)
.++|.+.+.||+|+||.||+|.+.. +..||||++.... ......+.+|+.++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3578889999999999999998653 2359999987643 334567899999999999999999999999999999
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceee
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 504 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~ 504 (672)
+||||+++++|.+++... ...+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 999999999999998542 346899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCCc-ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCccc
Q 005871 505 GGNQNQA-NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVE 582 (672)
Q Consensus 505 ~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (672)
....... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ..... ....+....
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~~----~~~~~~~~~ 270 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMK----AINDGFRLP 270 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHH----HHHTTCCCC
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---HHHHH----HHHCCCcCC
Confidence 5432211 1222346788999999999999999999999999999999 9999743221 11111 111110000
Q ss_pred ccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 583 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 583 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
.+......+.+++.+||+.||++||++.+|++.|...
T Consensus 271 ---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 271 ---------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp ---------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0111234577888899999999999999999999764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=329.28 Aligned_cols=252 Identities=24% Similarity=0.293 Sum_probs=201.0
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCc------ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 423 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 423 (672)
.++|.+.+.||+|+||.||++.+. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357999999999999999999986 689999999875431 2367899999999999999999999999999999
Q ss_pred EEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC----CeEEEeec
Q 005871 424 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM----NPKISDFG 499 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~----~~kL~DFg 499 (672)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999854 346899999999999999999999998 99999999999999877 89999999
Q ss_pred CceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCC
Q 005871 500 LARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGP 579 (672)
Q Consensus 500 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 579 (672)
++........ .....|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ... .. .....
T Consensus 158 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~---~~-~~~~~ 227 (283)
T 3bhy_A 158 IAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ---ETL---TN-ISAVN 227 (283)
T ss_dssp TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHH---HH-HHTTC
T ss_pred cceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH---HHH---HH-hHhcc
Confidence 9987643322 23356899999999999999999999999999999999999997532211 111 11 11110
Q ss_pred cccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 580 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 580 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
. .......... ...+.+++.+||+.||++|||+.++++.
T Consensus 228 ~--~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 228 Y--DFDEEYFSNT----SELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp C--CCCHHHHTTC----CHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred c--CCcchhcccC----CHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 0 0111111111 2346788889999999999999999973
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=333.15 Aligned_cols=247 Identities=23% Similarity=0.339 Sum_probs=202.6
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
.++|++.+.||+|+||.||++.+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 368999999999999999999976 57889999986532 23356789999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||+++++|.+++... ..+++..+..++.||+.||.|||+.| |+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999988543 35899999999999999999999997 99999999999999999999999999976543
Q ss_pred CCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
.. .....|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ....... ....
T Consensus 167 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~-~~~~------ 229 (284)
T 2vgo_A 167 LR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT------ETHRRIV-NVDL------ 229 (284)
T ss_dssp SC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHH-TTCC------
T ss_pred cc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh------HHHHHHh-cccc------
Confidence 22 23357899999999999999999999999999999999999998533211 1111111 1100
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.+ +......+.+++.+||+.||++|||++++++.
T Consensus 230 ~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 230 KF----PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp CC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred CC----CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 01 11112356788889999999999999999974
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=343.65 Aligned_cols=265 Identities=28% Similarity=0.355 Sum_probs=194.9
Q ss_pred hcCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHH--HHhccCCCeeeEEEEEEe-----CceE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNL--IAKLQHKNLVRLLGCCLE-----GQEL 423 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~i--l~~l~h~niv~l~~~~~~-----~~~~ 423 (672)
.++|++.+.||+|+||.||+|++ +++.||||++..... ..+..|.++ +..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 47899999999999999999977 689999999875432 344445444 445899999999986542 3467
Q ss_pred EEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhc---------CCCCeeecCCCCCcEEEcCCCCeE
Q 005871 424 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED---------SRLKIIHRDLKASNILLDDDMNPK 494 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---------g~~~iiHrDlkp~NIll~~~~~~k 494 (672)
++||||+++++|.+++... ..++..+..++.||+.||.|||+. + |+||||||+||||+.++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence 9999999999999998432 358999999999999999999998 7 99999999999999999999
Q ss_pred EEeecCceeeCCCCC------CcccccccccCCcCChhhhcC-------CCCChhhHHHHHHHHHHHHHcCCCCCCCCCc
Q 005871 495 ISDFGLARIFGGNQN------QANTNIIAGTYGYMAPEYAMG-------GIFSIKSDVFSFGVLLLEIISGRKNNGFYFS 561 (672)
Q Consensus 495 L~DFgla~~~~~~~~------~~~~~~~~gt~~Y~aPE~~~~-------~~~s~ksDvwSlGvil~elltG~~p~~~~~~ 561 (672)
|+|||+++.+..... ........||+.|+|||++.+ ..++.++||||||+++|||++|..|+.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987654321 112223579999999999987 3567899999999999999999877532221
Q ss_pred cccc-chhh----------hhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 562 EHGQ-TLLT----------YTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 562 ~~~~-~~~~----------~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
.... .... ..............+.... .........+.+|+.+||+.||++|||++||++.|...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 1111 0000 0000000000000011100 01223456788999999999999999999999999874
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=346.42 Aligned_cols=252 Identities=21% Similarity=0.253 Sum_probs=190.8
Q ss_pred cCCccc-cccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHh-ccCCCeeeEEEEEEe----CceEE
Q 005871 352 NHFSDE-NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAK-LQHKNLVRLLGCCLE----GQELL 424 (672)
Q Consensus 352 ~~~~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~-l~h~niv~l~~~~~~----~~~~~ 424 (672)
++|.+. +.||+|+||.||++.+. +++.||||++... ..+.+|+.++.+ .+||||+++++++.. ...++
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 567766 68999999999999976 6889999998632 456788888754 589999999999876 56799
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---CCCeEEEeecCc
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFGLA 501 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~---~~~~kL~DFgla 501 (672)
|||||+++|+|.+++... ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 999999999999998642 2345999999999999999999999997 999999999999997 789999999999
Q ss_pred eeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCccccc-chhhhhhhhccCCCc
Q 005871 502 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQ-TLLTYTWKLWCEGPA 580 (672)
Q Consensus 502 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~ 580 (672)
+...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ....... .+..
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~----~~~~ 284 (400)
T 1nxk_A 212 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR----MGQY 284 (400)
T ss_dssp EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----HTCC
T ss_pred cccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----cCcc
Confidence 8754322 223457899999999999999999999999999999999999998643322111 0111110 0000
Q ss_pred ccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 581 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 581 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
....+ ........+.+|+.+||+.||++|||+.||++.-
T Consensus 285 -~~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 285 -EFPNP-----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp -CCCTT-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred -cCCCc-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 00000 0011224577888899999999999999999864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=336.76 Aligned_cols=252 Identities=24% Similarity=0.330 Sum_probs=201.3
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
.++|.+.+.||+|+||.||++++. +++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 467999999999999999999976 6899999999876555556789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE---cCCCCeEEEeecCceeeCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll---~~~~~~kL~DFgla~~~~~ 506 (672)
+++++|.+++... ..+++..+..++.||+.||.|||+.| |+||||||+||++ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 9999999888543 45899999999999999999999998 9999999999999 7889999999999975432
Q ss_pred CCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
. ......|++.|+|||++.+..++.++||||||+++|+|++|+.||..... ........ .+.. .. ..
T Consensus 162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~----~~~~-~~-~~ 228 (304)
T 2jam_A 162 G----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE---SKLFEKIK----EGYY-EF-ES 228 (304)
T ss_dssp B----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHH----HCCC-CC-CT
T ss_pred C----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHH----cCCC-CC-Cc
Confidence 1 22335689999999999999999999999999999999999999753221 11111111 1100 00 00
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
.. .......+.+++.+||+.||++|||+.++++.-
T Consensus 229 ~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (304)
T 2jam_A 229 PF----WDDISESAKDFICHLLEKDPNERYTCEKALSHP 263 (304)
T ss_dssp TT----TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred cc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 01 111224577888899999999999999999743
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=335.31 Aligned_cols=254 Identities=25% Similarity=0.349 Sum_probs=199.8
Q ss_pred hcCCccccccccCCceeEEeeeecC----CceeEEEEeccc-CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l 425 (672)
.++|.+.+.||+|+||.||+|.+.+ +..||+|.+... .....+.+.+|+.++++++||||+++++++.++ ..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 4689999999999999999998642 346999998765 334567899999999999999999999998754 5689
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
||||+++++|.+++... ...+++..+..++.||+.||.|||+.| |+||||||+||+++.++.+||+|||++....
T Consensus 90 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 90 IMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 99999999999998543 345899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 506 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 506 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
..... ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||...... ........ +....
T Consensus 165 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~---~~~~~~~~----~~~~~-- 234 (281)
T 3cc6_A 165 DEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK---DVIGVLEK----GDRLP-- 234 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG---GHHHHHHH----TCCCC--
T ss_pred ccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH---HHHHHHhc----CCCCC--
Confidence 33221 1223457889999999998999999999999999999998 99997533221 11111111 00000
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
.+......+.+++.+||+.||++|||+.||++.|..
T Consensus 235 -------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 270 (281)
T 3cc6_A 235 -------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 270 (281)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence 011112347788889999999999999999999975
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=344.78 Aligned_cols=259 Identities=31% Similarity=0.428 Sum_probs=202.2
Q ss_pred hcCCccccccccCCceeEEeeee------cCCceeEEEEeccc-CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 423 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 423 (672)
.++|.+.+.||+|+||.||+|++ .++..||||++... .......+.+|+.++++++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46899999999999999999984 24778999999754 344556789999999999999999999999999999
Q ss_pred EEEEeecCCCChhHHhhhccc----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---CCCeEEE
Q 005871 424 LLIYEYMPNKSLDVHLFDATR----SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKIS 496 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~---~~~~kL~ 496 (672)
++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999975432 245899999999999999999999998 999999999999994 4469999
Q ss_pred eecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhc
Q 005871 497 DFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLW 575 (672)
Q Consensus 497 DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 575 (672)
|||++................|++.|+|||++.+..++.++||||||+++|+|++ |+.||..... .......
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~---- 258 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEFV---- 258 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHH----
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---HHHHHHH----
Confidence 9999986544333333334568899999999999999999999999999999998 8888753221 1111111
Q ss_pred cCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 576 CEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 576 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
..+.... .... ....+.+++.+||+.||++|||+.+|++.|...
T Consensus 259 ~~~~~~~-----~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 259 TSGGRMD-----PPKN----CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HTTCCCC-----CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCCCCC-----CCCC----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1111110 0111 223577888899999999999999999999764
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.86 Aligned_cols=259 Identities=24% Similarity=0.359 Sum_probs=205.5
Q ss_pred hHHHHHHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCc--------ccHHHHHHHHHHHHhc-cCCCeeeE
Q 005871 344 LRLALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--------QGLQEFKNEVNLIAKL-QHKNLVRL 413 (672)
Q Consensus 344 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l-~h~niv~l 413 (672)
........++|.+.+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+.+++++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3444556678999999999999999999986 699999999875432 1245678999999999 79999999
Q ss_pred EEEEEeCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCe
Q 005871 414 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP 493 (672)
Q Consensus 414 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~ 493 (672)
++++......++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence 9999999999999999999999999854 345999999999999999999999998 9999999999999999999
Q ss_pred EEEeecCceeeCCCCCCcccccccccCCcCChhhhcC------CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccch
Q 005871 494 KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG------GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTL 567 (672)
Q Consensus 494 kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~ 567 (672)
||+|||++..+..... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||..... ...
T Consensus 240 kl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---~~~ 313 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ---ILM 313 (365)
T ss_dssp EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHH
T ss_pred EEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH---HHH
Confidence 9999999987654322 234579999999999863 3588999999999999999999999753211 111
Q ss_pred hhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 568 LTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 568 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
..... .+... ...+ ..... ...+.+++.+||+.||++|||+.++++.
T Consensus 314 ~~~i~----~~~~~-~~~~-~~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 314 LRMIM----EGQYQ-FSSP-EWDDR----SSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHH----HTCCC-CCHH-HHSSS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHH----hCCCC-CCCc-ccccC----CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11110 01000 0000 00111 2347788889999999999999999873
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=336.47 Aligned_cols=250 Identities=26% Similarity=0.435 Sum_probs=205.4
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
.+.|++.++||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 467999999999999999999875 68999999987553 3456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|+++++|.+++.. ..+++..+..++.||+.||.|||+.| |+||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999998842 46899999999999999999999998 9999999999999999999999999998765433
Q ss_pred CCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhh
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 588 (672)
. ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ....... .... +.+
T Consensus 174 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~~~~-----~~~ 239 (303)
T 3a7i_A 174 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM------KVLFLIP-KNNP-----PTL 239 (303)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHH-HSCC-----CCC
T ss_pred c--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH------HHHHHhh-cCCC-----CCC
Confidence 2 223457899999999999999999999999999999999999997532211 1111110 0110 111
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 589 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 589 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
.... ...+.+++.+||+.||++|||+.+|++..
T Consensus 240 ~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 240 EGNY----SKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp CSSC----CHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred cccc----CHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 1122 23477888899999999999999998754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=370.28 Aligned_cols=259 Identities=31% Similarity=0.475 Sum_probs=207.6
Q ss_pred hcCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
.++|++.++||+|+||.||+|.++++..||||++.... ...+.|.+|+.+|++++||||+++++++.+ +..+|||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 46789999999999999999999888889999997654 335789999999999999999999999876 6789999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
++++|.+++... ....+++.++..|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 344 ~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 418 (535)
T 2h8h_A 344 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 418 (535)
T ss_dssp TTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH-
T ss_pred cCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce-
Confidence 999999999542 2245899999999999999999999997 99999999999999999999999999986542211
Q ss_pred cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhc
Q 005871 511 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 589 (672)
.......++..|+|||++.++.++.++||||||+++|||++ |+.||...... .....+ ..+...
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~~~~i----~~~~~~-------- 483 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQV----ERGYRM-------- 483 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HHHHHH----HTTCCC--------
T ss_pred ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HcCCCC--------
Confidence 11122346788999999999999999999999999999999 89887532211 111111 111100
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCCC
Q 005871 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTI 632 (672)
Q Consensus 590 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l 632 (672)
..+......+.+|+.+||+.||++|||+++|+++|...-.+.
T Consensus 484 -~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 484 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 011122345778888999999999999999999998764443
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=335.85 Aligned_cols=256 Identities=20% Similarity=0.232 Sum_probs=197.1
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
.++|++.+.||+|+||.||++.+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999975 68899999987653 23347789999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 9999999999998543 45899999999999999999999998 99999999999999999999999999986643
Q ss_pred CCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCC-CcccccC
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG-PAVELID 585 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~d 585 (672)
.... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ......... ....
T Consensus 187 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~--- 255 (309)
T 2h34_A 187 EKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIPRPS--- 255 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCCCGG---
T ss_pred cccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCCCcc---
Confidence 3221 222356899999999999999999999999999999999999997532211 111111111 1000
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhccC
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRP-TMSSVVVMLASD 628 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~ 628 (672)
...... ...+.+++.+||+.||++|| +++++++.|...
T Consensus 256 -~~~~~~----~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~ 294 (309)
T 2h34_A 256 -TVRPGI----PVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAA 294 (309)
T ss_dssp -GTSTTC----CTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHT
T ss_pred -ccCCCC----CHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHH
Confidence 011111 23467788899999999999 999999999875
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=348.74 Aligned_cols=265 Identities=25% Similarity=0.340 Sum_probs=203.2
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
.++|++.++||+|+||.||++.+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 468999999999999999999986 68999999987653 3445778999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED-SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
|+++++|.+++... ..+++..+..++.||+.||.|||+. | |+||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999998543 3589999999999999999999996 6 999999999999999999999999998754321
Q ss_pred CCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhh---------hhhhh----
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLT---------YTWKL---- 574 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~---------~~~~~---- 574 (672)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||............. ..+..
T Consensus 186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 186 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp ----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred ----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 1223578999999999999999999999999999999999999986432211000000 00000
Q ss_pred ----------ccCCCcccccChhhcCC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 575 ----------WCEGPAVELIDPVLKQS----CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 575 ----------~~~~~~~~l~d~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
.......+.++...... ........+.+|+.+||+.||++|||++|+++.-
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 326 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 00000000111100000 0011133577888899999999999999998743
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=343.20 Aligned_cols=248 Identities=29% Similarity=0.426 Sum_probs=198.5
Q ss_pred cCCccccccccCCceeEEeeee-cCCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
+.|++.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4699999999999999999997 478999999987543 234567899999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+. |+|.+.+... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 206 (348)
T ss_dssp ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence 9998 5676666432 346899999999999999999999998 99999999999999999999999999986532
Q ss_pred CCCcccccccccCCcCChhhhc---CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 508 QNQANTNIIAGTYGYMAPEYAM---GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
.....||+.|+|||++. ++.++.++||||||+++|||++|+.||..... ............ ....
T Consensus 207 -----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~~~~~~-~~~~ 274 (348)
T 1u5q_A 207 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNES-PALQ 274 (348)
T ss_dssp -----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCC-CCCC
T ss_pred -----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcCC-CCCC
Confidence 22357999999999985 56789999999999999999999999743211 111111111111 0110
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
.... ...+.+++.+||+.||++|||++++++..-
T Consensus 275 ----~~~~----~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 275 ----SGHW----SEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp ----CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred ----CCCC----CHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 1111 234667888999999999999999987543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=348.78 Aligned_cols=199 Identities=25% Similarity=0.431 Sum_probs=167.7
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeC-----ce
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QE 422 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~ 422 (672)
.++|.+.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+.+|++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 478999999999999999999975 5889999999764 334457889999999999999999999999876 57
Q ss_pred EEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCce
Q 005871 423 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 502 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~ 502 (672)
.++||||+. ++|..++. ....+++..++.++.||+.||.|||+.| |+||||||+||||+.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 999999987 58888884 3456999999999999999999999998 9999999999999999999999999999
Q ss_pred eeCCCCCC--------------------cccccccccCCcCChhhh-cCCCCChhhHHHHHHHHHHHHHcCCCCC
Q 005871 503 IFGGNQNQ--------------------ANTNIIAGTYGYMAPEYA-MGGIFSIKSDVFSFGVLLLEIISGRKNN 556 (672)
Q Consensus 503 ~~~~~~~~--------------------~~~~~~~gt~~Y~aPE~~-~~~~~s~ksDvwSlGvil~elltG~~p~ 556 (672)
........ ......+||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 76543221 112446799999999986 5567999999999999999999976654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=337.59 Aligned_cols=255 Identities=29% Similarity=0.418 Sum_probs=201.2
Q ss_pred hcCCcccc-ccccCCceeEEeeeec---CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEE
Q 005871 351 TNHFSDEN-KLGQGGFGPVYKGTLA---DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 424 (672)
Q Consensus 351 ~~~~~~~~-~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 424 (672)
.++|.+.+ .||+|+||.||+|.+. .++.||||++.... ....+.+.+|+.+++.++||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35788888 9999999999999642 47889999987653 23357899999999999999999999999 567789
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceee
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 504 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~ 504 (672)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 94 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 99999999999999854 345899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCCc-ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCccc
Q 005871 505 GGNQNQA-NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVE 582 (672)
Q Consensus 505 ~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (672)
....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...... ... .....+....
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~----~~~~~~~~~~ 240 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVT----AMLEKGERMG 240 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHH----HHHHTTCCCC
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHH----HHHHcCCCCC
Confidence 5433221 1222346788999999998889999999999999999999 99997543211 111 1111111111
Q ss_pred ccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 583 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 583 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
.+......+.+++.+||+.||++|||+.+|++.|+..
T Consensus 241 ---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 241 ---------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1112234577888899999999999999999999763
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=348.12 Aligned_cols=263 Identities=21% Similarity=0.286 Sum_probs=196.8
Q ss_pred hcCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCc------eEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------ELL 424 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~------~~~ 424 (672)
..+|.+.+.||+|+||.||+|++..+..+|+|++...... ..+|+.+++.++||||+++++++.... ..+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 3579999999999999999999987777999988654322 236999999999999999999996543 388
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc-CCCCeEEEeecCcee
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARI 503 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~-~~~~~kL~DFgla~~ 503 (672)
+||||++++.+............+++..+..++.||+.||.|||+.| |+||||||+||||+ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999998765554433344567999999999999999999999998 99999999999999 799999999999987
Q ss_pred eCCCCCCcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhh----------
Q 005871 504 FGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTW---------- 572 (672)
Q Consensus 504 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~---------- 572 (672)
+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||........ +.....
T Consensus 192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVEIIKVLGTPSREQI 266 (394)
T ss_dssp CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHH
T ss_pred ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHH
Confidence 643322 2234789999999998765 589999999999999999999999864322111 111000
Q ss_pred ----hhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 573 ----KLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 573 ----~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
..+........................+.+|+.+||+.||++|||+.|+++.-
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 323 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHP 323 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcCh
Confidence 00001111111000000001111234578888899999999999999999863
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=368.63 Aligned_cols=268 Identities=23% Similarity=0.262 Sum_probs=213.7
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEeccc---CcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEE
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELL 424 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~ 424 (672)
..++|++.+.||+|+||.||++++. +++.||||++.+. .....+.+..|..+|..+ +||||+++++++.+.+.++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999976 5888999999753 234457788999999988 7999999999999999999
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceee
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 504 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~ 504 (672)
|||||+++|+|..++... ..+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++++||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999998543 45999999999999999999999998 999999999999999999999999999864
Q ss_pred CCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 505 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 505 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+... ..
T Consensus 493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~-~~---- 559 (674)
T 3pfq_A 493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIMEH-NV---- 559 (674)
T ss_dssp CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHSS-CC----
T ss_pred ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH------HHHHHHHHhC-CC----
Confidence 3322 223456899999999999999999999999999999999999999853211 1111111111 10
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHHhccC--------CCCCCCCCCCcccc
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTM-----SSVVVMLASD--------SMTIPQPTEPAFSV 642 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~L~~~--------~~~l~~p~~p~~~~ 642 (672)
.++......+.+|+.+||+.||++||++ +||++.--.. ...+++|-.|....
T Consensus 560 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~~~ 624 (674)
T 3pfq_A 560 ------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKASG 624 (674)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBCCG
T ss_pred ------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcCCC
Confidence 0111223457788889999999999998 7777643221 23467777776543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=335.19 Aligned_cols=258 Identities=17% Similarity=0.269 Sum_probs=199.1
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhcc-CCCeeeEEEEEEe--CceEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLE--GQELLLI 426 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~--~~~~~lV 426 (672)
.++|++.++||+|+||.||+|.+. +++.||||++.... .+.+.+|+.++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 368999999999999999999874 68999999987533 467899999999997 9999999999998 6679999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-CeEEEeecCceeeC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIFG 505 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~-~~kL~DFgla~~~~ 505 (672)
|||+.+++|..++. .+++..+..++.||+.||.|||+.| |+||||||+|||++.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999998873 3889999999999999999999998 99999999999999776 89999999998765
Q ss_pred CCCCCcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhh--------hhhcc
Q 005871 506 GNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYT--------WKLWC 576 (672)
Q Consensus 506 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~ 576 (672)
.... .....|++.|+|||++.+ ..++.++||||||+++|+|++|+.||........ .+.... ...+.
T Consensus 183 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 183 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHHCHHHHHHHHH
T ss_pred CCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHHHHHhcCCchhhhHHH
Confidence 4332 233578999999999987 6789999999999999999999999743221110 000000 00000
Q ss_pred --------------CCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 577 --------------EGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 577 --------------~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
........+..............+.+|+.+||+.||++|||++|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000001111111111123567888899999999999999999974
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=341.84 Aligned_cols=255 Identities=30% Similarity=0.447 Sum_probs=200.3
Q ss_pred cCCccccccccCCceeEEeeeec-CCce--eEEEEeccc-CcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKA--IAVKRLSRT-SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lV 426 (672)
++|++.+.||+|+||.||++++. ++.. +|+|.+... .....+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 68999999999999999999975 4554 499988753 234456789999999999 999999999999999999999
Q ss_pred EeecCCCChhHHhhhcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCe
Q 005871 427 YEYMPNKSLDVHLFDAT-------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP 493 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~ 493 (672)
|||+++++|.+++.... ....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999986532 2346999999999999999999999998 9999999999999999999
Q ss_pred EEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhh
Q 005871 494 KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTW 572 (672)
Q Consensus 494 kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 572 (672)
||+|||+++..... .......+++.|+|||++.+..++.++||||||+++|+|++ |+.||...... ....
T Consensus 182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~--- 252 (327)
T 1fvr_A 182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYE--- 252 (327)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH---
T ss_pred EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH---HHHH---
Confidence 99999999743211 11223456889999999998889999999999999999998 99997532211 1111
Q ss_pred hhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 573 KLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 573 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
. ...+... .........+.+|+.+||+.||++|||++++++.|...
T Consensus 253 ~-~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 253 K-LPQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp H-GGGTCCC---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H-hhcCCCC---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1 1111000 01111224577888899999999999999999999764
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=335.35 Aligned_cols=266 Identities=24% Similarity=0.377 Sum_probs=186.2
Q ss_pred HHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
...++|.+.+.||+|+||.||++.+. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34578999999999999999999875 68999999886543 33456788999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCc
Q 005871 427 YEYMPNKSLDVHLFDA-----TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 501 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla 501 (672)
|||+++++|.+++... .....+++..+..++.||+.||.|||+.| |+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999998642 12346899999999999999999999998 999999999999999999999999999
Q ss_pred eeeCCCCC---CcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccC
Q 005871 502 RIFGGNQN---QANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCE 577 (672)
Q Consensus 502 ~~~~~~~~---~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 577 (672)
........ ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....... ...........
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~ 245 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---VLMLTLQNDPP 245 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHHHHHTSSCC
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---HHHHHhccCCC
Confidence 76543221 112234578999999999876 568999999999999999999999986432211 11111000000
Q ss_pred CCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 578 GPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 578 ~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.......+....... ...+.+++.+||+.||++|||+.++++.
T Consensus 246 ~~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 246 SLETGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp CTTC-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccccccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 000001111111122 2356788889999999999999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=357.33 Aligned_cols=251 Identities=25% Similarity=0.354 Sum_probs=196.8
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
.++|++.++||+|+||.||+|++. ++..+|+|++.+.. ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457999999999999999999986 68899999987643 334578899999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC---CCeEEEeecCceee
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD---MNPKISDFGLARIF 504 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~---~~~kL~DFgla~~~ 504 (672)
||+++|+|.+.+... ..+++..+..++.||+.||.|||+.| |+||||||+|||++.. +.+||+|||++..+
T Consensus 116 e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 999999998888543 45899999999999999999999998 9999999999999764 55999999999876
Q ss_pred CCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 505 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 505 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
.... ......||+.|+|||++. +.++.++|||||||++|+|++|+.||...... .+...... +.. ...
T Consensus 190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~----~~~-~~~ 257 (494)
T 3lij_A 190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ---EILRKVEK----GKY-TFD 257 (494)
T ss_dssp BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH----TCC-CCC
T ss_pred CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh----CCC-CCC
Confidence 5432 223457999999999886 56899999999999999999999998543211 11111111 100 000
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.+. .... ...+.+++.+||+.||++|||+.++++.
T Consensus 258 ~~~-~~~~----s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 258 SPE-WKNV----SEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp SGG-GTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred chh-cccC----CHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 010 0111 2346788889999999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=350.32 Aligned_cols=254 Identities=23% Similarity=0.319 Sum_probs=191.4
Q ss_pred HHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccC--------cccHHHHHHHHHHHHhccCCCeeeEEEEEEe
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--------GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE 419 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~il~~l~h~niv~l~~~~~~ 419 (672)
...++|.+.+.||+|+||.||+|.+. +++.||||++.+.. ......+.+|+.+|++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45689999999999999999999875 58999999987542 1122357899999999999999999999754
Q ss_pred CceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC---CeEEE
Q 005871 420 GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM---NPKIS 496 (672)
Q Consensus 420 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~---~~kL~ 496 (672)
+..++||||+++++|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred -CceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 56899999999999988874 3456999999999999999999999997 99999999999997544 59999
Q ss_pred eecCceeeCCCCCCcccccccccCCcCChhhhcC---CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhh
Q 005871 497 DFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWK 573 (672)
Q Consensus 497 DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~ 573 (672)
|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....... .+....
T Consensus 285 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~i-- 357 (419)
T 3i6u_A 285 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI-- 357 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHHH--
T ss_pred ecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHHH--
Confidence 999998764322 2234679999999999863 678899999999999999999999985432111 111111
Q ss_pred hccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 574 LWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 574 ~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
..+... . .+..... ....+.+++.+||+.||++|||++|+++.
T Consensus 358 --~~~~~~-~-~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 358 --TSGKYN-F-IPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp --HTTCCC-C-CHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --hcCCCC-C-Cchhhcc----cCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 111100 0 0111111 12457788889999999999999999974
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=353.43 Aligned_cols=242 Identities=15% Similarity=0.154 Sum_probs=188.5
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEeccc---CcccHHHHHHHH---HHHHhccCCCeeeEE-------EE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEV---NLIAKLQHKNLVRLL-------GC 416 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~---~il~~l~h~niv~l~-------~~ 416 (672)
.++|.+.+.||+|+||.||+|++. +|+.||||++... .....+.+.+|+ .++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 467999999999999999999974 6999999999743 344567889999 555556899999988 66
Q ss_pred EEeCc-----------------eEEEEEeecCCCChhHHhhhccc----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 005871 417 CLEGQ-----------------ELLLIYEYMPNKSLDVHLFDATR----SVQLDWKRRQSIINGIARGILYLHEDSRLKI 475 (672)
Q Consensus 417 ~~~~~-----------------~~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~i 475 (672)
+.+.+ ..++||||+ +|+|.+++..... ...+++..++.|+.||+.||.|||++| |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 66553 289999999 6899999865321 122445888899999999999999998 9
Q ss_pred eecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCC-----------CCChhhHHHHHHH
Q 005871 476 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-----------IFSIKSDVFSFGV 544 (672)
Q Consensus 476 iHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----------~~s~ksDvwSlGv 544 (672)
+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986322 2234567 999999999887 8999999999999
Q ss_pred HHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 545 LLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 545 il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
++|||++|+.||......... .. +... .... ...+.+|+.+||+.||++|||+.++++
T Consensus 302 il~elltg~~Pf~~~~~~~~~---~~------------~~~~--~~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGS---EW------------IFRS--CKNI----PQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CCS---GG------------GGSS--CCCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccch---hh------------hhhh--ccCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999998533211110 00 0000 0112 234677888999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=334.30 Aligned_cols=250 Identities=29% Similarity=0.379 Sum_probs=195.2
Q ss_pred hcCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeC-ceEEEEEee
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-QELLLIYEY 429 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-~~~~lV~Ey 429 (672)
.++|++.+.||+|+||.||++.+. ++.||+|++.... ..+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 368999999999999999999874 8899999987543 457889999999999999999999997654 478999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+++++|.+++.... ...+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 99999999985432 234889999999999999999999998 9999999999999999999999999998654321
Q ss_pred CcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhh
Q 005871 510 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 588 (672)
....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...... .... ....+.... .
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~----~~~~~~~~~-----~ 235 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVP----RVEKGYKMD-----A 235 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHH----HHTTTCCCC-----C
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHhcCCCCC-----C
Confidence 22357889999999999999999999999999999998 99997533211 1111 111111100 1
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 589 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 589 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
.......+.+++.+||+.||++|||+.++++.|...
T Consensus 236 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 236 ----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 111224577888899999999999999999999753
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=346.55 Aligned_cols=262 Identities=13% Similarity=0.182 Sum_probs=202.4
Q ss_pred hcCCccccccccCCceeEEeeeecC---------CceeEEEEecccCcccHHHHHHHHHHHHhccCCCeee---------
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLAD---------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR--------- 412 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~--------- 412 (672)
.++|.+.+.||+|+||.||+|++.. ++.||||++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4689999999999999999999763 789999998754 35789999999999999887
Q ss_pred ------EEEEEEe-CceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 005871 413 ------LLGCCLE-GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNI 485 (672)
Q Consensus 413 ------l~~~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NI 485 (672)
+++++.. ....++||||+ +++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6777776 77899999999 99999999643 2356999999999999999999999998 99999999999
Q ss_pred EEcCCC--CeEEEeecCceeeCCCCCC-----cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCC
Q 005871 486 LLDDDM--NPKISDFGLARIFGGNQNQ-----ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF 558 (672)
Q Consensus 486 ll~~~~--~~kL~DFgla~~~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~ 558 (672)
|++.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 8999999999876532211 112335799999999999999999999999999999999999999854
Q ss_pred CCcccccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 559 YFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
..... ..+.... ..+.. ....+.+...... .....+.+++.+||+.||++|||+++|++.|...
T Consensus 271 ~~~~~-~~~~~~~-~~~~~-~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 271 CLPNT-EDIMKQK-QKFVD-KPGPFVGPCGHWI---RPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp GTTCH-HHHHHHH-HHHHH-SCCCEECTTSCEE---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred CCcCH-HHHHHHH-HhccC-ChhhhhhhccccC---CCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 32111 1111111 11111 1111111111000 1124577788899999999999999999999764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=331.70 Aligned_cols=253 Identities=23% Similarity=0.296 Sum_probs=199.2
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC----cccHHHHHHHHHHHHhccCCCeeeEEEEEE--eCceE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKNLVRLLGCCL--EGQEL 423 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~h~niv~l~~~~~--~~~~~ 423 (672)
.++|.+.+.||+|+||.||++.+. +++.+|+|++.... ....+.+.+|+.++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999975 68899999987542 344578999999999999999999999984 45689
Q ss_pred EEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 424 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
++||||++++ |.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999987 65665432 3456999999999999999999999998 99999999999999999999999999988
Q ss_pred eCCCCCCcccccccccCCcCChhhhcCCC--CChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcc
Q 005871 504 FGGNQNQANTNIIAGTYGYMAPEYAMGGI--FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAV 581 (672)
Q Consensus 504 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (672)
..............|++.|+|||++.+.. ++.++||||||+++|+|++|+.||..... .... .....+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~-~~i~~~~~- 230 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI------YKLF-ENIGKGSY- 230 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHH-HHHHHCCC-
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH------HHHH-HHHhcCCC-
Confidence 75443333344557899999999997654 48899999999999999999999853211 1111 11111110
Q ss_pred cccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 582 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 582 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
.+.... ...+.+++.+||+.||++|||++|+++.-
T Consensus 231 -----~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 265 (305)
T 2wtk_C 231 -----AIPGDC----GPPLSDLLKGMLEYEPAKRFSIRQIRQHS 265 (305)
T ss_dssp -----CCCSSS----CHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred -----CCCCcc----CHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 011112 23467788899999999999999999764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=333.02 Aligned_cols=254 Identities=24% Similarity=0.401 Sum_probs=198.6
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
..++|++.+.||+|+||.||+|.+. +++.+|+|++........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4578999999999999999999986 589999999987777778899999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|+++++|..++... ...+++..+..++.||+.||.|||+.| |+||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred eCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 99999999888543 345899999999999999999999997 9999999999999999999999999875422110
Q ss_pred CCcccccccccCCcCChhhh-----cCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccc
Q 005871 509 NQANTNIIAGTYGYMAPEYA-----MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~-----~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 583 (672)
.......|++.|+|||++ .+..++.++||||||+++|+|++|+.||...... ........... ...
T Consensus 172 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~-~~~ 242 (302)
T 2j7t_A 172 --QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSDP-PTL 242 (302)
T ss_dssp --HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCC-CCC
T ss_pred --cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHHHHHhccCC-ccc
Confidence 111234689999999998 3667899999999999999999999997543211 11111111111 111
Q ss_pred cChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 584 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.. .......+.+++.+||+.||++|||+.+|++.
T Consensus 243 ~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 243 LT-------PSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp SS-------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred CC-------ccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 10 11112357788889999999999999999863
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=348.73 Aligned_cols=256 Identities=29% Similarity=0.420 Sum_probs=191.3
Q ss_pred cCCccccccccCCceeEEeeeecC----CceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEe-CceEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE-GQELLL 425 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~-~~~~~l 425 (672)
..|.+.+.||+|+||.||+|.+.+ +..+|+|.+.... ....+.+.+|+.++++++||||+++++++.+ ++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 357788999999999999998642 2468999886543 3456789999999999999999999998754 457899
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
||||+++++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 169 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999853 3345889999999999999999999998 9999999999999999999999999998664
Q ss_pred CCCCCc--ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCccc
Q 005871 506 GNQNQA--NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVE 582 (672)
Q Consensus 506 ~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (672)
...... ......+++.|+|||++.+..++.++||||||+++|||++ |.+||..... ........ .+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~---~~~~~~~~----~~~~~- 315 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVYLL----QGRRL- 315 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS---SCHHHHHH----TTCCC-
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH---HHHHHHHH----cCCCC-
Confidence 332211 1223457889999999999999999999999999999999 5666543221 11111111 11100
Q ss_pred ccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 583 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 583 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
.. .... ...+.+++.+||+.||++|||+++|++.|...
T Consensus 316 -~~---p~~~----~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 316 -LQ---PEYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp -CC---CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CC---CCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00 1111 23577888899999999999999999999875
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=355.68 Aligned_cols=253 Identities=26% Similarity=0.342 Sum_probs=201.1
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
..++|++.++||+|+||.||++.+. +++.||||++.+. .......+.+|+.+|++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4468999999999999999999976 6899999998653 234467889999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc---CCCCeEEEeecCcee
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARI 503 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~---~~~~~kL~DFgla~~ 503 (672)
|||+.+++|.+.+... ..+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999998888543 45999999999999999999999998 99999999999995 456799999999986
Q ss_pred eCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccc
Q 005871 504 FGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583 (672)
Q Consensus 504 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 583 (672)
+.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||..... ..... ... .+.....
T Consensus 174 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~---~i~-~~~~~~~ 242 (486)
T 3mwu_A 174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDILK---RVE-TGKYAFD 242 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHH-HTCCCSC
T ss_pred CCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHH---HHH-hCCCCCC
Confidence 54332 2234579999999999875 599999999999999999999999853221 11111 111 1110000
Q ss_pred cChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 584 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
. +. .......+.+++.+||+.||++|||+.++++.-
T Consensus 243 ~-~~-----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp 278 (486)
T 3mwu_A 243 L-PQ-----WRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278 (486)
T ss_dssp S-GG-----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCH
T ss_pred C-cc-----cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCH
Confidence 0 00 011223567888899999999999999999863
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=345.47 Aligned_cols=259 Identities=24% Similarity=0.329 Sum_probs=194.5
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCc------
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------ 421 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~------ 421 (672)
.++|.+.+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|+.+|+.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 367999999999999999999975 6899999998653 2334567899999999999999999999998653
Q ss_pred eEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCc
Q 005871 422 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 501 (672)
Q Consensus 422 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla 501 (672)
..++||||+ +++|..++.. ..+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 469999999 8899988853 35899999999999999999999998 999999999999999999999999999
Q ss_pred eeeCCCCCCcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCC-
Q 005871 502 RIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGP- 579 (672)
Q Consensus 502 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~- 579 (672)
+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .............
T Consensus 176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~~~~ 247 (367)
T 1cm8_A 176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD---QLKEIMKVTGTPPA 247 (367)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCH
T ss_pred cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCH
Confidence 875432 223578999999999887 679999999999999999999999986432211 1110000000000
Q ss_pred -----------------cccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 580 -----------------AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 580 -----------------~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
..+.....+. ...+.....+.+|+.+||+.||++|||++|+++.--
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~ 310 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 310 (367)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred HHHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChH
Confidence 0000000000 001112345778888999999999999999998643
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=350.85 Aligned_cols=260 Identities=21% Similarity=0.276 Sum_probs=204.4
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccC-CCeeeEEEEEEeCceEEEEEe
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH-KNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h-~niv~l~~~~~~~~~~~lV~E 428 (672)
.++|++.++||+|+||.||+|++. +++.||||++...... ..+.+|+++++.++| +++..+..++.+.+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 478999999999999999999974 6899999987654432 357889999999987 566667777778889999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE---cCCCCeEEEeecCceeeC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFG 505 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll---~~~~~~kL~DFgla~~~~ 505 (672)
|+ +++|.+++... ...+++..++.|+.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 99999998643 345999999999999999999999998 9999999999999 688999999999999876
Q ss_pred CCCCCc-----ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCc
Q 005871 506 GNQNQA-----NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPA 580 (672)
Q Consensus 506 ~~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (672)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||................... .
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~----~ 233 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK----V 233 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH----H
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc----c
Confidence 543321 2235679999999999999999999999999999999999999986533322211111111110 0
Q ss_pred ccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 581 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 581 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
...++ .+...+ ...+.+|+..||+.+|++||++.+|+++|..
T Consensus 234 ~~~~~-~l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~ 275 (483)
T 3sv0_A 234 ATSIE-ALCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRD 275 (483)
T ss_dssp HSCHH-HHHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred cccHH-HHhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 01111 111122 2357788889999999999999999998865
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=345.47 Aligned_cols=253 Identities=11% Similarity=0.039 Sum_probs=181.0
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCc---ccHHHHHHHHHHHHhc--cCCCeeeEE-------EEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKL--QHKNLVRLL-------GCCL 418 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l--~h~niv~l~-------~~~~ 418 (672)
.+|.+.++||+|+||.||+|++. +++.||||++..... ...+.+.+|+.+++.| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45899999999999999999975 689999999987542 3456678886656555 599988855 4444
Q ss_pred eC-----------------ceEEEEEeecCCCChhHHhhhccccCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCe
Q 005871 419 EG-----------------QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR------QSIINGIARGILYLHEDSRLKI 475 (672)
Q Consensus 419 ~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~qi~~~L~~LH~~g~~~i 475 (672)
.. ...++||||++ ++|.+++..... .+.+..+ ..++.||+.||.|||++| |
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i 215 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG---L 215 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence 33 34899999999 899999965422 3455555 677899999999999998 9
Q ss_pred eecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcC--CCCChhhHHHHHHHHHHHHHcCC
Q 005871 476 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG--GIFSIKSDVFSFGVLLLEIISGR 553 (672)
Q Consensus 476 iHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDvwSlGvil~elltG~ 553 (672)
+||||||+||||+.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999875321 113456799999999987 67999999999999999999999
Q ss_pred CCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 554 KNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 554 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
.||............ .......................+.+|+.+||+.||++|||+.++++
T Consensus 291 ~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGSWK--------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTCCC--------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccchh--------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 998654322111100 00000000000000001122345778888999999999999999974
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=368.26 Aligned_cols=254 Identities=26% Similarity=0.436 Sum_probs=198.4
Q ss_pred CCcccc-ccccCCceeEEeeeec---CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 353 HFSDEN-KLGQGGFGPVYKGTLA---DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 353 ~~~~~~-~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
++.+.+ +||+|+||.||+|.++ ++..||||++.... ....+.+.+|+.+|++++||||+++++++.. +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 444444 7999999999999864 45679999997653 3456889999999999999999999999976 5699999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+++|+|.+++.. ....+++..+..|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 415 E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 415 EMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp ECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred EeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 99999999999854 2456999999999999999999999997 999999999999999999999999999876433
Q ss_pred CCC-cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccC
Q 005871 508 QNQ-ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585 (672)
Q Consensus 508 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 585 (672)
... .......+++.|+|||++.++.++.++|||||||++|||++ |+.||...... ..... ...+....
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~----i~~~~~~~--- 559 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAF----IEQGKRME--- 559 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHHH----HHTTCCCC---
T ss_pred CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHH----HHcCCCCC---
Confidence 221 11122345689999999999999999999999999999998 99997543221 11111 11111111
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
.+......+.+|+.+||+.||++||++.+|++.|...
T Consensus 560 ------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 560 ------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp ------CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred ------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1112234577888899999999999999999999764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=328.96 Aligned_cols=253 Identities=25% Similarity=0.316 Sum_probs=202.4
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEecccC---------cccHHHHHHHHHHHHhcc-CCCeeeEEEEEE
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---------GQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCL 418 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~il~~l~-h~niv~l~~~~~ 418 (672)
..++|++.+.||+|+||.||++.+. +++.||||++.... ....+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3578999999999999999999986 68999999987543 122456889999999995 999999999999
Q ss_pred eCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEee
Q 005871 419 EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDF 498 (672)
Q Consensus 419 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DF 498 (672)
+....++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.| |+||||||+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 99999999999999999999854 346899999999999999999999998 999999999999999999999999
Q ss_pred cCceeeCCCCCCcccccccccCCcCChhhhc------CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhh
Q 005871 499 GLARIFGGNQNQANTNIIAGTYGYMAPEYAM------GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTW 572 (672)
Q Consensus 499 gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~ 572 (672)
|++....... ......|++.|+|||++. ...++.++||||||+++|+|++|+.||...... ....
T Consensus 169 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~--- 239 (298)
T 1phk_A 169 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---LMLR--- 239 (298)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---
T ss_pred cchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH---HHHH---
Confidence 9998765332 223357899999999985 456899999999999999999999997532211 1111
Q ss_pred hhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 573 KLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 573 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
... .+... ...+ ........+.+++.+||+.||++|||+.++++.
T Consensus 240 ~~~-~~~~~-~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 240 MIM-SGNYQ-FGSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HHH-HTCCC-CCTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHh-cCCcc-cCcc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 110 11100 0000 011223457788889999999999999999863
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=343.62 Aligned_cols=263 Identities=22% Similarity=0.277 Sum_probs=195.0
Q ss_pred HHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeC-------
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------- 420 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~------- 420 (672)
...++|++.+.||+|+||.||+|.+. +|+.||||++...... ..+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 45678999999999999999999874 6899999998655322 24799999999999999999998543
Q ss_pred -------------------------------ceEEEEEeecCCCChhHHhhhc-cccCCCCHHHHHHHHHHHHHHHHHHH
Q 005871 421 -------------------------------QELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLH 468 (672)
Q Consensus 421 -------------------------------~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH 468 (672)
...++||||+++ +|...+... .....+++..+..++.||+.||.|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 348999999984 777776542 33457999999999999999999999
Q ss_pred hcCCCCeeecCCCCCcEEEc-CCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHH
Q 005871 469 EDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLL 546 (672)
Q Consensus 469 ~~g~~~iiHrDlkp~NIll~-~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil 546 (672)
+.| |+||||||+|||++ .++.+||+|||+++.+..... .....||+.|+|||++.+. .++.++|||||||++
T Consensus 159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 998 99999999999998 688999999999997644332 2234689999999998875 489999999999999
Q ss_pred HHHHcCCCCCCCCCcccccchhhhhhhh--------------ccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCC
Q 005871 547 LEIISGRKNNGFYFSEHGQTLLTYTWKL--------------WCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDP 612 (672)
Q Consensus 547 ~elltG~~p~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP 612 (672)
|||++|+.||........ +....... +.......+.........+......+.+|+.+||+.||
T Consensus 233 ~ell~g~~pf~~~~~~~~--~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQ--LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHHhCCCCCCCCChHHH--HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 999999999864322111 11110000 00000000000000000111123457788889999999
Q ss_pred CCCCCHHHHHHH
Q 005871 613 ADRPTMSSVVVM 624 (672)
Q Consensus 613 ~~RPt~~evl~~ 624 (672)
++|||+.|+++.
T Consensus 311 ~~R~t~~e~l~h 322 (383)
T 3eb0_A 311 DLRINPYEAMAH 322 (383)
T ss_dssp GGSCCHHHHHTS
T ss_pred hhCCCHHHHhcC
Confidence 999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=343.92 Aligned_cols=264 Identities=22% Similarity=0.281 Sum_probs=202.0
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhcc--------CCCeeeEEEEEE--
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ--------HKNLVRLLGCCL-- 418 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~--------h~niv~l~~~~~-- 418 (672)
..++|.+.++||+|+||.||+|++. +++.||||++... ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 4578999999999999999999875 6889999998754 334567889999999996 788999999998
Q ss_pred --eCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEEcCCC----
Q 005871 419 --EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED-SRLKIIHRDLKASNILLDDDM---- 491 (672)
Q Consensus 419 --~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-g~~~iiHrDlkp~NIll~~~~---- 491 (672)
+....++||||+. ++|...+... ....+++..++.|+.||+.||.|||++ | |+||||||+||||+.++
T Consensus 114 ~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 114 GVNGTHICMVFEVLG-HHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp ETTEEEEEEEECCCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred CCCCceEEEEEeccC-ccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence 5568999999994 5555555332 234699999999999999999999998 7 99999999999999775
Q ss_pred ---------------------------------------------CeEEEeecCceeeCCCCCCcccccccccCCcCChh
Q 005871 492 ---------------------------------------------NPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 526 (672)
Q Consensus 492 ---------------------------------------------~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE 526 (672)
.+||+|||++...... .....||+.|+|||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE 263 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCCh
Confidence 8999999999876432 22347899999999
Q ss_pred hhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccc---hhhhhhhh------------------ccC-CCccccc
Q 005871 527 YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQT---LLTYTWKL------------------WCE-GPAVELI 584 (672)
Q Consensus 527 ~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~---~~~~~~~~------------------~~~-~~~~~l~ 584 (672)
++.+..++.++|||||||++|||++|+.||.......... ........ +.. +....+.
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 9999999999999999999999999999986543322111 00000000 000 0000000
Q ss_pred C-------hhh--cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 585 D-------PVL--KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 585 d-------~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
+ ..+ ...........+.+|+.+||+.||++|||++||++.
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0 000 112345667788999999999999999999999863
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=328.06 Aligned_cols=248 Identities=25% Similarity=0.395 Sum_probs=194.9
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
.++|.+.+.||+|+||.||+|.+. +++.||||++.... .+..+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999986 68999999986542 23456889999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 9999999999998543 35899999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCCcccccccccCCcCChhhhcCCCC-ChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccC
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 585 (672)
... .....|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||..... ....... ..+.. .
T Consensus 164 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~----~~~~~-~--- 229 (276)
T 2h6d_A 164 GEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV---PTLFKKI----RGGVF-Y--- 229 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH----HHCCC-C---
T ss_pred Ccc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHh----hcCcc-c---
Confidence 221 223468999999999988765 6899999999999999999999753211 1111111 11100 0
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
+.... ...+.+++.+||+.||++|||+.+|++.
T Consensus 230 --~~~~~----~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 230 --IPEYL----NRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp --CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --Cchhc----CHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 01111 2346778889999999999999999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=327.86 Aligned_cols=253 Identities=25% Similarity=0.402 Sum_probs=199.4
Q ss_pred HHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
...++|++.+.||+|+||.||+|.+. +|+.||+|++.... ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34578999999999999999999976 58999999987643 3467899999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+++++|.+++.. ....+++..+..++.||+.||.|||+.| |+|+||||+||+++.++.+||+|||++......
T Consensus 104 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 99999999999853 2346899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChh
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 587 (672)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ......... .......
T Consensus 179 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~-~~~~~~~-- 247 (314)
T 3com_A 179 MA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------RAIFMIPTN-PPPTFRK-- 247 (314)
T ss_dssp BS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHS-CCCCCSS--
T ss_pred cc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcC-CCcccCC--
Confidence 22 223357899999999999999999999999999999999999997532211 111111001 0000000
Q ss_pred hcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 588 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 588 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.......+.+++.+||+.||++|||+.++++.
T Consensus 248 -----~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 248 -----PELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp -----GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -----cccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11112457788889999999999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=354.57 Aligned_cols=253 Identities=25% Similarity=0.340 Sum_probs=199.8
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCc-------------ccHHHHHHHHHHHHhccCCCeeeEEE
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-------------QGLQEFKNEVNLIAKLQHKNLVRLLG 415 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~il~~l~h~niv~l~~ 415 (672)
..++|.+.++||+|+||.||+|.+. +++.||+|++.+... ...+.+.+|+.+|++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3578999999999999999999976 588999999875431 33567899999999999999999999
Q ss_pred EEEeCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC---C
Q 005871 416 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM---N 492 (672)
Q Consensus 416 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~---~ 492 (672)
++.+....++||||+++++|.+.+... ..+++..+..++.||+.||.|||+.| |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 999999999999999999999888543 45999999999999999999999998 99999999999999776 6
Q ss_pred eEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhh
Q 005871 493 PKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTW 572 (672)
Q Consensus 493 ~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~ 572 (672)
+||+|||++..+.... ......||+.|+|||++. +.++.++|||||||++|+|++|+.||...... ......
T Consensus 188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i- 259 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ---DIIKKV- 259 (504)
T ss_dssp EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH-
T ss_pred EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH-
Confidence 9999999998765432 223457999999999986 46899999999999999999999998543211 111111
Q ss_pred hhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 573 KLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 573 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
. .+... .+....... ...+.+|+.+||+.||.+|||++|+++.-
T Consensus 260 --~-~~~~~--~~~~~~~~~----s~~~~~li~~~L~~dp~~R~t~~e~l~h~ 303 (504)
T 3q5i_A 260 --E-KGKYY--FDFNDWKNI----SDEAKELIKLMLTYDYNKRCTAEEALNSR 303 (504)
T ss_dssp --H-HCCCC--CCHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred --H-cCCCC--CCccccCCC----CHHHHHHHHHHcCCChhHCCCHHHHhcCH
Confidence 1 11100 000000111 23577888899999999999999998753
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=339.92 Aligned_cols=260 Identities=25% Similarity=0.270 Sum_probs=192.3
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCc------
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------ 421 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~------ 421 (672)
.++|++.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999875 6889999998754 2344567889999999999999999999998664
Q ss_pred eEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCc
Q 005871 422 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 501 (672)
Q Consensus 422 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla 501 (672)
..++||||+++ +|.+.+. ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 78999999985 5666663 24899999999999999999999998 999999999999999999999999999
Q ss_pred eeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhc------
Q 005871 502 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLW------ 575 (672)
Q Consensus 502 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~------ 575 (672)
+...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .........
T Consensus 175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~ 248 (371)
T 2xrw_A 175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID---QWNKVIEQLGTPCPE 248 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHC-CCCCCHH
T ss_pred ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHH
Confidence 8654322 1233578999999999999999999999999999999999999986432111 000000000
Q ss_pred -------------cC------CCcccccChhhcCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 576 -------------CE------GPAVELIDPVLKQSC---APDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 576 -------------~~------~~~~~l~d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
.. ....+.+........ .......+.+|+.+||+.||++|||++|+++.-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 00 000001111100000 012245688999999999999999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=357.50 Aligned_cols=252 Identities=26% Similarity=0.342 Sum_probs=203.0
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
.++|++.++||+|+||.||++++. +++.||||++.+.. ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999986 68999999986542 34567899999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE---cCCCCeEEEeecCcee
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARI 503 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll---~~~~~~kL~DFgla~~ 503 (672)
|||+.+++|.+.+.. ...+++..+..++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++..
T Consensus 105 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999988853 346999999999999999999999998 9999999999999 5678999999999987
Q ss_pred eCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccc
Q 005871 504 FGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583 (672)
Q Consensus 504 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 583 (672)
+.... ......||+.|+|||++.+ .++.++|||||||++|+|++|++||..... ..... ... .+...-.
T Consensus 179 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~---~i~-~~~~~~~ 247 (484)
T 3nyv_A 179 FEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE---YDILK---KVE-KGKYTFE 247 (484)
T ss_dssp BCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHH-HCCCCCC
T ss_pred ccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH---HHHHH---HHH-cCCCCCC
Confidence 64332 2233579999999999876 689999999999999999999999853321 11111 111 1110000
Q ss_pred cChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 584 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
.+. .......+.+++.+||+.||++|||+.|+++.-
T Consensus 248 -~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~ 283 (484)
T 3nyv_A 248 -LPQ-----WKKVSESAKDLIRKMLTYVPSMRISARDALDHE 283 (484)
T ss_dssp -SGG-----GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred -Ccc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhhCh
Confidence 000 011224567888899999999999999998743
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=348.50 Aligned_cols=260 Identities=24% Similarity=0.310 Sum_probs=192.7
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeC------ceEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------QELL 424 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~------~~~~ 424 (672)
.+|.+.+.||+|+||.||+|++. +++.||||++..... ...+|+++|++++||||+++++++... ..++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46999999999999999999986 589999999865432 234699999999999999999998642 2477
Q ss_pred EEEeecCCCChhHHhhh-ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC-CCeEEEeecCce
Q 005871 425 LIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-MNPKISDFGLAR 502 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~-~~~kL~DFgla~ 502 (672)
+||||+++ ++...+.. ......+++..++.++.||+.||.|||++| |+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999986 45444432 233457999999999999999999999997 9999999999999965 568999999999
Q ss_pred eeCCCCCCcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhh--------
Q 005871 503 IFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWK-------- 573 (672)
Q Consensus 503 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~-------- 573 (672)
.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+......
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQ 280 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHH
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHH
Confidence 7643322 2235789999999999765 78999999999999999999999986432111 11111110
Q ss_pred --hccCCCcccccChhhcCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 574 --LWCEGPAVELIDPVLKQS-----CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 574 --~~~~~~~~~l~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
.... ...+..-+.+... +.......+.+|+.+||+.||++|||+.|+++.-
T Consensus 281 ~~~~~~-~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp 338 (420)
T 1j1b_A 281 IREMNP-NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338 (420)
T ss_dssp HHHHCS-CCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHhhCh-hhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence 0000 0000000000000 1111234578888899999999999999998754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=334.93 Aligned_cols=264 Identities=22% Similarity=0.306 Sum_probs=194.3
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEE-----------
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL----------- 418 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~----------- 418 (672)
.++|.+.+.||+|+||.||+|.+. +++.||+|++........+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468999999999999999999986 48999999998777777788999999999999999999999873
Q ss_pred ---eCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc-CCCCeE
Q 005871 419 ---EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPK 494 (672)
Q Consensus 419 ---~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~-~~~~~k 494 (672)
+....++||||++ ++|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 4468899999998 58888873 246899999999999999999999998 99999999999997 567899
Q ss_pred EEeecCceeeCCCCC-CcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhh
Q 005871 495 ISDFGLARIFGGNQN-QANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTW 572 (672)
Q Consensus 495 L~DFgla~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~ 572 (672)
|+|||+++....... ........|++.|+|||.+.+ ..++.++||||||+++|||++|+.||....... ......
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~ 238 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE---QMQLIL 238 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHH
Confidence 999999987643221 122233467999999998876 678999999999999999999999986432211 010000
Q ss_pred hhccCC----------CcccccChhhc-CCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 573 KLWCEG----------PAVELIDPVLK-QSC-----APDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 573 ~~~~~~----------~~~~l~d~~l~-~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
...... .....+..... ... .+.....+.+++.+||+.||++|||++|+++.-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHP 307 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSH
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCc
Confidence 000000 00000000000 000 011234577888899999999999999999754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=334.26 Aligned_cols=259 Identities=25% Similarity=0.333 Sum_probs=202.7
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEe--CceEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELLL 425 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~~l 425 (672)
.++|++.+.||+|+||.||++.+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999986 68999999987543 3445678999999999999999999998854 568999
Q ss_pred EEeecCCCChhHHhhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCcEEEcCCCCeEEEeecCce
Q 005871 426 IYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDS--RLKIIHRDLKASNILLDDDMNPKISDFGLAR 502 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~g--~~~iiHrDlkp~NIll~~~~~~kL~DFgla~ 502 (672)
||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ..+|+||||||+|||++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999986533 2345999999999999999999999985 1239999999999999999999999999998
Q ss_pred eeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccc
Q 005871 503 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVE 582 (672)
Q Consensus 503 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (672)
...... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||..... ..+... ...+....
T Consensus 165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~----i~~~~~~~ 235 (279)
T 2w5a_A 165 ILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGK----IREGKFRR 235 (279)
T ss_dssp HC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH----HHHTCCCC
T ss_pred eecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHHHH----Hhhccccc
Confidence 654322 112235689999999999999999999999999999999999999754321 111111 11111111
Q ss_pred ccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 583 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 583 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
+ ... ....+.+++.+||+.||++|||+.||++.+..
T Consensus 236 ~-----~~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 236 I-----PYR----YSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp C-----CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred C-----Ccc----cCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 1 111 22457788889999999999999999986644
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=344.11 Aligned_cols=271 Identities=21% Similarity=0.254 Sum_probs=198.1
Q ss_pred hHHHHHHhcCCccccccccCCceeEEeeeecCCceeEEEEecccCc-----------ccHHHHHHHHHHHHhccCCCeee
Q 005871 344 LRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG-----------QGLQEFKNEVNLIAKLQHKNLVR 412 (672)
Q Consensus 344 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~il~~l~h~niv~ 412 (672)
+.......++|.+.+.||+|+||.||+|.+.+++.||||++..... ...+.+.+|+.++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 4556677899999999999999999999988899999999865322 12378899999999999999999
Q ss_pred EEEEEEe-----CceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE
Q 005871 413 LLGCCLE-----GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 487 (672)
Q Consensus 413 l~~~~~~-----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll 487 (672)
+++++.. ....++||||+. ++|.+.+.. ....+++..+..++.||+.||.|||+.| |+||||||+|||+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 9999854 346899999998 577777643 3346999999999999999999999998 9999999999999
Q ss_pred cCCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccc
Q 005871 488 DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQT 566 (672)
Q Consensus 488 ~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~ 566 (672)
+.++.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.......
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--- 241 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN--- 241 (362)
T ss_dssp CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---
T ss_pred cCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH---
Confidence 999999999999998543322 2233578999999999887 678999999999999999999999986432111
Q ss_pred hhhhhhhhccCC-------------------CcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 567 LLTYTWKLWCEG-------------------PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 567 ~~~~~~~~~~~~-------------------~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
............ .......... ....+.....+.+|+.+||+.||++|||+.|+++.--.
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 320 (362)
T 3pg1_A 242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAW-TAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320 (362)
T ss_dssp HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCH-HHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhH-HhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchh
Confidence 111110000000 0000000000 00001113457788899999999999999999976433
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=333.09 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=185.8
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
.++|++.+.||+|+||.||++.+. +++.||+|++..... ...+.+..+...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 468999999999999999999974 689999999976532 22334455566688889999999999999999999999
Q ss_pred eecCCCChhHHhhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 428 EYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHED-SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~-g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
||+++ +|.+++... .....+++..++.++.||+.||.|||++ | |+||||||+|||++.++.+||+|||++....
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99985 777776542 3345799999999999999999999998 7 9999999999999999999999999998764
Q ss_pred CCCCCcccccccccCCcCChhhh----cCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcc
Q 005871 506 GNQNQANTNIIAGTYGYMAPEYA----MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAV 581 (672)
Q Consensus 506 ~~~~~~~~~~~~gt~~Y~aPE~~----~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (672)
.... .....||+.|+|||++ .+..++.++||||||+++|+|++|+.||....... ............
T Consensus 162 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~- 232 (290)
T 3fme_A 162 DDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-----QQLKQVVEEPSP- 232 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-----HHHHHHHHSCCC-
T ss_pred cccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-----HHHHHHhccCCC-
Confidence 3322 2234689999999996 55678999999999999999999999985322111 111111111111
Q ss_pred cccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 582 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 582 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
... ... ....+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~----~~~----~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 233 QLP----ADK----FSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CCC----TTT----SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred Ccc----ccc----CCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 100 011 1234778888999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=339.76 Aligned_cols=265 Identities=21% Similarity=0.305 Sum_probs=200.7
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeC-----ceE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QEL 423 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~~ 423 (672)
.++|++.+.||+|+||.||++.+. +++.||||++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999975 68899999997543 33457789999999999999999999999765 468
Q ss_pred EEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 424 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
++||||+.+ +|..++.. ..+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++..
T Consensus 106 ~iv~e~~~~-~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCSE-EHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccCc-CHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 999999985 88877743 35999999999999999999999998 99999999999999999999999999987
Q ss_pred eCCCCCCc-ccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcc
Q 005871 504 FGGNQNQA-NTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAV 581 (672)
Q Consensus 504 ~~~~~~~~-~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (672)
........ ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||........ ..............
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~~~ 254 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQE 254 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH---HHHHHHHHCSCCHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH---HHHHHHHhCCCCHH
Confidence 65332211 1234579999999998765 4589999999999999999999999854332211 11111000000000
Q ss_pred ---cccC--------hhh-cCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 582 ---ELID--------PVL-KQSC-----APDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 582 ---~l~d--------~~l-~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
...+ ... .... .+.....+.+|+.+||+.||++|||+.|+++.--
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 316 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 0000 000 0000 0111245778889999999999999999997653
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=334.50 Aligned_cols=254 Identities=22% Similarity=0.326 Sum_probs=195.3
Q ss_pred HhcCCccccccccCCceeEEeeeecCCceeEEEEecccC--cccHHHHHHHHHHHHhcc--CCCeeeEEEEEEeCceEEE
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQ--HKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~--h~niv~l~~~~~~~~~~~l 425 (672)
..++|++.+.||+|+||.||++.+.+++.||||++.... ....+.+.+|+.++++++ ||||+++++++.+.+..++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 346799999999999999999998889999999987543 345678899999999997 4999999999999999999
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
||| +.+++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++ +.+||+|||++..+.
T Consensus 106 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 106 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred EEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 999 678899999854 346899999999999999999999997 999999999999965 899999999998765
Q ss_pred CCCCCcccccccccCCcCChhhhcC-----------CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhh
Q 005871 506 GNQNQANTNIIAGTYGYMAPEYAMG-----------GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL 574 (672)
Q Consensus 506 ~~~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 574 (672)
............|++.|+|||++.+ ..++.++||||||+++|+|++|+.||....... ......
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~~~~~~ 252 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLHAI 252 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHHHH
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-----HHHHHH
Confidence 4433333334578999999999875 478999999999999999999999985322110 111111
Q ss_pred ccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 575 WCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 575 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
...... ...+......+.+++.+||+.||++|||+.|+++..
T Consensus 253 ~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 253 IDPNHE---------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp HCTTSC---------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred Hhcccc---------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 111100 011111123567788899999999999999999754
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=332.07 Aligned_cols=257 Identities=30% Similarity=0.398 Sum_probs=195.6
Q ss_pred hcCCccccccccCCceeEEeeeec--CCc--eeEEEEeccc---CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA--DGK--AIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 423 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 423 (672)
.++|++.+.||+|+||.||+|++. +++ .||+|++... .....+.+.+|+.++++++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 468999999999999999999863 233 6899988754 2345678899999999999999999999998765 8
Q ss_pred EEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 424 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
++||||+++++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 8999999999999998643 245899999999999999999999998 99999999999999999999999999987
Q ss_pred eCCCCCCc-ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcc
Q 005871 504 FGGNQNQA-NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAV 581 (672)
Q Consensus 504 ~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (672)
........ ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||..... ..............
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~~~~~ 244 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILHKIDKEGERL 244 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTSCCCC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH------HHHHHHHHccCCCC
Confidence 65433221 2223467888999999998889999999999999999999 9999753321 11111111111110
Q ss_pred cccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 582 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 582 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
. ........+.+++.+||+.||++|||+.+|++.|...
T Consensus 245 ~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 282 (291)
T 1u46_A 245 P---------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282 (291)
T ss_dssp C---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C---------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence 0 0111234577888899999999999999999999865
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=339.36 Aligned_cols=263 Identities=25% Similarity=0.343 Sum_probs=202.9
Q ss_pred hcCCccccccccCCceeEEeeeecCCceeEEEEecccCccc-----------------HHHHHHHHHHHHhccCCCeeeE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQG-----------------LQEFKNEVNLIAKLQHKNLVRL 413 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~il~~l~h~niv~l 413 (672)
.++|.+.+.||+|+||.||++.+ +++.||||++....... .+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 89999999986542211 2789999999999999999999
Q ss_pred EEEEEeCceEEEEEeecCCCChhHH------hhhccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEE
Q 005871 414 LGCCLEGQELLLIYEYMPNKSLDVH------LFDATRSVQLDWKRRQSIINGIARGILYLHE-DSRLKIIHRDLKASNIL 486 (672)
Q Consensus 414 ~~~~~~~~~~~lV~Ey~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~g~~~iiHrDlkp~NIl 486 (672)
++++.+.+..++||||+++++|.++ +.. .....+++..++.++.||+.||.|||+ .| |+||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999988 422 224679999999999999999999999 87 999999999999
Q ss_pred EcCCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCC-CCCh-hhHHHHHHHHHHHHHcCCCCCCCCCcccc
Q 005871 487 LDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSI-KSDVFSFGVLLLEIISGRKNNGFYFSEHG 564 (672)
Q Consensus 487 l~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~-ksDvwSlGvil~elltG~~p~~~~~~~~~ 564 (672)
++.++.+||+|||++...... ......|++.|+|||++.+. .++. ++||||||+++|+|++|+.||......
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-- 258 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-- 258 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--
Confidence 999999999999999876433 23345789999999999887 6666 999999999999999999998643221
Q ss_pred cchhhhhhhhccCCC--cccccChhhc---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 565 QTLLTYTWKLWCEGP--AVELIDPVLK---QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 565 ~~~~~~~~~~~~~~~--~~~l~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.............-. ......+... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111111100000000 0000000000 00001223457788889999999999999999974
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=344.75 Aligned_cols=275 Identities=24% Similarity=0.342 Sum_probs=186.3
Q ss_pred cCCcc-ccccccCCceeEEeeeec---CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEe--CceEEE
Q 005871 352 NHFSD-ENKLGQGGFGPVYKGTLA---DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELLL 425 (672)
Q Consensus 352 ~~~~~-~~~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~~l 425 (672)
+.|.+ .++||+|+||.||+|+++ +++.||||++..... ...+.+|+.+|++++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 45666 458999999999999965 478999999975432 3568899999999999999999999964 678999
Q ss_pred EEeecCCCChhHHhhhcc------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE----cCCCCeEE
Q 005871 426 IYEYMPNKSLDVHLFDAT------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL----DDDMNPKI 495 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll----~~~~~~kL 495 (672)
||||+.+ +|..++.... ....+++..++.|+.||+.||.|||+.+ |+||||||+|||| +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999975 6666664321 2235999999999999999999999998 9999999999999 67889999
Q ss_pred EeecCceeeCCCCCC-cccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccc------cch
Q 005871 496 SDFGLARIFGGNQNQ-ANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHG------QTL 567 (672)
Q Consensus 496 ~DFgla~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~------~~~ 567 (672)
+|||+++.+...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ...
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 999999876543221 223346799999999999874 589999999999999999999999864322110 011
Q ss_pred hhhhhhhccC---CCccccc------------ChhhcCCCC---------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 568 LTYTWKLWCE---GPAVELI------------DPVLKQSCA---------PDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 568 ~~~~~~~~~~---~~~~~l~------------d~~l~~~~~---------~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
+......+.. ..+..+. ......... ......+.+|+.+||+.||++|||++|+++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111111000 0000000 000000000 001235678889999999999999999998
Q ss_pred HhccCCCCC
Q 005871 624 MLASDSMTI 632 (672)
Q Consensus 624 ~L~~~~~~l 632 (672)
.--....++
T Consensus 334 hp~f~~~~~ 342 (405)
T 3rgf_A 334 DPYFLEDPL 342 (405)
T ss_dssp SGGGTSSSC
T ss_pred ChhhccCCC
Confidence 765444333
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=340.76 Aligned_cols=270 Identities=21% Similarity=0.248 Sum_probs=190.7
Q ss_pred HHHHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCce---
Q 005871 347 ALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE--- 422 (672)
Q Consensus 347 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~--- 422 (672)
.....++|.+.+.||+|+||.||+|++. +++.||||++..... ....+.+|+..++.++||||+++++++.....
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 4456789999999999999999999985 689999999865432 33466788899999999999999999976433
Q ss_pred ----EEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeeecCCCCCcEEEcC-CCCeEE
Q 005871 423 ----LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH--EDSRLKIIHRDLKASNILLDD-DMNPKI 495 (672)
Q Consensus 423 ----~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~g~~~iiHrDlkp~NIll~~-~~~~kL 495 (672)
.++||||++++.+............+++..+..++.||+.||.||| +.| |+||||||+||||+. ++.+||
T Consensus 97 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 97 RDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp TCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEE
T ss_pred cceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEE
Confidence 8999999987544433332345567899999999999999999999 877 999999999999996 899999
Q ss_pred EeecCceeeCCCCCCcccccccccCCcCChhhhcCCC-CChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhh--
Q 005871 496 SDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTW-- 572 (672)
Q Consensus 496 ~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~-- 572 (672)
+|||+++.+..... .....||+.|+|||++.+.. ++.++||||||+++|+|++|+.||........ +.....
T Consensus 174 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~~~~~~~ 248 (360)
T 3e3p_A 174 CDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ--LHEIVRVL 248 (360)
T ss_dssp CCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHH
T ss_pred eeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH--HHHHHHHc
Confidence 99999987653322 22357899999999987654 89999999999999999999999864322111 111100
Q ss_pred --------hhccCC-CcccccC------hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 573 --------KLWCEG-PAVELID------PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 573 --------~~~~~~-~~~~l~d------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
..+... ......+ ..............+.+|+.+||+.||++|||+.|+++.-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 316 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHP 316 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSG
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCc
Confidence 000000 0000000 0000111112345688899999999999999999999764
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=323.86 Aligned_cols=250 Identities=25% Similarity=0.368 Sum_probs=197.8
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEe----CceEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE----GQELL 424 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~----~~~~~ 424 (672)
..|.+.+.||+|+||.||+|.+. ++..||+|++... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 45888899999999999999875 5888999998754 34456788999999999999999999999875 46789
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc-CCCCeEEEeecCcee
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARI 503 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~-~~~~~kL~DFgla~~ 503 (672)
+||||+++++|.+++... ..+++..++.|+.||+.||.|||+.+ .+|+||||||+|||++ .++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 999999999999999542 45899999999999999999999974 2499999999999998 789999999999975
Q ss_pred eCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccc
Q 005871 504 FGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583 (672)
Q Consensus 504 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 583 (672)
.... ......|++.|+|||++. +.++.++||||||+++|+|++|+.||...... ... ......+...
T Consensus 182 ~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~-~~~~~~~~~~-- 248 (290)
T 1t4h_A 182 KRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQI-YRRVTSGVKP-- 248 (290)
T ss_dssp CCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHH-HHHHTTTCCC--
T ss_pred cccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-----HHH-HHHHhccCCc--
Confidence 4322 223356899999999886 45899999999999999999999998532211 111 1111111111
Q ss_pred cChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 584 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
....... ...+.+++.+||+.||++|||+++|++.
T Consensus 249 --~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 249 --ASFDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp --GGGGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --cccCCCC----CHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1111111 2347788889999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=332.87 Aligned_cols=252 Identities=23% Similarity=0.319 Sum_probs=195.1
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEecccC--------cccHHHHHHHHHHHHhccCCCeeeEEEEEEeC
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--------GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG 420 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~ 420 (672)
..++|.+.+.||+|+||.||+|.+. +++.||||++.... ......+.+|+.++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3468999999999999999999975 58899999986542 12234578999999999999999999998765
Q ss_pred ceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC---eEEEe
Q 005871 421 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN---PKISD 497 (672)
Q Consensus 421 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~---~kL~D 497 (672)
. .++||||+++++|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 5 899999999999998884 3456999999999999999999999998 999999999999987654 99999
Q ss_pred ecCceeeCCCCCCcccccccccCCcCChhhhc---CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhh
Q 005871 498 FGLARIFGGNQNQANTNIIAGTYGYMAPEYAM---GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL 574 (672)
Q Consensus 498 Fgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 574 (672)
||++....... ......||+.|+|||++. ...++.++||||||+++|+|++|+.||....... .+.....
T Consensus 161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~-- 233 (322)
T 2ycf_A 161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQIT-- 233 (322)
T ss_dssp CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHHH--
T ss_pred Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHHH--
Confidence 99998764321 123356899999999974 5678999999999999999999999985432211 1111111
Q ss_pred ccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 575 WCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 575 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
.+... ..+...... ...+.+++.+||+.||++|||+.++++
T Consensus 234 --~~~~~--~~~~~~~~~----~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 --SGKYN--FIPEVWAEV----SEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --HTCCC--CCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --hCccc--cCchhhhhc----CHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 11000 001111111 245778888999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=343.11 Aligned_cols=199 Identities=21% Similarity=0.291 Sum_probs=172.0
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhc------cCCCeeeEEEEEEeCce
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL------QHKNLVRLLGCCLEGQE 422 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l------~h~niv~l~~~~~~~~~ 422 (672)
...+|++.++||+|+||.||+|.+. +++.||||++... ....+.+.+|+.+++.+ +|+||+++++++.....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 3468999999999999999999875 5899999998754 23346778899999888 46799999999999999
Q ss_pred EEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC--eEEEeecC
Q 005871 423 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN--PKISDFGL 500 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~--~kL~DFgl 500 (672)
.++||||+. ++|.+++... ....+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++. +||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 999999996 5888887543 2345899999999999999999999998 999999999999999887 99999999
Q ss_pred ceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCC
Q 005871 501 ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY 559 (672)
Q Consensus 501 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~ 559 (672)
+...... .....||+.|+|||++.+..++.++|||||||++|||++|++||...
T Consensus 249 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 249 SCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp CEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 9764322 22357899999999999999999999999999999999999998643
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=368.13 Aligned_cols=247 Identities=30% Similarity=0.425 Sum_probs=194.3
Q ss_pred cccccCCceeEEeeeec---CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCC
Q 005871 358 NKLGQGGFGPVYKGTLA---DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 432 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~ 432 (672)
++||+|+||.||+|.+. .++.||||++.... ....+.+.+|+.+|++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 46789999997643 3346789999999999999999999999864 568999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC-c
Q 005871 433 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ-A 511 (672)
Q Consensus 433 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~-~ 511 (672)
|+|.+++.. ...+++..+..|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus 454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999953 346899999999999999999999998 999999999999999999999999999876543321 1
Q ss_pred ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcC
Q 005871 512 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590 (672)
Q Consensus 512 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 590 (672)
......||+.|+|||++.+..++.++|||||||++|||++ |+.||...... ... .....+....
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~----~~i~~~~~~~-------- 592 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVT----AMLEKGERMG-------- 592 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHH----HHHHTTCCCC--------
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCCCCC--------
Confidence 2223456788999999999999999999999999999998 99997533211 111 1111111111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 591 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
.+......+.+|+.+||+.||++|||+++|+++|+.
T Consensus 593 -~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 593 -CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 111223457788889999999999999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=330.99 Aligned_cols=263 Identities=20% Similarity=0.268 Sum_probs=202.4
Q ss_pred hcCCccccccccCCceeEEeeee-c-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCC------eeeEEEEEEeCce
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTL-A-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN------LVRLLGCCLEGQE 422 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n------iv~l~~~~~~~~~ 422 (672)
.++|++.+.||+|+||.||++.+ . +++.||||++... ....+.+.+|+.+++.++|++ ++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999986 3 6889999998654 344577889999999998765 9999999999999
Q ss_pred EEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-------------
Q 005871 423 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD------------- 489 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~------------- 489 (672)
.++||||+ +++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 88998888543 2346899999999999999999999998 999999999999987
Q ss_pred ------CCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCccc
Q 005871 490 ------DMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH 563 (672)
Q Consensus 490 ------~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~ 563 (672)
++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 678999999999864322 233578999999999999999999999999999999999999986432211
Q ss_pred ccchhhhh--------hhhccCC--------Cccc----------ccChhh-cCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 005871 564 GQTLLTYT--------WKLWCEG--------PAVE----------LIDPVL-KQSCAPDELLKFIHIGLLCVQQDPADRP 616 (672)
Q Consensus 564 ~~~~~~~~--------~~~~~~~--------~~~~----------l~d~~l-~~~~~~~~~~~l~~li~~cl~~dP~~RP 616 (672)
........ +...... .+.. ...+.. ...........+.+|+.+||+.||++||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 11000000 0000000 0000 000000 0011234456788999999999999999
Q ss_pred CHHHHHHH
Q 005871 617 TMSSVVVM 624 (672)
Q Consensus 617 t~~evl~~ 624 (672)
|+.||++.
T Consensus 322 t~~ell~h 329 (339)
T 1z57_A 322 TLREALKH 329 (339)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999854
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=341.53 Aligned_cols=259 Identities=26% Similarity=0.344 Sum_probs=183.5
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeC------c
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------Q 421 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~------~ 421 (672)
.++|.+.+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 468999999999999999999864 6899999998754 234456788999999999999999999999754 5
Q ss_pred eEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCc
Q 005871 422 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 501 (672)
Q Consensus 422 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla 501 (672)
..++|||++ +++|..++.. ..+++..+..++.||+.||.|||+.| |+||||||+||||+.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 689999999 6888887742 46999999999999999999999998 999999999999999999999999999
Q ss_pred eeeCCCCCCcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCc
Q 005871 502 RIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPA 580 (672)
Q Consensus 502 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (672)
+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ........... ..
T Consensus 180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~-p~ 250 (367)
T 2fst_X 180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLVGT-PG 250 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCS-CC
T ss_pred cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCC-CC
Confidence 865422 233578999999999987 678999999999999999999999986432211 11111110000 00
Q ss_pred ccccC----h----h---hc--CCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 581 VELID----P----V---LK--QSCA-----PDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 581 ~~l~d----~----~---l~--~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
.+.+. . . +. .... +.....+.+|+.+||+.||++|||+.|+++.--
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~ 314 (367)
T 2fst_X 251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314 (367)
T ss_dssp HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChh
Confidence 00000 0 0 00 0000 011235778888999999999999999998643
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=332.31 Aligned_cols=268 Identities=26% Similarity=0.403 Sum_probs=197.9
Q ss_pred hcCCccccccccCCceeEEeeeecCCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
.++|++.+.||+|+||.||+|.+++ .+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 4789999999999999999998753 59999987542 3334567889999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||++.......
T Consensus 110 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 110 LCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp CCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred cccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 99999999998542 346899999999999999999999998 99999999999998 6799999999987653221
Q ss_pred ---CCcccccccccCCcCChhhhcC---------CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhcc
Q 005871 509 ---NQANTNIIAGTYGYMAPEYAMG---------GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWC 576 (672)
Q Consensus 509 ---~~~~~~~~~gt~~Y~aPE~~~~---------~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 576 (672)
.........|++.|+|||++.+ ..++.++||||||+++|||++|+.||..... ....+...
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~- 256 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA------EAIIWQMG- 256 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH------HHHHHHHH-
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHhc-
Confidence 1122233568999999999874 4579999999999999999999999753221 11111111
Q ss_pred CCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCCCCCCCCCccc
Q 005871 577 EGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPAFS 641 (672)
Q Consensus 577 ~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~~p~~p~~~ 641 (672)
.+....... ... ...+.+++.+||+.||++|||+.+|+++|............|..+
T Consensus 257 ~~~~~~~~~----~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~ 313 (319)
T 2y4i_B 257 TGMKPNLSQ----IGM----GKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHF 313 (319)
T ss_dssp TTCCCCCCC----SSC----CTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------------
T ss_pred cCCCCCCCc----CCC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCccc
Confidence 111111111 011 123678888999999999999999999999876554444444443
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=334.95 Aligned_cols=253 Identities=26% Similarity=0.421 Sum_probs=195.5
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEe------Cc
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLE------GQ 421 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~------~~ 421 (672)
..++|++.+.||+|+||.||+|++. +++.||||++.... ...+.+.+|+.+++++ +||||+++++++.. ..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 4678999999999999999999975 68999999987543 3347789999999999 89999999999987 46
Q ss_pred eEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCc
Q 005871 422 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 501 (672)
Q Consensus 422 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla 501 (672)
..++||||+++++|.+++... ....+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred eEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 899999999999999998653 2356899999999999999999999998 999999999999999999999999999
Q ss_pred eeeCCCCCCcccccccccCCcCChhhhc-----CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhcc
Q 005871 502 RIFGGNQNQANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWC 576 (672)
Q Consensus 502 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 576 (672)
........ ......|++.|+|||++. +..++.++||||||+++|+|++|+.||...... ........
T Consensus 177 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~ 248 (326)
T 2x7f_A 177 AQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------RALFLIPR 248 (326)
T ss_dssp C---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHH
T ss_pred eecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HHHHHhhc
Confidence 86543221 223357899999999987 567899999999999999999999997532211 11111111
Q ss_pred CCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 577 EGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 577 ~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
. ...... .... ...+.+++.+||+.||++|||+.++++.
T Consensus 249 ~-~~~~~~----~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 249 N-PAPRLK----SKKW----SKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp S-CCCCCS----CSCS----CHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred C-ccccCC----cccc----CHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1 111110 1111 2356778889999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=326.76 Aligned_cols=253 Identities=28% Similarity=0.406 Sum_probs=192.0
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEe----------
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE---------- 419 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~---------- 419 (672)
.++|++.+.||+|+||.||+|++. +++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 467999999999999999999975 6899999998653 3445778999999999999999999999865
Q ss_pred ---CceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEE
Q 005871 420 ---GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKIS 496 (672)
Q Consensus 420 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~ 496 (672)
....++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 45789999999999999999642 345788999999999999999999998 9999999999999999999999
Q ss_pred eecCceeeCCCCC------------CcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCccc
Q 005871 497 DFGLARIFGGNQN------------QANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH 563 (672)
Q Consensus 497 DFgla~~~~~~~~------------~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~ 563 (672)
|||++........ ........|++.|+|||++.+. .++.++||||||+++|+|++ |+...
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~---- 231 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG---- 231 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH----
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc----
Confidence 9999986543211 1122345689999999999864 68999999999999999998 33211
Q ss_pred ccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 564 GQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.......... .... ..............+.+++.+||+.||++|||+.++++.
T Consensus 232 -~~~~~~~~~~-~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 232 -MERVNILKKL-RSVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp -HHHHHHHHHH-HSTT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -hhHHHHHHhc-cccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 0111111111 1100 001111222333457788889999999999999999974
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=332.57 Aligned_cols=265 Identities=25% Similarity=0.313 Sum_probs=198.8
Q ss_pred HhcCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeC-----ce
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QE 422 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~ 422 (672)
..++|.+.+.||+|+||.||+|.+. +|+.||||++.... ......+.+|+.++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3578999999999999999999976 68999999997543 33456788999999999999999999998754 67
Q ss_pred EEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCce
Q 005871 423 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 502 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~ 502 (672)
.++||||+. ++|..++.. ..+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++.
T Consensus 89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 999999997 588887743 35899999999999999999999998 9999999999999999999999999998
Q ss_pred eeCCCCCCc--------ccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhh
Q 005871 503 IFGGNQNQA--------NTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWK 573 (672)
Q Consensus 503 ~~~~~~~~~--------~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~ 573 (672)
.+....... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....... .......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~ 237 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH---QLLLIFG 237 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHH
Confidence 765332211 1223478999999998765 678999999999999999999999986432111 0100000
Q ss_pred hccCCC----cccccChh----hc-----CC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 574 LWCEGP----AVELIDPV----LK-----QS-----CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 574 ~~~~~~----~~~l~d~~----l~-----~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
...... ........ .. .. ..+.....+.+++.+||+.||++|||++|+++.-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP 307 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 000000 00000000 00 00 0011234567888899999999999999999854
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=330.62 Aligned_cols=264 Identities=24% Similarity=0.365 Sum_probs=198.3
Q ss_pred HhcCCccccccccCCceeEEeeee--cCCceeEEEEecccCc--ccHHHHHHHHHHHHhc---cCCCeeeEEEEEE----
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTL--ADGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKL---QHKNLVRLLGCCL---- 418 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l---~h~niv~l~~~~~---- 418 (672)
..++|++.+.||+|+||.||++.+ .+++.||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 3588999999865432 2233566788777776 8999999999987
Q ss_pred -eCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEe
Q 005871 419 -EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISD 497 (672)
Q Consensus 419 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~D 497 (672)
.....++||||+. ++|.+++.... ...+++..+..++.||+.||.|||+.| |+||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 5568999999998 58988885432 335899999999999999999999998 99999999999999999999999
Q ss_pred ecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhh---
Q 005871 498 FGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL--- 574 (672)
Q Consensus 498 Fgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~--- 574 (672)
||++....... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||....... ........
T Consensus 164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~ 237 (326)
T 1blx_A 164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGL 237 (326)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCC
T ss_pred CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcCC
Confidence 99998654221 2234578999999999999999999999999999999999999986432211 11111000
Q ss_pred -----ccCCCc--ccccCh---hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 575 -----WCEGPA--VELIDP---VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 575 -----~~~~~~--~~l~d~---~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
|..... ...... .............+.+|+.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000 000000 00000111123456788889999999999999999964
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=333.46 Aligned_cols=203 Identities=24% Similarity=0.338 Sum_probs=171.7
Q ss_pred HHHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhcc-CC-----CeeeEEEEEEeC
Q 005871 348 LEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HK-----NLVRLLGCCLEG 420 (672)
Q Consensus 348 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~-----niv~l~~~~~~~ 420 (672)
....++|++.+.||+|+||.||+|.+. +++.||||++... ......+..|+.+++.++ |+ +|+++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 345689999999999999999999976 6889999998753 234567788999999985 55 399999999999
Q ss_pred ceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc--CCCCeEEEee
Q 005871 421 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD--DDMNPKISDF 498 (672)
Q Consensus 421 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~--~~~~~kL~DF 498 (672)
+..++||||+.+ +|.+++.... ...+++..+..++.||+.||.|||.+. .+|+||||||+||||+ .++.+||+||
T Consensus 129 ~~~~lv~e~~~~-~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 129 NHLCLVFEMLSY-NLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp TEEEEEEECCCC-BHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred CceEEEEecCCC-CHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 999999999965 8888886532 245899999999999999999999531 2499999999999995 5788999999
Q ss_pred cCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCC
Q 005871 499 GLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY 559 (672)
Q Consensus 499 gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~ 559 (672)
|+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 206 G~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 206 GSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp TTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999876432 22357899999999999999999999999999999999999998643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=322.79 Aligned_cols=253 Identities=26% Similarity=0.350 Sum_probs=201.1
Q ss_pred HHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEE
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l 425 (672)
...++|++.+.||+|+||.||++++. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 44578999999999999999999986 68999999986543 3456789999999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC---CCeEEEeecCce
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD---MNPKISDFGLAR 502 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~---~~~kL~DFgla~ 502 (672)
||||+++++|.+.+... ..+++..++.++.||+.||.|||+.| |+||||||+||+++.+ +.+||+|||++.
T Consensus 99 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 99999999998888543 35899999999999999999999998 9999999999999754 469999999998
Q ss_pred eeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccc
Q 005871 503 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVE 582 (672)
Q Consensus 503 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (672)
....... .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||...... .... .. ..+....
T Consensus 173 ~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~---~~-~~~~~~~ 241 (287)
T 2wei_A 173 CFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILK---RV-ETGKYAF 241 (287)
T ss_dssp TBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HH-HHCCCCC
T ss_pred eecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH---HHHH---HH-HcCCCCC
Confidence 6543322 223468999999998865 4899999999999999999999997532211 1111 11 1111100
Q ss_pred ccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 583 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 583 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.. + ..... ...+.+++.+||+.||++|||+.++++.
T Consensus 242 ~~-~-~~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 242 DL-P-QWRTI----SDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp CS-G-GGTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred Cc-h-hhhhc----CHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 00 0 00111 2346788889999999999999999973
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=330.25 Aligned_cols=255 Identities=25% Similarity=0.369 Sum_probs=177.7
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHH-HHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVN-LIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
.++|.+.+.||+|+||.||++.+. +++.||||++.... ......+..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 368999999999999999999985 68999999997653 233445556665 777789999999999999999999999
Q ss_pred eecCCCChhHHhhhc--cccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEEcCCCCeEEEeecCceee
Q 005871 428 EYMPNKSLDVHLFDA--TRSVQLDWKRRQSIINGIARGILYLHED-SRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 504 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~-g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~ 504 (672)
||+++ +|.+++... .....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99986 777666431 2245689999999999999999999998 7 999999999999999999999999999876
Q ss_pred CCCCCCcccccccccCCcCChhhh----cCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCc
Q 005871 505 GGNQNQANTNIIAGTYGYMAPEYA----MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPA 580 (672)
Q Consensus 505 ~~~~~~~~~~~~~gt~~Y~aPE~~----~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (672)
..... .....||+.|+|||++ .+..++.++||||||+++|+|++|+.||........ ...... .+..
T Consensus 177 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~-~~~~ 247 (327)
T 3aln_A 177 VDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLTQVV-KGDP 247 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCC-CSCC
T ss_pred ccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHHHHh-cCCC
Confidence 43221 2234689999999998 456789999999999999999999999854321110 000000 1111
Q ss_pred ccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 581 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 581 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
..+ ...........+.+|+.+||+.||++|||+.+|++
T Consensus 248 ~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 PQL-----SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCC-----CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCC-----CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 111 11011112345778888999999999999999976
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=330.53 Aligned_cols=265 Identities=20% Similarity=0.275 Sum_probs=201.3
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhcc-----------CCCeeeEEEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-----------HKNLVRLLGCCL 418 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----------h~niv~l~~~~~ 418 (672)
.++|.+.+.||+|+||.||+|++. +++.||||++.... ...+.+.+|+.++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 368999999999999999999974 68999999987532 34567889999999987 899999999998
Q ss_pred eCc----eEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEEc-----
Q 005871 419 EGQ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED-SRLKIIHRDLKASNILLD----- 488 (672)
Q Consensus 419 ~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-g~~~iiHrDlkp~NIll~----- 488 (672)
..+ ..++||||+ +++|.+++.... ...+++..+..++.||+.||.|||++ | |+||||||+||||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 789999999 899998886532 34589999999999999999999998 7 99999999999994
Q ss_pred -CCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccc-
Q 005871 489 -DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQT- 566 (672)
Q Consensus 489 -~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~- 566 (672)
..+.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4447999999999876432 223478999999999999999999999999999999999999986433211110
Q ss_pred --hhhhhhhh------------------ccCCCcccccC--------hhh--cCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 005871 567 --LLTYTWKL------------------WCEGPAVELID--------PVL--KQSCAPDELLKFIHIGLLCVQQDPADRP 616 (672)
Q Consensus 567 --~~~~~~~~------------------~~~~~~~~l~d--------~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RP 616 (672)
........ +........+. ..+ ....+......+.+|+.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 00000000 00000000000 000 1123456677889999999999999999
Q ss_pred CHHHHHHHhc
Q 005871 617 TMSSVVVMLA 626 (672)
Q Consensus 617 t~~evl~~L~ 626 (672)
|++||++.--
T Consensus 327 t~~ell~hp~ 336 (373)
T 1q8y_A 327 DAGGLVNHPW 336 (373)
T ss_dssp CHHHHHTCGG
T ss_pred CHHHHhhChh
Confidence 9999998543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=337.35 Aligned_cols=258 Identities=24% Similarity=0.344 Sum_probs=194.9
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceE----
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL---- 423 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~---- 423 (672)
.++|.+.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999975 68999999997643 33457788999999999999999999999877654
Q ss_pred --EEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCc
Q 005871 424 --LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 501 (672)
Q Consensus 424 --~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla 501 (672)
++||||+. ++|...+. ..+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999998 57776662 24899999999999999999999998 999999999999999999999999999
Q ss_pred eeeCCCCCCcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCc
Q 005871 502 RIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPA 580 (672)
Q Consensus 502 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (672)
+..... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....... ........... ..
T Consensus 192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~-~~ 262 (371)
T 4exu_A 192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGV-PG 262 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCC-CC
T ss_pred cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCC-Cc
Confidence 865432 223578999999999987 678999999999999999999999985432111 01000000000 00
Q ss_pred ccccC----h-------hhcCC-------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 581 VELID----P-------VLKQS-------CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 581 ~~l~d----~-------~l~~~-------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
.+..+ . .+... ..+.....+.+|+.+||+.||++|||++|+++.--
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 326 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 326 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcc
Confidence 00000 0 00000 00112345778888999999999999999997643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=328.86 Aligned_cols=261 Identities=21% Similarity=0.268 Sum_probs=199.1
Q ss_pred HhcCCccccccccCCceeEEeeeec-CC-ceeEEEEecccCcccHHHHHHHHHHHHhccCCC------eeeEEEEEEeCc
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA-DG-KAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN------LVRLLGCCLEGQ 421 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n------iv~l~~~~~~~~ 421 (672)
..++|++.+.||+|+||.||++.+. ++ +.||+|++... ....+.+.+|+.++++++|++ ++.+++++...+
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 4578999999999999999999875 34 68999998653 344567889999999998776 999999999999
Q ss_pred eEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE--------------
Q 005871 422 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL-------------- 487 (672)
Q Consensus 422 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll-------------- 487 (672)
..++||||+ ++++.+.+... ....+++..+..++.||+.||.|||+++ |+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred eEEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence 999999999 55565565432 2246899999999999999999999997 9999999999999
Q ss_pred -----cCCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcc
Q 005871 488 -----DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSE 562 (672)
Q Consensus 488 -----~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~ 562 (672)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 56789999999999864322 22357899999999999999999999999999999999999998643221
Q ss_pred cccchhhhhhhhccCCC-------------------cccc----------cChh-hcCCCCHHHHHHHHHHHHHhcccCC
Q 005871 563 HGQTLLTYTWKLWCEGP-------------------AVEL----------IDPV-LKQSCAPDELLKFIHIGLLCVQQDP 612 (672)
Q Consensus 563 ~~~~~~~~~~~~~~~~~-------------------~~~l----------~d~~-l~~~~~~~~~~~l~~li~~cl~~dP 612 (672)
.. ..........-+ +... ..+. ............+.+|+.+||+.||
T Consensus 246 ~~---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 246 EH---LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp HH---HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred HH---HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 11 110000000000 0000 0000 0001123345578899999999999
Q ss_pred CCCCCHHHHHHH
Q 005871 613 ADRPTMSSVVVM 624 (672)
Q Consensus 613 ~~RPt~~evl~~ 624 (672)
++|||+.|+++.
T Consensus 323 ~~Rpt~~e~l~h 334 (355)
T 2eu9_A 323 AQRITLAEALLH 334 (355)
T ss_dssp TTSCCHHHHTTS
T ss_pred hhCcCHHHHhcC
Confidence 999999999853
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=328.06 Aligned_cols=247 Identities=22% Similarity=0.333 Sum_probs=192.0
Q ss_pred HHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcc------cHHHHHHHHHHHHhc----cCCCeeeEEEEE
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ------GLQEFKNEVNLIAKL----QHKNLVRLLGCC 417 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l----~h~niv~l~~~~ 417 (672)
...++|.+.+.||+|+||.||+|++. +++.||||++...... ....+.+|+.++.++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 34578999999999999999999874 6889999999765321 223456799999999 899999999999
Q ss_pred EeCceEEEEEee-cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc-CCCCeEE
Q 005871 418 LEGQELLLIYEY-MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPKI 495 (672)
Q Consensus 418 ~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~-~~~~~kL 495 (672)
.+.+..++|||| +.+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||+++ .++.+||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEE
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEE
Confidence 999999999999 789999999854 345899999999999999999999998 99999999999999 8899999
Q ss_pred EeecCceeeCCCCCCcccccccccCCcCChhhhcCCCC-ChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhh
Q 005871 496 SDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL 574 (672)
Q Consensus 496 ~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 574 (672)
+|||++....... .....|++.|+|||++.+..+ +.++||||||+++|+|++|+.||.... .....
T Consensus 182 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~- 248 (312)
T 2iwi_A 182 IDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------EILEA- 248 (312)
T ss_dssp CCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HHHHT-
T ss_pred EEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------HHhhh-
Confidence 9999998765432 233568999999999987766 459999999999999999999974211 00000
Q ss_pred ccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 575 WCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 575 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
... +... ....+.+++.+||+.||++|||++|+++.--..
T Consensus 249 --~~~--------~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~ 288 (312)
T 2iwi_A 249 --ELH--------FPAH----VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQ 288 (312)
T ss_dssp --CCC--------CCTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTC
T ss_pred --ccC--------Cccc----CCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence 000 0111 123467888899999999999999999865433
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=337.92 Aligned_cols=253 Identities=27% Similarity=0.317 Sum_probs=187.3
Q ss_pred cCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEEEEEeec
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
+.|.+.+.||+|+||+||.+...+|+.||||++.... .+.+.+|+.+|+++ +||||+++++++.+.+..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 4566778999999999987766679999999986532 35678999999987 8999999999999999999999999
Q ss_pred CCCChhHHhhhccccC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC-------------CCe
Q 005871 431 PNKSLDVHLFDATRSV----QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-------------MNP 493 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~-------------~~~ 493 (672)
. ++|.+++....... ..++..+..++.||+.||.|||+++ |+||||||+||||+.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 59999986432211 1133345789999999999999997 9999999999999754 479
Q ss_pred EEEeecCceeeCCCCCCc--ccccccccCCcCChhhhcC-------CCCChhhHHHHHHHHHHHHHc-CCCCCCCCCccc
Q 005871 494 KISDFGLARIFGGNQNQA--NTNIIAGTYGYMAPEYAMG-------GIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEH 563 (672)
Q Consensus 494 kL~DFgla~~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~-------~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~ 563 (672)
||+|||+++.+....... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||+......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 999999999875433221 2234579999999999976 568999999999999999999 899985332111
Q ss_pred ccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 564 GQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
............. ...........+.+++.+||+.||++|||+.+|++
T Consensus 248 ----~~i~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 ----SNIIRGIFSLDEM--------KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ----HHHHHTCCCCCCC--------TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HHHhcCCCCcccc--------cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1111111111110 11112344567889999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=331.26 Aligned_cols=247 Identities=23% Similarity=0.331 Sum_probs=199.1
Q ss_pred HHHHhcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcc------cHHHHHHHHHHHHhcc--CCCeeeEEEEE
Q 005871 347 ALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ------GLQEFKNEVNLIAKLQ--HKNLVRLLGCC 417 (672)
Q Consensus 347 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~--h~niv~l~~~~ 417 (672)
.....++|++.+.||+|+||.||+|.+. +++.||||++...... ..+.+.+|+.++++++ |+||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 3345678999999999999999999864 6899999998764321 2245678999999996 59999999999
Q ss_pred EeCceEEEEEeecCC-CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc-CCCCeEE
Q 005871 418 LEGQELLLIYEYMPN-KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPKI 495 (672)
Q Consensus 418 ~~~~~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~-~~~~~kL 495 (672)
.+.+..++|||++.+ ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++ +++.+||
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEE
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEE
Confidence 999999999999986 899998854 346899999999999999999999998 99999999999999 7899999
Q ss_pred EeecCceeeCCCCCCcccccccccCCcCChhhhcCCCC-ChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhh
Q 005871 496 SDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL 574 (672)
Q Consensus 496 ~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 574 (672)
+|||++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... ...
T Consensus 192 ~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------~~~--- 256 (320)
T 3a99_A 192 IDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------EII--- 256 (320)
T ss_dssp CCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HHH---
T ss_pred eeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------hhh---
Confidence 9999998765322 223568999999999987765 789999999999999999999974221 000
Q ss_pred ccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 575 WCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 575 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
.. .. ...... ...+.+++.+||+.||++|||+++|++.--
T Consensus 257 -~~-~~------~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~hp~ 296 (320)
T 3a99_A 257 -RG-QV------FFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNHPW 296 (320)
T ss_dssp -HC-CC------CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred -cc-cc------cccccC----CHHHHHHHHHHccCChhhCcCHHHHhcCHh
Confidence 00 00 001112 234678888999999999999999997543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=331.40 Aligned_cols=258 Identities=22% Similarity=0.311 Sum_probs=194.7
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCce-----
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE----- 422 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~----- 422 (672)
.++|.+.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 368999999999999999999975 68999999997643 3345678999999999999999999999987654
Q ss_pred -EEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCc
Q 005871 423 -LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 501 (672)
Q Consensus 423 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla 501 (672)
.++||||+. ++|..++. ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 599999998 57776652 24899999999999999999999998 999999999999999999999999999
Q ss_pred eeeCCCCCCcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhh------
Q 005871 502 RIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL------ 574 (672)
Q Consensus 502 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~------ 574 (672)
...... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....... ........
T Consensus 174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~ 245 (353)
T 3coi_A 174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGT 245 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH---HHHHHHHHHCBCCH
T ss_pred cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCH
Confidence 864322 223578999999999987 678999999999999999999999985432111 01000000
Q ss_pred -----ccCC-------CcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 575 -----WCEG-------PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 575 -----~~~~-------~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
+... .........+ ....+.....+.+++.+||+.||++|||++++++.--
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 308 (353)
T 3coi_A 246 EFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308 (353)
T ss_dssp HHHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred HHHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 0000 0000000000 0011122345778888999999999999999997543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=326.54 Aligned_cols=255 Identities=21% Similarity=0.222 Sum_probs=174.0
Q ss_pred HhcCCcccc-ccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEe----CceE
Q 005871 350 ATNHFSDEN-KLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE----GQEL 423 (672)
Q Consensus 350 ~~~~~~~~~-~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~----~~~~ 423 (672)
..++|.+.+ .||+|+||.||++.+. +++.||||++.... .........++.++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 357899865 6999999999999986 68999999986532 222233344677799999999999976 4568
Q ss_pred EEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---CCCeEEEeecC
Q 005871 424 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFGL 500 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~---~~~~kL~DFgl 500 (672)
++||||+++++|.+++... ....+++.+++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 9999999999999999643 2346999999999999999999999998 999999999999986 45599999999
Q ss_pred ceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCc
Q 005871 501 ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPA 580 (672)
Q Consensus 501 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (672)
+....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.......... ...........
T Consensus 178 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~ 250 (336)
T 3fhr_A 178 AKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP---GMKRRIRLGQY 250 (336)
T ss_dssp CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred ceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---hHHHhhhcccc
Confidence 98754322 233578999999999988889999999999999999999999985432211100 00000000000
Q ss_pred ccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 581 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 581 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
.. ...........+.+|+.+||+.||++|||++|+++.-
T Consensus 251 -~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 251 -GF-----PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp -CC-----CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred -cc-----CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 00 0000111234577888899999999999999999854
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=357.29 Aligned_cols=255 Identities=23% Similarity=0.339 Sum_probs=199.9
Q ss_pred HhcCCccccccccCCceeEEeeeecC----CceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEE
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 424 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 424 (672)
..++|.+.+.||+|+||.||+|.+.. +..||+|++.... ....+.+.+|+.++++++||||+++++++. ++..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 34689999999999999999998742 4579999887543 344578999999999999999999999985 45689
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceee
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 504 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~ 504 (672)
+||||+++|+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 467 lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 999999999999998542 345899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccc
Q 005871 505 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583 (672)
Q Consensus 505 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 583 (672)
...... ......|++.|+|||++.+..++.++||||||+++|||++ |..||...... .... .... +....
T Consensus 542 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~~---~i~~-~~~~~- 612 (656)
T 2j0j_A 542 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIG---RIEN-GERLP- 612 (656)
T ss_dssp CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH---HHHH-TCCCC-
T ss_pred CCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHHH---HHHc-CCCCC-
Confidence 433221 1223456789999999999999999999999999999997 88887532211 1111 1111 11000
Q ss_pred cChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 584 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
.+......+.+++.+||+.||++|||+.+|++.|..
T Consensus 613 --------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~ 648 (656)
T 2j0j_A 613 --------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 648 (656)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111122457788889999999999999999999975
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=319.22 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=178.3
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCc--ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
.++|++.+.||+|+||.||++.+. +++.||||++..... ...+.+..+..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 367999999999999999999986 689999999976532 22234455556788889999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED-SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
||+ ++.+..+... ....+++..+..++.||+.||.|||++ | |+||||||+|||++.++.+||+|||++.....
T Consensus 104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 5555544432 234689999999999999999999995 7 99999999999999999999999999976543
Q ss_pred CCCCcccccccccCCcCChhhhc-----CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcc
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAV 581 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (672)
... .....|++.|+|||++. ...++.++||||||+++|+|++|+.||...... ........... ..
T Consensus 178 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~-~~ 248 (318)
T 2dyl_A 178 DKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQEE-PP 248 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHSC-CC
T ss_pred Ccc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhccC-CC
Confidence 221 22346899999999994 456899999999999999999999997532111 11111111111 00
Q ss_pred cccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 582 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 582 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.... .... ...+.+++.+||+.||.+|||+++|++.
T Consensus 249 ~~~~---~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 249 LLPG---HMGF----SGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CCCS---SSCC----CHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCCc---cCCC----CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0000 0011 2346778889999999999999999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=331.43 Aligned_cols=250 Identities=23% Similarity=0.305 Sum_probs=185.4
Q ss_pred hcCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEEEEEee
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
..+|.+.+.||+|+||+||.....+++.||||++...... .+.+|+.+|+++ +||||+++++++.+.+..++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 3568999999999999976555567999999999764432 356799999999 799999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-----CCCeEEEeecCceee
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-----DMNPKISDFGLARIF 504 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~-----~~~~kL~DFgla~~~ 504 (672)
+. ++|.+++.... ....+..+..++.||+.||.|||+.+ |+||||||+||||+. ...+||+|||+++.+
T Consensus 100 ~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 100 CA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 97 58888885432 23455566789999999999999998 999999999999953 335889999999876
Q ss_pred CCCCCC-cccccccccCCcCChhhhc---CCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCC
Q 005871 505 GGNQNQ-ANTNIIAGTYGYMAPEYAM---GGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGP 579 (672)
Q Consensus 505 ~~~~~~-~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 579 (672)
...... .......||+.|+|||++. ...++.++|||||||++|||++ |..||+...... .........
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-------~~~~~~~~~ 246 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------ANILLGACS 246 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-------HHHHTTCCC
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-------HHHHhccCC
Confidence 533211 2233467999999999997 4567889999999999999999 888874321110 111111111
Q ss_pred cccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 580 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 580 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
. .... ........+.+|+.+||+.||++|||+.+|++
T Consensus 247 ~-~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 247 L-DCLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp C-TTSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c-cccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1 1111 01223345678889999999999999999995
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=347.46 Aligned_cols=259 Identities=24% Similarity=0.309 Sum_probs=198.1
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEeccc-CcccHHHHHHHHHHHHhccCCCeeeEEEEEEe------Cce
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE------GQE 422 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~------~~~ 422 (672)
.++|++.++||+|+||.||++.+. +|+.||||++... .....+.+.+|+.++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 478999999999999999999975 6899999998764 34456778999999999999999999999765 677
Q ss_pred EEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC---eEEEeec
Q 005871 423 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN---PKISDFG 499 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~---~kL~DFg 499 (672)
.++||||+++++|.+++........+++..++.++.||+.||.|||+.| |+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999976555556899999999999999999999998 999999999999997765 8999999
Q ss_pred CceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCC
Q 005871 500 LARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGP 579 (672)
Q Consensus 500 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 579 (672)
++........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ..+.........
T Consensus 170 ~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~ 241 (676)
T 3qa8_A 170 YAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSN 241 (676)
T ss_dssp CCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC----
T ss_pred cccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccc
Confidence 9987643322 23457899999999999999999999999999999999999998532111 111000000000
Q ss_pred cccc----------cChh--hcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 005871 580 AVEL----------IDPV--LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSS 620 (672)
Q Consensus 580 ~~~l----------~d~~--l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 620 (672)
.... .... ............+.+++.+||+.||++|||+.+
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 0000 0000 012233445677889999999999999999966
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=347.50 Aligned_cols=238 Identities=20% Similarity=0.333 Sum_probs=190.8
Q ss_pred HhcCCccccccccCCceeEEeeeec--CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCce----
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA--DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE---- 422 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~---- 422 (672)
..++|++.+.||+|+||.||++.+. +++.||||++.... ......+.+|+.++++++||||+++++++...+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 3478999999999999999999975 58999999986543 3445678999999999999999999999987655
Q ss_pred -EEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCc
Q 005871 423 -LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 501 (672)
Q Consensus 423 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla 501 (672)
.+|||||+++++|.+++.. .+++.++..|+.||+.||.|||++| |+||||||+||||+.+ .+||+|||++
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccc
Confidence 7999999999999887632 5999999999999999999999998 9999999999999985 9999999999
Q ss_pred eeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcc
Q 005871 502 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAV 581 (672)
Q Consensus 502 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (672)
+..... ....||+.|+|||++.++. +.++|||||||++|+|++|.+|+...... . ..
T Consensus 229 ~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------------~-~~ 285 (681)
T 2pzi_A 229 SRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD---------------G-LP 285 (681)
T ss_dssp EETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS---------------S-CC
T ss_pred hhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc---------------c-cc
Confidence 876432 3457999999999987654 99999999999999999998875421100 0 00
Q ss_pred cccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHhc
Q 005871 582 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT-MSSVVVMLA 626 (672)
Q Consensus 582 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~L~ 626 (672)
. ..+ .......+.+|+.+||+.||++||+ ++++.+.|.
T Consensus 286 ~-~~~------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 286 E-DDP------VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp T-TCH------HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred c-ccc------ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 0 000 0112245778889999999999995 555555554
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=301.49 Aligned_cols=229 Identities=12% Similarity=0.041 Sum_probs=181.5
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
.++|++.+.||+|+||.||+|++. +++.||||++.... .+..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 367999999999999999999986 48999999997653 23457889999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||+++++|.+++.. . ....++..|+.||+.||.|||++| |+||||||+||||+.++.+||+++
T Consensus 110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~-------- 173 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYP-------- 173 (286)
T ss_dssp EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSC--------
T ss_pred EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEec--------
Confidence 999999999999832 1 356678899999999999999998 999999999999999999999743
Q ss_pred CCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccC-
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID- 585 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d- 585 (672)
.|++| ++.++||||||+++|||++|+.||.......... ........ . ...
T Consensus 174 --------------~~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~---~~~~~~~~-~---~~~~ 225 (286)
T 3uqc_A 174 --------------ATMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA---PAERDTAG-Q---PIEP 225 (286)
T ss_dssp --------------CCCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE---ECCBCTTS-C---BCCH
T ss_pred --------------cccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH---HHHHHhcc-C---CCCh
Confidence 34443 6899999999999999999999986433221110 00000000 0 000
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
....... ...+.+++.+||+.||++| |+.|+++.|...
T Consensus 226 ~~~~~~~----~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~ 263 (286)
T 3uqc_A 226 ADIDRDI----PFQISAVAARSVQGDGGIR-SASTLLNLMQQA 263 (286)
T ss_dssp HHHCTTS----CHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred hhcccCC----CHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence 0111122 2347788889999999999 999999999874
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=321.93 Aligned_cols=240 Identities=17% Similarity=0.170 Sum_probs=177.2
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccC-CCe---------e------
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQH-KNL---------V------ 411 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h-~ni---------v------ 411 (672)
..|...+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+.+++.++| +|. +
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 45788899999999999999965 69999999987433 2336789999999999987 221 1
Q ss_pred ------eEEEEEEe-----CceEEEEEeecCCCChhHHhhhc----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 005871 412 ------RLLGCCLE-----GQELLLIYEYMPNKSLDVHLFDA----TRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 476 (672)
Q Consensus 412 ------~l~~~~~~-----~~~~~lV~Ey~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~ii 476 (672)
.++.++.. ....+++|+++ +++|.+++... .....+++..+..++.||+.||.|||+++ |+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 11111111 12467777765 67888887421 22445788899999999999999999998 99
Q ss_pred ecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhh----------cCCCCChhhHHHHHHHHH
Q 005871 477 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA----------MGGIFSIKSDVFSFGVLL 546 (672)
Q Consensus 477 HrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~----------~~~~~s~ksDvwSlGvil 546 (672)
||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||++
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 9999999999999999999999999865322 334577 999999999 555689999999999999
Q ss_pred HHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005871 547 LEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 622 (672)
Q Consensus 547 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 622 (672)
|||++|+.||........ ... ++.. ....+ ..+.+|+.+||+.||++|||+.+++
T Consensus 308 ~elltg~~Pf~~~~~~~~---~~~------------~~~~--~~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGG---SEW------------IFRS--CKNIP----QPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHSSCCCCTTGGGSC---SGG------------GGSS--CCCCC----HHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHCCCCCCCcchhhh---HHH------------HHhh--cccCC----HHHHHHHHHHccCChhhCcCHHHHH
Confidence 999999999854322111 000 0000 01122 4577888899999999999976664
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-34 Score=297.08 Aligned_cols=233 Identities=21% Similarity=0.235 Sum_probs=178.2
Q ss_pred hcCCccc-cccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHH-HhccCCCeeeEEEEEEe----CceE
Q 005871 351 TNHFSDE-NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLI-AKLQHKNLVRLLGCCLE----GQEL 423 (672)
Q Consensus 351 ~~~~~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il-~~l~h~niv~l~~~~~~----~~~~ 423 (672)
.++|.+. +.||+|+||.||++.+. +++.||+|++... ..+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567777 77999999999999975 6899999998642 4567889888 56699999999999987 6789
Q ss_pred EEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---CCCeEEEeecC
Q 005871 424 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFGL 500 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~---~~~~kL~DFgl 500 (672)
++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 9999999999999999653 2346999999999999999999999998 999999999999998 78899999999
Q ss_pred ceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCc
Q 005871 501 ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPA 580 (672)
Q Consensus 501 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (672)
+.... +..++.++||||||+++|||++|+.||.......... ........+..
T Consensus 167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~---~~~~~~~~~~~ 219 (299)
T 3m2w_A 167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIRMGQY 219 (299)
T ss_dssp CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C---CSCCSSCTTCC
T ss_pred ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH---HHHHHHhhccc
Confidence 97532 2346789999999999999999999985332111000 00000000000
Q ss_pred ccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005871 581 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625 (672)
Q Consensus 581 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 625 (672)
. ........ ....+.+++.+||+.||++|||++|+++.-
T Consensus 220 -~-~~~~~~~~----~~~~~~~li~~~l~~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 220 -E-FPNPEWSE----VSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258 (299)
T ss_dssp -S-SCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred -c-CCchhccc----CCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 0 00000011 124577888899999999999999999854
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=315.79 Aligned_cols=242 Identities=15% Similarity=0.150 Sum_probs=184.5
Q ss_pred hcCCccccccccCCceeEEeeeecCCceeEEEEecccC--------cccHHHHHHHHHHHHhcc---------CCCeeeE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--------GQGLQEFKNEVNLIAKLQ---------HKNLVRL 413 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~il~~l~---------h~niv~l 413 (672)
.++|++.++||+|+||+||+|++ +|+.||||++.... ....+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46799999999999999999998 68999999997653 233478899999999996 8888888
Q ss_pred EEEEE------------------------------eCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHH
Q 005871 414 LGCCL------------------------------EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARG 463 (672)
Q Consensus 414 ~~~~~------------------------------~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~ 463 (672)
.+.+. +.+..+|||||+++|++.+.+.. ..+++..++.|+.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 77753 26789999999999976665522 458999999999999999
Q ss_pred HHHHH-hcCCCCeeecCCCCCcEEEcCCC--------------------CeEEEeecCceeeCCCCCCcccccccccCCc
Q 005871 464 ILYLH-EDSRLKIIHRDLKASNILLDDDM--------------------NPKISDFGLARIFGGNQNQANTNIIAGTYGY 522 (672)
Q Consensus 464 L~~LH-~~g~~~iiHrDlkp~NIll~~~~--------------------~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y 522 (672)
|.||| +.+ |+||||||+||||+.++ .+||+|||+++..... ..+||+.|
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence 99999 887 99999999999999887 8999999999976532 34799999
Q ss_pred CChhhhcCCCCChhhHHHHHHHH-HHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHH
Q 005871 523 MAPEYAMGGIFSIKSDVFSFGVL-LLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFI 601 (672)
Q Consensus 523 ~aPE~~~~~~~s~ksDvwSlGvi-l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~ 601 (672)
+|||++.+.. +.++||||||++ .+++++|..||...... ..+. .............. ..........+.
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~--~~~~---~~~~~~~~~~~~~~----~~~~~~~s~~~~ 313 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL--HYLT---DKMLKQMTFKTKCN----TPAMKQIKRKIQ 313 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH--HHHH---HHHHHTCCCSSCCC----SHHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh--hHHH---HhhhhhhccCcccc----hhhhhhcCHHHH
Confidence 9999998766 999999998777 78888898885210000 0000 01110000000000 001233456788
Q ss_pred HHHHHhcccCCCCCCCHHHHH
Q 005871 602 HIGLLCVQQDPADRPTMSSVV 622 (672)
Q Consensus 602 ~li~~cl~~dP~~RPt~~evl 622 (672)
+|+.+||+.| |++|++
T Consensus 314 dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHhccC-----CHHHHH
Confidence 9999999976 999998
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-29 Score=283.70 Aligned_cols=185 Identities=16% Similarity=0.131 Sum_probs=131.5
Q ss_pred ccccCCceeEEeeeec-CCceeEEEEecccC----------cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEEEE
Q 005871 359 KLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS----------GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 359 ~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lV 426 (672)
.++.|++|.+..++.. .|+.+++|.+.+.. ....+.|.+|+++|+++ +|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 4667777777766543 58999999987542 22346799999999999 799999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||++|++|.+.|.. ...++.. .|+.||+.||+|||++| ||||||||+||||+.+|++||+|||+++....
T Consensus 321 MEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999954 3456654 48999999999999998 99999999999999999999999999987654
Q ss_pred CCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCC
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKN 555 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p 555 (672)
... .....+||+.|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus 392 ~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 332 2334689999999999865 467889999999998887666544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-26 Score=258.34 Aligned_cols=184 Identities=17% Similarity=0.179 Sum_probs=144.2
Q ss_pred ccccccccCCceeEEeeeecCCceeEEEEecccCc--------ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 355 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG--------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 355 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
...++||+|+||.||++.. .++.+++|+...... ...+.+.+|+++|++++||||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 578889998654321 1134589999999999999999666666677778999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||+++++|.+++.. +..++.||+++|.|||+++ |+||||||+|||++. ++||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999843 5689999999999999998 999999999999999 999999999998754
Q ss_pred CCCCc-----ccccccccCCcCChhhhcC--CCCChhhHHHHHHHHHHHHHcCCCC
Q 005871 507 NQNQA-----NTNIIAGTYGYMAPEYAMG--GIFSIKSDVFSFGVLLLEIISGRKN 555 (672)
Q Consensus 507 ~~~~~-----~~~~~~gt~~Y~aPE~~~~--~~~s~ksDvwSlGvil~elltG~~p 555 (672)
..... ......||+.|||||++.. ..|+..+|+|+..+-..+.+.++.+
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~r 537 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRAR 537 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccc
Confidence 32211 1235689999999999977 5678889999999998888877665
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=196.69 Aligned_cols=103 Identities=18% Similarity=0.374 Sum_probs=92.8
Q ss_pred CCcccccCCCCccCCCchHHHHHHHHHHhhhhcccCC--CCceecccC-CCCCcEEEEEeccCCCChhchHHHHHHHHHH
Q 005871 71 EEDMVLSCAVSNNTASNTFTSNLNILFNQKLHSEAGK--SLYYNASEG-EFPDSVYGLYLCKFNVSFQSCQNCIVAAVNS 147 (672)
Q Consensus 71 ~~~~~~~C~~~~~~~~s~f~~nl~~ll~~l~~~~~~~--~~f~~~~~g-~~~~~vygl~qCr~D~s~~~C~~Cl~~a~~~ 147 (672)
+..+++.|++++|+++++|++||+.||++| +++++. .+|+++..| .++++||||+|||||+++++|..||+.|+.+
T Consensus 3 t~~v~~~Cn~~~~t~~s~f~~nl~~ll~~L-~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~ 81 (108)
T 3a2e_A 3 TAFVSSACNTQKIPSGSPFNRNLRAMLADL-RQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNR 81 (108)
T ss_dssp CCEEEEEECSSBCCTTCTHHHHHHHHHHHH-HHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTT
T ss_pred cceeeeecCCCccCCCChHHHHHHHHHHHH-HhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHH
Confidence 456888999999999999999999999999 766655 456666655 4568999999999999999999999999999
Q ss_pred HhhcCCCccceEEeccccceEEEEcCCCC
Q 005871 148 VLQKCSGTKEAFIWYQVQECMVRFSDHSS 176 (672)
Q Consensus 148 ~~~~C~~~~~a~~~~~~~~C~lrYs~~~f 176 (672)
+.+.||++++|+||++. |+||||+++|
T Consensus 82 ~~~~C~~~~g~~i~~~~--C~lRY~~~~F 108 (108)
T 3a2e_A 82 IFSICNNAIGARVQLVD--CFIQYEQRSF 108 (108)
T ss_dssp HHHHTTSBSSEEEEETT--EEEEEESSCC
T ss_pred HHHHCCCCceEEEECCC--EEEEEeCCcC
Confidence 99999999999999999 9999999998
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.2e-23 Score=214.25 Aligned_cols=152 Identities=16% Similarity=0.106 Sum_probs=122.0
Q ss_pred HHHHHHhcCCccccccccCCceeEEeeeecCCceeEEEEecccCc------------------ccHHHHHHHHHHHHhcc
Q 005871 345 RLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG------------------QGLQEFKNEVNLIAKLQ 406 (672)
Q Consensus 345 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~il~~l~ 406 (672)
.........|.+.+.||+|+||.||+|.+.+|+.||||++..... .....+.+|+.+|++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 344445667888899999999999999997799999999864321 13456899999999999
Q ss_pred CCCeeeEEEEEEeCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 005871 407 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNIL 486 (672)
Q Consensus 407 h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIl 486 (672)
| +++.+++.. +..++||||+++++|.+ +. . .....++.||+.||.|||+.| |+||||||+|||
T Consensus 163 ~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~-------~--~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NIL 225 (282)
T 1zar_A 163 G---LAVPKVYAW-EGNAVLMELIDAKELYR-VR-------V--ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVL 225 (282)
T ss_dssp T---SSSCCEEEE-ETTEEEEECCCCEEGGG-CC-------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred C---CCcCeEEec-cceEEEEEecCCCcHHH-cc-------h--hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEE
Confidence 4 555554433 55699999999999987 41 1 224579999999999999998 999999999999
Q ss_pred EcCCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhc
Q 005871 487 LDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 529 (672)
Q Consensus 487 l~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 529 (672)
|+ ++.+||+|||+++. +..++|||++.
T Consensus 226 l~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp EE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred EE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 99 99999999999974 34578999874
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.83 E-value=9.5e-21 Score=165.31 Aligned_cols=92 Identities=16% Similarity=0.252 Sum_probs=82.7
Q ss_pred cccchHHHHHHHHHHHHHHhccCCCCccceeeeeccccccceeeEEeeeccCCChhhhhHHHHHHHHHhhhhcCCCCccc
Q 005871 189 IFQNTYNVTKSLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGF 268 (672)
Q Consensus 189 ~~~~~~~~~~~l~~~l~~~a~~~~~~~~~~a~~~~~~~~~~~vy~laQCt~DLs~~dC~~CL~~a~~~i~~~c~~~~~~g 268 (672)
....|+..++.|+..|...++ .+..+|+++.....+..+||||+||+|||++.+|..||+.++.+++.+|+++ +|
T Consensus 17 ~~s~f~~nl~~ll~~L~~~a~---~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~~~~C~~~--~g 91 (108)
T 3a2e_A 17 SGSPFNRNLRAMLADLRQNTA---FSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRIFSICNNA--IG 91 (108)
T ss_dssp TTCTHHHHHHHHHHHHHHHGG---GTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTHHHHTTSB--SS
T ss_pred CCChHHHHHHHHHHHHHhhCc---cccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHHHHHCCCC--ce
Confidence 346799999999999988876 4567788877766677899999999999999999999999999999999976 99
Q ss_pred eEEEcccccceeeeccc
Q 005871 269 GRILFPSCIMGFELYRY 285 (672)
Q Consensus 269 grv~~~~C~lRye~y~F 285 (672)
|+|++++|+||||.|+|
T Consensus 92 ~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 92 ARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp EEEEETTEEEEEESSCC
T ss_pred EEEECCCEEEEEeCCcC
Confidence 99999999999999998
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=4.4e-19 Score=180.79 Aligned_cols=137 Identities=19% Similarity=0.205 Sum_probs=107.3
Q ss_pred CCccccccccCCceeEEeeee-cCCce--eEEEEecccCcc------------------------cHHHHHHHHHHHHhc
Q 005871 353 HFSDENKLGQGGFGPVYKGTL-ADGKA--IAVKRLSRTSGQ------------------------GLQEFKNEVNLIAKL 405 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~il~~l 405 (672)
-|.+.+.||+|+||.||+|.+ .+|+. ||||++...... ....+.+|+.+|.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999998 67888 999987543211 113678999999999
Q ss_pred cCCCe--eeEEEEEEeCceEEEEEeecCC-C----ChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeee
Q 005871 406 QHKNL--VRLLGCCLEGQELLLIYEYMPN-K----SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH-EDSRLKIIH 477 (672)
Q Consensus 406 ~h~ni--v~l~~~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~g~~~iiH 477 (672)
+|+++ +.+++. ...+|||||+.+ | +|.+.... .++..+..++.||+.+|.||| +.| |+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVH 194 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 98864 444443 356899999942 3 56555421 224467789999999999999 887 999
Q ss_pred cCCCCCcEEEcCCCCeEEEeecCceee
Q 005871 478 RDLKASNILLDDDMNPKISDFGLARIF 504 (672)
Q Consensus 478 rDlkp~NIll~~~~~~kL~DFgla~~~ 504 (672)
|||||+|||++. .++|+|||++...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.65 E-value=3.8e-17 Score=173.98 Aligned_cols=143 Identities=15% Similarity=0.152 Sum_probs=104.6
Q ss_pred HHHHHhcCCccccccccCCceeEEeeeecCCceeEEEEecccCc--------------ccHH--------HHHHHHHHHH
Q 005871 346 LALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG--------------QGLQ--------EFKNEVNLIA 403 (672)
Q Consensus 346 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~E~~il~ 403 (672)
.......-|++.++||+|+||.||+|...+|+.||||+++.... .... ....|...|.
T Consensus 89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 33333445999999999999999999998999999998753210 0011 1235677777
Q ss_pred hccCCCee--eEEEEEEeCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 005871 404 KLQHKNLV--RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLK 481 (672)
Q Consensus 404 ~l~h~niv--~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlk 481 (672)
++.+.++. ..++. . ..+|||||++|++|..+.. ......++.||+.+|.+||+.| |||||||
T Consensus 169 rL~~~gv~vp~p~~~--~--~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~g---IVHrDLK 232 (397)
T 4gyi_A 169 ALYEEGFPVPEPIAQ--S--RHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHG---LIHGDFN 232 (397)
T ss_dssp HHHHTTCSCCCEEEE--E--TTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCS
T ss_pred HHHhcCCCCCeeeec--c--CceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCC
Confidence 77655542 22222 1 2379999999988865431 1234568899999999999998 9999999
Q ss_pred CCcEEEcCCCC----------eEEEeecCceee
Q 005871 482 ASNILLDDDMN----------PKISDFGLARIF 504 (672)
Q Consensus 482 p~NIll~~~~~----------~kL~DFgla~~~ 504 (672)
|.||||++++. +.|+||+.+...
T Consensus 233 p~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 233 EFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp TTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred HHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 99999987763 899999988753
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=5.1e-12 Score=128.24 Aligned_cols=146 Identities=16% Similarity=0.095 Sum_probs=114.7
Q ss_pred HHhcCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCceEEEEE
Q 005871 349 EATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 349 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lV~ 427 (672)
.....|.+...++.|+.+.||++... +..+++|+...........+.+|+.+++.+. +..+.+++++..+.+..++||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 34467988899999999999999864 6889999986532222346889999999995 677889999999989999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED------------------------------------- 470 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~------------------------------------- 470 (672)
||++|.+|...+. +......++.+++++|..||+.
T Consensus 90 e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 90 SEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp ECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999876531 1122346888999999999981
Q ss_pred -------------------CCCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 471 -------------------SRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 471 -------------------g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
.+..++|+|++|.|||++++..+.|+||+.+..
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 113499999999999998765567999988753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.16 E-value=5.8e-11 Score=119.70 Aligned_cols=138 Identities=17% Similarity=0.154 Sum_probs=102.7
Q ss_pred cCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCC--eeeEEEEEEeCceEEEEEee
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN--LVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~l~~~~~~~~~~~lV~Ey 429 (672)
..+.+....+.|..+.||++...+|..+++|+.... ....+..|+.+++.+.+.+ +.+++++....+..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 345554443456669999998777888999987654 2245788999999996555 55688888888889999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS-------------------------------------- 471 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g-------------------------------------- 471 (672)
++|.++. ... .+ ...++.++++.|..||+..
T Consensus 97 i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 97 VPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp CSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred cCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9998884 211 11 1256777888888888743
Q ss_pred -----------------CCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 472 -----------------RLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 472 -----------------~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
+..++|+|++|.|||+++++.+.|+||+.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998776677999998763
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.01 E-value=1e-09 Score=116.75 Aligned_cols=143 Identities=14% Similarity=0.251 Sum_probs=107.9
Q ss_pred ccccccccCCceeEEeeeecCCceeEEEEec--ccC-cccHHHHHHHHHHHHhcc--CCCeeeEEEEEEeC---ceEEEE
Q 005871 355 SDENKLGQGGFGPVYKGTLADGKAIAVKRLS--RTS-GQGLQEFKNEVNLIAKLQ--HKNLVRLLGCCLEG---QELLLI 426 (672)
Q Consensus 355 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~il~~l~--h~niv~l~~~~~~~---~~~~lV 426 (672)
...+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+.+++.|. +..+++++.++.+. +..++|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 346789999999999998754 678888775 322 122356788999999997 45578899888776 458999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS----------------------------------- 471 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g----------------------------------- 471 (672)
|||++|..+.+.. ...++..++..++.++++.|..||...
T Consensus 120 me~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 120 MEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9999998874321 123678888899999999999999731
Q ss_pred --------------------CCCeeecCCCCCcEEEcCCCC--eEEEeecCcee
Q 005871 472 --------------------RLKIIHRDLKASNILLDDDMN--PKISDFGLARI 503 (672)
Q Consensus 472 --------------------~~~iiHrDlkp~NIll~~~~~--~kL~DFgla~~ 503 (672)
+..++|+|++|.|||++.++. +.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 68999998874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.94 E-value=1.4e-09 Score=112.91 Aligned_cols=186 Identities=19% Similarity=0.226 Sum_probs=123.7
Q ss_pred ccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhcc-CCC--eeeEEEEEEeCc---eEEEEEeec
Q 005871 357 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKN--LVRLLGCCLEGQ---ELLLIYEYM 430 (672)
Q Consensus 357 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~n--iv~l~~~~~~~~---~~~lV~Ey~ 430 (672)
.+.++.|....||++. ..+++|+.... .....+.+|..+|+.+. +.. +.+++....... ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999875 56899986432 34567899999999984 332 445555443333 348899999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED---------------------------------------- 470 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---------------------------------------- 470 (672)
+|.++..... ..++..++..++.+++..|..||+.
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9998875432 2367778888889999998888862
Q ss_pred ---------------CCCCeeecCCCCCcEEEcC--CCCeEEEeecCceeeCCCCCCccc------------ccccccCC
Q 005871 471 ---------------SRLKIIHRDLKASNILLDD--DMNPKISDFGLARIFGGNQNQANT------------NIIAGTYG 521 (672)
Q Consensus 471 ---------------g~~~iiHrDlkp~NIll~~--~~~~kL~DFgla~~~~~~~~~~~~------------~~~~gt~~ 521 (672)
.+..++|+|++|.||++++ ...+.|+||+.+..-.....-... .......+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 1235899999999999998 456789999998753211000000 00000111
Q ss_pred cCC-hhhhcCCCCChhhHHHHHHHHHHHHHcCCCC
Q 005871 522 YMA-PEYAMGGIFSIKSDVFSFGVLLLEIISGRKN 555 (672)
Q Consensus 522 Y~a-PE~~~~~~~s~ksDvwSlGvil~elltG~~p 555 (672)
... |+.... .....+.|+++.++|.+.+|..+
T Consensus 254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~ 286 (304)
T 3sg8_A 254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMD 286 (304)
T ss_dssp CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHH
T ss_pred CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHH
Confidence 122 222211 12236899999999999999876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=1.3e-06 Score=90.50 Aligned_cols=136 Identities=20% Similarity=0.155 Sum_probs=96.5
Q ss_pred ccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCC---CeeeEEEEEE-eCceEEEEEeecCC
Q 005871 357 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHK---NLVRLLGCCL-EGQELLLIYEYMPN 432 (672)
Q Consensus 357 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~---niv~l~~~~~-~~~~~~lV~Ey~~~ 432 (672)
.+.++.|....||+. +..+++|+.. .......+..|..+|+.|.+. .+.+.+.+.. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888998999988 5778999853 223456789999999999753 2556666664 34567899999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 005871 433 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED------------------------------------------ 470 (672)
Q Consensus 433 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~------------------------------------------ 470 (672)
..+...... .++..+...++.++.+.|..||+.
T Consensus 98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 888753211 234455555556666666555542
Q ss_pred ---------------CCCCeeecCCCCCcEEEcC---CCCe-EEEeecCcee
Q 005871 471 ---------------SRLKIIHRDLKASNILLDD---DMNP-KISDFGLARI 503 (672)
Q Consensus 471 ---------------g~~~iiHrDlkp~NIll~~---~~~~-kL~DFgla~~ 503 (672)
.+..++|+|++|.|||++. ++.+ .|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999997 4564 8999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=1.4e-06 Score=88.15 Aligned_cols=135 Identities=16% Similarity=0.158 Sum_probs=98.0
Q ss_pred ccccCCce-eEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCceEEEEEeecCCCCh
Q 005871 359 KLGQGGFG-PVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEYMPNKSL 435 (672)
Q Consensus 359 ~LG~G~fg-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lV~Ey~~~gsL 435 (672)
.+..|..+ .||+.... ++..+++|+-... ....+..|..+|+.+. +--+.+++.++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34455554 68988765 4678999976433 3456788999999885 33467889999999999999999999888
Q ss_pred hHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 005871 436 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS-------------------------------------------- 471 (672)
Q Consensus 436 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g-------------------------------------------- 471 (672)
....... ......+..+++..|..||...
T Consensus 108 ~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 7654221 1223446667777777777421
Q ss_pred -----------CCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 472 -----------RLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 472 -----------~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12489999999999999877777999998763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=1.1e-06 Score=92.94 Aligned_cols=81 Identities=9% Similarity=0.022 Sum_probs=57.5
Q ss_pred ccccc-ccCCceeEEeeeec-------CCceeEEEEecccC---cccHHHHHHHHHHHHhccC---CCeeeEEEEEEeC-
Q 005871 356 DENKL-GQGGFGPVYKGTLA-------DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQH---KNLVRLLGCCLEG- 420 (672)
Q Consensus 356 ~~~~L-G~G~fg~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h---~niv~l~~~~~~~- 420 (672)
..+.| +.|....+|+.... ++..+++|+..... ......+..|+.+++.|.. -.+.+++.+..+.
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 34677 88999999998764 26788999765432 1012457789999998853 3577788887655
Q ss_pred --ceEEEEEeecCCCChh
Q 005871 421 --QELLLIYEYMPNKSLD 436 (672)
Q Consensus 421 --~~~~lV~Ey~~~gsL~ 436 (672)
+..++||||++|..+.
T Consensus 104 ~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTSSCEEEEECCCCBCCC
T ss_pred ccCCceEEEEecCCCChh
Confidence 3568999999987764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.01 E-value=1.7e-05 Score=82.83 Aligned_cols=141 Identities=18% Similarity=0.256 Sum_probs=81.8
Q ss_pred ccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCC--CeeeEEE------EEEeCceEEEEEe
Q 005871 357 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHK--NLVRLLG------CCLEGQELLLIYE 428 (672)
Q Consensus 357 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~--niv~l~~------~~~~~~~~~lV~E 428 (672)
.+.|+.|..+.||++...++ .+++|+.... ...+..|..+++.|... .+++++. +....+..+++||
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 34566677899999987554 5899988752 23344566666666421 2333332 1234667899999
Q ss_pred ecCCCChh--------------HHhhhccccC-----------CCCHHH-------------------------------
Q 005871 429 YMPNKSLD--------------VHLFDATRSV-----------QLDWKR------------------------------- 452 (672)
Q Consensus 429 y~~~gsL~--------------~~l~~~~~~~-----------~l~~~~------------------------------- 452 (672)
|++|..+. ..++...... .-.|..
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99987542 0111111100 012211
Q ss_pred HHHHHHHHHHHHHHHHh----------cCCCCeeecCCCCCcEEEcCCCCeEEEeecCce
Q 005871 453 RQSIINGIARGILYLHE----------DSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 502 (672)
Q Consensus 453 ~~~i~~qi~~~L~~LH~----------~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~ 502 (672)
...+...+..++.+|++ ..+..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11112223445666663 123469999999999999888899999999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.01 E-value=1.5e-05 Score=85.46 Aligned_cols=75 Identities=11% Similarity=0.161 Sum_probs=50.8
Q ss_pred ccccccCCceeEEeeeec-CCceeEEEEecccCc-------ccHHHHHHHHHHHHhccC--C-CeeeEEEEEEeCceEEE
Q 005871 357 ENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-------QGLQEFKNEVNLIAKLQH--K-NLVRLLGCCLEGQELLL 425 (672)
Q Consensus 357 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~il~~l~h--~-niv~l~~~~~~~~~~~l 425 (672)
.+.||.|..+.||++... +++.++||....... ...+.+..|.++|+.+.. + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 567999999999999764 468899997643211 123456789999998853 3 34456544 3445689
Q ss_pred EEeecCCC
Q 005871 426 IYEYMPNK 433 (672)
Q Consensus 426 V~Ey~~~g 433 (672)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.92 E-value=3.9e-05 Score=78.48 Aligned_cols=82 Identities=18% Similarity=0.187 Sum_probs=61.8
Q ss_pred HhcCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCC---CeeeEEEEEEeCceEEEE
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHK---NLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~---niv~l~~~~~~~~~~~lV 426 (672)
........+.+|.|..+.||+.+..||+.+++|+...........|..|...|+.|.-. -+++++... ..++|
T Consensus 13 ~G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv 88 (288)
T 3f7w_A 13 TGREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLA 88 (288)
T ss_dssp HCCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEE
T ss_pred cCCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEE
Confidence 34566778889999999999999999999999987655444445688999999998432 345555542 23789
Q ss_pred EeecCCCCh
Q 005871 427 YEYMPNKSL 435 (672)
Q Consensus 427 ~Ey~~~gsL 435 (672)
|||++++..
T Consensus 89 ~e~l~~~~~ 97 (288)
T 3f7w_A 89 MEWVDERPP 97 (288)
T ss_dssp EECCCCCCC
T ss_pred EEeecccCC
Confidence 999987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.81 E-value=0.00011 Score=76.21 Aligned_cols=140 Identities=19% Similarity=0.187 Sum_probs=93.3
Q ss_pred ccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccC---CCeeeEEEEEEeCceEEEEEeecC
Q 005871 355 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH---KNLVRLLGCCLEGQELLLIYEYMP 431 (672)
Q Consensus 355 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h---~niv~l~~~~~~~~~~~lV~Ey~~ 431 (672)
...+.|+.|....+|+... ++..+++|+.... ....+..|...|+.|.. ..+++++.+....+..++||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 4456899999999999986 4678889976543 35678899999999853 557888888887888999999999
Q ss_pred CCChhH-----------Hhhhccc--c-----------------CCCCHHHHH---HHH----------------HHHHH
Q 005871 432 NKSLDV-----------HLFDATR--S-----------------VQLDWKRRQ---SII----------------NGIAR 462 (672)
Q Consensus 432 ~gsL~~-----------~l~~~~~--~-----------------~~l~~~~~~---~i~----------------~qi~~ 462 (672)
+..+.. .|+.... . -.-+|.... ++. ..++.
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 986521 1221111 0 012344321 011 11222
Q ss_pred HH-HHHHh-cCCCCeeecCCCCCcEEEcCCCCeEEEeec
Q 005871 463 GI-LYLHE-DSRLKIIHRDLKASNILLDDDMNPKISDFG 499 (672)
Q Consensus 463 ~L-~~LH~-~g~~~iiHrDlkp~NIll~~~~~~kL~DFg 499 (672)
.+ ..|.. ..+..++|+|+.+.|++++.++ +.|+||.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 22 23432 2245799999999999999887 8899974
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00023 Score=76.95 Aligned_cols=78 Identities=13% Similarity=0.112 Sum_probs=47.6
Q ss_pred CCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCcccccccc--cCCcCChhhhcCC---CCChhhHHHHHHHHH
Q 005871 472 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAG--TYGYMAPEYAMGG---IFSIKSDVFSFGVLL 546 (672)
Q Consensus 472 ~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~g--t~~Y~aPE~~~~~---~~s~ksDvwSlGvil 546 (672)
...++|+|++|.|||++.++ ++|+||+.+..-.... ....... ...|++|+..... .-....++......+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~---Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF---DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH---HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH---HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 34699999999999999876 9999999887521000 0000010 1235666554311 112345566888888
Q ss_pred HHHHcCC
Q 005871 547 LEIISGR 553 (672)
Q Consensus 547 ~elltG~ 553 (672)
|+.+.+.
T Consensus 307 ~~~y~~~ 313 (420)
T 2pyw_A 307 WNLFNKR 313 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 8887653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00022 Score=73.86 Aligned_cols=143 Identities=16% Similarity=0.138 Sum_probs=80.6
Q ss_pred ccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCC--eeeEEEE------EEeCceEEEEEe
Q 005871 357 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN--LVRLLGC------CLEGQELLLIYE 428 (672)
Q Consensus 357 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~l~~~------~~~~~~~~lV~E 428 (672)
.+.|+.|....+|+....++ .+++|+..... ..+.+..|..+++.|...+ +.+++.. ....+..+++|+
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 35677788899999987655 68899886531 1234566888888775322 2333321 123456789999
Q ss_pred ecCCCChhH--------------Hhhhcccc------CCC---CHHHHHH------------HHHHHHHHHHHHHhc---
Q 005871 429 YMPNKSLDV--------------HLFDATRS------VQL---DWKRRQS------------IINGIARGILYLHED--- 470 (672)
Q Consensus 429 y~~~gsL~~--------------~l~~~~~~------~~l---~~~~~~~------------i~~qi~~~L~~LH~~--- 470 (672)
|++|..+.. .++..... ... .|..... +...+...+..++..
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 999865421 01111000 001 1221100 001133445555432
Q ss_pred -CCCCeeecCCCCCcEEEcCCCCeEEEeecCce
Q 005871 471 -SRLKIIHRDLKASNILLDDDMNPKISDFGLAR 502 (672)
Q Consensus 471 -g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~ 502 (672)
.+..++|+|+++.|||+++++.+.|+||+.+.
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 13469999999999999987656899998775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00027 Score=76.66 Aligned_cols=73 Identities=15% Similarity=0.243 Sum_probs=51.1
Q ss_pred ccccccCCceeEEeeeecC--------CceeEEEEecccCcccHHHHHHHHHHHHhccCCCe-eeEEEEEEeCceEEEEE
Q 005871 357 ENKLGQGGFGPVYKGTLAD--------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIY 427 (672)
Q Consensus 357 ~~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~ni-v~l~~~~~~~~~~~lV~ 427 (672)
.+.|+.|-...||++...+ +..+++|+..... ....+..|..+++.|...++ +++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4678888899999998653 4788999874321 12455689999999864444 567766542 3899
Q ss_pred eecCCCCh
Q 005871 428 EYMPNKSL 435 (672)
Q Consensus 428 Ey~~~gsL 435 (672)
||++|.++
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987444
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00046 Score=70.85 Aligned_cols=141 Identities=11% Similarity=0.136 Sum_probs=78.8
Q ss_pred CccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCe-eeEEEEEEeCceEEEEEeec-C
Q 005871 354 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIYEYM-P 431 (672)
Q Consensus 354 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~ni-v~l~~~~~~~~~~~lV~Ey~-~ 431 (672)
+.-.+.|+.|....+|+. ..+++|+........ ....+|+.+++.+...++ .++++. +.+.-++|+||+ +
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAG 91 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTT
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCC
Confidence 333788999999999998 578889876532221 223568888888854333 456554 333457899999 6
Q ss_pred CCChhHHh------------------hhccc--cCCCC-HHHHHHHHHH--------------HHHHHH----HHHh-cC
Q 005871 432 NKSLDVHL------------------FDATR--SVQLD-WKRRQSIING--------------IARGIL----YLHE-DS 471 (672)
Q Consensus 432 ~gsL~~~l------------------~~~~~--~~~l~-~~~~~~i~~q--------------i~~~L~----~LH~-~g 471 (672)
+.++.... +.... ....+ +.....+... +...+. .+.. ..
T Consensus 92 g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~ 171 (301)
T 3dxq_A 92 AQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPL 171 (301)
T ss_dssp CEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCC
T ss_pred CccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCC
Confidence 65553210 00000 00001 1111111110 111111 1111 12
Q ss_pred CCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 472 RLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 472 ~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
+..++|+|+.|.||+ ..++.+.|+||..+..
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 345899999999999 5667899999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.27 E-value=0.0017 Score=67.17 Aligned_cols=142 Identities=15% Similarity=0.158 Sum_probs=83.2
Q ss_pred cccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCC--eeeEEEE-----EEeCceEEEEEeec
Q 005871 358 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN--LVRLLGC-----CLEGQELLLIYEYM 430 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~l~~~-----~~~~~~~~lV~Ey~ 430 (672)
..|+ |....||++...+|+.+++|...... .....+..|..+++.+.... +++++.. ....+..+++|||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 88889999887778889999986332 12356677888888885322 3444432 12345678899999
Q ss_pred CCCChhH-----H---------hhhccc------cCCCCHHHH----------------------HHHHHHHHHHHHHHH
Q 005871 431 PNKSLDV-----H---------LFDATR------SVQLDWKRR----------------------QSIINGIARGILYLH 468 (672)
Q Consensus 431 ~~gsL~~-----~---------l~~~~~------~~~l~~~~~----------------------~~i~~qi~~~L~~LH 468 (672)
+|..+.. . ++.... ....++... ...+..++..+.-+-
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8855420 0 111000 011222111 111122222222221
Q ss_pred h-cCCCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 469 E-DSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 469 ~-~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
. ..+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1 1234589999999999999 4 899999988754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0015 Score=67.91 Aligned_cols=142 Identities=15% Similarity=0.155 Sum_probs=74.0
Q ss_pred ccccccCCcee-EEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCC--eeeEEEEEEeCceEEEEEeecCCC
Q 005871 357 ENKLGQGGFGP-VYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN--LVRLLGCCLEGQELLLIYEYMPNK 433 (672)
Q Consensus 357 ~~~LG~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~l~~~~~~~~~~~lV~Ey~~~g 433 (672)
.+.|+.|.... +|+....++..+++|....... ..+..|+.+++.+.... +.+++.+..+.+ +++||++.+.
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 34566565444 6677654467787876543321 23345777777774323 456666533333 7899999876
Q ss_pred ChhHHhhhccc-----------------------cCCCCHHHHH-------HHH-------------HHHHHHHHHHH--
Q 005871 434 SLDVHLFDATR-----------------------SVQLDWKRRQ-------SII-------------NGIARGILYLH-- 468 (672)
Q Consensus 434 sL~~~l~~~~~-----------------------~~~l~~~~~~-------~i~-------------~qi~~~L~~LH-- 468 (672)
.+...+..... ...++..... .+. ..+...+..+.
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 66543321100 0011111100 000 01111222221
Q ss_pred -hcCCCCeeecCCCCCcEEEcCC----CCeEEEeecCcee
Q 005871 469 -EDSRLKIIHRDLKASNILLDDD----MNPKISDFGLARI 503 (672)
Q Consensus 469 -~~g~~~iiHrDlkp~NIll~~~----~~~kL~DFgla~~ 503 (672)
...+..++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1123469999999999999875 6789999998875
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00084 Score=71.36 Aligned_cols=142 Identities=17% Similarity=0.244 Sum_probs=85.2
Q ss_pred ccccccCCceeEEeeeec--------CCceeEEEEecccCcccHHHHHHHHHHHHhccCCC-eeeEEEEEEeCceEEEEE
Q 005871 357 ENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN-LVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 357 ~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n-iv~l~~~~~~~~~~~lV~ 427 (672)
.+.|..|-...+|++... +++.+++|+.... ........+|..+++.|.-.+ ..++++.+.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 356777888899998864 2478899886332 234566778999999885333 3566666543 2999
Q ss_pred eecCCCChhHH--------------h---hhcc--ccCCC--CHHHHHHHHHHHHH-------------------HHHH-
Q 005871 428 EYMPNKSLDVH--------------L---FDAT--RSVQL--DWKRRQSIINGIAR-------------------GILY- 466 (672)
Q Consensus 428 Ey~~~gsL~~~--------------l---~~~~--~~~~l--~~~~~~~i~~qi~~-------------------~L~~- 466 (672)
||++|..|..- | +... -.... -+.++.++..++-. .+..
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998665311 0 0000 01112 24555555544422 1233
Q ss_pred ---HHhc-CCCCeeecCCCCCcEEEcCC----CCeEEEeecCcee
Q 005871 467 ---LHED-SRLKIIHRDLKASNILLDDD----MNPKISDFGLARI 503 (672)
Q Consensus 467 ---LH~~-g~~~iiHrDlkp~NIll~~~----~~~kL~DFgla~~ 503 (672)
|... .+..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3222 23469999999999999876 7899999998864
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0015 Score=71.34 Aligned_cols=75 Identities=13% Similarity=0.064 Sum_probs=49.9
Q ss_pred cccccccCCceeEEeeeecC-CceeEEEEecccCcccHHHHHHHHHHHHhccCCCe-eeEEEEEEeCceEEEEEeecCCC
Q 005871 356 DENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIYEYMPNK 433 (672)
Q Consensus 356 ~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~ni-v~l~~~~~~~~~~~lV~Ey~~~g 433 (672)
..+.|+.|-...+|++...+ +..+++|+........ -....|..+++.|...++ .++++.+. + .+||||++|.
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~ 186 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY 186 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence 34678888899999998765 5788899875433221 122589999999975555 56777663 2 3599999885
Q ss_pred Ch
Q 005871 434 SL 435 (672)
Q Consensus 434 sL 435 (672)
+|
T Consensus 187 ~l 188 (458)
T 2qg7_A 187 AL 188 (458)
T ss_dssp EC
T ss_pred cC
Confidence 54
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0009 Score=70.77 Aligned_cols=74 Identities=12% Similarity=0.138 Sum_probs=46.1
Q ss_pred ccccccCCceeEEeeeecC---------CceeEEEEecccCcccHHHHHHHHHHHHhccCCC-eeeEEEEEEeCceEEEE
Q 005871 357 ENKLGQGGFGPVYKGTLAD---------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN-LVRLLGCCLEGQELLLI 426 (672)
Q Consensus 357 ~~~LG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n-iv~l~~~~~~~~~~~lV 426 (672)
.+.|+.|....+|++...+ +..+++|+....... ......|..+++.+...+ ..++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 4567888888999998654 267888876543221 123467888888886444 34666554 2 2689
Q ss_pred EeecCCCCh
Q 005871 427 YEYMPNKSL 435 (672)
Q Consensus 427 ~Ey~~~gsL 435 (672)
|||++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999998544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0032 Score=65.85 Aligned_cols=68 Identities=10% Similarity=0.100 Sum_probs=44.5
Q ss_pred ccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccC---CCeeeEEEE------EEeCceEEEEEeecC
Q 005871 361 GQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH---KNLVRLLGC------CLEGQELLLIYEYMP 431 (672)
Q Consensus 361 G~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h---~niv~l~~~------~~~~~~~~lV~Ey~~ 431 (672)
|.|....||+....+| .+++|+...... ..|+.+++.|.. |.+++.+.. ....+..+++|+|++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 3344689999987777 899998765432 356666766642 224444432 233567899999999
Q ss_pred CCCh
Q 005871 432 NKSL 435 (672)
Q Consensus 432 ~gsL 435 (672)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8765
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.35 E-value=0.016 Score=55.82 Aligned_cols=104 Identities=13% Similarity=0.032 Sum_probs=66.7
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCc
Q 005871 432 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 511 (672)
Q Consensus 432 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 511 (672)
.-+|.+.|.- ...+++++++|.++.|.+..|.-+-... .+ ..+=+.|..|++..+|+|.+.+ ..+.
T Consensus 32 ~vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 32 ALSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred cccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc---------
Confidence 3467888853 4568999999999999999987762211 01 1223457899999999988764 1110
Q ss_pred ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCC
Q 005871 512 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKN 555 (672)
Q Consensus 512 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p 555 (672)
.....+.+||... ...+.+.=|||||+++|.-+--..|
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123466888763 3457899999999999999864433
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.44 E-value=0.05 Score=58.48 Aligned_cols=141 Identities=17% Similarity=0.200 Sum_probs=85.9
Q ss_pred ccccccCCceeEEeeeecC--------CceeEEEEecccCcccHHHHHHHHHHHHhccCCC-eeeEEEEEEeCceEEEEE
Q 005871 357 ENKLGQGGFGPVYKGTLAD--------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN-LVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 357 ~~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n-iv~l~~~~~~~~~~~lV~ 427 (672)
.+.|..|-...+|+....+ +..+++|+....... .....+|..+++.+...+ ..++++.+. -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 4567778888999998753 578899886543322 223467888888885433 345665432 27899
Q ss_pred eecCCCChhHH-----------------hhh--c-----c---ccCCCCHHHHHHHHHHHH-------------------
Q 005871 428 EYMPNKSLDVH-----------------LFD--A-----T---RSVQLDWKRRQSIINGIA------------------- 461 (672)
Q Consensus 428 Ey~~~gsL~~~-----------------l~~--~-----~---~~~~l~~~~~~~i~~qi~------------------- 461 (672)
||++|..|..- ++. . . ...+.-+.++.++..++-
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 99998664210 000 0 0 011112444444443321
Q ss_pred HHHHHHH---------------------hcCCCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 462 RGILYLH---------------------EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 462 ~~L~~LH---------------------~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
..+.+|. ...+..++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2223332 112346999999999999 8888999999998864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.33 E-value=0.086 Score=56.20 Aligned_cols=30 Identities=27% Similarity=0.416 Sum_probs=25.5
Q ss_pred CeeecCCCCCcEEE------cCCCCeEEEeecCcee
Q 005871 474 KIIHRDLKASNILL------DDDMNPKISDFGLARI 503 (672)
Q Consensus 474 ~iiHrDlkp~NIll------~~~~~~kL~DFgla~~ 503 (672)
.++|+|+.+.|||+ +++..++++||..+..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4567799999998864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=83.77 E-value=4.6 Score=38.61 Aligned_cols=115 Identities=10% Similarity=0.073 Sum_probs=80.1
Q ss_pred cCCCeeeEEEEEEeCceEEEEEeecCC-CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCc
Q 005871 406 QHKNLVRLLGCCLEGQELLLIYEYMPN-KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASN 484 (672)
Q Consensus 406 ~h~niv~l~~~~~~~~~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~N 484 (672)
.||++++. .+-.+.+.+.+.++.-+. .++.. + ..++...++.++.+|+....+++. -+|--|.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence 57888876 566667777777775542 22222 2 247888999999999988866654 4778899999
Q ss_pred EEEcCCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCC
Q 005871 485 ILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNG 557 (672)
Q Consensus 485 Ill~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~ 557 (672)
|+++.++.+++.--|+-. -++|. .+++..=+-.+=+++..+++++..|+
T Consensus 110 L~f~~~~~p~i~~RGik~-------------------~l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQN-------------------VVDPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEECTTSCEEESCCEETT-------------------TBSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEcCCCCEEEEEccCcc-------------------CCCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999997655432 12232 22333445577889999999988763
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 672 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-78 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-72 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-68 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-68 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-67 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-67 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-67 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-67 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-67 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-66 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-66 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-65 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-65 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-65 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-65 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-64 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-64 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-63 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-63 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-63 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-62 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-61 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-61 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-61 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-61 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-60 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-60 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-59 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-57 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-57 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-57 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-55 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-53 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-52 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-50 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-49 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-49 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-48 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-48 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-48 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-46 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-46 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-46 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-46 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-45 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-45 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-45 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-43 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-43 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-42 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-40 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-38 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-35 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-33 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-23 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 249 bits (638), Expect = 1e-78
Identities = 74/286 (25%), Positives = 137/286 (47%), Gaps = 20/286 (6%)
Query: 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 411
+ ++G G FG VYKG A+ + ++ + Q LQ FKNEV ++ K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 412 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 471
+G Q L ++ ++ SL HL + + + I A+G+ YLH
Sbjct: 68 LFMGYSTAPQ-LAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAK- 123
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG- 530
IIHRDLK++NI L +D+ KI DFGLA + ++G+ +MAPE
Sbjct: 124 --SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 531 --GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588
+S +SDV++FG++L E+++G+ Y + + + + + G + V
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQI---IFMVGRGYLSPDLSKV- 234
Query: 589 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQ 634
+S P + + + C+++ +RP ++ + + ++P+
Sbjct: 235 -RSNCPKAMKRLM---AECLKKKRDERPLFPQILASIELLARSLPK 276
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (592), Expect = 6e-72
Identities = 87/274 (31%), Positives = 131/274 (47%), Gaps = 22/274 (8%)
Query: 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 411
+LG G FG V+ G +AVK L + S F E NL+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 412 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 471
RL + + +I EYM N SL L ++L + + IA G+ ++ E
Sbjct: 72 RLYAVVTQE-PIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEE-- 127
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 531
IHRDL+A+NIL+ D ++ KI+DFGLAR+ N+ A + APE G
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTAPEAINYG 185
Query: 532 IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQS 591
F+IKSDV+SFG+LL EI++ + Y ++ + G ++ P
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRI--PYPGMTNPEVI----QNLERGY--RMVRP----D 233
Query: 592 CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
P+EL + + LC ++ P DRPT + +L
Sbjct: 234 NCPEELYQLM---RLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (569), Expect = 1e-68
Identities = 69/274 (25%), Positives = 120/274 (43%), Gaps = 22/274 (8%)
Query: 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 411
+ + ++G G FG V+ G + +A+K + R ++F E ++ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 412 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 471
+L G CLE + L++E+M + L +L + + + + G +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEG---MAYLE 118
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 531
+IHRDL A N L+ ++ K+SDFG+ R +Q ++ + +PE
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177
Query: 532 IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQS 591
+S KSDV+SFGVL+ E+ S K Y + ++ + L P L
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKI--PYENRSNSEVVEDISTGF------RLYKPRL--- 226
Query: 592 CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
A + + + C ++ P DRP S ++ L
Sbjct: 227 -ASTHVYQIM---NHCWKERPEDRPAFSRLLRQL 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 4e-68
Identities = 79/288 (27%), Positives = 132/288 (45%), Gaps = 22/288 (7%)
Query: 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 411
E KLGQG FG V+ GT +A+K L + + F E ++ KL+H+ LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 412 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 471
+L + + ++ EYM SL L T + + IA G+ Y+
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVE--- 130
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 531
R+ +HRDL+A+NIL+ +++ K++DFGLAR+ N+ A + APE A+ G
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYG 189
Query: 532 IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQS 591
F+IKSDV+SFG+LL E+ + + Y + +L + ++ +
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRV--PYPGMVNREVL-------------DQVERGYRMP 234
Query: 592 CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPA 639
C P+ + C +++P +RPT + L + +P
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 1e-67
Identities = 70/304 (23%), Positives = 122/304 (40%), Gaps = 44/304 (14%)
Query: 350 ATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGL-QEFKNEVNLIAKLQH 407
+ F ++LG G G V+K + G +A K + + + E+ ++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 408 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 467
+V G E+ + E+M SLD L A R + + + + +G+ YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120
Query: 468 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 527
+ KI+HRD+K SNIL++ K+ DFG++ + N GT YM+PE
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPER 174
Query: 528 AMGGIFSIKSDVFSFGVLLLEIISGR-----------------------KNNGFYFSEHG 564
G +S++SD++S G+ L+E+ GR G
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 565 QTLLTYTWKLWCEGPAVELID-------PVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 617
+ L +Y EL+D P L E F++ C+ ++PA+R
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN---KCLIKNPAERAD 291
Query: 618 MSSV 621
+ +
Sbjct: 292 LKQL 295
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 2e-67
Identities = 62/291 (21%), Positives = 114/291 (39%), Gaps = 28/291 (9%)
Query: 357 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 416
+ +G+G FG V++G G+ +AVK S + + E+ L+H+N++ +
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAA 65
Query: 417 CLEGQ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED-- 470
+ +L L+ +Y + SL +L + + + A G+ +LH +
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 471 ---SRLKIIHRDLKASNILLDDDMNPKISDFGLARIF--GGNQNQANTNIIAGTYGYMAP 525
+ I HRDLK+ NIL+ + I+D GLA + N GT YMAP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 526 EYAMGGI------FSIKSDVFSFGVLLLEIISGRKNNGFYFSE----HGQTLLTYTWKLW 575
E I ++D+++ G++ EI G + + + +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 576 CEGPAVELIDPVLKQSCAPDELLKFIH-IGLLCVQQDPADRPTMSSVVVML 625
+ + + P + E L+ + I C + A R T + L
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 3e-67
Identities = 69/274 (25%), Positives = 114/274 (41%), Gaps = 22/274 (8%)
Query: 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 411
+ +LG G FG V G +A+K + S EF E ++ L H+ LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 412 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 471
+L G C + + + +I EYM N L +L + + ++ + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK- 119
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 531
+ +HRDL A N L++D K+SDFGL+R ++ ++ + PE M
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK-FPVRWSPPEVLMYS 176
Query: 532 IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQS 591
FS KSD+++FGVL+ EI S K ++ + E I L+
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK---------------MPYERFTNSETAEHIAQGLRLY 221
Query: 592 CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
K I C + +RPT ++ +
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 4e-67
Identities = 71/301 (23%), Positives = 126/301 (41%), Gaps = 26/301 (8%)
Query: 345 RLALEATNHFSDENKLGQGGFGPVYKGTLA---DGKAIAVKRLSRTSGQG-LQEFKNEVN 400
+L L+ N + +LG G FG V +G +A+K L + + + +E E
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 401 LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI 460
++ +L + +VRL+G C + + L+L+ E L L + ++ +++ +
Sbjct: 62 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQV 118
Query: 461 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN-TNIIAGT 519
+ G+ YL +HRDL A N+LL + KISDFGL++ G + + +
Sbjct: 119 SMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
Query: 520 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGP 579
+ APE FS +SDV+S+GV + E +S + Y G ++ +G
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK--PYKKMKGPEVM----AFIEQGK 229
Query: 580 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPA 639
+E P EL + C DRP +V + + ++ E
Sbjct: 230 RMECPPEC------PPELYALM---SDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 280
Query: 640 F 640
Sbjct: 281 H 281
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 219 bits (558), Expect = 7e-67
Identities = 75/275 (27%), Positives = 126/275 (45%), Gaps = 22/275 (8%)
Query: 352 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 410
+ ++KLG G +G VY+G +AVK L + + ++EF E ++ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 411 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 470
V+LLG C +I E+M +L +L + R ++ + I+ + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE-- 132
Query: 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 530
+ IHRDL A N L+ ++ K++DFGL+R+ G+ A+ + APE
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAY 190
Query: 531 GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590
FSIKSDV++FGVLL EI + + Y + EL++ +
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMS--PYPGIDLSQVY-------------ELLEKDYRM 235
Query: 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
K + C Q +P+DRP+ + +
Sbjct: 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 4e-66
Identities = 74/276 (26%), Positives = 118/276 (42%), Gaps = 28/276 (10%)
Query: 356 DENKLGQGGFGPVYKGTLAD---GKAIAVKRLSRTSGQG--LQEFKNEVNLIAKLQHKNL 410
++ +LG G FG V KG K +AVK L + E E N++ +L + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 411 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 470
VR++G C E + +L+ E L+ +L + K +++ ++ G+ YL
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE-- 124
Query: 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI-IAGTYGYMAPEYAM 529
+HRDL A N+LL KISDFGL++ ++N + APE
Sbjct: 125 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 530 GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589
FS KSDV+SFGVL+ E S + Y G + + +G +
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQK--PYRGMKGSEVT----AMLEKGERMGCPAGC-- 235
Query: 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
P E+ + LC D +RP ++V + L
Sbjct: 236 ----PREMYDLM---NLCWTYDVENRPGFAAVELRL 264
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 6e-66
Identities = 77/275 (28%), Positives = 117/275 (42%), Gaps = 28/275 (10%)
Query: 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 411
+G+G FG V G G +AVK + + Q F E +++ +L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 412 RLLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 470
+LLG +E + L ++ EYM SL +L RSV L + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLE-- 120
Query: 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 530
+HRDL A N+L+ +D K+SDFGL + Q+ + APE
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----LPVKWTAPEALRE 174
Query: 531 GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590
FS KSDV+SFG+LL EI S + Y + ++ +G ++ D
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRV--PYPRIPLKDVV----PRVEKGYKMDAPDGC--- 225
Query: 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
P + + + C D A RP+ + L
Sbjct: 226 ---PPAVYEVM---KNCWHLDAAMRPSFLQLREQL 254
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 216 bits (552), Expect = 1e-65
Identities = 76/279 (27%), Positives = 123/279 (44%), Gaps = 34/279 (12%)
Query: 351 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG---LQEFKNEVNLIAKLQ 406
FSD ++G G FG VY + + + +A+K++S + Q Q+ EV + KL+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 407 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 466
H N ++ GC L L+ EY + D+ L ++ +G +G+ Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAY 130
Query: 467 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 526
LH +IHRD+KA NILL + K+ DFG A I A N GT +MAPE
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPE 181
Query: 527 YAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583
+ G + K DV+S G+ +E+ + F+ + + L + +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKP---PLFNMNAMSALYHI---------AQN 229
Query: 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 622
P L+ + F+ C+Q+ P DRPT ++
Sbjct: 230 ESPALQSGHWSEYFRNFV---DSCLQKIPQDRPTSEVLL 265
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 1e-65
Identities = 72/281 (25%), Positives = 129/281 (45%), Gaps = 27/281 (9%)
Query: 352 NHFSDENKLGQGGFGPVYKGTLADG-----KAIAVKRLSRTSGQG-LQEFKNEVNLIAKL 405
+ + + +G G FG VYKG L +A+K L + +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 406 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 465
H N++RL G + + +++I EYM N +LD L + + + + ++ GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124
Query: 466 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI-IAGTYGYMA 524
YL + +HRDL A NIL++ ++ K+SDFGL+R+ + T + A
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 525 PEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584
PE F+ SDV+SFG+++ E+++ + + S H ++ I
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---------------VMKAI 226
Query: 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
+ + D + + C QQ+ A RP + +V +L
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 215 bits (549), Expect = 2e-65
Identities = 74/294 (25%), Positives = 126/294 (42%), Gaps = 37/294 (12%)
Query: 349 EATNHFSDE---------NKLGQGGFGPVYKGTLA----DGKAIAVKRL-SRTSGQGLQE 394
EA F+ E +G G FG V G L +A+K L S + + ++
Sbjct: 14 EAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRD 73
Query: 395 FKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQ 454
F +E +++ + H N++ L G + +++I E+M N SLD L Q +
Sbjct: 74 FLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQFTVIQLV 131
Query: 455 SIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 514
++ GIA G+ YL + +HRDL A NIL++ ++ K+SDFGL+R + +
Sbjct: 132 GMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT 188
Query: 515 I---IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYT 571
+ APE F+ SDV+S+G+++ E++S + Y+ Q ++
Sbjct: 189 SALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER--PYWDMTNQDVI--- 243
Query: 572 WKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
I+ + D + L C Q+D RP +V L
Sbjct: 244 ----------NAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 214 bits (546), Expect = 5e-65
Identities = 77/302 (25%), Positives = 127/302 (42%), Gaps = 46/302 (15%)
Query: 352 NHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTSGQGLQ-EFKNEVNLIAK 404
N+ +G+G FG V++ +AVK L + +Q +F+ E L+A+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 405 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATR-------------------- 444
+ N+V+LLG C G+ + L++EYM L+ L +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 445 -SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503
L + I +A G+ YL E K +HRDL N L+ ++M KI+DFGL+R
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 504 FGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH 563
A +M PE ++ +SDV+++GV+L EI S Y+
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ--PYYGMA 247
Query: 564 GQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623
+ ++ +G + + P EL + LC + PADRP+ S+
Sbjct: 248 HEEVI----YYVRDGNILACPENC------PLELYNLM---RLCWSKLPADRPSFCSIHR 294
Query: 624 ML 625
+L
Sbjct: 295 IL 296
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 2e-64
Identities = 80/297 (26%), Positives = 118/297 (39%), Gaps = 40/297 (13%)
Query: 352 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQG-LQEFKNEVNLIAK 404
N S LG G FG V + T +AVK L ++ + +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 405 L-QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD---------------ATRSVQL 448
L H N+V LLG C G L+I EY L L + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 449 DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508
D + S +A+G+ +L IHRDL A NILL KI DFGLAR +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 509 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLL 568
N +MAPE +++ +SDV+S+G+ L E+ S + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--- 256
Query: 569 TYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
+K+ EG +L AP E+ + C DP RPT +V ++
Sbjct: 257 --FYKMIKEGF------RMLSPEHAPAEMYDIM---KTCWDADPLKRPTFKQIVQLI 302
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 2e-64
Identities = 77/281 (27%), Positives = 120/281 (42%), Gaps = 30/281 (10%)
Query: 353 HFSDENKLGQGGFGPVYKGTLADGK----AIAVKRLSRTSGQG-LQEFKNEVNLIAKLQH 407
HF +G+G FG VY GTL D AVK L+R + G + +F E ++ H
Sbjct: 30 HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 408 KNLVRLLGCCLEGQ-ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 466
N++ LLG CL + L++ YM + L + + T + + +
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG----- 142
Query: 467 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI--IAGTYGYMA 524
+ + K +HRDL A N +LD+ K++DFGLAR + + N +MA
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 525 PEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584
E F+ KSDV+SFGVLL E+++ Y + + Y + L+
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQ------GRRLL 254
Query: 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
P PD L + + L C RP+ S +V +
Sbjct: 255 QP----EYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRI 288
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 1e-63
Identities = 68/277 (24%), Positives = 118/277 (42%), Gaps = 27/277 (9%)
Query: 351 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 409
+ + +LG G FG VYK A K + S + L+++ E++++A H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 469
+V+LL L ++ E+ ++D + + R L + Q + + YLH+
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHD 128
Query: 470 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 529
KIIHRDLKA NIL D + K++DFG++ + ++ GT +MAPE M
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVM 183
Query: 530 G-----GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584
+ K+DV+S G+ L+E+ + + +L + L
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEP---PHHELNPMRVL----LKIAKSEPPTLA 236
Query: 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 621
P S F+ C++++ R T S +
Sbjct: 237 QP----SRWSSNFKDFL---KKCLEKNVDARWTTSQL 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 2e-63
Identities = 66/274 (24%), Positives = 119/274 (43%), Gaps = 31/274 (11%)
Query: 357 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLS--RTSGQGLQEFKNEVNLIAKLQHKNLVRL 413
+ ++G+G F VYKG + +A L + + Q FK E ++ LQH N+VR
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 414 LGCCLE----GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 469
+ ++L+ E M + +L +L R + K +S I +G+ +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 470 DSRLKIIHRDLKASNILLDD-DMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 528
+ IIHRDLK NI + + KI D GLA + + + GT +MAPE
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMY 185
Query: 529 MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588
+ DV++FG+ +LE+ + + ++ + ++ G P
Sbjct: 186 EEK-YDESVDVYAFGMCMLEMATSEYP--YSECQNAAQI----YRRVTSGV-----KPAS 233
Query: 589 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 622
A E+ + I C++Q+ +R ++ ++
Sbjct: 234 FDKVAIPEVKEII---EGCIRQNKDERYSIKDLL 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 4e-63
Identities = 71/277 (25%), Positives = 116/277 (41%), Gaps = 26/277 (9%)
Query: 354 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNL 410
+ +G G +G K +DGK + K L S Q +EVNL+ +L+H N+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 411 VRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGILYL 467
VR ++ L ++ EY L + T+ Q LD + ++ + +
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 468 HE--DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 525
H D ++HRDLK +N+ LD N K+ DFGLARI + + A GT YM+P
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMSP 183
Query: 526 EYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585
E ++ KSD++S G LL E+ + + + + L EG +
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMP---PFTAFSQKELA----GKIREGKFRRIPY 236
Query: 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 622
DEL + I + RP++ ++
Sbjct: 237 RY------SDELNEII---TRMLNLKDYHRPSVEEIL 264
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 2e-62
Identities = 74/304 (24%), Positives = 114/304 (37%), Gaps = 45/304 (14%)
Query: 352 NHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTSGQG-LQEFKNEVNLIAK 404
+ LG G FG V T +AVK L + + +E+ ++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 405 L-QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD--------------------AT 443
L H+N+V LLG C + LI+EY L +L
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 444 RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503
L ++ +A+G+ +L +HRDL A N+L+ KI DFGLAR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 504 FGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH 563
+ N +MAPE GI++IKSDV+S+G+LL EI S N +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP-YPGIPV 272
Query: 564 GQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623
+KL G ++ +E+ + C D RP+ ++
Sbjct: 273 DANF----YKLIQNGFKMDQPFYA------TEEIYIIM---QSCWAFDSRKRPSFPNLTS 319
Query: 624 MLAS 627
L
Sbjct: 320 FLGC 323
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 1e-61
Identities = 73/308 (23%), Positives = 133/308 (43%), Gaps = 41/308 (13%)
Query: 354 FSDENKLGQGGFGPVYKGT-LADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKLQH 407
F LG G FG VYKG + +G+ +A+K L TS + +E +E ++A + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 408 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 467
++ RLLG CL + LI + MP L ++ + + + + IA+G+ YL
Sbjct: 71 PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 468 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 527
+++HRDL A N+L+ + KI+DFGLA++ G + + + +MA E
Sbjct: 128 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 528 AMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587
+ I++ +SDV+S+GV + E+++ Y + +++
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSK--PYDGIPASEIS-------------SILEKG 229
Query: 588 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML--------------ASDSMTIP 633
+ P + I + C D RP +++ + M +P
Sbjct: 230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLP 289
Query: 634 QPTEPAFS 641
PT+ F
Sbjct: 290 SPTDSNFY 297
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 1e-61
Identities = 70/273 (25%), Positives = 114/273 (41%), Gaps = 23/273 (8%)
Query: 352 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKN 409
+ LG+G +G V +A+AVK + E K E+ + L H+N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 469
+V+ G EG L EY L + + + Q + + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 470 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 529
+ I HRD+K N+LLD+ N KISDFGLA +F N + N + GT Y+APE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 530 GGIF-SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588
F + DV+S G++L +++G + + + Y W E +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGE----LPWDQPSDSCQEY--SDWKEKKTYLNPWKKI 232
Query: 589 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 621
L +H + ++P+ R T+ +
Sbjct: 233 -----DSAPLALLH---KILVENPSARITIPDI 257
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 4e-61
Identities = 77/292 (26%), Positives = 128/292 (43%), Gaps = 39/292 (13%)
Query: 352 NHFSDENKLGQGGFGPVYKGTLADG---KAIAVKRLSRT-SGQGLQEFKNEVNLIAKL-Q 406
N ++ +G+G FG V K + A+KR+ S ++F E+ ++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 407 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL-------------FDATRSVQLDWKRR 453
H N++ LLG C L L EY P+ +L L + + L ++
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 454 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 513
+ARG+ YL + + IHRDL A NIL+ ++ KI+DFGL+R G +
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183
Query: 514 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWK 573
+ +MA E +++ SDV+S+GVLL EI+S Y L ++
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PYCGMTCAEL----YE 237
Query: 574 LWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
+G +E DE+ + C ++ P +RP+ + ++V L
Sbjct: 238 KLPQGYRLEKPLNC------DDEVYDLM---RQCWREKPYERPSFAQILVSL 280
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 8e-61
Identities = 75/276 (27%), Positives = 111/276 (40%), Gaps = 28/276 (10%)
Query: 358 NKLGQGGFGPVYKGTL----ADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQHKNL 410
KLG G FG V +G ++AVK L + + + +F EVN + L H+NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 411 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 470
+RL G L + ++ E P SL L +A G+ YL
Sbjct: 74 IRLYGVVLTP-PMKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLES- 129
Query: 471 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ-ANTNIIAGTYGYMAPEYAM 529
+ IHRDL A N+LL KI DFGL R N + + + APE
Sbjct: 130 --KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 530 GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589
FS SD + FGV L E+ + + + +G +L K+ EG + +
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQE--PWIGLNGSQIL---HKIDKEGERLPRPEDC-- 240
Query: 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
P ++ + + C P DRPT ++ L
Sbjct: 241 ----PQDIYNVM---VQCWAHKPEDRPTFVALRDFL 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 3e-60
Identities = 66/272 (24%), Positives = 122/272 (44%), Gaps = 24/272 (8%)
Query: 351 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 409
++ K+GQG G VY +A G+ +A+++++ + NE+ ++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 469
+V L L G EL ++ EY+ SL + + D + ++ + + +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFLHS 134
Query: 470 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 529
++IHRD+K+ NILL D + K++DFG Q++ +T + GT +MAPE
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV--GTPYWMAPEVVT 189
Query: 530 GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589
+ K D++S G++ +E+I G Y +E+ L L EL +P
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEP---PYLNENPLRAL----YLIATNGTPELQNP--- 239
Query: 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 621
F+ C+ D R + +
Sbjct: 240 -EKLSAIFRDFL---NRCLDMDVEKRGSAKEL 267
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (513), Expect = 4e-60
Identities = 79/304 (25%), Positives = 130/304 (42%), Gaps = 34/304 (11%)
Query: 352 NHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSR-TSGQGLQEFKNEVNLIAK 404
+ +LGQG FG VY+G +A+K ++ S + EF NE +++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 405 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLF-------DATRSVQLDWKRRQSII 457
++VRLLG +GQ L+I E M L +L + + +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 458 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 517
IA G+ YL+ + K +HRDL A N ++ +D KI DFG+ R
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 518 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCE 577
+M+PE G+F+ SDV+SFGV+L EI + + Y + +L + E
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--PYQGLSNEQVL----RFVME 250
Query: 578 GPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTE 637
G ++ D PD L + + +C Q +P RP+ ++ + + P E
Sbjct: 251 GGLLDKPDNC------PDMLFELM---RMCWQYNPKMRPSFLEIISSIKEEME--PGFRE 299
Query: 638 PAFS 641
+F
Sbjct: 300 VSFY 303
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 4e-59
Identities = 64/275 (23%), Positives = 112/275 (40%), Gaps = 31/275 (11%)
Query: 352 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQH 407
F LG+G FG VY +A+K L + + + EV + + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 408 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 467
N++RL G + + LI EY P ++ L ++ D +R + I +A + Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 468 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 527
H ++IHRD+K N+LL KI+DFG + ++ + GT Y+ PE
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175
Query: 528 AMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587
G + K D++S GVL E + G+ + + Q + ++
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKP---PFEANTYQETYK----------RISRVEFT 222
Query: 588 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVV 622
+ I ++ +P+ RP + V+
Sbjct: 223 FPDFV-TEGARDLI---SRLLKHNPSQRPMLREVL 253
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 6e-57
Identities = 84/297 (28%), Positives = 123/297 (41%), Gaps = 41/297 (13%)
Query: 352 NHFSDENKLGQGGFGPVYKGTL--------ADGKAIAVKRLSR-TSGQGLQEFKNEVNLI 402
+ LG+G FG V +AVK L + + L + +E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 403 AKL-QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLF-------------DATRSVQL 448
+ +HKN++ LLG C + L +I EY +L +L QL
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 449 DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508
K S +ARG+ YL K IHRDL A N+L+ +D KI+DFGLAR
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 509 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLL 568
T +MAPE I++ +SDV+SFGVLL EI + + Y + L
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--PYPGVPVEEL- 246
Query: 569 TYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
+KL EG ++ +EL + C P+ RPT +V L
Sbjct: 247 ---FKLLKEGHRMDKPSNC------TNELYMMM---RDCWHAVPSQRPTFKQLVEDL 291
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 6e-57
Identities = 79/296 (26%), Positives = 122/296 (41%), Gaps = 39/296 (13%)
Query: 352 NHFSDENKLGQGGFGPVYKGT------LADGKAIAVKRLSRTSGQG-LQEFKNEVNLIAK 404
+ LG+G FG V + A + +AVK L + + +E+ ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 405 -LQHKNLVRLLGCCLE-GQELLLIYEYMPNKSLDVHLF-------------DATRSVQLD 449
H N+V LLG C + G L++I E+ +L +L + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 450 WKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509
+ +A+G+ +L K IHRDL A NILL + KI DFGLAR + +
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 510 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLT 569
+MAPE +++I+SDV+SFGVLL EI S + G +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----YPGVKIDE 244
Query: 570 YTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
+ EG + D E+ + + L C +P+ RPT S +V L
Sbjct: 245 EFCRRLKEGTRMRAPDYT------TPEMYQTM---LDCWHGEPSQRPTFSELVEHL 291
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 9e-57
Identities = 60/281 (21%), Positives = 104/281 (37%), Gaps = 27/281 (9%)
Query: 352 NHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQ 406
+G+G FG V++G A+A+K + ++E F E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 407 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 466
H ++V+L+G E + +I E L L S LD ++ + Y
Sbjct: 67 HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123
Query: 467 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 526
L + +HRD+ A N+L+ + K+ DFGL+R + + +MAPE
Sbjct: 124 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK-GKLPIKWMAPE 179
Query: 527 YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586
F+ SDV+ FGV + EI+ + G + +
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGERLPMPPN 233
Query: 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627
P L + C DP+ RP + + L++
Sbjct: 234 C------PPTLYSLM---TKCWAYDPSRRPRFTELKAQLST 265
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 189 bits (481), Expect = 6e-55
Identities = 64/273 (23%), Positives = 110/273 (40%), Gaps = 24/273 (8%)
Query: 352 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 410
+H+ +LG G FG V++ T A G A K + + + E+ ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 411 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 470
V L + E+++IYE+M L + D ++ + + +G+ ++HE
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE- 142
Query: 471 SRLKIIHRDLKASNILLDDDMNP--KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 528
+H DLK NI+ + K+ DFGL Q+ T GT + APE A
Sbjct: 143 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVA 197
Query: 529 MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588
G +D++S GVL ++SG + E+ L C+ + +
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLS---PFGGENDDETLRNVKS--CDWNMDDSAFSGI 252
Query: 589 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 621
++ FI + DP R T+
Sbjct: 253 -----SEDGKDFI---RKLLLADPNTRMTIHQA 277
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 6e-53
Identities = 59/276 (21%), Positives = 102/276 (36%), Gaps = 37/276 (13%)
Query: 353 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQHK 408
F LG+G F V LA + A+K L + + E +++++L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 409 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 468
V+L + ++L Y N L ++ D + I + YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH 125
Query: 469 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 528
IIHRDLK NILL++DM+ +I+DFG A++ QA N GT Y++PE
Sbjct: 126 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 529 MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588
SD+++ G ++ ++++G + G + ++
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGL-------------------PPFRAGNEYLIFQKII 223
Query: 589 KQ-----SCAPDELLKFIHIGLLCVQQDPADRPTMS 619
K + + + D R
Sbjct: 224 KLEYDFPEKFFPKARDLV---EKLLVLDATKRLGCE 256
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 182 bits (462), Expect = 3e-52
Identities = 59/273 (21%), Positives = 108/273 (39%), Gaps = 24/273 (8%)
Query: 352 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 410
+++ +LG G FG V++ A G+ K ++ KNE++++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 411 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 470
+ L + E++LI E++ L + A ++ + + G+ ++HE
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHE- 145
Query: 471 SRLKIIHRDLKASNILLDDDMNP--KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 528
I+H D+K NI+ + KI DFGLA ++ + T + APE
Sbjct: 146 --HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIV 200
Query: 529 MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588
+D+++ GVL ++SG F + +TL +
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSP--FAGEDDLETLQNVK--------RCDWEFDED 250
Query: 589 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 621
S E FI +Q++P R T+
Sbjct: 251 AFSSVSPEAKDFIK---NLLQKEPRKRLTVHDA 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 3e-50
Identities = 58/295 (19%), Positives = 117/295 (39%), Gaps = 27/295 (9%)
Query: 348 LEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG-LQEFKNEVNLIAKL 405
+ +++ + +G+G +G V + +A+K++S Q Q E+ ++ +
Sbjct: 4 FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 63
Query: 406 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 465
+H+N++ + + Y+ + L+ ++ L + I RG+
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLK 123
Query: 466 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT-NIIAGTYGYMA 524
Y+H ++HRDLK SN+LL+ + KI DFGLAR+ + + T Y A
Sbjct: 124 YIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180
Query: 525 PEYAMGGIFSIKS-DVFSFGVLLLEIISGR-----KNNGFYFSEHGQTLLTYTWKLWCEG 578
PE + KS D++S G +L E++S R K+ + L + + +
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240
Query: 579 PAVELIDPVLKQ------------SCAPDELLKFIHIGLLCVQQDPADRPTMSSV 621
++ + +L A + L + + +P R +
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEVEQA 292
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 175 bits (444), Expect = 1e-49
Identities = 73/275 (26%), Positives = 113/275 (41%), Gaps = 32/275 (11%)
Query: 352 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQ- 406
N FS +G+GGFG VY AD GK A+K L + QG NE +++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 407 --HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 464
+V + +L I + M L HL + + I G+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 465 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 524
++H +++RDLK +NILLD+ + +ISD GLA F + + GT+GYMA
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173
Query: 525 PEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583
PE G+ + +D FS G +L +++ G F +H ++ VEL
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH----SPFRQHKTKDKHEIDRMTLTMA-VEL 228
Query: 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTM 618
D EL + +Q+D R
Sbjct: 229 PDSF------SPELRSLLE---GLLQRDVNRRLGC 254
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 2e-49
Identities = 54/266 (20%), Positives = 111/266 (41%), Gaps = 25/266 (9%)
Query: 359 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 417
LG+G FG V++ + K K + + G K E++++ +H+N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 418 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 477
+EL++I+E++ + + T + +L+ + S ++ + + +LH I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 478 RDLKASNILLDDDMNP--KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 535
D++ NI+ + KI +FG AR N ++ Y APE + S
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVST 182
Query: 536 KSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPD 595
+D++S G L+ ++SG + +E Q ++ + + K+
Sbjct: 183 ATDMWSLGTLVYVLLSGIN---PFLAETNQQII----ENIMNAE-YTFDEEAFKE--ISI 232
Query: 596 ELLKFIHIGLLCVQQDPADRPTMSSV 621
E + F+ + ++ R T S
Sbjct: 233 EAMDFVD---RLLVKERKSRMTASEA 255
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 171 bits (435), Expect = 2e-49
Identities = 65/276 (23%), Positives = 114/276 (41%), Gaps = 28/276 (10%)
Query: 351 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG---LQEFKNEVNLIAKLQ 406
++ + LG GG V+ L + +AVK L + F+ E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 407 HKNLVRLLGCCLE----GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR 462
H +V + G ++ EY+ +L + + KR +I +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 463 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ-ANTNIIAGTYG 521
+ + H+ IIHRD+K +NI++ K+ DFG+AR + N T + GT
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 522 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAV 581
Y++PE A G +SDV+S G +L E+++G F G + ++ ++ E P
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP--FT----GDSPVSVAYQHVREDP-- 231
Query: 582 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT 617
I P + +L + L + ++P +R
Sbjct: 232 --IPPSARHEGLSADLDAVV---LKALAKNPENRYQ 262
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (431), Expect = 1e-48
Identities = 56/284 (19%), Positives = 101/284 (35%), Gaps = 27/284 (9%)
Query: 352 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 410
N + K+G G FG +Y GT +A G+ +A+K + + E + +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 411 VRLLG-CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 469
+ + C EG +++ E + D+ F + + K + + + I Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIHS 121
Query: 470 DSRLKIIHRDLKASNIL---LDDDMNPKISDFGLARIFGGNQNQAN-----TNIIAGTYG 521
IHRD+K N L I DFGLA+ + + + + GT
Sbjct: 122 ---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 522 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAV 581
Y + +G S + D+ S G +L+ G + + + P
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238
Query: 582 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
L P E +++ C D+P S + +
Sbjct: 239 VLCKGY------PSEFATYLN---FCRSLRFDDKPDYSYLRQLF 273
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (428), Expect = 5e-48
Identities = 65/276 (23%), Positives = 111/276 (40%), Gaps = 27/276 (9%)
Query: 351 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHK 408
+ + + LG G F V K +A+K +++ + +G + +NE+ ++ K++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 409 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 468
N+V L G L LI + + L + + + +I + + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLH 124
Query: 469 EDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 525
+ I+HRDLK N+L D+D ISDFGL+++ + GT GY+AP
Sbjct: 125 DL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAP 178
Query: 526 EYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585
E +S D +S GV+ ++ G ++ E+ L K E
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGYP---PFYDENDAKLFEQILK-------AEYEF 228
Query: 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 621
D FI +++DP R T
Sbjct: 229 DSPYWDDISDSAKDFI---RHLMEKDPEKRFTCEQA 261
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 167 bits (425), Expect = 5e-48
Identities = 66/286 (23%), Positives = 113/286 (39%), Gaps = 39/286 (13%)
Query: 353 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGL---------QEFKNEVNLI 402
++ + LG+G V + K AVK + T G + EV+++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 403 AKLQ-HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIA 461
K+ H N+++L L+++ M L +L T V L K + I+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALL 120
Query: 462 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 521
I LH+ L I+HRDLK NILLDDDMN K++DFG + + + GT
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPS 174
Query: 522 YMAPEYAMGGI------FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLW 575
Y+APE + + + D++S GV++ +++G ++ +L
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP---PFWHRKQMLMLRMIMSGN 231
Query: 576 CEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 621
+ + E D D + + + P R T
Sbjct: 232 YQFGSPEWDD-------YSDTVKDLV---SRFLVVQPQKRYTAEEA 267
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 164 bits (415), Expect = 5e-46
Identities = 57/275 (20%), Positives = 110/275 (40%), Gaps = 42/275 (15%)
Query: 352 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQH 407
F LG G FG V+ +G+ A+K L + + ++ +E +++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 408 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 467
++R+ G + Q++ +I +Y+ L L + R K + + L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117
Query: 468 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 527
II+RDLK NILLD + + KI+DFG A+ + GT Y+APE
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGTPDYIAPEV 172
Query: 528 AMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587
++ D +SFG+L+ E+++G + + ++ + +
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGY-------------------TPFYDSNTMKTYEKI 213
Query: 588 LKQ-----SCAPDELLKFIHIGLLCVQQDPADRPT 617
L +++ + + +D + R
Sbjct: 214 LNAELRFPPFFNEDVKDLLS---RLITRDLSQRLG 245
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 5e-46
Identities = 70/306 (22%), Positives = 129/306 (42%), Gaps = 39/306 (12%)
Query: 358 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-----FKNEVNLIAKLQHKNLV 411
+ LG+G F VYK + +A+K++ ++ E+ L+ +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 412 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 471
LL + L++++M + S+ L ++ + +G+ YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 472 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG- 530
I+HRDLK +N+LLD++ K++DFGLA+ FG + T Y APE G
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV--VTRWYRAPELLFGA 175
Query: 531 GIFSIKSDVFSFGVLLLEIISGR-----KNNGFYFSEHGQTLLTYTWKLWCEG------- 578
++ + D+++ G +L E++ ++ + +TL T T + W +
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 579 --PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM-------LASDS 629
+ I S A D+LL I +P R T + + M +
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQALKMKYFSNRPGPTPG 292
Query: 630 MTIPQP 635
+P+P
Sbjct: 293 CQLPRP 298
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 163 bits (412), Expect = 5e-46
Identities = 47/286 (16%), Positives = 100/286 (34%), Gaps = 29/286 (10%)
Query: 352 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH-KN 409
H+ ++G+G FG +++GT L + + +A+K R S + ++E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 469
+ + EG +L+ + + D+ + K + + +HE
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLD---LCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 470 DSRLKIIHRDLKASNILLDDDMNP-----KISDFGLARIF-----GGNQNQANTNIIAGT 519
+++RD+K N L+ + + DFG+ + + + ++GT
Sbjct: 120 ---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 520 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGP 579
YM+ +G S + D+ + G + + + G G T K G
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW------QGLKAATNKQKYERIGE 230
Query: 580 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVML 625
+ + P+E K++H P + +
Sbjct: 231 KKQSTPLRELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLF 273
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 6e-46
Identities = 63/274 (22%), Positives = 104/274 (37%), Gaps = 30/274 (10%)
Query: 352 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAK-LQ 406
F LG+G FG V+ + A+K L + ++ E +++ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 407 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 466
H L + + L + EY+ L H+ + D R I G+ +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118
Query: 467 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 526
LH I++RDLK NILLD D + KI+DFG+ + + NT GT Y+APE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173
Query: 527 YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586
+G ++ D +SFGVLL E++ G+ + + + L P
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQS---PFHGQDEEELFHSIRMDNPFYP------- 223
Query: 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSS 620
E + ++P R +
Sbjct: 224 ----RWLEKEAKDLLV---KLFVREPEKRLGVRG 250
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 8e-46
Identities = 60/292 (20%), Positives = 117/292 (40%), Gaps = 26/292 (8%)
Query: 350 ATNHFSDENKLGQGGFGPVYKGT--LADGKAIAVKRLSRTSGQG--LQEFKNEVNLIAKL 405
A + ++G+G +G V+K G+ +A+KR+ +G+ EV ++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 406 ---QHKNLVRLLGCCLEGQELLLIYEYMPNKSLD---VHLFDATRSVQLDWKRRQSIING 459
+H N+VRL C + + + +D D + + + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 460 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 519
+ RG+ +LH +++HRDLK NIL+ K++DFGLARI+ + T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVT 178
Query: 520 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR-----KNNGFYFSEHGQTLLTYTWKL 574
Y APE + ++ D++S G + E+ + ++ + + +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 575 WCEGPAVELIDPVLKQSCAPDELLKFIHIGLL-----CVQQDPADRPTMSSV 621
W A+ K + ++ + I C+ +PA R + S
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 161 bits (409), Expect = 1e-45
Identities = 67/288 (23%), Positives = 120/288 (41%), Gaps = 29/288 (10%)
Query: 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKN 409
+ K+G+G +G VYK G+ A+K RL + E++++ +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 469
+V+L + L+L++E++ + L+ +S + + GI Y H+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 470 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 529
+++HRDLK N+L++ + KI+DFGLAR FG + I+ T Y AP+ M
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAPDVLM 173
Query: 530 G-GIFSIKSDVFSFGVLLLEIISGR-----KNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583
G +S D++S G + E+++G + + L T K W +
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 584 IDPVLKQ----------SCAPDELLKFIHIGLLCVQQDPADRPTMSSV 621
DP + + + ++ DP R T
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLS---KMLKLDPNQRITAKQA 278
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 4e-45
Identities = 68/291 (23%), Positives = 114/291 (39%), Gaps = 35/291 (12%)
Query: 354 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 412
++D +G G FG VY+ L D G+ +A+K++ + + E+ ++ KL H N+VR
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77
Query: 413 LLGCCLEGQE------LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 466
L E L L+ +Y+P V + L + + + R + Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 467 LHEDSRLKIIHRDLKASNILLDDD-MNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 525
+H I HRD+K N+LLD D K+ DFG A+ + + N + I Y
Sbjct: 138 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPE 192
Query: 526 EYAMGGIFSIKSDVFSFGVLLLEIISGR-----KNNGFYFSEHGQTLLTYTWKLWCEGPA 580
++ DV+S G +L E++ G+ + E + L T T + E
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 581 --VELIDPVLK--------QSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 621
E P +K + P E + ++ P R T
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCS---RLLEYTPTARLTPLEA 300
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 4e-45
Identities = 67/285 (23%), Positives = 121/285 (42%), Gaps = 23/285 (8%)
Query: 353 HFSDENKLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKN 409
+F K+G+G +G VYK G+ +A+K RL + E++L+ +L H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 410 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 469
+V+LL +L L++E++ DA+ + +S + + +G+ + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLK--KFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 470 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE-YA 528
+++HRDLK N+L++ + K++DFGLAR FG + T Y APE
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV--VTLWYRAPEILL 175
Query: 529 MGGIFSIKSDVFSFGVLLLEIISGR-----KNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583
+S D++S G + E+++ R + +TL T +W ++
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 584 IDPVLKQSCAPDELLKFIHIG-----LL--CVQQDPADRPTMSSV 621
P + D + LL + DP R + +
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 1e-43
Identities = 64/281 (22%), Positives = 107/281 (38%), Gaps = 33/281 (11%)
Query: 352 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTS------GQGLQEFKNEVNLIAK 404
+++ +LG G F V K + G A K + + G ++ + EV+++ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 405 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 464
+QH N++ L +++LI E + L L + L + + I G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNG- 125
Query: 465 LYLHEDSRLKIIHRDLKASNILLDDDMNP----KISDFGLARIFGGNQNQANTNIIAGTY 520
++ L+I H DLK NI+L D P KI DFGLA I GT
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTP 180
Query: 521 GYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPA 580
++APE +++D++S GV+ ++SG + + Q L
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS---PFLGDTKQETLANVSA------- 230
Query: 581 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 621
V S FI + +DP R T+
Sbjct: 231 VNYEFEDEYFSNTSALAKDFIR---RLLVKDPKKRMTIQDS 268
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 3e-43
Identities = 60/281 (21%), Positives = 98/281 (34%), Gaps = 43/281 (15%)
Query: 352 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE------FKNEVNLIAK 404
+ + LG GGFG VY G ++D +A+K + + E EV L+ K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 405 LQ--HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR 462
+ ++RLL +LI E T L + +S +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLE 121
Query: 463 GILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 521
+ + H ++HRD+K NIL+D + K+ DFG + GT
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRV 174
Query: 522 YMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPA 580
Y PE+ + V+S G+LL +++ G + E
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD--------------------IPFEHDE 214
Query: 581 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 621
+ V + E I C+ P+DRPT +
Sbjct: 215 EIIRGQVFFRQRVSSECQHLI---RWCLALRPSDRPTFEEI 252
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 9e-43
Identities = 58/274 (21%), Positives = 103/274 (37%), Gaps = 30/274 (10%)
Query: 357 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLL 414
LG G G V + + A+K L + + EV L + Q ++VR++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIV 71
Query: 415 GCC----LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 470
+ LL++ E + L + D + I+ I I YLH
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHS- 129
Query: 471 SRLKIIHRDLKASNILLDDDMNP---KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 527
+ I HRD+K N+L K++DFG A+ + + T Y+APE
Sbjct: 130 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEV 184
Query: 528 AMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587
+ D++S GV++ ++ G ++S HG + G + P
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYP---PFYSNHGLAISPGMKTRIRMG---QYEFPN 238
Query: 588 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 621
+ S +E+ I ++ +P R T++
Sbjct: 239 PEWSEVSEEVKMLIR---NLLKTEPTQRMTITEF 269
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 3e-42
Identities = 63/302 (20%), Positives = 116/302 (38%), Gaps = 41/302 (13%)
Query: 352 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG--LQEFKNEVNLIAKLQHK 408
+ + K+GQG FG V+K G+ +A+K++ + + E+ ++ L+H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 409 NLVRLLGCCLEGQE--------LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI 460
N+V L+ C + L++++ + + V+ + ++ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQML 126
Query: 461 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI--IAG 518
G L+ R KI+HRD+KA+N+L+ D K++DFGLAR F +N
Sbjct: 127 LNG---LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 519 TYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR-----KNNGFYFSEHGQTLLTYTW 572
T Y PE +G + D++ G ++ E+ + + Q + T
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 573 KLWCEGPAVEL-------------IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMS 619
++W EL + LK L I + DPA R
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID---KLLVLDPAQRIDSD 300
Query: 620 SV 621
Sbjct: 301 DA 302
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-40
Identities = 59/271 (21%), Positives = 101/271 (37%), Gaps = 29/271 (10%)
Query: 352 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQH 407
N F LG+G FG V A G+ A+K L + + + E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 408 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 467
L L L + EY L HL +R +R + I L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSA---L 118
Query: 468 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 527
+++RD+K N++LD D + KI+DFGL + G + A GT Y+APE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLAPEV 176
Query: 528 AMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587
+ D + GV++ E++ GR ++++ + L +
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRL---PFYNQDHERLFELILM----------EEIR 223
Query: 588 LKQSCAPDELLKFIHIGLLCVQQDPADRPTM 618
++ E + +++DP R
Sbjct: 224 FPRTL-SPEAKSLLA---GLLKKDPKQRLGG 250
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 2e-39
Identities = 63/300 (21%), Positives = 114/300 (38%), Gaps = 43/300 (14%)
Query: 349 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKL 405
E + D +G G +G V G +A+K+L R S + E+ L+ +
Sbjct: 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 74
Query: 406 QHKNLVRLLGCCLEGQ------ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING 459
+H+N++ LL + + L+ +M + + +L R Q ++
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQ 129
Query: 460 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 519
+ +G+ Y+H IIHRDLK N+ +++D KI DFGLAR T
Sbjct: 130 MLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG-----YVVT 181
Query: 520 YGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR-----KNNGFYFSEHGQTLLTYTWK 573
Y APE + + ++ D++S G ++ E+I+G+ ++ E + T +
Sbjct: 182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241
Query: 574 LWCEG------------PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 621
P +E D + A + + + D R T
Sbjct: 242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE---KMLVLDAEQRVTAGEA 298
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 4e-39
Identities = 52/286 (18%), Positives = 106/286 (37%), Gaps = 23/286 (8%)
Query: 352 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHK 408
+ K+G+G +G V+K + +A+K RL E+ L+ +L+HK
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 409 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 468
N+VRL ++L L++E+ + + + + + + L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115
Query: 469 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 528
++HRDLK N+L++ + K+++FGLAR FG + + + +
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLF 174
Query: 529 MGGIFSIKSDVFSFGVLLLEIISGR------KNNGFYFSEHGQTLLTYTWKLWCEGPAVE 582
++S D++S G + E+ + + + L T T + W +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 583 LIDPVLKQSCAPDELLKFIHIG-----LL--CVQQDPADRPTMSSV 621
P + + LL ++ +P R +
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 142 bits (358), Expect = 6e-38
Identities = 58/269 (21%), Positives = 99/269 (36%), Gaps = 32/269 (11%)
Query: 352 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQH 407
+ F LG G FG V G A+K L + + ++ NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 408 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 467
LV+L + L ++ EY+ + HL R + I YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYL 157
Query: 468 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 527
H L +I+RDLK N+L+D +++DFG A+ G + GT +APE
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEI 209
Query: 528 AMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587
+ ++ D ++ GVL+ E+ +G +F++ + P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYP---PFFADQPIQIYEKIVSGKVRFP-------- 258
Query: 588 LKQSCAPDELLKFIHIGLLCVQQDPADRP 616
S +L + +Q D R
Sbjct: 259 ---SHFSSDLKDLLRN---LLQVDLTKRF 281
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 1e-35
Identities = 62/279 (22%), Positives = 108/279 (38%), Gaps = 31/279 (11%)
Query: 352 NHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTS----GQGLQEFKNEVNLIA 403
+F LG G +G V+ GK A+K L + + + + + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 404 KLQHK-NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR 462
++ LV L +L LI +Y+ L HL R + + + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY------VGE 137
Query: 463 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 522
+L L +L II+RD+K NILLD + + ++DFGL++ F ++ + GT Y
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 196
Query: 523 MAPEYAMGGI--FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPA 580
MAP+ GG D +S GVL+ E+++G + + + + +
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS---PFTVDGEKNSQAEISRRILKSE- 252
Query: 581 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMS 619
P Q I + +DP R
Sbjct: 253 -----PPYPQEM-SALAKDLI---QRLLMKDPKKRLGCG 282
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 132 bits (333), Expect = 9e-35
Identities = 52/300 (17%), Positives = 110/300 (36%), Gaps = 48/300 (16%)
Query: 352 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKN 409
+ + KLG+G + V++ + + + + VK L ++ K E+ ++ L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 410 LVRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 467
++ L + + L++E++ N L + + I + + Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYC 145
Query: 468 HEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 526
H + I+HRD+K N+++D + ++ D+GLA + Q N+ + + PE
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPE 199
Query: 527 YAMG-GIFSIKSDVFSFGVLLLEIISGR------KNNGFYFSEHGQTLLTYTWKLWCEGP 579
+ ++ D++S G +L +I + +N + L T + +
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259
Query: 580 AVEL------------------IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSV 621
+EL Q E L F+ ++ D R T
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLD---KLLRYDHQSRLTAREA 316
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 6e-34
Identities = 66/307 (21%), Positives = 114/307 (37%), Gaps = 52/307 (16%)
Query: 352 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHK 408
+ + +G G G V + +A+K+LSR + + E+ L+ + HK
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 409 NLVRLLGCCL------EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR 462
N++ LL E Q++ L+ E M V +LD +R ++ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLC 130
Query: 463 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 522
GI +LH IIHRDLK SNI++ D KI DFGLAR G + T Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYY 184
Query: 523 MAPEYAMGGIFSIKSDVFSFGVLLLEIISGR-----KNNGFYFSEHGQTLLTYTWKLWCE 577
APE +G + D++S G ++ E++ + ++ +++ + L T + +
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 578 G-----------------------PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPAD 614
P + + + DPA
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS---KMLVIDPAK 301
Query: 615 RPTMSSV 621
R ++
Sbjct: 302 RISVDDA 308
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 1e-33
Identities = 69/290 (23%), Positives = 121/290 (41%), Gaps = 27/290 (9%)
Query: 349 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKL 405
E + + + +G G +G V G +AVK+LSR S + E+ L+ +
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 406 QHKNLVRLLGCCLEGQELLLI-YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 464
+H+N++ LL + L Y+ + L + + +L Q +I I RG+
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 465 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 524
Y+H IIHRDLK SN+ +++D KI DFGLAR T Y A
Sbjct: 135 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRA 186
Query: 525 PEYAMGGI-FSIKSDVFSFGVLLLEIISGR-----KNNGFYFSEHGQTLLTYTWKLWCEG 578
PE + + ++ D++S G ++ E+++GR ++ + + T +L +
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 579 PAVELIDPVLKQSCAPDELLKFIHIG-------LL--CVQQDPADRPTMS 619
+ + + + P + IG LL + D R T +
Sbjct: 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (293), Expect = 3e-29
Identities = 38/212 (17%), Positives = 77/212 (36%), Gaps = 18/212 (8%)
Query: 357 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 415
KLG G F V+ + + +A+K + + ++E+ L+ ++ + +
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDS 76
Query: 416 CCLEGQELLLIYEYMPNKSLDV-------------HLFDATRSVQLDWKRRQSIINGIAR 462
LL + + L + + I +
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 463 GILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 521
G+ Y+H R IIH D+K N+L++ D + +A + + T
Sbjct: 137 GLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 522 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 553
Y +PE +G + +D++S L+ E+I+G
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 96.4 bits (239), Expect = 1e-23
Identities = 28/155 (18%), Positives = 56/155 (36%), Gaps = 20/155 (12%)
Query: 358 NKLGQGGFGPVYKGTLADGKAIAVK--RLSRTSGQ--------GLQEFKNEVNLIAKLQH 407
+G+G V+ VK ++ TS + G F A+ +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 408 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 467
+ L +L G + Y + N ++ + L DA ++ + +++ I +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGN-AVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 468 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 502
+ I+H DL N+L+ + I DF +
Sbjct: 120 YHR---GIVHGDLSQYNVLV-SEEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 672 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.57 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.05 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.52 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.08 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.06 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.55 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=413.88 Aligned_cols=253 Identities=26% Similarity=0.340 Sum_probs=203.2
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
.++|++.+.||+|+||+||+|+++ +|+.||||++.... .+..+.+.+|+.+|++++||||+++++++.+++..+||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 367999999999999999999985 68999999987653 3345678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|+++|+|.+++. +...+++.++..++.||+.||.|||++| |+||||||+|||+++++++||+|||+++.+....
T Consensus 84 y~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999884 3456999999999999999999999998 9999999999999999999999999999875444
Q ss_pred CCcccccccccCCcCChhhhcCCCC-ChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChh
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 587 (672)
........+||+.|||||++.+..+ +.++|||||||++|||++|+.||....... ... .......... .+
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~---~~~~~~~~~~---~~- 228 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEY---SDWKEKKTYL---NP- 228 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS--HHH---HHHHTTCTTS---TT-
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH--HHH---HHHhcCCCCC---Cc-
Confidence 3344455789999999999988876 688999999999999999999985332111 000 0111111000 00
Q ss_pred hcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 588 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 588 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
.......+.+|+.+||+.||++|||++|+++
T Consensus 229 -----~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 229 -----WKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111234667888999999999999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=409.15 Aligned_cols=250 Identities=24% Similarity=0.389 Sum_probs=207.2
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
++|++.++||+|+||+||+|.+. +|+.||||++........+.+.+|+.+|++++||||+++++++.+++..+|||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 57999999999999999999975 69999999998766666788999999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
++|+|..++.. ..+++.++..|+.||+.||.|||++| |+||||||+|||++.++++||+|||+++.+.....
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence 99999987743 35999999999999999999999998 99999999999999999999999999998754332
Q ss_pred cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcC
Q 005871 511 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 590 (672)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ..........+.. .+.
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~~~~~~~~-~~~------ 237 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGTP-ELQ------ 237 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHHCSC-CCS------
T ss_pred -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH------HHHHHHHHhCCCC-CCC------
Confidence 23346799999999999999999999999999999999999999853221 1111111111110 000
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 591 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.+......+.+|+.+||+.||++|||++|+++.
T Consensus 238 -~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 238 -NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp -SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred -CcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011122457788889999999999999999753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-50 Score=410.36 Aligned_cols=263 Identities=28% Similarity=0.471 Sum_probs=202.9
Q ss_pred cCCccccccccCCceeEEeeeecCCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
++|++.++||+|+||+||+|+++ ..||||++... .....+.|.+|+.+|++++||||+++++++.+ +.+++||||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 67999999999999999999865 35999998654 34566789999999999999999999998754 568999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+++|+|.+++... ...+++..+..|+.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 85 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 85 CEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred CCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 9999999998543 346999999999999999999999997 99999999999999999999999999987655444
Q ss_pred CcccccccccCCcCChhhhcC---CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 510 QANTNIIAGTYGYMAPEYAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
........||+.|||||++.+ +.++.++|||||||++|||+||+.||....... .+..............+
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~~~~~~~~~~~~p~~~~---- 233 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIFMVGRGYLSPDLSK---- 233 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHHHHHHTSCCCCGGG----
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--HHHHHHhcCCCCCcchh----
Confidence 444455789999999999864 458999999999999999999999985322111 11111111111111111
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCCCC
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIP 633 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~ 633 (672)
.... ....+.+|+.+||+.||++|||++||++.|.....++|
T Consensus 234 -~~~~----~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 234 -VRSN----CPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp -SCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred -cccc----chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 1111 22457788889999999999999999999987654444
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-50 Score=407.83 Aligned_cols=255 Identities=27% Similarity=0.392 Sum_probs=197.2
Q ss_pred cCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecC
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 431 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 431 (672)
++|++.++||+|+||+||+|++.+++.||||++.... ...+.|.+|++++++++||||+++++++.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5789999999999999999999888899999997644 345789999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCc
Q 005871 432 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 511 (672)
Q Consensus 432 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 511 (672)
+|+|.+++.. ....+++..+..|+.||+.||.|||+++ |+||||||+||||++++++||+|||+++.+.......
T Consensus 84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 9999998854 3346899999999999999999999997 9999999999999999999999999998765433222
Q ss_pred ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCC
Q 005871 512 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQS 591 (672)
Q Consensus 512 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~ 591 (672)
.....||+.|+|||++.++.++.++|||||||++|||+|+..|+.... ....+...... +.. ...
T Consensus 159 -~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~--~~~~~~~~i~~----~~~--~~~------ 223 (263)
T d1sm2a_ 159 -STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDIST----GFR--LYK------ 223 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC--CHHHHHHHHHH----TCC--CCC------
T ss_pred -ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC--CHHHHHHHHHh----cCC--CCC------
Confidence 223578999999999999999999999999999999999654432111 11111111111 100 000
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 592 CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 592 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
+......+.+|+.+||+.||++|||++||+++|+..
T Consensus 224 -p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 224 -PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 111124577888899999999999999999999753
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=402.13 Aligned_cols=245 Identities=25% Similarity=0.390 Sum_probs=203.7
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEeccc---CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
++|++.+.||+|+||+||+|+++ +++.||+|++.+. .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999986 6889999998653 2344577899999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+++|+|.+++.. ...+++..+..|+.||+.||.|||+++ |+||||||+|||++.++++||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999999854 346999999999999999999999997 999999999999999999999999999865432
Q ss_pred CCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChh
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 587 (672)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....... ..... .
T Consensus 160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i-~~~~~------~ 222 (263)
T d2j4za1 160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QETYKRI-SRVEF------T 222 (263)
T ss_dssp ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHH-HTTCC------C
T ss_pred ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH------HHHHHHH-HcCCC------C
Confidence 23346799999999999999999999999999999999999999853221 1111111 11111 0
Q ss_pred hcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 588 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 588 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
+.... ...+.+|+.+||+.||++|||++||++
T Consensus 223 ~p~~~----s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 FPDFV----TEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCccC----CHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 11111 234677888999999999999999986
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=404.32 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=205.4
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
+.|++.++||+|+||+||+|++. +++.||||++........+.+.+|+++|++++|||||++++++.+++..+|||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56899999999999999999975 68999999998877777788999999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
++|+|..++... ...+++.++..++.||+.||.|||++| |+||||||+||||+.++++||+|||+++......
T Consensus 92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-- 164 (288)
T d2jfla1 92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 164 (288)
T ss_dssp TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence 999999987543 346999999999999999999999998 9999999999999999999999999998653221
Q ss_pred cccccccccCCcCChhhhc-----CCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccC
Q 005871 511 ANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 585 (672)
.......||+.|+|||++. +..|+.++|||||||++|||++|+.||...... .......... ...+..
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~------~~~~~i~~~~-~~~~~~ 237 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM------RVLLKIAKSE-PPTLAQ 237 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG------GHHHHHHHSC-CCCCSS
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH------HHHHHHHcCC-CCCCCc
Confidence 1223467999999999984 456899999999999999999999998543211 1111111111 111111
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
+......+.+|+.+||+.||++|||++|+++
T Consensus 238 -------~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 238 -------PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -------cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112345778888999999999999999976
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=405.27 Aligned_cols=254 Identities=33% Similarity=0.501 Sum_probs=203.9
Q ss_pred cCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecC
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 431 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 431 (672)
++|++.++||+|+||.||+|.+++++.||||++.... ...+.|.+|+.+|++++|||||++++++.+ +..++||||++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 5789999999999999999999888999999997654 345789999999999999999999998765 56799999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCc
Q 005871 432 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 511 (672)
Q Consensus 432 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 511 (672)
+|+|.+++... ....+++..+..|+.||++||.|||+++ |+||||||+||||++++.+||+|||+++.+......
T Consensus 91 ~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~- 165 (272)
T d1qpca_ 91 NGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT- 165 (272)
T ss_dssp TCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-
T ss_pred CCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc-
Confidence 99999887543 2335899999999999999999999997 999999999999999999999999999987543322
Q ss_pred ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCC
Q 005871 512 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQS 591 (672)
Q Consensus 512 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~ 591 (672)
......||+.|+|||++.++.++.++|||||||++|||+||..|+..... ....... ...+... .....
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~~~----i~~~~~~-----~~p~~ 234 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQN----LERGYRM-----VRPDN 234 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHH----HHTTCCC-----CCCTT
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHHHHHH----HHhcCCC-----CCccc
Confidence 22345789999999999999999999999999999999997665422111 1111111 1111110 01111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 592 CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 592 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
. ...+.+|+.+||+.||++|||+++|+++|+.
T Consensus 235 ~----~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 235 C----PEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp C----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C----hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 2 2357788889999999999999999998863
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=405.48 Aligned_cols=254 Identities=26% Similarity=0.355 Sum_probs=194.0
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEe--CceEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELLLI 426 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~~lV 426 (672)
++|++.+.||+|+||+||+|+++ +|+.||||++.... ....+.+.+|+++|++++||||+++++++.+ .+.+++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999975 68999999987653 3445678999999999999999999999975 4568999
Q ss_pred EeecCCCChhHHhhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 427 YEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDS--RLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
|||+++|+|.+++... .....+++..++.++.||+.||.|||+.+ ..+|+||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998653 23457999999999999999999999865 23599999999999999999999999999987
Q ss_pred eCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccc
Q 005871 504 FGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583 (672)
Q Consensus 504 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 583 (672)
+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.. . ...+....+
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~---~~~~~---~-i~~~~~~~~ 234 (269)
T d2java1 164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAG---K-IREGKFRRI 234 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHH---H-HHHTCCCCC
T ss_pred cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH---HHHHH---H-HHcCCCCCC
Confidence 654322 22346899999999999999999999999999999999999999853221 11111 1 111111111
Q ss_pred cChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 584 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
.... ...+.+|+.+||+.||++|||++||++
T Consensus 235 -----~~~~----s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 -----PYRY----SDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -----CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----Cccc----CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1112 234677888999999999999999985
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-49 Score=407.84 Aligned_cols=256 Identities=28% Similarity=0.408 Sum_probs=208.5
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
++|++.++||+|+||+||+|+++ +++.||||++.... ...+.|.+|+.+|++++|||||++++++.+++..++||||+
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 57889999999999999999986 58899999987654 34678999999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
++|+|..++... ....+++..+..|+.||+.||.|||+++ |+||||||+||||++++++||+|||+++........
T Consensus 96 ~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 96 TYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp TTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred cCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence 999999998653 3456999999999999999999999997 999999999999999999999999999876543322
Q ss_pred cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcC
Q 005871 511 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 590 (672)
......|++.|+|||++.++.++.++|||||||++|||++|+.|+..... ... .......+....
T Consensus 172 -~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~~----~~~~i~~~~~~~-------- 236 (287)
T d1opja_ 172 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQ----VYELLEKDYRME-------- 236 (287)
T ss_dssp -EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHH----HHHHHHTTCCCC--------
T ss_pred -eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--HHH----HHHHHhcCCCCC--------
Confidence 22334688999999999999999999999999999999998776522111 111 111111111111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 591 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
.+......+.+|+.+||+.||++|||++||++.|...
T Consensus 237 -~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 237 -RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred -CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1111224577888899999999999999999999764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-49 Score=407.60 Aligned_cols=249 Identities=23% Similarity=0.304 Sum_probs=202.2
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEeccc---CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
++|++.+.||+|+||+||+|++. +++.||||++.+. .....+.+.+|+++|++++||||+++++++.+++.+++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999975 6899999998753 2344578999999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 99999999988753 346999999999999999999999998 999999999999999999999999999987655
Q ss_pred CCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChh
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 587 (672)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ .... .
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~i~-~~~~-~----- 228 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------YLIFQKII-KLEY-D----- 228 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-TTCC-C-----
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH------HHHHHHHH-cCCC-C-----
Confidence 444444556899999999999999999999999999999999999999853211 11111111 1111 0
Q ss_pred hcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 588 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 588 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
+.... ...+.+|+.+||+.||++|||++|+++
T Consensus 229 ~p~~~----s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 229 FPEKF----FPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CCTTC----CHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CCccC----CHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 11122 234678888999999999999998743
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-49 Score=412.35 Aligned_cols=198 Identities=27% Similarity=0.402 Sum_probs=176.6
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
.++|++.++||+|+||+||+|++. +|+.||+|++.... ....+.+.+|+.+|++++|||||+++++|.+++.+++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 578999999999999999999975 68999999987653 3445678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED-SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
|+++|+|.+++.. ...+++..+..++.||+.||.|||++ | |+||||||+||||+.++++||+|||+|+.+...
T Consensus 85 y~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 9999999999954 34599999999999999999999974 6 999999999999999999999999999865322
Q ss_pred CCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCC
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF 558 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~ 558 (672)
.....+||+.|+|||++.+..|+.++||||+||++|||++|+.||..
T Consensus 159 ----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 159 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp ----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred ----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 22346899999999999999999999999999999999999999854
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=395.82 Aligned_cols=252 Identities=27% Similarity=0.395 Sum_probs=208.8
Q ss_pred cCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecC
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 431 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 431 (672)
++|++.++||+|+||+||+|++++++.||||++.+... ..+.|++|+.++++++||||+++++++.+++.+++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 68999999999999999999998888999999986543 45789999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCc
Q 005871 432 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 511 (672)
Q Consensus 432 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 511 (672)
+|+|..++... ...+++..+..++.||++||.|||++| |+||||||+||||++++.+||+|||+++.+......
T Consensus 83 ~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 83 NGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp TEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred CCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence 99999887543 346899999999999999999999997 999999999999999999999999999876543332
Q ss_pred ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcC
Q 005871 512 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590 (672)
Q Consensus 512 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 590 (672)
......||+.|+|||++.++.++.++||||||+++|||+| |+.||+..... .+.. ... .+... ..
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~~~---~i~-~~~~~--~~----- 222 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAE---HIA-QGLRL--YR----- 222 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHH---HHH-TTCCC--CC-----
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HHHH---HHH-hCCCC--CC-----
Confidence 2233568999999999999999999999999999999998 78887544321 1111 111 11110 01
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 591 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
+......+.+|+.+||+.||++|||+++|++.|.
T Consensus 223 --p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 256 (258)
T d1k2pa_ 223 --PHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256 (258)
T ss_dssp --CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred --cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence 1111235778888999999999999999999984
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-48 Score=406.07 Aligned_cols=255 Identities=28% Similarity=0.428 Sum_probs=194.3
Q ss_pred cCCccccccccCCceeEEeeeec-CCc---eeEEEEeccc-CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGK---AIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~---~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
++|++.++||+|+||+||+|+++ +++ .||||++... .....+.|.+|+.+|++++|||||++++++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 56888899999999999999875 232 5888888654 344567899999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||+++|+|.+++.. ....+++.++..|+.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999998854 2346999999999999999999999997 99999999999999999999999999987754
Q ss_pred CCCCcc---cccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCccc
Q 005871 507 NQNQAN---TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVE 582 (672)
Q Consensus 507 ~~~~~~---~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (672)
...... .....||+.|+|||++.++.++.++|||||||++|||+| |++||..... ..+...+.. ....
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---~~~~~~i~~---~~~~-- 252 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---QDVINAIEQ---DYRL-- 252 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHT---TCCC--
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH---HHHHHHHHc---CCCC--
Confidence 332221 122457899999999999999999999999999999998 8999753321 111111111 1110
Q ss_pred ccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 583 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 583 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
..+......+.+|+.+||+.||++|||++||++.|+.
T Consensus 253 --------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~ 289 (299)
T d1jpaa_ 253 --------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289 (299)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred --------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 0111223457788889999999999999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=402.70 Aligned_cols=266 Identities=30% Similarity=0.455 Sum_probs=206.0
Q ss_pred cCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecC
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 431 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 431 (672)
++|++.+.||+|+||+||+|++++++.||||++.... ...+.|.+|+.+|++++|||||++++++.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 5799999999999999999999888899999987544 345789999999999999999999999865 56799999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCc
Q 005871 432 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 511 (672)
Q Consensus 432 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 511 (672)
+|+|..++.... ...+++.+++.|+.||+.||.|||+++ |+||||||+||||+.++++||+|||+++.+......
T Consensus 95 ~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~- 169 (285)
T d1fmka3 95 KGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 169 (285)
T ss_dssp TCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce-
Confidence 999998886532 345999999999999999999999997 999999999999999999999999999876433322
Q ss_pred ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcCC
Q 005871 512 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQS 591 (672)
Q Consensus 512 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~ 591 (672)
......||+.|+|||++.++.++.++||||||+++|||++|..|+..... .......+. .+....
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~~~i~----~~~~~~--------- 234 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVE----RGYRMP--------- 234 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHH----TTCCCC---------
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--HHHHHHHHH----hcCCCC---------
Confidence 22335789999999999999999999999999999999997766432211 111111111 111101
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCCCCCCCCCc
Q 005871 592 CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASDSMTIPQPTEPA 639 (672)
Q Consensus 592 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~~p~~p~ 639 (672)
.+......+.+|+.+||+.||++|||+++|+++|...-.+.+++..|+
T Consensus 235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p~ 282 (285)
T d1fmka3 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282 (285)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCS
T ss_pred CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCCC
Confidence 111223457788889999999999999999999987644444444443
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.2e-47 Score=406.88 Aligned_cols=253 Identities=24% Similarity=0.333 Sum_probs=207.9
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
.++|++.+.||+|+||.||+|++. +|+.||||++........+.+.+|+.+|++++||||+++++++.+++.++|||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 368999999999999999999975 6899999999877766678899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc--CCCCeEEEeecCceeeCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD--DDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~--~~~~~kL~DFgla~~~~~~ 507 (672)
+++|+|.+++.. ....+++..+..|+.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++.+...
T Consensus 105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999988853 2346999999999999999999999998 99999999999996 4678999999999986543
Q ss_pred CCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChh
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 587 (672)
.. .....||+.|||||++.+..++.++|||||||++|||++|+.||..... .... ....... . . .+..
T Consensus 180 ~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~---~~i~~~~-~-~-~~~~ 247 (350)
T d1koaa2 180 QS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DETL---RNVKSCD-W-N-MDDS 247 (350)
T ss_dssp SC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH---HHHHHTC-C-C-SCCG
T ss_pred cc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH---HHHH---HHHHhCC-C-C-CCcc
Confidence 22 2346799999999999999999999999999999999999999853321 1111 1111110 0 0 0000
Q ss_pred hcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 588 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 588 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.. ......+.+|+.+||+.||++|||++|+++.
T Consensus 248 ~~----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 248 AF----SGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GG----GGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cc----cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 1112356788889999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=409.34 Aligned_cols=257 Identities=29% Similarity=0.407 Sum_probs=204.9
Q ss_pred cCCccccccccCCceeEEeeeecC-C-----ceeEEEEeccc-CcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLAD-G-----KAIAVKRLSRT-SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQEL 423 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~ 423 (672)
++|++.++||+|+||+||+|++.. + ..||+|++... .......+.+|+.+|.++ +|||||++++++.+.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 679999999999999999998643 2 36899988654 334456789999999998 899999999999999999
Q ss_pred EEEEeecCCCChhHHhhhccc--------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 005871 424 LLIYEYMPNKSLDVHLFDATR--------------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKAS 483 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~ 483 (672)
++||||+++|+|.+++..... ...+++..++.|+.||+.||.|||+++ |+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence 999999999999999965321 235899999999999999999999997 999999999
Q ss_pred cEEEcCCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcc
Q 005871 484 NILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSE 562 (672)
Q Consensus 484 NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~ 562 (672)
|||++.++++||+|||+++...............||+.|||||++.++.++.++|||||||++|||+| |+.||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987655444444445678999999999999999999999999999999998 89997532211
Q ss_pred cccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 005871 563 HGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLA 626 (672)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 626 (672)
..+. .....+.... .+......+.+|+.+||+.||++|||++||+++|.
T Consensus 274 --~~~~----~~~~~~~~~~---------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 --ANFY----KLIQNGFKMD---------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp --HHHH----HHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --HHHH----HHHhcCCCCC---------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 1111 1111111100 11112245778888999999999999999999995
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=392.32 Aligned_cols=247 Identities=25% Similarity=0.369 Sum_probs=196.1
Q ss_pred CccccccccCCceeEEeeeec-CCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEe----CceEEEE
Q 005871 354 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE----GQELLLI 426 (672)
Q Consensus 354 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~----~~~~~lV 426 (672)
|+..++||+|+||+||+|++. +++.||+|++... .....+.+.+|+++|++++||||+++++++.+ ...+++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 366778999999999999976 5889999998754 33456679999999999999999999999875 4568999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc-CCCCeEEEeecCceeeC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIFG 505 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~-~~~~~kL~DFgla~~~~ 505 (672)
|||+++|+|.+++.. ...+++..+..|+.||+.||+|||+++ .+|+||||||+||||+ +++.+||+|||+++...
T Consensus 91 mE~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999999999854 346999999999999999999999874 3499999999999997 57899999999998643
Q ss_pred CCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccC
Q 005871 506 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585 (672)
Q Consensus 506 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 585 (672)
.. .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||...... .........+...
T Consensus 167 ~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~------~~~~~~i~~~~~~---- 231 (270)
T d1t4ha_ 167 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKP---- 231 (270)
T ss_dssp TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCC----
T ss_pred CC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH------HHHHHHHHcCCCC----
Confidence 22 2334689999999998865 5999999999999999999999998532111 1111111121111
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
..+....+ ..+.+|+.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~----~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 232 ASFDKVAI----PEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGGGGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCccCC----HHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11112222 24677888999999999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.4e-48 Score=400.61 Aligned_cols=252 Identities=23% Similarity=0.283 Sum_probs=189.1
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
.+.|++.+.||+|+||+||+|+++ +++.||||++.+... .....+.+|+.+|++++||||+++++++.+++.++||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999976 689999999976542 334568899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc---CCCCeEEEeecCceeeC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARIFG 505 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~---~~~~~kL~DFgla~~~~ 505 (672)
|++||+|.+++.. ...+++.++..++.||+.||.|||+++ |+||||||+|||+. +++.+||+|||+++...
T Consensus 88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999853 456999999999999999999999998 99999999999995 57899999999998654
Q ss_pred CCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccC
Q 005871 506 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585 (672)
Q Consensus 506 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 585 (672)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......... .. . .+
T Consensus 162 ~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~i~~~-~~-~-~~ 229 (307)
T d1a06a_ 162 PGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND------AKLFEQILKA-EY-E-FD 229 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHTT-CC-C-CC
T ss_pred CCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHhcc-CC-C-CC
Confidence 332 22346799999999999999999999999999999999999999853221 1111111111 10 0 00
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
... .+.....+.+|+.+||+.||++|||++|+++.
T Consensus 230 ~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 230 SPY----WDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TTT----TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred Ccc----ccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 001 11122357788889999999999999999985
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-48 Score=398.28 Aligned_cols=257 Identities=28% Similarity=0.450 Sum_probs=198.1
Q ss_pred cCCccccccccCCceeEEeeeecCC-----ceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLADG-----KAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l 425 (672)
+.|++.+.||+|+||+||+|.++.. ..||||++.... ......|.+|+.+|++++|||||++++++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 5688899999999999999987532 369999997543 3345678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
||||+.++++...+... ...+++.++..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 87 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 99999999998877543 346999999999999999999999997 9999999999999999999999999998765
Q ss_pred CCCCC-cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 506 GNQNQ-ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 506 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
..... .......||+.|+|||++.++.++.++|||||||++|||++|..|+..... ...+... ...+...
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~~~~~~~----i~~~~~~--- 232 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEVMKA----INDGFRL--- 232 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHH----HHTTCCC---
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--HHHHHHH----HhccCCC---
Confidence 43322 223335689999999999999999999999999999999997666432211 1111111 1111111
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
..+......+.+|+.+||+.||++|||+.||+++|+..
T Consensus 233 ------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 233 ------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp ------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 11112234577888999999999999999999999753
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-48 Score=396.51 Aligned_cols=254 Identities=26% Similarity=0.434 Sum_probs=204.2
Q ss_pred cCCcccc-ccccCCceeEEeeeec---CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 352 NHFSDEN-KLGQGGFGPVYKGTLA---DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 352 ~~~~~~~-~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
++|.+.+ +||+|+||+||+|.++ ++..||||++.... ....+.|.+|+++|++++|||||++++++.+ +.++||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4566777 4999999999999864 35579999997654 3456789999999999999999999999865 568999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||+++|+|.+++.. ....+++..+..|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999998743 3346999999999999999999999997 99999999999999999999999999998765
Q ss_pred CCCC-cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 507 NQNQ-ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 507 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
.... .......||+.|+|||++.++.++.++|||||||++|||+| |+.||..... ..+... ...+...+.
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~---~~~~~~----i~~~~~~~~- 233 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAF----IEQGKRMEC- 233 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHH----HHTTCCCCC-
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH---HHHHHH----HHcCCCCCC-
Confidence 4332 22334568999999999999999999999999999999998 8999854321 111111 112221111
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
.... ...+.+|+.+||+.||++|||+.+|++.|+.
T Consensus 234 ----p~~~----~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 234 ----PPEC----PPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp ----CTTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCcC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1122 2457788889999999999999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.3e-47 Score=403.74 Aligned_cols=256 Identities=22% Similarity=0.286 Sum_probs=208.8
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeec
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 430 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 430 (672)
++|++.+.||+|+||.||+|++. +|+.||||++........+.+.+|+.+|++++||||+++++++.+++.++||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999975 69999999998776666678899999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc--CCCCeEEEeecCceeeCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD--DDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~--~~~~~kL~DFgla~~~~~~~ 508 (672)
++|+|.+.+.. ....+++.+++.|+.||+.||.|||++| |+||||||+||||+ .++.+||+|||+++.+....
T Consensus 109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999887743 3346999999999999999999999998 99999999999998 67899999999999875432
Q ss_pred CCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhh
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 588 (672)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........... . . ...
T Consensus 184 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~-~-~-~~~-- 249 (352)
T d1koba_ 184 ---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------LETLQNVKRCD-W-E-FDE-- 249 (352)
T ss_dssp ---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHHCC-C-C-CCS--
T ss_pred ---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC-C-C-CCc--
Confidence 23345799999999999999999999999999999999999999853221 11111111110 0 0 000
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--hccC
Q 005871 589 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM--LASD 628 (672)
Q Consensus 589 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~ 628 (672)
.........+.+|+.+||+.||.+|||++|+++. +...
T Consensus 250 --~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 250 --DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp --STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred --ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 1111122356788889999999999999999985 5443
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-47 Score=391.45 Aligned_cols=252 Identities=24% Similarity=0.283 Sum_probs=204.7
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC------cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS------GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 423 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 423 (672)
.++|++.+.||+|+||+||+|+++ +|+.||||++.+.. ....+.+.+|+.+|++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 468999999999999999999985 68999999986542 22367899999999999999999999999999999
Q ss_pred EEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC----CeEEEeec
Q 005871 424 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM----NPKISDFG 499 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~----~~kL~DFg 499 (672)
+||||||++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 9999999999999998543 46999999999999999999999998 99999999999998776 59999999
Q ss_pred CceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCC
Q 005871 500 LARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGP 579 (672)
Q Consensus 500 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 579 (672)
++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ ...
T Consensus 163 ~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~i~-~~~ 232 (293)
T d1jksa_ 163 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANVS-AVN 232 (293)
T ss_dssp TCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-TTC
T ss_pred hhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH------HHHHHHHH-hcC
Confidence 9988653322 2345789999999999999999999999999999999999999853221 11111111 111
Q ss_pred cccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 580 AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 580 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
. . ......... ...+.+|+.+||+.||++|||++|+++.
T Consensus 233 ~-~-~~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 233 Y-E-FEDEYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp C-C-CCHHHHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C-C-CCchhcCCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0 011111111 2356788889999999999999999874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-48 Score=396.48 Aligned_cols=247 Identities=30% Similarity=0.424 Sum_probs=195.7
Q ss_pred cccccCCceeEEeeeecC---CceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEeecCC
Q 005871 358 NKLGQGGFGPVYKGTLAD---GKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 432 (672)
Q Consensus 358 ~~LG~G~fg~Vy~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~ 432 (672)
++||+|+||+||+|.+++ ++.||||++.... ....+.|.+|+++|++++|||||++++++.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999998643 5689999986543 3345689999999999999999999999865 467899999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCCc-
Q 005871 433 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA- 511 (672)
Q Consensus 433 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~- 511 (672)
|+|.+++.. ...+++..+..|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+.......
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999998853 346999999999999999999999997 9999999999999999999999999999875443322
Q ss_pred ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhcC
Q 005871 512 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLKQ 590 (672)
Q Consensus 512 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 590 (672)
......||+.|+|||.+.++.++.++|||||||++|||+| |+.||..... ..+.. ....+..... ..
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~~~~~----~i~~~~~~~~-----p~ 233 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTA----MLEKGERMGC-----PA 233 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHH----HHHTTCCCCC-----CT
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---HHHHH----HHHcCCCCCC-----Cc
Confidence 2334578999999999999999999999999999999998 8999753321 11111 1112211111 11
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 591 SCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 591 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
.. ...+.+|+.+||+.||++|||+++|+++|+.
T Consensus 234 ~~----~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 234 GC----PREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp TC----CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred cc----CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 12 2457788889999999999999999988863
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-47 Score=397.72 Aligned_cols=245 Identities=29% Similarity=0.455 Sum_probs=199.5
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
+.|+.+++||+|+||+||+|++. +++.||||++.... ....+.+.+|+.+|++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35999999999999999999975 68899999987654 234567899999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
|||.+|+|..++.. ...+++.++..++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++....
T Consensus 95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 99999999766633 346999999999999999999999998 99999999999999999999999999986432
Q ss_pred CCCcccccccccCCcCChhhhcC---CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
.....||+.|||||++.+ +.|+.++|||||||++|||++|+.||..... ............ ....
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~------~~~~~~i~~~~~-~~~~ 235 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNES-PALQ 235 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCC-CCCS
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCC-CCCC
Confidence 233579999999999864 4689999999999999999999999753211 111111111111 1111
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
. ... ...+.+|+.+||+.||++|||++|+++
T Consensus 236 ~----~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 S----GHW----SEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp C----TTS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C----CCC----CHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1 111 234677888999999999999999987
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-47 Score=398.22 Aligned_cols=249 Identities=23% Similarity=0.292 Sum_probs=205.4
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEeccc---CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
.++|++++.||+|+||.||+|+++ +|+.||||++.+. .....+.+.+|+.+|++++||||+++++++.+++.+++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 367999999999999999999975 6999999999754 234567889999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||+++|+|..++.. ...+++..++.++.||+.||+|||++| |+||||||+|||++.+|++||+|||+++....
T Consensus 84 ~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 999999999998854 346899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
.. ......+||+.|+|||++.+..|+.++|||||||++|||++|++||..... ..+.. ... .+.. .
T Consensus 158 ~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~---~~~~~---~i~-~~~~-~---- 223 (337)
T d1o6la_ 158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFE---LIL-MEEI-R---- 223 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHH-HCCC-C----
T ss_pred CC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH---HHHHH---HHh-cCCC-C----
Confidence 22 223446899999999999999999999999999999999999999854321 11111 111 1111 0
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPT-----MSSVVVM 624 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 624 (672)
+....+ ..+.+|+.+||+.||++||+ ++|+++.
T Consensus 224 -~p~~~s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 224 -FPRTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -CCTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -CCccCC----HHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 111222 34678888999999999995 8888874
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.6e-46 Score=391.24 Aligned_cols=245 Identities=24% Similarity=0.309 Sum_probs=203.3
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEeccc---CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
++|++.+.||+|+||+||+|+++ +|+.||||++.+. .....+.+.+|+.+|++++||||+++++++.+++.+++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999975 6899999999753 2345678999999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||++||+|...+.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.+|++||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 99999999988843 345889999999999999999999997 999999999999999999999999999976432
Q ss_pred CCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChh
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 587 (672)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ........... .. .
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~i~~~-~~------~ 219 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN------TMKTYEKILNA-EL------R 219 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHC-CC------C
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC------HHHHHHHHHcC-CC------C
Confidence 234689999999999999999999999999999999999999985321 11111111111 10 0
Q ss_pred hcCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005871 588 LKQSCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVVM 624 (672)
Q Consensus 588 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 624 (672)
.++.....+.+++.+||+.||++|| |++++++.
T Consensus 220 ----~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 220 ----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 0111123467788899999999996 89999874
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=388.84 Aligned_cols=258 Identities=23% Similarity=0.311 Sum_probs=194.2
Q ss_pred cccccccCCceeEEeeeec-CCceeEEEEecccCcc-----cHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 356 DENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ-----GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 356 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
.+++||+|+||+||+|+++ +|+.||||++...... ..+.+.+|+.+|++++||||+++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4678999999999999975 6899999998654321 234688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+.++++...+ .....+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9998777665 33456899999999999999999999998 99999999999999999999999999986544322
Q ss_pred CcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccC---CCcccccC
Q 005871 510 QANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCE---GPAVELID 585 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~d 585 (672)
.....+||+.|+|||++.+. .++.++|||||||++|||++|++||....... .+....+.... ..+.....
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 156 --AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp --CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSSSTTS
T ss_pred --cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH---HHHHHHHhcCCCChhhccchhc
Confidence 22335799999999998755 57999999999999999999999985432211 11111111000 00000000
Q ss_pred ---hh-h--cCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 586 ---PV-L--KQSCA-----PDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 586 ---~~-l--~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.. . ..... +.....+.+|+.+||+.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00 0 00000 1112457888999999999999999999975
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.4e-46 Score=382.85 Aligned_cols=258 Identities=23% Similarity=0.325 Sum_probs=199.6
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCc----e
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ----E 422 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~----~ 422 (672)
.++|++.+.||+|+||.||+|++. +|+.||||++.+.. ......+.+|+.+|+.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 468999999999999999999975 69999999997643 334567899999999999999999999998643 4
Q ss_pred EEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCce
Q 005871 423 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 502 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~ 502 (672)
.+|||||++|++|..++.. ...+++.++..|+.||+.||.|||++| |+||||||+|||++.++..+|+|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 8999999999999988744 346999999999999999999999998 9999999999999999999999999998
Q ss_pred eeCCCC-CCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcc
Q 005871 503 IFGGNQ-NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAV 581 (672)
Q Consensus 503 ~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (672)
...... ........+||+.|+|||++.+..+++++|||||||++|||+||+.||.... ...............
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~------~~~~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS------PVSVAYQHVREDPIP 233 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHCCCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC------HHHHHHHHHhcCCCC
Confidence 654332 2223345689999999999999999999999999999999999999985322 112222222222111
Q ss_pred cccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhcc
Q 005871 582 ELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRP-TMSSVVVMLAS 627 (672)
Q Consensus 582 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~ 627 (672)
. ....... ...+.+++.+||+.||++|| |++++++.|..
T Consensus 234 ~---~~~~~~~----s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 234 P---SARHEGL----SADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp G---GGTSSSC----CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred C---chhccCC----CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 0 0111112 23567788899999999999 89999888753
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.8e-47 Score=393.60 Aligned_cols=260 Identities=28% Similarity=0.454 Sum_probs=208.3
Q ss_pred HhcCCccccccccCCceeEEeeeec------CCceeEEEEecccCc-ccHHHHHHHHHHHHhccCCCeeeEEEEEEeCce
Q 005871 350 ATNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 422 (672)
Q Consensus 350 ~~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~ 422 (672)
..++|++.++||+|+||+||+|+++ +++.||||++..... +..+.|.+|+.+|++++||||+++++++.+.+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 3468999999999999999999863 357899999976543 345679999999999999999999999999999
Q ss_pred EEEEEeecCCCChhHHhhhcc---------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 005871 423 LLLIYEYMPNKSLDVHLFDAT---------------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLK 481 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlk 481 (672)
.++||||+++|+|.+++.... ....+++..+..|+.||+.||+|||+++ |+|||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence 999999999999999986422 1234889999999999999999999997 9999999
Q ss_pred CCcEEEcCCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCC-CCCCCC
Q 005871 482 ASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRK-NNGFYF 560 (672)
Q Consensus 482 p~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~-p~~~~~ 560 (672)
|+||||+.++.+||+|||+++.+.............|++.|+|||.+.+..++.++|||||||++|||++|.. ||....
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 9999999999999999999987654444444445678999999999999999999999999999999999964 553221
Q ss_pred cccccchhhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 561 SEHGQTLLTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
. ..+ ... ..++..... .... ..++.+|+.+||+.||++|||+.||+++|...
T Consensus 248 ~---~e~---~~~-v~~~~~~~~-----p~~~----~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 248 H---EEV---IYY-VRDGNILAC-----PENC----PLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp H---HHH---HHH-HHTTCCCCC-----CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred H---HHH---HHH-HHcCCCCCC-----Cccc----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 1 111 111 112222111 1122 23577888999999999999999999999865
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-45 Score=390.82 Aligned_cols=263 Identities=22% Similarity=0.279 Sum_probs=212.0
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEeccc---CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~ 427 (672)
++|++++.||+|+||.||+|+++ +|+.||||++.+. .....+.+.+|+.+|+.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 58999999999999999999975 6999999998653 2344577899999999999999999999999999999999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 507 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 507 (672)
||+.+|+|..++... ..+++..++.++.||+.||.|||+++ ||||||||+||||+.++++||+|||+++.+...
T Consensus 121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 999999999988543 46999999999999999999999998 999999999999999999999999999976432
Q ss_pred CCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChh
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 587 (672)
.....||+.|||||++.+..++.++|||||||++|||++|+.||.... ........... .. .
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~i~~~-~~-~----- 256 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ------PIQIYEKIVSG-KV-R----- 256 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHC-CC-C-----
T ss_pred -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC------HHHHHHHHhcC-CC-C-----
Confidence 234679999999999999999999999999999999999999985321 11111111111 10 0
Q ss_pred hcCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH--hccC------CCCCCCCCCCcccc
Q 005871 588 LKQSCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVVM--LASD------SMTIPQPTEPAFSV 642 (672)
Q Consensus 588 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~--L~~~------~~~l~~p~~p~~~~ 642 (672)
..... ...+.+++.+||+.||.+|+ |+++|++. +... ...+++|-.|.+..
T Consensus 257 ~p~~~----s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~~~ 320 (350)
T d1rdqe_ 257 FPSHF----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKG 320 (350)
T ss_dssp CCTTC----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCS
T ss_pred CCccC----CHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcCccCCCCC
Confidence 01112 23467888899999999994 89999873 2221 22356666666543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=393.52 Aligned_cols=254 Identities=27% Similarity=0.452 Sum_probs=198.7
Q ss_pred cCCccccccccCCceeEEeeeec-CCc----eeEEEEeccc-CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGK----AIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l 425 (672)
.+|+++++||+|+||+||+|.+. +|+ +||+|++... ..+..+.|.+|+.+|++++|||||++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999875 344 5888888653 345567899999999999999999999999865 5678
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeC
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 505 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~ 505 (672)
++||+.+++|.+.+.. ....+++..++.|+.||+.||.|||+++ |+||||||+||||+.++++||+|||+++.+.
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999888754 3456999999999999999999999997 9999999999999999999999999999876
Q ss_pred CCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCccccc
Q 005871 506 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELI 584 (672)
Q Consensus 506 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 584 (672)
............||+.|+|||++.++.++.++|||||||++|||+| |++||..... ..+..... .+...
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~---~~~~~~i~----~~~~~--- 232 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSILE----KGERL--- 232 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG---GGHHHHHH----HTCCC---
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH---HHHHHHHH----cCCCC---
Confidence 5544444445678999999999999999999999999999999999 7888653321 11111111 11110
Q ss_pred ChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 585 DPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 585 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
..++.....+.+|+.+||+.||++|||+.||++.|..
T Consensus 233 ------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 233 ------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp ------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 0111223457788889999999999999999998865
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=382.51 Aligned_cols=248 Identities=29% Similarity=0.389 Sum_probs=193.8
Q ss_pred cCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEe-CceEEEEEeec
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE-GQELLLIYEYM 430 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~-~~~~~lV~Ey~ 430 (672)
++|++.++||+|+||.||+|.++ |+.||||+++... ..+.+.+|++++++++||||+++++++.+ .+.+++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 57889999999999999999985 7789999996543 45789999999999999999999999865 45689999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
++|+|.+++... ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 84 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence 999999998643 2235899999999999999999999997 999999999999999999999999999865432
Q ss_pred cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccChhhc
Q 005871 511 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVLK 589 (672)
Q Consensus 511 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 589 (672)
.....++..|+|||++.++.+++++||||||+++|||+| |++|+..... ..+...+ ..+...++
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~~~~i----~~~~~~~~------ 221 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRV----EKGYKMDA------ 221 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHH----TTTCCCCC------
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH---HHHHHHH----HcCCCCCC------
Confidence 223467899999999999999999999999999999998 6776543211 1111111 11111111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 590 QSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 590 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
+......+.+|+.+||+.||++|||+.+|+++|..
T Consensus 222 ---~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 222 ---PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 11122456788889999999999999999999965
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-46 Score=388.19 Aligned_cols=258 Identities=28% Similarity=0.397 Sum_probs=196.4
Q ss_pred cCCccccccccCCceeEEeeeec------CCceeEEEEecccC-cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeC-ce
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG-QE 422 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~-~~ 422 (672)
++|++.++||+|+||.||+|++. +++.||||++.... ....+.+.+|..++.++ +|+||+.+++++.+. ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 67999999999999999999853 24689999987543 34456788888888887 689999999998765 46
Q ss_pred EEEEEeecCCCChhHHhhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC
Q 005871 423 LLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD 489 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~ 489 (672)
+++|||||++|+|.+++..... ...+++.++..++.||++||.|||+++ |+||||||+||||++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECC
Confidence 8999999999999999965322 245899999999999999999999997 999999999999999
Q ss_pred CCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCC-CCCCCCcccccchh
Q 005871 490 DMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRK-NNGFYFSEHGQTLL 568 (672)
Q Consensus 490 ~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~-p~~~~~~~~~~~~~ 568 (672)
++++||+|||+++...............||+.|+|||++.++.++.++|||||||++|||++|.. ||..... ....
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~--~~~~- 246 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI--DEEF- 246 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC--SHHH-
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH--HHHH-
Confidence 99999999999997765555444556689999999999999999999999999999999999754 5532211 1111
Q ss_pred hhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 569 TYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 569 ~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
......+..... +......+.+++.+||+.||++|||++||+++|+.
T Consensus 247 ---~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 247 ---CRRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp ---HHHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---HHHHhcCCCCCC---------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111111111111 11122357788889999999999999999999974
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=383.66 Aligned_cols=253 Identities=23% Similarity=0.344 Sum_probs=192.6
Q ss_pred cCCccccccccCCceeEEeeeecC----CceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV 426 (672)
++|++.+.||+|+||.||+|++.. +..||||++.... ....+.+.+|+.+|++++||||+++++++. ++..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 579999999999999999998642 3468899886543 344567999999999999999999999996 4678999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||+++|+|..++.. ....+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 86 ~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 86 MELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccC
Confidence 999999999988753 3456899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCcccccC
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELID 585 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 585 (672)
.... ......||+.|+|||++.++.++.++|||||||++|||++ |.+||..... ..+...+ . .+.....
T Consensus 161 ~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~---~~~~~~i---~-~~~~~~~-- 230 (273)
T d1mp8a_ 161 STYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRI---E-NGERLPM-- 230 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHH---H-TTCCCCC--
T ss_pred Ccce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH---HHHHHHH---H-cCCCCCC--
Confidence 3322 2334578999999999999999999999999999999998 7888753321 1111111 1 1111111
Q ss_pred hhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 586 PVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 586 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
++.....+.+|+.+||+.||++|||++||++.|..
T Consensus 231 -------~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 231 -------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp -------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11122457788889999999999999999999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.7e-45 Score=377.78 Aligned_cols=251 Identities=25% Similarity=0.318 Sum_probs=202.4
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCcc---------cHHHHHHHHHHHHhcc-CCCeeeEEEEEEeC
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ---------GLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEG 420 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~il~~l~-h~niv~l~~~~~~~ 420 (672)
++|++.+.||+|+||+||+|++. +|+.||||++.+.... ..+.+.+|+.+|++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68999999999999999999975 6899999998765321 2346889999999997 99999999999999
Q ss_pred ceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecC
Q 005871 421 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 500 (672)
Q Consensus 421 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgl 500 (672)
+.++|||||+++|+|.+++.. ...+++.+++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 999999999999999999954 346999999999999999999999998 99999999999999999999999999
Q ss_pred ceeeCCCCCCcccccccccCCcCChhhhcC------CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhh
Q 005871 501 ARIFGGNQNQANTNIIAGTYGYMAPEYAMG------GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKL 574 (672)
Q Consensus 501 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 574 (672)
++.+..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... .......
T Consensus 157 a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~------~~~~~~i 227 (277)
T d1phka_ 157 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------MLMLRMI 227 (277)
T ss_dssp CEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHH
T ss_pred eeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH------HHHHHHH
Confidence 998754322 234679999999999853 3468999999999999999999999853321 1111111
Q ss_pred ccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 575 WCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 575 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
... .. +...+ ........+.+|+.+||+.||++|||++||++.
T Consensus 228 ~~~-~~-~~~~~-----~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 228 MSG-NY-QFGSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHT-CC-CCCTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HhC-CC-CCCCc-----ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111 11 00000 011122457788889999999999999999753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-46 Score=379.91 Aligned_cols=255 Identities=29% Similarity=0.404 Sum_probs=194.8
Q ss_pred cCCccccccccCCceeEEeeeecC--C--ceeEEEEeccc---CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLAD--G--KAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 424 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 424 (672)
++|++.+.||+|+||+||+|++.. + ..||||++.+. ..+..+.|.+|+.+|++++||||+++++++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 579999999999999999998642 2 37899988654 33446789999999999999999999999976 4678
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceee
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 504 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~ 504 (672)
+||||++++++.+.+... ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+
T Consensus 87 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 999999999999887543 345999999999999999999999997 999999999999999999999999999987
Q ss_pred CCCCCCc-ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccchhhhhhhhccCCCccc
Q 005871 505 GGNQNQA-NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTYTWKLWCEGPAVE 582 (672)
Q Consensus 505 ~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (672)
....... ......|+..|+|||.+.+..++.++||||||+++|||+| |+.||.... ...........+....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~------~~~~~~~i~~~~~~~~ 235 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN------GSQILHKIDKEGERLP 235 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHHHTSCCCCC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC------HHHHHHHHHhCCCCCC
Confidence 5543322 2234567889999999999999999999999999999998 899974221 1122222222221111
Q ss_pred ccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 583 LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 583 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
. .... ...+.+|+.+||+.||++|||++||++.|..
T Consensus 236 ~-----~~~~----~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 236 R-----PEDC----PQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp C-----CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C-----cccc----cHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1 1112 2347788889999999999999999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.5e-45 Score=391.15 Aligned_cols=249 Identities=27% Similarity=0.308 Sum_probs=197.6
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHH---HHHHHHhccCCCeeeEEEEEEeCceEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKN---EVNLIAKLQHKNLVRLLGCCLEGQELL 424 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---E~~il~~l~h~niv~l~~~~~~~~~~~ 424 (672)
++|++.+.||+|+||.||+|++. +|+.||||++.+.. ......+.+ |+.+++.++||||+++++++.+.+.++
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 68999999999999999999976 68999999986432 122233444 466777778999999999999999999
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceee
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 504 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~ 504 (672)
+||||+++|+|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++.+
T Consensus 84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 99999999999999854 346899999999999999999999998 999999999999999999999999999976
Q ss_pred CCCCCCcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccc
Q 005871 505 GGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVEL 583 (672)
Q Consensus 505 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 583 (672)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ........... . .
T Consensus 158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~~~~~~~~-~-~-- 226 (364)
T d1omwa3 158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEIDRMTLTM-A-V-- 226 (364)
T ss_dssp SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC---HHHHHHHSSSC-C-C--
T ss_pred CCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhcccC-C-C--
Confidence 5432 234579999999999975 468999999999999999999999986432221 11111111110 0 0
Q ss_pred cChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 005871 584 IDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPT-----MSSVVVM 624 (672)
Q Consensus 584 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 624 (672)
...... ...+.+|+.+||+.||++||| ++|+++.
T Consensus 227 ---~~~~~~----s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 227 ---ELPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp ---CCCSSS----CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ---CCCCCC----CHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 011112 234678888999999999999 6888764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=380.78 Aligned_cols=263 Identities=23% Similarity=0.327 Sum_probs=199.0
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
++|+++++||+|+||+||+|++. +|+.||||++.... ....+.+.+|+++|++++||||+++++++.++..+++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 58999999999999999999974 68999999996543 2345788999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
|+.++.+..... .....+++..+..++.||+.||.|||++| ||||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 998765554332 23456999999999999999999999998 9999999999999999999999999998764333
Q ss_pred CCcccccccccCCcCChhhhcCCC-CChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhc-c--CCCccc--
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLW-C--EGPAVE-- 582 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~-~--~~~~~~-- 582 (672)
. ......||+.|+|||.+.... ++.++|||||||++|+|++|+.||....... ......... . +.....
T Consensus 157 ~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 157 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID---QLFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp B--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGG
T ss_pred c--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH---HHHHHHHhcCCCchhhccccc
Confidence 2 233457999999999987765 5899999999999999999999985432111 000000000 0 000000
Q ss_pred -------ccChhhcCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 583 -------LIDPVLKQS---CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 583 -------l~d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
......... ........+.+|+.+||+.||++|||++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000000000 001112457788889999999999999999986
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=384.21 Aligned_cols=252 Identities=19% Similarity=0.263 Sum_probs=204.3
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
.++|++.+.||+|+||+||+|.+. +++.||||++.....+ ...+.+|+++|+.++||||+++++++.+++.++|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 468999999999999999999986 6889999999765433 45688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC--CCeEEEeecCceeeCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD--MNPKISDFGLARIFGGN 507 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~--~~~kL~DFgla~~~~~~ 507 (672)
|+||+|.+++.. ....+++.++..|+.||+.||.|||++| |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999998843 2346999999999999999999999998 9999999999999854 57999999999876432
Q ss_pred CCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChh
Q 005871 508 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPV 587 (672)
Q Consensus 508 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 587 (672)
. ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||..... ........... . .++..
T Consensus 158 ~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~------~~~~~~i~~~~-~--~~~~~ 225 (321)
T d1tkia_ 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN------QQIIENIMNAE-Y--TFDEE 225 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTC-C--CCCHH
T ss_pred C---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC-C--CCChh
Confidence 2 23345789999999999999999999999999999999999999854321 11111111110 0 01111
Q ss_pred hcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 588 LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 588 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
..... ...+.+|+.+||+.||++|||++|++++
T Consensus 226 ~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 226 AFKEI----SIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hccCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11112 2346788889999999999999999984
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-46 Score=386.88 Aligned_cols=259 Identities=30% Similarity=0.416 Sum_probs=208.4
Q ss_pred cCCccccccccCCceeEEeeee------cCCceeEEEEecccC-cccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQEL 423 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~ 423 (672)
++|++.++||+|+||.||+|++ .+++.||||++.... ......+.+|+.+++++ +|||||++++++.+.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 6899999999999999999975 246789999997654 34456789999999999 699999999999999999
Q ss_pred EEEEeecCCCChhHHhhhcc---------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc
Q 005871 424 LLIYEYMPNKSLDVHLFDAT---------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD 488 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~ 488 (672)
++||||+++|+|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccccc
Confidence 99999999999999986532 2235899999999999999999999998 99999999999999
Q ss_pred CCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchh
Q 005871 489 DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLL 568 (672)
Q Consensus 489 ~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~ 568 (672)
.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+|++.|+....... ..
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-~~-- 256 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-SK-- 256 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-HH--
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH-HH--
Confidence 999999999999998765555455556789999999999999999999999999999999999554432111111 11
Q ss_pred hhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 569 TYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 569 ~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
.+.....+.. ...+......+.+|+.+||+.||++|||+++|+++|.+
T Consensus 257 --~~~~i~~~~~---------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 257 --FYKMIKEGFR---------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp --HHHHHHHTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --HHHHHhcCCC---------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1111111110 01111123457788889999999999999999999975
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-46 Score=385.40 Aligned_cols=258 Identities=31% Similarity=0.426 Sum_probs=206.3
Q ss_pred cCCccccccccCCceeEEeeeecC--------CceeEEEEecccCc-ccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCc
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLAD--------GKAIAVKRLSRTSG-QGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ 421 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~ 421 (672)
++|++.+.||+|+||.||+|+... +..||||++.+... .....+.+|...+.++ +||||+++++++.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 689999999999999999998532 34799999976543 4457889999999998 8999999999999999
Q ss_pred eEEEEEeecCCCChhHHhhhcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc
Q 005871 422 ELLLIYEYMPNKSLDVHLFDAT-------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD 488 (672)
Q Consensus 422 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~ 488 (672)
..++||||+++|+|.+++.... ....+++.+++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeec
Confidence 9999999999999999996432 1245899999999999999999999998 99999999999999
Q ss_pred CCCCeEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHc-CCCCCCCCCcccccch
Q 005871 489 DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTL 567 (672)
Q Consensus 489 ~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~ 567 (672)
.++.+||+|||+++...............|++.|+|||.+.++.+++++||||||+++|||++ |++||.....
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~------ 243 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------ 243 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH------
Confidence 999999999999998766555555556789999999999999999999999999999999998 6777643221
Q ss_pred hhhhhhhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 568 LTYTWKLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 568 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
......+..+..... .... ...+.+|+.+||+.||++|||+.||++.|+..
T Consensus 244 -~~~~~~i~~~~~~~~-----p~~~----~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 244 -EELFKLLKEGHRMDK-----PSNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp -HHHHHHHHTTCCCCC-----CSSC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHHHHHcCCCCCC-----Cccc----hHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 112222222221111 1112 23577888999999999999999999999764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=387.06 Aligned_cols=247 Identities=25% Similarity=0.357 Sum_probs=201.0
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC---cccHHHHHHHHHHHH-hccCCCeeeEEEEEEeCceEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIA-KLQHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~-~l~h~niv~l~~~~~~~~~~~lV 426 (672)
++|++.+.||+|+||+||+|++. +++.||||++.+.. ....+.+..|..++. .++||||+++++++.+++.++||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999986 68999999997532 344566777777765 68999999999999999999999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCC
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 506 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 506 (672)
|||+++|+|..++.. ...+++.++..++.||+.||.|||+++ |+||||||+|||+++++++||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999854 345899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccCh
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDP 586 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 586 (672)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......... +..
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~-~~~------ 220 (320)
T d1xjda_ 156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE------EELFHSIRM-DNP------ 220 (320)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH-CCC------
T ss_pred cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHHc-CCC------
Confidence 32 223346799999999999999999999999999999999999999853221 111111111 111
Q ss_pred hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 005871 587 VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMS-SVVV 623 (672)
Q Consensus 587 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~ 623 (672)
...... ...+.+|+.+||+.||++|||+. +|++
T Consensus 221 ~~p~~~----s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 FYPRWL----EKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCCTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCccC----CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 111112 23467888899999999999995 7764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-46 Score=386.80 Aligned_cols=255 Identities=29% Similarity=0.420 Sum_probs=200.2
Q ss_pred cCCccccccccCCceeEEeeeecC-Cc--eeEEEEeccc-CcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEeCceEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLAD-GK--AIAVKRLSRT-SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lV 426 (672)
++|++.++||+|+||+||+|++++ +. .||||++... ..+..+.+.+|+++|+++ +||||+++++++.+++.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 689999999999999999999864 44 5788887644 344566899999999999 799999999999999999999
Q ss_pred EeecCCCChhHHhhhc-------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCe
Q 005871 427 YEYMPNKSLDVHLFDA-------------TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP 493 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~ 493 (672)
|||+++|+|.+++... .....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998643 23456999999999999999999999997 9999999999999999999
Q ss_pred EEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCC-CCCCCCcccccchhhhhh
Q 005871 494 KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRK-NNGFYFSEHGQTLLTYTW 572 (672)
Q Consensus 494 kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~-p~~~~~~~~~~~~~~~~~ 572 (672)
||+|||+++...... ......||..|+|||.+.++.++.++|||||||++|||++|.. ||.... ...+...+
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~---~~~~~~~i- 239 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYEKL- 239 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHG-
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC---HHHHHHHH-
Confidence 999999998643222 1223468999999999999999999999999999999999765 443221 11111111
Q ss_pred hhccCCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 573 KLWCEGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 573 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
..+.... .+......+.+|+.+||+.||++|||++||++.|+..
T Consensus 240 ---~~~~~~~---------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 240 ---PQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp ---GGTCCCC---------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HhcCCCC---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111111 1111234577888899999999999999999998764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-45 Score=383.08 Aligned_cols=253 Identities=21% Similarity=0.227 Sum_probs=196.7
Q ss_pred hcCCcccc-ccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhc-cCCCeeeEEEEEEe----CceE
Q 005871 351 TNHFSDEN-KLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLE----GQEL 423 (672)
Q Consensus 351 ~~~~~~~~-~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~----~~~~ 423 (672)
.++|.+.+ .||+|+||.||+|++. +++.||||++... ..+.+|+.++.++ +||||+++++++.+ ...+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 36798875 5999999999999974 6899999998642 4577899987655 89999999999875 4679
Q ss_pred EEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---CCCeEEEeecC
Q 005871 424 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFGL 500 (672)
Q Consensus 424 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~---~~~~kL~DFgl 500 (672)
+||||||+||+|.+++... ....+++.+++.|+.||+.||.|||++| |+||||||+|||++. ++.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 9999999999999999642 2346999999999999999999999998 999999999999985 56799999999
Q ss_pred ceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCc
Q 005871 501 ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPA 580 (672)
Q Consensus 501 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (672)
++....... .....||+.|+|||++.+..|+.++|||||||++|+|+||+.||........ ..........+..
T Consensus 161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---~~~~~~~i~~~~~ 234 (335)
T d2ozaa1 161 AKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKTRIRMGQY 234 (335)
T ss_dssp CEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSS
T ss_pred eeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH---HHHHHHHHhcCCC
Confidence 997654332 2345799999999999999999999999999999999999999853221110 0000000000000
Q ss_pred ccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 581 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 581 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.... .........+.+|+.+||+.||++|||+.|+++.
T Consensus 235 -~~~~-----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 235 -EFPN-----PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -SCCT-----THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -CCCC-----cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0000 0011223457888899999999999999999984
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=381.17 Aligned_cols=267 Identities=24% Similarity=0.300 Sum_probs=197.8
Q ss_pred cCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCc----eEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ----ELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~----~~~lV~ 427 (672)
++|.+.++||+|+||+||+|++ +|+.||||++...... ......|+..+.+++||||+++++++.+.+ .+++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4678889999999999999997 5889999998654321 122334555556789999999999998653 689999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeecCCCCCcEEEcCCCCeEEEeecCce
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS-----RLKIIHRDLKASNILLDDDMNPKISDFGLAR 502 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g-----~~~iiHrDlkp~NIll~~~~~~kL~DFgla~ 502 (672)
||+++|+|..++.. ..+++..+..++.|++.||.|||+.+ ..+|+||||||+||||+.++++||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999954 35899999999999999999999741 1359999999999999999999999999999
Q ss_pred eeCCCCCCc--ccccccccCCcCChhhhcCCC------CChhhHHHHHHHHHHHHHcCCCCCCCCCcccccc--------
Q 005871 503 IFGGNQNQA--NTNIIAGTYGYMAPEYAMGGI------FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQT-------- 566 (672)
Q Consensus 503 ~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~------~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~-------- 566 (672)
......... ......||+.|+|||++.+.. ++.++|||||||++|||+||..|++.........
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 875543222 233467999999999987643 5789999999999999999998875322111100
Q ss_pred hhhhhhhhccCCCcccccChhhcCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 567 LLTYTWKLWCEGPAVELIDPVLKQS-CAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 567 ~~~~~~~~~~~~~~~~l~d~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
...........+. .++.+... ...+....+.+|+.+||+.||++|||+.||+++|+..
T Consensus 237 ~~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 237 SVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CHHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 0001111111111 11111111 1223456688999999999999999999999999753
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.3e-45 Score=375.45 Aligned_cols=261 Identities=24% Similarity=0.342 Sum_probs=199.7
Q ss_pred cCCccccccccCCceeEEeeeecCCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEee
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 429 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~Ey 429 (672)
++|+++++||+|+||+||+|++++|+.||||++.... ....+.+.+|+.+|++++||||+++++++.+++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999999899999999997643 33457899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCC
Q 005871 430 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 509 (672)
Q Consensus 430 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 509 (672)
+.++.+..+. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||.+........
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9988777665 33456999999999999999999999997 99999999999999999999999999987654332
Q ss_pred CcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCC----------
Q 005871 510 QANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG---------- 578 (672)
Q Consensus 510 ~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 578 (672)
......|++.|+|||.+.+. .++.++|||||||++|||++|+.||....... ............
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGG
T ss_pred --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH---HHHHHHHhhCCCChhhccchhh
Confidence 22334689999999998765 56999999999999999999999985432111 111111000000
Q ss_pred --Cccc---ccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 579 --PAVE---LIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 579 --~~~~---l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
.... ..++.............+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 00000000011112245778888999999999999999985
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=383.68 Aligned_cols=258 Identities=27% Similarity=0.409 Sum_probs=209.5
Q ss_pred cCCccccccccCCceeEEeeeec------CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 424 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 424 (672)
++|.+.++||+|+||.||+|.+. +++.||||++.... ......|.+|+.++++++||||+++++++..++..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 68899999999999999999863 35789999997543 344557899999999999999999999999999999
Q ss_pred EEEeecCCCChhHHhhhcc-------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEe
Q 005871 425 LIYEYMPNKSLDVHLFDAT-------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISD 497 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~D 497 (672)
+||||+++|+|..++.... ....+++..+..++.|+++||.|||+++ |+||||||+||||+.++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEee
Confidence 9999999999999886432 2234789999999999999999999997 99999999999999999999999
Q ss_pred ecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCC-CCCCCCCcccccchhhhhhhhcc
Q 005871 498 FGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR-KNNGFYFSEHGQTLLTYTWKLWC 576 (672)
Q Consensus 498 Fgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~-~p~~~~~~~~~~~~~~~~~~~~~ 576 (672)
||+++.+.............||+.|+|||.+.++.++.++||||||+++|||+||. +|+.... .........
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~------~~~~~~~i~- 249 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------NEQVLRFVM- 249 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------HHHHHHHHH-
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC------HHHHHHHHH-
Confidence 99998776555444455567899999999999999999999999999999999985 5543221 111111111
Q ss_pred CCCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 577 EGPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 577 ~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
.+..... .... ...+.+|+.+||+.||++|||+++|+++|...
T Consensus 250 ~~~~~~~-----p~~~----~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 250 EGGLLDK-----PDNC----PDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp TTCCCCC-----CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred hCCCCCC-----cccc----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 1111111 1112 24578888899999999999999999999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=378.14 Aligned_cols=252 Identities=28% Similarity=0.406 Sum_probs=199.6
Q ss_pred ccccccCCceeEEeeeecCC----ceeEEEEeccc-CcccHHHHHHHHHHHHhccCCCeeeEEEEEEe-CceEEEEEeec
Q 005871 357 ENKLGQGGFGPVYKGTLADG----KAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE-GQELLLIYEYM 430 (672)
Q Consensus 357 ~~~LG~G~fg~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~-~~~~~lV~Ey~ 430 (672)
.++||+|+||+||+|++.++ ..||||++.+. .....+.|.+|+++|++++||||+++++++.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 56899999999999987532 35899999753 44556789999999999999999999999876 46899999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCCCC
Q 005871 431 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 510 (672)
Q Consensus 431 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 510 (672)
++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999998854 3445788899999999999999999997 999999999999999999999999999976544322
Q ss_pred c--ccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCcccccChhh
Q 005871 511 A--NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPAVELIDPVL 588 (672)
Q Consensus 511 ~--~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 588 (672)
. ......||+.|+|||.+.++.++.++||||||+++|||++|+.||....... ....... .+.... .
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i~----~g~~~~--~--- 255 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLL----QGRRLL--Q--- 255 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHH----TTCCCC--C---
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHHH----cCCCCC--C---
Confidence 2 2223568999999999999999999999999999999999888864322111 1111111 111110 0
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 589 KQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 589 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
... ....+.+|+.+||+.||++|||+.||++.|++.
T Consensus 256 p~~----~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 256 PEY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp CTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccc----CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111 123577888899999999999999999999875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-44 Score=372.40 Aligned_cols=264 Identities=23% Similarity=0.311 Sum_probs=195.7
Q ss_pred hcCCccccccccCCceeEEeeeec-C-CceeEEEEecccC--cccHHHHHHHHHHHHhc---cCCCeeeEEEEEEe----
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-D-GKAIAVKRLSRTS--GQGLQEFKNEVNLIAKL---QHKNLVRLLGCCLE---- 419 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~-~~~vavK~~~~~~--~~~~~~~~~E~~il~~l---~h~niv~l~~~~~~---- 419 (672)
.++|+++++||+|+||+||+|++. + ++.||||++.... ......+.+|+.+|+.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999974 4 5679999986542 22234566788777766 79999999999863
Q ss_pred -CceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEee
Q 005871 420 -GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDF 498 (672)
Q Consensus 420 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DF 498 (672)
....+++|||+.++.+..... .....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 347899999999987764442 34456899999999999999999999998 999999999999999999999999
Q ss_pred cCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhh-----
Q 005871 499 GLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWK----- 573 (672)
Q Consensus 499 gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~----- 573 (672)
|+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||........ +......
T Consensus 161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~~~~ 235 (305)
T d1blxa_ 161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LGKILDVIGLPG 235 (305)
T ss_dssp CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCC
T ss_pred hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH--HHHHHHhhCCCc
Confidence 998864322 233456899999999999999999999999999999999999999864322110 0000000
Q ss_pred --hccCCCc--ccccCh---hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 574 --LWCEGPA--VELIDP---VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 574 --~~~~~~~--~~l~d~---~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.|..... ...... .............+.+|+.+||+.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000 000000 00000111122356778889999999999999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=370.32 Aligned_cols=241 Identities=24% Similarity=0.352 Sum_probs=194.3
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCc------ccHHHHHHHHHHHHhcc--CCCeeeEEEEEEeCc
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG------QGLQEFKNEVNLIAKLQ--HKNLVRLLGCCLEGQ 421 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~il~~l~--h~niv~l~~~~~~~~ 421 (672)
.++|++.+.||+|+||+||+|++. +|+.||||++.+... .....+.+|+.+|++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 368999999999999999999975 689999999875421 11234678999999997 899999999999999
Q ss_pred eEEEEEeecCC-CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-CCCeEEEeec
Q 005871 422 ELLLIYEYMPN-KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFG 499 (672)
Q Consensus 422 ~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~-~~~~kL~DFg 499 (672)
..++||||+.+ +++.+++.. ...+++.+++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999986 566666633 346999999999999999999999998 999999999999985 4789999999
Q ss_pred CceeeCCCCCCcccccccccCCcCChhhhcCCCC-ChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCC
Q 005871 500 LARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 578 (672)
Q Consensus 500 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 578 (672)
+++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .+ .. .
T Consensus 157 ~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i---~~----~- 219 (273)
T d1xwsa_ 157 SGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EI---IR----G- 219 (273)
T ss_dssp TCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH---HH----C-
T ss_pred cceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HH---hh----c-
Confidence 998754322 234679999999999987765 678999999999999999999985321 00 00 0
Q ss_pred CcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 579 PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 579 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
. .......+ ..+.+|+.+||+.||++|||++|+++.
T Consensus 220 ~------~~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 220 Q------VFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp C------CCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred c------cCCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0 00111222 346778889999999999999999864
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-43 Score=367.98 Aligned_cols=272 Identities=22% Similarity=0.303 Sum_probs=198.4
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEe--------
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE-------- 419 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~-------- 419 (672)
.++|+++++||+|+||+||+|++. +|+.||||++... .......+.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 368999999999999999999975 7999999998654 23345778999999999999999999999865
Q ss_pred CceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeec
Q 005871 420 GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 499 (672)
Q Consensus 420 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFg 499 (672)
....++||||+.++.+.... .....+++..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 34689999999988776554 33456899999999999999999999998 9999999999999999999999999
Q ss_pred CceeeCCCCCC--cccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhcc
Q 005871 500 LARIFGGNQNQ--ANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWC 576 (672)
Q Consensus 500 la~~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 576 (672)
+++.+...... ......+||+.|+|||++.+. .+++++|||||||++|||++|+.||....................
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99876543322 222335799999999998765 689999999999999999999999854322111111100000000
Q ss_pred CC--------CcccccChhhcCCCCH-HH------HHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 005871 577 EG--------PAVELIDPVLKQSCAP-DE------LLKFIHIGLLCVQQDPADRPTMSSVVVMLASD 628 (672)
Q Consensus 577 ~~--------~~~~l~d~~l~~~~~~-~~------~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 628 (672)
.. ...+.+.......... +. ...+++|+.+||+.||++|||++|+++.=-..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~ 309 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 309 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGS
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhc
Confidence 00 0000000000000011 11 22466889999999999999999999764433
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-43 Score=373.16 Aligned_cols=260 Identities=23% Similarity=0.305 Sum_probs=195.5
Q ss_pred CCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCCeeeEEEEEEeC------ceEEE
Q 005871 353 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------QELLL 425 (672)
Q Consensus 353 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~------~~~~l 425 (672)
+|...++||+|+||+||+|++. +|+.||||++...... +.+|+.+|++++||||+++++++... ..++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 6888999999999999999986 6899999999765432 34799999999999999999998643 35899
Q ss_pred EEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-CeEEEeecCceee
Q 005871 426 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIF 504 (672)
Q Consensus 426 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~-~~kL~DFgla~~~ 504 (672)
||||++++.+............+++.+++.|+.||+.||+|||++| |+||||||+|||++.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987765555443445567999999999999999999999997 99999999999999775 8999999999876
Q ss_pred CCCCCCcccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhh----------hhh
Q 005871 505 GGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTY----------TWK 573 (672)
Q Consensus 505 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~----------~~~ 573 (672)
..... .....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||....... .+... .+.
T Consensus 174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHHCCCCHHHHH
T ss_pred cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH--HHHHHHHHhCCChHHhhh
Confidence 54332 223579999999998875 468999999999999999999999985432211 11110 011
Q ss_pred hccC----CCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 574 LWCE----GPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 574 ~~~~----~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.... ................+.....+.+|+.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1110 01111100000001111223357788889999999999999999964
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-42 Score=366.62 Aligned_cols=260 Identities=23% Similarity=0.308 Sum_probs=191.3
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEeccc--CcccHHHHHHHHHHHHhccCCCeeeEEEEEEeCc------
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------ 421 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~------ 421 (672)
.++|+++++||+|+||+||+|.+. +|+.||||++.+. .....+.+.+|+.+|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999975 6999999999754 3344567899999999999999999999998654
Q ss_pred eEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCc
Q 005871 422 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 501 (672)
Q Consensus 422 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla 501 (672)
.+++||||+ +.+|..++. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 579999999 556666653 345999999999999999999999998 999999999999999999999999999
Q ss_pred eeeCCCCCCcccccccccCCcCChhhhcCC-CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhh--------hh
Q 005871 502 RIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTY--------TW 572 (672)
Q Consensus 502 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~--------~~ 572 (672)
+...... ....||+.|+|||++.+. .++.++||||+||++|+|++|+.||.............. .+
T Consensus 169 ~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 169 RQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp EECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred eccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 8764322 345789999999998764 569999999999999999999999854321111000000 00
Q ss_pred hhccCC-------CcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 573 KLWCEG-------PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 573 ~~~~~~-------~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
...... ...+.....+. .........+.+|+.+||+.||++|||++|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000 00000000000 0001112346788889999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-42 Score=358.99 Aligned_cols=260 Identities=22% Similarity=0.273 Sum_probs=195.8
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccCCC-eeeEEEEEEeCceEEEEEe
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN-LVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n-iv~l~~~~~~~~~~~lV~E 428 (672)
.++|++.++||+|+||.||+|++. +|+.||||++...... ..+..|+++++.++|+| |+.+.+++.+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 367999999999999999999975 6899999988765432 45788999999998766 5556666778889999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---CCCeEEEeecCceeeC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFGLARIFG 505 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~---~~~~kL~DFgla~~~~ 505 (672)
|+.+ ++...+.. ....+++..+..++.|++.||+|||++| |+||||||+|||++. +..+||+|||+++.+.
T Consensus 84 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 84 LLGP-SLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp CCCC-BHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EcCC-chhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 9954 55544432 3346999999999999999999999998 999999999999863 5579999999999876
Q ss_pred CCCCC-----cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCc
Q 005871 506 GNQNQ-----ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPA 580 (672)
Q Consensus 506 ~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (672)
..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........................
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence 54322 1234568999999999999999999999999999999999999998654332222111111110000000
Q ss_pred ccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 581 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 581 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
+.+....+ ..+.+++..||+.+|++||+++++.+.|+.
T Consensus 238 -----~~~~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 238 -----EVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp -----HHHTTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred -----hHhccCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 11111222 346777889999999999999999888764
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-43 Score=370.56 Aligned_cols=260 Identities=20% Similarity=0.254 Sum_probs=195.3
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC-cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCc----eEE
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ----ELL 424 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~----~~~ 424 (672)
+++|+++++||+|+||+||+|++. +|+.||||++.+.. ....+.+.+|+.+|+.++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 468999999999999999999874 79999999997644 344567899999999999999999999997643 234
Q ss_pred EEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceee
Q 005871 425 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 504 (672)
Q Consensus 425 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~ 504 (672)
++++|+.+++|.+++.. ..+++..+..++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 55566779999999843 35999999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCC-cccccccccCCcCChhhhcC-CCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCC----
Q 005871 505 GGNQNQ-ANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG---- 578 (672)
Q Consensus 505 ~~~~~~-~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---- 578 (672)
...... ......+||+.|+|||++.. ..++.++||||+||++|+|++|+.||......... ..........
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL---NHILGILGSPSQED 236 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCHHH
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH---HHHhhhccCCChhh
Confidence 543222 22344679999999999855 46799999999999999999999998543221110 0000000000
Q ss_pred -----------------CcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 579 -----------------PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 579 -----------------~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
......-..+.... ..++.+|+.+||+.||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNA----DSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000000111 1357788999999999999999999975
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-42 Score=355.31 Aligned_cols=263 Identities=21% Similarity=0.288 Sum_probs=202.3
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeCceEEEEEe
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lV~E 428 (672)
++|+++++||+|+||+||+|++. +++.||||+++... ......+.+|+.+|+.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999975 68899999986543 3446788999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCceeeCCCC
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 508 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 508 (672)
++.++++..++. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999887774 3456899999999999999999999997 9999999999999999999999999999875433
Q ss_pred CCcccccccccCCcCChhhhcCCC-CChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccC---CCc----
Q 005871 509 NQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCE---GPA---- 580 (672)
Q Consensus 509 ~~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~---- 580 (672)
.. .....+++.|+|||++.+.. ++.++|||||||++|||++|+.||....... ............ ...
T Consensus 156 ~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 156 RC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp SC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGG
T ss_pred cc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCCChhhhhhhh
Confidence 22 22345788899999987665 6999999999999999999999963221111 111111111000 000
Q ss_pred -------ccccChh-hcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 581 -------VELIDPV-LKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 581 -------~~l~d~~-l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
....... ............+.+|+.+||+.||.+|||++||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000 0001111223457788889999999999999999864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.1e-42 Score=360.46 Aligned_cols=257 Identities=18% Similarity=0.269 Sum_probs=195.6
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeC--ceEEEEE
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEG--QELLLIY 427 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~--~~~~lV~ 427 (672)
++|+++++||+|+||+||+|++. +|+.||||++.... .+.+.+|+.+|++++ ||||+++++++... ..+++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 58999999999999999999975 68999999987543 467889999999995 99999999999843 5699999
Q ss_pred eecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-CeEEEeecCceeeCC
Q 005871 428 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIFGG 506 (672)
Q Consensus 428 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~-~~kL~DFgla~~~~~ 506 (672)
||+.+++|.... ..+++..+..++.||+.||.|||++| |+||||||+||||+.++ .+||+|||+++....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999987653 35899999999999999999999998 99999999999998665 589999999987654
Q ss_pred CCCCcccccccccCCcCChhhhcCCC-CChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchh--h-------hhh-hhc
Q 005871 507 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLL--T-------YTW-KLW 575 (672)
Q Consensus 507 ~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~--~-------~~~-~~~ 575 (672)
... .....||+.|+|||.+.+.. ++.++||||+||++|||++|+.||............ . ..+ ...
T Consensus 183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 183 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 332 23457899999999987754 799999999999999999999998543321110000 0 000 000
Q ss_pred cCCC-----------cccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005871 576 CEGP-----------AVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVV 623 (672)
Q Consensus 576 ~~~~-----------~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 623 (672)
.... ....................+.+|+.+||+.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 00000000011111112245778889999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.1e-42 Score=354.56 Aligned_cols=260 Identities=17% Similarity=0.229 Sum_probs=203.6
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhccC-CCeeeEEEEEEeCceEEEEEe
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH-KNLVRLLGCCLEGQELLLIYE 428 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h-~niv~l~~~~~~~~~~~lV~E 428 (672)
.++|++.++||+|+||+||+|++. +|+.||||++..... ...+.+|+++++.++| +|++.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999975 689999998865432 2456789999999976 899999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-----CCCeEEEeecCcee
Q 005871 429 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-----DMNPKISDFGLARI 503 (672)
Q Consensus 429 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~-----~~~~kL~DFgla~~ 503 (672)
|+ +++|.+++... ...+++.++..++.|++.||.|||++| |+||||||+|||++. ++.+||+|||+++.
T Consensus 82 ~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 98 68888887543 346899999999999999999999998 999999999999974 57899999999998
Q ss_pred eCCCCCC-----cccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCC
Q 005871 504 FGGNQNQ-----ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEG 578 (672)
Q Consensus 504 ~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 578 (672)
+...... .......||+.|||||++.+..++.++||||||+++|||++|+.||......................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 7543222 12344689999999999999999999999999999999999999986443332222111111111011
Q ss_pred CcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 005871 579 PAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVMLAS 627 (672)
Q Consensus 579 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 627 (672)
... .+....+ .++.+++..|++.+|++||+.+.+.+.|..
T Consensus 236 ~~~-----~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 236 PLR-----ELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp CHH-----HHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred ChH-----HhcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 111 1112222 346677779999999999999988887754
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-42 Score=359.16 Aligned_cols=268 Identities=24% Similarity=0.338 Sum_probs=206.5
Q ss_pred cCCccccccccCCceeEEeeeec----CCceeEEEEecccC----cccHHHHHHHHHHHHhccC-CCeeeEEEEEEeCce
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQH-KNLVRLLGCCLEGQE 422 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~h-~niv~l~~~~~~~~~ 422 (672)
++|++.+.||+|+||+||+|+.. +|+.||||++.+.. ....+.+.+|+++|++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999752 47899999986542 2345678899999999977 899999999999999
Q ss_pred EEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCce
Q 005871 423 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 502 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~ 502 (672)
.++||||+.+++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 99999999999999998543 35788999999999999999999997 9999999999999999999999999998
Q ss_pred eeCCCCCCcccccccccCCcCChhhhcCC--CCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhhhhhccCCCc
Q 005871 503 IFGGNQNQANTNIIAGTYGYMAPEYAMGG--IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYTWKLWCEGPA 580 (672)
Q Consensus 503 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (672)
.+...... ......|++.|++||.+.+. .++.++|||||||++|||++|+.||......... .......+.. ..
T Consensus 178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~--~~i~~~~~~~-~~ 253 (322)
T d1vzoa_ 178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKS-EP 253 (322)
T ss_dssp ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHC-CC
T ss_pred hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhcccC-CC
Confidence 76543322 22345799999999999765 4688999999999999999999998544322211 1111111111 00
Q ss_pred ccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH--hccC------CCCCCCCCCCc
Q 005871 581 VELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRP-----TMSSVVVM--LASD------SMTIPQPTEPA 639 (672)
Q Consensus 581 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~--L~~~------~~~l~~p~~p~ 639 (672)
..+......+.+++.+||+.||++|| |++|+++. +... ...+++|-.|.
T Consensus 254 ----------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p~ 315 (322)
T d1vzoa_ 254 ----------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPV 315 (322)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred ----------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCCC
Confidence 01112234577788899999999999 58899863 3221 23456666554
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-41 Score=357.05 Aligned_cols=261 Identities=25% Similarity=0.262 Sum_probs=190.6
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEe------Cce
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE------GQE 422 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~------~~~ 422 (672)
++|+++++||+|+||+||+|++. +|+.||||++.+.. ......+.+|+.+|++++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 68999999999999999999976 69999999997543 3445678999999999999999999999964 368
Q ss_pred EEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCce
Q 005871 423 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 502 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~ 502 (672)
+|+||||+.++.+.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 99999999876655432 34899999999999999999999998 9999999999999999999999999988
Q ss_pred eeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhh--------hhhh-
Q 005871 503 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLT--------YTWK- 573 (672)
Q Consensus 503 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~--------~~~~- 573 (672)
...... ......||+.|+|||++.+..+++++||||+||++|+|++|+.||............. ..|.
T Consensus 168 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 654332 2334578999999999999999999999999999999999999985332111000000 0000
Q ss_pred -------hc------cCCCcccccChhhcCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 574 -------LW------CEGPAVELIDPVLKQSC---APDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 574 -------~~------~~~~~~~l~d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.. ................. .......+.+|+.+||+.||++|||++|||+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 00011111111111111 12234578899999999999999999999865
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-41 Score=359.23 Aligned_cols=261 Identities=23% Similarity=0.283 Sum_probs=193.0
Q ss_pred hcCCccccccccCCceeEEeeeec-CCceeEEEEecccC--cccHHHHHHHHHHHHhccCCCeeeEEEEEEeC-----ce
Q 005871 351 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QE 422 (672)
Q Consensus 351 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~ 422 (672)
.++|+++++||+|+||+||+|++. +|+.||||++.+.. ....+.+.+|+.+|++++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 468999999999999999999975 69999999997653 33456788999999999999999999999643 34
Q ss_pred EEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEEeecCce
Q 005871 423 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 502 (672)
Q Consensus 423 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~ 502 (672)
.+++|+|+.+++|.+++.. ..+++.++..++.||+.||+|||++| |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 5677788899999998842 35999999999999999999999998 9999999999999999999999999997
Q ss_pred eeCCCCCCcccccccccCCcCChhhhcCCC-CChhhHHHHHHHHHHHHHcCCCCCCCCCcccccchhhhh--------hh
Q 005871 503 IFGGNQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYT--------WK 573 (672)
Q Consensus 503 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~--------~~ 573 (672)
.... ......|++.|+|||++.+.. ++.++|||||||++|+|++|+.||............... +.
T Consensus 170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred ccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 5432 223457899999999877654 689999999999999999999998543211110000000 00
Q ss_pred hccC-------CCcccccChhhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005871 574 LWCE-------GPAVELIDPVLKQSCAPDELLKFIHIGLLCVQQDPADRPTMSSVVVM 624 (672)
Q Consensus 574 ~~~~-------~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 624 (672)
.... ....+.....+.. ........+.+|+.+||+.||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccchhhhhhhhhcccCCCcchhh-hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 0000 0000000000000 000112346788899999999999999999984
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.6e-37 Score=326.51 Aligned_cols=283 Identities=19% Similarity=0.228 Sum_probs=205.1
Q ss_pred cCCccccccccCCceeEEeeeec-CCceeEEEEecccCcccHHHHHHHHHHHHhcc-----------CCCeeeEEEEEEe
Q 005871 352 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-----------HKNLVRLLGCCLE 419 (672)
Q Consensus 352 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----------h~niv~l~~~~~~ 419 (672)
.+|+++++||+|+||+||+|++. +|+.||||++.+.. ...+.+.+|+.++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 46999999999999999999975 69999999997653 23467788999998886 4789999988864
Q ss_pred --CceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEEcCCCC----
Q 005871 420 --GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE-DSRLKIIHRDLKASNILLDDDMN---- 492 (672)
Q Consensus 420 --~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~g~~~iiHrDlkp~NIll~~~~~---- 492 (672)
....+++|+++..+..............+++..+..++.||+.||+|||+ .| |+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 45677888877666555454445556678999999999999999999998 65 999999999999986654
Q ss_pred --eEEEeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHHHHHHcCCCCCCCCCcccccc----
Q 005871 493 --PKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQT---- 566 (672)
Q Consensus 493 --~kL~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~p~~~~~~~~~~~---- 566 (672)
++|+|||.+...... .....||+.|+|||++.+..++.++||||+||++++|++|+.||..........
T Consensus 169 ~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 899999999865322 234579999999999999999999999999999999999999986432211111
Q ss_pred hhhhhhh-----------------hccCCCcccccCh----------hhcCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 005871 567 LLTYTWK-----------------LWCEGPAVELIDP----------VLKQSCAPDELLKFIHIGLLCVQQDPADRPTMS 619 (672)
Q Consensus 567 ~~~~~~~-----------------~~~~~~~~~l~d~----------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 619 (672)
+....+. .+........+.. .............+.+|+.+||+.||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 1100000 0000000000000 001223456677899999999999999999999
Q ss_pred HHHHH--hcc--CCCCCCCCCCCccccc
Q 005871 620 SVVVM--LAS--DSMTIPQPTEPAFSVG 643 (672)
Q Consensus 620 evl~~--L~~--~~~~l~~p~~p~~~~~ 643 (672)
|+|+. +.. .......|.+|....+
T Consensus 324 e~L~Hp~f~~~~~~~~~~~p~~~~~~~~ 351 (362)
T d1q8ya_ 324 GLVNHPWLKDTLGMEEIRVPDRELYGSG 351 (362)
T ss_dssp HHHTCGGGTTCTTCTTCCCTTSCTTCBS
T ss_pred HHhcCcccCCCCCcccCCCCCcccCCCC
Confidence 99986 331 1334566666666544
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=2.1e-23 Score=200.54 Aligned_cols=170 Identities=16% Similarity=0.133 Sum_probs=121.7
Q ss_pred CccccccccCCceeEEeeeecCCceeEEEEecccCc------------------ccHHHHHHHHHHHHhccCCCeeeEEE
Q 005871 354 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG------------------QGLQEFKNEVNLIAKLQHKNLVRLLG 415 (672)
Q Consensus 354 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~il~~l~h~niv~l~~ 415 (672)
+.+.++||+|+||+||+|++.+|+.||||+++.... ........|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 346789999999999999988899999998753211 01233467899999999999999886
Q ss_pred EEEeCceEEEEEeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 005871 416 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 495 (672)
Q Consensus 416 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g~~~iiHrDlkp~NIll~~~~~~kL 495 (672)
+.. .+++|||+++..+.. ++......++.|++.+|.|||++| |+||||||+|||+++++ ++|
T Consensus 82 ~~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~l 143 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWI 143 (191)
T ss_dssp EET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEE
T ss_pred ecC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEE
Confidence 632 379999998865432 344456789999999999999998 99999999999999764 899
Q ss_pred EeecCceeeCCCCCCcccccccccCCcCChhhhcCCCCChhhHHHHHHHHH
Q 005871 496 SDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 546 (672)
Q Consensus 496 ~DFgla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil 546 (672)
+|||++.....+........ .... -.|. ....|+.++|+||+.--+
T Consensus 144 iDFG~a~~~~~~~~~~~l~r---d~~~-~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWREILER---DVRN-IITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHHHHHHH---HHHH-HHHH-HHHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcHHHHHH---HHHH-HHHH-HcCCCCCcccHHHHHHHH
Confidence 99999986543221110000 0000 0111 235577889999975443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.57 E-value=1.3e-07 Score=92.84 Aligned_cols=147 Identities=16% Similarity=0.106 Sum_probs=103.3
Q ss_pred HHHhcCCccccccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhcc-CCCeeeEEEEEEeCceEEEE
Q 005871 348 LEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLI 426 (672)
Q Consensus 348 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lV 426 (672)
....+.|+..+..+-++.+.||+... +++.++||+...........+.+|...+..+. +--+.+++.+..+++..++|
T Consensus 10 ~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 10 KKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 34456777777655555678999864 46677889886655444456788999888874 33467788888888899999
Q ss_pred EeecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 005871 427 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS----------------------------------- 471 (672)
Q Consensus 427 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g----------------------------------- 471 (672)
|++++|.++....... .....++.++++.+..||+..
T Consensus 89 ~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 9999998876544211 112334555666666666421
Q ss_pred ---------------------CCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 472 ---------------------RLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 472 ---------------------~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
+..++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12389999999999999876677999988763
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.05 E-value=7.4e-06 Score=79.49 Aligned_cols=131 Identities=18% Similarity=0.174 Sum_probs=87.3
Q ss_pred ccccCCc-eeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCC--CeeeEEEEEEeCceEEEEEeecCCCCh
Q 005871 359 KLGQGGF-GPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHK--NLVRLLGCCLEGQELLLIYEYMPNKSL 435 (672)
Q Consensus 359 ~LG~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~--niv~l~~~~~~~~~~~lV~Ey~~~gsL 435 (672)
.+..|.. +.||+...+++..+++|....... ..+..|...++.+... .+.+++.+..+++..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4455543 679999988888899997654432 3467788888887543 356788888888889999999998765
Q ss_pred hHHhhhccccCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q 005871 436 DVHLFDATRSVQLDWKRRQSIINGIARGILYLH----------------------------------------------- 468 (672)
Q Consensus 436 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH----------------------------------------------- 468 (672)
.... .... ..+.++.+.|.-||
T Consensus 94 ~~~~--------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 3211 1110 11222333333333
Q ss_pred ----hc----CCCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 469 ----ED----SRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 469 ----~~----g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
.. .+..++|+|+.|.|||++++..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 11 123489999999999999876678999988753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.52 E-value=0.00011 Score=76.16 Aligned_cols=77 Identities=12% Similarity=0.188 Sum_probs=50.2
Q ss_pred ccccccCCceeEEeeeecC-CceeEEEEeccc-------CcccHHHHHHHHHHHHhcc-C--CCeeeEEEEEEeCceEEE
Q 005871 357 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRT-------SGQGLQEFKNEVNLIAKLQ-H--KNLVRLLGCCLEGQELLL 425 (672)
Q Consensus 357 ~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~il~~l~-h--~niv~l~~~~~~~~~~~l 425 (672)
.+.||.|....||++...+ ++.++||.-... -.....+...|.+.|+.+. + ..+++++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4578999999999998764 678899964321 1123345667888888773 2 345566654 4455689
Q ss_pred EEeecCCCCh
Q 005871 426 IYEYMPNKSL 435 (672)
Q Consensus 426 V~Ey~~~gsL 435 (672)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.08 E-value=0.00056 Score=70.67 Aligned_cols=73 Identities=15% Similarity=0.252 Sum_probs=50.4
Q ss_pred ccccccCCceeEEeeeecC--------CceeEEEEecccCcccHHHHHHHHHHHHhccCCCe-eeEEEEEEeCceEEEEE
Q 005871 357 ENKLGQGGFGPVYKGTLAD--------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIY 427 (672)
Q Consensus 357 ~~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~ni-v~l~~~~~~~~~~~lV~ 427 (672)
+++|+.|---.+|++...+ .+.|.+++.. .. .......+|..+++.+.-.++ .++++++.+ .+||
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 3578888889999998643 2456666554 22 233456789999999964454 467777643 6899
Q ss_pred eecCCCCh
Q 005871 428 EYMPNKSL 435 (672)
Q Consensus 428 Ey~~~gsL 435 (672)
||++|..+
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987554
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.06 E-value=0.0016 Score=65.27 Aligned_cols=136 Identities=15% Similarity=0.142 Sum_probs=79.2
Q ss_pred ceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCee--eEE-----EEEEeCceEEEEEeecCCCChhH
Q 005871 365 FGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV--RLL-----GCCLEGQELLLIYEYMPNKSLDV 437 (672)
Q Consensus 365 fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv--~l~-----~~~~~~~~~~lV~Ey~~~gsL~~ 437 (672)
--.||+++.++|..+++|+.+... ...+.+..|...+..|...++. ..+ ..+...+..+.+++++.|..++.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 458999999999999999876542 2346678899988888643321 111 11234567888999988744310
Q ss_pred -----------H---hhhc------cccCCCCH-------------------H---HHHHHHHHHHHHHHHH-HhcCCCC
Q 005871 438 -----------H---LFDA------TRSVQLDW-------------------K---RRQSIINGIARGILYL-HEDSRLK 474 (672)
Q Consensus 438 -----------~---l~~~------~~~~~l~~-------------------~---~~~~i~~qi~~~L~~L-H~~g~~~ 474 (672)
. ++.. ......+. . .....+.++...+.-+ .+..+..
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 0 0000 00111111 1 1122223333333222 1222346
Q ss_pred eeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 475 IIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 475 iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
+||+|+.|.|||++++ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999754 46899998864
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.55 E-value=0.0043 Score=61.36 Aligned_cols=157 Identities=11% Similarity=0.015 Sum_probs=81.1
Q ss_pred hHHHHHHhcCCcccc-----ccccCCceeEEeeeecCCceeEEEEecccCcccHHHHHHHHHHHHhccCCCe-----eeE
Q 005871 344 LRLALEATNHFSDEN-----KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL-----VRL 413 (672)
Q Consensus 344 ~~~~~~~~~~~~~~~-----~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~ni-----v~l 413 (672)
...+.....+|.+.+ .|..|---+.|+.+.++| .+++|+...... .+.+..|++++..|...++ +..
T Consensus 5 ~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi~~ 81 (316)
T d2ppqa1 5 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPLPR 81 (316)
T ss_dssp HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred HHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC--HHHHHHHHHHHHhhhhcccccccccee
Confidence 344455556676543 344666678899987655 599999865422 2345557777777754322 111
Q ss_pred ---EEEEEeCceEEEEEeecCCCChhHH--------------hhhccc------------------------cCCCCHHH
Q 005871 414 ---LGCCLEGQELLLIYEYMPNKSLDVH--------------LFDATR------------------------SVQLDWKR 452 (672)
Q Consensus 414 ---~~~~~~~~~~~lV~Ey~~~gsL~~~--------------l~~~~~------------------------~~~l~~~~ 452 (672)
..+.........++.+..+...... ++.... ........
T Consensus 82 ~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (316)
T d2ppqa1 82 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG 161 (316)
T ss_dssp TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred cCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchh
Confidence 0111224456667777665433100 000000 00000111
Q ss_pred HHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEEcCCCCeEEEeecCcee
Q 005871 453 RQSIINGIARGILYLHED-SRLKIIHRDLKASNILLDDDMNPKISDFGLARI 503 (672)
Q Consensus 453 ~~~i~~qi~~~L~~LH~~-g~~~iiHrDlkp~NIll~~~~~~kL~DFgla~~ 503 (672)
....+..+...+.-.+.. -+.++||+|+.++||+++.+...-|+||+.+..
T Consensus 162 ~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 162 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 112222233333333322 134599999999999999887778999998863
|